Citrus Sinensis ID: 005760

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------68
Protein Sequence
MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCKTSIHHISRKNAFLLGIVLPLSTVFMIVVIFLIVKCRKRERGPPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRNV
Secondary Structure (PSIPRED)
cEEEcccccEEcccccccccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccccccccEEEccccccccccccccccccccccccEEccccEEEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccccccccccccccccHHHHccccccccccccccccccHHHHHccccccccccccccccccccHHHHccccccccccccccccEEEccccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEEcccccccccHHHHHHHHHcccccccccEEEEEEcccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccccccccccccccccHHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccccccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEEcccccccccccccccHHHccccccEEEEEccccccccccHHHHHcccccccEEEcccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEccccccccccHHHccccccEEEEcccccccccccHHHcccccccHHHcccccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEccccccHHHccHHHcccccEEEcccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHHcccHccEEEcccccEEEEEEcccccEEEEEEcccccccccccHHHHHHHHHHcccHcHHHHHEEcccccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEEcccccEEEcccccHHHHHccHHHEEccccccccEEEEccccccccccHEEEEEEcccccHEHHHHHHHHHHcccccccccccccccHHHHHHHHHccccEEEccHHHcccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHccHHccc
Coil and Loop (DISEMBL)
MLQMWennfsgtiprfifnasklsilelsdnsfsgfipntfgnLRNLQALRlsnnyltssTLELSFLsslsncksltlisfsnnpldgilpktsvgnlshSLEYFEMAYCnvsggipeeignltNLTIIYLggnklngsipstLGKLQKlqglglennklegsipdsichsdelyklelggnklsgsipECFNNLASLRILLLgsneltsipltfwNLKDILYLnfssnfftgplpleignlkiaridscdlISLISLnlsnnnlsgaipasLEKLSYLKDLNLSFnklegeiprggsfgnfsaesfegnellcgspnlrvppcktsihhisRKNAFLLGIVLPLSTVFMIVVIFLIVKCrkrergppndanmppEAMQRMFSYLELCratdgfsennligrgsfgSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEymphgslekylhsSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIhcdlkpsnvllddnmvahlsdfgiaklltredqstIQTQTLATigymapeygkegrvsangdvYSFGIMLMETftrkkptdeifngeMTLKHWVndwlpistkeivdpnllsredinfvaKEQCVSFVFNVAMectvespeqrINAKEIVTKLLKIRDSLLRNV
Flexible Loop (DISEMBL)
MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCKTSIHHISRKNAFLLGIVLPLSTVFMIVVIFLIVKcrkrergppndanmppEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMEctvespeqrinakeiVTKLLKIrdsllrnv
Low Complexity Region (SEG)
MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYltsstlelsflsslsNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTlgklqklqglglENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDlislislnlsnnnlsGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCKTSIHHISRKNAFLLGIVLPLSTVFMIVVIFLIVKCRKRERGPPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRNV
Disordered region (IsUnstruct)
****WENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCKTSIHHISRKNAFLLGIVLPLSTVFMIVVIFLIVKCR*******************MFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR*******
Disordered Region (DISOPRED)
MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN********************LGIVLPLSTVFMIVVIFLIVK********************RMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED***I*TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN*
Disordered Region (DISEMBL)
MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCKTSIHHISRKNAFLLGIVLPLSTVFMIVVIFLIVKCRKRERGPPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRNV
Disordered Region (DISPRO)
MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCKTSIHHISRKNAFLLGIVLPLSTVFMIVVIFLIVKCRKRER********PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS*****
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCKTSIHHISRKNAFLLGIVLPLSTVFMIVVIFLIVKCRKRERGPPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRNV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	678	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.988	0.663	0.383	1e-123
C0LGT6	1031	LRR receptor-like serine/	no	no	0.958	0.630	0.371	1e-110
Q9SD62	1025	Putative receptor-like pr	no	no	0.995	0.658	0.361	1e-104
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.974	0.674	0.329	1e-96
Q9FL28	1173	LRR receptor-like serine/	no	no	0.974	0.563	0.332	4e-92
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.954	0.518	0.322	4e-87
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.914	0.495	0.324	5e-84
C0LGW6	966	LRR receptor-like serine/	no	no	0.949	0.666	0.335	4e-83
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.957	0.589	0.327	1e-82
Q42371	976	LRR receptor-like serine/	no	no	0.930	0.646	0.331	2e-82

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  444 bits (1142), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 284/741 (38%), Positives = 410/741 (55%), Gaps = 71/741 (9%)

Query: 4    MWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS-STL 62
            M  N F+G+IP  + N S L  L +++N+ +G IP TFGN+ NL+ L L  N L S S+ 
Sbjct: 266  MGGNYFTGSIPTTLSNISTLERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSR 324

Query: 63   ELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGN 122
            +L FL+SL+NC  L  +    N L G LP  S+ NLS  L   ++    +SG IP +IGN
Sbjct: 325  DLEFLTSLTNCTQLETLGIGRNRLGGDLP-ISIANLSAKLVTLDLGGTLISGSIPYDIGN 383

Query: 123  LTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGN 182
            L NL  + L  N L+G +P++LGKL  L+ L L +N+L G IP  I +   L  L+L  N
Sbjct: 384  LINLQKLILDQNMLSGPLPTSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNN 443

Query: 183  KLSGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGN 241
               G +P    N + L  L +G N+L  +IPL    ++ +L L+ S N   G LP +IG 
Sbjct: 444  GFEGIVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGA 503

Query: 242  LK----------------IARIDSC---------------------DLISLISLNLSNNN 264
            L+                   + +C                      L+ +  ++LSNN+
Sbjct: 504  LQNLGTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEVDLSNND 563

Query: 265  LSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLRVPP 323
            LSG+IP      S L+ LNLSFN LEG++P  G F N +  S  GN  LCG     ++ P
Sbjct: 564  LSGSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKP 623

Query: 324  CKTSI-----HHISRKNAFLLGIVLPLSTV---FMIVVIFLIVKCRKRERGPPNDANMPP 375
            C +        H SR    ++G+ + ++ +   FM  V  + ++ RK+ +   N      
Sbjct: 624  CLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTL 683

Query: 376  EAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKS 434
            E +    SY +L  AT+GFS +N++G GSFG+V+KA L  +   VA+KV N+Q     KS
Sbjct: 684  EVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKS 743

Query: 435  FDVECEMMKSIRHRNIIKVISSCSN-----EEFKALVLEYMPHGSLEKYLHSS------- 482
            F  ECE +K IRHRN++K++++CS+      EF+AL+ E+MP+GSL+ +LH         
Sbjct: 744  FMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHR 803

Query: 483  -NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 541
             +  L + +RLNI IDVAS L+YLH      + HCDLKPSNVLLDD++ AH+SDFG+A+L
Sbjct: 804  PSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARL 863

Query: 542  LTREDQSTIQTQ-----TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDE 596
            L + D+ +   Q        TIGY APEYG  G+ S NGDVYSFGI+L+E FT K+PT+E
Sbjct: 864  LLKFDEESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNE 923

Query: 597  IFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE-DINFVAKEQCVSFVFNVAMECTVESPE 655
            +F G  TL  +    LP    +IVD ++L     + F   E C++ VF V + C  ESP 
Sbjct: 924  LFGGNFTLNSYTKSALPERILDIVDESILHIGLRVGFPVVE-CLTMVFEVGLRCCEESPM 982

Query: 656  QRINAKEIVTKLLKIRDSLLR 676
             R+    +V +L+ IR+   +
Sbjct: 983  NRLATSIVVKELISIRERFFK 1003

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  400 bits (1028), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 274/737 (37%), Positives = 389/737 (52%), Gaps = 87/737 (11%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRL-SNNYLTSSTLELS 65
           N F+G IP+ + N S L   ++S N  SG IP +FG LRNL  L + +N+   +S+  L 
Sbjct: 276 NQFTGAIPKTLANISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLE 335

Query: 66  FLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTN 125
           F+ +++NC  L  +    N L G LP  S+ NLS +L    +    +SG IP +IGNL +
Sbjct: 336 FIGAVANCTQLEYLDVGYNRLGGELP-ASIANLSTTLTSLFLGQNLISGTIPHDIGNLVS 394

Query: 126 LTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLS 185
           L  + L  N L+G +P + GKL  LQ + L +N + G IP    +   L KL L  N   
Sbjct: 395 LQELSLETNMLSGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFH 454

Query: 186 GSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKI 244
           G IP+       L  L + +N L  +IP     +  + Y++ S+NF TG  P E+G L++
Sbjct: 455 GRIPQSLGRCRYLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLEL 514

Query: 245 -------------------------------------ARIDSCDLISLISLNLSNNNLSG 267
                                                A  D   L+SL +++ SNNNLSG
Sbjct: 515 LVGLGASYNKLSGKMPQAIGGCLSMEFLFMQGNSFDGAIPDISRLVSLKNVDFSNNNLSG 574

Query: 268 AIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS-PNLRVPPCKT 326
            IP  L  L  L++LNLS NK EG +P  G F N +A S  GN  +CG    +++ PC  
Sbjct: 575 RIPRYLASLPSLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIV 634

Query: 327 SIHHISRK-----NAFLLGIVLPLSTVFMIVVIFLIVKCRKRER------GPPNDANMPP 375
                 RK        + GI + ++++ +I+++  +    KR++      G P+D+    
Sbjct: 635 QASPRKRKPLSVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLG 694

Query: 376 EAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKS 434
              +++ SY EL  AT  FS  NLIG G+FG+VFK  LG +   VA+KV NL      KS
Sbjct: 695 MFHEKV-SYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKS 753

Query: 435 FDVECEMMKSIRHRNIIKVISSCSN-----EEFKALVLEYMPHGSLEKYL---------- 479
           F  ECE  K IRHRN++K+I+ CS+      +F+ALV E+MP GSL+ +L          
Sbjct: 754 FMAECETFKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVND 813

Query: 480 HSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA 539
           HS +  L   ++LNI IDVASALEYLH      V HCD+KPSN+LLDD++ AH+SDFG+A
Sbjct: 814 HSRS--LTPAEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLA 871

Query: 540 KLLTREDQSTIQTQ-----TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPT 594
           +LL + D+ +   Q        TIGY APEYG  G+ S  GDVYSFGI+L+E F+ KKPT
Sbjct: 872 QLLYKYDRESFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPT 931

Query: 595 DEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESP 654
           DE F G+  L  +        TK I+     S    N  A ++ +  V  V ++C+ E P
Sbjct: 932 DESFAGDYNLHSY--------TKSILS-GCTSSGGSN--AIDEGLRLVLQVGIKCSEEYP 980

Query: 655 EQRINAKEIVTKLLKIR 671
             R+   E V +L+ IR
Sbjct: 981 RDRMRTDEAVRELISIR 997

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  381 bits (978), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 278/770 (36%), Positives = 396/770 (51%), Gaps = 95/770 (12%)

Query: 2    LQMWENNFSGTI-PRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS- 59
            L +  N+FSGT+ P F      L IL +  NSF+G IP T  N+ +L+ L + +N+LT  
Sbjct: 254  LSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIPSNHLTGK 313

Query: 60   ------------------------STLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSV 95
                                    S+ +L FL +L+NC  L  ++   N L G LP   +
Sbjct: 314  IPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGGQLP-VFI 372

Query: 96   GNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGL 155
             NLS  L    +    +SG IP  IGNL +L  + LG N L G +P +LG+L +L+ + L
Sbjct: 373  ANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSELRKVLL 432

Query: 156  ENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELT-SIPLT 214
             +N L G IP S+ +   L  L L  N   GSIP    + + L  L LG+N+L  SIP  
Sbjct: 433  YSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLNGSIPHE 492

Query: 215  FWNLKDILYLNFSSNFFTGPLPLEIGNLKI----------------ARIDSC-------- 250
               L  ++ LN S N   GPL  +IG LK                   + +C        
Sbjct: 493  LMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCLSLEFLLL 552

Query: 251  -------------DLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGG 297
                          L  L  L+LS NNLSG IP  +   S L++LNLS N  +G +P  G
Sbjct: 553  QGNSFVGPIPDIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPTEG 612

Query: 298  SFGNFSAESFEGNELLCGS-PNLRVPPCKTSI--HHISRKNAFLLGIVLPLSTVFMIVVI 354
             F N SA S  GN  LCG  P+L++ PC   +   H S +    + +   ++ + ++ + 
Sbjct: 613  VFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLC 672

Query: 355  FLIVKCRK------RERGPPNDANMPP-EAMQRMFSYLELCRATDGFSENNLIGRGSFGS 407
             + +   K      R     ND +  P ++     SY EL + T GFS +NLIG G+FG+
Sbjct: 673  VVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGA 732

Query: 408  VFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF---- 462
            VFK  LG     VA+KV NL      KSF  ECE +  IRHRN++K+++ CS+ +F    
Sbjct: 733  VFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGND 792

Query: 463  -KALVLEYMPHGSLEKYLH--------SSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
             +ALV E+MP+G+L+ +LH        + +  L ++ RLNI IDVASAL YLH      +
Sbjct: 793  FRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPI 852

Query: 514  IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-----TLATIGYMAPEYGKE 568
             HCD+KPSN+LLD ++ AH+SDFG+A+LL + D+ T   Q        TIGY APEYG  
Sbjct: 853  AHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPEYGMG 912

Query: 569  GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK-EIVDPNLLSR 627
            G  S  GDVYSFGI+L+E FT K+PT+++F   +TL  +    L      +I D  +L  
Sbjct: 913  GHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDETILRG 972

Query: 628  EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
                     +C++ VF V + C+ ESP  RI+  E ++KL+ IR+S  R+
Sbjct: 973  AYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSIRESFFRD 1022

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  354 bits (909), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 256/777 (32%), Positives = 388/777 (49%), Gaps = 116/777 (14%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPN-TFGNLRNLQALRLSNNYLTS- 59
           L +W N  +GT+P  + N++ L  ++L  N  SG +P+     +  LQ L LS N+  S 
Sbjct: 196 LLLWSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSH 255

Query: 60  ---STLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGI 116
              + LE  F +SL+N   L  +  + N L G +  +SV +LS +L    +    + G I
Sbjct: 256 NNNTNLE-PFFASLANSSDLQELELAGNSLGGEI-TSSVRHLSVNLVQIHLDQNRIHGSI 313

Query: 117 PEEIG------------------------NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQG 152
           P EI                          L+ L  +YL  N L G IP  LG + +L  
Sbjct: 314 PPEISNLLNLTLLNLSSNLLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGL 373

Query: 153 LGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELT-SI 211
           L +  N L GSIPDS  +  +L +L L GN LSG++P+      +L IL L  N LT +I
Sbjct: 374 LDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTI 433

Query: 212 PL-TFWNLKDI-LYLNFSSNFFTGPLPLEIGNLKIA----------------RIDSCDLI 253
           P+    NL+++ LYLN SSN  +GP+PLE+  + +                 ++ SC  I
Sbjct: 434 PVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSC--I 491

Query: 254 SLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG----------------- 296
           +L  LNLS N  S  +P+SL +L YLK+L++SFN+L G IP                   
Sbjct: 492 ALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLL 551

Query: 297 -------GSFGNFSAESFEGNELLCGSPNLRVPPCKTSIHHISRKNAFLLGIVLPLSTVF 349
                  GSF   + ESF G+ LLCGS        K   +        L  I  P+  VF
Sbjct: 552 SGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQACKKKHKYPSVLLPVLLSLIATPVLCVF 611

Query: 350 MI-----------VVIFLIVKCRKRERGPPNDANMPPEAMQRMFSYLELCRATDGFSENN 398
                        + ++   +    E+   ND   P        SY +L  AT GF+ ++
Sbjct: 612 GYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYP------RISYQQLIAATGGFNASS 665

Query: 399 LIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIKVISSC 457
           LIG G FG V+K  L +  +VA+KV + +    F  SF  EC+++K  RHRN+I++I++C
Sbjct: 666 LIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTC 725

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYI---LDIYQRLNIMIDVASALEYLHFGYSAQVI 514
           S   F ALVL  MP+GSLE++L+   Y    LD+ Q +NI  DVA  + YLH     +V+
Sbjct: 726 SKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVV 785

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA----------TIGYMAPE 564
           HCDLKPSN+LLDD M A ++DFGI++L+   +++     +++          ++GY+APE
Sbjct: 786 HCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPE 845

Query: 565 YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
           YG   R S +GDVYSFG++L+E  + ++PTD + N   +L  ++    P S + I++   
Sbjct: 846 YGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIE-QA 904

Query: 625 LSREDINFVAKEQCVSFVFNVAME-------CTVESPEQRINAKEIVTKLLKIRDSL 674
           LSR        E+C      V +E       CT  +P  R +  ++  ++ ++++ L
Sbjct: 905 LSRWKPQG-KPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  339 bits (870), Expect = 4e-92,   Method: Compositional matrix adjust.
 Identities = 259/778 (33%), Positives = 404/778 (51%), Gaps = 117/778 (15%)

Query: 2    LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
            L   +N  +G IP  I N + L +L+LS N  +G IP  FG + NL  + +  N+ T   
Sbjct: 389  LSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRNHFTGEI 447

Query: 62   LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG 121
             +  F     NC +L  +S ++N L G L K  +G L   L   +++Y +++G IP EIG
Sbjct: 448  PDDIF-----NCSNLETLSVADNNLTGTL-KPLIGKL-QKLRILQVSYNSLTGPIPREIG 500

Query: 122  NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG 181
            NL +L I+YL  N   G IP  +  L  LQGL + +N LEG IP+ +     L  L+L  
Sbjct: 501  NLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSN 560

Query: 182  NKLSGSIPECFNNLASLRILLLGSNELT-SIP-----LTFWNLKDI-------------- 221
            NK SG IP  F+ L SL  L L  N+   SIP     L+  N  DI              
Sbjct: 561  NKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELL 620

Query: 222  -------LYLNFSSNFFTGPLPLEIGNLKIAR-ID-SCDLIS------------------ 254
                   LYLNFS+N  TG +P E+G L++ + ID S +L S                  
Sbjct: 621  ASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDF 680

Query: 255  -------------------LISLNLS------------------------NNNLSGAIPA 271
                               +ISLNLS                        +NNL+G IP 
Sbjct: 681  SQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPE 740

Query: 272  SLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPC--KTSIH 329
            SL  LS LK L L+ N L+G +P  G F N +A    GN  LCGS    + PC  K    
Sbjct: 741  SLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSS 799

Query: 330  HISRKNAFLLGIVLPLSTVFMIVVIFLIVKCRKRERGP---PNDANMP--PEAMQ-RMFS 383
            H S++   +L I+   + + +++++ LI+ C K++       +++++P    A++ + F 
Sbjct: 800  HFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFE 859

Query: 384  YLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQ--YGRVFKSFDVECEM 441
              EL +ATD F+  N+IG  S  +V+K +L DG  +A+KV NL+       K F  E + 
Sbjct: 860  PKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKT 919

Query: 442  MKSIRHRNIIKVIS-SCSNEEFKALVLEYMPHGSLEKYLH-SSNYILDIYQRLNIMIDVA 499
            +  ++HRN++K++  +  + + KALVL +M +G+LE  +H S+  I  + +++++ + +A
Sbjct: 920  LSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIA 979

Query: 500  SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-REDQSTIQTQTL--A 556
            S ++YLH GY   ++HCDLKP+N+LLD + VAH+SDFG A++L  RED ST  + +    
Sbjct: 980  SGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAFEG 1039

Query: 557  TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPT--DEIFNGEMTLKHWVNDWLPI 614
            TIGY+APE+    +V+   DV+SFGI++ME  T+++PT  ++  + +MTL+  V   +  
Sbjct: 1040 TIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGN 1099

Query: 615  STKEIVDP-NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
              K +V   ++   + I  + +E+ +     + + CT   PE R +  EI+T L+K+R
Sbjct: 1100 GRKGMVRVLDMELGDSIVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  323 bits (827), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 251/778 (32%), Positives = 381/778 (48%), Gaps = 131/778 (16%)

Query: 1    MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
            +L + +N   G +P  + N  +L+IL+L+DN  SG IP++FG L+ L+ L L NN     
Sbjct: 484  LLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNN----- 538

Query: 61   TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEY--FEMAYCNVSGGIPE 118
            +L+ +   SL + ++LT I+ S+N L+G     ++  L  S  Y  F++        IP 
Sbjct: 539  SLQGNLPDSLISLRNLTRINLSHNRLNG-----TIHPLCGSSSYLSFDVTNNGFEDEIPL 593

Query: 119  EIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIP------DSICHSD 172
            E+GN  NL  + LG N+L G IP TLGK+++L  L + +N L G+IP        + H D
Sbjct: 594  ELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHID 653

Query: 173  ------------------------------------------ELYKLELGGNKLSGSIPE 190
                                                      +L  L L GN L+GSIP+
Sbjct: 654  LNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQ 713

Query: 191  CFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDS 249
               NL +L +L L  N+ + S+P     L  +  L  S N  TG +P+EIG L+      
Sbjct: 714  EIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQ------ 767

Query: 250  CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR-------------- 295
             DL S  +L+LS NN +G IP+++  LS L+ L+LS N+L GE+P               
Sbjct: 768  -DLQS--ALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVS 824

Query: 296  ----GG----SFGNFSAESFEGNELLCGSPNLRVPPCKTSIHH--ISRKNAFLLGIVLPL 345
                GG     F  + A+SF GN  LCGSP  R    +++     +S ++  ++  +  L
Sbjct: 825  FNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISAL 884

Query: 346  STV-FMIVVIFLIVKCR-----KRERGPP--------NDANMPP----EAMQRMFSYLEL 387
            + +  MI+VI L  K R     K   G          + A   P     A +    + ++
Sbjct: 885  TAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDI 944

Query: 388  CRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIR 446
              AT   SE  +IG G  G V+KA L +G  VA+K    +   +  KSF  E + +  IR
Sbjct: 945  MEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIR 1004

Query: 447  HRNIIKVISSCSN--EEFKALVLEYMPHGSLEKYLHSSNYIL-------DIYQRLNIMID 497
            HR+++K++  CS+  E    L+ EYM +GS+  +LH    +L       D   RL I + 
Sbjct: 1005 HRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVG 1064

Query: 498  VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-- 555
            +A  +EYLH      ++H D+K SNVLLD NM AHL DFG+AK+LT    +   + T   
Sbjct: 1065 LAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFA 1124

Query: 556  ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI- 614
             + GY+APEY    + +   DVYS GI+LME  T K PTD +F  EM +  WV   L + 
Sbjct: 1125 CSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVA 1184

Query: 615  --STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
              +  +++DP L  +  + F     C   V  +A++CT  SP++R ++++    LL +
Sbjct: 1185 GSARDKLIDPKL--KPLLPFEEDAACQ--VLEIALQCTKTSPQERPSSRQACDSLLHV 1238

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  312 bits (800), Expect = 5e-84,   Method: Compositional matrix adjust.
 Identities = 226/696 (32%), Positives = 352/696 (50%), Gaps = 76/696 (10%)

Query: 6    ENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST-LEL 64
            EN F G IP  +  ++ L  L L  N F+G IP TFG +  L  L +S N L+    +EL
Sbjct: 585  ENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVEL 644

Query: 65   SFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT 124
                    CK LT I  +NN L G++P T +G L   L   +++     G +P EI +LT
Sbjct: 645  GL------CKKLTHIDLNNNYLSGVIP-TWLGKLPL-LGELKLSSNKFVGSLPTEIFSLT 696

Query: 125  NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
            N+  ++L GN LNGSIP  +G LQ L  L LE N+L G +P +I    +L++L L  N L
Sbjct: 697  NILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNAL 756

Query: 185  SGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKI 244
            +G IP     L  L+                        L+ S N FTG +P  I  L  
Sbjct: 757  TGEIPVEIGQLQDLQS----------------------ALDLSYNNFTGRIPSTISTLP- 793

Query: 245  ARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSA 304
                      L SL+LS+N L G +P  +  +  L  LNLS+N LEG++ +   F  + A
Sbjct: 794  ---------KLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQA 842

Query: 305  ESFEGNELLCGSPNLRVPPCKTS----IHHISRKNAFLLGIVLPLSTV-FMIVVIFLIVK 359
            ++F GN  LCGSP   +  C  +       +S K   ++  +  L+ +  M++VI L  K
Sbjct: 843  DAFVGNAGLCGSP---LSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFK 899

Query: 360  CR----KRERGPPNDANMPPEAMQR-MFS---------YLELCRATDGFSENNLIGRGSF 405
                  K+ RG  +  +    + Q  +FS         + ++  AT   +E  +IG G  
Sbjct: 900  QNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGS 959

Query: 406  GSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCSNEE--F 462
            G V+KA L +G  +A+K    +   +  KSF+ E + + +IRHR+++K++  CS++    
Sbjct: 960  GKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGL 1019

Query: 463  KALVLEYMPHGSLEKYLHSS-----NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
              L+ EYM +GS+  +LH++       +L    RL I + +A  +EYLH+     ++H D
Sbjct: 1020 NLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRD 1079

Query: 518  LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL--ATIGYMAPEYGKEGRVSANG 575
            +K SNVLLD N+ AHL DFG+AK+LT    +  ++ T+   + GY+APEY    + +   
Sbjct: 1080 IKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKS 1139

Query: 576  DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK 635
            DVYS GI+LME  T K PT+ +F+ E  +  WV   L           L+  E  + +  
Sbjct: 1140 DVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLPC 1199

Query: 636  EQCVSF-VFNVAMECTVESPEQRINAKEIVTKLLKI 670
            E+  ++ V  +A++CT   P++R ++++    LL +
Sbjct: 1200 EEEAAYQVLEIALQCTKSYPQERPSSRQASEYLLNV 1235

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1

 Score =  309 bits (792), Expect = 4e-83,   Method: Compositional matrix adjust.
 Identities = 242/721 (33%), Positives = 353/721 (48%), Gaps = 77/721 (10%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
           NN +GTIP  I N +   IL++S N  +G IP   G L+ +  L L  N LT    E+  
Sbjct: 225 NNLTGTIPESIGNCTSFQILDISYNQITGEIPYNIGFLQ-VATLSLQGNRLTGRIPEVIG 283

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNL 126
           L      ++L ++  S+N L G +P   +GNLS + + +      ++G IP E+GN++ L
Sbjct: 284 L-----MQALAVLDLSDNELVGPIPPI-LGNLSFTGKLYLHGNM-LTGPIPSELGNMSRL 336

Query: 127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSG 186
           + + L  NKL G+IP  LGKL++L  L L NN+L G IP +I     L +  + GN LSG
Sbjct: 337 SYLQLNDNKLVGTIPPELGKLEQLFELNLANNRLVGPIPSNISSCAALNQFNVHGNLLSG 396

Query: 187 SIPECFNNLASLRILLLGSNELT-------------------------SIPLTFWNLKDI 221
           SIP  F NL SL  L L SN                            SIPLT  +L+ +
Sbjct: 397 SIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHL 456

Query: 222 LYLNFSSNFFTGPLPLEIGNLK-IARID-SCDLIS-LISLNLSNNNLS-----------G 267
           L LN S N  +G LP E GNL+ I  ID S +L+S +I   L                 G
Sbjct: 457 LILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHG 516

Query: 268 AIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCKTS 327
            IP  L     L +LN+SFN L G +P   +F  F+  SF GN  LCG  N     C   
Sbjct: 517 KIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFSRFAPASFVGNPYLCG--NWVGSICGP- 573

Query: 328 IHHISRKNAFLLG--IVLPLSTVFMIVVIFLIVKCRKRERGPPNDANMPPEAMQRMF--- 382
              + +   F  G  I + L  + ++ +IFL V    +++     ++   E + ++    
Sbjct: 574 ---LPKSRVFSRGALICIVLGVITLLCMIFLAVYKSMQQKKILQGSSKQAEGLTKLVILH 630

Query: 383 ------SYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFD 436
                 ++ ++ R T+  +E  +IG G+  +V+K  L     +A+K    QY    + F+
Sbjct: 631 MDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCALKSSRPIAIKRLYNQYPHNLREFE 690

Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS--NYILDIYQRLNI 494
            E E + SIRHRNI+ +     +     L  +YM +GSL   LH S     LD   RL I
Sbjct: 691 TELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKI 750

Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
            +  A  L YLH   + ++IH D+K SN+LLD+N  AHLSDFGIAK +    ++   T  
Sbjct: 751 AVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEAHLSDFGIAKSIP-ASKTHASTYV 809

Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI 614
           L TIGY+ PEY +  R++   D+YSFGI+L+E  T KK  D   N    +    +D    
Sbjct: 810 LGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGKKAVDNEANLHQLILSKADD---N 866

Query: 615 STKEIVDPNL-LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
           +  E VDP + ++  D+  + K       F +A+ CT  +P +R    E+   LL +  S
Sbjct: 867 TVMEAVDPEVTVTCMDLGHIRK------TFQLALLCTKRNPLERPTMLEVSRVLLSLVPS 920

Query: 674 L 674
           L
Sbjct: 921 L 921

Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  307 bits (787), Expect = 1e-82,   Method: Compositional matrix adjust.
 Identities = 234/714 (32%), Positives = 346/714 (48%), Gaps = 65/714 (9%)

Query: 2    LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
            LQ+++N   G IP  I   S  S+L++S NS SG IP  F   + L  L L +N L+ + 
Sbjct: 384  LQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGN- 442

Query: 62   LELSFLSSLSNCKSLTLISFSNNPLDGILP--------KTSV--------GNLS------ 99
                    L  CKSLT +   +N L G LP         T++        GN+S      
Sbjct: 443  ----IPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKL 498

Query: 100  HSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNK 159
             +LE   +A  N +G IP EIGNLT +    +  N+L G IP  LG    +Q L L  NK
Sbjct: 499  KNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNK 558

Query: 160  LEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELT-SIPLTFWNL 218
              G I   +     L  L L  N+L+G IP  F +L  L  L LG N L+ +IP+    L
Sbjct: 559  FSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKL 618

Query: 219  KDI-LYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLS 277
              + + LN S N  +G +P  +GNL++  I          L L++N LSG IPAS+  L 
Sbjct: 619  TSLQISLNISHNNLSGTIPDSLGNLQMLEI----------LYLNDNKLSGEIPASIGNLM 668

Query: 278  YLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLR----VPPCKTSIHHI-- 331
             L   N+S N L G +P    F    + +F GN  LC S        VP   + ++ +  
Sbjct: 669  SLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLIN 728

Query: 332  -SRKNAFLLGIVLPLSTVFMIVVIFLIVKCRKRERG-PPNDANMPPEAM------QRMFS 383
             S++   L    + + +VF+I  + L    ++RE      +    P+ M      ++ F+
Sbjct: 729  GSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFT 788

Query: 384  YLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNL--QYGRVFKSFDVECEM 441
            Y  L  AT  FSE+ ++GRG+ G+V+KA +  G  +A+K  N   +      SF  E   
Sbjct: 789  YQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEIST 848

Query: 442  MKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH--SSNYILDIYQRLNIMIDVA 499
            +  IRHRNI+K+   C ++    L+ EYM  GSL + L     N +LD   R  I +  A
Sbjct: 849  LGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAA 908

Query: 500  SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG 559
              L YLH     Q++H D+K +N+LLD+   AH+ DFG+AKL+      ++ +    + G
Sbjct: 909  EGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSM-SAVAGSYG 967

Query: 560  YMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP--ISTK 617
            Y+APEY    +V+   D+YSFG++L+E  T K P   +  G   L +WV   +   I T 
Sbjct: 968  YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG-DLVNWVRRSIRNMIPTI 1026

Query: 618  EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
            E+ D    +R D N       +S V  +A+ CT  SP  R   +E+V  + + R
Sbjct: 1027 EMFD----ARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1

 Score =  307 bits (787), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 240/724 (33%), Positives = 352/724 (48%), Gaps = 93/724 (12%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
           N+ +G+IP  I N +   +L+LS N  +G IP   G L+ +  L L  N L+        
Sbjct: 222 NSLTGSIPETIGNCTAFQVLDLSYNQLTGEIPFDIGFLQ-VATLSLQGNQLSGK-----I 275

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNL 126
            S +   ++L ++  S N L G +P   +GNL+ + E   +    ++G IP E+GN++ L
Sbjct: 276 PSVIGLMQALAVLDLSGNLLSGSIPPI-LGNLTFT-EKLYLHSNKLTGSIPPELGNMSKL 333

Query: 127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSG 186
             + L  N L G IP  LGKL  L  L + NN LEG IPD +     L  L + GNK SG
Sbjct: 334 HYLELNDNHLTGHIPPELGKLTDLFDLNVANNDLEGPIPDHLSSCTNLNSLNVHGNKFSG 393

Query: 187 SIPECFNNLASLRILLLGSNELTS-------------------------IPLTFWNLKDI 221
           +IP  F  L S+  L L SN +                           IP +  +L+ +
Sbjct: 394 TIPRAFQKLESMTYLNLSSNNIKGPIPVELSRIGNLDTLDLSNNKINGIIPSSLGDLEHL 453

Query: 222 LYLNFSSNFFTGPLPLEIGNLK-IARIDSCD-------------LISLISLNLSNNNLSG 267
           L +N S N  TG +P + GNL+ I  ID  +             L ++I L L NNNL+G
Sbjct: 454 LKMNLSRNHITGVVPGDFGNLRSIMEIDLSNNDISGPIPEELNQLQNIILLRLENNNLTG 513

Query: 268 AIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCKTS 327
            +  SL     L  LN+S N L G+IP+  +F  FS +SF GN  LCGS      PC  S
Sbjct: 514 NV-GSLANCLSLTVLNVSHNNLVGDIPKNNNFSRFSPDSFIGNPGLCGS--WLNSPCHDS 570

Query: 328 IH--HISRKNAFLLGIVLPLSTVFMIVVIFLIVKCRKRERGP--------PNDANMPPEA 377
                +S   A +LGI +      +I+++ LI  CR     P        P   + P   
Sbjct: 571 RRTVRVSISRAAILGIAI---GGLVILLMVLIAACRPHNPPPFLDGSLDKPVTYSTPKLV 627

Query: 378 MQRM----FSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFK 433
           +  M      Y ++ R T+  SE  +IG G+  +V+K  L +   VA+K       +  K
Sbjct: 628 ILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCVLKNCKPVAIKRLYSHNPQSMK 687

Query: 434 SFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH--SSNYILDIYQR 491
            F+ E EM+ SI+HRN++ + +   +     L  +Y+ +GSL   LH  +    LD   R
Sbjct: 688 QFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKKTLDWDTR 747

Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
           L I    A  L YLH   S ++IH D+K SN+LLD ++ A L+DFGIAK L    +S   
Sbjct: 748 LKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSLCVS-KSHTS 806

Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWV--- 608
           T  + TIGY+ PEY +  R++   DVYS+GI+L+E  TR+K  D+    E  L H +   
Sbjct: 807 TYVMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRRKAVDD----ESNLHHLIMSK 862

Query: 609 ---NDWLPISTKEIVDPNLLSR-EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
              N+ +     E+ DP++ S  +D+  V K      VF +A+ CT   P  R    + V
Sbjct: 863 TGNNEVM-----EMADPDITSTCKDLGVVKK------VFQLALLCTKRQPNDRPTMHQ-V 910

Query: 665 TKLL 668
           T++L
Sbjct: 911 TRVL 914

Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	678
224139658	1019	predicted protein [Populus trichocarpa]	0.994	0.661	0.511	0.0
255572272	1089	serine-threonine protein kinase, plant-t	0.986	0.614	0.501	0.0
224116832	1061	predicted protein [Populus trichocarpa]	0.983	0.628	0.509	0.0
359483198	1087	PREDICTED: probable LRR receptor-like se	0.977	0.609	0.523	0.0
359483683	1228	PREDICTED: LRR receptor-like serine/thre	0.977	0.539	0.516	0.0
359485451	1454	PREDICTED: LRR receptor-like serine/thre	0.986	0.460	0.507	0.0
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.977	0.539	0.510	0.0
359483688	1197	PREDICTED: LRR receptor-like serine/thre	0.980	0.555	0.517	0.0
359483685	1046	PREDICTED: LRR receptor-like serine/thre	0.979	0.634	0.516	0.0
359485453	1202	PREDICTED: probable LRR receptor-like se	0.974	0.549	0.511	0.0

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  668 bits (1724), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/719 (51%), Positives = 472/719 (65%), Gaps = 45/719 (6%)

Query: 2    LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS-- 59
            LQ+  N  +G++PRF+ N S+L IL+LS N  +G +   FGNLR LQ L L +N  T+  
Sbjct: 297  LQLNLNGITGSMPRFLGNMSRLEILDLSYNKMTGNVLQEFGNLRALQVLSLQSNSFTNHP 356

Query: 60   STLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEE 119
            S+  L+F++SL+N + L  +   +NPLDG+LP  SVGNLS  L  F +    + G IP E
Sbjct: 357  SSQTLNFITSLTNSRQLKELHIGDNPLDGMLPN-SVGNLSSFLTKFYVYASKLKGNIPGE 415

Query: 120  IGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL 179
            IGNL+NL ++ L  N L G IP+T+G L+K+Q L L  N L GSIP  IC +  L  + L
Sbjct: 416  IGNLSNLIVLSLEENSLMGPIPTTVGGLRKIQVLYLHKNNLNGSIPSDICLARRLVDITL 475

Query: 180  GGNKLSGSIPECFNNLASLRILLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTGPLPLE 238
              N LSG IP C  NL SLR L L  N L+S IP+  W+LKD+L LN  SNF  G LP +
Sbjct: 476  NNNVLSGEIPSCIGNLTSLRNLYLHFNILSSTIPMALWSLKDLLILNLHSNFLYGSLPSQ 535

Query: 239  IGNLKIA---RIDSCDL-----------------------------------ISLISLNL 260
            +G ++ A   R+ S  L                                   +SL  L+L
Sbjct: 536  VGEMEAAIGIRLSSNQLSGNIPSTIGSLQNLIRFSLSKNSFQGSIPEAFGGLVSLELLDL 595

Query: 261  SNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLR 320
            S NNLSG IP SLE L YL+  ++SFN L+GEIPRGG F NF+A SF  N+ LCG   L+
Sbjct: 596  SQNNLSGEIPKSLEALRYLEFFSVSFNGLQGEIPRGGPFANFTARSFIMNKGLCGPSRLQ 655

Query: 321  VPPCKTSIHHISRKNAFLLGIVLPLSTVFMIVV--IFLIVKCRKRERGPPNDANMPPEAM 378
            VPPC       S+  + LL   LP     ++VV  IFL++ CR+R R  P    +P  A+
Sbjct: 656  VPPCSIESRKDSKTKSRLLRFSLPTVASILLVVAFIFLVMGCRRRYRKDPIPEALPVTAI 715

Query: 379  QRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVE 438
            QR  SYLEL  AT+ F E+NL+G GSFGSV++ RL DG+ VA+K+FNLQ  R F+SFD E
Sbjct: 716  QRRISYLELLHATNEFHESNLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTE 775

Query: 439  CEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDV 498
            CE+M++IRHRN++K+I SCSN +FKALVLEYMP GSLEK+L+S NY LDI QR+NIMIDV
Sbjct: 776  CEIMRNIRHRNLVKIICSCSNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDV 835

Query: 499  ASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI 558
            ASALEYLH GY + V+HCDLKPSNVLLD++MVAH+ DFGIAKLL  E++S  QT+TLATI
Sbjct: 836  ASALEYLHHGYPSPVVHCDLKPSNVLLDEDMVAHVCDFGIAKLLG-ENESFAQTRTLATI 894

Query: 559  GYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 618
            GYMAPEYG +G VS   DVYSFGIMLME  TRK+PTDE+F GEM+LK  V + LP S  +
Sbjct: 895  GYMAPEYGLDGLVSTKIDVYSFGIMLMEMLTRKRPTDEMFEGEMSLKRLVKESLPDSVID 954

Query: 619  IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
            IVD N+L+R D   V KE CV+ +  +A++C  ESP +R+   EI+ +L  I+   LR+
Sbjct: 955  IVDSNMLNRGDGYSVKKEHCVTSIMELALQCVNESPGERMAMVEILARLKNIKAEFLRD 1013

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  664 bits (1712), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 360/718 (50%), Positives = 473/718 (65%), Gaps = 49/718 (6%)

Query: 7    NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS--STLEL 64
            N  SG IP +I NASKL+ILEL  NSF+GFIP++ G+LRNLQ L+L  N L+S  ++ EL
Sbjct: 371  NKLSGPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKTSQEL 430

Query: 65   SFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT 124
            +  SSL NC++L  +  S NPLDG LP  SVGNLS+SLE F  +   + G + E IGNL+
Sbjct: 431  TIFSSLKNCQNLKYLWLSYNPLDGYLPH-SVGNLSNSLESFLASDGLIKGSVHESIGNLS 489

Query: 125  NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
            +LT + LG N L G IP+T+G L+ LQGL L  N L+GSIP  +C    LY LEL GNKL
Sbjct: 490  SLTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTGNKL 549

Query: 185  SGSIPECFNNLASLRILLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK 243
            SGSIP CF+NL SLR L L SN   S I  T W LKDIL +N +SN+ TG LP EI NL+
Sbjct: 550  SGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIENLR 609

Query: 244  IARIDSC--------------------------------------DLISLISLNLSNNNL 265
               + +                                       D+ SL  L+LS+NNL
Sbjct: 610  AVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSSNNL 669

Query: 266  SGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCK 325
            SG IP SL+ L YLK  N+SFN L+GEIP GGSF NFSA+SF GNE LCGS  L+V PCK
Sbjct: 670  SGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVSPCK 729

Query: 326  TSIHHISRK--NAFLLGIVLPLSTVFMIVVIFLIV---KCRKRERGPPNDANMPPEAMQR 380
                  +    +  +L  VLP     + V+ F+I+    C ++ +    D  +    ++R
Sbjct: 730  DDNSRATETPGSKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDDFLALTTIRR 789

Query: 381  MFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECE 440
            + SY EL  AT+GF E+N +G GSFGSV+K  L DG  +A KVFNLQ  R FKSFD ECE
Sbjct: 790  I-SYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSFDTECE 848

Query: 441  MMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
            +++++RHRN++K+I+SCS   FKALVLE+MP+ SLEK+L+S +Y L+  QRLNIM+DVAS
Sbjct: 849  VLRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIMLDVAS 908

Query: 501  ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
             LEYLH GY+  + HCD+KPSNVLL+++MVA L+DFGI+KLL  E+ S +QT TLATIGY
Sbjct: 909  VLEYLHHGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISKLLG-EEGSVMQTMTLATIGY 967

Query: 561  MAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 620
            MAPEYG EG VS  GDVYS+G++LMETFT+KKPTD++F  +++LK WV   L     +++
Sbjct: 968  MAPEYGSEGIVSVRGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCEVTQVI 1027

Query: 621  DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRNV 678
            D NLL  E+ +  AK+ C+  +  +A++C+ + P  RI+ K +VT L KI+   LR++
Sbjct: 1028 DANLLGIEEDHLAAKKDCIVSILKLALQCSADLPHDRIDMKHVVTTLQKIKTKFLRDI 1085

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  663 bits (1710), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 363/713 (50%), Positives = 473/713 (66%), Gaps = 46/713 (6%)

Query: 2    LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
            L + +N  SG IP  I NASKL +L+LS NSFSG IP+  GNLRNLQ L L+ N LTS +
Sbjct: 337  LYLEKNELSGPIPDSIGNASKLIVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTSKS 396

Query: 62   LELSFLSSLS--NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEE 119
            L        S  NC+SL  + F+ NPL G LP  S+GNLS SLE      C + G IP  
Sbjct: 397  LRSELSFLSSLSNCRSLAYLRFNGNPLRGRLP-VSIGNLSASLEELYAFDCRIIGNIPRG 455

Query: 120  IGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL 179
            IGNL+NL  + L  N+L G+IPS +G+L+ LQ   L +NKL+G IP+ ICH + L  L L
Sbjct: 456  IGNLSNLIGLILQQNELTGAIPSEIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYL 515

Query: 180  GGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEI 239
              N  SGS+P C +N+ SLR L LGSN  TSIP TFW+LKD+L +N S N  TG LPLEI
Sbjct: 516  LENGFSGSLPACLSNITSLRELYLGSNRFTSIPTTFWSLKDLLQINLSFNSLTGTLPLEI 575

Query: 240  GNLKIARI--------------------------------------DSCDLISLISLNLS 261
            GNLK+  +                                         DL+SL  L+LS
Sbjct: 576  GNLKVVTVIDFSSNQLSGDIPTSIADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLS 635

Query: 262  NNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRV 321
             N+LSGAIP SLEKL +LK  N+SFN+L+GEI  GG F NFS  SF  NE LCG   ++V
Sbjct: 636  RNSLSGAIPKSLEKLVHLKTFNVSFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQV 695

Query: 322  PPCKT-SIHHIS-RKNAFLLGIVLP-LSTVFMIVVIFLIVKCRKRERGPPNDANMPPEAM 378
            PPCK+ S H  S R   F++  ++P ++ + +++ + +I+  R  +R      +  P A 
Sbjct: 696  PPCKSISTHRQSKRPREFVIRYIVPAIAFIILVLALAVIIFRRSHKRKLSTQEDPLPPAT 755

Query: 379  QRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVE 438
             R  SY EL RAT+GF+E NL+G GS GSV+K  L DG+ +A+KVF+LQ       FD E
Sbjct: 756  WRKISYHELYRATEGFNETNLLGTGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSE 815

Query: 439  CEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDV 498
            CE+++ +RHRN++K+ISSC N +FKAL+LE++PHGSLEK+L+S NY LDI QRLNIMIDV
Sbjct: 816  CEVLRMLRHRNLVKIISSCCNLDFKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDV 875

Query: 499  ASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI 558
            ASALEYLH G +  V+HCDLKPSNVL++++MVAH+SDFGI++LL   D  T QT TLATI
Sbjct: 876  ASALEYLHHGCTRPVVHCDLKPSNVLINEDMVAHVSDFGISRLLGEGDAVT-QTLTLATI 934

Query: 559  GYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 618
            GYMAPEYG EG VS  GDVYS+GI LMETFTRKKPTD++F GEM+LK+WV   LP +  E
Sbjct: 935  GYMAPEYGLEGIVSVKGDVYSYGIFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITE 994

Query: 619  IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
            ++D NLL  E+ +FVAK+ C++ + N+A+EC+ + P +RI  ++++  L KI+
Sbjct: 995  VIDANLLIEEE-HFVAKKDCITSILNLALECSADLPGERICMRDVLPALEKIK 1046

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483198|ref|XP_002271405.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  661 bits (1706), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 372/710 (52%), Positives = 472/710 (66%), Gaps = 47/710 (6%)

Query: 7    NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTL--EL 64
            N  SG IP  I NASKL  L+   N  +G IP+  G+LR L+ L L  N L   +   EL
Sbjct: 375  NWLSGIIPSSIGNASKLRSLDFGYNMLTGSIPHALGSLRFLERLNLGVNNLKGESYIQEL 434

Query: 65   SFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT 124
            SFL+SL+NCK L ++  S NPL GILP  S+GNLS SL+ FE   C + G IP EIGNL+
Sbjct: 435  SFLTSLTNCKRLRILYLSFNPLIGILP-ISIGNLSTSLQRFEANTCKLKGNIPTEIGNLS 493

Query: 125  NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
            NL ++ L  N L G+IP ++G+LQKLQGL L +NKL+GSIP+ IC    L +L L  N+L
Sbjct: 494  NLYLLSLNNNDLTGTIPPSIGQLQKLQGLYLPSNKLQGSIPNDICQLRNLGELFLTNNQL 553

Query: 185  SGSIPECFNNLASLRILLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK 243
            SGSIP C   L  LR L LGSN+L S IP T W+L  IL L+ SSNF  G LP ++GNLK
Sbjct: 554  SGSIPACLGELTFLRHLYLGSNKLNSTIPSTLWSLIHILSLDMSSNFLVGYLPSDMGNLK 613

Query: 244  I-ARID-------------------------------------SCDLISLISLNLSNNNL 265
            +  +ID                                       +L SL  ++LS+N L
Sbjct: 614  VLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDLSDNAL 673

Query: 266  SGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCK 325
             G IP SLE L YLK L++SFN L GEIP  G F NFSAESF  N+ LCGSP L++PPC+
Sbjct: 674  FGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCGSPRLKLPPCR 733

Query: 326  TSIHHISRKNAFLLGIVLP--LSTVFMIVVIFLIVKCRKRERGPPNDANMPPEAMQRMFS 383
            T     +  +  LL  +LP  LST+  + +IF+  +CRKR    P  +     A  R  S
Sbjct: 734  TGTRWSTTISWLLLKYILPAILSTLLFLALIFVWTRCRKRNAVLPTQSESLLTATWRRIS 793

Query: 384  YLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMK 443
            Y E+ +AT+GFS  NL+GRGS GSV++  L DG   A+KVFNLQ    FKSFD ECE+M 
Sbjct: 794  YQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNLQEEAAFKSFDAECEVMH 853

Query: 444  SIRHRNIIKVISSCSNE--EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
             IRHRN+IK++SSCSN   +FKALVLEY+P+GSLE++L+S NY LDI QRLNIMIDVA A
Sbjct: 854  HIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNYCLDILQRLNIMIDVALA 913

Query: 502  LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
            +EYLH G S  V+HCDLKPSN+LLD++   H+ DFGIAKLL RE++S  +TQTLATIGYM
Sbjct: 914  MEYLHHGCSTPVVHCDLKPSNILLDEDFGGHVGDFGIAKLL-REEESIRETQTLATIGYM 972

Query: 562  APEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 621
            AP+Y   G V+ +GDVYS+GI+LMETFTR++PTDEIF+ EM++K+WV DWL  S  E+VD
Sbjct: 973  APKYVSNGIVTTSGDVYSYGIVLMETFTRRRPTDEIFSEEMSMKNWVWDWLCGSITEVVD 1032

Query: 622  PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
             NLL  ED  F+AK+QC+S +  +AM+C  +SPE+RI  K++VT L KI+
Sbjct: 1033 ANLLRGEDEQFMAKKQCISLILGLAMDCVADSPEERIKMKDVVTTLKKIK 1082

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  659 bits (1700), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/715 (51%), Positives = 477/715 (66%), Gaps = 52/715 (7%)

Query: 7    NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTL--EL 64
            N FSGTIP  I N SKL  L +SDN F+G +P    NLR L+ L L+ N LT   L  E+
Sbjct: 519  NEFSGTIPVSISNMSKLIRLHISDNYFTGNVPKDLSNLRKLEVLNLAGNQLTDEHLTSEV 578

Query: 65   SFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT 124
             FL+SL+NCK L  +    NPL G LP  S+GNLS +LE F  + C+  G IP  IGNLT
Sbjct: 579  GFLTSLTNCKFLRTLWIDYNPLKGTLPN-SLGNLSVALESFTASACHFRGTIPTGIGNLT 637

Query: 125  NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
            NL  + LG N L GSIP+TLG LQKLQ L +  N+++GSIP+ +CH   L  L L  NKL
Sbjct: 638  NLIWLDLGANDLTGSIPTTLGHLQKLQRLYIAGNRIQGSIPNDLCHLKNLGYLHLSSNKL 697

Query: 185  SGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK 243
            SGSIP CF +L +LR L L SN L  +IP++FW+L+D++ L+ SSNF TG LP E+GN+K
Sbjct: 698  SGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLMVLSLSSNFLTGNLPPEVGNMK 757

Query: 244  ---------------IAR--------IDSC---------------DLISLISLNLSNNNL 265
                           I R        ++ C               DL+SL S++LS NNL
Sbjct: 758  SITTLDLSKNLISGYIPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNL 817

Query: 266  SGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCK 325
             G IP SLE L YLK LN+SFNKL+GEIP GG F NF+AESF  NE LCG+P+ +V  C 
Sbjct: 818  FGTIPKSLEALIYLKHLNVSFNKLQGEIPNGGPFVNFTAESFIFNEALCGAPHFQVIACD 877

Query: 326  TSIHHISRKN-AFLLG-IVLPLSTVFMIVVIFLIVKCRKR---ERGPPNDANMPPEAMQR 380
             +    S K  +F+L  I+LP+ +   +V  F+++  R+R   E   P D+ +P      
Sbjct: 878  KNNRTQSWKTKSFILKYILLPVGSAVTLVA-FIVLWIRRRDNTEIPAPIDSWLP--GAHE 934

Query: 381  MFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECE 440
              S  +L  AT+GF E+NLIG+GS G V+K  L +G+ VA+KVFNL++    +SFD ECE
Sbjct: 935  KISQQQLLYATNGFGEDNLIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECE 994

Query: 441  MMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
            +M+ I HRN+I++I+ CSN +FKALVLEYMP GSL+K+L+S NY LD++QRLNIMIDVAS
Sbjct: 995  VMQGICHRNLIRIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVAS 1054

Query: 501  ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
            ALEYLH   S+ V+HCDLKPSNVLLD+NMVAH++DFGIA+LLT E +S  QT+TL TIGY
Sbjct: 1055 ALEYLHHDCSSLVVHCDLKPSNVLLDNNMVAHVADFGIARLLT-ETESMQQTKTLGTIGY 1113

Query: 561  MAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 620
            MAPEYG +G VS  GDVYS+GI+LME F RKKP DE+F G++TLK WV + L  S  E+V
Sbjct: 1114 MAPEYGSDGIVSTKGDVYSYGILLMEVFARKKPMDEMFTGDVTLKTWV-ESLSSSVIEVV 1172

Query: 621  DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
            D NLL R+D +   K   +S +  +A+ CT +SPE+RIN K++V +L KI+  LL
Sbjct: 1173 DANLLRRDDEDLATKLSYLSSLMALALACTADSPEERINMKDVVVELKKIKIKLL 1227

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485451|ref|XP_002276944.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  657 bits (1696), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 365/719 (50%), Positives = 470/719 (65%), Gaps = 50/719 (6%)

Query: 2    LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS-- 59
            L +  N FSG IP  I N S+L+ L++ DN F+G +P   GNLR L+ L L +N LT   
Sbjct: 740  LAIGRNEFSGIIPMSISNMSELTELDIWDNFFTGDVPKDLGNLRRLEFLNLGSNQLTDEH 799

Query: 60   STLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEE 119
            S  E+ FL+SL+NC  L  +   +NPL GILP  S+GNLS SLE F+ + C   G IP  
Sbjct: 800  SASEVGFLTSLTNCNFLRTLWIEDNPLKGILPN-SLGNLSISLESFDASACQFRGTIPTG 858

Query: 120  IGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL 179
            IGNLT+L  + LG N L G IP+TLG+L+KLQ LG+  N+L GSIP+ +C    L  L L
Sbjct: 859  IGNLTSLISLELGDNDLTGLIPTTLGQLKKLQELGIAGNRLRGSIPNDLCRLKNLGYLFL 918

Query: 180  GGNKLSGSIPECFNNLASLRILLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTGPLPLE 238
              N+L+GSIP C   L  LR L L SN L S IP + W L+ +L LN SSNF TG LP E
Sbjct: 919  SSNQLTGSIPSCLGYLPPLRELYLHSNALASNIPPSLWTLRGLLVLNLSSNFLTGHLPPE 978

Query: 239  IGNLKIAR--------------------------------------IDSCDLISLISLNL 260
            +GN+K  R                                      ++  DL+SL  L+L
Sbjct: 979  VGNIKSIRTLDLSKNQVSGHIPRTLGELQNLEDLSLSQNRLQGPIPLEFGDLLSLKFLDL 1038

Query: 261  SNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLR 320
            S NNLSG IP SL+ L+YLK LN+SFNKL+GEIP GG F NF+AESF  NE LCG+P+ +
Sbjct: 1039 SQNNLSGVIPKSLKALTYLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNEALCGAPHFQ 1098

Query: 321  VPPCKTSIHHIS-RKNAFLLGIVLPLSTVFMIVVIFLIVKCRKR---ERGPPNDANMPPE 376
            V  C  S    S R   F+L  +LP     + +V+FL++  R+R   E   P D+ +P  
Sbjct: 1099 VIACDKSTRSRSWRTKLFILKYILPPVISIITLVVFLVLWIRRRKNLEVPTPIDSWLP-- 1156

Query: 377  AMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFD 436
                  S+ +L  AT+ F E+NLIG+GS   V+K  L +G+ VA+KVFNL++   F+SFD
Sbjct: 1157 GSHEKISHQQLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFD 1216

Query: 437  VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
             ECE+M+SIRHRN++K+I+ CSN +FKALVLEYMP GSL+K+L+S NY LD+ QRLNIMI
Sbjct: 1217 SECEVMQSIRHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMI 1276

Query: 497  DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            DVASALEYLH    + V+HCDLKP+N+LLDD+MVAH+ DFGIA+LLT E +S  QT+TL 
Sbjct: 1277 DVASALEYLHHDCPSLVVHCDLKPNNILLDDDMVAHVGDFGIARLLT-ETESMQQTKTLG 1335

Query: 557  TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST 616
            TIGYMAPEYG +G VS  GDV+S+GIMLME F RKKP DE+FNG++TLK WV   L  S 
Sbjct: 1336 TIGYMAPEYGSDGIVSTKGDVFSYGIMLMEVFARKKPMDEMFNGDLTLKSWVES-LADSM 1394

Query: 617  KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
             E+VD NLL RED +F  K  C+S +  +A+ CT +SPE+RI+ K++V  L KI+  LL
Sbjct: 1395 IEVVDANLLRREDEDFATKLSCLSSIMALALACTTDSPEERIDMKDVVVGLKKIKIELL 1453

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  654 bits (1686), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 365/715 (51%), Positives = 474/715 (66%), Gaps = 52/715 (7%)

Query: 7    NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTL--EL 64
            N FSG IP  I N SKL++L LS NSF+G +P   GNL  L+ L L+ N LT   +  E+
Sbjct: 520  NEFSGIIPMSISNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVASEV 579

Query: 65   SFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT 124
             FL+SL+NCK L  +   NNP  G LP  S+GNL  +LE F  + C   G IP  IGNLT
Sbjct: 580  GFLTSLTNCKFLKNLWIGNNPFKGTLPN-SLGNLPIALESFIASACQFRGTIPTRIGNLT 638

Query: 125  NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
            NL  + LG N L GSIP+TLG+L+KLQ L +  N+L GSIP+ +CH   L  L L  NKL
Sbjct: 639  NLIWLDLGANDLTGSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSSNKL 698

Query: 185  SGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK 243
            SGSIP CF +L +L+ L L SN L  +IP + W+L+D+L LN SSNF TG LP E+GN+K
Sbjct: 699  SGSIPSCFGDLPALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMK 758

Query: 244  ---------------IAR-----------------------IDSCDLISLISLNLSNNNL 265
                           I R                       I+  DL+SL SL+LS NNL
Sbjct: 759  SITTLDLSKNLVSGHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNL 818

Query: 266  SGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCK 325
            SG IP SLE L YLK LN+S NKL+GEIP GG F NF+AESF  NE LCG+P+ +V  C 
Sbjct: 819  SGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACD 878

Query: 326  TSIHHISRKN-AFLLG-IVLPLSTVFMIVVIFLIVKCRKR---ERGPPNDANMPPEAMQR 380
             +    S K  +F+L  I+LP+ ++  +VV F+++  R+R   E   P D+ +P      
Sbjct: 879  KNNRTQSWKTKSFILKYILLPVGSIVTLVV-FIVLWIRRRDNMEIPTPIDSWLP--GTHE 935

Query: 381  MFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECE 440
              S+ +L  AT+ F E+NLIG+GS G V+K  L +G+ VA+KVFNL++    +SFD ECE
Sbjct: 936  KISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECE 995

Query: 441  MMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
            +M+ IRHRN++++I+ CSN +FKALVLEYMP+GSLEK+L+S NY LD+ QRLNIMIDVAS
Sbjct: 996  VMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVAS 1055

Query: 501  ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
            ALEYLH   S+ V+HCDLKP+NVLLDD+MVAH++DFGI KLLT+  +S  QT+TL TIGY
Sbjct: 1056 ALEYLHHDCSSLVVHCDLKPNNVLLDDDMVAHVADFGITKLLTKT-ESMQQTKTLGTIGY 1114

Query: 561  MAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 620
            MAPE+G +G VS   DVYS+GI+LME F+RKKP DE+F G++TLK WV + L  S  ++V
Sbjct: 1115 MAPEHGSDGIVSTKSDVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWV-ESLSNSVIQVV 1173

Query: 621  DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
            D NLL RED +   K  C+S +  +A+ CT +SPE+R+N K+ V +L K R  LL
Sbjct: 1174 DANLLRREDEDLATKLSCLSSIMALALACTTDSPEERLNMKDAVVELKKSRMKLL 1228

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483688|ref|XP_003633002.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FLS2-like [Vitis vinifera]

 Score =  653 bits (1685), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/713 (51%), Positives = 472/713 (66%), Gaps = 48/713 (6%)

Query: 7    NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLE--L 64
            N FSG IP  I N SKL  L++ DNSF+G +P   GNL  L+ L L+NN LT   L   +
Sbjct: 488  NEFSGIIPMSISNMSKLIQLQVWDNSFTGNVPKDLGNLTKLEVLNLANNQLTDEHLASGV 547

Query: 65   SFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT 124
            SFL+SL+NCK L  +    NPL G LP  S+GNL  +LE F    C   G IP  IGNLT
Sbjct: 548  SFLTSLTNCKFLRTLWIGYNPLKGTLPN-SLGNLPIALESFNAYACQFRGTIPTGIGNLT 606

Query: 125  NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
            NL +++LG N L GSIP+TLG+LQKLQ L +  N++ GSIP+ +CH   L  L L  NKL
Sbjct: 607  NLIMLHLGANDLTGSIPTTLGQLQKLQALSIAGNRIRGSIPNDLCHLKNLGYLGLSSNKL 666

Query: 185  SGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK 243
            SGS P CF +L +LR L L SN L  +IP + W+L+D+L LN SSNF TG LP E+GN+K
Sbjct: 667  SGSTPSCFGDLLALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMK 726

Query: 244  -IARID------------------------------------SC-DLISLISLNLSNNNL 265
             I  +D                                     C DL+SL SL+LS NNL
Sbjct: 727  YIITLDLSKNLVSGYIPSRMGKLQNLITLSLSQNKLQGPIPVECGDLVSLESLDLSQNNL 786

Query: 266  SGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCK 325
            S  IP SLE L YLK LN+SFNKL+GEIP GG F NF+AESF  NE LCG+P+ +V  C 
Sbjct: 787  SRIIPKSLEALIYLKYLNVSFNKLQGEIPNGGPFVNFNAESFMFNEALCGAPHFQVMACD 846

Query: 326  TSIHHISRKN-AFLLG-IVLPL-STVFMIVVIFLIVKCRKRERGPPNDANMPPEAMQRMF 382
             +    S K  +F+L  I+LP+ STV ++V I L ++ R     P   A+  P   +++ 
Sbjct: 847  KNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPIASWLPGTHEKI- 905

Query: 383  SYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMM 442
            S+ +L  AT+ F E+NLIG+GS G V+K  L +G+ VA+KVFNL++ R  +SFD ECE+M
Sbjct: 906  SHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQRALRSFDSECEVM 965

Query: 443  KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
            + IRHRN++++I+ CSN +FKALVLEYMP+GSLEK+L+S NY LD+ QRLNIMI VASAL
Sbjct: 966  QGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIYVASAL 1025

Query: 503  EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
            EYLH   S+ V+HCDLKPSNVLLDDNMVAH++DFGIAKLLT E +S  QT+TL TIGYMA
Sbjct: 1026 EYLHHDCSSLVVHCDLKPSNVLLDDNMVAHVADFGIAKLLT-ETESMQQTKTLGTIGYMA 1084

Query: 563  PEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 622
            PE+G  G VS   DVYS+ I+LME F RKKP DE+F G++TLK WV   L  S  ++VD 
Sbjct: 1085 PEHGSAGIVSTKSDVYSYEILLMEVFARKKPMDEMFTGDLTLKTWVES-LSNSVIQVVDV 1143

Query: 623  NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
            NLL RED +   K  C+S +  +A+ CT +SP++RI+ K++V +L K R  LL
Sbjct: 1144 NLLRREDEDLGTKLSCLSSIMALALACTTDSPKERIDMKDVVVELKKSRIKLL 1196

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483685|ref|XP_002263372.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase EFR-like [Vitis vinifera]

 Score =  652 bits (1681), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/714 (51%), Positives = 471/714 (65%), Gaps = 50/714 (7%)

Query: 7    NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLE--L 64
            N FSGTIP  I N SKL++L LSDNSF+G +P    NL  LQ L L+ N LT   L   +
Sbjct: 337  NEFSGTIPMSISNMSKLTVLSLSDNSFTGNVPKDLCNLTKLQFLDLAYNQLTDEHLASGV 396

Query: 65   SFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT 124
             FL+SL+NCK L  +    NPL G LP  S+GNL  +LE F  + C   G IP  IGNLT
Sbjct: 397  GFLTSLTNCKFLRNLWIGYNPLTGTLPN-SLGNLPIALEIFIASACQFRGTIPTGIGNLT 455

Query: 125  NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
            NL  + LG N L GSIP+TLG+LQKLQ L +  N++ GSIP+ +CH   L  L L  NKL
Sbjct: 456  NLIWLDLGANDLTGSIPTTLGQLQKLQALSIVGNRIRGSIPNDLCHLKNLGYLRLSYNKL 515

Query: 185  SGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK 243
            SGSIP CF +L +LR L L SN L  +IP++FW+L+D+L LN SSNF TG LP E+GN+K
Sbjct: 516  SGSIPSCFGDLPALRELSLDSNVLAFNIPMSFWSLRDLLVLNLSSNFLTGNLPPEVGNMK 575

Query: 244  -IARIDSC-------------------------------------DLISLISLNLSNNNL 265
             I  +D                                       DL+SL SL+LS NNL
Sbjct: 576  SITTLDLSKNLVSGYIPSRMGKLQNLITLSLSQNKLQGPIPVEFGDLVSLESLDLSQNNL 635

Query: 266  SGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCK 325
            SG IP +LE L YLK LN+SFNKL+GEIP GG F  F+AESF  NE LCG+P+ +V  C 
Sbjct: 636  SGTIPKTLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACD 695

Query: 326  TSIHHISRKN-AFLLG-IVLPL-STVFMIVVIFLIVKCRKRERGP-PNDANMPPEAMQRM 381
             +    S K  +F+L  I+LP+ STV ++V I L ++ R     P P D+ +P       
Sbjct: 696  KNNRTQSWKTKSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPIDSWLP--GTHEK 753

Query: 382  FSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEM 441
             S+ +L  AT+ F E+NLIG+GS G V+K  L +G+ VA+KVFNL++    +SF+ ECE+
Sbjct: 754  ISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFNSECEV 813

Query: 442  MKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
            M+ IRHRN++++I+ CSN +FKALVL+YMP+GSLEK L+S  Y LD+ QRLNIMIDVASA
Sbjct: 814  MQGIRHRNLVRIITCCSNLDFKALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASA 873

Query: 502  LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
            LEYLH   S+ V+HCDLKPSNVLLDD+MVAH++DFGIAKLLT E +S  QT+TL+TIGYM
Sbjct: 874  LEYLHHDCSSLVVHCDLKPSNVLLDDDMVAHVADFGIAKLLT-ETESMQQTKTLSTIGYM 932

Query: 562  APEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 621
            APE+G  G VS   DVYS+GI+LME F RKKP DE+F G++TLK WV   L  S  ++VD
Sbjct: 933  APEHGSAGIVSTKSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWVES-LSNSVIQVVD 991

Query: 622  PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
             NLL RED +   K  C+S +  +A+ CT +SPE+RI+ K+ V +L K R  LL
Sbjct: 992  VNLLRREDEDLATKLSCLSSIMALALACTTDSPEERIDMKDAVVELKKSRIKLL 1045

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  650 bits (1678), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 365/714 (51%), Positives = 465/714 (65%), Gaps = 53/714 (7%)

Query: 7    NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS--STLEL 64
            N FSG IP  I N S L  L++SDN F G +P   GNLR LQ L LS+N LT+  S  EL
Sbjct: 490  NEFSGIIPMSISNMSNLISLDISDNFFIGNVPKDLGNLRQLQLLGLSHNQLTNEHSASEL 549

Query: 65   SFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT 124
            +FL+SL+NC  L  +S S+NPL G++P  S+GNLS SLE    + C + G IP  I NLT
Sbjct: 550  AFLTSLTNCIFLRTLSISDNPLKGMIPN-SLGNLSISLEIIYASDCQLRGTIPTGISNLT 608

Query: 125  NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
            NL  + L  N L G IP+  G+LQKLQ L +  N++ GSIP  +CH   L  L+L  NKL
Sbjct: 609  NLIGLRLDDNDLTGLIPTPFGRLQKLQMLSISQNRIHGSIPSGLCHLTNLAFLDLSSNKL 668

Query: 185  SGSIPECFNNLASLRILLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK 243
            SG+IP C  NL  LR + L SN L S IP +  NL+ +L LN SSNF    LPL++GN+K
Sbjct: 669  SGTIPSCSGNLTGLRNVYLHSNGLASEIPSSLCNLRGLLVLNLSSNFLNSQLPLQVGNMK 728

Query: 244  -IARIDSC-------------------------------------DLISLISLNLSNNNL 265
             +  +D                                       DL+SL SL+LS NNL
Sbjct: 729  SLVALDLSKNQFSGNIPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLESLDLSGNNL 788

Query: 266  SGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCK 325
            SG IP SLE L YL+ LN+SFNKL+GEIP GG F NF+AESF  N  LCG+P  +V  C+
Sbjct: 789  SGTIPKSLEHLKYLEYLNVSFNKLQGEIPNGGPFANFTAESFISNLALCGAPRFQVMACE 848

Query: 326  TSIHHISRKN--AFLLGIVLPLS---TVFMIVVIFLIVKCRKRERGPPNDANMPPEAMQR 380
                  SRKN  + LL  ++PLS   +  ++VV+F+  K R+ +   P   ++    M R
Sbjct: 849  KD----SRKNTKSLLLKCIVPLSVSLSTIILVVLFVQWKRRQTKSETPIQVDLSLPRMHR 904

Query: 381  MFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECE 440
            M  + EL  AT+ F E+NLIG+GS G V+K  L DG+ VA+KVFNL+    FKSF+VECE
Sbjct: 905  MIPHQELLYATNYFGEDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECE 964

Query: 441  MMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
            +M++IRHRN+ K+ISSCSN +FKALVLEYMP+GSLEK+L+S NY LD  QRL IMIDVAS
Sbjct: 965  VMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVAS 1024

Query: 501  ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
             LEYLH  YS  V+HCDLKPSNVLLDD+MVAH+SDFGIAKLL   +    +T+TL T+GY
Sbjct: 1025 GLEYLHHYYSNPVVHCDLKPSNVLLDDDMVAHISDFGIAKLLMGSEFMK-RTKTLGTVGY 1083

Query: 561  MAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 620
            MAPEYG EG VS  GD+YS+GI+LMETF RKKPTDE+F  E+TLK WV      +  E++
Sbjct: 1084 MAPEYGSEGIVSTKGDIYSYGILLMETFVRKKPTDEMFVEELTLKSWVESSTN-NIMEVI 1142

Query: 621  DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL 674
            D NLL+ ED +F  K  C S +  +A++CTVE PE+RIN K++V +L K+ + +
Sbjct: 1143 DANLLTEEDESFALKRACFSSIMTLALDCTVEPPEKRINTKDVVVRLKKLLNQI 1196

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	678
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.520	0.349	0.395	6.9e-95
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.761	0.503	0.354	4.6e-70
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.771	0.517	0.352	4.5e-75
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.861	0.569	0.364	2.1e-91
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.945	0.635	0.345	3.2e-88
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.469	0.308	0.414	4e-87
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.963	0.556	0.324	1.6e-86
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.955	0.661	0.332	6e-80
TAIR|locus:2167948	966	ERL1 "ERECTA-like 1" [Arabidop	0.949	0.666	0.312	1.7e-73
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.414	0.224	0.363	3.2e-73

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 676 (243.0 bits), Expect = 6.9e-95, Sum P(2) = 6.9e-95
 Identities = 149/377 (39%), Positives = 222/377 (58%)

Query:   322 PPCKTSIHHISRKNAFLLGIVLPLSTVFMIVVIFLIVKCRKRERGPPNDANMPP--EAMQ 379
             PP +T      +K A L+ I + L  + +++   ++   RKR +    +  +P   E   
Sbjct:   630 PPVETKHSSHLKKVAILVSIGIAL-LLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFH 688

Query:   380 RMFSYLELCRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVE 438
                SY +L  AT+GFS +N++G GSFG+VFKA L  +   VA+KV N+Q     KSF  E
Sbjct:   689 EKISYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAE 748

Query:   439 CEMMKSIRHRNIIKVISSCSN-----EEFKALVLEYMPHGSLEKYLHSSNY--------I 485
             CE +K  RHRN++K++++C++      EF+AL+ EY+P+GS++ +LH             
Sbjct:   749 CESLKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRT 808

Query:   486 LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 545
             L + +RLNI+IDVAS L+YLH      + HCDLKPSNVLL+D++ AH+SDFG+A+LL + 
Sbjct:   809 LTLLERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKF 868

Query:   546 DQSTIQTQTLA-----TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNG 600
             D+ +   Q  +     TIGY APEYG  G+ S +GDVYSFG++L+E FT K+PTDE+F G
Sbjct:   869 DKESFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGG 928

Query:   601 EMTLKHWVNDWLPISTKEIVDPNLLSRE-DINFVAKEQCVSFVFNVAMECTVESPEQRIN 659
              +TL  +    LP    EI D  +L     + F   E C++ V  V + C  E P  R+ 
Sbjct:   929 NLTLHSYTKLALPEKVFEIADKAILHIGLRVGFRTAE-CLTLVLEVGLRCCEEYPTNRLA 987

Query:   660 AKEIVTKLLKIRDSLLR 676
               E+  +L+ IR+   +
Sbjct:   988 TSEVAKELISIRERFFK 1004

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 712 (255.7 bits), Expect = 4.6e-70, P = 4.6e-70
 Identities = 199/562 (35%), Positives = 278/562 (49%)

Query:    19 NASKLSILELSDNSFSGFIPNTFGNLRN-LQALRLSNNYXXXXXXXXXXXXXXXNCKSLT 77
             N S+L  L +  N   G +P    NL   L  L L  N                N  SL 
Sbjct:   350 NCSQLQYLNVGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIG-----NLVSLQ 404

Query:    78 LISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCN-VSGGIPEEIGNLTNLTIIYLGGNKL 136
              +    N L G LP  S+G LS   +   + Y N +SG IP  +GN++ LT +YL  N  
Sbjct:   405 TLDLGENLLTGKLPP-SLGELSELRKV--LLYSNGLSGEIPSSLGNISGLTYLYLLNNSF 461

Query:   137 NGSIPSTXXXXXXXXXXXXENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLA 196
              GSIPS+              NKL GSIP  +     L  L +  N L G + +    L 
Sbjct:   462 EGSIPSSLGSCSYLLDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLK 521

Query:   197 SLRILLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDXXXX 255
              L  L +  N+L+  IP T  N   + +L    N F GP+P +I  L   R    D    
Sbjct:   522 FLLALDVSYNKLSGQIPQTLANCLSLEFLLLQGNSFVGPIP-DIRGLTGLRF--LDLSKN 578

Query:   256 XXXXXXXXXXXGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCG 315
                        G IP  +   S L++LNLS N  +G +P  G F N SA S  GN  LCG
Sbjct:   579 NLS--------GTIPEYMANFSKLQNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCG 630

Query:   316 S-PNLRVPPCKTSI--HHISRKNAFLLGIVLPLSTVFMIV--VIFLI-VKCRK---RERG 366
               P+L++ PC   +   H S +    + +   ++ + ++   V++L   K R    R   
Sbjct:   631 GIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANN 690

Query:   367 PPNDANMPP-EAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVF 424
               ND +  P ++     SY EL + T GFS +NLIG G+FG+VFK  LG     VA+KV 
Sbjct:   691 NENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVL 750

Query:   425 NLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF-----KALVLEYMPHGSLEKYL 479
             NL      KSF  ECE +  IRHRN++K+++ CS+ +F     +ALV E+MP+G+L+ +L
Sbjct:   751 NLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWL 810

Query:   480 H--------SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVA 531
             H        + +  L ++ RLNI IDVASAL YLH      + HCD+KPSN+LLD ++ A
Sbjct:   811 HPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTA 870

Query:   532 HLSDFGIAKLLTREDQSTIQTQ 553
             H+SDFG+A+LL + D+ T   Q
Sbjct:   871 HVSDFGLAQLLLKFDRDTFHIQ 892

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 757 (271.5 bits), Expect = 4.5e-75, P = 4.5e-75
 Identities = 199/565 (35%), Positives = 293/565 (51%)

Query:    19 NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYXXXXXXXXXXXXXXXNCKSLTL 78
             N ++L  L +  N   G +P +  NL + + + L                   N + L L
Sbjct:   334 NCTQLETLGIGRNRLGGDLPISIANL-SAKLVTLDLGGTLISGSIPYDIGNLINLQKLIL 392

Query:    79 ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG 138
                  N L G LP TS+G L + L Y  +    +SGGIP  IGN+T L  + L  N   G
Sbjct:   393 ---DQNMLSGPLP-TSLGKLLN-LRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEG 447

Query:   139 SIPSTXXXXXXXXXXXXENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASL 198
              +P++             +NKL G+IP  I    +L +L++ GN L GS+P+    L +L
Sbjct:   448 IVPTSLGNCSHLLELWIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNL 507

Query:   199 RILLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDXXXXXX 257
               L LG N+L+  +P T  N   +  L    N F G +P   G + +  +D  +      
Sbjct:   508 GTLSLGDNKLSGKLPQTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEVDLSNNDLS-- 565

Query:   258 XXXXXXXXXGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGS- 316
                      G+IP      S L+ LNLSFN LEG++P  G F N +  S  GN  LCG  
Sbjct:   566 ---------GSIPEYFASFSKLEYLNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGI 616

Query:   317 PNLRVPPCKT---SI--HHISRKNAFLLGI---VLPLSTVFMIVVIFLIVKCRKRERGPP 368
                ++ PC +   S+   H SR    ++G+   +  L  +FM  V  + ++ RK+ +   
Sbjct:   617 MGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETN 676

Query:   369 NDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ 427
             N      E +    SY +L  AT+GFS +N++G GSFG+V+KA L  +   VA+KV N+Q
Sbjct:   677 NPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQ 736

Query:   428 YGRVFKSFDVECEMMKSIRHRNIIKVISSCSN-----EEFKALVLEYMPHGSLEKYLHSS 482
                  KSF  ECE +K IRHRN++K++++CS+      EF+AL+ E+MP+GSL+ +LH  
Sbjct:   737 RRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPE 796

Query:   483 NY--------ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLS 534
                        L + +RLNI IDVAS L+YLH      + HCDLKPSNVLLDD++ AH+S
Sbjct:   797 EVEEIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVS 856

Query:   535 DFGIAKLLTREDQSTIQTQTLATIG 559
             DFG+A+LL + D+ +   Q L++ G
Sbjct:   857 DFGLARLLLKFDEESFFNQ-LSSAG 880

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 911 (325.7 bits), Expect = 2.1e-91, P = 2.1e-91
 Identities = 229/629 (36%), Positives = 341/629 (54%)

Query:    19 NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYXXXXXXXXXXXXXXXNCKSLTL 78
             N SKL  L L +N+  G +PN+F NL    +  LS                  N   L  
Sbjct:   349 NCSKLQTLNLGENNLGGVLPNSFSNL----STSLSFLALELNKITGSIPKDIGNLIGLQH 404

Query:    79 ISFSNNPLDGILPKTSVGNLSHSLEYFEMAY-CNVSGGIPEEIGNLTNLTIIYLGGNKLN 137
             +   NN   G LP +S+G L + L    +AY  N+SG IP  IGNLT L I+ LG NK +
Sbjct:   405 LYLCNNNFRGSLP-SSLGRLKN-LGIL-LAYENNLSGSIPLAIGNLTELNILLLGTNKFS 461

Query:   138 GSIPSTXXXXXXXXXXXXENNKLEGSIPDSICHSDEL-YKLELGGNKLSGSIPECFNNLA 196
             G IP T              N L G IP  + +   L   + +  N L GSIP+   +L 
Sbjct:   462 GWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLK 521

Query:   197 SLRILLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDXXXX 255
             +L      SN L+  IP T  + + + YL   +N  +G +P  +G LK   +++ D    
Sbjct:   522 NLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNNLLSGSIPSALGQLK--GLETLDLSSN 579

Query:   256 XXXXXXXXXXXGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCG 315
                        G IP SL  ++ L  LNLSFN   GE+P  G+F   S  S +GN  LCG
Sbjct:   580 NLS--------GQIPTSLADITMLHSLNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCG 631

Query:   316 S-PNLRVPPCKTSIHHISRKNAFLLGIVLPLSTVFMIVV-IFLIVKCRKR-ERGPPNDAN 372
               P+L +P C   + +  RK+  +L I + L+    I+  ++L++   KR ++G P+  +
Sbjct:   632 GIPDLHLPRCCPLLEN--RKHFPVLPISVSLAAALAILSSLYLLITWHKRTKKGAPSRTS 689

Query:   373 MPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF 432
             M    +    SY +L +ATDGF+  NL+G GSFGSV+K +L     VA+KV  L+  +  
Sbjct:   690 MKGHPL---VSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKAL 746

Query:   433 KSFDVECEMMKSIRHRNIIKVISSCSN-----EEFKALVLEYMPHGSLEKYLH------S 481
             KSF  ECE ++++RHRN++K+++ CS+      +FKA+V ++MP+GSLE ++H      +
Sbjct:   747 KSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQA 806

Query:   482 SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 541
                 L++++R+ I++DVA AL+YLH      V+HCD+K SNVLLD +MVAH+ DFG+A++
Sbjct:   807 DQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARI 866

Query:   542 LTREDQSTIQTQT-----LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDE 596
             L  +  S IQ  T     + TIGY APEYG     S +GD+YS+GI+++E  T K+PTD 
Sbjct:   867 LV-DGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDS 925

Query:   597 IFNGEMTLKHWVNDWLPISTKEIVDPNLL 625
              F  ++ L+ +V   L     ++VD  L+
Sbjct:   926 TFRPDLGLRQYVELGLHGRVTDVVDTKLI 954

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 881 (315.2 bits), Expect = 3.2e-88, P = 3.2e-88
 Identities = 237/685 (34%), Positives = 341/685 (49%)

Query:    19 NASKLSILELSDNSFSGFIPNTFGNLRN-LQALRLSNNYXXXXXXXXXXXXXXXNCKSLT 77
             N S L  L +S N   G +P +  N+   L  L L  N                N   L 
Sbjct:   335 NCSHLHGLSVSYNRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIG-----NLIGLQ 389

Query:    78 LISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCN-VSGGIPEEIGNLTNLTIIYLGGNKL 136
              +  ++N L G LP TS+GNL    E   + + N  SG IP  IGNLT L  +YL  N  
Sbjct:   390 SLLLADNLLTGPLP-TSLGNLVGLGEL--ILFSNRFSGEIPSFIGNLTQLVKLYLSNNSF 446

Query:   137 NGSIPSTXXXXXXXXXXXXENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLA 196
              G +P +              NKL G+IP  I     L  L +  N LSGS+P     L 
Sbjct:   447 EGIVPPSLGDCSHMLDLQIGYNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPNDIGRLQ 506

Query:   197 SLRILLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDXXXX 255
             +L  LLLG+N L+  +P T      +  +    N F G +P   G + +  +D  +    
Sbjct:   507 NLVELLLGNNNLSGHLPQTLGKCLSMEVIYLQENHFDGTIPDIKGLMGVKNVDLSNNNLS 566

Query:   256 XXXXXXXXXXXGAIPASLEKLSYLKDLNLSFN-KLEGEIPRGGSFGNFSAESFEGN--EL 312
                            + LE L+ L D N       EG          F  ++  G+  EL
Sbjct:   567 GSISEYFENF-----SKLEYLN-LSDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKEL 620

Query:   313 LCGSPNLRVPPCKTSIHHISRKNAFLLGIVLPLSTVFMIVVIFLI-VKCRKRERGPPNDA 371
                    + PP +T   H S      +G+ + ++ + ++ ++ L   K RK  +   N A
Sbjct:   621 KLKPCIAQAPPVET--RHPSLLKKVAIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSA 678

Query:   372 NMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGR 430
                 E      SY +L  ATDGFS +N++G GSFG+VFKA L  +   VA+KV N+Q   
Sbjct:   679 PFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRG 738

Query:   431 VFKSFDVECEMMKSIRHRNIIKVISSCSN-----EEFKALVLEYMPHGSLEKYLHSSNY- 484
               KSF  ECE +K IRHRN++K++++C++      EF+AL+ E+MP+GSL+K+LH     
Sbjct:   739 AMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVE 798

Query:   485 -------ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG 537
                     L + +RLNI IDVAS L+YLH      + HCDLKPSN+LLDD++ AH+SDFG
Sbjct:   799 EIHRPSRTLTLLERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFG 858

Query:   538 IAKLLTREDQSTIQTQTLA-----TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK 592
             +A+LL + DQ +   Q  +     TIGY APEYG  G+ S +GDVYSFG++++E FT K+
Sbjct:   859 LARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKR 918

Query:   593 PTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL-SREDINFVAKEQCVSFVFNVAMECTV 651
             PT+E+F G  TL  +    LP    +I D ++L S   + F   E C+  + +V + C  
Sbjct:   919 PTNELFGGNFTLNSYTKAALPERVLDIADKSILHSGLRVGFPVLE-CLKGILDVGLRCCE 977

Query:   652 ESPEQRINAKEIVTKLLKIRDSLLR 676
             ESP  R+   E   +L+ IR+   +
Sbjct:   978 ESPLNRLATSEAAKELISIRERFFK 1002

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 585 (211.0 bits), Expect = 4.0e-87, Sum P(2) = 4.0e-87
 Identities = 148/357 (41%), Positives = 205/357 (57%)

Query:   339 LGIVLPLSTVFMIVVIFLIVKCRKRER---GPPNDANMPPEAMQRMFSYLELCRATDGFS 395
             +GI   L  + ++  +   +K +K+     G P+D+       +++ SY EL  AT  FS
Sbjct:   656 IGIA-SLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKV-SYEELHSATSRFS 713

Query:   396 ENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
               NLIG G+FG+VFK  LG +   VA+KV NL      KSF  ECE  K IRHRN++K+I
Sbjct:   714 STNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLI 773

Query:   455 SSCSN-----EEFKALVLEYMPHGSLEKYL----------HSSNYILDIYQRLNIMIDVA 499
             + CS+      +F+ALV E+MP GSL+ +L          HS +  L   ++LNI IDVA
Sbjct:   774 TVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRS--LTPAEKLNIAIDVA 831

Query:   500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-----T 554
             SALEYLH      V HCD+KPSN+LLDD++ AH+SDFG+A+LL + D+ +   Q      
Sbjct:   832 SALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGV 891

Query:   555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI 614
               TIGY APEYG  G+ S  GDVYSFGI+L+E F+ KKPTDE F G+  L  +       
Sbjct:   892 RGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSY------- 944

Query:   615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
              TK I+     S    N +  ++ +  V  V ++C+ E P  R+   E V +L+ IR
Sbjct:   945 -TKSILS-GCTSSGGSNAI--DEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 865 (309.6 bits), Expect = 1.6e-86, P = 1.6e-86
 Identities = 225/693 (32%), Positives = 365/693 (52%)

Query:     1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYXXXX 60
             +LQ+  N+ +G IPR I N   L+IL L  N F+G IP    NL  LQ LR+ +N     
Sbjct:   483 ILQVSYNSLTGPIPREIGNLKDLNILYLHSNGFTGRIPREMSNLTLLQGLRMYSN----- 537

Query:    61 XXXXXXXXXXXNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
                        + K L+++  SNN   G +P  ++ +   SL Y  +     +G IP  +
Sbjct:   538 DLEGPIPEEMFDMKLLSVLDLSNNKFSGQIP--ALFSKLESLTYLSLQGNKFNGSIPASL 595

Query:   121 GNLTNLTIIYLGGNKLNGSIPSTXXXXXXXXXXXXE--NNKLEGSIPDSICHSDELYKLE 178
              +L+ L    +  N L G+IP                 NN L G+IP  +   + + +++
Sbjct:   596 KSLSLLNTFDISDNLLTGTIPGELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEID 655

Query:   179 LGGNKLSGSIPECFNNLASLRILLLGSNELTS-IP-LTFWNLKDILYLNFSSNFFTGPLP 236
             L  N  SGSIP       ++  L    N L+  IP   F  +  I+ LN S N F+G +P
Sbjct:   656 LSNNLFSGSIPRSLQACKNVFTLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIP 715

Query:   237 LEIGNLKIARIDSCDXXXXXXXXXXXXXXXGAIPASLEKLSYLKDLNLSFNKLEGEIPRG 296
                GN+    + S D               G IP SL  LS LK L L+ N L+G +P  
Sbjct:   716 QSFGNM--THLVSLDLSSNNLT--------GEIPESLANLSTLKHLKLASNNLKGHVPES 765

Query:   297 GSFGNFSAESFEGNELLCGSPNLRVPPC--KTSIHHISRKNAFLLGIVLPLSTVFMIVVI 354
             G F N +A    GN  LCGS    + PC  K    H S++   +L I+   + + +++++
Sbjct:   766 GVFKNINASDLMGNTDLCGSKK-PLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLL 824

Query:   355 FLIVKC-RKRERGPPN--DANMPP--EAMQ-RMFSYLELCRATDGFSENNLIGRGSFGSV 408
              LI+ C +K+E+   N  ++++P    A++ + F   EL +ATD F+  N+IG  S  +V
Sbjct:   825 VLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTV 884

Query:   409 FKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVIS-SCSNEEFKAL 465
             +K +L DG  +A+KV NL+       K F  E + +  ++HRN++K++  +  + + KAL
Sbjct:   885 YKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKILGFAWESGKTKAL 944

Query:   466 VLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVL 524
             VL +M +G+LE  +H S   I  + +++++ + +AS ++YLH GY   ++HCDLKP+N+L
Sbjct:   945 VLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANIL 1004

Query:   525 LDDNMVAHLSDFGIAKLLT-REDQSTIQTQTL--ATIGYMAPEYGKEGRVSANGDVYSFG 581
             LD + VAH+SDFG A++L  RED ST  + +    TIGY+APE+    +V+   DV+SFG
Sbjct:  1005 LDSDRVAHVSDFGTARILGFREDGSTTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFG 1064

Query:   582 IMLMETFTRKKPT--DEIFNGEMTLKHWVNDWLPISTKEIVDP-NLLSREDINFVAKEQC 638
             I++ME  T+++PT  ++  + +MTL+  V   +    K +V   ++   + I  + +E+ 
Sbjct:  1065 IIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVRVLDMELGDSIVSLKQEEA 1124

Query:   639 VSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
             +     + + CT   PE R +  EI+T L+K+R
Sbjct:  1125 IEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLR 1157

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 803 (287.7 bits), Expect = 6.0e-80, P = 6.0e-80
 Identities = 236/709 (33%), Positives = 356/709 (50%)

Query:     2 LQMWENNFSGTIPRFIFNAS-KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYXXXX 60
             L++  N+  G I   + + S  L  + L  N   G IP    NL NL  L LS+N     
Sbjct:   277 LELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSNLLSGP 336

Query:    61 XXXXXXXXXXXNCK--SLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPE 118
                         CK   L  +  SNN L G +P   +G++   L   +++  N+SG IP+
Sbjct:   337 IPREL-------CKLSKLERVYLSNNHLTGEIPM-ELGDIPR-LGLLDVSRNNLSGSIPD 387

Query:   119 EIGNLTNLTIIYLGGNKLNGSIPSTXXXXXXXXXXXXENNKLEGSIPDSIC---HSDELY 175
               GNL+ L  + L GN L+G++P +             +N L G+IP  +     + +LY
Sbjct:   388 SFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLY 447

Query:   176 KLELGGNKLSGSIPECFNNLASLRILLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTGP 234
              L L  N LSG IP   + +  +  + L SNEL+  IP    +   + +LN S N F+  
Sbjct:   448 -LNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSST 506

Query:   235 LPLEIGNLKIARIDSCDXXXXXXXXXXXXXXXGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
             LP  +G L   +    D               GAIP S ++ S LK LN SFN L G + 
Sbjct:   507 LPSSLGQLPYLK--ELDVSFNRLT--------GAIPPSFQQSSTLKHLNFSFNLLSGNVS 556

Query:   295 RGGSFGNFSAESFEGNELLCGSPNLRVPPCKTSIHHISRKNAFLLGIVL-PLSTVFMIVV 353
               GSF   + ESF G+ LLCGS    +  CK    + S     LL ++  P+  VF   +
Sbjct:   557 DKGSFSKLTIESFLGDSLLCGSIK-GMQACKKKHKYPSVLLPVLLSLIATPVLCVFGYPL 615

Query:   354 I----F---LIVKCRKRERGPPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFG 406
             +    F   L V   K E       N       R+ SY +L  AT GF+ ++LIG G FG
Sbjct:   616 VQRSRFGKNLTVYA-KEEVEDEEKQNQNDPKYPRI-SYQQLIAATGGFNASSLIGSGRFG 673

Query:   407 SVFKARLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIKVISSCSNEEFKAL 465
              V+K  L +  +VA+KV + +    F  SF  EC+++K  RHRN+I++I++CS   F AL
Sbjct:   674 HVYKGVLRNNTKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSKPGFNAL 733

Query:   466 VLEYMPHGSLEKYLHSSNYI---LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSN 522
             VL  MP+GSLE++L+   Y    LD+ Q +NI  DVA  + YLH     +V+HCDLKPSN
Sbjct:   734 VLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSN 793

Query:   523 VLLDDNMVAHLSDFGIAKLL--TREDQSTIQTQTLAT--------IGYMAPEYGKEGRVS 572
             +LLDD M A ++DFGI++L+    E  ST  + +  +        +GY+APEYG   R S
Sbjct:   794 ILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRAS 853

Query:   573 ANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR----- 627
              +GDVYSFG++L+E  + ++PTD + N   +L  ++    P S + I++   LSR     
Sbjct:   854 THGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIE-QALSRWKPQG 912

Query:   628 --EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL 674
               E    + +E  +  +  + + CT  +P  R +  ++  ++ ++++ L
Sbjct:   913 KPEKCEKLWREVILEMI-ELGLVCTQYNPSTRPDMLDVAHEMGRLKEYL 960

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 742 (266.3 bits), Expect = 1.7e-73, P = 1.7e-73
 Identities = 214/684 (31%), Positives = 320/684 (46%)

Query:     2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYXXXXX 61
             L +  N  +G IP  I     L++L+LSDN   G IP   GNL     L L  N      
Sbjct:   267 LSLQGNRLTGRIPEVIGLMQALAVLDLSDNELVGPIPPILGNLSFTGKLYLHGNMLTGPI 326

Query:    62 XXXXXXXXXXNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG 121
                       N   L+ +  ++N L G +P   +G L    E   +A   + G IP  I 
Sbjct:   327 PSELG-----NMSRLSYLQLNDNKLVGTIPP-ELGKLEQLFE-LNLANNRLVGPIPSNIS 379

Query:   122 NLTNLTIIYLGGNKLNGSIPSTXXXXXXXXXXXXENNKLEGSIPDSICHSDELYKLELGG 181
             +   L    + GN L+GSIP               +N  +G IP  + H   L KL+L G
Sbjct:   380 SCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVELGHIINLDKLDLSG 439

Query:   182 NKLSGSIPECFNNLASLRILLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTGPLPLEIG 240
             N  SGSIP    +L  L IL L  N L+  +P  F NL+ I  ++ S N  +G +P E+G
Sbjct:   440 NNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVSFNLLSGVIPTELG 499

Query:   241 NLKIARIDSCDXXXXXXXXXXXXXXXGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFG 300
              L+   ++S                 G IP  L     L +LN+SFN L G +P   +F 
Sbjct:   500 QLQ--NLNSL--------ILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMKNFS 549

Query:   301 NFSAESFEGNELLCGS--PNLRVPPCKTSIHHISRKNAFLLGIVLPLSTVFMIVVIFLIV 358
              F+  SF GN  LCG+   ++  P  K+ +         +LG++  L  +F+ V  +  +
Sbjct:   550 RFAPASFVGNPYLCGNWVGSICGPLPKSRVFSRGALICIVLGVITLLCMIFLAV--YKSM 607

Query:   359 KCRKRERGPPNDANMPPEAM-----QRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL 413
             + +K  +G    A    + +       + ++ ++ R T+  +E  +IG G+  +V+K  L
Sbjct:   608 QQKKILQGSSKQAEGLTKLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTVYKCAL 667

Query:   414 GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG 473
                  +A+K    QY    + F+ E E + SIRHRNI+ +     +     L  +YM +G
Sbjct:   668 KSSRPIAIKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYDYMENG 727

Query:   474 SLEKYLHSS--NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVA 531
             SL   LH S     LD   RL I +  A  L YLH   + ++IH D+K SN+LLD+N  A
Sbjct:   728 SLWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDENFEA 787

Query:   532 HLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK 591
             HLSDFGIAK +    ++   T  L TIGY+ PEY +  R++   D+YSFGI+L+E  T K
Sbjct:   788 HLSDFGIAKSIPAS-KTHASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLELLTGK 846

Query:   592 KPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL-LSREDINFVAKEQCVSFVFNVAMECT 650
             K  D   N    +    +D    +  E VDP + ++  D+  + K       F +A+ CT
Sbjct:   847 KAVDNEANLHQLILSKADD---NTVMEAVDPEVTVTCMDLGHIRK------TFQLALLCT 897

Query:   651 VESPEQRINAKEIVTKLLKIRDSL 674
               +P +R    E+   LL +  SL
Sbjct:   898 KRNPLERPTMLEVSRVLLSLVPSL 921

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010103 "stomatal complex morphogenesis" evidence=IGI;RCA

GO:0009553 "embryo sac development" evidence=IGI

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0016020 "membrane" evidence=IDA

GO:0001708 "cell fate specification" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0009886 "post-embryonic morphogenesis" evidence=RCA

GO:0009909 "regulation of flower development" evidence=RCA

GO:0009965 "leaf morphogenesis" evidence=RCA

GO:0048441 "petal development" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

GO:0048507 "meristem development" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 462 (167.7 bits), Expect = 3.2e-73, Sum P(2) = 3.2e-73
 Identities = 109/300 (36%), Positives = 165/300 (55%)

Query:   386 ELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKS 444
             ++  AT   SE  +IG G  G V+KA L +G  VA+K    +   +  KSF  E + +  
Sbjct:   943 DIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGR 1002

Query:   445 IRHRNIIKVISSCSN--EEFKALVLEYMPHGSLEKYLHSSNYIL-------DIYQRLNIM 495
             IRHR+++K++  CS+  E    L+ EYM +GS+  +LH    +L       D   RL I 
Sbjct:  1003 IRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIA 1062

Query:   496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT- 554
             + +A  +EYLH      ++H D+K SNVLLD NM AHL DFG+AK+LT    +   + T 
Sbjct:  1063 VGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTW 1122

Query:   555 -LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
                + GY+APEY    + +   DVYS GI+LME  T K PTD +F  EM +  WV   L 
Sbjct:  1123 FACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLE 1182

Query:   614 I--STKE-IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
             +  S ++ ++DP L  +  + F  +E     V  +A++CT  SP++R ++++    LL +
Sbjct:  1183 VAGSARDKLIDPKL--KPLLPF--EEDAACQVLEIALQCTKTSPQERPSSRQACDSLLHV 1238

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	678
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-63
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-51
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-45
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-44
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-43
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-42
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-42
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-40
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-38
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-38
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-36
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-33
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-31
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-29
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	4e-29
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-28
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-28
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-27
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-27
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-26
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-25
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-23
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-23
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	9e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-22
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-22
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-22
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-21
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	6e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-20
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-20
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-19
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	8e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-18
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-17
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-17
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-17
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-17
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-16
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	8e-16
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-15
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-14
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-14
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	7e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	8e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-13
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-13
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-13
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-13
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-12
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	5e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-12
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	9e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-11
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-10
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-10
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-10
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-09
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	5e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-08
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-08
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	8e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-08
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	5e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	8e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-06
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-06
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	8e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
pfam03109	117	pfam03109, ABC1, ABC1 family	1e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-04
COG2334	331	COG2334, COG2334, Putative homoserine kinase type	1e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.003

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  227 bits (581), Expect = 1e-63
 Identities = 197/683 (28%), Positives = 308/683 (45%), Gaps = 62/683 (9%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           +L ++ NNF+G IP  + +  +L +L+L  N FSG IP   G   NL  L LS N LT  
Sbjct: 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371

Query: 61  TLELSFLSSLSNCKSLT-LISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEE 119
             E      L +  +L  LI FSN+ L+G +PK S+G    SL    +   + SG +P E
Sbjct: 372 IPE-----GLCSSGNLFKLILFSNS-LEGEIPK-SLGACR-SLRRVRLQDNSFSGELPSE 423

Query: 120 IGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL 179
              L  +  + +  N L G I S    +  LQ L L  NK  G +PDS   S  L  L+L
Sbjct: 424 FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDL 482

Query: 180 GGNKLSGSIPECFNNLASLRILLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTGPLPLE 238
             N+ SG++P    +L+ L  L L  N+L+  IP    + K ++ L+ S N  +G +P  
Sbjct: 483 SRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPAS 542

Query: 239 IGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGS 298
              + +          L  L+LS N LSG IP +L  +  L  +N+S N L G +P  G+
Sbjct: 543 FSEMPV----------LSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592

Query: 299 FGNFSAESFEGNELLCGSPNLR-VPPCKTSIHHISR--KNAFLLGIVLPLSTVFMIVVIF 355
           F   +A +  GN  LCG      +PPCK      S        LG  L L+ V    V  
Sbjct: 593 FLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFI 652

Query: 356 LIVKCRKRERGPPNDANMPPEAMQRMFS-YLELCRATDGFSENNLIGRGSFGSVFKAR-L 413
                 + +R    D     +      S  + +        E N+I RG  G+ +K + +
Sbjct: 653 RGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSI 712

Query: 414 GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG 473
            +GM+  +K  N     +  S   +   M  ++H NI+K+I  C +E+   L+ EY+   
Sbjct: 713 KNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768

Query: 474 SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL 533
           +L + L +    L   +R  I I +A AL +LH   S  V+  +L P  +++D     HL
Sbjct: 769 NLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Query: 534 SDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
               +  LL  + +  I +       Y+APE  +   ++   D+Y FG++L+E  T K P
Sbjct: 825 R-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877

Query: 594 TDEIFNGEMTLKHW---------VNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFN 644
            D  F    ++  W         ++ W        +DP++     +N   + + V  V N
Sbjct: 878 ADAEFGVHGSIVEWARYCYSDCHLDMW--------IDPSIRGDVSVN---QNEIVE-VMN 925

Query: 645 VAMECTVESPEQRINAKEIVTKL 667
           +A+ CT   P  R  A +++  L
Sbjct: 926 LALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  176 bits (449), Expect = 9e-51
 Identities = 76/268 (28%), Positives = 120/268 (44%), Gaps = 26/268 (9%)

Query: 398 NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVIS 455
             +G GSFG V+ AR    G  VA+KV   +  +   +    E +++K ++H NI+++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
              +E+   LV+EY   G L   L      L   +    +  + SALEYLH   S  ++H
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DLKP N+LLD++    L+DFG+A+ L   ++    T  + T  YMAPE           
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKL---TTFVGTPEYMAPEVLLGKGYGKAV 177

Query: 576 DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK 635
           D++S G++L E  T K P    F G+  L                    +S E  + +  
Sbjct: 178 DIWSLGVILYELLTGKPP----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLI-- 231

Query: 636 EQCVSFVFNVAMECTVESPEQRINAKEI 663
            +    V +         PE+R+ A+E 
Sbjct: 232 RKL--LVKD---------PEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  166 bits (423), Expect = 1e-47
 Identities = 69/191 (36%), Positives = 104/191 (54%), Gaps = 9/191 (4%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           +G G FG+V+ AR    G +VA+K+   +    + +    E E++K + H NI+K+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            +E    LV+EY   GSL+  L  +   L   + L I++ +   LEYLH   S  +IH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 518 LKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK-EGRVSANG 575
           LKP N+LLD DN    L+DFG++KLLT     ++    + T  YMAPE    +G  S   
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKS 175

Query: 576 DVYSFGIMLME 586
           D++S G++L E
Sbjct: 176 DIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  163 bits (416), Expect = 5e-46
 Identities = 76/281 (27%), Positives = 125/281 (44%), Gaps = 42/281 (14%)

Query: 400 IGRGSFGSVFKARL-----GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV 453
           +G G+FG V+K  L     G   +VA+K           + F  E  +MK + H NI+++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
           +  C+  E   +V EYMP G L  +L      L +   L + + +A  +EYL    S   
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           +H DL   N L+ +N+V  +SDFG+++ +  +D    +      I +MAPE  K+G+ ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183

Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV 633
             DV+SFG++L E FT          GE                    P + + E +  +
Sbjct: 184 KSDVWSFGVLLWEIFTL---------GEQPY-----------------PGMSNEEVLELL 217

Query: 634 AK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                    E C   ++ + ++C    PE R    E+V  L
Sbjct: 218 EDGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  162 bits (412), Expect = 1e-45
 Identities = 84/275 (30%), Positives = 133/275 (48%), Gaps = 36/275 (13%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G GSFG+V+KA+  G G  VA+K+   +    +  ++   E  +++ + H NI+++I +
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
             +++   LV+EY   G L  YL      L   +   I + +   LEYLH   S  +IH 
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLH---SNGIIHR 122

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-------YGKEG 569
           DLKP N+LLD+N V  ++DFG+AK L +   S   T  + T  YMAPE       YG + 
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGNGYGPK- 179

Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
                 DV+S G++L E  T K P    F+GE        D L +  + +  P       
Sbjct: 180 -----VDVWSLGVILYELLTGKPP----FSGENI-----LDQLQLIRRILGPPLEFDEPK 225

Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
            +  ++E     +      C  + P +R  A+EI+
Sbjct: 226 WSSGSEE-AKDLIKK----CLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  159 bits (404), Expect = 3e-44
 Identities = 78/278 (28%), Positives = 132/278 (47%), Gaps = 31/278 (11%)

Query: 397 NNLIGRGSFGSVFKARLGD-----GMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRNI 450
              +G G+FG V+K +L        +EVA+K           + F  E  +M+ + H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
           +K++  C+ EE   +V+EYM  G L  YL  +   L +   L+  + +A  +EYL    S
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
              IH DL   N L+ +N+V  +SDFG+++ L  +D    +      I +MAPE  KEG+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 571 VSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
            ++  DV+SFG++L E FT  ++P        M+ +  +          + +   L +  
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEY--------LKNGYRLPQP- 225

Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   C   ++++ ++C  E PE R    E+V  L
Sbjct: 226 ------PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  166 bits (423), Expect = 4e-43
 Identities = 121/296 (40%), Positives = 160/296 (54%), Gaps = 22/296 (7%)

Query: 2   LQMWENNFSGTIPR-FIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L +  NNF+G+IPR  I N   L  L+LS+N  SG IPN  G+  +L+ L L  N L   
Sbjct: 123 LNLSNNNFTGSIPRGSIPN---LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
                  +SL+N  SL  ++ ++N L G +P+  +G +  SL++  + Y N+SG IP EI
Sbjct: 180 -----IPNSLTNLTSLEFLTLASNQLVGQIPR-ELGQMK-SLKWIYLGYNNLSGEIPYEI 232

Query: 121 GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG 180
           G LT+L  + L  N L G IPS+LG L+ LQ L L  NKL G IP SI    +L  L+L 
Sbjct: 233 GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLS 292

Query: 181 GNKLSGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEI 239
            N LSG IPE    L +L IL L SN  T  IP+   +L  +  L   SN F+G +P  +
Sbjct: 293 DNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNL 352

Query: 240 GNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR 295
           G             +L  L+LS NNL+G IP  L     L  L L  N LEGEIP+
Sbjct: 353 GKHN----------NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398

Length = 968

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  152 bits (386), Expect = 7e-42
 Identities = 82/285 (28%), Positives = 131/285 (45%), Gaps = 44/285 (15%)

Query: 397 NNLIGRGSFGSVFKARLGDG-----MEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNI 450
              +G G+FG V+K  L        +EVA+K        +  + F  E  +M+ + H NI
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGY 509
           +K++  C+ EE   +V+EYMP G L  YL  +    L +   L+  + +A  +EYL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
           S   IH DL   N L+ +N+V  +SDFG+++ L  +D           I +MAPE  KEG
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY-DDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
           + ++  DV+SFG++L E FT          GE         +  +S  E+          
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTL---------GEE-------PYPGMSNAEV---------- 213

Query: 630 INFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
           + ++ K         C   ++ + ++C  E PE R    E+V  L
Sbjct: 214 LEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  152 bits (386), Expect = 9e-42
 Identities = 82/284 (28%), Positives = 132/284 (46%), Gaps = 37/284 (13%)

Query: 398 NLIGRGSFGSVFKARL----GDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIK 452
             +G G+FG V+K +L    G   EVA+K          +  F  E  +MK + H N+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSS--------NYILDIYQRLNIMIDVASALEY 504
           ++  C+ EE   LVLEYM  G L  YL  S           L +   L+  I +A  +EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           L    S + +H DL   N L+ +++V  +SDFG+++ +  +D    +T     I +MAPE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 565 YGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 623
             K+G  ++  DV+SFG++L E FT    P   + N E+ L++            +    
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-LEY------------LRKGY 224

Query: 624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
            L +        E C   ++ + + C    PE R    E+V +L
Sbjct: 225 RLPK-------PEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  157 bits (399), Expect = 5e-40
 Identities = 114/293 (38%), Positives = 152/293 (51%), Gaps = 23/293 (7%)

Query: 7   NNFSGTIPRFIFN-ASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST-LEL 64
           N  SG IP  IF  +S L  L LS+N+F+G IP   G++ NL+ L LSNN L+     ++
Sbjct: 103 NQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDI 160

Query: 65  SFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT 124
              SSL       ++    N L G +P  S+ NL+ SLE+  +A   + G IP E+G + 
Sbjct: 161 GSFSSLK------VLDLGGNVLVGKIP-NSLTNLT-SLEFLTLASNQLVGQIPRELGQMK 212

Query: 125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
           +L  IYLG N L+G IP  +G L  L  L L  N L G IP S+ +   L  L L  NKL
Sbjct: 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL 272

Query: 185 SGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK 243
           SG IP    +L  L  L L  N L+  IP     L+++  L+  SN FTG +P+ +    
Sbjct: 273 SGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL---- 328

Query: 244 IARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG 296
                   L  L  L L +N  SG IP +L K + L  L+LS N L GEIP G
Sbjct: 329 ------TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG 375

Length = 968

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  142 bits (361), Expect = 2e-38
 Identities = 80/285 (28%), Positives = 120/285 (42%), Gaps = 47/285 (16%)

Query: 398 NLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVI 454
            L+GRGSFGSV+ A   D G  +A+K   L        ++ + E  ++ S++H NI++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 455 SSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYILDIYQRLNI------MIDVASALEYLH 506
            S  +EE   L   LEY+  GSL   L         + +L           +   L YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKK-------FGKLPEPVIRKYTRQILEGLAYLH 118

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
              S  ++H D+K +N+L+D + V  L+DFG AK L   +          T  +MAPE  
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD--PNL 624
           +        D++S G  ++E  T K P  E+ N    L         I +       P  
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK-------IGSSGEPPEIPEH 228

Query: 625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK 669
           LS E  +F+ K             C    P++R  A E    LL+
Sbjct: 229 LSEEAKDFLRK-------------CLRRDPKKRPTADE----LLQ 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  151 bits (384), Expect = 3e-38
 Identities = 108/303 (35%), Positives = 151/303 (49%), Gaps = 21/303 (6%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
           NN SG IP  I   + L+ L+L  N+ +G IP++ GNL+NLQ L L  N L+        
Sbjct: 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGP-----I 276

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNL 126
             S+ + + L  +  S+N L G +P+  V  L  +LE   +   N +G IP  + +L  L
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEIPEL-VIQL-QNLEILHLFSNNFTGKIPVALTSLPRL 334

Query: 127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSG 186
            ++ L  NK +G IP  LGK   L  L L  N L G IP+ +C S  L+KL L  N L G
Sbjct: 335 QVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEG 394

Query: 187 SIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPL--------PL 237
            IP+      SLR + L  N  +  +P  F  L  + +L+ S+N   G +         L
Sbjct: 395 EIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL 454

Query: 238 EIGNLKIARI-----DSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGE 292
           ++ +L   +      DS     L +L+LS N  SGA+P  L  LS L  L LS NKL GE
Sbjct: 455 QMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGE 514

Query: 293 IPR 295
           IP 
Sbjct: 515 IPD 517

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  146 bits (370), Expect = 2e-36
 Identities = 111/322 (34%), Positives = 161/322 (50%), Gaps = 29/322 (9%)

Query: 8   NFSGTIPRFIFNASKLSILELSDNSFSGFIP-NTFGNLRNLQALRLSNNYLTSSTLELSF 66
           N SG I   IF    +  + LS+N  SG IP + F    +L+ L LSNN  T S      
Sbjct: 80  NISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--- 136

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNL 126
             S+ N ++L L   SNN L G +P   +G+ S SL+  ++    + G IP  + NLT+L
Sbjct: 137 -GSIPNLETLDL---SNNMLSGEIPN-DIGSFS-SLKVLDLGGNVLVGKIPNSLTNLTSL 190

Query: 127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSG 186
             + L  N+L G IP  LG+++ L+ + L  N L G IP  I     L  L+L  N L+G
Sbjct: 191 EFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTG 250

Query: 187 SIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIA 245
            IP    NL +L+ L L  N+L+  IP + ++L+ ++ L+ S N  +G +P  +  L+  
Sbjct: 251 PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ-- 308

Query: 246 RIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG-GSFGNFSA 304
                   +L  L+L +NN +G IP +L  L  L+ L L  NK  GEIP+  G   N + 
Sbjct: 309 --------NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTV 360

Query: 305 ESFEGNEL-------LCGSPNL 319
                N L       LC S NL
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNL 382

Length = 968

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  129 bits (326), Expect = 2e-33
 Identities = 85/296 (28%), Positives = 130/296 (43%), Gaps = 54/296 (18%)

Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNI 450
           +G G+FG VF           D   VA+K          R  K F+ E E++ + +H NI
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNFQHENI 70

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-------------YILDIYQRLNIMID 497
           +K    C+  +   +V EYM HG L K+L S                 L + Q L I + 
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 498 VASALEYL---HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
           +AS + YL   HF      +H DL   N L+  ++V  + DFG+++ +   D   +   T
Sbjct: 131 IASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184

Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLP 613
           +  I +M PE     + +   DV+SFG++L E FT  K+P   + N E+           
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV----------- 233

Query: 614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK 669
              + I    LL R          C S V+++ + C    P+QRIN K+I  +L K
Sbjct: 234 --IECITQGRLLQR-------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  122 bits (309), Expect = 2e-31
 Identities = 82/274 (29%), Positives = 129/274 (47%), Gaps = 31/274 (11%)

Query: 399 LIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIKVISSC 457
            IG+G+FG V+K  L    EVA+K          K  F  E E++K   H NI+K+I  C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
             ++   +V+E +P GSL  +L      L + + L + +D A+ +EYL    S   IH D
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT----IGYMAPEYGKEGRVSA 573
           L   N L+ +N V  +SDFG    ++RE++  I T +       I + APE    GR ++
Sbjct: 119 LAARNCLVGENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV 633
             DV+S+GI+L ETF+          G+       N      T+E ++            
Sbjct: 175 ESDVWSYGILLWETFSL---------GDTPYPGMSNQ----QTRERIESGY------RMP 215

Query: 634 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
           A + C   ++ + ++C    PE R +  EI  +L
Sbjct: 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  122 bits (309), Expect = 2e-31
 Identities = 65/196 (33%), Positives = 98/196 (50%), Gaps = 9/196 (4%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG+G FG V+KAR    G EVA+KV  L+     +    E +++K  +H NI+K   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            ++   +V+E+   GSL+  L S+N  L   Q   +  ++   LEYLH   S  +IH D+
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPEYGKEGRVSANGDV 577
           K +N+LL  +    L DFG++  L+     T    T+  T  +MAPE           D+
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLS----DTKARNTMVGTPYWMAPEVINGKPYDYKADI 180

Query: 578 YSFGIMLMETFTRKKP 593
           +S GI  +E    K P
Sbjct: 181 WSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  119 bits (301), Expect = 4e-30
 Identities = 72/293 (24%), Positives = 129/293 (44%), Gaps = 37/293 (12%)

Query: 398 NLIGRGSFGSVFKARL-----GDGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNII 451
             +G G FG V   R        G +VA+K  N     +    F+ E E+++++ H NI+
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 452 KVISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           K    C     ++  L++EY+P GSL  YL      +++ + L     +   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKE 568
           S + IH DL   N+L++   +  +SDFG+AK+L  + D   ++    + I + APE  + 
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186

Query: 569 GRVSANGDVYSFGIMLMETFTRKKPTDE----------IFNGEMTLKHWVNDWLPISTKE 618
            + S+  DV+SFG+ L E FT   P+            I  G+M +   +          
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE--------- 237

Query: 619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
                 L +E         C   V+++   C    P+ R +  +++  + ++R
Sbjct: 238 ------LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  116 bits (294), Expect = 2e-29
 Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 25/215 (11%)

Query: 398 NLIGRGSFGSVFKAR-LGDGMEVAMKVFNL------QYGRVFKSFDVECEMMKSIRHRNI 450
             IG+GSFG V+  R   DG    +K  +L      +          E +++K + H NI
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN----EVKILKKLNHPNI 61

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIY---QRLNIMIDVASALEYLHF 507
           IK   S   +    +V+EY   G L + +         +   Q L+  + +  AL+YLH 
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPEYG 566
             S +++H D+KP N+ L  N +  L DFGI+K+L     +    +T+  T  Y++PE  
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLSPELC 175

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
           +    +   D++S G +L E  T K P    F GE
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (299), Expect = 3e-29
 Identities = 85/296 (28%), Positives = 128/296 (43%), Gaps = 33/296 (11%)

Query: 399 LIGRGSFGSVFKARLGDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRH-RNIIKVI 454
            +G GSFG V+ AR  D   VA+KV   +     +  + F  E +++ S+ H  NI+K+ 
Sbjct: 7   KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIY--QRLNIMIDVASALEYLHFGYSAQ 512
               +E    LV+EY+  GSLE  L        +   + L I+  + SALEYLH   S  
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKG 121

Query: 513 VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLA----TIGYMAPEY-- 565
           +IH D+KP N+LLD D  V  L DFG+AKLL     ++      +    T GYMAPE   
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 566 -GKEGRVSANGDVYSFGIMLMETFTRKKP---TDEIFNGEMTLKHWVNDWLPISTKEIVD 621
                  S++ D++S GI L E  T   P            TLK  +    P     +  
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
            N            E       ++  +   + P+ R+++   ++  L     L  +
Sbjct: 242 SN-----------PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286

Length = 384

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  116 bits (292), Expect = 4e-29
 Identities = 70/276 (25%), Positives = 125/276 (45%), Gaps = 27/276 (9%)

Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           F+    +G G FG V++    + + VA+K+         + F  E + +K +RH+++I +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQ 512
            + CS  E   ++ E M  GSL  +L S    +L +   +++   VA  + YL       
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            IH DL   N+L+ +++V  ++DFG+A+L+  ++   + +       + APE    G  S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLSSDKKIPYKWTAPEAASHGTFS 182

Query: 573 ANGDVYSFGIMLMETFTRKK-PTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN 631
              DV+SFGI+L E FT  + P   + N E+  +      +P   K              
Sbjct: 183 TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAK-------------- 228

Query: 632 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                 C   ++ + +EC    PE R + K +  +L
Sbjct: 229 ------CPQEIYKIMLECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  116 bits (293), Expect = 5e-29
 Identities = 78/267 (29%), Positives = 119/267 (44%), Gaps = 25/267 (9%)

Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG G+ G V+KA     G EVA+K   L+  +  +    E  +MK  +H NI+    S  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLR-KQNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             +   +V+EYM  GSL   +  +   ++  Q   +  +V   LEYLH   S  VIH D+
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  N+LL  +    L+DFG A  LT+E     +   + T  +MAPE  K        D++
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIW 200

Query: 579 SFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQC 638
           S GIM +E    + P          L       +P     + +P   S E  +F+ K   
Sbjct: 201 SLGIMCIEMAEGEPPYLR-EPPLRALFLITTKGIP----PLKNPEKWSPEFKDFLNK--- 252

Query: 639 VSFVFNVAMECTVESPEQRINAKEIVT 665
                     C V+ PE+R +A+E++ 
Sbjct: 253 ----------CLVKDPEKRPSAEELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  115 bits (291), Expect = 6e-29
 Identities = 66/195 (33%), Positives = 104/195 (53%), Gaps = 14/195 (7%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K   L+ G +  ++F  E ++MK +RH  ++++ + CS
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMID----VASALEYLHFGYSAQVI 514
            EE   +V EYM  GSL  +L S         RL  ++D    +A  + YL    S   I
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSAN 574
           H DL   N+L+ +N+V  ++DFG+A+L+  +D+ T +      I + APE    GR +  
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184

Query: 575 GDVYSFGIMLMETFT 589
            DV+SFGI+L E  T
Sbjct: 185 SDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  115 bits (290), Expect = 1e-28
 Identities = 72/262 (27%), Positives = 115/262 (43%), Gaps = 42/262 (16%)

Query: 399 LIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECE---MMKSIRHRNIIKV 453
           +IG GSF +V  A+      E A+K+ + +   +  K   V+ E   + +   H  IIK+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
             +  +EE    VLEY P+G L +Y+      LD         ++  ALEYLH   S  +
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLH---SKGI 123

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG-------------- 559
           IH DLKP N+LLD +M   ++DFG AK+L   + S    +  AT                
Sbjct: 124 IHRDLKPENILLDKDMHIKITDFGTAKVLD-PNSSPESNKGDATNIDSQIEKNRRRFASF 182

Query: 560 -----YMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI 614
                Y++PE   E     + D+++ G ++ +  T K P    F G        N++L  
Sbjct: 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP----FRG-------SNEYLTF 231

Query: 615 STKEIVDPNLLSREDINFVAKE 636
             ++I+        +    AK+
Sbjct: 232 --QKILKLEYSFPPNFPPDAKD 251

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (288), Expect = 1e-28
 Identities = 78/278 (28%), Positives = 126/278 (45%), Gaps = 46/278 (16%)

Query: 399 LIGRGSFGSVFKARLGD--GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
            IG+G FG V    LGD  G +VA+K          ++F  E  +M ++RH N+++++  
Sbjct: 13  TIGKGEFGDVM---LGDYRGQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
                   +V EYM  GSL  YL S    ++ + Q+L   +DV   +EYL        +H
Sbjct: 69  VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVH 125

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DL   NVL+ +++VA +SDFG+AK    E      +  L  + + APE  +E + S   
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLP-VKWTAPEALREKKFSTKS 180

Query: 576 DVYSFGIMLMETFT------RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
           DV+SFGI+L E ++       + P  ++      + H    +               R +
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDV------VPHVEKGY---------------RME 219

Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
               A E C   V+ V  +C    P +R   K++  +L
Sbjct: 220 ----APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 2e-28
 Identities = 71/211 (33%), Positives = 98/211 (46%), Gaps = 19/211 (9%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN----LQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           +G+GSFG V   R    G   AMKV      ++   V  +   E  ++  I H  I+K+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIVKLH 59

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
            +   EE   LVLEY P G L  +L       +   R     ++  ALEYLH   S  +I
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH---SLGII 115

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPEYGKEGRVSA 573
           + DLKP N+LLD +    L+DFG+AK L+ E     +T T   T  Y+APE         
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAPEVLLGKGYGK 172

Query: 574 NGDVYSFGIMLMETFTRKKP-----TDEIFN 599
             D +S G++L E  T K P       EI+ 
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE 203

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 2e-27
 Identities = 79/302 (26%), Positives = 129/302 (42%), Gaps = 67/302 (22%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV----ECEMMKSIRHRNIIK-- 452
           IG G++G V+KAR    G  VA+K   ++  +  + F +    E ++++ +RH NI++  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 453 --VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
             V S      +  +V EYM H  L   L S        Q    M  +   L+YLH   S
Sbjct: 65  EIVTSKGKGSIY--MVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---S 118

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE------ 564
             ++H D+K SN+L++++ V  L+DFG+A+  T+   S   T  + T+ Y  PE      
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR-NSADYTNRVITLWYRPPELLLGAT 177

Query: 565 -YGKEGRVSANGDVYSFGIMLMETFTRK--------------------KPTDEIFNGEMT 603
            YG E  V    D++S G +L E F  K                     PTDE + G   
Sbjct: 178 RYGPE--V----DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231

Query: 604 LKHWVNDWLPISTKEIVD---PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
           L  + N       K  +     +L+    ++ + K        +         P++RI+A
Sbjct: 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDK----LLTLD---------PKKRISA 278

Query: 661 KE 662
            +
Sbjct: 279 DQ 280

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  112 bits (281), Expect = 2e-27
 Identities = 79/290 (27%), Positives = 129/290 (44%), Gaps = 53/290 (18%)

Query: 400 IGRGSFGSVFKAR------LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +G G+FG VF A         D M VA+K          K F  E E++ +++H +I+K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHS---------------SNYILDIYQRLNIMIDV 498
              C + +   +V EYM HG L K+L +               +   L + Q L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI 558
           AS + YL    S   +H DL   N L+  N++  + DFG+++ +   D   +   T+  I
Sbjct: 133 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 559 GYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTK 617
            +M PE     + +   DV+SFG++L E FT  K+P                 W  +S  
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP-----------------WFQLSNT 232

Query: 618 EIVD----PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
           E+++      +L R  +       C   V+++ + C    P+QR+N KEI
Sbjct: 233 EVIECITQGRVLERPRV-------CPKEVYDIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  107 bits (268), Expect = 9e-26
 Identities = 76/291 (26%), Positives = 124/291 (42%), Gaps = 44/291 (15%)

Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +G G+FG VF A         D M VA+K          + F  E E++  ++H++I++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSN---YILD-----------IYQRLNIMIDVA 499
              C+      +V EYM HG L ++L S      IL            + Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG 559
           S + YL    S   +H DL   N L+   +V  + DFG+++ +   D   +  +T+  I 
Sbjct: 133 SGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 560 YMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKE 618
           +M PE     + +   D++SFG++L E FT  K+P                 W  +S  E
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP-----------------WYQLSNTE 232

Query: 619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK 669
            ++     RE         C   V+ +   C    P+QR+  K+I ++L  
Sbjct: 233 AIECITQGRE---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  106 bits (265), Expect = 9e-26
 Identities = 66/194 (34%), Positives = 99/194 (51%), Gaps = 9/194 (4%)

Query: 399 LIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIKVISSC 457
           L+G+G+FG VFK  L D   VA+K       +  K  F  E  ++K   H NI+K+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
           +  +   +V+E +P G    +L      L   Q +   +D A+ + YL    S   IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGKEGRVSANG 575
           L   N L+ +N V  +SDFG+++   +ED     +  L    I + APE    GR S+  
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 576 DVYSFGIMLMETFT 589
           DV+S+GI+L ETF+
Sbjct: 176 DVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  106 bits (267), Expect = 1e-25
 Identities = 72/280 (25%), Positives = 120/280 (42%), Gaps = 53/280 (18%)

Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSC 457
           +G+GS G V+K R    G   A+K  ++     F K    E + ++S     ++K    C
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64

Query: 458 SNEEFK----ALVLEYMPHGSLEKYLHSSNYILDIYQRLN---------IMIDVASALEY 504
               +K    ++VLEYM  GSL           D+ +++          I   +   L+Y
Sbjct: 65  YGAFYKEGEISIVLEYMDGGSLA----------DLLKKVGKIPEPVLAYIARQILKGLDY 114

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT-LATIGYMAP 563
           LH      +IH D+KPSN+L++      ++DFGI+K+L   + +  Q  T + T+ YM+P
Sbjct: 115 LH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSP 169

Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKP-TDEIFNGEMTLKHWVNDWLPISTKEIVDP 622
           E  +    S   D++S G+ L+E    K P           L   + D  P S    +  
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS----LPA 225

Query: 623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKE 662
              S E  +F++              C  + P++R +A E
Sbjct: 226 EEFSPEFRDFISA-------------CLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  105 bits (265), Expect = 2e-25
 Identities = 65/192 (33%), Positives = 103/192 (53%), Gaps = 8/192 (4%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V++    +   VA+K   L+ G +  K F  E ++MK +RH  +I++ + C+
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            EE   +V E M +GSL +YL       L + Q +++   VAS + YL    +   IH D
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   NVL+ +N +  ++DFG+A+++ +ED    +      I + APE     R S   DV
Sbjct: 129 LAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 578 YSFGIMLMETFT 589
           +SFGI+L E  T
Sbjct: 188 WSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  104 bits (262), Expect = 3e-25
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 27/208 (12%)

Query: 398 NLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVI 454
           +LIGRG+FG V+K   L  G  VA+K  +L+       KS   E +++K+++H NI+K I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALEYL 505
            S    +   ++LEY  +GSL + +           + Y+   YQ       V   L YL
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV---YQ-------VLQGLAYL 115

Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      VIH D+K +N+L   + V  L+DFG+A  L    +       + T  +MAPE 
Sbjct: 116 H---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAPEV 170

Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP 593
            +    S   D++S G  ++E  T   P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  105 bits (263), Expect = 4e-25
 Identities = 73/290 (25%), Positives = 138/290 (47%), Gaps = 44/290 (15%)

Query: 400 IGRGSFGSVFKARL----GDGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIK 452
           +G G+FG V+K  L          ++ +  L+     +V + F  E E+M  ++H NI+ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSN-------------YILDIYQRLNIMID 497
           ++  C+ E+   ++ EY+ HG L ++L  +S +               LD    L+I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           +A+ +EYL    S   +H DL   N L+ + +   +SDFG+++ +   D   +Q+++L  
Sbjct: 133 IAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE    G+ +   D++SFG++L E F+                + +  +   S +
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFS----------------YGLQPYYGFSNQ 233

Query: 618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
           E+++   + R        E C + V+ + +EC  E P +R   K+I T+L
Sbjct: 234 EVIE---MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  103 bits (259), Expect = 9e-25
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 13/206 (6%)

Query: 393 GFSENNLIGRGSFGSVFKARLGDGMEV-AMKVFN----LQYGRVFKSFDVECEMMKSIRH 447
            F    +IG+G+FG V   +  D  ++ AMK  N    ++ G V    + E  +++ + H
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLN-ERRILQELNH 59

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++ +  S  +EE   LV++ +  G L +Y  S        Q    + ++  ALEYLH 
Sbjct: 60  PFLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLH- 117

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
             S  +IH D+KP N+LLD+    H++DF IA  +T +  +   T T  T GYMAPE   
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLC 172

Query: 568 EGRVSANGDVYSFGIMLMETFTRKKP 593
               S   D +S G+   E    K+P
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  104 bits (262), Expect = 2e-24
 Identities = 81/274 (29%), Positives = 126/274 (45%), Gaps = 65/274 (23%)

Query: 398 NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKS-FDV-----ECEMMKSIRHRNI 450
             IG G++G V  A     G +VA+K  +     VF    D      E ++++ +RH NI
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKIS----NVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 451 IK---VISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYILD------IYQRLNIMIDVA 499
           I    ++   S E+F  +  V E M    L K + S   + D      +YQ L       
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQIL------- 113

Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TREDQSTIQTQTLATI 558
             L+YLH   SA VIH DLKPSN+L++ N    + DFG+A+ +   ED+    T+ + T 
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170

Query: 559 GYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW 611
            Y APE       Y K   +    D++S G +  E  TR KP   +F G    + +++  
Sbjct: 171 WYRAPELLLSSSRYTKA--I----DIWSVGCIFAELLTR-KP---LFPG----RDYIDQL 216

Query: 612 LPISTKEIVDPNLL---SREDINFVAKEQCVSFV 642
                  IV+  +L   S ED+ F+  E+  +++
Sbjct: 217 -----NLIVE--VLGTPSEEDLKFITSEKARNYL 243

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  101 bits (254), Expect = 4e-24
 Identities = 70/194 (36%), Positives = 104/194 (53%), Gaps = 17/194 (8%)

Query: 400 IGRGSFGSVFKARLGD--GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG+G FG V    LGD  G +VA+K   ++     ++F  E  +M  +RH N+++++   
Sbjct: 14  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 458 SNEEFKA-LVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL    +   +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVH 125

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DL   NVL+ ++ VA +SDFG    LT+E  ST  T  L  + + APE  +E + S   
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLP-VKWTAPEALREKKFSTKS 180

Query: 576 DVYSFGIMLMETFT 589
           DV+SFGI+L E ++
Sbjct: 181 DVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 8/204 (3%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V   +    ++VA+K+  ++ G + +  F  E ++M  + H N++++   C+
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKM--IREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            +    +V EYM +G L  YL      L     L++  DV  A+EYL    S   IH DL
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDL 126

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
              N L+ ++ V  +SDFG+A+ +  +DQ T    T   + +  PE     R S+  DV+
Sbjct: 127 AARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185

Query: 579 SFGIMLMETFTRKK-PTDEIFNGE 601
           SFG+++ E F+  K P +   N E
Sbjct: 186 SFGVLMWEVFSEGKMPYERFSNSE 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  100 bits (249), Expect = 1e-23
 Identities = 73/267 (27%), Positives = 121/267 (45%), Gaps = 34/267 (12%)

Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKVISSC 457
           IGRG+FG VF  RL  D   VA+K          K+ F  E  ++K   H NI+++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
           + ++   +V+E +  G    +L +    L + + + ++ + A+ +EYL    S   IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT----LATIGYMAPEYGKEGRVSA 573
           L   N L+ +  V  +SDFG    ++RE++  +   T       + + APE    GR S+
Sbjct: 120 LAARNCLVTEKNVLKISDFG----MSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175

Query: 574 NGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF 632
             DV+SFGI+L E F+    P   + N +              T+E ++      + +  
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQ--------------TREAIE------QGVRL 215

Query: 633 VAKEQCVSFVFNVAMECTVESPEQRIN 659
              E C   V+ +   C    P QR +
Sbjct: 216 PCPELCPDAVYRLMERCWEYDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 1e-23
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 11/205 (5%)

Query: 400 IGRGSFGSVFKAR---LGDG--MEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRNIIKV 453
           +G G+FG+V+K      G+   + VA+KV   +      K    E  +M S+ H +++++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
           +  C + +   L+ + MP G L  Y+ +    +     LN  + +A  + YL      ++
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           +H DL   NVL+       ++DFG+AKLL  +++          I +MA E       + 
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190

Query: 574 NGDVYSFGIMLMETFT-RKKPTDEI 597
             DV+S+G+ + E  T   KP + I
Sbjct: 191 KSDVWSYGVTVWELMTFGAKPYEGI 215

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 99.6 bits (248), Expect = 2e-23
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 8/205 (3%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKVISSCS 458
           IG G FG V+     +  +VA+K   ++ G + +  F  E ++M  + H  ++++   C+
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIK--TIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
                 LV E+M HG L  YL +          L + +DV   + YL    S+ VIH DL
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDL 126

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
              N L+ +N V  +SDFG+ + +  +DQ T  T T   + + +PE     + S+  DV+
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185

Query: 579 SFGIMLMETFTR-KKPTDEIFNGEM 602
           SFG+++ E F+  K P +   N E+
Sbjct: 186 SFGVLMWEVFSEGKTPYENRSNSEV 210

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 98.7 bits (246), Expect = 8e-23
 Identities = 84/295 (28%), Positives = 135/295 (45%), Gaps = 43/295 (14%)

Query: 399 LIGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRV--FKSFDVECEMMKSIRHRNII 451
            +G+G+FGSV   R   L D  G  VA+K   LQ+      + F+ E E++KS++H NI+
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 452 K---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           K   V  S      + LV+EY+P+GSL  YL      LD  + L     +   +EYL   
Sbjct: 69  KYKGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG-- 125

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGK 567
            S + +H DL   N+L++      + DFG+ K+L ++ +   ++    + I + APE   
Sbjct: 126 -SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184

Query: 568 EGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTLKHWVNDWLPIST 616
           E + S   DV+SFG++L E FT       P  E          G+M + H +        
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE------- 237

Query: 617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
                   L + +    A   C + ++ +  EC    P QR +  E+  ++  IR
Sbjct: 238 --------LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 98.3 bits (246), Expect = 9e-23
 Identities = 78/296 (26%), Positives = 126/296 (42%), Gaps = 60/296 (20%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V+KAR    G  VA+K   L      +  +   E  ++K ++H NI+K++  
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
              E    LV EY     L+KYL      L      +IM  +   L Y H   S +++H 
Sbjct: 67  IHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHR 122

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-------YGKEG 569
           DLKP N+L++ + V  L+DFG+A+      ++   T  + T+ Y APE       Y    
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAPEILLGSKHYSTA- 179

Query: 570 RVSANGDVYSFGIMLMETFTRK--------------------KPTDEIFNGEMTLKHWVN 609
            V    D++S G +  E  T K                     PT+E + G   L  +  
Sbjct: 180 -V----DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234

Query: 610 D---WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKE 662
               + P   ++++    L  E I+ ++K       +N         P +RI+AKE
Sbjct: 235 TFPKFPPKDLEKVLPR--LDPEGIDLLSK----MLQYN---------PAKRISAKE 275

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 77/279 (27%), Positives = 124/279 (44%), Gaps = 39/279 (13%)

Query: 398 NLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVI 454
           N IG G+FG V+ A  L  G  +A+K   +Q       K    E ++++ ++H N++K  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD--IYQRLNIMIDVASALEYLHFGYSAQ 512
               + E   + +EY   G+LE+ L     ILD  + +   + +     L YLH   S  
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQL--LEGLAYLH---SHG 119

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS--TIQTQTLATIGYMAPEYGKEGR 570
           ++H D+KP+N+ LD N V  L DFG A  L     +          T  YMAPE    G+
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179

Query: 571 VSANG---DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE---IVDPNL 624
              +G   D++S G +++E  T K+P  E+ N    + H       +       I D   
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH-------VGAGHKPPIPDSLQ 232

Query: 625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
           LS E  +F+  ++C     +         P++R  A E+
Sbjct: 233 LSPEGKDFL--DRC--LESD---------PKKRPTASEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 97.6 bits (243), Expect = 1e-22
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 9/206 (4%)

Query: 386 ELCRATDGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKS 444
           E+ R TD  +  + +G G +G V++       + VA+K        V + F  E  +MK 
Sbjct: 2   EMER-TD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKE 58

Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALE 503
           I+H N+++++  C+ E    ++ E+M +G+L  YL   N   ++    L +   ++SA+E
Sbjct: 59  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 118

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL        IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + AP
Sbjct: 119 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 174

Query: 564 EYGKEGRVSANGDVYSFGIMLMETFT 589
           E     + S   DV++FG++L E  T
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 96.7 bits (241), Expect = 2e-22
 Identities = 77/286 (26%), Positives = 117/286 (40%), Gaps = 51/286 (17%)

Query: 393 GFSENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDV--ECEMMKSIRHRN 449
            F     +G+GS+GSV+K  RL D    A+K  +L      +  D   E  ++ S+ H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 450 IIKVISSCSNEEF-----KALVLEYMPHGSLEKYLHSSNYILDIYQR---LNIMIDVASA 501
           II        E F       +V+EY P G L K +        +        I I +   
Sbjct: 61  II-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           L+ LH     +++H DLK +N+LL  N +  + D GI+K+L    ++  +TQ   T  YM
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQI-GTPHYM 168

Query: 562 APEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNG----EMTLKHWVNDWLPISTK 617
           APE  K    S   D++S G +L E  T   P    F      ++  K     + PI   
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPP----FEARSMQDLRYKVQRGKYPPI--- 221

Query: 618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
               P + S++  NF+                    P+ R N  +I
Sbjct: 222 ----PPIYSQDLQNFI-------------RSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 96.3 bits (239), Expect = 4e-22
 Identities = 63/206 (30%), Positives = 112/206 (54%), Gaps = 10/206 (4%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 459 NEEFKALVLEYMPHGSLEKYLH-SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            EE   +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 72  -EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 127

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 578 YSFGIMLMETFTRKK-PTDEIFNGEM 602
           +SFGI+L E  T+ + P   + N E+
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNREV 212

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 34/220 (15%)

Query: 400 IGRGSFGSVFKAR---LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           I +G++G VF A+    GD    A+KV     +           E +++   +   ++K+
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
             S   ++   LV+EY+P G L   L +    LD       + ++  ALEYLH   S  +
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGI 114

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKL------LTREDQSTIQTQTLATIGYMAPE--- 564
           IH DLKP N+L+D N    L+DFG++K+      +   D      + + T  Y+APE   
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174

Query: 565 ---YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
              + K        D +S G +L E      P    F+GE
Sbjct: 175 GQGHSKT------VDWWSLGCILYEFLVGIPP----FHGE 204

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 95.8 bits (238), Expect = 5e-22
 Identities = 55/191 (28%), Positives = 105/191 (54%), Gaps = 13/191 (6%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG G FG+V +     G +VA+K  N++     ++F  E  +M  + H+N+++++    +
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 460 EEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
                +V+E M  G+L  +L +    ++ + Q L   +DVA  +EYL    S +++H DL
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDL 126

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
              N+L+ ++ VA +SDFG+A++ +    ++        + + APE  K  + S+  DV+
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNS-----KLPVKWTAPEALKHKKFSSKSDVW 181

Query: 579 SFGIMLMETFT 589
           S+G++L E F+
Sbjct: 182 SYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 96.7 bits (240), Expect = 5e-22
 Identities = 76/290 (26%), Positives = 125/290 (43%), Gaps = 48/290 (16%)

Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +G G+FG VF A         D + VA+K          K F  E E++ +++H +I+K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYIL----------DIYQRLNIMIDVASA 501
              C   +   +V EYM HG L K+L  H  + +L             Q L+I   +A+ 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YL    S   +H DL   N L+ +N++  + DFG+++ +   D   +   T+  I +M
Sbjct: 133 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 562 APEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 621
            PE     + +   DV+S G++L E FT  K                  W  +S  E+++
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK----------------QPWYQLSNNEVIE 233

Query: 622 ----PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                 +L R          C   V+++ + C    P  R+N KEI + L
Sbjct: 234 CITQGRVLQR-------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLL 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 96.1 bits (239), Expect = 5e-22
 Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 32/216 (14%)

Query: 398 NLIGRGSFGSVFKAR----LGDGME---VAMKVFNLQYGRV---FKSFDVECEMMKSIRH 447
           N +G G+FG V++      LG G     VA+K   L+ G      K F  E  +M +  H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVK--TLRKGATDQEKKEFLKEAHLMSNFNH 58

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY------ILDIYQRLNIMIDVASA 501
            NI+K++  C   E + +++E M  G L  YL  +        +L + + L+I +DVA  
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 502 LEYL---HFGYSAQVIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
             YL   HF      IH DL   N L+     D + V  + DFG+A+ + + D    + +
Sbjct: 119 CVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
            L  + +MAPE   +G+ +   DV+SFG+++ E  T
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 18/207 (8%)

Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF---KSFDV-ECEMMKSIRHRNIIKVI 454
           IG+GSFG+V K  R  DG  +  K  +  YG +    K   V E  +++ ++H NI++  
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 455 SSCSNEEFKAL--VLEYMPHGSL----EKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
               +   + L  V+EY   G L    +K      YI +      I+  +  AL   H  
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI-EEEFIWRILTQLLLALYECHNR 124

Query: 509 YSA--QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
                 V+H DLKP+N+ LD N    L DFG+AK+L  +         + T  YM+PE  
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA--KTYVGTPYYMSPEQL 182

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKP 593
                    D++S G ++ E      P
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 33/203 (16%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG G++G V+KAR +  G  VA+KV  L+ G  F+    E  M+K  RH NI+    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN----------IMIDVASALEYLHFG 508
             +   +V+EY   GSL+          DIYQ             +  +    L YLH  
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT--LATIGYMAPEYG 566
                IH D+K +N+LL ++    L+DFG++  LT     TI  +   + T  +MAPE  
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA----TIAKRKSFIGTPYWMAPEVA 173

Query: 567 ---KEGRVSANGDVYSFGIMLME 586
              ++G      D+++ GI  +E
Sbjct: 174 AVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 94.2 bits (234), Expect = 2e-21
 Identities = 65/270 (24%), Positives = 121/270 (44%), Gaps = 26/270 (9%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V   +     +VA+K+  ++ G + +  F  E ++M  + H  ++++   C+
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            +    +V EYM +G L  YL          Q L +  DV   + YL    S Q IH DL
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDL 126

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
              N L+DD     +SDFG+++ +  +D+ T    +   + +  PE     + S+  DV+
Sbjct: 127 AARNCLVDDQGCVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185

Query: 579 SFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQC 638
           +FG+++ E ++  K   E FN   T++             +  P+L S +          
Sbjct: 186 AFGVLMWEVYSLGKMPYERFNNSETVEK------VSQGLRLYRPHLASEK---------- 229

Query: 639 VSFVFNVAMECTVESPEQRINAKEIVTKLL 668
              V+ +   C  E  E+R   +++++ + 
Sbjct: 230 ---VYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 79/276 (28%), Positives = 121/276 (43%), Gaps = 38/276 (13%)

Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           F     +G GS+GSV+KA     G  VA+KV  ++     +    E  ++K      I+K
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
              S        +V+EY   GS+   +  +N  L   +   I+      LEYLH   S +
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPEYGKEG 569
            IH D+K  N+LL++   A L+DFG++  LT    +  +  T+  IG   +MAPE  +E 
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLT---DTMAKRNTV--IGTPFWMAPEVIQEI 174

Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK---EIVDPNLLS 626
             +   D++S GI  +E    K P  +I        H +     I  K    + DP   S
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDI--------HPMRAIFMIPNKPPPTLSDPEKWS 226

Query: 627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKE 662
            E  +FV K             C V+ PE+R +A +
Sbjct: 227 PEFNDFVKK-------------CLVKDPEERPSAIQ 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 75/295 (25%), Positives = 126/295 (42%), Gaps = 45/295 (15%)

Query: 399 LIGRGSFGSVFKARLGD------GMEVAMKVFNLQ-YGRVFKSFDVECEMMKSI-RHRNI 450
            +G G+FG V KA             VA+K+       +       E EMMK I +H+NI
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHS-------SNYILDIYQRLNIMI------- 496
           I ++  C+ E    +V+EY  HG+L  +L +       ++          +         
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 497 -DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
             VA  +E+L    S + IH DL   NVL+ ++ V  ++DFG+A+ +   D     T   
Sbjct: 139 YQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195

Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 615
             + +MAPE   +   +   DV+SFG++L E FT          G        + +  I 
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--------LGG--------SPYPGIP 239

Query: 616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
            +E+     L +E       + C   ++++  +C  E P QR   K++V  L ++
Sbjct: 240 VEELFK---LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 8/196 (4%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNL-QYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           +G G+ G V K      G  +A+K   L     + K    E +++       I+    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            N    ++ +EYM  GSL+K L      +       I + V   L YLH  +  ++IH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--KIIHRD 126

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           +KPSN+L++      L DFG++  L     +++    + T  YMAPE  +    S   D+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV----NSLAKTFVGTSSYMAPERIQGNDYSVKSDI 182

Query: 578 YSFGIMLMETFTRKKP 593
           +S G+ L+E  T + P
Sbjct: 183 WSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 67/228 (29%), Positives = 104/228 (45%), Gaps = 9/228 (3%)

Query: 394 FSENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQ-YGRVFKSFDV-ECEMMKSIRHRNI 450
           F   N IG+GSFG VFK  R  D    AMK  +L    R  +   + E  ++  +    I
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGY 509
           I+   S  ++    +V+EY  +G L K L       L   Q     I +   L +LH   
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--- 118

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
           S +++H D+K  N+ LD      + D G+AKLL+  D +      + T  Y++PE  ++ 
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS--DNTNFANTIVGTPYYLSPELCEDK 176

Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
             +   DV++ G++L E  T K P D    G + LK     + P+S  
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM 224

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 93.9 bits (233), Expect = 3e-21
 Identities = 73/292 (25%), Positives = 136/292 (46%), Gaps = 48/292 (16%)

Query: 400 IGRGSFGSVFKARLG-DGME----VAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +G  +FG ++K  L   GM+    VA+K   ++   + +  F  E  +M  + H NI+ +
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYL-----HSS-----------NYILDIYQRLNIMID 497
           +   + E+   ++ EY+  G L ++L     HS               LD    L+I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 498 VASALEYL--HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
           +A+ +EYL  HF      +H DL   N+L+ + +   +SD G+++ +   D   +Q ++L
Sbjct: 133 IAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 615
             I +M PE    G+ S++ D++SFG++L E F+                  +  +   S
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS----------------FGLQPYYGFS 231

Query: 616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
            +E+++   + R+       E C   ++++  EC  E P +R   K+I T+L
Sbjct: 232 NQEVIE---MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 93.8 bits (233), Expect = 3e-21
 Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 14/203 (6%)

Query: 400 IGRGSFGSVFKARL-----GDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKV 453
           +G G FG V          G G  VA+K    + G+   S +  E  ++K++ H NI+K 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 454 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              CS +  K   L++EY+P GSL  YL      L++ Q L     +   + YLH   S 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TREDQSTIQTQTLATIGYMAPEYGKEGR 570
             IH DL   NVLLD++ +  + DFG+AK +    +   ++    + + + A E  KE +
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186

Query: 571 VSANGDVYSFGIMLMETFTRKKP 593
            S   DV+SFG+ L E  T    
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDS 209

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 93.1 bits (231), Expect = 6e-21
 Identities = 72/283 (25%), Positives = 133/283 (46%), Gaps = 30/283 (10%)

Query: 395 SENNLIGRGSFGSVFKA--RLGDGMEVAMKVFNLQYGRVFKS---FDVECEMMKSIRHRN 449
           ++  +IG G FG VF+   ++    EVA+ +  L+ G   K    F  E  +M    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           II++    +  +   ++ EYM +G+L+KYL   +     YQ + ++  +A+ ++YL    
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS--- 124

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYGKE 568
               +H DL   N+L++ N+   +SDFG++++L  + + T  T      I + APE    
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 569 GRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
            + ++  DV+SFGI++ E  +  ++P  ++ N E+              K I        
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV-------------MKAI-------N 224

Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +     A   C S V+ + ++C  +   +R    +IV  L K+
Sbjct: 225 DGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 92.8 bits (231), Expect = 6e-21
 Identities = 71/277 (25%), Positives = 118/277 (42%), Gaps = 29/277 (10%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNL-QYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G+   V+ A  L +  +VA+K  +L +          E + M    H N++K  +S 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
              +   LV+ Y+  GSL   + SS     LD      ++ +V   LEYLH   S   IH
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIH 125

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLL--TREDQSTIQTQTLATIGYMAPEYGKEGR-VS 572
            D+K  N+LL ++    ++DFG++  L    +    ++   + T  +MAPE  ++     
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 573 ANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF 632
              D++SFGI  +E  T   P  +    ++ +    ND  P S +   D    S+     
Sbjct: 186 FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND--PPSLETGADYKKYSKSFRKM 243

Query: 633 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK 669
           ++              C  + P +R  A+E    LLK
Sbjct: 244 ISL-------------CLQKDPSKRPTAEE----LLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 74/294 (25%), Positives = 128/294 (43%), Gaps = 49/294 (16%)

Query: 399 LIGRGSFGSVFKARL----GDGMEVA---MKVFNLQYGRVFKSFDVECEMMKSIRHRNII 451
           ++G G FGSV + +L    G  ++VA   MK+    Y  + + F  E   MK   H N++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI-EEFLSEAACMKDFDHPNVM 64

Query: 452 KVISSC----SNEEFKA--LVLEYMPHGSLEKYLHSSN-----YILDIYQRLNIMIDVAS 500
           K+I  C    S ++     ++L +M HG L  +L  S        L +   L  M+D+A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED---QSTIQTQTLAT 557
            +EYL    +   IH DL   N +L ++M   ++DFG++K +   D   Q  I       
Sbjct: 125 GMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---P 178

Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPIST 616
           + ++A E   +   ++  DV++FG+ + E  TR + P   + N E+       D+L    
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY------DYL-RHG 231

Query: 617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
             +  P             E C+  ++++   C    P+ R    ++   L  I
Sbjct: 232 NRLKQP-------------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 91.3 bits (226), Expect = 2e-20
 Identities = 63/206 (30%), Positives = 114/206 (55%), Gaps = 10/206 (4%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+        +VA+K   L+ G +  ++F  E ++MK +RH  ++ + +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIK--TLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCD 517
            EE   +V E+M  GSL  +L   +     Y +L  ++D+A+ + + + +      IH D
Sbjct: 72  -EEPIYIVTEFMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ DN+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 578 YSFGIMLMETFTRKK-PTDEIFNGEM 602
           +SFGI+L E  T+ + P   + N E+
Sbjct: 187 WSFGILLTELVTKGRVPYPGMVNREV 212

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 69/280 (24%), Positives = 111/280 (39%), Gaps = 33/280 (11%)

Query: 399 LIGRGSFGSV----FKARLGDGMEVAMKVFNLQYGRVFK---SFDVECEMMKSIRHRNII 451
            +G GSFG V    +    G  + VA+K   L+  ++      F  E  +M S+ H N+I
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKC--LKSDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYS 510
           ++           +V E  P GSL   L         I    +  + +A+ + YL    S
Sbjct: 60  RLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---S 115

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAK-LLTREDQSTIQTQTLATIGYMAPEYGKEG 569
            + IH DL   N+LL  +    + DFG+ + L   ED   ++        + APE  +  
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175

Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
             S   DV+ FG+ L E FT          GE         W  +S  +I+    + +E 
Sbjct: 176 TFSHASDVWMFGVTLWEMFTY---------GEEP-------WAGLSGSQIL--KKIDKEG 217

Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK 669
                 E C   ++NV ++C   +P  R     +   L +
Sbjct: 218 ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.8 bits (225), Expect = 3e-20
 Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 9/195 (4%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K   L+ G +  +SF  E ++MK +RH  ++++ +  S
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVK--TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L       L +   +++   VA+ + Y+        IH D
Sbjct: 72  EEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T+ +
Sbjct: 187 WSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 90.2 bits (224), Expect = 5e-20
 Identities = 68/271 (25%), Positives = 119/271 (43%), Gaps = 31/271 (11%)

Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G+FG V+KA+  + G+  A K+  ++     + F VE +++   +H NI+ +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            E    +++E+   G+L+  +      L   Q   +   +  AL +LH   S +VIH DL
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDL 129

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY-----GKEGRVSA 573
           K  N+LL  +    L+DFG++       Q   +   + T  +MAPE       K+     
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPEVVACETFKDNPYDY 187

Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD-PNLLSREDINF 632
             D++S GI L+E    + P  E+    + LK      +  S    +D P+  S    +F
Sbjct: 188 KADIWSLGITLIELAQMEPPHHELNPMRVLLK------ILKSEPPTLDQPSKWSSSFNDF 241

Query: 633 VAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
           +               C V+ P+ R  A E+
Sbjct: 242 LKS-------------CLVKDPDDRPTAAEL 259

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 80/279 (28%), Positives = 125/279 (44%), Gaps = 47/279 (16%)

Query: 399 LIGRGSFGSVFKA-RLGDGMEVAMKVFNL----QYGR-VFKSFDVECEMMKSIRHRNIIK 452
           L+G GSFGSV++   L DG   A+K  +L    Q G+   K  + E  ++  ++H NI++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHS----SNYILDIYQRLNIMIDVASALEYLHFG 508
            + +   E+   + LE +P GSL K L         ++ +Y R      +   LEYLH  
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLH-- 119

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPEY 565
                +H D+K +N+L+D N V  L+DFG+AK      Q    +   +  G   +MAPE 
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSFKGSPYWMAPEV 172

Query: 566 -GKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
             ++G      D++S G  ++E  T K P  ++       K   +  LP     I  P+ 
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP----PI--PDH 226

Query: 625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
           LS E  +F+ K             C    P  R  A E+
Sbjct: 227 LSDEAKDFILK-------------CLQRDPSLRPTAAEL 252

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 21/201 (10%)

Query: 399 LIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVIS 455
           ++G G++G V K R    G  VA+K F        V K+   E ++++ +RH NI+ +  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
           +   +    LV EY+    LE  L +S   L      + +  +  A+ Y H   S  +IH
Sbjct: 68  AFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-------YGKE 568
            D+KP N+L+ ++ V  L DFG A+ L     S + T  +AT  Y APE       YGK 
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYRAPELLVGDTNYGKP 182

Query: 569 GRVSANGDVYSFGIMLMETFT 589
                  DV++ G ++ E   
Sbjct: 183 ------VDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 18/215 (8%)

Query: 394 FSENN---LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRN 449
           + EN    ++G+G++G V+ AR L   + +A+K    +  R  +    E  +   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI----DVASALEYL 505
           I++ + S S   F  + +E +P GSL   L S    L   +    +I     +   L+YL
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE--QTIIFYTKQILEGLKYL 124

Query: 506 HFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           H     Q++H D+K  NVL++  + V  +SDFG +K L   +  T +T T  T+ YMAPE
Sbjct: 125 H---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT-ETFT-GTLQYMAPE 179

Query: 565 YGKEGR--VSANGDVYSFGIMLMETFTRKKPTDEI 597
              +G     A  D++S G  ++E  T K P  E+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 20/215 (9%)

Query: 400 IGRGSFGSVFKA--RLGDG--MEVAMKVF---NLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G G+FGSV K    +  G  +EVA+K     ++  G+  K F  E  +M  + H  I++
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCIVR 60

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
           +I  C  E    LV+E  P G L KYL       + D+     +   VA  + YL    S
Sbjct: 61  LIGVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDL---KELAHQVAMGMAYLE---S 113

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TREDQSTIQTQTLATIGYMAPEYGKEG 569
              +H DL   NVLL +   A +SDFG+++ L    D     T     + + APE    G
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173

Query: 570 RVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMT 603
           + S+  DV+S+G+ L E F+   KP  E+   E+ 
Sbjct: 174 KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI 208

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 57/197 (28%), Positives = 91/197 (46%), Gaps = 12/197 (6%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNL-QYGRVFKSFDV-ECEMMKSIRHRNIIKVISS 456
           IG G++G V+KAR    G  VA+K   L           + E +++K + H NIIK++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
             ++    LV E+M    L K +      L      + +  +   L + H   S  ++H 
Sbjct: 67  FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE--YGKEGRVSAN 574
           DLKP N+L++   V  L+DFG+A+           T  + T  Y APE   G +G  S  
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFG--SPVRPYTHYVVTRWYRAPELLLGDKG-YSTP 179

Query: 575 GDVYSFGIMLMETFTRK 591
            D++S G +  E  +R+
Sbjct: 180 VDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 88.5 bits (219), Expect = 3e-19
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 28/210 (13%)

Query: 398 NLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYGRV--FKSFDVECEMM-KSIRHRNII 451
           ++IG G+FG V +A +   G  M  A+K+   ++      + F  E E++ K   H NII
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNIMI 496
            ++ +C N  +  + +EY P+G+L  +L               H +   L   Q L    
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
           DVA+ ++YL      Q IH DL   NVL+ +N+ + ++DFG+++    E+    +T    
Sbjct: 127 DVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTMGRL 180

Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
            + +MA E       +   DV+SFG++L E
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWE 210

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 87.2 bits (216), Expect = 5e-19
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 28/214 (13%)

Query: 399 LIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG---------RVFKSFDVECEMMKSI 445
           LIG GSFGSV+   LG     G  +A+K   L             +  +   E  ++K +
Sbjct: 7   LIGSGSFGSVY---LGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           +H NI++ + S  + +   + LEY+P GS+   L++     +   R N +  +   L YL
Sbjct: 64  QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR-NFVRQILKGLNYL 122

Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA------TIG 559
           H   +  +IH D+K +N+L+D+     +SDFGI+K L  E  S       A      ++ 
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPSLQGSVF 177

Query: 560 YMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           +MAPE  K+   +   D++S G +++E  T K P
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 87.6 bits (218), Expect = 5e-19
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 33/201 (16%)

Query: 400 IGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDV-----ECEMMKSIRHRNIIKV 453
           +G GSFG V   R     +  A+K+ +    ++ K   V     E  +++SIRH  ++ +
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKA--KIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
             S  ++    LV+EY+P G L  +L  S               V  ALEYLH   S  +
Sbjct: 67  YGSFQDDSNLYLVMEYVPGGELFSHLRKSGR-FPEPVARFYAAQVVLALEYLH---SLDI 122

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAK-LLTREDQSTIQTQTL-ATIGYMAPE------Y 565
           ++ DLKP N+LLD +    ++DFG AK +  R       T TL  T  Y+APE      Y
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-------TYTLCGTPEYLAPEIILSKGY 175

Query: 566 GKEGRVSANGDVYSFGIMLME 586
           GK    +   D ++ GI++ E
Sbjct: 176 GK----AV--DWWALGILIYE 190

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 86.9 bits (215), Expect = 6e-19
 Identities = 67/230 (29%), Positives = 111/230 (48%), Gaps = 27/230 (11%)

Query: 394 FSENNLIGRGSFGSVFKARL----GDGMEVAMKVFNLQYGRVFKSFDVE-----CEMMKS 444
           F+   ++G+G FGSV +A+L    G   +VA+K+       +F S D+E        MK 
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD---IFSSSDIEEFLREAACMKE 57

Query: 445 IRHRNIIKVISSCSNEEFKA------LVLEYMPHGSLEKYLHSSN-----YILDIYQRLN 493
             H N+IK+I        K       ++L +M HG L  +L  S      + L +   + 
Sbjct: 58  FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117

Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
            MID+AS +EYL    S   IH DL   N +L++NM   ++DFG++K +   D       
Sbjct: 118 FMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174

Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEM 602
           +   + ++A E   +   + + DV++FG+ + E  TR + P   + N E+
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 87.4 bits (216), Expect = 7e-19
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 28/210 (13%)

Query: 398 NLIGRGSFGSVFKARL-GDG--MEVAMKVFNLQYGRV--FKSFDVECEMMKSI-RHRNII 451
           ++IG G+FG V KAR+  DG  M+ A+K    +Y      + F  E E++  +  H NII
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNIMI 496
            ++ +C +  +  L +EY PHG+L  +L               +S+   L   Q L+   
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
           DVA  ++YL      Q IH DL   N+L+ +N VA ++DFG+++    ++    +T    
Sbjct: 132 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 185

Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
            + +MA E       + N DV+S+G++L E
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWE 215

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 86.7 bits (215), Expect = 8e-19
 Identities = 70/283 (24%), Positives = 121/283 (42%), Gaps = 33/283 (11%)

Query: 397 NNLIGRGSFGSVFKA----RLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNII 451
              IG G FG V++        + + VA+K   N     V + F  E  +M+   H +I+
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K+I   + E    +V+E  P G L  YL  + Y LD+   +     +++AL YL    S 
Sbjct: 71  KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGYMAPEYGKEGR 570
           + +H D+   NVL+       L DFG+++ L  ED+S  + ++    I +MAPE     R
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL--EDESYYKASKGKLPIKWMAPESINFRR 184

Query: 571 VSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
            ++  DV+ FG+ + E      KP   + N ++  +    + LP+               
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP-------------- 230

Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD 672
                   C   ++++  +C    P +R    E+  +L  I  
Sbjct: 231 ------PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 87.2 bits (217), Expect = 8e-19
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 31/210 (14%)

Query: 398 NLIGRGSFGSVFKAR-LGDGMEVA---MKVFNLQYGRVFKSFDV--ECEMMKSIRHRNII 451
             +G G++  V+KAR    G  VA   +K+   +  +   +F    E ++++ ++H NII
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYIL---DIYQRLNIMIDVASALEYLHFG 508
            ++    ++    LV E+M    LEK +   + +L   DI      M+     LEYLH  
Sbjct: 66  GLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKS---YMLMTLRGLEYLH-- 119

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE---- 564
            S  ++H DLKP+N+L+  + V  L+DFG+A+  +    +   T  + T  Y APE    
Sbjct: 120 -SNWILHRDLKPNNLLIASDGVLKLADFGLAR--SFGSPNRKMTHQVVTRWYRAPELLFG 176

Query: 565 ---YGKEGRVSANGDVYSFGIMLMETFTRK 591
              YG    V    D++S G +  E   R 
Sbjct: 177 ARHYG----VGV--DMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 51/206 (24%), Positives = 96/206 (46%), Gaps = 19/206 (9%)

Query: 400 IGRGSFGSVFK---ARLGDG---MEVAMK-VFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G+GSFG V++     +  G     VA+K V      R    F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL--------HSSNYILDIYQR-LNIMIDVASALE 503
           ++   S  +   +V+E M  G L+ YL        ++        Q+ + +  ++A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL    + + +H DL   N ++ +++   + DFG+ + +   D      + L  + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 564 EYGKEGRVSANGDVYSFGIMLMETFT 589
           E  K+G  +   DV+SFG++L E  T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 67/252 (26%), Positives = 110/252 (43%), Gaps = 41/252 (16%)

Query: 399 LIGRGSFGSVFKARLGD-GMEVAMKVFNL-----QYGRVFKSFDVECEMMKSIRHRNIIK 452
           L+G+G+FG V+     D G E+A+K         +  +   + + E +++K+++H  I++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHS----SNYILDIYQRLNIMIDVASALEYLHFG 508
                 ++E  ++ +EYMP GS++  L +    +  +   Y R      +   +EYLH  
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-----QILEGVEYLH-- 121

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK-LLTREDQSTIQTQTLATIGYMAPE--- 564
            S  ++H D+K +N+L D      L DFG +K L T     T       T  +M+PE   
Sbjct: 122 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVIS 180

Query: 565 ---YGKEGRVSANGDVYSFGIMLMETFTRKKPTDE------IFNGEMTLKHWVNDWLPIS 615
              YG++       DV+S G  ++E  T K P  E      IF          N  LP  
Sbjct: 181 GEGYGRK------ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK---IATQPTNPQLPSH 231

Query: 616 TKEIVDPNLLSR 627
                  N L R
Sbjct: 232 VSPDAR-NFLRR 242

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 86.5 bits (214), Expect = 1e-18
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 10/197 (5%)

Query: 399 LIGRGSFGSVFKARL---GDGME--VAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIK 452
           L+G G FG+V K      GD ++  VA+K    + GR  F+        M S+ H  I++
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           ++  C     + LV +  P GSL  ++      LD  + LN  + +A  + YL      +
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
           ++H +L   N+LL  + +  ++DFG+A LL  +D+    ++    I +MA E    GR +
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189

Query: 573 ANGDVYSFGIMLMETFT 589
              DV+S+G+ + E  +
Sbjct: 190 HQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 23/206 (11%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSIRH---RN 449
           LIGRG++G+V++ + +  G  VA+K+ NL         DV     E  ++  +R     N
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPN 63

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           I K   S        +++EY   GS+ + L  +  I + Y  + I+ +V  AL+Y+H   
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH--- 118

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY-MAPEYGKE 568
              VIH D+K +N+L+ +     L DFG+A LL    Q++ +  T     Y MAPE   E
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN---QNSSKRSTFVGTPYWMAPEVITE 175

Query: 569 GRV-SANGDVYSFGIMLMETFTRKKP 593
           G+      D++S GI + E  T   P
Sbjct: 176 GKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 66/251 (26%), Positives = 106/251 (42%), Gaps = 37/251 (14%)

Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVIS 455
           +G G FG V   ++       A+K    ++       +    E E+++   H  I+K+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
           +  ++++  +++EY   G L   L       D Y     +  V  A EYLH   +  +I+
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRGIIY 116

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPE--YGKEGRVS 572
            DLKP N+LLD N    L DFG AK L    +S  +T T   T  Y+APE    K    S
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVAPEIILNKGYDFS 172

Query: 573 ANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVD-------PNL 624
              D +S GI+L E  T + P    F  +        D  P+    +I+        PN 
Sbjct: 173 V--DYWSLGILLYELLTGRPP----FGED--------DEDPMEIYNDILKGNGKLEFPNY 218

Query: 625 LSREDINFVAK 635
           + +   + + +
Sbjct: 219 IDKAAKDLIKQ 229

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 85.7 bits (212), Expect = 1e-18
 Identities = 61/262 (23%), Positives = 121/262 (46%), Gaps = 32/262 (12%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K  +L+ G +    F  E  +MK ++H  ++++ +  +
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L +   I L I + +++   +A  + ++        IH D
Sbjct: 72  QEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRD 127

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ + +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186

Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF--VAK 635
           +SFGI+L E  T  +                     I    + +P ++   +  +     
Sbjct: 187 WSFGILLTEIVTYGR---------------------IPYPGMTNPEVIQNLERGYRMPRP 225

Query: 636 EQCVSFVFNVAMECTVESPEQR 657
           + C   ++ +   C  E PE+R
Sbjct: 226 DNCPEELYELMRLCWKEKPEER 247

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 14/211 (6%)

Query: 391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMK---VFNLQYGRVFKSFDVECEMMKSIR 446
              F     IG+G F  V+KA  L DG  VA+K   +F +   +  +    E +++K + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLE---KYLHSSNYILDIYQRLNIMIDVASALE 503
           H N+IK ++S        +VLE    G L    K+      ++         + + SALE
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMA 562
           ++H   S +++H D+KP+NV +    V  L D G+ +  + +   T    +L  T  YM+
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK---TTAAHSLVGTPYYMS 174

Query: 563 PEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           PE   E   +   D++S G +L E    + P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 67/290 (23%), Positives = 133/290 (45%), Gaps = 44/290 (15%)

Query: 400 IGRGSFGSVFKARL-----GDGME-VAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIK 452
           +G   FG V+K  L     G+  + VA+K    +  G + + F  E  M   ++H NI+ 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL-----HSS----------NYILDIYQRLNIMID 497
           ++   + E+  +++  Y  H  L ++L     HS              L+    ++I+  
Sbjct: 73  LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           +A+ +E+L    S  V+H DL   NVL+ D +   +SD G+ + +   D   +   +L  
Sbjct: 133 IAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           I +M+PE    G+ S + D++S+G++L E F+                + +  +   S +
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS----------------YGLQPYCGYSNQ 233

Query: 618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
           ++++   + R        + C ++V+ + +EC  E P +R   K+I ++L
Sbjct: 234 DVIE---MIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 54/195 (27%), Positives = 105/195 (53%), Gaps = 8/195 (4%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+     +  +VA+K   L+ G +  ++F  E  +MK+++H  ++++ +  +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 459 NEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            EE   ++ EYM  GSL  +L S     + + + ++    +A  + Y+        IH D
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +NVL+ ++++  ++DFG+A+++  +++ T +      I + APE    G  +   DV
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187

Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  K
Sbjct: 188 WSFGILLYEIVTYGK 202

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 23/198 (11%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVI-- 454
           IG G+ G VFKA+    G  VA+K   L+   G +      E + +++ +H  ++K++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 455 ----SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
               S         LV+EYMP   L + L      L   Q  + M  +   + Y+H   +
Sbjct: 68  FPHGSGFV------LVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---A 117

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE--YGKE 568
             ++H DLKP+N+L+  + V  ++DFG+A+L + E++  + +  +AT  Y APE  YG  
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFS-EEEPRLYSHQVATRWYRAPELLYGAR 176

Query: 569 GRVSANGDVYSFGIMLME 586
            +     D+++ G +  E
Sbjct: 177 -KYDPGVDLWAVGCIFAE 193

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 84.4 bits (209), Expect = 4e-18
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 19/208 (9%)

Query: 398 NLIGRGSFGSVFKARL----GDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSIRHR 448
            +IG+G FG V+   L    G  +  A+K  N    R+    +V     E  +MK   H 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN----RITDLEEVEQFLKEGIIMKDFSHP 56

Query: 449 NIIKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
           N++ ++  C   E   LV L YM HG L  ++ S  +   +   +   + VA  +EYL  
Sbjct: 57  NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA- 115

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEY 565
             S + +H DL   N +LD++    ++DFG+A+ +  ++  ++   T A   + +MA E 
Sbjct: 116 --SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP 593
            +  + +   DV+SFG++L E  TR  P
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 84.1 bits (208), Expect = 9e-18
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 37/221 (16%)

Query: 400 IGRGSFGSVFKAR-LG-----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           IG+G+FG VF+AR  G         VA+K+   +    +   F  E  +M    H NI+K
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYI--------------------LDIYQR 491
           ++  C+  +   L+ EYM +G L ++L H S                       L   ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 492 LNIMIDVASALEYL---HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS 548
           L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DFG+++ +   D  
Sbjct: 133 LCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
                    I +M PE     R +   DV+++G++L E F+
Sbjct: 187 KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 83.8 bits (207), Expect = 1e-17
 Identities = 61/195 (31%), Positives = 96/195 (49%), Gaps = 8/195 (4%)

Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG+G+ G+V+ A  +  G EVA+K  NLQ     +    E  +M+  +H NI+  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S QVIH D+
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH---SNQVIHRDI 141

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  N+LL  +    L+DFG    +T E     ++  + T  +MAPE           D++
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 579 SFGIMLMETFTRKKP 593
           S GIM +E    + P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 62/202 (30%), Positives = 88/202 (43%), Gaps = 14/202 (6%)

Query: 392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRN 449
           +   E + +G G+ GSV K RL   GM  A+K         + K    E E+ KS +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 450 IIKVISSCSNEEFK--ALVLEYMPHGSLE---KYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+K   +  +E      + +EY   GSL+   K +      +       I   V   L Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           LH   S ++IH D+KPSN+LL       L DFG++  L      T       T  YMAPE
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF----TGTSFYMAPE 173

Query: 565 YGKEGRVSANGDVYSFGIMLME 586
             +    S   DV+S G+ L+E
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLE 195

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)

Query: 399 LIGRGSFGSVFKA-RLGDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           ++GRG+FG V    R  D   V +K   ++        +   EC+++K + H NII+   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
           +   ++   +V+EY P G+L +Y+    N +LD    L+  + +  AL ++H   +  ++
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123

Query: 515 HCDLKPSNVLLDDN-MVAHLSDFGIAKLL-TREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
           H DLK  N+LLD + MV  + DFGI+K+L ++    T+    + T  Y++PE  +    +
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV----VGTPCYISPELCEGKPYN 179

Query: 573 ANGDVYSFGIMLMETFTRKKPTD 595
              D+++ G +L E  + K+  +
Sbjct: 180 QKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.0 bits (205), Expect = 1e-17
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 11/198 (5%)

Query: 399 LIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV 453
           +IG G FG V   RL       + VA+K     Y  +  + F  E  +M    H NII +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH-FGYSAQ 512
               +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYGKEGRV 571
            +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + APE     + 
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186

Query: 572 SANGDVYSFGIMLMETFT 589
           ++  DV+S+GI++ E  +
Sbjct: 187 TSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 68/268 (25%), Positives = 120/268 (44%), Gaps = 24/268 (8%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           +G G FG V   +    ++VA+K  N +     + F  E ++M  + H  ++++   C+ 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
           ++   +V E+M +G L  YL      L     L++  DV   +EYL        IH DL 
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127

Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYS 579
             N L+    V  +SDFG+ + +  +D+ T  +     + +  PE     + S+  DV+S
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWS 186

Query: 580 FGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCV 639
           FG+++ E FT          G+M  +   N        E+V+  ++SR    +  K   +
Sbjct: 187 FGVLMWEVFTE---------GKMPFEKKSN-------YEVVE--MISRGFRLYRPKLASM 228

Query: 640 SFVFNVAMECTVESPEQRINAKEIVTKL 667
           + V+ V   C  E PE R    E++  +
Sbjct: 229 T-VYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 83.7 bits (207), Expect = 1e-17
 Identities = 76/238 (31%), Positives = 112/238 (47%), Gaps = 39/238 (16%)

Query: 389 RATDGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV----ECEMMK 443
           R  D F     IG G++G V+KAR  D G  VA+K   L   +  + F +    E ++++
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILR 61

Query: 444 SIRHRNIIK----VISSCSNEEFKA------LVLEYMPH---GSLEKYL--HSSNYILDI 488
            + HRNI+     V       +FK       LV EYM H   G LE  L   S ++I   
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSF 121

Query: 489 YQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS 548
            ++L         LE L++ +    +H D+K SN+LL++     L+DFG+A+L   E+  
Sbjct: 122 MKQL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 549 TIQTQTLATIGYMAPE--YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTL 604
              T  + T+ Y  PE   G+E R     DV+S G +L E FT+K     IF     L
Sbjct: 173 PY-TNKVITLWYRPPELLLGEE-RYGPAIDVWSCGCILGELFTKKP----IFQANQEL 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 67/307 (21%), Positives = 123/307 (40%), Gaps = 45/307 (14%)

Query: 380 RMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG---RVFKSFD 436
             F  + LC A DG  + +        +     L     VA+KV  L+        + F 
Sbjct: 16  GQFGEVHLCEA-DGLQDFSEKAFAENDNADAPVL-----VAVKV--LRPDASDNAREDFL 67

Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH--------SSNYILDI 488
            E +++  +   NI +++  C+ +    +++EYM +G L ++L          +     +
Sbjct: 68  KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 489 YQR--LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
                L +   +AS + YL    S   +H DL   N L+  N    ++DFG+++ L   D
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT--RKKPTDEIFNGEMTL 604
              +Q +    I +MA E    G+ +   DV++FG+ L E  T  R++P + + +     
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD----- 239

Query: 605 KHWVNDWLPISTKEIVDPNLLSREDINFVAKEQ---CVSFVFNVAMECTVESPEQRINAK 661
              V          I +     R+D   +   +   C   ++ + +EC     E R   +
Sbjct: 240 -QQV----------IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR 288

Query: 662 EIVTKLL 668
           EI   L 
Sbjct: 289 EIHLFLQ 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 18/203 (8%)

Query: 397 NNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNII 451
             +IG G FG V + RL       ++VA+K        +    F  E  +M    H NII
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL-HFGYS 510
           ++    +      ++ EYM +GSL+K+L  ++    + Q + ++  +AS ++YL    Y 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA----TIGYMAPEYG 566
              +H DL   N+L++ N+V  +SDFG    L+R  + +  T T       I + APE  
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFG----LSRRLEDSEATYTTKGGKIPIRWTAPEAI 180

Query: 567 KEGRVSANGDVYSFGIMLMETFT 589
              + ++  DV+SFGI++ E  +
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 82.7 bits (204), Expect = 3e-17
 Identities = 68/284 (23%), Positives = 123/284 (43%), Gaps = 37/284 (13%)

Query: 400 IGRGSFGSVFKARL---GD--GMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKV 453
           +G G FG V   R    GD  G +VA+K    +  G        E E+++++ H NI+K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 454 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              C+ +      L++E++P GSL++YL  +   +++ Q+L   + +   ++YL    S 
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TREDQSTIQTQTLATIGYMAPEYGKEGR 570
           Q +H DL   NVL++      + DFG+ K + T ++  T++    + + + APE   + +
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188

Query: 571 VSANGDVYSFGIMLMETFT----RKKPTDEIF------NGEMTLKHWVNDWLPISTKEIV 620
                DV+SFG+ L E  T       P           +G+MT+   V            
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR----------- 237

Query: 621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
               +  E         C   V+ +  +C    P +R   + ++
Sbjct: 238 ----VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 66/290 (22%), Positives = 125/290 (43%), Gaps = 37/290 (12%)

Query: 393 GFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFN-LQYGRVFKSFDVECEMMKSI 445
              E   +GRG FG VF A+       G    V +K     +   +   F  E +M + +
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI--------LDIYQRLNIMID 497
            H+N+++++  C   E   ++LEY   G L+++L ++           L   Q++ +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           +A  +++L    +A+ +H DL   N L+       +S   ++K      +       L  
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNALIP 181

Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + ++APE  +E   S   DV+SFG+++ E FT+         GE+           +S +
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQ---------GELPFY-------GLSDE 225

Query: 618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
           E++  N L    +     E C S ++ +   C   +P+ R +  E+V+ L
Sbjct: 226 EVL--NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.4 bits (201), Expect = 5e-17
 Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 35/223 (15%)

Query: 399 LIGRGSFGSVF---KARLGDGMEV---------AMKVFNLQYGRVFKSFDVECEMMKSIR 446
           LIG+G++G V+       G+ M V         A +  + Q   V K+   E E +K + 
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMV-KALRSEIETLKDLD 66

Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN------IMIDVAS 500
           H NI++ +   + EE+ ++ LEY+P GS+          L  Y R            V  
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGS-------CLRTYGRFEEQLVRFFTEQVLE 119

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIG 559
            L YLH   S  ++H DLK  N+L+D + +  +SDFGI+K  + +     Q  ++  ++ 
Sbjct: 120 GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK-KSDDIYDNDQNMSMQGSVF 175

Query: 560 YMAPE--YGKEGRVSANGDVYSFGIMLMETFTRKKP--TDEIF 598
           +MAPE  +      SA  D++S G +++E F  ++P   +E  
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.9 bits (205), Expect = 5e-17
 Identities = 67/255 (26%), Positives = 114/255 (44%), Gaps = 58/255 (22%)

Query: 367 PPNDANMPPEAMQRMFSYLELCRATDGFSE---NNLIGRGSFGSVFKAR-LGDGMEVAMK 422
           PP  ++    +     +      A    SE    N IG G+ G+V+K      G   A+K
Sbjct: 48  PPPSSSSSSSSSSS--ASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALK 105

Query: 423 VFNLQYGR----VFKSFDVECEMMKSIRHRNIIKVISSC-----SNEEFKALVLEYMPHG 473
           V    YG     V +    E E+++ + H N++K    C      N E + L LE+M  G
Sbjct: 106 VI---YGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVL-LEFMDGG 157

Query: 474 SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL 533
           SLE       +I D     ++   + S + YLH      ++H D+KPSN+L++      +
Sbjct: 158 SLE-----GTHIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKI 209

Query: 534 SDFGIAKLLTREDQSTIQT-----QTLATIGYMAPEYGKEGRVSAN----------GDVY 578
           +DFG++++L        QT      ++ TI YM+PE     R++ +          GD++
Sbjct: 210 ADFGVSRILA-------QTMDPCNSSVGTIAYMSPE-----RINTDLNHGAYDGYAGDIW 257

Query: 579 SFGIMLMETFTRKKP 593
           S G+ ++E +  + P
Sbjct: 258 SLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 81.2 bits (200), Expect = 5e-17
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 12/207 (5%)

Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMK---VFNLQYGRVFKSFDVECEMMKSIRHRN 449
           F     IGRG F  V++A  L DG+ VA+K   +F+L   +       E +++K + H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLE---KYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           +IK  +S   +    +VLE    G L    K+      ++         + + SALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
              S +V+H D+KP+NV +    V  L D G+ +  +   ++T     + T  YM+PE  
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTPYYMSPERI 178

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKP 593
            E   +   D++S G +L E    + P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 82.4 bits (204), Expect = 6e-17
 Identities = 65/226 (28%), Positives = 104/226 (46%), Gaps = 49/226 (21%)

Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDV---------ECEMMKSIRHRN 449
           IG G++G V  A     G +VA+K       ++  +FDV         E ++++  +H N
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIK-------KIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 450 I--IKVISSCSNEEFKA--LVLEYMPHGSLEKYLHSS--------NYILDIYQRLNIMID 497
           I  I+ I      +FK   +V++ M    L   +HS          Y L  YQ L     
Sbjct: 66  IIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFL--YQLLR---- 118

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR--EDQSTIQTQTL 555
               L+Y+H   SA VIH DLKPSN+L++++    + DFG+A+ L+    +     T+ +
Sbjct: 119 ---GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172

Query: 556 ATIGYMAPEYG-KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNG 600
           AT  Y APE        +   D++S G +  E   R+    ++F G
Sbjct: 173 ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR----QLFPG 214

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 80.9 bits (200), Expect = 7e-17
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 19/208 (9%)

Query: 398 NLIGRGSFGSVFKA----RLGDG--MEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNI 450
             +G G+FG V++     R GD   ++VA+K          +S F +E  +M    H+NI
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN------YILDIYQRLNIMIDVASALEY 504
           +++I        + ++LE M  G L+ +L  +         L +   L    DVA   +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 505 LHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           L        IH D+   N LL       VA ++DFG+A+ + R        + +  I +M
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 562 APEYGKEGRVSANGDVYSFGIMLMETFT 589
            PE   +G  ++  DV+SFG++L E F+
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 81.7 bits (202), Expect = 8e-17
 Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 34/225 (15%)

Query: 388 CRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV----ECEMM 442
           C     + +   IG+G+FG VFKAR       VA+K   +      + F +    E +++
Sbjct: 8   CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKIL 65

Query: 443 KSIRHRNIIKVISSCSNE-----EFKA---LVLEYMPHGSLEKYLHSSNYILDIYQRLNI 494
           + ++H N++ +I  C  +      +K    LV E+  H  L   L + N    + +   +
Sbjct: 66  QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV 124

Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK--LLTREDQSTIQT 552
           M  + + L Y+H     +++H D+K +N+L+  + +  L+DFG+A+   L++  +    T
Sbjct: 125 MKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 553 QTLATIGYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTR 590
             + T+ Y  PE       YG         D++  G ++ E +TR
Sbjct: 182 NRVVTLWYRPPELLLGERDYGPP------IDMWGAGCIMAEMWTR 220

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 80.5 bits (198), Expect = 9e-17
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 28/210 (13%)

Query: 398 NLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYGRV--FKSFDVECEMM-KSIRHRNII 451
           ++IG G+FG V KAR+   G  M+ A+K    +Y      + F  E E++ K   H NII
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNIMI 496
            ++ +C +  +  L +EY PHG+L  +L               +S+   L   Q L+   
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
           DVA  ++YL      Q IH DL   N+L+ +N VA ++DFG+++    ++    +T    
Sbjct: 120 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 173

Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
            + +MA E       + N DV+S+G++L E
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWE 203

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.7 bits (199), Expect = 9e-17
 Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 24/217 (11%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYG------RVFKSFDVECEMMKSIRHRNII 451
            +G G+F S ++AR +  G  +A+K              V ++   E  +M  + H +II
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHS----SNYILDIYQRLNIMIDVASALEYLHF 507
           +++ +   +    L +E+M  GS+   L         ++  Y        +   L YLH 
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTE-----QLLRGLSYLH- 120

Query: 508 GYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTREDQST--IQTQTLATIGYMAPE 564
               Q+IH D+K +N+L+D       ++DFG A  L  +       Q Q L TI +MAPE
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 565 YGKEGRVSANGDVYSFGIMLMETFTRKKP--TDEIFN 599
             +  +   + DV+S G +++E  T K P   ++  N
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 81.2 bits (200), Expect = 1e-16
 Identities = 65/230 (28%), Positives = 108/230 (46%), Gaps = 34/230 (14%)

Query: 400 IGRGSFGSVF--------KARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSI-RHRN 449
           +G G FG V         K +  + + VA+K+  +    +       E EMMK I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-----NYILDIYQ----------RLNI 494
           II ++ +C+ +    +++EY   G+L +YL +       Y  DI +           ++ 
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 143 TYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIF 598
              + +MAPE   +   +   DV+SFG+++ E FT         P +E+F
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 15/201 (7%)

Query: 399 LIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV 453
           +IG G FG V + RL       + VA+K     Y  +  + F  E  +M    H NII +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
               +      ++ E+M +G+L+ +L  ++    + Q + ++  +A+ ++YL        
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-----TIGYMAPEYGKE 568
           +H DL   N+L++ N+V  +SDFG+++ L  ED ++  T T +      I + APE    
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 569 GRVSANGDVYSFGIMLMETFT 589
            + ++  DV+S+GI++ E  +
Sbjct: 186 RKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 28/204 (13%)

Query: 399 LIGRGSFGSVFKARLGD-GMEVAMKVF--NLQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           L+G GS+G V K +  + G  VA+K F  +     V K    E  M+K +RH N++ +I 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 456 SCSNEEFKALVLEYMPH---GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
               ++   LV E++ H     LEKY +     LD  +    +  +   +E+ H   S  
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIEFCH---SHN 120

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-------Y 565
           +IH D+KP N+L+  + V  L DFG A+ L    +  + T  +AT  Y APE       Y
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKY 178

Query: 566 GKEGRVSANGDVYSFGIMLMETFT 589
           G+        D+++ G ++ E  T
Sbjct: 179 GRA------VDIWAVGCLVTEMLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 54/214 (25%), Positives = 105/214 (49%), Gaps = 22/214 (10%)

Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG------RVFKSFDVECEMMKSIRH 447
           +++  ++G+G++G+V+      G  +A+K   L         + ++    E +++KS++H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDI----YQRLNIMIDVASALE 503
            NI++ + +C ++   ++ +E++P GS+   L+    + +     Y +  I+  VA    
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA---- 116

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---- 559
           YLH   +  V+H D+K +NV+L  N +  L DFG A+ L         +  L ++     
Sbjct: 117 YLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 560 YMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           +MAPE   E       D++S G  + E  T K P
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 21/208 (10%)

Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI------R 446
           F+    IG+GSFG V+KA        VA+KV +L+        ++E ++ + I      R
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA----EDEIE-DIQQEIQFLSQCR 57

Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
              I K   S        +++EY   GS    L      LD      I+ +V   LEYLH
Sbjct: 58  SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLH 115

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPEY 565
                  IH D+K +N+LL +     L+DFG++  LT    +  +  T   T  +MAPE 
Sbjct: 116 ---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLT---STMSKRNTFVGTPFWMAPEV 169

Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP 593
            K+       D++S GI  +E    + P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.4 bits (195), Expect = 3e-16
 Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 12/221 (5%)

Query: 376 EAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKS 434
           E M+++ + + +      ++    IG+G+ G+VF A  +  G EVA+K  NLQ     + 
Sbjct: 3   EIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL 62

Query: 435 FDVECEMMKSIRHRNIIKVISS--CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL 492
              E  +MK +++ NI+  + S    +E F  +V+EY+  GSL   +  +   +D  Q  
Sbjct: 63  IINEILVMKELKNPNIVNFLDSFLVGDELF--VVMEYLAGGSLTDVVTET--CMDEAQIA 118

Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT 552
            +  +   ALE+LH   + QVIH D+K  NVLL  +    L+DFG    +T E     ++
Sbjct: 119 AVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RS 173

Query: 553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
             + T  +MAPE           D++S GIM +E    + P
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 79.6 bits (196), Expect = 3e-16
 Identities = 77/303 (25%), Positives = 128/303 (42%), Gaps = 61/303 (20%)

Query: 400 IGRGSFGSVFKARLGDGME---------VAMKVF-NLQYGRVFKSFDVECEMMKSI-RHR 448
           +G G FG V +A    G++         VA+K+  +    +       E E+MK I +H+
Sbjct: 20  LGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78

Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-----NYILDIYQR----------LN 493
           NII ++  C+ E    +++EY   G+L ++L +      +Y  DI +           ++
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
               VA  +EYL    S + IH DL   NVL+ ++ V  ++DFG+A+ +   D     + 
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNGEMTLKHW 607
               + +MAPE   +   +   DV+SFGI++ E FT         P +E+F         
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK-------- 247

Query: 608 VNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                            L RE         C   ++ +  EC    P QR   K++V  L
Sbjct: 248 -----------------LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290

Query: 668 LKI 670
            K+
Sbjct: 291 DKV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 79.3 bits (195), Expect = 4e-16
 Identities = 73/282 (25%), Positives = 131/282 (46%), Gaps = 32/282 (11%)

Query: 399 LIGRGSFGSVFKA-RLGDG----MEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           ++G G+FG+V+K   + +G    + VA+K+ N   G +    F  E  +M S+ H ++++
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           ++  C +   + LV + MPHG L  Y+H     +     LN  + +A  + YL      +
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERR 129

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
           ++H DL   NVL+       ++DFG+A+LL  +++          I +MA E     + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 573 ANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN 631
              DV+S+G+ + E  T   KP D                  I T+EI  P+LL + +  
Sbjct: 190 HQSDVWSYGVTIWELMTFGGKPYDG-----------------IPTREI--PDLLEKGE-R 229

Query: 632 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI-RD 672
                 C   V+ V ++C +   + R   KE+  +  ++ RD
Sbjct: 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 79.3 bits (195), Expect = 5e-16
 Identities = 75/302 (24%), Positives = 125/302 (41%), Gaps = 59/302 (19%)

Query: 400 IGRGSFGSVF--------KARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSI-RHRN 449
           +G G FG V         K +    + VA+K+  +    +       E EMMK I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-----NYILDIYQRLNIMI-------- 496
           II ++ +C+ +    +++EY   G+L +YL +      +Y  D  +     +        
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 497 --DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  +EYL    S + IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 140 AYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNGEMTLKHWV 608
              + +MAPE   +   +   DV+SFG++L E FT         P +E+F          
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK--------- 247

Query: 609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                           L +E         C   ++ +  EC    P QR   K++V  L 
Sbjct: 248 ----------------LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291

Query: 669 KI 670
           ++
Sbjct: 292 RV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 78.2 bits (192), Expect = 6e-16
 Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G++G V+KAR L  G   A+K+  L+ G  F     E  M+K  +H NI+    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
           + E   + +EY   GSL+   H +  + ++ Q   +  +    L YLH   S   +H D+
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGPLSEL-QIAYVCRETLQGLAYLH---SKGKMHRDI 132

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT--LATIGYMAPEYG---KEGRVSA 573
           K +N+LL DN    L+DFG+A  +T    +TI  +   + T  +MAPE     K G  + 
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKIT----ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188

Query: 574 NGDVYSFGIMLMETFTRKKP 593
             D+++ GI  +E    + P
Sbjct: 189 LCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 78.2 bits (192), Expect = 7e-16
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 20/220 (9%)

Query: 400 IGRGSFGSVFKARLGDG---MEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVI 454
           +G G FGSV + +L      ++VA+K   +        + F  E   MK   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 455 SSC----SNEEFKA--LVLEYMPHGSLEKYLHSSNY-----ILDIYQRLNIMIDVASALE 503
             C     +E + +  ++L +M HG L  +L  S        L     +  M D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL    S   IH DL   N +L++NM   ++DFG++K +   D           + ++A 
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEM 602
           E   +   +   DV+SFG+ + E  TR + P   + N E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI 223

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 78.5 bits (193), Expect = 8e-16
 Identities = 54/183 (29%), Positives = 87/183 (47%), Gaps = 25/183 (13%)

Query: 438 ECEMMKSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HS 481
           E EMMK I +H+NII ++ +C+ +    +++EY   G+L +YL                 
Sbjct: 73  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132

Query: 482 SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL 541
               L     ++    VA  +EYL    S + IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189

Query: 542 LTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTD 595
           +   D     T     + +MAPE   +   +   DV+SFG++L E FT         P +
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249

Query: 596 EIF 598
           E+F
Sbjct: 250 ELF 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 77.8 bits (191), Expect = 8e-16
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 12/201 (5%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMK---VFNLQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IGRG F  V++A  L D   VA+K   +F +   +  +    E +++K + H N+IK + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 456 SCSNEEFKALVLEYMPHGSLE---KYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           S   +    +VLE    G L    KY      ++         + + SA+E++H   S +
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRR 126

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
           V+H D+KP+NV +    V  L D G+ +  + +  +T     + T  YM+PE   E   +
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYN 184

Query: 573 ANGDVYSFGIMLMETFTRKKP 593
              D++S G +L E    + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 77.8 bits (191), Expect = 9e-16
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 14/200 (7%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG G++G V+KAR +  G   A+KV  L+ G  F     E  MMK  +H NI+    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             +   + +E+   GSL+   H +  +        I       L+ L++ +S   +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVTGPL----SESQIAYVSRETLQGLYYLHSKGKMHRDI 132

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT--LATIGYMAPEYG---KEGRVSA 573
           K +N+LL DN    L+DFG++  +T    +TI  +   + T  +MAPE     ++G  + 
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQIT----ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQ 188

Query: 574 NGDVYSFGIMLMETFTRKKP 593
             D+++ GI  +E    + P
Sbjct: 189 LCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 80/306 (26%), Positives = 131/306 (42%), Gaps = 72/306 (23%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVISS 456
           IG G++G V+K R    G  VAMK   L+     V  +   E  ++K ++H NI+ +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHS--SNYILD-------IYQRLNIMIDVASALEYLHF 507
              E    L+ E++    L+KYL S      +D       +YQ L  ++          F
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----------F 116

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL---TREDQSTIQTQTLATIGYMAPE 564
            +S +V+H DLKP N+L+D+  V  L+DFG+A+      R     + T  + T+ Y APE
Sbjct: 117 CHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-----VYTHEVVTLWYRAPE 171

Query: 565 --YGKEGRVSANGDVYSFGIMLMETFTRK--------------------KPTDEIFNGEM 602
              G   R S   D++S G +  E  T+K                     PT++++ G  
Sbjct: 172 VLLGSP-RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230

Query: 603 TLKHWVN---DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN 659
           +L  + N    W   S +  V  N L  + ++ + K               +  P +RI+
Sbjct: 231 SLPDYKNTFPKWKKGSLRSAV-KN-LDEDGLDLLEK-------------MLIYDPAKRIS 275

Query: 660 AKEIVT 665
           AK+ + 
Sbjct: 276 AKKALN 281

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 17/210 (8%)

Query: 394 FSENNL-----IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVFK-SFDVECEM 441
           F  NNL     +G G+FG V +A      +    M+VA+K+         + +   E ++
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91

Query: 442 MKSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVA 499
           M  +  H NI+ ++ +C+      ++ EY  +G L  +L       L +   L+    VA
Sbjct: 92  MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151

Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG 559
             + +L    S   IH DL   NVLL    +  + DFG+A+ +  +    ++      + 
Sbjct: 152 KGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208

Query: 560 YMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           +MAPE       +   DV+S+GI+L E F+
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 65/225 (28%), Positives = 113/225 (50%), Gaps = 26/225 (11%)

Query: 388 CRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV----ECEMM 442
           CR+ D + + N I  G++G V++AR    G  VA+K   L+  +  + F +    E  ++
Sbjct: 1   CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINIL 58

Query: 443 KSIRHRNIIKV--ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
             ++H NI+ V  +   SN +   +V+EY+ H  L+  + +        +   +M+ + S
Sbjct: 59  LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLS 117

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ--TQTLATI 558
            + +LH      ++H DLK SN+LL++  +  + DFG+A    RE  S ++  TQ + T+
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLA----REYGSPLKPYTQLVVTL 170

Query: 559 GYMAPE--YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
            Y APE   G     S   D++S G +  E    KKP   +F G+
Sbjct: 171 WYRAPELLLG-AKEYSTAIDMWSVGCIFAE-LLTKKP---LFPGK 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 76.3 bits (187), Expect = 3e-15
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 8/219 (3%)

Query: 376 EAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKS 434
           E ++++ S + +      ++    IG+G+ G+V+ A  +  G EVA++  NLQ     + 
Sbjct: 4   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 63

Query: 435 FDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI 494
              E  +M+  ++ NI+  + S    +   +V+EY+  GSL   +  +   +D  Q   +
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAV 121

Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
             +   ALE+LH   S QVIH D+K  N+LL  +    L+DFG    +T E     ++  
Sbjct: 122 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTM 176

Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           + T  +MAPE           D++S GIM +E    + P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 70/299 (23%), Positives = 123/299 (41%), Gaps = 67/299 (22%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECE-----------MMKSIRH 447
           IG G++G V+KAR    G  VA+K   L         D E E           ++K + H
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRL---------DTETEGVPSTAIREISLLKELNH 58

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLH 506
            NI+K++     E    LV E++ H  L+K++ +S    + +    + +  +   L + H
Sbjct: 59  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
              S +V+H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y APE  
Sbjct: 118 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEIL 172

Query: 567 KEGRV-SANGDVYSFGIMLMETFTRK--------------------KPTDEIFNGEMTLK 605
              +  S   D++S G +  E  TR+                     P + ++ G  +L 
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232

Query: 606 HWVND---WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAK 661
            +      W      ++V P  L  +  + +++                  P +RI+AK
Sbjct: 233 DYKPSFPKWARQDFSKVVPP--LDEDGRDLLSQMLHY-------------DPNKRISAK 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 78.7 bits (194), Expect = 4e-15
 Identities = 49/156 (31%), Positives = 78/156 (50%), Gaps = 19/156 (12%)

Query: 211 IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP 270
           IP     L+ +  +N S N   G +P  +G++           SL  L+LS N+ +G+IP
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT----------SLEVLDLSYNSFNGSIP 483

Query: 271 ASLEKLSYLKDLNLSFNKLEGEIPR--GGSFGNFSAESFEGNELLCGSPNLRVPPCKTSI 328
            SL +L+ L+ LNL+ N L G +P   GG   + ++ +F  N  LCG P LR   C    
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLR--ACGP-- 539

Query: 329 HHISRKNAFLLGIVLPLSTVFMIVVIFLIVKCRKRE 364
            H+S      +GI   +S  F+ +VI  +   ++R+
Sbjct: 540 -HLSV--GAKIGIAFGVSVAFLFLVICAMCWWKRRQ 572

Length = 623

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 57/191 (29%), Positives = 101/191 (52%), Gaps = 7/191 (3%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           +G G FG V+ A      +VA+K        V ++F  E  +MK+++H  ++K+ +  + 
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVTK 72

Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCDL 518
           E    ++ E+M  GSL  +L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 73  EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           + +N+L+  ++V  ++DFG+A+++  +++ T +      I + APE    G  +   DV+
Sbjct: 129 RAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187

Query: 579 SFGIMLMETFT 589
           SFGI+LME  T
Sbjct: 188 SFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 29/207 (14%)

Query: 399 LIGRGSFGSVFKARLGDGME-VAMKVFNLQYGRVFKSFDV-----ECEMMKSIRHRNIIK 452
            +G G+FG V   R        A+KV  +    V +         E  ++K + H  II+
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIP--EVIRLKQEQHVHNEKRVLKEVSHPFIIR 65

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHS----SNYILDIYQRLNIMIDVASALEYLHFG 508
           +  +  ++ F  +++EY+P G L  YL +    SN     Y       ++  ALEYLH  
Sbjct: 66  LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS-----EIVCALEYLH-- 118

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPE-YG 566
            S ++++ DLKP N+LLD      L+DFG AK L        +T TL  T  Y+APE   
Sbjct: 119 -SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------RTWTLCGTPEYLAPEVIQ 171

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKP 593
            +G   A  D ++ GI++ E      P
Sbjct: 172 SKGHNKAV-DWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 76.5 bits (189), Expect = 5e-15
 Identities = 61/191 (31%), Positives = 98/191 (51%), Gaps = 49/191 (25%)

Query: 400 IGRGSFGSVFKARLGD---GMEVAMKVFNLQYGRVFKSFDVECEMMKSIR---------- 446
           +G+G++G V+KA   D      VA+K       ++F +F    +  ++ R          
Sbjct: 15  LGKGAYGIVWKAI--DRRTKEVVALK-------KIFDAFRNATDAQRTFREIMFLQELGD 65

Query: 447 HRNIIKVISSCSNEEFKA-------LVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMI 496
           H NI+K+++       KA       LV EYM     E  LH+   +N + D+++R  IM 
Sbjct: 66  HPNIVKLLNV-----IKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IMY 114

Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST---IQTQ 553
            +  AL+Y+H   S  VIH DLKPSN+LL+ +    L+DFG+A+ L+  +++    + T 
Sbjct: 115 QLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171

Query: 554 TLATIGYMAPE 564
            +AT  Y APE
Sbjct: 172 YVATRWYRAPE 182

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 47/166 (28%), Positives = 86/166 (51%), Gaps = 14/166 (8%)

Query: 435 FDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYL----------HSSNY 484
           F  E ++M  +++ NII+++  C +++   ++ EYM +G L ++L          H++N 
Sbjct: 64  FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123

Query: 485 ILDIYQRLNIM-IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 543
                  L  M + +AS ++YL    S   +H DL   N L+ ++    ++DFG+++ L 
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180

Query: 544 REDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
             D   IQ + +  I +MA E    G+ +   DV++FG+ L E FT
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 75.6 bits (186), Expect = 7e-15
 Identities = 68/212 (32%), Positives = 101/212 (47%), Gaps = 30/212 (14%)

Query: 400 IGRGSFGSVFKARLGDGME-VAMKVFNL---QYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IG GSFG+V+ AR     E VA+K  +    Q    ++    E   ++ +RH N I+   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-YK 81

Query: 456 SCSNEEFKA-LVLEYMPHGSLEKYLHSSNYILDIY----QRLNIMIDVASALEYLHFGYS 510
            C   E  A LV+EY         L S++ IL+++    Q + I      AL+ L + +S
Sbjct: 82  GCYLREHTAWLVMEYC--------LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY---GK 567
            + IH D+K  N+LL +     L+DFG A L++    S + T       +MAPE      
Sbjct: 134 HERIHRDIKAGNILLTEPGTVKLADFGSASLVS-PANSFVGTPY-----WMAPEVILAMD 187

Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFN 599
           EG+     DV+S GI  +E   RK P   +FN
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPP---LFN 216

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 11/198 (5%)

Query: 400 IGRGSFGS-VFKARLGDGMEVAMKVFNLQYGRVFKSFDV--ECEMMKSIRHRNIIKVISS 456
           +G+G+FG      R  D   V  K  NL      +  D   E  ++  ++H NII   + 
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 457 CSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             ++    + +EY   G+L +K +     + +    L  +  + SA+ Y+H    A ++H
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILH 124

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT-LATIGYMAPEYGKEGRVSAN 574
            D+K  N+ L    +  L DFGI+K+L  E       +T + T  YM+PE  +  + +  
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISKILGSE---YSMAETVVGTPYYMSPELCQGVKYNFK 181

Query: 575 GDVYSFGIMLMETFTRKK 592
            D+++ G +L E  T K+
Sbjct: 182 SDIWALGCVLYELLTLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 75.0 bits (184), Expect = 9e-15
 Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 33/220 (15%)

Query: 400 IGRGSFGSVFKAR------LGDGMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRNIIK 452
           +G G FG V KA             VA+K+          +    E  ++K + H ++IK
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-----------------------LDIY 489
           +  +CS +    L++EY  +GSL  +L  S  +                       L + 
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST 549
             ++    ++  ++YL      +++H DL   NVL+ +     +SDFG+++ +  ED   
Sbjct: 128 DLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
            +++    + +MA E   +   +   DV+SFG++L E  T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 74.8 bits (183), Expect = 1e-14
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 8/219 (3%)

Query: 376 EAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKS 434
           E ++++ S + +      ++    IG+G+ G+V+ A  +  G EVA+K  NLQ     + 
Sbjct: 3   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL 62

Query: 435 FDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI 494
              E  +M+  ++ NI+  + S    +   +V+EY+  GSL   +  +   +D  Q   +
Sbjct: 63  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAV 120

Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
             +   AL++LH   S QVIH D+K  N+LL  +    L+DFG    +T E     ++  
Sbjct: 121 CRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTM 175

Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           + T  +MAPE           D++S GIM +E    + P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 11/199 (5%)

Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           +G+G FG V   ++   G   A K  +   L+  +  +    E ++++ +  R I+ +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 456 SCSNEEFKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
           +   ++   LV+  M  G L+ ++ +         + +     +   LE+LH     +++
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSAN 574
           + DLKP NVLLDD+    +SD G+A  L       I      T GYMAPE  +      +
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELK--GGKKI-KGRAGTPGYMAPEVLQGEVYDFS 174

Query: 575 GDVYSFGIMLMETFTRKKP 593
            D ++ G  L E    + P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 73.8 bits (181), Expect = 1e-14
 Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 11/196 (5%)

Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVI 454
           +G G+FG V    +K R    ++VA+KV   +  + V      E E+M  + +  I+++I
Sbjct: 3   LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
             C  E    LV+E    G L K+L      + +   + +M  V+  ++YL        +
Sbjct: 62  GVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTLATIGYMAPEYGKEGRVSA 573
           H DL   NVLL +   A +SDFG++K L  +D     ++     + + APE     + S+
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 574 NGDVYSFGIMLMETFT 589
             DV+S+GI + E F+
Sbjct: 178 RSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 74.0 bits (181), Expect = 2e-14
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 9/206 (4%)

Query: 394 FSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGR-VFKSFDVECEMMKSIRHRNII 451
           F++   IG+GSFG VFK       +V A+K+ +L+      +    E  ++       + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 120

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
           + IH D+K +NVLL ++    L+DFG+A  LT  D    +   + T  +MAPE  K+   
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 572 SANGDVYSFGIMLMETFTRKKPTDEI 597
            +  D++S GI  +E    + P  E+
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 19/208 (9%)

Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G+FG V+KA+  + G   A KV   +     + + VE E++ +  H  I+K++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            +    +++E+ P G+++  +   +  L       I +     LE L + +S ++IH DL
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMKIIHRDL 136

Query: 519 KPSNVLLDDNMVAHLSDFGIA----KLLTREDQSTIQTQTLATIGYMAPEY-----GKEG 569
           K  NVLL  +    L+DFG++    K L R D        + T  +MAPE       K+ 
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD------SFIGTPYWMAPEVVMCETMKDT 190

Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEI 597
                 D++S GI L+E    + P  E+
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 70/231 (30%), Positives = 100/231 (43%), Gaps = 47/231 (20%)

Query: 394 FSENNL-----IGRGSFGSVFKARLGD-GMEVAMK-----VFNLQYGRVFKSFDVECEMM 442
           F+  +L     IGRG+FG+V K      G  +A+K     V   +  R+    DV   +M
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV---VM 57

Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEK-----YLHSSNYILDIYQRLNIMID 497
           +S     I+K   +   E    + +E M   SL+K     Y    + I +      I+  
Sbjct: 58  RSSDCPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE-----EILGK 111

Query: 498 VA----SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           +A     AL YL      ++IH D+KPSN+LLD N    L DFGI+  L     S  +T+
Sbjct: 112 IAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTR 166

Query: 554 TLATIGYMAPEYGKEGRVSANG--------DVYSFGIMLMETFTRKKPTDE 596
                 YMAPE     R+  +         DV+S GI L E  T K P  +
Sbjct: 167 DAGCRPYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 22/207 (10%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVF-NLQYGRVFK---SFDVECEMMKSIRHRNIIKVIS 455
           IG G FG V       GM  A  V   L+          F  E +  + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYIL------DIYQRLNIMIDVASALEYLHFGY 509
            C       LVLE+ P G L+ YL S+  ++      D+ QR+    +VAS L +LH   
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLH--- 117

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE- 568
            A  IH DL   N  L  ++   + D+G+A     ED    +      + ++APE  +  
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 569 ------GRVSANGDVYSFGIMLMETFT 589
                    +   +++S G+ + E FT
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 71/274 (25%), Positives = 116/274 (42%), Gaps = 46/274 (16%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMM-KSI-----RHRNII 451
           ++G+GSFG V  A L    E+ A+KV  L+   + +  DVEC M  K +     +H  + 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           ++ S    ++    V+EY+  G L  ++  S    D  +      ++   L++LH     
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ER 115

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
            +I+ DLK  NVLLD      ++DFG+ K       +T  +    T  Y+APE       
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT--STFCGTPDYIAPEILSYQPY 173

Query: 572 SANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 626
               D ++ G++L E    + P      DE+F               I   E+  P  LS
Sbjct: 174 GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS-------------ILEDEVRYPRWLS 220

Query: 627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
           +E     AK    SF+         ++PE+R+  
Sbjct: 221 KE-----AKSILKSFL--------TKNPEKRLGC 241

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 65/291 (22%), Positives = 125/291 (42%), Gaps = 58/291 (19%)

Query: 400 IGRGSFGSVFKARL---GDG--------MEVAMKVFNLQYGRVFKSFDVECEMMKSIRHR 448
           +G+G+F +++K  L    D         + V +KV      R   +F     +M  + H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG-SDHRDSLAFFETASLMSQLSHK 61

Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           +++K+   C  +E   +V EY+  G L+ +LH     + ++ +L++   +ASAL YL   
Sbjct: 62  HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-- 118

Query: 509 YSAQVIHCDLKPSNVLL---DDNM----VAHLSDFGIAK-LLTREDQSTIQTQTLATIGY 560
              +++H ++   N+L+     N        LSD GI   +L+RE++       +  I +
Sbjct: 119 -DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER-------VERIPW 170

Query: 561 MAPEYGKEGRVS--ANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPI-ST 616
           +APE  + G+ S     D +SFG  L+E  +  ++P   + + E    +     LP+   
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDC 230

Query: 617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
            E+                        N+  +C    P +R + + I+  L
Sbjct: 231 AEL-----------------------ANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 3e-14
 Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 51/221 (23%)

Query: 398 NLIGRGSFGSVFKA-RLGDGMEVAMK--------VFNLQYGRVFKSFDVECEMMKSIRHR 448
           + IG G++G V  A     G++VA+K         F  +  R       E ++++  +H 
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-------EIKILRRFKHE 63

Query: 449 NIIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILD-----IYQRLNIMIDV 498
           NII    +I   S E F    +V E M    L K + + +   D     +YQ L      
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQHLSNDHIQYFLYQILR----- 117

Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLAT 557
              L+Y+H   SA V+H DLKPSN+LL+ N    + DFG+A++   E D +   T+ +AT
Sbjct: 118 --GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172

Query: 558 IGYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRK 591
             Y APE       Y K        D++S G +L E  + +
Sbjct: 173 RWYRAPEIMLNSKGYTKA------IDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 73.2 bits (180), Expect = 4e-14
 Identities = 56/188 (29%), Positives = 77/188 (40%), Gaps = 49/188 (26%)

Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECE--------------MMKS 444
           IG GS+G VFK R  + G  VA+K F            VE E              M+K 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF------------VESEDDPVIKKIALREIRMLKQ 56

Query: 445 IRHRNIIKVISSCSNEEFKA-----LVLEYMPH---GSLEKYLHSSNYILDIYQRLNIMI 496
           ++H N++ +I     E F+      LV EY  H     LEK        +  +    I+ 
Sbjct: 57  LKHPNLVNLI-----EVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEHLIKKIIW 107

Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
               A+ + H       IH D+KP N+L+       L DFG A++LT        T  +A
Sbjct: 108 QTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--YTDYVA 162

Query: 557 TIGYMAPE 564
           T  Y APE
Sbjct: 163 TRWYRAPE 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.0 bits (182), Expect = 4e-14
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 37/225 (16%)

Query: 400 IGRGSFGSVFKARLGDGME-VAMKVFNLQYGRVFKSFDV-----ECEMMKSIRHRNIIKV 453
           +G+G +G VF A+  D  E VA+K        +FK  +V     E +++ + +   ++K+
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSL--LFKLNEVRHVLTERDILTTTKSEWLVKL 66

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH-FGYSAQ 512
           + +  ++E+  L +EY+P G     L++   + + + R   M ++  A++ LH  GY   
Sbjct: 67  LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALHELGY--- 122

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE--YGK 567
            IH DLKP N L+D +    L+DFG++K         I T   + +G   YMAPE   GK
Sbjct: 123 -IHRDLKPENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGK 173

Query: 568 EGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHW 607
               +   D +S G ML E      P      +E +     LK+W
Sbjct: 174 GYDFTV--DYWSLGCMLYEFLCGFPPFSGSTPNETWE---NLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 68/235 (28%), Positives = 104/235 (44%), Gaps = 47/235 (20%)

Query: 399 LIGRGSFGSVFKARLGDGME----VAMKVFNLQYGRVFKS------FDVECEMMKSIRHR 448
           ++G+G +G VF+ R   G +     AMKV  L+   + ++         E  ++++++H 
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKV--LKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI-MIDVAS------- 500
            I+ +I +        L+LEY+  G L  +L          +R  I M D A        
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGELFMHL----------EREGIFMEDTACFYLSEIS 110

Query: 501 -ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATI 558
            ALE+LH      +I+ DLKP N+LLD      L+DFG+ K    E      T T   TI
Sbjct: 111 LALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT---VTHTFCGTI 164

Query: 559 GYMAPEYGKEGRVSANGDVYSFGIMLMETFT---------RKKPTDEIFNGEMTL 604
            YMAPE           D +S G ++ +  T         RKK  D+I  G++ L
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 73.5 bits (181), Expect = 5e-14
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 51/219 (23%)

Query: 398 NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDV------ECEMMKSIRHRNI 450
           + +G G++G V  A     G +VA+K  +    R F+S         E  ++K + H N+
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLS----RPFQSAIHAKRTYRELRLLKHMDHENV 76

Query: 451 IKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLH----SSNYI-LDIYQRLNIMIDVA 499
           I ++     + S E+F+   LV   M    L   +     S ++I   +YQ L       
Sbjct: 77  IGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILR------ 129

Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG 559
             L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  
Sbjct: 130 -GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 180

Query: 560 YMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRK 591
           Y APE       Y +        D++S G ++ E  T K
Sbjct: 181 YRAPEIMLNWMHYNQ------TVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 73.2 bits (180), Expect = 7e-14
 Identities = 75/271 (27%), Positives = 122/271 (45%), Gaps = 66/271 (24%)

Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFD---------VECEMMKSIRHRN 449
           IGRG++G V  A+  +   +VA+K       ++  +FD          E ++++ + H N
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIK-------KIANAFDNRIDAKRTLREIKLLRHLDHEN 65

Query: 450 IIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILD------IYQRLNIMIDV 498
           +I    ++     E F    +V E M    L + + SS  + D      +YQ L      
Sbjct: 66  VIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLR----- 119

Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI 558
              L+Y+H   SA V+H DLKPSN+LL+ N    + DFG+A+  T  ++    T+ + T 
Sbjct: 120 --GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTR 172

Query: 559 GYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW 611
            Y APE       Y          DV+S G +  E   RK     +F G    K +V+  
Sbjct: 173 WYRAPELLLNCSEYT------TAIDVWSVGCIFAELLGRKP----LFPG----KDYVHQ- 217

Query: 612 LPISTKEIVDPNLLSREDINFVAKEQCVSFV 642
           L + T+ +  P   S ED+ F+  E+   ++
Sbjct: 218 LKLITELLGSP---SEEDLGFIRNEKARRYI 245

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 56/206 (27%), Positives = 98/206 (47%), Gaps = 9/206 (4%)

Query: 394 FSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGR-VFKSFDVECEMMKSIRHRNII 451
           F++   IG+GSFG VFK       +V A+K+ +L+      +    E  ++       + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K   S        +++EY+  GS    L +  +  D +Q   ++ ++   L+YLH   S 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---SE 120

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
           + IH D+K +NVLL +     L+DFG+A  LT  D    +   + T  +MAPE  ++   
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQSAY 178

Query: 572 SANGDVYSFGIMLMETFTRKKPTDEI 597
            +  D++S GI  +E    + P  ++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 72.3 bits (178), Expect = 7e-14
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 19/210 (9%)

Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIR---H 447
           + E   IG G++G+V+KAR L  G  VA+K   +      +  S   E  ++K +    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 448 RNIIKVISSC----SNEEFK-ALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASA 501
            NI++++  C    ++ E K  LV E++    L  YL       L      ++M  +   
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119

Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           +++LH   S +++H DLKP N+L+  +    ++DFG+A++ + E   T    TL    Y 
Sbjct: 120 VDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTL---WYR 173

Query: 562 APEYGKEGRVSANGDVYSFGIMLMETFTRK 591
           APE   +   +   D++S G +  E F R+
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 71.8 bits (176), Expect = 8e-14
 Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 27/214 (12%)

Query: 399 LIGRGSFGSVFKARLGDGME--VAMK---VFNLQYGRVFKSFD-------VECEMMK-SI 445
            +G G+FG V+K R  +  +  +A+K   V N  +G+  +  D        E  ++K  +
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL------NIMIDVA 499
           RH NI++   +    +   +V++ +    L ++ +S   + +  QR       NI + + 
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS---LKEKKQRFTEERIWNIFVQMV 123

Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG 559
            AL YLH     +++H DL P+N++L ++    ++DFG+AK    E +    T  + TI 
Sbjct: 124 LALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTIL 178

Query: 560 YMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           Y  PE  K        DV++FG +L +  T + P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 74.9 bits (184), Expect = 8e-14
 Identities = 52/186 (27%), Positives = 83/186 (44%), Gaps = 16/186 (8%)

Query: 416 GMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEE-FKALVLEYMP 471
           G EVA+K+              F  E  +   + H NI+ ++ S          V EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDN 528
             +L + L +    L   +   +M+ V  AL   H   +  ++H DLKP N+++      
Sbjct: 63  GRTLREVLAADG-ALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVR 118

Query: 529 MVAHLSDFGIAKLL--TRED---QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIM 583
             A + DFGI  LL   R+      T  T+ L T  Y APE  +   V+ N D+Y++G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 584 LMETFT 589
            +E  T
Sbjct: 179 FLECLT 184

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 72.1 bits (177), Expect = 8e-14
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 30/199 (15%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNL--QYGR--VFKSFDVECEMMKSIRHRNIIKVI 454
           IG GS G V  A     G +VA+K  +L  Q  R  +F     E  +M+  +H NI+++ 
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN----EVVIMRDYQHPNIVEMY 82

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
           SS    +   +V+E++  G+L   +  +   ++  Q   + + V  AL +LH   +  VI
Sbjct: 83  SSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVI 137

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY-MAPE------YGK 567
           H D+K  ++LL  +    LSDFG    +++E     + ++L    Y MAPE      YG 
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAPEVISRLPYGT 194

Query: 568 EGRVSANGDVYSFGIMLME 586
           E       D++S GIM++E
Sbjct: 195 E------VDIWSLGIMVIE 207

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 14/207 (6%)

Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSC 457
           +G G+ G+V+KA  L     +A+KV  L     + K    E E++       II    + 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
             E   ++  E+M  GSL+ Y     ++L       I + V   L YL   +S +++H D
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL---WSLKILHRD 120

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           +KPSN+L++      L DFG++  L     ++I    + T  YMAPE     +   + DV
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQYGIHSDV 176

Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTL 604
           +S GI  ME    + P  +I   + +L
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQGSL 203

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 25/213 (11%)

Query: 399 LIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECE--MMKSIRHRNIIK 452
           L+GRG+FG V+     D G E+A+K           S +V   ECE  ++K++RH  I++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 453 VISSCSNEEFKALVL--EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
                 + E K L +  EYMP GS++  L +   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVSYLH---S 124

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY-MAPE----- 564
             ++H D+K +N+L D      L DFG +K +     S    +++    Y M+PE     
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE 184

Query: 565 -YGKEGRVSANGDVYSFGIMLMETFTRKKPTDE 596
            YG++       DV+S    ++E  T K P  E
Sbjct: 185 GYGRK------ADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 24/207 (11%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVF-------NLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           IG G FG V    +  G   A  V        ++Q    F     E +  +S++H N+++
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLE---EAQPYRSLQHSNLLQ 59

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHS----SNYILDIYQRLNIMIDVASALEYLHFG 508
            +  C+      LV+E+ P G L+ YL S         D      +  ++A  L +LH  
Sbjct: 60  CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-- 117

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
                IH DL   N LL  ++   + D+G++    +ED      Q    + ++APE   E
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176

Query: 569 --GRV-----SANGDVYSFGIMLMETF 588
             G +     +   +V+S G+ + E F
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 10/197 (5%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G+GS+G V   R   DG +  +K  NL+    R  K+ + E +++  ++H NI+    S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 457 CSNEE-FKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              E+    +V+ +   G L   L      +L   Q +   + +A AL+YLH      ++
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSAN 574
           H DLK  NV L    +  + D GIA++L  E+Q  + +  + T  YM+PE       +  
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPYNYK 182

Query: 575 GDVYSFGIMLMETFTRK 591
            DV++ G  + E  T K
Sbjct: 183 SDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 48/178 (26%), Positives = 88/178 (49%), Gaps = 19/178 (10%)

Query: 435 FDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYL---------HSSNYI 485
           F  E ++M  ++  NII++++ C   +   ++ EYM +G L ++L           ++ +
Sbjct: 66  FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 486 LDIYQRLNIM-IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 544
              Y  L  M   +AS ++YL    S   +H DL   N L+  N    ++DFG+++ L  
Sbjct: 126 TISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT--RKKP----TDE 596
            D   IQ + +  I +M+ E    G+ +   DV++FG+ L E  T  +++P    +DE
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 68/284 (23%), Positives = 122/284 (42%), Gaps = 38/284 (13%)

Query: 400 IGRGSFGSVFKARLGDGME------VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           +G+GSFG V++    D ++      VA+K  N     R    F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHS-----SNYILDIYQRLNIMI----DVASALE 503
           ++   S  +   +V+E M HG L+ YL S      N        L  MI    ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL+   + + +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 623
           E  K+G  + + D++SFG++L E  +  +   +  + E  LK             ++D  
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------------VMDGG 238

Query: 624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
            L +        + C   V ++   C   +P+ R    EIV  L
Sbjct: 239 YLDQ-------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 64/284 (22%), Positives = 127/284 (44%), Gaps = 38/284 (13%)

Query: 400 IGRGSFGSVF----KARLGDGME--VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           +G+GSFG V+    K  + D  E  VA+K  N     R    F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHS------SNYIL---DIYQRLNIMIDVASALE 503
           ++   S  +   +++E M  G L+ YL S      +N +     + + + +  ++A  + 
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL+   + + +H DL   N ++ ++    + DFG+ + +   D      + L  + +M+P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 623
           E  K+G  +   DV+SFG++L E  T  +   +  + E  L+             +++  
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF------------VMEGG 238

Query: 624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
           LL + D        C   +F +   C   +P+ R +  EI++ +
Sbjct: 239 LLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 15/206 (7%)

Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G+FG V+KA+  + G+  A KV + +     + + VE +++ S  H NI+K++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            E    +++E+   G+++  +      L   Q   +      AL YLH     ++IH DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT--LATIGYMAPEY-----GKEGRV 571
           K  N+L   +    L+DFG++   TR    TIQ +   + T  +MAPE       K+   
Sbjct: 130 KAGNILFTLDGDIKLADFGVSAKNTR----TIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185

Query: 572 SANGDVYSFGIMLMETFTRKKPTDEI 597
               DV+S GI L+E    + P  E+
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 11/217 (5%)

Query: 394 FSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRH 447
           F +  ++G G+FG+V+K      G+ +++ + +  L+     +  K    E  +M S+ +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            ++ +++  C     + L+ + MP G L  Y+      +     LN  + +A  + YL  
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 126

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
               +++H DL   NVL+       ++DFG+AKLL  +++          I +MA E   
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184

Query: 568 EGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
               +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 38/233 (16%)

Query: 397 NNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV--------------ECEM 441
              +G G++G V KA     G  VA+K   +       + D               E ++
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 442 MKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
           M  I+H NI+ ++      +F  LV++ M    L+K +      L   Q   I++ + + 
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV-DRKIRLTESQVKCILLQILNG 131

Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK-------LLTREDQSTIQ--- 551
           L  LH  Y    +H DL P+N+ ++   +  ++DFG+A+         T     T+Q   
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 552 --TQTLATIGYMAPE--YGKEGRVSANGDVYSFGIMLMETFTRKK---PTDEI 597
             T  + T+ Y APE   G E    A  D++S G +  E  T K      +EI
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAV-DMWSVGCIFAELLTGKPLFPGENEI 240

Length = 335

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 23/243 (9%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMMK------SIRHRNII 451
           ++G+GSFG V  A L    E  A+K   L+   V +  DVEC M++      +  H  + 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
            +  +   +E    V+EY+  G L  ++ SS    D  +      ++   L++LH     
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KK 115

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKL-LTREDQSTIQTQTLATIGYMAPEYGKEGR 570
            +I+ DLK  NVLLD +    ++DFG+ K  +  E ++   +    T  Y+APE  K  +
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDYIAPEILKGQK 172

Query: 571 VSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 625
            + + D +SFG++L E    + P      DE+F+  +  +     W+    K+ +   L 
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLS-KLF 231

Query: 626 SRE 628
            R+
Sbjct: 232 ERD 234

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 64/213 (30%), Positives = 102/213 (47%), Gaps = 18/213 (8%)

Query: 388 CRATDGFSENNLIGRGSFGSVFKARLGDGME-VAMKVFNLQYGR--VFKSFDVECEMMKS 444
           CR+   F + N IG G++G V++AR     E VA+K   +   R  +  S   E  ++ +
Sbjct: 3   CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLN 62

Query: 445 IRHRNIIK----VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
           +RH NI++    V+    +  F  LV+EY     L   L +        Q   +M+ +  
Sbjct: 63  LRHPNIVELKEVVVGKHLDSIF--LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLR 119

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
            L+YLH  +   +IH DLK SN+LL D     ++DFG+A+  T    +   T  + T+ Y
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWY 174

Query: 561 MAPE--YGKEGRVSANGDVYSFGIMLMETFTRK 591
            APE   G     +A  D+++ G +L E    K
Sbjct: 175 RAPELLLGCTTYTTAI-DMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 62/240 (25%), Positives = 113/240 (47%), Gaps = 47/240 (19%)

Query: 400 IGRGSFGSV-----------------FKARLGDGMEVAMKVFNLQYGRVFKS-FDVECEM 441
           +G G FG V                 F  R G  + VA+K+      +  ++ F  E ++
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72

Query: 442 MKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-------------- 487
           +  ++  NII+++  C +E+   ++ EYM +G L ++L SS+++ D              
Sbjct: 73  LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL-SSHHLDDKEENGNDAVPPAHC 131

Query: 488 ----IYQRL-NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 542
                Y  L ++ + +AS ++YL    S   +H DL   N L+ +N+   ++DFG+++ L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 543 TREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT--RKKP----TDE 596
              D   IQ + +  I +MA E    G+ +   DV++FG+ L E     +++P    TDE
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 72.2 bits (177), Expect = 4e-13
 Identities = 32/74 (43%), Positives = 42/74 (56%)

Query: 136 LNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNL 195
           L G IP+ + KL+ LQ + L  N + G+IP S+     L  L+L  N  +GSIPE    L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 196 ASLRILLLGSNELT 209
            SLRIL L  N L+
Sbjct: 490 TSLRILNLNGNSLS 503

Length = 623

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 71.3 bits (175), Expect = 4e-13
 Identities = 64/210 (30%), Positives = 100/210 (47%), Gaps = 33/210 (15%)

Query: 400 IGRGSFG---SVFKARLGDGMEVAMK----VF-NL-QYGRVFKSFDVECEMMKSIRHRNI 450
           IG G+FG   SV   R  DG  VA+K    VF NL    RVF+    E +M+   +H N+
Sbjct: 8   IGYGAFGVVWSVTDPR--DGKRVALKKMPNVFQNLVSCKRVFR----ELKMLCFFKHDNV 61

Query: 451 IKVIS-------SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALE 503
           +  +            E +   V+  +    L K + S   +   + ++  +  +   L+
Sbjct: 62  LSALDILQPPHIDPFEEIY---VVTELMQSDLHKIIVSPQPLSSDHVKV-FLYQILRGLK 117

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YLH   SA ++H D+KP N+L++ N V  + DFG+A+ +   D+S   TQ + T  Y AP
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAP 173

Query: 564 E--YGKEGRVSANGDVYSFGIMLMETFTRK 591
           E   G     SA  D++S G +  E   R+
Sbjct: 174 EILMGSRHYTSAV-DIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 13/207 (6%)

Query: 399 LIGRGSFGSVFKARLGD-GMEVAMKVFNL-----QYGRVFKSFDVECEMMKSIRHRNIIK 452
           L+G+G+FG V+     D G E+A K         +  +   + + E +++K+++H  I++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 453 VISSCSNEEFKALV--LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
                 +   K L   +EYMP GS++  L +   + +   R      +   + YLH   S
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLH---S 124

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY-MAPEYGKEG 569
             ++H D+K +N+L D      L DFG +K L     S    +++    Y M+PE     
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184

Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDE 596
                 DV+S G  ++E  T K P  E
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 70.6 bits (173), Expect = 4e-13
 Identities = 57/174 (32%), Positives = 85/174 (48%), Gaps = 19/174 (10%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEM------MKSIRHRNIIK 452
           IG+GSFG V  A+   DG   A+KV  LQ   + K  + +  M      +K+++H  ++ 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +  S    +    VL+Y+  G L  +L       +   R     ++ASAL YLH   S  
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARF-YAAEIASALGYLH---SLN 116

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED-QSTIQTQTL-ATIGYMAPE 564
           +I+ DLKP N+LLD      L+DFG+ K    E  + +  T T   T  Y+APE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 48/144 (33%), Positives = 77/144 (53%), Gaps = 7/144 (4%)

Query: 400 IGRGSFGSVFKARLGDGME-VAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVISS 456
           IG G++G+VFKA+  +  E VA+K   L      V  S   E  ++K ++H+NI+++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
             +++   LV EY     L+KY  S N  +D     + M  +   L + H   S  V+H 
Sbjct: 68  LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAK 540
           DLKP N+L++ N    L+DFG+A+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 10/199 (5%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRV--FKSFDVECEMMKSIRHRNIIKVISS 456
           IG GSFG ++ A+   D     +K  +L    V   ++   E  ++  ++H NI+   +S
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYIL-DIYQRLNIMIDVASALEYLHFGYSAQVIH 515
                   +V+EY   G L K ++    +L    Q L+  + ++  L+++H     +++H
Sbjct: 68  FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILH 124

Query: 516 CDLKPSNVLLDDN-MVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSAN 574
            D+K  N+ L  N MVA L DFGIA+ L   D   +    + T  Y++PE  +    +  
Sbjct: 125 RDIKSQNIFLSKNGMVAKLGDFGIARQLN--DSMELAYTCVGTPYYLSPEICQNRPYNNK 182

Query: 575 GDVYSFGIMLMETFTRKKP 593
            D++S G +L E  T K P
Sbjct: 183 TDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 69.7 bits (170), Expect = 7e-13
 Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 44/290 (15%)

Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVA----MKVFNLQYGRVFKSFDVECEMMKSIRHRN 449
           F++   IG GSFG+V+ AR     EV     M     Q    ++    E + ++ I+H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS----ALEYL 505
            I+       E    LV+EY         L S++ +L+++++    +++A+    AL+ L
Sbjct: 87  SIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGL 138

Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
            + +S  +IH D+K  N+LL +     L+DFG A + +  +        + T  +MAPE 
Sbjct: 139 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN------SFVGTPYWMAPEV 192

Query: 566 ---GKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 622
                EG+     DV+S GI  +E   RK P   + N    L H       I+  E   P
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYH-------IAQNE--SP 242

Query: 623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD 672
            L S E  ++           N    C  + P+ R  ++E++  +  +R+
Sbjct: 243 TLQSNEWSDYFR---------NFVDSCLQKIPQDRPTSEELLKHMFVLRE 283

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 26/232 (11%)

Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVA----MKVFNLQYGRVFKSFDVECEMMKSIRHRN 449
           FS+   IG GSFG+V+ AR     EV     M     Q    ++    E   ++ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS----ALEYL 505
            I+       E    LV+EY         L S++ +L+++++    +++A+    AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
            + +S  +IH D+K  N+LL +  +  L DFG A ++   +        + T  +MAPE 
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEV 182

Query: 566 ---GKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI 614
                EG+     DV+S GI  +E   RK P   + N    L H   +  P 
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPA 233

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 62/195 (31%), Positives = 94/195 (48%), Gaps = 15/195 (7%)

Query: 399 LIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDVECEM------MKSIRHRNII 451
           +IG+GSFG V  A R  DG   A+KV  LQ   + K  +    M      +K+++H  ++
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
            +  S    E    VL+Y+  G L  +L      L+   R     +VASA+ YLH   S 
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF-YAAEVASAIGYLH---SL 115

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
            +I+ DLKP N+LLD      L+DFG+ K     +++T  +    T  Y+APE  ++   
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT--STFCGTPEYLAPEVLRKEPY 173

Query: 572 SANGDVYSFGIMLME 586
               D +  G +L E
Sbjct: 174 DRTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 77/306 (25%), Positives = 118/306 (38%), Gaps = 68/306 (22%)

Query: 390 ATDGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RH 447
            T  F    +IG G++G V+KAR    G  VA+K+ ++      +    E  +++    H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNH 62

Query: 448 RNI-------IKVISSCSNEEFKALVLEYMPHGS---LEKYLHSSNYILDIYQRLNIMID 497
            NI       IK     ++++   LV+E    GS   L K L      L       I+ +
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQL-WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
               L YLH     +VIH D+K  N+LL  N    L DFG++  L        +  T   
Sbjct: 122 TLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG---RRNT--F 173

Query: 558 IG---YMAPE-----YGKEGRVSANGDVYSFGIMLMET------FTRKKPTDEIF----N 599
           IG   +MAPE        +    A  DV+S GI  +E            P   +F    N
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233

Query: 600 GEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN 659
              TLK                P   S++  +F++             EC +++ EQR  
Sbjct: 234 PPPTLKS---------------PENWSKKFNDFIS-------------ECLIKNYEQRPF 265

Query: 660 AKEIVT 665
            +E++ 
Sbjct: 266 MEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 31/210 (14%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIR---HRNIIKV 453
           IG G++G+V+KAR    G  VA+K   +Q     +  S   E  ++K +    H NI+++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 454 ISSC----SNEEFK-ALVLEYMPHGSLEKYLHSS-------NYILDIYQRLNIMIDVASA 501
           +  C    ++ E K  LV E++    L  YL            I D+ ++          
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF------LRG 120

Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           L++LH   +  ++H DLKP N+L+       L+DFG+A++ + +      T  + T+ Y 
Sbjct: 121 LDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYR 174

Query: 562 APEYGKEGRVSANGDVYSFGIMLMETFTRK 591
           APE   +   +   D++S G +  E F RK
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 57/217 (26%), Positives = 103/217 (47%), Gaps = 24/217 (11%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFD----------VECEMMKSIRHRN 449
           +G G+FG+V K     GM    K       ++ K+ +           E  +M+ + +  
Sbjct: 3   LGSGNFGTVKK-----GMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPY 57

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           I+++I  C  E +  LV+E    G L K+L  + ++ +      ++  V+  ++YL    
Sbjct: 58  IVRMIGICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE--- 112

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
               +H DL   NVLL     A +SDFG++K L   D++  + +T     + + APE   
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-GADENYYKAKTHGKWPVKWYAPECMN 171

Query: 568 EGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMT 603
             + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVISS 456
           IG G++G V+KAR    G  VA+K   L+     V  +   E  ++K + H NI++++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 457 CSNEEFKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             +E    LV E++    L+KY+  S    LD     + +  +   + Y H   S +V+H
Sbjct: 67  VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLH 122

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAK---LLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            DLKP N+L+D      L+DFG+A+   +  R       T  + T+ Y APE     R  
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVR-----TYTHEVVTLWYRAPEILLGSRQY 177

Query: 573 ANG-DVYSFGIMLMETFTRK------KPTDEIF 598
           +   D++S G +  E   R+         D++F
Sbjct: 178 STPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 24/183 (13%)

Query: 392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHR 448
           D + +   +G GS+ +V+K +   +G  VA+KV  LQ   G  F +   E  ++K ++H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63

Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKY-------LHSSNYILDIYQRLNIMIDVASA 501
           NI+ +      +E   LV EY+ H  L +Y       LH  N  L ++Q L         
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR-------G 115

Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           L Y+H  Y   ++H DLKP N+L+ D     L+DFG+A+   +   S   +  + T+ Y 
Sbjct: 116 LSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYR 170

Query: 562 APE 564
            P+
Sbjct: 171 PPD 173

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 56/227 (24%), Positives = 99/227 (43%), Gaps = 29/227 (12%)

Query: 388 CRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMK---VFNLQYGRVFKSFDVECEMMK 443
           C     +     +G G+FG V+KAR +  G  VA+K   + N + G    +   E +++K
Sbjct: 4   CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILK 62

Query: 444 SIRHRNIIK----VISSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIM 495
            ++H N++      +      + K     +V  YM H  L   L + +  L   Q    M
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYM 121

Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS------- 548
           + +   + YLH      ++H D+K +N+L+D+  +  ++DFG+A+       +       
Sbjct: 122 LQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178

Query: 549 --TIQTQTLATIGYMAPEY--GKEGRVSANGDVYSFGIMLMETFTRK 591
                T  + T  Y  PE   G E R +   D++  G +  E FTR+
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 69/282 (24%), Positives = 123/282 (43%), Gaps = 32/282 (11%)

Query: 399 LIGRGSFGSVFKA-RLGDG----MEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           ++G G+FG+V+K   + DG    + VA+KV       +  K    E  +M  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           ++  C     + LV + MP+G L  Y+  +   +     LN  + +A  + YL      +
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
           ++H DL   NVL+       ++DFG+A+LL  ++           I +MA E     R +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 573 ANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN 631
              DV+S+G+ + E  T   KP D                  I  +EI  P+LL + +  
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDG-----------------IPAREI--PDLLEKGE-R 229

Query: 632 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI-RD 672
                 C   V+ + ++C +   E R   +E+V +  ++ RD
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 64/284 (22%), Positives = 114/284 (40%), Gaps = 70/284 (24%)

Query: 400 IGRGSFGSVFKAR---LGDGMEVAM----------KVFNLQYGRVFKSFDVECEMMKSIR 446
           I +G+FGSV+ A+    GD   + +          +V N++  R          MM    
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI--------MMIQGE 55

Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
              + K+  S  ++++  LV+EY+  G     + +   + + + +   + +V   +E LH
Sbjct: 56  SPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-QYIAEVVLGVEDLH 114

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-- 564
                 +IH D+KP N+L+D      L+DFG+++            + + T  Y+APE  
Sbjct: 115 ---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETI 165

Query: 565 YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
            G         D +S G ++ E      P    F+ E              T + V  N+
Sbjct: 166 LGVGD--DKMSDWWSLGCVIFEFLFGYPP----FHAE--------------TPDAVFDNI 205

Query: 625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
           LSR  IN+  + +               SPE    A +++ +LL
Sbjct: 206 LSR-RINWPEEVK------------EFCSPE----AVDLINRLL 232

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 32/211 (15%)

Query: 400 IGRGSFGSVFKAR--LGDGMEVAMKVFNLQYGRVFKSFDVECEM-----MKSIRHRNIIK 452
           IG G++G VFKAR     G  VA+K   +Q G          E+     +++  H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 453 VISSCS----NEEFK-ALVLEYMPHGSLEKYLHS-------SNYILDIYQRLNIMIDVAS 500
           +   C+    + E K  LV E++    L  YL         +  I D+      M  +  
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM------MFQLLR 121

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
            L++LH   S +V+H DLKP N+L+  +    L+DFG+A++ + +      T  + T+ Y
Sbjct: 122 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWY 175

Query: 561 MAPEYGKEGRVSANGDVYSFGIMLMETFTRK 591
            APE   +   +   D++S G +  E F RK
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 8/195 (4%)

Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG GS G V  AR    G +VA+K+ +L+  +  +    E  +M+  +H+N++++  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             E   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   S  VIH D+
Sbjct: 89  VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  ++LL  +    LSDFG    ++++     +   + T  +MAPE           D++
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIW 201

Query: 579 SFGIMLMETFTRKKP 593
           S GIM++E    + P
Sbjct: 202 SLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 17/197 (8%)

Query: 399 LIGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKV 453
           ++G G FG + +   +L    E+ + +  L+ G   +  + F  E   +    H NI+++
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL-HFGYSAQ 512
               +      +V EYM +G+L+ +L      L   Q + ++  +AS ++YL   GY   
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGY--- 128

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL---ATIGYMAPEYGKEG 569
            +H  L    VL++ ++V  +S F   +    ED+S     T+   + + + APE  +  
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLWAAPEAIQYH 183

Query: 570 RVSANGDVYSFGIMLME 586
             S+  DV+SFGI++ E
Sbjct: 184 HFSSASDVWSFGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 41/106 (38%), Positives = 53/106 (50%), Gaps = 9/106 (8%)

Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           I + +  ALEYLH   S  VIH D+KPSNVL++ N    L DFGI+  L     S  +T 
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTI 162

Query: 554 TLATIGYMAPEY----GKEGRVSANGDVYSFGIMLMETFTRKKPTD 595
                 YMAPE       +       DV+S GI ++E  T + P D
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)

Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVISSC 457
           +G G+ GSV K   +  G  +A KV ++     V K    E ++M   R   I+    + 
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
            NE    + +E+M  GSL++       I ++I  +  I + V   L YL+     +++H 
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLY--NVHRIMHR 128

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGD 576
           D+KPSN+L++      L DFG++  L     ++I    + T  YM+PE  + G+ +   D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELI----NSIADTFVGTSTYMSPERIQGGKYTVKSD 184

Query: 577 VYSFGIMLMETFTRKKPTDE 596
           V+S GI ++E    K P   
Sbjct: 185 VWSLGISIIELALGKFPFAF 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 9/206 (4%)

Query: 394 FSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGR-VFKSFDVECEMMKSIRHRNII 451
           F++   IG+GSFG V+K       EV A+K+ +L+      +    E  ++       I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           +   S        +++EY+  GS    L      L+      I+ ++   L+YLH   S 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLH---SE 120

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
           + IH D+K +NVLL +     L+DFG+A  LT  D    +   + T  +MAPE  K+   
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 572 SANGDVYSFGIMLMETFTRKKPTDEI 597
               D++S GI  +E    + P  ++
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 68.0 bits (166), Expect = 6e-12
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 25/219 (11%)

Query: 399 LIGRGSFGSVFKA-RLGDGMEVAMKVFNLQ-YGRVFK---SFDVECEMMKSIRHRNIIK- 452
           ++G G+ G+V  A R+ DG   A+KV +++      K     +V C +  +    +I+K 
Sbjct: 39  VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLL--NCDFFSIVKC 96

Query: 453 ----VISSCSNEE---FKALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASAL 502
                     N E     ALVL+Y   G L + + S   +N     ++   + I V  A+
Sbjct: 97  HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
            ++H   S  +IH D+K +N+LL  N +  L DFG +K+        +      T  Y+A
Sbjct: 157 HHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 563 PEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
           PE  +    S   D++S G++L E  T K+P    F+GE
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRP----FDGE 248

Length = 496

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 66.9 bits (163), Expect = 7e-12
 Identities = 63/234 (26%), Positives = 106/234 (45%), Gaps = 20/234 (8%)

Query: 399 LIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMK------SIRHRNII 451
           ++G+GSFG VF A L G     A+K   L+   V    DVEC M++      +  H  + 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
            +  +   +E    V+EY+  G L  ++ S  +  D+ +      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SK 115

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
            +++ DLK  N+LLD +    ++DFG+ K     D  T       T  Y+APE     + 
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT--CTFCGTPDYIAPEILLGQKY 173

Query: 572 SANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWVNDWLPISTKEIV 620
           + + D +SFG++L E    + P      +E+F            WL    K+I+
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDIL 227

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.4 bits (162), Expect = 8e-12
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 16/205 (7%)

Query: 400 IGRGSFGSVFKAR-LG---DGMEVAMKVFN----LQYGRVFKSFDVECEMMKSIRHRNII 451
           +G G++G VF  R +G    G   AMKV      +Q  +  +    E ++++++R    +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 452 KVISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
             +      + K  L+L+Y+  G L  +L+   +  +   R+ I  ++  AL++LH    
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---Q 123

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY--GKE 568
             +I+ D+K  N+LLD      L+DFG++K    E++    +    TI YMAPE   G  
Sbjct: 124 LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGS 182

Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
           G      D +S G++  E  T   P
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 8e-12
 Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 51/227 (22%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFN----LQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +IGRG+FG V+  R  D  +V AMKV      ++  ++      E +++       I+K+
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQI-AHVRAERDILADADSPWIVKL 66

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH-FGYSAQ 512
             S  +EE   LV+EYMP G L   L   +   +   R  I  ++  AL+ +H  G+   
Sbjct: 67  YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLGF--- 122

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ------------------- 553
            IH D+KP N+L+D +    L+DFG+ K + +                            
Sbjct: 123 -IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK 181

Query: 554 --------TLATIGYMAPE------YGKEGRVSANGDVYSFGIMLME 586
                   T+ T  Y+APE      YG E       D +S G++L E
Sbjct: 182 QRRVRANSTVGTPDYIAPEVLRGTPYGLE------CDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 66.4 bits (162), Expect = 9e-12
 Identities = 64/245 (26%), Positives = 107/245 (43%), Gaps = 33/245 (13%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMMK------SIRHRNII 451
           ++G+GSFG V  A L    EV A+KV  L+   + +  DV+C M +      + +H  + 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
            +      ++    V+EY+  G L   +  S    +   R     +V  AL +LH     
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF-YAAEVTLALMFLH---RH 115

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
            VI+ DLK  N+LLD      L+DFG+ K       +T  T    T  Y+APE  +E   
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--TTFCGTPDYIAPEILQELEY 173

Query: 572 SANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 626
             + D ++ G+++ E    + P      D++F               I   +++ P  LS
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES-------------ILHDDVLYPVWLS 220

Query: 627 REDIN 631
           +E ++
Sbjct: 221 KEAVS 225

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 65.9 bits (161), Expect = 9e-12
 Identities = 57/231 (24%), Positives = 101/231 (43%), Gaps = 26/231 (11%)

Query: 392 DGFSENNLIGRGSFGSVFKARLGDGM-----EVAMKVFN-----LQYGRVFKSFDVECEM 441
           D  + ++L+  G+FG +F   L D       EV +K        +Q   + +    E  +
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQ----ESCL 61

Query: 442 MKSIRHRNIIKVISSCSNEEFKALVLE-YMPHGSLEKYLHSSNYI-------LDIYQRLN 493
           +  + H+NI+ ++  C  +     VL  YM  G+L+ +L             L   Q ++
Sbjct: 62  LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121

Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           + I +A  + YLH      VIH D+   N ++D+ +   ++D  +++ L   D   +   
Sbjct: 122 MAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN 178

Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
               + +MA E       S+  DV+SFG++L E  T  + P  EI   EM 
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 15/207 (7%)

Query: 394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSIRH 447
           F +  ++G+G FG V   ++   G   A K   L+  R+ K         E ++++ +  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGESMALNEKQILEKVNS 59

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASALEYLH 506
           R ++ +  +   ++   LVL  M  G L+ ++ H      +  + +    ++   LE LH
Sbjct: 60  RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
                ++++ DLKP N+LLDD+    +SD G+A +   E Q TI+ + + T+GYMAPE  
Sbjct: 120 ---QERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQ-TIKGR-VGTVGYMAPEVV 173

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKP 593
           K  R + + D ++ G +L E    + P
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 65/243 (26%), Positives = 115/243 (47%), Gaps = 23/243 (9%)

Query: 399 LIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMK----SIRHRN--II 451
           ++G+GSFG V  A L G G   A+K   L+   V    DVEC M++    ++   N  + 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
            +  +   +E    V+E++  G L  ++       D+Y+      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH---SK 115

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
            +I+ DLK  NV+LD +    ++DFG+ K     D     +    T  Y+APE  +  + 
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA--STFCGTPDYIAPEILQGLKY 173

Query: 572 SANGDVYSFGIMLMETFTRKKP-----TDEIFNG-EMTLKHWVNDWLPISTKEIVDPNLL 625
           + + D +SFG++L E    + P      DE+F    +   H+   W+   +K+I++  L 
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR-WITKESKDILE-KLF 231

Query: 626 SRE 628
            R+
Sbjct: 232 ERD 234

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 32/234 (13%)

Query: 394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFD---VECEMMKSIRHRN 449
           F     +G GSFG V  A+  G G   A+K    +     K       E  ++  + H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS----NYILDIYQRLNIMIDVASALEYL 505
           I+ ++ S  +E     +LE++  G L  +L  +    N +   Y       ++  A EYL
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH-----AELVLAFEYL 134

Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPE 564
           H   S  +I+ DLKP N+LLD+     ++DFG AK +        +T TL  T  Y+APE
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPE 185

Query: 565 YGKEGRVSANGDVYSFGIMLMETFTRKKP---------TDEIFNGEMTLKHWVN 609
             +        D ++ G++L E      P          ++I  G +   +W +
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFD 239

Length = 329

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 19/207 (9%)

Query: 399 LIGRGSFGSVFKARLGDGMEV----AMKVFN----LQYGRVFKSFDVECEMMKSIRHRNI 450
           ++G G++G VF  R   G +     AMKV      +Q  +  +    E  +++ +R    
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66

Query: 451 IKVISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           +  +      E K  L+L+Y+  G +  +L+  +   +   R     ++  ALE+LH   
Sbjct: 67  LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-EIILALEHLH--- 122

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK-LLTREDQSTIQTQTLATIGYMAPEY--G 566
              +++ D+K  N+LLD      L+DFG++K  L+ E + T       TI YMAPE   G
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTIEYMAPEIIRG 180

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKP 593
           K G   A  D +S GI++ E  T   P
Sbjct: 181 KGGHGKAV-DWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 15/208 (7%)

Query: 399 LIGRGSFGSVFKARLGD-GMEVAMKV--FNLQYGRVFKSFD-VECE--MMKSIRHRNIIK 452
           L+G+G+FG V+     D G E+A+K   F+ +     K  + +ECE  ++K++ H  I++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 453 VISSCSN--EEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRLNIMIDVASALEYLHFGY 509
                 +  E   ++ +E+MP GS++  L S   + + + ++    I     LE + + +
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYLH 123

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY-MAPEYGKE 568
           S  ++H D+K +N+L D      L DFG +K L     S    +++    Y M+PE    
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 569 GRVSANGDVYSFGIMLMETFTRKKPTDE 596
                  D++S G  ++E  T K P  E
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 39/112 (34%), Positives = 53/112 (47%), Gaps = 25/112 (22%)

Query: 494 IMIDVASALEYL---HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI 550
           + + +  AL YL   H      VIH D+KPSN+LLD +    L DFGI+  L     S  
Sbjct: 119 MTVAIVKALHYLKEKH-----GVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKA 170

Query: 551 QTQTLATIGYMAPEYGKEGRVSAN---------GDVYSFGIMLMETFTRKKP 593
           +T++     YMAPE     R+             DV+S GI L+E  T + P
Sbjct: 171 KTRSAGCAAYMAPE-----RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 65.2 bits (160), Expect = 2e-11
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 52/227 (22%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMM---KSIR----HRNII 451
           +G G+FGSV+ AR    G  VA+K       + F S++ EC  +   KS+R    H NI+
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREVKSLRKLNEHPNIV 61

Query: 452 K---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLH- 506
           K   V     N+E    V EYM  G+L + +              +I+  +   L ++H 
Sbjct: 62  KLKEVFRE--NDELY-FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGYMAPE- 564
            G+     H DLKP N+L+    V  ++DFG+A    RE +S    T  ++T  Y APE 
Sbjct: 118 HGF----FHRDLKPENLLVSGPEVVKIADFGLA----REIRSRPPYTDYVSTRWYRAPEI 169

Query: 565 ------YGKEGRVSANGDVYSFGIMLMETFTRKKP-------TDEIF 598
                 Y      S+  D+++ G ++ E +T  +P        D+++
Sbjct: 170 LLRSTSY------SSPVDIWALGCIMAELYTL-RPLFPGSSEIDQLY 209

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 36/213 (16%)

Query: 399 LIGRGSFGSVFKARLGDGMEV----AMKVFNLQYGRVFKSF--DVECEMMKSIRHRNIIK 452
           ++G+GSFG VF  R   G +     AMKV      +V       +E +++  + H  I+K
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN--IMI----------DVAS 500
           +  +   E    L+L+++  G             D++ RL+  +M           ++A 
Sbjct: 63  LHYAFQTEGKLYLILDFLRGG-------------DLFTRLSKEVMFTEEDVKFYLAELAL 109

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           AL++LH   S  +I+ DLKP N+LLD+     L+DFG++K     D          T+ Y
Sbjct: 110 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEY 164

Query: 561 MAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           MAPE       + + D +SFG+++ E  T   P
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 33/195 (16%)

Query: 393 GFSENNLIGRGSFGSVFKARL---GDGMEVAMKVF---NLQYGRVFKSFDVECEMMKSIR 446
            +     IGRG++G V+KA+     DG E A+K F     QY  + +S   E  +++ ++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 447 HRNIIKVISSCSNEEFKA--LVLEYMPHGSLE--KYLHSSNYILDIYQRL--NIMIDVAS 500
           H N++ ++        K+  L+ +Y  H   +  K+ H     + I   +  +++  + +
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKF-HRQAKRVSIPPSMVKSLLWQILN 119

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIA-------KLLTREDQST 549
            + YLH   S  V+H DLKP+N+L+     +  V  + D G+A       K L   D   
Sbjct: 120 GVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 550 IQTQTLATIGYMAPE 564
           +      TI Y APE
Sbjct: 177 V------TIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.6 bits (160), Expect = 4e-11
 Identities = 39/120 (32%), Positives = 60/120 (50%), Gaps = 31/120 (25%)

Query: 26  LELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNP 85
           L L +    GFIPN    LR+LQ++ LS N                              
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNS----------------------------- 453

Query: 86  LDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLG 145
           + G +P  S+G+++ SLE  +++Y + +G IPE +G LT+L I+ L GN L+G +P+ LG
Sbjct: 454 IRGNIP-PSLGSIT-SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 65.6 bits (160), Expect = 4e-11
 Identities = 33/76 (43%), Positives = 43/76 (56%)

Query: 114 GGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDE 173
           G IP +I  L +L  I L GN + G+IP +LG +  L+ L L  N   GSIP+S+     
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 174 LYKLELGGNKLSGSIP 189
           L  L L GN LSG +P
Sbjct: 492 LRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 18/207 (8%)

Query: 399 LIGRGSFGSVFKARLGDGMEV----AMKVFN----LQYGRVFKSFDVECEMMKSIRHRNI 450
           ++G G++G VF  R   G +     AMKV      +Q  +  +    E ++++ IR    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 451 IKVISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI-DVASALEYLHFG 508
           +  +      + K  L+L+Y+  G L  + H S       Q + I   ++  ALE+LH  
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGEIVLALEHLH-- 122

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY--G 566
               +I+ D+K  N+LLD N    L+DFG++K    ED+         TI YMAP+   G
Sbjct: 123 -KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYMAPDIVRG 180

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKP 593
            +G      D +S G+++ E  T   P
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 28/211 (13%)

Query: 400 IGRGSFGSVFKARLGDGMEVA----MKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IG GSFG+V+ A      EV     M     Q    ++    E + ++ ++H N I+   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS----ALEYLHFGYSA 511
               E    LV+EY         L S++ +L+++++    +++A+    AL+ L + +S 
Sbjct: 89  CYLKEHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY---GKE 568
            +IH D+K  N+LL +     L+DFG A        S+     + T  +MAPE      E
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASK------SSPANSFVGTPYWMAPEVILAMDE 194

Query: 569 GRVSANGDVYSFGIMLMETFTRKKPTDEIFN 599
           G+     DV+S GI  +E   RK P   +FN
Sbjct: 195 GQYDGKVDVWSLGITCIELAERKPP---LFN 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.4 bits (154), Expect = 6e-11
 Identities = 62/254 (24%), Positives = 109/254 (42%), Gaps = 56/254 (22%)

Query: 400 IGRGSFGSVFK--ARLGDGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           +G GS+ +V+K  +R+ +G  VA+KV ++  + G  F +   E  ++K ++H NI+ +  
Sbjct: 13  LGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHD 70

Query: 456 SCSNEEFKALVLEYMPHGSLEKY-------LHSSNYILDIYQRLNIMIDVASALEYLHFG 508
               +E    V EYM H  L +Y       LH  N  L ++Q L         L Y+H  
Sbjct: 71  IIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIH-- 120

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT----LATIGYMAPE 564
               ++H DLKP N+L+       L+DFG+A+        +I +QT    + T+ Y  P+
Sbjct: 121 -GQHILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSSEVVTLWYRPPD 173

Query: 565 -YGKEGRVSANGDVYSFGIMLMETFTRKK---------------------PTDEIFNGEM 602
                   S+  D++  G + +E    +                      PT++ + G  
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233

Query: 603 TLKHWVNDWLPIST 616
            L ++  +W     
Sbjct: 234 KLPNYKPEWFLPCK 247

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 64.2 bits (156), Expect = 7e-11
 Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 29/297 (9%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGF--IPNTFGNLRNLQALRLSNNYLT 58
           + ++  N  S T+     + S+L  L+L   S            NL  L +L L+ N L 
Sbjct: 47  VNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLR 106

Query: 59  SSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPE 118
           S+      +S L    +LT +   NN +  I     +G L  +L+  +    N    +P 
Sbjct: 107 SN------ISELLELTNLTSLDLDNNNITDI--PPLIGLLKSNLKELD-LSDNKIESLPS 157

Query: 119 EIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLE 178
            + NL NL  + L  N L+  +P  L  L  L  L L  NK+   +P  I     L +L+
Sbjct: 158 PLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELD 215

Query: 179 LGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLE 238
           L  N +   +    +NL +L  L L +N+L  +P +  NL ++  L+ S+N         
Sbjct: 216 LSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNN--------- 265

Query: 239 IGNLKIARIDS-CDLISLISLNLSNNNLSGAIPASLE-KLSYLKDLNLSFNKLEGEI 293
               +I+ I S   L +L  L+LS N+LS A+P      L     LNL       E+
Sbjct: 266 ----QISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALEL 318

Length = 394

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 400 IGRGSFGSVFKARLGDGME-VAMKVFNL-QYGRVFKSFDV-ECEMMKSIRHRNIIKVISS 456
           IG G++G V+KAR     E +A+K   L Q      S  + E  ++K ++H NI+++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             +E+   LV EY+    L+K++ SS ++  +       +  +   + Y H   S +V+H
Sbjct: 70  VHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLH 125

Query: 516 CDLKPSNVLLDDNMVA-HLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR-VSA 573
            DLKP N+L+D    A  L+DFG+A+      ++   T  + T+ Y APE     R  S 
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF--THEVVTLWYRAPEILLGSRHYST 183

Query: 574 NGDVYSFGIMLMETFTRK 591
             D++S G +  E   +K
Sbjct: 184 PVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 72/266 (27%), Positives = 115/266 (43%), Gaps = 52/266 (19%)

Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVI---- 454
           +G GS G VF A   D    VA+K   L   +  K    E ++++ + H NI+KV     
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 455 --SSCSNEEFKAL--------VLEYMP---HGSLEKYLHSSNYI-LDIYQRLNIMIDVAS 500
              S   E+  +L        V EYM       LE+   S  +  L +YQ L        
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR------- 125

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATI 558
            L+Y+H   SA V+H DLKP+NV ++ +++V  + DFG+A+++          ++ L T 
Sbjct: 126 GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182

Query: 559 GYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNG--EMTLKHWVN 609
            Y +P        Y K        D+++ G +  E  T K     +F G  E+     + 
Sbjct: 183 WYRSPRLLLSPNNYTKA------IDMWAAGCIFAEMLTGKP----LFAGAHELEQMQLIL 232

Query: 610 DWLPISTKEIVDPNLLSREDINFVAK 635
           + +P+  +E  D N L     +FV  
Sbjct: 233 ESVPVVREE--DRNELLNVIPSFVRN 256

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 36/235 (15%)

Query: 399 LIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS- 456
           +IGRG FG V+  R  D G   AMK  +       K   ++     ++  R ++ ++S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54

Query: 457 ------CSNEEFKA-----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
                 C    F        +L+ M  G L  +L       +   R     ++   LE++
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIILGLEHM 113

Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H  +   V++ DLKP+N+LLD++    +SD G+A   +++        ++ T GYMAPE 
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEV 166

Query: 566 GKEGRV-SANGDVYSFGIMLME------TFTRKKPTDEIFNGEMTLKHWVNDWLP 613
            ++G    ++ D +S G ML +       F + K  D+     MTL   VN  LP
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VNVELP 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.7 bits (155), Expect = 2e-10
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 2/90 (2%)

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG 138
           +   N  L G +P   +  L H L+   ++  ++ G IP  +G++T+L ++ L  N  NG
Sbjct: 423 LGLDNQGLRGFIPND-ISKLRH-LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG 480

Query: 139 SIPSTLGKLQKLQGLGLENNKLEGSIPDSI 168
           SIP +LG+L  L+ L L  N L G +P ++
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 56/199 (28%), Positives = 92/199 (46%), Gaps = 19/199 (9%)

Query: 400 IGRGSFGSVFKARLGDGME-VAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRNIIKVISSC 457
           +G G++ +V+K R     E VA+K  +L       S  + E  +MK ++H NI+++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 458 SNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             E    LV EYM    L+KY+  H     LD     +    +   + + H     +V+H
Sbjct: 68  HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA----TIGYMAPEYGKEGRV 571
            DLKP N+L++      L+DFG+A+         I   T +    T+ Y AP+     R 
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAF------GIPVNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 572 -SANGDVYSFGIMLMETFT 589
            S + D++S G ++ E  T
Sbjct: 178 YSTSIDIWSVGCIMAEMIT 196

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 24/227 (10%)

Query: 399 LIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMK------SIRHRNII 451
           ++G+GSFG V  ARL   G   A+KV  L+   + +  DVEC M +      +  H  + 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           ++       +    V+E++  G L  ++  S    +   R     ++ SAL +LH     
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEITSALMFLH---DK 115

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
            +I+ DLK  NVLLD      L+DFG+ K      ++T  +    T  Y+APE  +E   
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STFCGTPDYIAPEILQEMLY 173

Query: 572 SANGDVYSFGIMLMETFTRKKP-----TDEIF----NGEMTLKHWVN 609
             + D ++ G++L E      P      D++F    N E+    W++
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLS 220

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 32/212 (15%)

Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKS----FDVECEMMKSIR 446
           + F    +IGRG+FG V   R     +V AMK+ + ++  + +S    F  E ++M    
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEERDIMAHAN 101

Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYL 505
              I+++  +  ++++  +V+EYMP G L   +  SNY I + + R     +V  AL+ +
Sbjct: 102 SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTA-EVVLALDAI 158

Query: 506 H-FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           H  G+    IH D+KP N+LLD +    L+DFG    +         T  + T  Y++PE
Sbjct: 159 HSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT-AVGTPDYISPE 213

Query: 565 ----------YGKEGRVSANGDVYSFGIMLME 586
                     YG+E       D +S G+ L E
Sbjct: 214 VLKSQGGDGYYGRE------CDWWSVGVFLYE 239

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 14/202 (6%)

Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           +G+G FG V   ++   G   A K  N   L+  + ++   VE  ++  +  R I+ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +   +    LV+  M  G L  ++++    N      +       + S LE+LH     +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPEYGKEGRV 571
           +I+ DLKP NVLLD++    +SD G+A  L ++ QS  +T+  A T G+MAPE  +    
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVEL-KDGQS--KTKGYAGTPGFMAPELLQGEEY 174

Query: 572 SANGDVYSFGIMLMETFTRKKP 593
             + D ++ G+ L E    + P
Sbjct: 175 DFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 8/195 (4%)

Query: 400 IGRGSFGSV-FKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG GS G V        G +VA+K  +L+  +  +    E  +M+   H N++ + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL YLH   +  VIH D+
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  ++LL  +    LSDFG    +++E     +   + T  +MAPE           D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEVDIW 202

Query: 579 SFGIMLMETFTRKKP 593
           S GIM++E    + P
Sbjct: 203 SLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 58/207 (28%), Positives = 103/207 (49%), Gaps = 22/207 (10%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKS----FDVECEMMKSIRHRNIIKV 453
           +IGRG+FG V   R     +V AMK+ + ++  + +S    F  E ++M       ++++
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN--IMIDVASALEYLHFGYSA 511
             +  ++++  +V+EYMP G L   +  SNY  D+ ++       +V  AL+ +H   S 
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DVPEKWAKFYTAEVVLALDAIH---SM 161

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT-LATIGYMAPEY----G 566
            +IH D+KP N+LLD +    L+DFG    +  ++   ++  T + T  Y++PE     G
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKP 593
            +G      D +S G+ L E      P
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 28/208 (13%)

Query: 400 IGRGSFGSVFKA---RLGDG-----MEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNII 451
           +G+G+F  +FK     +GD       EV +KV +  +    +SF     MM  + H++++
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
                C   +   +V EY+  GSL+ YL  +  +++I  +L +   +A AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119

Query: 512 QVIHCDLKPSNVLL---DDNMVAH-----LSDFGIA-KLLTREDQSTIQTQTLATIGYMA 562
            + H ++   NVLL   +D    +     LSD GI+  +L +E         L  I ++ 
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-------ILLERIPWVP 172

Query: 563 PEYGKEGR-VSANGDVYSFGIMLMETFT 589
           PE  +  + +S   D +SFG  L E F+
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 62.3 bits (151), Expect = 3e-10
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 18/205 (8%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKS----FDVECEMMKSIRHRNIIKV 453
           +IGRG+FG V   R     +V AMK+ + ++  + +S    F  E ++M       ++++
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQ 512
             +  ++ +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H   S  
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMG 162

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY----GKE 568
            IH D+KP N+LLD +    L+DFG    + +E      T  + T  Y++PE     G +
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGD 221

Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
           G      D +S G+ L E      P
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 21/210 (10%)

Query: 394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMM----KSIRHR 448
           F    ++G+G FG V   ++   G   A K   L+  R+ K    + E M    K I  +
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKR---KGEAMALNEKQILEK 56

Query: 449 -NIIKVISSCSNEEFK---ALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASALE 503
            N   V+S     E K    LVL  M  G L+ ++++  N   D  + +    ++   LE
Sbjct: 57  VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
            LH     ++++ DLKP N+LLDD     +SD G+A +   E + TI+ + + T+GYMAP
Sbjct: 117 DLH---RERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGE-TIRGR-VGTVGYMAP 170

Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           E  K  R + + D +  G ++ E    K P
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 36/214 (16%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV--ECEMMKSIRHRNIIKVIS 455
           +IG+GS+G V  A     G +VA+K  N  +  V  +  +  E ++++ +RH +I+++  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 456 ---SCSNEEFKAL--VLEYMPHGSLEKYLHS----------SNYILDIYQRLNIMIDVAS 500
                S  EFK +  V E M     E  LH            ++   +YQ L        
Sbjct: 67  IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR------- 114

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI-QTQTLATIG 559
           AL+Y+H   +A V H DLKP N+L + +    + DFG+A++   +  + I  T  +AT  
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 560 YMAPEYGKE--GRVSANGDVYSFGIMLMETFTRK 591
           Y APE       + +   D++S G +  E  T K
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 16/230 (6%)

Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG GS G V  A +   G  VA+K  +L+  +  +    E  +M+  +H N++++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  ++LL  +    LSDFG    +++E     +   + T  +MAPE           D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELISRLPYGPEVDIW 200

Query: 579 SFGIMLMETFTRKKPTDEIFNGEMTLK--HWVNDWLPISTKEI--VDPNL 624
           S GIM++E    + P    FN E  LK    + D LP   K +  V P+L
Sbjct: 201 SLGIMVIEMVDGEPP---YFN-EPPLKAMKMIRDNLPPKLKNLHKVSPSL 246

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 24/223 (10%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEM------MKSIRHRNII 451
           +IG+GSFG V  AR   +    A+KV  LQ   + K  + +  M      +K+++H  ++
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
            +  S    +    VL+Y+  G L  +L      L+   R     ++ASAL YLH   S 
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SL 115

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
            +++ DLKP N+LLD      L+DFG+ K     + +T  +    T  Y+APE   +   
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT--STFCGTPEYLAPEVLHKQPY 173

Query: 572 SANGDVYSFGIMLMETFTRKKP---------TDEIFNGEMTLK 605
               D +  G +L E      P          D I N  + LK
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 216

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 60.3 bits (146), Expect = 6e-10
 Identities = 66/253 (26%), Positives = 114/253 (45%), Gaps = 39/253 (15%)

Query: 399 LIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS- 456
           +IGRG FG V+  R  D G   AMK  +       K   ++     ++  R ++ ++S+ 
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLSLVSTG 54

Query: 457 ------CSNEEFK-----ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
                 C +  F      + +L+ M  G L  +L       +   R     ++   LE++
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIILGLEHM 113

Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H  +   V++ DLKP+N+LLD++    +SD G+A   +++        ++ T GYMAPE 
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMAPEV 166

Query: 566 GKEGRV-SANGDVYSFGIMLME------TFTRKKPTDEIFNGEMTLKHWVNDWLPIS-TK 617
            ++G    ++ D +S G ML +       F + K  D+     MTL   +   LP S + 
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSP 224

Query: 618 EIVDP--NLLSRE 628
           E+      LL R+
Sbjct: 225 ELRSLLEGLLQRD 237

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.7 bits (147), Expect = 7e-10
 Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 40/208 (19%)

Query: 400 IGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG+G+FG V++ R  D   + AMKV +       K    + E+  +I  RNI+ V +   
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNIL-VRTLLD 53

Query: 459 NEEFKA-------------LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
              F               LV +YM  G L  +L       +   +  I  ++  ALE+L
Sbjct: 54  ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLALEHL 112

Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE- 564
           H      +++ DLKP N+LLD      L DFG++K    ++++T       T  Y+APE 
Sbjct: 113 H---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT--NTFCGTTEYLAPEV 167

Query: 565 ------YGKEGRVSANGDVYSFGIMLME 586
                 Y K        D +S G+++ E
Sbjct: 168 LLDEKGYTKH------VDFWSLGVLVFE 189

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 60.4 bits (146), Expect = 9e-10
 Identities = 61/195 (31%), Positives = 91/195 (46%), Gaps = 15/195 (7%)

Query: 399 LIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDVECEM------MKSIRHRNII 451
           +IG+GSFG V  A R  DG   A+KV  LQ   V    + +  M      +K+++H  ++
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKV--LQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
            +  S    E    VL+++  G L  +L       +   R     ++ASAL YLH   S 
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SI 115

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
            +++ DLKP N+LLD      L+DFG+ K      QS   T    T  Y+APE  ++   
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173

Query: 572 SANGDVYSFGIMLME 586
               D +  G +L E
Sbjct: 174 DNTVDWWCLGAVLYE 188

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 46/172 (26%), Positives = 90/172 (52%), Gaps = 18/172 (10%)

Query: 400 IGRGSFGSVFKAR--LGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRNIIKVISS 456
           +G G++ +V+K R  L D + VA+K   L++        + E  ++K ++H NI+ +   
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
              E+   LV EY+    L++YL      ++++   N+ + +   L  L++ +  +V+H 
Sbjct: 73  IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMH---NVKLFLFQLLRGLNYCHRRKVLHR 128

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT----LATIGYMAPE 564
           DLKP N+L+++     L+DFG+A+        +I T+T    + T+ Y  P+
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR------AKSIPTKTYSNEVVTLWYRPPD 174

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 37/219 (16%)

Query: 403 GSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE 461
           GS G VF A   G    V +K+   Q G       +E  +++++ H ++I++  +  +  
Sbjct: 77  GSEGRVFVATKPGQPDPVVLKIG--QKGTTL----IEAMLLQNVNHPSVIRMKDTLVSGA 130

Query: 462 FKALVLEYMPHGS--LEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
              +VL   PH S  L  YL   +  L I Q L I   +   L YLH   + ++IH D+K
Sbjct: 131 ITCMVL---PHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVK 184

Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQ-----STIQTQTLATIGYMAPEYGKEGRVSAN 574
             N+ ++D     + D G A+             T++T         APE     + ++ 
Sbjct: 185 TENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN--------APEVLARDKYNSK 236

Query: 575 GDVYSFGIMLMETFTRKK---------PTDEIFNGEMTL 604
            D++S GI+L E               P + + +    L
Sbjct: 237 ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275

Length = 357

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 67/227 (29%), Positives = 98/227 (43%), Gaps = 58/227 (25%)

Query: 391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---------ECE 440
           T+ + +   +G G+FG V  AR    G  VA+K       ++ K F           E +
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-------KIMKPFSTPVLAKRTYRELK 61

Query: 441 MMKSIRHRNIIKV----ISSCSNEEFKALVLEYMPH-----GSLEKYLHSSNYILDIYQR 491
           ++K +RH NII +    IS   +  F   +L    H       LEK      Y L  YQ 
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQF--IQYFL--YQI 117

Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
           L         L+Y+H   SA V+H DLKPSN+L+++N    + DFG+A++     Q    
Sbjct: 118 LR-------GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQM 162

Query: 552 TQTLATIGYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRK 591
           T  ++T  Y APE       Y  E       D++S G +  E    K
Sbjct: 163 TGYVSTRYYRAPEIMLTWQKYDVE------VDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 54/202 (26%), Positives = 95/202 (47%), Gaps = 16/202 (7%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFD------VECEMMKSIRHRNII 451
           L+G+G+FG V   R    G   AMK+   +   V  + D       E  ++K+ RH  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKE---VIIAKDEVAHTLTESRVLKNTRHPFLT 58

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
            +  S   ++    V+EY+  G L  +L       +   R     ++ SAL+YLH   S 
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLH---SG 114

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
           ++++ DLK  N++LD +    ++DFG+ K     D +T++T    T  Y+APE  ++   
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI-TDAATMKT-FCGTPEYLAPEVLEDNDY 172

Query: 572 SANGDVYSFGIMLMETFTRKKP 593
               D +  G+++ E    + P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 43/158 (27%), Positives = 79/158 (50%), Gaps = 7/158 (4%)

Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIM 495
           +E E+++ +    I+ +  +  ++    LV+  M  G L+ ++ +     L++ + ++  
Sbjct: 42  LEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYS 101

Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
             +   + +LH   S  +++ D+KP NVLLDD     LSD G+A  L ++ ++   TQ  
Sbjct: 102 AQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTI--TQRA 155

Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
            T GYMAPE  KE   S   D ++ G  + E    + P
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 52/207 (25%), Positives = 100/207 (48%), Gaps = 15/207 (7%)

Query: 394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFK----SFDV-ECEMMKSIRH 447
           F +  ++G+G FG V   ++   G   A K   L+  R+ K    S  + E ++++ +  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACK--RLEKKRIKKRKGESMALNEKQILEKVNS 59

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASALEYLH 506
           + ++ +  +   ++   LVL  M  G L+ ++++  N   +  + L    ++   LE LH
Sbjct: 60  QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
                  ++ DLKP N+LLDD     +SD G+A  +   +  +I+ + + T+GYMAPE  
Sbjct: 120 ---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--SIRGR-VGTVGYMAPEVL 173

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKP 593
              R + + D +  G ++ E    + P
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 8/144 (5%)

Query: 400 IGRGSFGSVFKAR--LGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRNIIKVISS 456
           +G G++ +VFK R  L + + VA+K   L++        + E  ++K+++H NI+ +   
Sbjct: 13  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
              E    LV EY+    L++YL +   ++ ++     M  +   L Y H     +++H 
Sbjct: 72  IHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHR 127

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAK 540
           DLKP N+L+++     L+DFG+A+
Sbjct: 128 DLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 34/172 (19%)

Query: 380 RMFSYLELCRATDGFSENNLIGRGSFGSVFKAR--LGDGMEVAMKVFNLQY--GRVFKSF 435
           ++ +Y +L +          +G GS+ +V+K R  L   + VA+K   L++  G  F + 
Sbjct: 3   KLETYKKLDK----------LGEGSYATVYKGRSKLTGQL-VALKEIRLEHEEGAPFTAI 51

Query: 436 DVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKY-------LHSSNYILDI 488
             E  ++K ++H NI+ +      ++   LV EY+    L++Y       L   N  L +
Sbjct: 52  R-EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFL 109

Query: 489 YQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 540
           +Q L         L Y H     +V+H DLKP N+L+ +     L+DFG+A+
Sbjct: 110 FQLLR-------GLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 43/168 (25%), Positives = 87/168 (51%), Gaps = 10/168 (5%)

Query: 400 IGRGSFGSVFKAR--LGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRNIIKVISS 456
           +G G++ +VFK R  L + + VA+K   L++        + E  ++K ++H NI+ +   
Sbjct: 14  LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
              ++   LV EY+    L++Y+     I+ ++   N+ I +   L  L + +  +V+H 
Sbjct: 73  VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRRKVLHR 128

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           DLKP N+L+++     L+DFG+A+   +   +   +  + T+ Y  P+
Sbjct: 129 DLKPQNLLINERGELKLADFGLAR--AKSVPTKTYSNEVVTLWYRPPD 174

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 14/196 (7%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRNIIKVISSC 457
           +G+G++GSV+K      G+ +AMK   L+     F    +E +++       I+    + 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
             E    + +EYM  GSL+K          I + +   I  A             +IH D
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRD 128

Query: 518 LKPSNVLLDDNMVAHLSDFGIA-KLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG- 575
           +KP+NVL++ N    L DFG++  L+    ++ I  Q+     YMAPE  K G  + N  
Sbjct: 129 VKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS-----YMAPERIKSGGPNQNPT 183

Query: 576 -----DVYSFGIMLME 586
                DV+S G+ ++E
Sbjct: 184 YTVQSDVWSLGLSILE 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 52/191 (27%), Positives = 91/191 (47%), Gaps = 8/191 (4%)

Query: 399 LIGRGSFGSVFKARLGDGME-VAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVIS 455
           ++G G++G V K R  +  E VA+K F        V ++   E +M+++++  NI+++  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
           +        LV EY+    LE      N +     R  I       ++ +H+ +   ++H
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIY----QLIKAIHWCHKNDIVH 123

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            D+KP N+L+  N V  L DFG A+ L+ E  +   T+ +AT  Y +PE           
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKAV 182

Query: 576 DVYSFGIMLME 586
           D++S G +L E
Sbjct: 183 DMWSVGCILGE 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 70/311 (22%), Positives = 126/311 (40%), Gaps = 58/311 (18%)

Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHR 448
           D + +   IG G++G V+KAR    G  VA+K   L+     +  +   E  +++ +   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 449 N-IIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLHS----SNYILDIYQRLNIMIDV 498
             I++++     EE        LV EY+    L+K++ S        L      + M  +
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
              + + H      V+H DLKP N+L+D    +  ++D G+ +  +   +S   T  + T
Sbjct: 120 LKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVT 174

Query: 558 IGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRK--------------------KPTDE 596
           + Y APE        S   D++S G +  E   ++                     PT++
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234

Query: 597 IFNGEMTLKHW--VNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESP 654
           ++ G   L+ W     W P      V P+ LS E ++ + K       ++         P
Sbjct: 235 VWPGVSKLRDWHEFPQWKPQDLSRAV-PD-LSPEGLDLLQK----MLRYD---------P 279

Query: 655 EQRINAKEIVT 665
            +RI+AK  +T
Sbjct: 280 AKRISAKAALT 290

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 46/227 (20%)

Query: 400 IGRGSFGSVFKAR---LGDGMEVAMK----VFN--LQYGRVFKSFDVECEMMKSIR-HRN 449
           +G+G++G V  AR     +   VA+K    VF+  +   R  +    E ++++  R H+N
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR----ELKLLRHFRGHKN 63

Query: 450 IIK------VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD------IYQRLNIMID 497
           I        V     NE +  L  E M    L + + S   + D      IYQ L     
Sbjct: 64  ITCLYDMDIVFPGNFNELY--LYEELM-EADLHQIIRSGQPLTDAHFQSFIYQIL----- 115

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT--REDQSTIQTQTL 555
               L+Y+H   SA V+H DLKP N+L++ +    + DFG+A+  +    + +   T+ +
Sbjct: 116 --CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 556 ATIGYMAPEYG-KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
           AT  Y APE        +   DV+S G +L E   RK     +F G+
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP----VFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 57.3 bits (138), Expect = 5e-09
 Identities = 48/198 (24%), Positives = 92/198 (46%), Gaps = 28/198 (14%)

Query: 417 MEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLE 476
           ++V +KV +  +  +  +F     MM+ + H++I+ +   C  +    +V E++  G L+
Sbjct: 33  IKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92

Query: 477 KYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL-------DDNM 529
            ++H  + +L    +  +   +ASAL YL       ++H ++   N+LL       +   
Sbjct: 93  LFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGP 149

Query: 530 VAHLSDFGIA-KLLTREDQSTIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLMET 587
              LSD GI   +L+R+       + +  I ++APE  ++ +  S   D +SFG  L E 
Sbjct: 150 FIKLSDPGIPITVLSRQ-------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Query: 588 FTRKKPTDEIFNGEMTLK 605
                     +NGE+ LK
Sbjct: 203 ---------CYNGEIPLK 211

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 18/203 (8%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFD------VECEMMKSIRHRNII 451
           L+G+G+FG V   R    G   AMK+   +   V  + D       E  ++++ RH  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKE---VIIAKDEVAHTVTESRVLQNTRHPFLT 58

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM-IDVASALEYLHFGYS 510
            +  +    +    V+EY   G L  + H S   +   +R      ++ SALEYLH   S
Sbjct: 59  ALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLH---S 113

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
             V++ D+K  N++LD +    ++DFG+ K     D +T++T    T  Y+APE  ++  
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKT-FCGTPEYLAPEVLEDND 171

Query: 571 VSANGDVYSFGIMLMETFTRKKP 593
                D +  G+++ E    + P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.1 bits (140), Expect = 7e-09
 Identities = 55/209 (26%), Positives = 86/209 (41%), Gaps = 26/209 (12%)

Query: 399 LIGRGSFGSVFKA-RLGDGME-VAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
           L+GR    + F A R  D  E V  K   L   R       E   + +  H  I+K    
Sbjct: 74  LVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDD 133

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN------------IMIDVASALEY 504
             +++   L++EY   G L K          I QRL             +   +  AL+ 
Sbjct: 134 FKSDDKLLLIMEYGSGGDLNK---------QIKQRLKEHLPFQEYEVGLLFYQIVLALDE 184

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           +H   S +++H DLK +N+ L    +  L DFG +K  +      + +    T  Y+APE
Sbjct: 185 VH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241

Query: 565 YGKEGRVSANGDVYSFGIMLMETFTRKKP 593
             +  R S   D++S G++L E  T  +P
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRP 270

Length = 478

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 62/231 (26%), Positives = 99/231 (42%), Gaps = 57/231 (24%)

Query: 399 LIGRGSFGSVFKARL-GDGMEVAMKVFNLQ-------YGRVFKSFDVECEMMKSIRHRNI 450
           L+G+G  G VF  RL G G   A+KV + +         RV      E E++ ++ H  +
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL----TEQEILATLDHPFL 63

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEYLH-F 507
             + +S   E +  LV++Y P G L + L       + +   R     +V  ALEYLH  
Sbjct: 64  PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA-EVLLALEYLHLL 122

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT---------------REDQSTIQT 552
           G     ++ DLKP N+LL ++    LSDF ++K                  R   ++I +
Sbjct: 123 GI----VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 553 QTLATIG------------YMAPEYGKEGRVSANG-----DVYSFGIMLME 586
           +T +               Y+APE      +S +G     D ++ GI+L E
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEV-----ISGDGHGSAVDWWTLGILLYE 224

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 28/161 (17%)

Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLH------SSNYI 485
           E  +MK + H+NII +++      S EEF+   LV+E M   +L + +         +Y+
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSYL 123

Query: 486 LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 545
           L  YQ L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+     
Sbjct: 124 L--YQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 168

Query: 546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
             S + T  + T  Y APE         N D++S G ++ E
Sbjct: 169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 209

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 53/236 (22%), Positives = 96/236 (40%), Gaps = 33/236 (13%)

Query: 438 ECEMMKSIRHRNIIKV----ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN 493
           E + ++ I   NI+K+    I    +    +L+LEY   G L + L      L    +L+
Sbjct: 68  EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-DKEKDLSFKTKLD 126

Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           + ID    L  L+   +    + +L   + L+ +N    +   G+ K+L     S+   +
Sbjct: 127 MAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKIL-----SSPPFK 179

Query: 554 TLATIGYMAPEYGKE--GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW 611
            +  + Y + +   +     +   D+YS G++L E FT K P    F             
Sbjct: 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIP----FEN----------- 224

Query: 612 LPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
             ++TKEI D  L+  ++ +      C   +  +   CT     +R N KEI+  L
Sbjct: 225 --LTTKEIYD--LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 13/198 (6%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
           IG GSFG     +   DG +  +K  N+     +  +    E  ++ +++H NI++   S
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYIL-DIYQRLNIMIDVASALEYLHFGYSAQVIH 515
                   +V++Y   G L K +++   +L    Q L+  + +  AL+++H     +++H
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILH 124

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ--TQTLATIGYMAPEYGKEGRVSA 573
            D+K  N+ L  +    L DFGIA++L     ST++     + T  Y++PE  +    + 
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELARTCIGTPYYLSPEICENRPYNN 180

Query: 574 NGDVYSFGIMLMETFTRK 591
             D+++ G +L E  T K
Sbjct: 181 KSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 23/201 (11%)

Query: 400 IGRGSFGSV---FKARLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVI 454
           +G G++GSV   F  +   G+ VA+K  +  +  +   K    E  ++K ++H N+I ++
Sbjct: 25  VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82

Query: 455 S----SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
                + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   
Sbjct: 83  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH--- 137

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
           SA +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE     
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNW 192

Query: 570 -RVSANGDVYSFGIMLMETFT 589
              +   D++S G ++ E  T
Sbjct: 193 MHYNQTVDIWSVGCIMAELLT 213

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 69/314 (21%), Positives = 105/314 (33%), Gaps = 75/314 (23%)

Query: 1   MLQMWENNFSGTIPRFIFNA----SKLSILELSDNSFSGFIPNT------FGNLRNLQAL 50
           +L++  N       + + +A      L  L LS N                     LQ L
Sbjct: 27  VLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQEL 86

Query: 51  RLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPL-DGILPK--TSVGNLSHSLEYFEM 107
            LS+N L         L SL    SL  +  +NN L D  L      + +L  +LE   +
Sbjct: 87  DLSDNALGPDGCG--VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVL 144

Query: 108 AYCNVSGGIPEEIGNL----TNLTIIYLGGNKLNGS-IPST---LGKLQKLQGLGLENNK 159
               + G   E +        +L  + L  N +  + I +    L     L+ L L NN 
Sbjct: 145 GRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNG 204

Query: 160 LEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLK 219
           L                 + G + L+    E   +L SL +L LG N LT          
Sbjct: 205 LT----------------DEGASALA----ETLASLKSLEVLNLGDNNLTDAGA------ 238

Query: 220 DILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNL--SGAIPAS--LEK 275
                                   +A       ISL++L+LS N++   GA   +  L +
Sbjct: 239 ----------------------AALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAE 276

Query: 276 LSYLKDLNLSFNKL 289
              L +L+L  NK 
Sbjct: 277 KESLLELDLRGNKF 290

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 61/218 (27%), Positives = 93/218 (42%), Gaps = 20/218 (9%)

Query: 392 DGFSENNLIGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVECEMMKSIR 446
             F   +L+GRG FG V   R    GD   M+V  K   L    V   F+ E +++    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETV-SFFEEERDILSISN 59

Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
              I ++  +  +++   LV+EY P G L   L+      D       + ++  A+  +H
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119

Query: 507 -FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE- 564
             GY    +H D+KP NVL+D      L+DFG A  LT  ++       + T  Y+APE 
Sbjct: 120 QMGY----VHRDIKPENVLIDRTGHIKLADFGSAARLTA-NKMVNSKLPVGTPDYIAPEV 174

Query: 565 ------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDE 596
                  GK G      D +S G++  E    + P  E
Sbjct: 175 LTTMNGDGK-GTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 14/234 (5%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFD---VECEMMKSIRHRNIIKVI 454
           +IGRGS+  V   RL    ++ AMKV   +     +  D    E  + +       +  +
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61

Query: 455 SSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            SC     +  LV+EY+  G L  ++     + + + R     ++  AL +LH      +
Sbjct: 62  HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-YAAEICIALNFLH---ERGI 117

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           I+ DLK  NVLLD +    L+D+G+ K       +T  +    T  Y+APE  +      
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT--STFCGTPNYIAPEILRGEEYGF 175

Query: 574 NGDVYSFGIMLMETFTRKKPTDEIF-NGEMTLKHWVNDWLPISTKEIVDPNLLS 626
           + D ++ G+++ E    + P D I  N +M  + ++  +  I  K I  P  LS
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL--FQVILEKPIRIPRFLS 227

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 51/205 (24%), Positives = 100/205 (48%), Gaps = 11/205 (5%)

Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRN 449
           D F   + +G G+ G V K +    G+ +A K+ +L+     ++  + E +++       
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFG 508
           I+    +  ++   ++ +E+M  GSL++ L  +  I  +I  +++I   V   L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREK 122

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  Q++H D+KPSN+L++      L DFG++  L      ++    + T  YM+PE  + 
Sbjct: 123 H--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG 176

Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
              S   D++S G+ L+E    + P
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 11/202 (5%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFD---VECEMMKSIRHRNIIKVI 454
           +IGRGS+  V   RL     + AMKV   +     +  D    E  + +   +   +  +
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            SC   E +   V+EY+  G L  ++     + + + R     +++ AL YLH      +
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 117

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           I+ DLK  NVLLD      L+D+G+ K   R   +T  +    T  Y+APE  +      
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEILRGEDYGF 175

Query: 574 NGDVYSFGIMLMETFTRKKPTD 595
           + D ++ G+++ E    + P D
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 50/177 (28%), Positives = 88/177 (49%), Gaps = 22/177 (12%)

Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  ++K + H+NII +++      S EEF+   LV+E M   +L + +H     LD ++R
Sbjct: 70  ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHME---LD-HER 124

Query: 492 LNIMI-DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI 550
           ++ ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       + +
Sbjct: 125 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFM 178

Query: 551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
            T  + T  Y APE         N D++S G ++ E          IF G   +  W
Sbjct: 179 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK----GSVIFQGTDHIDQW 231

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.0 bits (135), Expect = 3e-08
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 3/104 (2%)

Query: 486 LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 545
           LD+   L     VA  +++L    S   IH D+   NVLL D  VA + DFG+A+ +  +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
               ++      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 37/211 (17%)

Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNI 450
           D F +   +G G+ G V K      G+ +A K+ +L             E+  +IR++ I
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL-------------EIKPAIRNQII 47

Query: 451 --IKVISSC-------------SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM 495
             +KV+  C             S+ E  ++ +E+M  GSL++ L  +  I +      I 
Sbjct: 48  RELKVLHECNSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPENILG-KIS 105

Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
           I V   L YL   +  +++H D+KPSN+L++      L DFG++  L      ++    +
Sbjct: 106 IAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFV 159

Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
            T  YM+PE  +    +   D++S G+ L+E
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)

Query: 392 DGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRN 449
           D F + + +G G+ G VFK +    G+ +A K+ +L+     ++  + E +++       
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-NIMIDVASALEYLHFG 508
           I+    +  ++   ++ +E+M  GSL++ L  +  I +  Q L  + I V   L YL   
Sbjct: 65  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 122

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  +++H D+KPSN+L++      L DFG++  L      ++    + T  YM+PE  + 
Sbjct: 123 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG 176

Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
              S   D++S G+ L+E    + P
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 4e-08
 Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 22/204 (10%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRNIIKVIS--- 455
           IG+GSFG V + R  D      +++ L+  R  K+  V   E+  ++  R ++  ++   
Sbjct: 1   IGKGSFGKVMQVRKRD----TQRIYALKTIR--KAHIVSRSEVTHTLAERTVLAQVNCPF 54

Query: 456 ------SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
                 S  + E   LVL ++  G L  +L       D+ +      ++  ALE LH   
Sbjct: 55  IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYTAELLCALENLH--- 110

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
              VI+ DLKP N+LLD      L DFG+ KL  ++D  T       T  Y+APE     
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT--NTFCGTPEYLAPELLLGH 168

Query: 570 RVSANGDVYSFGIMLMETFTRKKP 593
             +   D ++ G++L E  T   P
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 49/197 (24%), Positives = 92/197 (46%), Gaps = 17/197 (8%)

Query: 400 IGRGSFGSVF-----KARLGDGMEV--AMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G+GSFG+V+     KA   + ++V   + V  L      ++ + E +++  + H  I+K
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66

Query: 453 VISSCSNEEFKALVLEYMPHGSLE---KYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
             +S    +   ++ EY     L+   + L  +   L   Q     I +   + Y+H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--- 123

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
             +++H DLK  N+ L +N++  + DFG+++LL       + T    T  YM+PE  K  
Sbjct: 124 QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLM--GSCDLATTFTGTPYYMSPEALKHQ 180

Query: 570 RVSANGDVYSFGIMLME 586
              +  D++S G +L E
Sbjct: 181 GYDSKSDIWSLGCILYE 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 50/207 (24%), Positives = 97/207 (46%), Gaps = 15/207 (7%)

Query: 394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSIRH 447
           F    ++G+G FG V   ++   G   A K   L+  R+ K         E  +++ +  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACK--KLEKKRIKKRKGEAMALNEKRILEKVNS 59

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASALEYLH 506
           R ++ +  +   ++   LVL  M  G L+ ++++  N   D  + +    ++   LE L 
Sbjct: 60  RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
                ++++ DLKP N+LLDD     +SD G+A  +   +  T++ + + T+GYMAPE  
Sbjct: 120 ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIP--EGETVRGR-VGTVGYMAPEVI 173

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKP 593
              + + + D +  G ++ E    + P
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 56.0 bits (135), Expect = 6e-08
 Identities = 46/129 (35%), Positives = 61/129 (47%), Gaps = 12/129 (9%)

Query: 191 CFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSC 250
           C N+   + I L G N    I    + L  I  +N S+N  +GP+P +I           
Sbjct: 65  CNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS------- 117

Query: 251 DLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEG 309
              SL  LNLSNNN +G+IP     +  L+ L+LS N L GEIP   GSF +       G
Sbjct: 118 --SSLRYLNLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGG 173

Query: 310 NELLCGSPN 318
           N L+   PN
Sbjct: 174 NVLVGKIPN 182

Length = 968

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.9 bits (132), Expect = 6e-08
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           VA  +E+L    S + IH DL   N+LL +N V  + DFG+A+ + ++     +      
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           VA  +E+L    S + IH DL   N+LL +N V  + DFG+A+ + ++     +      
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 32/208 (15%)

Query: 400 IGRGSFGSVFKARL--GDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSIRHRNIIK 452
           +G GSFG V  A     D   VA+K F  +  ++ K   V     E +++  I H   + 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRF--EKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSS----NYILDIYQRLNIMIDVASALEYLHFG 508
           +  S  +E +  LVLE++  G    +L  +    N +   Y    ++I      EYL   
Sbjct: 96  LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI-----FEYLQ-- 148

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPEY 565
            S  +++ DLKP N+LLD +    ++DFG AK+        + T+T    G   Y+APE 
Sbjct: 149 -SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPEYIAPEI 199

Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP 593
                     D ++ GI + E      P
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 55.5 bits (134), Expect = 8e-08
 Identities = 64/233 (27%), Positives = 94/233 (40%), Gaps = 49/233 (21%)

Query: 399 LIGRGSFGSVFKARLGD---GMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIK 452
           LIG+G  G V+ A   D      VA+K       +   + K F  E ++   + H  I+ 
Sbjct: 9   LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 453 VISSCSNEEFKALVLEYMPH----------------GSLEKYLHSSNYILDIYQRLNIMI 496
           V S CS+ +    V   MP+                 SL K L     +      L+I  
Sbjct: 67  VYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF---LSIFH 120

Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG--IAKLLTREDQS------ 548
            + + +EY+H   S  V+H DLKP N+LL       + D+G  I K L  ED        
Sbjct: 121 KICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177

Query: 549 --------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
                   TI  + + T  YMAPE       S + D+Y+ G++L +  T   P
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           VA  +E+L    S + IH DL   N+LL +N V  + DFG+A+ + ++     +      
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 68/272 (25%), Positives = 94/272 (34%), Gaps = 51/272 (18%)

Query: 44  LRNLQALRLSNNYLTSSTLELSFLSS-LSNCKSLTLISFSNNPLDGILPKTSVGNLSHSL 102
           L  LQ LRL  N L         L+S L    SL  +  S N    I     + +L   L
Sbjct: 22  LLCLQVLRLEGNTL--GEEAAKALASALRPQPSLKELCLSLNETGRIPR--GLQSLLQGL 77

Query: 103 EYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQK---LQGLGLENNK 159
                                  L  + L  N L       L  L +   LQ L L NN 
Sbjct: 78  ------------------TKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNG 119

Query: 160 LEGSIPDSIC-----HSDELYKLELGGNKLSG----SIPECFNNLASLRILLLGSNELTS 210
           L       +          L KL LG N+L G    ++ +       L+ L L +N +  
Sbjct: 120 LGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179

Query: 211 --IPLTFWNLKD---ILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNL 265
             I      LK    +  L+ ++N  T     + G   +A   +  L SL  LNL +NNL
Sbjct: 180 AGIRALAEGLKANCNLEVLDLNNNGLT-----DEGASALAETLA-SLKSLEVLNLGDNNL 233

Query: 266 SGAI-----PASLEKLSYLKDLNLSFNKLEGE 292
           + A       A L     L  L+LS N +  +
Sbjct: 234 TDAGAAALASALLSPNISLLTLSLSCNDITDD 265

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 3/104 (2%)

Query: 486 LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 545
           LD    L+    VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
               ++      + +MAPE       +   DV+S+GI+L E F+
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 26/205 (12%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVI-- 454
           ++G G++G V+K R +  G   A+KV ++      +   +E  M+K    HRNI      
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGA 81

Query: 455 ----SSCSNEEFKALVLEYMPHGSLEKYLHSS--NYILDIYQRLNIMIDVASALEYLHFG 508
               S   +++   LV+E+   GS+   + ++  N + + +    I  ++   L +LH  
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLH-- 138

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI--QTQTLATIGYMAPEY- 565
            + +VIH D+K  NVLL +N    L DFG++  L R    T+  +   + T  +MAPE  
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR----TVGRRNTFIGTPYWMAPEVI 193

Query: 566 ----GKEGRVSANGDVYSFGIMLME 586
                 +       D++S GI  +E
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIE 218

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 67/296 (22%), Positives = 113/296 (38%), Gaps = 59/296 (19%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFN-LQYGRVFK---SFDVECEMMKSIRHRNIIKVIS 455
           IG G FG V  + +     VA  V   L+     K    F  + +  + ++H NI++ + 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYIL---DIYQRLNIMIDVASALEYLHFGYSAQ 512
            C       LV EY   G L+ YL    +      +     +  ++A+ + ++H      
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHN 119

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE---G 569
            +H DL   N  L  ++   + D+GI     +ED    +      + ++APE   E   G
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179

Query: 570 RVSAN----GDVYSFGIMLMETF-TRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
            ++A      +V++ G+ L E F    +P                             +L
Sbjct: 180 LITAEQTKPSNVWALGVTLWELFENAAQPY---------------------------SHL 212

Query: 625 LSREDINFVAKEQCVSFV------------FNVAMECTVESPEQRINAKEIVTKLL 668
             RE +N V K+Q V               + V   C + SPE+R  A+E V +LL
Sbjct: 213 SDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWL-SPEKRATAEE-VHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           VA+ +E+L    S   +H DL   NVL+ +  +  + DFG+A+ + R+     +  T   
Sbjct: 248 VANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           + +MAPE       +   DV+SFGI+L E FT
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 15/166 (9%)

Query: 433 KSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-----LD 487
           K+   E +++K+I HR II +I +      K+ V   MP    + +     Y+     L 
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRW---KSTVCMVMPKYKCDLF----TYVDRSGPLP 183

Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
           + Q + I   +  AL YLH      +IH D+K  N+ LD+   A L DFG A  L     
Sbjct: 184 LEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240

Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           +        T+   +PE        A  D++S G++L E   +   
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 52.9 bits (128), Expect = 2e-07
 Identities = 49/194 (25%), Positives = 81/194 (41%), Gaps = 17/194 (8%)

Query: 441 MMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
           +MK   + N IK+  S +  +   L+++Y+  G L   L      L   +   I+  +  
Sbjct: 64  LMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVE 120

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMV-AHLSDFGIAKLLTREDQSTIQTQTLATIG 559
           AL  LH      +IH D+K  NVL D      +L D+G+ K        +    TL    
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK---IIGTPSCYDGTLD--- 171

Query: 560 YMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI 619
           Y +PE  K      + D ++ G++  E  T K P  E  + E+ L+      L    K++
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE----SLLKRQQKKL 227

Query: 620 VDPNLLSREDINFV 633
                +S+   +FV
Sbjct: 228 PFIKNVSKNANDFV 241

Length = 267

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 22/158 (13%)

Query: 400 IGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMMKSIR-HRN-------- 449
           I RG+FG V+  R  +  ++ A+KV       V K+  +   M+  ++  R+        
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKV-------VKKADMINKNMVHQVQAERDALALSKSP 64

Query: 450 -IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
            I+ +  S  +     LV+EY+  G ++  LH   Y  D    +  + +VA AL+YLH  
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH-- 121

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
               +IH DLKP N+L+ +     L+DFG++K+    +
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 3/104 (2%)

Query: 486 LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 545
           L     L+    VA  +E+L    S   +H DL   NVLL    +  + DFG+A+ +  +
Sbjct: 234 LTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHD 290

Query: 546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
                +  T   + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 291 SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 24/204 (11%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNI------ 450
           L+G G++G V+K R +  G   A+KV ++  G   +    E  M+K    HRNI      
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 451 -IKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASALEYLHFG 508
            IK      +++   LV+E+   GS+   + ++    L       I  ++   L +LH  
Sbjct: 72  FIKKNPPGMDDQL-WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH-- 128

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT-LATIGYMAPEY-- 565
              +VIH D+K  NVLL +N    L DFG++  L   D++  +  T + T  +MAPE   
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIA 184

Query: 566 ---GKEGRVSANGDVYSFGIMLME 586
                +       D++S GI  +E
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIE 208

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 16/202 (7%)

Query: 399 LIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDV------ECEMMKSIRHRNIIK 452
           ++G GSFG     +       + + + ++  R+ KS         E  ++  ++H NI+ 
Sbjct: 7   VVGEGSFGRALLVQ----HVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62

Query: 453 VISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              S   +    +V+EY   G L +K       +      L   + +   ++++H     
Sbjct: 63  FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EK 119

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
           +V+H D+K  N+ L  N    L DFG A+LLT           + T  Y+ PE  +    
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT--SPGAYACTYVGTPYYVPPEIWENMPY 177

Query: 572 SANGDVYSFGIMLMETFTRKKP 593
           +   D++S G +L E  T K P
Sbjct: 178 NNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)

Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 121

Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 122 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 175

Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 45/174 (25%), Positives = 82/174 (47%), Gaps = 21/174 (12%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSIR-HRNIIK 452
           IG G+F  V KA+    G   A+K       + FKS +      E + ++ +  H NI++
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMK----KHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 453 VISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
           +I    + +    ALV E M   +L + +      L   +  + M  +  +L+++H    
Sbjct: 63  LIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---R 118

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
             + H D+KP N+L+ D+++  L+DFG  + +         T+ ++T  Y APE
Sbjct: 119 NGIFHRDIKPENILIKDDIL-KLADFGSCRGI---YSKPPYTEYISTRWYRAPE 168

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 40/184 (21%)

Query: 400 IGRGSFGSV---FKARLGDGMEVAMKVFNLQYGRVFKSF------DVECEMMKSIRHRNI 450
           +G G++GSV   +  RL    +VA+K    +  R F+S         E  ++K ++H N+
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ--KVAVK----KLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 451 IKVIS----SCSNEEFKALVLEYMPHGSLEKYLHSSNYILD------IYQRLNIMIDVAS 500
           I ++     + S E F  + L     G+    +     + D      IYQ L        
Sbjct: 77  IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR------- 129

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
            L+Y+H   SA +IH DLKPSNV ++++    + DFG+A+    E      T  +AT  Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWY 181

Query: 561 MAPE 564
            APE
Sbjct: 182 RAPE 185

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 39/146 (26%), Positives = 61/146 (41%), Gaps = 13/146 (8%)

Query: 399 LIGRGSFG--SVFKARLGD-GMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHRNIIKV 453
           LIG+       V  A+       VA+K  NL        K    E    + ++H NI+  
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL---NIMIDVASALEYLHFGYS 510
           ++S   +    +V   M +GS E  L    +  +    L    I+ DV +AL+Y+H   S
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIH---S 119

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDF 536
              IH  +K S++LL  +    LS  
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.7 bits (126), Expect = 4e-07
 Identities = 58/181 (32%), Positives = 86/181 (47%), Gaps = 26/181 (14%)

Query: 398 NLIGRGSFGSVFKARLGDGME-VAMK--VFNLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           N+IG GSFG V++A   D  E VA+K  + + QY       + E  +MK++ H NII + 
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK------NRELLIMKNLNHINIIFLK 125

Query: 455 SSCSNEEFKA--------LVLEYMPHG--SLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                E FK         +V+E++P       K+   +N+ L ++        +  AL Y
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           +H   S  + H DLKP N+L+D N     L DFG AK L    +S      + +  Y AP
Sbjct: 186 IH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS---VSYICSRFYRAP 239

Query: 564 E 564
           E
Sbjct: 240 E 240

Length = 440

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 59/217 (27%), Positives = 97/217 (44%), Gaps = 22/217 (10%)

Query: 399 LIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDVECEMMK------SIRHRNII 451
           ++G+GSFG V  A R G     A+K+  L+   V +  DVEC M++      S +   + 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           ++ S     +    V+EY+  G L   +       + +       ++A  L +LH   S 
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVF-YAAEIAIGLFFLH---SK 120

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPEYGKEGR 570
            +I+ DLK  NV+LD      ++DFG+ K         + T+T   T  Y+APE      
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEIIAYQP 177

Query: 571 VSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEM 602
              + D ++FG++L E    + P      DE+F   M
Sbjct: 178 YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.7 bits (124), Expect = 5e-07
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 19/214 (8%)

Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVFN----LQYGRVFKSFDVECEMMKSIR 446
           D F    +IGRG+FG V   ++ +  +V AMK+ N    L+       F  E +++ +  
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET-ACFREERDVLVNGD 59

Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASALEYL 505
            R I  +  +  +E    LV++Y   G L   L    + + +   R  +  ++  A++ +
Sbjct: 60  RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVLAIDSV 118

Query: 506 H-FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           H  GY    +H D+KP NVLLD N    L+DFG + L    D +      + T  Y++PE
Sbjct: 119 HQLGY----VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPE 173

Query: 565 Y-----GKEGRVSANGDVYSFGIMLMETFTRKKP 593
                   +GR     D +S G+ + E    + P
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFD------VECEMMKSIRHRNII 451
           L+G+G+FG V   +    G   AMK+   +   V  + D       E  ++++ RH  + 
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKE---VIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM-IDVASALEYLHFGYS 510
            +  S    +    V+EY   G L  + H S   +    R      ++ SAL+YLH    
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLH--SE 114

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
             V++ DLK  N++LD +    ++DFG+ K   + D +T++T    T  Y+APE  ++  
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT-FCGTPEYLAPEVLEDND 172

Query: 571 VSANGDVYSFGIMLMETFTRKKP 593
                D +  G+++ E    + P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 51.6 bits (124), Expect = 6e-07
 Identities = 67/255 (26%), Positives = 108/255 (42%), Gaps = 46/255 (18%)

Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVE---CE-----MMKSIRHRNI 450
           +GRG FG V  A     G   A+K   L+ G +    +VE   CE        S RH  +
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKA--LKKGDIIARDEVESLMCEKRIFETANSERHPFL 64

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS---ALEYLHF 507
           + + +    E+    V+EY   G L  ++H+     D++     +   A     L+YLH 
Sbjct: 65  VNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH- 118

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTL-ATIGYMAPEY 565
               ++++ DLK  N+LLD      ++DFG+ K    E       T T   T  ++APE 
Sbjct: 119 --ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTPEFLAPEV 172

Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWVNDWLPISTKEIV 620
             E   +   D +  G+++ E    + P      +E+F+        VND       E+ 
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS------IVND-------EVR 219

Query: 621 DPNLLSREDINFVAK 635
            P  LSRE I+ + +
Sbjct: 220 YPRFLSREAISIMRR 234

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.8 bits (124), Expect = 6e-07
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 56/220 (25%)

Query: 399 LIGRGSFGSVFKA-RLGDGMEVAMKVFNLQY-GRVF-KSFDVECEMMKSIRHRNIIKVI- 454
            +G G++GSV  A     G +VA+K  +  +   +F K    E  ++K ++H N+I ++ 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 455 ---SSCSNEEFKA--LVLEYM---------PHGSLEK--YLHSSNYILDIYQRLNIMIDV 498
              S+ S +EF+   LV+ YM            S +K  YL        +YQ L      
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYL--------VYQML------ 127

Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI 558
              L+Y+H   SA +IH DLKP N+ ++++    + DFG+A+    E      T  + T 
Sbjct: 128 -CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTR 178

Query: 559 GYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRK 591
            Y APE       Y +        D++S G ++ E  T K
Sbjct: 179 WYRAPEVILNWMHYNQ------TVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 64/232 (27%), Positives = 101/232 (43%), Gaps = 52/232 (22%)

Query: 399 LIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDVECEMMK------SIRHRNII 451
           ++G+GSFG V  A R G     A+K+  L+   + +  DVEC M++        +   + 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64

Query: 452 KVISSCSNEEFKALVLEYMPHGSLE---------KYLHSSNYILDIYQRLNIMIDVASAL 502
           ++ S     +    V+EY+  G L          K  H+  Y  +I          A  L
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI----------AIGL 114

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYM 561
            +LH   S  +I+ DLK  NV+LD      ++DFG+ K      ++   T+T   T  Y+
Sbjct: 115 FFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYI 168

Query: 562 APE------YGKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEM 602
           APE      YGK      + D ++FG++L E    + P      DE+F   M
Sbjct: 169 APEIIAYQPYGK------SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 35/222 (15%)

Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMMKSIRHRNI 450
           D F    +IGRG+FG V   ++     + AMK+ N     + K  +  C      R    
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN--KWEMLKRAETAC-----FREERN 53

Query: 451 IKVISSCS----------NEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNI--MID 497
           + V   C           +E +  LV++Y   G L   L    + + +   R  I  M+ 
Sbjct: 54  VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVL 113

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLA 556
              ++  LH+      +H D+KP NVLLD N    L+DFG    L      T+Q+   + 
Sbjct: 114 AIHSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVG 165

Query: 557 TIGYMAPEYGKE-----GRVSANGDVYSFGIMLMETFTRKKP 593
           T  Y++PE  +      G+     D +S G+ + E    + P
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 19/208 (9%)

Query: 400 IGRGSFGSVFKARLGDG---MEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNII---KV 453
           +GRG++G V+KA+  DG    E A+K   ++   +  S   E  +++ ++H N+I   KV
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALK--QIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 454 ISSCSNEEFKALVLEYMPHG--SLEKYLHSSNYILDIYQRLNIMID--VASALEYLHFGY 509
             S S+ +   L+ +Y  H    + K+  +S       Q    M+   +   L+ +H+ +
Sbjct: 67  FLSHSDRKV-WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 510 SAQVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPE 564
           +  V+H DLKP+N+L+     +     ++D G A+L     +        + T  Y APE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 565 YGKEGRVSANG-DVYSFGIMLMETFTRK 591
                R      D+++ G +  E  T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 51.6 bits (123), Expect = 8e-07
 Identities = 51/181 (28%), Positives = 82/181 (45%), Gaps = 30/181 (16%)

Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKAL--VLEYMPHG-----SLEKYLHSSNYIL 486
           E  +MK + H+NII +++      S EEF+ +  V+E M         +E      +Y+L
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLL 132

Query: 487 DIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
             YQ L         +++LH   SA +IH DLKPSN+++  +    + DFG+A+      
Sbjct: 133 --YQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG 177

Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKH 606
            S + T  + T  Y APE         N D++S G ++ E          +F G   +  
Sbjct: 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQ 233

Query: 607 W 607
           W
Sbjct: 234 W 234

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 23/209 (11%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVEC-----EMMKSIRHRNIIK 452
           +IGRG+FG V   +L +  +V AMK+ N     + K  +  C     +++ +  ++ I  
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVNGDNQWITT 65

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNI--MIDVASALEYLHFGY 509
           +  +  +E    LV++Y   G L   L    + + +   R  +  M+    ++  LH+  
Sbjct: 66  LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY-- 123

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK-- 567
               +H D+KP N+L+D N    L+DFG + L   ED +   +  + T  Y++PE  +  
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178

Query: 568 ---EGRVSANGDVYSFGIMLMETFTRKKP 593
              +G+     D +S G+ + E    + P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 61/227 (26%), Positives = 102/227 (44%), Gaps = 33/227 (14%)

Query: 381 MFSYLELCRATDGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDVEC 439
           M     L   TD +     IG+G++G V+K     DG   A+K+ +     V +  + E 
Sbjct: 11  MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEY 69

Query: 440 EMMKSI-RHRNIIKVI------SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL 492
            +++S+  H N++K              +   LVLE    GS+ + +     +L   QRL
Sbjct: 70  NILQSLPNHPNVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKG---LLICGQRL 125

Query: 493 N------IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT--R 544
           +      I+      L++LH   + ++IH D+K +N+LL       L DFG++  LT  R
Sbjct: 126 DEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182

Query: 545 EDQSTIQTQTLATIGYMAPEY-----GKEGRVSANGDVYSFGIMLME 586
             ++T    ++ T  +MAPE        +    A  DV+S GI  +E
Sbjct: 183 LRRNT----SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 61/231 (26%), Positives = 105/231 (45%), Gaps = 36/231 (15%)

Query: 391 TDGFSENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDVECEMMK----SI 445
              F    ++G+GSFG V  A R G     A+K+  L+   V +  DVEC M++    ++
Sbjct: 1   DFNFL--MVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLAL 56

Query: 446 RHRN-IIKVISSC-SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALE 503
           + +   +  + SC    +    V+EY+  G L  ++       +  Q +    +++  L 
Sbjct: 57  QDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-QAVFYAAEISVGLF 115

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMA 562
           +LH      +I+ DLK  NV+LD      ++DFG+ K    +    + T+T   T  Y+A
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPDYIA 169

Query: 563 PE------YGKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEM 602
           PE      YGK      + D +++G++L E    + P      DE+F   M
Sbjct: 170 PEIIAYQPYGK------SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 51/211 (24%), Positives = 91/211 (43%), Gaps = 29/211 (13%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           +IGRGS+  V    L     + AMKV      +   + D + + +++ +H     V  + 
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIK----KELVNDDEDIDWVQTEKH-----VFETA 52

Query: 458 SNEEFKA-------------LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           SN  F                V+E++  G L  ++     + + + R     +++ AL +
Sbjct: 53  SNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF-YSAEISLALNF 111

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           LH      +I+ DLK  NVLLD      L+D+G+ K   R   +T  +    T  Y+APE
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--STFCGTPNYIAPE 166

Query: 565 YGKEGRVSANGDVYSFGIMLMETFTRKKPTD 595
             +      + D ++ G+++ E    + P D
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 28/138 (20%), Positives = 62/138 (44%), Gaps = 17/138 (12%)

Query: 408 VFKARLGDGMEVAMKVFNLQYGRVFKSFDVECE--MMKSIRHRNII--KVISSCSNEEFK 463
           V+     D  +  +K+   +     K  D E E  +++ +  + +   KV++S  ++ + 
Sbjct: 14  VYLLGTKDE-DYVLKINPSRE----KGADREREVAILQLLARKGLPVPKVLASGESDGWS 68

Query: 464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNV 523
            L++E++   +L++        +   ++ +I   +A  L  LH      + H DL P N+
Sbjct: 69  YLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNI 120

Query: 524 LLDDNMVAHLSDFGIAKL 541
           L+DD  +  + D+  A  
Sbjct: 121 LVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 50.2 bits (120), Expect = 3e-06
 Identities = 21/53 (39%), Positives = 33/53 (62%)

Query: 6   ENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLT 58
            N+  G IP  + + + L +L+LS NSF+G IP + G L +L+ L L+ N L+
Sbjct: 451 GNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503

Length = 623

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 24/169 (14%)

Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRN 449
           D F    +IGRG+FG V   +  D G   AMK+         K+  +E E +  IR  R+
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR-------KADMLEKEQVAHIRAERD 53

Query: 450 I---------IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
           I         +K+  S  ++    L++E++P G +   L   + + +   +  I  +   
Sbjct: 54  ILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIA-ETVL 112

Query: 501 ALEYLH-FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS 548
           A++ +H  G+    IH D+KP N+LLD      LSDFG+   L +  ++
Sbjct: 113 AIDAIHQLGF----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.4 bits (115), Expect = 5e-06
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 28/201 (13%)

Query: 414 GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG 473
           G  + V +KV +  +  +  +F     +M  + H ++  V   C       +V E++ HG
Sbjct: 42  GRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHG 101

Query: 474 SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH- 532
            L+  L      + +  ++ +   +ASAL YL       ++H ++   N+LL    +A  
Sbjct: 102 PLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG 158

Query: 533 ------LSDFGIA-KLLTREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIML 584
                 LSD G++   L+RE++       +  I ++APE    G  +S   D +SFG  L
Sbjct: 159 TSPFIKLSDPGVSFTALSREER-------VERIPWIAPECVPGGNSLSTAADKWSFGTTL 211

Query: 585 METFTRKKPTDEIFNGEMTLK 605
           +E           F+GE+ LK
Sbjct: 212 LEI---------CFDGEVPLK 223

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 49.0 bits (117), Expect = 6e-06
 Identities = 31/90 (34%), Positives = 42/90 (46%), Gaps = 5/90 (5%)

Query: 11  GTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSL 70
           G IP  I     L  + LS NS  G IP + G++ +L+ L LS N    S  E     SL
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE-----SL 486

Query: 71  SNCKSLTLISFSNNPLDGILPKTSVGNLSH 100
               SL +++ + N L G +P    G L H
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALGGRLLH 516

Length = 623

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.7 bits (104), Expect = 6e-06
 Identities = 20/57 (35%), Positives = 28/57 (49%), Gaps = 1/57 (1%)

Query: 174 LYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN 229
           L  L+L  N+L+      F  L +L++L L  N LTSI    F  L  +  L+ S N
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.5 bits (116), Expect = 7e-06
 Identities = 48/154 (31%), Positives = 72/154 (46%), Gaps = 24/154 (15%)

Query: 399 LIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNI------ 450
           +IGRG+FG V   +  D G   AMK          KS  +E E +  +R  R+I      
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLR-------KSEMLEKEQVAHVRAERDILAEADN 60

Query: 451 ---IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH- 506
              +K+  S  +E +  L++EY+P G +   L   +   +   R  I  +   A++ +H 
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETILAIDSIHK 119

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 540
            GY    IH D+KP N+LLD      LSDFG+  
Sbjct: 120 LGY----IHRDIKPDNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 45/175 (25%), Positives = 77/175 (44%), Gaps = 22/175 (12%)

Query: 392 DGFSENNLIGRGSFGSV-FKARLGDGMEVAMKVFNLQYGRVFKS-----FDVECEMMKSI 445
           + F    +IG+G+FG V    +   G   AMK   L    +FK         E +++   
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK--TLLKSEMFKKDQLAHVKAERDVLAES 58

Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLE----KYLHSSNYILDIYQRLNIMIDVASA 501
               ++ +  S  + ++  L++E++P G L     KY   S  +   Y     M +   A
Sbjct: 59  DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY-----MAECVLA 113

Query: 502 LEYLH-FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
           +E +H  G+    IH D+KP N+L+D      LSDFG++    ++  S    + L
Sbjct: 114 IEAVHKLGF----IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLL 164

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.2 bits (114), Expect = 1e-05
 Identities = 58/273 (21%), Positives = 96/273 (35%), Gaps = 77/273 (28%)

Query: 364 ERGPPNDANMPPEA---MQRMFSYLELCRATDGFSENNLIGRGSFGSVF--KARLGDGME 418
           +  PP+ A   P A   ++    +L   R  D          G+FG +F    R      
Sbjct: 123 DEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPA------GAFGKIFICALRASTEEA 176

Query: 419 VAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEK- 477
            A +  N       K     CE + + R +   +      NE    L L  + H ++ K 
Sbjct: 177 EARRGVNSTNQGKPK-----CERLIAKRVKAGSRAAIQLENE---ILALGRLNHENILKI 228

Query: 478 ----------YLHSSNYILDIY-----------------QRLNIMIDVASALEYLHFGYS 510
                     Y+ +  Y  D+Y                 Q   IM  +  A+EY+H    
Sbjct: 229 EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---D 285

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
            ++IH D+K  N+ L+ +    L DFG A    +E +              A +YG  G 
Sbjct: 286 KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE--------------AFDYGWVGT 331

Query: 571 VSANG-------------DVYSFGIMLMETFTR 590
           V+ N              D++S G++L++  + 
Sbjct: 332 VATNSPEILAGDGYCEITDIWSCGLILLDMLSH 364

Length = 501

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 29/206 (14%)

Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNIIKVI-- 454
           +G G++G+V  A     G +VA+K      Q     K    E  ++K ++H N+I ++  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 455 --SSCSNEEFKA--LVLEYMPH--GSLEKY--LHSSNYILDIYQRLNIMIDVASALEYLH 506
                S + F    LV+ +M    G L K+  L        +YQ L         L+Y+H
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK-------GLKYIH 135

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
              +A +IH DLKP N+ ++++    + DFG+A+    E      T  + T  Y APE  
Sbjct: 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVI 187

Query: 567 KEG-RVSANGDVYSFGIMLMETFTRK 591
                 +   D++S G ++ E  T K
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 35/212 (16%)

Query: 399 LIGRGSFGSVFKARLGDGME-VAMKVFNLQ----YGRVFKSFDVECEMMKSIRHRNIIKV 453
           LI  G++G+V+  R  +  +  AMK  N Q      ++ + F VE +++    +  ++ +
Sbjct: 8   LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM 66

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
             S   +    +V+EY+  G     L +   +     R+     V  ALEYLH   +  +
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLH---NYGI 122

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKL-------------LTREDQSTIQTQTLATIGY 560
           +H DLKP N+L+       L+DFG++K+             + ++ +  +  Q   T  Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182

Query: 561 MAPE------YGKEGRVSANGDVYSFGIMLME 586
           +APE      YGK        D ++ GI+L E
Sbjct: 183 IAPEVILRQGYGKP------VDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.5 bits (101), Expect = 2e-05
 Identities = 23/65 (35%), Positives = 30/65 (46%), Gaps = 5/65 (7%)

Query: 22 KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF 81
           L  L+LS+N  +      F  L NL+ L LS N LTS + E     + S   SL  +  
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPE-----AFSGLPSLRSLDL 55

Query: 82 SNNPL 86
          S N L
Sbjct: 56 SGNNL 60

Length = 60

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 59/247 (23%), Positives = 100/247 (40%), Gaps = 57/247 (23%)

Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRN 449
           + F    +IGRG+FG V   +  D G   AMK+         K+  +E E +  IR  R+
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR-------KADMLEKEQVGHIRAERD 53

Query: 450 I---------IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
           I         +K+  S  ++    L++E++P G +   L   + + +   +  I  +   
Sbjct: 54  ILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVL 112

Query: 501 ALEYLH-FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS----------- 548
           A++ +H  G+    IH D+KP N+LLD      LSDFG+   L +  ++           
Sbjct: 113 AIDSIHQLGF----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP 168

Query: 549 ---TIQT-------------------QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
              T Q                     T+ T  Y+APE   +   +   D +S G+++ E
Sbjct: 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228

Query: 587 TFTRKKP 593
                 P
Sbjct: 229 MLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 31/207 (14%)

Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSC 457
           IG+G++G VFK     +G + A+K+ +  +  + +  + E  ++K++  H N++K     
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 458 SNEEFKA-----LVLEYMPHGSLEKYLHSSNYILDIYQRLN------IMIDVASALEYLH 506
             ++ K      LVLE    GS+   +      L   +R+       I+ +    L++LH
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKG---FLKRGERMEEPIIAYILHEALMGLQHLH 141

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--TREDQSTIQTQTLATIGYMAPE 564
                + IH D+K +N+LL       L DFG++  L  TR  ++T    ++ T  +MAPE
Sbjct: 142 ---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT----SVGTPFWMAPE 194

Query: 565 Y-----GKEGRVSANGDVYSFGIMLME 586
                   +    A  DV+S GI  +E
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIE 221

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 50/208 (24%), Positives = 96/208 (46%), Gaps = 19/208 (9%)

Query: 400 IGRGSFGSVFKARLGDGME---VAMKVFNLQYGRVFKSFDVECEMMKSIRHRNII---KV 453
           +GRG++G V+KA+  DG +    A+K   ++   +  S   E  +++ ++H N+I   KV
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALK--QIEGTGISMSACREIALLRELKHPNVISLQKV 66

Query: 454 ISSCSNEEFKALVLEYMPHG--SLEKYLHSSNYILDIYQRLNIMID--VASALEYLHFGY 509
             S ++ +   L+ +Y  H    + K+  +S       Q    M+   +   L+ +H+ +
Sbjct: 67  FLSHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 510 SAQVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPE 564
           +  V+H DLKP+N+L+     +     ++D G A+L     +        + T  Y APE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 565 YGKEGRVSANG-DVYSFGIMLMETFTRK 591
                R      D+++ G +  E  T +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 18/174 (10%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFN----LQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           L+G+G+FG V   R     +  AMK+      +    V  +   E  ++++ RH  +  +
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTL-TESRVLQNTRHPFLTAL 60

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM-IDVASALEYLHFGYSAQ 512
             S    +    V+EY   G L  + H S   +    R      ++ SAL YLH   S  
Sbjct: 61  KYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLH---SCD 115

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL--ATIGYMAPE 564
           V++ DLK  N++LD +    ++DFG+ K    E  S   T      T  Y+APE
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 45.6 bits (108), Expect = 5e-05
 Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 14/146 (9%)

Query: 400 IGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDV-----ECEMMKSIRHRNIIKV 453
           IG G+FG V   R  D   + AMK   L+   V           E +++    +  ++K+
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKT--LRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH-FGYSAQ 512
             S  +++    V++Y+P G +   L       +   R  I  ++  A+E +H  G+   
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIA-ELTCAIESVHKMGF--- 122

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGI 538
            IH D+KP N+L+D +    L+DFG+
Sbjct: 123 -IHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 62/276 (22%), Positives = 103/276 (37%), Gaps = 52/276 (18%)

Query: 41  FGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSH 100
             +       +  N     S LE   ++ L+   S   +    + L  +    S+  LS 
Sbjct: 21  LSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRL---LSLDLLSP 77

Query: 101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKL 160
           S           S    E + NL  L  + L  N+L  +I S L +L  L  L L+NN +
Sbjct: 78  SG--------ISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNI 128

Query: 161 EGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKD 220
              IP  I                            +L+ L L  N++ S+P    NL +
Sbjct: 129 T-DIPPLIGLLKS-----------------------NLKELDLSDNKIESLPSPLRNLPN 164

Query: 221 ILYLNFSSNFFTGPLPLEIGNLKIARID--SCDLISLISLNLSNNNLSGAIPASLEKLSY 278
           +  L+ S N              ++ +     +L +L +L+LS N +S  +P  +E LS 
Sbjct: 165 LKNLDLSFN-------------DLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSA 210

Query: 279 LKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC 314
           L++L+LS N +   +    +  N S      N+L  
Sbjct: 211 LEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED 246

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.2 bits (95), Expect = 1e-04
 Identities = 16/57 (28%), Positives = 25/57 (43%)

Query: 1  MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYL 57
           L +  N  +            L +L+LS N+ +   P  F  L +L++L LS N L
Sbjct: 4  SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|111949 pfam03109, ABC1, ABC1 family

 Score = 41.8 bits (99), Expect = 1e-04
 Identities = 16/44 (36%), Positives = 22/44 (50%), Gaps = 3/44 (6%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMK 443
           I   S   V +A L DG EVA+KV   Q   V K    + +++K
Sbjct: 19  IAAASIAQVHRAVLKDGEEVAVKV---QRPGVKKRIRSDLKLLK 59

This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 8/106 (7%)

Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT---REDQST 549
           NIM D+ + LEY+H      + H D+KP N+++D N   ++ D+GIA       +  + +
Sbjct: 130 NIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYS 186

Query: 550 IQTQTL--ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
            + + L   T+ Y   +      V+  GD+ S G  +++    K P
Sbjct: 187 KEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|225213 COG2334, COG2334, Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 20/76 (26%), Positives = 27/76 (35%), Gaps = 6/76 (7%)

Query: 466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL--HF-GYSAQVIHCDLKPSN 522
            LE+               +     R  ++  +   L  L  H      Q+IH DL P N
Sbjct: 151 RLEWDILEPRALLRLD--LVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDN 208

Query: 523 VLLD-DNMVAHLSDFG 537
           VL D D  V+   DF 
Sbjct: 209 VLFDDDTDVSGFIDFD 224

Length = 331

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 45.1 bits (106), Expect = 1e-04
 Identities = 66/290 (22%), Positives = 118/290 (40%), Gaps = 63/290 (21%)

Query: 400 IGRGSFGSVFKARLGDGMEV----AMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IG G FG VF  +     E     A+    L+  R      +E  +M+ ++H+NI++ I 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYID 79

Query: 456 SCSNEEFKAL--VLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALEY 504
              N+  + L  ++E+   G L + +            + I+DI ++L        AL Y
Sbjct: 80  RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL------LHALAY 133

Query: 505 LHF----GYSAQVIHCDLKPSNVLLDDNM-----------------VAHLSDFGIAKLLT 543
            H         +V+H DLKP N+ L   +                 +A + DFG++K + 
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193

Query: 544 REDQSTIQTQTLATIGYMAPE--YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
            E   ++    + T  Y +PE    +        D+++ G ++ E  + K P    F+  
Sbjct: 194 IE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP----FHKA 246

Query: 602 MTLKHWVNDW-----LPISTKEIVDPNLLSREDINFVAKE-----QCVSF 641
                 +++      LPI  K   + N+L +  +N  AKE     QC+ +
Sbjct: 247 NNFSQLISELKRGPDLPIKGKS-KELNILIKNLLNLSAKERPSALQCLGY 295

Length = 1021

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 19/47 (40%), Positives = 27/47 (57%), Gaps = 2/47 (4%)

Query: 258 LNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSA 304
           L L N  L G IP  + KL +L+ +NLS N + G IP   S G+ ++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP--PSLGSITS 467

Length = 623

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 8/153 (5%)

Query: 438 ECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH-SSNYILDIYQRLNIMI 496
           E  ++++I H +II++  + +  +F  L+L   P    + Y + ++   + I   L I  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            V  A++YLH     ++IH D+K  N+ ++      L DFG A      + +        
Sbjct: 190 SVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA-G 245

Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           TI   APE           D++S GI+L E  T
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278

Length = 391

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 68/296 (22%), Positives = 114/296 (38%), Gaps = 61/296 (20%)

Query: 394 FSENNLIGRGSFGSVFKARLGD-GMEVAMKVFN----LQYGRVFKSFDVECEMMKSIRHR 448
           F +   +G G+FG V  A   D     AMK       L   +V      E +++    + 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQV-AHVKAERDILAEADNE 61

Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH-F 507
            ++K+  S  +++    V++Y+P G +   L       ++  R  I  ++  A+E +H  
Sbjct: 62  WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA-ELTLAIESVHKM 120

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA---------------------------- 539
           G+    IH D+KP N+L+D +    L+DFG+                             
Sbjct: 121 GF----IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176

Query: 540 -----------KLLTREDQSTIQTQT------LATIGYMAPEYGKEGRVSANGDVYSFGI 582
                      +L T E ++T Q Q       + T  Y+APE       +   D +S G+
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236

Query: 583 MLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQC 638
           +L E    + P       E  LK  V +W   +T  I     LS E ++ + K  C
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLK--VINWE--NTLHIPPQVKLSPEAVDLITKLCC 288

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	678
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.91
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.91
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.87
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.86
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.8
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.79
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.79
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.78
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.75
PRK10345	210	hypothetical protein; Provisional	99.75
smart00090	237	RIO RIO-like kinase.	99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
PRK14879	211	serine/threonine protein kinase; Provisional	99.7
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.67
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.64
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.61
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.6
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.58
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.53
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.51
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.48
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.46
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.44
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.43
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.42
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.41
KOG1243	690	consensus Protein kinase [General function predict	99.41
PLN03150	623	hypothetical protein; Provisional	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.35
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.35
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.34
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.33
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.29
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.26
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.26
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.26
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.25
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.21
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.19
PLN03150	623	hypothetical protein; Provisional	99.18
COG4248	637	Uncharacterized protein with protein kinase and he	99.12
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.08
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.07
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.03
KOG3087	229	consensus Serine/threonine protein kinase [General	99.02
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	99.01
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.99
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.93
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.93
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.92
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.9
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.89
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.83
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.81
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.79
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.78
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.76
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.75
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.75
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.61
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.61
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.6

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.9e-75  Score=690.04  Aligned_cols=635  Identities=28%  Similarity=0.464  Sum_probs=457.5

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      .|+|++|.+++.+|..+..+++|+.|++++|.+.+..|..+..+++|+.|+|++|.+....+     ..+..+++|+.|+
T Consensus       288 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-----~~l~~~~~L~~L~  362 (968)
T PLN00113        288 SLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP-----KNLGKHNNLTVLD  362 (968)
T ss_pred             EEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCC-----hHHhCCCCCcEEE
Confidence            36888898888888888888999999999999888888888888899999998888864332     2456677777777


Q ss_pred             CccCCCcccCChhhhhccc-----------------------ccccEEEcccccccccCCccccCCCCCcEEEccCCccC
Q 005760           81 FSNNPLDGILPKTSVGNLS-----------------------HSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLN  137 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~-----------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~  137 (678)
                      +++|++.+..|.. +..+.                       .+|+.|++++|++++..|..|..+++|+.|++++|.++
T Consensus       363 Ls~n~l~~~~p~~-~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  441 (968)
T PLN00113        363 LSTNNLTGEIPEG-LCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQ  441 (968)
T ss_pred             CCCCeeEeeCChh-HhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCccc
Confidence            7777776655543 22222                       14555555555555555555555555555555555555


Q ss_pred             CcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccc-ccccccc
Q 005760          138 GSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELT-SIPLTFW  216 (678)
Q Consensus       138 ~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~-~l~~~~~  216 (678)
                      +..+..+..+++|++|+|++|.+.+.+|..+ ..++|+.|++++|++.+..|..+.++++|+.|+|++|+++ .+|..+.
T Consensus       442 ~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  520 (968)
T PLN00113        442 GRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELS  520 (968)
T ss_pred             CccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHc
Confidence            5555555555666666666666655555433 3467777888888888888888888888999999999887 5677888


Q ss_pred             ccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC
Q 005760          217 NLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG  296 (678)
Q Consensus       217 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  296 (678)
                      .+++|+.|+|++|.+++..|..|.+++          +|+.|+|++|++++..|..+..++.|+.|++++|++.+.+|..
T Consensus       521 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~----------~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~  590 (968)
T PLN00113        521 SCKKLVSLDLSHNQLSGQIPASFSEMP----------VLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST  590 (968)
T ss_pred             CccCCCEEECCCCcccccCChhHhCcc----------cCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc
Confidence            888999999999999988888888777          9999999999999999999999999999999999999999998


Q ss_pred             CccccccccccccCccccCCCCC-CCCCCCCcccccccccceeeeehhhhHHHHHHHhhhhheeccccCCCCCC-CCCCC
Q 005760          297 GSFGNFSAESFEGNELLCGSPNL-RVPPCKTSIHHISRKNAFLLGIVLPLSTVFMIVVIFLIVKCRKRERGPPN-DANMP  374 (678)
Q Consensus       297 ~~~~~l~~~~~~~n~~~c~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  374 (678)
                      +.+..+...++.||+..|+.+.. ..++|.....  ...+.+++++++++.+++++++++++++++|+....+. +....
T Consensus       591 ~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  668 (968)
T PLN00113        591 GAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK--TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDG  668 (968)
T ss_pred             chhcccChhhhcCCccccCCccccCCCCCccccc--cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccc
Confidence            88888888899999999975422 2445543211  11122222222122122222222222222222111111 10000


Q ss_pred             hhhh---h-ccCCHHHHHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCcc
Q 005760          375 PEAM---Q-RMFSYLELCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRN  449 (678)
Q Consensus       375 ~~~~---~-~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n  449 (678)
                      ....   . ..............|...+.||+|+||.||+|.. .++..||+|++.....    ....|++.+++++|||
T Consensus       669 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~Hpn  744 (968)
T PLN00113        669 TWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPN  744 (968)
T ss_pred             cccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCC
Confidence            0000   0 0001122333445678889999999999999986 5889999999864322    2235688999999999


Q ss_pred             ceeeeeeeecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC
Q 005760          450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM  529 (678)
Q Consensus       450 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~  529 (678)
                      |++++++|.+++..++||||+++|+|.++++.    +++..+..++.|+++|++|||..++.+|+|||+||+||+++.++
T Consensus       745 Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~  820 (968)
T PLN00113        745 IVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD  820 (968)
T ss_pred             cceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC
Confidence            99999999999999999999999999999963    78999999999999999999976677999999999999999999


Q ss_pred             cEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhh
Q 005760          530 VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN  609 (678)
Q Consensus       530 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~  609 (678)
                      .+++. ||.......      .....+++.|+|||++.+..++.++|||||||++|||++|+.||+...........|.+
T Consensus       821 ~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~  893 (968)
T PLN00113        821 EPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR  893 (968)
T ss_pred             ceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHH
Confidence            88876 665433211      12236789999999999999999999999999999999999999765555555666655


Q ss_pred             cccC-CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          610 DWLP-ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       610 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      .... .....+.|+.......    .......++.+++.+||+.||++||+|.|++++|+++...
T Consensus       894 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        894 YCYSDCHLDMWIDPSIRGDVS----VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             HhcCccchhheeCccccCCCC----ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            3322 2233445554432211    1123456788999999999999999999999999998653

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-49  Score=406.43  Aligned_cols=288  Identities=41%  Similarity=0.656  Sum_probs=243.9

Q ss_pred             hhccCCHHHHHHhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeee
Q 005760          378 MQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC  457 (678)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  457 (678)
                      ....|++.++..+|++|...+.||+|+||.||+|...+|+.||||++.........+|..|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            34568999999999999999999999999999999999999999988665433135599999999999999999999999


Q ss_pred             ecCC-eEEEEEEecCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEe
Q 005760          458 SNEE-FKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD  535 (678)
Q Consensus       458 ~~~~-~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~D  535 (678)
                      .+.+ ..++|+||+++|+|.++++.... .++|.+|.+|+.++|+||+|||+.+...|+|||||++|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9988 59999999999999999998776 799999999999999999999988777899999999999999999999999


Q ss_pred             eccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCccc-CCccchhhhhhcccC-
Q 005760          536 FGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIF-NGEMTLKHWVNDWLP-  613 (678)
Q Consensus       536 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~-~~~~~~~~~~~~~~~-  613 (678)
                      ||+|+......... .....||.+|+|||+...+..+.|+|||||||++.|++||+.|.+... ..+..+..|...... 
T Consensus       221 FGLa~~~~~~~~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~  299 (361)
T KOG1187|consen  221 FGLAKLGPEGDTSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE  299 (361)
T ss_pred             ccCcccCCccccce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence            99996543211111 111179999999999999999999999999999999999999887644 344457788654443 


Q ss_pred             CcccccccCccCC-ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          614 ISTKEIVDPNLLS-REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       614 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                      ....+++|+.+.. .....     .....+..++.+|++.+|.+||+|.||+++|+.+.
T Consensus       300 ~~~~eiiD~~l~~~~~~~~-----~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  300 GKLREIVDPRLKEGEYPDE-----KEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             cchhheeCCCccCCCCChH-----HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            3688999998763 22211     34555889999999999999999999999997664

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-48  Score=393.12  Aligned_cols=256  Identities=30%  Similarity=0.504  Sum_probs=221.9

Q ss_pred             CCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          393 GFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      .+...+.||+|.||.||.|.++....||+|.++.. ....++|.+|+++|++|+|++||+++++|..++.+||||||++.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            34557899999999999999988889999999764 23447889999999999999999999999998899999999999


Q ss_pred             CCHHHHhhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          473 GSLEKYLHS-SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       473 ~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      |+|.++++. .+..+...+.+.++.|||+|++||+   ++++|||||.++|||++++..|||+|||+|+.. ..+.+...
T Consensus       286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~~~  361 (468)
T KOG0197|consen  286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYTAS  361 (468)
T ss_pred             CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc-CCCceeec
Confidence            999999997 5567899999999999999999999   999999999999999999999999999999944 34455556


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccch
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI  630 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  630 (678)
                      ....-+..|+|||.+..+.++.|||||||||+|||++| |+.||..+...+..  +.                  -..+.
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~--~~------------------le~Gy  421 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL--EL------------------LERGY  421 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH--HH------------------HhccC
Confidence            66778899999999999999999999999999999999 88888764443211  11                  12334


Q ss_pred             hhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       631 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      +...|..|+.+++++|..||+.+|++|||++.+...|+.+...
T Consensus       422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            5556678999999999999999999999999999999988653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9e-47  Score=366.02  Aligned_cols=252  Identities=25%  Similarity=0.345  Sum_probs=209.3

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCC-eEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE-FKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  469 (678)
                      +.+..+.||+|..|+||+++++ +++-+|+|++.... ....+++.+|+++++..+||+||++||.|.... ..+++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            4455789999999999999865 78999999995443 446788999999999999999999999999888 59999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      |++|+|.+++...+ .+++....+++.+|++||.|||+  .++||||||||+|||++..|+|||||||.+..+.+.    
T Consensus       160 MDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             cCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            99999999998764 48999999999999999999994  499999999999999999999999999999887543    


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+......+...        .+++....    
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~--------~Iv~~ppP----  300 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC--------AIVDEPPP----  300 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH--------HHhcCCCC----
Confidence            456788999999999999999999999999999999999999998764222222222111        11110000    


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                       .++ ...+++++.+++..|+++||.+||+++|+++
T Consensus       301 -~lP-~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  301 -RLP-EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -CCC-cccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             000 0136788999999999999999999999985

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-46  Score=380.29  Aligned_cols=258  Identities=31%  Similarity=0.493  Sum_probs=213.1

Q ss_pred             CCCCccccCCCceeEEEEEeCCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCC-eEEEEEEec
Q 005760          394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEE-FKALVLEYM  470 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~  470 (678)
                      ....+.+|.|+||+||+|.+.....||+|++.....  ...++|.+|+.++++++|||||+++|+|.++. ..++||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            344566999999999999996555599999975432  22568999999999999999999999999887 789999999


Q ss_pred             CCCCHHHHhhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEEcCCCCCCeeecCCC-cEEEEeeccccccCCCCC
Q 005760          471 PHGSLEKYLHS-SNYILDIYQRLNIMIDVASALEYLHFGYSAQ-VIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       471 ~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dl~~~Nill~~~~-~~kl~Dfg~~~~~~~~~~  547 (678)
                      ++|+|.++++. ....+++..+..++.|||+||.|||   +++ |||||||++|||++.++ ++||+|||+++...... 
T Consensus       123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            99999999988 3667999999999999999999999   888 99999999999999997 99999999998664321 


Q ss_pred             cceeecccCCccccCccccC--CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          548 STIQTQTLATIGYMAPEYGK--EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                       ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.+.........-.....         .|.  
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~---------Rp~--  266 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL---------RPP--  266 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC---------CCC--
Confidence             3334478999999999999  56899999999999999999999999987554211111100100         000  


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                              .+..|++.+..+|.+||+.||++||++.|++..|+.+...+.
T Consensus       267 --------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  267 --------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             --------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence                    112267779999999999999999999999999999987653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-46  Score=363.03  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=209.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccCc-------hhhhHHHHHHHHHhCCCccceeeeeeeecCC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR-------VFKSFDVECEMMKSIRHRNIIKVISSCSNEE  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  461 (678)
                      ..+.|.+.+.+|+|+||.|-+|. .++|+.||||++......       ....+.+|+++|++|+||+||+++++|..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            35678889999999999999996 568999999999654211       1234568999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC---CcEEEEeecc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGI  538 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~---~~~kl~Dfg~  538 (678)
                      ..|+||||++||+|.+++-..+. +.+.....++.|++.|+.|||   +.||+||||||+|||+..+   ..+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccch
Confidence            99999999999999999987664 777778899999999999999   9999999999999999755   7899999999


Q ss_pred             ccccCCCCCcceeecccCCccccCccccCCCCC---CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCc
Q 005760          539 AKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV---SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS  615 (678)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  615 (678)
                      |+..+   ........+||+.|.|||++.++.+   ..++|+||+||+||-+++|.+||.+.........+..++.    
T Consensus       326 AK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~----  398 (475)
T KOG0615|consen  326 AKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGR----  398 (475)
T ss_pred             hhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCc----
Confidence            99765   2333446789999999999887653   3478999999999999999999988655543333332221    


Q ss_pred             ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                  .+...+.....+++..+++.+||..||++|||+.|+++
T Consensus       399 ------------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  399 ------------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ------------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                        12222334567888999999999999999999999985

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.2e-46  Score=396.75  Aligned_cols=260  Identities=30%  Similarity=0.519  Sum_probs=226.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeecccCc-hhhhHHHHHHHHHhCCCccceeeeeeeecCCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  463 (678)
                      ..+....+.||+|+||.||+|+.      ++.+.||||.++..... .+++|++|++++..++|||||+++|+|.+++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            34556678999999999999973      34567999999877665 789999999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc
Q 005760          464 ALVLEYMPHGSLEKYLHSSN-------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV  530 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~  530 (678)
                      ++|+|||..|||.+|++...             ..++..+.+.||.|||.|++||.   ++++|||||..+|+|+.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceE
Confidence            99999999999999997432             13778899999999999999999   999999999999999999999


Q ss_pred             EEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhh
Q 005760          531 AHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVN  609 (678)
Q Consensus       531 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~  609 (678)
                      |||+|||+++..-..+++.......-+.+|||||.+..++++.+||||||||+|||+++ |+.||++....+.-  +.++
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI--e~i~  719 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI--ECIR  719 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH--HHHH
Confidence            99999999998888888888878889999999999999999999999999999999999 99999875554321  1111


Q ss_pred             cccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          610 DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                                 ..       .-+..+++||.++++||.+||+..|++||+++||-..|+++.+.
T Consensus       720 -----------~g-------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  720 -----------AG-------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             -----------cC-------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                       11       11335578999999999999999999999999999999998654

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-45  Score=376.66  Aligned_cols=247  Identities=24%  Similarity=0.353  Sum_probs=210.8

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      .+|...+.||+|||+.+|.++. .+|+.||+|++...   .....+.+.+|+++.+.|+|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999986 79999999999653   4556788899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+|..++|.+++++. ..+++.++..+.+||+.|+.|||   +++|+|||||..|++++++.+|||+|||+|+.+...+ 
T Consensus        98 ELC~~~sL~el~Krr-k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR-KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-  172 (592)
T ss_pred             EecCCccHHHHHHhc-CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence            999999999999844 46999999999999999999999   9999999999999999999999999999999886432 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                       ......+|||.|.|||++.+...+..+||||+||+||-|+.|++||+...-.+ .+....       ..+..-|     
T Consensus       173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-ty~~Ik-------~~~Y~~P-----  238 (592)
T KOG0575|consen  173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-TYNKIK-------LNEYSMP-----  238 (592)
T ss_pred             -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-HHHHHH-------hcCcccc-----
Confidence             23445789999999999999999999999999999999999999997632111 111110       1111111     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              ...+.++.+||.++|+.||.+|||+++|+.
T Consensus       239 --------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  239 --------SHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             --------cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                    133455889999999999999999999985

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-45  Score=358.26  Aligned_cols=203  Identities=31%  Similarity=0.526  Sum_probs=182.4

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc--cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ...+|...+.||.|+||+||+|+++ ++.+||||.+...  .....+-...|+.+++.++|||||.+++++..++..|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            3467889999999999999999854 7899999999765  344567778899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC------CcEEEEeecccc
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN------MVAHLSDFGIAK  540 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~------~~~kl~Dfg~~~  540 (678)
                      ||||.||||.+|+++.+ .+++..+..++.|||.|+++||   +++||||||||.|||++..      -.+||+|||+|+
T Consensus        88 MEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999999886 4999999999999999999999   9999999999999999754      568999999999


Q ss_pred             ccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccC
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFN  599 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~  599 (678)
                      .+.   ........+|++.|||||++...+|+.|+|+||+|+++|||++|+.||+....
T Consensus       164 ~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  164 FLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             hCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            875   33445567899999999999999999999999999999999999999986433

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-45  Score=341.41  Aligned_cols=256  Identities=25%  Similarity=0.385  Sum_probs=204.8

Q ss_pred             cCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecc--cCchhhhHHHHHHHHHhCCCccceeeee-eeecCC-eEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVIS-SCSNEE-FKALV  466 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~-~~~lv  466 (678)
                      .+|++.++||.|.||+||++. ..+|..||.|.+.-.  .....++...|+.++++|+|||||++++ .+.+.. .+++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            457888999999999999996 679999999998633  3456678889999999999999999998 454444 48999


Q ss_pred             EEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          467 LEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      |||+..|||..+++.   .+..+++..+|+++.|++.||.++|..+.+ -|+||||||.||+++.+|.||++|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999998863   445799999999999999999999943323 2889999999999999999999999999987


Q ss_pred             CCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ...  .......+|||.||+||.+.+..|+.+|||||+||++|||+.-++||.+.  .-..+...+.           . 
T Consensus       179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~-----------q-  242 (375)
T KOG0591|consen  179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIE-----------Q-  242 (375)
T ss_pred             cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHH-----------c-
Confidence            533  33345688999999999999999999999999999999999999999863  1111111111           0 


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                           ........+-++.++.+++..|+..||+.||+.-.++..+.
T Consensus       243 -----gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  243 -----GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             -----CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence                 00000112457888999999999999999998544444433

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.4e-44  Score=338.63  Aligned_cols=267  Identities=22%  Similarity=0.319  Sum_probs=208.4

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc--cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      +.|+...++|+|+||+||+.+.+ +|+-||||++...  .+...+-..+|++++++++|||+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46788889999999999999865 7999999998532  23344556899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      ||+. ++.+-+.......+...+..+..|++.|+.|+|   +++++||||||+||+++.+|.+|+||||+|+.+..  ..
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pg  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PG  155 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC--Cc
Confidence            9977 666666666667999999999999999999999   99999999999999999999999999999998863  33


Q ss_pred             ceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccch--hhhhhcccCCc---------c
Q 005760          549 TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTL--KHWVNDWLPIS---------T  616 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~--~~~~~~~~~~~---------~  616 (678)
                      ...+.++.|.+|.|||.+.+ .+|+..+||||+||++.||++|.+-|++..+-+...  ...+....|+-         +
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            44567889999999999887 679999999999999999999999887633321110  11111111110         1


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .-+.-|.....+..+.-. ...+..+.++++.|++.||++|++.+|++.
T Consensus       236 ~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111112222222211111 234557899999999999999999999875

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-44  Score=365.68  Aligned_cols=267  Identities=27%  Similarity=0.436  Sum_probs=219.8

Q ss_pred             HHHHHhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCe
Q 005760          385 LELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF  462 (678)
Q Consensus       385 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  462 (678)
                      .+.....+.+.+...||+|.||+||+|.|-  -.||||++....  .+..++|+.|+.++++-+|.||+-+.|+|..+..
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            444555666778899999999999999973  359999997653  3467899999999999999999999999999887


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                       .||+.||+|.+|+.+++-.+..+++.+...|++|||.|+.|||   .++|||||+|..||++.+++.|||+|||+++..
T Consensus       463 -AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             -eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeee
Confidence             8999999999999999988888999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCCcceeecccCCccccCccccCCC---CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccc
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEG---RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI  619 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (678)
                      ..-..........|..-|||||+++.+   .|++++||||||+++|||++|..||.. ...+.-+  |           .
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIi--f-----------m  604 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQII--F-----------M  604 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheE--E-----------E
Confidence            544333344556688899999988754   589999999999999999999999973 2221111  1           1


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      +-.......  ......+|+.++.+|+..||.+++++||.+.+|+..|+++..+
T Consensus       605 VGrG~l~pd--~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  605 VGRGYLMPD--LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             ecccccCcc--chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            111100000  1112346888999999999999999999999999999998764

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-44  Score=347.20  Aligned_cols=243  Identities=30%  Similarity=0.381  Sum_probs=201.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ..++|++.+.||+|+||.||+++. ++++.+|+|++++..   ....+....|..++..++||+||+++..|++++.+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            356899999999999999999974 578999999996542   2346778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      |+||+.||.|..++++.+. +++..+..++.+|+.||.|||   +++|||||+||+|||+|.+|+++|+|||+++.....
T Consensus       103 Vld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            9999999999999987764 888888899999999999999   999999999999999999999999999999855332


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                        .......+||+.|||||++.+..|+.++|.||+|+++|||++|.+||.+......     .+.......  ..-|.  
T Consensus       179 --~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-----~~~I~~~k~--~~~p~--  247 (357)
T KOG0598|consen  179 --GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-----YDKILKGKL--PLPPG--  247 (357)
T ss_pred             --CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-----HHHHhcCcC--CCCCc--
Confidence              2223447899999999999999999999999999999999999999987433221     111111110  00000  


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCC
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRI  658 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  658 (678)
                                 -.+.+..+++.++++.||++|.
T Consensus       248 -----------~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  248 -----------YLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -----------cCCHHHHHHHHHHhccCHHHhc
Confidence                       1234578999999999999996

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.2e-43  Score=322.91  Aligned_cols=264  Identities=24%  Similarity=0.370  Sum_probs=210.3

Q ss_pred             cCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ++|...+++|+|.||.||+|+ .++|+.||||+++....  .......+|+..++.++|+||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            468888999999999999997 56899999999976532  234556889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |++. +|...++...-.++..++..++.++++|++|||   .+.|+|||+||.|+|++++|.+||+|||+|+.++.....
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9966 999999998889999999999999999999999   999999999999999999999999999999988755433


Q ss_pred             ceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhh---hcccC---C---cccc
Q 005760          549 TIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWV---NDWLP---I---STKE  618 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~---~~~~~---~---~~~~  618 (678)
                        .+..+.|.+|.|||.+.+. .|+..+||||.||++.||+-|.+-|.+    +.++.+..   +....   +   .+..
T Consensus       158 --~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG----~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  158 --QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPG----DSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             --cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCC----CchHHHHHHHHHHcCCCCcccCccccc
Confidence              3444789999999988876 599999999999999999988876654    22332221   11110   0   1111


Q ss_pred             cccCccCC---ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          619 IVDPNLLS---REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       619 ~~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      +.|.....   ....+. --..++.++.+++..|+.+||.+|++++|++++
T Consensus       232 lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  232 LPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            22211111   111111 112466778999999999999999999999864

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=355.92  Aligned_cols=253  Identities=26%  Similarity=0.423  Sum_probs=210.1

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecc---cCchhhhHHHHHHHHHhC-CCccceeeeeeeecCCe
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEF  462 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  462 (678)
                      .....+|..++.||+|+|++|++|+ ..+++.+|||++...   .....+.+..|-..|..| .||.|++++..|++...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            3345789999999999999999997 558999999998643   233446677899999999 79999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      +|+|+||+++|+|.+++++.+. +++.....++.||+.|++|||   ++|||||||||+|||+|.+|+++|+|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999999998864 888889999999999999999   999999999999999999999999999999988


Q ss_pred             CCCCCc---------c--eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcc
Q 005760          543 TREDQS---------T--IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW  611 (678)
Q Consensus       543 ~~~~~~---------~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~  611 (678)
                      .+....         .  ....++||..|.+||++..+..+..+|+|+|||++|+|+.|++||-+..+ ...++..    
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yliFqkI----  299 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLIFQKI----  299 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHHHHHH----
Confidence            653221         1  12558999999999999999999999999999999999999999965221 1111111    


Q ss_pred             cCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          612 LPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              ++        .+...++..++.+.+|+++.|..||.+|++++||.+
T Consensus       300 --------~~--------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  300 --------QA--------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             --------HH--------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence                    11        001112234566889999999999999999988865

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-43  Score=349.89  Aligned_cols=268  Identities=27%  Similarity=0.351  Sum_probs=211.9

Q ss_pred             hcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecC--CeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE--EFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  465 (678)
                      .+.|+..++||+|.||.||+|+ ..+|+.||+|++..+.  .+......+||.+|++|+||||+++.+...+.  ..+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            4567778999999999999997 5689999999997664  34455668999999999999999999988776  68999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      |+|||++ ||..++....-.++..++..++.|++.||+|||   .+||+|||||.+|||+|.+|.+||+|||+|+.+...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999988 999999987778999999999999999999999   999999999999999999999999999999987654


Q ss_pred             CCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhh--------cccCCcc
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN--------DWLPIST  616 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~  616 (678)
                      . ....+..+.|.+|.|||++.+. .|+.++|+||.||||.||++|++.|.+..+.+.. ....+        .|....+
T Consensus       272 ~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl-~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  272 G-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL-HKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             C-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH-HHHHHHhCCCChhccccccC
Confidence            3 3346778899999999988775 5999999999999999999999998774432211 11111        1111111


Q ss_pred             c--ccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          617 K--EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       617 ~--~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .  ..+.+...-....... ....+....+|+..+|..||++|.||.++++
T Consensus       350 P~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1  1111111100111111 1345677899999999999999999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-43  Score=352.39  Aligned_cols=267  Identities=22%  Similarity=0.311  Sum_probs=212.2

Q ss_pred             HhhcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccCchhhh-HHHHHHHHHhCC-CccceeeeeeeecCC-eEE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIR-HRNIIKVISSCSNEE-FKA  464 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~-~~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~  464 (678)
                      ...++|...++||.|.||.||+|+ ..+|..||||.++.......+. -.+|+..+++++ ||||+++.+++.+.+ .+|
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            346789999999999999999997 5579999999997654433222 368999999998 999999999999888 999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +|||||+. +|+++++.++..+++..+..|+.||++||+|+|   ++|+.|||+||+|||+.....+||+|||+|+.+..
T Consensus        87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc
Confidence            99999966 999999988889999999999999999999999   99999999999999999999999999999987753


Q ss_pred             CCCcceeecccCCccccCcccc-CCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcc-------
Q 005760          545 EDQSTIQTQTLATIGYMAPEYG-KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-------  616 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------  616 (678)
                      .   ...+.++.|.+|+|||++ +.+.|+.+.||||+||+++|+.+-++-|.+..+.+.-.+  +-.....+.       
T Consensus       163 k---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K--Ic~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  163 K---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK--ICEVLGTPDKDSWPEG  237 (538)
T ss_pred             C---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH--HHHHhCCCccccchhH
Confidence            3   345678899999999965 556799999999999999999999988876444322111  111111110       


Q ss_pred             ---cc---cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          617 ---KE---IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       617 ---~~---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                         ..   +.-|.... .......+ +++.++.+++.+|+.+||.+||||+|+++.
T Consensus       238 ~~La~~mnf~~P~~~~-~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKP-SPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHhccCCCcCCC-CChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence               01   11111111 11112222 378889999999999999999999999863

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-43  Score=355.25  Aligned_cols=251  Identities=25%  Similarity=0.357  Sum_probs=213.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ....|....+||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+.+++|||
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            34578888999999999999996 56889999999987766667888999999999999999999999988899999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |++||+|.+.+....  +++.++..|+++++.||+|||   .+||+|||||.+|||++.+|.+||+|||+|..+...  .
T Consensus       351 ym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~--~  423 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE--Q  423 (550)
T ss_pred             ecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccc--c
Confidence            999999999997765  899999999999999999999   999999999999999999999999999999877543  2


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                      ..+...+||+.|||||+.....|++++||||||++++||+.|.+||-...+-.   .-|.-          .     ...
T Consensus       424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr---AlyLI----------a-----~ng  485 (550)
T KOG0578|consen  424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLI----------A-----TNG  485 (550)
T ss_pred             CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH---HHHHH----------h-----hcC
Confidence            35567889999999999999999999999999999999999999986522111   11100          0     001


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..++..++..++.+.+++.+||+.||++|++|+|+++
T Consensus       486 ~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  486 TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            1111223345677999999999999999999999986

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=342.23  Aligned_cols=257  Identities=30%  Similarity=0.453  Sum_probs=205.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCC--eEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE--FKALVL  467 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  467 (678)
                      ..++...+.||+|+||+||++... +|...|||.+........+.+.+|++++++++|||||+++|......  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            345777899999999999999854 59999999997664444677899999999999999999999854444  688999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-CCcEEEEeeccccccCC-C
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTR-E  545 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-~~~~kl~Dfg~~~~~~~-~  545 (678)
                      ||+++|+|.+++.+.+..+++..+..+.+||++||+|||   ++||+|+||||+|||++. ++.+||+|||.+..... .
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            999999999999987756899999999999999999999   999999999999999999 79999999999987653 1


Q ss_pred             CCcceeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ..........||+.|||||++..+. ...++||||+||++.||+||++||.............   ......     |. 
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i---g~~~~~-----P~-  243 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI---GREDSL-----PE-  243 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH---hccCCC-----CC-
Confidence            1223344678999999999998643 3458999999999999999999997631111111110   000000     10 


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                               .+...+.++.+++.+|++.||++||||+|+++.--
T Consensus       244 ---------ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  244 ---------IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             ---------CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence                     11124556889999999999999999999997543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=333.48  Aligned_cols=262  Identities=24%  Similarity=0.323  Sum_probs=213.2

Q ss_pred             hhcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccCc-hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ..+.|++...||.|..++||+|+ ...++.||||++..+... ..+.+.+|++.|+.++||||++.+.+|..+..+|+||
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            34679999999999999999997 567899999999776433 3588899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          468 EYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       468 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      +||.+|++.++++.. ...+++..+..|.+++++||.|||   .+|.||||||+.|||++.+|.|||+|||.+..+...+
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999999754 346899999999999999999999   9999999999999999999999999999987776544


Q ss_pred             Ccc-ee-ecccCCccccCccccCCC--CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          547 QST-IQ-TQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       547 ~~~-~~-~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ... .. ....|++.|||||++...  .|+.|+||||||++..||.+|..||....+..+.+... +.-+|...      
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn~pp~~~------  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QNDPPTLL------  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cCCCCCcc------
Confidence            221 11 456899999999995543  59999999999999999999999998755554433322 11111111      


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                          ....+.-....+...+.+++..|+++||++||||+++++
T Consensus       254 ----t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 ----TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ----cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                001111122334557899999999999999999999986

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-43  Score=366.83  Aligned_cols=255  Identities=24%  Similarity=0.459  Sum_probs=221.3

Q ss_pred             CCCCccccCCCceeEEEEEeC----CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          394 FSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ..+.+.||.|-||.||+|+++    ....||||.++.... ..+.+|..|+.+|.+++||||+++-|+.......+||+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            456789999999999999864    235699999987654 456789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC-C
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED-Q  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~-~  547 (678)
                      ||++|+|..|++.....+.+.+.+.|.++||.|+.||.   ++++|||||.++|||++.+..+|++|||+++.+.+.. .
T Consensus       711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~  787 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  787 (996)
T ss_pred             hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence            99999999999998888999999999999999999999   9999999999999999999999999999999774432 3


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                      ......-..+.+|.|||.+...+++.++||||||++|||.++ |..||.++.+.+.-..                    -
T Consensus       788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka--------------------I  847 (996)
T KOG0196|consen  788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA--------------------I  847 (996)
T ss_pred             cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH--------------------H
Confidence            333444566789999999999999999999999999999998 9999987666543111                    0


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                      .+.++++.+.+|+..+.+||..||++|-.+||.+.|++..|.++-
T Consensus       848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence            233455566789999999999999999999999999999998773

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=381.45  Aligned_cols=263  Identities=28%  Similarity=0.472  Sum_probs=223.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC--CCc----EEEEEEeecc-cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG--DGM----EVAMKVFNLQ-YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  463 (678)
                      ....+..+.||+|+||.||.|...  +|.    .||+|.++.. +.+...+|.+|..+|+.++|||||+++|++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            455667789999999999999753  343    4899988654 345678999999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeec
Q 005760          464 ALVLEYMPHGSLEKYLHSS------NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG  537 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg  537 (678)
                      ++++|||++|||..|+++.      ...+.......++.|||+|+.||+   ++++|||||.++|+|++....|||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999999987      557889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcc
Q 005760          538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPIST  616 (678)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  616 (678)
                      +|+..-+.+.+.......-+..|||||.+..+.++.|+|||||||++||++| |..||.+..+.+... .+.        
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~-~~~--------  918 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL-DVL--------  918 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH-HHH--------
Confidence            9996665555555555577789999999999999999999999999999999 888987654433211 011        


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHhh
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLR  676 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~~  676 (678)
                                 ...++..+..|+..++++|..||+.+|++||++..+++++.++.+.+..
T Consensus       919 -----------~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  919 -----------EGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             -----------hCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence                       1113445567999999999999999999999999999999998876543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.5e-41  Score=352.75  Aligned_cols=261  Identities=23%  Similarity=0.409  Sum_probs=205.8

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceeeeeeeecC-
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKVISSCSNE-  460 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-  460 (678)
                      ..++|++.+.||+|+||.||+|..      .+++.||+|++..... ...+.+.+|+.+++.+ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            457899999999999999999963      2356899999864332 3346788999999999 899999999988764 


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCC---------------------------------------------------------
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSN---------------------------------------------------------  483 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------  483 (678)
                      +..++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            46789999999999999987532                                                         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCcc
Q 005760          484 ----YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG  559 (678)
Q Consensus       484 ----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~  559 (678)
                          ..+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++...............++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                23667888999999999999999   99999999999999999999999999999976543322222334456788


Q ss_pred             ccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHH
Q 005760          560 YMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQC  638 (678)
Q Consensus       560 y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  638 (678)
                      |+|||.+.+..++.++|||||||++|||++ |..||......+. .......           .....       .+..+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~~-----------~~~~~-------~~~~~  302 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLKD-----------GTRMR-------APENA  302 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHhc-----------CCCCC-------CCCCC
Confidence            999999998899999999999999999997 9999876332211 1111110           00000       01134


Q ss_pred             HHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          639 VSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       639 ~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                      ++++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       303 ~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         303 TPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            5568899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=318.05  Aligned_cols=238  Identities=26%  Similarity=0.342  Sum_probs=200.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      -++|+..+.||.|+||+|.+++.+ +|..+|+|+++.+.   -...+....|..+++.+.||+++++++.+.+.+.+|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            357888999999999999999854 78999999997653   23456778899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||++||.|..++++.+. +++.++..++.||+.|++|||   +++|++||+||+|||+|.+|.+||+|||+|+.+... 
T Consensus       123 meyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            999999999999998775 888999999999999999999   999999999999999999999999999999877422 


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                          ....+|||.|+|||++....+..++|.|||||++|||+.|.+||.+..+... ....+.       .++.-|    
T Consensus       198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i-Y~KI~~-------~~v~fP----  261 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI-YEKILE-------GKVKFP----  261 (355)
T ss_pred             ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH-HHHHHh-------CcccCC----
Confidence                3356799999999999999999999999999999999999999987544211 111111       111111    


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCC
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRI  658 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  658 (678)
                               ...+.++.+|++..++.|-.+|.
T Consensus       262 ---------~~fs~~~kdLl~~LL~vD~t~R~  284 (355)
T KOG0616|consen  262 ---------SYFSSDAKDLLKKLLQVDLTKRF  284 (355)
T ss_pred             ---------cccCHHHHHHHHHHHhhhhHhhh
Confidence                     22445688999999999999883

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.6e-41  Score=340.12  Aligned_cols=251  Identities=25%  Similarity=0.371  Sum_probs=204.6

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ..++|++++.||+|+||.||+|+- .+|..+|+|+++..   .....+.+..|-.+|...++|.||+++..|++.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            357899999999999999999974 58999999999754   23456778889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||++|||+.+++.+.+. +++..+..++.+.+-|++.+|   +.|+|||||||+|+|||..|++||+|||+++-+...
T Consensus       219 iMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             EEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            9999999999999987765 888899999999999999999   999999999999999999999999999998533210


Q ss_pred             ----------------------CCc-----------------------ceeecccCCccccCccccCCCCCCccchHHHH
Q 005760          546 ----------------------DQS-----------------------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSF  580 (678)
Q Consensus       546 ----------------------~~~-----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  580 (678)
                                            +..                       ......+|||-|+|||++.+..|+..+|.||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                  000                       00112469999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCcccCCcc--chhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCC
Q 005760          581 GIMLMETFTRKKPTDEIFNGEM--TLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI  658 (678)
Q Consensus       581 Gv~l~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  658 (678)
                      ||++|||+.|.+||.+..+.+.  .+..|...+.                   ++....++.++.+||.+|+. ||++|.
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-------------------fP~~~~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-------------------FPEEVDLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-------------------CCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence            9999999999999987554322  1222221111                   11112234678899999999 999998


Q ss_pred             C---HHHHH
Q 005760          659 N---AKEIV  664 (678)
Q Consensus       659 s---~~ell  664 (678)
                      .   ++||.
T Consensus       435 G~~G~~EIK  443 (550)
T KOG0605|consen  435 GSKGAEEIK  443 (550)
T ss_pred             CcccHHHHh
Confidence            5   55554

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-41  Score=345.73  Aligned_cols=249  Identities=26%  Similarity=0.368  Sum_probs=205.5

Q ss_pred             HhhcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecc----cC-chhhhHHHHHHHHHhCC-CccceeeeeeeecCC
Q 005760          389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQ----YG-RVFKSFDVECEMMKSIR-HRNIIKVISSCSNEE  461 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  461 (678)
                      ...++|.+.+.||+|+||.|+.|. ..+++.||+|++...    .. ...+.+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            345789999999999999999996 457899999977553    11 23456678999999999 999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC-CcEEEEeecccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAK  540 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~-~~~kl~Dfg~~~  540 (678)
                      ..++||||+.+|+|.+++.. ..++.+..+..+++|+++|++|||   ++||+||||||+||+++.+ +++||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999998 446888999999999999999999   9999999999999999999 999999999998


Q ss_pred             ccCCCCCcceeecccCCccccCccccCCCC-CC-ccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKEGR-VS-ANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE  618 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  618 (678)
                      ...  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||++......... ..+.       +
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k-i~~~-------~  239 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK-IRKG-------E  239 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH-HhcC-------C
Confidence            763  2233345678999999999999877 75 779999999999999999999987322211111 1110       1


Q ss_pred             cccCccCCccchhhHHHHHH-HHHHHHHHhhccccCcCCCCCHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQC-VSFVFNVAMECTVESPEQRINAKEIV  664 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~Rps~~ell  664 (678)
                      ..-|.             .. ++++..++.+|++.||.+|+++.|++
T Consensus       240 ~~~p~-------------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  240 FKIPS-------------YLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             ccCCC-------------CcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            11111             12 45688999999999999999999998

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=351.17  Aligned_cols=259  Identities=28%  Similarity=0.423  Sum_probs=213.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC--CC---cEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG--DG---MEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~--~~---~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  461 (678)
                      ..++....++||+|+||.||+|.++  ++   ..||+|..+..   ......++.+|+++|+.++|||||+++|++....
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            3455666799999999999999753  23   22899998742   2456788999999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      .+++|||+|.||+|.+++++.+..++..++..++.+.|.||+|||   +++++||||.++|+|++.++.+||+|||+++.
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence            999999999999999999998877999999999999999999999   99999999999999999999999999999864


Q ss_pred             cCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhh-hcccCCccccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWV-NDWLPISTKEI  619 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~  619 (678)
                      -.  ...........+..|+|||.+..+.|++++|||||||++||+++ |..||.+....  ....++ ....+..    
T Consensus       312 ~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~r~~----  383 (474)
T KOG0194|consen  312 GS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGYRMP----  383 (474)
T ss_pred             Cc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCccCC----
Confidence            32  12222224457889999999999999999999999999999999 88898774433  222222 2111111    


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                                    .+...+.++..++.+||..+|++||+|.++.+.++.+...
T Consensus       384 --------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  384 --------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             --------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence                          1113466788999999999999999999999999998754

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=342.18  Aligned_cols=245  Identities=24%  Similarity=0.434  Sum_probs=208.3

Q ss_pred             CccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCHH
Q 005760          397 NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLE  476 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  476 (678)
                      .+.+|.|+.|.||+|+. .++.||||+++...       ..+|.-|++|+||||+.+.|+|...-.+|||||||..|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            67899999999999998 46889999875322       34788899999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccC
Q 005760          477 KYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA  556 (678)
Q Consensus       477 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  556 (678)
                      +.++..+. +.....+.|..+||.|+.|||   .+.|||||||.-||||+.+..|||+|||-++.....   ...-.+.|
T Consensus       201 ~VLka~~~-itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG  273 (904)
T KOG4721|consen  201 EVLKAGRP-ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG  273 (904)
T ss_pred             HHHhccCc-cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence            99987764 778888999999999999999   999999999999999999999999999999876433   22346789


Q ss_pred             CccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHH
Q 005760          557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKE  636 (678)
Q Consensus       557 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  636 (678)
                      |..|||||+++...+++|+|||||||+||||+||..||.+......-   |                -.......++.+.
T Consensus       274 TVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---w----------------GVGsNsL~LpvPs  334 (904)
T KOG4721|consen  274 TVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---W----------------GVGSNSLHLPVPS  334 (904)
T ss_pred             hHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---E----------------eccCCcccccCcc
Confidence            99999999999999999999999999999999999999764332111   0                0112233445566


Q ss_pred             HHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          637 QCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       637 ~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                      .|+..+.-|+++||+..|..||+|.+++..|.-+...+.
T Consensus       335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell  373 (904)
T KOG4721|consen  335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL  373 (904)
T ss_pred             cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence            789999999999999999999999999999876655443

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-40  Score=316.89  Aligned_cols=270  Identities=24%  Similarity=0.305  Sum_probs=208.6

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCc--hhhhHHHHHHHHHhCCCccceeeeeeee--cCCe
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVISSCS--NEEF  462 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~  462 (678)
                      ++..+.|+..+.|++|.||.||+|+. ++++.||+|+++.....  .--...+|+.++.+.+|||||.+-.+..  +-+.
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            33456788899999999999999985 47899999999765432  1233478999999999999999988764  4567


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .|+|||||+. ||..++...+.++...++..++.|+++|++|||   ++.|+|||+|++|+|+...|.+||+|||+|+.+
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhh
Confidence            9999999988 999999988888999999999999999999999   999999999999999999999999999999988


Q ss_pred             CCCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhh-h--------ccc
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWV-N--------DWL  612 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~-~--------~~~  612 (678)
                      +..  ....+..+.|.+|.|||++.+. .|+.+.|+||+||++.||+++++-|.+..+.+  ..+.+ +        .|+
T Consensus       228 gsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~llGtPte~iwp  303 (419)
T KOG0663|consen  228 GSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLLGTPSEAIWP  303 (419)
T ss_pred             cCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHhCCCccccCC
Confidence            754  3335677899999999988775 49999999999999999999999887643322  21111 1        111


Q ss_pred             CCcccccccCccCCccchhhHHH----HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          613 PISTKEIVDPNLLSREDINFVAK----EQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       613 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .-.....+..............+    ...+..-++|+..++.+||.+|.||.|.++
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            11111111101111111111111    013366889999999999999999999875

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-41  Score=344.43  Aligned_cols=247  Identities=26%  Similarity=0.357  Sum_probs=207.7

Q ss_pred             cCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      +-|.+++.||.|+-|.|-.|+ ..+|+.+|||++....   ......+.+|+-+|+.+.|||++++|+++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            457889999999999999997 4689999999996542   223466788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|-|.+++.+.+. +++..+.++++||+.|+.|+|   ..+|+|||+||+|+|+|..+++||+|||+|..-.   .
T Consensus        92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV---P  164 (786)
T ss_pred             EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc---C
Confidence            99999999999987765 777888899999999999999   9999999999999999999999999999997532   2


Q ss_pred             cceeecccCCccccCccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                      ...-...+|+++|.+||++++..| +.++||||+||+||.|+||+.||++ .+-...+....+                 
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~~-----------------  226 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQR-----------------  226 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHHc-----------------
Confidence            334456789999999999999988 5789999999999999999999984 111111111111                 


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                         ..+..+.+.++++++|+.+|+..||++|.|++||.+.
T Consensus       227 ---G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  227 ---GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             ---CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence               1222334567789999999999999999999999874

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.1e-40  Score=335.90  Aligned_cols=246  Identities=28%  Similarity=0.424  Sum_probs=208.2

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ++|.+.+.||+|.||+||+|+- .+.+.||+|.+.+...  ...+.+.+|+++++.++||||+.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            5678889999999999999974 4789999999965432  345668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+.| +|.+++...+. ++++.+..++.+++.||.|||   +.+|.|||+||.||+++.+|.+|+||||+|+.+.  ...
T Consensus        82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~--~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS--TNT  154 (808)
T ss_pred             hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcc--cCc
Confidence            9977 99999987664 999999999999999999999   9999999999999999999999999999998764  345


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                      ...+...|||.|||||+..++.|+..+|+||+||++|||++|++||...     .+.+.++....+       +....  
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d-------~v~~p--  220 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKD-------PVKPP--  220 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcC-------CCCCc--
Confidence            5677889999999999999999999999999999999999999999752     122222222111       11110  


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                             ...+..+..++...+.+||.+|.+..+++.
T Consensus       221 -------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  221 -------STASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             -------ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence                   134556889999999999999999999874

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=331.66  Aligned_cols=249  Identities=28%  Similarity=0.392  Sum_probs=209.5

Q ss_pred             hcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ...|+..+.||+|.||.||+|. ..+++.||+|++..... ...+++.+|+.++..++++||.++|+.+..+..++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            4567788999999999999997 55889999999987644 456889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+.||++.+.++.... +++..+..+.++++.|+.|||   .++.+|||||+.||++..+|.||++|||.+..+...  .
T Consensus        92 y~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~  165 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--V  165 (467)
T ss_pred             HhcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech--h
Confidence            9999999999987653 477778889999999999999   999999999999999999999999999999876533  3


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                      ......+||+.|||||++....|+.|+||||||++.+||.+|.+|+....+....              .++...-....
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl--------------flIpk~~PP~L  231 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL--------------FLIPKSAPPRL  231 (467)
T ss_pred             hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE--------------EeccCCCCCcc
Confidence            3336788999999999999889999999999999999999999999775442211              11111111000


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .      ..+++.+.+++..|+++||+.||+|.++++
T Consensus       232 ~------~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  232 D------GDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             c------cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            0      135566899999999999999999999986

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-41  Score=304.86  Aligned_cols=263  Identities=22%  Similarity=0.294  Sum_probs=213.5

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecC-----C
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNE-----E  461 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  461 (678)
                      ....++|++.+.+|+|||+.||.++ ..++..+|+|++.....+..+...+|++..++++|||+++++++...+     .
T Consensus        17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            3456789999999999999999997 678999999999888777888899999999999999999999987433     3


Q ss_pred             eEEEEEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEcCCCCCCeeecCCCcEEEEee
Q 005760          462 FKALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPSNVLLDDNMVAHLSDF  536 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dl~~~Nill~~~~~~kl~Df  536 (678)
                      ..|++++|...|+|.+.+..   .+..+++.+++.|+.+|++||++||   +..  ++||||||.||++++.+.+++.||
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceEEEec
Confidence            58999999999999998864   3447899999999999999999999   666  999999999999999999999999


Q ss_pred             ccccccCCCCC-------cceeecccCCccccCccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhh
Q 005760          537 GIAKLLTREDQ-------STIQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKH  606 (678)
Q Consensus       537 g~~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~  606 (678)
                      |.++...-.-.       -........|..|.|||.+.   +...++++|||||||++|+|+.|..||+...+....+.-
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL  253 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL  253 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence            99976532111       11123456899999999875   345789999999999999999999999876654433322


Q ss_pred             hhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          607 WVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                      .+.           .      ..+.++....+++.+.++++.|++.||.+||++.|++..+..+
T Consensus       254 Av~-----------n------~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  254 AVQ-----------N------AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             eee-----------c------cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            111           0      0111112223667799999999999999999999999988765

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-39  Score=330.79  Aligned_cols=247  Identities=21%  Similarity=0.301  Sum_probs=199.9

Q ss_pred             CccccCCCceeEEEEEeCCCcEEEEEEeecccCc---hhhhHHHHHHHHHhCCCccceeeeeeeec----CCeEEEEEEe
Q 005760          397 NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGR---VFKSFDVECEMMKSIRHRNIIKVISSCSN----EEFKALVLEY  469 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~  469 (678)
                      ...||+|++|.||+|.. +|+.||||+++.....   ..+.+.+|+.++++++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 6899999998654322   24677899999999999999999999866    3567899999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++|+|.+++.... .+++.....++.|++.|+.|||   + .+++||||||+||+++.++.+||+|||++.......  
T Consensus       104 ~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999998764 4888999999999999999999   6 488999999999999999999999999987653221  


Q ss_pred             ceeecccCCccccCccccCC--CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          549 TIQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                         ....++..|+|||++.+  ..++.++|||||||++|||++|+.||......+. .........        .+.   
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~-~~~i~~~~~--------~~~---  242 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI-YDLIINKNN--------SLK---  242 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhcCC--------CCC---
Confidence               23457889999999876  6789999999999999999999999976432111 111111000        000   


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                             .+..+++++.+++.+||+.||++|||++|+++.|+.++.
T Consensus       243 -------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        243 -------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             -------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                   001345678999999999999999999999999998763

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.3e-39  Score=332.60  Aligned_cols=262  Identities=23%  Similarity=0.423  Sum_probs=202.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-----------------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCcccee
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-----------------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK  452 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~  452 (678)
                      .++|++.+.||+|+||.||+|.++                 ++..||+|++..... .....+.+|+++++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            467889999999999999999743                 234699999875432 23467889999999999999999


Q ss_pred             eeeeeecCCeEEEEEEecCCCCHHHHhhhCC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 005760          453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN------------------YILDIYQRLNIMIDVASALEYLHFGYSAQVI  514 (678)
Q Consensus       453 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv  514 (678)
                      +++++.+.+..++||||+++++|.+++....                  ..+++..+..++.||+.|++|||   +.+|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            9999999999999999999999999986432                  23577888999999999999999   99999


Q ss_pred             EcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc--CCC
Q 005760          515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT--RKK  592 (678)
Q Consensus       515 H~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~--g~~  592 (678)
                      ||||||+||+++.++.+||+|||++................++..|+|||++.++.++.++||||||+++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999976543333233344456788999999988889999999999999999987  556


Q ss_pred             CCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          593 PTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       593 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      ||......+  ....+.............           ..+..++..+.+++.+||+.||++|||+.|+.+.|+
T Consensus       241 p~~~~~~~~--~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQ--VIENAGEFFRDQGRQVYL-----------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHH--HHHHHHHHhhhccccccc-----------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            776532211  111111111000000000           001134567899999999999999999999998886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.5e-39  Score=343.92  Aligned_cols=259  Identities=24%  Similarity=0.390  Sum_probs=204.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhC-CCccceeeeeeeecCC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEE  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  461 (678)
                      ..++|++.+.||+|+||.||+|.+      .++..||+|+++... ....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            355789999999999999999963      246689999986432 23446788999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCC----------------------------------------------------------
Q 005760          462 FKALVLEYMPHGSLEKYLHSSN----------------------------------------------------------  483 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------  483 (678)
                      ..++||||+++|+|.++++...                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999986432                                                          


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          484 ----------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       484 ----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                                      ..+++..+..++.||+.|++|||   +++|+||||||+||+++.++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                            13677888999999999999999   99999999999999999999999999999976643322


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                      ........++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....++.....     ...+    
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~-----~~~~----  339 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYR-----MLSP----  339 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCcc-----CCCC----
Confidence            222233445678999999999999999999999999999998 888886533221 11111111000     0000    


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                               ...+.++.+++.+||+.||++||++.|+++.|++.
T Consensus       340 ---------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         340 ---------ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ---------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                     11245688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-40  Score=339.83  Aligned_cols=243  Identities=24%  Similarity=0.325  Sum_probs=202.2

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  464 (678)
                      .-++|.+.+.||+|.||.|++|..+ +++.+|||++++..   ....+..+.|.+++.... ||+++.++.+|+..+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4568999999999999999999854 78899999997652   345677788999988775 999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+.||++..+.+.  ..+++..+..++..|+.||.|||   +++||+||||.+|||+|.+|++||+|||+++.-- 
T Consensus       446 fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-  519 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-  519 (694)
T ss_pred             EEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccC-
Confidence            99999999995444443  34899999999999999999999   9999999999999999999999999999998542 


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                       ......+..+||+.|+|||++.+..|+.++|.|||||+||||+.|+.||.+..+.+. ....+.+              
T Consensus       520 -~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~-FdsI~~d--------------  583 (694)
T KOG0694|consen  520 -GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV-FDSIVND--------------  583 (694)
T ss_pred             -CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHhcC--------------
Confidence             233455678999999999999999999999999999999999999999987444321 1111110              


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA  660 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  660 (678)
                        ..    ..+..++.+..++|++++..+|++|..+
T Consensus       584 --~~----~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 --EV----RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --CC----CCCCcccHHHHHHHHHHhccCcccccCC
Confidence              00    0122456678899999999999999966

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.1e-39  Score=342.52  Aligned_cols=260  Identities=24%  Similarity=0.417  Sum_probs=205.5

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhC-CCccceeeeeeeecCC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEE  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  461 (678)
                      ..++|++.+.||+|+||.||+|..      .++..||+|++.... ....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            456899999999999999999873      234579999996543 23346678899999999 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCC----------------------------------------------------------
Q 005760          462 FKALVLEYMPHGSLEKYLHSSN----------------------------------------------------------  483 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------  483 (678)
                      ..++||||+++|+|.++++...                                                          
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            9999999999999999986421                                                          


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          484 -----------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       484 -----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                                 ..+++..+.+++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++............
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                       13677888999999999999999   9999999999999999999999999999997654332222223


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN  631 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  631 (678)
                      ...++..|+|||++.+..++.++|||||||++|||++ |+.||........ .........     ....+         
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~~~~-----~~~~~---------  337 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVKRGY-----QMSRP---------  337 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHHccc-----CccCC---------
Confidence            3345678999999988899999999999999999997 9999876433221 111111000     00000         


Q ss_pred             hHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          632 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       632 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                          ...++++.+++.+||+.||++||++.|+++.|+++.
T Consensus       338 ----~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 ----DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                112456889999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.1e-40  Score=298.87  Aligned_cols=248  Identities=26%  Similarity=0.364  Sum_probs=208.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      -++|++++.||+|.||.||.|+. +++-.||+|++-..   ......++.+|+++-+.|+||||+++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            46899999999999999999984 57888999998432   334567788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          467 LEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      +||.++|.+...++..+ ..+++...+.++.|+|.|+.|+|   .++|+||||||+|+|++..+..|++|||-+..-.  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999998443 25888889999999999999999   9999999999999999999999999999986432  


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                        .......+||.-|.|||...+...+..+|+|++|++.||++.|.+||..... ........+       .++.+|.  
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI~k-------~~~~~p~--  243 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRIRK-------VDLKFPS--  243 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHHHH-------ccccCCc--
Confidence              3344567899999999999999999999999999999999999999987552 222222211       1122222  


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                                 ..+.++.+++.+|+.++|.+|.+..|+++.
T Consensus       244 -----------~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  244 -----------TISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             -----------ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                       234558899999999999999999998864

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.9e-39  Score=325.38  Aligned_cols=256  Identities=21%  Similarity=0.355  Sum_probs=205.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC----CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      .++|++.+.||+|+||.||+|.++    .+..||+|.++.... .....+.+|+.+++.++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888999999999999999742    467899999875432 334578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++|+|.+++......+++..++.++.|++.|++|||   +.+++||||||+||+++.++.++++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999876556899999999999999999999   999999999999999999999999999987643221


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      . ........++..|+|||.+.+..++.++|||||||++||+++ |..||......+  ....+.....           
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~~~~-----------  226 (266)
T cd05064         161 A-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAVEDGFR-----------  226 (266)
T ss_pred             c-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCCC-----------
Confidence            1 111112335678999999998999999999999999999875 999986532211  1111110000           


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                             ...+..++..+.+++.+||+.+|++||++.|+.+.|+++
T Consensus       227 -------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         227 -------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                   001123556688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=329.00  Aligned_cols=265  Identities=22%  Similarity=0.423  Sum_probs=223.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      +.+...+.++||+|-||.|.+.....+..||||.++.... ..+.+|..|+++|.+++||||+.++|+|..++.+++++|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            4556778899999999999999987789999999976643 456899999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCC-CHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSSNYIL-DIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~-~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+++|+|..|+..+..+. +.....+|+.||+.|++||.   +.++||||+.+.|+|+|.++++||+|||+++.+-..+.
T Consensus       616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence            999999999998875433 55677889999999999999   99999999999999999999999999999998777788


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc--CCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT--RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                      +..++..+.+.+|||||.+.-++++.++|||+||+++||+++  ...||.......  ..+-.....+...         
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~---------  761 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQG---------  761 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCC---------
Confidence            888888999999999999999999999999999999999887  788887643321  1111111111111         


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                        ...-+..+.-|+.+++++|.+||..|-++||+++++...|++.
T Consensus       762 --~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 --RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             --cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence              1112223456888999999999999999999999999988764

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-40  Score=315.85  Aligned_cols=271  Identities=24%  Similarity=0.334  Sum_probs=232.9

Q ss_pred             HHHHHhhcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccCc-hhhhHHHHHHHHHhCCCccceeeeeee
Q 005760          385 LELCRATDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVISSC  457 (678)
Q Consensus       385 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~  457 (678)
                      .++.....+++....+.+|.||.||+|.+.      +.+.|.+|.++.+..+ ....+..|..++..+.|||+..+.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            345555677888889999999999999543      4566888888766544 346678899999999999999999987


Q ss_pred             e-cCCeEEEEEEecCCCCHHHHhhhCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC
Q 005760          458 S-NEEFKALVLEYMPHGSLEKYLHSSN-------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM  529 (678)
Q Consensus       458 ~-~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~  529 (678)
                      . +.+.+++++.+..-|+|..|++..+       ...+..+.+.++.|++.|++|||   +++|||.||.++|+++|+..
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~L  433 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQL  433 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhe
Confidence            4 4567889999999999999998322       24566788899999999999999   99999999999999999999


Q ss_pred             cEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhh
Q 005760          530 VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWV  608 (678)
Q Consensus       530 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~  608 (678)
                      +||++|=.+++.+.+.+.++.......+..||+||.+....|+.++|||||||+||||+| |+.|+.+.++.++.  +++
T Consensus       434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~--~yl  511 (563)
T KOG1024|consen  434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME--HYL  511 (563)
T ss_pred             eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH--HHH
Confidence            999999999999999999999999999999999999999999999999999999999999 99999876554432  222


Q ss_pred             hcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHhhcC
Q 005760          609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRNV  678 (678)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~  678 (678)
                                        .+++++..+-+|+.+++.+|.-||..+|++||+++|++.-|++++.++.++|
T Consensus       512 ------------------kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~YV  563 (563)
T KOG1024|consen  512 ------------------KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTRYV  563 (563)
T ss_pred             ------------------hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhhcC
Confidence                              2344556667899999999999999999999999999999999999999986

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-38  Score=325.36  Aligned_cols=269  Identities=19%  Similarity=0.242  Sum_probs=202.8

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++....  ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999865 68899999986542  2334667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |++++.+..+.. ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++....... .
T Consensus        81 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  155 (287)
T cd07848          81 YVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-N  155 (287)
T ss_pred             cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-c
Confidence            999876655443 3345889999999999999999999   9999999999999999999999999999997654222 1


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccc--hhhhh--------hcccCCc-cc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT--LKHWV--------NDWLPIS-TK  617 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~--~~~~~--------~~~~~~~-~~  617 (678)
                      .......+++.|+|||++.+..++.++||||+||++|||++|+.||......+..  .....        ..+.... ..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            1223456899999999998888999999999999999999999999763321110  00000        0000000 00


Q ss_pred             ccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ....+................+.++.+++.+||++||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000011111111111111235677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=312.92  Aligned_cols=269  Identities=26%  Similarity=0.304  Sum_probs=205.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeec--ccCchhhhHHHHHHHHHhCCCccceeeeeeeec-----CC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN-----EE  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~  461 (678)
                      ....|...+.||.|+||.|+.|.. .+|+.||+|++..  ......++..+|+.+++.++|+||+.+++.+..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            455666689999999999999975 4899999999863  333456778899999999999999999998754     45


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..|+|+|+| +.+|...++.+.. ++..++..++.|+++|+.|+|   +.+|+|||+||.|++++.+...||+|||+|+.
T Consensus       100 DvYiV~elM-etDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence            789999999 5599999987754 899999999999999999999   99999999999999999999999999999998


Q ss_pred             cCCCCCcceeecccCCccccCccccC-CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccc---
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGK-EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK---  617 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---  617 (678)
                      ..........+.++.|.+|.|||++. ...|+.+.||||.||++.||++|++-|.+...-  .....+-...+.+..   
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v--~Ql~lI~~~lGtP~~e~l  252 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV--HQLQLILELLGTPSEEDL  252 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH--HHHHHHHHhcCCCCHHHH
Confidence            75443344457788999999999765 457999999999999999999999988763221  111111111111100   


Q ss_pred             -ccc-------cCccCCccchhhHH-HHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          618 -EIV-------DPNLLSREDINFVA-KEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       618 -~~~-------~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                       .+-       -.++.......+.. -....+.+.+|+.+||..||.+|+|++|+++
T Consensus       253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence             000       00000011111110 1256777999999999999999999999986

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.6e-38  Score=308.80  Aligned_cols=268  Identities=25%  Similarity=0.343  Sum_probs=204.0

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCc--hhhhHHHHHHHHHhCCCcc-ceeeeeeeecCC------
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRN-IIKVISSCSNEE------  461 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------  461 (678)
                      ..|...++||+|.||+||+|+. .+|+.||+|+++....+  ......+|+.+++.++|+| |+++++++....      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            4466678899999999999974 58899999999876442  4456689999999999999 999999997766      


Q ss_pred             eEEEEEEecCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSN---YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI  538 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~  538 (678)
                      ..++|+||++. +|..++....   ...+...+..++.||+.|++|||   +++|+||||||.||+++++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence            88999999955 9999998766   35777889999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhh--------h
Q 005760          539 AKLLTREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWV--------N  609 (678)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~--------~  609 (678)
                      |+.+.-+  ....+..++|.+|.|||++.+. .|+...||||+||+++||++++.-|.+..+.+ .+....        .
T Consensus       167 Ara~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~-ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  167 ARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID-QLFRIFRLLGTPNEK  243 (323)
T ss_pred             HHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHHcCCCCcc
Confidence            9866422  2235677899999999998887 68999999999999999999998887643311 111111        1


Q ss_pred             cccCCcccccccCccCCccchhhHHH--HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          610 DWLPISTKEIVDPNLLSREDINFVAK--EQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      .|+......-.++.............  ..-.++..+++.+|++++|.+|.|++.+++.
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            11111100000100000000000011  1112468899999999999999999999885

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.1e-38  Score=323.84  Aligned_cols=265  Identities=20%  Similarity=0.283  Sum_probs=201.5

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|++.+.||+|+||.||+|..+ +++.||+|+++.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            57899999999999999999754 789999999865432 2345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++ +|.+++......++...+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++.......  .
T Consensus        85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~  158 (288)
T cd07871          85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--K  158 (288)
T ss_pred             CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--c
Confidence            975 999998776666888999999999999999999   9999999999999999999999999999987543221  1


Q ss_pred             eeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcc---cCCcccc-------
Q 005760          550 IQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW---LPISTKE-------  618 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~-------  618 (678)
                      ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ........   .+.....       
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchhh
Confidence            2234567899999998765 4588999999999999999999999975332211 11111000   0000000       


Q ss_pred             --cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 --IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 --~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                        ...+.......  .......+.++.+++.+|+++||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~--~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         238 RSYLFPQYRAQPL--INHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hccccCccCCCch--HHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence              01111000000  0001124566889999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.3e-38  Score=326.10  Aligned_cols=269  Identities=22%  Similarity=0.327  Sum_probs=202.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999865 789999999865432 223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |++ ++|.+++......++...+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++......  .
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--S  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--C
Confidence            995 6888888776666888999999999999999999   999999999999999999999999999998754322  1


Q ss_pred             ceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhc--------ccCCccccc
Q 005760          549 TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND--------WLPISTKEI  619 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~  619 (678)
                      .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.......+......        +........
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            22234568899999998765 457889999999999999999999997643221111111110        000000000


Q ss_pred             ccCccC---Cccch-hhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 VDPNLL---SREDI-NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ~~~~~~---~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .++...   ..... ........+.++.+++.+|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            011000   00000 00111123456889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.8e-38  Score=336.55  Aligned_cols=260  Identities=23%  Similarity=0.394  Sum_probs=206.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCC-CccceeeeeeeecCC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIR-HRNIIKVISSCSNEE  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  461 (678)
                      ..++|.+.+.||+|+||.||+|...      .+..||||++..... ...+.+..|+++++.+. ||||+++++++.+.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            4678999999999999999999742      234699999965432 33467889999999996 999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCC----------------------------------------------------------
Q 005760          462 FKALVLEYMPHGSLEKYLHSSN----------------------------------------------------------  483 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------------  483 (678)
                      ..++||||+++|+|.++++...                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999886431                                                          


Q ss_pred             -------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec
Q 005760          484 -------------------------------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD  526 (678)
Q Consensus       484 -------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~  526 (678)
                                                           ..+++..+..++.|++.|++|||   +.+|+||||||+||+++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEe
Confidence                                                 13667788899999999999999   99999999999999999


Q ss_pred             CCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchh
Q 005760          527 DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLK  605 (678)
Q Consensus       527 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~  605 (678)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......... 
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~-  350 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY-  350 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH-
Confidence            999999999999976543322222334456788999999988889999999999999999997 899987543221111 


Q ss_pred             hhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          606 HWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                      ..+....        .+          ..+..++.++.+++.+||+.||++||++.++.+.|+++.
T Consensus       351 ~~~~~~~--------~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         351 NKIKSGY--------RM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHHhcCC--------CC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            1111000        00          011234567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.8e-38  Score=323.84  Aligned_cols=250  Identities=20%  Similarity=0.274  Sum_probs=199.9

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .|+..+.||+|+||.||+|.. .+|+.||+|.+....   ......+.+|+++++.++|++|+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367789999999999999975 579999999986432   2223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+++|+|.+++.... ..+++..+..++.|++.|++|||   +++|+||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            999999998876433 35889999999999999999999   9999999999999999999999999999997653221 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        ......|+..|+|||++.+..++.++||||+||++|||++|+.||........ ......... ....      .   
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~-~~~~------~---  223 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDRRVK-EDQE------E---  223 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHHHhh-cccc------c---
Confidence              22345689999999999999999999999999999999999999976432211 011100000 0000      0   


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ell~  665 (678)
                            .+...+.++.+|+.+||+.||++||+     ++|+++
T Consensus       224 ------~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         224 ------YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ------CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                  01123556889999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.4e-39  Score=312.52  Aligned_cols=252  Identities=25%  Similarity=0.351  Sum_probs=204.2

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      +.|+..+.||.|.-|+||+++.+ ++..+|+|++....   .....+...|.+||+.++||.++.+|+.|+.++..|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            45677899999999999999865 56899999997653   234456677999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          468 EYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+||+|...++++. ..+++..+..++.+++-||+|||   ..|||+|||||+|||+.++|++.++||.++.......
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            9999999999998764 36899999999999999999999   9999999999999999999999999999975432100


Q ss_pred             ------------------------------------------------------CcceeecccCCccccCccccCCCCCC
Q 005760          547 ------------------------------------------------------QSTIQTQTLATIGYMAPEYGKEGRVS  572 (678)
Q Consensus       547 ------------------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~  572 (678)
                                                                            ........+||-.|+|||++.+...+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                                                  00112345799999999999999999


Q ss_pred             ccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhcccc
Q 005760          573 ANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVE  652 (678)
Q Consensus       573 ~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  652 (678)
                      .++|+|+|||++|||+.|..||-+.... .++...+..            .      ..++.....+..+.+||++.|.+
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~-~Tl~NIv~~------------~------l~Fp~~~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNK-ETLRNIVGQ------------P------LKFPEEPEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCch-hhHHHHhcC------------C------CcCCCCCcchhHHHHHHHHHhcc
Confidence            9999999999999999999999874432 233222211            0      11111113455688999999999


Q ss_pred             CcCCCCC----HHHHHH
Q 005760          653 SPEQRIN----AKEIVT  665 (678)
Q Consensus       653 dP~~Rps----~~ell~  665 (678)
                      ||.+|..    |+||.+
T Consensus       375 dP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             ChhhhhccccchHHhhc
Confidence            9999998    777754

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-38  Score=324.84  Aligned_cols=256  Identities=29%  Similarity=0.529  Sum_probs=207.2

Q ss_pred             cCCCCCccccCCCceeEEEEEeCC------CcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGD------GMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      ++|++.+.||+|+||.||+|....      ...||+|.+..... .....+.+|+++++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468889999999999999997532      25799999864432 34466889999999999999999999999988999


Q ss_pred             EEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC
Q 005760          465 LVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM  529 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~  529 (678)
                      ++|||+++++|.+++....               ..+++..+..++.|++.|++|||   +.+++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999997542               34778889999999999999999   99999999999999999999


Q ss_pred             cEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhh
Q 005760          530 VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWV  608 (678)
Q Consensus       530 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~  608 (678)
                      .++|+|||++................+++.|+|||.+.++.++.++|||||||++|||++ |..||.+....+  ....+
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~~~i  239 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VIEMI  239 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH
Confidence            999999999976543333333445567889999999988899999999999999999998 999987633321  11111


Q ss_pred             hcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                      ....            ..      ..+..++.++.+++.+||+.||.+||+++|+++.|+++
T Consensus       240 ~~~~------------~~------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         240 RSRQ------------LL------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             HcCC------------cC------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence            1000            00      01234667799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-39  Score=326.15  Aligned_cols=249  Identities=34%  Similarity=0.560  Sum_probs=195.3

Q ss_pred             CCccccCCCceeEEEEEeC-----CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          396 ENNLIGRGSFGSVFKARLG-----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       396 ~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +.+.||.|.||.||+|.+.     .+..|+||.++.... +..+.+.+|++.++.++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999864     367799999965433 3468899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++|+|.+++... ...+++..+..|+.||++||+|||   +++++|+||+++||+++.++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999887 556899999999999999999999   899999999999999999999999999999876333333


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      ...........|+|||.+.+..++.++||||||+++||+++ |+.||.+....  .....+....     .         
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~--~~~~~~~~~~-----~---------  223 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE--EIIEKLKQGQ-----R---------  223 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH--HHHHHHHTTE-----E---------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccc-----c---------
Confidence            33444567789999999999889999999999999999999 67887653221  1111111000     0         


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                          ...+..++..+.+++.+||..||++||++.|++++|
T Consensus       224 ----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 ----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                000112455688999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.7e-38  Score=326.00  Aligned_cols=266  Identities=22%  Similarity=0.327  Sum_probs=204.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||.||+|+.. +|..+|+|++..... ...+.+.+|+++++.++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999854 788999999875432 345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+++++|.+++.... .+++..+..++.|++.|+.|||   +. +|+||||||+||+++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999997655 4888999999999999999999   64 6999999999999999999999999998755322  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc--------------C
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL--------------P  613 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--------------~  613 (678)
                        ......++..|+|||.+.+..++.++|||||||++|||++|+.||......+  +........              +
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccCccc
Confidence              1234568999999999998899999999999999999999999996432211  111100000              0


Q ss_pred             CcccccccCccC-Cccc---hhhH-----------HHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          614 ISTKEIVDPNLL-SRED---INFV-----------AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       614 ~~~~~~~~~~~~-~~~~---~~~~-----------~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      ............ ....   .+..           ....++.++.+++.+||++||++|||+.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000000000 0000   0000           001246679999999999999999999999875

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.8e-38  Score=324.44  Aligned_cols=260  Identities=28%  Similarity=0.498  Sum_probs=209.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      .++|.+.+.||+|+||.||++..      .++..+|+|.+........+.+.+|+++++.++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            45788999999999999999974      234568999987554445667899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEE
Q 005760          465 LVLEYMPHGSLEKYLHSSN------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH  532 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~k  532 (678)
                      +||||+++++|.+++....            ..+++..+..++.|++.|++|||   +++++||||||+||++++++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            9999999999999997543            24889999999999999999999   99999999999999999999999


Q ss_pred             EEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcc
Q 005760          533 LSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDW  611 (678)
Q Consensus       533 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~  611 (678)
                      ++|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......+ .........
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-~~~~i~~~~  239 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-VIECITQGR  239 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCC
Confidence            999999976543322222334446778999999988889999999999999999998 888886533221 111111100


Q ss_pred             cCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          612 LPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      ..    .  .+             ..++.++.+++.+||+.||.+|||+.|+.+.|+++.+.
T Consensus       240 ~~----~--~~-------------~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         240 VL----Q--RP-------------RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             cC----C--CC-------------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            00    0  00             11345588999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=326.62  Aligned_cols=255  Identities=25%  Similarity=0.417  Sum_probs=217.8

Q ss_pred             CCCCCccccCCCceeEEEEEeC---CC--cEEEEEEeecc-cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLG---DG--MEVAMKVFNLQ-YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~---~~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .....++||+|.||.||+|.+.   .|  -.||||.-+.+ .....+.|..|..+|+.++||||++++|+|.+. ..++|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            3445678999999999999742   23  45899988764 345678899999999999999999999999875 46899


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      ||.++.|.|.+|++.....++.....-++.||+.+|+|||   ++++|||||.++|||+.....||++|||+++.+....
T Consensus       469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~  545 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA  545 (974)
T ss_pred             EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence            9999999999999999888999999999999999999999   9999999999999999999999999999999876544


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                      .+ ..+...-+..|||||-+.-.+++.++|||-|||.+||++. |..||.+..+.+.-.                    .
T Consensus       546 yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~--------------------~  604 (974)
T KOG4257|consen  546 YY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG--------------------H  604 (974)
T ss_pred             hh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE--------------------E
Confidence            33 3445667889999999999999999999999999999998 999998755443211                    1


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                      -..+.+++.+++|++.++.+|.+||.+||.+||.+.|+...|+.+..
T Consensus       605 iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  605 IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            12233455667899999999999999999999999999999999875

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.5e-38  Score=319.31  Aligned_cols=252  Identities=25%  Similarity=0.407  Sum_probs=203.4

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      ++|++.+.||+|+||.||+|.++++..+|+|.+... ....+.+..|+.+++.++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            457888999999999999999888889999987643 2234678889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      +|+|.++++.....+++..+..++.|++.|++|||   +++++|+||+|+||+++.++.+|++|||.++...... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eecc
Confidence            99999999865556889999999999999999999   9999999999999999999999999999987653222 1112


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccch
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI  630 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  630 (678)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+....     ....+.       
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~~~-----~~~~~~-------  224 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISRGF-----RLYRPK-------  224 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCC-----CCCCCC-------
Confidence            23345678999999988889999999999999999999 88898653221  1111111000     001111       


Q ss_pred             hhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       631 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                            ..+.++.+++.+||+.+|++||++.|+++.|.
T Consensus       225 ------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 ------LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ------CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  12345889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-39  Score=328.79  Aligned_cols=251  Identities=25%  Similarity=0.369  Sum_probs=212.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCe-EEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF-KALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv  466 (678)
                      .++|..++.+|+|+||.++.++.+ ++..+|+|.+....  ........+|+.++++++|||||.+.+.+.+.+. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            357888999999999999999754 67889999986543  3445577889999999999999999999998888 9999


Q ss_pred             EEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          467 LEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      |+|++||++.+.+.+.+ ..+++.++..|+.|++.|+.|||   +++|+|||||+.||+++.++.|||+|||+|+.+.+.
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999998766 57899999999999999999999   999999999999999999999999999999988654


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                      .  .......||+.|+.||++.+..|..|+||||+||++|||++-+++|.+........ ...+..        .     
T Consensus       160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~-ki~~~~--------~-----  223 (426)
T KOG0589|consen  160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL-KINRGL--------Y-----  223 (426)
T ss_pred             h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH-HHhhcc--------C-----
Confidence            3  23456789999999999999999999999999999999999999997643322111 111110        0     


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                            .+.+..++.++..+++.|++.+|+.||++.+++.+
T Consensus       224 ------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  224 ------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                  11123456778999999999999999999999987

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=329.51  Aligned_cols=256  Identities=26%  Similarity=0.405  Sum_probs=216.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCC-CcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..+....++||.|.||.||.|.|+. ..-||||.++.+. ...++|..|+.+|+.++|||+|+++|+|..+-..|||+||
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            3455677899999999999999874 5669999997654 3468899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |.+|+|.+|++.... .++.-..+.|+.||.+|++||.   ++++|||||.++|+|+.++..||+.|||+++.+.. +++
T Consensus       345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg-DTY  420 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG-DTY  420 (1157)
T ss_pred             ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcC-Cce
Confidence            999999999987643 4666777899999999999999   99999999999999999999999999999998864 344


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      .......-+..|.|||-+....++.|+|||+|||+|||+.| |..||.+....     +... .              -.
T Consensus       421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----qVY~-L--------------LE  480 (1157)
T KOG4278|consen  421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYG-L--------------LE  480 (1157)
T ss_pred             ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----HHHH-H--------------Hh
Confidence            44455667889999999999999999999999999999999 88888764322     1110 0              01


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                      ..++...++.|++.+++||+.||+++|.+||++.|+-+.++.+-
T Consensus       481 kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  481 KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence            12233345679999999999999999999999999999999874

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-38  Score=329.83  Aligned_cols=259  Identities=23%  Similarity=0.385  Sum_probs=206.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCc----EEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGM----EVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      ..+|+..+.||+|+||.||+|.+. +++    .||+|++.... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            356899999999999999999753 343    48999986432 23456788999999999999999999998765 467


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +|+||+++|+|.+++......+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            999999999999999887667889999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ............+..|+|||.+.+..++.++|||||||++|||++ |..||.+....  ..........     ...   
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~-----~~~---  231 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE-----RLP---  231 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCCC-----CCC---
Confidence            333222233445678999999999999999999999999999998 99998653221  1111111000     000   


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                                .+..++.++.+++.+||+.+|++||++.|++..+..+...
T Consensus       232 ----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         232 ----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence                      0012345588999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-39  Score=327.65  Aligned_cols=245  Identities=25%  Similarity=0.340  Sum_probs=199.9

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46889999999999999999864 78999999986532   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++++|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            9999999999998665 4888899999999999999999   999999999999999999999999999998765321  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                         .....|++.|+|||++.+..++.++||||+||++|||++|+.||.......  ....+..   ..   ..-+     
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~~~i~~---~~---~~~~-----  218 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IYEKILA---GK---LEFP-----  218 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh---CC---cCCC-----
Confidence               123468999999999998889999999999999999999999987532211  1111100   00   0000     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCC-----HHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVTK  666 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ell~~  666 (678)
                              ...+..+.+++.+||+.||.+||+     ++|+++.
T Consensus       219 --------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         219 --------RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             --------ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                    112445789999999999999995     8887753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-39  Score=317.80  Aligned_cols=258  Identities=26%  Similarity=0.356  Sum_probs=199.6

Q ss_pred             HHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--------------chhhhHHHHHHHHHhCCCccce
Q 005760          387 LCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--------------RVFKSFDVECEMMKSIRHRNII  451 (678)
Q Consensus       387 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv  451 (678)
                      -...-++|++.+.||+|.||.|-+|+. .+++.||||++.....              ...+...+|+.+|++++|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            344568899999999999999999985 4899999999954311              1235788999999999999999


Q ss_pred             eeeeeeec--CCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC
Q 005760          452 KVISSCSN--EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM  529 (678)
Q Consensus       452 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~  529 (678)
                      +++.+..+  .+.+|+|+|||..|.+...=.... .++..+++.++++++.||+|||   .+||+||||||+|+|++++|
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~-els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKP-ELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCCCCcc-cccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCC
Confidence            99999866  468999999999887643322221 2788999999999999999999   99999999999999999999


Q ss_pred             cEEEEeeccccccCCC---CCcceeecccCCccccCccccCCCC----CCccchHHHHHHHHHHHHcCCCCCCcccCCcc
Q 005760          530 VAHLSDFGIAKLLTRE---DQSTIQTQTLATIGYMAPEYGKEGR----VSANGDVYSFGIMLMETFTRKKPTDEIFNGEM  602 (678)
Q Consensus       530 ~~kl~Dfg~~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~  602 (678)
                      +|||+|||.+......   +....-....|||.|+|||...++.    .+.+.||||+||+||.|+.|+.||-+.+..+ 
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-  326 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-  326 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH-
Confidence            9999999999765221   1122233478999999999887743    3567899999999999999999986533221 


Q ss_pred             chhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 005760          603 TLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                       +-+           .++...+      .++...+..+++.+|+.+||++||++|.+..+|....
T Consensus       327 -l~~-----------KIvn~pL------~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  327 -LFD-----------KIVNDPL------EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             -HHH-----------HHhcCcc------cCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence             111           1111111      1112223456689999999999999999999987543

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-38  Score=318.90  Aligned_cols=257  Identities=26%  Similarity=0.450  Sum_probs=207.8

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC----CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      .++|++.+.||+|+||.||+|.++    +...||+|.+.... ......+..|+.+++.++||||+++++++.+.+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            357889999999999999999864    24679999986543 2345678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++++|.+++......+++..+..++.|++.|++|||   +++|+|+||+|+||++++++.++++|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999876667899999999999999999999   999999999999999999999999999999876522


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ..........++..|+|||...+..++.++||||||+++|||++ |..||......  .....+....       ..+  
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~-------~~~--  228 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGY-------RLP--  228 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCC-------CCC--
Confidence            22222223345678999999998899999999999999999998 99998653221  1111111000       000  


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                               .+..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       229 ---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 ---------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                     0112455688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=9.7e-39  Score=321.65  Aligned_cols=257  Identities=27%  Similarity=0.506  Sum_probs=210.8

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ++..+|++.+.||.|+||.||+|...++..+|+|++..........+..|+++++.++||||+++++++.+.+..++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567899999999999999999988899999999976655456778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+++++|.++++... ..+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.+|++|||.+....... 
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~-  158 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-  158 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence            999999999997643 35789999999999999999999   9999999999999999999999999999997654321 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                       .......++..|+|||...++.++.++||||||+++|+|++ |+.||......+ ..........      ..      
T Consensus       159 -~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-~~~~~~~~~~------~~------  224 (261)
T cd05148         159 -YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-VYDQITAGYR------MP------  224 (261)
T ss_pred             -ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-HHHHHHhCCc------CC------
Confidence             11223446778999999988889999999999999999998 889986533211 1111111000      00      


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                             .+..+++.+.+++.+||+.||++|||+.++++.|+++
T Consensus       225 -------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         225 -------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             -------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                   0112345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=302.04  Aligned_cols=251  Identities=23%  Similarity=0.345  Sum_probs=205.0

Q ss_pred             hcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecc--cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++.|++-+.||+|.|+.||+.. ..+|+.+|+|++...  .....+.+.+|+++-+.|+||||+++.+.+.+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            4677888899999999999985 458999999988543  3446788899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec---CCCcEEEEeeccccccCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~---~~~~~kl~Dfg~~~~~~~  544 (678)
                      |++.|++|..-+-.. ...++..+..+++||++++.|+|   .++|||||+||+|+++.   ...-+|++|||+|..+. 
T Consensus        90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-  164 (355)
T ss_pred             ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence            999999997554333 34788888999999999999999   99999999999999994   45578999999999886 


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                        .........|||+|||||+++..+|+-.+|||+.||+||-++.|.+||.+.+..+ ...+.....+.           
T Consensus       165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-lye~I~~g~yd-----------  230 (355)
T KOG0033|consen  165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYEQIKAGAYD-----------  230 (355)
T ss_pred             --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-HHHHHhccccC-----------
Confidence              3344567889999999999999999999999999999999999999998733321 11222221111           


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           .+.......+++..+|+++|+..||.+|.|+.|+++
T Consensus       231 -----~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  231 -----YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             -----CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                 111112234566889999999999999999999875

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=330.98  Aligned_cols=253  Identities=22%  Similarity=0.333  Sum_probs=204.0

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+..|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46889999999999999999865 68999999997542   233466788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||++.....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999997654 4788899999999999999999   99999999999999999999999999999975432   


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        ......|++.|+|||++.+..++.++||||+||++|||++|..||......+. . ..+..+..    ....+.....
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~-~~i~~~~~----~~~~~~~~~~  225 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-W-ENLKYWKE----TLQRPVYDDP  225 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-H-HHHHhccc----cccCCCCCcc
Confidence              22345689999999999998999999999999999999999999975322111 1 11111100    0000110000


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                             ....+.++.+++.+||+.+|.+||++.|+++.
T Consensus       226 -------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         226 -------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                   01245668899999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-39  Score=314.86  Aligned_cols=260  Identities=25%  Similarity=0.337  Sum_probs=195.9

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecC---C--eEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNE---E--FKALV  466 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---~--~~~lv  466 (678)
                      .|...+.+|.|+||.||+|.. .+++.||||+.-.+.+    --.+|+++|+.++|||||++..+|...   +  ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            466679999999999999985 4679999999854322    224699999999999999999887432   2  33489


Q ss_pred             EEecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC-CcEEEEeecccccc
Q 005760          467 LEYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLL  542 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~-~~~kl~Dfg~~~~~  542 (678)
                      |||++. +|.++++..   +..++...+.-+..||.+|++|||   +.+|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999977 999998742   345777888889999999999999   9999999999999999965 99999999999988


Q ss_pred             CCCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc--CCccc--
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL--PISTK--  617 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~--  617 (678)
                      ......   ..+..|..|.|||.+.+. .|+.+.||||.||++.||+-|++-|.+... ...+...++-..  .....  
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~-~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS-VDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH-HHHHHHHHHHhCCCCHHHHhh
Confidence            654333   456788999999988775 599999999999999999999999877322 222233322111  00000  


Q ss_pred             ------ccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          618 ------EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       618 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                            +...|......-.+ ......+++..+++.++++++|.+|.++.|++.
T Consensus       253 mn~~y~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cCcccccccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                  11111111111111 122346788999999999999999999999985

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.4e-38  Score=330.43  Aligned_cols=241  Identities=24%  Similarity=0.307  Sum_probs=195.6

Q ss_pred             ccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCC
Q 005760          398 NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG  473 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  473 (678)
                      +.||+|+||.||+|.. .+|+.||+|+++...   ......+..|+.+++.++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999975 578999999997542   233456778999999999999999999999999999999999999


Q ss_pred             CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeec
Q 005760          474 SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ  553 (678)
Q Consensus       474 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  553 (678)
                      +|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  ......
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCcccc
Confidence            9999997655 4889999999999999999999   999999999999999999999999999998753221  112234


Q ss_pred             ccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhH
Q 005760          554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV  633 (678)
Q Consensus       554 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  633 (678)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+.   ..   ....            
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~~---~~---~~~~------------  214 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELIL---ME---EIRF------------  214 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHHH---cC---CCCC------------
Confidence            56899999999999999999999999999999999999999652211  1111110   00   0000            


Q ss_pred             HHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          634 AKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       634 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                       +...+.++.+++.+||+.||++||     ++.|+++
T Consensus       215 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         215 -PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence             012345688999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.3e-38  Score=328.93  Aligned_cols=261  Identities=25%  Similarity=0.437  Sum_probs=205.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceeeeeeeec-C
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKVISSCSN-E  460 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~  460 (678)
                      ..++|++.+.||+|+||.||+|..      .+++.||+|++..... ...+.+..|+++++++ +|+||+++++++.. .
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            346799999999999999999953      2357899999864332 2345677899999999 79999999998754 4


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCC---------------------------------------------------------
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSN---------------------------------------------------------  483 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------  483 (678)
                      ...++++||+++++|.+++....                                                         
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            57889999999999999986421                                                         


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccc
Q 005760          484 ---YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY  560 (678)
Q Consensus       484 ---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y  560 (678)
                         ..+++..+..++.||+.|++|||   +++|+||||||+||+++.++.++|+|||++..+.............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               14788899999999999999999   999999999999999999999999999999876433322233344567789


Q ss_pred             cCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHH
Q 005760          561 MAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCV  639 (678)
Q Consensus       561 ~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  639 (678)
                      +|||++.+..++.++||||+||++|||++ |..||......+ ...........     ..             .+..++
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~-----~~-------------~~~~~~  302 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTR-----MR-------------APEYAT  302 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCC-----CC-------------CCccCC
Confidence            99999999999999999999999999998 999986532221 11111110000     00             011234


Q ss_pred             HHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          640 SFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       640 ~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                      +++.+++.+||+.+|++||++.|+++.|+.+..
T Consensus       303 ~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         303 PEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.4e-39  Score=310.54  Aligned_cols=248  Identities=23%  Similarity=0.356  Sum_probs=206.8

Q ss_pred             hcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ..+|++.+.||+|.||.|-+|+ .+.|+.||||.++...   .+..-.+.+|+++|+.|+||||+.++.+|+..+.+.+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            3578888999999999999997 5789999999996543   34455678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||..+|.|++|+...+. +++.....+++||.+|+.|+|   +++++|||+|.+|||+|.++++||.|||++..+... 
T Consensus       132 MEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~-  206 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK-  206 (668)
T ss_pred             EEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence            999999999999987764 899999999999999999999   999999999999999999999999999999876432 


Q ss_pred             CcceeecccCCccccCccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                        ..-..++|++-|.+||+..+..| ++.+|-||+||+||-++.|..||++.+- .....+.-++.+.       .|   
T Consensus       207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-k~lvrQIs~GaYr-------EP---  273 (668)
T KOG0611|consen  207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-KRLVRQISRGAYR-------EP---  273 (668)
T ss_pred             --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-HHHHHHhhccccc-------CC---
Confidence              23346789999999999999988 5789999999999999999999987321 1111221111111       01   


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                                 ..+.++.-||++|+..+|++|-|+.++....
T Consensus       274 -----------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  274 -----------ETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             -----------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                       1233466799999999999999999987543

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-38  Score=317.17  Aligned_cols=256  Identities=29%  Similarity=0.459  Sum_probs=206.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..++|++.+.||+|++|.||+|...+++.||+|.++... ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            346788999999999999999998778889999986532 2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++++|.+++.... ..+++..+..++.|++.|+.|||   +++++|+||||+||++++++.++|+|||+++...... .
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~  158 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI-Y  158 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc-c
Confidence            99999999997643 45889999999999999999999   9999999999999999999999999999998764221 1


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      ........+..|+|||+..+..++.++||||||+++|||++ |+.||.+.....  ....+.....     .  +     
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~-----~--~-----  224 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQQVDQGYR-----M--P-----  224 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCC-----C--C-----
Confidence            11122233467999999998899999999999999999999 999986532211  1111110000     0  0     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                            .+..++..+.+++.+|++.+|++||++.++++.|+++
T Consensus       225 ------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         225 ------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                  0012345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.8e-38  Score=321.79  Aligned_cols=255  Identities=31%  Similarity=0.509  Sum_probs=205.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccCc-hhhhHHHHHHHHHhCCCccceeeeeeeecCCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  463 (678)
                      .++|.+.+.||+|+||.||+|...      ++..||+|.+...... ..+.+.+|+++++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            356888899999999999999753      3578999998654333 457889999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc
Q 005760          464 ALVLEYMPHGSLEKYLHSSN-------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV  530 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~  530 (678)
                      ++||||+++++|.++++..+             ..+++..+..++.|++.|+.|||   +++++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence            99999999999999997542             24678889999999999999999   999999999999999999999


Q ss_pred             EEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhh
Q 005760          531 AHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVN  609 (678)
Q Consensus       531 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~  609 (678)
                      +|++|||++................+++.|+|||++.++.++.++||||+||++|||++ |..||......+  ....+.
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~~  238 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECIT  238 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH
Confidence            99999999876533222222334456788999999999999999999999999999998 999986532211  111111


Q ss_pred             cccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          610 DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      .   ....         .      .+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus       239 ~---~~~~---------~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         239 Q---GRLL---------Q------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             c---CCcC---------C------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            0   0000         0      00123456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-38  Score=331.91  Aligned_cols=245  Identities=22%  Similarity=0.268  Sum_probs=199.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            357889999999999999999864 78999999986532   23346688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++.......
T Consensus        97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence            99999999999998765 4788888999999999999999   9999999999999999999999999999997653221


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                           ....|++.|+|||++.+..++.++|||||||++|||++|+.||.+....  .....+.   ..   ...-|.   
T Consensus       173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i~---~~---~~~~p~---  236 (329)
T PTZ00263        173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RIYEKIL---AG---RLKFPN---  236 (329)
T ss_pred             -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HHHHHHh---cC---CcCCCC---
Confidence                 2346899999999999988999999999999999999999998653211  1111100   00   000011   


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ell~  665 (678)
                                .++.++.+++.+||+.||.+||+     ++|+++
T Consensus       237 ----------~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        237 ----------WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ----------CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                      12345789999999999999997     677764

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.1e-38  Score=314.63  Aligned_cols=248  Identities=27%  Similarity=0.448  Sum_probs=197.9

Q ss_pred             ccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCH
Q 005760          398 NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL  475 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  475 (678)
                      +.||+|+||.||+|.. .+++.||+|.+.... .+....+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4699999999999986 478999999876432 23456788999999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeeccc
Q 005760          476 EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL  555 (678)
Q Consensus       476 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  555 (678)
                      .+++......+++..+..++.|++.||+|||   +++++||||+|+||+++.++.+|++|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999876656889999999999999999999   9999999999999999999999999999987543221111111223


Q ss_pred             CCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHH
Q 005760          556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVA  634 (678)
Q Consensus       556 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  634 (678)
                      .+..|+|||.+.++.++.++||||+||++|||++ |..||.......  ....+....+        .          ..
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~~~--------~----------~~  217 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGVR--------L----------PC  217 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCC--------C----------CC
Confidence            3567999999998889999999999999999998 888886432211  1111110000        0          00


Q ss_pred             HHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          635 KEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       635 ~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      +..++..+.+++.+||+.+|++||++.|+.++|+
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1123556889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.9e-38  Score=318.16  Aligned_cols=255  Identities=24%  Similarity=0.415  Sum_probs=206.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      .++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+.+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            46788999999999999999998888899999976432 23567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          471 PHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       471 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      ++++|.++++.. ....++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++++|||++........ .
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            999999999754 345788899999999999999999   89999999999999999999999999999986543221 1


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                      ......++..|+|||...++.++.++|||||||++|+|++ |+.||......  .....+....        ...     
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~--------~~~-----  224 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQRGY--------RMP-----  224 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCC--------CCC-----
Confidence            1223345678999999988889999999999999999998 89998653221  1111111100        000     


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                           ....++.++.+++.+||..+|++||+++++.+.|+++
T Consensus       225 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         225 -----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                 0012345588999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.1e-38  Score=321.62  Aligned_cols=259  Identities=30%  Similarity=0.496  Sum_probs=208.9

Q ss_pred             cCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      .+|.+.+.||+|+||.||+|..      .++..+++|.+........+.+.+|+++++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            4577889999999999999973      2456689999875555555778899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc
Q 005760          466 VLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV  530 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~  530 (678)
                      ||||+++++|.+++....               ..+++..++.++.|++.|++|||   +++++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999997542               24788999999999999999999   999999999999999999999


Q ss_pred             EEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhh
Q 005760          531 AHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVN  609 (678)
Q Consensus       531 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~  609 (678)
                      ++++|||++................++..|+|||.+.+..++.++|||||||++|||++ |+.||......+ .......
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~  240 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-VIECITQ  240 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHhC
Confidence            99999999976543322223344556788999999998899999999999999999999 999986532211 1111100


Q ss_pred             cccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          610 DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      ...+    .     .          +..++.++.+++.+||+.+|++||++.+++++|+++.+.
T Consensus       241 ~~~~----~-----~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         241 GRVL----E-----R----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             CCCC----C-----C----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            0000    0     0          012345688999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-38  Score=308.63  Aligned_cols=271  Identities=25%  Similarity=0.397  Sum_probs=212.2

Q ss_pred             HHHhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHh--CCCccceeeeeeeecC----
Q 005760          387 LCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKS--IRHRNIIKVISSCSNE----  460 (678)
Q Consensus       387 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~----  460 (678)
                      ......+..+.+.||+|.||.||+|+| .|+.||||+|...   +.+.+.+|.++.+.  ++|+||+.+++....+    
T Consensus       206 QRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  206 QRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             HHhhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            444566788899999999999999999 5899999999743   33667788888875  5999999999876443    


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCCCeEEcCCCCCCeeecCCCcEEEEe
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF-----GYSAQVIHCDLKPSNVLLDDNMVAHLSD  535 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivH~dl~~~Nill~~~~~~kl~D  535 (678)
                      .++++|++|.+.|+|.||+.+.  .++.....+++..+|.||+|||.     +.+..|.|||||+.|||+..+|.+.|+|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence            3678999999999999999875  48899999999999999999995     3356799999999999999999999999


Q ss_pred             eccccccCCCC--CcceeecccCCccccCccccCCCC----C-C-ccchHHHHHHHHHHHHcC----------CCCCCcc
Q 005760          536 FGIAKLLTRED--QSTIQTQTLATIGYMAPEYGKEGR----V-S-ANGDVYSFGIMLMETFTR----------KKPTDEI  597 (678)
Q Consensus       536 fg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~----~-~-~~~DvwslGv~l~ell~g----------~~p~~~~  597 (678)
                      +|+|.......  -.......+||-+|||||++...-    + + ..+||||||.++||+..+          +.||++.
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            99998775432  122345678999999999986542    1 2 358999999999999853          4688887


Q ss_pred             cCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          598 FNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                      .+.+....+.-+-.--.+....++.         .....++...+.++|+.||..+|..|.||-.+.+.|.++.+
T Consensus       440 Vp~DPs~eeMrkVVCv~~~RP~ipn---------rW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  440 VPSDPSFEEMRKVVCVQKLRPNIPN---------RWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCCHHHHhcceeecccCCCCCc---------ccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            7766665543221111112222222         22234566678899999999999999999999999998863

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.4e-38  Score=315.73  Aligned_cols=252  Identities=25%  Similarity=0.412  Sum_probs=203.1

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      ++|++.+.||+|+||.||.|+..++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4578889999999999999988777789999886432 234678899999999999999999999998888999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      +++|.+++......+++..++.++.|++.|++|||   +.+++|+||+|+||+++.++.+|++|||.++...... ....
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-eeec
Confidence            99999999876556899999999999999999999   9999999999999999999999999999987654322 1122


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccch
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI  630 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  630 (678)
                      ....++..|+|||...+..++.++|||||||++|||++ |..||......+  ....+.....     ...+        
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~-----~~~~--------  223 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQGLR-----LYRP--------  223 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcCCC-----CCCC--------
Confidence            23345678999999988889999999999999999998 899986432211  1111110000     0000        


Q ss_pred             hhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       631 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                           ...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       224 -----~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 -----HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                 012455889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.4e-38  Score=317.54  Aligned_cols=258  Identities=25%  Similarity=0.418  Sum_probs=203.5

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCc----EEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGM----EVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ++|++.+.||+|+||.||+|.+. +++    .+++|.+..... ....++..|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            56888899999999999999853 454    477777753322 233567778888999999999999998864 45679


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ++||+++|+|.+++......+++..+..++.|++.|++|||   +++++||||||+||++++++.+|++|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999876667899999999999999999999   899999999999999999999999999999866433


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ..........++..|+|||...++.++.++|||||||++||+++ |..||.+.....  ..+.+....     ....+  
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~-----~~~~~--  233 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEKGE-----RLAQP--  233 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCCC-----cCCCC--
Confidence            32223334557788999999988899999999999999999998 999986533221  111111000     00011  


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                                 ..++.++.+++.+||..+|++|||+.|+++.|..+...
T Consensus       234 -----------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         234 -----------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             -----------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence                       11344578899999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.9e-37  Score=323.05  Aligned_cols=198  Identities=25%  Similarity=0.388  Sum_probs=174.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||.||+|... ++..+|+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999865 788999999875422 344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+++++|.+++.... .+++..+..++.|++.|+.|||   + .+++|+||||+||+++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999997654 4788899999999999999999   6 47999999999999999999999999998754321  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDE  596 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~  596 (678)
                        ......++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence              12334688999999999988899999999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.8e-38  Score=342.47  Aligned_cols=250  Identities=23%  Similarity=0.305  Sum_probs=202.0

Q ss_pred             CCCCCccccCCCceeEEEEEeC-C-CcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-D-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      .|.+.+.||+|++|.||+|... + ++.||+|.+..........+..|+++++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999743 4 6788999876554444566788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          471 PHGSLEKYLHSS---NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       471 ~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ++|+|.+++...   ...+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999987542   335788899999999999999999   99999999999999999999999999999987643322


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+     ..........    ++     
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~-----~~~~~~~~~~----~~-----  290 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE-----IMQQVLYGKY----DP-----  290 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCCC----CC-----
Confidence            223345569999999999999899999999999999999999999986532211     1110000000    00     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                            .+..++.++.+++.+||+.||++||++.|++.
T Consensus       291 ------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 ------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence                  01123456889999999999999999999875

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.8e-37  Score=313.54  Aligned_cols=258  Identities=24%  Similarity=0.359  Sum_probs=207.6

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+....   ......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5789999999999999999985 478999999875422   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          468 EYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       468 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      ||+++++|.+++..   ....++...+..++.|++.|++|||   +++++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988853   2335788899999999999999999   99999999999999999999999999999876543


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ..  .......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||.............+..        ...+..
T Consensus       159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~  228 (267)
T cd08228         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ--------CDYPPL  228 (267)
T ss_pred             hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc--------CCCCCC
Confidence            22  11223468889999999988889999999999999999999999986532221112111110        000110


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                               ....++.++.+++.+||+.+|++||++.|+++.++.++
T Consensus       229 ---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         229 ---------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ---------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                     01234566899999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.6e-38  Score=325.19  Aligned_cols=241  Identities=23%  Similarity=0.326  Sum_probs=195.1

Q ss_pred             ccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCC
Q 005760          398 NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG  473 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  473 (678)
                      +.||+|+||.||++.. .+|..||+|++....   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999985 478999999997542   233456678999999999999999999999999999999999999


Q ss_pred             CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeec
Q 005760          474 SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ  553 (678)
Q Consensus       474 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  553 (678)
                      +|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++.......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence            9999887654 4889999999999999999999   9999999999999999999999999999987532211  12234


Q ss_pred             ccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhH
Q 005760          554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV  633 (678)
Q Consensus       554 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  633 (678)
                      ..|++.|+|||.+.+..++.++|||||||++|||++|+.||....... ........       ....|           
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~~~~~-------~~~~p-----------  215 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILME-------EIRFP-----------  215 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHhcC-------CCCCC-----------
Confidence            568999999999999899999999999999999999999986532211 11111000       00000           


Q ss_pred             HHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          634 AKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       634 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                        ..+++++.+++.+||++||++||     ++.++++
T Consensus       216 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         216 --RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             --CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence              12345688999999999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-38  Score=313.42  Aligned_cols=251  Identities=27%  Similarity=0.428  Sum_probs=202.4

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      .+|++.+.||+|+||.||+|.++++..+|+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            3578899999999999999998777889999986432 233568889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      +++|.+++......+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+|++|||+++...... ....
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~  158 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSS  158 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc-cccc
Confidence            99999999876556899999999999999999999   9999999999999999999999999999987653221 1111


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccch
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI  630 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  630 (678)
                      ....++..|+|||...+..++.++||||||+++|||++ |+.||......+.  ...+...        ....       
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~~--------~~~~-------  221 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV--VESVSAG--------YRLY-------  221 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH--HHHHHcC--------CcCC-------
Confidence            22234567999999998899999999999999999999 7888865332211  1111100        0000       


Q ss_pred             hhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 005760          631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       631 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                         .+..++.++.+++.+||+.+|++|||+.|+++.|
T Consensus       222 ---~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         222 ---RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               0012455689999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=8e-38  Score=318.93  Aligned_cols=255  Identities=27%  Similarity=0.471  Sum_probs=203.5

Q ss_pred             cCCCCCccccCCCceeEEEEEe-----CCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-----GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ++|++.+.||+|+||.||+|..     .++..||+|.+..... +....+.+|+++++.++||||+++++++..++..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4678889999999999999973     2567899999864322 334678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCC----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC
Q 005760          466 VLEYMPHGSLEKYLHSSN----------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM  529 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~  529 (678)
                      ||||+++++|.+++....                ..+++.++..++.|++.|++|||   +++++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985321                24678888999999999999999   99999999999999999999


Q ss_pred             cEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhh
Q 005760          530 VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWV  608 (678)
Q Consensus       530 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~  608 (678)
                      .+|++|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+...  ....+.+
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--~~~~~~~  239 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--QEVIEMV  239 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHH
Confidence            999999999976643332223344456778999999988889999999999999999998 8888865322  1111111


Q ss_pred             hcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                      .....           ..       .+..+++++.+++.+||+.||++||++.++.+.|.+
T Consensus       240 ~~~~~-----------~~-------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         240 RKRQL-----------LP-------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HcCCc-----------CC-------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11000           00       011245568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-38  Score=338.25  Aligned_cols=260  Identities=22%  Similarity=0.321  Sum_probs=209.3

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeCCC-cEEEEEEeecccCchhhhHHHHHHHHHhCC-Cccceeeeee-eec------
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLGDG-MEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISS-CSN------  459 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~------  459 (678)
                      ....++++.+.|.+|||+.||.|....+ ..+|+|++-.......+.+.+|+++|+.|+ |+|||.+++. ...      
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            3455678889999999999999986554 999999987777778899999999999997 9999999993 211      


Q ss_pred             CCeEEEEEEecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecc
Q 005760          460 EEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI  538 (678)
Q Consensus       460 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~  538 (678)
                      ....+|+||||.||.|-+++..+ ...+++.++++|+.++++|+++|| ..+..|||||||-+|||++.+|+.||||||.
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            24678999999999999999743 234999999999999999999999 3345599999999999999999999999999


Q ss_pred             ccccCCCCCcc-------eeecccCCccccCcccc---CCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhh
Q 005760          539 AKLLTREDQST-------IQTQTLATIGYMAPEYG---KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWV  608 (678)
Q Consensus       539 ~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~  608 (678)
                      |+.........       ..-....|+.|+|||.+   .+..+++|+|||+|||+||-|+....||+..-..  .+    
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--aI----  266 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--AI----  266 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--eE----
Confidence            97544332111       11223589999999964   5667899999999999999999999999763221  11    


Q ss_pred             hcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                                 ++      ..+.++....++..+.+||+.||+.||.+||++.|++..+.++..
T Consensus       267 -----------ln------g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  267 -----------LN------GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             -----------Ee------ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                       11      111222223577889999999999999999999999999998864

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-37  Score=314.30  Aligned_cols=254  Identities=25%  Similarity=0.415  Sum_probs=204.4

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      .+|++.+.||+|+||.||+|..+ +++.||+|.+... ......+.+|+++++.++||||+++++++...+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45778899999999999999754 6889999998643 233467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          471 PHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       471 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      ++++|.+++.... ..+++..+..++.|+++|++|||   +++++||||||+||++++++.+||+|||++....... ..
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~-~~  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YT  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccce-ee
Confidence            9999999997543 35889999999999999999999   9999999999999999999999999999997654321 11


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                      .......+..|+|||.+.+..++.++|||||||++|||++ |..||......  ..........        .+.     
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~--------~~~-----  225 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKGY--------RME-----  225 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCC--------CCC-----
Confidence            1222334678999999988899999999999999999998 88888653211  1111111000        000     


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                           .+..++.++.+++.+||+.+|++||++.|+++.|+++
T Consensus       226 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 -----RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                 0112456688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7e-38  Score=318.74  Aligned_cols=256  Identities=29%  Similarity=0.476  Sum_probs=204.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      ..+|...+.||+|+||.||+|..      .++..+|+|.+..........+.+|+++++.++|+||+++++++.+.+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            35678889999999999999963      246679999886554455678899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc
Q 005760          465 LVLEYMPHGSLEKYLHSSN--------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV  530 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~  530 (678)
                      ++|||+++++|.+++....              ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence            9999999999999997643              24788999999999999999999   999999999999999999999


Q ss_pred             EEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhh
Q 005760          531 AHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVN  609 (678)
Q Consensus       531 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~  609 (678)
                      +||+|||++................+++.|+|||...+..++.++|||||||++|||++ |..||......+.  .....
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~~~~~  238 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--IECIT  238 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--HHHHH
Confidence            99999999875543222222233445788999999998899999999999999999998 8888865322211  11110


Q ss_pred             cccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          610 DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                      ...     ....             +..+++.+.+++.+||+.||.+||++.|+.+.|++
T Consensus       239 ~~~-----~~~~-------------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         239 QGR-----ELER-------------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             cCc-----cCCC-------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            000     0000             01244568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.8e-38  Score=329.47  Aligned_cols=246  Identities=22%  Similarity=0.273  Sum_probs=199.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-C-CcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-D-GMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      .++|.+.+.||+|+||.||+|..+ + +..||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            457899999999999999999753 3 4689999986432   2344667889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++......
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999998765 4888999999999999999999   999999999999999999999999999999765321


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                           .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........       ..-|   
T Consensus       185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-~~~~i~~~~-------~~~p---  248 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-IYQKILEGI-------IYFP---  248 (340)
T ss_pred             -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-HHHHHhcCC-------CCCC---
Confidence                 123568999999999988889999999999999999999999997532211 111111000       0001   


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK  666 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~~  666 (678)
                                ...+.++.+++.+|++.||++|+     +++|+++.
T Consensus       249 ----------~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        249 ----------KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ----------CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                      11234577999999999999995     88888753

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.1e-37  Score=314.60  Aligned_cols=269  Identities=25%  Similarity=0.412  Sum_probs=204.1

Q ss_pred             cCC-CCCccccCCCceeEEEEEe-----CCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeec--CCe
Q 005760          392 DGF-SENNLIGRGSFGSVFKARL-----GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSN--EEF  462 (678)
Q Consensus       392 ~~~-~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~  462 (678)
                      ++| ...+.||+|+||+||++..     .+++.||+|.+..... .....+.+|+++++.++||||+++++++..  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            344 7889999999999988642     3678899999865432 345678889999999999999999998765  346


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .++||||+++++|.+++....  +++..+..++.|++.|+.|||   +++++||||||+||+++.++.++++|||++...
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            789999999999999997653  899999999999999999999   999999999999999999999999999999765


Q ss_pred             CCCCCc-ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhh-cccCCcccccc
Q 005760          543 TREDQS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN-DWLPISTKEIV  620 (678)
Q Consensus       543 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~  620 (678)
                      ...... .......++..|+|||...+..++.++||||||+++|||++|..||............... ...........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            432211 1122234566799999998888999999999999999999999998653221111111000 00000011111


Q ss_pred             cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                      +....      ...+..++.++.+++.+||+.+|++||+++++++.|++++
T Consensus       238 ~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         238 ERGMR------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hcCCC------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            11110      0011235667999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.2e-38  Score=318.20  Aligned_cols=256  Identities=24%  Similarity=0.420  Sum_probs=201.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF  462 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  462 (678)
                      ..++|++.+.||+|+||.||+|...      ++..||+|++..... .....+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999998642      356799999854322 234568889999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCCC---------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEE
Q 005760          463 KALVLEYMPHGSLEKYLHSSNY---------ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL  533 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl  533 (678)
                      .++||||+++++|.++++....         .+++..+..++.|++.|++|||   +.+++|+||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            9999999999999999975321         3567888999999999999999   899999999999999999999999


Q ss_pred             EeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhccc
Q 005760          534 SDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWL  612 (678)
Q Consensus       534 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~  612 (678)
                      +|||++................++..|+|||.+.++.++.++|||||||++|||++ |..||...... ...........
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~  239 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-QVLRFVMEGGL  239 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCc
Confidence            99999876543322222223345788999999998889999999999999999999 68888653221 11111111000


Q ss_pred             CCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          613 PISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      +       +  .          +..++..+.+++.+||+.||++||++.|+++.|+
T Consensus       240 ~-------~--~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         240 L-------D--K----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             C-------C--C----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            0       0  0          0123456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=8.7e-38  Score=327.31  Aligned_cols=266  Identities=22%  Similarity=0.318  Sum_probs=196.3

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecC-----CeEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE-----EFKA  464 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~  464 (678)
                      +|++.+.||+|+||.||+|.. .+++.||+|++....  ......+.+|+++++.++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478889999999999999985 478999999986432  22345678899999999999999999987533     3579


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+. ++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 68999887654 4889999999999999999999   99999999999999999999999999999975432


Q ss_pred             CCC-cceeecccCCccccCccccCC--CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccc----
Q 005760          545 EDQ-STIQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK----  617 (678)
Q Consensus       545 ~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----  617 (678)
                      ... ........+++.|+|||++.+  ..++.++|||||||++|||++|+.||.+....  .....+.........    
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV--HQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHHhCCCCHHHHH
Confidence            211 122234578999999998865  57899999999999999999999999653211  000111000000000    


Q ss_pred             ccccC-------ccCCccchhhH-HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          618 EIVDP-------NLLSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       618 ~~~~~-------~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .+...       ........... .....++++.+++.+||+.||++||++.|+++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00000       00000000000 00123566889999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-38  Score=324.95  Aligned_cols=239  Identities=25%  Similarity=0.277  Sum_probs=192.5

Q ss_pred             ccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCH
Q 005760          400 IGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL  475 (678)
Q Consensus       400 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  475 (678)
                      ||+|+||.||+|... +++.||+|++....   ......+..|+.+++.++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999854 68899999986432   23445677899999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeeccc
Q 005760          476 EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL  555 (678)
Q Consensus       476 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  555 (678)
                      .+++.... .+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++.....  ........
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCcccccc
Confidence            99997654 4889999999999999999999   999999999999999999999999999998753221  12223456


Q ss_pred             CCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHH
Q 005760          556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK  635 (678)
Q Consensus       556 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  635 (678)
                      ||+.|+|||.+.+..++.++||||+||++|||++|+.||......     ...........   .             .+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-----~~~~~~~~~~~---~-------------~~  213 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-----EMYRKILQEPL---R-------------FP  213 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-----HHHHHHHcCCC---C-------------CC
Confidence            899999999999989999999999999999999999999653211     11111110000   0             00


Q ss_pred             HHHHHHHHHHHhhccccCcCCCCC---HHHHHH
Q 005760          636 EQCVSFVFNVAMECTVESPEQRIN---AKEIVT  665 (678)
Q Consensus       636 ~~~~~~l~~l~~~cl~~dP~~Rps---~~ell~  665 (678)
                      ...++++.+++.+||+.||++||+   +.|++.
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            123456889999999999999985   566553

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8.8e-38  Score=324.85  Aligned_cols=242  Identities=24%  Similarity=0.334  Sum_probs=195.7

Q ss_pred             ccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCC
Q 005760          398 NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG  473 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  473 (678)
                      +.||+|+||.||++.. .+|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4689999999999985 478999999997542   234466788999999999999999999999999999999999999


Q ss_pred             CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeec
Q 005760          474 SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ  553 (678)
Q Consensus       474 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  553 (678)
                      +|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++.....  ......
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~  154 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKT  154 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--cccccc
Confidence            9999887654 4889999999999999999999   999999999999999999999999999998753221  112234


Q ss_pred             ccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhH
Q 005760          554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV  633 (678)
Q Consensus       554 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  633 (678)
                      ..||+.|+|||.+.+..++.++||||+||++|||++|+.||......+     ........   ....|           
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~-----~~~~~~~~---~~~~p-----------  215 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-----LFELILME---DIKFP-----------  215 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH-----HHHHhccC---CccCC-----------
Confidence            568999999999998899999999999999999999999996532211     11100000   00000           


Q ss_pred             HHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 005760          634 AKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK  666 (678)
Q Consensus       634 ~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~~  666 (678)
                        ...+.++.+++.+||++||++|+     ++.|+++.
T Consensus       216 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         216 --RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             --CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence              12345688999999999999997     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=309.65  Aligned_cols=275  Identities=26%  Similarity=0.345  Sum_probs=206.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHh--CCCccceeeeeeeecCC----eEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKS--IRHRNIIKVISSCSNEE----FKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~~  464 (678)
                      -......+.||+|.||.||+|.+. ++.||||++..   +..+.|..|..+.+.  ++|+||+++++.-...+    .++
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            345566789999999999999984 59999999974   345778888888775  58999999999876555    889


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC------CCCeEEcCCCCCCeeecCCCcEEEEeecc
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY------SAQVIHCDLKPSNVLLDDNMVAHLSDFGI  538 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~dl~~~Nill~~~~~~kl~Dfg~  538 (678)
                      +|+||.+.|+|.+++..+-  .+|...-+|+..+++||+|||++.      +..|+|||||++|||+..|+++.|+|||+
T Consensus       285 LVt~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             EEeeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            9999999999999998775  899999999999999999999744      45799999999999999999999999999


Q ss_pred             ccccCCCCCcceeecccCCccccCccccCCCCC------CccchHHHHHHHHHHHHcCCCCCCc-ccCC-ccchhhhhhc
Q 005760          539 AKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV------SANGDVYSFGIMLMETFTRKKPTDE-IFNG-EMTLKHWVND  610 (678)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~------~~~~DvwslGv~l~ell~g~~p~~~-~~~~-~~~~~~~~~~  610 (678)
                      |.++............+||.+|||||++.+.--      -.+.||||+|.+||||+++-.-++. ..+. ...+..-+..
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            998875544444445789999999999876421      2358999999999999986543321 0000 0011100000


Q ss_pred             ccC-CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          611 WLP-ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       611 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                      .+. +.+...+-.....+.-.+..........+.+.+..||+.||+.|.|+.=+-+++.++.
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            000 0111122122222222333444456677899999999999999999999999988875

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-37  Score=327.29  Aligned_cols=263  Identities=21%  Similarity=0.215  Sum_probs=199.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..+|.+.+.||+|+||.||+|.. .+++.||+|...      ...+.+|+++++.++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            46799999999999999999975 578999999753      24567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +. ++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++....... ..
T Consensus       165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~  238 (391)
T PHA03212        165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN  238 (391)
T ss_pred             CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence            95 68988887654 4889999999999999999999   9999999999999999999999999999996543221 11


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCc------cchhhhhhccc--CCcc-----
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE------MTLKHWVNDWL--PIST-----  616 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~------~~~~~~~~~~~--~~~~-----  616 (678)
                      ......||+.|+|||++.+..++.++||||+||++|||++|+.||.......      ..+...+....  +...     
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            2234579999999999999899999999999999999999998865422111      11111111000  0000     


Q ss_pred             ---cccc-----cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          617 ---KEIV-----DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       617 ---~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                         ....     ..................+.++.+++.+||+.||++|||++|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence               0000     000000000011111235667999999999999999999999985

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.2e-37  Score=313.83  Aligned_cols=267  Identities=28%  Similarity=0.434  Sum_probs=203.8

Q ss_pred             cCCCCCccccCCCceeEEEEEe-----CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeec--CCeEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-----GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN--EEFKA  464 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  464 (678)
                      .+|++.+.||+|+||.||+|..     .++..||+|.+........+.+.+|+++++.++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4788899999999999999974     3578999999876555556778899999999999999999997643  45688


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +|+||+++++|.+++...+..+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999999876656899999999999999999999   99999999999999999999999999999986643


Q ss_pred             CCCcc-eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC--Cc---ccc
Q 005760          545 EDQST-IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP--IS---TKE  618 (678)
Q Consensus       545 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~---~~~  618 (678)
                      ..... ......++..|+|||.+.+..++.++|||||||++|||++|..|+......   ..........  ..   ..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchHHHHH
Confidence            32211 111223445699999998888999999999999999999987765432110   0000000000  00   000


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                      .....      .....+..++.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus       238 ~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNN------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcC------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00000      00001123456799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.1e-37  Score=331.14  Aligned_cols=252  Identities=21%  Similarity=0.307  Sum_probs=196.8

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .|...+.||+|+||+||+|.. ++++.||+|++....   ....+.+..|+++++.++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            578899999999999999974 578999999996532   2344668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC-
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~-  547 (678)
                      |+++|+|.+++.+.. .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++++||+|||+++.+..... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999997665 4788888999999999999999   99999999999999999999999999999754321000 


Q ss_pred             --------------------------------------------cceeecccCCccccCccccCCCCCCccchHHHHHHH
Q 005760          548 --------------------------------------------STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIM  583 (678)
Q Consensus       548 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~  583 (678)
                                                                  ........||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                        000123469999999999988889999999999999


Q ss_pred             HHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhh--ccccCcCCCCCHH
Q 005760          584 LMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAME--CTVESPEQRINAK  661 (678)
Q Consensus       584 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--cl~~dP~~Rps~~  661 (678)
                      +|||++|+.||......+.. .... .+..    ....+.           ...+++++.+++.+  |+..+|..||++.
T Consensus       238 l~elltG~~Pf~~~~~~~~~-~~i~-~~~~----~~~~~~-----------~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQ-LKVI-NWEN----TLHIPP-----------QVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHH-HHHH-cccc----ccCCCC-----------CCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            99999999999753322111 1110 0000    000000           01234567788887  5556666799999


Q ss_pred             HHHH
Q 005760          662 EIVT  665 (678)
Q Consensus       662 ell~  665 (678)
                      |+++
T Consensus       301 ~~l~  304 (381)
T cd05626         301 DIKA  304 (381)
T ss_pred             HHhc
Confidence            9986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.3e-37  Score=318.16  Aligned_cols=259  Identities=24%  Similarity=0.389  Sum_probs=206.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhC-CCccceeeeeeeecCC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEE  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  461 (678)
                      ..++|.+.+.||+|+||.||+|..      .++..||+|.++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            346789999999999999999963      235579999986542 23346788999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      ..++||||+++++|.++++... ..+++.++..++.|++.|++|||   +++++|+||||+||+++.++.++++|||++.
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence            9999999999999999997643 34799999999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCccccc
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEI  619 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (678)
                      ...............++..|+|||.+.++.++.++||||+||++|||++ |+.||......+. ..........     .
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~~~~~~~-----~  263 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKLIKEGYR-----M  263 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHHHHcCCc-----C
Confidence            6543322222233456788999999988889999999999999999998 9999865332211 1111110000     0


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                      ..             +...++++.+++.+||+++|++||++.|+++.|+++
T Consensus       264 ~~-------------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         264 AQ-------------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CC-------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            00             011234588999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.7e-37  Score=316.04  Aligned_cols=261  Identities=24%  Similarity=0.385  Sum_probs=208.8

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCC-----CcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeec-CCe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGD-----GMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSN-EEF  462 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  462 (678)
                      ..++|.+.+.||+|+||.||+|...+     +..|++|.+..... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35688899999999999999998654     68899998864422 345667889999999999999999998755 577


Q ss_pred             EEEEEEecCCCCHHHHhhhCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEe
Q 005760          463 KALVLEYMPHGSLEKYLHSSN-------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD  535 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~D  535 (678)
                      .++++||+++++|.+++....       ..+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+|++|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            889999999999999987542       34789999999999999999999   99999999999999999999999999


Q ss_pred             eccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCC
Q 005760          536 FGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPI  614 (678)
Q Consensus       536 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  614 (678)
                      ||+++.+.............++..|+|||.+.+..++.++|||||||++||+++ |+.||.....  .....++..... 
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~-  237 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYR-  237 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCC-
Confidence            999976543332222233445678999999988889999999999999999999 9999865322  122222211000 


Q ss_pred             cccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                          ..             ....+++++.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       238 ----~~-------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         238 ----LA-------------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             ----CC-------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence                00             0112345688999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.6e-37  Score=317.36  Aligned_cols=258  Identities=26%  Similarity=0.448  Sum_probs=202.6

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCc--EEEEEEeeccc-CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGM--EVAMKVFNLQY-GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ++|++.+.||+|+||.||+|..+ ++.  .+++|.++... ....+.+..|+++++++ +||||+++++++.+.+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            67899999999999999999764 333  47888876422 23346788899999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcE
Q 005760          467 LEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVA  531 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~  531 (678)
                      +||+++++|.++++...               ..+++..+..++.|++.|++|||   +++++||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999997532               24778899999999999999999   9999999999999999999999


Q ss_pred             EEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhc
Q 005760          532 HLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVND  610 (678)
Q Consensus       532 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~  610 (678)
                      ||+|||++.....   .........+..|+|||...+..++.++|||||||++|||++ |..||......+. .......
T Consensus       159 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-~~~~~~~  234 (297)
T cd05089         159 KIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-YEKLPQG  234 (297)
T ss_pred             EECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhcC
Confidence            9999999853221   111111223557999999988889999999999999999997 9999865322110 1110000


Q ss_pred             ccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          611 WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                      .         .+.          .+..++.++.+++.+||+.+|.+||++.++++.|+.+.+...
T Consensus       235 ~---------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         235 Y---------RME----------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             C---------CCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            0         000          011244568899999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-38  Score=331.38  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=199.9

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999854 78999999997532   234456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.++|+|||+++.+.....
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            9999999999998655 4889999999999999999999   99999999999999999999999999999875432110


Q ss_pred             cc------------------------------------eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCC
Q 005760          548 ST------------------------------------IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK  591 (678)
Q Consensus       548 ~~------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~  591 (678)
                      ..                                    ......||+.|+|||++.+..++.++||||+||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            00                                    011245899999999999989999999999999999999999


Q ss_pred             CCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCC---HHHHHH
Q 005760          592 KPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN---AKEIVT  665 (678)
Q Consensus       592 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~ell~  665 (678)
                      .||......+.  ...+..+..    ....+.           ....++++.+++.+|+. +|.+|++   +.|+++
T Consensus       237 ~Pf~~~~~~~~--~~~i~~~~~----~~~~~~-----------~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         237 PPFCSDNPQET--YRKIINWKE----TLQFPD-----------EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCHHHH--HHHHHcCCC----ccCCCC-----------CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99975332111  111111100    000000           00234567899999997 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-37  Score=312.44  Aligned_cols=254  Identities=26%  Similarity=0.452  Sum_probs=200.5

Q ss_pred             CCCCccccCCCceeEEEEEeC----CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCe-----
Q 005760          394 FSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF-----  462 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  462 (678)
                      |.+.+.||+|+||.||+|...    .+..||+|.++....  .....+..|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567899999999999999753    247799999875432  234678899999999999999999998765443     


Q ss_pred             -EEEEEEecCCCCHHHHhhhC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEee
Q 005760          463 -KALVLEYMPHGSLEKYLHSS-----NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF  536 (678)
Q Consensus       463 -~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Df  536 (678)
                       .++++||+++++|.+++...     ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             78999999999999988543     235788999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCc
Q 005760          537 GIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPIS  615 (678)
Q Consensus       537 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  615 (678)
                      |+++................+..|+|||.+.+..++.++|||||||++|||++ |..||.+....  ....++.....  
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~--  233 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHGNR--  233 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC--
Confidence            99986644333222223345678999999988889999999999999999999 88888653321  11111110000  


Q ss_pred             ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                               ..       .+..++.++.+++.+||+.||.+||++.|+++.|+++
T Consensus       234 ---------~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         234 ---------LK-------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ---------CC-------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     00       0113456689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.6e-37  Score=316.28  Aligned_cols=257  Identities=25%  Similarity=0.403  Sum_probs=203.8

Q ss_pred             CCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      +|++.+.||+|+||.||+|...      ....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999742      235688888864432 234678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCC
Q 005760          466 VLEYMPHGSLEKYLHSSN-----------------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSN  522 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~N  522 (678)
                      |+||+++++|.+++....                       ..+++..+..++.|++.|++|||   +.+++||||+|+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999986431                       24678889999999999999999   9999999999999


Q ss_pred             eeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCc
Q 005760          523 VLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGE  601 (678)
Q Consensus       523 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~  601 (678)
                      |++++++.+||+|||+++...............++..|+|||...+..++.++||||||+++|||++ |..||.+.... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            9999999999999999976543332222233446678999999888889999999999999999998 99998653221 


Q ss_pred             cchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          602 MTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                       .+........        ...          .+..++.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus       237 -~~~~~~~~~~--------~~~----------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         237 -RLFNLLKTGY--------RME----------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -HHHHHHhCCC--------CCC----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence             1111111100        000          011234568899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=323.89  Aligned_cols=244  Identities=27%  Similarity=0.434  Sum_probs=204.6

Q ss_pred             cccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCHHH
Q 005760          399 LIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEK  477 (678)
Q Consensus       399 ~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~  477 (678)
                      .+|+|.||+||-|+.. ++..+|||.+.....+..+...+|+...+.++|.|||+++|++.+.+..-+.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999854 667799999987777778889999999999999999999999999999999999999999999


Q ss_pred             HhhhCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec-CCCcEEEEeeccccccCCCCCcceeecc
Q 005760          478 YLHSSNYIL--DIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQT  554 (678)
Q Consensus       478 ~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  554 (678)
                      +++..-.++  .+.+.-.+.+||++||.|||   ...|||||||..||+++ -.|.+||+|||-++++..  -......+
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence            999876666  77888899999999999999   99999999999999995 679999999999988753  33445567


Q ss_pred             cCCccccCccccCCCC--CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          555 LATIGYMAPEYGKEGR--VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       555 ~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      .||..|||||++..+.  |+.++|||||||++.||.||++||...-......   .+    ..+.. +.|          
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---Fk----VGmyK-vHP----------  798 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---FK----VGMYK-VHP----------  798 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---hh----hccee-cCC----------
Confidence            8999999999998774  8899999999999999999999997643321111   00    00000 011          


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..++..+.++..++.+|+.+||.+||+|++++.
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            123566778999999999999999999999875

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.2e-37  Score=319.39  Aligned_cols=260  Identities=29%  Similarity=0.456  Sum_probs=205.9

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceeeeeeeecC
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKVISSCSNE  460 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  460 (678)
                      ...++|++.+.||+|+||.||+|...      ....+|+|.+..... +....+.+|+++++.+ +||||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34567889999999999999999753      346799999865422 3345688899999999 799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee
Q 005760          461 EFKALVLEYMPHGSLEKYLHSS---------------NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL  525 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill  525 (678)
                      +..+++|||+++++|.++++..               ...+++..+..++.|++.|++|||   +.+|+||||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEE
Confidence            9999999999999999998642               235788999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccch
Q 005760          526 DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTL  604 (678)
Q Consensus       526 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~  604 (678)
                      +.++.+|++|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |..||......+  .
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~  243 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--L  243 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--H
Confidence            9999999999999986643322222223345678999999988889999999999999999998 888886532211  1


Q ss_pred             hhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          605 KHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                      ........        .+.          .+..++.++.+++.+||++||++|||+.|+++.|+++.
T Consensus       244 ~~~~~~~~--------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         244 FKLLKEGY--------RME----------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHHcCC--------cCC----------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            11111000        000          01123456889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.3e-37  Score=311.63  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=207.9

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||.||+|.. .+++.+|||.+....   .....++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999985 589999999875432   223467888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          468 EYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       468 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      ||+++++|.+++..   ....+++..++.++.|++.|++|||   +++++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998864   2335789999999999999999999   99999999999999999999999999999876542


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ..  .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.............+.        ....+..
T Consensus       159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~  228 (267)
T cd08229         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE--------QCDYPPL  228 (267)
T ss_pred             CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh--------cCCCCCC
Confidence            22  1123346888999999998888999999999999999999999998643222111111111        0001110


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                               ....++.++.+++.+||+.||++|||+.+|++.+++++
T Consensus       229 ---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         229 ---------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ---------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                     01134567899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1e-37  Score=318.16  Aligned_cols=254  Identities=25%  Similarity=0.443  Sum_probs=201.9

Q ss_pred             CCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      +|.+.+.||+|+||.||+|...      ++..||+|+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4677889999999999999742      357899999875433 234668889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc
Q 005760          466 VLEYMPHGSLEKYLHSS---------------NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV  530 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~  530 (678)
                      ++||+++++|.+++...               ...+++..+..++.|++.|++|+|   +++++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCc
Confidence            99999999999998532               124778889999999999999999   999999999999999999999


Q ss_pred             EEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhh
Q 005760          531 AHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVN  609 (678)
Q Consensus       531 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~  609 (678)
                      +||+|||+++...............+++.|+|||.+.++.++.++||||+||++|||++ |..||.+....  .....+.
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~i~  240 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEMIR  240 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH
Confidence            99999999876543332222334456789999999988889999999999999999998 77787653221  1111111


Q ss_pred             cccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          610 DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                      .           .....       .+..++..+.+++.+||+.+|++||+++|++..|+.
T Consensus       241 ~-----------~~~~~-------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         241 N-----------RQVLP-------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             c-----------CCcCC-------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            0           00000       012356668899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=4.2e-37  Score=309.75  Aligned_cols=254  Identities=26%  Similarity=0.451  Sum_probs=203.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      .++|++.+.||+|+||.||+|...++..||+|++.... ...+.+.+|+++++.++||||+++++.+.+ +..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            45789999999999999999987776789999987432 234678899999999999999999998754 5578999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          471 PHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       471 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      ++++|.+++.... ..+++..+..++.|++.||+|+|   +.+++|+||+|+||++++++.++|+|||.+........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence            9999999997643 35788999999999999999999   99999999999999999999999999999976543322 1


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                      ......++..|+|||...++.++.++||||||+++|||++ |..||......+. ........         ..      
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-~~~~~~~~---------~~------  222 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQVERGY---------RM------  222 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-HHHHhcCC---------CC------
Confidence            2223446678999999988889999999999999999999 7788765332111 11000000         00      


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                          .....++..+.+++.+|++.+|++||++.++++.|+..
T Consensus       223 ----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                00123456688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.9e-37  Score=327.14  Aligned_cols=261  Identities=25%  Similarity=0.390  Sum_probs=204.9

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCC-CccceeeeeeeecC
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIR-HRNIIKVISSCSNE  460 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  460 (678)
                      ...++|.+.+.||+|+||.||+|.+.      .+..||+|++..... ...+.+..|+.++..+. ||||+++++++...
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~  113 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG  113 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence            34557888999999999999999753      346899999975432 23456889999999997 99999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCC---------------------------------------------------------
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSN---------------------------------------------------------  483 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------  483 (678)
                      +..++|+||+++|+|.++++..+                                                         
T Consensus       114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (401)
T cd05107         114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ  193 (401)
T ss_pred             CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence            99999999999999999996532                                                         


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCe
Q 005760          484 ----------------------------------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNV  523 (678)
Q Consensus       484 ----------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Ni  523 (678)
                                                              ..+++..+..++.|++.|++|||   +.+++||||||+||
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~Ni  270 (401)
T cd05107         194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNV  270 (401)
T ss_pred             cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceE
Confidence                                                    12466678889999999999999   99999999999999


Q ss_pred             eecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCcc
Q 005760          524 LLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEM  602 (678)
Q Consensus       524 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~  602 (678)
                      +++.++.+|++|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.
T Consensus       271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~  350 (401)
T cd05107         271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ  350 (401)
T ss_pred             EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence            999999999999999976532222122233456788999999988889999999999999999998 8889865322211


Q ss_pred             chhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          603 TLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                      ..........      ...             +..++.++.+++.+||+.+|.+||+++|+++.|+.+.
T Consensus       351 ~~~~~~~~~~------~~~-------------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         351 FYNAIKRGYR------MAK-------------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             HHHHHHcCCC------CCC-------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            1110000000      000             1123456889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.8e-38  Score=327.77  Aligned_cols=252  Identities=24%  Similarity=0.328  Sum_probs=201.5

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|.+.+.||+|+||.||+|.. .+++.||+|+++...   .+..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4688999999999999999985 478999999997542   234466788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.+++.+....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999887566899999999999999999999   99999999999999999999999999999976643222


Q ss_pred             cceeecccCCccccCccccC------CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          548 STIQTQTLATIGYMAPEYGK------EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                       .......+|+.|+|||++.      ...++.++||||+||++|||++|+.||....... ........   ......  
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~~~---~~~~~~--  230 (330)
T cd05601         158 -VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYNNIMNF---QRFLKF--  230 (330)
T ss_pred             -eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHHHHHcC---CCccCC--
Confidence             1223456899999999876      4567889999999999999999999996532211 11111000   000000  


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      +           .....+.++.+++..|++ +|++||++.++++
T Consensus       231 ~-----------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         231 P-----------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             C-----------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            0           001234558899999998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.2e-37  Score=314.94  Aligned_cols=260  Identities=24%  Similarity=0.397  Sum_probs=206.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCc----EEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGM----EVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      .++|+..+.||+|+||+||+|.+ .+++    .||+|++.... ......+..|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            45788899999999999999974 3444    48999986543 23456778899999999999999999998764 467


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +++||+++|+|.++++.....+++..+..++.|++.|++|||   +++++||||||+||+++.++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999999876666899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ...........++..|+|||...+..++.++|||||||++|||++ |..||......  ....++......       + 
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~~-------~-  231 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLEKGERL-------P-  231 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCcC-------C-
Confidence            322222223345678999999988889999999999999999998 88888653221  122222111000       0 


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                                .+..++.++.+++.+||+.||++||++.|+++.|+.+....
T Consensus       232 ----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         232 ----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             ----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence                      00124456889999999999999999999999998886543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.7e-37  Score=310.49  Aligned_cols=255  Identities=27%  Similarity=0.372  Sum_probs=202.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            45799999999999999999985 57899999999765444556778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|.++++... .+++..+..++.|++.|++|||   +.+|+|||++|+||+++.++.++|+|||++.......  .
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06646          88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A  161 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence            99999999987654 4889999999999999999999   9999999999999999999999999999997653221  1


Q ss_pred             eeecccCCccccCccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          550 IQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                      ......++..|+|||.+.   ...++.++||||+||++|||++|+.||......+.. ..+...       ....+... 
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~~~~-------~~~~~~~~-  232 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMSKS-------NFQPPKLK-  232 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eeeecC-------CCCCCCCc-
Confidence            123346888999999874   345788999999999999999999998643221111 000000       00000000 


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                             .....+..+.+++.+||+.+|++||+++++++.+
T Consensus       233 -------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 -------DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             -------cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                   0112345688999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.1e-37  Score=326.96  Aligned_cols=202  Identities=24%  Similarity=0.375  Sum_probs=174.9

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||+||+|.. .+++.||+|++....   ......+..|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4688999999999999999975 478999999996532   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.+++.+.+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999999998654 4889999999999999999999   99999999999999999999999999999875432110


Q ss_pred             c---------------------------------ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005760          548 S---------------------------------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPT  594 (678)
Q Consensus       548 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~  594 (678)
                      .                                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence            0                                 0012346999999999999989999999999999999999999999


Q ss_pred             Ccc
Q 005760          595 DEI  597 (678)
Q Consensus       595 ~~~  597 (678)
                      .+.
T Consensus       237 ~~~  239 (363)
T cd05628         237 CSE  239 (363)
T ss_pred             CCC
Confidence            753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=9.5e-37  Score=308.20  Aligned_cols=258  Identities=23%  Similarity=0.361  Sum_probs=208.0

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++...   ....+.+.+|+++++.++|+|++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999865 89999999886422   233567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          468 EYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       468 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      ||+++++|.+++...   ...++...+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998642   335788999999999999999999   99999999999999999999999999999875532


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ..  .......++..|+|||.+.+..++.++||||+||++|+|++|+.||.....   .............    . +. 
T Consensus       159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----~-~~-  227 (267)
T cd08224         159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEKCD----Y-PP-  227 (267)
T ss_pred             CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhhhcCC----C-CC-
Confidence            21  112234578899999999888899999999999999999999999854321   1111111100000    0 00 


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                              .....++.++.+++.+||+.+|++||++.++++.|+.++
T Consensus       228 --------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         228 --------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             --------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                    001134566889999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=303.83  Aligned_cols=248  Identities=26%  Similarity=0.386  Sum_probs=212.2

Q ss_pred             CCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      |.++.+||+|+||.||+|.+ ..|+.||+|.+...  ...+++..|+.++++++.|++|++||.+.....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            55678999999999999975 47999999998654  3568889999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      |+..+.++..+..+.+..+..+.+..++||+|||   ...-+|||||+.|||++.+|.+|+.|||.|-.+++  +-....
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN  187 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN  187 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence            9999999988888999999999999999999999   88889999999999999999999999999976643  334456


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...||+.|||||++..-.|..++||||+|++..||..|++||.+..+...-              .++ |.   ..+..+
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------FMI-PT---~PPPTF  249 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------FMI-PT---KPPPTF  249 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------------Eec-cC---CCCCCC
Confidence            778999999999999999999999999999999999999999875443211              111 11   111223


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      -.++..+.++-+++++|+.+.|++|-||.++++.
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            3456677889999999999999999999998763

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.6e-37  Score=318.93  Aligned_cols=261  Identities=28%  Similarity=0.422  Sum_probs=205.8

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC--------CCcEEEEEEeeccc-CchhhhHHHHHHHHHhC-CCccceeeeeeeecC
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG--------DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNE  460 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  460 (678)
                      .++|.+.+.||+|+||.||+|...        ++..+|+|.+.... ......+..|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467999999999999999999742        23569999987542 23445688899999999 799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL  525 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill  525 (678)
                      +..++||||+++++|.+++....               ..+++..+..++.|++.|++|||   +++++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            99999999999999999997642               24788899999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccch
Q 005760          526 DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTL  604 (678)
Q Consensus       526 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~  604 (678)
                      +.++.+||+|||.+................++..|+|||.+.+..++.++||||+||++|||++ |..||.....  ...
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--~~~  251 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--EEL  251 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--HHH
Confidence            9999999999999876543221111222334578999999988889999999999999999998 8888754221  111


Q ss_pred             hhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          605 KHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      ...+....        ...          .+..++.++.+++.+||+.+|++||++.|+++.|+++.+..
T Consensus       252 ~~~~~~~~--------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         252 FKLLKEGH--------RMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             HHHHHcCC--------CCC----------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence            11111000        000          01124556889999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-38  Score=330.11  Aligned_cols=253  Identities=26%  Similarity=0.379  Sum_probs=204.1

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....   ......+..|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47889999999999999999864 79999999997532   234567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC-
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED-  546 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~-  546 (678)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            999999999999876 35889999999999999999999   9999999999999999999999999999997654322 


Q ss_pred             --------------------------CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCC
Q 005760          547 --------------------------QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNG  600 (678)
Q Consensus       547 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~  600 (678)
                                                .........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                      011233456899999999999999999999999999999999999999763321


Q ss_pred             ccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCC-HHHHHHH
Q 005760          601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN-AKEIVTK  666 (678)
Q Consensus       601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~ell~~  666 (678)
                      .. ... +..+..    ....+..           ..+++++.+++.+|++ ||.+||+ +.|+++.
T Consensus       237 ~~-~~~-i~~~~~----~~~~p~~-----------~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         237 ET-YNK-IINWKE----SLRFPPD-----------PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HH-HHH-HhccCC----cccCCCC-----------CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            11 110 110000    0000000           0135668899999998 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.2e-37  Score=314.54  Aligned_cols=256  Identities=26%  Similarity=0.410  Sum_probs=201.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF  462 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  462 (678)
                      .+++|.+.+.||+|++|.||+|...      .+..||+|.+..... .....+..|+.+++.++|+||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3567899999999999999999764      357789998764432 234568889999999999999999999998889


Q ss_pred             EEEEEEecCCCCHHHHhhhCCC------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC---cEEE
Q 005760          463 KALVLEYMPHGSLEKYLHSSNY------ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM---VAHL  533 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~---~~kl  533 (678)
                      .++||||+++++|.+++...+.      .+++..+..++.||+.|++|||   +++++|+||+|+||+++.++   .+|+
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999976532      4788999999999999999999   99999999999999998654   6999


Q ss_pred             EeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhccc
Q 005760          534 SDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWL  612 (678)
Q Consensus       534 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~  612 (678)
                      +|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||......+  ....+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~  238 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGGG  238 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCC
Confidence            99999986633222222223334568999999988899999999999999999997 999987533221  111111100


Q ss_pred             CCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          613 PISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      .     ...             +..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus       239 ~-----~~~-------------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         239 R-----LDP-------------PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             c-----CCC-------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            0     000             1123456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.9e-37  Score=315.09  Aligned_cols=266  Identities=24%  Similarity=0.349  Sum_probs=195.6

Q ss_pred             cCCCCCccccCCCceeEEEEEe-C-CCcEEEEEEeecccC--chhhhHHHHHHHHHhC---CCccceeeeeeee-----c
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-G-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSI---RHRNIIKVISSCS-----N  459 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~-----~  459 (678)
                      ++|++.+.||+|+||.||+|.. . +++.||+|++.....  .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            4789999999999999999975 3 478899999865432  2234556777777765   6999999999874     3


Q ss_pred             CCeEEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecc
Q 005760          460 EEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI  538 (678)
Q Consensus       460 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~  538 (678)
                      ....++||||++ ++|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 59999987543 35789999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc---CCc
Q 005760          539 AKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL---PIS  615 (678)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---~~~  615 (678)
                      +......   .......+++.|+|||.+.+..++.++||||+||++|||++|++||.+....+ .+........   +..
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~~~~~~~~  232 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEED  232 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhh
Confidence            9765422   22334568999999999988889999999999999999999999997633211 1111111000   000


Q ss_pred             ccccc--cCccCCccchhhH--HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          616 TKEIV--DPNLLSREDINFV--AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       616 ~~~~~--~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .....  .............  .....++.+.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00000  0000000000000  00134567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=339.18  Aligned_cols=256  Identities=23%  Similarity=0.325  Sum_probs=203.3

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCC---
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE---  461 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---  461 (678)
                      ....++|.+.+.||+|+||.||+|.. .+|+.||||++....  ......+.+|+..+..++|+|++++.+.+...+   
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34567999999999999999999974 579999999986542  234456788999999999999999887764332   


Q ss_pred             -----eEEEEEEecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEE
Q 005760          462 -----FKALVLEYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL  533 (678)
Q Consensus       462 -----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl  533 (678)
                           ..++||||+++|+|.+++...   ...+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEE
Confidence                 367999999999999998643   235888999999999999999999   999999999999999999999999


Q ss_pred             EeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC
Q 005760          534 SDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP  613 (678)
Q Consensus       534 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  613 (678)
                      +|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||......     ..+.....
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----~~~~~~~~  259 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-----EVMHKTLA  259 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHhc
Confidence            9999997664332222334567999999999999999999999999999999999999999653211     11111110


Q ss_pred             CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      ..    .++           .+..+++++.+++.+||+.||++||++.++++.
T Consensus       260 ~~----~~~-----------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        260 GR----YDP-----------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CC----CCC-----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            00    000           011245668899999999999999999999863

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.1e-37  Score=321.61  Aligned_cols=241  Identities=26%  Similarity=0.351  Sum_probs=193.2

Q ss_pred             ccccCCCceeEEEEEe----CCCcEEEEEEeeccc----CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          398 NLIGRGSFGSVFKARL----GDGMEVAMKVFNLQY----GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +.||+|+||.||++..    .+++.||+|++....    ......+..|+++++.++||||+++++++...+..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999974    368899999987532    12335567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|.+++.... .+.+..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++.......  .
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--T  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--C
Confidence            99999999997665 4778888889999999999999   9999999999999999999999999999987543221  1


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      ......|++.|+|||.+.+..++.++||||+||++|||++|+.||.......     .........        ..    
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~-----~~~~~~~~~--------~~----  218 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK-----TIDKILKGK--------LN----  218 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH-----HHHHHHcCC--------CC----
Confidence            2233568999999999998889999999999999999999999996532211     111100000        00    


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                          .+...++++.+++.+||+.||++||     ++.++++
T Consensus       219 ----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 ----LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ----CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                0011345588999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-37  Score=317.79  Aligned_cols=261  Identities=27%  Similarity=0.438  Sum_probs=206.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe--------CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhC-CCccceeeeeeeec
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL--------GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSI-RHRNIIKVISSCSN  459 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  459 (678)
                      ..++|.+.+.||+|+||.||+|+.        .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            456788999999999999999963        134579999986432 23456788999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCee
Q 005760          460 EEFKALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVL  524 (678)
Q Consensus       460 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nil  524 (678)
                      .+..++||||+++++|.+++....               ..+++..+..++.|++.|++|||   +++++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence            999999999999999999997642               24677888999999999999999   999999999999999


Q ss_pred             ecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccc
Q 005760          525 LDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT  603 (678)
Q Consensus       525 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~  603 (678)
                      ++.++.+||+|||.++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......  .
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~  247 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E  247 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--H
Confidence            99999999999999986643332222233445678999999988889999999999999999998 77887542211  1


Q ss_pred             hhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          604 LKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      ....+.....     ..             .+..++.++.+++.+||+.+|++||++.|+++.|+++...
T Consensus       248 ~~~~~~~~~~-----~~-------------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         248 LFKLLKEGHR-----MD-------------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHHHHHcCCc-----CC-------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            1111110000     00             0113456788999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.6e-37  Score=325.00  Aligned_cols=248  Identities=24%  Similarity=0.372  Sum_probs=192.8

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            4566778999999999999985 4789999999864432 3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|.+..     ..++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  .
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~  223 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--D  223 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--c
Confidence            9999986532     2566778889999999999999   9999999999999999999999999999997654221  1


Q ss_pred             eeecccCCccccCccccCC-----CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          550 IQTQTLATIGYMAPEYGKE-----GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ......|+..|+|||.+..     ...+.++|||||||++|||++|+.||......+  ...........     ..+. 
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~-----~~~~-  295 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAICMS-----QPPE-  295 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhcc-----CCCC-
Confidence            1234568999999998743     234568999999999999999999997322211  11110000000     0000 


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                               .+..++.++.+++.+||+.||++||++.|+++.
T Consensus       296 ---------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        296 ---------APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     011345568899999999999999999999863

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.8e-37  Score=322.41  Aligned_cols=244  Identities=23%  Similarity=0.336  Sum_probs=193.2

Q ss_pred             CCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHH---HhCCCccceeeeeeeecCCeEEEE
Q 005760          394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMM---KSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      |++.+.||+|+||.||+|.. .+++.||+|+++...   ....+.+..|++++   +.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            66788999999999999975 478999999997532   22345566666655   466799999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|..+++..  .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++..... 
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-  154 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-  154 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC-
Confidence            9999999999888654  4899999999999999999999   999999999999999999999999999998643221 


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                       ........|++.|+|||.+.+..++.++|||||||++|||++|+.||......+. .......    .   ..-     
T Consensus       155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-~~~i~~~----~---~~~-----  220 (324)
T cd05589         155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-FDSIVND----E---VRY-----  220 (324)
T ss_pred             -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhC----C---CCC-----
Confidence             1223345689999999999998999999999999999999999999865322111 1111000    0   000     


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                              +..++.++.+++.+||+.||++||     ++.++++
T Consensus       221 --------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         221 --------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             --------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                    012345678999999999999999     5666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.8e-37  Score=321.54  Aligned_cols=261  Identities=24%  Similarity=0.423  Sum_probs=202.5

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceeeeeeeecC-
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKVISSCSNE-  460 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-  460 (678)
                      ..++|++.+.||+|+||.||+|..      .+++.||||+++.... .....+.+|+.++..+ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            346899999999999999999963      3578899999965432 2345678899999999 689999999987654 


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCC---------------------------------------------------------
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSN---------------------------------------------------------  483 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------------  483 (678)
                      ...++||||+++|+|.++++...                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            46789999999999999986432                                                         


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecc
Q 005760          484 ---------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT  554 (678)
Q Consensus       484 ---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  554 (678)
                               ..+++..+..++.|+++|++|||   +++|+||||||+||+++.++.+|++|||++...............
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                     13567788899999999999999   999999999999999999999999999999765333222222334


Q ss_pred             cCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhH
Q 005760          555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV  633 (678)
Q Consensus       555 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  633 (678)
                      .++..|+|||.+.+..++.++||||||+++|||++ |..||........ .........     ....+           
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~-----~~~~~-----------  304 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGT-----RMRAP-----------  304 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhccC-----CCCCC-----------
Confidence            45678999999988889999999999999999997 8889865322211 111110000     00000           


Q ss_pred             HHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          634 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       634 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                        ...++++.+++.+||+.||++||++.|+++.|+.+.+
T Consensus       305 --~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         305 --DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             --CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence              1123458899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.4e-37  Score=309.36  Aligned_cols=253  Identities=27%  Similarity=0.447  Sum_probs=203.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      .++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.+++.++||+++++++++.+ +..+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            457889999999999999999988888899999875433 34678899999999999999999998754 5678999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          471 PHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       471 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      ++++|.++++... ..+++.++..++.|++.|++|||   +.+++|+||+|+||++++++.++++|||.+........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-c
Confidence            9999999997643 34789999999999999999999   89999999999999999999999999999976543221 1


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                      ......++..|+|||...+..++.++||||||+++|||++ |..||.+....+  .........+        +.     
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~--------~~-----  223 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VLEQVERGYR--------MP-----  223 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCC--------CC-----
Confidence            1223345678999999988889999999999999999999 888886532211  1111110000        00     


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                           .+...+..+.+++.+||+++|++|||+.++.+.|+.
T Consensus       224 -----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         224 -----CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -----CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                 011234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=330.92  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=219.6

Q ss_pred             CCCCccccCCCceeEEEEEe-CCC----cEEEEEEeecc-cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          394 FSENNLIGRGSFGSVFKARL-GDG----MEVAMKVFNLQ-YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ....++||+|+||+||+|.+ .+|    -+||+|++... ..+...++.+|+-.|.+++|||+++++++|...+ ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            34568999999999999974 344    46899988544 3445688999999999999999999999998766 77999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      +|++.|+|.++++.++..+.....+.|..|||+||.|||   .+++|||||.++|||+..-..|||.|||+++.....+.
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999999888999999999999999999999   99999999999999999999999999999999887776


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                      ........-.+.|||-|.+....|+.++|||||||++||++| |..|+++....+..  .                 ++ 
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~--d-----------------ll-  913 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP--D-----------------LL-  913 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh--H-----------------HH-
Confidence            666666677889999999999999999999999999999999 99998874433221  0                 01 


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      ....++..+..|+-+++.+|.+||..|+..||+|+++...+.++-..-
T Consensus       914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            111234455678999999999999999999999999999999886543

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=5.3e-37  Score=311.02  Aligned_cols=254  Identities=25%  Similarity=0.430  Sum_probs=196.6

Q ss_pred             CCCCccccCCCceeEEEEEeCC-Cc--EEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeec------CCe
Q 005760          394 FSENNLIGRGSFGSVFKARLGD-GM--EVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSN------EEF  462 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  462 (678)
                      |.+.+.||+|+||.||+|...+ +.  .||+|.++...  ....+.+..|+++++.++||||+++++++..      ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999998643 33  58999886532  2345678889999999999999999997632      225


Q ss_pred             EEEEEEecCCCCHHHHhhhC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeec
Q 005760          463 KALVLEYMPHGSLEKYLHSS-----NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG  537 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg  537 (678)
                      .++++||+++|+|.+++...     ...+++..+..++.|++.|++|||   +++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999887432     234788999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcc
Q 005760          538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPIST  616 (678)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  616 (678)
                      +++...............+++.|+|||...+..++.++||||||+++|||++ |+.||......  .....+....  . 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~--~-  232 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQGN--R-  232 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcCC--C-
Confidence            9987643322222223346678999999998899999999999999999999 78888653221  1111111100  0 


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                        ...             +..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       233 --~~~-------------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 --LKQ-------------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --CCC-------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              000             012345588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.7e-37  Score=322.37  Aligned_cols=251  Identities=23%  Similarity=0.300  Sum_probs=197.3

Q ss_pred             CCCCCccccCCCceeEEEEEe----CCCcEEEEEEeeccc----CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeE
Q 005760          393 GFSENNLIGRGSFGSVFKARL----GDGMEVAMKVFNLQY----GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  463 (678)
                      +|++.+.||+|+||.||+++.    .+++.||+|++....    ....+.+..|+.+++.+ +||+|+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478899999999999999864    368899999986432    22345677899999999 499999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++||||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999997654 4888999999999999999999   9999999999999999999999999999997653


Q ss_pred             CCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      .... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ ..........      .++
T Consensus       157 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~~~~~------~~~  228 (332)
T cd05614         157 SEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSRRILK------CDP  228 (332)
T ss_pred             ccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHHHHhc------CCC
Confidence            3221 122345689999999998765 478899999999999999999999964322211 1111110000      001


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                      ..          +...+..+.+++.+||+.||++||     +++|+++
T Consensus       229 ~~----------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         229 PF----------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CC----------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            00          012345578999999999999999     7778875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=329.64  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=197.3

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688999999999999999975 578999999986432   233466788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999997654 4788889999999999999999   99999999999999999999999999999864321100


Q ss_pred             c---------------------------------------------ceeecccCCccccCccccCCCCCCccchHHHHHH
Q 005760          548 S---------------------------------------------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGI  582 (678)
Q Consensus       548 ~---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv  582 (678)
                      .                                             .......||+.|+|||++.+..++.++||||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0                                             0001246899999999999889999999999999


Q ss_pred             HHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCC---CC
Q 005760          583 MLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQR---IN  659 (678)
Q Consensus       583 ~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---ps  659 (678)
                      ++|||++|..||......+ ...... .+..    .+.-|.           ....+.++.+++.+|++ +|.+|   ++
T Consensus       237 il~elltG~~Pf~~~~~~~-~~~~i~-~~~~----~~~~p~-----------~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         237 IMFECLIGWPPFCSENSHE-TYRKII-NWRE----TLYFPD-----------DIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHH-HHHHHH-ccCC----ccCCCC-----------CCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            9999999999996533211 111111 0000    000000           01134558899999998 67765   59


Q ss_pred             HHHHHHH
Q 005760          660 AKEIVTK  666 (678)
Q Consensus       660 ~~ell~~  666 (678)
                      +.|++..
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-38  Score=324.57  Aligned_cols=253  Identities=24%  Similarity=0.403  Sum_probs=210.7

Q ss_pred             CCCccccCCCceeEEEEEeC--CC--cEEEEEEeecccCc-hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          395 SENNLIGRGSFGSVFKARLG--DG--MEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       395 ~~~~~ig~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ...++||+|.||+|++|.|.  .|  -.||||.++..... ...+|.+|+.+|.+|+|||++++||++.+ ....+|+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            34678999999999999875  34  34899999766443 66899999999999999999999999987 556799999


Q ss_pred             cCCCCHHHHhhh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC-CC
Q 005760          470 MPHGSLEKYLHS-SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQ  547 (678)
Q Consensus       470 ~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~-~~  547 (678)
                      ++.|+|.+.+++ .+..+-....-.++.|||.|+.||.   .+++||||+.++|+++.....|||+|||+.+-++.. +.
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            999999999988 4446777888889999999999999   999999999999999999999999999999988654 34


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                      +.+.........|+|||.+....++.++|||+|||++|||++ |..||.+-..  ..+.            +.+|     
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--~qIL------------~~iD-----  329 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--IQIL------------KNID-----  329 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--HHHH------------Hhcc-----
Confidence            455667778889999999999999999999999999999999 7888865211  1111            1111     


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                       ...++..+..|+++++++|++||..+|++||+|..+.+.+-..+
T Consensus       330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence             22234455689999999999999999999999999986554443

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-36  Score=312.65  Aligned_cols=261  Identities=24%  Similarity=0.406  Sum_probs=201.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCC---------------CcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeee
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGD---------------GMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVI  454 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~  454 (678)
                      .++|++.+.||+|+||.||++...+               ...||+|.++.... .....+.+|+++++.++|||+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4689999999999999999986532               23489999865422 3346788999999999999999999


Q ss_pred             eeeecCCeEEEEEEecCCCCHHHHhhhCC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCe
Q 005760          455 SSCSNEEFKALVLEYMPHGSLEKYLHSSN-----------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNV  523 (678)
Q Consensus       455 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Ni  523 (678)
                      +++...+..++||||+++++|.+++....           ..+++..+..++.|++.|++|||   +.+++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence            99999999999999999999999986432           13678889999999999999999   99999999999999


Q ss_pred             eecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc--CCCCCCcccCCc
Q 005760          524 LLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT--RKKPTDEIFNGE  601 (678)
Q Consensus       524 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~--g~~p~~~~~~~~  601 (678)
                      ++++++.+|++|||++................++..|+|||...++.++.++|||||||++|||++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999976543322222334456778999999988889999999999999999998  556765432211


Q ss_pred             cchhhhhhcccCCc-ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          602 MTLKHWVNDWLPIS-TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       602 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                       ........+.... ......+             ..+++.+.+++.+||+.||++||++.++++.|+
T Consensus       241 -~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 -VIENTGEFFRNQGRQIYLSQT-------------PLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             -HHHHHHHhhhhccccccCCCC-------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence             1111111000000 0000000             113456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.6e-37  Score=320.34  Aligned_cols=236  Identities=25%  Similarity=0.325  Sum_probs=190.1

Q ss_pred             ccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|..+ +++.||+|++....   ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 68999999987532   23445667788888776 699999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      |+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++......  .....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTTS  154 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCccc
Confidence            99999987665 4889999999999999999999   999999999999999999999999999998753221  12233


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...||+.|+|||.+.+..++.++||||+||++|||++|+.||......+  ....+   ...   ....+          
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~~~i---~~~---~~~~~----------  216 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEAI---LND---EVVYP----------  216 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHHH---hcC---CCCCC----------
Confidence            4568999999999998899999999999999999999999997532211  11111   000   00011          


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINA  660 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~  660 (678)
                         ...+.++.+++.+||+.||++||++
T Consensus       217 ---~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 ---TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             ---CCCCHHHHHHHHHHcccCHHHCCCC
Confidence               1134568899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.5e-37  Score=310.99  Aligned_cols=256  Identities=24%  Similarity=0.449  Sum_probs=203.6

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CC---cEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DG---MEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      +.|++.+.||+|+||.||+|..+ ++   ..||+|.+.... ......+..|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            35778899999999999999854 33   369999986542 33456789999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.+++......+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+|++|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999876666899999999999999999999   9999999999999999999999999999987654322


Q ss_pred             Ccceeecc---cCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          547 QSTIQTQT---LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       547 ~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ........   ..+..|+|||.+.+..++.++||||+||++||+++ |..||......  ....++....+         
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~~---------  229 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDYR---------  229 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCc---------
Confidence            11111111   12457999999998899999999999999999887 99998653221  11222111000         


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                               ...+..++..+.+++.+||+.+|.+||++.+++..|+++
T Consensus       230 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 ---------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     000123456688999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.9e-37  Score=316.06  Aligned_cols=265  Identities=20%  Similarity=0.280  Sum_probs=200.9

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|.+.+.||+|+||.||+|+.+ +++.||+|.++.... .....+.+|+++++.++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57889999999999999999854 788999999875432 2334577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++ +|.+++......++...+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++.......  .
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--K  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--c
Confidence            975 899888776666889999999999999999999   9999999999999999999999999999987543221  1


Q ss_pred             eeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC---Cccccc------
Q 005760          550 IQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP---ISTKEI------  619 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~------  619 (678)
                      ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. ..........   .....+      
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE-LHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhhcchhhh
Confidence            1233457899999998765 4578999999999999999999999975432211 1111100000   000000      


Q ss_pred             ---ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 ---VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                         ..+.......  .......+.++.+++.+|++.||.+|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         239 KNYNFPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhcCccCCCch--hhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence               0000000000  0011234667889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.9e-37  Score=329.72  Aligned_cols=251  Identities=22%  Similarity=0.330  Sum_probs=195.3

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .|+..+.||+|+||.||+|.. .+++.||+|++....   ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999975 478899999986532   2334677889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC-
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~-  547 (678)
                      |+++|+|.+++.+.+ .++...+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++..+..... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            999999999997654 4788888999999999999999   99999999999999999999999999999753211000 


Q ss_pred             --------------------------------------------cceeecccCCccccCccccCCCCCCccchHHHHHHH
Q 005760          548 --------------------------------------------STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIM  583 (678)
Q Consensus       548 --------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~  583 (678)
                                                                  ........||+.|+|||++.+..++.++||||+||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000123468999999999999899999999999999


Q ss_pred             HHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCC---H
Q 005760          584 LMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN---A  660 (678)
Q Consensus       584 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~  660 (678)
                      +|||++|+.||......+. ...... +..    ....|.           ....++++.+++.+|+ .+|++|++   +
T Consensus       238 l~elltG~~Pf~~~~~~~~-~~~i~~-~~~----~~~~p~-----------~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLET-QMKVIN-WQT----SLHIPP-----------QAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHH-HHHHHc-cCC----CcCCCC-----------cccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            9999999999975332211 111100 000    000000           0123445778888876 59999997   8


Q ss_pred             HHHHH
Q 005760          661 KEIVT  665 (678)
Q Consensus       661 ~ell~  665 (678)
                      .|+++
T Consensus       300 ~ei~~  304 (382)
T cd05625         300 DEIKA  304 (382)
T ss_pred             HHHhc
Confidence            88764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=7.3e-37  Score=307.17  Aligned_cols=247  Identities=23%  Similarity=0.386  Sum_probs=196.5

Q ss_pred             cccCCCceeEEEEEe---CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCC
Q 005760          399 LIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG  473 (678)
Q Consensus       399 ~ig~G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  473 (678)
                      .||+|+||.||+|.+   +++..+|+|+++....  ...+.+..|+.+++.++||||+++++++.. +..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999964   3678899999864432  245678899999999999999999998864 4678999999999


Q ss_pred             CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc-eee
Q 005760          474 SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST-IQT  552 (678)
Q Consensus       474 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~  552 (678)
                      +|.+++.... .+++..+..++.|++.|++|||   +++++||||||.||+++.++.+|++|||++.......... ...
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999997654 4889999999999999999999   9999999999999999999999999999997664332211 112


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN  631 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  631 (678)
                      ...++..|+|||.+....++.++|||||||++|||++ |+.||......  .....+.....        +.        
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~~--------~~--------  218 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGER--------ME--------  218 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCCC--------CC--------
Confidence            2234578999999988889999999999999999998 99998753221  11122111000        00        


Q ss_pred             hHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          632 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       632 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                        .+..+++++.+++.+||+.||++||++.+|++.|+++
T Consensus       219 --~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 --CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence              0113456688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.4e-37  Score=314.06  Aligned_cols=253  Identities=27%  Similarity=0.352  Sum_probs=205.6

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .....+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++.+...+..++|
T Consensus        16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            34456899999999999999999985 47899999999766555567788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.+++...  .+++.++..++.|++.|++|||   +.+|+||||+|+||+++.++.+||+|||++.......
T Consensus        96 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          96 MEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             ecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            9999999999998754  3788999999999999999999   9999999999999999999999999999987543221


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                        .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ .......    .......     
T Consensus       171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~~----~~~~~~~-----  238 (296)
T cd06654         171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATN----GTPELQN-----  238 (296)
T ss_pred             --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhcC----CCCCCCC-----
Confidence              112334688899999999888899999999999999999999999965332111 1111000    0000000     


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              +...+..+.+++.+||+++|++||++.|+++
T Consensus       239 --------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         239 --------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             --------ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                    1123455889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.3e-37  Score=308.23  Aligned_cols=254  Identities=24%  Similarity=0.422  Sum_probs=204.4

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..++|++.++||+|+||.||+|..++++.||+|.+..... ..+.+.+|+.+++.++|||++++++++. .+..+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3567899999999999999999988899999999864432 3467889999999999999999999874 4568999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++++|.+++.... ..+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++++|||++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  157 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-  157 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence            99999999986533 35788999999999999999999   99999999999999999999999999999976542221 


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      .......++..|+|||.+....++.++||||||+++||+++ |+.||.+....+  ..........        ..    
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~--------~~----  223 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYR--------MP----  223 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHcCCC--------CC----
Confidence            12223445678999999988889999999999999999999 999987533211  1111110000        00    


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                            .+...+.++.+++.+||+.+|++||++++++..|+.
T Consensus       224 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 ------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                  001234568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-37  Score=305.18  Aligned_cols=248  Identities=30%  Similarity=0.494  Sum_probs=199.9

Q ss_pred             ccccCCCceeEEEEEeCCCcEEEEEEeecccCc-hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCHH
Q 005760          398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLE  476 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  476 (678)
                      +.||+|+||.||+|...+++.||+|.+...... ....+..|+++++.++||||+++++++.+.+..++|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999998766999999998654333 4567889999999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccC
Q 005760          477 KYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA  556 (678)
Q Consensus       477 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  556 (678)
                      +++......+++..+..++.+++.|++|||   +.+++||||+|+||+++.++.+||+|||.+.................
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999776556889999999999999999999   99999999999999999999999999999876532211111122334


Q ss_pred             CccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHH
Q 005760          557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK  635 (678)
Q Consensus       557 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  635 (678)
                      +..|+|||.+.++.++.++|+||+||++|||++ |..||.......  ....+....     ...             .+
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~~~~~~-----~~~-------------~~  217 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERIESGY-----RMP-------------AP  217 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHHHhcCC-----CCC-------------CC
Confidence            567999999988889999999999999999999 788876533211  111111000     000             01


Q ss_pred             HHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          636 EQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       636 ~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      ..++.++.+++.+||+.+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            123456899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.6e-37  Score=306.51  Aligned_cols=248  Identities=25%  Similarity=0.430  Sum_probs=196.4

Q ss_pred             cccCCCceeEEEEEeC---CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCC
Q 005760          399 LIGRGSFGSVFKARLG---DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGS  474 (678)
Q Consensus       399 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  474 (678)
                      .||+|+||.||+|.+.   ++..||+|++..... ...+.+.+|+.+++.++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999753   456799999865432 234668899999999999999999998864 56789999999999


Q ss_pred             HHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc-eeec
Q 005760          475 LEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST-IQTQ  553 (678)
Q Consensus       475 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~  553 (678)
                      |.+++......+++..+..++.|++.|++|||   +++++||||||+||+++.++.+|++|||++.......... ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99999866666899999999999999999999   9999999999999999999999999999997554322211 1122


Q ss_pred             ccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       554 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ..++..|+|||.+....++.++|||||||++||+++ |+.||......+  ....+.....        +.         
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~--------~~---------  218 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKR--------LD---------  218 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCCC--------CC---------
Confidence            234578999999888889999999999999999996 999987533221  1111111000        00         


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                       .+..+++++.+++.+||+.+|++||++.++.+.|+.+
T Consensus       219 -~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         219 -CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence             0112456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2e-37  Score=322.18  Aligned_cols=241  Identities=24%  Similarity=0.317  Sum_probs=194.1

Q ss_pred             ccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCC
Q 005760          398 NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG  473 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  473 (678)
                      +.||+|+||.||+|.. .+|+.||+|++....   ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999975 578999999997542   223456678999999999999999999999999999999999999


Q ss_pred             CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          474 SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       474 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      +|.+++.... .+++..+..++.||+.||+|||   + ++|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccc
Confidence            9999887654 4889999999999999999999   7 799999999999999999999999999987532221  1123


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||......  .....+.   ..   ...-+          
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--~~~~~i~---~~---~~~~p----------  216 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELIL---ME---EIRFP----------  216 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--HHHHHHh---cC---CCCCC----------
Confidence            356899999999999889999999999999999999999999653221  1111100   00   00000          


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                         ...++++.+++.+||+.||++|+     ++.|+++
T Consensus       217 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         217 ---RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             ---CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence               12345688999999999999997     8999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-36  Score=305.68  Aligned_cols=250  Identities=28%  Similarity=0.387  Sum_probs=206.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .++|+..+.||+|+||.||+|... +++.+++|.+.....  .+.+.+|+++++.++||||+++++++.+....++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            467899999999999999999865 488999999875432  57889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|.+++......+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||++.......  .
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~  154 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--A  154 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--c
Confidence            9999999999876667899999999999999999999   9999999999999999999999999999987654322  1


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........  ....        ..+       
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--~~~~--------~~~-------  217 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--IPNK--------PPP-------  217 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--hccC--------CCC-------
Confidence            22334578899999999888899999999999999999999999875332211100  0000        000       


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                       ....+..++.++.+++.+||+.||++||++.|+++
T Consensus       218 -~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         218 -TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence             00112234567899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.8e-37  Score=309.25  Aligned_cols=256  Identities=26%  Similarity=0.466  Sum_probs=204.6

Q ss_pred             cCCCCCccccCCCceeEEEEEeC----CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .+|++.+.||+|+||.||+|...    .+..+|+|.++... ....+.+..|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56888999999999999999753    23479999986432 23346788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.+++......+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++++|||++.......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999876666899999999999999999999   9999999999999999999999999999998664332


Q ss_pred             Ccce-eecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          547 QSTI-QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       547 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      .... .....++..|+|||.+.+..++.++|+||||+++||+++ |..||......  .....+.....     .  +  
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~-----~--~--  229 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGYR-----L--P--  229 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCCc-----C--C--
Confidence            2111 122233568999999998889999999999999999887 99998653221  11111111000     0  0  


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                               ....+++.+.+++.+||+.+|.+||++.++++.|+++
T Consensus       230 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         230 ---------APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ---------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                     0012345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=9e-37  Score=340.25  Aligned_cols=260  Identities=25%  Similarity=0.354  Sum_probs=204.8

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.....   ...+++.+|+++++.++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999854 689999999864322   23467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeec
Q 005760          468 EYMPHGSLEKYLHSS----------NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG  537 (678)
Q Consensus       468 e~~~~~~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg  537 (678)
                      ||+++++|.+++...          ....++..+..++.||++||+|||   +++|+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999998642          123456778899999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCC----------------cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCc
Q 005760          538 IAKLLTREDQ----------------STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE  601 (678)
Q Consensus       538 ~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~  601 (678)
                      ++........                ........||+.|+|||.+.+..++.++||||+||++|||++|+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9976521110                011123468999999999999999999999999999999999999996532221


Q ss_pred             cchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHHHH
Q 005760          602 MTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI-NAKEIVTKLLKIRD  672 (678)
Q Consensus       602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~ell~~L~~~~~  672 (678)
                      .....           ...++...       ......++.+.+++.+|++.||++|| +++++++.|+.+.+
T Consensus       239 i~~~~-----------~i~~P~~~-------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 ISYRD-----------VILSPIEV-------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhhh-----------hccChhhc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            11110           00111100       01123456688999999999999996 67778888877644

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=306.70  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=209.5

Q ss_pred             hhcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      +.+-|.+.+.||+|.|++|-+|+ .-+|..||||++....-  -....+.+|++.|+.++|||||++|++......+|+|
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            45568889999999999999997 45899999999976543  2456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee-cCCCcEEEEeeccccccCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL-DDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill-~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      +|.-++|+|.+|+-++...+.+.-..+++.||+.|+.|+|   +.++||||+||+||.+ ..-|-||++|||++..+.+ 
T Consensus        96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P-  171 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP-  171 (864)
T ss_pred             EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC-
Confidence            9999999999999988888999999999999999999999   9999999999999976 5779999999999976643 


Q ss_pred             CCcceeecccCCccccCccccCCCCCC-ccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVS-ANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                        ...-+..+|+..|.|||++.+..|+ +++||||+||+||.+++|+.||......+.             +..++|-..
T Consensus       172 --G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------------LTmImDCKY  236 (864)
T KOG4717|consen  172 --GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------------LTMIMDCKY  236 (864)
T ss_pred             --cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------hhhhhcccc
Confidence              3334567899999999999999986 678999999999999999999976333221             122233221


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .        .+.-.+.++.+||..|++.||.+|.+.+||+.
T Consensus       237 t--------vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  237 T--------VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             c--------CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            1        12234566889999999999999999999874

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.9e-37  Score=320.35  Aligned_cols=241  Identities=23%  Similarity=0.315  Sum_probs=193.1

Q ss_pred             ccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|+.+ +++.||+|++....   ....+.+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999854 68899999997542   23345567788888865 799999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      ++|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTT  154 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC--cccc
Confidence            99999987665 4888899999999999999999   9999999999999999999999999999987543221  2233


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||......+ ........       ....|.         
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~~~i~~~-------~~~~p~---------  217 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-LFESILHD-------DVLYPV---------  217 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-HHHHHHcC-------CCCCCC---------
Confidence            4568999999999998899999999999999999999999997533211 11111100       000111         


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCC-------CHHHHHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRI-------NAKEIVT  665 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-------s~~ell~  665 (678)
                          .++.++.+++.+||+.||++||       ++.++++
T Consensus       218 ----~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         218 ----WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             ----CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                1345688999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=314.93  Aligned_cols=252  Identities=24%  Similarity=0.313  Sum_probs=211.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCc---hhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGR---VFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  464 (678)
                      ....|++.+.||.|.||.||+++.+ +|+.+|+|++......   ..+.+.+|+++|+++. |||||.+.+.|++.+..+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4567889999999999999999855 6999999999765432   3468899999999998 999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC----CCcEEEEeecccc
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD----NMVAHLSDFGIAK  540 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~----~~~~kl~Dfg~~~  540 (678)
                      +|||++.||.|.+.+...  ..++..+..++.|++.++.|||   +.||+|||+||+|+++..    ++.+|++|||++.
T Consensus       113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999876  3899999999999999999999   999999999999999953    3589999999998


Q ss_pred             ccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccc
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV  620 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (678)
                      ....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+........ ......+     .+.
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~i~~~~~-----~f~  258 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-AILRGDF-----DFT  258 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-HHHcCCC-----CCC
Confidence            8754   445567889999999999999999999999999999999999999998755433222 1111100     011


Q ss_pred             cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      +           ......+..+.+++..|+..||.+|+++.++++.
T Consensus       259 ~-----------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  259 S-----------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             C-----------CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            1           1123456678899999999999999999999873

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.8e-37  Score=309.40  Aligned_cols=258  Identities=25%  Similarity=0.408  Sum_probs=205.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCC----CcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGD----GMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      .++|.+.+.||+|+||.||+|...+    ...||+|...... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3568888999999999999997532    3568999886543 3345678899999999999999999998876 45689


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++++|.+++......+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+|++|||++......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999999876656899999999999999999999   999999999999999999999999999998765432


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      . ........++..|+|||.+....++.++||||||+++||+++ |..||......+.. .......      ...    
T Consensus       161 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~-~~~~~~~------~~~----  228 (270)
T cd05056         161 S-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIENGE------RLP----  228 (270)
T ss_pred             c-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHcCC------cCC----
Confidence            2 112223345568999999888889999999999999999996 99998654332111 1110000      000    


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                               .+..++..+.+++.+|+..+|++|||+.|+++.|+++++.
T Consensus       229 ---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         229 ---------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                     0113455688999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.4e-37  Score=330.28  Aligned_cols=253  Identities=22%  Similarity=0.314  Sum_probs=197.6

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++....   ......+.+|+++++.++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            4688999999999999999985 478999999986432   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC-
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED-  546 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~-  546 (678)
                      ||+++|+|.+++...+ .++...+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++..+.... 
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            9999999999997765 4788888899999999999999   9999999999999999999999999999975331000 


Q ss_pred             ----------------------------------------CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHH
Q 005760          547 ----------------------------------------QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME  586 (678)
Q Consensus       547 ----------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~e  586 (678)
                                                              .........||+.|+|||++.+..++.++||||+||++||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                    0000123469999999999999899999999999999999


Q ss_pred             HHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCC---CHHHH
Q 005760          587 TFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI---NAKEI  663 (678)
Q Consensus       587 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp---s~~el  663 (678)
                      |++|+.||......+..  ..+..+...    ...+.           ....++++.+++.+|+ .+|.+|+   ++.|+
T Consensus       237 ll~G~~Pf~~~~~~~~~--~~i~~~~~~----~~~~~-----------~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         237 MLVGQPPFLADTPAETQ--LKVINWETT----LHIPS-----------QAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             hhhCCCCCCCCCHHHHH--HHHhccCcc----ccCCC-----------CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            99999999763322111  111111000    00000           0123445778888876 5999999   88998


Q ss_pred             HHH
Q 005760          664 VTK  666 (678)
Q Consensus       664 l~~  666 (678)
                      ++.
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=5.1e-37  Score=313.72  Aligned_cols=259  Identities=24%  Similarity=0.405  Sum_probs=203.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF  462 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  462 (678)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999999643      245799998754322 233467789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEE
Q 005760          463 KALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL  533 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl  533 (678)
                      .++||||+++|+|.++++...         ...+...+..++.|++.|+.|||   +++++||||||+||++++++.+++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999997532         23456778889999999999999   999999999999999999999999


Q ss_pred             EeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhccc
Q 005760          534 SDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWL  612 (678)
Q Consensus       534 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~  612 (678)
                      +|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......  .....+.   
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--~~~~~~~---  235 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--QVLKFVM---  235 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH---
Confidence            99999875543222222233345678999999988889999999999999999998 78888653221  1111110   


Q ss_pred             CCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          613 PISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                              +.....       .+..+++.+.+++.+||+.||++|||+.|+++.|++..
T Consensus       236 --------~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         236 --------DGGYLD-------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             --------cCCCCC-------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence                    000000       01123456899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.8e-37  Score=326.11  Aligned_cols=254  Identities=22%  Similarity=0.278  Sum_probs=200.3

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ..++|++.+.||+|+||.||+|..+ +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3567999999999999999999854 78999999986431   2233557789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++|+|.+++....  ++...+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++......
T Consensus       121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999997653  778888899999999999999   999999999999999999999999999999765432


Q ss_pred             CCcceeecccCCccccCccccCCC----CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEG----RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      .. .......||+.|+|||++.+.    .++.++||||+||++|||++|+.||....... ..........     .+..
T Consensus       196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~-----~~~~  268 (370)
T cd05596         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMDHKN-----SLTF  268 (370)
T ss_pred             Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHHHHcCCC-----cCCC
Confidence            21 122345699999999987653    47889999999999999999999997532211 1111111000     0000


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVTK  666 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~ell~~  666 (678)
                      +           ....++.++.+++.+|++.+|.+  |+++.|+++.
T Consensus       269 ~-----------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         269 P-----------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             C-----------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            0           01123556889999999999988  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.6e-37  Score=305.35  Aligned_cols=247  Identities=30%  Similarity=0.465  Sum_probs=198.5

Q ss_pred             ccccCCCceeEEEEEeCCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCHH
Q 005760          398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLE  476 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  476 (678)
                      +.||+|+||.||+|...++..+|+|.+..... .....+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988899999999865432 23456888999999999999999999999999999999999999999


Q ss_pred             HHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccC
Q 005760          477 KYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA  556 (678)
Q Consensus       477 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  556 (678)
                      +++......+++..+..++.|++.|+.|+|   +++++|+||+|+||+++.++.+|++|||++....... ........+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence            999876656889999999999999999999   9999999999999999999999999999986543221 111122334


Q ss_pred             CccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHH
Q 005760          557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK  635 (678)
Q Consensus       557 ~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  635 (678)
                      +..|+|||+..++.++.++||||||+++||+++ |..||........  ...+....        ...          .+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~--~~~~~~~~--------~~~----------~~  216 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA--REQVEKGY--------RMS----------CP  216 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH--HHHHHcCC--------CCC----------CC
Confidence            577999999988889999999999999999998 8889865322211  11111000        000          00


Q ss_pred             HHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          636 EQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       636 ~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      ..++.++.+++.+||+.+|++||++.|+++.|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            123456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-37  Score=308.47  Aligned_cols=255  Identities=28%  Similarity=0.487  Sum_probs=206.5

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..++|.+.+.||+|+||.||+|..++++.||+|.+.... ...+++.+|+.+++.++|||++++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            457899999999999999999998788889999987433 2346788999999999999999999999988899999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++++|.+++.... ..+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.++++|||.++...... .
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~  158 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-Y  158 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-h
Confidence            99999999997643 45889999999999999999999   9999999999999999999999999999987654321 1


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      ........+..|+|||.+.+..++.++||||+|+++||+++ |+.||.+.... ...........      ...      
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~~~~~~~~------~~~------  225 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLEQVERGYR------MPR------  225 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCC------CCC------
Confidence            11223335678999999998889999999999999999998 89998653221 11111111000      000      


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                             +..++.++.+++.+|++.+|++||+++|+.+.|+.
T Consensus       226 -------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         226 -------PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                   01124568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.1e-37  Score=308.94  Aligned_cols=257  Identities=28%  Similarity=0.495  Sum_probs=204.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CC---cEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DG---MEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      .++|+..+.||+|+||.||+|..+ ++   ..+|+|.+.... ....+.+..|+++++.++|||++++.+++.+.+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            356788899999999999999854 33   379999986542 2335678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++++|.+++......+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.+|++|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999876566899999999999999999999   999999999999999999999999999999765432


Q ss_pred             CCcce-eecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          546 DQSTI-QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       546 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ..... ......+..|+|||.+....++.++|||||||++|||++ |+.||......  .....+....       ..+ 
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~~~~-------~~~-  230 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAINDGF-------RLP-  230 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhcCC-------CCC-
Confidence            21111 112223457999999988889999999999999999998 99998653221  1111111000       000 


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                                ....++.++.+++.+||+.+|++||++.++++.|+++
T Consensus       231 ----------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         231 ----------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                      0112455688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.2e-37  Score=319.63  Aligned_cols=241  Identities=22%  Similarity=0.268  Sum_probs=192.7

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCc-cceeeeeeeecCCeEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHR-NIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~  467 (678)
                      +|++.+.||+|+||.||+|... +++.||+|++....   ....+.+..|.++++.++|+ +|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999854 67899999997532   23446677899999998765 5888899999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-  155 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-  155 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-
Confidence            9999999999997654 4788999999999999999999   9999999999999999999999999999986432211 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+  ....+...   .   ..-+     
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~~i~~~---~---~~~~-----  221 (324)
T cd05587         156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQSIMEH---N---VSYP-----  221 (324)
T ss_pred             -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHcC---C---CCCC-----
Confidence             12234568999999999999899999999999999999999999997533211  11111100   0   0000     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINA  660 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  660 (678)
                              ...+.++.+++.+||+.||.+|+++
T Consensus       222 --------~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         222 --------KSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --------CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                    1134557899999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.2e-37  Score=318.12  Aligned_cols=240  Identities=24%  Similarity=0.330  Sum_probs=189.2

Q ss_pred             ccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHh-CCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKS-IRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|.. .+++.||+|+++...   ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999985 468899999997542   2233445566666664 4899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      |+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99999997655 4888999999999999999999   9999999999999999999999999999997543222  2233


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...||+.|+|||.+.+..++.++||||+||++|||++|+.||.+....+  ....+..   .      .+..        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--~~~~i~~---~------~~~~--------  215 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--LFDSILN---D------RPHF--------  215 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHc---C------CCCC--------
Confidence            4568999999999998889999999999999999999999997532211  1110100   0      0000        


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCHH-HHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINAK-EIV  664 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-ell  664 (678)
                        +..++.++.+++.+||+.||++||++. +++
T Consensus       216 --~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         216 --PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             --CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence              011345578999999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1e-36  Score=306.87  Aligned_cols=248  Identities=32%  Similarity=0.538  Sum_probs=203.5

Q ss_pred             ccccCCCceeEEEEEeCC----CcEEEEEEeecccCc-hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARLGD----GMEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|....    +..|++|.+...... ..+.+.+|+++++.++|+|++++++++.+.+..++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998643    888999998755433 367888999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          473 GSLEKYLHSS--------NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       473 ~~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      ++|.+++...        ...+++..+..++.|++.|++|||   +++++|+||+|+||+++.++.++++|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        356899999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ...........++..|+|||......++.++||||+|+++|||++ |..||......  ........           ..
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~-----------~~  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLEYLRK-----------GY  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc-----------CC
Confidence            432233445567889999999988889999999999999999999 68898764221  11111110           00


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      .       ...+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus       225 ~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 R-------LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             C-------CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            0       0011233567899999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=305.76  Aligned_cols=252  Identities=24%  Similarity=0.359  Sum_probs=201.4

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC-----chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-----RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ++|.+.+.||+|++|.||+|.. .+++.||+|.+.....     .....+.+|++++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999975 4789999999864321     123567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      |+||+++++|.+++.... .++...+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||+++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999997654 4788888999999999999999   999999999999999999999999999998765322


Q ss_pred             CCcc-eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          546 DQST-IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       546 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      .... ......++..|+|||.+.+..++.++||||+|+++|||++|+.||........ .... ....       ..+. 
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~-~~~~-------~~~~-  227 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-IFKI-ATQP-------TNPQ-  227 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-HHHH-hccC-------CCCC-
Confidence            1111 11234577899999999998899999999999999999999999865322111 1110 0000       0000 


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                               .+..++.++.+++.+||+.+|.+||++.|+++.
T Consensus       228 ---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         228 ---------LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ---------CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                     011244568899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.1e-37  Score=315.35  Aligned_cols=257  Identities=28%  Similarity=0.460  Sum_probs=201.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCc--EEEEEEeeccc-CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGM--EVAMKVFNLQY-GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  465 (678)
                      .++|++.+.||+|+||.||+|..+ ++.  .+|+|.+.... ......+.+|++++.++ +||||+++++++.+.+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            467888999999999999999854 454  45777765332 23446788899999999 89999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc
Q 005760          466 VLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV  530 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~  530 (678)
                      |+||+++++|.++++...               ..+++..+..++.|++.|++|||   +++++||||||+||+++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999997543               24688899999999999999999   999999999999999999999


Q ss_pred             EEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhh
Q 005760          531 AHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVN  609 (678)
Q Consensus       531 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~  609 (678)
                      +||+|||++.....   .........+..|+|||.+.+..++.++|||||||++|||++ |..||......+  ......
T Consensus       163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~  237 (303)
T cd05088         163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLP  237 (303)
T ss_pred             EEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHHHHh
Confidence            99999999853211   111122234667999999888889999999999999999998 999986532211  111111


Q ss_pred             cccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          610 DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      ...        ...          .+..+++++.+++.+||+.+|++||++.+++..|+++...
T Consensus       238 ~~~--------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         238 QGY--------RLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             cCC--------cCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            000        000          0012345688999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.6e-37  Score=316.02  Aligned_cols=261  Identities=28%  Similarity=0.427  Sum_probs=205.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC--------CCcEEEEEEeeccc-CchhhhHHHHHHHHHhC-CCccceeeeeeeecC
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG--------DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNE  460 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  460 (678)
                      .++|.+.+.||+|+||.||+|...        .+..+|+|.+.... ......+..|+++++.+ +||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            467888999999999999999641        24568999986432 23446688899999999 699999999999998


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL  525 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill  525 (678)
                      +..++||||+++|+|.+++....               ..+++..+..++.|++.|+.|||   +++++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            89999999999999999997532               24788889999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccch
Q 005760          526 DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTL  604 (678)
Q Consensus       526 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~  604 (678)
                      +.++.+|++|||.++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......  ..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~  245 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--EL  245 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence            9999999999999976543222221222234567999999988889999999999999999999 88888653211  11


Q ss_pred             hhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          605 KHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      .........        ..          .+..++.++.+++.+||+.+|++||++.|+++.|+++....
T Consensus       246 ~~~~~~~~~--------~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         246 FKLLREGHR--------MD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             HHHHHcCCC--------CC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            111110000        00          01123456889999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.4e-36  Score=306.81  Aligned_cols=245  Identities=23%  Similarity=0.300  Sum_probs=192.6

Q ss_pred             ccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCH
Q 005760          400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL  475 (678)
Q Consensus       400 ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  475 (678)
                      ||+|+||.||++.. .+|+.||+|.+....   ......+..|+++++.++||||+++.+++.+....++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999985 479999999986422   11234456799999999999999999999999999999999999999


Q ss_pred             HHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecc
Q 005760          476 EKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT  554 (678)
Q Consensus       476 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  554 (678)
                      .+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||++......   ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeecc
Confidence            98886543 35888899999999999999999   999999999999999999999999999998765322   122345


Q ss_pred             cCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHH
Q 005760          555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVA  634 (678)
Q Consensus       555 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  634 (678)
                      .++..|+|||++.+..++.++||||+||++|||++|+.||....... ...........        .....       .
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~~--------~~~~~-------~  218 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLE--------DEVKF-------E  218 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhhc--------ccccc-------c
Confidence            68999999999988889999999999999999999999986532211 11111110000        00000       0


Q ss_pred             HHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          635 KEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       635 ~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      ...++.++.+++.+||++||++||++.|+++.
T Consensus       219 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         219 HQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             cccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            01245568899999999999999999776643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-36  Score=309.27  Aligned_cols=244  Identities=24%  Similarity=0.293  Sum_probs=193.0

Q ss_pred             ccCCCceeEEEEEe-CCCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCH
Q 005760          400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL  475 (678)
Q Consensus       400 ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  475 (678)
                      ||+|+||+||++.. .+++.||+|.+.....   ...+.+..|+++++.++||||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999975 4789999999864321   2335667899999999999999999999999999999999999999


Q ss_pred             HHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          476 EKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       476 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      .+++..   ....+++..+..++.|++.|++|||   +++|+||||||+||+++.++.++|+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            988753   2235889999999999999999999   99999999999999999999999999999976543221  123


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...+++.|+|||.+.+..++.++||||+||++|||++|+.||........ ..........       .+.         
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~-------~~~---------  218 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILN-------DSV---------  218 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhcc-------cCC---------
Confidence            45689999999999999999999999999999999999999965322111 1111110000       000         


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                      ..+..++.++.+++.+||+.||++||     +++|+++
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            00112456688999999999999999     6777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-37  Score=312.14  Aligned_cols=255  Identities=25%  Similarity=0.414  Sum_probs=203.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  463 (678)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+..... .....+.+|+++++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            467888999999999999999753      347899999864422 3345678899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEE
Q 005760          464 ALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLS  534 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~  534 (678)
                      ++||||+++++|.+++....         ..+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986532         23678889999999999999999   9999999999999999999999999


Q ss_pred             eeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccC
Q 005760          535 DFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLP  613 (678)
Q Consensus       535 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  613 (678)
                      |||+++...............++..|+|||.+.++.++.++|||||||++||+++ |..||......+  ...+....  
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~--  237 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKFVIDG--  237 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHHHhcC--
Confidence            9999876544332222334456788999999988889999999999999999998 888886432211  11111100  


Q ss_pred             CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                       ..     +.          .+..++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus       238 -~~-----~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         238 -GH-----LD----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -CC-----CC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence             00     00          00123456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.7e-36  Score=311.21  Aligned_cols=262  Identities=23%  Similarity=0.427  Sum_probs=201.8

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-----------------CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCcccee
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-----------------DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIK  452 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  452 (678)
                      .++|++.+.||+|+||.||++...                 ++..||+|++.... .....++.+|+++++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            457999999999999999998532                 24468999986543 234567889999999999999999


Q ss_pred             eeeeeecCCeEEEEEEecCCCCHHHHhhhCCC----------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCC
Q 005760          453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNY----------ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSN  522 (678)
Q Consensus       453 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~N  522 (678)
                      +++++...+..++||||+++++|.+++.....          .+++..+..++.|++.|++|||   +.+++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence            99999999999999999999999999976431          3567789999999999999999   9999999999999


Q ss_pred             eeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc--CCCCCCcccCC
Q 005760          523 VLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT--RKKPTDEIFNG  600 (678)
Q Consensus       523 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~--g~~p~~~~~~~  600 (678)
                      |+++.++.++++|||++..+.........+...++..|+|||...++.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999976543322222333445678999998888889999999999999999998  67787543221


Q ss_pred             ccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      +. . .....+..........+           .+..++..+.+++.+||+.||++||++.|+++.|+
T Consensus       241 ~~-~-~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QV-I-ENTGEFFRDQGRQVYLP-----------KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HH-H-HHHHHHHhhccccccCC-----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11 0 00000000000000000           01124466889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.5e-37  Score=318.97  Aligned_cols=241  Identities=23%  Similarity=0.301  Sum_probs=189.3

Q ss_pred             ccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|.. .+++.||+|++....   ......+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999985 478899999997542   23345577888888776 799999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      |+|..++.... .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cccc
Confidence            99999887654 4889999999999999999999   9999999999999999999999999999987532211  1223


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCcc---chhhhhh-cccCCcccccccCccCCcc
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM---TLKHWVN-DWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~~~~~~  628 (678)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||........   ....+.. ......   ..        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---~~--------  223 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---IR--------  223 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---CC--------
Confidence            45689999999999999999999999999999999999999964221111   1111110 000000   00        


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINA  660 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  660 (678)
                           .+...+.++.+++.+||+.||++||++
T Consensus       224 -----~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 -----IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             -----CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                 001234557899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.1e-38  Score=288.84  Aligned_cols=251  Identities=26%  Similarity=0.363  Sum_probs=203.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--------chhhhHHHHHHHHHhC-CCccceeeeeeeecC
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--------RVFKSFDVECEMMKSI-RHRNIIKVISSCSNE  460 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  460 (678)
                      -..|.-.+.+|.|..++|.+... ++|...|+|++.....        +..++-.+|+.+++++ .||+|+++.++++.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            45677788999999999998864 5788999999854321        2345567899999998 599999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      ...++|+|.++.|.|.|++...-. +++....+|++|+.+|++|||   .+.|||||+||+|||+|++.++||+|||+++
T Consensus        96 sF~FlVFdl~prGELFDyLts~Vt-lSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVT-LSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhhee-ecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceee
Confidence            999999999999999999987654 888999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCcceeecccCCccccCccccCC------CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKE------GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI  614 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  614 (678)
                      .+.+.   ..-...+|||+|+|||.+.-      ..|+..+|+||+||+||-++.|.+||.--...  .....+      
T Consensus       172 ~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm--lMLR~I------  240 (411)
T KOG0599|consen  172 QLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM--LMLRMI------  240 (411)
T ss_pred             ccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH--HHHHHH------
Confidence            87543   33456789999999998752      35788899999999999999999998641110  000000      


Q ss_pred             cccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               ..+.......+..+++....+++.+|++.||.+|.|++|++.
T Consensus       241 ---------meGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  241 ---------MEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             ---------HhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                     011122223344567788999999999999999999999986

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.4e-36  Score=307.07  Aligned_cols=253  Identities=26%  Similarity=0.379  Sum_probs=201.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|+++.........+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            45788889999999999999975 57899999998766555556678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|.+++...+ .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++......  ..
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~  161 (267)
T cd06645          88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA  161 (267)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence            99999999987655 4889999999999999999999   999999999999999999999999999998765322  11


Q ss_pred             eeecccCCccccCccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          550 IQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                      ......++..|+|||.+.   .+.++.++||||+||++|+|++|+.||....+...... ....       ....+....
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~-~~~~-------~~~~~~~~~  233 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-MTKS-------NFQPPKLKD  233 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh-hhcc-------CCCCCcccc
Confidence            223456889999999874   45588899999999999999999999865332211110 0000       000000000


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              ...++..+.+++.+||+.+|++||++.++++
T Consensus       234 --------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         234 --------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             --------cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                    0112345789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-37  Score=310.32  Aligned_cols=262  Identities=25%  Similarity=0.404  Sum_probs=208.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCc----EEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGM----EVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      ..+|++.+.||+|+||.||+|..+ +|.    .+|+|....... .....+.+|+.+++.++|||++++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            357888899999999999999853 333    589998765432 344678889999999999999999999887 7889


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +|+||+++|+|.+++......+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||.++....
T Consensus        85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999999887666899999999999999999999   89999999999999999999999999999987653


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ...........++..|+|||......++.++|+||||+++||+++ |+.||......  ...+.+....     ....+ 
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~-----~~~~~-  233 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEKGE-----RLPQP-  233 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhCCC-----CCCCC-
Confidence            332222222334568999999988889999999999999999999 99998753221  1111111100     00000 


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHhh
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLR  676 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~~  676 (678)
                                  ..++.++.+++.+||..+|.+||++.++++.|+.+.+.-.|
T Consensus       234 ------------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~~  274 (279)
T cd05057         234 ------------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQR  274 (279)
T ss_pred             ------------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCcc
Confidence                        11334578999999999999999999999999998665433

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.4e-36  Score=304.83  Aligned_cols=249  Identities=26%  Similarity=0.382  Sum_probs=202.8

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc--cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|++.+.||+|++|.||+|..+ +++.|++|.+...  .......+..|+++++.++|||++++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4777899999999999999854 7899999998643  233456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++++|.++++.. ...+++..++.++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||++........ 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999999875 346889999999999999999999   99999999999999999999999999999876643221 


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                       ......+++.|+|||+..++.++.++|+||||+++|||++|+.||....... ..........         +..    
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~---------~~~----  221 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-LILKIIRGVF---------PPV----  221 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC---------CCC----
Confidence             1233457889999999999889999999999999999999999986533211 0111100000         000    


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                            ...++.++.+++.+||+.+|++||++.|+++.
T Consensus       222 ------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 ------SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ------ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                  01244568899999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=310.81  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=199.6

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      +|++.+.||+|+||.||++.. .+++.||+|++....   ......+.+|+++++.++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            477889999999999999985 478999999986432   1223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+++++|.+++.... ..+++..+..++.|++.|+.|||   +.+++||||+|+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999998886543 35889999999999999999999   9999999999999999999999999999987653221 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        ......++..|+|||.+.+..++.++||||+||++|||++|+.||.+.... .............         ... 
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~~---------~~~-  223 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERRVKED---------QEE-  223 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHHhhhc---------ccc-
Confidence              122346899999999998888999999999999999999999999753221 1111111100000         000 


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK  666 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~~  666 (678)
                            .+...+..+.+++.+||+.||++||     ++.++++.
T Consensus       224 ------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         224 ------YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ------cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                  0112455688999999999999999     88888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-36  Score=303.53  Aligned_cols=254  Identities=26%  Similarity=0.391  Sum_probs=206.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .++|++.+.||+|+||.||+|.. .+++.+++|++........+.+..|+++++.++||||+++++++.+.+..+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            46788999999999999999985 46788999999866555667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|.+++......++...+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||.+.......  .
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence            9999999999876556899999999999999999999   9999999999999999999999999999987654321  1


Q ss_pred             eeecccCCccccCccccCCC---CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          550 IQTQTLATIGYMAPEYGKEG---RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                      ......++..|+|||...+.   .++.++||||+|+++|||++|+.||........... ....       . ..+..  
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-~~~~-------~-~~~~~--  225 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-ISKS-------N-FPPPK--  225 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhc-------c-CCCcc--
Confidence            22345678899999998776   788999999999999999999999865332211110 0000       0 00000  


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           .......+.++.+++.+||+.+|.+||++.+++.
T Consensus       226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         226 -----LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -----ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 0012234567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-36  Score=304.69  Aligned_cols=250  Identities=30%  Similarity=0.486  Sum_probs=204.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      .++|++.+.||.|+||.||+|... |+.||+|.+..... ..+++..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            457888999999999999999874 78899999975533 4577889999999999999999999999899999999999


Q ss_pred             CCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          471 PHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       471 ~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      ++++|.+++..... .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||.+.......   
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---  156 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---  156 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence            99999999976542 5899999999999999999999   9999999999999999999999999999997653211   


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                        .....+..|+|||.+..+.++.++||||||+++||+++ |..||......  .....+.....        ..     
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~--------~~-----  219 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEKGYR--------ME-----  219 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhcCCC--------CC-----
Confidence              12334667999999988889999999999999999997 99998653221  11111110000        00     


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                           .+..+++++.+++.+||+.+|++||++.|++++|+++
T Consensus       220 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         220 -----APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -----CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                 0112356688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.4e-36  Score=305.76  Aligned_cols=252  Identities=27%  Similarity=0.448  Sum_probs=201.5

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      ++|.+.+.||+|++|.||+|..+.+..+|+|.+.... ...+.+.+|+++++.++|||++++++++.. +..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            5688899999999999999998777789999876432 234678889999999999999999998754 56789999999


Q ss_pred             CCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce
Q 005760          472 HGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI  550 (678)
Q Consensus       472 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  550 (678)
                      +++|.++++... ..+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++|+|||.+....... ...
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-ccc
Confidence            999999997643 34788999999999999999999   9999999999999999999999999999997653322 112


Q ss_pred             eecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      .....++..|+|||...+..++.++||||+|+++|||++ |..||.+....+  ..........        +.      
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~--------~~------  223 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYR--------MP------  223 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC--------CC------
Confidence            223346678999999988889999999999999999999 888987533221  1111110000        00      


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                          .+...+..+.+++.+||++||++||+++++++.|++
T Consensus       224 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 ----CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                001234568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3e-36  Score=307.43  Aligned_cols=260  Identities=24%  Similarity=0.440  Sum_probs=203.1

Q ss_pred             CCCCCccccCCCceeEEEEEe-----CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecC--CeEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-----GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE--EFKA  464 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  464 (678)
                      -|++.+.||+|+||.||++..     .++..||+|.+.... ......+.+|+++++.++|||++++.+++.+.  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            467889999999999999973     357889999986543 23446788999999999999999999988764  5688


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+++++|.+++.+....+++..+..++.|++.|++|||   +++++||||||+||+++.++.++|+|||+++....
T Consensus        85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999999776556899999999999999999999   99999999999999999999999999999986643


Q ss_pred             CCCc-ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCC----------ccchhhhhhcccC
Q 005760          545 EDQS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNG----------EMTLKHWVNDWLP  613 (678)
Q Consensus       545 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~----------~~~~~~~~~~~~~  613 (678)
                      .... .......++..|+|||.+.+..++.++|||||||++|||+++..|+......          .......+..   
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  238 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV---  238 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH---
Confidence            3221 1222345677899999998888999999999999999999987765331110          0000000000   


Q ss_pred             CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                           ..+...       ...+..++.++.+++.+||+.+|++||++.|+++.|+++
T Consensus       239 -----~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         239 -----LEEGKR-------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             -----HHcCcc-------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence                 000000       000123456799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.6e-37  Score=312.55  Aligned_cols=257  Identities=26%  Similarity=0.430  Sum_probs=203.2

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF  462 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  462 (678)
                      ..++|+..+.||+|+||.||+|..+      ++..||+|++..... .....+.+|+.+++.++||||+++++++.+++.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            3567899999999999999999753      567899999865432 334668889999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCC
Q 005760          463 KALVLEYMPHGSLEKYLHSSN---------------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPS  521 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~  521 (678)
                      .++|+||+++++|.+++....                     ..+++..++.++.|++.||+|||   ..+++||||+|+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence            999999999999999997432                     13677888999999999999999   999999999999


Q ss_pred             CeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCC
Q 005760          522 NVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNG  600 (678)
Q Consensus       522 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~  600 (678)
                      ||+++.++.++++|||++.................+..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999875533222222223345678999999988899999999999999999998 87887543221


Q ss_pred             ccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                           +........        ....       .+..++.++.+++.+||+.||++|||+.|+++.|++
T Consensus       240 -----~~~~~~~~~--------~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 -----EVIYYVRDG--------NVLS-------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -----HHHHHHhcC--------CCCC-------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                 111110000        0000       011234568899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.5e-36  Score=311.46  Aligned_cols=254  Identities=27%  Similarity=0.343  Sum_probs=206.4

Q ss_pred             HHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          387 LCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       387 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      .....++|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++
T Consensus        14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   93 (297)
T cd06656          14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   93 (297)
T ss_pred             cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence            344567899999999999999999985 5799999999976555555778889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++++|.+++.+.  .+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++++|||++......
T Consensus        94 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          94 VMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             eecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999999999754  3788899999999999999999   999999999999999999999999999998765332


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                      .  .......+++.|+|||...+..++.++|+||+||++|++++|+.||............+..     .     .+...
T Consensus       169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-----~-----~~~~~  236 (297)
T cd06656         169 Q--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-----G-----TPELQ  236 (297)
T ss_pred             c--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-----C-----CCCCC
Confidence            2  1123346888999999998888999999999999999999999999653321111100000     0     00000


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              .+...+..+.+++.+||+.+|++||++.++++
T Consensus       237 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         237 --------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             --------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    01123455789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.1e-36  Score=309.90  Aligned_cols=265  Identities=20%  Similarity=0.282  Sum_probs=202.2

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|++.+.||+|+||.||+|... ++..+|+|.+..... .....+.+|+++++.++||||+++++++.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46889999999999999999854 688899999865422 3345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++++|.++++... .+++..+..++.|+++|++|||   + .+++|+||+|+||+++.++.+|++|||++......   
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            99999999998764 4788899999999999999999   6 58999999999999999999999999998654322   


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccc--ccccCccCC
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK--EIVDPNLLS  626 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  626 (678)
                       ......++..|+|||.+.+..++.++|||||||++|+|++|+.||......  ....+..........  ....+....
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccccCCC
Confidence             123456889999999998888999999999999999999999998643321  111111110000000  000000000


Q ss_pred             c---cch--------------hhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          627 R---EDI--------------NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       627 ~---~~~--------------~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      .   ...              .......++.++.+++.+||+.+|++||++.|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0   000              000001245678999999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.3e-36  Score=309.22  Aligned_cols=262  Identities=24%  Similarity=0.420  Sum_probs=204.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCC-----------------CcEEEEEEeecccC-chhhhHHHHHHHHHhCCCcccee
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGD-----------------GMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK  452 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~  452 (678)
                      .++|++.+.||+|+||.||+|...+                 +..||+|.+..... ...+.+.+|+++++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4678999999999999999987532                 34689999865432 34567889999999999999999


Q ss_pred             eeeeeecCCeEEEEEEecCCCCHHHHhhhCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCC
Q 005760          453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN----------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSN  522 (678)
Q Consensus       453 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~N  522 (678)
                      +++++...+..++|+||+++++|.+++....          ..+++..+..++.|++.|++|||   +.+++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999899999999999999999997654          25789999999999999999999   9999999999999


Q ss_pred             eeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc--CCCCCCcccCC
Q 005760          523 VLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT--RKKPTDEIFNG  600 (678)
Q Consensus       523 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~--g~~p~~~~~~~  600 (678)
                      |+++.++.++++|||++................++..|+|||.+.++.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999876543332233344556788999999988889999999999999999998  66777542211


Q ss_pred             ccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      . .+ ................+           .+..++.++.+++.+||+.||++|||+.|+++.|+
T Consensus       241 ~-~~-~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 Q-VI-ENAGHFFRDDGRQIYLP-----------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             H-HH-HHHHhccccccccccCC-----------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            1 11 11111100000000000           01124466899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.4e-37  Score=315.73  Aligned_cols=240  Identities=24%  Similarity=0.329  Sum_probs=190.5

Q ss_pred             ccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHh-CCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKS-IRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|... +++.||+|+++...   ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999864 68899999997542   2233455667777775 4899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      |+|.+++.... .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||++......  .....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTC  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC--CCcee
Confidence            99999997654 4788899999999999999999   999999999999999999999999999998643211  11223


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||......  ...+.+...         .+. .       
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~---------~~~-~-------  215 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMD---------NPC-Y-------  215 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC---------CCC-C-------
Confidence            456899999999999888999999999999999999999999753221  111111100         000 0       


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCHH-HHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINAK-EIV  664 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-ell  664 (678)
                        +...+.++.+++.+||+.||++||++. ++.
T Consensus       216 --~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         216 --PRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             --CccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence              011344578999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.6e-37  Score=318.56  Aligned_cols=247  Identities=21%  Similarity=0.299  Sum_probs=193.2

Q ss_pred             ccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|.. .+++.||+|+++...   ....+.+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999985 478999999997532   23345677899999888 699999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      |+|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC--CCccc
Confidence            99999887654 4899999999999999999999   999999999999999999999999999998642211  11223


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCc---cchhhhhhcccCCcccccccCccCCccc
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE---MTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||+.....+   .....+.....       ......    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~~----  223 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-------LEKQIR----  223 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-------HcCCCC----
Confidence            4568999999999999899999999999999999999999996422111   11111111000       000000    


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCC------HHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRIN------AKEIVT  665 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps------~~ell~  665 (678)
                          .+..++.++.+++.+||+.||.+|++      +.|+++
T Consensus       224 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 ----IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence                00123455889999999999999997      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.4e-36  Score=309.51  Aligned_cols=249  Identities=24%  Similarity=0.338  Sum_probs=199.3

Q ss_pred             CCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          394 FSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      |++.+.||+|+||.||+|... ++..+++|.+........+.+..|+++++.++|||++++++++..++..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            566788999999999999864 6788999998655445567788899999999999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      ++|.+++.+....+++..+..++.|+++||+|||   +.+++||||+|+||+++.++.+|++|||++......  .....
T Consensus        87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~  161 (282)
T cd06643          87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD  161 (282)
T ss_pred             CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence            9999988765556899999999999999999999   999999999999999999999999999998754322  12223


Q ss_pred             cccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          553 QTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      ...++..|+|||++.     +..++.++||||+||++|||++|+.||......+. .........    .....      
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~----~~~~~------  230 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSEP----PTLAQ------  230 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhhcCC----CCCCC------
Confidence            456889999999874     34577899999999999999999999875332111 111111000    00000      


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                             +..++.++.+++.+||+.||.+||++.++++
T Consensus       231 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         231 -------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   1123456889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.4e-37  Score=317.20  Aligned_cols=241  Identities=22%  Similarity=0.288  Sum_probs=193.2

Q ss_pred             ccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|..+ +++.||+|++....   ......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999854 68899999997542   23345667888888877 699999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      ++|.+++.+.. .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cccc
Confidence            99999987664 4899999999999999999999   9999999999999999999999999999986432111  1122


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...+++.|+|||++.+..++.++||||+||++|||++|+.||......  .....+..   .   ....+          
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~~i~~---~---~~~~~----------  216 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQSILE---D---EVRYP----------  216 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHHHHHc---C---CCCCC----------
Confidence            346899999999999999999999999999999999999999653211  11111100   0   00000          


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCH-----HHHHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINA-----KEIVT  665 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~ell~  665 (678)
                         ..++.++.+++.+||+.||++||++     .++++
T Consensus       217 ---~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 ---RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ---CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence               1234568899999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.2e-36  Score=304.69  Aligned_cols=252  Identities=25%  Similarity=0.376  Sum_probs=191.4

Q ss_pred             ccccCCCceeEEEEEeC---CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCC
Q 005760          398 NLIGRGSFGSVFKARLG---DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG  473 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  473 (678)
                      +.||+|+||.||+|...   ++..+|+|.++.... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46899999999999753   346799998865432 23356888999999999999999999999989999999999999


Q ss_pred             CHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          474 SLEKYLHSSN----YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       474 ~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +|.++++...    ...++..+..++.|++.|++|||   +.+++|+||||+||+++.++++|++|||.+..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997532    23567778889999999999999   9999999999999999999999999999987544333222


Q ss_pred             eeecccCCccccCccccCCC-------CCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          550 IQTQTLATIGYMAPEYGKEG-------RVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |..||......+... ..+.    .......+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-~~~~----~~~~~~~~  232 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT-YTVR----EQQLKLPK  232 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH-HHhh----cccCCCCC
Confidence            23344577889999987542       35789999999999999996 999996543322111 1000    00011111


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      +....          ..+..+.+++..|| .+|++|||++||++.|+
T Consensus       233 ~~~~~----------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRLKL----------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CccCC----------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11110          12344778999999 68999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.9e-37  Score=323.79  Aligned_cols=255  Identities=22%  Similarity=0.282  Sum_probs=199.0

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      ...++|++.+.||+|+||.||+|... +++.+|+|++....   ......+.+|+.+++.++||||+++++++.+++..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34578999999999999999999864 68899999986421   223455778999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+++|+|.+++....  ++...+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++.....
T Consensus       120 lv~Ey~~gg~L~~~l~~~~--~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             EEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            9999999999999997653  788889999999999999999   99999999999999999999999999999986543


Q ss_pred             CCCcceeecccCCccccCccccCCC----CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEG----RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV  620 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (678)
                      .. ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||....... ..........     ...
T Consensus       195 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~~~i~~~~~-----~~~  267 (370)
T cd05621         195 TG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TYSKIMDHKN-----SLN  267 (370)
T ss_pred             CC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCc-----ccC
Confidence            22 1122355799999999988653    37889999999999999999999997532211 1111111000     000


Q ss_pred             cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 005760          621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVTK  666 (678)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~ell~~  666 (678)
                                 .......+..+.+++..|++.+|.+  |+++.|+++.
T Consensus       268 -----------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         268 -----------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -----------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                       0001123455778999999865544  8899998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-36  Score=327.55  Aligned_cols=263  Identities=25%  Similarity=0.337  Sum_probs=193.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecC--------
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNE--------  460 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------  460 (678)
                      ...+|++.+.||+|+||.||+|.. .+++.||||++....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            356799999999999999999985 478999999885322    2345799999999999999998876321        


Q ss_pred             CeEEEEEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC-cEEEEee
Q 005760          461 EFKALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDF  536 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~-~~kl~Df  536 (678)
                      ..+++||||+++ ++.+++..   ....+++..+..++.||+.||+|||   +++|+||||||+||+++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999975 77777643   3346889999999999999999999   99999999999999999654 7999999


Q ss_pred             ccccccCCCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCc
Q 005760          537 GIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS  615 (678)
Q Consensus       537 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  615 (678)
                      |+++......   ......+|+.|+|||++.+. .++.++||||+||++|||++|.+||.+....+ .+...+.......
T Consensus       216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~  291 (440)
T PTZ00036        216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPT  291 (440)
T ss_pred             ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCC
Confidence            9998654322   12345689999999987654 68999999999999999999999997633211 1111111000000


Q ss_pred             ----------ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          616 ----------TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       616 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                ...+.-+.. .........+...+.++.+|+.+||++||.+|||+.|+++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~-~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDV-KPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHHhchhhhcccCCcc-CchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                      000000100 0111111122235677999999999999999999999984

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-37  Score=310.92  Aligned_cols=253  Identities=25%  Similarity=0.366  Sum_probs=204.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .++|++.+.||.|+||.||+|... ++..+|+|++........+.+..|+++++.++||||+++++++.++...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467899999999999999999864 6899999999766555567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|.+++......+++..+..++.|++.|+.|||   +.+|+|+||+|+||+++.++.++|+|||.+......  ..
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence            9999999999876667899999999999999999999   999999999999999999999999999998654322  11


Q ss_pred             eeecccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          550 IQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ......+++.|+|||.+.     ...++.++||||+|+++|||++|+.||....... ....+....    .     +..
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~----~-----~~~  228 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILKSE----P-----PTL  228 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhcCC----C-----CCc
Confidence            223446888999999874     3346779999999999999999999986532211 111111000    0     000


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                              ..+..++.++.+++.+||+.+|++||++.++++.
T Consensus       229 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         229 --------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             --------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                    0112345568899999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2e-36  Score=310.00  Aligned_cols=252  Identities=25%  Similarity=0.334  Sum_probs=202.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .+.|++.+.||.|+||.||+|... ++..||+|.+........+.+..|+++++.++|||++++++++..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            467899999999999999999864 6899999999766555667788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|..++.+....+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++......  ..
T Consensus        91 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~  165 (292)
T cd06644          91 CPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ  165 (292)
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence            9999999988766566899999999999999999999   999999999999999999999999999998654221  11


Q ss_pred             eeecccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          550 IQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ......++..|+|||++.     ...++.++|||||||++|||++|..||...... .....+...    .     .+..
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~----~-----~~~~  235 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKS----E-----PPTL  235 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-HHHHHHhcC----C-----CccC
Confidence            223445788999999874     344678999999999999999999998653221 111111100    0     0000


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .        .+..++.++.+++.+||+.+|++||++.|+++
T Consensus       236 ~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 S--------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             C--------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0        01123456889999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.4e-37  Score=318.08  Aligned_cols=241  Identities=21%  Similarity=0.269  Sum_probs=192.6

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      +|++.+.||+|+||.||+|... +++.||+|++....   ......+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999754 67899999987542   22334566677887776 5899999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-  155 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence            9999999999987654 4888999999999999999999   9999999999999999999999999999987532211 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .....+....      ..-|     
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i~~~~------~~~p-----  221 (323)
T cd05616         156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSIMEHN------VAYP-----  221 (323)
T ss_pred             -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHHHhCC------CCCC-----
Confidence             1223456899999999999999999999999999999999999999753221  1111111000      0000     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINA  660 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  660 (678)
                              ...+.++.+++.+|++.||++|+++
T Consensus       222 --------~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         222 --------KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --------CcCCHHHHHHHHHHcccCHHhcCCC
Confidence                    1234568899999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-36  Score=309.62  Aligned_cols=270  Identities=24%  Similarity=0.424  Sum_probs=207.2

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-----CCcEEEEEEeecccCc-hhhhHHHHHHHHHhCCCccceeeeeeeec--CCeE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-----DGMEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVISSCSN--EEFK  463 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  463 (678)
                      ..|++.+.||+|+||.||+|...     ++..+|+|++...... ..+.+..|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999743     4788999999755442 46788999999999999999999999877  5678


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++++|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999877666899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCc-ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhc-ccCCccccccc
Q 005760          544 REDQS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND-WLPISTKEIVD  621 (678)
Q Consensus       544 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  621 (678)
                      ..... .......++..|+|||...+..++.++||||||+++|||++|+.|+................ .......+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            32221 11222345567999999988889999999999999999999999976532221110000000 00000000000


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                      ...      ....+..++.++.+++.+||+.+|++||++.|++++|+++
T Consensus       241 ~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         241 EGE------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cCC------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            000      0011123456799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.8e-36  Score=313.36  Aligned_cols=240  Identities=22%  Similarity=0.305  Sum_probs=190.6

Q ss_pred             ccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHh-CCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKS-IRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|..+ +|+.||+|+++...   ....+....|..++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999864 78999999997542   2234556677777775 4899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      |+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.++|+|||+++.....  .....
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DNRAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC--CCcee
Confidence            99999987654 4888999999999999999999   999999999999999999999999999998643211  12233


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||......  .....+...         .+..        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~~---------~~~~--------  215 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRVD---------TPHY--------  215 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC---------CCCC--------
Confidence            456899999999999999999999999999999999999999653221  111111100         0000        


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCHH-HHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINAK-EIV  664 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-ell  664 (678)
                        +..++.++.+++.+||+.||++||++. +++
T Consensus       216 --~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 --PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             --CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence              011345578999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.6e-36  Score=323.49  Aligned_cols=266  Identities=19%  Similarity=0.199  Sum_probs=198.8

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..+|.+.+.||+|+||.||+|... .++.||+|...      ...+.+|+++++.++||||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999999854 68899999642      23467899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +. ++|.+++......+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++.........
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            95 6999988766556899999999999999999999   9999999999999999999999999999997654322222


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCc------cchhhhhhccc--CCccccccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE------MTLKHWVNDWL--PISTKEIVD  621 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~------~~~~~~~~~~~--~~~~~~~~~  621 (678)
                      ......||..|+|||++.+..++.++|||||||++|||++|..|+.......      ..+...+....  .........
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            2234569999999999999999999999999999999999887653321110      01111111000  000000000


Q ss_pred             Ccc------------CCc-cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          622 PNL------------LSR-EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       622 ~~~------------~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      ..+            ... .............++.+|+.+||+.||.+|||+.|+++.
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000            000 000000001233468899999999999999999999863

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.6e-36  Score=304.71  Aligned_cols=248  Identities=25%  Similarity=0.418  Sum_probs=199.2

Q ss_pred             ccccCCCceeEEEEEeCC--C--cEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARLGD--G--MEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+..|++++++++||||+++++.+.+ ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999997532  3  3699999876554 556788999999999999999999999888 889999999999


Q ss_pred             CCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc-ce
Q 005760          473 GSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS-TI  550 (678)
Q Consensus       473 ~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~  550 (678)
                      ++|.+++.... ..+++..++.++.|++.||+|||   +++++|+||+|+||+++.++.+||+|||++......... ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997765 46899999999999999999999   999999999999999999999999999999876543221 12


Q ss_pred             eecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+  .......    ......         
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~----~~~~~~---------  221 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDK----EGERLE---------  221 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHh----cCCcCC---------
Confidence            223456788999999988899999999999999999999 999986432211  1111110    000000         


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                          .+..++..+.+++.+||+.+|++||++.|+++.|.
T Consensus       222 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 ----RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                01123456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.2e-36  Score=322.40  Aligned_cols=266  Identities=24%  Similarity=0.318  Sum_probs=197.5

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCC-----eEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE-----FKA  464 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  464 (678)
                      +|+..+.||+|+||.||+|.. .+|+.||+|++....  ....+.+.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999985 479999999985432  223456788999999999999999999998766     789


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +|+||+. ++|.+++.... .+++..+..++.||+.||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 58888886544 4889999999999999999999   99999999999999999999999999999976532


Q ss_pred             CCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc-----
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE-----  618 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  618 (678)
                      .. ........++..|+|||.+.+. .++.++||||+||++|||++|+.||.+.....  ....+.........+     
T Consensus       156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ--QLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCCCHHHHHHh
Confidence            22 2222345678999999988764 47899999999999999999999997533211  111110000000000     


Q ss_pred             ------cccCccCCccchh--hHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          619 ------IVDPNLLSREDIN--FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       619 ------~~~~~~~~~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                            .............  .......++++.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                  0000000000000  00001235668899999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.4e-36  Score=309.67  Aligned_cols=255  Identities=28%  Similarity=0.357  Sum_probs=206.7

Q ss_pred             HHHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          386 ELCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       386 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      +......+|+..+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..+
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (296)
T cd06655          13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELF   92 (296)
T ss_pred             hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEE
Confidence            3344456799999999999999999974 578999999997655555677889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +|+||+++++|.+++...  .+++.++..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus        93 lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          93 VVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            999999999999998754  3789999999999999999999   99999999999999999999999999999876543


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ...  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ........    .....    
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~~~~----~~~~~----  236 (296)
T cd06655         168 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNG----TPELQ----  236 (296)
T ss_pred             ccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcC----CcccC----
Confidence            221  12334688899999999888899999999999999999999999865332211 11000000    00000    


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               .+..++..+.+++.+||+.||++||++.++++
T Consensus       237 ---------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 ---------NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ---------CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                     01124456889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.7e-36  Score=304.28  Aligned_cols=251  Identities=27%  Similarity=0.440  Sum_probs=202.6

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|+++++.++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46788899999999999999887788999998864322 23578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      +++|.+++......+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-cccc
Confidence            99999999876656889999999999999999999   9999999999999999999999999999987653321 1112


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccch
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI  630 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  630 (678)
                      ....++..|+|||...++.++.++||||+|+++|||++ |..||......  ........    . .....+.       
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~----~-~~~~~~~-------  224 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINA----G-FRLYKPR-------  224 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhC----C-CCCCCCC-------
Confidence            23345678999999988889999999999999999998 88998642221  11111100    0 0001111       


Q ss_pred             hhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 005760          631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       631 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                            ..+.++.+++.+||+.+|++||++.|++++|
T Consensus       225 ------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         225 ------LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                  1235588999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.6e-36  Score=304.41  Aligned_cols=249  Identities=22%  Similarity=0.323  Sum_probs=201.0

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      +|++.+.||+|+||.||++... ++..+|+|.++... ....+.+..|+.+++.++||||+++++++.+.+..++|+||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999854 78999999986432 334567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          471 PHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       471 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      ++++|.+++... ...++...+..++.|++.|+.|||   +++++|+||+|+||++++++.++++|||.+.......  .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence            999999988653 335788999999999999999999   9999999999999999999999999999987654322  1


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      ......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||........ .........    .    +       
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~----~----~-------  219 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-ILKVCQGSY----K----P-------  219 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-HHHHhcCCC----C----C-------
Confidence            22345688899999999888899999999999999999999999975321111 000000000    0    0       


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                          .+..++.++.+++.+||+.||++||++.|++.+
T Consensus       220 ----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 ----LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                001234458899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-36  Score=303.84  Aligned_cols=239  Identities=22%  Similarity=0.383  Sum_probs=189.2

Q ss_pred             ccccCCCceeEEEEEeCC-------------CcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          398 NLIGRGSFGSVFKARLGD-------------GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      +.||+|+||.||+|....             ...|++|++..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997432             2358999886554455567888999999999999999999999988999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc-------EEEEeec
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV-------AHLSDFG  537 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~-------~kl~Dfg  537 (678)
                      +||||+++++|..++......+++..+..++.||++|++|||   +++|+||||||+||+++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999998876666899999999999999999999   999999999999999987664       8999999


Q ss_pred             cccccCCCCCcceeecccCCccccCccccC-CCCCCccchHHHHHHHHHHHH-cCCCCCCcccCCccchhhhhhcccCCc
Q 005760          538 IAKLLTREDQSTIQTQTLATIGYMAPEYGK-EGRVSANGDVYSFGIMLMETF-TRKKPTDEIFNGEMTLKHWVNDWLPIS  615 (678)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGv~l~ell-~g~~p~~~~~~~~~~~~~~~~~~~~~~  615 (678)
                      ++.....      .....++..|+|||.+. +..++.++|||||||++|||+ +|..|+......+  .......     
T Consensus       158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~-----  224 (262)
T cd05077         158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--KERFYEG-----  224 (262)
T ss_pred             CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--HHHHHhc-----
Confidence            9865432      12345778899999886 456889999999999999998 4778775422111  0110000     


Q ss_pred             ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 005760          616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                      ......               ....++.+++.+||+.||.+||++.|+++.+
T Consensus       225 ~~~~~~---------------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         225 QCMLVT---------------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             CccCCC---------------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            000000               1234588999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.5e-36  Score=318.43  Aligned_cols=263  Identities=24%  Similarity=0.298  Sum_probs=196.3

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCC-----
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE-----  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  461 (678)
                      ..++|++.+.||+|+||.||+|.. .+|..||+|++....  ......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999975 478999999986432  233466778999999999999999999885443     


Q ss_pred             -eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          462 -FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       462 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                       ..++||||+++ ++.+.+..   .++...+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++.
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             57899999965 67666643   3788889999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhc----------
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND----------  610 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~----------  610 (678)
                      ....   ........+|+.|+|||.+.+..++.++||||+||++|+|++|+.||.+....+ ........          
T Consensus       172 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         172 TACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             cccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHHHH
Confidence            5432   122234568999999999999999999999999999999999999997532211 00000000          


Q ss_pred             --------cc-------CCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          611 --------WL-------PISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       611 --------~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                              +.       .....+.. +......  ........+.++.+++.+||++||++|||+.|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELF-PDWIFPS--ESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhc-ccccccc--ccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                    00       00000000 0000000  000001234568899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.9e-36  Score=303.75  Aligned_cols=252  Identities=26%  Similarity=0.436  Sum_probs=193.9

Q ss_pred             ccccCCCceeEEEEEeC----CCcEEEEEEeecc-cCchhhhHHHHHHHHHhCCCccceeeeeeee-cCCeEEEEEEecC
Q 005760          398 NLIGRGSFGSVFKARLG----DGMEVAMKVFNLQ-YGRVFKSFDVECEMMKSIRHRNIIKVISSCS-NEEFKALVLEYMP  471 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  471 (678)
                      +.||+|+||.||+|...    ++..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999742    3467999987533 2234567888999999999999999999765 4556789999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc--c
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS--T  549 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~  549 (678)
                      +++|.+++.+.....++..+..++.|+++|++|||   +.+++||||||+||++++++.+|++|||+++........  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999876555778888899999999999999   899999999999999999999999999998754322111  1


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCC-CCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK-KPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                      ......++..|+|||.+.+..++.++|||||||++|||++|+ +||......  .....+....        .+.     
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--~~~~~~~~~~--------~~~-----  222 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--DITVYLLQGR--------RLL-----  222 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhcCC--------CCC-----
Confidence            112334567899999998888999999999999999999955 455432111  1111111000        000     


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                           .+..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus       223 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         223 -----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                 001234558899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.7e-36  Score=310.42  Aligned_cols=266  Identities=21%  Similarity=0.290  Sum_probs=200.9

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|.+.+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57889999999999999999754 68899999986543 22335677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      ++ ++|.+++......+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......  .
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~  159 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  159 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--C
Confidence            97 5999998876666889999999999999999999   9999999999999999999999999999987543221  1


Q ss_pred             eeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC----cccccccCcc
Q 005760          550 IQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI----STKEIVDPNL  624 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~  624 (678)
                      ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+  ....+......    ....+.+...
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCChhhchhhhcccc
Confidence            12234568899999987654 47889999999999999999999997533211  11111111100    0000000000


Q ss_pred             C-----Cccchhh--HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 L-----SREDINF--VAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~-----~~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .     .....+.  ......+.++.+++.+|++.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0     0000000  011234667889999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.1e-37  Score=322.10  Aligned_cols=258  Identities=23%  Similarity=0.286  Sum_probs=200.1

Q ss_pred             HHHHhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCC
Q 005760          386 ELCRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE  461 (678)
Q Consensus       386 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  461 (678)
                      ++....++|++.+.||+|+||.||+|..+ +++.+|+|++....   ......+.+|+.+++.++||||+++++++.+.+
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34445689999999999999999999864 78899999986421   223455778999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..++||||+++|+|.+++....  ++...+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++..
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            9999999999999999997653  788888899999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCCcceeecccCCccccCccccCCC----CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEG----RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK  617 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  617 (678)
                      ..... ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||....... .........   ...
T Consensus       192 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~---~~~  266 (371)
T cd05622         192 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMNHK---NSL  266 (371)
T ss_pred             cCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-HHHHHHcCC---Ccc
Confidence            64322 1122345799999999988653    37889999999999999999999997532211 111111000   000


Q ss_pred             ccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 005760          618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVTK  666 (678)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~ell~~  666 (678)
                      .             +......+..+.+++.+|++.++.+  |+++.|+++.
T Consensus       267 ~-------------~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         267 T-------------FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             c-------------CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            0             0011124556789999999844433  7799998874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2e-36  Score=311.54  Aligned_cols=259  Identities=25%  Similarity=0.434  Sum_probs=203.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCc----EEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGM----EVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      .++|+..+.||+|+||.||+|.+. ++.    .||+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356788899999999999999753 444    478888764432 2234678899999999999999999998764 467


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +++||+++|+|.+++......+++..+..++.|++.|++|||   +++|+|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999999876666889999999999999999999   99999999999999999999999999999986643


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ...........++..|+|||.+.+..++.++|||||||++|||++ |+.||.+....  ....++....     ....  
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~-----~~~~--  232 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDLLEKGE-----RLPQ--  232 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCC-----CCCC--
Confidence            322222233446778999999988889999999999999999998 88998653211  1122211100     0000  


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                                 +..++.++.+++.+||..+|++||++.|+++.|+++...
T Consensus       233 -----------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         233 -----------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             -----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                       012344588999999999999999999999999998644

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-36  Score=323.12  Aligned_cols=263  Identities=23%  Similarity=0.233  Sum_probs=200.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC---CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG---DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ..+|.+.+.||+|+||.||++...   .+..||+|.+...     ....+|+++++.++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            457999999999999999999642   4678999987532     34567999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |++. ++|.+++... ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.++|+|||++........
T Consensus       166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9995 5898888544 45899999999999999999999   99999999999999999999999999999976654433


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCc--cchhhhhhccc--CCcccc-----
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE--MTLKHWVNDWL--PISTKE-----  618 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~--~~~~~~~~~~~--~~~~~~-----  618 (678)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.....  ..+...+....  +.....     
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence            333345679999999999999999999999999999999999999986533221  01111111000  000000     


Q ss_pred             ----------cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          619 ----------IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       619 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                                ...+...   ..........+.++.+++.+||+.||++||++.|++..
T Consensus       321 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYT---IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCcc---ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                      0000000   00001112235568899999999999999999999864

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-36  Score=302.46  Aligned_cols=249  Identities=28%  Similarity=0.424  Sum_probs=197.2

Q ss_pred             ccccCCCceeEEEEEeC----CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|.+.    .+..+|+|.+..... ...+.+..|+++++.+.|||++++++++.. +..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            47999999999999642    236899999875433 245678899999999999999999998764 467899999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce-e
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI-Q  551 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~  551 (678)
                      ++|.+++.... .+++..+..++.|++.|++|||   ..+++|+||+|+||+++.++.+|++|||++........... .
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999998765 5889999999999999999999   99999999999999999999999999999976643322111 1


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccch
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI  630 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  630 (678)
                      ....++..|+|||...+..++.++||||||+++|||++ |..||.....  .....++....+     ..          
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~-----~~----------  218 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER-----LP----------  218 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc-----CC----------
Confidence            12223467999999988899999999999999999998 9999865332  122222211100     00          


Q ss_pred             hhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       631 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                         .+..++..+.+++.+||+.+|++||++.++++.|+++.
T Consensus       219 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         219 ---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence               01123456889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.4e-37  Score=318.66  Aligned_cols=238  Identities=26%  Similarity=0.345  Sum_probs=191.6

Q ss_pred             ccccCCCceeEEEEEe----CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          398 NLIGRGSFGSVFKARL----GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      +.||+|+||.||+++.    .+|+.||+|++.....  .....+..|+++++.++||||+++++++.+.+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999864    3689999999975422  233456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      +++|.+++.+.. .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||++.......  ...
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~  155 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA  155 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence            999999997654 4889999999999999999999   9999999999999999999999999999987653221  122


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchh
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN  631 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  631 (678)
                      ....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ ........    ..         .     
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~~~~i~~~----~~---------~-----  216 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-TMTMILKA----KL---------G-----  216 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-HHHHHHcC----CC---------C-----
Confidence            34568999999999988889999999999999999999999996532211 11110000    00         0     


Q ss_pred             hHHHHHHHHHHHHHHhhccccCcCCCCCHHH
Q 005760          632 FVAKEQCVSFVFNVAMECTVESPEQRINAKE  662 (678)
Q Consensus       632 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  662 (678)
                        .+...+.++.+++.+||+.||++||++.+
T Consensus       217 --~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 --MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence              00123455789999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.7e-36  Score=301.77  Aligned_cols=254  Identities=27%  Similarity=0.421  Sum_probs=200.1

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      .+++.+.....||+|+||.||+|.. .++..||+|.+........+.+.+|+++++.++|+||+++++++..++..++|+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            3455666667999999999999984 468889999987655555678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-CCcEEEEeeccccccCC
Q 005760          468 EYMPHGSLEKYLHSSNYIL--DIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-~~~~kl~Dfg~~~~~~~  544 (678)
                      ||+++++|.++++.....+  +...+..++.|++.|++|||   +++|+||||+|+||+++. ++.++|+|||.+.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            9999999999998654434  78888899999999999999   999999999999999976 67999999999876532


Q ss_pred             CCCcceeecccCCccccCccccCCCC--CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGR--VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ..  .......++..|+|||++.+..  ++.++||||+|+++|+|++|+.||..........  +......      ..+
T Consensus       162 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~--~~~~~~~------~~~  231 (268)
T cd06624         162 IN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM--FKVGMFK------IHP  231 (268)
T ss_pred             CC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH--hhhhhhc------cCC
Confidence            21  1122345788999999886644  7889999999999999999999986532211111  1000000      000


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .          .+..+.+++.+++.+||+.+|++||++.|++.
T Consensus       232 ~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         232 E----------IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             C----------CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            0          01124456889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.3e-36  Score=303.41  Aligned_cols=249  Identities=29%  Similarity=0.445  Sum_probs=199.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeee-ecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC-SNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e~  469 (678)
                      .++|.+.+.||+|+||.||+|.. .|..||+|.++..  ...+.+.+|+.+++.++|+|++++++++ .+.+..++|+||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            35788899999999999999976 4788999998643  2346788999999999999999999975 455678999999


Q ss_pred             cCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++++|.++++.... .+++..+..++.|++.|++|||   +++++||||||+||+++.++.+|++|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999999976543 4788999999999999999999   9999999999999999999999999999987543211  


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                         .....+..|+|||++.+..++.++|||||||++|||++ |+.||......  .....+....+        +.    
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~~~~--------~~----  219 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYK--------MD----  219 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCCC--------CC----
Confidence               22334568999999988889999999999999999998 88888642111  11111110000        00    


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                            .+..+++.+.+++.+||+.+|++|||+.++++.|+++
T Consensus       220 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         220 ------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                  0012456688999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.9e-37  Score=322.29  Aligned_cols=252  Identities=24%  Similarity=0.366  Sum_probs=196.5

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++....   ......+..|+.++..++||+|+++++++.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4688899999999999999975 478999999996432   234466788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.+++.+.+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.++|+|||++........
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            9999999999997654 4888999999999999999999   99999999999999999999999999999875432110


Q ss_pred             c---------------------------------ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005760          548 S---------------------------------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPT  594 (678)
Q Consensus       548 ~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~  594 (678)
                      .                                 .......||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                 0011346899999999999999999999999999999999999999


Q ss_pred             CcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCC---HHHHHH
Q 005760          595 DEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN---AKEIVT  665 (678)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~ell~  665 (678)
                      ........ ... +..+.    .....|.           ....+.++.+++.+|+. ||.+|++   +.|+++
T Consensus       237 ~~~~~~~~-~~~-i~~~~----~~~~~p~-----------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         237 CSETPQET-YRK-VMNWK----ETLVFPP-----------EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCHHHH-HHH-HHcCC----CceecCC-----------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            76332211 111 00000    0000000           00134457788888764 9999995   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.8e-36  Score=303.50  Aligned_cols=254  Identities=25%  Similarity=0.448  Sum_probs=204.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|+++++.++|+|++++.+++.+ ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            356889999999999999999998778889999886432 234678889999999999999999999887 778999999


Q ss_pred             cCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++++|.+++... ....++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.+|++|||.+....... .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~  157 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y  157 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-c
Confidence            9999999999764 345788899999999999999999   8999999999999999999999999999987654322 1


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      .......++..|+|||.+..+.++.++|+|||||++|++++ |+.||......  ....+.......       +     
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~-------~-----  223 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRM-------P-----  223 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCCC-------C-----
Confidence            12223345678999999988889999999999999999999 88898653221  111111110000       0     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                            .....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       224 ------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 ------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                  001234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-35  Score=302.21  Aligned_cols=248  Identities=25%  Similarity=0.375  Sum_probs=202.4

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45777889999999999999864 68999999987543 23456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|.+++...  .++...+..++.|++.|++|+|   +.+++|+||+|+||+++.++.++++|||++.......  .
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~  156 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I  156 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence            9999999998754  4788899999999999999999   9999999999999999999999999999997654322  1


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      ......++..|+|||.+.+..++.++|+|||||++|||++|+.||.........  .....        ...+       
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~--------~~~~-------  219 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--FLIPK--------NNPP-------  219 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--hhhhc--------CCCC-------
Confidence            123345788899999998888999999999999999999999998653322110  00000        0000       


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                         .....++..+.+++.+||+.+|++||++.|+++.
T Consensus       220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 ---TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ---CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence               0112356678899999999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-36  Score=303.87  Aligned_cols=248  Identities=29%  Similarity=0.478  Sum_probs=194.0

Q ss_pred             ccccCCCceeEEEEEeC-CCc--EEEEEEeeccc-CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARLG-DGM--EVAMKVFNLQY-GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|..+ ++.  .+++|.+.... ....+.+..|+++++++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999864 443  46888876432 23446788899999999 799999999999999999999999999


Q ss_pred             CCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeec
Q 005760          473 GSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG  537 (678)
Q Consensus       473 ~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg  537 (678)
                      ++|.+++....               ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999997543               24678899999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcc
Q 005760          538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPIST  616 (678)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  616 (678)
                      ++....   ..........+..|+|||++....++.++|||||||++|||++ |..||......+  ....+....    
T Consensus       158 l~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~----  228 (270)
T cd05047         158 LSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLPQGY----  228 (270)
T ss_pred             Cccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HHHHHhCCC----
Confidence            985321   1111122234567999999988889999999999999999997 999986532211  111110000    


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                          ...          .+..++.++.+++.+||+.+|.+|||+.|+++.|+++.
T Consensus       229 ----~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         229 ----RLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ----CCC----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                000          00123456889999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.2e-36  Score=316.04  Aligned_cols=237  Identities=27%  Similarity=0.320  Sum_probs=187.2

Q ss_pred             ccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHH-HHHhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECE-MMKSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|... +|+.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999864 79999999996532   122234444444 56789999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      |+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++......  .....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTS  154 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccc
Confidence            99999997654 4888899999999999999999   999999999999999999999999999998653221  12223


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...|++.|+|||.+.+..++.++|||||||++|||++|+.||......     ...........      . .       
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~~~~------~-~-------  215 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-----EMYDNILNKPL------R-L-------  215 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcCCC------C-C-------
Confidence            456899999999999989999999999999999999999999653211     11111000000      0 0       


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINAK  661 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  661 (678)
                        +...+.++.+++.+|++.||.+||++.
T Consensus       216 --~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 --KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             --CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence              011245588999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=9.4e-37  Score=317.12  Aligned_cols=241  Identities=25%  Similarity=0.286  Sum_probs=188.2

Q ss_pred             ccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHH-HHHHHhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVE-CEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e-~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|... +++.||+|++....   ......+..| ..+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999854 67889999986532   1222333444 3456788999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      ++|.+++.... .+....+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCcc
Confidence            99999998655 3777888889999999999999   999999999999999999999999999998754221  11233


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||......+.  ...+.   ...        ...      
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~---~~~--------~~~------  215 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YDNIL---NKP--------LQL------  215 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH--HHHHH---hCC--------cCC------
Confidence            45689999999999998999999999999999999999999975322111  11100   000        000      


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                        ....+..+.+++.+|++.||.+||++.+.+.
T Consensus       216 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         216 --KPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             --CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence              0123455789999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.2e-36  Score=310.85  Aligned_cols=195  Identities=23%  Similarity=0.344  Sum_probs=159.9

Q ss_pred             CccccCCCceeEEEEEeC---CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeec--CCeEEEEEEecC
Q 005760          397 NNLIGRGSFGSVFKARLG---DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN--EEFKALVLEYMP  471 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  471 (678)
                      .++||+|+||.||+|..+   +++.||+|.+...  .....+.+|+++++.++||||+++++++..  ....++|+||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999853   5688999998643  223557789999999999999999998854  456789999985


Q ss_pred             CCCHHHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee----cCCCcEEEEeeccc
Q 005760          472 HGSLEKYLHSS--------NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIA  539 (678)
Q Consensus       472 ~~~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill----~~~~~~kl~Dfg~~  539 (678)
                      + +|.+++...        ...++...+..++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 888887532        124788899999999999999999   9999999999999999    46689999999999


Q ss_pred             cccCCCCC-cceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcc
Q 005760          540 KLLTREDQ-STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEI  597 (678)
Q Consensus       540 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~  597 (678)
                      ........ ........+|+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            76643221 1122345789999999988764 5889999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.7e-36  Score=317.90  Aligned_cols=266  Identities=23%  Similarity=0.257  Sum_probs=196.8

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecC------
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE------  460 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  460 (678)
                      ..++|++.+.||+|+||.||+|.. ..++.||+|++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999975 478999999986532  22345677899999999999999999987543      


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      ...++||||+++ ++.+.+..   .++...+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            357899999965 67777653   3788889999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhh-----------
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN-----------  609 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~-----------  609 (678)
                      ....   ........+|..|+|||++.+..++.++||||+||++|||++|+.||.+....+. ....+.           
T Consensus       168 ~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         168 TAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             cCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHH
Confidence            5432   2222345689999999999988899999999999999999999999965321110 000000           


Q ss_pred             -------cccCC--cccccccCccCCccc--hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          610 -------DWLPI--STKEIVDPNLLSRED--INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       610 -------~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                             .+...  .......+.......  .+.........++.+++.+|++.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   00000  000000000000000  0000111234568899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.3e-36  Score=302.61  Aligned_cols=239  Identities=23%  Similarity=0.354  Sum_probs=188.2

Q ss_pred             cccCCCceeEEEEEeC-------------------------CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceee
Q 005760          399 LIGRGSFGSVFKARLG-------------------------DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV  453 (678)
Q Consensus       399 ~ig~G~~g~V~~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  453 (678)
                      +||+|+||.||+|...                         ....||+|++..........+.+|+++++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6999999999998631                         123589998865544445678889999999999999999


Q ss_pred             eeeeecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC----
Q 005760          454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM----  529 (678)
Q Consensus       454 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~----  529 (678)
                      ++++.+.+..++||||+++++|..++......+++..+..++.|++.||+|||   +++|+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999999776666899999999999999999999   99999999999999997544    


Q ss_pred             ---cEEEEeeccccccCCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHH-cCCCCCCcccCCccch
Q 005760          530 ---VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETF-TRKKPTDEIFNGEMTL  604 (678)
Q Consensus       530 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell-~g~~p~~~~~~~~~~~  604 (678)
                         .+|++|||.+......      ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||......+.  
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--  230 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--  230 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence               4899999987543211      22346788999998865 55889999999999999995 68888865332211  


Q ss_pred             hhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          605 KHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      ..+.....       ..+             ....+++.+++.+||+.+|++||++.++++.|+
T Consensus       231 ~~~~~~~~-------~~~-------------~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ERFYEKKH-------RLP-------------EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHhcc-------CCC-------------CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11111000       000             011235789999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.7e-36  Score=314.05  Aligned_cols=260  Identities=28%  Similarity=0.427  Sum_probs=204.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC--------CCcEEEEEEeeccc-CchhhhHHHHHHHHHhC-CCccceeeeeeeecC
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG--------DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNE  460 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  460 (678)
                      ..+|++.+.||+|+||.||+|...        ++..||+|.+.... ....+.+.+|+++++.+ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            346889999999999999999632        12368999886432 23456788999999999 799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL  525 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill  525 (678)
                      +..++++||+++|+|.+++....               ..+++..+..++.|++.|++|||   +++++||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence            99999999999999999987532               24678889999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccch
Q 005760          526 DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTL  604 (678)
Q Consensus       526 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~  604 (678)
                      +.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......  ..
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~  245 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--EL  245 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HH
Confidence            9999999999999976543222222223344567999999998899999999999999999998 88888653211  11


Q ss_pred             hhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          605 KHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      ...+.....        +.          .+..++.++.+++.+||+.+|++||++.|+++.|+++...
T Consensus       246 ~~~~~~~~~--------~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         246 FKLLKEGHR--------MD----------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             HHHHHcCCC--------CC----------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            111110000        00          0012345688999999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-36  Score=306.71  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=205.4

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecc--cCchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  466 (678)
                      ....|++.++||+||.+.||++...+.+.+|+|++...  +.+....|..|+..|.+|+ |.+||++++|-..++.+|+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            34579999999999999999999888888888876433  3456788999999999996 99999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||= ..||..++++.....+...+..++.|++.++.++|   .+||||.||||.|+++=. |.+||+|||.|..+....
T Consensus       439 mE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             eecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence            9986 45999999988776665688999999999999999   999999999999999854 689999999999887777


Q ss_pred             CcceeecccCCccccCccccCCC-----------CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCc
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEG-----------RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS  615 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  615 (678)
                      +.......+||+.||+||.+...           +++.++||||+||+||+|+.|+.||......-.            .
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a------------K  581 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA------------K  581 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH------------H
Confidence            77778888999999999976432           267889999999999999999999976332211            1


Q ss_pred             ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      +..+.+|...-... +..    ...++.++|+.||..||.+||++.|+++
T Consensus       582 l~aI~~P~~~Iefp-~~~----~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  582 LHAITDPNHEIEFP-DIP----ENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHhhcCCCcccccc-CCC----CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            22233332211100 000    1122889999999999999999999985

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.5e-36  Score=306.02  Aligned_cols=252  Identities=25%  Similarity=0.348  Sum_probs=198.1

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeecC------
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNE------  460 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------  460 (678)
                      .+++.|+..+.||+|+||.||+|.. .+++.||+|++.... .....+..|+.+++.+ +|||++++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            3567788899999999999999975 478899999986543 3346778899999998 699999999988642      


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccc
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA  539 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~  539 (678)
                      ...++||||+++++|.+++.... ..+++..+..++.|++.|++|||   +++|+|+|++|+||++++++.++|+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            46889999999999999988643 35789999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCCcceeecccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC
Q 005760          540 KLLTREDQSTIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI  614 (678)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  614 (678)
                      .......  .......++..|+|||++.     ...++.++||||+||++|||++|+.||...........  ...   .
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~--~~~---~  231 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--IPR---N  231 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH--Hhc---C
Confidence            7653221  1223456889999999875     33578899999999999999999999865322111100  000   0


Q ss_pred             cccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           ..+...         ...++.++.+++.+||+.+|.+|||+.|+++
T Consensus       232 -----~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         232 -----PAPRLK---------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -----CCCCCC---------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence                 000000         0123456889999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.3e-35  Score=299.64  Aligned_cols=251  Identities=23%  Similarity=0.388  Sum_probs=200.8

Q ss_pred             CCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccC------chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG------RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      +|+..+.||+|+||.||+|...+++.+|+|.+.....      .....+.+|+++++.++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4788899999999999999888899999999864321      1235678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      +||+++++|.+++.+.. .+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999997654 4788899999999999999999   8999999999999999999999999999987543211


Q ss_pred             C----cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          547 Q----STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       547 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      .    ........++..|+|||...+..++.++||||+|+++|||++|+.||........ ........       ...+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~~~-------~~~~  228 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFYIGAHR-------GLMP  228 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHHhhhcc-------CCCC
Confidence            1    1112334688899999999988899999999999999999999999965322111 10000000       0001


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..          +..++.++.+++.+||+.+|++||++.|++.
T Consensus       229 ~~----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         229 RL----------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CC----------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00          0123456889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-36  Score=311.84  Aligned_cols=255  Identities=23%  Similarity=0.281  Sum_probs=196.8

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||.||++.. .+++.||+|++...   .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4788999999999999999985 46899999998642   1223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.+++.+....+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999875556889999999999999999999   99999999999999999999999999999876543221


Q ss_pred             cceeecccCCccccCccccCC-----CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          548 STIQTQTLATIGYMAPEYGKE-----GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                       .......||+.|+|||++..     +.++.++||||+||++|||++|+.||......+. ......   ......+  +
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-~~~i~~---~~~~~~~--~  230 (331)
T cd05597         158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMN---HKEHFQF--P  230 (331)
T ss_pred             -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-HHHHHc---CCCcccC--C
Confidence             12223468999999998863     4578899999999999999999999865322111 111000   0000000  0


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcC--CCCCHHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPE--QRINAKEIVTK  666 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~--~Rps~~ell~~  666 (678)
                      .          ....++.++.+++.+|+..++.  .|+++.++++.
T Consensus       231 ~----------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         231 P----------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             C----------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0          0011455678899988765443  37899988764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.8e-36  Score=304.26  Aligned_cols=250  Identities=22%  Similarity=0.317  Sum_probs=198.5

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.....   .....+..|+.+++.++|++++++++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            367788999999999999975 4789999999864321   223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+++++|.+++.... ..++...+..++.|++.|+.|||   +.+|+||||||+||+++.++.++++|||++....... 
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            999999999886433 35888999999999999999999   9999999999999999999999999999987543221 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        ......|+..|+|||.+.+..++.++||||+||++|+|++|+.||........ .... .....    .. ..     
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~-~~~~~----~~-~~-----  222 (285)
T cd05630         157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEV-ERLVK----EV-QE-----  222 (285)
T ss_pred             --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHH-Hhhhh----hh-hh-----
Confidence              11234689999999999988999999999999999999999999975322110 0000 00000    00 00     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ell~  665 (678)
                           ..+..+++++.+++.+||+.||++|||     +.|+++
T Consensus       223 -----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 -----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             -----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                 001124556889999999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7e-36  Score=301.88  Aligned_cols=249  Identities=25%  Similarity=0.415  Sum_probs=199.4

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCc---------hhhhHHHHHHHHHhCCCccceeeeeeeecCCe
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGR---------VFKSFDVECEMMKSIRHRNIIKVISSCSNEEF  462 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  462 (678)
                      +|.+.+.||+|++|.||+|.. .+++.+|+|.+......         ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477889999999999999975 46899999988643221         23567889999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .++|+||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++||||+|+||++++++.++|+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999997764 4788889999999999999999   999999999999999999999999999998766


Q ss_pred             CCCCC----cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc
Q 005760          543 TREDQ----STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE  618 (678)
Q Consensus       543 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  618 (678)
                      .....    ........++..|+|||.+.+..++.++|+||+||++|+|++|+.||....... .... ...        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~-~~~--------  226 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFK-IGE--------  226 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHH-Hhc--------
Confidence            42211    111123457889999999988889999999999999999999999987532211 1100 000        


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ...+..          +..++.++.+++.+||+.||.+||++.|+++
T Consensus       227 ~~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         227 NASPEI----------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             cCCCcC----------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            000110          0123456889999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.1e-35  Score=302.35  Aligned_cols=249  Identities=25%  Similarity=0.342  Sum_probs=197.5

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3678889999999999999974 578999999986542 23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|..+.     .+++..+..++.|++.|++|||   +.+|+|+||||+||+++.++.++|+|||++......    
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            9999997653     3678888999999999999999   999999999999999999999999999998755322    


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccch--hhhhhcccCCcccccccCccCCc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTL--KHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||..........  ..........     ..+.. . 
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-~-  221 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----DPPVL-P-  221 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----CCCCC-C-
Confidence            1234568899999999998889999999999999999999999987533221110  0111000000     00000 0 


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                             ....++++.+++.+||+.+|++||++.|+++.
T Consensus       222 -------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 -------VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                   01134458899999999999999999999764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.7e-36  Score=304.25  Aligned_cols=249  Identities=28%  Similarity=0.493  Sum_probs=196.5

Q ss_pred             ccccCCCceeEEEEEeCC-------CcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          398 NLIGRGSFGSVFKARLGD-------GMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +.||+|+||.||+|...+       ++.+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999997532       2579999875432 23456788999999999999999999999998999999999


Q ss_pred             cCCCCHHHHhhhC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC-----cEEEEeecc
Q 005760          470 MPHGSLEKYLHSS------NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM-----VAHLSDFGI  538 (678)
Q Consensus       470 ~~~~~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~-----~~kl~Dfg~  538 (678)
                      +++++|.+++...      ...+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999753      234778899999999999999999   89999999999999999877     899999999


Q ss_pred             ccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCccc
Q 005760          539 AKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTK  617 (678)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  617 (678)
                      +................++..|+|||.+.++.++.++|||||||++|||++ |+.||......  .....+...      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~------  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVTAG------  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHhcC------
Confidence            876543322222233445678999999999999999999999999999998 99998643221  111111100      


Q ss_pred             ccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                           .       ....+..++..+.+++.+||+.+|++||++.++++.|++
T Consensus       230 -----~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         230 -----G-------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -----C-------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                 0       000112245668899999999999999999999998863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.2e-36  Score=304.97  Aligned_cols=265  Identities=25%  Similarity=0.315  Sum_probs=193.8

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhC---CCccceeeeeeeec-----CC
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSI---RHRNIIKVISSCSN-----EE  461 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~  461 (678)
                      +|++.+.||+|+||.||+|..+ +++.||+|.++....  .....+.+|+++++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5788899999999999999754 789999999865422  1223456677777665   69999999998754     34


Q ss_pred             eEEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      ..++|+||+++ +|.+++.... ..+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            67899999975 8988887543 34889999999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc---CCccc
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL---PISTK  617 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  617 (678)
                      ......   ......++..|+|||++.+..++.++||||+||++|||++|++||......+ ..........   .....
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhCc
Confidence            654221   1233567899999999988899999999999999999999999986532211 1111111000   00000


Q ss_pred             cccc--CccCCccchhhH--HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          618 EIVD--PNLLSREDINFV--AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       618 ~~~~--~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ....  ............  ....++.++.+++.+|+++||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000  000000000000  01234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-36  Score=302.97  Aligned_cols=248  Identities=27%  Similarity=0.362  Sum_probs=202.7

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|+..+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|||++++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888899999999999999854 78999999987543 33446788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|.+++...  .+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.++++|||+++......  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999999865  5899999999999999999999   9999999999999999999999999999998764321  2


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .......         ..+....   
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-~~~~~~~---------~~~~~~~---  220 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-LFLIPKN---------NPPSLEG---  220 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-HHHhhhc---------CCCCCcc---
Confidence            22345678899999999988899999999999999999999999865332111 0000000         0000000   


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                            ..++.++.+++.+||..+|++||+++++++
T Consensus       221 ------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         221 ------NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ------cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                  014456889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-36  Score=316.40  Aligned_cols=240  Identities=27%  Similarity=0.328  Sum_probs=188.4

Q ss_pred             ccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHH-HHHhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECE-MMKSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|.. .+|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999975 478999999996532   223344455544 56779999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      |+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++......  .....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~  154 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTT  154 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcc
Confidence            99999887654 4889999999999999999999   999999999999999999999999999998643221  12223


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||......+. ......    ...  ...           
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-~~~~~~----~~~--~~~-----------  216 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM-YDNILH----KPL--VLR-----------  216 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH-HHHHHc----CCc--cCC-----------
Confidence            45689999999999999999999999999999999999999965322111 111100    000  000           


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINAKEIV  664 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell  664 (678)
                         ...+..+.+++.+|++.+|.+||++.+.+
T Consensus       217 ---~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         217 ---PGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             ---CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence               01234577999999999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.2e-36  Score=312.53  Aligned_cols=241  Identities=21%  Similarity=0.273  Sum_probs=191.9

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  467 (678)
                      +|+..+.||+|+||.||+|.. .+|+.||+|++....   ....+.+..|..+++.+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            467789999999999999985 478999999987532   223455677888888875 577888999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.+++.... .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            9999999999997654 4889999999999999999999   9999999999999999999999999999987532211 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+.   ...   ...|     
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~---~~~---~~~p-----  221 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQSIM---EHN---VSYP-----  221 (323)
T ss_pred             -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHH---hCC---CCCC-----
Confidence             1223456899999999999888999999999999999999999999753221  1111110   000   0000     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINA  660 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  660 (678)
                              ..++.++.+++.+||+.+|.+|+++
T Consensus       222 --------~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         222 --------KSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --------ccCCHHHHHHHHHHcccCHhhCCCC
Confidence                    1234557899999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.7e-36  Score=310.27  Aligned_cols=243  Identities=23%  Similarity=0.299  Sum_probs=190.7

Q ss_pred             ccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|.. .+++.||+|++....   ....+.+..|+.++..+ +||+|+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999985 468899999997542   23345677899998888 699999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      ++|.+++...+ .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTS  154 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC--CCcee
Confidence            99999887654 4899999999999999999999   999999999999999999999999999998753221  11223


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCc-cchhhhhhcccCCcccccccCccCCccchh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE-MTLKHWVNDWLPISTKEIVDPNLLSREDIN  631 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  631 (678)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....+........  ....|         
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~p---------  223 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--PIRIP---------  223 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--CCCCC---------
Confidence            4568999999999999999999999999999999999999996432211 11111111000000  00000         


Q ss_pred             hHHHHHHHHHHHHHHhhccccCcCCCCCHH
Q 005760          632 FVAKEQCVSFVFNVAMECTVESPEQRINAK  661 (678)
Q Consensus       632 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  661 (678)
                          ...+..+.+++.+||+.||++|+++.
T Consensus       224 ----~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         224 ----RFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             ----CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence                11334578999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-35  Score=300.55  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=188.5

Q ss_pred             ccccCCCceeEEEEEeC---CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCC
Q 005760          398 NLIGRGSFGSVFKARLG---DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG  473 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  473 (678)
                      +.||+|+||.||+|...   ....+|+|.+..... .....+.+|++.++.++||||+++++++.+.+..++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            36899999999999743   345688887754322 23456788999999999999999999999999999999999999


Q ss_pred             CHHHHhhhCCC----CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          474 SLEKYLHSSNY----ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       474 ~L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +|.+++.....    ..++.....++.|++.|++|||   +++|+||||||+||+++.++.+|++|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999976532    2456778899999999999999   9999999999999999999999999999986543322222


Q ss_pred             eeecccCCccccCccccCC-------CCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          550 IQTQTLATIGYMAPEYGKE-------GRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      ......++..|+|||+...       ..++.++||||+||++|||++ |..||......+ .....+..    ....+..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~----~~~~~~~  232 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVRE----QDIKLPK  232 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhc----cCccCCC
Confidence            2233446678999998643       356789999999999999999 777876532211 11111111    0001111


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      +..          ...++..+.+++..|| .||++||+++||++.|.
T Consensus       233 ~~~----------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         233 PQL----------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             Ccc----------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111          1123455778889998 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.5e-36  Score=305.21  Aligned_cols=266  Identities=25%  Similarity=0.316  Sum_probs=197.8

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|++.+.||+|++|.||+|+.. +++.||+|.+....  ......+.+|+.+++.++|||++++++++.+++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999854 78999999986542  22345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          470 MPHGSLEKYLHSSN--YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       470 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ++ ++|.+++....  ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++......  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  154 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--  154 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--
Confidence            97 58988886533  45889999999999999999999   999999999999999999999999999998754322  


Q ss_pred             cceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC---Cccc---ccc
Q 005760          548 STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP---ISTK---EIV  620 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~---~~~  620 (678)
                      ........+++.|+|||.+.+. .++.++||||+||++|||++|+.||.......... ........   ....   ...
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF-RIFRILGTPTEDVWPGVTSLP  233 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHHHHhCCCChhhhhcchhhH
Confidence            1122334578899999987654 47889999999999999999999987532211110 00000000   0000   000


Q ss_pred             c--CccCCccchh-hHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          621 D--PNLLSREDIN-FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       621 ~--~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      +  +......... ......+++++.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            0  0000000000 0001125677889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7.9e-36  Score=304.32  Aligned_cols=250  Identities=21%  Similarity=0.287  Sum_probs=197.6

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .|+..+.||+|+||+||+|.. .+++.||+|.+....   ......+.+|+++++.++|+|++++.+++..++..++|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            366778999999999999975 478999999986432   1223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+++++|.+++.... ..+++..+..++.|++.|+.|||   +++|+||||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-  156 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence            999999998886543 35899999999999999999999   9999999999999999999999999999986543221 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        ......++..|+|||++.+..++.++|+||+||++|||++|..||........ ............  .    .    
T Consensus       157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~~~~--~----~----  223 (285)
T cd05632         157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVLETE--E----V----  223 (285)
T ss_pred             --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhhccc--c----c----
Confidence              12344689999999999888899999999999999999999999975322111 111111000000  0    0    


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ell~  665 (678)
                            .....+.++.+++..||+.||++||+     +.|+++
T Consensus       224 ------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         224 ------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                  01123455789999999999999999     666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-35  Score=298.24  Aligned_cols=238  Identities=23%  Similarity=0.420  Sum_probs=189.4

Q ss_pred             ccccCCCceeEEEEEeCC-C----------cEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          398 NLIGRGSFGSVFKARLGD-G----------MEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      +.||+|+||.||+|...+ +          ..+++|.+...... ...+.+|+.+++.++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            468999999999998653 3          25788877544332 5788899999999999999999999887 778999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC-------cEEEEeeccc
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM-------VAHLSDFGIA  539 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~-------~~kl~Dfg~~  539 (678)
                      |||+++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++       .+|++|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999876656899999999999999999999   99999999999999999887       7999999998


Q ss_pred             cccCCCCCcceeecccCCccccCccccCCC--CCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcc
Q 005760          540 KLLTREDQSTIQTQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPIST  616 (678)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  616 (678)
                      .....      .....++..|+|||++.+.  .++.++||||+|+++|||++ |..||......  ....+...      
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~~~~~~~~------  221 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--EKERFYQD------  221 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--hHHHHHhc------
Confidence            76532      2234466789999998876  78899999999999999999 56676553221  11111110      


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                           .......         ...++.+++.+||..+|++||++.|+++.|+
T Consensus       222 -----~~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 -----QHRLPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -----CCCCCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                 0000000         0145889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.1e-35  Score=300.11  Aligned_cols=253  Identities=25%  Similarity=0.328  Sum_probs=204.7

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|+..+.||.|++|.||+|..+ +++.||+|.+.... ......+.+|+++++.++||||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788899999999999999865 78999999986553 23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++++|.+++......++...+..++.|++.|++|||   + .+++|+||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            9999999999876556889999999999999999999   8 9999999999999999999999999999865532211 


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                         ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||.....................     .+..    
T Consensus       157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~----  224 (265)
T cd06605         157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-----PPRL----  224 (265)
T ss_pred             ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-----CCCC----
Confidence               1156888999999998889999999999999999999999998764322222222221111000     0000    


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           ....++.++.+++.+||..+|++||++.|++.
T Consensus       225 -----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 -----PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             -----ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence                 01114566889999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9e-36  Score=313.38  Aligned_cols=263  Identities=21%  Similarity=0.250  Sum_probs=195.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ...+|++.+.||+|+||.||+|... +++.||+|+...      .....|+.+++.++||||+++++++...+..++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            4467999999999999999999854 678899997532      233569999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+. ++|.+++......+++..+..++.||+.||.|||   +++|+||||||+||+++.++.+||+|||+++.....   
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  210 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---  210 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC---
Confidence            995 5899998776667899999999999999999999   999999999999999999999999999998743211   


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCC-CcccCC-cc-------chhhhhhcc--cCCccc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPT-DEIFNG-EM-------TLKHWVNDW--LPISTK  617 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~-~~~~~~-~~-------~~~~~~~~~--~~~~~~  617 (678)
                      .......||..|+|||++.+..++.++|||||||++|||+++..|+ ...... ..       .+...+...  .+....
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            1123456899999999999999999999999999999999965554 321111 00       011111100  000000


Q ss_pred             ---------ccccCccCC---ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          618 ---------EIVDPNLLS---REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       618 ---------~~~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               ...+.....   ............+.++.+++.+||+.||++||||.|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence                     000000000   000011111234556778999999999999999999985

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.2e-35  Score=298.31  Aligned_cols=249  Identities=23%  Similarity=0.325  Sum_probs=203.2

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|+..+.||.|+||.||.++. .+++.+++|.+....  ......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478899999999999999974 578999999986542  33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++++|.+++... ...+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999765 345889999999999999999999   89999999999999999999999999999976543221 


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                       ......+++.|+|||...+..++.++||||+|+++|||++|..||......+ .......    .....         .
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-~~~~~~~----~~~~~---------~  221 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-LVVKIVQ----GNYTP---------V  221 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHc----CCCCC---------C
Confidence             2334568899999999988888999999999999999999999986522211 1111110    00000         0


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                            ...++.++.+++.+||+.+|++||++.|+++.
T Consensus       222 ------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         222 ------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence                  02345568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-35  Score=298.69  Aligned_cols=250  Identities=31%  Similarity=0.566  Sum_probs=200.6

Q ss_pred             CCCCccccCCCceeEEEEEeCC-----CcEEEEEEeecccCc-hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          394 FSENNLIGRGSFGSVFKARLGD-----GMEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      +++.+.||.|+||.||++...+     +..||+|++...... ..+.+..|+++++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999998643     488999999655432 5678889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      ||+++++|.+++...... +++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999865544 899999999999999999999   9999999999999999999999999999997665432


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                      ... .....++..|+|||...+..++.++||||+|+++|+|++ |..||......  ...+.+....     ....    
T Consensus       158 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~~~-----~~~~----  225 (258)
T smart00219      158 YYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYLKKGY-----RLPK----  225 (258)
T ss_pred             ccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCC-----CCCC----
Confidence            221 112336789999999988889999999999999999998 77887642111  1111111000     0000    


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                               +..++.++.+++.+|++.||++|||+.|+++.|
T Consensus       226 ---------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 ---------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                     012456688999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.3e-35  Score=308.95  Aligned_cols=266  Identities=20%  Similarity=0.276  Sum_probs=194.9

Q ss_pred             CCccccCC--CceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          396 ENNLIGRG--SFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       396 ~~~~ig~G--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      +.+.||+|  +|++||++.. .+|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  7899999975 589999999987542  233456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          471 PHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       471 ~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      ++++|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.++++||+.+..........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            999999999653 234889999999999999999999   9999999999999999999999999998754432211110


Q ss_pred             -----eeecccCCccccCccccCC--CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcc------
Q 005760          550 -----IQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST------  616 (678)
Q Consensus       550 -----~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~------  616 (678)
                           ......++..|+|||++.+  ..++.++||||+||++|||++|+.||........... ......+...      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~  237 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-KLNGTVPCLLDTTTIP  237 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH-HhcCCccccccccchh
Confidence                 1122346678999999876  3588999999999999999999999975322211111 0000000000      


Q ss_pred             -ccc--------ccCcc--------CC---ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          617 -KEI--------VDPNL--------LS---REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       617 -~~~--------~~~~~--------~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                       .+.        .+...        ..   ...........+++++.+++.+||++||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence             000        00000        00   000000011234667999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=7.2e-36  Score=303.19  Aligned_cols=254  Identities=24%  Similarity=0.428  Sum_probs=202.6

Q ss_pred             cCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccCc-hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      ++|++.+.||+|+||.||+|+.+      +...|++|.+...... ..+.+.+|+++++.++||||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57888999999999999999853      3467999988654433 4577899999999999999999999999989999


Q ss_pred             EEEEecCCCCHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEee
Q 005760          465 LVLEYMPHGSLEKYLHSSN--------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF  536 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Df  536 (678)
                      +||||+++++|.+++....        ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999997654        14789999999999999999999   999999999999999999999999999


Q ss_pred             ccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCc
Q 005760          537 GIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPIS  615 (678)
Q Consensus       537 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  615 (678)
                      |++....... ........++..|+|||.+.+..++.++||||||+++|++++ |..||.......  .......   ..
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~~~~~---~~  235 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLNRLQA---GK  235 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHHHHHc---CC
Confidence            9986543221 122233456778999999888888999999999999999999 778885432211  1111110   00


Q ss_pred             ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      . .+..             +..++..+.+++.+||+.+|++||++.|+++.|+
T Consensus       236 ~-~~~~-------------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         236 L-ELPV-------------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             c-CCCC-------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            0 0000             0123456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.9e-36  Score=314.90  Aligned_cols=264  Identities=22%  Similarity=0.235  Sum_probs=196.3

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecC------
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE------  460 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  460 (678)
                      ..++|.+.+.||+|+||.||+|.. ..++.||||++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            457899999999999999999975 478899999986432  23346678899999999999999999987543      


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      ...|+||||+++ +|.+.+..   .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999965 78777753   3788889999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccc-
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI-  619 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  619 (678)
                      .....   .......++..|+|||++.+..++.++||||+||++|||++|+.||......+ .....+.... ....+. 
T Consensus       175 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~-~~~~~~~  249 (364)
T cd07875         175 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLG-TPCPEFM  249 (364)
T ss_pred             ccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC-CCCHHHH
Confidence            54322   22234568999999999999899999999999999999999999997533211 1111110000 000000 


Q ss_pred             ----------c--cCccC--------Cc--cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 ----------V--DPNLL--------SR--EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ----------~--~~~~~--------~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                .  .+...        ..  .............++.+++.+|++.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                      0  00000        00  00000000112456889999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.2e-36  Score=305.18  Aligned_cols=267  Identities=25%  Similarity=0.299  Sum_probs=198.6

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|+..+.||+|+||.||+|... +|+.||+|.+.....  .....+.+|+++++.++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999854 789999999865422  2335677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      ++ ++|.+++......+++..+..++.||++|+.|||   +++++||||+|+||+++.++.+||+|||++.......  .
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--R  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--C
Confidence            96 5888888765556899999999999999999999   9999999999999999999999999999987653221  1


Q ss_pred             eeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCc------ccccccC
Q 005760          550 IQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS------TKEIVDP  622 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~  622 (678)
                      ......++..|+|||.+.+.. ++.++||||+||++|||++|+.|+.........+...........      .....+.
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            123345788999999876654 689999999999999999999886432222111111100000000      0000000


Q ss_pred             ccCCccch--h-hHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 NLLSREDI--N-FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ~~~~~~~~--~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ........  . .......++++.+++.+||+.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00000000  0 0001234667889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.9e-35  Score=302.77  Aligned_cols=269  Identities=22%  Similarity=0.276  Sum_probs=199.4

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++++|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.+++.++|+||+++++++.+.+..++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            457899999999999999999975 4789999999865432 22345678999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+. +++.+++......+.+..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 6888777655555788888999999999999999   99999999999999999999999999999875432211


Q ss_pred             cceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc-C------------
Q 005760          548 STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL-P------------  613 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~------------  613 (678)
                        ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||+........+...+.... +            
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence              12334578899999988754 4788999999999999999999999754332111111110000 0            


Q ss_pred             CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ....... +................+.++.+++.+|++.||++|||+.|++.
T Consensus       237 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         237 NYKPEWF-LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccchhc-cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0000000 00000000000001112456889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.3e-35  Score=300.16  Aligned_cols=267  Identities=25%  Similarity=0.333  Sum_probs=201.4

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ++|+..+.||+|++|.||+|..+ +|+.||+|++....  ....+.+.+|+++++.++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999865 68999999986432  2234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |++++.|..+..... .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            999988887775543 4899999999999999999999   89999999999999999999999999999986643321 


Q ss_pred             ceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccch--hhhhhcccCC--------c-c
Q 005760          549 TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTL--KHWVNDWLPI--------S-T  616 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~--~~~~~~~~~~--------~-~  616 (678)
                       ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.+....+...  ........+.        . .
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             1223457789999998766 457889999999999999999999997543321111  1110000000        0 0


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .....+.......... .....+..+.+++.+||+.+|++||++.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         235 KGLSIPEPETREPLES-KFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccCCCcccccCHHH-HhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0001111111000000 01134667899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=314.05  Aligned_cols=250  Identities=25%  Similarity=0.360  Sum_probs=207.0

Q ss_pred             CCCCCccccCCCceeEEEEEeCC-CcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          393 GFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      -|.++..||.|+||.||+|..++ +-..|.|++.....+..+++.-|++++..+.||+||++++.|...+.++++.|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            34556789999999999998764 45567899888888888999999999999999999999999988899999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      ||.+..++-.-+..+...++..++.|++.||.|||   +..|+|||+|+.|||++-+|.+++.|||.+....  ..-...
T Consensus       113 GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qkR  187 (1187)
T KOG0579|consen  113 GGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQKR  187 (1187)
T ss_pred             CchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhhh
Confidence            99999988777778999999999999999999999   9999999999999999999999999999986432  233456


Q ss_pred             ecccCCccccCcccc-----CCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          552 TQTLATIGYMAPEYG-----KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                      ..+.|||+|||||+.     ...+|+.++||||||++|.||..+.+|-.........+.. .+.         ..|.   
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi-aKS---------ePPT---  254 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKS---------EPPT---  254 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH-hhc---------CCCc---
Confidence            778999999999964     4567999999999999999999999997654433222211 111         1111   


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           +..+...+..+.+++++|+.+||..||++.++++
T Consensus       255 -----LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  255 -----LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             -----ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                 1222234556889999999999999999999985

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.4e-36  Score=310.56  Aligned_cols=255  Identities=21%  Similarity=0.268  Sum_probs=197.6

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|.+.+.||+|+||.||+++.+ +++.||+|++....   ......+.+|..++..++|++|+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999854 78899999986421   223455778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++........
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999875556889999999999999999999   99999999999999999999999999999976543221


Q ss_pred             cceeecccCCccccCccccCC-----CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          548 STIQTQTLATIGYMAPEYGKE-----GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                       .......|++.|+|||++.+     +.++.++||||+||++|||++|+.||......+ .........  .   ...-+
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~~~--~---~~~~p  230 (331)
T cd05624         158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHE--E---RFQFP  230 (331)
T ss_pred             -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-HHHHHHcCC--C---cccCC
Confidence             12234568999999998865     467889999999999999999999996532211 111110000  0   00000


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVTK  666 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~ell~~  666 (678)
                      ...          ...+.++.+++.+|+..++.+  |++++++++.
T Consensus       231 ~~~----------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         231 SHI----------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             Ccc----------ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            000          123456889999999876554  4688887753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.7e-36  Score=303.60  Aligned_cols=252  Identities=28%  Similarity=0.450  Sum_probs=198.4

Q ss_pred             CCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchh--hhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          394 FSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      |++.+.||+|+||+||++... +++.+|+|++........  .....|+.+++.++||||+++++++.+.+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567889999999999999854 677899999976543222  23355999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI  550 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  550 (678)
                      ++++|.+++.... .++...+..++.|+++||++||   +.+++|+||||+||+++.++.++|+|||.+....  .....
T Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNEN  154 (260)
T ss_dssp             TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSE
T ss_pred             ccccccccccccc-cccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccccc
Confidence            9999999998433 4899999999999999999999   8999999999999999999999999999997541  22334


Q ss_pred             eecccCCccccCccccC-CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          551 QTQTLATIGYMAPEYGK-EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      .....++..|+|||... +..++.++||||+|+++|+|++|..||......  ............   . ..        
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~--~~~~~~~~~~~~---~-~~--------  220 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD--DQLEIIEKILKR---P-LP--------  220 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH--HHHHHHHHHHHT---H-HH--------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccch--hhhhhhhhcccc---c-cc--------
Confidence            45667899999999988 788999999999999999999999998764100  000000000000   0 00        


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ...........++.+++.+||+.||++||++.|+++
T Consensus       221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000011267999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-35  Score=309.51  Aligned_cols=255  Identities=21%  Similarity=0.272  Sum_probs=197.7

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||.||++..+ +++.+|+|++...   .......+.+|+.++..++|++|+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999854 6788999998642   1223345788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.+++.+....+++..+..++.|++.|+.|||   +++|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-  156 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-
Confidence            999999999999876556899999999999999999999   9999999999999999999999999999987553222 


Q ss_pred             cceeecccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          548 STIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ........||+.|+|||++.     ...++.++|||||||++|||++|+.||......+ ........    . ....-+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~~----~-~~~~~p  230 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNH----K-ERFQFP  230 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-HHHHHhCC----C-ccccCC
Confidence            22223456899999999875     3457889999999999999999999997532111 11111000    0 000000


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCC--CCCHHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVTK  666 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~ell~~  666 (678)
                      .          ....++.++.+++.+|+..+|..  |+++.|+++.
T Consensus       231 ~----------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         231 A----------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             C----------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0          00134566889999988665444  7899998765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3e-36  Score=312.89  Aligned_cols=237  Identities=26%  Similarity=0.301  Sum_probs=186.0

Q ss_pred             ccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHH-HHHHhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVEC-EMMKSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999864 78999999986432   12233444454 467889999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      ++|..++.... .++...+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  .....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~  154 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTS  154 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccc
Confidence            99998887654 4788888899999999999999   999999999999999999999999999998753221  12233


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...|++.|+|||.+.+..++.++||||+||++|||++|+.||......     ..........       ....      
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~-------~~~~------  216 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS-----QMYDNILHKP-------LQLP------  216 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH-----HHHHHHhcCC-------CCCC------
Confidence            456899999999999888999999999999999999999999653211     1111100000       0000      


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINAK  661 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  661 (678)
                         ...+.++.+++.+|++.||.+||++.
T Consensus       217 ---~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 ---GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ---CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence               11234578999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-37  Score=311.13  Aligned_cols=245  Identities=29%  Similarity=0.418  Sum_probs=202.1

Q ss_pred             CCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      -|.-.+.||.|+||.||-|+ ..+.+.||||++.-.   ..+.+.++..|+..++.++|||++.+.|||..+.+.++|||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            35557889999999999997 457889999998543   34567889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      ||- |+-.|++.-.+.++.+..+..|..+.+.||+|||   +.+.||||||+.|||+++.|.||++|||.|....+.   
T Consensus       107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---  179 (948)
T KOG0577|consen  107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---  179 (948)
T ss_pred             HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence            995 4888888777777889999999999999999999   999999999999999999999999999999776432   


Q ss_pred             ceeecccCCccccCcccc---CCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          549 TIQTQTLATIGYMAPEYG---KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                         ..++|||.|||||++   ..++|+-++||||+|++..|+..+++|...+. .-..+.+...         -..|.+.
T Consensus       180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-AMSALYHIAQ---------NesPtLq  246 (948)
T KOG0577|consen  180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQ---------NESPTLQ  246 (948)
T ss_pred             ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-HHHHHHHHHh---------cCCCCCC
Confidence               457899999999975   46789999999999999999999999965422 1122222221         1112222


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      +         ...+..+..++..|+++-|.+|||..++++.
T Consensus       247 s---------~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  247 S---------NEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             C---------chhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            1         2345568899999999999999999998763

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.3e-36  Score=303.04  Aligned_cols=246  Identities=26%  Similarity=0.365  Sum_probs=199.2

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            455678899999999999975 468899999986443 334567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI  550 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  550 (678)
                      ++++|.+++...  .+++..+..++.|++.|+.|||   +++++|+||+|+||+++.++.++++|||++.......  ..
T Consensus        85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            999999998754  4788999999999999999999   9999999999999999999999999999987654321  12


Q ss_pred             eecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccch
Q 005760          551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI  630 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  630 (678)
                      .....++..|+|||.+.+..++.++|||||||++|||++|+.|+........  .......        ..+..      
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~--------~~~~~------  221 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLIPKN--------SPPTL------  221 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--HhhhhcC--------CCCCC------
Confidence            2234578899999999988899999999999999999999999865332211  1110000        00000      


Q ss_pred             hhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       631 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                          ...++.++.+++.+||+.+|++||++.|+++
T Consensus       222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         222 ----EGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             ----CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence                0123456889999999999999999999998

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-35  Score=311.19  Aligned_cols=264  Identities=22%  Similarity=0.292  Sum_probs=195.5

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecC-----
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNE-----  460 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  460 (678)
                      ...++|++.+.||+|+||.||+|.. .++..||+|++.....  .....+.+|+++++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3467899999999999999999974 5788999999864322  2335577899999999999999999887532     


Q ss_pred             -CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccc
Q 005760          461 -EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA  539 (678)
Q Consensus       461 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~  539 (678)
                       ...++++|++ +++|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccc
Confidence             3568999988 77998888644  4889999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc
Q 005760          540 KLLTREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE  618 (678)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  618 (678)
                      ......     .....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||....... .+..+... .......
T Consensus       166 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~-~~~~~~~  238 (343)
T cd07878         166 RQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEV-VGTPSPE  238 (343)
T ss_pred             eecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHH-hCCCCHH
Confidence            765322     233568999999998876 468899999999999999999999986532111 11111100 0000000


Q ss_pred             ccc-----------CccCCccchhhH-HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 IVD-----------PNLLSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 ~~~-----------~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ...           ..+......+.. ......+.+.+++.+|++.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000           000000000000 00123455789999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.2e-36  Score=302.65  Aligned_cols=240  Identities=25%  Similarity=0.371  Sum_probs=189.4

Q ss_pred             ccccCCCceeEEEEEeC-C-------CcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          398 NLIGRGSFGSVFKARLG-D-------GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +.||+|+||.||+|..+ .       ..+||+|.+........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            46999999999999753 2       334888888655445557788999999999999999999999998899999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc--------EEEEeeccccc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV--------AHLSDFGIAKL  541 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~--------~kl~Dfg~~~~  541 (678)
                      +++|+|.++++..+..+++..+..++.||+.|++|||   +++|+||||||+||+++.++.        ++++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999876666899999999999999999999   999999999999999987765        69999999865


Q ss_pred             cCCCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCC-CCCCcccCCccchhhhhhcccCCccccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRK-KPTDEIFNGEMTLKHWVNDWLPISTKEI  619 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (678)
                      ....      ....++..|+|||.+.+. .++.++|||||||++|||++|. .|+.......  ........        
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~--------  221 (258)
T cd05078         158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK--KLQFYEDR--------  221 (258)
T ss_pred             cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH--HHHHHHcc--------
Confidence            4321      224577889999998764 4789999999999999999985 5544321111  01111000        


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                        ....          .....++.+++.+||+.||++|||++|+++.|+
T Consensus       222 --~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 --HQLP----------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --ccCC----------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence              0000          011245789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-35  Score=301.11  Aligned_cols=255  Identities=23%  Similarity=0.330  Sum_probs=203.6

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|++.+.||+|+||+||+|.. ++|+.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            5688889999999999999985 468999999986543 33457788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|.+++...+ .+++..+..++.+++.|+.|||+  ..+++|+||+|+||+++.++.++|+|||++.......   
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~---  158 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI---  158 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence            99999999987654 48899999999999999999993  2689999999999999999999999999986542211   


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCcc------chhhhhhcccCCcccccccCc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM------TLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~  623 (678)
                       .....++..|+|||.+.++.++.++|||||||++|++++|..||+.....+.      ....+........     .+.
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~  232 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-----PPR  232 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----CCC
Confidence             1234688999999998888899999999999999999999999975433210      0111111110000     000


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                      .         ....++.++.+++.+||++||++||++.|+++..
T Consensus       233 ~---------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         233 L---------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             C---------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            0         0112456789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-35  Score=303.46  Aligned_cols=259  Identities=23%  Similarity=0.316  Sum_probs=200.7

Q ss_pred             HHHHHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeee---
Q 005760          384 YLELCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCS---  458 (678)
Q Consensus       384 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~---  458 (678)
                      +..+..++++|++.+.||+|+||.||+|.. .+++.+|+|++.... .....+..|+.+++.+ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            455566789999999999999999999975 468899999876432 2335678899999999 6999999999873   


Q ss_pred             --cCCeEEEEEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEE
Q 005760          459 --NEEFKALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL  533 (678)
Q Consensus       459 --~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl  533 (678)
                        ..+..++||||+++++|.+++..   ....+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.+++
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEE
Confidence              44678999999999999998753   2335788889999999999999999   999999999999999999999999


Q ss_pred             EeeccccccCCCCCcceeecccCCccccCccccCC-----CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhh
Q 005760          534 SDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE-----GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWV  608 (678)
Q Consensus       534 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~  608 (678)
                      +|||+++......  .......++..|+|||++..     ..++.++||||+||++|||++|+.||........ .....
T Consensus       166 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~~~~  242 (286)
T cd06638         166 VDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LFKIP  242 (286)
T ss_pred             ccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hhhcc
Confidence            9999987654221  12233468899999998753     3478899999999999999999999865322111 10000


Q ss_pred             hcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      .    .......++             ..++.++.+++.+||+.||++||++.|+++.
T Consensus       243 ~----~~~~~~~~~-------------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         243 R----NPPPTLHQP-------------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             c----cCCCcccCC-------------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            0    000001111             1133458899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4e-35  Score=296.28  Aligned_cols=256  Identities=26%  Similarity=0.347  Sum_probs=204.6

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|++.+.||.|+||+||+|.. .++..+|+|++.... ....+.+.+|+++++.++|+|++++++.+...+..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4788999999999999999985 478899999986432 23457788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          470 MPHGSLEKYLHSSN--YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       470 ~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      +++++|.++++...  ..+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.++++|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999997642  35789999999999999999999   99999999999999999999999999999876654322


Q ss_pred             cc--eeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          548 ST--IQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       548 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ..  ......++..|+|||.+... .++.++|+|||||++|||++|+.||........ ........          +..
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~----------~~~  226 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQND----------PPS  226 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhcCC----------CCC
Confidence            21  22334688899999988777 789999999999999999999999975433221 11111110          000


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .....    ....+++++.+++.+||+.||++||++.|+++
T Consensus       227 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         227 LETGA----DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cCCcc----ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00000    01234566889999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.9e-35  Score=295.57  Aligned_cols=248  Identities=24%  Similarity=0.383  Sum_probs=198.8

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeec-CCeEEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSN-EEFKALVLE  468 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  468 (678)
                      +|++.+.||+|++|.||++..+ +++.||+|.+....  ....+.+.+|+++++.++|||++++++.+.. ....++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5888999999999999999854 67899999986542  2344667889999999999999999998764 446789999


Q ss_pred             ecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+++++|.+++.... ..+++.++..++.|++.|+++||   +.+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~-  156 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC-  156 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence            999999999997643 35889999999999999999999   9999999999999999999999999999997653321 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                       .......+++.|+|||...+..++.++||||+|+++|+|++|+.||....... ..........+         ..   
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~---------~~---  222 (257)
T cd08223         157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-LVYRIIEGKLP---------PM---  222 (257)
T ss_pred             -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCCC---------CC---
Confidence             12234567889999999998889999999999999999999999986432111 11111111100         00   


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                             +...++++.+++.+||+.+|++||++.|+++
T Consensus       223 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         223 -------PKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             -------ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                   0124456889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4e-35  Score=297.24  Aligned_cols=254  Identities=25%  Similarity=0.398  Sum_probs=197.9

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC----------chhhhHHHHHHHHHhCCCccceeeeeeeecCC
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG----------RVFKSFDVECEMMKSIRHRNIIKVISSCSNEE  461 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  461 (678)
                      +|...+.||+|+||.||+|.. .+|+.||+|.++....          ...+.+..|+++++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            467789999999999999974 4789999998854211          12346778999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..++|+||+++++|.++++... .++...+..++.|++.|+.|||   +.+++||||+|+||+++.++.++++|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999998764 5888899999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCCcceeecccCCccccCccccCCCC--CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEGR--VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI  619 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (678)
                      ..............++..|+|||......  ++.++|+||+|+++||+++|..||.......    .... .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~-~~~~~~~~~  232 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA----AMFK-LGNKRSAPP  232 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH----HHHH-hhccccCCc
Confidence            43221111223345788999999877654  7889999999999999999999986422211    1110 000000000


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ....          ....++.++.+++.+||+++|++||++.|+++
T Consensus       233 ~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         233 IPPD----------VSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CCcc----------ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            0000          00124566889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-35  Score=300.86  Aligned_cols=251  Identities=23%  Similarity=0.349  Sum_probs=198.5

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|++.+.||+|+||.||+|..+ ++..||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888999999999999999865 78999999986542 23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          470 MPHGSLEKYLHSS--NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       470 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      +++++|.+++...  ...+++..+..++.|++.|+.|||+  +.+++|+||+|+||+++.++.++++|||.+....... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            9999999998764  2258999999999999999999992  3599999999999999999999999999987553221 


Q ss_pred             cceeecccCCccccCccccCCCC------CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGR------VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                         .....++..|+|||.+.+..      ++.++|+||+||++|+|++|+.||........ . ..........     .
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~-~~~~~~~~~~-----~  227 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-F-AQLSAIVDGD-----P  227 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-H-HHHHHHhhcC-----C
Confidence               12345778899999885543      47899999999999999999999865322111 0 0000000000     0


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      +.          .+..++.++.+++.+||+.+|++||++.|++.
T Consensus       228 ~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         228 PT----------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             CC----------CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            00          01125566889999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2e-35  Score=299.56  Aligned_cols=254  Identities=27%  Similarity=0.470  Sum_probs=197.7

Q ss_pred             CCCCccccCCCceeEEEEEeC----CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCC------
Q 005760          394 FSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE------  461 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  461 (678)
                      |.+.+.||+|+||.||+|...    +++.||+|++....  ....+++.+|+++++.++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999742    46889999986542  234567888999999999999999999875432      


Q ss_pred             eEEEEEEecCCCCHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEee
Q 005760          462 FKALVLEYMPHGSLEKYLHSSN-----YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF  536 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Df  536 (678)
                      ..++++||+.+|+|.+++....     ..++...+..++.|++.|++|||   +++|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            3478999999999998875321     24788889999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCc
Q 005760          537 GIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPIS  615 (678)
Q Consensus       537 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  615 (678)
                      |.++...............+++.|++||.+....++.++|||||||++|||++ |+.||......  ....++.....  
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~--  233 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLIKGNR--  233 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHHcCCc--
Confidence            99986543322222233445678999999988889999999999999999999 88887653221  11111111000  


Q ss_pred             ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                         ...+             ..++..+.+++.+||+.+|++||++.|+++.|+++
T Consensus       234 ---~~~~-------------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 ---LKQP-------------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ---CCCC-------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               0000             12345688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.8e-35  Score=294.72  Aligned_cols=252  Identities=23%  Similarity=0.382  Sum_probs=186.8

Q ss_pred             ccccCCCceeEEEEEeCCC---cEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCC
Q 005760          398 NLIGRGSFGSVFKARLGDG---MEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG  473 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  473 (678)
                      +.||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999974333   346677665433 234567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce
Q 005760          474 SLEKYLHSSN---YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI  550 (678)
Q Consensus       474 ~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  550 (678)
                      +|.++++...   ...+...+..++.||+.||+|||   +.+++||||||+||+++.++.++++|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999997642   23566677889999999999999   89999999999999999999999999999854322111122


Q ss_pred             eecccCCccccCccccCC-------CCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          551 QTQTLATIGYMAPEYGKE-------GRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||......+ .......    .......++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~----~~~~~~~~~  232 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-VLNHVIK----DQQVKLFKP  232 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHh----hcccccCCC
Confidence            234567889999998743       235788999999999999997 566775422211 1111111    111112222


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      ....          .....+.+++..|| .+|++||+++|+++.|.
T Consensus       233 ~~~~----------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         233 QLEL----------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccCC----------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2211          12345778999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.3e-35  Score=296.14  Aligned_cols=248  Identities=21%  Similarity=0.347  Sum_probs=200.9

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|++.+.||+|+||.||.+.. .+++.||+|.+....  ....+++.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            588899999999999999975 478999999986532  23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++++|.+++.... ..+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999987643 35788999999999999999999   89999999999999999999999999999976543221 


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                       ......+++.|+|||...+..++.++|+|||||++|+|++|+.||......+ ..........+         .     
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-~~~~~~~~~~~---------~-----  220 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-LVLKIIRGSYP---------P-----  220 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-HHHHHhcCCCC---------C-----
Confidence             1223457888999999988889999999999999999999999986421111 11111110000         0     


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           .+..++.++.+++.+||+.+|++||++.|+++
T Consensus       221 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 -----VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -----CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                 01124556889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.2e-35  Score=302.16  Aligned_cols=253  Identities=27%  Similarity=0.339  Sum_probs=204.6

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ...++|.+.+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            3457899999999999999999975 478899999986554445577889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++++|.+++.+..  +++..+..++.|++.|+.|||   +++++|+|++|+||+++.++.++|+|||++........
T Consensus        96 e~~~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          96 EYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             ecCCCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            9999999999997653  788899999999999999999   99999999999999999999999999999875543221


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        ......+++.|+|||....+.++.++||||||+++|++++|+.||........... ...           .+..   
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-~~~-----------~~~~---  233 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IAT-----------NGTP---  233 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-hhc-----------CCCC---
Confidence              22334688899999999888899999999999999999999999975332211100 000           0000   


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                         ....+...+..+.+++.+||+.+|++||++.|++..
T Consensus       234 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 ---ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000111234568899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.3e-35  Score=297.46  Aligned_cols=246  Identities=28%  Similarity=0.504  Sum_probs=197.6

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      ++|++.+.||+|+||.||+|.. +++.||+|.+....  ..+.+.+|+.+++.++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4688899999999999999975 67889999986432  346788999999999999999999998764 4789999999


Q ss_pred             CCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce
Q 005760          472 HGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI  550 (678)
Q Consensus       472 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  550 (678)
                      +++|.+++.... ..+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.+||+|||.+......     
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----  153 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----  153 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----
Confidence            999999997643 35788999999999999999999   999999999999999999999999999998754321     


Q ss_pred             eecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      ......+..|+|||.+.++.++.++|+||+||++|||++ |+.||......+  ..........      .++       
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~------~~~-------  218 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVEKGYR------MEP-------  218 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhCCCC------CCC-------
Confidence            112334578999999988889999999999999999998 889986532211  1111110000      000       


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                           ...++..+.+++.+||+.+|++||++.++++.|++
T Consensus       219 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 -----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -----CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                 01235568899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.6e-36  Score=310.70  Aligned_cols=195  Identities=26%  Similarity=0.392  Sum_probs=169.1

Q ss_pred             CCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-Cc-----cceeeeeeeecCCeEEE
Q 005760          393 GFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HR-----NIIKVISSCSNEEFKAL  465 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~~l  465 (678)
                      +|.+.+.||+|.||.|.+|. .++++.||||+++.... -..+...|+.+|..++ |.     |+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            88999999999999999996 56899999999976532 3455677999999997 33     79999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC--CCcEEEEeecccccc
Q 005760          466 VLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLL  542 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~--~~~~kl~Dfg~~~~~  542 (678)
                      |+|.+. .+|+++++..+. .++...+..++.||+.||..||   ..+|||+||||+|||+.+  ...|||+|||.++..
T Consensus       266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            999994 499999987653 6889999999999999999999   999999999999999953  348999999999865


Q ss_pred             CCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcc
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEI  597 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~  597 (678)
                      ...-     ..+.-+..|.|||++.+.+|+.+.|||||||+++||++|.+-|.+.
T Consensus       342 ~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  342 SQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             CCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            3221     2566788999999999999999999999999999999998777653

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-35  Score=301.35  Aligned_cols=268  Identities=21%  Similarity=0.311  Sum_probs=198.4

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|+..+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67889999999999999999865 789999999865432 2234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++ +|.+++......+++..+..++.|+++||.|||   +.+++||||+|+||+++.++.+|++|||+++......  .
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~  158 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--K  158 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--c
Confidence            975 999998876667899999999999999999999   9999999999999999999999999999986542211  1


Q ss_pred             eeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc---CCcccccccC---
Q 005760          550 IQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL---PISTKEIVDP---  622 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~---  622 (678)
                      ......++..|+|||...+ ..++.++||||+|+++|||++|+.||..................   +.........   
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            1122346788999998765 45788999999999999999999999654321111111111000   0000000000   


Q ss_pred             ---c--cCCccch-hhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 ---N--LLSREDI-NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ---~--~~~~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                         .  ....... ..........++.+++.+|++.+|++||++.|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence               0  0000000 00000011256789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-35  Score=332.46  Aligned_cols=253  Identities=21%  Similarity=0.314  Sum_probs=195.6

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeec--CCeEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSN--EEFKA  464 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  464 (678)
                      ..++|.+.+.||+|+||+||+|... ++..||+|++....  ......+..|+.+++.++||||++++++|.+  .+.+|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            4568999999999999999999854 67889999986432  2345678899999999999999999998854  45789


Q ss_pred             EEEEecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCeEEcCCCCCCeeecC----------
Q 005760          465 LVLEYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASALEYLHFGY----SAQVIHCDLKPSNVLLDD----------  527 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~dl~~~Nill~~----------  527 (678)
                      +||||+++++|.+++...   ...+++..++.|+.||+.||+|||+..    ..+|+||||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999999753   235899999999999999999999311    145999999999999964          


Q ss_pred             -------CCcEEEEeeccccccCCCCCcceeecccCCccccCccccCC--CCCCccchHHHHHHHHHHHHcCCCCCCccc
Q 005760          528 -------NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLMETFTRKKPTDEIF  598 (678)
Q Consensus       528 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~ell~g~~p~~~~~  598 (678)
                             .+.+||+|||++.......   ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                   3458999999997653221   2234568999999998754  458899999999999999999999996422


Q ss_pred             CCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          599 NGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .    ....+......       +...         ....+.++.+|+..||+.+|.+||++.|++.
T Consensus       248 ~----~~qli~~lk~~-------p~lp---------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 N----FSQLISELKRG-------PDLP---------IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             c----HHHHHHHHhcC-------CCCC---------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            2    11111111000       0000         0113456889999999999999999999984

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.9e-35  Score=296.27  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=195.1

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC-----chhhhHHHHHHHHHhCCCccceeeeeeeec--CCeE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-----RVFKSFDVECEMMKSIRHRNIIKVISSCSN--EEFK  463 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  463 (678)
                      .+|+..+.||+|+||.||+|.. .++..||+|++.....     +....+.+|+.+++.++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688999999999999999975 4689999999864321     234567889999999999999999998865  4678


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++++||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++|+|||++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999997655 3788889999999999999999   9999999999999999999999999999987553


Q ss_pred             CCCC-cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          544 REDQ-STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       544 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      .... ........++..|+|||.+.+..++.++||||+||++|||++|+.||........ .... ..       ....+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-~~~~-~~-------~~~~~  228 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-IFKI-AT-------QPTNP  228 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-HHHH-hc-------CCCCC
Confidence            2111 1112234578899999999888899999999999999999999999875322111 1100 00       00001


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..          +..+.+.+.+++ +||..+|++||++.|+++
T Consensus       229 ~~----------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         229 QL----------PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CC----------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            10          112344566777 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.6e-35  Score=322.70  Aligned_cols=267  Identities=21%  Similarity=0.264  Sum_probs=192.5

Q ss_pred             HHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCC------ccceeeeeeeec
Q 005760          387 LCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRH------RNIIKVISSCSN  459 (678)
Q Consensus       387 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~~  459 (678)
                      +....++|++.+.||+|+||+||+|.. .+++.||||+++... ........|+++++.++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            334568899999999999999999975 468899999986432 223445667777777654      458888888865


Q ss_pred             C-CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEcCCCCCCeeecCCC--------
Q 005760          460 E-EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPSNVLLDDNM--------  529 (678)
Q Consensus       460 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dl~~~Nill~~~~--------  529 (678)
                      . +..++|||++ +++|.+++.+.+ .+++..+..++.||+.||+|||   + .+|+||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence            4 5788999988 778999887654 4889999999999999999999   7 5999999999999998765        


Q ss_pred             --------cEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCc
Q 005760          530 --------VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE  601 (678)
Q Consensus       530 --------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~  601 (678)
                              .+||+|||.+....     .......||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             cccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                    49999999875432     12234678999999999999999999999999999999999999997533211


Q ss_pred             cchhhhhh--cccCCcc---------ccccc------CccCCccc-----hhhHHHHHHHHHHHHHHhhccccCcCCCCC
Q 005760          602 MTLKHWVN--DWLPIST---------KEIVD------PNLLSRED-----INFVAKEQCVSFVFNVAMECTVESPEQRIN  659 (678)
Q Consensus       602 ~~~~~~~~--~~~~~~~---------~~~~~------~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  659 (678)
                      . +.....  ...+..+         ..+.+      +.......     ..........+.+.+|+.+||++||++|||
T Consensus       353 ~-~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        353 H-LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             H-HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            0 000000  0000000         00000      00000000     000000112456889999999999999999


Q ss_pred             HHHHHH
Q 005760          660 AKEIVT  665 (678)
Q Consensus       660 ~~ell~  665 (678)
                      +.|+++
T Consensus       432 a~e~L~  437 (467)
T PTZ00284        432 ARQMTT  437 (467)
T ss_pred             HHHHhc
Confidence            999986

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3.3e-35  Score=297.36  Aligned_cols=251  Identities=23%  Similarity=0.363  Sum_probs=198.7

Q ss_pred             CCCCCccccCCCceeEEEEEeCC--CcEEEEEEeeccc----------CchhhhHHHHHHHHHh-CCCccceeeeeeeec
Q 005760          393 GFSENNLIGRGSFGSVFKARLGD--GMEVAMKVFNLQY----------GRVFKSFDVECEMMKS-IRHRNIIKVISSCSN  459 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  459 (678)
                      +|++.+.||+|+||.||+|..+.  ++.+|+|.+....          .....++..|+.++.. ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999998654  7889999885321          1223456678887765 799999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEcCCCCCCeeecCCCcEEEEe
Q 005760          460 EEFKALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSD  535 (678)
Q Consensus       460 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dl~~~Nill~~~~~~kl~D  535 (678)
                      .+..++||||+++++|.+++..   ....+++..++.++.|++.|+.|||   . .+++|+||+|+||+++.++.++++|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   3346889999999999999999999   5 6899999999999999999999999


Q ss_pred             eccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCc
Q 005760          536 FGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS  615 (678)
Q Consensus       536 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  615 (678)
                      ||.+.......   ......++..|+|||...++.++.++||||||+++|||++|+.||......  .....+..     
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--~~~~~~~~-----  227 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--SLATKIVE-----  227 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--HHHHHHhh-----
Confidence            99997654322   234556888999999999888999999999999999999999998642211  11111100     


Q ss_pred             ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                            ......      ....+++++.+++.+||+.||++||++.|+..+++
T Consensus       228 ------~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 ------AVYEPL------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ------ccCCcC------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                  000000      00123456889999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=9.6e-35  Score=296.75  Aligned_cols=267  Identities=23%  Similarity=0.304  Sum_probs=202.2

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|++.+.||+|++|.||+|.. .+|+.||+|++....  ......+.+|+.+++.++|||++++++++..++..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            478889999999999999985 478999999987543  23356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      + +++|.+++......+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||.+........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 99999999876667899999999999999999999   99999999999999999999999999999976643221 1


Q ss_pred             eeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC---cc---cccccC
Q 005760          550 IQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI---ST---KEIVDP  622 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~  622 (678)
                      ......++..|+|||.+.+.. ++.++||||+|+++|||++|.+||...... .............   ..   ....+.
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLPDY  234 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcchh
Confidence            223456889999999876544 689999999999999999998777543221 1111111100000   00   000000


Q ss_pred             cc---CCccchhhH-HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 NL---LSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ~~---~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..   ......... ...+.+.++.+++.+|++++|++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         235 NKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00   000000000 00134577999999999999999999999985

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7e-35  Score=292.91  Aligned_cols=247  Identities=26%  Similarity=0.361  Sum_probs=199.9

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-----CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-----GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      +|+..+.||+|++|.||+|..+ +++.|++|.+....     .+..+.+..|+++++.++||||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999865 78999999986533     22456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      +||+++++|.+++.+.. .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999998764 4788899999999999999999   9999999999999999999999999999987653322


Q ss_pred             CcceeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                         ......++..|+|||...... ++.++|+||+|+++|+|++|+.||......... ... ....  ..     +.  
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~-~~~-~~~~--~~-----~~--  222 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV-FKI-GRSK--EL-----PP--  222 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH-HHH-Hhcc--cC-----CC--
Confidence               223456888999999887766 899999999999999999999998653321111 000 0000  00     00  


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              .+..+++++.+++.+||+.+|++||++.|+++
T Consensus       223 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 --------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                    00123456889999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.8e-35  Score=301.46  Aligned_cols=260  Identities=24%  Similarity=0.325  Sum_probs=202.0

Q ss_pred             CCHHHHHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeec
Q 005760          382 FSYLELCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSN  459 (678)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  459 (678)
                      +...++..+.++|.+.+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            34455666789999999999999999999985 578999999986432 2345677899999998 79999999998864


Q ss_pred             C-----CeEEEEEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcE
Q 005760          460 E-----EFKALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVA  531 (678)
Q Consensus       460 ~-----~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~  531 (678)
                      .     +..++|+||+++++|.++++.   ....+++..++.++.|++.|+.|||   +.+++|+||+|+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999998863   2345889999999999999999999   8999999999999999999999


Q ss_pred             EEEeeccccccCCCCCcceeecccCCccccCccccCCCC-----CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhh
Q 005760          532 HLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR-----VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKH  606 (678)
Q Consensus       532 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~  606 (678)
                      |++|||.+.......  .......++..|+|||.+....     ++.++||||+||++|||++|+.||....... ....
T Consensus       168 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~~  244 (291)
T cd06639         168 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLFK  244 (291)
T ss_pred             EEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHHH
Confidence            999999987654221  1123346788999999876443     6789999999999999999999986533211 1111


Q ss_pred             hhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          607 WVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      +...    ....+.+             +......+.+++.+||+.+|++||++.|+++
T Consensus       245 ~~~~----~~~~~~~-------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         245 IPRN----PPPTLLH-------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HhcC----CCCCCCc-------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1100    0001111             1123345889999999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=298.08  Aligned_cols=252  Identities=26%  Similarity=0.344  Sum_probs=200.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeecC------C
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNE------E  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~  461 (678)
                      ++++|++.+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++.+.      +
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            5689999999999999999999864 678999999875433 346788999999998 699999999998654      3


Q ss_pred             eEEEEEEecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecc
Q 005760          462 FKALVLEYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI  538 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~  538 (678)
                      ..++||||+++++|.+++...   ...+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence            589999999999999998653   246889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCCcceeecccCCccccCccccCC-----CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC
Q 005760          539 AKLLTREDQSTIQTQTLATIGYMAPEYGKE-----GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP  613 (678)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  613 (678)
                      +......  ........++..|+|||.+..     ..++.++||||+||++|+|++|+.||....... ...+.....  
T Consensus       160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~--  234 (275)
T cd06608         160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKIPRNP--  234 (275)
T ss_pred             ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHhhccC--
Confidence            8765322  122334568889999998753     346788999999999999999999986532211 111111100  


Q ss_pred             CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                             .+.        ...+..++.++.+++.+||..||++|||+.|+++
T Consensus       235 -------~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         235 -------PPT--------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -------CCC--------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                   000        1112235567889999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.8e-35  Score=303.34  Aligned_cols=249  Identities=25%  Similarity=0.324  Sum_probs=199.3

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      .|+....||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            344456899999999999975 4789999999876544455678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      +++|.+++...  .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||++.......  ...
T Consensus       102 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~  174 (297)
T cd06659         102 GGALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKR  174 (297)
T ss_pred             CCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccc
Confidence            99999988653  3789999999999999999999   9999999999999999999999999999986543221  122


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchh
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN  631 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  631 (678)
                      ....++..|+|||++.+..++.++||||+||++|||++|+.||......+  ....+.....   ..     ..      
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~---~~-----~~------  238 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLRDSPP---PK-----LK------  238 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhccCC---CC-----cc------
Confidence            34568899999999988889999999999999999999999986422111  1111111000   00     00      


Q ss_pred             hHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          632 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       632 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                        .....+.++.+++.+||+.+|++||++.|+++.
T Consensus       239 --~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         239 --NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             --ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              001234557899999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.2e-34  Score=300.81  Aligned_cols=195  Identities=23%  Similarity=0.348  Sum_probs=159.1

Q ss_pred             CccccCCCceeEEEEEeC---CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeee--cCCeEEEEEEecC
Q 005760          397 NNLIGRGSFGSVFKARLG---DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS--NEEFKALVLEYMP  471 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~~~  471 (678)
                      .++||+|+||.||+|+.+   ++..||+|.+....  ....+.+|+++++.++||||+++++++.  .....++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            368999999999999854   45789999886432  2356788999999999999999999884  3567889999986


Q ss_pred             CCCHHHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee----cCCCcEEEEeeccc
Q 005760          472 HGSLEKYLHSS--------NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIA  539 (678)
Q Consensus       472 ~~~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill----~~~~~~kl~Dfg~~  539 (678)
                      + +|.+++...        ...+++..+..++.|++.||.|||   +.+|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 787777422        124788889999999999999999   9999999999999999    56789999999999


Q ss_pred             cccCCCCCc-ceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcc
Q 005760          540 KLLTREDQS-TIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEI  597 (678)
Q Consensus       540 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~  597 (678)
                      +........ .......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            866432211 122345688999999988764 5789999999999999999999998653

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.6e-35  Score=299.80  Aligned_cols=265  Identities=23%  Similarity=0.326  Sum_probs=199.6

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCc-----hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGR-----VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      +|++.+.||+|++|.||+|.. .+++.||+|.+......     ....+..|+++++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477889999999999999985 47899999999654322     334567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+ +++|.+++......+++..+..++.||++||+|||   +++++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 88999999876546899999999999999999999   9999999999999999999999999999997664322


Q ss_pred             CcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc---CC------cc
Q 005760          547 QSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL---PI------ST  616 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---~~------~~  616 (678)
                      .  ......++..|+|||.+.+ ..++.++||||+||++|||++|..||......+ ..........   ..      ..
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (298)
T cd07841         157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTSL  233 (298)
T ss_pred             c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhcccc
Confidence            1  1223356788999998754 457889999999999999999987776432211 1111111000   00      00


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ............... ......+.++.+++.+||++||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         234 PDYVEFKPFPPTPLK-QIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccCCcchh-hhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            000000000000000 011234567899999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3e-35  Score=299.76  Aligned_cols=257  Identities=24%  Similarity=0.339  Sum_probs=200.3

Q ss_pred             HHHHHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeee---
Q 005760          384 YLELCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCS---  458 (678)
Q Consensus       384 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~---  458 (678)
                      ..++..+.+.|++.+.||+|+||.||+|.. .+++.+|+|++.... .....+..|+.+++.+ +||||+++++++.   
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   86 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS   86 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence            344555678899999999999999999985 578999999986543 2345678899999988 6999999999884   


Q ss_pred             ---cCCeEEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEE
Q 005760          459 ---NEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLS  534 (678)
Q Consensus       459 ---~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~  534 (678)
                         ..+..+++|||+++|+|.+++.... ..+++..+..++.|++.|++|||   +.+++|+|++|+||+++.++.++|+
T Consensus        87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          87 PPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             ccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEe
Confidence               2467899999999999999997643 34778888999999999999999   9999999999999999999999999


Q ss_pred             eeccccccCCCCCcceeecccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhh
Q 005760          535 DFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN  609 (678)
Q Consensus       535 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~  609 (678)
                      |||++.......  .......++..|+|||.+.     ...++.++|||||||++|||++|+.||.......... ....
T Consensus       164 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-~~~~  240 (282)
T cd06636         164 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-LIPR  240 (282)
T ss_pred             eCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-hHhh
Confidence            999987543211  1223456888999999875     3457889999999999999999999986532211110 0000


Q ss_pred             cccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          610 DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               ...+..         ....++.++.+++.+||+.||.+||++.|+++
T Consensus       241 ---------~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         241 ---------NPPPKL---------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ---------CCCCCC---------cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                     000000         01134567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.4e-35  Score=303.45  Aligned_cols=248  Identities=25%  Similarity=0.338  Sum_probs=198.4

Q ss_pred             CCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      |.....||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            34456799999999999975 47899999998765555566788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      ++|.+++...  .+++..+..++.||+.|++|||   +++++||||+|+||+++.++.++|+|||++.......  ....
T Consensus       104 ~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~  176 (292)
T cd06658         104 GALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRK  176 (292)
T ss_pred             CcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCc
Confidence            9999988654  3788999999999999999999   8999999999999999999999999999987543221  1122


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...++..|+|||...+..++.++||||+|+++|||++|+.||....... ... .+...        ..+....      
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~-~~~~~--------~~~~~~~------  240 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMR-RIRDN--------LPPRVKD------  240 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHHhc--------CCCcccc------
Confidence            3457889999999988889999999999999999999999986522211 011 01000        0010000      


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                        ....+..+.+++.+||..||.+|||+.|+++.
T Consensus       241 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 --SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             --ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence              01234457899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6e-35  Score=295.26  Aligned_cols=253  Identities=25%  Similarity=0.398  Sum_probs=200.4

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC------chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG------RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      +|+..+.||+|++|.||+|.. .+++.||+|++.....      ...+.+..|+.+++.++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999974 5789999999864321      134678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC-cEEEEeeccccccCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTR  544 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~-~~kl~Dfg~~~~~~~  544 (678)
                      |+||+++++|.+++.+.. .+++..+..++.|++.|+.|||   +++++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999997654 4788999999999999999999   99999999999999998776 599999999876643


Q ss_pred             CCCc--ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          545 EDQS--TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       545 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ....  .......++..|+|||.+.+..++.++||||+|+++|+|++|..||........  .........    ....+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~----~~~~~  230 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIFKIAS----ATTAP  230 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHHHHhc----cCCCC
Confidence            3111  112234678899999999888899999999999999999999999864222111  111100000    00000


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .          .+...++++.+++.+|++.+|++||++.|+++
T Consensus       231 ~----------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         231 S----------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             C----------CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            0          11234566889999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-35  Score=298.34  Aligned_cols=269  Identities=23%  Similarity=0.310  Sum_probs=201.6

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc--cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ++|++.+.||+|+||.||+|..+ +++.||+|.+...  .....+.+.+|+++++.++|+||+++++++.+.+..++|+|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999865 6889999998643  23345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |++++.+..+.... ..++...+..++.|++.|+.|||   ..+++|+|++|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            99886666555443 45889999999999999999999   89999999999999999999999999999876643322 


Q ss_pred             ceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchh--hhhhcccCCccccc-ccC--
Q 005760          549 TIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK--HWVNDWLPISTKEI-VDP--  622 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~--  622 (678)
                      .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||......+....  .......+...... .++  
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            122345678899999999888 789999999999999999999999875322111000  00000000000000 000  


Q ss_pred             ------ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 ------NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                            ............+..++.++.+++.+||..+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                  0000000000111224678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-36  Score=311.31  Aligned_cols=240  Identities=23%  Similarity=0.284  Sum_probs=184.8

Q ss_pred             ccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhC---CCccceeeeeeeecCCeEEEEEEecCC
Q 005760          400 IGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSI---RHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       400 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      ||+|+||+||+|+.. +++.||+|++....   .........|..++...   +||||+++++++.+.+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999854 68999999986432   12223344566666654   699999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      |+|.+++.... .+++..+..++.||++|++|||   +++|+||||||+||+++.++.+||+|||++.......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~  154 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTN  154 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCcc
Confidence            99999987654 4889999999999999999999   9999999999999999999999999999986532211  1223


Q ss_pred             cccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchh
Q 005760          553 QTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN  631 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  631 (678)
                      ...||..|+|||.+.+. .++.++||||+||++|||++|+.||......+. .......    .. .+  +         
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-~~~i~~~----~~-~~--~---------  217 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-YRNIAFG----KV-RF--P---------  217 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-HHHHHcC----CC-CC--C---------
Confidence            45689999999988754 478999999999999999999999865322111 1110000    00 00  0         


Q ss_pred             hHHHHHHHHHHHHHHhhccccCcCCCC----CHHHHHH
Q 005760          632 FVAKEQCVSFVFNVAMECTVESPEQRI----NAKEIVT  665 (678)
Q Consensus       632 ~~~~~~~~~~l~~l~~~cl~~dP~~Rp----s~~ell~  665 (678)
                         ....+.++.+++.+||+.||.+||    ++.|+++
T Consensus       218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence               011344578999999999999998    4666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.7e-35  Score=293.73  Aligned_cols=252  Identities=28%  Similarity=0.405  Sum_probs=201.7

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCc--hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|...+.||+|+||.||+|.. .+++.||+|.+......  ..+.+..|+++++.++|+||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            578889999999999999975 47899999998765442  567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|.+++.... .+++..+..++.|++.|++|||   +.+++|+||+|+||++++++.+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999998754 4788899999999999999999   9999999999999999999999999999997764332211


Q ss_pred             e--eecccCCccccCccccCCCC---CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          550 I--QTQTLATIGYMAPEYGKEGR---VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       550 ~--~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      .  .....++..|+|||.+.+..   ++.++||||||+++||+++|+.||....... .........        ..+..
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~~~--------~~~~~  227 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVGAG--------HKPPI  227 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHhcC--------CCCCC
Confidence            1  12345788999999988766   8899999999999999999999996532211 111100000        00000


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              .....++..+.+++.+||+.+|++||++.|++.
T Consensus       228 --------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         228 --------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --------CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                    001123455789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.7e-35  Score=296.58  Aligned_cols=249  Identities=28%  Similarity=0.361  Sum_probs=192.6

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHH-HHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEM-MKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|+++.... .....+..|... ++..+||||+++++++...+..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999864 799999999865422 223445555554 667789999999999999999999999


Q ss_pred             ecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          469 YMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       469 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      |++ ++|.+++..   ....+++..++.++.|++.|++|||   ++ +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 588887754   2335889999999999999999999   76 999999999999999999999999999876532


Q ss_pred             CCCcceeecccCCccccCccccCC----CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKE----GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV  620 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (678)
                      .   .......++..|+|||.+.+    ..++.++|+||+||++|||++|+.||.................         
T Consensus       157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------  224 (283)
T cd06617         157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP---------  224 (283)
T ss_pred             c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC---------
Confidence            1   12233457889999998765    4468899999999999999999999864322211111111100         


Q ss_pred             cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .+...         ...++.++.+++.+||..+|++||++.|+++
T Consensus       225 ~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         225 SPQLP---------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCC---------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00000         0124566889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.6e-35  Score=299.93  Aligned_cols=266  Identities=24%  Similarity=0.369  Sum_probs=200.0

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ++|+..+.||+|+||.||+|..+ +++.||+|++.....  ...+.+.+|+++++.++||||+++++++.+++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888999999999999999865 689999999754322  234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |++++++.++..... .+++..+..++.|++.|++|||   +.+++|+|++|+||++++++.++++|||++.......  
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--  154 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--  154 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--
Confidence            999998888776543 4899999999999999999999   8999999999999999999999999999987654322  


Q ss_pred             ceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCcc--chhhhhhcccCCcccc-------
Q 005760          549 TIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM--TLKHWVNDWLPISTKE-------  618 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~-------  618 (678)
                      .......++..|+|||+..+. .++.++||||||+++|||++|+.||......+.  ....+..... .....       
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  233 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLI-PRHQEIFQKNPL  233 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCc-hhhHHHhccchH
Confidence            122334578899999987653 478899999999999999999998864322110  0000000000 00000       


Q ss_pred             ---cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 ---IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 ---~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                         ...+........ ......++..+.+++.+||+.+|++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         234 FAGMRLPEVKEIEPL-EKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hhccccccccCcchH-HHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence               000110000000 0011245677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=5.7e-35  Score=293.25  Aligned_cols=247  Identities=24%  Similarity=0.399  Sum_probs=199.4

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|+..+.||+|+||.||+|.. .+++.+|+|.+....  ......+..|+++++.++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999975 478999999986542  23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC-CcEEEEeeccccccCCCCC
Q 005760          470 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       470 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~-~~~kl~Dfg~~~~~~~~~~  547 (678)
                      +++++|.+++.... ..+++..+..++.|++.|++|||   +++++|+||+|+||+++++ +.+|++|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999997643 35788999999999999999999   9999999999999999855 468999999997664322 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||.......  .......   .....+        
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~~~---~~~~~~--------  221 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLKIMS---GTFAPI--------  221 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHHHHh---cCCCCC--------
Confidence              1223457889999999988888999999999999999999999986532211  1111100   000000        


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                             +..++.++.+++.+||+.+|++|||+.|++.
T Consensus       222 -------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 -------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             -------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                   0124556889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-34  Score=294.09  Aligned_cols=255  Identities=26%  Similarity=0.328  Sum_probs=199.0

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeec--CCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSN--EEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  467 (678)
                      ++|+..+.||.|++|.||+|.. .+++.+|+|.+..... .....+.+|+++++.++||||+++++++.+  .+..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4678889999999999999986 4689999999875422 345678899999999999999999998854  44789999


Q ss_pred             EecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          468 EYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       468 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      ||+++++|.+++..   ....++...+..++.|++.|++|||   +.+++|+||+|.||+++.++.++++|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988753   2345788899999999999999999   99999999999999999999999999999865432


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccC---CccchhhhhhcccCCccccccc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFN---GEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      ..    .....++..|+|||.+.+..++.++||||+||++|+|++|+.||.....   .......+......   ..+.+
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  230 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN---PELKD  230 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc---hhhcc
Confidence            21    1234577889999999888899999999999999999999999976422   11112222111110   00000


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .     ...+    ...++.+.+++.+||+.+|++|||+.|+++
T Consensus       231 ~-----~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 E-----PGNG----IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             C-----CCCC----CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0     0000    113456889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=325.26  Aligned_cols=263  Identities=27%  Similarity=0.424  Sum_probs=214.8

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEeC----C----CcEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceeeeeee
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARLG----D----GMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKVISSC  457 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~  457 (678)
                      +...++..+.+.+|+|+||.|++|...    .    ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|+|
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            344455567779999999999999632    1    45699999875433 4567889999999998 599999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCC
Q 005760          458 SNEEFKALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSN  522 (678)
Q Consensus       458 ~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~N  522 (678)
                      ...+..++|+||+..|+|.++++..+               ..+.......++.|||.|++||+   +.++||||+.++|
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRN  448 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARN  448 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhh
Confidence            99999999999999999999999877               34888899999999999999999   9999999999999


Q ss_pred             eeecCCCcEEEEeeccccccCCCCCccee-ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCC
Q 005760          523 VLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNG  600 (678)
Q Consensus       523 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~  600 (678)
                      |+++.+..+||+|||+|+...+.+..... +...-+..|||||.+....|+.++|||||||+|||++| |..||.+....
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~  528 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT  528 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence            99999999999999999876554444322 22125677999999999999999999999999999999 88898762211


Q ss_pred             ccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                       ..+.++++                  .+.+...+..|+.+++++|+.||+.+|++||++.|+++.++....
T Consensus       529 -~~l~~~l~------------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  529 -EELLEFLK------------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             -HHHHHHHh------------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence             11122222                  122333445688899999999999999999999999999999643

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1e-34  Score=299.25  Aligned_cols=255  Identities=23%  Similarity=0.284  Sum_probs=198.7

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999854 68899999986543   223456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++++|.+++...+ .+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.++++|||+++.......
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999997664 4788889999999999999999   99999999999999999999999999999863211000


Q ss_pred             -------------cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC
Q 005760          548 -------------STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI  614 (678)
Q Consensus       548 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  614 (678)
                                   ........++..|+|||.+.+..++.++|+|||||++|||++|..||.+....+ .........   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-~~~~~~~~~---  232 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDD---  232 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcc---
Confidence                         001112357788999999988889999999999999999999999986532211 111111000   


Q ss_pred             cccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                          ...+..          ...++.++.+++.+||+.||++||++.++.+.|+
T Consensus       233 ----~~~~~~----------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         233 ----IEWPEG----------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             ----cCCCCc----------cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence                000000          0124556889999999999999999655555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.1e-34  Score=296.36  Aligned_cols=253  Identities=29%  Similarity=0.350  Sum_probs=206.0

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ..++.|+..+.||+|++|.||+|..+ ++..|++|++..... ..+.+..|+++++.++|+|++++++++...+..++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            45677888999999999999999865 789999999976543 4567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++++|.+++......+++..+..++.|++.|++|||   +.+++|+|++|+||+++.++.++|+|||++........
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            999999999999877546899999999999999999999   99999999999999999999999999999865532211


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||....... .........    ..          
T Consensus       172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~~~~~~----~~----------  234 (286)
T cd06614         172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFLITTKG----IP----------  234 (286)
T ss_pred             --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcC----CC----------
Confidence              1223457789999999988889999999999999999999999986422211 111110000    00          


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                         .......++.++.+++.+||+.+|.+||++.|+++
T Consensus       235 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         235 ---PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             ---CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence               00011224566889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.6e-34  Score=289.82  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=205.2

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|++.+.||+|++|.||+|... +++.||+|++..... .....+..|+++++.++|+|++++++++...+..++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999865 699999999876543 4467789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++++|.+++.... .+++..+..++.|+++|++|||   + .+++|+||+|+||+++.++.++++|||.+.........
T Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            99999999998653 5899999999999999999999   8 99999999999999999999999999998766432221


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                        .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......  ...+.........     .+..    
T Consensus       157 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~-----~~~~----  223 (264)
T cd06623         157 --CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAICDGP-----PPSL----  223 (264)
T ss_pred             --ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHhcCC-----CCCC----
Confidence              12345788999999999888999999999999999999999998764321  1111111110000     0000    


Q ss_pred             chhhHHHHH-HHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          629 DINFVAKEQ-CVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       629 ~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                            ... ++..+.+++.+||..+|++||++.|+++.
T Consensus       224 ------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 ------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                  011 45568899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-35  Score=295.49  Aligned_cols=247  Identities=26%  Similarity=0.413  Sum_probs=198.6

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCC---CccceeeeeeeecCCeEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIR---HRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  467 (678)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++   |||++++++++.+.+..++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477788999999999999985 578999999986542 334567888999999986   999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++++|.++++..  .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||++....... 
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-  155 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence            999999999998764  4889999999999999999999   9999999999999999999999999999997764332 


Q ss_pred             cceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          548 STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                       .......++..|+|||.+.++ .++.++|+|||||++|+|++|..||.......     ......     ....+....
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-----~~~~~~-----~~~~~~~~~  224 (277)
T cd06917         156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-----AMMLIP-----KSKPPRLED  224 (277)
T ss_pred             -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-----hhhccc-----cCCCCCCCc
Confidence             222344688899999987654 46889999999999999999999986532211     100000     000011100


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               ...+.++.+++.+||+.||++||++.|+++
T Consensus       225 ---------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         225 ---------NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ---------ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                     113456889999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-34  Score=298.95  Aligned_cols=248  Identities=29%  Similarity=0.388  Sum_probs=197.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ....|+..+.||+|+||.||+|... +++.||+|.+.....   +..+.+.+|+++++.++|||++++.+++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            3456888999999999999999854 789999999864322   233568889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      |+||++ |++.+++......+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++......
T Consensus        93 v~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          93 VMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             EHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            999996 5888877655556899999999999999999999   999999999999999999999999999998654321


Q ss_pred             CCcceeecccCCccccCccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                            ....++..|+|||.+.   .+.++.++||||||+++|||++|+.||........ ... ....        ..+
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-~~~-~~~~--------~~~  232 (307)
T cd06607         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYH-IAQN--------DSP  232 (307)
T ss_pred             ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-HHH-HhcC--------CCC
Confidence                  2345778899999874   45688999999999999999999999864321110 000 0000        000


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      ..         ....++.++.+++.+||+.+|++||++.+++..
T Consensus       233 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         233 TL---------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CC---------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00         012245678999999999999999999999873

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-35  Score=301.31  Aligned_cols=252  Identities=27%  Similarity=0.353  Sum_probs=200.3

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|+..+.||+|++|.||+|... +++.||+|.+.....   ...+.+..|+++++.++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999854 689999999875432   24456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          468 EYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      ||+.+++|.+++.... ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999987542 45889999999999999999999   9999999999999999999999999999987543211


Q ss_pred             Cc---------------------------ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccC
Q 005760          547 QS---------------------------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFN  599 (678)
Q Consensus       547 ~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~  599 (678)
                      ..                           .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                           011133578899999999988899999999999999999999999865332


Q ss_pred             CccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCC----HHHHHH
Q 005760          600 GEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN----AKEIVT  665 (678)
Q Consensus       600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps----~~ell~  665 (678)
                      .. .......            ......      .....+.++.+++.+||+.||++||+    +.|++.
T Consensus       238 ~~-~~~~~~~------------~~~~~~------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DE-TFSNILK------------KEVTFP------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HH-HHHHHhc------------CCccCC------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            21 1111100            000000      00114566899999999999999999    777765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.5e-34  Score=287.66  Aligned_cols=249  Identities=29%  Similarity=0.403  Sum_probs=204.0

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      .|+..+.||+|++|.||+|... ++..+++|++........+.+.+|+++++.++||+++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999864 789999999976554456788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      +++|.+++......+++..+..++.|++.|+++||   ..+++|+||+|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999999876556899999999999999999999   89999999999999999999999999999876643321   2


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchh
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN  631 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  631 (678)
                      ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||.......... ....    .......           
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~----~~~~~~~-----------  218 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-KIAT----NGPPGLR-----------  218 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH-HHHh----cCCCCcC-----------
Confidence            34568889999999988889999999999999999999999986532211110 0000    0000000           


Q ss_pred             hHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          632 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       632 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                        ....++.++.+++.+||+.||++|||+.|+++
T Consensus       219 --~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 --NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             --cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              01112456889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.9e-35  Score=298.29  Aligned_cols=244  Identities=25%  Similarity=0.301  Sum_probs=199.2

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999854 68999999986432   234466888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++++|.+++.... .++...+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++......  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999998764 5889999999999999999999   999999999999999999999999999998765432  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                         .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...... ...........          ..   
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~----------~~---  217 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKILEGKV----------RF---  217 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCc----------cC---
Confidence               23446889999999998888899999999999999999999998653311 11111110000          00   


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                             +...+..+.+++.+||+.||.+|+     +++|+++
T Consensus       218 -------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         218 -------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                   011245578999999999999999     7777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.5e-34  Score=291.84  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=195.3

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC-----chhhhHHHHHHHHHhCCCccceeeeeeeecC--CeE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-----RVFKSFDVECEMMKSIRHRNIIKVISSCSNE--EFK  463 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  463 (678)
                      .+|++.+.||+|+||.||.|.. .++..||+|.+.....     ...+.+.+|+++++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4788899999999999999985 4689999999854321     2345678899999999999999999988663  567


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++||||+++++|.+++.+.. .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999997654 3788888999999999999999   9999999999999999999999999999987553


Q ss_pred             CCCCc-ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          544 REDQS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       544 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ..... .......++..|+|||.+.+..++.++|||||||++|||++|+.||....... .......    ..    ..+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~----~~----~~~  228 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-AIFKIAT----QP----TNP  228 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-HHHHHhc----CC----CCC
Confidence            21111 11223458889999999988889999999999999999999999986532111 1111000    00    000


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .          .+...+..+.+++.+|+. +|++||+++|+++
T Consensus       229 ~----------~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         229 V----------LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             C----------CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            0          112234557789999995 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.2e-34  Score=297.20  Aligned_cols=267  Identities=22%  Similarity=0.269  Sum_probs=198.6

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecC--CeEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNE--EFKALV  466 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  466 (678)
                      ++|+..+.||+|+||.||+|..+ +++.+|+|.++....  .....+.+|+.+++.++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999999865 688999999875432  2233567899999999999999999998776  889999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      +||+++ +|.+++......+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++++|||++.......
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            999975 999998876656899999999999999999999   9999999999999999999999999999998664332


Q ss_pred             CcceeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC---C------cc
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP---I------ST  616 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---~------~~  616 (678)
                        .......++..|+|||.+.+.. ++.++|+||+|+++|||++|..||........ .......+..   .      ..
T Consensus       161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ-LNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchHHHHHhhcc
Confidence              1223345788899999887654 68899999999999999999999875322111 1110000000   0      00


Q ss_pred             cccccCccCCcc--chhhHHHHH-HHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          617 KEIVDPNLLSRE--DINFVAKEQ-CVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       617 ~~~~~~~~~~~~--~~~~~~~~~-~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ............  ......+.. .++.+.+++.+||+.+|++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            000000000000  000000001 3566889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-36  Score=282.94  Aligned_cols=242  Identities=21%  Similarity=0.287  Sum_probs=199.5

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ..++|+..+.||+|.||.|-+++- .+|+.+|+|+++...   ......-..|-++++..+||.+..+...|+..+.+|+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            456899999999999999999974 489999999997642   2334555678999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+.||.|.-++.+.+. +++.....+-.+|+.||.|||   +++||.||+|.+|.|+|.+|++||+|||+++.-.  
T Consensus       246 VMeyanGGeLf~HLsrer~-FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRERV-FSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--  319 (516)
T ss_pred             EEEEccCceEeeehhhhhc-ccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc--
Confidence            9999999999988877654 777788889999999999999   9999999999999999999999999999997533  


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                      .........+|||.|+|||++....|+.++|.|.+||++|||++|+.||+...-..  +-..+      -+.++.-|.  
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k--LFeLI------l~ed~kFPr--  389 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK--LFELI------LMEDLKFPR--  389 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH--HHHHH------HhhhccCCc--
Confidence            23334556889999999999999999999999999999999999999998633221  11100      011111222  


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCC
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRI  658 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  658 (678)
                                 ..++++..|+...+.+||.+|.
T Consensus       390 -----------~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  390 -----------TLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -----------cCCHHHHHHHHHHhhcChHhhc
Confidence                       2345677899999999999998

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.2e-34  Score=295.65  Aligned_cols=248  Identities=26%  Similarity=0.335  Sum_probs=199.5

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      .|...+.||+|++|.||+|.. .+++.+++|++........+.+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            455568999999999999985 5789999999875544455678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      +++|.+++...  .+++..+..++.|++.|++|||   +++++||||+|+||+++.++.++++|||.+......  ....
T Consensus       100 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~  172 (285)
T cd06648         100 GGALTDIVTHT--RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRR  172 (285)
T ss_pred             CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Cccc
Confidence            99999999873  4888999999999999999999   999999999999999999999999999988654322  1122


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchh
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN  631 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  631 (678)
                      ....+++.|+|||...+..++.++||||+||++|||++|+.||....... ... ......        .+...      
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~-~~~-~~~~~~--------~~~~~------  236 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ-AMK-RIRDNL--------PPKLK------  236 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH-HHH-HHHhcC--------CCCCc------
Confidence            33568899999999988889999999999999999999999986522111 111 111000        00000      


Q ss_pred             hHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          632 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       632 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                        ....++..+.+++.+||+++|++||++.|+++
T Consensus       237 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 --NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             --ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence              00113456889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.6e-34  Score=288.84  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=200.4

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeec--CCeEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSN--EEFKALVL  467 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  467 (678)
                      +|++.+.||.|+||.||+|.. .+++.||+|.+....  ....+.+..|+++++.++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478889999999999999974 578899999986432  2334667889999999999999999997753  45678999


Q ss_pred             EecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          468 EYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASALEYLHFGY--SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       468 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      ||+++++|.+++...   ...+++..++.++.|++.|++|||..+  +.+++|+||+|+||+++.++.+|++|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998753   346889999999999999999999544  678999999999999999999999999999876


Q ss_pred             CCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      .....  ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.....  ......+....   .     +
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~---~-----~  228 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIKEGK---F-----R  228 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHhcCC---C-----C
Confidence            43221  12334688999999999988899999999999999999999999875331  11111111000   0     0


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .          .+...+.++.+++.+|++.+|++||++.|+++
T Consensus       229 ~----------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         229 R----------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             C----------CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            0          01134556889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.5e-34  Score=294.96  Aligned_cols=264  Identities=25%  Similarity=0.336  Sum_probs=196.9

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|+..+.||.|++|.||+|+.. +|+.||+|.+....  ......+..|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999854 78999999986442  22345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +. ++|.+++.... ..+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+|++|||++........ 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 58998886543 45789999999999999999999   99999999999999999999999999999875532211 


Q ss_pred             ceeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc-CCc-c----ccc--
Q 005760          549 TIQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL-PIS-T----KEI--  619 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~-~----~~~--  619 (678)
                       ......++..|+|||...+.. ++.++||||||+++|||++|+.||......+ ...+...... +.. .    ..+  
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHHH
Confidence             122334678899999876654 5889999999999999999999986532211 1111111000 000 0    000  


Q ss_pred             ---ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 ---VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                         ..+.... ..... .....++++.+++.+||+.||++||++.|+++
T Consensus       234 ~~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWAR-QDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccc-cCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence               0000000 00000 01124566889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.5e-34  Score=292.20  Aligned_cols=247  Identities=27%  Similarity=0.384  Sum_probs=199.5

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      -|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+..++.++||||+++++++.+.+..++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            467788999999999999975 478999999986432 233467888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI  550 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  550 (678)
                      ++++|.+++...  .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||++.......  ..
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hh
Confidence            999999998754  4789999999999999999999   9999999999999999999999999999987654321  11


Q ss_pred             eecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccch
Q 005760          551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI  630 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  630 (678)
                      .....++..|+|||.+.+..++.++|+||+||++|+|++|..||.......  ....+....        .+..      
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~--------~~~~------  221 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFLIPKNN--------PPTL------  221 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHHHhcCC--------CCCC------
Confidence            223457889999999988888999999999999999999999986532211  111110000        0000      


Q ss_pred             hhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       631 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                          ...++.++.+++.+||+.+|++||++.|+++.
T Consensus       222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 ----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                01245568899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.3e-34  Score=291.30  Aligned_cols=260  Identities=21%  Similarity=0.262  Sum_probs=194.4

Q ss_pred             CCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC-chhhhHHHHHHHHHhCC-CccceeeeeeeecC--CeEEEEEE
Q 005760          394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIR-HRNIIKVISSCSNE--EFKALVLE  468 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  468 (678)
                      |++.+.||+|+||.||+|.. .+++.||+|+++.... ........|+.+++++. |||++++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            56788999999999999985 4789999999865422 22234457888888885 99999999999877  88999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |++ +++.+++......+++..+..++.|++.||.|||   +.+++||||+|+||+++. +.+||+|||++........ 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            996 5888888766556899999999999999999999   999999999999999999 9999999999976543221 


Q ss_pred             ceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC------------c
Q 005760          549 TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI------------S  615 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------------~  615 (678)
                        .....++..|+|||.+.. +.++.++||||+||++|||++|+.||......+  ...........            .
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhcccc
Confidence              123457889999997644 557889999999999999999999996532211  11111111100            0


Q ss_pred             ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ......+...... .. ......+.++.+++.+||+++|++||++.|+++
T Consensus       231 ~~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTG-LR-KLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCccccccc-HH-HHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000111100000 00 011245778999999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=297.37  Aligned_cols=269  Identities=21%  Similarity=0.291  Sum_probs=197.5

Q ss_pred             CCCCCccccCCCceeEEEEEeC---CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecC--CeEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLG---DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE--EFKA  464 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  464 (678)
                      +|++.+.||+|+||.||+|...   +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999854   57999999997632   33446778899999999999999999999887  8899


Q ss_pred             EEEEecCCCCHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC----CCcEEEEee
Q 005760          465 LVLEYMPHGSLEKYLHSSN----YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD----NMVAHLSDF  536 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~----~~~~kl~Df  536 (678)
                      +||||+++ ++.+++....    ..++...++.++.|++.|++|||   +++++||||+|+||+++.    ++.+|++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 7777664322    25788999999999999999999   999999999999999999    999999999


Q ss_pred             ccccccCCCCC-cceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCcc--------chhh
Q 005760          537 GIAKLLTREDQ-STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM--------TLKH  606 (678)
Q Consensus       537 g~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~--------~~~~  606 (678)
                      |++........ ........++..|+|||.+.+. .++.++|||||||++|||++|+.||........        ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986543322 1122344678899999987664 578999999999999999999999975433220        0000


Q ss_pred             hhhcccCC------------cccc---cccCccCCccchhhHHHH--HHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          607 WVNDWLPI------------STKE---IVDPNLLSREDINFVAKE--QCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       607 ~~~~~~~~------------~~~~---~~~~~~~~~~~~~~~~~~--~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .+......            ....   ..................  ....++.+++.+|+++||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000000            0000   000000000000001111  34567899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2e-34  Score=297.80  Aligned_cols=268  Identities=25%  Similarity=0.308  Sum_probs=198.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecC--CeEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNE--EFKA  464 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  464 (678)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++.....  .....+.+|+.+++.++|+|++++++++.+.  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            457899999999999999999985 4789999999865432  2223456799999999999999999998654  5689


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+.+ +|.+++......+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+||+|||++.....
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            99999965 899988876566899999999999999999999   99999999999999999999999999999986643


Q ss_pred             CCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc----c
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE----I  619 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~  619 (678)
                      ...  ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+ .+.... .........    .
T Consensus       161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~-~~~~~~~~~~~~~~  236 (309)
T cd07845         161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLII-QLLGTPNESIWPGF  236 (309)
T ss_pred             ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHH-HhcCCCChhhchhh
Confidence            221  1223345788999998865 457899999999999999999999997533211 111111 100000000    0


Q ss_pred             ccCc-----cCCccchhhH--HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 VDPN-----LLSREDINFV--AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ~~~~-----~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .+..     ..........  .....++++.+++.+|++.||++|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000     0000000000  01123667889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-36  Score=293.44  Aligned_cols=245  Identities=22%  Similarity=0.307  Sum_probs=199.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ..+.|+.-+.||+||||.||-.+.+ +|+-+|.|.+...   ..........|.+|++.++.++||.+-..|+.++.+++
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            3467888999999999999998754 7999999988543   22333455789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          466 VLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      |+..|+||||.-++...+ ..+++..+..++.+|+-||++||   +.+||.||+||+|||+|+.|+|+|+|.|+|..+..
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999998886554 36899999999999999999999   99999999999999999999999999999987753


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCc--cchhhhhhcccCCcccccccC
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE--MTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      .   ......+||.+|||||++.++.|+...|.||+||++|||+.|+.||-.-.+..  ..+.+.+          ..|+
T Consensus       340 g---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~----------~~~~  406 (591)
T KOG0986|consen  340 G---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT----------LEDP  406 (591)
T ss_pred             C---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH----------hcch
Confidence            2   33345689999999999999999999999999999999999999986422210  0111100          0111


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCC
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN  659 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  659 (678)
                      ..+         ++..++++.++....|++||++|..
T Consensus       407 ~ey---------~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  407 EEY---------SDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             hhc---------ccccCHHHHHHHHHHHccCHHHhcc
Confidence            111         1346777899999999999999974

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.6e-35  Score=299.47  Aligned_cols=249  Identities=27%  Similarity=0.364  Sum_probs=207.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ....|.+.+.||+|.|+.|.+|+. .++..||+|.+.....  ...+.+.+|+++|..++|||||+++++...+..+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            356789999999999999999974 4799999999865432  2335588999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+.+|.+.+++.+.+. ..+..+..++.|+.++++|||   ++.|||||||++||+++.+.++||+|||++..+.   
T Consensus       134 ~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---  206 (596)
T ss_pred             EEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeec---
Confidence            999999999999998876 445888899999999999999   9999999999999999999999999999998875   


Q ss_pred             CcceeecccCCccccCccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                      ........+|++.|.|||+..+.+| ++.+|+||+|+++|-|+.|..||++..-.+                 +-++.+.
T Consensus       207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----------------Lr~rvl~  269 (596)
T KOG0586|consen  207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----------------LRPRVLR  269 (596)
T ss_pred             ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----------------ccchhee
Confidence            3334456789999999999998876 688999999999999999999998633221                 1112222


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      ......+.    .+.+..+++++++..+|.+|++.+++.+.
T Consensus       270 gk~rIp~~----ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  270 GKYRIPFY----MSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             eeecccce----eechhHHHHHHhhccCccccCCHHHhhhh
Confidence            22222221    23446689999999999999999998763

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6e-34  Score=287.44  Aligned_cols=248  Identities=21%  Similarity=0.254  Sum_probs=194.0

Q ss_pred             HHHHhhcCCCCCccc--cCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeecCC
Q 005760          386 ELCRATDGFSENNLI--GRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEE  461 (678)
Q Consensus       386 ~~~~~~~~~~~~~~i--g~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  461 (678)
                      +.....++|++.+.+  |+|+||.||++.. .++..+|+|.+.......     .|+.....+ +|||++++++++...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence            334445677777777  9999999999975 478899999986432211     122222222 6999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC-cEEEEeecccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAK  540 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~-~~kl~Dfg~~~  540 (678)
                      ..++||||+++++|.+++.... .+++..+..++.|+++|+.|||   +.+++||||+|+||+++.++ .++++|||++.
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            9999999999999999998765 5899999999999999999999   99999999999999999988 99999999987


Q ss_pred             ccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccc
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV  620 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (678)
                      .....      ....++..|+|||++.+..++.++||||+|+++|||++|+.||............+..... .   .. 
T Consensus       159 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~---~~-  227 (267)
T PHA03390        159 IIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ-K---KL-  227 (267)
T ss_pred             ecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc-c---cC-
Confidence            55322      1235788999999999888999999999999999999999999754433333232222110 0   00 


Q ss_pred             cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCC-HHHHHH
Q 005760          621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN-AKEIVT  665 (678)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~ell~  665 (678)
                                  ......++.+.+++.+||+.+|.+||+ ++|+++
T Consensus       228 ------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        228 ------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                        001134566889999999999999996 588874

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.2e-34  Score=289.44  Aligned_cols=247  Identities=26%  Similarity=0.341  Sum_probs=200.9

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      +|++.+.||.|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999865 68999999997542   2345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+.+++|.+++... ..+++..+..++.|+++|+.|||   +.+++|+||+|+||++++++.++++|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999999766 35889999999999999999999   9999999999999999999999999999987654322  


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                       ......++..|+|||...+..++.++|+||+|+++|+|++|..||......  ...........   ....        
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~---~~~~--------  220 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET---ADVL--------  220 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc---cccc--------
Confidence             223456788999999998888999999999999999999999998754321  11111111000   0000        


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCH--HHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINA--KEIV  664 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~--~ell  664 (678)
                           .+...+.++.+++.+||+.||.+||++  +|++
T Consensus       221 -----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         221 -----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -----CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                 011234668899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=292.44  Aligned_cols=263  Identities=27%  Similarity=0.341  Sum_probs=196.9

Q ss_pred             CCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      |++.+.||.|++|.||+|.. .+|+.||+|++.....  ...+.+.+|+++++.++|||++++++++.+.+..++++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            66788999999999999985 4799999999875432  23356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          471 PHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       471 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      + ++|.+++.... ..+++..+..++.|+++||+|||   +++++||||+|+||+++.++.++++|||.+........  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 68999987654 35889999999999999999999   89999999999999999999999999999875532211  


Q ss_pred             eeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc-CC--------ccccc
Q 005760          550 IQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL-PI--------STKEI  619 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~--------~~~~~  619 (678)
                      ......++..|+|||++.+. .++.++||||+|+++|+|++|+.||....... ......+... +.        .....
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchhh
Confidence            12233568889999987664 46889999999999999999999986532211 1111111000 00        00000


Q ss_pred             c--cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 V--DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ~--~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .  -+.... ... .......+.++.+++.+||+.||++||+++|+++
T Consensus       234 ~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWAR-QDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccc-cch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0  000000 000 0011234467889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.8e-34  Score=285.27  Aligned_cols=251  Identities=28%  Similarity=0.372  Sum_probs=204.3

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecC--CeEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNE--EFKALVL  467 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  467 (678)
                      +|...+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++||||+++++.+.+.  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4777899999999999999865 789999999865542  3467788999999999999999999999888  8899999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++|+|++|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999998765 6899999999999999999999   89999999999999999999999999999987654332


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      ........++..|+|||...+..++.++||||+|+++|+|++|..||.............   ........         
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~---------  224 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKI---GSSGEPPE---------  224 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhc---cccCCCcC---------
Confidence            112344568889999999988889999999999999999999999987643111100000   00000000         


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                            .+...+.++.+++.+|++.+|++||++.|+++
T Consensus       225 ------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         225 ------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                  01122566889999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=7e-34  Score=290.07  Aligned_cols=266  Identities=23%  Similarity=0.316  Sum_probs=199.3

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      +|+..+.||.|++|.||+|+.. +|+.||+|+++.... ...+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788999999999999999864 789999999875533 23456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          471 PHGSLEKYLHSSN--YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       471 ~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      ++ +|.+++....  ..+++..+..++.|++.|++|||   +.+++||||+|+||++++++.++++|||++.......  
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--  154 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--  154 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--
Confidence            75 8988886543  35889999999999999999999   8999999999999999999999999999997553221  


Q ss_pred             ceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc---CCccccccc---
Q 005760          549 TIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL---PISTKEIVD---  621 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~---  621 (678)
                      .......++..|+|||.+.+. .++.++||||+||++|+|++|+.||.+....+. .........   ...+..+.+   
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhHHHHhcCch
Confidence            112334568899999987654 468899999999999999999999875432211 111110000   000000000   


Q ss_pred             --CccCCccchh-hHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 --PNLLSREDIN-FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 --~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                        .......... .......+.++.+++.+|++.||++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              0000000000 0011234677899999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.7e-34  Score=293.16  Aligned_cols=259  Identities=20%  Similarity=0.288  Sum_probs=185.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCC----CcEEEEEEeecccCchh-----------hhHHHHHHHHHhCCCccceeeee
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGD----GMEVAMKVFNLQYGRVF-----------KSFDVECEMMKSIRHRNIIKVIS  455 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~  455 (678)
                      .++|.+.+.||+|+||.||+|...+    +..+|+|+.........           .....+...+..+.|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4689999999999999999998643    45667776433222110           11122334455678999999998


Q ss_pred             eeecCC----eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcE
Q 005760          456 SCSNEE----FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVA  531 (678)
Q Consensus       456 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~  531 (678)
                      ++....    ..++++|++.. ++.+.+.... ..++..+..++.|++.|++|||   +++|+||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcE
Confidence            765433    34678887743 6766665443 3577888999999999999999   9999999999999999999999


Q ss_pred             EEEeeccccccCCCCCc-----ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhh
Q 005760          532 HLSDFGIAKLLTREDQS-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKH  606 (678)
Q Consensus       532 kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~  606 (678)
                      +|+|||+++.+......     .......||+.|+|||+..+..++.++||||+||++|||++|+.||............
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            99999999766432211     1123346999999999999999999999999999999999999999764222111110


Q ss_pred             hhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 005760          607 WVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                      ...++.    ..+..+.         .....++.++.+++..|++.+|++||+++++++.|
T Consensus       246 ~~~~~~----~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AKCDFI----KRLHEGK---------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHHHH----HHhhhhh---------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            000000    0000000         01123466789999999999999999999999876

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-34  Score=291.95  Aligned_cols=266  Identities=25%  Similarity=0.334  Sum_probs=199.7

Q ss_pred             CCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecC--CeEEEEEE
Q 005760          394 FSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE--EFKALVLE  468 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  468 (678)
                      |++.+.||+|++|.||+|... +++.+|+|++....  ......+.+|+++++.++|||++++++++.+.  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999865 68999999997653  33445678899999999999999999999887  88999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+++ +|.+++......+++..+..++.|+++|++|||   +.+++|+||+|+||++++++.+|++|||++........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 899998776556899999999999999999999   89999999999999999999999999999986643321 


Q ss_pred             ceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc---CCccccccc---
Q 005760          549 TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL---PISTKEIVD---  621 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~---  621 (678)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..........   ........+   
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSKLPW  234 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhccccccchh
Confidence            12233456788999997664 457899999999999999999999987533211 1111111000   000000000   


Q ss_pred             -----CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 -----PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 -----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           +...............++.++.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                 00000000000011113678999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.4e-34  Score=292.59  Aligned_cols=265  Identities=23%  Similarity=0.305  Sum_probs=195.3

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCC-CccceeeeeeeecCCe-----
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEF-----  462 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----  462 (678)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+.....  .....+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4688899999999999999985 4789999999865432  23456788999999995 6999999999876655     


Q ss_pred             EEEEEEecCCCCHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-CCcEEEEeec
Q 005760          463 KALVLEYMPHGSLEKYLHSSN----YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFG  537 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-~~~~kl~Dfg  537 (678)
                      .++||||+++ +|.+++....    ..+++..+..++.||+.||.|||   +++++||||+|+||+++. ++.+|++|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 8988886532    34789999999999999999999   999999999999999998 8999999999


Q ss_pred             cccccCCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc-CC-
Q 005760          538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL-PI-  614 (678)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~-  614 (678)
                      ++........  ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.......... ....... +. 
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLGTPTE  233 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHHhCCCCh
Confidence            9876532211  1223356788999998765 457899999999999999999999987533221111 1111000 00 


Q ss_pred             -cccccc-------cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          615 -STKEIV-------DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       615 -~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                       ......       .+.. ...... ......+.++.+++.+||++||.+||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQW-KPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhCcchhhccchhhcCcc-cchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence             000000       0000 000000 011235677999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=6.5e-34  Score=294.80  Aligned_cols=246  Identities=28%  Similarity=0.378  Sum_probs=196.6

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .|...+.||+|+||.||+|.. .++..||+|.+.....   +....+..|+++++.++|||++++++++.+++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            477788999999999999985 4789999999864322   234568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+++ ++.+.+......+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++++|||++.....    
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----  177 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----  177 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence            9965 888888665666899999999999999999999   99999999999999999999999999999865432    


Q ss_pred             ceeecccCCccccCccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          549 TIQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                        .....++..|+|||.+.   .+.++.++|||||||++|||++|+.||....... ....+.....         +.. 
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~---------~~~-  244 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNES---------PTL-  244 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhccC---------CCC-
Confidence              12345788999999873   4568899999999999999999999986532111 1111111100         000 


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                              ....++..+.+++.+||+.+|.+||++.|+++..
T Consensus       245 --------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         245 --------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             --------CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                    0112345688999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=7.9e-34  Score=294.07  Aligned_cols=263  Identities=21%  Similarity=0.266  Sum_probs=193.8

Q ss_pred             CCccccCCCceeEEEEEeCCCcEEEEEEeecc--cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCC
Q 005760          396 ENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG  473 (678)
Q Consensus       396 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  473 (678)
                      +++.+|.|+++.||++.. +++.||+|++...  .....+.+..|+++++.++||||+++++++.+.+..+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344455555555555544 7899999998754  2345567899999999999999999999999999999999999999


Q ss_pred             CHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC-----
Q 005760          474 SLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-----  547 (678)
Q Consensus       474 ~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~-----  547 (678)
                      +|.+++... ...+++..+..++.|++.||+|||   +++|+||||+|+||+++.++.+|++|||.+........     
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999999754 335788899999999999999999   99999999999999999999999999999865532221     


Q ss_pred             cceeecccCCccccCccccCCC--CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC---------c-
Q 005760          548 STIQTQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI---------S-  615 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---------~-  615 (678)
                      ........++..|+|||++...  .++.++||||+||++|||++|+.||............ .....+.         . 
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK-VRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhccCccccccCchhhhc
Confidence            1112334567789999988663  5788999999999999999999999754332211111 1100000         0 


Q ss_pred             --ccc----cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          616 --TKE----IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       616 --~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                        ...    ..++...  ...........+.++.+++.+||++||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         241 DSMSQSRSSNEHPNNR--DSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CCcCcccccccccchh--hhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence              000    0111100  11111122345677999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.1e-34  Score=294.96  Aligned_cols=272  Identities=22%  Similarity=0.320  Sum_probs=195.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCC-----
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEE-----  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  461 (678)
                      ..++|++.+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+++++.++||||+++++++...+     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3467999999999999999999854 789999999864422  22334567999999999999999999886543     


Q ss_pred             ---eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecc
Q 005760          462 ---FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI  538 (678)
Q Consensus       462 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~  538 (678)
                         ..++||||+.+ ++.+++......+++..+..++.|+++|++|||   +++++|+||+|+||+++.++.+||+|||+
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence               45999999964 888888776556899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCc--ceeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCcccCCcc--chhhhhhcccC
Q 005760          539 AKLLTREDQS--TIQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEM--TLKHWVNDWLP  613 (678)
Q Consensus       539 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~--~~~~~~~~~~~  613 (678)
                      +.........  .......++..|+|||.+.+.. ++.++||||+|+++|||++|..||........  .+........+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9765432211  1123345788899999876654 68899999999999999999999865322110  00000000000


Q ss_pred             Cccccc---------ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          614 ISTKEI---------VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       614 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ......         ..+...................+.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            000000         0000000000000000112345789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.2e-35  Score=319.11  Aligned_cols=255  Identities=24%  Similarity=0.396  Sum_probs=190.8

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeee----------
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISS----------  456 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~----------  456 (678)
                      +-..+|+..+.||+||||.||+++.+ ||+.+|||++.... ......+.+|+..+++|+|||||+++..          
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            34567888899999999999999977 99999999997653 3345678899999999999999999821          


Q ss_pred             ------------------------------------------------e--e----------------------------
Q 005760          457 ------------------------------------------------C--S----------------------------  458 (678)
Q Consensus       457 ------------------------------------------------~--~----------------------------  458 (678)
                                                                      .  .                            
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                            0  0                            


Q ss_pred             ------------------------c-------CCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 005760          459 ------------------------N-------EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF  507 (678)
Q Consensus       459 ------------------------~-------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~  507 (678)
                                              +       +..+||=||||+...+.++++++...-.....++++++|++||+|+| 
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH-  714 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH-  714 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH-
Confidence                                    0       02357889999998888888776543256778999999999999999 


Q ss_pred             CCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC----C------------CCCcceeecccCCccccCccccCCCC-
Q 005760          508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT----R------------EDQSTIQTQTLATIGYMAPEYGKEGR-  570 (678)
Q Consensus       508 ~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~----~------------~~~~~~~~~~~~~~~y~aPE~~~~~~-  570 (678)
                        ++|+|||||||.||++|+++.|||+|||+|+...    .            .......+..+||.-|+|||++.+.. 
T Consensus       715 --~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  715 --DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             --hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence              9999999999999999999999999999998721    0            01122456788999999999887654 


Q ss_pred             --CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhh
Q 005760          571 --VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAME  648 (678)
Q Consensus       571 --~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  648 (678)
                        |+.|+|+||+||+++||+   .||....+.    ...+....        ++.+..+  .++.  .+..+.-..++.+
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~---yPF~TsMER----a~iL~~LR--------~g~iP~~--~~f~--~~~~~~e~slI~~  853 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEML---YPFGTSMER----ASILTNLR--------KGSIPEP--ADFF--DPEHPEEASLIRW  853 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHh---ccCCchHHH----HHHHHhcc--------cCCCCCC--cccc--cccchHHHHHHHH
Confidence              999999999999999999   456542221    22221111        1111110  0000  0112234579999


Q ss_pred             ccccCcCCCCCHHHHHH
Q 005760          649 CTVESPEQRINAKEIVT  665 (678)
Q Consensus       649 cl~~dP~~Rps~~ell~  665 (678)
                      |++.||.+||||.|+++
T Consensus       854 Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  854 LLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HhcCCCccCCCHHHHhh
Confidence            99999999999999985

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.5e-34  Score=286.19  Aligned_cols=242  Identities=26%  Similarity=0.324  Sum_probs=194.4

Q ss_pred             ccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCH
Q 005760          400 IGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL  475 (678)
Q Consensus       400 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  475 (678)
                      ||.|++|.||+|... +++.+|+|++....   ....+.+..|+++++.++||||+++++.+.+++..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999864 58999999986532   23446788999999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeeccc
Q 005760          476 EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL  555 (678)
Q Consensus       476 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  555 (678)
                      .+++.+.. .++...+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||.+.......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99998764 3788999999999999999999   9999999999999999999999999999997664322   123346


Q ss_pred             CCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHH
Q 005760          556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK  635 (678)
Q Consensus       556 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  635 (678)
                      ++..|+|||.+.+..++.++|+||+|+++|+|++|..||.............+..  .        ...       ...+
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~--------~~~-------~~~~  216 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--G--------NGK-------LEFP  216 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc--c--------CCC-------CCCC
Confidence            7889999999888889999999999999999999999997644211111111000  0        000       0001


Q ss_pred             HHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 005760          636 EQCVSFVFNVAMECTVESPEQRIN-----AKEIVT  665 (678)
Q Consensus       636 ~~~~~~l~~l~~~cl~~dP~~Rps-----~~ell~  665 (678)
                      ...+.++.+++.+||+.+|++||+     +.|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            112456889999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.2e-33  Score=294.24  Aligned_cols=273  Identities=21%  Similarity=0.341  Sum_probs=196.8

Q ss_pred             ccccCC--CceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRG--SFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G--~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      ..||.|  +||+||+|.. .+|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  9999999985 4899999999865422  2346788899999999999999999999999999999999999


Q ss_pred             CCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc--
Q 005760          473 GSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST--  549 (678)
Q Consensus       473 ~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--  549 (678)
                      +++.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999987643 34788889999999999999999   9999999999999999999999999998654332111110  


Q ss_pred             ---eeecccCCccccCccccCCC--CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhc-c-------cCCcc
Q 005760          550 ---IQTQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND-W-------LPIST  616 (678)
Q Consensus       550 ---~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~-------~~~~~  616 (678)
                         ......++..|+|||++.+.  .++.++||||+||++|||++|+.||................ +       .+...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence               01112345679999998764  47899999999999999999999997643321111100000 0       00000


Q ss_pred             cccc---------------cCc---cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH--HHHHHHHH
Q 005760          617 KEIV---------------DPN---LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT--KLLKIRDS  673 (678)
Q Consensus       617 ~~~~---------------~~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~--~L~~~~~~  673 (678)
                      ....               .+.   ..............++.++.+++.+||+.||++|||+.|+++  .++.+.++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence            0000               000   000011112223456788999999999999999999999974  44444443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=7.3e-34  Score=292.67  Aligned_cols=270  Identities=26%  Similarity=0.334  Sum_probs=199.2

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCC----
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEE----  461 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  461 (678)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|+++....  .....+.+|+++++.++|||++++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999864 689999999865432  23356678999999999999999999886654    


Q ss_pred             ------eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEe
Q 005760          462 ------FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD  535 (678)
Q Consensus       462 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~D  535 (678)
                            ..++|+||+++ ++.+.+......+++..+..++.|++.||+|||   +.+|+|+||+|+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999976 787777765556899999999999999999999   99999999999999999999999999


Q ss_pred             eccccccCCCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhh---cc
Q 005760          536 FGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN---DW  611 (678)
Q Consensus       536 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~---~~  611 (678)
                      ||.+........ .......++..|+|||.+.+. .++.++||||+||++|||++|+.||...... ..+.....   ..
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~~  237 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGSP  237 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Confidence            999976543221 112223457789999977653 5788999999999999999999998653211 11111111   00


Q ss_pred             cCCcccccc--------cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          612 LPISTKEIV--------DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       612 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .+.....+.        ++........ .......+..+.+++.+||+.||++||++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         238 CPAVWPDVIKLPYFNTMKPKKQYRRRL-REEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             Chhhcccccccccccccccccccccch-hhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000000000        0000000000 0011124567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-36  Score=327.06  Aligned_cols=253  Identities=27%  Similarity=0.391  Sum_probs=203.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .+-++.....||.|.||.||-|. ..+|.-.|+|-++.+.  ....+.+.+|..++..++|||+|+++|+-...+..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            34467788899999999999997 5689999999886553  34557788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      ||||.+|+|.+.+...+ ..++.....+..|++.|++|||   +.|||||||||+||+++.+|.+|++|||.|..+.+..
T Consensus      1313 MEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            99999999999998665 3566666778899999999999   9999999999999999999999999999998776542


Q ss_pred             C--cceeecccCCccccCccccCCCC---CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          547 Q--STIQTQTLATIGYMAPEYGKEGR---VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       547 ~--~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      .  ........||+.|||||++.+..   ...++||||+||+..||+||+.||...+..-.-..+......|        
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P-------- 1460 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP-------- 1460 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC--------
Confidence            1  12234568999999999987643   5678999999999999999999997644321111111111110        


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                 ..|+..+++-.+++.+|++.||++|+++.|+++
T Consensus      1461 -----------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1461 -----------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             -----------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence                       011224556778999999999999999998875

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=9.1e-34  Score=289.88  Aligned_cols=244  Identities=25%  Similarity=0.315  Sum_probs=196.1

Q ss_pred             CccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCH
Q 005760          397 NNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL  475 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  475 (678)
                      ...||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            36799999999999976 47899999998655445566788999999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeeccc
Q 005760          476 EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL  555 (678)
Q Consensus       476 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  555 (678)
                      .+++...  .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++++|||++.......  .......
T Consensus       105 ~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~  177 (292)
T cd06657         105 TDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLV  177 (292)
T ss_pred             HHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccccc
Confidence            9988654  3788899999999999999999   8999999999999999999999999999986553221  1123346


Q ss_pred             CCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHH
Q 005760          556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK  635 (678)
Q Consensus       556 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  635 (678)
                      ++..|+|||...+..++.++|+||+|+++|+|++|..||......  ..........+..        ...        .
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~~~~--------~~~--------~  239 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLPPK--------LKN--------L  239 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhCCcc--------cCC--------c
Confidence            788999999988888899999999999999999999998642211  1111111111100        000        0


Q ss_pred             HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          636 EQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       636 ~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ...+.++.+++.+||+.+|.+||++.|+++
T Consensus       240 ~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         240 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            123445789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.1e-33  Score=283.93  Aligned_cols=248  Identities=27%  Similarity=0.388  Sum_probs=202.9

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|.+.+.||.|+||.||++... +++.+|+|++.....  .....+.+|+++++.++|||++++.+.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999854 689999999875433  4556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          470 MPHGSLEKYLHSSN---YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       470 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      +++++|.+++....   ..+++..+..++.+++.|++|||   +.+++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999998753   56899999999999999999999   8999999999999999999999999999997654332


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                        .......+++.|+|||...+..++.++|+||+|+++|+|++|+.||.......     ............     .  
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~-----~--  223 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-----LALKILKGQYPP-----I--  223 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-----HHHHHhcCCCCC-----C--
Confidence              22334568889999999988889999999999999999999999986532211     111100000000     0  


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              +..++.++.+++.+||..+|++||++.|+++
T Consensus       224 --------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 --------PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             --------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    0123456889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.7e-35  Score=275.49  Aligned_cols=271  Identities=22%  Similarity=0.302  Sum_probs=198.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC---CC--cEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeec-CCe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG---DG--MEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSN-EEF  462 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~---~~--~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  462 (678)
                      -..|+....||+|.||.||+|.-+   +.  ..+|+|.++.++.  .......+|+..++.++|||++.+..++.+ +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            346888999999999999999532   32  3789999965432  344567889999999999999999998877 778


Q ss_pred             EEEEEEecCCCCHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC----CcEEEE
Q 005760          463 KALVLEYMPHGSLEKYLHSSN----YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN----MVAHLS  534 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~----~~~kl~  534 (678)
                      .++++||.+. +|...++-.+    ..++...+..|..||+.|+.|||   ++=|+|||+||.|||+..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence            8999999988 9999886332    36888999999999999999999   8889999999999999866    999999


Q ss_pred             eeccccccCCCCCc-ceeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCcccCC-----ccchhhh
Q 005760          535 DFGIAKLLTREDQS-TIQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNG-----EMTLKHW  607 (678)
Q Consensus       535 Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~g~~p~~~~~~~-----~~~~~~~  607 (678)
                      |||+++.+.+.-.. ......+.|.+|.|||.+.+.. |+.+.||||+||++.||++-++-|.+....     .....+.
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl  258 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL  258 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence            99999988655332 2455678899999999888764 899999999999999999988877542211     0111111


Q ss_pred             --hhcccCCc-ccccccCccCCcc-------------chhhH---HH-HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          608 --VNDWLPIS-TKEIVDPNLLSRE-------------DINFV---AK-EQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       608 --~~~~~~~~-~~~~~~~~~~~~~-------------~~~~~---~~-~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                        +-.....+ ...+.+-......             ...+.   .. ...++..++|+.+++++||.+|.|++++++
T Consensus       259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence              10111100 1111110001000             00000   00 112344889999999999999999999876

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.3e-33  Score=286.95  Aligned_cols=242  Identities=22%  Similarity=0.290  Sum_probs=186.4

Q ss_pred             cccCCCceeEEEEEe-CCCcEEEEEEeecccC---chhhhHHHHHHHHHh---CCCccceeeeeeeecCCeEEEEEEecC
Q 005760          399 LIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKS---IRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       399 ~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~---l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      .||+|+||.||+|.. .+++.+|+|.+.....   .....+.+|..+++.   .+||+++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999985 4689999999864321   112233445444443   479999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      +++|.+++.... .+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++++|||++.......    .
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~  152 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----c
Confidence            999999987654 4899999999999999999999   9999999999999999999999999999986543221    2


Q ss_pred             ecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccch
Q 005760          552 TQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI  630 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  630 (678)
                      ....++..|+|||...+ ..++.++||||+||++|||++|..||..........   ......     .....       
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~-----~~~~~-------  217 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTL-----TVNVE-------  217 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---HHHHhh-----cCCcC-------
Confidence            23468999999998764 457899999999999999999999997533221111   100000     00000       


Q ss_pred             hhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 005760          631 NFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK  666 (678)
Q Consensus       631 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~~  666 (678)
                         .+..++.++.+++.+||+.||++||     +++|+++.
T Consensus       218 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 ---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ---CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence               0123456688999999999999999     69988773

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=300.41  Aligned_cols=277  Identities=25%  Similarity=0.336  Sum_probs=203.7

Q ss_pred             CCCCccccCCCceeEEEEE-eCCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecC------CeEEE
Q 005760          394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE------EFKAL  465 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l  465 (678)
                      +...+.||+|+||.||+|+ ..+|+.||||.+.... ....+...+|++++++++|||||+++++-.+.      +...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            4456789999999999999 4589999999997543 34567788999999999999999999886543      35679


Q ss_pred             EEEecCCCCHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec--CCC--cEEEEeeccc
Q 005760          466 VLEYMPHGSLEKYLHSSN--YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD--DNM--VAHLSDFGIA  539 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~--~~~--~~kl~Dfg~~  539 (678)
                      |||||.+|||...+.+..  ..+++.+...+...++.||.|||   .++|+||||||.||++-  .+|  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999999997543  36999999999999999999999   99999999999999983  333  4699999999


Q ss_pred             cccCCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhh--cccCCcc
Q 005760          540 KLLTREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN--DWLPIST  616 (678)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~--~~~~~~~  616 (678)
                      +.....   ......+||..|++||.... +.|+..+|.|||||++|+++||..||-............+.  ...+...
T Consensus       172 rel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  172 RELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             ccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            977533   25678899999999999884 78999999999999999999999999754333211100111  0011111


Q ss_pred             cccccCccCCc--cchhhHHH----HHHHHHHHHHHhhccccCcCCCC--CHHHHHHHHHHHHHHHhh
Q 005760          617 KEIVDPNLLSR--EDINFVAK----EQCVSFVFNVAMECTVESPEQRI--NAKEIVTKLLKIRDSLLR  676 (678)
Q Consensus       617 ~~~~~~~~~~~--~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~Rp--s~~ell~~L~~~~~~~~~  676 (678)
                      .-..++..-++  ....++.+    ......+-..+..+|..+|.+|.  .+.+.-..+..|......
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vv  316 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVV  316 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhee
Confidence            10001000000  00000000    12223355677889999999999  888888888777665443

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=287.40  Aligned_cols=263  Identities=24%  Similarity=0.311  Sum_probs=201.6

Q ss_pred             CCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          394 FSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      |+..+.||+|++|.||+|... +++.+++|.+.....  .....+..|+++++.++|+||+++++++.+++..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999854 789999999865432  24467788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI  550 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  550 (678)
                      ++ ++.+++......+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            75 898888776556899999999999999999999   9999999999999999999999999999997664332  12


Q ss_pred             eecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc---CCccccccc-----
Q 005760          551 QTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL---PISTKEIVD-----  621 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-----  621 (678)
                      .....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+. .........   +.......+     
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchHhcccchhhhhhh
Confidence            2334578889999988776 688999999999999999999999865332111 000000000   000000000     


Q ss_pred             ----CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 ----PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 ----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                          +...... . .......+.++.+++.+||++||.+||++.|++.
T Consensus       234 ~~~~~~~~~~~-~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         234 KFSFPKKAGMP-L-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhccccccC-H-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                0000000 0 1112356788999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-34  Score=299.10  Aligned_cols=268  Identities=22%  Similarity=0.287  Sum_probs=196.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc-cCchhhhHHHHHHHHHhCCCccceeeeeeeecC-----CeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ-YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNE-----EFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  463 (678)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++... .......+.+|+.+++.++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999974 47899999998643 223445678899999999999999999876543     357


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++|+||+++ ++.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            899999965 888888654  4889999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCCc-ceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC----ccc
Q 005760          544 REDQS-TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI----STK  617 (678)
Q Consensus       544 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~  617 (678)
                      ..... .......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+....  ............    ...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~~~~~~~~~~~  235 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVLGTPSQEDLN  235 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCHHHHH
Confidence            32211 11233567899999998654 46889999999999999999999998653211  000001000100    000


Q ss_pred             ccccCcc-------CCccchhhH-HHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          618 EIVDPNL-------LSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       618 ~~~~~~~-------~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      .+.+...       ......... .....+.++.+++.+||+.||++||++.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000000       000000000 011235678999999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.1e-35  Score=300.42  Aligned_cols=245  Identities=27%  Similarity=0.432  Sum_probs=198.9

Q ss_pred             CCCccccCCCceeEEEEEe-CCCcEEEEEEeec----ccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCe--EEEEE
Q 005760          395 SENNLIGRGSFGSVFKARL-GDGMEVAMKVFNL----QYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF--KALVL  467 (678)
Q Consensus       395 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~lv~  467 (678)
                      +....||+|+|-+||+|.+ .+|.+||=-.++.    +.++..++|..|+++|+.|+||||+++|+++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4456899999999999975 3677775332221    234456889999999999999999999998877554  77999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec-CCCcEEEEeeccccccCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~-~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |.+..|+|..|+++.+. .+...++.|++||++||.|||+ ...+|+|||||-.||+++ ..|.|||+|+|+|+......
T Consensus       123 EL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            99999999999998875 8899999999999999999994 367899999999999997 67999999999999875332


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                          .....|||.|||||... ..|.+.+||||||+.+.||+|+..||..=.....-++....+..|..+..+.||    
T Consensus       201 ----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP----  271 (632)
T KOG0584|consen  201 ----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP----  271 (632)
T ss_pred             ----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH----
Confidence                22378999999999876 789999999999999999999999986533332223333344555555555554    


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                    ++.+||.+|+.. .++|||+.|+++
T Consensus       272 --------------evr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  272 --------------EVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             --------------HHHHHHHHHhcC-chhccCHHHHhh
Confidence                          377899999999 999999999985

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-34  Score=313.30  Aligned_cols=270  Identities=18%  Similarity=0.192  Sum_probs=189.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC--CCcEEEEEEe--------------ec---ccCchhhhHHHHHHHHHhCCCccce
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG--DGMEVAMKVF--------------NL---QYGRVFKSFDVECEMMKSIRHRNII  451 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~--------------~~---~~~~~~~~~~~e~~~l~~l~h~niv  451 (678)
                      .++|++.+.||+|+||.||++..+  .+..++.|.+              ..   ........+.+|+++++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            468999999999999999998643  2222222211              00   1112345678899999999999999


Q ss_pred             eeeeeeecCCeEEEEEEecCCCCHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC
Q 005760          452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN----YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD  527 (678)
Q Consensus       452 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~  527 (678)
                      ++++++.+.+..|+|+|++. +++.+++....    .......+..++.|++.||.|||   +++|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence            99999999999999999985 57887775432    12335667789999999999999   999999999999999999


Q ss_pred             CCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCc--cchh
Q 005760          528 NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE--MTLK  605 (678)
Q Consensus       528 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~--~~~~  605 (678)
                      ++.+||+|||++..+.... ........||..|+|||++.+..++.++|||||||++|||++|..++.......  ..+.
T Consensus       303 ~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            9999999999998664322 222234578999999999999999999999999999999999876433211111  1111


Q ss_pred             hhhhcc------cCCc---ccccccCccCC---ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          606 HWVNDW------LPIS---TKEIVDPNLLS---REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       606 ~~~~~~------~~~~---~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      +.+...      .+..   ....++.....   ............+.++.+++.+|+++||.+|||+.|++.
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111100      0000   00000000000   000111122234556788999999999999999999986

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.4e-34  Score=298.52  Aligned_cols=263  Identities=23%  Similarity=0.290  Sum_probs=196.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecC------
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE------  460 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  460 (678)
                      ..++|+..+.||+|+||.||+|.. .+++.||+|++....  ......+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999985 478999999986432  23345677899999999999999999987543      


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      ...++||||+. ++|.+.+...   ++...+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            35799999995 4888887643   788889999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhc----------
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND----------  610 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~----------  610 (678)
                      .....   .......++..|+|||.+.+..++.++||||+||++|+|++|+.||....... ........          
T Consensus       167 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         167 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             eCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence            65322   11233457889999999998899999999999999999999999986532110 00000000          


Q ss_pred             --------ccC-------CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          611 --------WLP-------ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       611 --------~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              +..       ....+........... . ......+.++.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDS-E-SHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCccc-c-cccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    000       0000000000000000 0 001134566889999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=8.9e-34  Score=284.75  Aligned_cols=248  Identities=23%  Similarity=0.333  Sum_probs=198.5

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|...+.||+|+||.||+|..+ +|..+|+|.+....  ....+.+.+|+++++.++|+||+++++.+.+.+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999864 68899999986542  12345778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC-cEEEEeeccccccCCCCC
Q 005760          470 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       470 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~-~~kl~Dfg~~~~~~~~~~  547 (678)
                      +++++|.+++.... ..+++..+..++.|++.|++|||   +.+++|+||+|+||++++++ .+|++|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM-  156 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence            99999999987643 24789999999999999999999   99999999999999999886 46999999987654322 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                       .......+++.|+|||...+..++.++|+||||+++|||++|+.||......+     ............. .      
T Consensus       157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~-~------  223 (257)
T cd08225         157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----LVLKICQGYFAPI-S------  223 (257)
T ss_pred             -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHhcccCCCC-C------
Confidence             11223458889999999988889999999999999999999999986432211     1111111000000 0      


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              ...+.++.+++.+||+.+|++|||+.|+++
T Consensus       224 --------~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         224 --------PNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             --------CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                    123345889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=7.1e-34  Score=297.26  Aligned_cols=268  Identities=26%  Similarity=0.343  Sum_probs=198.4

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc--cCchhhhHHHHHHHHHhC-CCccceeeeeeeecC--CeE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNE--EFK  463 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~  463 (678)
                      ..++|++.+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++.+ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4568899999999999999999864 6889999988532  223345677899999999 999999999988643  468


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++||||++ ++|.+++...  .+++..+..++.|++.||+|||   +++|+|+||+|+||+++.++.+||+|||++....
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999997 5999998765  5788899999999999999999   9999999999999999999999999999997664


Q ss_pred             CCCCc---ceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCc----
Q 005760          544 REDQS---TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS----  615 (678)
Q Consensus       544 ~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~----  615 (678)
                      .....   .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+. ...... ..+..    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~-~~~~~~~~~  236 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIE-VIGPPSAED  236 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHH-HhCCCCHHH
Confidence            33221   12234468889999997754 4578899999999999999999999865332211 110000 00000    


Q ss_pred             --------ccccccCccCCccchhhH-HHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          616 --------TKEIVDPNLLSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       616 --------~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                              ...+.+. .......... ....++.++.+++.+||+.||++|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDS-LPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhh-cccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                    0000000 0000000000 001256778999999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.2e-33  Score=287.20  Aligned_cols=243  Identities=22%  Similarity=0.266  Sum_probs=191.3

Q ss_pred             ccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCH
Q 005760          400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL  475 (678)
Q Consensus       400 ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  475 (678)
                      ||+|+||+||+|.. .+|+.||+|.+....   ......+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999974 478999999986432   22334567899999999999999999999999999999999999999


Q ss_pred             HHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecc
Q 005760          476 EKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT  554 (678)
Q Consensus       476 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  554 (678)
                      .+++.... ..+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++++|||.+.....   .......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccc
Confidence            99997654 35889999999999999999999   99999999999999999999999999999875432   1122334


Q ss_pred             cCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHH
Q 005760          555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVA  634 (678)
Q Consensus       555 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  634 (678)
                      .++..|+|||.+.++.++.++||||+||++|+|++|+.||....... ...........       .+..         .
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-------~~~~---------~  217 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRTLE-------MAVE---------Y  217 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhcccc-------cccc---------C
Confidence            57889999999988889999999999999999999999986533211 11111000000       0000         0


Q ss_pred             HHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          635 KEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       635 ~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                      +...++++.+++.+||+.||++||     ++.+++.
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            112355688999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.1e-34  Score=297.29  Aligned_cols=268  Identities=23%  Similarity=0.317  Sum_probs=198.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeec----CCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSN----EEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  463 (678)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++....  ......+..|+.+++.++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            47899999999999999999975 479999999986542  2334567789999999999999999988753    3568


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++|+||+. ++|.+++.... .+++..+..++.|++.||+|||   +++++||||||+||++++++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 58999987654 3899999999999999999999   9999999999999999999999999999997654


Q ss_pred             CCCCc--ceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccc
Q 005760          544 REDQS--TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV  620 (678)
Q Consensus       544 ~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (678)
                      .....  .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.+.....  ....+..........+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~--~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH--QLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH--HHHHHHHHhCCChhHhh
Confidence            32211  11234468889999998765 458899999999999999999999996532211  00111100000000000


Q ss_pred             cC-----------ccCCccchhh-HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          621 DP-----------NLLSREDINF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       621 ~~-----------~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      +.           .......... ......+.++.+++.+||+.+|++||++.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00           0000000000 001234677999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.3e-34  Score=291.01  Aligned_cols=253  Identities=26%  Similarity=0.305  Sum_probs=192.1

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|...+.||+|+||.||++.. .+++.||+|.+.... ......+..|+.++.++. ||||+++++++..++..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            455678899999999999975 478999999986543 234567788999999996 99999999999988899999999


Q ss_pred             cCCCCHHHHh---hh-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          470 MPHGSLEKYL---HS-SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       470 ~~~~~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ++. ++.++.   .. ....+++..+..++.|++.|++|||+  ..+++||||||+||+++.++.++|+|||++......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 555443   22 22458899999999999999999992  359999999999999999999999999998755322


Q ss_pred             CCcceeecccCCccccCccccCCC---CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEG---RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      .   ......++..|+|||.+.+.   .++.++||||+||++|||++|+.||.................         .+
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------~~  229 (288)
T cd06616         162 I---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD---------PP  229 (288)
T ss_pred             C---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCC---------CC
Confidence            1   11233578899999998776   688999999999999999999999865321101111110000         01


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      .....      .+..++.++.+++.+||+.+|++|||+.|+++.
T Consensus       230 ~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         230 ILSNS------EEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cCCCc------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11000      002345668999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=8e-36  Score=302.04  Aligned_cols=306  Identities=21%  Similarity=0.242  Sum_probs=263.7

Q ss_pred             CccccCCcCcccCC-ccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEE
Q 005760            1 MLQMWENNFSGTIP-RFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLI   79 (678)
Q Consensus         1 ~L~l~~~~~~~~~p-~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L   79 (678)
                      .||||+|.|+ .+| .+|..-.++++|+|++|.|+....++|..+.+|.+|.|+.|+++.+|..     .|.++++|+.|
T Consensus       153 slDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r-----~Fk~L~~L~~L  226 (873)
T KOG4194|consen  153 SLDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQR-----SFKRLPKLESL  226 (873)
T ss_pred             hhhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHH-----Hhhhcchhhhh
Confidence            3789999998 555 6777778999999999999988889999999999999999999998875     58889999999


Q ss_pred             ECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCc
Q 005760           80 SFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNK  159 (678)
Q Consensus        80 ~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~  159 (678)
                      +|..|+|... .+..|..++ +|+.|.|..|.+.......|..+.++++|+|+.|+++..-.+.+.+|++|+.|+|+.|.
T Consensus       227 dLnrN~iriv-e~ltFqgL~-Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~Na  304 (873)
T KOG4194|consen  227 DLNRNRIRIV-EGLTFQGLP-SLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNA  304 (873)
T ss_pred             hccccceeee-hhhhhcCch-hhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhh
Confidence            9999999643 344477787 89999999999998888889999999999999999987777888899999999999999


Q ss_pred             CCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccCCCCcc
Q 005760          160 LEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLE  238 (678)
Q Consensus       160 i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~  238 (678)
                      |...-++.+...++|+.|+|++|+|+...+.+|..+.+|++|.|++|.|+.+.+ +|..+++|+.|||++|.|...+...
T Consensus       305 I~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDa  384 (873)
T KOG4194|consen  305 IQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDA  384 (873)
T ss_pred             hheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecc
Confidence            988888899999999999999999998888899999999999999999999877 6889999999999999887544322


Q ss_pred             ccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccCccccCCCC
Q 005760          239 IGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN  318 (678)
Q Consensus       239 ~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~c~~~~  318 (678)
                             ...+..+++|+.|+|.+|+|..+...+|.+++.|+.|||.+|.+.+.-+....-..|+.+.+....+.|||..
T Consensus       385 -------a~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql  457 (873)
T KOG4194|consen  385 -------AVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQL  457 (873)
T ss_pred             -------hhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccH
Confidence                   1233456699999999999998888999999999999999999987766653334889999999999999998


Q ss_pred             CCC
Q 005760          319 LRV  321 (678)
Q Consensus       319 ~~~  321 (678)
                      .|+
T Consensus       458 ~Wl  460 (873)
T KOG4194|consen  458 KWL  460 (873)
T ss_pred             HHH
Confidence            776

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.2e-33  Score=289.92  Aligned_cols=264  Identities=24%  Similarity=0.301  Sum_probs=195.2

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ++|++.+.||+|++|.||+|..+ +++.||+|.+....  ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            47888999999999999999864 78999999985432  2234567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-CCcEEEEeeccccccCCCC
Q 005760          469 YMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |++ +++.+++..... ..++..+..++.||+.||+|||   +++++|+||+|+||+++. ++.+|++|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 588887755432 3578888899999999999999   899999999999999985 5679999999997543221


Q ss_pred             CcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccc------
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI------  619 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------  619 (678)
                        .......+++.|+|||.+.+. .++.++||||+||++|+|++|+.||......+.. ..... .........      
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~  233 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL-FKIFR-ILGTPNEETWPGVTS  233 (294)
T ss_pred             --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHH-HhCCCChhhcccccc
Confidence              112234567899999987664 5788999999999999999999998753322111 11100 000000000      


Q ss_pred             -cc-----CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 -VD-----PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 -~~-----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                       .+     +.... . .........++++.+++.+|++.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        234 LPDYKSAFPKWPP-K-DLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             chhhhhhcccCCC-C-CHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00     00000 0 000011234566889999999999999999999986

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=283.21  Aligned_cols=247  Identities=28%  Similarity=0.407  Sum_probs=201.5

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|++.+.||+|++|.||+|... +++.|++|.+.....  ...+.+.+|++++++++|||++++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999754 688999999976543  3556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|.+++.... .+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||.+......... 
T Consensus        81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            99999999997663 5899999999999999999999   999999999999999999999999999999876533221 


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                       .....++..|+|||...+..++.++||||+|+++|+|++|..||......    ........ ..     .+..     
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~~~~~-~~-----~~~~-----  219 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALFRIVQ-DD-----HPPL-----  219 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHhc-cC-----CCCC-----
Confidence             23346788999999988888899999999999999999999998653211    11110000 00     0000     


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           +...+..+.+++.+||+.+|++||++.|++.
T Consensus       220 -----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 -----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                 0123455889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-35  Score=268.90  Aligned_cols=249  Identities=23%  Similarity=0.286  Sum_probs=195.2

Q ss_pred             CCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEEEec
Q 005760          394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      ...+..||.|..|.||+++. ++|..+|||.+.... .+.-+++...+.++..- .+|+||+.+|+|......++.||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            34467799999999999985 478999999996543 34456666666665544 4899999999999988888999998


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI  550 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  550 (678)
                      . ..+..++++...++++..+-.+...+++||.||.+  +++|+|||+||+|||+|+.|++|+||||.+-.+..+..   
T Consensus       174 s-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA---  247 (391)
T KOG0983|consen  174 S-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA---  247 (391)
T ss_pred             H-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc---
Confidence            4 37777787777778888888899999999999997  88999999999999999999999999999977654333   


Q ss_pred             eecccCCccccCccccCCC---CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          551 QTQTLATIGYMAPEYGKEG---RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      .+...|-+.|||||.+...   .|+.++||||||+.++|+.||+.||..-...-..+....+..+         |.+.. 
T Consensus       248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP---------P~L~~-  317 (391)
T KOG0983|consen  248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP---------PLLPG-  317 (391)
T ss_pred             cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC---------CCCCc-
Confidence            3456688999999987643   6889999999999999999999999763222222222111111         11111 


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                             ....++++.+++..||++|+.+||...++++
T Consensus       318 -------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  318 -------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             -------ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence                   1225677999999999999999999999875

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.5e-33  Score=289.37  Aligned_cols=252  Identities=23%  Similarity=0.289  Sum_probs=194.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  467 (678)
                      .++|++.+.||+|+||.||+|..+ +++.||||.++... ......+..|+.++.... ||||+++++++.+....++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            467888999999999999999875 48999999986532 223345666777666664 999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      ||++ +++.+++......+++..+..++.|++.|++|||   + .+|+||||+|+||+++.++.+||+|||++.......
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9985 4788877665556899999999999999999999   6 599999999999999999999999999987653322


Q ss_pred             CcceeecccCCccccCccccCCCC----CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGR----VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      .   .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||.........+........    ..+...
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~  242 (296)
T cd06618         170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP----PSLPPN  242 (296)
T ss_pred             c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC----CCCCCC
Confidence            1   22335778899999887553    788999999999999999999998642221111111111100    000000


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                                   ..++.++.+++.+||+.||++||++.++++.
T Consensus       243 -------------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         243 -------------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -------------CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                         0234568899999999999999999999765

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.2e-34  Score=287.10  Aligned_cols=245  Identities=27%  Similarity=0.349  Sum_probs=194.2

Q ss_pred             ccCCCceeEEEEEeC-CCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCH
Q 005760          400 IGRGSFGSVFKARLG-DGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL  475 (678)
Q Consensus       400 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  475 (678)
                      ||.|+||.||+|... +|+.+++|++.....   ...+.+.+|+++++.++||||+++++.+...+..++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999865 599999999865432   3456788899999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC------cc
Q 005760          476 EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ------ST  549 (678)
Q Consensus       476 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~------~~  549 (678)
                      .+++.+.. .+++..+..++.|+++||+|||   +.+++|+||+|+||++++++.++++|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99998765 5899999999999999999999   99999999999999999999999999999875432211      11


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      ......++..|+|||...+...+.++||||||+++|++++|+.||......+  .......   ...   ..+       
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~~---~~~---~~~-------  221 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--IFQNILN---GKI---EWP-------  221 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhc---CCc---CCC-------
Confidence            2334567889999999988889999999999999999999999986533211  1111100   000   000       


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                          .....+..+.+++.+||+.+|++||++.++.+.|
T Consensus       222 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         222 ----EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ----ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                0001256688999999999999999995554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.1e-33  Score=283.73  Aligned_cols=246  Identities=26%  Similarity=0.366  Sum_probs=200.6

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|++.+.||+|+||.||++.. .+++.+|+|.+....  ......+.+|+++++.++||||+++.+++.+.+..++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            478889999999999999974 478899999986532  23345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          470 MPHGSLEKYLHSS---NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       470 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      +++++|.+++.+.   ...+++..++.++.|++.|++|||   +.+++|+||+|+||+++.++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999998662   235788999999999999999999   999999999999999999999999999999776433 


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                         ......++..|+|||.+.+..++.++|+||+|+++|||++|+.||......  .....+..   ..         ..
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~---~~---------~~  219 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQR---GK---------YP  219 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc---CC---------CC
Confidence               222345788999999998888999999999999999999999998653321  11111110   00         00


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .      .+..++.++.+++.+|++.+|++||++.|+++
T Consensus       220 ~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         220 P------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             C------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0      01134566899999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=284.22  Aligned_cols=241  Identities=22%  Similarity=0.299  Sum_probs=185.9

Q ss_pred             ccccCCCceeEEEEEe-CCCcEEEEEEeecccC---chhhhHHHHHHHH-HhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG---RVFKSFDVECEMM-KSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|.. .+++.||+|++.....   .....+..|..++ ...+|+|++++++++.+.+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999975 4689999999864321   1122334454443 455899999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      ++|.+++.... .++...+..++.|++.||.|||   +.+++|+||+|+||+++.++.++++|||++.....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999997654 4788999999999999999999   89999999999999999999999999999865432      22


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...++..|+|||...+..++.++||||+|+++|||++|..||....... ........    ..   ..+.         
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~----~~---~~~~---------  214 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-VFDNILSR----RI---NWPE---------  214 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhc----cc---CCCC---------
Confidence            3457889999999988888999999999999999999999986532211 01100000    00   0000         


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .....++.++.+++.+||+.+|++||++.++.+
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            001134567899999999999999997754433

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-33  Score=281.36  Aligned_cols=250  Identities=23%  Similarity=0.327  Sum_probs=196.3

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-----CchhhhHHHHHHHHHhCCCccceeeeeeeecC--CeE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-----GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE--EFK  463 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  463 (678)
                      .+|++.+.||+|+||.||+|.. .++..||+|.+....     .+....+.+|+++++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788999999999999999985 478999999875321     23345788899999999999999999998654  468


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++|+||+++++|.+++..... +++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~-l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGA-LTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            899999999999999976543 788889999999999999999   9999999999999999999999999999997653


Q ss_pred             CCCC-cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          544 REDQ-STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       544 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      .... ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||....... ...+..    .....    +
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~----~~~~~----~  228 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIFKIA----TQPTK----P  228 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHHHHH----cCCCC----C
Confidence            2111 111223458889999999988889999999999999999999999986532211 111110    00000    0


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .          .+...++++.+++.+||+ +|..||++.+++.
T Consensus       229 ~----------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         229 M----------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             C----------CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            0          011234568899999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-33  Score=285.12  Aligned_cols=264  Identities=24%  Similarity=0.326  Sum_probs=195.3

Q ss_pred             CCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhC---CCccceeeeeeeecCCe-----
Q 005760          394 FSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSI---RHRNIIKVISSCSNEEF-----  462 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  462 (678)
                      |++.+.||+|+||.||+|..+ +++.||+|++.....  .....+..|+.+++.+   +|||++++++++.+.+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999875 589999999964322  2234566787777666   59999999999987776     


Q ss_pred             EEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      .+++|||+++ +|.+++.... ..+++..+..++.|++.||.|||   +.+++|+|++|+||+++.++.+||+|||.+..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            8999999975 8999887643 35899999999999999999999   99999999999999999999999999999977


Q ss_pred             cCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      ......   .....++..|+|||.+.+..++.++|+||+||++|||++|..||......+ ....+...........+..
T Consensus       157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCC
Confidence            643221   123347888999999998889999999999999999999999987533221 1111111100000000000


Q ss_pred             -----CccCCccc-hh-hHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 -----PNLLSRED-IN-FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 -----~~~~~~~~-~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           ........ .. .......+..+.+++.+||+.||++||++.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                 00000000 00 0011234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.5e-33  Score=335.29  Aligned_cols=301  Identities=34%  Similarity=0.557  Sum_probs=247.6

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      .|+|++|++.+.+|..+.++++|++|+|++|.+.+..|..|.++++|+.|++++|.+....+     ..+..+++|+.|+
T Consensus       264 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~-----~~~~~l~~L~~L~  338 (968)
T PLN00113        264 YLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP-----VALTSLPRLQVLQ  338 (968)
T ss_pred             EEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCC-----hhHhcCCCCCEEE
Confidence            37899999999999999999999999999999999999999999999999999999976443     3578999999999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcC
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKL  160 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i  160 (678)
                      |++|.+.+..|.. +..+. +|+.|++++|++.+..|..+..+++|+.|++++|++.+..|..+..+++|+.|+|++|.+
T Consensus       339 L~~n~l~~~~p~~-l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l  416 (968)
T PLN00113        339 LWSNKFSGEIPKN-LGKHN-NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSF  416 (968)
T ss_pred             CcCCCCcCcCChH-HhCCC-CCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEe
Confidence            9999999887765 66665 899999999999998898888888888888888888888888888888888888888888


Q ss_pred             CCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceecccccccc------------------------cccccc
Q 005760          161 EGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTS------------------------IPLTFW  216 (678)
Q Consensus       161 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~------------------------l~~~~~  216 (678)
                      ++.+|..|..+++|+.|++++|.+.+..+..+..+++|+.|+|++|++..                        +|..+.
T Consensus       417 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~  496 (968)
T PLN00113        417 SGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLG  496 (968)
T ss_pred             eeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhh
Confidence            87777778888888888888888877777666666666666666655442                        233445


Q ss_pred             ccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC
Q 005760          217 NLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG  296 (678)
Q Consensus       217 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  296 (678)
                      .+++|+.|+|++|.+.+..|..+.+++          +|+.|+|++|.+++..|..+..+++|+.|++++|++++..|..
T Consensus       497 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~----------~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  566 (968)
T PLN00113        497 SLSELMQLKLSENKLSGEIPDELSSCK----------KLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKN  566 (968)
T ss_pred             hhhccCEEECcCCcceeeCChHHcCcc----------CCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChh
Confidence            555555555555555555555555444          9999999999999999999999999999999999999877764


Q ss_pred             -CccccccccccccCccccCCCC
Q 005760          297 -GSFGNFSAESFEGNELLCGSPN  318 (678)
Q Consensus       297 -~~~~~l~~~~~~~n~~~c~~~~  318 (678)
                       ..+..+..+++.+|++.+..|.
T Consensus       567 l~~l~~L~~l~ls~N~l~~~~p~  589 (968)
T PLN00113        567 LGNVESLVQVNISHNHLHGSLPS  589 (968)
T ss_pred             HhcCcccCEEeccCCcceeeCCC
Confidence             6677899999999998876663

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-33  Score=295.59  Aligned_cols=273  Identities=23%  Similarity=0.264  Sum_probs=200.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc--cCchhhhHHHHHHHHHhCCCccceeeeeeeecC-----Ce
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNE-----EF  462 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  462 (678)
                      .++|.+.+.||+|+||+||+|.. .+++.||+|.+...  .......+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45789999999999999999975 47899999998643  223345677899999999999999999987543     35


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .++|+||+. ++|.+++.... .+++..+..++.|++.|+.|||   +++++||||+|+||+++.++.+||+|||++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999995 68998887654 4899999999999999999999   999999999999999999999999999999765


Q ss_pred             CCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcc---cCCcccc
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW---LPISTKE  618 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~  618 (678)
                      ....  .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.... ..........   .+.....
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhCCCChHHhhh
Confidence            4321  12234457889999998764 46889999999999999999999998653211 0010000000   0000000


Q ss_pred             cccCccC-------Cccchh-hHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHHH
Q 005760          619 IVDPNLL-------SREDIN-FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK--LLKIR  671 (678)
Q Consensus       619 ~~~~~~~-------~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~--L~~~~  671 (678)
                      +.++...       ...... ......+++++.+++.+||+.+|++|||+.|+++.  ++.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence            0000000       000000 01112456778999999999999999999999876  55443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.6e-33  Score=289.11  Aligned_cols=246  Identities=28%  Similarity=0.387  Sum_probs=194.9

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ..|+..+.||+|+||.||+|... ++..+|+|.+...   ......++.+|+++++.++|+|++++.+++...+..++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34667789999999999999854 6888999998642   1223456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+. |++.+.+......+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++++|||++......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9996 5888887665556889999999999999999999   999999999999999999999999999998755321  


Q ss_pred             cceeecccCCccccCccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          548 STIQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                          ....++..|+|||.+.   .+.++.++|||||||++|||++|+.||....... ....+.....         +..
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~---------~~~  234 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNES---------PAL  234 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCC---------CCc
Confidence                2345788999999864   3567889999999999999999999986532111 1111111000         000


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                               ....++..+.+++.+||+.+|++||++.++++.
T Consensus       235 ---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         235 ---------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ---------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence                     011244558899999999999999999998865

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-33  Score=293.94  Aligned_cols=272  Identities=26%  Similarity=0.320  Sum_probs=204.5

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCC-----eEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE-----FKA  464 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~  464 (678)
                      +|++.+.||.|++|.||+|... +++.||+|++....  ....+.+.+|+++++.++||||+++.+++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5788999999999999999864 58999999986543  334567889999999999999999999987765     789


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||++ ++|.+++.... .+++..+..++.|++.|++|||   +.+++|+||||.||+++.++.++++|||.+.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 48999887655 6899999999999999999999   99999999999999999999999999999987643


Q ss_pred             CCC-cceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc-c--
Q 005760          545 EDQ-STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE-I--  619 (678)
Q Consensus       545 ~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~--  619 (678)
                      ... ........++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+. ...... ........ +  
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~-~~~~~~~~~~~~  233 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVE-VLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHH-hcCCCChhHhhh
Confidence            321 0123345678899999998887 789999999999999999999999976432111 111000 00000000 0  


Q ss_pred             ccCcc--------CCccchhh-HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHHH
Q 005760          620 VDPNL--------LSREDINF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK--LLKIR  671 (678)
Q Consensus       620 ~~~~~--------~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~--L~~~~  671 (678)
                      .....        ........ ......+.++.+++.+||+++|++||++.+++..  ++.++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            00000        00000000 0011246778999999999999999999999974  55544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.7e-33  Score=291.73  Aligned_cols=269  Identities=21%  Similarity=0.236  Sum_probs=196.1

Q ss_pred             hcCCCC-CccccCCCceeEEEEEeC-CCcEEEEEEeecccCch--------------hhhHHHHHHHHHhCCCccceeee
Q 005760          391 TDGFSE-NNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRV--------------FKSFDVECEMMKSIRHRNIIKVI  454 (678)
Q Consensus       391 ~~~~~~-~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~  454 (678)
                      .++|.. .+.||.|+||.||+|..+ +++.||+|++.......              ...+.+|+++++.++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            456654 577999999999999854 78999999986432211              12467899999999999999999


Q ss_pred             eeeecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEE
Q 005760          455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLS  534 (678)
Q Consensus       455 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~  534 (678)
                      +++...+..++||||+. ++|.+++.... .++...+..++.|++.|++|||   +.+++|+||+|+||+++.++.++++
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence            99999999999999996 59999987644 4889999999999999999999   9999999999999999999999999


Q ss_pred             eeccccccCCCCC------------cceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCc
Q 005760          535 DFGIAKLLTREDQ------------STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGE  601 (678)
Q Consensus       535 Dfg~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~  601 (678)
                      |||.+........            ........++..|+|||.+.+. .++.++||||+||++|||++|+.||......+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999976541110            1111233467889999988764 46889999999999999999999987543221


Q ss_pred             cchhhhhhccc---CCcccccc-----cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          602 MTLKHWVNDWL---PISTKEIV-----DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       602 ~~~~~~~~~~~---~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                       ..........   ...+....     .+...............++.++.+++.+||+.+|++||++.|++.
T Consensus       242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        242 -QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             -HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence             1111110000   00000000     000000000000011234567889999999999999999999985

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5e-34  Score=269.42  Aligned_cols=259  Identities=21%  Similarity=0.329  Sum_probs=200.8

Q ss_pred             ccccCCCceeEEEEE-eCCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEEEEecCCCCH
Q 005760          398 NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALVLEYMPHGSL  475 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L  475 (678)
                      +.||+|+|+.|--+. ..+|.++|||++.++..+.+.++.+|++++...+ |+||+.++++|++++..|+|||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            689999999998875 6799999999999888889999999999999986 99999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC---CcEEEEeeccccccCC-----CCC
Q 005760          476 EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTR-----EDQ  547 (678)
Q Consensus       476 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~---~~~kl~Dfg~~~~~~~-----~~~  547 (678)
                      ..++++... +++..+.++.++|+.||.+||   ++||.|||+||+|||....   --||||||.+..-...     ...
T Consensus       164 LshI~~~~~-F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  164 LSHIQKRKH-FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             HHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            999988765 888889999999999999999   9999999999999998643   3589999988643211     111


Q ss_pred             cceeecccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcc-ccccc
Q 005760          548 STIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVD  621 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  621 (678)
                      ...-...+|+..|||||+..     ...|+.+.|.||+||++|=|++|.+||.+.-..+-.   |-+...=... ..++.
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG---WdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG---WDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC---ccCCCccHHHHHHHHH
Confidence            22234567899999999642     234788999999999999999999999864332211   1110000000 00000


Q ss_pred             CccCCccchhhH--HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 PNLLSREDINFV--AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 ~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .  +...-++++  .+...+.+..+++...+..||.+|.++.+++.
T Consensus       317 s--IQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  317 S--IQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             H--HhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            0  111112222  23457888999999999999999999998875

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.1e-33  Score=285.94  Aligned_cols=244  Identities=27%  Similarity=0.361  Sum_probs=193.5

Q ss_pred             CCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      |...+.||+|+||.||+|+. .+++.|++|++.....   .....+..|+++++.++|||++++++++.+.+..++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66678899999999999985 4789999999864322   2335678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +. +++.+++......+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||++.....     
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence            95 5888888766666899999999999999999999   99999999999999999999999999999864321     


Q ss_pred             eeecccCCccccCccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          550 IQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                       .....++..|+|||.+.   .+.++.++|||||||++|||++|..||........ .......    ..     +... 
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~----~~-----~~~~-  241 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN----DS-----PTLQ-  241 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhc----CC-----CCCC-
Confidence             12346788999999874   45688899999999999999999999865322111 1110000    00     0000 


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                              ...++..+.+++.+||+++|.+||++.+++..
T Consensus       242 --------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 --------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             --------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    01223457899999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=9.1e-33  Score=280.67  Aligned_cols=241  Identities=22%  Similarity=0.301  Sum_probs=185.9

Q ss_pred             cccCCCceeEEEEEe-CCCcEEEEEEeecccC---chhhhHHHHHH---HHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          399 LIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG---RVFKSFDVECE---MMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       399 ~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      .||+|+||.||+|.. .+++.||+|.+.....   .....+..|..   .++...||+|+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999975 4689999999865321   11122333433   3444579999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      +++|.+++.... .+++..+..++.|+++|++|||   +.+++||||+|+||+++.++.++|+|||++.......    .
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~  152 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----P  152 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----C
Confidence            999999887654 5899999999999999999999   8999999999999999999999999999987553221    2


Q ss_pred             ecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccch
Q 005760          552 TQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI  630 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  630 (678)
                      ....++..|+|||.+.++ .++.++||||+||++|||++|+.||..............  ..      ..++..      
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~------~~~~~~------  218 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--TL------TMAVEL------  218 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH--hh------ccCCCC------
Confidence            234688999999998754 588999999999999999999999976422211100000  00      000110      


Q ss_pred             hhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          631 NFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       631 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                          +..++.++.+++.+|++.+|++||     ++.|+++
T Consensus       219 ----~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 ----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ----CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                012345688999999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-35  Score=270.42  Aligned_cols=271  Identities=20%  Similarity=0.321  Sum_probs=201.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeec--ccCchhhhHHHHHHHHHhCCCccceeeeeeeec--------
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN--------  459 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  459 (678)
                      .+.|....+||+|.||.||+|+. ++|+.||+|+.-.  ....-.....+|+.++..++|+|++.+++.|..        
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            44566778999999999999975 4678899987533  222333556789999999999999999887733        


Q ss_pred             CCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccc
Q 005760          460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA  539 (678)
Q Consensus       460 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~  539 (678)
                      ....|+|+++|+. +|..++......++..++..++.++++||.|+|   +..|+|||+||+|++++.+|.+||+|||++
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence            3468999999977 999999887777999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCC--CcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCcc--chhhhhhcccCC
Q 005760          540 KLLTRED--QSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM--TLKHWVNDWLPI  614 (678)
Q Consensus       540 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~  614 (678)
                      +.+....  .....+..+.|.+|.+||.+.+. .|+++.|||+.||++.||++|.+-+.+..+...  .+...+....++
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            6554322  23345677789999999977765 589999999999999999999988776443311  111122222222


Q ss_pred             cccccccCccC--------CccchhhH----HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          615 STKEIVDPNLL--------SREDINFV----AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       615 ~~~~~~~~~~~--------~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .+.....-.+.        .....+..    .+-...++..+++..++..||.+|+++++++.
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            22222111111        11100000    00111336889999999999999999988874

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.7e-33  Score=288.66  Aligned_cols=270  Identities=20%  Similarity=0.274  Sum_probs=195.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecC-------
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNE-------  460 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  460 (678)
                      .++|++.+.||+|+||.||+|..+ +++.+|+|++.....  .....+.+|+++++.++||||+++++++.+.       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999854 789999999864422  2234567899999999999999999877443       


Q ss_pred             -CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccc
Q 005760          461 -EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA  539 (678)
Q Consensus       461 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~  539 (678)
                       ...++|+||+.+ ++.+.+......+++..+..++.|+++||+|||   +.+++|+||+|+||++++++.++++|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence             346899999965 788877765556999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCCcc---------eeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhh
Q 005760          540 KLLTREDQST---------IQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN  609 (678)
Q Consensus       540 ~~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~  609 (678)
                      ..........         ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+..... .......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-~~~~~~~  241 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-QLHLIFK  241 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence            7654322111         11233567889999987654 57899999999999999999999986532211 0111110


Q ss_pred             ccc---CCc------ccccccCccCCccchhhH-HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          610 DWL---PIS------TKEIVDPNLLSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       610 ~~~---~~~------~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ...   +..      .....+............ ......+++.+++.+|++.||++|||+.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            000   000      000000000000000000 01123466889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-33  Score=282.82  Aligned_cols=263  Identities=21%  Similarity=0.259  Sum_probs=195.2

Q ss_pred             CCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEEEEec
Q 005760          394 FSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      |.+.+.||+|++|.||+|... +++.||+|.+..... .......+|+..++.++ |||++++++++.+.+..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999865 588999999864432 12233456889999999 999999999999999999999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          471 PHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       471 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                       +++|.+++.... ..+++..+..++.|++.++.|||   +++++|+||+|+||++++++.++|+|||.++......   
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence             779999887654 45899999999999999999999   8999999999999999999999999999997654322   


Q ss_pred             eeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCc----------ccc
Q 005760          550 IQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS----------TKE  618 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~  618 (678)
                      ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||......+. ...... .....          ...
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICS-VLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHH-hcCCCChhhhhhHhhhhc
Confidence            1233557889999997754 4578999999999999999999999865322111 000000 00000          000


Q ss_pred             cccCccCCccchhh-HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 IVDPNLLSREDINF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 ~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..+........... ......+.++.+++.+||+.+|++||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000000000 000112467899999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.8e-33  Score=286.14  Aligned_cols=254  Identities=22%  Similarity=0.283  Sum_probs=197.3

Q ss_pred             CCCCCccccCCCceeEEEEEe----CCCcEEEEEEeeccc----CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeE
Q 005760          393 GFSENNLIGRGSFGSVFKARL----GDGMEVAMKVFNLQY----GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  463 (678)
                      +|++.+.||+|++|.||+|..    .+++.||+|++....    ....+.+..|+++++.+ +||||+++++++...+..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999863    367889999986432    22345678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++||||+++++|.+++.... .+++..+..++.|+++||.|||   +.+++|+||+|.||+++.++.++++|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999987654 4788899999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCCcceeecccCCccccCccccCCCC--CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKEGR--VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      .... .......++..|+|||...+..  .+.++||||+|+++|||++|..||...... .......+.....      .
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~------~  228 (288)
T cd05583         157 AEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKS------K  228 (288)
T ss_pred             cccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHcc------C
Confidence            3221 1222345788999999887655  788999999999999999999998532111 1111111110000      0


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL  668 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~  668 (678)
                      +.          .+..++.++.+++.+||+.||++|||+.++.+.|+
T Consensus       229 ~~----------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         229 PP----------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             CC----------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            00          01123456889999999999999999888776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.6e-33  Score=285.09  Aligned_cols=249  Identities=29%  Similarity=0.430  Sum_probs=200.9

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  466 (678)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+..|+++++.++ ||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999854 79999999986431   233466788999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.+++.+.+ .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999998765 4899999999999999999999   9999999999999999999999999999987654322


Q ss_pred             Cc------------------ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhh
Q 005760          547 QS------------------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWV  608 (678)
Q Consensus       547 ~~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~  608 (678)
                      ..                  .......++..|+|||......++.++|+||+|++++++++|..||....... ......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~  235 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-TFQKIL  235 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHH
Confidence            11                  22234457889999999888889999999999999999999999987533111 011100


Q ss_pred             hcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCH----HHHHH
Q 005760          609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA----KEIVT  665 (678)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~----~ell~  665 (678)
                      ..       ....+             ...++.+.+++.+||+.+|++||++    .|+++
T Consensus       236 ~~-------~~~~~-------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         236 KL-------EYSFP-------------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             hc-------CCCCC-------------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            00       00000             1124558899999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-33  Score=293.08  Aligned_cols=266  Identities=23%  Similarity=0.297  Sum_probs=197.0

Q ss_pred             HHHhhcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCC--
Q 005760          387 LCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE--  461 (678)
Q Consensus       387 ~~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  461 (678)
                      +....++|++.+.||+|+||.||+|. ..++..||+|++....  ......+..|+++++.++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            44467889999999999999999997 4579999999985432  223456788999999999999999999886543  


Q ss_pred             ----eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeec
Q 005760          462 ----FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG  537 (678)
Q Consensus       462 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg  537 (678)
                          ..++||||+ +++|.+++...  .+++..+..++.|++.|++|||   +.+|+||||+|+||+++.++.++++|||
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg  163 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  163 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecc
Confidence                458999999 77999888653  4889999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc--CC
Q 005760          538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL--PI  614 (678)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~  614 (678)
                      ++......     .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||........ .........  +.
T Consensus       164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~  237 (343)
T cd07880         164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ-LMEIMKVTGTPSK  237 (343)
T ss_pred             cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCH
Confidence            98754321     123457889999998766 4578899999999999999999999875322111 111000000  00


Q ss_pred             cccccccCc--------cCCccchhh-HHHHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 005760          615 STKEIVDPN--------LLSREDINF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIV  664 (678)
Q Consensus       615 ~~~~~~~~~--------~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell  664 (678)
                      .+.......        ......... .....++.++.+++.+|++.||++|||+.+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l  296 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL  296 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence            000000000        000000000 01123566789999999999999999999998

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4e-33  Score=291.96  Aligned_cols=266  Identities=22%  Similarity=0.300  Sum_probs=194.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecC------C
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE------E  461 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  461 (678)
                      .++|...+.||+|+||.||+|.. .+|+.||+|++....  ......+.+|+++++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            47899999999999999999985 478999999986432  22335678899999999999999999988654      3


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..++|+||+.. ++.++..   ..+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+|++|||++..
T Consensus        94 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            46899999964 7776653   24788999999999999999999   99999999999999999999999999999875


Q ss_pred             cCCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccc---
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK---  617 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---  617 (678)
                      ....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...... ..+....   
T Consensus       167 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~-~~~~~~-~~~~~~~~~~  239 (342)
T cd07879         167 ADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ-LTQILK-VTGVPGPEFV  239 (342)
T ss_pred             CCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-hcCCCCHHHH
Confidence            4221     123456888999998876 4588999999999999999999999975321110 110000 0000000   


Q ss_pred             ---------cccc-CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH--HHHHH
Q 005760          618 ---------EIVD-PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK--LLKIR  671 (678)
Q Consensus       618 ---------~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~--L~~~~  671 (678)
                               .... ........... .....+.++.+++.+||+.||++||++.|++..  ++.++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFST-LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHH-HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                     0000 00000000000 001245568899999999999999999999943  65554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.3e-33  Score=293.74  Aligned_cols=267  Identities=23%  Similarity=0.288  Sum_probs=194.8

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecC---------
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNE---------  460 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---------  460 (678)
                      .++|...+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|+++++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            46899999999999999999975 47899999998766555567788999999999999999999766443         


Q ss_pred             -----CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec-CCCcEEEE
Q 005760          461 -----EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLS  534 (678)
Q Consensus       461 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~-~~~~~kl~  534 (678)
                           ...++|+||++ ++|.+++...  .+++..+..++.||++|+.|||   +.+++||||||+||+++ .++.++++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999997 5898888654  3788999999999999999999   99999999999999997 55678999


Q ss_pred             eeccccccCCCCCc-ceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc
Q 005760          535 DFGIAKLLTREDQS-TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL  612 (678)
Q Consensus       535 Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  612 (678)
                      |||.+......... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. .........
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~  236 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVP  236 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence            99999765322111 11123457889999997654 4578899999999999999999999965332111 111110000


Q ss_pred             CCc---cccc-------cc-CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          613 PIS---TKEI-------VD-PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       613 ~~~---~~~~-------~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ...   ....       .. ........... .....+.++.+++.+||+.||++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            000   0000       00 00000000000 00124567889999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.7e-33  Score=283.24  Aligned_cols=251  Identities=23%  Similarity=0.333  Sum_probs=194.8

Q ss_pred             CCCCCccccCCCceeEEEEEe----CCCcEEEEEEeeccc----CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeE
Q 005760          393 GFSENNLIGRGSFGSVFKARL----GDGMEVAMKVFNLQY----GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  463 (678)
                      +|++.+.||+|+||.||.|..    .+|..||+|++....    ....+.+..|+++++.+ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999975    378999999986532    22346678899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++|+||+++++|.+++.... .+++..+..++.|+++|+.|||   +.+++||||+|+||+++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999997654 4788889999999999999999   9999999999999999999999999999987653


Q ss_pred             CCCCcceeecccCCccccCccccCCC--CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      .... .......++..|+|||.+...  .++.++||||||+++|+|++|..||...... .............      .
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~------~  228 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKS------E  228 (290)
T ss_pred             cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhcc------C
Confidence            3221 112234578899999988653  4678999999999999999999998642111 1111111110000      0


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                      +..          +..++..+.+++.+||+.||++||     ++.++++
T Consensus       229 ~~~----------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 PPY----------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CCC----------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            000          112345688999999999999997     6777665

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.8e-33  Score=289.31  Aligned_cols=266  Identities=26%  Similarity=0.335  Sum_probs=196.5

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeec-CCeEE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSN-EEFKA  464 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~  464 (678)
                      ..+++|++.+.||.|+||.||+|.. .+++.||+|++....  ....+.+..|+++++.++||||+++.+++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            3678899999999999999999974 489999999875432  2334677889999999999999999998865 56788


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +++||+ +++|.+++...  .++...+..++.|+++|++|||   +.+++||||+|.||+++.++.++++|||.+.....
T Consensus        87 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~  160 (328)
T cd07856          87 FVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDP  160 (328)
T ss_pred             EEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence            999998 56899888654  3678888899999999999999   99999999999999999999999999999875422


Q ss_pred             CCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccc--h--------hhhhhcccC
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT--L--------KHWVNDWLP  613 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~--~--------~~~~~~~~~  613 (678)
                      .     .....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.........  .        .++......
T Consensus       161 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         161 Q-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             C-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            1     123456788999998765 56899999999999999999999998653221000  0        000000000


Q ss_pred             CcccccccCccCCccchhhH-HHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          614 ISTKEIVDPNLLSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      ....+... ........... ....++.++.+++.+||+.+|++||++.|++..
T Consensus       236 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         236 ENTLRFVQ-SLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhhHHHHh-hccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000 00000000000 001245678999999999999999999999764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-33  Score=281.88  Aligned_cols=263  Identities=26%  Similarity=0.344  Sum_probs=198.5

Q ss_pred             CCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          394 FSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      |+..+.||+|++|.||+|... +++.+|+|++....  ....+.+..|+++++.++|+|++++++++.+.+..++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999999864 69999999987643  233466788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI  550 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  550 (678)
                      + ++|.+++......+++..+..++.|++.|++|||   +.+++||||+|+||++++++.++|+|||.+........  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 5999999876456899999999999999999999   89999999999999999999999999999876543221  2


Q ss_pred             eecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhh-----------cccCCcccc
Q 005760          551 QTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN-----------DWLPISTKE  618 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~-----------~~~~~~~~~  618 (678)
                      .....++..|+|||.+.+. .++.++||||+||++||+++|+.||......+. ......           .........
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-LFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHHHhCCCcHHHHHhhccccccc
Confidence            2234457789999988766 789999999999999999999999865322110 000000           000000000


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..-+...... ..... ...+.++.+++.+||+.||++||++.|++.
T Consensus       234 ~~~~~~~~~~-~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKD-LEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccc-hHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000000000 00000 122567999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-34  Score=309.64  Aligned_cols=257  Identities=25%  Similarity=0.331  Sum_probs=206.0

Q ss_pred             HHHHhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeec---ccCchhhhHHHHHHHHHhCCCccceeeeeeeecCC
Q 005760          386 ELCRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL---QYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE  461 (678)
Q Consensus       386 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  461 (678)
                      ++.-..++|.+.+.||+|+||.|..++.+ +++.+|+|++..   -......-|.+|-.+|..-+.+-|+.+...|++..
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~  148 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER  148 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence            44455789999999999999999999864 788999999865   23445577899999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ++|+||||++||||..++.+.. .+++..+..++..|+-||..+|   +.|+|||||||.|||+|..|++|++|||.|-.
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClk  224 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLK  224 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHh
Confidence            9999999999999999999888 6899999999999999999999   99999999999999999999999999999988


Q ss_pred             cCCCCCcceeecccCCccccCccccC----C-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGK----E-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST  616 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  616 (678)
                      +...+ .......+|||-|.+||++.    + +.|+..+|.||+||++|||+.|..||+...-.    ..|-+       
T Consensus       225 m~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv----eTY~K-------  292 (1317)
T KOG0612|consen  225 MDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV----ETYGK-------  292 (1317)
T ss_pred             cCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH----HHHHH-------
Confidence            76443 44556778999999999875    2 56899999999999999999999999863221    11111       


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCC---HHHHHH
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN---AKEIVT  665 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps---~~ell~  665 (678)
                        +++.    .....++.....++++.+||.+.+. +|+.|..   +.++..
T Consensus       293 --Im~h----k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  293 --IMNH----KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             --Hhch----hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence              1111    0011111112245667788887665 5677776   777653

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-34  Score=265.75  Aligned_cols=252  Identities=21%  Similarity=0.254  Sum_probs=196.7

Q ss_pred             hhcCCCCC-ccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeec----CCe
Q 005760          390 ATDGFSEN-NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSN----EEF  462 (678)
Q Consensus       390 ~~~~~~~~-~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~  462 (678)
                      .+++|++. ++||-|-.|.|-.... .+|+.+|+|++..     .....+|++..-.. .|||||.++++|..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45666654 5789999999998865 4899999999852     24446677765444 59999999998743    457


Q ss_pred             EEEEEEecCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec---CCCcEEEEeecc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGI  538 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~---~~~~~kl~Dfg~  538 (678)
                      +.+|||.++||.|.+.++.++. .+++.++..|++||+.|+.|||   +.+|.||||||+|+|..   .+..+|++|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            7899999999999999987654 6889999999999999999999   99999999999999996   566899999999


Q ss_pred             ccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc
Q 005760          539 AKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE  618 (678)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  618 (678)
                      |+.-..   ...-....-|+.|.|||++...+|+...|+||+||++|-|++|.+||+.......  ..-        +..
T Consensus       211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--spg--------Mk~  277 (400)
T KOG0604|consen  211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPG--------MKR  277 (400)
T ss_pred             ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--Chh--------HHh
Confidence            986432   2233456789999999999999999999999999999999999999987433211  000        000


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      -+   ..........++...+++..++++.+|+.+|++|.|+.|++.
T Consensus       278 rI---~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  278 RI---RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             Hh---hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            00   011111122344567888999999999999999999999875

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-33  Score=291.49  Aligned_cols=270  Identities=23%  Similarity=0.298  Sum_probs=198.0

Q ss_pred             HHHHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecC-
Q 005760          385 LELCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE-  460 (678)
Q Consensus       385 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-  460 (678)
                      .++...+++|.+.+.||+|+||.||+|.. .+++.||+|++....  ....+.+.+|++++++++||||+++++++... 
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            45666789999999999999999999974 578999999986432  22345677899999999999999999987532 


Q ss_pred             -----CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEe
Q 005760          461 -----EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD  535 (678)
Q Consensus       461 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~D  535 (678)
                           ...+++++++ +++|.+++...  .+++..+..++.|++.|++|||   +.+++||||+|+||++++++.+||+|
T Consensus        90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~d  163 (345)
T cd07877          90 SLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD  163 (345)
T ss_pred             cccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEEEec
Confidence                 3467888887 77998888654  3889999999999999999999   99999999999999999999999999


Q ss_pred             eccccccCCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcc--c
Q 005760          536 FGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW--L  612 (678)
Q Consensus       536 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~--~  612 (678)
                      ||++......     .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... .........  .
T Consensus       164 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~  237 (345)
T cd07877         164 FGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTP  237 (345)
T ss_pred             cccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            9998754321     223467889999998766 467889999999999999999999986432211 111111100  0


Q ss_pred             CCc-ccccccCc-------cCCccchhhHH-HHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          613 PIS-TKEIVDPN-------LLSREDINFVA-KEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       613 ~~~-~~~~~~~~-------~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      +.. ...+.+..       ........+.. ....+.++.+++.+|++.||.+||++.|++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            000 00000000       00000000000 01235668899999999999999999998853

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-33  Score=293.10  Aligned_cols=263  Identities=24%  Similarity=0.329  Sum_probs=196.4

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCe----
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF----  462 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  462 (678)
                      ..++|++.+.||+|++|.||+|... +++.||+|++....  ......+.+|+.+++.++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4678999999999999999999864 68899999986432  2234567789999999999999999988765544    


Q ss_pred             --EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          463 --KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       463 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                        .++|+||+ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||+|+||+++.++.++|+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence              89999999 66999998764  4899999999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccc
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI  619 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (678)
                      .....     .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ....... ..+.....+
T Consensus       167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~-~~~~~~~~~  239 (343)
T cd07851         167 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMN-LVGTPDEEL  239 (343)
T ss_pred             ccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH-hcCCCCHHH
Confidence            65322     223457888999998765 357889999999999999999999986532211 1111100 000000000


Q ss_pred             ccCc-----------cCCccchhhHH-HHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 VDPN-----------LLSREDINFVA-KEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ~~~~-----------~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ....           .......++.. ....+.++.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0000           00000000000 1124677999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.9e-33  Score=278.40  Aligned_cols=247  Identities=22%  Similarity=0.297  Sum_probs=192.3

Q ss_pred             CCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-----CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-----GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      +|.+.+.||+|+||.||+|... .+..+++|+++...     ......+..|+.+++.++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5788899999999999999754 34556666654311     12234566789999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          467 LEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      +||+++++|.+++..   ....+++..+..++.|++.|+.|||   +.+++|+|++|+||+++. +.++++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998864   2346889999999999999999999   999999999999999975 569999999987654


Q ss_pred             CCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ...  .......++..|+|||...+..++.++|+||+|+++|+|++|..||.......     ........     ..+.
T Consensus       157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-----~~~~~~~~-----~~~~  224 (260)
T cd08222         157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS-----VVLRIVEG-----PTPS  224 (260)
T ss_pred             CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHHHcC-----CCCC
Confidence            322  22234457889999999888888999999999999999999999986422111     10000000     0000


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                .+..++.++.+++.+||+.+|++||++.|+++
T Consensus       225 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         225 ----------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             ----------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                      01234567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-34  Score=278.58  Aligned_cols=256  Identities=26%  Similarity=0.424  Sum_probs=199.6

Q ss_pred             cCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccCc-------hhhhHHHHHHHHHhCCCccceeeeeeee-cCCe
Q 005760          392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR-------VFKSFDVECEMMKSIRHRNIIKVISSCS-NEEF  462 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~  462 (678)
                      ++|-+.++||+|||+.||+|. ..+.+.||+|+-.....+       -.+...+|.++.+.|.||.||++|++|. +.+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            457788899999999999996 567899999986544322       1244568999999999999999999984 5677


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee---cCCCcEEEEeeccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIA  539 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill---~~~~~~kl~Dfg~~  539 (678)
                      +|-|+|||+|.+|.-+++..+. +++..+..|+.||+.||.||.+ .+.+|+|-|+||.|||+   +.-|.+||+|||++
T Consensus       543 FCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            8899999999999999987764 8888999999999999999994 47889999999999999   36689999999999


Q ss_pred             cccCCCCCc-----ceeecccCCccccCccccCCC----CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhc
Q 005760          540 KLLTREDQS-----TIQTQTLATIGYMAPEYGKEG----RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND  610 (678)
Q Consensus       540 ~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~  610 (678)
                      +++......     ...+...||.+|++||.+.-+    +++.|+||||+||++|+++.|+.||......    ......
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ----QdILqe  696 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ----QDILQE  696 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH----HHHHhh
Confidence            988754332     234567899999999976433    4688999999999999999999999752221    111110


Q ss_pred             ccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 005760          611 WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV  664 (678)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell  664 (678)
                      .           ..+......++.+...+.++.++|++|+++--++|..+.++.
T Consensus       697 N-----------TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  697 N-----------TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             h-----------chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            0           011111122333334566788999999999999999888875

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-33  Score=239.99  Aligned_cols=263  Identities=25%  Similarity=0.320  Sum_probs=201.8

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +|...++||+|.||+||+|+. .+++-||+|.++.+.  ........+|+-+++.++|+|||++++....+..+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            466678999999999999985 468889999987653  33456778999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      |.. +|..+...-...++.+.+..++.|+++|+.++|   ++++.|||+||.|.+++.+|+.|+.|||+++-++-.  ..
T Consensus        83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip--vr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VR  156 (292)
T ss_pred             hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eE
Confidence            955 999999887778999999999999999999999   999999999999999999999999999999876422  22


Q ss_pred             eeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhh--------cccCCccccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVN--------DWLPISTKEI  619 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~  619 (678)
                      -.+..+.|.+|.+|.++.+.+ |+...|+||.||++.|+.. |.+-|++..-.+ .+.....        .|+  .+..+
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd-qlkrif~~lg~p~ed~wp--s~t~l  233 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEDQWP--SMTKL  233 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH-HHHHHHHHhCCCccccCC--ccccC
Confidence            345667899999999988876 8899999999999999998 555565432221 1222111        111  12233


Q ss_pred             ccCccCCccchhhHHHH----HHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 VDPNLLSREDINFVAKE----QCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~----~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .|........... ...    .....=.+++...+.-+|.+|.+++++++
T Consensus       234 pdyk~yp~ypatt-swsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  234 PDYKPYPIYPATT-SWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCcccCCccccc-hHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            3333222211110 111    12222457888899999999999998875

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.1e-32  Score=285.38  Aligned_cols=267  Identities=23%  Similarity=0.262  Sum_probs=191.2

Q ss_pred             CCCCCccccCCCceeEEEEEeC-C--CcEEEEEEeeccc--CchhhhHHHHHHHHHhC-CCccceeeeeeeec----CCe
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-D--GMEVAMKVFNLQY--GRVFKSFDVECEMMKSI-RHRNIIKVISSCSN----EEF  462 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~  462 (678)
                      +|++.+.||+|+||.||+|... +  +..||+|++....  ....+.+.+|+++++.+ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999854 4  7889999986432  22345678899999999 59999999986532    245


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .++++||+. ++|.+++.... .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            788999885 58999886554 4889999999999999999999   999999999999999999999999999999765


Q ss_pred             CCCCCc--ceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc--C-Ccc
Q 005760          543 TREDQS--TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL--P-IST  616 (678)
Q Consensus       543 ~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--~-~~~  616 (678)
                      ......  .......++..|+|||...+ ..++.++||||+||++|+|++|+.||...... ......+....  + ...
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEETL  234 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            432211  11233568899999998765 46889999999999999999999998652211 00000000000  0 000


Q ss_pred             cccccCc-------cCCccchhhH-HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          617 KEIVDPN-------LLSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       617 ~~~~~~~-------~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..+.++.       ........+. ....++..+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000       0000000000 00123566889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-32  Score=269.99  Aligned_cols=236  Identities=29%  Similarity=0.335  Sum_probs=191.2

Q ss_pred             ccCCCceeEEEEEeC-CCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCH
Q 005760          400 IGRGSFGSVFKARLG-DGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL  475 (678)
Q Consensus       400 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  475 (678)
                      ||+|+||.||++... +++.+|+|++.....   .....+..|+++++.++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999864 689999999865422   2345788899999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeeccc
Q 005760          476 EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL  555 (678)
Q Consensus       476 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  555 (678)
                      .+++.... .+++..+..++.|++.|+.|+|   +.+++|+||+|+||+++.++.++++|||++.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99998765 4889999999999999999999   8999999999999999999999999999987654321  1234456


Q ss_pred             CCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHH
Q 005760          556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK  635 (678)
Q Consensus       556 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  635 (678)
                      ++..|+|||...+...+.++|+||||+++|++++|+.||.....  ......+..      .....             +
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~------~~~~~-------------~  213 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKILK------DPLRF-------------P  213 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHhc------CCCCC-------------C
Confidence            78899999999888889999999999999999999999865332  111111100      00000             0


Q ss_pred             HHHHHHHHHHHhhccccCcCCCCCHHH
Q 005760          636 EQCVSFVFNVAMECTVESPEQRINAKE  662 (678)
Q Consensus       636 ~~~~~~l~~l~~~cl~~dP~~Rps~~e  662 (678)
                      ...+.++.+++.+||..||++||++.+
T Consensus       214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         214 EFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            112455789999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=291.59  Aligned_cols=298  Identities=22%  Similarity=0.268  Sum_probs=172.1

Q ss_pred             cccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECc
Q 005760            3 QMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFS   82 (678)
Q Consensus         3 ~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~   82 (678)
                      +|.+|.++ .+|.......+|+.|+|.+|.|+.+..+++..++.|+.||||.|.|+.++..     .|..-.++++|+|+
T Consensus       108 ~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~-----sfp~~~ni~~L~La  181 (873)
T KOG4194|consen  108 NLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKP-----SFPAKVNIKKLNLA  181 (873)
T ss_pred             eeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCC-----CCCCCCCceEEeec
Confidence            34444444 5554444444455555555555555455555555555555555555554432     24444445555555


Q ss_pred             cCCCcccCChhhhhcccccccEEEcccccccccCCccc------------------------cCCCCCcEEEccCCccCC
Q 005760           83 NNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI------------------------GNLTNLTIIYLGGNKLNG  138 (678)
Q Consensus        83 ~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~------------------------~~l~~L~~L~l~~N~l~~  138 (678)
                      +|.|+.+.... |..+. +|.+|-|+.|+++...+..|                        .+|++|+.|.|..|.+..
T Consensus       182 ~N~It~l~~~~-F~~ln-sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~k  259 (873)
T KOG4194|consen  182 SNRITTLETGH-FDSLN-SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISK  259 (873)
T ss_pred             ccccccccccc-ccccc-hheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccc
Confidence            55554333332 44444 44445555555544444444                        444455555555555544


Q ss_pred             cCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-cccc
Q 005760          139 SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWN  217 (678)
Q Consensus       139 ~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~  217 (678)
                      ...++|..+.++++|+|..|++...-..++.+++.|+.|+|++|.|..+-+++++.+++|+.|+|++|+|+++++ .|..
T Consensus       260 L~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~  339 (873)
T KOG4194|consen  260 LDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRV  339 (873)
T ss_pred             ccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHH
Confidence            445555566666666666666665555566666666666666666666666666666666666666666666655 5666


Q ss_pred             cccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcch---HHHhcccCCCceecccccccccCC
Q 005760          218 LKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP---ASLEKLSYLKDLNLSFNKLEGEIP  294 (678)
Q Consensus       218 l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l~~N~~~~~~~  294 (678)
                      +..|++|+|++|.+..+....|.+++          +|++|||++|.|+..+.   .+|.+|++|..|.+.||++.....
T Consensus       340 L~~Le~LnLs~Nsi~~l~e~af~~ls----------sL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~k  409 (873)
T KOG4194|consen  340 LSQLEELNLSHNSIDHLAEGAFVGLS----------SLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPK  409 (873)
T ss_pred             HHHhhhhcccccchHHHHhhHHHHhh----------hhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecch
Confidence            66666666666666665556666665          77777777777665443   456667777777777777765443


Q ss_pred             C-CCccccccccccccCccccCCCC
Q 005760          295 R-GGSFGNFSAESFEGNELLCGSPN  318 (678)
Q Consensus       295 ~-~~~~~~l~~~~~~~n~~~c~~~~  318 (678)
                      . +..++.|..+++.+|+...-.++
T Consensus       410 rAfsgl~~LE~LdL~~NaiaSIq~n  434 (873)
T KOG4194|consen  410 RAFSGLEALEHLDLGDNAIASIQPN  434 (873)
T ss_pred             hhhccCcccceecCCCCcceeeccc
Confidence            3 35566777777777776655543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=285.11  Aligned_cols=239  Identities=24%  Similarity=0.309  Sum_probs=193.9

Q ss_pred             hcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ++.|.....+|.|+|+.|-.+. ..+++..++|++....    .+-.+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            5678888889999999998886 4578899999997542    3334566665554 69999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee-cCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL-DDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill-~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      .+.++-+.+.+...+. .. ..+..|+.+|+.++.|||   .+|+||||+||+|||+ ++.++++|+|||.+....+.  
T Consensus       397 ~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--  469 (612)
T ss_pred             hccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence            9999988888876654 22 677789999999999999   9999999999999999 69999999999999876433  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                         .....-|..|.|||++....|++++|+||||++||+|++|+.||.....+ ..+...+.           .+.    
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~-----------~~~----  530 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQ-----------MPK----  530 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhc-----------CCc----
Confidence               23446788999999999999999999999999999999999999764443 11111110           000    


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                            .....+.++.+|+.+||+.||.+||++.|+..
T Consensus       531 ------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  531 ------FSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ------cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                  00345667899999999999999999999864

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.7e-32  Score=288.66  Aligned_cols=258  Identities=24%  Similarity=0.330  Sum_probs=210.0

Q ss_pred             HHHHHHhhcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeee---
Q 005760          384 YLELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCS---  458 (678)
Q Consensus       384 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~---  458 (678)
                      +..+...++.|++.+.||.|.+|.||+++ .++++.+|+|+...... ..+++..|+++++.. .|||++.++|++.   
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            44455677889999999999999999997 45899999999865533 346778899999987 5999999999873   


Q ss_pred             --cCCeEEEEEEecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEe
Q 005760          459 --NEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD  535 (678)
Q Consensus       459 --~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~D  535 (678)
                        .++.+++|||||.+|+..|+++.- +..+.+..+..|.+.++.|+.+||   ...++|||||-.||+++.++.||++|
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEee
Confidence              367999999999999999999754 346889999999999999999999   99999999999999999999999999


Q ss_pred             eccccccCCCCCcceeecccCCccccCccccCCC-----CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhc
Q 005760          536 FGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-----RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND  610 (678)
Q Consensus       536 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~  610 (678)
                      ||.+..++.  +-.......||+.|||||++.-.     .|+.++|+||+|++..||--|.+|+.++.+....+.     
T Consensus       167 FGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~-----  239 (953)
T KOG0587|consen  167 FGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL-----  239 (953)
T ss_pred             eeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc-----
Confidence            999987653  33345667899999999987643     367789999999999999999999876544322111     


Q ss_pred             ccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          611 WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               +.    ...+..+..++.-..++.++|..|+.+|-++||++.++++
T Consensus       240 ---------Ip----RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  240 ---------IP----RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ---------CC----CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                     00    1111223334456777999999999999999999999875

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=1e-31  Score=302.83  Aligned_cols=146  Identities=29%  Similarity=0.438  Sum_probs=131.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....   ......+..|+.+++.++||||+++++++...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            367899999999999999999865 78999999986532   22346678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      |||+.+++|.+++.... .+++..++.++.||+.||+|||   .++|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999997654 4788889999999999999999   8999999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.6e-33  Score=269.06  Aligned_cols=243  Identities=21%  Similarity=0.268  Sum_probs=194.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  464 (678)
                      ...+|..+..||+|+||.|-+|..+ +.+.+|||+++.+.   ....+--+.|-+++... +-|.++++..+|+..+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3457888999999999999999744 66789999987542   12223345577777755 5789999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+.||+|--.++..+. +.+..++.++.+||-||-+||   ++||+.||+|..|||+|.+|++||+|||+++.---
T Consensus       427 FVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             eEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            99999999999888887664 677788899999999999999   99999999999999999999999999999975332


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      .+  .......||+.|+|||++....|+..+|.||+||+||||+.|++||++.++.+.-  +.+           .+...
T Consensus       503 ~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF--~aI-----------~ehnv  567 (683)
T KOG0696|consen  503 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF--QAI-----------MEHNV  567 (683)
T ss_pred             CC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHH-----------HHccC
Confidence            22  2234578999999999999999999999999999999999999999885544321  111           11110


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCC
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN  659 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  659 (678)
                      .        -+...+.++.++.+..+.+.|.+|..
T Consensus       568 s--------yPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  568 S--------YPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             c--------CcccccHHHHHHHHHHhhcCCccccC
Confidence            0        11234556788999999999999973

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1e-31  Score=266.09  Aligned_cols=220  Identities=20%  Similarity=0.160  Sum_probs=175.4

Q ss_pred             CCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCHHHHhhh
Q 005760          403 GSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS  481 (678)
Q Consensus       403 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  481 (678)
                      |.+|.||++.. .+++.+|+|.+....     .+..|...+....|||++++++++.+.+..++||||+++++|.+++.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999975 578999999986532     233455555556799999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCcccc
Q 005760          482 SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM  561 (678)
Q Consensus       482 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~  561 (678)
                      .. .+++..+..++.|+++|++|||   +++++||||||+||+++.++.++++|||.+......     .....++..|+
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~  149 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC  149 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence            54 4889999999999999999999   999999999999999999999999999987654322     12234567799


Q ss_pred             CccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHH
Q 005760          562 APEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSF  641 (678)
Q Consensus       562 aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  641 (678)
                      |||...+..++.++||||+|+++|||++|..|+.......       ..     ...+.             .+..+++.
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------~~-----~~~~~-------------~~~~~~~~  204 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------NT-----HTTLN-------------IPEWVSEE  204 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------cc-----ccccC-------------CcccCCHH
Confidence            9999988889999999999999999999998864311100       00     00000             01123456


Q ss_pred             HHHHHhhccccCcCCCCCHH
Q 005760          642 VFNVAMECTVESPEQRINAK  661 (678)
Q Consensus       642 l~~l~~~cl~~dP~~Rps~~  661 (678)
                      +.+++.+|++.||++||++.
T Consensus       205 ~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHHHccCCHHHhcCCC
Confidence            88999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=8.7e-34  Score=261.54  Aligned_cols=250  Identities=28%  Similarity=0.285  Sum_probs=190.6

Q ss_pred             CccccCCCceeEEEEEe-CCCcEEEEEEeecccC-chhhhHHHHHHH-HHhCCCccceeeeeeeecCCeEEEEEEecCCC
Q 005760          397 NNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-RVFKSFDVECEM-MKSIRHRNIIKVISSCSNEEFKALVLEYMPHG  473 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  473 (678)
                      ...||.|+||+|++-.. +.|+..|||+++.... ....++..|.+. +++-++||||++||.+-.++..++.||.|+- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            56799999999999875 4799999999976543 455677777775 4455799999999998888889999999943 


Q ss_pred             CHHHHhh---h-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          474 SLEKYLH---S-SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       474 ~L~~~l~---~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      ++..+-.   . ....+++...-.|..-.+.||.||-+  ...|+|||+||+|||++..|.||+||||.+-.+..   +.
T Consensus       148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---Si  222 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SI  222 (361)
T ss_pred             hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH---HH
Confidence            6654432   1 22357888888888889999999996  78899999999999999999999999999865532   33


Q ss_pred             eeecccCCccccCccccCCC--CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          550 IQTQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      ..+...|-..|||||.+...  .|+.+|||||+|++|||+.||..|+..+...-..+.+.+...+|.         +...
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~---------l~~~  293 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI---------LLFD  293 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe---------ecCc
Confidence            34556788899999987643  489999999999999999999999877554333333333222211         1111


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      ..     -...+..+..++..|+.+|-..||+..+++++
T Consensus       294 ~~-----~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  294 KE-----CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cc-----ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            00     01234558899999999999999999998763

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.7e-32  Score=255.88  Aligned_cols=249  Identities=23%  Similarity=0.295  Sum_probs=199.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc---cCchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  464 (678)
                      .-++|+..+.||.|+|+.|-+++. ++.+-+|+|+++..   ..+..+-.+.|..+.... +||.+|.+..+|+.+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            346899999999999999999985 57888999998754   334455667788887766 6999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +|.||++||+|--++++++. ++++++..+..+|.-||.|||   ++||+.||+|..||++|..|++|++|+|+++.--.
T Consensus       328 fvieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence            99999999999888877764 899999999999999999999   99999999999999999999999999999975432


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCc--ccCCccchhhhhhcccCCcccccccC
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDE--IFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                        .....+..+||+.|.|||++.+..|...+|.|++||+++||+.|+.||+.  +.+.++.-..+.-...-+  .++--|
T Consensus       404 --~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile--kqirip  479 (593)
T KOG0695|consen  404 --PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE--KQIRIP  479 (593)
T ss_pred             --CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--hccccc
Confidence              23344678899999999999999999999999999999999999999974  233333323322111100  011111


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCC
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN  659 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  659 (678)
                      .             ..+..+..+++..+++||.+|..
T Consensus       480 r-------------slsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  480 R-------------SLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             c-------------eeehhhHHHHHHhhcCCcHHhcC
Confidence            1             12333567889999999999863

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-32  Score=273.21  Aligned_cols=242  Identities=21%  Similarity=0.372  Sum_probs=194.8

Q ss_pred             CccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCC
Q 005760          397 NNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG  473 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~  473 (678)
                      .+.||+|.||+||-|.. ++|+.||||++.+..  ....+.+..|+.+++.++||.||.+-.-|+.++..++|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            47899999999999974 589999999996532  23347788999999999999999999999999999999999955 


Q ss_pred             CHHHHh-hhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec---CCCcEEEEeeccccccCCCCCcc
Q 005760          474 SLEKYL-HSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       474 ~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~---~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +..+++ ......+++.....+..||+.||.|||   -++|+|+|+||+|||+.   .-.++||||||+|+..+..   .
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---s  721 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---S  721 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchh---h
Confidence            665555 455567999999999999999999999   99999999999999995   3458999999999987532   3


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      .....+||+.|+|||++..+.|...-|+||.||++|--++|..||..    ++++.+.++.     ...+..|.      
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE----dEdIndQIQN-----AaFMyPp~------  786 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE----DEDINDQIQN-----AAFMYPPN------  786 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC----ccchhHHhhc-----cccccCCC------
Confidence            34567899999999999999999999999999999999999999864    2222222110     00001111      


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV  664 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell  664 (678)
                          .+.+.++++.++|...++..=.+|-|+.+.+
T Consensus       787 ----PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  787 ----PWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             ----chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence                1234566788999999999999999987654

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-33  Score=277.81  Aligned_cols=243  Identities=21%  Similarity=0.276  Sum_probs=199.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCc-EEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGM-EVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~-~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      -.++..+..||-||||.|=++..+... .+|+|+++..   .....+.+..|-.+|...+.|.||++|-.|.+....|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            345666788999999999999865433 3788887542   334557788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      ||-|-||.++..++..+. ++..+...++..+++|++|||   +++||.||+||+|.++|.+|-+|+.|||+|+..+...
T Consensus       499 mEaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             HHhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            999999999999987765 888888999999999999999   9999999999999999999999999999999886443


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                         .....+||+.|.|||++.....+.++|.||+|+++||+++|.+||.+..+..... ...+..     ..+       
T Consensus       575 ---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn-~ILkGi-----d~i-------  638 (732)
T KOG0614|consen  575 ---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN-LILKGI-----DKI-------  638 (732)
T ss_pred             ---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH-HHHhhh-----hhh-------
Confidence               3345789999999999999999999999999999999999999998755432211 111110     001       


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCC
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRIN  659 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  659 (678)
                            ..|........+++++.+..+|.+|..
T Consensus       639 ------~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  639 ------EFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ------hcccccchhHHHHHHHHHhcCcHhhhc
Confidence                  111234455778999999999999985

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-32  Score=262.29  Aligned_cols=265  Identities=22%  Similarity=0.312  Sum_probs=197.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCC--Ccc----ceeeeeeeecCCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR--HRN----IIKVISSCSNEEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~n----iv~~~~~~~~~~~~  463 (678)
                      +++|.+...+|+|.||.|-..-. ..+..||||+++.- ....++...|+++++++.  .|+    +|.+.++|.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            68899999999999999999853 45899999998643 234566778999999983  233    77888899999999


Q ss_pred             EEEEEecCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC---------------
Q 005760          464 ALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---------------  527 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~---------------  527 (678)
                      ++|+|.+ |.++.+++..+.. +++..++..|+.|+++++++||   +.+++|-|+||+||++-+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999988 6699999987543 7899999999999999999999   999999999999999831               


Q ss_pred             -----CCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCcc
Q 005760          528 -----NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM  602 (678)
Q Consensus       528 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~  602 (678)
                           +..++++|||.|+.-...     .+..+.|..|.|||++.+-.++.++||||+||+|+|+.+|..-|+...+.+-
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             eccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                 346899999999764322     2456789999999999999999999999999999999999998876442210


Q ss_pred             -chhhhhhcccCCcc-ccc----------cc-CccCC----------ccchhh--HHHHHHHHHHHHHHhhccccCcCCC
Q 005760          603 -TLKHWVNDWLPIST-KEI----------VD-PNLLS----------REDINF--VAKEQCVSFVFNVAMECTVESPEQR  657 (678)
Q Consensus       603 -~~~~~~~~~~~~~~-~~~----------~~-~~~~~----------~~~~~~--~~~~~~~~~l~~l~~~cl~~dP~~R  657 (678)
                       ..-+.+-+-.|..+ ...          +| ++...          ......  ........++++|+.+|+.+||.+|
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R  397 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR  397 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence             00011100000000 000          00 00000          000110  1112345669999999999999999


Q ss_pred             CCHHHHHH
Q 005760          658 INAKEIVT  665 (678)
Q Consensus       658 ps~~ell~  665 (678)
                      +|+.|++.
T Consensus       398 iTl~EAL~  405 (415)
T KOG0671|consen  398 ITLREALS  405 (415)
T ss_pred             ccHHHHhc
Confidence            99999975

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=2.3e-30  Score=257.09  Aligned_cols=238  Identities=31%  Similarity=0.380  Sum_probs=192.7

Q ss_pred             CceeEEEEEeC-CCcEEEEEEeecccCch-hhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCHHHHhhh
Q 005760          404 SFGSVFKARLG-DGMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS  481 (678)
Q Consensus       404 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  481 (678)
                      +||.||+|... +++.+|+|++....... .+.+.+|++.++.++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999865 58999999997654433 67889999999999999999999999998999999999999999999976


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCcccc
Q 005760          482 SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM  561 (678)
Q Consensus       482 ~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~  561 (678)
                      ... +++..+..++.+++.++.+||   +.+++|+||+|.||+++.++.++++|||.+.......   ......++..|+
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            654 788999999999999999999   8999999999999999999999999999998764332   233456788999


Q ss_pred             CccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHH
Q 005760          562 APEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSF  641 (678)
Q Consensus       562 aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  641 (678)
                      +||...+..++.++||||+|+++|++++|..||....... ...+.......    ....            ....++.+
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~~~~~----~~~~------------~~~~~~~~  216 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIGKPKP----PFPP------------PEWKISPE  216 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHhccCC----CCcc------------ccccCCHH
Confidence            9999988888999999999999999999999986532211 11111110000    0000            00004456


Q ss_pred             HHHHHhhccccCcCCCCCHHHHHH
Q 005760          642 VFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       642 l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      +.+++.+|+..+|++||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.1e-30  Score=286.96  Aligned_cols=258  Identities=22%  Similarity=0.260  Sum_probs=168.8

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-C----CcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeee------ee
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-D----GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS------CS  458 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~~  458 (678)
                      ..++|.+.+.||+|+||.||+|... +    +..||+|++.....  .+....|  .++...+.++..+...      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999999864 5    78999998753221  1111111  1122222233222221      24


Q ss_pred             cCCeEEEEEEecCCCCHHHHhhhCCCC-------------------CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCC
Q 005760          459 NEEFKALVLEYMPHGSLEKYLHSSNYI-------------------LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK  519 (678)
Q Consensus       459 ~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~  519 (678)
                      .....++|+||+++++|.+++......                   .....+..++.|++.||+|||   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            566789999999999999998754321                   112345679999999999999   9999999999


Q ss_pred             CCCeeecC-CCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCC----------------------CCCccch
Q 005760          520 PSNVLLDD-NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG----------------------RVSANGD  576 (678)
Q Consensus       520 ~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~D  576 (678)
                      |+|||++. ++.+||+|||+++..... .........+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 689999999999765322 22233456789999999954322                      2345679


Q ss_pred             HHHHHHHHHHHHcCCCCCCcccC--------CccchhhhhhcccCCcccccccCccCCccchh-hHHHHHHHHHHHHHHh
Q 005760          577 VYSFGIMLMETFTRKKPTDEIFN--------GEMTLKHWVNDWLPISTKEIVDPNLLSREDIN-FVAKEQCVSFVFNVAM  647 (678)
Q Consensus       577 vwslGv~l~ell~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~  647 (678)
                      |||+||++|||+++..|++....        .......|...         ..+. ....... +...........+|+.
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~---------~~~~-~~~~~~~~~~~~d~~~~~~~dLi~  431 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL---------VEPR-ASPDLRRGFEVLDLDGGAGWELLK  431 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh---------hccc-cchhhhhhhhhccccchHHHHHHH
Confidence            99999999999997766543110        01111112111         1110 0000000 0000011233568999


Q ss_pred             hccccCcCCCCCHHHHHH
Q 005760          648 ECTVESPEQRINAKEIVT  665 (678)
Q Consensus       648 ~cl~~dP~~Rps~~ell~  665 (678)
                      +|+++||++|||+.|+++
T Consensus       432 ~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        432 SMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHccCCcccCCCHHHHhC
Confidence            999999999999999986

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.7e-31  Score=268.27  Aligned_cols=206  Identities=23%  Similarity=0.359  Sum_probs=175.2

Q ss_pred             CCCCCccccCCCceeEEEEE-eCCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      -|..++.||-|+||.|.+++ .++...+|+|.+++.+   ......++.|-.||...+.+-||++|..|++++.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            47778899999999999996 5566779999986542   2344667789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC--CC-
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT--RE-  545 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~--~~-  545 (678)
                      |++||++-.++-+.+ .+++.-+..++.++.-|+++.|   +.|+|||||||.|||||.+|++||+|||+|+-+.  .. 
T Consensus       710 YIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             ccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            999999999987665 4788888889999999999999   9999999999999999999999999999996331  00 


Q ss_pred             -----CCc--------------------------------ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHH
Q 005760          546 -----DQS--------------------------------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETF  588 (678)
Q Consensus       546 -----~~~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell  588 (678)
                           +..                                ......+||+.|+|||++....|+..+|.||.||+||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                 000                                0112346999999999999999999999999999999999


Q ss_pred             cCCCCCCcccCCcc
Q 005760          589 TRKKPTDEIFNGEM  602 (678)
Q Consensus       589 ~g~~p~~~~~~~~~  602 (678)
                      .|+.||.+..+++.
T Consensus       866 ~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  866 VGQPPFLADTPGET  879 (1034)
T ss_pred             hCCCCccCCCCCcc
Confidence            99999987666654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=3.8e-30  Score=275.13  Aligned_cols=261  Identities=20%  Similarity=0.266  Sum_probs=179.5

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-----------------CCCcEEEEEEeecccCchh--------------hhHHHH
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-----------------GDGMEVAMKVFNLQYGRVF--------------KSFDVE  438 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~--------------~~~~~e  438 (678)
                      ..++|++.++||+|+||.||+|..                 ..++.||||.+........              +....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999953                 2456899999865432222              223346


Q ss_pred             HHHHHhCCCccc-----eeeeeeeec--------CCeEEEEEEecCCCCHHHHhhhCCC---------------------
Q 005760          439 CEMMKSIRHRNI-----IKVISSCSN--------EEFKALVLEYMPHGSLEKYLHSSNY---------------------  484 (678)
Q Consensus       439 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~---------------------  484 (678)
                      +.++..++|.++     ++++++|..        .+..++||||+++++|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     667776643        3567999999999999999874311                     


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccC
Q 005760          485 --ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA  562 (678)
Q Consensus       485 --~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  562 (678)
                        ..++..+..++.|++.|+.|+|   +.+|+||||||+||+++.++.+||+|||++....... ........+++.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence              2356678889999999999999   8999999999999999999999999999997553221 111122345789999


Q ss_pred             ccccCCCCC----------------------CccchHHHHHHHHHHHHcCCC-CCCcccCCccchhhh---hhcccCCcc
Q 005760          563 PEYGKEGRV----------------------SANGDVYSFGIMLMETFTRKK-PTDEIFNGEMTLKHW---VNDWLPIST  616 (678)
Q Consensus       563 PE~~~~~~~----------------------~~~~DvwslGv~l~ell~g~~-p~~~~~~~~~~~~~~---~~~~~~~~~  616 (678)
                      ||.+.....                      ..+.||||+||++|||++|.. |+............+   ...|.... 
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~-  457 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK-  457 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc-
Confidence            998654321                      234699999999999999875 664321111111110   00010000 


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCc---CCCCCHHHHHH
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESP---EQRINAKEIVT  665 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~Rps~~ell~  665 (678)
                                ....++......++...+++.+|+..+|   .+|+|++|+++
T Consensus       458 ----------~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        458 ----------GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             ----------ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence                      0000111112245668899999999866   68999999985

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-31  Score=280.57  Aligned_cols=243  Identities=26%  Similarity=0.425  Sum_probs=187.9

Q ss_pred             CCCCccccCCCcee-EEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEEEecC
Q 005760          394 FSENNLIGRGSFGS-VFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       394 ~~~~~~ig~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      |.-.+.+|.|+.|+ ||+|.. +|++||||++-..   ......+|++.++.- +|||||++++.-.++...|++.|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            44456789999876 599998 6889999998532   234557899999977 59999999999999999999999996


Q ss_pred             CCCHHHHhhhCCC---CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-----CCcEEEEeeccccccC
Q 005760          472 HGSLEKYLHSSNY---ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLLT  543 (678)
Q Consensus       472 ~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-----~~~~kl~Dfg~~~~~~  543 (678)
                      . +|.+++.....   .......+....|+++|+++||   +.+|||||+||.||||+.     ...++|+|||+++.+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            6 99999987421   1111344678899999999999   999999999999999974     3578999999999886


Q ss_pred             CCCCcc-eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          544 REDQST-IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       544 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      ...... ......||.+|+|||.+....-+.++||||+||++|+.++ |.+||.+....+..+..   .           
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~---~-----------  728 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT---G-----------  728 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc---C-----------
Confidence            543322 3456789999999999999888889999999999999999 58999764433221111   0           


Q ss_pred             CccCCccchhhHHH-HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 PNLLSREDINFVAK-EQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 ~~~~~~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           ........+ .++  ++.+||.+|+.++|..||+|.+|+.
T Consensus       729 -----~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  729 -----NYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             -----ccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence                 000000000 112  6889999999999999999999974

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=3.7e-30  Score=232.48  Aligned_cols=262  Identities=21%  Similarity=0.332  Sum_probs=193.5

Q ss_pred             hhcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-CccceeeeeeeecC--CeEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSCSNE--EFKAL  465 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~l  465 (678)
                      ..++|++.+++|.|.++.||.|. ..+.+.++||++++-   ..+.+.+|+.+++.++ ||||+++++...++  ..+.+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            34679999999999999999997 567889999999753   3477889999999997 99999999998664  46779


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-CCcEEEEeeccccccCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-~~~~kl~Dfg~~~~~~~  544 (678)
                      ++||+++.+...+-.    .++...+..++.+++.||.|+|   ++||+|||+||.|+++|. .-..+++|+|+|..+.+
T Consensus       113 iFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             HhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            999999977766553    2677788899999999999999   999999999999999984 56799999999988764


Q ss_pred             CCCcceeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCc-ccCCc-----------cchhhhhhcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDE-IFNGE-----------MTLKHWVNDW  611 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~g~~p~~~-~~~~~-----------~~~~~~~~~~  611 (678)
                      ....   .-.+.+..|--||.+...+ |+..-|+|||||++..|+-.+.||-. ..+.+           ..+..++..+
T Consensus       186 ~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  186 GKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             Ccee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            4332   3345677899999877654 78889999999999999999999732 21111           1111111111


Q ss_pred             c---CCcccccccCccCCccchhhHH---HHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          612 L---PISTKEIVDPNLLSREDINFVA---KEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       612 ~---~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .   +.....++..-... .-..+..   ..-.++++.+++...+.+|-.+|+||+|++.
T Consensus       263 ~i~Ldp~~~~i~~~~~rk-~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRK-PWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ccCCChhHhhHhhccccc-cHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            0   00111111000000 0000000   1123577899999999999999999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=5.5e-30  Score=227.99  Aligned_cols=215  Identities=26%  Similarity=0.335  Sum_probs=170.7

Q ss_pred             HhhcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeeccc-CchhhhHHHHHHHHH-hCCCccceeeeeeeecCCeEEE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY-GRVFKSFDVECEMMK-SIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ...+....+..||+|++|.|-+.+ ..+|+..|+|.++..- .+..++...|+.+.. ...+|++|.++|........++
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            344455556789999999998886 4589999999986542 344566677777654 4579999999999888888999


Q ss_pred             EEEecCCCCHHHHhh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          466 VLEYMPHGSLEKYLH---SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       466 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .||.|.. +|..+-+   ..+...++..+-+|+..+.+||.|||+  +..++|||+||+|||++.+|+||+||||.+-.+
T Consensus       123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L  199 (282)
T KOG0984|consen  123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYL  199 (282)
T ss_pred             eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence            9999954 7765543   344568888899999999999999996  789999999999999999999999999998766


Q ss_pred             CCCCCcceeecccCCccccCccccCC----CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhh
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKE----GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN  609 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~  609 (678)
                      .++-   ..+-..|-..|||||.+..    ..|+.++||||+|+.+.||.+++.||+.+...-..+.+.+.
T Consensus       200 ~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  200 VDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            4332   2233457778999998653    36899999999999999999999999887665555555443

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-31  Score=247.32  Aligned_cols=262  Identities=23%  Similarity=0.348  Sum_probs=190.6

Q ss_pred             CCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecC-----CeEEEE
Q 005760          395 SENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNE-----EFKALV  466 (678)
Q Consensus       395 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~lv  466 (678)
                      +-.+.||.|+||.||.+++ ++|+.||+|++..-..  ...+.+.+|+.++..++|.|++..++..+-.     ..+|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3458999999999999975 5899999999854322  2457788999999999999999888766433     246788


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      +|.+ ..+|...+-... .++...+.-+..||++||.|||   +.+|.||||||.|.+++++...||||||+++..... 
T Consensus       136 TELm-QSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d-  209 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR-  209 (449)
T ss_pred             HHHH-HhhhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchh-
Confidence            8888 458887775443 5888888889999999999999   999999999999999999999999999999876433 


Q ss_pred             CcceeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc-------
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE-------  618 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  618 (678)
                      .....+..+.|..|.|||++++.+ |+.+.||||.||++.|++.++.-|....+  ....+.+.+....+..+       
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P--iqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP--IEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh--HHHHHHHHHHhCCCcHHHHHHHhh
Confidence            333456677899999999998864 89999999999999999988877754221  11111111111111000       


Q ss_pred             -----ccc-----CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          619 -----IVD-----PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       619 -----~~~-----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                           +..     |+....  +....+.....+...+...++..||++|.+..+.+..
T Consensus       288 GAk~H~LR~~~k~Ps~~vL--YtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRL--YKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             hhHHHhhccCCCCCCccce--eeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence                 000     110000  0011111223346678889999999999999987654

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.96  E-value=4.7e-31  Score=269.08  Aligned_cols=294  Identities=26%  Similarity=0.379  Sum_probs=238.5

Q ss_pred             cccCCcCcc-cCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            3 QMWENNFSG-TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         3 ~l~~~~~~~-~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      +++.|+++. -+|..++.++.|+.|||++|+++ ..|..+.+-+++-.|+||+|+|..+|..+     |.++.-|-+|+|
T Consensus        84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~l-----finLtDLLfLDL  157 (1255)
T KOG0444|consen   84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSL-----FINLTDLLFLDL  157 (1255)
T ss_pred             hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchH-----HHhhHhHhhhcc
Confidence            455566643 46677788888888888888887 66777778888888888888888877654     667777788888


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccC-CcCChhhhccCCCCEEEccCCcC
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLN-GSIPSTLGKLQKLQGLGLENNKL  160 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~n~i  160 (678)
                      |+|++....|+  +..+. .|++|.|++|.+....-.-+..+++|+.|.+++.+=+ ..+|..+.++.+|..++|+.|.+
T Consensus       158 S~NrLe~LPPQ--~RRL~-~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~L  234 (1255)
T KOG0444|consen  158 SNNRLEMLPPQ--IRRLS-MLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNL  234 (1255)
T ss_pred             ccchhhhcCHH--HHHHh-hhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCC
Confidence            88887644433  45555 6788888888776443333445677777777775432 35788899999999999999999


Q ss_pred             CCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCC-CCccc
Q 005760          161 EGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGP-LPLEI  239 (678)
Q Consensus       161 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~-~~~~~  239 (678)
                      . .+|+.+.++++|+.|+||+|.|+ .+........+|++|+||.|+|+.+|.+++++++|+.|.+.+|+++-. +|..+
T Consensus       235 p-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeGiPSGI  312 (1255)
T KOG0444|consen  235 P-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEGIPSGI  312 (1255)
T ss_pred             C-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccCCccch
Confidence            9 88999999999999999999999 555667778899999999999999999999999999999999998733 46677


Q ss_pred             cccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccCccccCCCC
Q 005760          240 GNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN  318 (678)
Q Consensus       240 ~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~c~~~~  318 (678)
                      +.+.          +|+++..++|++. ..|..+..+.+|+.|.|+.|.+-..+.....++.+..+++..||...-.|.
T Consensus       313 GKL~----------~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  313 GKLI----------QLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             hhhh----------hhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCCC
Confidence            7766          9999999999998 899999999999999999999998888888899999999999998766553

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-29  Score=254.12  Aligned_cols=198  Identities=23%  Similarity=0.349  Sum_probs=169.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--------CchhhhHHHHHHHHHhCC---Cccceeeeeeee
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--------GRVFKSFDVECEMMKSIR---HRNIIKVISSCS  458 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~  458 (678)
                      ..+|+..+.+|+|+||.|+.|.++ +...|+||.+.+..        ....-.+-.|+++|..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            346899999999999999999865 56779999885432        112234567999999997   999999999999


Q ss_pred             cCCeEEEEEEe-cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeec
Q 005760          459 NEEFKALVLEY-MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG  537 (678)
Q Consensus       459 ~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg  537 (678)
                      +.+.+|++||- -++.+|.+++..... +++.....|++||+-|+++||   +.+|||||||-+||.++.+|-+|++|||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence            99999999996 456799999986654 888899999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcceeecccCCccccCccccCCCCCC-ccchHHHHHHHHHHHHcCCCCCCc
Q 005760          538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS-ANGDVYSFGIMLMETFTRKKPTDE  596 (678)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGv~l~ell~g~~p~~~  596 (678)
                      .+....    .......+||..|.|||++.+..|- ..-|||++|++||-++....||+.
T Consensus       716 saa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  716 SAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             chhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            986543    2234557899999999999999885 457999999999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.5e-27  Score=231.34  Aligned_cols=210  Identities=35%  Similarity=0.559  Sum_probs=183.0

Q ss_pred             ccCCCceeEEEEEeC-CCcEEEEEEeecccCc-hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCHHH
Q 005760          400 IGRGSFGSVFKARLG-DGMEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEK  477 (678)
Q Consensus       400 ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~  477 (678)
                      ||+|++|.||++... +++.+++|++...... ..+.+.+|++.++.++|++++++++++...+..++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999865 4899999999755332 34678899999999999999999999999899999999999999999


Q ss_pred             HhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-CCcEEEEeeccccccCCCCCcceeecccC
Q 005760          478 YLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTREDQSTIQTQTLA  556 (678)
Q Consensus       478 ~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  556 (678)
                      ++.......++..+..++.++++++.+||   +.+++|+||+|.||+++. ++.++++|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            99876445889999999999999999999   899999999999999999 89999999999976543221  2233557


Q ss_pred             CccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHH
Q 005760          557 TIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK  635 (678)
Q Consensus       557 ~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  635 (678)
                      ...|++||..... .++.++|+|++|++++++                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            8889999998877 788999999999999999                                                


Q ss_pred             HHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          636 EQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       636 ~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                          ..+.+++.+|++.+|++||++.++++.
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                236789999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=7.4e-30  Score=263.02  Aligned_cols=254  Identities=27%  Similarity=0.412  Sum_probs=205.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ..++|+..+.+|.|.||.||+|+. ..++..|+|+++.......+.+.+|+-+++..+||||+.++|.+...+..+++||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            456899999999999999999985 4789999999998888888888999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      ||.+|+|.+.=+-.+ ++++.++..+.++.++|++|||   +.+=+|||||..||++++.|.+|+.|||.+..++.  +-
T Consensus        93 ycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti  166 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI  166 (829)
T ss_pred             ecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence            999999998776554 4888999999999999999999   99999999999999999999999999999876653  23


Q ss_pred             ceeecccCCccccCcccc---CCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          549 TIQTQTLATIGYMAPEYG---KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                      .......||+.|||||+.   +.+.|...+|||+.|+...|+-.-++|.-+..+....   +..      .....+|.-.
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l---~Lm------TkS~~qpp~l  237 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL---FLM------TKSGFQPPTL  237 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH---HHh------hccCCCCCcc
Confidence            345567899999999964   4667899999999999999998888774332221111   000      0001111111


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .       .+..-++.+-++++.|+.++|++||+++.++.
T Consensus       238 k-------Dk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  238 K-------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             c-------CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1       11123445778999999999999999988764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-27  Score=237.92  Aligned_cols=132  Identities=27%  Similarity=0.380  Sum_probs=111.8

Q ss_pred             hcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-----C---ccceeeeeeee---
Q 005760          391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-----H---RNIIKVISSCS---  458 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~---  458 (678)
                      ..+|-+.++||.|.|++||++. ..+.+.||+|+.+.. ..-.+....||.++++++     |   ..||++++.|.   
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            3678899999999999999996 457889999998753 344567788999999984     3   35999999884   


Q ss_pred             -cCCeEEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec
Q 005760          459 -NEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD  526 (678)
Q Consensus       459 -~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~  526 (678)
                       .+.+.++|+|++ |.+|..++.... ..++...+..|++||+.||.|||+  +.||+|-||||+|||+.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeee
Confidence             467999999999 668988887553 368999999999999999999997  67999999999999983

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-28  Score=230.92  Aligned_cols=256  Identities=25%  Similarity=0.292  Sum_probs=193.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecC------C
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE------E  461 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  461 (678)
                      ..+|.-.+.+|.|+- .|..|.+ -.+++||+|....+.  ....++..+|...+..+.|+|+++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            456777888999998 6666643 378999999985442  23346667899999999999999999998433      3


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..|+|||++. .+|...++.   .++-.++..++.|++.|+.|||   +.||+||||||+||++..++.+||.|||+|+.
T Consensus        95 e~y~v~e~m~-~nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence            6689999994 499988873   3777888999999999999999   99999999999999999999999999999975


Q ss_pred             cCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcc--cCCc----
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW--LPIS----  615 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~--~~~~----  615 (678)
                      -   +...+.+.++.+..|.|||++.+..+.+.+||||+||++.||++|+.-|.+    +..+.+|.+..  ....    
T Consensus       168 e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g----~d~idQ~~ki~~~lgtpd~~F  240 (369)
T KOG0665|consen  168 E---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG----KDHIDQWNKIIEQLGTPDPSF  240 (369)
T ss_pred             c---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC----chHHHHHHHHHHHhcCCCHHH
Confidence            3   233466778899999999999988899999999999999999999987653    33344443210  0000    


Q ss_pred             ----------------------ccccc-cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          616 ----------------------TKEIV-DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       616 ----------------------~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                            ..+.+ |......  .+.  ..--...+.+++.+||..||++|.+++++++
T Consensus       241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~--~e~--~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVV--LEG--SKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHhhHHHHHHhhcChHhhccchhhhCCccccccc--ccC--CccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                                  00000 0000000  000  0112344789999999999999999999975

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.95  E-value=7.1e-30  Score=260.51  Aligned_cols=271  Identities=27%  Similarity=0.362  Sum_probs=242.2

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      +||||+|++. ..|..+...+++-+|+|++|+|..+.-..|.+|+.|-.||||+|++..+|+.      ...+.+|++|.
T Consensus       107 ~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ------~RRL~~LqtL~  179 (1255)
T KOG0444|consen  107 ILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQ------IRRLSMLQTLK  179 (1255)
T ss_pred             eeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHH------HHHHhhhhhhh
Confidence            5899999999 9999999999999999999999977778899999999999999999998865      68899999999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEccccccc-ccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCc
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVS-GGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNK  159 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~  159 (678)
                      |++|++.-..-.. ...+. +|+.|.+++.+-+ ..+|.++..+.||..+|||.|.+. ..|+.+..+++|+.|+|++|+
T Consensus       180 Ls~NPL~hfQLrQ-LPsmt-sL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~  256 (1255)
T KOG0444|consen  180 LSNNPLNHFQLRQ-LPSMT-SLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNK  256 (1255)
T ss_pred             cCCChhhHHHHhc-Cccch-hhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCc
Confidence            9999986332111 22233 7888999988766 567999999999999999999998 899999999999999999999


Q ss_pred             CCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccc--cccccccccccccEEEecCCcccCCCCc
Q 005760          160 LEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELT--SIPLTFWNLKDILYLNFSSNFFTGPLPL  237 (678)
Q Consensus       160 i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~--~l~~~~~~l~~L~~L~l~~N~l~~~~~~  237 (678)
                      |+ .+........+|++|+||+|+++ .+|+++.+++.|+.|++.+|+|+  .||..++++.+|+.+..++|.+. ..|+
T Consensus       257 it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPE  333 (1255)
T KOG0444|consen  257 IT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPE  333 (1255)
T ss_pred             ee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCch
Confidence            99 66667777889999999999999 89999999999999999999988  79999999999999999999998 8888


Q ss_pred             cccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCC
Q 005760          238 EIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR  295 (678)
Q Consensus       238 ~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  295 (678)
                      .+..+.          +|+.|.|+.|++- ..|+++.-++.|+.||+..||-.-.+|.
T Consensus       334 glcRC~----------kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  334 GLCRCV----------KLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             hhhhhH----------HHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence            887666          9999999999998 7899999999999999999996645444

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=9.9e-27  Score=228.27  Aligned_cols=199  Identities=31%  Similarity=0.455  Sum_probs=172.8

Q ss_pred             CCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCc-hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          394 FSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      |.+.+.||+|++|.||+|... +++.+|+|.+...... ..+.+..|++.++.++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            566789999999999999865 4899999999765444 56788899999999999999999999998899999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      +++|.+++......+++..+..++.+++.++.+||   +.+++|+|++|.||+++.++.++++|||.+........ ...
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccc
Confidence            99999999876543788999999999999999999   88999999999999999999999999999987643321 122


Q ss_pred             ecccCCccccCcccc-CCCCCCccchHHHHHHHHHHHHcCCCCCCc
Q 005760          552 TQTLATIGYMAPEYG-KEGRVSANGDVYSFGIMLMETFTRKKPTDE  596 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~-~~~~~~~~~DvwslGv~l~ell~g~~p~~~  596 (678)
                      ....++..|++||.. ....++.++|+|++|++++||++|+.||+.
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            334577889999988 666778899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=8e-28  Score=222.82  Aligned_cols=257  Identities=20%  Similarity=0.299  Sum_probs=191.7

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeee-eeecCCeEEE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVIS-SCSNEEFKAL  465 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~-~~~~~~~~~l  465 (678)
                      .-.+.|.+.+.+|+|.||.+-+++++ ..+.+++|.+..+. ...++|.+|...--.| .|.||+.-|+ .|+..+.+++
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            34567999999999999999999865 67889999986442 2457888888765555 4999998887 4688888999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec--CCCcEEEEeeccccccC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~--~~~~~kl~Dfg~~~~~~  543 (678)
                      ++||++.|+|.+-+...+  +.+.....++.|+++|+.|+|   ++.+||||||.+|||+-  +..+||+||||+++..+
T Consensus       100 ~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             eeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999999999887754  778888999999999999999   99999999999999983  34589999999987553


Q ss_pred             CCCCcceeecccCCccccCccccCC---C--CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKE---G--RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE  618 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~---~--~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  618 (678)
                      ..     ......+..|.|||....   +  .+.+.+|+|.||+++|.++||+.||....-.+.....|.+ |.......
T Consensus       175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~-w~~rk~~~  248 (378)
T KOG1345|consen  175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ-WLKRKNPA  248 (378)
T ss_pred             ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH-HhcccCcc
Confidence            21     122334567899996532   2  3567899999999999999999999754444444443332 11111110


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                        -|.    ..      ...++.+.++.++-+..+|++|-...++.++-..
T Consensus       249 --~P~----~F------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~  287 (378)
T KOG1345|consen  249 --LPK----KF------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC  287 (378)
T ss_pred             --Cch----hh------cccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence              011    11      1234557889999999999999666666655443

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=1.9e-27  Score=238.29  Aligned_cols=203  Identities=25%  Similarity=0.305  Sum_probs=170.9

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCC------CccceeeeeeeecC
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR------HRNIIKVISSCSNE  460 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~  460 (678)
                      +...++|.+....|+|-|++|.+|.. ..|..||||++..+. -..+.-..|+++|+.|+      --|.++++..|...
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            34567898889999999999999974 467899999997542 22345567999999995      34789999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC-CcEEEEeec
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFG  537 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~-~~~kl~Dfg  537 (678)
                      .++|+|+|-+ ..+|.+++.+.+.  .+....+..++.|+.-||..|-   ..+|+|.||||.|||+.+. ..+||||||
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCc
Confidence            9999999988 5599999987654  5778889999999999999999   9999999999999999865 467999999


Q ss_pred             cccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccC
Q 005760          538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFN  599 (678)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~  599 (678)
                      .|-......    .+.+..+-.|.|||++.+-.|+...|+||.||+|||+.||+.-|++.++
T Consensus       583 SA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN  640 (752)
T KOG0670|consen  583 SASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN  640 (752)
T ss_pred             ccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence            997654332    3445567789999999999999999999999999999999998877443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=9e-27  Score=229.80  Aligned_cols=269  Identities=24%  Similarity=0.318  Sum_probs=198.3

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEeC----CCcEEEEEEeecccCchhhhHHHHHHHHHhCC-CccceeeeeeeecCCe
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEF  462 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  462 (678)
                      ....+.|..+++||+|.|++||+|...    .++.||+|.+.....  ...+..|++++..+. +.||+++.+++...+.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            345567899999999999999999643    467899999865433  366889999999995 8999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec-CCCcEEEEeeccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKL  541 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~-~~~~~kl~Dfg~~~~  541 (678)
                      ..+|+||++.....++...    ++...+..+++.+..||+++|   ..|||||||||.|++.+ ..+.-.|.|||+|..
T Consensus       110 v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~  182 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR  182 (418)
T ss_pred             eEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHH
Confidence            9999999999998888864    567888899999999999999   99999999999999997 567889999999972


Q ss_pred             cCCCC------------------------------------------CcceeecccCCccccCccccCCC-CCCccchHH
Q 005760          542 LTRED------------------------------------------QSTIQTQTLATIGYMAPEYGKEG-RVSANGDVY  578 (678)
Q Consensus       542 ~~~~~------------------------------------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dvw  578 (678)
                      .....                                          .........||++|.|||++.+. .-++++|||
T Consensus       183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw  262 (418)
T KOG1167|consen  183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW  262 (418)
T ss_pred             HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence            21000                                          00112335699999999988765 468899999


Q ss_pred             HHHHHHHHHHcCCCCCCcccCCccchhhhhhccc----------CCc--cc---------------cccc-CccCCccc-
Q 005760          579 SFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL----------PIS--TK---------------EIVD-PNLLSRED-  629 (678)
Q Consensus       579 slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~----------~~~--~~---------------~~~~-~~~~~~~~-  629 (678)
                      |.||++.-++++..||......-..+.+.+..+.          +..  ..               +-++ ........ 
T Consensus       263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~  342 (418)
T KOG1167|consen  263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP  342 (418)
T ss_pred             eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence            9999999999999998654333223322221100          000  00               0000 00000000 


Q ss_pred             -hhhHHH-HHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          630 -INFVAK-EQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       630 -~~~~~~-~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                       ...... +..+..+++++.+|+..||.+|.||+|+++
T Consensus       343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             ceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence             000011 123447899999999999999999999986

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=8.1e-27  Score=215.99  Aligned_cols=250  Identities=22%  Similarity=0.361  Sum_probs=194.0

Q ss_pred             CCCCccccCCCceeEEEEEeCCCcEEEEEEeecc--cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      ....-+|.+...|..|+|++ .|..+++|++...  ......+|.+|.-.++-+.||||.++++.|..+..+.++..|++
T Consensus       192 lnl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            34456788999999999999 4677778887543  23455788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce
Q 005760          472 HGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI  550 (678)
Q Consensus       472 ~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  550 (678)
                      .|+|+..++.... ..+..+.++++.++|+|++|||+ ...-|.---+.+..+++|++.+++|+- +-+      ..+..
T Consensus       271 ~gslynvlhe~t~vvvd~sqav~faldiargmaflhs-lep~ipr~~lns~hvmidedltarism-ad~------kfsfq  342 (448)
T KOG0195|consen  271 FGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS-LEPMIPRFYLNSKHVMIDEDLTARISM-ADT------KFSFQ  342 (448)
T ss_pred             chHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh-cchhhhhhhcccceEEecchhhhheec-ccc------eeeee
Confidence            9999999987654 46678899999999999999993 223344456889999999999988851 111      11222


Q ss_pred             eecccCCccccCccccCCCCC---CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          551 QTQTLATIGYMAPEYGKEGRV---SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~~~~~---~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      .....-.+.|++||.++..+.   -.++|+|||++++||+-|+..||.+..+.+...+.....                 
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg-----------------  405 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG-----------------  405 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc-----------------
Confidence            234456789999999987764   356899999999999999999999876665544322211                 


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                        .+-..+...+..+.++|.-|++.||.+||.+..++-.||++.
T Consensus       406 --lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  406 --LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence              111122345566889999999999999999999999999874

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=2.2e-25  Score=209.92  Aligned_cols=171  Identities=22%  Similarity=0.217  Sum_probs=131.3

Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      |+|.++++..+..+++..++.++.|++.||+|||   +.+      ||+||+++.++.+|+  ||.+......       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence            6899999876667999999999999999999999   666      999999999999999  9998765322       


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ...+++.|+|||++.+..++.++|||||||++|||++|+.||............+.....+..      +..       .
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~-------~  129 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD------PRD-------R  129 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC------ccc-------c
Confidence            125889999999999999999999999999999999999998654332222222222111100      000       0


Q ss_pred             HHHHHHH--HHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          633 VAKEQCV--SFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       633 ~~~~~~~--~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      .......  .++.+++.+||+.+|++||++.|+++.+..+..+-
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~  173 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET  173 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence            0011222  26899999999999999999999999998876553

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.93  E-value=3.1e-28  Score=237.13  Aligned_cols=294  Identities=29%  Similarity=0.443  Sum_probs=189.7

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchh----------------
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELS----------------   65 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~----------------   65 (678)
                      |+..+|+++ ++|..++++..+..|++.+|+++...|+.+. ++.|++||...|.++.+|.+++                
T Consensus       142 l~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~  219 (565)
T KOG0472|consen  142 LDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR  219 (565)
T ss_pred             hhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc
Confidence            344455555 4555555555555555555555533222222 5555555555555554444321                


Q ss_pred             hcccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhh
Q 005760           66 FLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLG  145 (678)
Q Consensus        66 ~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  145 (678)
                      ..+.|.+|..|..|+++.|+|. ..|.....++. +|..|||++|+++ ..|+.+.-+.+|++||+|+|.|+ ..|..++
T Consensus       220 ~lPef~gcs~L~Elh~g~N~i~-~lpae~~~~L~-~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLg  295 (565)
T KOG0472|consen  220 FLPEFPGCSLLKELHVGENQIE-MLPAEHLKHLN-SLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLG  295 (565)
T ss_pred             cCCCCCccHHHHHHHhcccHHH-hhHHHHhcccc-cceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccc
Confidence            1124666777777777777774 55555455666 7778888888877 56777777788888888888877 5666777


Q ss_pred             ccCCCCEEEccCCcCCC---------------------------------------------------------------
Q 005760          146 KLQKLQGLGLENNKLEG---------------------------------------------------------------  162 (678)
Q Consensus       146 ~l~~L~~L~L~~n~i~~---------------------------------------------------------------  162 (678)
                      ++ .|+.|.+.+|.+..                                                               
T Consensus       296 nl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~ql  374 (565)
T KOG0472|consen  296 NL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQL  374 (565)
T ss_pred             cc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccccc
Confidence            77 77777777777531                                                               


Q ss_pred             -CCCCcccCCCC---ccEEecCCCcCC-----------------------CCChhhhhccccccceeccccccccccccc
Q 005760          163 -SIPDSICHSDE---LYKLELGGNKLS-----------------------GSIPECFNNLASLRILLLGSNELTSIPLTF  215 (678)
Q Consensus       163 -~~~~~~~~l~~---L~~L~l~~N~i~-----------------------~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~  215 (678)
                       .+|+..+....   ....+++.|++.                       +..|..++.+++|+.|+|++|.+..+|..+
T Consensus       375 t~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~LP~e~  454 (565)
T KOG0472|consen  375 TLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLNDLPEEM  454 (565)
T ss_pred             ccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhhhcchhh
Confidence             01111111001   223334444443                       133344455667777777777777777777


Q ss_pred             cccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCC
Q 005760          216 WNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR  295 (678)
Q Consensus       216 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  295 (678)
                      ..+-.|+.|++|.|++. ..|.....+.          .|+.+-.++|++..+.++.+..|.+|++||+.+|.+...+|.
T Consensus       455 ~~lv~Lq~LnlS~NrFr-~lP~~~y~lq----------~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~  523 (565)
T KOG0472|consen  455 GSLVRLQTLNLSFNRFR-MLPECLYELQ----------TLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPI  523 (565)
T ss_pred             hhhhhhheecccccccc-cchHHHhhHH----------HHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChh
Confidence            77777777777777776 5666655555          566666677888877778789999999999999999999999


Q ss_pred             CCccccccccccccCccc
Q 005760          296 GGSFGNFSAESFEGNELL  313 (678)
Q Consensus       296 ~~~~~~l~~~~~~~n~~~  313 (678)
                      .+.+.++..+.+.|||+.
T Consensus       524 LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  524 LGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hccccceeEEEecCCccC
Confidence            999999999999999986

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-27  Score=232.57  Aligned_cols=297  Identities=21%  Similarity=0.223  Sum_probs=227.4

Q ss_pred             cCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECcc-
Q 005760            5 WENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSN-   83 (678)
Q Consensus         5 ~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~-   83 (678)
                      ++-+++ .+|..+..  .-++++|..|+|+.+.+++|+.+++|+.|||++|.|+.+.+.     +|.++++|..|-+-+ 
T Consensus        54 r~~GL~-eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~-----AF~GL~~l~~Lvlyg~  125 (498)
T KOG4237|consen   54 RGKGLT-EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPD-----AFKGLASLLSLVLYGN  125 (498)
T ss_pred             cCCCcc-cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChH-----hhhhhHhhhHHHhhcC
Confidence            344455 66755443  678999999999988889999999999999999999988865     689999888877666 


Q ss_pred             CCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCC--
Q 005760           84 NPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLE--  161 (678)
Q Consensus        84 n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~--  161 (678)
                      |+|+.+ |...|+.|. +|+.|.++-|++.....+.|..+++|..|.+.+|.+..+.-++|.++.+++++.+..|.+-  
T Consensus       126 NkI~~l-~k~~F~gL~-slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icd  203 (498)
T KOG4237|consen  126 NKITDL-PKGAFGGLS-SLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICD  203 (498)
T ss_pred             Cchhhh-hhhHhhhHH-HHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccc
Confidence            888755 445588887 8999999999999888899999999999999999998555558999999999999998832  


Q ss_pred             ----------CCCCCcccCCCCccEEecCCCcCCCCChhhhhcc-ccc-cceeccccccccccc-cccccccccEEEecC
Q 005760          162 ----------GSIPDSICHSDELYKLELGGNKLSGSIPECFNNL-ASL-RILLLGSNELTSIPL-TFWNLKDILYLNFSS  228 (678)
Q Consensus       162 ----------~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l-~~L-~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~  228 (678)
                                ...|-.++...-..-..|.++++..+.+..|... +++ ..+....+....-|. .|.++++|+.|+|++
T Consensus       204 CnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsn  283 (498)
T KOG4237|consen  204 CNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSN  283 (498)
T ss_pred             cccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCC
Confidence                      2334444444445555566666665555555422 222 223333334444455 688899999999999


Q ss_pred             CcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC-Ccccccccccc
Q 005760          229 NFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG-GSFGNFSAESF  307 (678)
Q Consensus       229 N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~-~~~~~l~~~~~  307 (678)
                      |+|+.+-+..|.++.          .++.|.|..|+|..+....|.++..|+.|+|.+|++++..|.. .....+.++.+
T Consensus       284 N~i~~i~~~aFe~~a----------~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l  353 (498)
T KOG4237|consen  284 NKITRIEDGAFEGAA----------ELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNL  353 (498)
T ss_pred             Cccchhhhhhhcchh----------hhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeeh
Confidence            999988888888877          8999999999998888888889999999999999999877664 55566778888


Q ss_pred             ccCccccCCCCCCC
Q 005760          308 EGNELLCGSPNLRV  321 (678)
Q Consensus       308 ~~n~~~c~~~~~~~  321 (678)
                      .+|||.|+|-..|.
T Consensus       354 ~~Np~~CnC~l~wl  367 (498)
T KOG4237|consen  354 LSNPFNCNCRLAWL  367 (498)
T ss_pred             ccCcccCccchHHH
Confidence            89999999886664

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=1.8e-25  Score=258.54  Aligned_cols=195  Identities=15%  Similarity=0.234  Sum_probs=138.2

Q ss_pred             CCC-ccceeeeeee-------ecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEc
Q 005760          445 IRH-RNIIKVISSC-------SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC  516 (678)
Q Consensus       445 l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  516 (678)
                      ++| +||++++++|       .+.+..+.++||+ +++|.+++......+++.+++.++.||++||+|||   +++|+||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHr  104 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIVVH  104 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence            455 6888888877       2334567888987 55999999865556899999999999999999999   9999999


Q ss_pred             CCCCCCeeecCCCc-------------------EEEEeeccccccCCCC--------------CcceeecccCCccccCc
Q 005760          517 DLKPSNVLLDDNMV-------------------AHLSDFGIAKLLTRED--------------QSTIQTQTLATIGYMAP  563 (678)
Q Consensus       517 dl~~~Nill~~~~~-------------------~kl~Dfg~~~~~~~~~--------------~~~~~~~~~~~~~y~aP  563 (678)
                      ||||+|||++..+.                   +|++|||+++......              .........+|+.|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999965444                   4555555554221000              00011124578899999


Q ss_pred             cccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHH
Q 005760          564 EYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVF  643 (678)
Q Consensus       564 E~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  643 (678)
                      |++.+..++.++|||||||++|||++|..|+.....   .........        ..+..           ....++..
T Consensus       185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~~~--------~~~~~-----------~~~~~~~~  242 (793)
T PLN00181        185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRHRV--------LPPQI-----------LLNWPKEA  242 (793)
T ss_pred             hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHHhh--------cChhh-----------hhcCHHHH
Confidence            999999999999999999999999998888643111   111110000        00000           01123356


Q ss_pred             HHHhhccccCcCCCCCHHHHHH
Q 005760          644 NVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       644 ~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      +++.+||+++|.+||++.|+++
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhh
Confidence            7888999999999999999975

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.91  E-value=2.1e-27  Score=231.40  Aligned_cols=265  Identities=28%  Similarity=0.400  Sum_probs=171.7

Q ss_pred             CCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccccc
Q 005760           22 KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHS  101 (678)
Q Consensus        22 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~  101 (678)
                      .++.|.+++|.+. .+.+.+.++..|..|++++|++...++.      +..+..++.++.++|+++ ..|.. +..+. +
T Consensus        46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~lp~a------ig~l~~l~~l~vs~n~ls-~lp~~-i~s~~-~  115 (565)
T KOG0472|consen   46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQLPAA------IGELEALKSLNVSHNKLS-ELPEQ-IGSLI-S  115 (565)
T ss_pred             chhhhhhccCchh-hccHhhhcccceeEEEeccchhhhCCHH------HHHHHHHHHhhcccchHh-hccHH-Hhhhh-h
Confidence            3555555555555 3334445555555555555555555432      344455555555555554 22333 33333 4


Q ss_pred             ccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCC
Q 005760          102 LEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG  181 (678)
Q Consensus       102 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~  181 (678)
                      +..|+.++|.+. .+|+.++.+-.|+.|+..+|+++ ..|+.+..+.+|..|++.+|.++.. |...-.|..|+.||+.+
T Consensus       116 l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~  192 (565)
T KOG0472|consen  116 LVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNS  192 (565)
T ss_pred             hhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccch
Confidence            555666666655 34555666777777777777776 5667777777777777777777733 33343477777777777


Q ss_pred             CcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEcc
Q 005760          182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLS  261 (678)
Q Consensus       182 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~  261 (678)
                      |.++ .+|..++.+.+|..|+|..|+|..+| .|.+++.|++|+++.|.|.-...+...++.          +|..|||.
T Consensus       193 N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~----------~l~vLDLR  260 (565)
T KOG0472|consen  193 NLLE-TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLN----------SLLVLDLR  260 (565)
T ss_pred             hhhh-cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHHhhHHHHhcccc----------cceeeecc
Confidence            7777 66666777777777777777777777 677777777777777777733333333444          77777888


Q ss_pred             CCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccCccc
Q 005760          262 NNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL  313 (678)
Q Consensus       262 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~  313 (678)
                      +|+++ ..|+.+..+.+|.+||+++|.+++.++..+.+ .+..+.+.|||..
T Consensus       261 dNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlr  310 (565)
T KOG0472|consen  261 DNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLR  310 (565)
T ss_pred             ccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchH
Confidence            88777 66777777777778888888887777777776 7777777777753

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.91  E-value=3.2e-27  Score=229.89  Aligned_cols=298  Identities=21%  Similarity=0.238  Sum_probs=247.8

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccC-ccCCCCccchhhcccccCCCCCcEEE
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSN-NYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      |+|..|+|+...|.+|+.+++|+.|||++|+|+.+-|++|..+++|.+|-+-+ |+|++++.+     .|.++.+|+.|.
T Consensus        72 irLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~-----~F~gL~slqrLl  146 (498)
T KOG4237|consen   72 IRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKG-----AFGGLSSLQRLL  146 (498)
T ss_pred             EEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhh-----HhhhHHHHHHHh
Confidence            78999999966668899999999999999999999999999999999997766 999999987     599999999999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCcc------------CCcCChhhhccC
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKL------------NGSIPSTLGKLQ  148 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l------------~~~~~~~~~~l~  148 (678)
                      +.-|++.-+.... +.+++ +|..|.+.+|.+..+-..+|..+.+++.+.+..|.+            ....|..++++.
T Consensus       147 lNan~i~Cir~~a-l~dL~-~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgar  224 (498)
T KOG4237|consen  147 LNANHINCIRQDA-LRDLP-SLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGAR  224 (498)
T ss_pred             cChhhhcchhHHH-HHHhh-hcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccce
Confidence            9999998665555 88888 899999999999977667899999999999999983            223455666677


Q ss_pred             CCCEEEccCCcCCCCCCCcccCC-CCccEEecCCCcCCCCCh-hhhhccccccceeccccccccccc-cccccccccEEE
Q 005760          149 KLQGLGLENNKLEGSIPDSICHS-DELYKLELGGNKLSGSIP-ECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLN  225 (678)
Q Consensus       149 ~L~~L~L~~n~i~~~~~~~~~~l-~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~  225 (678)
                      -..-..+.++++...-+..|... .++..=..+.+...+..| ..|..+++|+.|+|++|+|+.+.+ +|.++..+++|.
T Consensus       225 c~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~  304 (498)
T KOG4237|consen  225 CVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELY  304 (498)
T ss_pred             ecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhh
Confidence            77777888888875555555432 222222223333333444 578999999999999999999965 799999999999


Q ss_pred             ecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCcccccccc
Q 005760          226 FSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAE  305 (678)
Q Consensus       226 l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~  305 (678)
                      |..|+|.......|.++.          +|+.|+|.+|+|+...|.+|..+..|.+|++-.|||.|.|.-.|...|+..-
T Consensus       305 L~~N~l~~v~~~~f~~ls----------~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~  374 (498)
T KOG4237|consen  305 LTRNKLEFVSSGMFQGLS----------GLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKK  374 (498)
T ss_pred             cCcchHHHHHHHhhhccc----------cceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhC
Confidence            999999988888888888          9999999999999999999999999999999999999999998888888877


Q ss_pred             ccccCccccCCC
Q 005760          306 SFEGNELLCGSP  317 (678)
Q Consensus       306 ~~~~n~~~c~~~  317 (678)
                      ...||| .|..|
T Consensus       375 ~~~~~~-~Cq~p  385 (498)
T KOG4237|consen  375 SVVGNP-RCQSP  385 (498)
T ss_pred             CCCCCC-CCCCC
Confidence            755554 45555

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=3.8e-23  Score=228.81  Aligned_cols=256  Identities=26%  Similarity=0.290  Sum_probs=192.2

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      .|+|+.|+++ .+|..+..  +|+.|++++|+|+. +|.   .+++|++|+|++|+|+.++..         .++|+.|+
T Consensus       205 ~LdLs~~~Lt-sLP~~l~~--~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsLP~l---------p~sL~~L~  268 (788)
T PRK15387        205 VLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLPVL---------PPGLLELS  268 (788)
T ss_pred             EEEcCCCCCC-cCCcchhc--CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcccCc---------ccccceee
Confidence            3789999998 78987764  89999999999995 554   368999999999999988632         36889999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcC
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKL  160 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i  160 (678)
                      +++|.+..+.      .++.+|+.|++++|+++.. |.   .+++|+.|+|++|++++ +|..   ..+|+.|++++|.|
T Consensus       269 Ls~N~L~~Lp------~lp~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L  334 (788)
T PRK15387        269 IFSNPLTHLP------ALPSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQL  334 (788)
T ss_pred             ccCCchhhhh------hchhhcCEEECcCCccccc-cc---cccccceeECCCCcccc-CCCC---cccccccccccCcc
Confidence            9999987432      2334789999999999854 43   25789999999999985 4442   24688888999999


Q ss_pred             CCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCcccc
Q 005760          161 EGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIG  240 (678)
Q Consensus       161 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  240 (678)
                      + .+|..   ..+|+.|+|++|+|+. +|..   .++|+.|++++|+|+.+|...   .+|+.|++++|+|++ +|... 
T Consensus       335 ~-~LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~LP~l~---~~L~~LdLs~N~Lt~-LP~l~-  401 (788)
T PRK15387        335 T-SLPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPALP---SGLKELIVSGNRLTS-LPVLP-  401 (788)
T ss_pred             c-ccccc---ccccceEecCCCccCC-CCCC---CcccceehhhccccccCcccc---cccceEEecCCcccC-CCCcc-
Confidence            8 45542   2478899999999984 4442   257888889999988887543   468889999998884 33321 


Q ss_pred             ccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccCccccC
Q 005760          241 NLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCG  315 (678)
Q Consensus       241 ~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~c~  315 (678)
                        .          +|+.|++++|+|++ +|..   ..+|+.|++++|+++..+.....+..+..+++.+|++...
T Consensus       402 --s----------~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~  460 (788)
T PRK15387        402 --S----------ELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSER  460 (788)
T ss_pred             --c----------CCCEEEccCCcCCC-CCcc---hhhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCch
Confidence              2          68888888888875 4433   2457778888888886555556677788888888887644

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=3.3e-23  Score=212.58  Aligned_cols=168  Identities=20%  Similarity=0.188  Sum_probs=130.5

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEeC--CCcEEEEEEeeccc-----CchhhhHHHHHHHHHhCCCccceeeeeeeecC
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARLG--DGMEVAMKVFNLQY-----GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE  460 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  460 (678)
                      ....++|++.+.||+|+||+||+|..+  +++.||||+.....     ....+.+.+|+++++.++|+|+++.+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            345678999999999999999999754  57888999865321     12345688999999999999998533222   


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCC-CCCCeeecCCCcEEEEeeccc
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL-KPSNVLLDDNMVAHLSDFGIA  539 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-~~~Nill~~~~~~kl~Dfg~~  539 (678)
                      +..++||||+++++|... ...    .   ...++.|++++|+|||   ++||+|||| ||+||+++.++.+||+|||+|
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            457999999999999632 111    1   1467889999999999   999999999 999999999999999999999


Q ss_pred             cccCCCCCcce------eecccCCccccCccccCCC
Q 005760          540 KLLTREDQSTI------QTQTLATIGYMAPEYGKEG  569 (678)
Q Consensus       540 ~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~  569 (678)
                      +.+........      .....+++.|+|||++...
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            87754432211      1345678889999987654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=7.9e-22  Score=203.70  Aligned_cols=261  Identities=21%  Similarity=0.238  Sum_probs=197.3

Q ss_pred             CCCCCccccCCCceeEEEEEeCC--CcEEEEEEeecccCchhhhHHHHHHHHHhCCC----ccceeeeeee-ecCCeEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLGD--GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRH----RNIIKVISSC-SNEEFKAL  465 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l  465 (678)
                      +|.+.+.||+|+||.||.|....  ...+|+|+...........+..|..++..+..    +++..+++.. ..++..++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            89999999999999999998644  35789998765433333377889999998873    5888999888 57778899


Q ss_pred             EEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC-----CcEEEEeeccc
Q 005760          466 VLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN-----MVAHLSDFGIA  539 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~-----~~~kl~Dfg~~  539 (678)
                      ||+.+ |.+|.++..... ..++..++..++.|++.+|.++|   +.|++||||||.|+++...     ..+.+.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 779999886554 67999999999999999999999   9999999999999999854     46999999999


Q ss_pred             c--ccCCCCCc----c-e-eecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcc
Q 005760          540 K--LLTREDQS----T-I-QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW  611 (678)
Q Consensus       540 ~--~~~~~~~~----~-~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~  611 (678)
                      +  .+......    . . .....||..|.++....+...+.+.|+||++.++.|+..|..||........ ........
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~~  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKDP  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHHh
Confidence            8  33222211    1 1 2345699999999999999999999999999999999999999965333211 11111100


Q ss_pred             cCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          612 LPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      ..    .....           .....+.++.+++..+-..+..++|....+.+.++.....
T Consensus       254 ~~----~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  254 RK----LLTDR-----------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             hh----hcccc-----------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            00    00000           0011234566677777778999999999999998776543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=7.8e-23  Score=223.88  Aligned_cols=254  Identities=20%  Similarity=0.228  Sum_probs=186.5

Q ss_pred             CCCccccCCCceeEEEEE-eCCCcEEEEEEeec----c-cCch-hhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          395 SENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNL----Q-YGRV-FKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       395 ~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~----~-~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ...+.+|.|++|.|+.+. .......+.|.+..    . .... ...+..|+.+-..+.|||++..+..+.+....+-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            456789999999888775 33344444444321    1 1111 122556777778889999988888777766666669


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++ +|..++.... ++....+-.++.|++.|+.|+|   ..|+.|||+|++|++++.+|.+||+|||.+..+.-...
T Consensus       401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 9999998763 4777788889999999999999   99999999999999999999999999999976654333


Q ss_pred             c--ceeecccCCccccCccccCCCCCCcc-chHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          548 S--TIQTQTLATIGYMAPEYGKEGRVSAN-GDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       548 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      .  .......|+..|+|||++.+..|.+. .||||.|++++.|.+|+.||-.....+....+   ....         ..
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---~~~~---------~~  543 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---NNYS---------DQ  543 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---hccc---------cc
Confidence            3  55677889999999999999998765 89999999999999999998653332221100   0000         00


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..............+.+...++.+|++.||.+|.|+.+|++
T Consensus       544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00000011111345666788999999999999999999975

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=4.5e-21  Score=183.24  Aligned_cols=265  Identities=19%  Similarity=0.196  Sum_probs=207.1

Q ss_pred             hcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .-.|+++++||+|.||+++.|+ .-++++||||.-...  ....++..|.+..+.|. .+.|..++.+.+++.+-.+|+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            3479999999999999999997 458999999986432  34467788999999885 7899999988888888889999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-----CCcEEEEeeccccccC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLLT  543 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-----~~~~kl~Dfg~~~~~~  543 (678)
                      .+ |-+|.|++.-.+..++..++.-+|.|++.-++|+|   ++..|.|||||+|+||..     ...+.++|||+|+.+.
T Consensus       105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            98 77999999888888999999999999999999999   999999999999999963     3358999999999887


Q ss_pred             CCCCc-----ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc
Q 005760          544 REDQS-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE  618 (678)
Q Consensus       544 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  618 (678)
                      +..+.     .......||..||+-....+.+-+.+-|+=|+|=++++.+.|..||.+...+..  ++...        .
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn--K~kYe--------K  250 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN--KEKYE--------K  250 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch--HHHHH--------H
Confidence            65432     223445699999999999999999999999999999999999999987433311  11110        0


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      +-+....  .+.+- --++.+.++..-+...-..+=++-|..+-+.+-+..+.+.+
T Consensus       251 IGe~Kr~--T~i~~-Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  251 IGETKRS--TPIEV-LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             hcccccc--CCHHH-HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence            1111100  00111 11346677778888777888888898888777777776654

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.87  E-value=5.2e-22  Score=219.76  Aligned_cols=237  Identities=29%  Similarity=0.392  Sum_probs=190.8

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      |++++|+++ .+|.   ..++|++|+|++|+|+. +|..   .++|+.|+|++|.+..++..         ..+|+.|++
T Consensus       227 L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~~Lp~l---------p~~L~~L~L  289 (788)
T PRK15387        227 LVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLTHLPAL---------PSGLCKLWI  289 (788)
T ss_pred             EEccCCcCC-CCCC---CCCCCcEEEecCCccCc-ccCc---ccccceeeccCCchhhhhhc---------hhhcCEEEC
Confidence            688999998 6775   25789999999999995 4543   47899999999999877632         257899999


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCC
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLE  161 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~  161 (678)
                      ++|+++.+ |.     .+++|++|+|++|+++++ |..   ..+|+.|++++|++++ +|..   ..+|++|+|++|+|+
T Consensus       290 s~N~Lt~L-P~-----~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls  355 (788)
T PRK15387        290 FGNQLTSL-PV-----LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA  355 (788)
T ss_pred             cCCccccc-cc-----cccccceeECCCCccccC-CCC---cccccccccccCcccc-cccc---ccccceEecCCCccC
Confidence            99999854 22     234899999999999964 432   3568899999999984 5532   258999999999999


Q ss_pred             CCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccc
Q 005760          162 GSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGN  241 (678)
Q Consensus       162 ~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  241 (678)
                       .+|..   .++|+.|++++|.|+. +|..   .++|+.|+|++|+|+.+|...   ++|+.|++++|++++ +|..+  
T Consensus       356 -~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~LP~l~---s~L~~LdLS~N~Lss-IP~l~--  421 (788)
T PRK15387        356 -SLPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTSLPVLP---SELKELMVSGNRLTS-LPMLP--  421 (788)
T ss_pred             -CCCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccCCCCcc---cCCCEEEccCCcCCC-CCcch--
Confidence             56653   3578999999999994 5543   357999999999999988643   589999999999985 44322  


Q ss_pred             cccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCC
Q 005760          242 LKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR  295 (678)
Q Consensus       242 l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  295 (678)
                       .          +|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+.
T Consensus       422 -~----------~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        422 -S----------GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             -h----------hhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence             2          7889999999998 6788899999999999999999976554

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=3.2e-22  Score=223.00  Aligned_cols=242  Identities=25%  Similarity=0.401  Sum_probs=139.9

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      |++++++++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|++|++++|++++++..      +  ..+|+.|+|
T Consensus       183 L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~------l--~~~L~~L~L  248 (754)
T PRK15370        183 LRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPAT------L--PDTIQEMEL  248 (754)
T ss_pred             EEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChh------h--hccccEEEC
Confidence            556666666 5565443  36677777777776 3444333  3677777777776665532      1  135677777


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCC
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLE  161 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~  161 (678)
                      ++|++..+ |..    ++.+|++|++++|++.. +|..+.  ++|+.|++++|+|++ +|..+.  ++|+.|++++|.++
T Consensus       249 s~N~L~~L-P~~----l~s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt  317 (754)
T PRK15370        249 SINRITEL-PER----LPSALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLT  317 (754)
T ss_pred             cCCccCcC-Chh----HhCCCCEEECcCCccCc-cccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccc
Confidence            77776533 322    22356677777776663 344432  466777777777663 444332  35666777777776


Q ss_pred             CCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccc
Q 005760          162 GSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGN  241 (678)
Q Consensus       162 ~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  241 (678)
                       .+|..+.  ++|+.|++++|.++. +|..+.  ++|+.|++++|+|+.+|..+.  ++|+.|++++|+++. +|..+. 
T Consensus       318 -~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~-  387 (754)
T PRK15370        318 -ALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALTN-LPENLP-  387 (754)
T ss_pred             -cCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCCC-CCHhHH-
Confidence             3443332  466777777777663 444442  567777777777766665443  466777777776663 333322 


Q ss_pred             cccccccccCcccccEEEccCCcCCCcchHH----HhcccCCCceeccccccc
Q 005760          242 LKIARIDSCDLISLISLNLSNNNLSGAIPAS----LEKLSYLKDLNLSFNKLE  290 (678)
Q Consensus       242 l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~l~~N~~~  290 (678)
                       .          +|+.|++++|+|+. +|..    +..++.+..|++.+|+++
T Consensus       388 -~----------sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        388 -A----------ALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             -H----------HHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCcc
Confidence             1          56667777777663 3332    233456666777777765

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.87  E-value=1.3e-23  Score=224.93  Aligned_cols=293  Identities=30%  Similarity=0.410  Sum_probs=189.4

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhc--------------
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFL--------------   67 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~--------------   67 (678)
                      |++++|.|. ..|.+.+.+.+|++|+|.+|.+. .+|..+..+++|+.|+++.|++..+|..+...              
T Consensus        73 ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~~Pl~i~~lt~~~~~~~s~N~~~  150 (1081)
T KOG0618|consen   73 LNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGPIPLVIEVLTAEEELAASNNEKI  150 (1081)
T ss_pred             cccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCCCchhHHhhhHHHHHhhhcchhh
Confidence            566677776 67777777888888888888877 67888888888888888888887777533100              


Q ss_pred             -----------------------c-------------------cccCCCCCcEEECccCCCcccCC--------------
Q 005760           68 -----------------------S-------------------SLSNCKSLTLISFSNNPLDGILP--------------   91 (678)
Q Consensus        68 -----------------------~-------------------~~~~l~~L~~L~L~~n~i~~~~~--------------   91 (678)
                                             .                   .++.+.+|+.|....|++....-              
T Consensus       151 ~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~  230 (1081)
T KOG0618|consen  151 QRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNP  230 (1081)
T ss_pred             hhhccccchhhhhhhhhcccchhcchhhhheeeecccchhhhhhhhhccchhhhhhhhcccceEEecCcchheeeeccCc
Confidence                                   0                   01122222222222222211100              


Q ss_pred             --hhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCccc
Q 005760           92 --KTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSIC  169 (678)
Q Consensus        92 --~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~  169 (678)
                        .......+.+|+++++++|+++.. |+++..+.+|+.|+...|++. ..|..+....+|+.|.+..|.+. .+|....
T Consensus       231 l~~~~~~p~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le  307 (1081)
T KOG0618|consen  231 LTTLDVHPVPLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLE  307 (1081)
T ss_pred             ceeeccccccccceeeecchhhhhcc-hHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCccc
Confidence              001112234678888888888744 588888888888888888876 45544444444444444444444 3444444


Q ss_pred             CCCCccEEecCCCcCC-------------------------------------------------CCChhhhhccccccc
Q 005760          170 HSDELYKLELGGNKLS-------------------------------------------------GSIPECFNNLASLRI  200 (678)
Q Consensus       170 ~l~~L~~L~l~~N~i~-------------------------------------------------~~~~~~~~~l~~L~~  200 (678)
                      ++.+|++|+|..|+|.                                                 +..-..+.+...|+.
T Consensus       308 ~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKV  387 (1081)
T KOG0618|consen  308 GLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKV  387 (1081)
T ss_pred             ccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceee
Confidence            4555555555554444                                                 333334445577888


Q ss_pred             eeccccccccccc-cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCC
Q 005760          201 LLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYL  279 (678)
Q Consensus       201 L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L  279 (678)
                      |+|++|+|+++|. .+.+++.|++|+||||+++ .+|.....+.          .|++|...+|+|. ..| .+.+++.|
T Consensus       388 LhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~----------~L~tL~ahsN~l~-~fP-e~~~l~qL  454 (1081)
T KOG0618|consen  388 LHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLG----------RLHTLRAHSNQLL-SFP-ELAQLPQL  454 (1081)
T ss_pred             eeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhh----------hhHHHhhcCCcee-ech-hhhhcCcc
Confidence            8888888888877 5778888888888888887 5566666666          7888888888877 566 67788888


Q ss_pred             Cceeccccccccc-CCCCCccccccccccccCcc
Q 005760          280 KDLNLSFNKLEGE-IPRGGSFGNFSAESFEGNEL  312 (678)
Q Consensus       280 ~~L~l~~N~~~~~-~~~~~~~~~l~~~~~~~n~~  312 (678)
                      +.+|++.|+++-. .+....+++|+-+++.||.|
T Consensus       455 ~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  455 KVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             eEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            8888888888754 34445557888889999885

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=1.6e-21  Score=178.22  Aligned_cols=264  Identities=18%  Similarity=0.189  Sum_probs=200.4

Q ss_pred             hhcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCC-ccceeeeeeeecCCeEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRH-RNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  467 (678)
                      ..++|.++++||+|+||.+|.|. ..+|++||+|+-+....+  .+...|..+.+.+++ ..|..+..+..+...-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            45789999999999999999996 678999999997655443  567789999999974 56777788888888889999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec---CCCcEEEEeeccccccCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~---~~~~~kl~Dfg~~~~~~~  544 (678)
                      +.+ |.+|.+++.-....+++.++.-.+-|++.-++|+|   .++++||||||+|+++.   ....+.++|||+|+.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            998 77999999877777999999999999999999999   99999999999999996   345688999999988754


Q ss_pred             CCC-----cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccc
Q 005760          545 EDQ-----STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI  619 (678)
Q Consensus       545 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (678)
                      ..+     ........||..|.+-....+..-+.+-|+=|+|.+|...-.|..||.+.....-. ..+-+ ..+..+.. 
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~-QKyEk-I~EkK~s~-  243 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK-QKYEK-ISEKKMST-  243 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH-HHHHH-HHHhhcCC-
Confidence            332     22234456999999888777777788899999999999999999999875443211 11100 00000000 


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                               ..+. --...|.++.-.+..|-..-=++-|...-+.+.+.-+..
T Consensus       244 ---------~ie~-LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  244 ---------PIEV-LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             ---------CHHH-HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence                     0000 012456677778888888888888887777666665543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=1.8e-20  Score=195.57  Aligned_cols=258  Identities=31%  Similarity=0.431  Sum_probs=197.6

Q ss_pred             CCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCc---hhhhHHHHHHHHHhCCCc-cceeeeeeeecCCeEEEEEEe
Q 005760          394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGR---VFKSFDVECEMMKSIRHR-NIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  469 (678)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+..++.+.|+ +++++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667789999999999999876  78999998655332   367789999999999988 799999999877778999999


Q ss_pred             cCCCCHHHHhhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC-cEEEEeeccccccCCCC
Q 005760          470 MPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTRED  546 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~-~~kl~Dfg~~~~~~~~~  546 (678)
                      +.++++.+++.....  .........++.|++.++.|+|   ..+++|||+||+||+++..+ .++++|||.+.......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977776542  5888899999999999999999   99999999999999999988 79999999997654333


Q ss_pred             Ccc----eeecccCCccccCccccCC---CCCCccchHHHHHHHHHHHHcCCCCCCcccCC--ccchhhhhhcccCCccc
Q 005760          547 QST----IQTQTLATIGYMAPEYGKE---GRVSANGDVYSFGIMLMETFTRKKPTDEIFNG--EMTLKHWVNDWLPISTK  617 (678)
Q Consensus       547 ~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~  617 (678)
                      ...    ......++..|+|||...+   ..++...|+||+|++++++++|..||......  .......+.........
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence            221    3456789999999999887   57888999999999999999999997653321  11111111111000000


Q ss_pred             ccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      ....+...          ......+.+++..|+..+|..|.++.+....
T Consensus       237 ~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         237 SPLSPSNP----------ELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccCcccc----------chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000000          1223457789999999999999999887764

>PLN03210 Resistant to P

Probab=99.86  E-value=1.5e-20  Score=224.16  Aligned_cols=277  Identities=21%  Similarity=0.272  Sum_probs=170.5

Q ss_pred             cccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCcc-CCCCccchhhcccccCCCCCcEEEC
Q 005760            3 QMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNY-LTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         3 ~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      ++.++.+. .+|..+ ...+|++|+|++|++. .++..+..+++|+.|+|++|. +..++       .+..+++|+.|+|
T Consensus       595 ~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-------~ls~l~~Le~L~L  664 (1153)
T PLN03210        595 RWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-------DLSMATNLETLKL  664 (1153)
T ss_pred             EecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-------ccccCCcccEEEe
Confidence            34444444 455443 4566666666666666 455666666667777766553 33332       2455666677777


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCC
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLE  161 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~  161 (678)
                      ++|......|.. +..+. +|+.|++++|...+.+|..+ ++++|+.|++++|.....+|..   .++|++|+|++|.++
T Consensus       665 ~~c~~L~~lp~s-i~~L~-~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~  738 (1153)
T PLN03210        665 SDCSSLVELPSS-IQYLN-KLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE  738 (1153)
T ss_pred             cCCCCccccchh-hhccC-CCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc
Confidence            666554444443 45555 66666666665555555544 5666666666666443333322   245666666666665


Q ss_pred             CCCCCcc------------------------------cCCCCccEEecCCCcCCCCChhhhhccccccceecccc-cccc
Q 005760          162 GSIPDSI------------------------------CHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSN-ELTS  210 (678)
Q Consensus       162 ~~~~~~~------------------------------~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N-~l~~  210 (678)
                       .+|..+                              ...++|+.|++++|.....+|..+.++++|+.|+|++| .++.
T Consensus       739 -~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~  817 (1153)
T PLN03210        739 -EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLET  817 (1153)
T ss_pred             -cccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCe
Confidence             334321                              11245666666666655566666777777777777665 4666


Q ss_pred             ccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccc-cc
Q 005760          211 IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFN-KL  289 (678)
Q Consensus       211 l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-~~  289 (678)
                      +|..+ .+++|+.|+|++|......|..             .++|+.|+|++|.|+ .+|..+..+++|+.|+|++| ++
T Consensus       818 LP~~~-~L~sL~~L~Ls~c~~L~~~p~~-------------~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L  882 (1153)
T PLN03210        818 LPTGI-NLESLESLDLSGCSRLRTFPDI-------------STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNL  882 (1153)
T ss_pred             eCCCC-CccccCEEECCCCCcccccccc-------------ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCc
Confidence            66544 5666777777766443333321             237899999999998 67888999999999999984 56


Q ss_pred             cccCCCCCccccccccccccCc
Q 005760          290 EGEIPRGGSFGNFSAESFEGNE  311 (678)
Q Consensus       290 ~~~~~~~~~~~~l~~~~~~~n~  311 (678)
                      .+.++....+..+..+++.+++
T Consensus       883 ~~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        883 QRVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             CccCcccccccCCCeeecCCCc
Confidence            6655555667777777777654

syringae 6; Provisional

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=3.3e-21  Score=214.99  Aligned_cols=248  Identities=25%  Similarity=0.348  Sum_probs=196.3

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccc
Q 005760           21 SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSH  100 (678)
Q Consensus        21 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~  100 (678)
                      .+.+.|++++++++ .+|..+.  ++|+.|+|++|+++.++...        ..+|+.|++++|+++.+ |..    ++.
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~~l--------~~nL~~L~Ls~N~LtsL-P~~----l~~  241 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPENL--------QGNIKTLYANSNQLTSI-PAT----LPD  241 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCChhh--------ccCCCEEECCCCccccC-Chh----hhc
Confidence            46899999999999 5676654  58999999999999887542        25899999999999854 432    334


Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      +|+.|+|++|++. .+|..+.  ++|+.|++++|+++ .+|..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+++
T Consensus       242 ~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls  312 (754)
T PRK15370        242 TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQ  312 (754)
T ss_pred             cccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhc
Confidence            8999999999998 4566553  58999999999998 5676664  58999999999999 5665543  579999999


Q ss_pred             CCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEc
Q 005760          181 GNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNL  260 (678)
Q Consensus       181 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L  260 (678)
                      +|.++. +|..+.  ++|+.|++++|.++.+|..+.  ++|+.|++++|+|+ .+|..+.  +          +|+.|+|
T Consensus       313 ~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~----------~L~~LdL  374 (754)
T PRK15370        313 SNSLTA-LPETLP--PGLKTLEAGENALTSLPASLP--PELQVLDVSKNQIT-VLPETLP--P----------TITTLDV  374 (754)
T ss_pred             CCcccc-CCcccc--ccceeccccCCccccCChhhc--CcccEEECCCCCCC-cCChhhc--C----------CcCEEEC
Confidence            999994 454443  689999999999999998664  69999999999998 4555442  2          8999999


Q ss_pred             cCCcCCCcchHHHhcccCCCceecccccccccCCCC----CccccccccccccCcccc
Q 005760          261 SNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG----GSFGNFSAESFEGNELLC  314 (678)
Q Consensus       261 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~----~~~~~l~~~~~~~n~~~c  314 (678)
                      ++|+|+.. |..+.  ..|+.|++++|++.+.+...    ...+.+..+++.+||+..
T Consensus       375 s~N~Lt~L-P~~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls~  429 (754)
T PRK15370        375 SRNALTNL-PENLP--AALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFSE  429 (754)
T ss_pred             CCCcCCCC-CHhHH--HHHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCccH
Confidence            99999954 54444  36999999999998654332    223566788899998753

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.9e-21  Score=185.19  Aligned_cols=171  Identities=12%  Similarity=0.129  Sum_probs=133.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhh---------hHHHHHHHHHhCCCccceeeeeeeecC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFK---------SFDVECEMMKSIRHRNIIKVISSCSNE  460 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~e~~~l~~l~h~niv~~~~~~~~~  460 (678)
                      ..++|+..+.+|.|+||.||++.. ++..+|+|++.........         .+.+|++.+.+++||+|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            478999999999999999999876 5778999999754332222         257899999999999999998875432


Q ss_pred             --------CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEE
Q 005760          461 --------EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH  532 (678)
Q Consensus       461 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~k  532 (678)
                              ...++||||++|.+|.++..     .+.    ....+++.++..+|   +.|++|||++|+||+++++| ++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EE
Confidence                    35789999999999988742     222    24569999999999   99999999999999999998 99


Q ss_pred             EEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHH
Q 005760          533 LSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETF  588 (678)
Q Consensus       533 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell  588 (678)
                      ++|||...........              ..+.....+..++|+|+||+.+....
T Consensus       175 liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            9999987654211111              01334445667899999999887554

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=2.3e-20  Score=176.31  Aligned_cols=139  Identities=17%  Similarity=0.167  Sum_probs=108.1

Q ss_pred             CccccCCCceeEEEEEeCCCcEEEEEEeecccCc--h-------hhh-----------------HHHHHHHHHhCCCccc
Q 005760          397 NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGR--V-------FKS-----------------FDVECEMMKSIRHRNI  450 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~e~~~l~~l~h~ni  450 (678)
                      ...||+|++|.||+|...+|+.||+|+++.....  .       ...                 ...|++.+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999778999999999754221  0       112                 2349999999988776


Q ss_pred             eeeeeeeecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEEcCCCCCCeeecCCC
Q 005760          451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL-HFGYSAQVIHCDLKPSNVLLDDNM  529 (678)
Q Consensus       451 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dl~~~Nill~~~~  529 (678)
                      .....+...  ..++||||++++++....... ..++...+..++.|++.++.++ |   +.||+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            433332222  237999999988776553322 3578889999999999999999 7   88999999999999998 47


Q ss_pred             cEEEEeecccccc
Q 005760          530 VAHLSDFGIAKLL  542 (678)
Q Consensus       530 ~~kl~Dfg~~~~~  542 (678)
                      .++++|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.83  E-value=3.1e-22  Score=214.58  Aligned_cols=247  Identities=31%  Similarity=0.338  Sum_probs=122.2

Q ss_pred             CCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccc
Q 005760           20 ASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLS   99 (678)
Q Consensus        20 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~   99 (678)
                      -.+|+++++++|++. .+|+.++.+.+|+.|+..+|++..++..      +..+.+|+.|++..|.+.-+.|.  ...+.
T Consensus       240 p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~~lp~r------i~~~~~L~~l~~~~nel~yip~~--le~~~  310 (1081)
T KOG0618|consen  240 PLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLVALPLR------ISRITSLVSLSAAYNELEYIPPF--LEGLK  310 (1081)
T ss_pred             cccceeeecchhhhh-cchHHHHhcccceEecccchhHHhhHHH------HhhhhhHHHHHhhhhhhhhCCCc--ccccc
Confidence            345556666666665 3345555666666666666665544432      34455555555555555433331  11122


Q ss_pred             ccccEEEcccccccccCCccccCCCC-CcEEEccCCccCCcCCh-hhhccCCCCEEEccCCcCCCCCCCcccCCCCccEE
Q 005760          100 HSLEYFEMAYCNVSGGIPEEIGNLTN-LTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKL  177 (678)
Q Consensus       100 ~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L  177 (678)
                       +|++|+|..|+|....+..|.-+.. |..|+.+.|++. ..|. .=..++.|+.|++.+|.++...-..+.+.++|+.|
T Consensus       311 -sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVL  388 (1081)
T KOG0618|consen  311 -SLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVL  388 (1081)
T ss_pred             -eeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeee
Confidence             4555555555555433333333332 455555555554 2221 11123445555555555554333345555555555


Q ss_pred             ecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccE
Q 005760          178 ELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLIS  257 (678)
Q Consensus       178 ~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~  257 (678)
                      +|++|++.......+.+++.|++|+||+|+|+.+|.++..++.|++|...+|.+. ..| ++..++          +|+.
T Consensus       389 hLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~----------qL~~  456 (1081)
T KOG0618|consen  389 HLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLP----------QLKV  456 (1081)
T ss_pred             eecccccccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcC----------cceE
Confidence            5555555544444455555555555555555555555555555555555555555 333 333333          5555


Q ss_pred             EEccCCcCCCcchHHHhcccCCCceecccccc
Q 005760          258 LNLSNNNLSGAIPASLEKLSYLKDLNLSFNKL  289 (678)
Q Consensus       258 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  289 (678)
                      +|++.|+|+...-......++|++||++||.+
T Consensus       457 lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  457 LDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             EecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            55555555532222222224555555555553

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=2.8e-21  Score=210.40  Aligned_cols=248  Identities=21%  Similarity=0.240  Sum_probs=179.5

Q ss_pred             CCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCc-hhhhHH---HHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGR-VFKSFD---VECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      +|...+.+|.+.|=.|.+|+..+|. |+||++-.+.+. ..+.|.   +|++ ...++|||.+++.-+-......|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6777899999999999999998888 999998655432 233343   3444 556789999998888777778889999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC-CC--
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-RE--  545 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~-~~--  545 (678)
                      |+.+ +|+|.+..+. ++...+.+.|+.|++.|+..+|   +.||+|||||.+|||++.=.-+.|+||..-+..- ++  
T Consensus       102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            9966 9999997654 5788888899999999999999   9999999999999999999999999997643211 11  


Q ss_pred             --CCcceeecccCCccccCccccCCC----------C-CCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcc
Q 005760          546 --DQSTIQTQTLATIGYMAPEYGKEG----------R-VSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDW  611 (678)
Q Consensus       546 --~~~~~~~~~~~~~~y~aPE~~~~~----------~-~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~  611 (678)
                        +.............|.|||.+-..          . .+++-||||+||++.|+++ |.+||.-        .+...- 
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--------SQL~aY-  247 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--------SQLLAY-  247 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH--------HHHHhH-
Confidence              122222333344569999965331          1 4677899999999999999 7777742        111100 


Q ss_pred             cCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 005760          612 LPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                                 ..-.....+..-..-....+..++..|++.||++|.+|++.++.-
T Consensus       248 -----------r~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  248 -----------RSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             -----------hccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence                       000000001111111122477899999999999999999999873

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=3.5e-20  Score=193.27  Aligned_cols=216  Identities=27%  Similarity=0.427  Sum_probs=166.0

Q ss_pred             HHhCCCccceeeeeeeecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe-EEcCCCC
Q 005760          442 MKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV-IHCDLKP  520 (678)
Q Consensus       442 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~dl~~  520 (678)
                      |+.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+......+++.....+.++|+.|++|+|   .-.| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            35678999999999999999999999999999999999987778999999999999999999999   4444 9999999


Q ss_pred             CCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCC-------CCccchHHHHHHHHHHHHcCCCC
Q 005760          521 SNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR-------VSANGDVYSFGIMLMETFTRKKP  593 (678)
Q Consensus       521 ~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslGv~l~ell~g~~p  593 (678)
                      .|+++|....+|++|||+.................-..-|.|||.+....       .+.++||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            99999999999999999987654211112222333556799999887641       46679999999999999999999


Q ss_pred             CCcccCCccc--hhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          594 TDEIFNGEMT--LKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       594 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                      |+........  +..++..    .......|.....        .+..+++..++..||..+|++||++.++-..++.+.
T Consensus       158 ~~~~~~~~~~~eii~~~~~----~~~~~~rP~i~~~--------~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKK----GGSNPFRPSIELL--------NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             cccccccCChHHHHHHHHh----cCCCCcCcchhhh--------hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            9874433322  2222221    1111222222211        134446889999999999999999999999988776


Q ss_pred             H
Q 005760          672 D  672 (678)
Q Consensus       672 ~  672 (678)
                      .
T Consensus       226 ~  226 (484)
T KOG1023|consen  226 K  226 (484)
T ss_pred             c
Confidence            4

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=1.8e-19  Score=167.63  Aligned_cols=189  Identities=14%  Similarity=0.118  Sum_probs=139.4

Q ss_pred             CCCccccCCCceeEEEEEeCCCcEEEEEEeecccCch----hhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEEEEe
Q 005760          395 SENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRV----FKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       395 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .....|+.|+||+||.+.. .+.+++.+.+.......    ...+.+|+++++++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3467899999999998876 67888877775432211    125788999999995 5789998886    346899999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCC-CCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL-KPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +.|.+|......        ....++.|++.++.++|   +.||+|||| ||+||+++.++.++|+|||++.........
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998754321        11357789999999999   999999999 799999999999999999999865433211


Q ss_pred             ----c-------eeecccCCccccCccccC--CCCCCccchHHHHHHHHHHHHcCCCCCCcccC
Q 005760          549 ----T-------IQTQTLATIGYMAPEYGK--EGRVSANGDVYSFGIMLMETFTRKKPTDEIFN  599 (678)
Q Consensus       549 ----~-------~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~  599 (678)
                          .       .......++.|++|+--.  ...--.+.+.++.|+-+|.++|+..|..+..+
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence                0       011223566777776321  12222567999999999999999998755333

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.81  E-value=4.2e-21  Score=199.26  Aligned_cols=281  Identities=22%  Similarity=0.267  Sum_probs=186.3

Q ss_pred             ccccCCcCc-ccCCccccCCCCCCEEecCCCccccc----CCccccCCCCCCEEEccCccCCCCccc-hhhcccccCCCC
Q 005760            2 LQMWENNFS-GTIPRFIFNASKLSILELSDNSFSGF----IPNTFGNLRNLQALRLSNNYLTSSTLE-LSFLSSLSNCKS   75 (678)
Q Consensus         2 L~l~~~~~~-~~~p~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~~~~-~~~~~~~~~l~~   75 (678)
                      |+|++++++ ...+..+..+.+|++|++++|.++..    ++..+...++|++|+++++.+...+.. ..+...|..+++
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~   82 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG   82 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence            788899997 45566667788899999999998543    456677888899999999988742221 123345777899


Q ss_pred             CcEEECccCCCcccCChhhhhcccc--cccEEEcccccccc----cCCccccCC-CCCcEEEccCCccCCc----CChhh
Q 005760           76 LTLISFSNNPLDGILPKTSVGNLSH--SLEYFEMAYCNVSG----GIPEEIGNL-TNLTIIYLGGNKLNGS----IPSTL  144 (678)
Q Consensus        76 L~~L~L~~n~i~~~~~~~~~~~l~~--~L~~L~l~~n~l~~----~~~~~~~~l-~~L~~L~l~~N~l~~~----~~~~~  144 (678)
                      |+.|++++|.+....+.. +..+..  +|++|++++|++.+    .+...+..+ ++|+.|++++|.+++.    .+..+
T Consensus        83 L~~L~l~~~~~~~~~~~~-~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~  161 (319)
T cd00116          83 LQELDLSDNALGPDGCGV-LESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL  161 (319)
T ss_pred             eeEEEccCCCCChhHHHH-HHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence            999999999987543333 444432  38888888888873    233445566 8888888888888732    23355


Q ss_pred             hccCCCCEEEccCCcCCCC----CCCcccCCCCccEEecCCCcCCCCC----hhhhhccccccceecccccccccc-ccc
Q 005760          145 GKLQKLQGLGLENNKLEGS----IPDSICHSDELYKLELGGNKLSGSI----PECFNNLASLRILLLGSNELTSIP-LTF  215 (678)
Q Consensus       145 ~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~l~~N~i~~~~----~~~~~~l~~L~~L~l~~N~l~~l~-~~~  215 (678)
                      ..+++|++|+|++|.+++.    ++..+..+++|+.|++++|.+++..    +..+..+++|++|++++|.++... ..+
T Consensus       162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l  241 (319)
T cd00116         162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL  241 (319)
T ss_pred             HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence            6667888888888888732    2334455568888888888877443    234456677888888888777421 111


Q ss_pred             c-----ccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCc----chHHHhcc-cCCCceecc
Q 005760          216 W-----NLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGA----IPASLEKL-SYLKDLNLS  285 (678)
Q Consensus       216 ~-----~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~----~~~~~~~l-~~L~~L~l~  285 (678)
                      .     ..++|+.|++++|.++......+...      ...+++|+.+++++|.++..    ....+... +.|..|++.
T Consensus       242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~------~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~  315 (319)
T cd00116         242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEV------LAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVK  315 (319)
T ss_pred             HHHHhccCCCceEEEccCCCCCcHHHHHHHHH------HhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccC
Confidence            1     23678888888887763222211110      01224788888888888754    33344444 577777777


Q ss_pred             cccc
Q 005760          286 FNKL  289 (678)
Q Consensus       286 ~N~~  289 (678)
                      +|+|
T Consensus       316 ~~~~  319 (319)
T cd00116         316 DDSF  319 (319)
T ss_pred             CCCC
Confidence            7765

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=2.8e-19  Score=169.84  Aligned_cols=139  Identities=22%  Similarity=0.269  Sum_probs=109.9

Q ss_pred             CccccCCCceeEEEEEeCCCcEEEEEEeecccCch--------------------------hhhHHHHHHHHHhCCCccc
Q 005760          397 NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRV--------------------------FKSFDVECEMMKSIRHRNI  450 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~ni  450 (678)
                      ...||+|++|.||+|...+|+.||||+++......                          ......|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            56899999999999987789999999987542110                          1123578899999999987


Q ss_pred             eeeeeeeecCCeEEEEEEecCCCCHHHH-hhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEcCCCCCCeeecCC
Q 005760          451 IKVISSCSNEEFKALVLEYMPHGSLEKY-LHSSNYILDIYQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPSNVLLDDN  528 (678)
Q Consensus       451 v~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dl~~~Nill~~~  528 (678)
                      .....+....  .++||||++++++... +..  ..++......++.|++.++.++|   . .||+||||||+||+++ +
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            5444433322  4799999998755433 333  24677888999999999999999   7 9999999999999999 8


Q ss_pred             CcEEEEeeccccccC
Q 005760          529 MVAHLSDFGIAKLLT  543 (678)
Q Consensus       529 ~~~kl~Dfg~~~~~~  543 (678)
                      +.++++|||++....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=6.5e-20  Score=179.18  Aligned_cols=195  Identities=23%  Similarity=0.338  Sum_probs=139.8

Q ss_pred             CCccceeeeeeeec---------------------------CCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHH
Q 005760          446 RHRNIIKVISSCSN---------------------------EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDV  498 (678)
Q Consensus       446 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i  498 (678)
                      +|||||++.++|.+                           +...|+||..+++ +|.+++....  .+.....-+..|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            59999999876522                           2367899998866 9999997665  4555666788999


Q ss_pred             HHHHHHHhcCCCCCeEEcCCCCCCeee--cCCC--cEEEEeeccccccCCCC----CcceeecccCCccccCccccCCCC
Q 005760          499 ASALEYLHFGYSAQVIHCDLKPSNVLL--DDNM--VAHLSDFGIAKLLTRED----QSTIQTQTLATIGYMAPEYGKEGR  570 (678)
Q Consensus       499 ~~~l~~LH~~~~~~ivH~dl~~~Nill--~~~~--~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~  570 (678)
                      ++|+.|||   ++||.|||+|++||++  |+++  ...++|||.+---...+    ........-|....||||+.....
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999   9999999999999998  4444  45789999874222211    111112233667799999865322


Q ss_pred             ------CCccchHHHHHHHHHHHHcCCCCCCcccCCccch--hhhhhcccCCcccccccCccCCccchhhHHHHHHHHHH
Q 005760          571 ------VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTL--KHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFV  642 (678)
Q Consensus       571 ------~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  642 (678)
                            --.|+|.|+.|.+.||+++...||+.  .+++.+  ..|-.+..|                   ..++.+++.+
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGem~L~~r~Yqe~qLP-------------------alp~~vpp~~  486 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGEMLLDTRTYQESQLP-------------------ALPSRVPPVA  486 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccc--cchheechhhhhhhhCC-------------------CCcccCChHH
Confidence                  13579999999999999999999987  333332  222111111                   1224577889


Q ss_pred             HHHHhhccccCcCCCCCHHHHHHHH
Q 005760          643 FNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       643 ~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                      .+++...++.||++|++..=....|
T Consensus       487 rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  487 RQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHHHhcCCccccCCccHHHhHH
Confidence            9999999999999999876655544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.80  E-value=2.6e-19  Score=175.72  Aligned_cols=231  Identities=20%  Similarity=0.266  Sum_probs=145.6

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC---chhhhHHHHHHHHHhCCC----------ccceeeeeee-
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRH----------RNIIKVISSC-  457 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h----------~niv~~~~~~-  457 (678)
                      .+...+.||.|+++.||.+++ .+++++|+|++.....   ...+.+.+|.-....+.+          -.++..++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            345568899999999999985 4799999999865432   344566666654444322          1222222211 


Q ss_pred             --------ec---CC-----eEEEEEEecCCCCHHHHhh---hCCC---CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEE
Q 005760          458 --------SN---EE-----FKALVLEYMPHGSLEKYLH---SSNY---ILDIYQRLNIMIDVASALEYLHFGYSAQVIH  515 (678)
Q Consensus       458 --------~~---~~-----~~~lv~e~~~~~~L~~~l~---~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  515 (678)
                              ..   ..     ..+++|+-+ .+||.+++.   ....   ......+..+..|+++.+++||   ..|++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence                    11   11     235778877 458887754   2221   2334555677789999999999   999999


Q ss_pred             cCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCC--------CCCCccchHHHHHHHHHHH
Q 005760          516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE--------GRVSANGDVYSFGIMLMET  587 (678)
Q Consensus       516 ~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslGv~l~el  587 (678)
                      +||+|+|++++.+|.+.++||+.....+.   .  ......+..|.+||....        -.++.+.|.|++|+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~--~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT---R--YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTE---E--EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCc---e--eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            99999999999999999999998875432   1  111445678999996543        2478889999999999999


Q ss_pred             HcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCC
Q 005760          588 FTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQR  657 (678)
Q Consensus       588 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  657 (678)
                      ++|..||+..........                         ++..-.+.++.+.+|+..+|+++|.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~-------------------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW-------------------------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG-------------------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc-------------------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999999975332211100                         000001456679999999999999998

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.79  E-value=3e-21  Score=167.38  Aligned_cols=160  Identities=28%  Similarity=0.504  Sum_probs=113.9

Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      .++.|.|++|+++ ..|..+..+.+|+.|++++|+|+ ..|..++.++.|+.|+++-|++. .+|..|+.+|.|+.|||.
T Consensus        34 ~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt  110 (264)
T KOG0617|consen   34 NITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT  110 (264)
T ss_pred             hhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence            4555666666665 33445667777777777777776 67777777777777777777777 677777777777777777


Q ss_pred             CCcCC-CCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEE
Q 005760          181 GNKLS-GSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLN  259 (678)
Q Consensus       181 ~N~i~-~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~  259 (678)
                      +|++. ..+|..|-.++.|..|+|++|.+.-+|..++++.+|+.|.+..|.+. ..|.+++.++          .|+.|.
T Consensus       111 ynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt----------~lrelh  179 (264)
T KOG0617|consen  111 YNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLT----------RLRELH  179 (264)
T ss_pred             ccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHH----------HHHHHh
Confidence            77776 45677777777777777777777777777777777777777777776 5666666666          777777


Q ss_pred             ccCCcCCCcchHHHhc
Q 005760          260 LSNNNLSGAIPASLEK  275 (678)
Q Consensus       260 L~~N~l~~~~~~~~~~  275 (678)
                      +.+|+++ ..|..++.
T Consensus       180 iqgnrl~-vlppel~~  194 (264)
T KOG0617|consen  180 IQGNRLT-VLPPELAN  194 (264)
T ss_pred             cccceee-ecChhhhh
Confidence            7777776 44444443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.79  E-value=1.9e-20  Score=194.68  Aligned_cols=224  Identities=25%  Similarity=0.301  Sum_probs=177.4

Q ss_pred             ccCCCceeEEEEE----eCCCcEEEEEEeecccC--chhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEEEEecCC
Q 005760          400 IGRGSFGSVFKAR----LGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       400 ig~G~~g~V~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +|+|.||.|+++.    .+.|..+|+|+......  ........|..++...+ ||.++++...++.+...+++.+|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            6899999999874    34577899998754422  12224556888888887 99999999999999999999999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT  552 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  552 (678)
                      |++...+..... +.......+...++-+++++|   +.+|+|||+|++||+++.+|++++.|||+++..-.....    
T Consensus        82 g~lft~l~~~~~-f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----  153 (612)
T KOG0603|consen   82 GDLFTRLSKEVM-FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----  153 (612)
T ss_pred             chhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence            999988877664 555666677888999999999   999999999999999999999999999999876433222    


Q ss_pred             cccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       553 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                        +||..|||||+..  ....++|.||||++++||+||..||..     .......+                    ..+
T Consensus       154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~--------------------~~~  204 (612)
T KOG0603|consen  154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILK--------------------AEL  204 (612)
T ss_pred             --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhh--------------------hcc
Confidence              7899999999987  566789999999999999999999875     11111100                    011


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINA  660 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~  660 (678)
                      ..+......+.+++..++..+|..|.-.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            2233455668889999999999999855

>PLN03210 Resistant to P

Probab=99.78  E-value=3.3e-18  Score=204.30  Aligned_cols=279  Identities=20%  Similarity=0.244  Sum_probs=180.5

Q ss_pred             CCccccCCCCCCEEecCCCc------ccccCCccccCCC-CCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCC
Q 005760           13 IPRFIFNASKLSILELSDNS------FSGFIPNTFGNLR-NLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNP   85 (678)
Q Consensus        13 ~p~~~~~l~~L~~L~l~~n~------i~~~~~~~~~~l~-~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~   85 (678)
                      -+++|..+.+|+.|.+..+.      +...+|+.|..++ +|+.|++.+|.+..+|..      | ...+|+.|+|.+|+
T Consensus       550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~------f-~~~~L~~L~L~~s~  622 (1153)
T PLN03210        550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSN------F-RPENLVKLQMQGSK  622 (1153)
T ss_pred             cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCc------C-CccCCcEEECcCcc
Confidence            34567778888888886653      2334566676664 588888888888877753      3 45788888888888


Q ss_pred             CcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCC
Q 005760           86 LDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIP  165 (678)
Q Consensus        86 i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~  165 (678)
                      +.... .. +..++ +|+.|+|++|...+.+|. +..+++|+.|+|++|.....+|..+..+++|+.|++++|.....+|
T Consensus       623 l~~L~-~~-~~~l~-~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp  698 (1153)
T PLN03210        623 LEKLW-DG-VHSLT-GLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILP  698 (1153)
T ss_pred             ccccc-cc-cccCC-CCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccC
Confidence            76442 22 44555 788888888776666664 6778888888888876555778888888888888888765433566


Q ss_pred             CcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccc
Q 005760          166 DSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIA  245 (678)
Q Consensus       166 ~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~  245 (678)
                      ..+ ++++|+.|++++|......|..   .++|+.|++++|.++.+|..+ .+++|..|++.++... ..+..+..+.  
T Consensus       699 ~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~~~-~l~~L~~L~l~~~~~~-~l~~~~~~l~--  770 (1153)
T PLN03210        699 TGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPSNL-RLENLDELILCEMKSE-KLWERVQPLT--  770 (1153)
T ss_pred             CcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccccccc-cccccccccccccchh-hccccccccc--
Confidence            554 6788888888887655455543   357788888888888877654 4666666666664322 1111111110  


Q ss_pred             cccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccC
Q 005760          246 RIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGN  310 (678)
Q Consensus       246 ~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n  310 (678)
                      ...+...++|+.|+|++|.....+|..+.++++|+.|++++|+....+|....+..|..++++++
T Consensus       771 ~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~c  835 (1153)
T PLN03210        771 PLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSGC  835 (1153)
T ss_pred             hhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCCC
Confidence            01112234677777777765556666667777777777776654444454445555666666654

syringae 6; Provisional

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.78  E-value=2.6e-20  Score=193.35  Aligned_cols=281  Identities=23%  Similarity=0.260  Sum_probs=204.5

Q ss_pred             EEecCCCccc-ccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCC-----hhhhhcc
Q 005760           25 ILELSDNSFS-GFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILP-----KTSVGNL   98 (678)
Q Consensus        25 ~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-----~~~~~~l   98 (678)
                      .|+|..+.++ ......|..+.+|+.|++++|.++..... .++..+...++|+.|+++++.+.+...     ...+..+
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~-~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~   80 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAK-ALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG   80 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHH-HHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhc
Confidence            5788889887 33456677889999999999998654322 344567788899999999998863111     1123444


Q ss_pred             cccccEEEcccccccccCCccccCCCC---CcEEEccCCccCCc----CChhhhcc-CCCCEEEccCCcCCCC----CCC
Q 005760           99 SHSLEYFEMAYCNVSGGIPEEIGNLTN---LTIIYLGGNKLNGS----IPSTLGKL-QKLQGLGLENNKLEGS----IPD  166 (678)
Q Consensus        99 ~~~L~~L~l~~n~l~~~~~~~~~~l~~---L~~L~l~~N~l~~~----~~~~~~~l-~~L~~L~L~~n~i~~~----~~~  166 (678)
                      + +|++|++++|.+.+..+..+..+.+   |++|++++|++.+.    ....+..+ ++|+.|+|++|.+++.    ++.
T Consensus        81 ~-~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~  159 (319)
T cd00116          81 C-GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK  159 (319)
T ss_pred             C-ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence            4 8999999999998777777766665   99999999998732    23345667 8999999999999842    334


Q ss_pred             cccCCCCccEEecCCCcCCCC----Chhhhhccccccceecccccccc-----ccccccccccccEEEecCCcccCCCCc
Q 005760          167 SICHSDELYKLELGGNKLSGS----IPECFNNLASLRILLLGSNELTS-----IPLTFWNLKDILYLNFSSNFFTGPLPL  237 (678)
Q Consensus       167 ~~~~l~~L~~L~l~~N~i~~~----~~~~~~~l~~L~~L~l~~N~l~~-----l~~~~~~l~~L~~L~l~~N~l~~~~~~  237 (678)
                      .+..+++|++|++++|.+++.    ++..+..+++|+.|+|++|.++.     ++..+..+++|+.|++++|.+++....
T Consensus       160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~  239 (319)
T cd00116         160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA  239 (319)
T ss_pred             HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence            567778999999999999853    23445566799999999999873     344577889999999999998864333


Q ss_pred             cccccccccccccCcccccEEEccCCcCCCc----chHHHhcccCCCceecccccccccC----CC-CCcc-cccccccc
Q 005760          238 EIGNLKIARIDSCDLISLISLNLSNNNLSGA----IPASLEKLSYLKDLNLSFNKLEGEI----PR-GGSF-GNFSAESF  307 (678)
Q Consensus       238 ~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~~~~~~----~~-~~~~-~~l~~~~~  307 (678)
                      .+...    . ....++|+.|++++|.++..    ....+..+++|+.+++++|+++...    .. ...+ ..+..+++
T Consensus       240 ~l~~~----~-~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~  314 (319)
T cd00116         240 ALASA----L-LSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWV  314 (319)
T ss_pred             HHHHH----H-hccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhccc
Confidence            33211    0 00234899999999999732    3345566789999999999998552    11 1222 46677777


Q ss_pred             ccCcc
Q 005760          308 EGNEL  312 (678)
Q Consensus       308 ~~n~~  312 (678)
                      .+|||
T Consensus       315 ~~~~~  319 (319)
T cd00116         315 KDDSF  319 (319)
T ss_pred             CCCCC
Confidence            77764

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.76  E-value=2.1e-20  Score=162.08  Aligned_cols=179  Identities=30%  Similarity=0.497  Sum_probs=160.7

Q ss_pred             ccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhcccccc
Q 005760          120 IGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLR  199 (678)
Q Consensus       120 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~  199 (678)
                      +.++.+++.|-||.|+++ ..|..+.++.+|+.|++.+|+|+ .+|..+..+++|+.|+++-|++. .+|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            556889999999999998 77888999999999999999999 88999999999999999999999 8999999999999


Q ss_pred             ceeccccccc--cccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhccc
Q 005760          200 ILLLGSNELT--SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLS  277 (678)
Q Consensus       200 ~L~l~~N~l~--~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~  277 (678)
                      .|||++|.+.  .+|..|..+..|+.|+|+.|.+. .+|...+.++          +|+.|.+.+|.+- ..|..++.+.
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt----------~lqil~lrdndll-~lpkeig~lt  173 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLT----------NLQILSLRDNDLL-SLPKEIGDLT  173 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhc----------ceeEEeeccCchh-hCcHHHHHHH
Confidence            9999999998  58999999999999999999998 7888888888          9999999999998 7888999999


Q ss_pred             CCCceecccccccccCCCCCcccccc---ccccccCccc
Q 005760          278 YLKDLNLSFNKLEGEIPRGGSFGNFS---AESFEGNELL  313 (678)
Q Consensus       278 ~L~~L~l~~N~~~~~~~~~~~~~~l~---~~~~~~n~~~  313 (678)
                      .|+.|.+.||.++-.+|+.+.+....   ...++.|||.
T Consensus       174 ~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  174 RLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             HHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            99999999999998888865543332   3345677774

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=9.2e-18  Score=187.23  Aligned_cols=252  Identities=22%  Similarity=0.254  Sum_probs=186.4

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCC---CccceeeeeeeecCCeEEE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR---HRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  465 (678)
                      .....|.+.+.||+|+||.||+|...+|+.||+|+=+....+   +|..-.+++.+|+   -+-|..+..++.-.+..++
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            344568888999999999999999878999999997665443   2333345556665   2334455555566777889


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec-------CCCcEEEEeecc
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD-------DNMVAHLSDFGI  538 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~-------~~~~~kl~Dfg~  538 (678)
                      |+||.+.|+|.+++...+ .+++.-++.++.|++..+++||   ..+|||+||||+|.||.       ...-++|+|||-
T Consensus       772 v~ey~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eeeccccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            999999999999998554 5899999999999999999999   99999999999999994       345689999999


Q ss_pred             ccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc
Q 005760          539 AKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE  618 (678)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  618 (678)
                      +..+.--.........++|-.+-=+|...+...++++|-|.++.+++-|+-|+.-=  ...+.               ..
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~g~---------------~~  910 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKNGS---------------SW  910 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcCCc---------------ce
Confidence            98776444455666778999999999999999999999999999999999887531  00000               00


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      .++.. .    .+....    .-..+++..+|+.|-..=|...++...|+++.+.
T Consensus       911 ~~~~~-~----~Ry~~~----~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  911 MVKTN-F----PRYWKR----DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             ecccc-c----hhhhhH----HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence            01110 0    011111    1133566777776666667788888888777554

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=1.3e-17  Score=158.94  Aligned_cols=136  Identities=15%  Similarity=0.255  Sum_probs=106.5

Q ss_pred             CCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhC-----CCccceeeeeeeecCC---eEE-E
Q 005760          395 SENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-----RHRNIIKVISSCSNEE---FKA-L  465 (678)
Q Consensus       395 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~~-l  465 (678)
                      .-.+.||+|+||.||. ...++.. +||++........+.+.+|+.+++.+     .||||++++|++.+..   ..+ +
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3467899999999996 3334444 79988765444567789999999999     5799999999998763   333 7


Q ss_pred             EEEe--cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEEcCCCCCCeeecC----CCcEEEEeecc
Q 005760          466 VLEY--MPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCDLKPSNVLLDD----NMVAHLSDFGI  538 (678)
Q Consensus       466 v~e~--~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~dl~~~Nill~~----~~~~kl~Dfg~  538 (678)
                      |+||  +.+++|.+++.+..  +++.  ..++.|++.++ +|||   +++|+||||||+||+++.    ++.++|+||+.
T Consensus        83 I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  55799999997643  5544  35677888777 9999   999999999999999973    34899999544


Q ss_pred             c
Q 005760          539 A  539 (678)
Q Consensus       539 ~  539 (678)
                      +
T Consensus       156 ~  156 (210)
T PRK10345        156 E  156 (210)
T ss_pred             C
Confidence            3

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=2.9e-17  Score=160.64  Aligned_cols=141  Identities=18%  Similarity=0.176  Sum_probs=110.5

Q ss_pred             CCCCCccccCCCceeEEEEE--eCCCcEEEEEEeecccCc------------------------hhhhHHHHHHHHHhCC
Q 005760          393 GFSENNLIGRGSFGSVFKAR--LGDGMEVAMKVFNLQYGR------------------------VFKSFDVECEMMKSIR  446 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  446 (678)
                      .|.+.+.||+|++|.||+|.  ..+|+.||+|++......                        ....+..|++.++.+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47889999999999999998  568999999998753210                        1123467999999997


Q ss_pred             Ccc--ceeeeeeeecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-eEEcCCCCCCe
Q 005760          447 HRN--IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ-VIHCDLKPSNV  523 (678)
Q Consensus       447 h~n--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dl~~~Ni  523 (678)
                      +..  +.++++.    ...++||||+++.++........ .........++.|++.++.+||   +.+ ++||||||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence            533  3344443    23479999999988876653332 3556667889999999999999   999 99999999999


Q ss_pred             eecCCCcEEEEeecccccc
Q 005760          524 LLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       524 ll~~~~~~kl~Dfg~~~~~  542 (678)
                      +++ ++.++++|||.+...
T Consensus       181 li~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEE-CCCEEEEEChhhhcc
Confidence            999 889999999998754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=1.5e-16  Score=152.43  Aligned_cols=141  Identities=22%  Similarity=0.184  Sum_probs=110.7

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCc----------------------hhhhHHHHHHHHHhCC
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGR----------------------VFKSFDVECEMMKSIR  446 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~  446 (678)
                      .....|.+.+.||+|+||.||+|..++|+.||||++......                      .......|+.++..+.
T Consensus        12 ~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   91 (198)
T cd05144          12 KRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY   91 (198)
T ss_pred             HcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH
Confidence            333448888999999999999999888999999997643210                      1123567888888887


Q ss_pred             Ccc--ceeeeeeeecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCee
Q 005760          447 HRN--IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVL  524 (678)
Q Consensus       447 h~n--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nil  524 (678)
                      |++  +...++.    ...++||||+++++|.+....       .....++.+++.++.++|   ..+++||||+|+||+
T Consensus        92 ~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nil  157 (198)
T cd05144          92 EEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNIL  157 (198)
T ss_pred             HcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEE
Confidence            774  4444432    345899999999998765431       234568899999999999   899999999999999


Q ss_pred             ecCCCcEEEEeeccccccC
Q 005760          525 LDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       525 l~~~~~~kl~Dfg~~~~~~  543 (678)
                      +++++.++++|||.+....
T Consensus       158 l~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         158 VDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EcCCCcEEEEECCccccCC
Confidence            9999999999999996554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=1.6e-16  Score=154.12  Aligned_cols=134  Identities=25%  Similarity=0.347  Sum_probs=112.6

Q ss_pred             ccccCCCceeEEEEEeCCCcEEEEEEeecccCc--------hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGR--------VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      +.||+|++|.||+|.. +|..|++|+.......        ....+..|++++..++|+++.....++.+.+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 6788999986532211        124567899999999999988777777677778899999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ++|++|.+++....    . .+..++.+++.++.++|   ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986542    2 77889999999999999   99999999999999999 78999999998753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.67  E-value=5.2e-17  Score=177.45  Aligned_cols=212  Identities=23%  Similarity=0.274  Sum_probs=148.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .++|..++.|..|+||.||.++++ +.+.+|+|+=+ +     ..+.+.  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNk-q-----~lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-Q-----NLILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccc-c-----chhhhc--cccccCCccee------------------
Confidence            468999999999999999999875 56778885422 1     111111  22222334333                  


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc-
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS-  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  548 (678)
                         ||-.+.++..+. ++...        +.+++|+|   ..+|+|||+||.|.+++.-|++|++|||+++........ 
T Consensus       136 ---gDc~tllk~~g~-lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGP-LPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             ---chhhhhcccCCC-Ccchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence               455555554332 33222        77899999   999999999999999999999999999998643211111 


Q ss_pred             ------------ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcc
Q 005760          549 ------------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST  616 (678)
Q Consensus       549 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  616 (678)
                                  ....+.+||+.|.|||++....|...+|+|++|+++||.+.|..||.+.++ ++.+.+.+.+...   
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp-eelfg~visd~i~---  276 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-EELFGQVISDDIE---  276 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH-HHHHhhhhhhhcc---
Confidence                        112345899999999999999999999999999999999999999987433 3334444332110   


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHH
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAK  661 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  661 (678)
                        +.+.            .+..++++.+++.+.++.+|..|--..
T Consensus       277 --wpE~------------dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  277 --WPEE------------DEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             --cccc------------CcCCCHHHHHHHHHHHHhChHhhcccc
Confidence              0000            012456688999999999999997443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=4.5e-16  Score=171.87  Aligned_cols=139  Identities=22%  Similarity=0.298  Sum_probs=112.0

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEe-ecccC-------chhhhHHHHHHHHHhCCCccceeeeeeeecC
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVF-NLQYG-------RVFKSFDVECEMMKSIRHRNIIKVISSCSNE  460 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~-~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  460 (678)
                      .....|...+.||+|+||+||+|.+... .+++|+. .....       ...+.+.+|+++++.++|++++....++.+.
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            3345567789999999999999987543 3444432 21111       1235678899999999999998887777777


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      ...++||||+++++|.+++.         ....++.+++.++.+||   +.+++|||+||+||++ .++.++++|||+++
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            77889999999999999885         34678999999999999   9999999999999999 67899999999986


Q ss_pred             c
Q 005760          541 L  541 (678)
Q Consensus       541 ~  541 (678)
                      .
T Consensus       476 ~  476 (535)
T PRK09605        476 Y  476 (535)
T ss_pred             c
Confidence            4

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.67  E-value=4.6e-16  Score=149.44  Aligned_cols=130  Identities=20%  Similarity=0.331  Sum_probs=105.7

Q ss_pred             cccCCCceeEEEEEeCCCcEEEEEEeecccC---c-----hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          399 LIGRGSFGSVFKARLGDGMEVAMKVFNLQYG---R-----VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       399 ~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      .||+|++|.||+|.. +|..|++|+......   +     ....+.+|+++++.++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 678899998643211   1     1255678999999999887655555555566678999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      +|++|.+++.....        .++.+++.++.++|   +.+++|+|++|+||+++ ++.++++|||.+..
T Consensus        80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998764321        68999999999999   99999999999999999 88999999999754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=4.5e-17  Score=166.56  Aligned_cols=122  Identities=28%  Similarity=0.501  Sum_probs=107.6

Q ss_pred             eEEEEEEecCCCCHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSS--NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA  539 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~  539 (678)
                      ..|+.|+++...+|.+|+...  ....++.....++.|++.|++|      ++.+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999643  3457788889999999999999      67899999999999999999999999999


Q ss_pred             cccCCCC----CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc
Q 005760          540 KLLTRED----QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT  589 (678)
Q Consensus       540 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~  589 (678)
                      +......    .....+...||..||+||-+.+..|+.++||||+|++|+|++.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            8775444    3445667789999999999999999999999999999999996

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=9e-17  Score=176.33  Aligned_cols=256  Identities=23%  Similarity=0.289  Sum_probs=197.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC--CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG--DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  465 (678)
                      ...|...+.||+|+|+.|-.....  ....+|+|.+....  .........|..+-+.+. |+|++.+++...+.+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            567888899999999999888643  34556777665432  223344555777777776 9999999999999999999


Q ss_pred             EEEecCCCCHHHHh-hhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC-cEEEEeeccccccC
Q 005760          466 VLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLT  543 (678)
Q Consensus       466 v~e~~~~~~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~-~~kl~Dfg~~~~~~  543 (678)
                      .++|..++++.+-+ .......+......++.|+..++.|+|.  ..++.|+|+||+|.+++..+ ..++.|||+|+.+.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999999888 5554346666778899999999999995  67899999999999999999 99999999999887


Q ss_pred             C-CCCcceeecccC-CccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccc
Q 005760          544 R-EDQSTIQTQTLA-TIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV  620 (678)
Q Consensus       544 ~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (678)
                      . .+.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...........|.......      
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~------  250 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRF------  250 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccccc------
Confidence            7 566666677778 9999999998874 456789999999999999999999987655554444433221000      


Q ss_pred             cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 005760          621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV  664 (678)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell  664 (678)
                                .............++..+++..+|+.|.+.+++.
T Consensus       251 ----------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  251 ----------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ----------ccCccccCChhhhhcccccccCCchhcccccccc
Confidence                      0000111233356788889999999999988764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.60  E-value=6.8e-15  Score=139.82  Aligned_cols=136  Identities=23%  Similarity=0.261  Sum_probs=96.7

Q ss_pred             CccccCCCceeEEEEEeCCCcEEEEEEeecccCc--hhhh----------------------HHHHHHHHHhCCCcc--c
Q 005760          397 NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGR--VFKS----------------------FDVECEMMKSIRHRN--I  450 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i  450 (678)
                      .+.||+|+||.||+|...+++.||||++......  ....                      ...|.+.+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            5689999999999999878999999998653221  1111                      124555555554332  3


Q ss_pred             eeeeeeeecCCeEEEEEEecCCCCHHH-HhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEcCCCCCCeeecCC
Q 005760          451 IKVISSCSNEEFKALVLEYMPHGSLEK-YLHSSNYILDIYQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPSNVLLDDN  528 (678)
Q Consensus       451 v~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dl~~~Nill~~~  528 (678)
                      .+.+++    ...++||||++++++.. .+....  .. .....++.+++.++.++|   . .+++|+|++|+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            333333    23589999999854321 111111  11 456789999999999999   7 9999999999999999 8


Q ss_pred             CcEEEEeeccccccC
Q 005760          529 MVAHLSDFGIAKLLT  543 (678)
Q Consensus       529 ~~~kl~Dfg~~~~~~  543 (678)
                      +.++++|||.+....
T Consensus       151 ~~~~liDfg~a~~~~  165 (187)
T cd05119         151 GKVYIIDVPQAVEID  165 (187)
T ss_pred             CcEEEEECccccccc
Confidence            999999999996553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.58  E-value=2e-14  Score=131.44  Aligned_cols=135  Identities=20%  Similarity=0.264  Sum_probs=112.8

Q ss_pred             CCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCC--ccceeeeeeeecCCeEEEEEEecCCC
Q 005760          396 ENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRH--RNIIKVISSCSNEEFKALVLEYMPHG  473 (678)
Q Consensus       396 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~  473 (678)
                      +.+.||+|.++.||++...+ ..+++|.......  ...+..|+..++.++|  .++.++++++...+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999754 7899999865433  4678899999999976  58899999888888899999999887


Q ss_pred             CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          474 SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       474 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      .+..+        +......++.+++++++++|.....+++|+|++|+||+++..+.+++.|||.+..
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77544        4556677899999999999943335799999999999999999999999998853

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=5.4e-14  Score=137.90  Aligned_cols=135  Identities=18%  Similarity=0.237  Sum_probs=104.8

Q ss_pred             Ccccc-CCCceeEEEEEeCCCcEEEEEEeeccc-------------CchhhhHHHHHHHHHhCCCccc--eeeeeeeecC
Q 005760          397 NNLIG-RGSFGSVFKARLGDGMEVAMKVFNLQY-------------GRVFKSFDVECEMMKSIRHRNI--IKVISSCSNE  460 (678)
Q Consensus       397 ~~~ig-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  460 (678)
                      ...|| .||.|+||.+... +..++||.+....             ......+.+|++++..++|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35787 8999999999874 7789999885311             1223567789999999998875  5666654332


Q ss_pred             -C---eEEEEEEecCC-CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEe
Q 005760          461 -E---FKALVLEYMPH-GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD  535 (678)
Q Consensus       461 -~---~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~D  535 (678)
                       .   ..++|||++++ .+|.+++....  ++..    .+.+++.++.++|   +.||+|+||||+|||++.++.++++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence             2   23599999997 69998886532  4433    3678999999999   99999999999999999999999999


Q ss_pred             eccccc
Q 005760          536 FGIAKL  541 (678)
Q Consensus       536 fg~~~~  541 (678)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            999864

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.53  E-value=9.1e-16  Score=148.67  Aligned_cols=248  Identities=20%  Similarity=0.247  Sum_probs=175.6

Q ss_pred             cccCCCCCCEEecCCCccccc----CCccccCCCCCCEEEccCccCCCCccchh-----hcccccCCCCCcEEECccCCC
Q 005760           16 FIFNASKLSILELSDNSFSGF----IPNTFGNLRNLQALRLSNNYLTSSTLELS-----FLSSLSNCKSLTLISFSNNPL   86 (678)
Q Consensus        16 ~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~~~~~~-----~~~~~~~l~~L~~L~L~~n~i   86 (678)
                      .+..++.++.|+|++|.+...    +...+.+.++|+..++++-........++     +.+++.+++.|++|+||+|-+
T Consensus        25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~  104 (382)
T KOG1909|consen   25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF  104 (382)
T ss_pred             HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence            456688999999999999744    55667788999999999876554443321     224667888999999999998


Q ss_pred             cccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChh-------------hhccCCCCEE
Q 005760           87 DGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPST-------------LGKLQKLQGL  153 (678)
Q Consensus        87 ~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-------------~~~l~~L~~L  153 (678)
                      ..-.+.. +..                     -+.++.+|++|.|.+|.+....-..             ..+-+.|+.+
T Consensus       105 G~~g~~~-l~~---------------------ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~  162 (382)
T KOG1909|consen  105 GPKGIRG-LEE---------------------LLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVF  162 (382)
T ss_pred             CccchHH-HHH---------------------HHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEE
Confidence            6444433 222                     2344666666667666664221112             1234678888


Q ss_pred             EccCCcCCCCC----CCcccCCCCccEEecCCCcCCC----CChhhhhccccccceecccccccc-----cccccccccc
Q 005760          154 GLENNKLEGSI----PDSICHSDELYKLELGGNKLSG----SIPECFNNLASLRILLLGSNELTS-----IPLTFWNLKD  220 (678)
Q Consensus       154 ~L~~n~i~~~~----~~~~~~l~~L~~L~l~~N~i~~----~~~~~~~~l~~L~~L~l~~N~l~~-----l~~~~~~l~~  220 (678)
                      ..++|++....    ...|...+.|+.+.++.|.|.-    .+...|..+++|+.|||.+|.++.     +...++.+++
T Consensus       163 i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~  242 (382)
T KOG1909|consen  163 ICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPH  242 (382)
T ss_pred             EeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccch
Confidence            88888876432    3356667888888888888773    233567788999999999998883     4557888999


Q ss_pred             ccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcch----HHHhcccCCCceeccccccc
Q 005760          221 ILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP----ASLEKLSYLKDLNLSFNKLE  290 (678)
Q Consensus       221 L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~l~~N~~~  290 (678)
                      |+.|++++|.+......+|..     ......|+|+.|.|.+|.|+..-.    .++...+.|..|+|++|.+.
T Consensus       243 L~El~l~dcll~~~Ga~a~~~-----al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  243 LRELNLGDCLLENEGAIAFVD-----ALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             heeecccccccccccHHHHHH-----HHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            999999999998777665532     111237799999999999985322    34456789999999999984

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.51  E-value=7.8e-16  Score=157.53  Aligned_cols=194  Identities=30%  Similarity=0.424  Sum_probs=106.2

Q ss_pred             EEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcE
Q 005760           49 ALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTI  128 (678)
Q Consensus        49 ~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  128 (678)
                      .|.|++-++...+..-    +=..+.--...+|+.|++..+ |.. +..+. .|+.+.|+.|.+. .+|..+.++..|++
T Consensus        54 ~l~Ls~rrlk~fpr~a----~~~~ltdt~~aDlsrNR~~el-p~~-~~~f~-~Le~liLy~n~~r-~ip~~i~~L~~lt~  125 (722)
T KOG0532|consen   54 RLLLSGRRLKEFPRGA----ASYDLTDTVFADLSRNRFSEL-PEE-ACAFV-SLESLILYHNCIR-TIPEAICNLEALTF  125 (722)
T ss_pred             ccccccchhhcCCCcc----ccccccchhhhhccccccccC-chH-HHHHH-HHHHHHHHhccce-ecchhhhhhhHHHH
Confidence            3455555555554331    113334444566666666432 222 22222 4555566666555 34555556666666


Q ss_pred             EEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceecccccc
Q 005760          129 IYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNEL  208 (678)
Q Consensus       129 L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l  208 (678)
                      |||+.|+++ ..|..++.|+ |+.|.+++|+++ .+|..++.++.|..||.+.|++. .+|..+.++.+|..|.+..|++
T Consensus       126 l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l  201 (722)
T KOG0532|consen  126 LDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHL  201 (722)
T ss_pred             hhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhh
Confidence            666666665 4555555443 566666666666 55555555566666666666666 4455556666666666666666


Q ss_pred             ccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCC
Q 005760          209 TSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLS  266 (678)
Q Consensus       209 ~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~  266 (678)
                      ..+|..+..| .|..||+|.|++. .+|..|.+|+          .|++|-|.+|.++
T Consensus       202 ~~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~----------~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  202 EDLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMR----------HLQVLQLENNPLQ  247 (722)
T ss_pred             hhCCHHHhCC-ceeeeecccCcee-ecchhhhhhh----------hheeeeeccCCCC
Confidence            6666555543 3556666666665 5555555555          6666666666665

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.48  E-value=3.2e-15  Score=153.09  Aligned_cols=198  Identities=24%  Similarity=0.412  Sum_probs=144.6

Q ss_pred             EEecCCCcccccCCcccc-CCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccccccc
Q 005760           25 ILELSDNSFSGFIPNTFG-NLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLE  103 (678)
Q Consensus        25 ~L~l~~n~i~~~~~~~~~-~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~  103 (678)
                      .|.|++-+++....+++. .+.--...||+.|++..++.+      +..+..|+.+.|..|.+. .+|.. +.++. .|+
T Consensus        54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~elp~~------~~~f~~Le~liLy~n~~r-~ip~~-i~~L~-~lt  124 (722)
T KOG0532|consen   54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSELPEE------ACAFVSLESLILYHNCIR-TIPEA-ICNLE-ALT  124 (722)
T ss_pred             ccccccchhhcCCCccccccccchhhhhccccccccCchH------HHHHHHHHHHHHHhccce-ecchh-hhhhh-HHH
Confidence            455666666544333333 344456677777777777654      445566777777777775 33433 56665 677


Q ss_pred             EEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCc
Q 005760          104 YFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNK  183 (678)
Q Consensus       104 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~  183 (678)
                      .|+|+.|++. .+|..+..|+ |+.|.+++|+++ .+|..++.++.|..|+.+.|.|. .+|.-++++.+|+.|.+..|+
T Consensus       125 ~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~  200 (722)
T KOG0532|consen  125 FLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNH  200 (722)
T ss_pred             Hhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhh
Confidence            7788888777 4566666665 888889999987 67788888888889999999888 677778888899999999998


Q ss_pred             CCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCcc
Q 005760          184 LSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLE  238 (678)
Q Consensus       184 i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~  238 (678)
                      +. .+|..+..+ .|..||+|+|++..||..|.+|..|++|-|.+|++. ..|..
T Consensus       201 l~-~lp~El~~L-pLi~lDfScNkis~iPv~fr~m~~Lq~l~LenNPLq-SPPAq  252 (722)
T KOG0532|consen  201 LE-DLPEELCSL-PLIRLDFSCNKISYLPVDFRKMRHLQVLQLENNPLQ-SPPAQ  252 (722)
T ss_pred             hh-hCCHHHhCC-ceeeeecccCceeecchhhhhhhhheeeeeccCCCC-CChHH
Confidence            88 445556644 588899999999999988999999999999999887 44443

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.46  E-value=7.6e-15  Score=146.05  Aligned_cols=215  Identities=21%  Similarity=0.243  Sum_probs=130.6

Q ss_pred             CCccccCCCCCCEEecCCCcccccCC-ccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCC
Q 005760           13 IPRFIFNASKLSILELSDNSFSGFIP-NTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILP   91 (678)
Q Consensus        13 ~p~~~~~l~~L~~L~l~~n~i~~~~~-~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~   91 (678)
                      +.+--+++++|++..|.++.+..... .....+++++.|||+.|-+........+   ...+++|+.|+|+.|++.....
T Consensus       113 i~akQsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i---~eqLp~Le~LNls~Nrl~~~~~  189 (505)
T KOG3207|consen  113 IAAKQSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKI---AEQLPSLENLNLSSNRLSNFIS  189 (505)
T ss_pred             HHHHhhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHH---HHhcccchhcccccccccCCcc
Confidence            33334667888888888888873221 4667788888888888888776654333   4567888888888888864433


Q ss_pred             hhhhhcccccccEEEcccccccc-cCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCC--Ccc
Q 005760           92 KTSVGNLSHSLEYFEMAYCNVSG-GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIP--DSI  168 (678)
Q Consensus        92 ~~~~~~l~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~--~~~  168 (678)
                      ......++ .|+.|.|+.|.++. .+-..+..+|+|+.|+|..|...........-+..|++|+|++|.+- ..+  ...
T Consensus       190 s~~~~~l~-~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~  267 (505)
T KOG3207|consen  190 SNTTLLLS-HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKV  267 (505)
T ss_pred             ccchhhhh-hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-cccccccc
Confidence            33222333 67777777777762 12233445677777777777422233333344566777777777765 333  345


Q ss_pred             cCCCCccEEecCCCcCCCCC-hhh-----hhccccccceeccccccccccc--cccccccccEEEecCCccc
Q 005760          169 CHSDELYKLELGGNKLSGSI-PEC-----FNNLASLRILLLGSNELTSIPL--TFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       169 ~~l~~L~~L~l~~N~i~~~~-~~~-----~~~l~~L~~L~l~~N~l~~l~~--~~~~l~~L~~L~l~~N~l~  232 (678)
                      ..+|.|..|.++.+.|..+- |+.     ...+++|++|+++.|+|...+.  .+..+++|+.|.+..|.++
T Consensus       268 ~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  268 GTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             ccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence            56666677777776666432 221     2335566666666666665543  3445555566665566555

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.44  E-value=9.7e-14  Score=148.29  Aligned_cols=196  Identities=29%  Similarity=0.449  Sum_probs=103.0

Q ss_pred             EEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCC-CCCcEEECccCCCcccCChhhhhccccccc
Q 005760           25 ILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNC-KSLTLISFSNNPLDGILPKTSVGNLSHSLE  103 (678)
Q Consensus        25 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l-~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~  103 (678)
                      .|++..|.+. .....+..++.++.|++.+|.+.+++...      ..+ .+|+.|++++|.+..+.  .....++ .|+
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i~~~~------~~~~~nL~~L~l~~N~i~~l~--~~~~~l~-~L~  166 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDIPPLI------GLLKSNLKELDLSDNKIESLP--SPLRNLP-NLK  166 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccccCcccc------ccchhhcccccccccchhhhh--hhhhccc-ccc
Confidence            5888888885 33455666788999999999999988652      334 37888888888886431  0123333 444


Q ss_pred             EEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCc
Q 005760          104 YFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNK  183 (678)
Q Consensus       104 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~  183 (678)
                      .|++++|++... |...+.+++|+.|++++|+++ .+|.....+.+|++|.+++|.+. ..+..+..+.++..|.+.+|+
T Consensus       167 ~L~l~~N~l~~l-~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~  243 (394)
T COG4886         167 NLDLSFNDLSDL-PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNK  243 (394)
T ss_pred             ccccCCchhhhh-hhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCce
Confidence            444444444422 222224445555555555554 33333333333555555555322 233344444444444444444


Q ss_pred             CCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCC
Q 005760          184 LSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPL  235 (678)
Q Consensus       184 i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~  235 (678)
                      +. ..+..++.+++|+.|++++|+++.++. +..+.+|+.|++++|.+....
T Consensus       244 ~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~~~  293 (394)
T COG4886         244 LE-DLPESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSNAL  293 (394)
T ss_pred             ee-eccchhccccccceecccccccccccc-ccccCccCEEeccCccccccc
Confidence            44 223344444444455555554444443 444444444444444444333

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.43  E-value=6e-13  Score=141.96  Aligned_cols=141  Identities=23%  Similarity=0.273  Sum_probs=99.9

Q ss_pred             CccccCCCceeEEEEEeCCCcEEEEEEeecccCchh----------------------------------------hhHH
Q 005760          397 NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF----------------------------------------KSFD  436 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~  436 (678)
                      .+.||.|++|.||+|+.++|+.||||+.++...+..                                        -++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            368999999999999999999999999864321100                                        1244


Q ss_pred             HHHHHHHhCC----Cccceeeeeee-ecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHH-HHHHHhcCCC
Q 005760          437 VECEMMKSIR----HRNIIKVISSC-SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS-ALEYLHFGYS  510 (678)
Q Consensus       437 ~e~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~~~  510 (678)
                      .|.+.+..++    |.+-+.+-..+ ...+..++||||++|++|.++........+   ...++.+++. .+..+|   .
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~---~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL---R  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH---h
Confidence            5555555542    32222222222 223446899999999999887754322222   3446666665 478889   8


Q ss_pred             CCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       511 ~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      .|++|+|++|.||+++.++.++++|||++..+.
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999999997664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.42  E-value=2.8e-13  Score=144.70  Aligned_cols=179  Identities=34%  Similarity=0.481  Sum_probs=102.4

Q ss_pred             cccEEEcccccccccCCccccCCC-CCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEec
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLT-NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL  179 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l  179 (678)
                      .++.|++.+|.++.+. .....++ +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|.....+++|+.|++
T Consensus       117 ~l~~L~l~~n~i~~i~-~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l  193 (394)
T COG4886         117 NLTSLDLDNNNITDIP-PLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL  193 (394)
T ss_pred             ceeEEecCCcccccCc-cccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence            4555555555555332 2233332 6666666666665 44455566666666666666666 44444445666666666


Q ss_pred             CCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEE
Q 005760          180 GGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLN  259 (678)
Q Consensus       180 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~  259 (678)
                      ++|++. .+|........|++|.+++|.+..++..+..+.++..|.+.+|++... +..+..+.          +|+.|+
T Consensus       194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~----------~l~~L~  261 (394)
T COG4886         194 SGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDL-PESIGNLS----------NLETLD  261 (394)
T ss_pred             cCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeec-cchhcccc----------ccceec
Confidence            666666 444433444456666666665555555566666666666666665521 33333333          666666


Q ss_pred             ccCCcCCCcchHHHhcccCCCceecccccccccCCCC
Q 005760          260 LSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG  296 (678)
Q Consensus       260 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  296 (678)
                      +++|+++...+  ++.+.+++.|++++|.+...++..
T Consensus       262 ~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         262 LSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             ccccccccccc--ccccCccCEEeccCccccccchhh
Confidence            66666664433  566666666666666666554443

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.41  E-value=5.4e-14  Score=133.14  Aligned_cols=135  Identities=26%  Similarity=0.385  Sum_probs=89.2

Q ss_pred             ccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhcccccc
Q 005760          120 IGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLR  199 (678)
Q Consensus       120 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~  199 (678)
                      ....+.|++||||+|.|+ .+.+...-+|.++.|+++.|+|+ .+. .+..+++|+.|||++|.++ ..-..-.++-+.+
T Consensus       280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK  355 (490)
T KOG1259|consen  280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK  355 (490)
T ss_pred             cchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence            334566777777777776 55666666677777777777776 433 3777777777777777777 3333334566777


Q ss_pred             ceeccccccccccccccccccccEEEecCCcccCCCC-ccccccccccccccCcccccEEEccCCcCCCcc
Q 005760          200 ILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLP-LEIGNLKIARIDSCDLISLISLNLSNNNLSGAI  269 (678)
Q Consensus       200 ~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~  269 (678)
                      .|.|+.|.|.++. ++.++-+|..||+++|+|..... ..++          ++|-|+.|.|.+|.+....
T Consensus       356 tL~La~N~iE~LS-GL~KLYSLvnLDl~~N~Ie~ldeV~~IG----------~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  356 TLKLAQNKIETLS-GLRKLYSLVNLDLSSNQIEELDEVNHIG----------NLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             eeehhhhhHhhhh-hhHhhhhheeccccccchhhHHHhcccc----------cccHHHHHhhcCCCccccc
Confidence            7777777777664 45666677777888887763221 2233          4458888888888887443

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.41  E-value=6.6e-12  Score=132.65  Aligned_cols=168  Identities=18%  Similarity=0.237  Sum_probs=130.0

Q ss_pred             EeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHH
Q 005760          412 RLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQR  491 (678)
Q Consensus       412 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  491 (678)
                      +..++.+|.|..++....+..+...+-++.++.++||+|+++++.....+..|+|+|.+  ..|..++....    ...+
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~----~~~v  106 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG----KEEV  106 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH----HHHH
Confidence            34578899999987665555566788889999999999999999999999999999987  35777776543    4555


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCC
Q 005760          492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV  571 (678)
Q Consensus       492 ~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  571 (678)
                      ..-+.||+.||.+||+  +.+++|+++.-..|++++.|+.||++|.++......  .......+.-..|..|+.+.... 
T Consensus       107 ~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~--~~~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  107 CLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGF--NAPAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccC--CcccccchhhhcccChhhcCccc-
Confidence            6678899999999986  789999999999999999999999999988654321  11112222333466676543333 


Q ss_pred             CccchHHHHHHHHHHHHcCC
Q 005760          572 SANGDVYSFGIMLMETFTRK  591 (678)
Q Consensus       572 ~~~~DvwslGv~l~ell~g~  591 (678)
                       -..|.|.|||+++|++.|.
T Consensus       182 -~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             -cchhhhhHHHHHHHHhCcc
Confidence             2459999999999999983

>PLN03150 hypothetical protein; Provisional

Probab=99.36  E-value=1.7e-12  Score=145.10  Aligned_cols=111  Identities=34%  Similarity=0.509  Sum_probs=88.5

Q ss_pred             ccceeccccccc-cccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcc
Q 005760          198 LRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKL  276 (678)
Q Consensus       198 L~~L~l~~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l  276 (678)
                      ++.|+|++|.++ .+|..+..+++|+.|+|++|.+.+.+|..+..++          +|+.|+|++|++++.+|..+..+
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~----------~L~~LdLs~N~lsg~iP~~l~~L  489 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSIT----------SLEVLDLSYNSFNGSIPESLGQL  489 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCC----------CCCEEECCCCCCCCCCchHHhcC
Confidence            677888888887 5677788888888888888888888888777776          88888888888888888888888


Q ss_pred             cCCCceecccccccccCCCCC--ccccccccccccCccccCCCC
Q 005760          277 SYLKDLNLSFNKLEGEIPRGG--SFGNFSAESFEGNELLCGSPN  318 (678)
Q Consensus       277 ~~L~~L~l~~N~~~~~~~~~~--~~~~l~~~~~~~n~~~c~~~~  318 (678)
                      ++|+.|+|++|++++.+|...  ....+..+++.+|+..|+.|.
T Consensus       490 ~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~  533 (623)
T PLN03150        490 TSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG  533 (623)
T ss_pred             CCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence            888888888888888877641  123455678889999998764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=1.4e-12  Score=136.66  Aligned_cols=248  Identities=24%  Similarity=0.288  Sum_probs=181.2

Q ss_pred             CCCCCccccC--CCceeEEEEEe---CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEE
Q 005760          393 GFSENNLIGR--GSFGSVFKARL---GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       393 ~~~~~~~ig~--G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  464 (678)
                      .|...+.+|.  |.+|.||.+..   .++..+|+|.-+....  .....=.+|+...+.++ |++.++....+.+.+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4556788999  99999999975   3678899988433222  33333355676666664 999999888899999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEEcCCCCCCeeecCC-CcEEEEeeccc
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS----ALEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIA  539 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~dl~~~Nill~~~-~~~kl~Dfg~~  539 (678)
                      +-+|++. .++.++.+.....++....+....+...    |+.++|   ..+++|-|++|.||+...+ ..++++|||+.
T Consensus       195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCccee
Confidence            9999984 6888888877667888888889988888    999999   9999999999999999998 89999999999


Q ss_pred             cccCCCCCcce---eecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcc
Q 005760          540 KLLTREDQSTI---QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST  616 (678)
Q Consensus       540 ~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  616 (678)
                      ..+........   .-...+...|++||... +.++...|+|++|.+..+-.++..++..-     ....|    .+.+ 
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g-----~~~~W----~~~r-  339 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG-----KNSSW----SQLR-  339 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC-----CCCCc----cccc-
Confidence            88765542211   12236788899999864 46788899999999999999887664220     00111    1111 


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                       ....+.-.-         .....++...+..|++.+|-.|++++.+..
T Consensus       340 -~~~ip~e~~---------~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  340 -QGYIPLEFC---------EGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             -cccCchhhh---------cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence             000110000         011233445888999999999999887754

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.35  E-value=1.3e-13  Score=130.52  Aligned_cols=136  Identities=26%  Similarity=0.354  Sum_probs=114.2

Q ss_pred             hccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEE
Q 005760          145 GKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYL  224 (678)
Q Consensus       145 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L  224 (678)
                      .....|++|+|+.|.|+ .+..+..-+|.++.|++++|.|..+  ..++.+++|+.||||+|.++++...-.++.+.+.|
T Consensus       281 dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  281 DTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTL  357 (490)
T ss_pred             chHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhhhhhHhhhcCEeee
Confidence            33467999999999999 7888999999999999999999944  33899999999999999999998777788899999


Q ss_pred             EecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcch-HHHhcccCCCceecccccccccCCC
Q 005760          225 NFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP-ASLEKLSYLKDLNLSFNKLEGEIPR  295 (678)
Q Consensus       225 ~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~~~~~~~~  295 (678)
                      .|++|.|.     .++++.       .+.+|..||+++|+|..... ..++++|.|+.+.|.+||+.+.+.-
T Consensus       358 ~La~N~iE-----~LSGL~-------KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY  417 (490)
T KOG1259|consen  358 KLAQNKIE-----TLSGLR-------KLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY  417 (490)
T ss_pred             ehhhhhHh-----hhhhhH-------hhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence            99999986     233332       34489999999999985443 4678899999999999999876543

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.35  E-value=1.2e-13  Score=137.73  Aligned_cols=217  Identities=24%  Similarity=0.229  Sum_probs=128.4

Q ss_pred             CCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccC
Q 005760           43 NLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGN  122 (678)
Q Consensus        43 ~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~  122 (678)
                      ++++|+...|.+..+...+.+    .....|++++.|||++|-+....+..                        ....+
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~----~~~k~~~~v~~LdLS~NL~~nw~~v~------------------------~i~eq  170 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIE----EYSKILPNVRDLDLSRNLFHNWFPVL------------------------KIAEQ  170 (505)
T ss_pred             hHHhhhheeecCccccccchh----hhhhhCCcceeecchhhhHHhHHHHH------------------------HHHHh
Confidence            566777777777776655532    12456677777777777665443322                        22456


Q ss_pred             CCCCcEEEccCCccCCcCCh-hhhccCCCCEEEccCCcCCCC-CCCcccCCCCccEEecCCCcCCCCChhhhhccccccc
Q 005760          123 LTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLENNKLEGS-IPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRI  200 (678)
Q Consensus       123 l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~  200 (678)
                      |++|+.|+|+.|++...... .-..+++|+.|.|+.|.++-. +......+|+|+.|+|.+|...........-++.|+.
T Consensus       171 Lp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~  250 (505)
T KOG3207|consen  171 LPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQE  250 (505)
T ss_pred             cccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhh
Confidence            78888888888877622211 112467788888888887621 2223445678888888888533233334445667888


Q ss_pred             eeccccccccccc--cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcch-HHHhccc
Q 005760          201 LLLGSNELTSIPL--TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP-ASLEKLS  277 (678)
Q Consensus       201 L~l~~N~l~~l~~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~-~~~~~l~  277 (678)
                      |+|++|.+-.++.  ....++.|..|+++.+.+..+.-..-..+.    ....+|+|++|+++.|+|..... ..+..++
T Consensus       251 LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~----kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~  326 (505)
T KOG3207|consen  251 LDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLD----KTHTFPKLEYLNISENNIRDWRSLNHLRTLE  326 (505)
T ss_pred             ccccCCcccccccccccccccchhhhhccccCcchhcCCCccchh----hhcccccceeeecccCccccccccchhhccc
Confidence            8888888777763  466777777777777776532211110000    01246677777777777753211 3344455


Q ss_pred             CCCceecccccccc
Q 005760          278 YLKDLNLSFNKLEG  291 (678)
Q Consensus       278 ~L~~L~l~~N~~~~  291 (678)
                      +|+.|.+..|+++.
T Consensus       327 nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  327 NLKHLRITLNYLNK  340 (505)
T ss_pred             hhhhhhcccccccc
Confidence            66666666666553

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=2.1e-12  Score=124.23  Aligned_cols=198  Identities=18%  Similarity=0.289  Sum_probs=137.5

Q ss_pred             HHhCCCccceeeeeeeecC-----CeEEEEEEecCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 005760          442 MKSIRHRNIIKVISSCSNE-----EFKALVLEYMPHGSLEKYLHSSN---YILDIYQRLNIMIDVASALEYLHFGYSAQV  513 (678)
Q Consensus       442 l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  513 (678)
                      +-.+.|.|||++..|+.+.     ....+++||+..|++..++++..   ..+......+|..||++||.||| +++..|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCcc
Confidence            3345699999998887543     35678999999999999997543   35667777889999999999999 678999


Q ss_pred             EEcCCCCCCeeecCCCcEEEEeecccccc--CCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCC
Q 005760          514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLL--TREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK  591 (678)
Q Consensus       514 vH~dl~~~Nill~~~~~~kl~Dfg~~~~~--~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~  591 (678)
                      +|+++.-.-|++..+|-+|+.--.-....  .............+-++|.+||.-.....+.++|||+||....||..+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            99999999999999999998532111100  0001111223344678999999988888888999999999999999877


Q ss_pred             CCCCcccC---CccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          592 KPTDEIFN---GEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       592 ~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      .-......   .+......        ..-..++.                  =..++..|++..|..||+|.+++..
T Consensus       280 iq~tnseS~~~~ee~ia~~--------i~~len~l------------------qr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENIANV--------IIGLENGL------------------QRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             eccCCCcceeehhhhhhhh--------eeeccCcc------------------ccCcCcccccCCCCCCcchhhhhcC
Confidence            54211111   01111100        00000000                  1146778999999999999988653

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.33  E-value=1.4e-13  Score=147.23  Aligned_cols=195  Identities=26%  Similarity=0.307  Sum_probs=101.0

Q ss_pred             CCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccc
Q 005760           20 ASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLS   99 (678)
Q Consensus        20 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~   99 (678)
                      +..++.++++.|.|.. .-..+..+++|+.|++.+|+|..+...      +..+++|++|+|++|.|+.+.+   +..+.
T Consensus        71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~------l~~~~~L~~L~ls~N~I~~i~~---l~~l~  140 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENL------LSSLVNLQVLDLSFNKITKLEG---LSTLT  140 (414)
T ss_pred             hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccc------hhhhhcchheeccccccccccc---hhhcc
Confidence            4555556666666663 234455666666666666666655531      3556666666666666665544   22333


Q ss_pred             ccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCC-hhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEe
Q 005760          100 HSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIP-STLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLE  178 (678)
Q Consensus       100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~  178 (678)
                       .|+.|++++|.|..+  ..+..+++|+.+++++|++..+.+ . ...+.+++.+.+.+|.+.  ....+..+..+..++
T Consensus       141 -~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~  214 (414)
T KOG0531|consen  141 -LLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR--EIEGLDLLKKLVLLS  214 (414)
T ss_pred             -chhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh--cccchHHHHHHHHhh
Confidence             355555555555543  224445555556666665553322 1 344555555555555554  122334444444445


Q ss_pred             cCCCcCCCCChhhhhccc--cccceeccccccccccccccccccccEEEecCCccc
Q 005760          179 LGGNKLSGSIPECFNNLA--SLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       179 l~~N~i~~~~~~~~~~l~--~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~  232 (678)
                      +..|.++..-+  +..+.  .|+.+++++|.+..++..+..+.++..|++++|++.
T Consensus       215 l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~  268 (414)
T KOG0531|consen  215 LLDNKISKLEG--LNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRIS  268 (414)
T ss_pred             cccccceeccC--cccchhHHHHHHhcccCccccccccccccccccccchhhcccc
Confidence            55555552211  11122  255555555555555444444555555555555544

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.29  E-value=3.5e-12  Score=116.76  Aligned_cols=122  Identities=28%  Similarity=0.352  Sum_probs=31.2

Q ss_pred             cccCCcCcccCCccccCCCCCCEEecCCCcccccCCcccc-CCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            3 QMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFG-NLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         3 ~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~-~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      .|..+-|. ..|. +-+...+++|+|++|+|+.+  +.++ .+.+|+.|+|++|.|++++       .+..+++|++|++
T Consensus         3 ~lt~~~i~-~~~~-~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l~-------~l~~L~~L~~L~L   71 (175)
T PF14580_consen    3 RLTANMIE-QIAQ-YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKLE-------GLPGLPRLKTLDL   71 (175)
T ss_dssp             -------------------------------------S--TT-TT--EEE-TTS--S--T-------T----TT--EEE-
T ss_pred             cccccccc-cccc-cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcccc-------CccChhhhhhccc
Confidence            34444454 4443 34455678899999999854  3454 5788889999999988766       3667888888888


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccC-CccccCCCCCcEEEccCCccC
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGI-PEEIGNLTNLTIIYLGGNKLN  137 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~N~l~  137 (678)
                      ++|.|+.+.+ .....++ +|++|+|++|+|.... -..+..+++|+.|+|.+|.+.
T Consensus        72 ~~N~I~~i~~-~l~~~lp-~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   72 SNNRISSISE-GLDKNLP-NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             -SS---S-CH-HHHHH-T-T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CCCCCCcccc-chHHhCC-cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            8888875532 1112233 5555555555555322 133444555555555555554

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.26  E-value=1.7e-11  Score=132.15  Aligned_cols=147  Identities=20%  Similarity=0.199  Sum_probs=93.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCC-CcEEEEEEeecccCc----------------------------------hhh--
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGR----------------------------------VFK--  433 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~--  433 (678)
                      -..|+. +.||+|++|.||+|+.++ |+.||||+.++...+                                  ..+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 789999999999999876 999999999754210                                  011  


Q ss_pred             ----hHHHHHHHHHhCC----Cccceeeeeeeec-CCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHH-HHHH
Q 005760          434 ----SFDVECEMMKSIR----HRNIIKVISSCSN-EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA-SALE  503 (678)
Q Consensus       434 ----~~~~e~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~-~~l~  503 (678)
                          ++..|+..+.+++    +...+.+-.++.+ ....++||||++|+++.++-.-.....+...   ++...+ .-+.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~  274 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFT  274 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHH
Confidence                2333444443332    3333333232222 3346799999999999875321111122221   222111 1233


Q ss_pred             HHhcCCCCCeEEcCCCCCCeeecCCC----cEEEEeeccccccCC
Q 005760          504 YLHFGYSAQVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLLTR  544 (678)
Q Consensus       504 ~LH~~~~~~ivH~dl~~~Nill~~~~----~~kl~Dfg~~~~~~~  544 (678)
                      .+.   ..|++|+|++|.||+++.++    .+++.|||++..+..
T Consensus       275 Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            344   68999999999999999888    999999999987654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.26  E-value=2.5e-11  Score=113.21  Aligned_cols=127  Identities=20%  Similarity=0.208  Sum_probs=95.4

Q ss_pred             CccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccce-eeeeeeecCCeEEEEEEecCCCCH
Q 005760          397 NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNII-KVISSCSNEEFKALVLEYMPHGSL  475 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~~~L  475 (678)
                      .+.++.|.++.||+++.. +..+++|+...... ....+..|+.+++.+.+.+++ +++.+..  +..++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            357899999999999874 77899999754322 234567899999988655544 4454433  234799999999877


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          476 EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ-----VIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       476 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      .+.    .  .   .....+.+++++++.||   ..+     ++|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~----~--~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTE----D--F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc----c--c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            543    0  1   11245678999999999   666     59999999999999 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.26  E-value=5.1e-13  Score=129.79  Aligned_cols=245  Identities=21%  Similarity=0.265  Sum_probs=161.4

Q ss_pred             ccccCCcCcc----cCCccccCCCCCCEEecCCC---cccccC-------CccccCCCCCCEEEccCccCCCCccchhhc
Q 005760            2 LQMWENNFSG----TIPRFIFNASKLSILELSDN---SFSGFI-------PNTFGNLRNLQALRLSNNYLTSSTLELSFL   67 (678)
Q Consensus         2 L~l~~~~~~~----~~p~~~~~l~~L~~L~l~~n---~i~~~~-------~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~   67 (678)
                      |+|++|.+..    .+.+.+.+.++|+..+++.=   +....+       .+++...++|++||||+|.+..-... ++-
T Consensus        35 l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~-~l~  113 (382)
T KOG1909|consen   35 LDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIR-GLE  113 (382)
T ss_pred             EeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchH-HHH
Confidence            6889998853    45566777888999888863   222223       34455668999999999999865543 233


Q ss_pred             ccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCC----hh
Q 005760           68 SSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIP----ST  143 (678)
Q Consensus        68 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~----~~  143 (678)
                      +-++.+..|+.|.|.+|.+.......    +...|..|.  .++       -...-++|+.+...+|++.....    ..
T Consensus       114 ~ll~s~~~L~eL~L~N~Glg~~ag~~----l~~al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~ga~~~A~~  180 (382)
T KOG1909|consen  114 ELLSSCTDLEELYLNNCGLGPEAGGR----LGRALFELA--VNK-------KAASKPKLRVFICGRNRLENGGATALAEA  180 (382)
T ss_pred             HHHHhccCHHHHhhhcCCCChhHHHH----HHHHHHHHH--HHh-------ccCCCcceEEEEeeccccccccHHHHHHH
Confidence            34567899999999999885322211    111222222  111       13345778888888888863322    35


Q ss_pred             hhccCCCCEEEccCCcCCCC----CCCcccCCCCccEEecCCCcCCCC----Chhhhhccccccceecccccccc-----
Q 005760          144 LGKLQKLQGLGLENNKLEGS----IPDSICHSDELYKLELGGNKLSGS----IPECFNNLASLRILLLGSNELTS-----  210 (678)
Q Consensus       144 ~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~l~~N~i~~~----~~~~~~~l~~L~~L~l~~N~l~~-----  210 (678)
                      |...+.|+.+.++.|.|...    +..+|..+++|+.|||..|-++..    +.+.++.+++|+.|++++|.++.     
T Consensus       181 ~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a  260 (382)
T KOG1909|consen  181 FQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIA  260 (382)
T ss_pred             HHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHH
Confidence            56678888888888888621    234677888888888888888843    34556677888888888888873     


Q ss_pred             ccccc-cccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCC
Q 005760          211 IPLTF-WNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLS  266 (678)
Q Consensus       211 l~~~~-~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~  266 (678)
                      +-..+ ...|+|+.|.|.+|.|+......+.      ......|.|+.|+|++|.+.
T Consensus       261 ~~~al~~~~p~L~vl~l~gNeIt~da~~~la------~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  261 FVDALKESAPSLEVLELAGNEITRDAALALA------ACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HHHHHhccCCCCceeccCcchhHHHHHHHHH------HHHhcchhhHHhcCCccccc
Confidence            22222 3467888999999988733322211      11223558899999999884

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.25  E-value=5.7e-12  Score=115.34  Aligned_cols=107  Identities=26%  Similarity=0.365  Sum_probs=27.5

Q ss_pred             CCCCCcEEEccCCccCCcCChhhh-ccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccc
Q 005760          122 NLTNLTIIYLGGNKLNGSIPSTLG-KLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRI  200 (678)
Q Consensus       122 ~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~  200 (678)
                      +..++++|+|.+|+|+.+  +.++ .+.+|+.|+|++|.|+ .++ .+..++.|++|++++|.|+...+.....+++|+.
T Consensus        17 n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~   92 (175)
T PF14580_consen   17 NPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE   92 (175)
T ss_dssp             ---------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred             cccccccccccccccccc--cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence            344566666666666532  2233 3556666666666666 332 3555666666666666666332222234566666


Q ss_pred             eeccccccccccc--cccccccccEEEecCCccc
Q 005760          201 LLLGSNELTSIPL--TFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       201 L~l~~N~l~~l~~--~~~~l~~L~~L~l~~N~l~  232 (678)
                      |+|++|+|.++..  .+..+++|+.|+|.+|++.
T Consensus        93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             EECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            6666666655432  3444555555555555543

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.21  E-value=2.1e-12  Score=138.21  Aligned_cols=210  Identities=29%  Similarity=0.373  Sum_probs=163.6

Q ss_pred             cccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECc
Q 005760            3 QMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFS   82 (678)
Q Consensus         3 ~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~   82 (678)
                      +++.|.|. .+-..+..+++|+.|++.+|+|..+ ...+..+++|+.|+|++|+|+++.       .+..++.|+.|+++
T Consensus        78 ~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~-------~l~~l~~L~~L~l~  148 (414)
T KOG0531|consen   78 NLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE-------GLSTLTLLKELNLS  148 (414)
T ss_pred             ccchhhhh-hhhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc-------chhhccchhhheec
Confidence            45666666 3445578899999999999999954 333889999999999999999877       46788889999999


Q ss_pred             cCCCcccCChhhhhcccccccEEEcccccccccCC-ccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCC
Q 005760           83 NNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIP-EEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLE  161 (678)
Q Consensus        83 ~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~  161 (678)
                      +|.|..+..   +..+. .|+.+++++|++....+ . ...+.+|+.+.+++|.+..+  ..+..+..+..+++..|.++
T Consensus       149 ~N~i~~~~~---~~~l~-~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~  221 (414)
T KOG0531|consen  149 GNLISDISG---LESLK-SLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKIS  221 (414)
T ss_pred             cCcchhccC---Cccch-hhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccce
Confidence            999986644   33344 89999999999997765 3 57889999999999999733  44555667777799999998


Q ss_pred             CCCCCcccCCCC--ccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCccc
Q 005760          162 GSIPDSICHSDE--LYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       162 ~~~~~~~~~l~~--L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~  232 (678)
                       .+ ..+..++.  |+.+++++|++. ..+..+..+.++..|++.+|++..+.. +.....+..+.++.|.+.
T Consensus       222 -~~-~~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~-~~~~~~~~~~~~~~~~~~  290 (414)
T KOG0531|consen  222 -KL-EGLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEG-LERLPKLSELWLNDNKLA  290 (414)
T ss_pred             -ec-cCcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccccc-ccccchHHHhccCcchhc
Confidence             33 23444444  899999999999 444667888999999999999987642 344556666667777655

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.19  E-value=3.2e-10  Score=106.01  Aligned_cols=136  Identities=21%  Similarity=0.237  Sum_probs=97.8

Q ss_pred             ccccCCCceeEEEEEeCC-------CcEEEEEEeecccC----------------------chhhhHH----HHHHHHHh
Q 005760          398 NLIGRGSFGSVFKARLGD-------GMEVAMKVFNLQYG----------------------RVFKSFD----VECEMMKS  444 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~~----~e~~~l~~  444 (678)
                      ..||.|.-+.||.|...+       +..+|||+++....                      .....+.    +|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999997543       57999999864210                      0112233    78888888


Q ss_pred             CCC--ccceeeeeeeecCCeEEEEEEecCCCCHHH-HhhhCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEEcCCCC
Q 005760          445 IRH--RNIIKVISSCSNEEFKALVLEYMPHGSLEK-YLHSSNYILDIYQRLNIMIDVASALEYL-HFGYSAQVIHCDLKP  520 (678)
Q Consensus       445 l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dl~~  520 (678)
                      +..  -++.+++++    ..-++||||+.+..+.. .++..  .++......+..+++.++..+ |   +.++||+|+++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            853  345555654    34579999997654322 22221  244556677889999999998 8   89999999999


Q ss_pred             CCeeecCCCcEEEEeeccccccC
Q 005760          521 SNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       521 ~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      .||+++ ++.++++|||.+....
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeCC
Confidence            999997 4689999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PLN03150 hypothetical protein; Provisional

Probab=99.18  E-value=5.1e-11  Score=133.22  Aligned_cols=113  Identities=32%  Similarity=0.436  Sum_probs=103.2

Q ss_pred             CccEEecCCCcCCCCChhhhhccccccceeccccccc-cccccccccccccEEEecCCcccCCCCccccccccccccccC
Q 005760          173 ELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCD  251 (678)
Q Consensus       173 ~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~  251 (678)
                      .++.|+|++|.+.+.+|..+..+++|+.|+|++|.|+ .+|..+..+++|+.|+|++|++++.+|..+.+++        
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~--------  490 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT--------  490 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCC--------
Confidence            3789999999999999999999999999999999998 7888999999999999999999999999998888        


Q ss_pred             cccccEEEccCCcCCCcchHHHhcc-cCCCceecccccccccCCC
Q 005760          252 LISLISLNLSNNNLSGAIPASLEKL-SYLKDLNLSFNKLEGEIPR  295 (678)
Q Consensus       252 ~~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~N~~~~~~~~  295 (678)
                        +|+.|+|++|++++..|..+..+ .++..+++.+|+..|..|.
T Consensus       491 --~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~  533 (623)
T PLN03150        491 --SLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG  533 (623)
T ss_pred             --CCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence              99999999999999999888764 4678899999998876554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.12  E-value=4e-09  Score=105.49  Aligned_cols=267  Identities=13%  Similarity=0.121  Sum_probs=165.3

Q ss_pred             CCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeee------eeec-CCeEEEE
Q 005760          395 SENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVIS------SCSN-EEFKALV  466 (678)
Q Consensus       395 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~------~~~~-~~~~~lv  466 (678)
                      ...+.||+|+-+.+|-.--  -..-+.|++.........   +.+.+|... .||-+-.-+.      +..+ .....++
T Consensus        14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecch--hhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            3467899999999995421  112345776543322112   122333333 4554332111      1122 2236788


Q ss_pred             EEecCCC-CHHHHhh-----hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          467 LEYMPHG-SLEKYLH-----SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       467 ~e~~~~~-~L~~~l~-----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      |+.+++. ....+..     .+-....|...++.++.++.+.+.||   ..|.+-+|+.++|+|+++++.|++.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccccee
Confidence            8887764 2222221     11124678999999999999999999   8999999999999999999999999855433


Q ss_pred             ccCCCCCcceeecccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHcC-CCCCCcccCC---ccchh-hhhhc
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNG---EMTLK-HWVND  610 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~ell~g-~~p~~~~~~~---~~~~~-~~~~~  610 (678)
                      ..   ......-..+|...|++||...     +-..+...|.|.+||++++++.| .+||.+....   ..... .....
T Consensus       166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g  242 (637)
T COG4248         166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG  242 (637)
T ss_pred             ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence            32   2333445567899999999754     33456778999999999999985 8999875322   11111 01000


Q ss_pred             ccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccC--cCCCCCHHHHHHHHHHHHHHHhh
Q 005760          611 WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVES--PEQRINAKEIVTKLLKIRDSLLR  676 (678)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d--P~~Rps~~ell~~L~~~~~~~~~  676 (678)
                      .+... .+ ..+....  .-..+.....++++..+..+|+...  |.-||+++-++..|.++.+++..
T Consensus       243 ~f~ya-~~-~~~g~~p--~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         243 RFAYA-SD-QRRGLKP--PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             eeeec-hh-ccCCCCC--CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            00000 00 0000000  0011112345667888999999774  56899999999999999998763

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.08  E-value=1.3e-09  Score=106.55  Aligned_cols=141  Identities=18%  Similarity=0.199  Sum_probs=108.7

Q ss_pred             ccccCCCceeEEEEEeCCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCc--cceeeeeeeecC---CeEEEEEEecC
Q 005760          398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHR--NIIKVISSCSNE---EFKALVLEYMP  471 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~---~~~~lv~e~~~  471 (678)
                      +.|+.|..+.||++...+|+.+++|....... .....+..|+++++.+++.  ++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999877778999999754322 1346788999999999753  456677776654   35689999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------------------------------------
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY------------------------------------------  509 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------------------  509 (678)
                      |.++.+.+..  ..++......++.++++++.+||+..                                          
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9888776532  23666777778888888888888421                                          


Q ss_pred             -----------CCCeEEcCCCCCCeeecC--CCcEEEEeecccc
Q 005760          510 -----------SAQVIHCDLKPSNVLLDD--NMVAHLSDFGIAK  540 (678)
Q Consensus       510 -----------~~~ivH~dl~~~Nill~~--~~~~kl~Dfg~~~  540 (678)
                                 ...++|+|+.+.||+++.  ++.+.++||+.+.
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                       245799999999999998  6778999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.07  E-value=1.7e-09  Score=97.28  Aligned_cols=131  Identities=21%  Similarity=0.338  Sum_probs=98.7

Q ss_pred             ccccCCCceeEEEEEeCCCcEEEEEEe-ecccCc-------hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          398 NLIGRGSFGSVFKARLGDGMEVAMKVF-NLQYGR-------VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~~~~vavK~~-~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..+++|+-+.+|.+.+. |.++++|.= ++....       ......+|+.+++.++--.|...+=++.+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999774 444666653 222111       124556799999988655555555555666777799999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ++|..|.+.+....        ..++..+-.-+.-||   ..||+|+|++++||++..++ +.++|||++..
T Consensus        81 I~G~~lkd~l~~~~--------~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEAR--------PDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhcc--------hHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999998987652        346777778888999   99999999999999998775 99999999863

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.03  E-value=1.4e-10  Score=121.84  Aligned_cols=250  Identities=20%  Similarity=0.155  Sum_probs=174.0

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEe--CCCcEEEEEEeecccCchhhhH--HHHHHHHHhC-CCccceeeeeeeecCCeE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARL--GDGMEVAMKVFNLQYGRVFKSF--DVECEMMKSI-RHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~--~~e~~~l~~l-~h~niv~~~~~~~~~~~~  463 (678)
                      ....+|..+..||.|.|+.|+....  .++..+++|..........+++  ..|+.+...+ .|.+++.....+......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            3456788899999999999999863  3677888888754433222222  3466666655 488888887777666677


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC-CcEEEEeecccccc
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLL  542 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~-~~~kl~Dfg~~~~~  542 (678)
                      |+=-||++++++....... ..++...++++..|++.++.++|   ++..+|+|++|+||++..+ +..+++|||.++.+
T Consensus       342 ~ip~e~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~  417 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL  417 (524)
T ss_pred             cCchhhhcCcchhhhhHHH-HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence            7888999999887766322 24677788899999999999999   9999999999999999875 88899999998753


Q ss_pred             CCCCCcceeecccCCcccc--CccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccc
Q 005760          543 TREDQSTIQTQTLATIGYM--APEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV  620 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (678)
                      ....     .......++.  +|+......+..++|++|||.-+.|.+++..--.. .      .+|..         +.
T Consensus       418 ~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~------~~~~~---------i~  476 (524)
T KOG0601|consen  418 AFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-G------VQSLT---------IR  476 (524)
T ss_pred             ceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcc-c------cccee---------ee
Confidence            2211     1122333444  55566666788999999999999999987653221 0      01100         00


Q ss_pred             cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                       ........       ....++..+.+.+..+++..||.+.++....+-.+
T Consensus       477 -~~~~p~~~-------~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  477 -SGDTPNLP-------GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             -cccccCCC-------chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence             00000000       11134667888899999999999998877665544

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.02  E-value=3.3e-09  Score=94.76  Aligned_cols=142  Identities=20%  Similarity=0.266  Sum_probs=101.9

Q ss_pred             CCccccCCCceeEEEEEeCCCcEEEEEE-eecccCc-------hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          396 ENNLIGRGSFGSVFKARLGDGMEVAMKV-FNLQYGR-------VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       396 ~~~~ig~G~~g~V~~~~~~~~~~vavK~-~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ....+-+|+-+.|+++.+. |+..+||. +.....+       ...+..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4568889999999999984 66666654 3332221       2356678999998876444443333444444556999


Q ss_pred             EecCC-CCHHHHhhhCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC---cEEEEeeccccc
Q 005760          468 EYMPH-GSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM---VAHLSDFGIAKL  541 (678)
Q Consensus       468 e~~~~-~~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~---~~kl~Dfg~~~~  541 (678)
                      ||++| .++.+++...... .+.......+..|-+.+.-||   ..+|+|+|++.+||++.+++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 5888888765432 233333678899999999999   99999999999999996544   458999999854

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=99.01  E-value=5.4e-11  Score=111.63  Aligned_cols=249  Identities=20%  Similarity=0.252  Sum_probs=164.2

Q ss_pred             ccCCCCCCEEecCCCccccc----CCccccCCCCCCEEEccCccCCCCccchh-----hcccccCCCCCcEEECccCCCc
Q 005760           17 IFNASKLSILELSDNSFSGF----IPNTFGNLRNLQALRLSNNYLTSSTLELS-----FLSSLSNCKSLTLISFSNNPLD   87 (678)
Q Consensus        17 ~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~~~~~~-----~~~~~~~l~~L~~L~L~~n~i~   87 (678)
                      +..++.+++++||+|-|...    +...+.+-++|+..++++-..+.....+.     +.+++-+|+.|+.++||+|.+.
T Consensus        26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg  105 (388)
T COG5238          26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFG  105 (388)
T ss_pred             HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccC
Confidence            44588999999999999755    44556677999999999876655443321     2356789999999999999997


Q ss_pred             ccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhh-------------ccCCCCEEE
Q 005760           88 GILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLG-------------KLQKLQGLG  154 (678)
Q Consensus        88 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-------------~l~~L~~L~  154 (678)
                      ...|.. .                     -+.+++-++|++|.|++|.+..+.-+.++             +-|.|++..
T Consensus       106 ~~~~e~-L---------------------~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vi  163 (388)
T COG5238         106 SEFPEE-L---------------------GDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVI  163 (388)
T ss_pred             cccchH-H---------------------HHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEE
Confidence            554433 1                     23345567777777777776533222222             346788888


Q ss_pred             ccCCcCCCCCCC----cccCCCCccEEecCCCcCCCC--C---hhhhhccccccceecccccccc-----cccccccccc
Q 005760          155 LENNKLEGSIPD----SICHSDELYKLELGGNKLSGS--I---PECFNNLASLRILLLGSNELTS-----IPLTFWNLKD  220 (678)
Q Consensus       155 L~~n~i~~~~~~----~~~~l~~L~~L~l~~N~i~~~--~---~~~~~~l~~L~~L~l~~N~l~~-----l~~~~~~l~~  220 (678)
                      ..+|++......    .+..-.+|+++.+..|.|.-.  .   -..+..+.+|+.|||++|.++.     +...++.++.
T Consensus       164 cgrNRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~  243 (388)
T COG5238         164 CGRNRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNL  243 (388)
T ss_pred             eccchhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccch
Confidence            888887632211    222225677888888877722  1   1223456788888998888873     3446778888


Q ss_pred             ccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcch-----HHH--hcccCCCceecccccccc
Q 005760          221 ILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP-----ASL--EKLSYLKDLNLSFNKLEG  291 (678)
Q Consensus       221 L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~-----~~~--~~l~~L~~L~l~~N~~~~  291 (678)
                      |+.|.+..|-++.....++-    ..+..-..|+|..|.+.+|-+.+...     ..+  ..+|-|..|.++||.+..
T Consensus       244 lrEL~lnDClls~~G~~~v~----~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~E  317 (388)
T COG5238         244 LRELRLNDCLLSNEGVKSVL----RRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIKE  317 (388)
T ss_pred             hhhccccchhhccccHHHHH----HHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcchh
Confidence            89999998888766654431    12223346788888888886543211     222  346777788888888764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.99  E-value=2.1e-10  Score=126.67  Aligned_cols=250  Identities=24%  Similarity=0.293  Sum_probs=168.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ..+.+.+.+-+..|.++.++.+.-. .|.-.+.|+....   .....+....+-.+.-..++|.++.....+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4456777788889999999988632 3433333332211   11112222233333333456777776666666778899


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      |++|+.+++|..-++..+. .+..........+..+.+|||   ...+.|+|++|.|.+...+++.+++|||.....+-.
T Consensus       882 ~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence            9999999999999987764 444444456667888999999   777999999999999999999999999843221100


Q ss_pred             ---------------------C--------CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCc
Q 005760          546 ---------------------D--------QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDE  596 (678)
Q Consensus       546 ---------------------~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~  596 (678)
                                           .        .........+|+.|.+||...+......+|+|+.|++++|.++|.+||..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                 0        00123456799999999999999999999999999999999999999876


Q ss_pred             ccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHH
Q 005760          597 IFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAK  661 (678)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~  661 (678)
                      .......     +...........-+             ...+.++.+++...+..+|.+|..|.
T Consensus      1038 ~tpq~~f-----~ni~~~~~~~p~g~-------------~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1038 ETPQQIF-----ENILNRDIPWPEGP-------------EEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             cchhhhh-----hccccCCCCCCCCc-------------cccChhhhhhhhhhhccCchhccCcc
Confidence            4443211     11111111111111             12334466788888899999998765

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.93  E-value=1.4e-11  Score=129.89  Aligned_cols=129  Identities=32%  Similarity=0.283  Sum_probs=93.6

Q ss_pred             CCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEec
Q 005760          149 KLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFS  227 (678)
Q Consensus       149 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~  227 (678)
                      .|.+.+.+.|++. ....++.-++.|+.|+|++|++++.  +.+..|+.|++|||++|.|+.+|. ...+. +|..|.|+
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lr  240 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLR  240 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhh-hheeeeec
Confidence            5777788888887 5667777788888888888888855  367788888888888888888875 33333 38888888


Q ss_pred             CCcccCCCCccccccccccccccCcccccEEEccCCcCCCcch-HHHhcccCCCceecccccccccC
Q 005760          228 SNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP-ASLEKLSYLKDLNLSFNKLEGEI  293 (678)
Q Consensus       228 ~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~~~~~~  293 (678)
                      +|.++..  ..+.+++          +|+.|||++|-|.+-.- ..+..+..|..|+|.|||+.|.+
T Consensus       241 nN~l~tL--~gie~Lk----------sL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  241 NNALTTL--RGIENLK----------SLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             ccHHHhh--hhHHhhh----------hhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            8877622  2344455          88888888887764222 34556777888888888887765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.93  E-value=7.6e-09  Score=96.51  Aligned_cols=125  Identities=25%  Similarity=0.312  Sum_probs=81.9

Q ss_pred             eEEEEEeCCCcEEEEEEeecccC-------------c-------------hhhhHHHHHHHHHhCCCc--cceeeeeeee
Q 005760          407 SVFKARLGDGMEVAMKVFNLQYG-------------R-------------VFKSFDVECEMMKSIRHR--NIIKVISSCS  458 (678)
Q Consensus       407 ~V~~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~e~~~l~~l~h~--niv~~~~~~~  458 (678)
                      .||.|...+|..+|+|+.+....             .             ......+|.+.|..+..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999988999999999864210             0             123456799999999755  455665443 


Q ss_pred             cCCeEEEEEEecC--CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEEcCCCCCCeeecCCCcEEEEe
Q 005760          459 NEEFKALVLEYMP--HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY-LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD  535 (678)
Q Consensus       459 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~dl~~~Nill~~~~~~kl~D  535 (678)
                         .-.+||||++  |..+..+....   ++......++.+++..+.. +|   ..|++|+|+++.||+++++ .+.++|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence               2359999998  54554433322   1123345677788875444 68   9999999999999999988 999999


Q ss_pred             ecccccc
Q 005760          536 FGIAKLL  542 (678)
Q Consensus       536 fg~~~~~  542 (678)
                      ||.+...
T Consensus       150 f~qav~~  156 (188)
T PF01163_consen  150 FGQAVDS  156 (188)
T ss_dssp             GTTEEET
T ss_pred             cCcceec
Confidence            9998754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.92  E-value=3.4e-11  Score=127.03  Aligned_cols=181  Identities=27%  Similarity=0.332  Sum_probs=130.8

Q ss_pred             CccccCCCCCcEEEccCCccCCcCChhhhcc-CCCCEEEccCCcCC-------CCCCCcccC---CCCccEEecCCCcCC
Q 005760          117 PEEIGNLTNLTIIYLGGNKLNGSIPSTLGKL-QKLQGLGLENNKLE-------GSIPDSICH---SDELYKLELGGNKLS  185 (678)
Q Consensus       117 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~L~~n~i~-------~~~~~~~~~---l~~L~~L~l~~N~i~  185 (678)
                      |-.+..+.+|+.|.|.++.|.. . ..+.++ ..|++|.-. |.+.       .-. ..+.+   ...|.+.+.+.|.+.
T Consensus       102 pi~ifpF~sLr~LElrg~~L~~-~-~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascg-gd~~ns~~Wn~L~~a~fsyN~L~  177 (1096)
T KOG1859|consen  102 PISIFPFRSLRVLELRGCDLST-A-KGLQELRHQLEKLICH-NSLDALRHVFASCG-GDISNSPVWNKLATASFSYNRLV  177 (1096)
T ss_pred             CceeccccceeeEEecCcchhh-h-hhhHHHHHhhhhhhhh-ccHHHHHHHHHHhc-cccccchhhhhHhhhhcchhhHH
Confidence            4445667777777777777652 1 112111 234444222 2211       000 11111   246889999999999


Q ss_pred             CCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcC
Q 005760          186 GSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNL  265 (678)
Q Consensus       186 ~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l  265 (678)
                       ....++.-++.|+.|+|++|++++.. .+..+++|++|||++|.++........+.           .|+.|.|+||-+
T Consensus       178 -~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-----------~L~~L~lrnN~l  244 (1096)
T KOG1859|consen  178 -LMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVGC-----------KLQLLNLRNNAL  244 (1096)
T ss_pred             -hHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhccccccchhhh-----------hheeeeecccHH
Confidence             67778888999999999999999987 78899999999999999985444444332           599999999999


Q ss_pred             CCcchHHHhcccCCCceeccccccccc--CCCCCccccccccccccCccccCC
Q 005760          266 SGAIPASLEKLSYLKDLNLSFNKLEGE--IPRGGSFGNFSAESFEGNELLCGS  316 (678)
Q Consensus       266 ~~~~~~~~~~l~~L~~L~l~~N~~~~~--~~~~~~~~~l~~~~~~~n~~~c~~  316 (678)
                      +..  ..+.++.+|..||+++|-+.+.  +...+.+..|..++++|||..|..
T Consensus       245 ~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  245 TTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             Hhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            854  3478899999999999998754  455578888999999999998853

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.90  E-value=1.1e-09  Score=82.33  Aligned_cols=59  Identities=29%  Similarity=0.451  Sum_probs=29.5

Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCc
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNK  159 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~  159 (678)
                      +|++|++++|+++.+.+..|.++++|++|++++|+++.+.+++|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34455555555554444445555555555555555544444455555555555555544

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.89  E-value=1.4e-09  Score=81.82  Aligned_cols=61  Identities=34%  Similarity=0.491  Sum_probs=53.6

Q ss_pred             CCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcC
Q 005760          124 TNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL  184 (678)
Q Consensus       124 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i  184 (678)
                      ++|++|++++|+++.+.++.|.++++|++|++++|.|+...+..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5788999999999877778889999999999999999877778899999999999999875

...

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.83  E-value=1.5e-07  Score=97.11  Aligned_cols=167  Identities=19%  Similarity=0.206  Sum_probs=125.6

Q ss_pred             CceeEEEEE-eCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeec----CCeEEEEEEecCC-CCHHH
Q 005760          404 SFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN----EEFKALVLEYMPH-GSLEK  477 (678)
Q Consensus       404 ~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-~~L~~  477 (678)
                      -..+.|++. ..||..+++|++.............-+++++++.|+|+|++-+++..    +..+++|++|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            346789996 45899999999943333333334456889999999999999988752    4477899999876 57776


Q ss_pred             Hhhh--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          478 YLHS--------------SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       478 ~l~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      .-..              .+...++...|.++.|+..||.++|   +.|...+-+.+.+|+++.+.+++|+..|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            5421              1224667899999999999999999   9999999999999999999999998887765543


Q ss_pred             CCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCC
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK  592 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~  592 (678)
                      ....                |.+.+   -.+-|.=.||.++..|.||..
T Consensus       445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            3220                11111   124689999999999999854

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.81  E-value=7e-10  Score=105.61  Aligned_cols=218  Identities=16%  Similarity=0.115  Sum_probs=132.2

Q ss_pred             cCCccccCCCCCCEEecCCCcccccCC-cccc-CCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCccc
Q 005760           12 TIPRFIFNASKLSILELSDNSFSGFIP-NTFG-NLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGI   89 (678)
Q Consensus        12 ~~p~~~~~l~~L~~L~l~~n~i~~~~~-~~~~-~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~   89 (678)
                      ..|-.++.+.-++.|.+.++.|..+.- ..|+ ....+++|||..|+|++-+   +++.-+.++|.|++|+|+.|++...
T Consensus        36 ~s~~~v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWs---eI~~ile~lP~l~~LNls~N~L~s~  112 (418)
T KOG2982|consen   36 LSYLGVSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWS---EIGAILEQLPALTTLNLSCNSLSSD  112 (418)
T ss_pred             cceeeeccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHH---HHHHHHhcCccceEeeccCCcCCCc
Confidence            334334444556677888888874421 1222 3578899999999987654   3455678899999999999998755


Q ss_pred             CChhhhhcccccccEEEccccccccc-CCccccCCCCCcEEEccCCccCC--cCChhhhcc-CCCCEEEccCCcCCCC--
Q 005760           90 LPKTSVGNLSHSLEYFEMAYCNVSGG-IPEEIGNLTNLTIIYLGGNKLNG--SIPSTLGKL-QKLQGLGLENNKLEGS--  163 (678)
Q Consensus        90 ~~~~~~~~l~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l-~~L~~L~L~~n~i~~~--  163 (678)
                      +... ...+ .+|+.|.|++..+.-. ....+..+|.+++|.+|.|.+.-  ...+..... +.+++|.+..|.....  
T Consensus       113 I~~l-p~p~-~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~  190 (418)
T KOG2982|consen  113 IKSL-PLPL-KNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLN  190 (418)
T ss_pred             cccC-cccc-cceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHH
Confidence            4321 1112 3788888888887733 33456778888888888885431  111111111 2344444444443210  


Q ss_pred             CCCcccCCCCccEEecCCCcCCCCC-hhhhhccccccceeccccccccccc--cccccccccEEEecCCcccCC
Q 005760          164 IPDSICHSDELYKLELGGNKLSGSI-PECFNNLASLRILLLGSNELTSIPL--TFWNLKDILYLNFSSNFFTGP  234 (678)
Q Consensus       164 ~~~~~~~l~~L~~L~l~~N~i~~~~-~~~~~~l~~L~~L~l~~N~l~~l~~--~~~~l~~L~~L~l~~N~l~~~  234 (678)
                      ....-...|++..+.+..|.+.... .+.+..++.+..|+|+.|+|.+...  .+.++++|..|.+++|++...
T Consensus       191 ~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~  264 (418)
T KOG2982|consen  191 KNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDP  264 (418)
T ss_pred             HHhHHhhcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccccc
Confidence            0011112356777777777776432 2445556677777888887776644  567777777777777776533

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.79  E-value=9.3e-09  Score=117.67  Aligned_cols=202  Identities=21%  Similarity=0.267  Sum_probs=125.3

Q ss_pred             CCCCCCEEecCCCcccccCCccccCCCCCCEEEccCcc--CCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhh
Q 005760           19 NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNY--LTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVG   96 (678)
Q Consensus        19 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~--i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~   96 (678)
                      +...++.+.+.+|++. .+++...+ ++|++|-+..|.  +..++..     -|..++.|++|||++|.=.+-.|.. ++
T Consensus       521 ~~~~~rr~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~-----ff~~m~~LrVLDLs~~~~l~~LP~~-I~  592 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGE-----FFRSLPLLRVLDLSGNSSLSKLPSS-IG  592 (889)
T ss_pred             chhheeEEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHH-----HHhhCcceEEEECCCCCccCcCChH-Hh
Confidence            3466778888888776 34444433 378888888885  5555543     2677888888888877655555554 66


Q ss_pred             cccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCC--CCCCCcccCCCCc
Q 005760           97 NLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLE--GSIPDSICHSDEL  174 (678)
Q Consensus        97 ~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~--~~~~~~~~~l~~L  174 (678)
                      .+- +|++|+|++..+. .+|..+.+|..|.+||+..+.-...+|+....+.+|++|.+..-...  ...-..+..+.+|
T Consensus       593 ~Li-~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L  670 (889)
T KOG4658|consen  593 ELV-HLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHL  670 (889)
T ss_pred             hhh-hhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccch
Confidence            666 7777888877777 66777777888888888776654455666667778887777665422  1122334444555


Q ss_pred             cEEecCCCcCCCCChhhhhccccc----cceeccccccccccccccccccccEEEecCCccc
Q 005760          175 YKLELGGNKLSGSIPECFNNLASL----RILLLGSNELTSIPLTFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       175 ~~L~l~~N~i~~~~~~~~~~l~~L----~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~  232 (678)
                      +.+........  .-..+..++.|    +.+.+..+.....+..+..+.+|+.|.+.++.+.
T Consensus       671 ~~ls~~~~s~~--~~e~l~~~~~L~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~  730 (889)
T KOG4658|consen  671 ENLSITISSVL--LLEDLLGMTRLRSLLQSLSIEGCSKRTLISSLGSLGNLEELSILDCGIS  730 (889)
T ss_pred             hhheeecchhH--hHhhhhhhHHHHHHhHhhhhcccccceeecccccccCcceEEEEcCCCc
Confidence            55554333220  11112222222    3444444455555667778888888888888875

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.78  E-value=8.9e-08  Score=95.01  Aligned_cols=139  Identities=15%  Similarity=0.105  Sum_probs=98.4

Q ss_pred             ccccCCCceeEEEEEeCCCcEEEEEEeecccC-c----------hhhhHHHHHHHHHhCCCccc--eeeeeeeec-----
Q 005760          398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG-R----------VFKSFDVECEMMKSIRHRNI--IKVISSCSN-----  459 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~----------~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~-----  459 (678)
                      +.+-+.....|+++.. +|+.+.||....... +          ....+.+|...+..+...+|  ...+++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444455777766 678899997743221 0          11136789998888753333  233444432     


Q ss_pred             CCeEEEEEEecCCC-CHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-------CCc
Q 005760          460 EEFKALVLEYMPHG-SLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-------NMV  530 (678)
Q Consensus       460 ~~~~~lv~e~~~~~-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-------~~~  530 (678)
                      ....++|||++++. +|.+++... ....+......++.+++..+.-||   ..||+|+|++++|||++.       ++.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            23467999999886 899988532 223456677789999999999999   999999999999999975       568


Q ss_pred             EEEEeecccc
Q 005760          531 AHLSDFGIAK  540 (678)
Q Consensus       531 ~kl~Dfg~~~  540 (678)
                      +.++||+.+.
T Consensus       184 ~~LIDl~r~~  193 (268)
T PRK15123        184 LSVIDLHRAQ  193 (268)
T ss_pred             EEEEECCccc
Confidence            9999999875

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.76  E-value=8.1e-10  Score=93.22  Aligned_cols=134  Identities=22%  Similarity=0.192  Sum_probs=84.7

Q ss_pred             CCEEEccCCcCCCCCCCc---ccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEe
Q 005760          150 LQGLGLENNKLEGSIPDS---ICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNF  226 (678)
Q Consensus       150 L~~L~L~~n~i~~~~~~~---~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l  226 (678)
                      +..++|+++.+- .+++.   +....+|+..+|++|.+.+..+..-...+.++.|+|++|+|+++|..+..++.|+.|++
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl  107 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNL  107 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhccc
Confidence            444555555554 33332   23345566667777777744444444556777788888888888877777788888888


Q ss_pred             cCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC
Q 005760          227 SSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG  296 (678)
Q Consensus       227 ~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  296 (678)
                      +.|++. ..|..+..+.          +|-.|+..+|.+..+.-+ +-.-+.....++.+++|.+.++..
T Consensus       108 ~~N~l~-~~p~vi~~L~----------~l~~Lds~~na~~eid~d-l~~s~~~al~~lgnepl~~~~~~k  165 (177)
T KOG4579|consen  108 RFNPLN-AEPRVIAPLI----------KLDMLDSPENARAEIDVD-LFYSSLPALIKLGNEPLGDETKKK  165 (177)
T ss_pred             ccCccc-cchHHHHHHH----------hHHHhcCCCCccccCcHH-HhccccHHHHHhcCCcccccCccc
Confidence            888777 4555555566          777888888877744334 222233444566788888777664

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.75  E-value=5.8e-08  Score=92.81  Aligned_cols=135  Identities=21%  Similarity=0.196  Sum_probs=97.7

Q ss_pred             CCCCccccCCCceeEEEEEeCCCcEEEEEEeeccc-------------------C---chhhhHHHHHHHHHhCCCc--c
Q 005760          394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQY-------------------G---RVFKSFDVECEMMKSIRHR--N  449 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~-------------------~---~~~~~~~~e~~~l~~l~h~--n  449 (678)
                      +.++..||-|.-+.||.|..++|.++|||.=+...                   +   -.+....+|.++|..|.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            45668999999999999999999999999743210                   0   0123456789999988654  5


Q ss_pred             ceeeeeeeecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC
Q 005760          450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM  529 (678)
Q Consensus       450 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~  529 (678)
                      +.+.+++    +.-.+||||++|-.|...--      +......++..|+.-+.-+-   ..||||+|+++.||+++++|
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            6555554    34569999999866654331      22233345555565555555   68899999999999999999


Q ss_pred             cEEEEeeccccc
Q 005760          530 VAHLSDFGIAKL  541 (678)
Q Consensus       530 ~~kl~Dfg~~~~  541 (678)
                      .+.++||--+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999976654

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.75  E-value=3.6e-09  Score=100.84  Aligned_cols=208  Identities=19%  Similarity=0.151  Sum_probs=121.9

Q ss_pred             CCcEEECccCCCcccCChhhhhcccccccEEEcccccccc--cCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCE
Q 005760           75 SLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSG--GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQG  152 (678)
Q Consensus        75 ~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  152 (678)
                      .++.|.+.++.|........++.....+++|||..|.|++  .+..-+.++|.|++|+|+.|.+.+.+...-..+.+|++
T Consensus        46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~  125 (418)
T KOG2982|consen   46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRV  125 (418)
T ss_pred             chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEE
Confidence            4445566666665555544455544456666666666662  23344567788888888888876433222135567888


Q ss_pred             EEccCCcCCC-CCCCcccCCCCccEEecCCCcCCCCC--hhhhhcc-ccccceeccccccccc---cccccccccccEEE
Q 005760          153 LGLENNKLEG-SIPDSICHSDELYKLELGGNKLSGSI--PECFNNL-ASLRILLLGSNELTSI---PLTFWNLKDILYLN  225 (678)
Q Consensus       153 L~L~~n~i~~-~~~~~~~~l~~L~~L~l~~N~i~~~~--~~~~~~l-~~L~~L~l~~N~l~~l---~~~~~~l~~L~~L~  225 (678)
                      |.|.+..+.- .....+..+|.++.|+++.|.+....  .+..... +.+.+|+...|....-   -.--.-.|++..+-
T Consensus       126 lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~  205 (418)
T KOG2982|consen  126 LVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVF  205 (418)
T ss_pred             EEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchhee
Confidence            8877777642 12334566777777777777443211  1111111 2444444444433211   11112345777777


Q ss_pred             ecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcch-HHHhcccCCCceecccccccc
Q 005760          226 FSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP-ASLEKLSYLKDLNLSFNKLEG  291 (678)
Q Consensus       226 l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~~~~  291 (678)
                      +..|++.......         .+-.+|.+.-|+|+.|+|.+... +++.+++.|..|.+++||+..
T Consensus       206 v~e~PlK~~s~ek---------~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d  263 (418)
T KOG2982|consen  206 VCEGPLKTESSEK---------GSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD  263 (418)
T ss_pred             eecCcccchhhcc---------cCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence            8888776444321         11245578889999999875433 677888999999999998763

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.61  E-value=1.4e-08  Score=108.25  Aligned_cols=150  Identities=17%  Similarity=0.252  Sum_probs=102.2

Q ss_pred             HHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC-----cc--eeecccCCccccCccccCC
Q 005760          496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-----ST--IQTQTLATIGYMAPEYGKE  568 (678)
Q Consensus       496 ~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~-----~~--~~~~~~~~~~y~aPE~~~~  568 (678)
                      .+++.|+.|+|.  +.++||++|.|++|.++.++..||+.|+++........     +.  ..........|.|||++..
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345599999996  78999999999999999999999999999865433111     00  1111224567999999999


Q ss_pred             CCCCccchHHHHHHHHHHHHcCCCC-CCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHh
Q 005760          569 GRVSANGDVYSFGIMLMETFTRKKP-TDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAM  647 (678)
Q Consensus       569 ~~~~~~~DvwslGv~l~ell~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  647 (678)
                      ...+.++|+||+||++|-+..|..+ +.. ........ ...  .       .      .+...+....+.++++.+=+.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~~~-~~~--~-------~------~~~~~~~~s~~~p~el~~~l~  246 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAA-NGGLLSYS-FSR--N-------L------LNAGAFGYSNNLPSELRESLK  246 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhc-cCCcchhh-hhh--c-------c------cccccccccccCcHHHHHHHH
Confidence            8889999999999999999855544 332 11111110 000  0       0      000011111345677889999


Q ss_pred             hccccCcCCCCCHHHHH
Q 005760          648 ECTVESPEQRINAKEIV  664 (678)
Q Consensus       648 ~cl~~dP~~Rps~~ell  664 (678)
                      +++..++..||++.++.
T Consensus       247 k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             HHhcCCcccCcchhhhh
Confidence            99999999999777664

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.61  E-value=3.2e-08  Score=113.31  Aligned_cols=205  Identities=21%  Similarity=0.229  Sum_probs=135.1

Q ss_pred             CCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCC-cccCChhhhhcccccccEEEcccccccccCCcccc
Q 005760           43 NLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPL-DGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG  121 (678)
Q Consensus        43 ~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i-~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~  121 (678)
                      +....+.+.+-+|.+..++..       ..++.|++|-+.+|.- ...++..+|..++ .|+.|||++|.-.+.+|+.++
T Consensus       521 ~~~~~rr~s~~~~~~~~~~~~-------~~~~~L~tLll~~n~~~l~~is~~ff~~m~-~LrVLDLs~~~~l~~LP~~I~  592 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIEHIAGS-------SENPKLRTLLLQRNSDWLLEISGEFFRSLP-LLRVLDLSGNSSLSKLPSSIG  592 (889)
T ss_pred             chhheeEEEEeccchhhccCC-------CCCCccceEEEeecchhhhhcCHHHHhhCc-ceEEEECCCCCccCcCChHHh
Confidence            346778888888888877754       3556788998888862 2345555566676 888889988888888888888


Q ss_pred             CCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCC--CCChhhhhcccccc
Q 005760          122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLS--GSIPECFNNLASLR  199 (678)
Q Consensus       122 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~--~~~~~~~~~l~~L~  199 (678)
                      .|-+|++|++++..++ .+|..+.+|..|.+|++..+.-...+|.....+.+|++|.+..-...  ...-..+..+++|+
T Consensus       593 ~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~  671 (889)
T KOG4658|consen  593 ELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLE  671 (889)
T ss_pred             hhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchh
Confidence            8888888888888887 78888888888888888888866566777777888888888665422  22333445555666


Q ss_pred             ceecccccccccccccccccccc----EEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCc
Q 005760          200 ILLLGSNELTSIPLTFWNLKDIL----YLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGA  268 (678)
Q Consensus       200 ~L~l~~N~l~~l~~~~~~l~~L~----~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~  268 (678)
                      .+....... .+-..+..+..|.    .+.+.++... ..+..+..          +.+|+.|.+.++.++..
T Consensus       672 ~ls~~~~s~-~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~----------l~~L~~L~i~~~~~~e~  732 (889)
T KOG4658|consen  672 NLSITISSV-LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGS----------LGNLEELSILDCGISEI  732 (889)
T ss_pred             hheeecchh-HhHhhhhhhHHHHHHhHhhhhcccccc-eeeccccc----------ccCcceEEEEcCCCchh
Confidence            666544433 2211222222222    2222222211 22223333          33888888888887643

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.60  E-value=2.7e-09  Score=90.09  Aligned_cols=136  Identities=18%  Similarity=0.262  Sum_probs=84.0

Q ss_pred             ccEEEccccccccc--CCccccCCCCCcEEEccCCccCCcCChhhh-ccCCCCEEEccCCcCCCCCCCcccCCCCccEEe
Q 005760          102 LEYFEMAYCNVSGG--IPEEIGNLTNLTIIYLGGNKLNGSIPSTLG-KLQKLQGLGLENNKLEGSIPDSICHSDELYKLE  178 (678)
Q Consensus       102 L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~  178 (678)
                      +-.++|++|++-.+  .+..+.....|+..+|++|.+. .+|..|. .++-+++|+|++|.|+ .+|..+..+|.|+.|+
T Consensus        29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN  106 (177)
T KOG4579|consen   29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN  106 (177)
T ss_pred             hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence            44555666655421  1222344566667788888877 4555554 3457777788888877 5666677777777777


Q ss_pred             cCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCcccc
Q 005760          179 LGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIG  240 (678)
Q Consensus       179 l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  240 (678)
                      ++.|.+. ..|..+..+.+|-.|+..+|.+..+|-++..-.++-..++.++++.+..+....
T Consensus       107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~~~~klq  167 (177)
T KOG4579|consen  107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDETKKKLQ  167 (177)
T ss_pred             cccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcccccCccccc
Confidence            7777777 556666667777777777777777765433222233333455566555554433

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	678
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-36
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-35
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-33
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-32
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-24
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-23
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-23
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-23
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-22
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		6e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		6e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		6e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-22
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-22
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		7e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		7e-22
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-22
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-21
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-21
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-21
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-21
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-21
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-21
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		9e-21
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-20
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-19
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-19
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-19
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-19
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-19
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-19
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		4e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-19
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-19
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-19
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-18
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-18
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		8e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-18
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		8e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-17
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-17
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-17
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-17
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		9e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-16
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-16
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-16
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-16
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-16
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-16
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-16
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-16
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-16
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		4e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-16
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-16
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-16
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-16
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-16
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		8e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		9e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-15
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-15
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-15
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-15
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-15
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-15
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-15
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-15
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-15
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-15
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		4e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		5e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		5e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-14
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-14
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-14
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		8e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-14
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		9e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-13
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-13
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-13
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-13
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-13
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-13
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-13
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-13
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-13
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-13
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-13
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-13
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-13
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-13
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-13
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-13
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-13
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-13
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-13
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-13
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-13
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-13
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-13
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-13
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-13
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		8e-13
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		8e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-12
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		5e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-12
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		8e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		8e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		8e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-11
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-11
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-11
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		8e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-11
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		9e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-10
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-10
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		6e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-09
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		7e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-08
3soa_A	444	Full-Length Human Camkii Length = 444		3e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		4e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		6e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		6e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		7e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		7e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-07
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		6e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		7e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		8e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-06
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-06
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-06
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-06
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-06
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-06
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-06
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		7e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		8e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-06
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-05
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-05
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		5e-05
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		5e-05
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		5e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-05
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		5e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		6e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		6e-05
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		7e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		7e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		7e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		7e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  149 bits (377), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 104/298 (34%), Positives = 153/298 (51%), Gaps = 19/298 (6%)
Query: 380 RMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFN---LQYGRVFKSFD 436
           + FS  EL  A+D FS  N++GRG FG V+K RL DG  VA+K       Q G +   F 
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL--QFQ 83
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS---SNYILDIYQRLN 493
            E EM+    HRN++++   C     + LV  YM +GS+   L     S   LD  +R  
Sbjct: 84  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           I +  A  L YLH     ++IH D+K +N+LLD+   A + DFG+AKL+  +D   +   
Sbjct: 144 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH-VXXA 202
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIF---NGEMTLKHWVND 610
              TIG++APEY   G+ S   DV+ +G+ML+E  T ++  D      + ++ L  WV  
Sbjct: 203 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 262
Query: 611 WLPISTKE-IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
            L     E +VD +L      N+  K++ V  +  VA+ CT  SP +R    E+V  L
Sbjct: 263 LLKEKKLEALVDVDLQG----NY--KDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  145 bits (367), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 102/298 (34%), Positives = 151/298 (50%), Gaps = 19/298 (6%)
Query: 380 RMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFN---LQYGRVFKSFD 436
           + FS  EL  A+D F   N++GRG FG V+K RL DG  VA+K       Q G +   F 
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL--QFQ 75
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS---SNYILDIYQRLN 493
            E EM+    HRN++++   C     + LV  YM +GS+   L     S   LD  +R  
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           I +  A  L YLH     ++IH D+K +N+LLD+   A + DFG+AKL+  +D   +   
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXH-VXXA 194
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIF---NGEMTLKHWVND 610
               IG++APEY   G+ S   DV+ +G+ML+E  T ++  D      + ++ L  WV  
Sbjct: 195 VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 611 WLPISTKE-IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
            L     E +VD +L      N+  K++ V  +  VA+ CT  SP +R    E+V  L
Sbjct: 255 LLKEKKLEALVDVDLQG----NY--KDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 96/299 (32%), Positives = 159/299 (53%), Gaps = 17/299 (5%)
Query: 385 LELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKS 444
           ++L  AT+ F    LIG G FG V+K  L DG +VA+K    +  +  + F+ E E +  
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---YILDIYQRLNIMIDVASA 501
            RH +++ +I  C       L+ +YM +G+L+++L+ S+     +   QRL I I  A  
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           L YLH   +  +IH D+K  N+LLD+N V  ++DFGI+K  T  DQ+ +      T+GY+
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 562 APEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT-LKHW-VNDWLPISTKEI 619
            PEY  +GR++   DVYSFG++L E    +    +    EM  L  W V        ++I
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL---LKIRDSLL 675
           VDPNL  +       + + +    + A++C   S E R +  +++ KL   L++++S++
Sbjct: 269 VDPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  137 bits (345), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 95/299 (31%), Positives = 158/299 (52%), Gaps = 17/299 (5%)
Query: 385 LELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKS 444
           ++L  AT+ F    LIG G FG V+K  L DG +VA+K    +  +  + F+ E E +  
Sbjct: 32  VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSF 91
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---YILDIYQRLNIMIDVASA 501
            RH +++ +I  C       L+ +YM +G+L+++L+ S+     +   QRL I I  A  
Sbjct: 92  CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG 151
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           L YLH   +  +IH D+K  N+LLD+N V  ++DFGI+K  T   Q+ +      T+GY+
Sbjct: 152 LHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 562 APEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT-LKHW-VNDWLPISTKEI 619
            PEY  +GR++   DVYSFG++L E    +    +    EM  L  W V        ++I
Sbjct: 209 DPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268
Query: 620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL---LKIRDSLL 675
           VDPNL  +       + + +    + A++C   S E R +  +++ KL   L++++S++
Sbjct: 269 VDPNLADK------IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 128/289 (44%), Gaps = 51/289 (17%)
Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +G G+FG VF A         D M VA+K          K F  E E++ +++H +I+K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYI-------------LDIYQRLNIMIDV 498
              C + +   +V EYM HG L K+L  H  + +             L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI 558
           AS + YL    S   +H DL   N L+  N++  + DFG+++ +   D   +   T+  I
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 559 GYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 618
            +M PE     + +   DV+SFG++L E FT  K                  W  +S  E
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK----------------QPWFQLSNTE 243
Query: 619 IVD----PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
           +++      +L R  +       C   V++V + C    P+QR+N KEI
Sbjct: 244 VIECITQGRVLERPRV-------CPKEVYDVMLGCWQREPQQRLNIKEI 285

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 119/227 (52%), Gaps = 17/227 (7%)
Query: 382 FSYLELCRATDGFSEN------NLIGRGSFGSVFKARLGDGMEVAMK----VFNLQYGRV 431
           FS+ EL   T+ F E       N +G G FG V+K  + +   VA+K    + ++    +
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 432 FKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI--LDIY 489
            + FD E ++M   +H N+++++   S+ +   LV  YMP+GSL   L   +    L  +
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST 549
            R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+   +  Q+ 
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDE 596
           + ++ + T  YMAPE    G ++   D+YSFG++L+E  T     DE
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 118/227 (51%), Gaps = 17/227 (7%)
Query: 382 FSYLELCRATDGFSEN------NLIGRGSFGSVFKARLGDGMEVAMK----VFNLQYGRV 431
           FS+ EL   T+ F E       N +G G FG V+K  + +   VA+K    + ++    +
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 432 FKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI--LDIY 489
            + FD E ++M   +H N+++++   S+ +   LV  YMP+GSL   L   +    L  +
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST 549
            R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+   +  Q+ 
Sbjct: 134 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDE 596
           +  + + T  YMAPE    G ++   D+YSFG++L+E  T     DE
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 117/227 (51%), Gaps = 17/227 (7%)
Query: 382 FSYLELCRATDGFSEN------NLIGRGSFGSVFKARLGDGMEVAMK----VFNLQYGRV 431
           FS+ EL   T+ F E       N +G G FG V+K  + +   VA+K    + ++    +
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 432 FKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI--LDIY 489
            + FD E ++M   +H N+++++   S+ +   LV  YMP+GSL   L   +    L  +
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST 549
            R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+   +  Q  
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDE 596
           +  + + T  YMAPE    G ++   D+YSFG++L+E  T     DE
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 230

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 104/198 (52%), Gaps = 8/198 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG GSFG+V +A    G +VA+K+   Q  +      F  E  +MK +RH NI+  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
           +     ++V EY+  GSL + LH S     LD  +RL++  DVA  + YLH   +  ++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DLK  N+L+D      + DFG+++L  +            T  +MAPE  ++   +   
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 576 DVYSFGIMLMETFTRKKP 593
           DVYSFG++L E  T ++P
Sbjct: 221 DVYSFGVILWELATLQQP 238

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/199 (33%), Positives = 110/199 (55%), Gaps = 10/199 (5%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG GSFG+V +A    G +VA+K+   Q  +      F  E  +MK +RH NI+  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
           +     ++V EY+  GSL + LH S     LD  +RL++  DVA  + YLH   +  ++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPEYGKEGRVSAN 574
            +LK  N+L+D      + DFG+++L   +  + + +++ A T  +MAPE  ++   +  
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 575 GDVYSFGIMLMETFTRKKP 593
            DVYSFG++L E  T ++P
Sbjct: 220 SDVYSFGVILWELATLQQP 238

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 145/311 (46%), Gaps = 44/311 (14%)
Query: 389 RATDGFSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVE 438
           R    F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E
Sbjct: 33  RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 92
Query: 439 CEMMKSIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E++KS++H NI+K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTL 555
            +   +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    
Sbjct: 153 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 209
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTL 604
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 210 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 605 KHWVNDWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
            H +         E++  N  L R D        C   ++ +  EC   +  QR + +++
Sbjct: 270 FHLI---------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 313
Query: 664 VTKLLKIRDSL 674
             ++ +IRD +
Sbjct: 314 ALRVDQIRDQM 324

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 146/311 (46%), Gaps = 44/311 (14%)
Query: 389 RATDGFSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVE 438
           R    F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E
Sbjct: 7   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 66
Query: 439 CEMMKSIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E++KS++H NI+K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 126
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTL 555
            +   +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    
Sbjct: 127 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 183
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTL 604
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 184 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 243
Query: 605 KHWVNDWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
            H +         E++  N  L R D        C   ++ +  EC   +  QR + +++
Sbjct: 244 FHLI---------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 287
Query: 664 VTKLLKIRDSL 674
             ++ +IRD++
Sbjct: 288 ALRVDQIRDNM 298

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 146/311 (46%), Gaps = 44/311 (14%)
Query: 389 RATDGFSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVE 438
           R    F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 439 CEMMKSIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E++KS++H NI+K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 124
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTL 555
            +   +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    
Sbjct: 125 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTL 604
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 241
Query: 605 KHWVNDWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
            H +         E++  N  L R D        C   ++ +  EC   +  QR + +++
Sbjct: 242 FHLI---------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 285
Query: 664 VTKLLKIRDSL 674
             ++ +IRD++
Sbjct: 286 ALRVDQIRDNM 296

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 146/311 (46%), Gaps = 44/311 (14%)
Query: 389 RATDGFSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVE 438
           R    F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E
Sbjct: 6   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 65
Query: 439 CEMMKSIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E++KS++H NI+K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 125
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTL 555
            +   +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    
Sbjct: 126 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 182
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTL 604
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 183 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 242
Query: 605 KHWVNDWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
            H +         E++  N  L R D        C   ++ +  EC   +  QR + +++
Sbjct: 243 FHLI---------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 286
Query: 664 VTKLLKIRDSL 674
             ++ +IRD++
Sbjct: 287 ALRVDQIRDNM 297

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 146/311 (46%), Gaps = 44/311 (14%)
Query: 389 RATDGFSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVE 438
           R    F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E
Sbjct: 2   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 61
Query: 439 CEMMKSIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E++KS++H NI+K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTL 555
            +   +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    
Sbjct: 122 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTL 604
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 605 KHWVNDWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
            H +         E++  N  L R D        C   ++ +  EC   +  QR + +++
Sbjct: 239 FHLI---------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 282
Query: 664 VTKLLKIRDSL 674
             ++ +IRD++
Sbjct: 283 ALRVDQIRDNM 293

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 146/311 (46%), Gaps = 44/311 (14%)
Query: 389 RATDGFSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVE 438
           R    F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E
Sbjct: 1   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 60
Query: 439 CEMMKSIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E++KS++H NI+K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 120
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTL 555
            +   +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    
Sbjct: 121 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 177
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTL 604
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 178 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 237
Query: 605 KHWVNDWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
            H +         E++  N  L R D        C   ++ +  EC   +  QR + +++
Sbjct: 238 FHLI---------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 281
Query: 664 VTKLLKIRDSL 674
             ++ +IRD++
Sbjct: 282 ALRVDQIRDNM 292

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 146/311 (46%), Gaps = 44/311 (14%)
Query: 389 RATDGFSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVE 438
           R    F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E
Sbjct: 9   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 68
Query: 439 CEMMKSIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E++KS++H NI+K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 128
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTL 555
            +   +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    
Sbjct: 129 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 185
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTL 604
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 186 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 245
Query: 605 KHWVNDWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
            H +         E++  N  L R D        C   ++ +  EC   +  QR + +++
Sbjct: 246 FHLI---------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 289
Query: 664 VTKLLKIRDSL 674
             ++ +IRD++
Sbjct: 290 ALRVDQIRDNM 300

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 145/306 (47%), Gaps = 44/306 (14%)
Query: 394 FSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVECEMMK 443
           F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E E++K
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 444 SIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
           S++H NI+K    C +   +   L++EY+P+GSL  YL      +D  + L     +   
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTLATIGY 560
           +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    + I +
Sbjct: 145 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 201
Query: 561 MAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTLKHWVN 609
            APE   E + S   DV+SFG++L E FT     K P  E          G+M + H + 
Sbjct: 202 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI- 260
Query: 610 DWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                   E++  N  L R D        C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 261 --------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 305
Query: 669 KIRDSL 674
           +IRD++
Sbjct: 306 QIRDNM 311

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 145/306 (47%), Gaps = 44/306 (14%)
Query: 394 FSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVECEMMK 443
           F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E E++K
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 444 SIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
           S++H NI+K    C +   +   L++EY+P+GSL  YL      +D  + L     +   
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 144
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTLATIGY 560
           +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    + I +
Sbjct: 145 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 201
Query: 561 MAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTLKHWVN 609
            APE   E + S   DV+SFG++L E FT     K P  E          G+M + H + 
Sbjct: 202 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI- 260
Query: 610 DWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                   E++  N  L R D        C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 261 --------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 305
Query: 669 KIRDSL 674
           +IRD++
Sbjct: 306 QIRDNM 311

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 146/311 (46%), Gaps = 44/311 (14%)
Query: 389 RATDGFSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVE 438
           R    F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E
Sbjct: 8   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 67
Query: 439 CEMMKSIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E++KS++H NI+K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 127
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTL 555
            +   +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    
Sbjct: 128 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 184
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTL 604
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 185 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 244
Query: 605 KHWVNDWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
            H +         E++  N  L R D        C   ++ +  EC   +  QR + +++
Sbjct: 245 FHLI---------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 288
Query: 664 VTKLLKIRDSL 674
             ++ +IRD++
Sbjct: 289 ALRVDQIRDNM 299

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 145/306 (47%), Gaps = 44/306 (14%)
Query: 394 FSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVECEMMK 443
           F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E E++K
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 444 SIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
           S++H NI+K    C +   +   L++EY+P+GSL  YL      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTLATIGY 560
           +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    + I +
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 183
Query: 561 MAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTLKHWVN 609
            APE   E + S   DV+SFG++L E FT     K P  E          G+M + H + 
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI- 242
Query: 610 DWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                   E++  N  L R D        C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 243 --------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
Query: 669 KIRDSL 674
           +IRD++
Sbjct: 288 QIRDNM 293

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 147/311 (47%), Gaps = 44/311 (14%)
Query: 389 RATDGFSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVE 438
           R    F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E
Sbjct: 5   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 439 CEMMKSIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E++KS++H NI+K    C +   +   L++EY+P+GSL  YL +    +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS 124
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTL 555
            +   +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    
Sbjct: 125 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTL 604
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 241
Query: 605 KHWVNDWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
            H +         E++  N  L R D        C   ++ +  EC   +  QR + +++
Sbjct: 242 FHLI---------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 285
Query: 664 VTKLLKIRDSL 674
             ++ +IRD++
Sbjct: 286 ALRVDQIRDNM 296

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 144/306 (47%), Gaps = 44/306 (14%)
Query: 394 FSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVECEMMK 443
           F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E E++K
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 64
Query: 444 SIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
           S++H NI+K    C +   +   L++EY+P+GSL  YL      +D  + L     +   
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 124
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTLATIGY 560
           +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    + I +
Sbjct: 125 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFW 181
Query: 561 MAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTLKHWVN 609
            APE   E + S   DV+SFG++L E FT     K P  E          G+M + H + 
Sbjct: 182 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI- 240
Query: 610 DWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                   E++  N  L R D        C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 241 --------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 285
Query: 669 KIRDSL 674
           +IRD +
Sbjct: 286 QIRDQM 291

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  102 bits (253), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 397 NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
             ++GRG+FG V KA+     +VA+K    +  R  K+F VE   +  + H NI+K+  +
Sbjct: 14  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 70
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM---IDVASALEYLHFGYSAQV 513
           C N     LV+EY   GSL   LH +   L  Y   + M   +  +  + YLH      +
Sbjct: 71  CLNP--VCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 127
Query: 514 IHCDLKPSNVLL-DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
           IH DLKP N+LL     V  + DFG A      D  T  T    +  +MAPE  +    S
Sbjct: 128 IHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYS 182
Query: 573 ANGDVYSFGIMLMETFTRKKPTDEI 597
              DV+S+GI+L E  TR+KP DEI
Sbjct: 183 EKCDVFSWGIILWEVITRRKPFDEI 207

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 102/205 (49%), Gaps = 15/205 (7%)
Query: 397 NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
             ++GRG+FG V KA+     +VA+K    +  R  K+F VE   +  + H NI+K+  +
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGA 69
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM---IDVASALEYLHFGYSAQV 513
           C N     LV+EY   GSL   LH +   L  Y   + M   +  +  + YLH      +
Sbjct: 70  CLNP--VCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 514 IHCDLKPSNVLL-DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
           IH DLKP N+LL     V  + DFG A      D  T  T    +  +MAPE  +    S
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYS 181
Query: 573 ANGDVYSFGIMLMETFTRKKPTDEI 597
              DV+S+GI+L E  TR+KP DEI
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEI 206

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 147/311 (47%), Gaps = 44/311 (14%)
Query: 389 RATDGFSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVE 438
           R    F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E
Sbjct: 5   RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 64
Query: 439 CEMMKSIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E++KS++H NI+K    C +   +   L++E++P+GSL +YL      +D  + L    
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS 124
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTL 555
            +   +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    
Sbjct: 125 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTL 604
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 182 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 241
Query: 605 KHWVNDWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
            H +         E++  N  L R D        C   ++ +  EC   +  QR + +++
Sbjct: 242 FHLI---------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 285
Query: 664 VTKLLKIRDSL 674
             ++ +IRD++
Sbjct: 286 ALRVDQIRDNM 296

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 145/306 (47%), Gaps = 44/306 (14%)
Query: 394 FSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVECEMMK 443
           F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E E++K
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 444 SIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
           S++H NI+K    C +   +   L++EY+P+GSL  YL      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTLATIGY 560
           +EYL    + + IH DL   N+L+++     + DFG+ K+L ++ +   ++    + I +
Sbjct: 127 MEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 561 MAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTLKHWVN 609
            APE   E + S   DV+SFG++L E FT     K P  E          G+M + H + 
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI- 242
Query: 610 DWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                   E++  N  L R D        C   ++ +  EC   +  QR + +++  ++ 
Sbjct: 243 --------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
Query: 669 KIRDSL 674
           +IRD++
Sbjct: 288 QIRDNM 293

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/311 (27%), Positives = 146/311 (46%), Gaps = 44/311 (14%)
Query: 389 RATDGFSENNL-----IGRGSFGSVFKAR---LGD--GMEVAMKVFNLQYGRVFKSFDVE 438
           R    F E +L     +G+G+FGSV   R   L D  G  VA+K          + F+ E
Sbjct: 3   RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE 62
Query: 439 CEMMKSIRHRNIIKVISSCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E++KS++H NI+K    C +   +   L++EY+P+GSL  YL      +D  + L    
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 122
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTL 555
            +   +EYL    + + IH +L   N+L+++     + DFG+ K+L ++ +   ++    
Sbjct: 123 QICKGMEYLG---TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 179
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT----RKKPTDEIF-------NGEMTL 604
           + I + APE   E + S   DV+SFG++L E FT     K P  E          G+M +
Sbjct: 180 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 239
Query: 605 KHWVNDWLPISTKEIVDPN-LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
            H +         E++  N  L R D        C   ++ +  EC   +  QR + +++
Sbjct: 240 FHLI---------ELLKNNGRLPRPD-------GCPDEIYMIMTECWNNNVNQRPSFRDL 283
Query: 664 VTKLLKIRDSL 674
             ++ +IRD++
Sbjct: 284 ALRVDQIRDNM 294

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 126/278 (45%), Gaps = 28/278 (10%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG G FG V      +  +VA+K    +     + F  E E+M  + H  ++++   C  
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
           +    LV E+M HG L  YL +   +      L + +DV   + YL     A VIH DL 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 133
Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYS 579
             N L+ +N V  +SDFG+ + +  +DQ T  T T   + + +PE     R S+  DV+S
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 192
Query: 580 FGIMLMETFTRKK-PTDEIFNGEMTLKHWVNDWLPISTK-EIVDPNLLSREDINFVAKEQ 637
           FG+++ E F+  K P +   N E+     V D   IST   +  P L S           
Sbjct: 193 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 233
Query: 638 CVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
             + V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 234 --THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 269

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 126/278 (45%), Gaps = 28/278 (10%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG G FG V      +  +VA+K    +     + F  E E+M  + H  ++++   C  
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
           +    LV E+M HG L  YL +   +      L + +DV   + YL     A VIH DL 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 128
Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYS 579
             N L+ +N V  +SDFG+ + +  +DQ T  T T   + + +PE     R S+  DV+S
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 187
Query: 580 FGIMLMETFTRKK-PTDEIFNGEMTLKHWVNDWLPISTK-EIVDPNLLSREDINFVAKEQ 637
           FG+++ E F+  K P +   N E+     V D   IST   +  P L S           
Sbjct: 188 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 228
Query: 638 CVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
             + V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 229 --THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 264

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 126/278 (45%), Gaps = 28/278 (10%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG G FG V      +  +VA+K    +     + F  E E+M  + H  ++++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
           +    LV E+M HG L  YL +   +      L + +DV   + YL     A VIH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 130
Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYS 579
             N L+ +N V  +SDFG+ + +  +DQ T  T T   + + +PE     R S+  DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 580 FGIMLMETFTRKK-PTDEIFNGEMTLKHWVNDWLPISTK-EIVDPNLLSREDINFVAKEQ 637
           FG+++ E F+  K P +   N E+     V D   IST   +  P L S           
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 230
Query: 638 CVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
             + V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 231 --THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 266

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 124/285 (43%), Gaps = 46/285 (16%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKVISSC 457
           IGRG+FG VF  RL  D   VA+K          K+ F  E  ++K   H NI+++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
           + ++   +V+E +  G    +L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT----LATIGYMAPEYGKEGRVSA 573
           L   N L+ +  V  +SDFG    ++RE+   +   +       + + APE    GR S+
Sbjct: 239 LAARNCLVTEKNVLKISDFG----MSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV 633
             DV+SFGI+L ETF                          S      PNL +++   FV
Sbjct: 295 ESDVWSFGILLWETF--------------------------SLGASPYPNLSNQQTREFV 328
Query: 634 AK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
            K       E C   VF +  +C    P QR +   I  +L  IR
Sbjct: 329 EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +G G+FG VF A         D M VA+K          + F  E E++  ++H++I++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHS--------------SNYILDIYQRLNIMIDVA 499
              C+      +V EYM HG L ++L S              +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 500 SALEYL---HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D   +  +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST 616
            I +M PE     + +   DV+SFG++L E FT  K                  W  +S 
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK----------------QPWYQLSN 266
Query: 617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
            E +D     RE         C   V+ +   C    P+QR + K++  +L
Sbjct: 267 TEAIDCITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 129/279 (46%), Gaps = 30/279 (10%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKVISSCS 458
           IG G FG V      +  +VA+K   ++ G + +  F  E E+M  + H  ++++   C 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIK--TIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            +    LV E+M HG L  YL +   +      L + +DV   + YL     A VIH DL
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDL 149
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
              N L+ +N V  +SDFG+ + +  +DQ T  T T   + + +PE     R S+  DV+
Sbjct: 150 AARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 208
Query: 579 SFGIMLMETFTRKK-PTDEIFNGEMTLKHWVNDWLPISTK-EIVDPNLLSREDINFVAKE 636
           SFG+++ E F+  K P +   N E+     V D   IST   +  P L S          
Sbjct: 209 SFGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS---------- 250
Query: 637 QCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
              + V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 251 ---THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL 286

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 139/291 (47%), Gaps = 34/291 (11%)
Query: 395 SENNLIGRGSFGSVFKARLGDG---MEVAMKVFNLQYGRVFKS---FDVECEMMKSIRHR 448
           +   +IG G FG V+K  L       EV + +  L+ G   K    F  E  +M    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NII++    S  +   ++ EYM +G+L+K+L   +    + Q + ++  +A+ ++YL   
Sbjct: 107 NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA-- 164
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYGK 567
            +   +H DL   N+L++ N+V  +SDFG++++L  + ++T  T      I + APE   
Sbjct: 165 -NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 568 EGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 626
             + ++  DV+SFGI++ E  T  ++P  E+ N E+     +ND   + T          
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA--INDGFRLPT---------- 271
Query: 627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT---KLLKIRDSL 674
                      C S ++ + M+C  +   +R    +IV+   KL++  DSL
Sbjct: 272 --------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 314

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 124/285 (43%), Gaps = 46/285 (16%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKVISSC 457
           IGRG+FG VF  RL  D   VA+K          K+ F  E  ++K   H NI+++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
           + ++   +V+E +  G    +L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT----LATIGYMAPEYGKEGRVSA 573
           L   N L+ +  V  +SDFG    ++RE+   +   +       + + APE    GR S+
Sbjct: 239 LAARNCLVTEKNVLKISDFG----MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV 633
             DV+SFGI+L ETF                          S      PNL +++   FV
Sbjct: 295 ESDVWSFGILLWETF--------------------------SLGASPYPNLSNQQTREFV 328
Query: 634 AK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
            K       E C   VF +  +C    P QR +   I  +L  IR
Sbjct: 329 EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 126/278 (45%), Gaps = 28/278 (10%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG G FG V      +  +VA+K    +     + F  E E+M  + H  ++++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
           +    LV E+M HG L  YL +   +      L + +DV   + YL     A VIH DL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 131
Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYS 579
             N L+ +N V  +SDFG+ + +  +DQ T  T T   + + +PE     R S+  DV+S
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190
Query: 580 FGIMLMETFTRKK-PTDEIFNGEMTLKHWVNDWLPISTK-EIVDPNLLSREDINFVAKEQ 637
           FG+++ E F+  K P +   N E+     V D   IST   +  P L S           
Sbjct: 191 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 231
Query: 638 CVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
             + V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 232 --THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 124/278 (44%), Gaps = 28/278 (10%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG G FG V      +  +VA+K    +     + F  E E+M  + H  ++++   C  
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
           +    LV E+M HG L  YL +   +      L + +DV   + YL     A VIH DL 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIHRDLA 130
Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYS 579
             N L+ +N V  +SDFG+ + +  +DQ T  T T   + + +PE     R S+  DV+S
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 189
Query: 580 FGIMLMETFTRKK-PTDEIFNGEMTLKHWVNDWLPISTK-EIVDPNLLSREDINFVAKEQ 637
           FG+++ E F+  K P +   N E+     V D   IST   +  P L S           
Sbjct: 190 FGVLMWEVFSEGKIPYENRSNSEV-----VED---ISTGFRLYKPRLAS----------- 230
Query: 638 CVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
             + V+ +   C  E PE R     ++ +L  I  S L
Sbjct: 231 --THVYQIMNHCWKERPEDRPAFSRLLRQLAAIAASGL 266

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +G G+FG VF A         D M VA+K          + F  E E++  ++H++I++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHS--------------SNYILDIYQRLNIMIDVA 499
              C+      +V EYM HG L ++L S              +   L + Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 500 SALEYL---HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D   +  +T+ 
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST 616
            I +M PE     + +   DV+SFG++L E FT  K                  W  +S 
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK----------------QPWYQLSN 237
Query: 617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
            E +D     RE         C   V+ +   C    P+QR + K++  +L
Sbjct: 238 TEAIDCITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 285

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 122/291 (41%), Gaps = 48/291 (16%)
Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +G G+FG VF A         D M VA+K          + F  E E++  ++H++I++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHS--------------SNYILDIYQRLNIMIDVA 499
              C+      +V EYM HG L ++L S              +   L + Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 500 SALEYL---HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D   +  +T+ 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST 616
            I +M PE     + +   DV+SFG++L E FT  K                  W  +S 
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK----------------QPWYQLSN 243
Query: 617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
            E +D     RE         C   V+ +   C    P+QR + K++  +L
Sbjct: 244 TEAIDCITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 291

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 113/227 (49%), Gaps = 17/227 (7%)
Query: 382 FSYLELCRATDGFSEN------NLIGRGSFGSVFKARLGDGMEVAMK----VFNLQYGRV 431
           FS+ EL   T+ F E       N  G G FG V+K  + +   VA+K    + ++    +
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 432 FKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI--LDIY 489
            + FD E ++    +H N+++++   S+ +   LV  Y P+GSL   L   +    L  +
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST 549
            R  I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+   +  Q  
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDE 596
             ++ + T  Y APE    G ++   D+YSFG++L+E  T     DE
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 227

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 40/286 (13%)
Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +G G+FG VF A         D + VA+K          K F  E E++ +++H +I+K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYIL----------DIYQRLNIMIDVASA 501
              C   +   +V EYM HG L K+L  H  + +L             Q L+I   +A+ 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YL    S   +H DL   N L+ +N++  + DFG+++ +   D   +   T+  I +M
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 562 APEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 621
            PE     + +   DV+S G++L E FT  K                  W  +S  E+++
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK----------------QPWYQLSNNEVIE 241
Query: 622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                R          C   V+ + + C    P  R N K I T L
Sbjct: 242 CITQGR---VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLL 284

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 92
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQ 209
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 250
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 251 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 85
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 142
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 202
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 203 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 243
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 244 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 111
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 168
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 228
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 229 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 269
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 270 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 91
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 148
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 208
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 249
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 250 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 112
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 169
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 229
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 230 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 270
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 271 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 251
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 252 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 88
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 246
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 247 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 92
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 149
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 209
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 210 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 250
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 251 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 90
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 147
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 207
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 248
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 13/211 (6%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
           IG GSFG+V+K +  GD   VA+K+  +       F++F  E  +++  RH NI+  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
            + +   A+V ++    SL K+LH       ++Q ++I    A  ++YLH   +  +IH 
Sbjct: 101 MTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHR 156
Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSA 573
           D+K +N+ L + +   + DFG+A + +R   S    Q   ++ +MAPE  +       S 
Sbjct: 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSF 216
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTL 604
             DVYS+GI+L E  T + P   I N +  +
Sbjct: 217 QSDVYSYGIVLYELMTGELPYSHINNRDQII 247

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  ++YL    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---A 150
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 210
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 251
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 252 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 130/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 459 NEEFKALVLEYMPHGSLEKYLH-SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 74  EEPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 129
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 130 LRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 189 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 222
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 223 RMPCPPECPESLHDLMCQCWRKEPEER 249

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 130/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 459 NEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V+EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 199 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 232
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 233 RMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 130/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 459 NEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 333 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 388
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 389 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 448 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 481
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 482 RMPCPPECPESLHDLMCQCWRKEPEER 508

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 130/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 459 NEEFKALVLEYMPHGSLEKYLH-SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 77  EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 132
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 133 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 192 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 225
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 226 RMPCPPECPESLHDLMCQCWRKEPEER 252

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 130/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 459 NEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V+EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 199 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 232
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 233 RMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 129/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK IRH  ++++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 459 NEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 199 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 232
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 233 RMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 130/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 459 NEEFKALVLEYMPHGSLEKYLH-SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 365 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 398
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 399 RMPCPPECPESLHDLMCQCWRKEPEER 425

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 152
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  +++L    
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 310
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 311 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 130/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 459 NEEFKALVLEYMPHGSLEKYLH-SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 365 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 398
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 399 RMPCPPECPESLHDLMCQCWRKEPEER 425

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 32/288 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  +++L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 251
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
           +    +  E C   ++ V ++C     E R +  E+V+++  I  + +
Sbjct: 252 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 98
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  +++L    
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 155
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 215
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 216 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 256
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 257 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 94
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  +++L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 252
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 253 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 94
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  +++L    
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 151
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 211
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 252
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 253 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 32/288 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 93
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  +++L    
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 150
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 210
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 251
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
           +    +  E C   ++ V ++C     E R +  E+V+++  I  + +
Sbjct: 252 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 299

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNI 450
           N +IGRG FG V+   L    G  +  A+K  N     G V   F  E  +MK   H N+
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-SQFLTEGIIMKDFSHPNV 91
Query: 451 IKVISSCSNEEFKALV-LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           + ++  C   E   LV L YM HG L  ++ +  +   +   +   + VA  +++L    
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---A 148
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
           S + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 208
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
             + +   DV+SFG++L E  TR  P                   P       D  +   
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMTRGAP-------------------PYPDVNTFDITVYLL 249
Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +    +  E C   ++ V ++C     E R +  E+V+++  I
Sbjct: 250 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 103/194 (53%), Gaps = 17/194 (8%)
Query: 400 IGRGSFGSVFKARLGD--GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG+G FG V    LGD  G +VA+K   ++     ++F  E  +M  +RH N+++++   
Sbjct: 14  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 458 SNEEFKA-LVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL        +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 125
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DL   NVL+ ++ VA +SDFG    LT+E  ST  T  L  + + APE  +E + S   
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLP-VKWTAPEALREKKFSTKS 180
Query: 576 DVYSFGIMLMETFT 589
           DV+SFGI+L E ++
Sbjct: 181 DVWSFGILLWEIYS 194

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 130/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 459 NEEFKALVLEYMPHGSLEKYLH-SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI-EDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 196 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 229
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 230 RMPCPPECPESLHDLMCQCWRKEPEER 256

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 129/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 459 NEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 73  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 128
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 129 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 188 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 221
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 222 RMPCPPECPESLHDLMCQCWRKDPEER 248

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 103/194 (53%), Gaps = 17/194 (8%)
Query: 400 IGRGSFGSVFKARLGD--GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG+G FG V    LGD  G +VA+K   ++     ++F  E  +M  +RH N+++++   
Sbjct: 29  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 458 SNEEFK-ALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DL   NVL+ ++ VA +SDFG    LT+E  ST  T  L  + + APE  +E + S   
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLP-VKWTAPEALREKKFSTKS 195
Query: 576 DVYSFGIMLMETFT 589
           DV+SFGI+L E ++
Sbjct: 196 DVWSFGILLWEIYS 209

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 129/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 459 NEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 75  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 130
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 131 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 190 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 223
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 224 RMPCPPECPESLHDLMCQCWRKDPEER 250

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 129/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 459 NEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 199 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 232
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 233 RMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 129/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 459 NEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 199 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 232
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 233 RMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 102/194 (52%), Gaps = 17/194 (8%)
Query: 400 IGRGSFGSVFKARLGD--GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG+G FG V    LGD  G +VA+K   ++     ++F  E  +M  +RH N+++++   
Sbjct: 20  IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 458 SNEEFKA-LVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL        +H
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 131
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DL   NVL+ ++ VA +SDFG    LT+E  ST  T  L  + + APE  +E   S   
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLP-VKWTAPEALREAAFSTKS 186
Query: 576 DVYSFGIMLMETFT 589
           DV+SFGI+L E ++
Sbjct: 187 DVWSFGILLWEIYS 200

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 130/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 459 NEEFKALVLEYMPHGSLEKYLH-SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHRD 136
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 137 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 196 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 229
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 230 RMPCPPECPESLHDLMCQCWRKEPEER 256

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 130/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 459 NEEFKALVLEYMPHGSLEKYLH-SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L   +   L + Q +++   +AS + Y+        +H D
Sbjct: 250 EEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 365 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 398
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 399 RMPCPPECPESLHDLMCQCWRKEPEER 425

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 70/194 (36%), Positives = 103/194 (53%), Gaps = 17/194 (8%)
Query: 400 IGRGSFGSVFKARLGD--GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG+G FG V    LGD  G +VA+K   ++     ++F  E  +M  +RH N+++++   
Sbjct: 201 IGKGEFGDVM---LGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 458 SNEEFK-ALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL        +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 312
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DL   NVL+ ++ VA +SDFG    LT+E  ST  T  L  + + APE  +E + S   
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFG----LTKEASSTQDTGKLP-VKWTAPEALREKKFSTKS 367
Query: 576 DVYSFGIMLMETFT 589
           DV+SFGI+L E ++
Sbjct: 368 DVWSFGILLWEIYS 381

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 129/267 (48%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 459 NEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V+EYM  G L  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 199 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 232
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 233 RMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 128/267 (47%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 459 NEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 251 EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 306
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+ +L+  +++ T +      I + APE    GR +   DV
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 366 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 399
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 400 RMPCPPECPESLHDLMCQCWRKDPEER 426

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 28/275 (10%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V   +     +VA+K+  ++ G + +  F  E + M  + H  ++K    CS
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKM--IKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            E    +V EY+ +G L  YL S    L+  Q L +  DV   + +L    S Q IH DL
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDL 130
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
              N L+D ++   +SDFG+ + +  +DQ      T   + + APE     + S+  DV+
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVW 189
Query: 579 SFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQ 637
           +FGI++ E F+  K P D   N E+ LK             +  P+L S           
Sbjct: 190 AFGILMWEVFSLGKMPYDLYTNSEVVLK-------VSQGHRLYRPHLAS----------- 231
Query: 638 CVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD 672
               ++ +   C  E PE+R   +++++ +  +R+
Sbjct: 232 --DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 111/212 (52%), Gaps = 13/212 (6%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISS 456
           IG GSFG+V+K +  GD   VA+K+ N+     +  ++F  E  +++  RH NI+  +  
Sbjct: 20  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
            +  +  A+V ++    SL  +LH+S    ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 77  STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 132
Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSA 573
           DLK +N+ L ++    + DFG+A + +R   S    Q   +I +MAPE  +       S 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
             DVY+FGI+L E  T + P   I N +  ++
Sbjct: 193 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 224

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 128/267 (47%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 459 NEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L  +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 140 LAAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 199 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 232
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 233 RMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 148/313 (47%), Gaps = 37/313 (11%)
Query: 373 MPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQY 428
           +P  + Q +  + +   AT+  S + ++G G FG V   RL       + VA+K   + Y
Sbjct: 15  VPRGSTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 73
Query: 429 G-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  + F  E  +M    H NII++    +  +   +V EYM +GSL+ +L   +    
Sbjct: 74  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 133
Query: 488 IYQRLNIMIDVASALEYL-HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
           + Q + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L  + 
Sbjct: 134 VIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 189
Query: 547 QSTIQTQTLAT-IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTL 604
           ++   T+     I + +PE     + ++  DV+S+GI+L E  +  ++P  E+ N ++  
Sbjct: 190 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI- 248
Query: 605 KHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
                        + VD      E         C + ++ + ++C  +    R   ++IV
Sbjct: 249 -------------KAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 289
Query: 665 TKLLKIRDSLLRN 677
           +    I D L+RN
Sbjct: 290 S----ILDKLIRN 298

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 128/267 (47%), Gaps = 42/267 (15%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG V+         VA+K   L+ G +  ++F  E ++MK +RH  ++++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 459 NEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  G L  +L       L + Q +++   +AS + Y+        +H D
Sbjct: 84  EEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 139
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 140 LRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L E  T+ +                          +  P +++RE ++ V +  
Sbjct: 199 WSFGILLTELTTKGR--------------------------VPYPGMVNREVLDQVERGY 232
Query: 636 -----EQCVSFVFNVAMECTVESPEQR 657
                 +C   + ++  +C  + PE+R
Sbjct: 233 RMPCPPECPESLHDLMCQCWRKDPEER 259

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 138/292 (47%), Gaps = 36/292 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHR 448
            S + ++G G FG V   RL       + VA+K   + Y  +  + F  E  +M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL-HF 507
           NII++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYG 566
           GY    +H DL   N+L++ N+V  +SDFG+A++L  + ++   T+     I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 567 KEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 625
              + ++  DV+S+GI+L E  +  ++P  E+ N ++               + VD    
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------------KAVD---- 264
Query: 626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
             E         C + ++ + ++C  +    R   ++IV+    I D L+RN
Sbjct: 265 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 7/208 (3%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG GSFG+V+K +    + V M        +  ++F  E  +++  RH NI+  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
            +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 131
Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSANGD 576
            +N+ L +++   + DFG+A + +R   S    Q   +I +MAPE  +   +   S   D
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 577 VYSFGIMLMETFTRKKPTDEIFNGEMTL 604
           VY+FGI+L E  T + P   I N +  +
Sbjct: 192 VYAFGIVLYELMTGQLPYSNINNRDQII 219

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 7/208 (3%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG GSFG+V+K +    + V M        +  ++F  E  +++  RH NI+  +   + 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
            +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH DLK
Sbjct: 81  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 136
Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSANGD 576
            +N+ L +++   + DFG+A + +R   S    Q   +I +MAPE  +   +   S   D
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 196
Query: 577 VYSFGIMLMETFTRKKPTDEIFNGEMTL 604
           VY+FGI+L E  T + P   I N +  +
Sbjct: 197 VYAFGIVLYELMTGQLPYSNINNRDQII 224

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 7/208 (3%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG GSFG+V+K +    + V M        +  ++F  E  +++  RH NI+  +   + 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
            +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH DLK
Sbjct: 81  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 136
Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSANGD 576
            +N+ L +++   + DFG+A + +R   S    Q   +I +MAPE  +   +   S   D
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 196
Query: 577 VYSFGIMLMETFTRKKPTDEIFNGEMTL 604
           VY+FGI+L E  T + P   I N +  +
Sbjct: 197 VYAFGIVLYELMTGQLPYSNINNRDQII 224

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 7/208 (3%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG GSFG+V+K +    + V M        +  ++F  E  +++  RH NI+  +   + 
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
            +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH DLK
Sbjct: 78  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 133
Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSANGD 576
            +N+ L +++   + DFG+A + +R   S    Q   +I +MAPE  +   +   S   D
Sbjct: 134 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 193
Query: 577 VYSFGIMLMETFTRKKPTDEIFNGEMTL 604
           VY+FGI+L E  T + P   I N +  +
Sbjct: 194 VYAFGIVLYELMTGQLPYSNINNRDQII 221

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 13/212 (6%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISS 456
           IG GSFG+V+K +  GD   VA+K+ N+     +  ++F  E  +++  RH NI+  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
            +  +  A+V ++    SL  +LH+S    ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 89  STKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSA 573
           DLK +N+ L ++    + DFG+A   +R   S    Q   +I +MAPE  +       S 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
             DVY+FGI+L E  T + P   I N +  ++
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 236

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 148/316 (46%), Gaps = 37/316 (11%)
Query: 370 DANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFN 425
           D +   +  Q +  + +   AT+  S + ++G G FG V   RL       + VA+K   
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 426 LQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY 484
           + Y  +  + F  E  +M    H NII++    +  +   +V EYM +GSL+ +L   + 
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 142
Query: 485 ILDIYQRLNIMIDVASALEYL-HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 543
              + Q + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 544 REDQSTIQTQ-TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGE 601
            + ++   T+     I + +PE     + ++  DV+S+GI+L E  +  ++P  E+ N +
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 602 MTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAK 661
           +               + VD      E         C + ++ + ++C  +    R   +
Sbjct: 259 VI--------------KAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 662 EIVTKLLKIRDSLLRN 677
           +IV+    I D L+RN
Sbjct: 299 QIVS----ILDKLIRN 310

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 7/208 (3%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG GSFG+V+K +    + V M        +  ++F  E  +++  RH NI+  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
            +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 131
Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSANGD 576
            +N+ L +++   + DFG+A + +R   S    Q   +I +MAPE  +   +   S   D
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 577 VYSFGIMLMETFTRKKPTDEIFNGEMTL 604
           VY+FGI+L E  T + P   I N +  +
Sbjct: 192 VYAFGIVLYELMTGQLPYSNINNRDQII 219

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 148/316 (46%), Gaps = 37/316 (11%)
Query: 370 DANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFN 425
           D +   +  Q +  + +   AT+  S + ++G G FG V   RL       + VA+K   
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 426 LQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY 484
           + Y  +  + F  E  +M    H NII++    +  +   +V EYM +GSL+ +L   + 
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 142
Query: 485 ILDIYQRLNIMIDVASALEYL-HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 543
              + Q + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 544 REDQSTIQTQ-TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGE 601
            + ++   T+     I + +PE     + ++  DV+S+GI+L E  +  ++P  E+ N +
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 602 MTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAK 661
           +               + VD      E         C + ++ + ++C  +    R   +
Sbjct: 259 VI--------------KAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 662 EIVTKLLKIRDSLLRN 677
           +IV+    I D L+RN
Sbjct: 299 QIVS----ILDKLIRN 310

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 110/211 (52%), Gaps = 13/211 (6%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISS 456
           IG GSFG+V+K +  GD   VA+K+ N+     +  ++F  E  +++  RH NI+  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
            +  +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 156
Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSA 573
           DLK +N+ L +++   + DFG+A + +R   S    Q   +I +MAPE  +   +   S 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTL 604
             DVY+FGI+L E  T + P   I N +  +
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINNRDQII 247

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 7/208 (3%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG GSFG+V+K +    + V M        +  ++F  E  +++  RH NI+  +   + 
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
            +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH DLK
Sbjct: 103 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 158
Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSANGD 576
            +N+ L +++   + DFG+A + +R   S    Q   +I +MAPE  +   +   S   D
Sbjct: 159 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 218
Query: 577 VYSFGIMLMETFTRKKPTDEIFNGEMTL 604
           VY+FGI+L E  T + P   I N +  +
Sbjct: 219 VYAFGIVLYELMTGQLPYSNINNRDQII 246

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/316 (24%), Positives = 148/316 (46%), Gaps = 37/316 (11%)
Query: 370 DANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFN 425
           D +   +  Q +  + +   AT+  S + ++G G FG V   RL       + VA+K   
Sbjct: 22  DPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 80
Query: 426 LQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY 484
           + Y  +  + F  E  +M    H NII++    +  +   +V EYM +GSL+ +L   + 
Sbjct: 81  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA 140
Query: 485 ILDIYQRLNIMIDVASALEYL-HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 543
              + Q + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L 
Sbjct: 141 QFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLE 196
Query: 544 REDQSTIQTQ-TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGE 601
            + ++   T+     I + +PE     + ++  DV+S+GI+L E  +  ++P  E+ N +
Sbjct: 197 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 256
Query: 602 MTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAK 661
           +               + VD      E         C + ++ + ++C  +    R   +
Sbjct: 257 VI--------------KAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 296
Query: 662 EIVTKLLKIRDSLLRN 677
           +IV+    I D L+RN
Sbjct: 297 QIVS----ILDKLIRN 308

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 138/292 (47%), Gaps = 36/292 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHR 448
            S + ++G G FG V   RL       + VA+K   + Y  +  + F  E  +M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL-HF 507
           NII++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYG 566
           GY    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 567 KEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 625
              + ++  DV+S+GI+L E  +  ++P  E+ N ++               + VD    
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------------KAVD---- 264
Query: 626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
             E         C + ++ + ++C  +    R   ++IV+    I D L+RN
Sbjct: 265 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 138/292 (47%), Gaps = 36/292 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHR 448
            S + ++G G FG V   RL       + VA+K   + Y  +  + F  E  +M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL-HF 507
           NII++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYG 566
           GY    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 567 KEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 625
              + ++  DV+S+GI+L E  +  ++P  E+ N ++               + VD    
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------------KAVD---- 264
Query: 626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
             E         C + ++ + ++C  +    R   ++IV+    I D L+RN
Sbjct: 265 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V   +     +VA+K+  ++ G + +  F  E ++M ++ H  ++++   C+
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S Q +H DL
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
              N L++D  V  +SDFG+++ +  +D+ T    +   + +  PE     + S+  D++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVL-DDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 579 SFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQC 638
           +FG+++ E ++  K   E F    T +H            +  P+L S +          
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQG------LRLYRPHLASEK---------- 249
Query: 639 VSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD 672
              V+ +   C  E  ++R   K +++ +L + D
Sbjct: 250 ---VYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 110/212 (51%), Gaps = 13/212 (6%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISS 456
           IG GSFG+V+K +  GD   VA+K+ N+     +  ++F  E  +++  RH NI+  +  
Sbjct: 32  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
            +  +  A+V ++    SL  +LH+S    ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 89  STAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSA 573
           DLK +N+ L ++    + DFG+A   +R   S    Q   +I +MAPE  +       S 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
             DVY+FGI+L E  T + P   I N +  ++
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 236

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 138/292 (47%), Gaps = 36/292 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHR 448
            S + ++G G FG V   RL       + VA+K   + Y  +  + F  E  +M    H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL-HF 507
           NII++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT-IGYMAPEYG 566
           GY    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + +PE  
Sbjct: 138 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 567 KEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 625
              + ++  DV+S+GI+L E  +  ++P  E+ N ++               + VD    
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------------KAVD---- 235
Query: 626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
             E         C + ++ + ++C  +    R   ++IV+    I D L+RN
Sbjct: 236 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 281

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/292 (25%), Positives = 137/292 (46%), Gaps = 36/292 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHR 448
            S + ++G G FG V   RL       + VA+K   + Y  +  + F  E  +M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL-HF 507
           NII++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYG 566
           GY    +H DL   N+L++ N+V  +SDFG+ ++L  + ++   T+     I + +PE  
Sbjct: 167 GY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 567 KEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 625
              + ++  DV+S+GI+L E  +  ++P  E+ N ++               + VD    
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------------KAVD---- 264
Query: 626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
             E         C + ++ + ++C  +    R   ++IV+    I D L+RN
Sbjct: 265 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V   +     +VA+K+  ++ G + +  F  E ++M ++ H  ++++   C+
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S Q +H DL
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
              N L++D  V  +SDFG+++ +  +D+ T    +   + +  PE     + S+  D++
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 205
Query: 579 SFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQC 638
           +FG+++ E ++  K   E F    T +H            +  P+L S +          
Sbjct: 206 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQG------LRLYRPHLASEK---------- 249
Query: 639 VSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD 672
              V+ +   C  E  ++R   K +++ +L + D
Sbjct: 250 ---VYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 7/208 (3%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG GSFG+V+K +    + V M        +  ++F  E  +++  RH NI+  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
            +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 131
Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSANGD 576
            +N+ L +++   + DFG+A   +R   S    Q   +I +MAPE  +   +   S   D
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 191
Query: 577 VYSFGIMLMETFTRKKPTDEIFNGEMTL 604
           VY+FGI+L E  T + P   I N +  +
Sbjct: 192 VYAFGIVLYELMTGQLPYSNINNRDQII 219

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 7/208 (3%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG GSFG+V+K +    + V M        +  ++F  E  +++  RH NI+  +   + 
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
            +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH DLK
Sbjct: 96  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 151
Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSANGD 576
            +N+ L +++   + DFG+A   +R   S    Q   +I +MAPE  +   +   S   D
Sbjct: 152 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSD 211
Query: 577 VYSFGIMLMETFTRKKPTDEIFNGEMTL 604
           VY+FGI+L E  T + P   I N +  +
Sbjct: 212 VYAFGIVLYELMTGQLPYSNINNRDQII 239

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V   +     +VA+K+  ++ G + +  F  E ++M ++ H  ++++   C+
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S Q +H DL
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 137
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
              N L++D  V  +SDFG+++ +  +D+ T    +   + +  PE     + S+  D++
Sbjct: 138 AARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 196
Query: 579 SFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQC 638
           +FG+++ E ++  K   E F    T +H            +  P+L S +          
Sbjct: 197 AFGVLMWEIYSLGKMPYERFTNSETAEH------IAQGLRLYRPHLASEK---------- 240
Query: 639 VSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD 672
              V+ +   C  E  ++R   K +++ +L + D
Sbjct: 241 ---VYTIMYSCWHEKADERPTFKILLSNILDVMD 271

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 112/251 (44%), Gaps = 39/251 (15%)
Query: 101 SLEYFEMAYC----NVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTXXXXXXXXXXXXE 156
           +L Y    Y     N+ G IP  I  LT L  +Y+    ++G+IP               
Sbjct: 74  NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 157 NNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASL-RILLLGSNELTS-IPLT 214
            N L G++P SI     L  +   GN++SG+IP+ + + + L   + +  N LT  IP T
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 215 FWNLKDILYLNFSSNFFTG--------------------PLPLEIGNLKIAR-IDSCDXX 253
           F NL ++ +++ S N   G                     L  ++G + +++ ++  D  
Sbjct: 194 FANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLR 252
Query: 254 XXXXXXXXXXXXXGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL 313
                        G +P  L +L +L  LN+SFN L GEIP+GG+   F   ++  N+ L
Sbjct: 253 NNRIY--------GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
Query: 314 CGSPNLRVPPC 324
           CGSP   +P C
Sbjct: 305 CGSP---LPAC 312

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 109/211 (51%), Gaps = 13/211 (6%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISS 456
           IG GSFG+V+K +  GD   VA+K+ N+     +  ++F  E  +++  RH NI+  +  
Sbjct: 44  IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
            +  +  A+V ++    SL  +LH      ++ + ++I    A  ++YLH   +  +IH 
Sbjct: 101 STKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 156
Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSA 573
           DLK +N+ L +++   + DFG+A   +R   S    Q   +I +MAPE  +   +   S 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTL 604
             DVY+FGI+L E  T + P   I N +  +
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINNRDQII 247

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 101/373 (27%), Positives = 147/373 (39%), Gaps = 56/373 (15%)
Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYXXXXX 61
           L +  N F+G IP  + N S+L  L LS N  SG IP++ G+L  L+ L+L  N      
Sbjct: 396 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 455
Query: 62  XXXXXXXXX-------------------XNCKSLTLISFSNNPLDGILPKTSVGNLSHSL 102
                                        NC +L  IS SNN L G +PK  +G L  +L
Sbjct: 456 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW-IGRL-ENL 513
Query: 103 EYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTXXXXXXXXXXXXENNKLEG 162
              +++  + SG IP E+G+  +L  + L  N  NG+IP+                K   
Sbjct: 514 AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV 573
Query: 163 SIPDSI----CH------------SDELYKLE------LGGNKLSGSIPECFNNLASLRI 200
            I +      CH            S++L +L       +      G     F+N  S+  
Sbjct: 574 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 633
Query: 201 LLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDXXXXXXXX 259
           L +  N L+  IP    ++  +  LN   N  +G +P E+G+L+   I            
Sbjct: 634 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI----------LD 683
Query: 260 XXXXXXXGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNL 319
                  G IP ++  L+ L +++LS N L G IP  G F  F    F  N  LCG P  
Sbjct: 684 LSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP 743
Query: 320 RVPPCKTS--IHH 330
           R  P       HH
Sbjct: 744 RCDPSNADGYAHH 756

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V   +     +VA+K+  ++ G + +  F  E ++M ++ H  ++++   C+
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S Q +H DL
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
              N L++D  V  +SDFG+++ +  +D+ T    +   + +  PE     + S+  D++
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 579 SFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQC 638
           +FG+++ E ++  K   E F    T +H            +  P+L S +          
Sbjct: 191 AFGVLMWEIYSLGKMPYERFTNSETAEH------IAQGLRLYRPHLASEK---------- 234
Query: 639 VSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD 672
              V+ +   C  E  ++R   K +++ +L + D
Sbjct: 235 ---VYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V   +     +VA+K+  ++ G + +  F  E ++M ++ H  ++++   C+
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S Q +H DL
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 130
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
              N L++D  V  +SDFG+++ +  +D+ T    +   + +  PE     + S+  D++
Sbjct: 131 AARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 189
Query: 579 SFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQC 638
           +FG+++ E ++  K   E F    T +H            +  P+L S +          
Sbjct: 190 AFGVLMWEIYSLGKMPYERFTNSETAEH------IAQGLRLYRPHLASEK---------- 233
Query: 639 VSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD 672
              V+ +   C  E  ++R   K +++ +L + D
Sbjct: 234 ---VYTIMYSCWHEKADERPTFKILLSNILDVMD 264

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V   +     +VA+K+  ++ G + +  F  E ++M ++ H  ++++   C+
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S Q +H DL
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 131
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
              N L++D  V  +SDFG+++ +  +D+ T    +   + +  PE     + S+  D++
Sbjct: 132 AARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDIW 190
Query: 579 SFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQC 638
           +FG+++ E ++  K   E F    T +H            +  P+L S +          
Sbjct: 191 AFGVLMWEIYSLGKMPYERFTNSETAEH------IAQGLRLYRPHLASEK---------- 234
Query: 639 VSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD 672
              V+ +   C  E  ++R   K +++ +L + D
Sbjct: 235 ---VYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 127/274 (46%), Gaps = 26/274 (9%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V   +     +VA+K+  ++ G + +  F  E ++M ++ H  ++++   C+
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKM--IKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S Q +H DL
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 126
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
              N L++D  V  +SDFG+++ +  +D+ T    +   + +  PE     + S+  D++
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 579 SFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQC 638
           +FG+++ E ++  K   E F    T +H            +  P+L S +          
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETAEH------IAQGLRLYRPHLASEK---------- 229
Query: 639 VSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD 672
              V+ +   C  E  ++R   K +++ +L + D
Sbjct: 230 ---VYTIMYSCWHEKADERPTFKILLSNILDVMD 260

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 138/292 (47%), Gaps = 36/292 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHR 448
            S + ++G G FG V   RL       + VA+K   + Y  +  + F  E  +M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL-HF 507
           NII++    +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYG 566
           G+    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + +PE  
Sbjct: 167 GF----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 567 KEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 625
              + ++  DV+S+GI+L E  +  ++P  E+ N ++               + VD    
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------------KAVD---- 264
Query: 626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
             E         C + ++ + ++C  +    R   ++IV+    I D L+RN
Sbjct: 265 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/320 (26%), Positives = 138/320 (43%), Gaps = 45/320 (14%)
Query: 375 PEAMQRMFSYLELCRATDGFSEN---------NLIGRGSFGSVFKARL----GDGMEVAM 421
           P+      +Y E  RA   F+            +IG G  G V   RL       + VA+
Sbjct: 23  PQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82
Query: 422 KVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH 480
           K     Y  R  + F  E  +M    H NII++    +      +V EYM +GSL+ +L 
Sbjct: 83  KALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 481 SSNYILDIYQRLNIMIDVASALEYL-HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA 539
           + +    I Q + ++  V + + YL   GY    +H DL   NVL+D N+V  +SDFG++
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLS 198
Query: 540 KLLTRE-DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEI 597
           ++L  + D +   T     I + APE       S+  DV+SFG+++ E     ++P   +
Sbjct: 199 RVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258
Query: 598 FNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQR 657
            N ++           IS+ E         E     A   C   +  + ++C  +   QR
Sbjct: 259 TNRDV-----------ISSVE---------EGYRLPAPMGCPHALHQLMLDCWHKDRAQR 298
Query: 658 INAKEIVTKLLKIRDSLLRN 677
               +IV+ L    D+L+R+
Sbjct: 299 PRFSQIVSVL----DALIRS 314

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/195 (29%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K   L+ G +  +SF  E ++MK ++H  ++++ +  S
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKT--LKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYM  GSL  +L       L +   +++   VA+ + Y+        IH D
Sbjct: 75  EEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 130
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ + ++  ++DFG+A+L+  +++ T +      I + APE    GR +   DV
Sbjct: 131 LRSANILVGNGLICKIADFGLARLI-EDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T+ +
Sbjct: 190 WSFGILLTELVTKGR 204

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/320 (26%), Positives = 138/320 (43%), Gaps = 45/320 (14%)
Query: 375 PEAMQRMFSYLELCRATDGFSEN---------NLIGRGSFGSVFKARL----GDGMEVAM 421
           P+      +Y E  RA   F+            +IG G  G V   RL       + VA+
Sbjct: 23  PQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82
Query: 422 KVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH 480
           K     Y  R  + F  E  +M    H NII++    +      +V EYM +GSL+ +L 
Sbjct: 83  KALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 481 SSNYILDIYQRLNIMIDVASALEYL-HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA 539
           + +    I Q + ++  V + + YL   GY    +H DL   NVL+D N+V  +SDFG++
Sbjct: 143 THDGQFTIMQLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLS 198
Query: 540 KLLTRE-DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEI 597
           ++L  + D +   T     I + APE       S+  DV+SFG+++ E     ++P   +
Sbjct: 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258
Query: 598 FNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQR 657
            N ++           IS+ E         E     A   C   +  + ++C  +   QR
Sbjct: 259 TNRDV-----------ISSVE---------EGYRLPAPMGCPHALHQLMLDCWHKDRAQR 298
Query: 658 INAKEIVTKLLKIRDSLLRN 677
               +IV+ L    D+L+R+
Sbjct: 299 PRFSQIVSVL----DALIRS 314

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 399 LIGRGSFGSVFKA-RLGDGMEVAMKVF----NLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +IG G FG V++A  +GD  EVA+K      +    +  ++   E ++   ++H NII +
Sbjct: 14  IIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
              C  E    LV+E+   G L + L       DI   +N  + +A  + YLH      +
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVPI 129
Query: 514 IHCDLKPSNVLLDD--------NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           IH DLK SN+L+          N +  ++DFG+A    RE   T +        +MAPE 
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEV 185
Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP 593
            +    S   DV+S+G++L E  T + P
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 99/364 (27%), Positives = 145/364 (39%), Gaps = 54/364 (14%)
Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYXXXXX 61
           L +  N F+G IP  + N S+L  L LS N  SG IP++ G+L  L+ L+L  N      
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458
Query: 62  XXXXXXXXX-------------------XNCKSLTLISFSNNPLDGILPKTSVGNLSHSL 102
                                        NC +L  IS SNN L G +PK  +G L  +L
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW-IGRL-ENL 516
Query: 103 EYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTXXXXXXXXXXXXENNKLEG 162
              +++  + SG IP E+G+  +L  + L  N  NG+IP+                K   
Sbjct: 517 AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV 576
Query: 163 SIPDS----ICH------------SDELYKLE------LGGNKLSGSIPECFNNLASLRI 200
            I +      CH            S++L +L       +      G     F+N  S+  
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636
Query: 201 LLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDXXXXXXXX 259
           L +  N L+  IP    ++  +  LN   N  +G +P E+G+L+   I            
Sbjct: 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI----------LD 686
Query: 260 XXXXXXXGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNL 319
                  G IP ++  L+ L +++LS N L G IP  G F  F    F  N  LCG P  
Sbjct: 687 LSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP 746
Query: 320 RVPP 323
           R  P
Sbjct: 747 RCDP 750

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 400 IGRGSFGSVFKARL---GD--GMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV 453
           +G G FG V   R    GD  G +VA+K    + G         E E+++++ H NI+K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 454 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              C+ +      L++E++P GSL++YL  +   +++ Q+L   + +   ++YL    S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TREDQSTIQTQTLATIGYMAPEYGKEGR 570
           Q +H DL   NVL++      + DFG+ K + T ++  T++    + + + APE   + +
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 193
Query: 571 VSANGDVYSFGIMLMETFT 589
                DV+SFG+ L E  T
Sbjct: 194 FYIASDVWSFGVTLHELLT 212

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/316 (24%), Positives = 147/316 (46%), Gaps = 37/316 (11%)
Query: 370 DANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFN 425
           D +   +  Q +  + +   AT+  S + ++G G FG V   RL       + VA+K   
Sbjct: 24  DPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK 82
Query: 426 LQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY 484
           + Y  +  + F  E  +M    H NII++    +  +   +V E M +GSL+ +L   + 
Sbjct: 83  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA 142
Query: 485 ILDIYQRLNIMIDVASALEYL-HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 543
              + Q + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG++++L 
Sbjct: 143 QFTVIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 544 REDQSTIQTQ-TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGE 601
            + ++   T+     I + +PE     + ++  DV+S+GI+L E  +  ++P  E+ N +
Sbjct: 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
Query: 602 MTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAK 661
           +               + VD      E         C + ++ + ++C  +    R   +
Sbjct: 259 VI--------------KAVD------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298
Query: 662 EIVTKLLKIRDSLLRN 677
           +IV+    I D L+RN
Sbjct: 299 QIVS----ILDKLIRN 310

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 400 IGRGSFGSVFKARL---GD--GMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV 453
           +G G FG V   R    GD  G +VA+K    + G         E E+++++ H NI+K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 454 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              C+ +      L++E++P GSL++YL  +   +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TREDQSTIQTQTLATIGYMAPEYGKEGR 570
           Q +H DL   NVL++      + DFG+ K + T ++  T++    + + + APE   + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSK 205
Query: 571 VSANGDVYSFGIMLMETFT 589
                DV+SFG+ L E  T
Sbjct: 206 FYIASDVWSFGVTLHELLT 224

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 137/292 (46%), Gaps = 36/292 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHR 448
            S + ++G G FG V   RL       + VA+K   + Y  +  + F  E  +M    H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL-HF 507
           NII++    +  +   +V E M +GSL+ +L   +    + Q + ++  +AS ++YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 137
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT-IGYMAPEYG 566
           GY    +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + +PE  
Sbjct: 138 GY----VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 567 KEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 625
              + ++  DV+S+GI+L E  +  ++P  E+ N ++               + VD    
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------------KAVD---- 235
Query: 626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
             E         C + ++ + ++C  +    R   ++IV+    I D L+RN
Sbjct: 236 --EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 281

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 109/236 (46%), Gaps = 16/236 (6%)
Query: 365 RGPPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMK- 422
           +GPP     P +A++    Y  L      F     IGRG F  V++A  L DG+ VA+K 
Sbjct: 9   QGPPVPQFQPQKALRPDMGYNTLA----NFRIEKKIGRGQFSEVYRAACLLDGVPVALKK 64
Query: 423 --VFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLE---K 477
             +F+L   +       E +++K + H N+IK  +S   +    +VLE    G L    K
Sbjct: 65  VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124
Query: 478 YLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG 537
           +      ++         + + SALE++H   S +V+H D+KP+NV +    V  L D G
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG 181
Query: 538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           + +  +   ++T     + T  YM+PE   E   +   D++S G +L E    + P
Sbjct: 182 LGRFFS--SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 106/195 (54%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K  +L+ G +   +F  E  +MK ++H+ ++++ +  +
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 87
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L + +    I   +N ++D+A+ + E + F      IH D
Sbjct: 88  QEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 143
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 202
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  +
Sbjct: 203 WSFGILLTEIVTHGR 217

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 106/195 (54%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K  +L+ G +   +F  E  +MK ++H+ ++++ +  +
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 80
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L + +    I   +N ++D+A+ + E + F      IH D
Sbjct: 81  QEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 136
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 195
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  +
Sbjct: 196 WSFGILLTEIVTHGR 210

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 28/211 (13%)
Query: 397 NNLIGRGSFGSVFKARLG-DG--MEVAMKVFNLQYGRV--FKSFDVECEMMKSIRHR-NI 450
            ++IG G+FG V KAR+  DG  M+ A+K    +Y      + F  E E++  + H  NI
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI---------------LDIYQRLNIM 495
           I ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q L+  
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
            DVA  ++YL      Q IH DL   N+L+ +N VA ++DFG+++    ++    +T   
Sbjct: 139 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 192
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
             + +MA E       + N DV+S+G++L E
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 223

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 106/195 (54%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K  +L+ G +   +F  E  +MK ++H+ ++++ +  +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L + +    I   +N ++D+A+ + E + F      IH D
Sbjct: 79  QEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  +
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 106/195 (54%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K  +L+ G +   +F  E  +MK ++H+ ++++ +  +
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 79
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L + +    I   +N ++D+A+ + E + F      IH D
Sbjct: 80  QEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 135
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 194
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  +
Sbjct: 195 WSFGILLTEIVTHGR 209

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 28/211 (13%)
Query: 397 NNLIGRGSFGSVFKARLG-DG--MEVAMKVFNLQYGRV--FKSFDVECEMMKSIRHR-NI 450
            ++IG G+FG V KAR+  DG  M+ A+K    +Y      + F  E E++  + H  NI
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI---------------LDIYQRLNIM 495
           I ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q L+  
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
            DVA  ++YL      Q IH DL   N+L+ +N VA ++DFG+++    ++    +T   
Sbjct: 149 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 202
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
             + +MA E       + N DV+S+G++L E
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 233

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K  +L+ G +   +F  E  +MK ++H+ ++++ +  +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L + + I L I + L++   +A  + ++        IH D
Sbjct: 79  QEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  +
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K  +L+ G +   +F  E  +MK ++H+ ++++ +  +
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 86
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L + + I L I + L++   +A  + ++        IH D
Sbjct: 87  QEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 142
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 201
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  +
Sbjct: 202 WSFGILLTEIVTHGR 216

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 106/195 (54%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K  +L+ G +   +F  E  +MK ++H+ ++++ +  +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L + +    I   +N ++D+A+ + E + F      IH D
Sbjct: 85  QEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  +
Sbjct: 200 WSFGILLTEIVTHGR 214

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 109/240 (45%), Gaps = 21/240 (8%)
Query: 391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR---VFKSFDVECEMMKSIR 446
           +D +    ++G G    V  AR L D  +VA+KV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 447 HRNIIKVISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
           H  I+ V  +   E        +V+EY+   +L   +H+      +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT-LATIGYM 561
           + L+F +   +IH D+KP+N+L+       + DFGIA+ +     S  QT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 562 APEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE----MTLKHWVNDWLPISTK 617
           +PE  +   V A  DVYS G +L E  T + P    F G+    +  +H   D +P S +
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPSAR 242

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 111/242 (45%), Gaps = 25/242 (10%)
Query: 391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR---VFKSFDVECEMMKSIR 446
           +D +    ++G G    V  AR L D  +VA+KV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 447 HRNIIKVISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
           H  I+ V  +   E        +V+EY+   +L   +H+      +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG--- 559
           + L+F +   +IH D+KP+N+++       + DFGIA+ +   D     TQT A IG   
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 560 YMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE----MTLKHWVNDWLPIS 615
           Y++PE  +   V A  DVYS G +L E  T + P    F G+    +  +H   D +P S
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 240
Query: 616 TK 617
            +
Sbjct: 241 AR 242

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K  +L+ G +   +F  E  +MK ++H+ ++++ +  +
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L + + I L I + L++   +A  + ++        IH D
Sbjct: 79  QEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 134
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  +
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 111/242 (45%), Gaps = 25/242 (10%)
Query: 391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR---VFKSFDVECEMMKSIR 446
           +D +    ++G G    V  AR L D  +VA+KV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 447 HRNIIKVISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
           H  I+ V  +   E        +V+EY+   +L   +H+   +     +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT---PKRAIEV-IADAC 126
Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG--- 559
           + L+F +   +IH D+KP+N+++       + DFGIA+ +   D     TQT A IG   
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 560 YMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE----MTLKHWVNDWLPIS 615
           Y++PE  +   V A  DVYS G +L E  T + P    F G+    +  +H   D +P S
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPDSVAYQHVREDPIPPS 240
Query: 616 TK 617
            +
Sbjct: 241 AR 242

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 106/195 (54%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K  +L+ G +   +F  E  +MK ++H+ ++++ +  +
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 83
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L + +    I   +N ++D+A+ + E + F      IH D
Sbjct: 84  QEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 139
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 198
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  +
Sbjct: 199 WSFGILLTEIVTHGR 213

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 106/195 (54%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K  +L+ G +   +F  E  +MK ++H+ ++++ +  +
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 84
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L + +    I   +N ++D+A+ + E + F      IH D
Sbjct: 85  QEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 199
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  +
Sbjct: 200 WSFGILLTEIVTHGR 214

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 135/291 (46%), Gaps = 34/291 (11%)
Query: 394 FSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHR 448
            S + ++G G FG V   RL       + VA+K   + Y  +  + F  E  +M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NII++    +  +   +V E M +GSL+ +L   +    + Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS-- 164
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYGK 567
                +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + +PE   
Sbjct: 165 -DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 568 EGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 626
             + ++  DV+S+GI+L E  +  ++P  E+ N ++               + VD     
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI--------------KAVD----- 264
Query: 627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
            E         C + ++ + ++C  +    R   ++IV+    I D L+RN
Sbjct: 265 -EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS----ILDKLIRN 310

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 106/195 (54%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K  +L+ G +   +F  E  +MK ++H+ ++++ +  +
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 73
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L + +    I   +N ++D+A+ + E + F      IH D
Sbjct: 74  QEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 129
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  +
Sbjct: 189 WSFGILLTEIVTHGR 203

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 121/260 (46%), Gaps = 28/260 (10%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           +G G FG V+ A      +VA+K        V ++F  E  +MK+++H  ++K+ +  + 
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCDL 518
           E    ++ E+M  GSL  +L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 82  EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           + +N+L+  ++V  ++DFG+A+++  +++ T +      I + APE    G  +   DV+
Sbjct: 138 RAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 196
Query: 579 SFGIMLMETFTRKK-PTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQ 637
           SFGI+LME  T  + P   + N E+                      L R        E 
Sbjct: 197 SFGILLMEIVTYGRIPYPGMSNPEVI-------------------RALER-GYRMPRPEN 236
Query: 638 CVSFVFNVAMECTVESPEQR 657
           C   ++N+ M C    PE+R
Sbjct: 237 CPEELYNIMMRCWKNRPEER 256

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 105/195 (53%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K  +L+ G +   +F  E  +MK ++H+ ++++ +  +
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 88
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L + + I L I + L++   +A  + ++        IH D
Sbjct: 89  QEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRD 144
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 203
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  +
Sbjct: 204 WSFGILLTEIVTHGR 218

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 16/215 (7%)
Query: 388 CRATDGFSENNL-----IGRGSFGSVFKAR---LGDGMEVAMKVFNLQYG--RVFKSFDV 437
           C+    F E +L     +G+G+FGSV   R   LGD     + V  LQ+      + F  
Sbjct: 1   CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR 60
Query: 438 ECEMMKSIRHRNIIKV--ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM 495
           E +++K++    I+K   +S     +   LV+EY+P G L  +L      LD  + L   
Sbjct: 61  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 120
Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-REDQSTIQTQT 554
             +   +EYL    S + +H DL   N+L++      ++DFG+AKLL   +D   ++   
Sbjct: 121 SQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 177
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
            + I + APE   +   S   DV+SFG++L E FT
Sbjct: 178 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 105/218 (48%), Gaps = 16/218 (7%)
Query: 385 LELCRATDGFSENNL-----IGRGSFGSVFKAR---LGDGMEVAMKVFNLQYG--RVFKS 434
           L  C+    F E +L     +G+G+FGSV   R   LGD     + V  LQ+      + 
Sbjct: 11  LYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 435 FDVECEMMKSIRHRNIIKV--ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL 492
           F  E +++K++    I+K   +S     +   LV+EY+P G L  +L      LD  + L
Sbjct: 71  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL 130
Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-REDQSTIQ 551
                +   +EYL    S + +H DL   N+L++      ++DFG+AKLL   +D   ++
Sbjct: 131 LYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
               + I + APE   +   S   DV+SFG++L E FT
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI------DVASALEYLHFGYSAQ 512
            E    +++E+M +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 132
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFS 191
Query: 573 ANGDVYSFGIMLMETFT 589
              DV++FG++L E  T
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 100/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 205
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E   S + D+++ G ++ +
Sbjct: 206 LTEKSASKSSDLWALGCIIYQ 226

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 95/192 (49%), Gaps = 7/192 (3%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V+        + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +V EYMP+G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRD 155
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   N L+ +N V  ++DFG+++L+T  D  T        I + APE       S   DV
Sbjct: 156 LAARNCLVGENHVVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDV 214
Query: 578 YSFGIMLMETFT 589
           ++FG++L E  T
Sbjct: 215 WAFGVLLWEIAT 226

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 134/288 (46%), Gaps = 36/288 (12%)
Query: 398 NLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
            +IG G FG V   RL       + VA+K   + Y  +  + F  E  +M    H NII 
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIH 87
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL-HFGYSA 511
           +    +  +   +V EYM +GSL+ +L  ++    + Q + ++  +++ ++YL   GY  
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGY-- 145
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYGKEGR 570
             +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + APE     +
Sbjct: 146 --VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 571 VSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
            ++  DV+S+GI++ E  +  ++P  E+ N ++           I   E         E 
Sbjct: 204 FTSASDVWSYGIVMWEVVSYGERPYWEMTNQDV-----------IKAVE---------EG 243
Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
               +   C + ++ + ++C  +    R    EIV  L    D L+RN
Sbjct: 244 YRLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNML----DKLIRN 287

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 101/209 (48%), Gaps = 16/209 (7%)
Query: 394 FSENNL-----IGRGSFGSVFKAR---LGDGMEVAMKVFNLQYG--RVFKSFDVECEMMK 443
           F E +L     +G+G+FGSV   R   LGD     + V  LQ+      + F  E +++K
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 444 SIRHRNIIKV--ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
           ++    I+K   +S         LV+EY+P G L  +L      LD  + L     +   
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 123
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-REDQSTIQTQTLATIGY 560
           +EYL    S + +H DL   N+L++      ++DFG+AKLL   +D   ++    + I +
Sbjct: 124 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 561 MAPEYGKEGRVSANGDVYSFGIMLMETFT 589
            APE   +   S   DV+SFG++L E FT
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 394 FSENNL-----IGRGSFGSVFKAR---LGDGMEVAMKVFNLQYG--RVFKSFDVECEMMK 443
           F E +L     +G+G+FGSV   R   LGD     + V  LQ+      + F  E +++K
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 444 SIRHRNIIKV--ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
           ++    I+K   +S     +   LV+EY+P G L  +L      LD  + L     +   
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 127
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-REDQSTIQTQTLATIGY 560
           +EYL    S + +H DL   N+L++      ++DFG+AKLL   +D   ++    + I +
Sbjct: 128 MEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 184
Query: 561 MAPEYGKEGRVSANGDVYSFGIMLMETFT 589
            APE   +   S   DV+SFG++L E FT
Sbjct: 185 YAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 28/214 (13%)
Query: 397 NNLIGRGSFGSVFKARLG-DG--MEVAMKVFNLQYGRV--FKSFDVECEMMKSIRHR-NI 450
            ++IG G+FG V KAR+  DG  M+ A+K    +Y      + F  E E++  + H  NI
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI---------------LDIYQRLNIM 495
           I ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q L+  
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
            DVA  ++YL      Q IH +L   N+L+ +N VA ++DFG+++    ++    +T   
Sbjct: 146 ADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGR 199
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
             + +MA E       + N DV+S+G++L E  +
Sbjct: 200 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI------DVASALEYLHFGYSAQ 512
            E    +++E+M +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 573 ANGDVYSFGIMLMETFT 589
              DV++FG++L E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G GSFG V    + A  G  + VA+K      L        F  E   M S+ HRN+I+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
           +         K +V E  P GSL   L  H  +++L    R    + VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 139
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEG 569
            + IH DL   N+LL    +  + DFG+ + L + +D   +Q        + APE  K  
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
             S   D + FG+ L E FT  +                  W+ ++  +I+  + + +E 
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQ----------------EPWIGLNGSQIL--HKIDKEG 241
Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQR 657
                 E C   ++NV ++C    PE R
Sbjct: 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDR 269

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 109/228 (47%), Gaps = 18/228 (7%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNL---QYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           +G G   +V+ A      ++VA+K   +   +     K F+ E      + H+NI+ +I 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               ++   LV+EY+   +L +Y+ S    L +   +N    +   +++ H     +++H
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAH---DMRIVH 134
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            D+KP N+L+D N    + DFGIAK L+ E   T     L T+ Y +PE  K        
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDECT 193
Query: 576 DVYSFGIMLMETFTRKKPTDEIFNGE----MTLKHWVNDWLPISTKEI 619
           D+YS GI+L E    + P    FNGE    + +KH + D +P  T ++
Sbjct: 194 DIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDV 236

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G GSFG V    + A  G  + VA+K      L        F  E   M S+ HRN+I+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
           +         K +V E  P GSL   L  H  +++L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEG 569
            + IH DL   N+LL    +  + DFG+ + L + +D   +Q        + APE  K  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
             S   D + FG+ L E FT  +                  W+ ++  +I+  + + +E 
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQ----------------EPWIGLNGSQIL--HKIDKEG 231
Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQR 657
                 E C   ++NV ++C    PE R
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 121/260 (46%), Gaps = 28/260 (10%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           +G G FG V+ A      +VA+K        V ++F  E  +MK+++H  ++K+ +  + 
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCDL 518
           E    ++ E+M  GSL  +L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           + +N+L+  ++V  ++DFG+A+++  +++ T +      I + APE    G  +   DV+
Sbjct: 311 RAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 369
Query: 579 SFGIMLMETFTRKK-PTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQ 637
           SFGI+LME  T  + P   + N E+                      L R        E 
Sbjct: 370 SFGILLMEIVTYGRIPYPGMSNPEVI-------------------RALER-GYRMPRPEN 409
Query: 638 CVSFVFNVAMECTVESPEQR 657
           C   ++N+ M C    PE+R
Sbjct: 410 CPEELYNIMMRCWKNRPEER 429

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 400 IGRGSFGSVF-----KARLGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKV 453
           +G G FG V          G G  VA+K      G   +S +  E ++++++ H +IIK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 454 ISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              C ++  K+L  V+EY+P GSL  YL    + + + Q L     +   + YLH   S 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---SQ 136
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEGR 570
             IH +L   NVLLD++ +  + DFG+AK +    +   ++    + + + APE  KE +
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 571 VSANGDVYSFGIMLMETFT 589
                DV+SFG+ L E  T
Sbjct: 197 FYYASDVWSFGVTLYELLT 215

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 140/307 (45%), Gaps = 39/307 (12%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKA-RLGDG----MEVAMKVFNLQY 428
           P +A  R+    EL R         ++G G+FG+V+K   + +G    + VA+K+ N   
Sbjct: 27  PNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 79
Query: 429 G-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
           G +    F  E  +M S+ H ++++++  C +   + LV + MPHG L +Y+H     + 
Sbjct: 80  GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIG 138
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+A+LL  +++
Sbjct: 139 SQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 195
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKH 606
                     I +MA E     + +   DV+S+G+ + E  T   KP D           
Sbjct: 196 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG---------- 245
Query: 607 WVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 666
                  I T+EI  P+LL + +        C   V+ V ++C +   + R   KE+  +
Sbjct: 246 -------IPTREI--PDLLEKGE-RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 295
Query: 667 LLKI-RD 672
             ++ RD
Sbjct: 296 FSRMARD 302

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 96/192 (50%), Gaps = 7/192 (3%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S   DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 578 YSFGIMLMETFT 589
           ++FG++L E  T
Sbjct: 194 WAFGVLLWEIAT 205

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 7/192 (3%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +++E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S   DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 578 YSFGIMLMETFT 589
           ++FG++L E  T
Sbjct: 194 WAFGVLLWEIAT 205

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMM 442
           +  + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 64
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
             + H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SAL
Sbjct: 65  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 123
Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           EYLH      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++
Sbjct: 124 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 180
Query: 563 PEYGKEGRVSANGDVYSFGIMLME 586
           PE   E     + D+++ G ++ +
Sbjct: 181 PELLTEKSACKSSDLWALGCIIYQ 204

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMM 442
           +  + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 63
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
             + H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SAL
Sbjct: 64  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 122
Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           EYLH      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++
Sbjct: 123 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 179
Query: 563 PEYGKEGRVSANGDVYSFGIMLME 586
           PE   E     + D+++ G ++ +
Sbjct: 180 PELLTEKSACKSSDLWALGCIIYQ 203

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI------DVASALEYLHFGYSAQ 512
            E    ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 573 ANGDVYSFGIMLMETFT 589
              DV++FG++L E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMM 442
           +  + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 61
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
             + H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SAL
Sbjct: 62  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 120
Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           EYLH      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++
Sbjct: 121 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 177
Query: 563 PEYGKEGRVSANGDVYSFGIMLME 586
           PE   E     + D+++ G ++ +
Sbjct: 178 PELLTEKSACKSSDLWALGCIIYQ 201

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G GSFG V    + A  G  + VA+K      L        F  E   M S+ HRN+I+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
           +         K +V E  P GSL   L  H  +++L    R    + VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 139
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEG 569
            + IH DL   N+LL    +  + DFG+ + L + +D   +Q        + APE  K  
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
             S   D + FG+ L E FT  +                  W+ ++  +I+  + + +E 
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQ----------------EPWIGLNGSQIL--HKIDKEG 241
Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQR 657
                 E C   ++NV ++C    PE R
Sbjct: 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDR 269

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 105/195 (53%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+        +VA+K  +L+ G +   +F  E  +MK ++H+ ++++ +  +
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 74
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L + + I L I + L++   +A  + ++        IH +
Sbjct: 75  QEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRN 130
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  +
Sbjct: 190 WSFGILLTEIVTHGR 204

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMM 442
           +  + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVM 62
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
             + H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SAL
Sbjct: 63  SRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSAL 121
Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           EYLH      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 178
Query: 563 PEYGKEGRVSANGDVYSFGIMLME 586
           PE   E     + D+++ G ++ +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQ 202

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 7/192 (3%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +++E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 578 YSFGIMLMETFT 589
           ++FG++L E  T
Sbjct: 196 WAFGVLLWEIAT 207

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G GSFG V    + A  G  + VA+K      L        F  E   M S+ HRN+I+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
           +         K +V E  P GSL   L  H  +++L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEG 569
            + IH DL   N+LL    +  + DFG+ + L + +D   +Q        + APE  K  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
             S   D + FG+ L E FT  +                  W+ ++  +I+  + + +E 
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQ----------------EPWIGLNGSQIL--HKIDKEG 231
Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQR 657
                 E C   ++NV ++C    PE R
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 7/192 (3%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    +++E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 578 YSFGIMLMETFT 589
           ++FG++L E  T
Sbjct: 196 WAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI------DVASALEYLHFGYSAQ 512
            E    ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 573 ANGDVYSFGIMLMETFT 589
              DV++FG++L E  T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G GSFG V    + A  G  + VA+K      L        F  E   M S+ HRN+I+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
           +         K +V E  P GSL   L  H  +++L    R    + VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 133
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEG 569
            + IH DL   N+LL    +  + DFG+ + L + +D   +Q        + APE  K  
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
             S   D + FG+ L E FT  +                  W+ ++  +I+  + + +E 
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQ----------------EPWIGLNGSQIL--HKIDKEG 235
Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQR 657
                 E C   ++NV ++C    PE R
Sbjct: 236 ERLPRPEDCPQDIYNVMVQCWAHKPEDR 263

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 399 LIGRGSFGSVFKARL-GDGME---VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV 453
           +IG G FG V + RL   G +   VA+K     Y  R  + F  E  +M    H NII++
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
               +N     ++ E+M +G+L+ +L  ++    + Q + ++  +AS + YL        
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EMSY 139
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA---TIGYMAPEYGKEGR 570
           +H DL   N+L++ N+V  +SDFG+++ L        +T +L     I + APE     +
Sbjct: 140 VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRK 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            ++  D +S+GI++ E  +
Sbjct: 200 FTSASDAWSYGIVMWEVMS 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G GSFG V    + A  G  + VA+K      L        F  E   M S+ HRN+I+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
           +         K +V E  P GSL   L  H  +++L    R    + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 129
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEG 569
            + IH DL   N+LL    +  + DFG+ + L + +D   +Q        + APE  K  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
             S   D + FG+ L E FT  +                  W+ ++  +I+  + + +E 
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQ----------------EPWIGLNGSQIL--HKIDKEG 231
Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQR 657
                 E C   ++NV ++C    PE R
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDR 259

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 90
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 149
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 150 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 206
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 207 LTEKSACKSSDLWALGCIIYQ 227

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI------DVASALEYLHFGYSAQ 512
            E    ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 573 ANGDVYSFGIMLMETFT 589
              DV++FG++L E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI------DVASALEYLHFGYSAQ 512
            E    ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 573 ANGDVYSFGIMLMETFT 589
              DV++FG++L E  T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 140/307 (45%), Gaps = 39/307 (12%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKA-RLGDG----MEVAMKVFNLQY 428
           P +A  R+    EL R         ++G G+FG+V+K   + +G    + VA+K+ N   
Sbjct: 4   PNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 56
Query: 429 G-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
           G +    F  E  +M S+ H ++++++  C +   + LV + MPHG L +Y+H     + 
Sbjct: 57  GPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIG 115
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+A+LL  +++
Sbjct: 116 SQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 172
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKH 606
                     I +MA E     + +   DV+S+G+ + E  T   KP D           
Sbjct: 173 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG---------- 222
Query: 607 WVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 666
                  I T+EI  P+LL + +        C   V+ V ++C +   + R   KE+  +
Sbjct: 223 -------IPTREI--PDLLEKGE-RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 272
Query: 667 LLKI-RD 672
             ++ RD
Sbjct: 273 FSRMARD 279

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G GSFG V    + A  G  + VA+K      L        F  E   M S+ HRN+I+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
           +         K +V E  P GSL   L  H  +++L    R    + VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLE---S 133
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEG 569
            + IH DL   N+LL    +  + DFG+ + L + +D   +Q        + APE  K  
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
             S   D + FG+ L E FT  +                  W+ ++  +I+  + + +E 
Sbjct: 194 TFSHASDTWMFGVTLWEMFTYGQ----------------EPWIGLNGSQIL--HKIDKEG 235
Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQR 657
                 E C   ++NV ++C    PE R
Sbjct: 236 ERLPRPEDCPQDIYNVMVQCWAHKPEDR 263

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI------DVASALEYLHFGYSAQ 512
            E    ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 135
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 573 ANGDVYSFGIMLMETFT 589
              DV++FG++L E  T
Sbjct: 195 IKSDVWAFGVLLWEIAT 211

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 206 LTEKSAXKSSDLWALGCIIYQ 226

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI------DVASALEYLHFGYSAQ 512
            E    ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 144
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFS 203
Query: 573 ANGDVYSFGIMLMETFT 589
              DV++FG++L E  T
Sbjct: 204 IKSDVWAFGVLLWEIAT 220

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 206 LTEKSACKSSDLWALGCIIYQ 226

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 400 IGRGSFGSVF-----KARLGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKV 453
           +G G FG V          G G  VA+K      G   +S +  E ++++++ H +IIK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 454 ISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              C ++  K+L  V+EY+P GSL  YL    + + + Q L     +   + YLH   + 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQ 136
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEGR 570
             IH +L   NVLLD++ +  + DFG+AK +    +   ++    + + + APE  KE +
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 196
Query: 571 VSANGDVYSFGIMLMETFT 589
                DV+SFG+ L E  T
Sbjct: 197 FYYASDVWSFGVTLYELLT 215

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 90
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 91  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 149
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 150 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 206
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 207 LTEKSACKSSDLWALGCIIYQ 227

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPEL 203
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 204 LTEKSACKSSDLWALGCIIYQ 224

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 71
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 72  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 130
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 131 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 187
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 188 LTEKSACKSSDLWALGCIIYQ 208

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 92
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 93  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 151
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 152 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 208
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 209 LTEKSACKSSDLWALGCIIYQ 229

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 204 LTEKSACKSSDLWALGCIIYQ 224

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 206 LTEKSACKSSDLWALGCIIYQ 226

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 206 LTEKSACKSSDLWALGCIIYQ 226

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI------DVASALEYLHFGYSAQ 512
            E    ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 573 ANGDVYSFGIMLMETFT 589
              DV++FG++L E  T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 204 LTEKSACKSSDLWALGCIIYQ 224

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI------DVASALEYLHFGYSAQ 512
            E    ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 573 ANGDVYSFGIMLMETFT 589
              DV++FG++L E  T
Sbjct: 196 IKSDVWAFGVLLWEIAT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI------DVASALEYLHFGYSAQ 512
            E    ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 573 ANGDVYSFGIMLMETFT 589
              DV++FG++L E  T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 89
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 148
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 205
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 206 LTEKSACKSSDLWALGCIIYQ 226

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 127/285 (44%), Gaps = 44/285 (15%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNL-------QYGRVFKSFDVECEMMKSIRHRNII 451
           IG+G FG V K RL  D   VA+K   L       +    F+ F  E  +M ++ H NI+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K+     N     +V+E++P G L   L    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 512 QVIHCDLKPSNVL---LDDN--MVAHLSDFGIAKLLTREDQSTIQTQT--LATIGYMAPE 564
            ++H DL+  N+    LD+N  + A ++DFG++       Q ++ + +  L    +MAPE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-------QQSVHSVSGLLGNFQWMAPE 196
Query: 565 Y--GKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 622
               +E   +   D YSF ++L    T + P DE   G++                    
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI----------------- 239
Query: 623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
           N++  E +     E C   + NV   C    P++R +   IV +L
Sbjct: 240 NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 86
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 145
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 146 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 202
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 203 LTEKSACKSSDLWALGCIIYQ 223

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 86
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 87  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 145
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 146 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 202
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 203 LTEKSACKSSDLWALGCIIYQ 223

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 400 IGRGSFGSVF-----KARLGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKV 453
           +G G FG V          G G  VA+K      G   +S +  E ++++++ H +IIK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 454 ISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              C +    +L  V+EY+P GSL  YL    + + + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEGR 570
             IH DL   NVLLD++ +  + DFG+AK +    +   ++    + + + APE  KE +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYK 213
Query: 571 VSANGDVYSFGIMLMETFTR 590
                DV+SFG+ L E  T 
Sbjct: 214 FYYASDVWSFGVTLYELLTH 233

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 400 IGRGSFGSVF-----KARLGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKV 453
           +G G FG V          G G  VA+K      G   +S +  E E+++++ H +I+K 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 454 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              C ++  K+  LV+EY+P GSL  YL    + + + Q L     +   + YLH   + 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLH---AQ 130
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEGR 570
             IH  L   NVLLD++ +  + DFG+AK +    +   ++    + + + APE  KE +
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 190
Query: 571 VSANGDVYSFGIMLMETFT 589
                DV+SFG+ L E  T
Sbjct: 191 FYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 400 IGRGSFGSVF-----KARLGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKV 453
           +G G FG V          G G  VA+K      G   +S +  E E+++++ H +I+K 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 454 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              C ++  K+  LV+EY+P GSL  YL    + + + Q L     +   + YLH   + 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLH---AQ 131
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEGR 570
             IH  L   NVLLD++ +  + DFG+AK +    +   ++    + + + APE  KE +
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECK 191
Query: 571 VSANGDVYSFGIMLMETFT 589
                DV+SFG+ L E  T
Sbjct: 192 FYYASDVWSFGVTLYELLT 210

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 392 DGFSENNLIGRGSFGSVF--------KARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMM 442
           D  +    +G G+FG V         K +  + + VA+K+  +    +       E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 443 KSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YILDIYQ------ 490
           K I +H+NII ++ +C+ +    +++EY   G+L +YL +       Y  DI +      
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 491 ----RLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
                ++    +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNG 600
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +E+F  
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 661 KEIVTKLLKI 670
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI------DVASALEYLHFGYSAQ 512
            E    ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 132
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFS 191
Query: 573 ANGDVYSFGIMLMETFT 589
              DV++FG++L E  T
Sbjct: 192 IKSDVWAFGVLLWEIAT 208

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 7/192 (3%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 578 YSFGIMLMETFT 589
           ++FG++L E  T
Sbjct: 196 WAFGVLLWEIAT 207

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 134/290 (46%), Gaps = 44/290 (15%)
Query: 400 IGRGSFGSVFKARL-----GDGME-VAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G   FG V+K  L     G+  + VA+K   +   G + + F  E  +   ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL-----HSS----------NYILDIYQRLNIMID 497
           ++   + ++  +++  Y  HG L ++L     HS              L+    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           +A+ +EYL    S  V+H DL   NVL+ D +   +SD G+ + +   D   +   +L  
Sbjct: 137 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           I +MAPE    G+ S + D++S+G++L E F+                + +  +   S +
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS----------------YGLQPYCGYSNQ 237
Query: 618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
           ++V+   + R        + C ++V+ + +EC  E P +R   K+I ++L
Sbjct: 238 DVVE---MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 7/192 (3%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S   DV
Sbjct: 142 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 578 YSFGIMLMETFT 589
           ++FG++L E  T
Sbjct: 201 WAFGVLLWEIAT 212

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 17/197 (8%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI------DVASALEYLHFGYSAQ 512
            E    ++ E+M +G+L  YL   N      Q +N ++       ++SA+EYL       
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFS 192
Query: 573 ANGDVYSFGIMLMETFT 589
              DV++FG++L E  T
Sbjct: 193 IKSDVWAFGVLLWEIAT 209

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 111/242 (45%), Gaps = 25/242 (10%)
Query: 391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR---VFKSFDVECEMMKSIR 446
           +D +    ++G G    V  AR L    +VA+KV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 447 HRNIIKVISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
           H  I+ V ++   E        +V+EY+   +L   +H+      +  +  I + +A A 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG--- 559
           + L+F +   +IH D+KP+N+++       + DFGIA+ +   D     TQT A IG   
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 560 YMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE----MTLKHWVNDWLPIS 615
           Y++PE  +   V A  DVYS G +L E  T + P    F G+    +  +H   D +P S
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 240
Query: 616 TK 617
            +
Sbjct: 241 AR 242

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/237 (31%), Positives = 116/237 (48%), Gaps = 36/237 (15%)
Query: 372 NMPP---EAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQ 427
           +MPP   E     F + E+ RA         IG+GSFG V   +  D  ++ AMK  N Q
Sbjct: 1   SMPPVFDENEDVNFDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQ 51
Query: 428 -------YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH 480
                     VFK    E ++M+ + H  ++ +  S  +EE   +V++ +  G L  +L 
Sbjct: 52  KCVERNEVRNVFK----ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQ 107
Query: 481 SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK 540
            + +  +   +L I  ++  AL+YL    + ++IH D+KP N+LLD++   H++DF IA 
Sbjct: 108 QNVHFKEETVKLFI-CELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163
Query: 541 LLTREDQSTIQTQTLA-TIGYMAPEY---GKEGRVSANGDVYSFGIMLMETFTRKKP 593
           +L RE Q T    T+A T  YMAPE     K    S   D +S G+   E    ++P
Sbjct: 164 MLPRETQIT----TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 7/192 (3%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 578 YSFGIMLMETFT 589
           ++FG++L E  T
Sbjct: 196 WAFGVLLWEIAT 207

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 134/290 (46%), Gaps = 44/290 (15%)
Query: 400 IGRGSFGSVFKARL-----GDGME-VAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G   FG V+K  L     G+  + VA+K   +   G + + F  E  +   ++H N++ 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL-----HSS----------NYILDIYQRLNIMID 497
           ++   + ++  +++  Y  HG L ++L     HS              L+    ++++  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           +A+ +EYL    S  V+H DL   NVL+ D +   +SD G+ + +   D   +   +L  
Sbjct: 154 IAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           I +MAPE    G+ S + D++S+G++L E F+                + +  +   S +
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS----------------YGLQPYCGYSNQ 254
Query: 618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
           ++V+   + R        + C ++V+ + +EC  E P +R   K+I ++L
Sbjct: 255 DVVE---MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +V  AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 94
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+     ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 95  DHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 153
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 154 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 211 LTEKSACKSSDLWALGCIIYQ 231

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+     +  +VA+K   L+ G +  ++F  E  +MK+++H  ++++ +  +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-NIMIDVASALEYLHFGYSAQVIHCD 517
            EE   ++ EYM  GSL  +L S      +  +L +    +A  + Y+        IH D
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 135
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +NVL+ ++++  ++DFG+A+++  +++ T +      I + APE    G  +   DV
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  K
Sbjct: 195 WSFGILLYEIVTYGK 209

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 126/285 (44%), Gaps = 44/285 (15%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNL-------QYGRVFKSFDVECEMMKSIRHRNII 451
           IG+G FG V K RL  D   VA+K   L       +    F+ F  E  +M ++ H NI+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K+     N     +V+E++P G L   L    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 512 QVIHCDLKPSNVL---LDDN--MVAHLSDFGIAKLLTREDQSTIQTQT--LATIGYMAPE 564
            ++H DL+  N+    LD+N  + A ++DFG +       Q ++ + +  L    +MAPE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS-------QQSVHSVSGLLGNFQWMAPE 196
Query: 565 Y--GKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 622
               +E   +   D YSF ++L    T + P DE   G++                    
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI----------------- 239
Query: 623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
           N++  E +     E C   + NV   C    P++R +   IV +L
Sbjct: 240 NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 96/192 (50%), Gaps = 7/192 (3%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S   DV
Sbjct: 135 LAARNCLVGENHLVKVADFGLSRLMTG-DTFTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 578 YSFGIMLMETFT 589
           ++FG++L E  T
Sbjct: 194 WAFGVLLWEIAT 205

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 399 LIGRGSFGSVFKARL-GDGME---VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV 453
           +IG G FG V + RL   G +   VA+K     Y  R  + F  E  +M    H NII++
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
               +N     ++ E+M +G+L+ +L  ++    + Q + ++  +AS + YL        
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EMSY 137
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA---TIGYMAPEYGKEGR 570
           +H DL   N+L++ N+V  +SDFG+++ L         T +L     I + APE     +
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFRK 197
Query: 571 VSANGDVYSFGIMLMETFT 589
            ++  D +S+GI++ E  +
Sbjct: 198 FTSASDAWSYGIVMWEVMS 216

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 392 DGFSENNLIGRGSFGSVF--------KARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMM 442
           D  +    +G G+FG V         K +  + + VA+K+  +    +       E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 443 KSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YILDIYQR----- 491
           K I +H+NII ++ +C+ +    +++EY   G+L +YL +       Y  DI +      
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 492 -----LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
                ++    +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNG 600
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +E+F  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 661 KEIVTKLLKI 670
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 104/195 (53%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G  G V+        +VA+K  +L+ G +   +F  E  +MK ++H+ ++++ +  +
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVK--SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCD 517
            E    ++ EYM +GSL  +L + +    I   +N ++D+A+ + E + F      IH D
Sbjct: 79  QEPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +N+L+ D +   ++DFG+A+L+  + + T +      I + APE    G  +   DV
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLI-EDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  +
Sbjct: 194 WSFGILLTEIVTHGR 208

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 392 DGFSENNLIGRGSFGSVF--------KARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMM 442
           D  +    +G G+FG V         K +  + + VA+K+  +    +       E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 443 KSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YILDIYQR----- 491
           K I +H+NII ++ +C+ +    +++EY   G+L +YL +       Y  DI +      
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 492 -----LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
                ++    +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNG 600
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +E+F  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 661 KEIVTKLLKI 670
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 110/242 (45%), Gaps = 25/242 (10%)
Query: 391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR---VFKSFDVECEMMKSIR 446
           +D +    ++G G    V  AR L    +VA+KV      R    +  F  E +   ++ 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 447 HRNIIKVISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
           H  I+ V  +   E        +V+EY+   +L   +H+      +  +  I + +A A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 126
Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG--- 559
           + L+F +   +IH D+KP+N+++       + DFGIA+ +   D     TQT A IG   
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 184
Query: 560 YMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE----MTLKHWVNDWLPIS 615
           Y++PE  +   V A  DVYS G +L E  T + P    F G+    +  +H   D +P S
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 240
Query: 616 TK 617
            +
Sbjct: 241 AR 242

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 12/201 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSI 445
           + F    ++G GSF +   AR L    E A+K+  L+   + K   V     E ++M  +
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKI--LEKRHIIKENKVPYVTRERDVMSRL 87
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H   +K+  +  ++E     L Y  +G L KY+       +   R     ++ SALEYL
Sbjct: 88  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYL 146
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE 
Sbjct: 147 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 203
Query: 566 GKEGRVSANGDVYSFGIMLME 586
             E     + D+++ G ++ +
Sbjct: 204 LTEKSACKSSDLWALGCIIYQ 224

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 392 DGFSENNLIGRGSFGSVF--------KARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMM 442
           D  +    +G G+FG V         K +  + + VA+K+  +    +       E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 443 KSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YILDIYQR----- 491
           K I +H+NII ++ +C+ +    +++EY   G+L +YL +       Y  DI +      
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 492 -----LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
                ++    +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNG 600
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +E+F  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 661 KEIVTKLLKI 670
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 397 NNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNII 451
             +IG G FG V   RL       + VA+K   + Y  +  + F  E  +M    H N++
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL-HFGYS 510
            +    +  +   +V+E+M +G+L+ +L   +    + Q + ++  +A+ + YL   GY 
Sbjct: 108 HLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY- 166
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI--GYMAPEYGKE 568
              +H DL   N+L++ N+V  +SDFG+++++  +D   + T T   I   + APE  + 
Sbjct: 167 ---VHRDLAARNILVNSNLVCKVSDFGLSRVI-EDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 569 GRVSANGDVYSFGIMLMETFT 589
            + ++  DV+S+GI++ E  +
Sbjct: 223 RKFTSASDVWSYGIVMWEVMS 243

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 130/310 (41%), Gaps = 59/310 (19%)
Query: 392 DGFSENNLIGRGSFGSVF--------KARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMM 442
           D  +    +G G FG V         K +  + + VA+K+  +    +       E EMM
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 443 KSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YILDIYQR----- 491
           K I +H+NII ++ +C+ +    +++EY   G+L +YL +       Y  DI +      
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 492 -----LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
                ++    +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 144 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNG 600
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +E+F  
Sbjct: 201 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 259
Query: 601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 260 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 295
Query: 661 KEIVTKLLKI 670
           K++V  L +I
Sbjct: 296 KQLVEDLDRI 305

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 131/310 (42%), Gaps = 59/310 (19%)
Query: 392 DGFSENNLIGRGSFGSVF--------KARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMM 442
           D  +    +G G+FG V         K +  + + VA+K+  +    +       E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 443 KSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YILDIYQR----- 491
           K I +H+NII ++ +C+ +    +++EY   G+L +YL +       Y  DI +      
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 492 -----LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
                ++    +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNG 600
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +E+F  
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 661 KEIVTKLLKI 670
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 400 IGRGSFGSVF--------KARLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRN 449
           +G G+FG V         K +     +VA+K+       +       E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNI 494
           II ++ +C+ +    +++EY   G+L +YL               H+    L     ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  +EYL    S + IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNGEMTLKHWV 608
              + +MAPE   +   +   DV+SFG++L E FT         P +E+F          
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 263
Query: 609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                           L +E         C + ++ +  +C    P QR   K++V  L 
Sbjct: 264 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 669 KI 670
           +I
Sbjct: 308 RI 309

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 110/243 (45%), Gaps = 25/243 (10%)
Query: 391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR---VFKSFDVECEMMKSIR 446
           +D +    ++G G    V  AR L    +VA+KV      R    +  F  E +   ++ 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 447 HRNIIKVISSCSNEE----FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
           H  I+ V  +   E        +V+EY+   +L   +H+      +  +  I + +A A 
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEV-IADAC 143
Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG--- 559
           + L+F +   +IH D+KP+N+++       + DFGIA+ +   D     TQT A IG   
Sbjct: 144 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQ 201
Query: 560 YMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE----MTLKHWVNDWLPIS 615
           Y++PE  +   V A  DVYS G +L E  T + P    F G+    +  +H   D +P S
Sbjct: 202 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQHVREDPIPPS 257
Query: 616 TKE 618
            + 
Sbjct: 258 ARH 260

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 97/192 (50%), Gaps = 7/192 (3%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    ++ E+M +G+L  YL   N   ++    L +   ++SA+EYL        IH +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRN 382
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S   DV
Sbjct: 383 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 578 YSFGIMLMETFT 589
           ++FG++L E  T
Sbjct: 442 WAFGVLLWEIAT 453

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 130/310 (41%), Gaps = 59/310 (19%)
Query: 392 DGFSENNLIGRGSFGSVF--------KARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMM 442
           D  +    +G G FG V         K +  + + VA+K+  +    +       E EMM
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 443 KSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YILDIYQR----- 491
           K I +H+NII ++ +C+ +    +++EY   G+L +YL +       Y  DI +      
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 492 -----LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
                ++    +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 142 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNG 600
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +E+F  
Sbjct: 199 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 257
Query: 601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 258 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 293
Query: 661 KEIVTKLLKI 670
           K++V  L +I
Sbjct: 294 KQLVEDLDRI 303

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 130/310 (41%), Gaps = 59/310 (19%)
Query: 392 DGFSENNLIGRGSFGSVF--------KARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMM 442
           D  +    +G G FG V         K +  + + VA+K+  +    +       E EMM
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 443 KSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YILDIYQR----- 491
           K I +H+NII ++ +C+ +    +++EY   G+L +YL +       Y  DI +      
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 492 -----LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
                ++    +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 147 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNG 600
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +E+F  
Sbjct: 204 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 262
Query: 601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 263 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 298
Query: 661 KEIVTKLLKI 670
           K++V  L +I
Sbjct: 299 KQLVEDLDRI 308

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 130/310 (41%), Gaps = 59/310 (19%)
Query: 392 DGFSENNLIGRGSFGSVF--------KARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMM 442
           D  +    +G G FG V         K +  + + VA+K+  +    +       E EMM
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 443 KSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YILDIYQR----- 491
           K I +H+NII ++ +C+ +    +++EY   G+L +YL +       Y  DI +      
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 492 -----LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
                ++    +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 201 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNG 600
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +E+F  
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 316
Query: 601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 317 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 352
Query: 661 KEIVTKLLKI 670
           K++V  L +I
Sbjct: 353 KQLVEDLDRI 362

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/285 (24%), Positives = 128/285 (44%), Gaps = 47/285 (16%)
Query: 394 FSENNLIGRGSFGSVFKARL----GDGMEVAMKVFNLQYGRVFKSFDVE-----CEMMKS 444
           F+   ++G+G FGSV +A+L    G  ++VA+K+       +  S D+E        MK 
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK---ADIIASSDIEEFLREAACMKE 81
Query: 445 IRHRNIIKVISSCSNEEFKA------LVLEYMPHGSLEKYLHSSN-----YILDIYQRLN 493
             H ++ K++        K       ++L +M HG L  +L +S      + L +   + 
Sbjct: 82  FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
            M+D+A  +EYL    S   IH DL   N +L ++M   ++DFG+++ +   D       
Sbjct: 142 FMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWL 612
           +   + ++A E   +   + + DV++FG+ + E  TR + P   I N E      + ++L
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IYNYL 252
Query: 613 PISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQR 657
            I    +  P              +C+  V+++  +C    P+QR
Sbjct: 253 -IGGNRLKQP-------------PECMEEVYDLMYQCWSADPKQR 283

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 400 IGRGSFGSVF--------KARLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRN 449
           +G G+FG V         K +     +VA+K+       +       E EMMK I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNI 494
           II ++ +C+ +    +++EY   G+L +YL               H+    L     ++ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  +EYL    S + IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNGEMTLKHWV 608
              + +MAPE   +   +   DV+SFG++L E FT         P +E+F          
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 304
Query: 609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                           L +E         C + ++ +  +C    P QR   K++V  L 
Sbjct: 305 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348
Query: 669 KI 670
           +I
Sbjct: 349 RI 350

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 100/198 (50%), Gaps = 9/198 (4%)
Query: 398 NLIGRGSFGSVFKARLG--DGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIK 452
            +IG G FG V   RL      E+ + +  L+ G   +  + F  E  +M    H NII 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +    +  +   ++ EYM +GSL+ +L  ++    + Q + ++  + S ++YL       
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMS 151
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYGKEGRV 571
            +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + APE     + 
Sbjct: 152 AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 572 SANGDVYSFGIMLMETFT 589
           ++  DV+S+GI++ E  +
Sbjct: 212 TSASDVWSYGIVMWEVMS 229

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/310 (24%), Positives = 129/310 (41%), Gaps = 59/310 (19%)
Query: 392 DGFSENNLIGRGSFGSVF--------KARLGDGMEVAMKVFNLQYGRV-FKSFDVECEMM 442
           D  +    +G G+FG V         K +  + + VA+K+               E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 443 KSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YILDIYQ------ 490
           K I +H+NII ++ +C+ +    +++EY   G+L +YL +       Y  DI +      
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 491 ----RLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
                ++    +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNG 600
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +E+F  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 661 KEIVTKLLKI 670
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 96/192 (50%), Gaps = 7/192 (3%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRN 343
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S   DV
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 578 YSFGIMLMETFT 589
           ++FG++L E  T
Sbjct: 403 WAFGVLLWEIAT 414

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/285 (25%), Positives = 126/285 (44%), Gaps = 44/285 (15%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNL-------QYGRVFKSFDVECEMMKSIRHRNII 451
           IG+G FG V K RL  D   VA+K   L       +    F+ F  E  +M ++ H NI+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K+     N     +V+E++P G L   L    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143
Query: 512 QVIHCDLKPSNVL---LDDN--MVAHLSDFGIAKLLTREDQSTIQTQT--LATIGYMAPE 564
            ++H DL+  N+    LD+N  + A ++DF ++       Q ++ + +  L    +MAPE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS-------QQSVHSVSGLLGNFQWMAPE 196
Query: 565 Y--GKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 622
               +E   +   D YSF ++L    T + P DE   G++                    
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI----------------- 239
Query: 623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
           N++  E +     E C   + NV   C    P++R +   IV +L
Sbjct: 240 NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 100/198 (50%), Gaps = 9/198 (4%)
Query: 398 NLIGRGSFGSVFKARLG--DGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIK 452
            +IG G FG V   RL      E+ + +  L+ G   +  + F  E  +M    H NII 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +    +  +   ++ EYM +GSL+ +L  ++    + Q + ++  + S ++YL       
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMS 130
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYGKEGRV 571
            +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + APE     + 
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 572 SANGDVYSFGIMLMETFT 589
           ++  DV+S+GI++ E  +
Sbjct: 191 TSASDVWSYGIVMWEVMS 208

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/310 (23%), Positives = 130/310 (41%), Gaps = 59/310 (19%)
Query: 392 DGFSENNLIGRGSFGSVF--------KARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMM 442
           D  +    +G G+FG V         K +  + + VA+K+  +    +       E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 443 KSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-----------NYILDIYQ 490
           K I +H+NII ++ +C+ +    +++EY   G+L +YL +            N + +   
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 491 RLNIMI----DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
               ++     +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNG 600
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +E+F  
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 661 KEIVTKLLKI 670
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 100/198 (50%), Gaps = 9/198 (4%)
Query: 398 NLIGRGSFGSVFKARLG--DGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIK 452
            +IG G FG V   RL      E+ + +  L+ G   +  + F  E  +M    H NII 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +    +  +   ++ EYM +GSL+ +L  ++    + Q + ++  + S ++YL       
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMS 136
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYGKEGRV 571
            +H DL   N+L++ N+V  +SDFG++++L  + ++   T+     I + APE     + 
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 572 SANGDVYSFGIMLMETFT 589
           ++  DV+S+GI++ E  +
Sbjct: 197 TSASDVWSYGIVMWEVMS 214

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 400 IGRGSFGSVF--------KARLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRN 449
           +G G+FG V         K +     +VA+K+       +       E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNI 494
           II ++ +C+ +    +++EY   G+L +YL               H+    L     ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  +EYL    S + IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNGEMTLKHWV 608
              + +MAPE   +   +   DV+SFG++L E FT         P +E+F          
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 263
Query: 609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                           L +E         C + ++ +  +C    P QR   K++V  L 
Sbjct: 264 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 669 KI 670
           +I
Sbjct: 308 RI 309

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV---- 453
           +G G FG V +    D G +VA+K    +   +  + + +E ++MK + H N++      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 454 --ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQR--LNIMIDVASALEYLHFGY 509
             +   +  +   L +EY   G L KYL+       + +     ++ D++SAL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138
Query: 510 SAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
             ++IH DLKP N++L      ++  + D G AK L   DQ  + T+ + T+ Y+APE  
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELL 195
Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKP 593
           ++ + +   D +SFG +  E  T  +P
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV---- 453
           +G G FG V +    D G +VA+K    +   +  + + +E ++MK + H N++      
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 454 --ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQR--LNIMIDVASALEYLHFGY 509
             +   +  +   L +EY   G L KYL+       + +     ++ D++SAL YLH   
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 139
Query: 510 SAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
             ++IH DLKP N++L      ++  + D G AK L   DQ  + T+ + T+ Y+APE  
Sbjct: 140 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELL 196
Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKP 593
           ++ + +   D +SFG +  E  T  +P
Sbjct: 197 EQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 400 IGRGSFGSVF--------KARLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRN 449
           +G G+FG V         K +     +VA+K+       +       E EMMK I +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNI 494
           II ++ +C+ +    +++EY   G+L +YL               H+    L     ++ 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  +EYL    S + IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 148 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNGEMTLKHWV 608
              + +MAPE   +   +   DV+SFG++L E FT         P +E+F          
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 255
Query: 609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                           L +E         C + ++ +  +C    P QR   K++V  L 
Sbjct: 256 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 299
Query: 669 KI 670
           +I
Sbjct: 300 RI 301

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 400 IGRGSFGSVF--------KARLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRN 449
           +G G+FG V         K +     +VA+K+       +       E EMMK I +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNI 494
           II ++ +C+ +    +++EY   G+L +YL               H+    L     ++ 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  +EYL    S + IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 145 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNGEMTLKHWV 608
              + +MAPE   +   +   DV+SFG++L E FT         P +E+F          
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 252
Query: 609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                           L +E         C + ++ +  +C    P QR   K++V  L 
Sbjct: 253 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 296
Query: 669 KI 670
           +I
Sbjct: 297 RI 298

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 400 IGRGSFGSVF--------KARLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRN 449
           +G G+FG V         K +     +VA+K+       +       E EMMK I +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNI 494
           II ++ +C+ +    +++EY   G+L +YL               H+    L     ++ 
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  +EYL    S + IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 141 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNGEMTLKHWV 608
              + +MAPE   +   +   DV+SFG++L E FT         P +E+F          
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 248
Query: 609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                           L +E         C + ++ +  +C    P QR   K++V  L 
Sbjct: 249 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 669 KI 670
           +I
Sbjct: 293 RI 294

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 400 IGRGSFGSVF--------KARLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRN 449
           +G G+FG V         K +     +VA+K+       +       E EMMK I +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNI 494
           II ++ +C+ +    +++EY   G+L +YL               H+    L     ++ 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  +EYL    S + IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 149 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNGEMTLKHWV 608
              + +MAPE   +   +   DV+SFG++L E FT         P +E+F          
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 256
Query: 609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                           L +E         C + ++ +  +C    P QR   K++V  L 
Sbjct: 257 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 300
Query: 669 KI 670
           +I
Sbjct: 301 RI 302

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 400 IGRGSFGSVF--------KARLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRN 449
           +G G+FG V         K +     +VA+K+       +       E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNI 494
           II ++ +C+ +    +++EY   G+L +YL               H+    L     ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  +EYL    S + IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNGEMTLKHWV 608
              + +MAPE   +   +   DV+SFG++L E FT         P +E+F          
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 263
Query: 609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                           L +E         C + ++ +  +C    P QR   K++V  L 
Sbjct: 264 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 669 KI 670
           +I
Sbjct: 308 RI 309

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/302 (24%), Positives = 125/302 (41%), Gaps = 59/302 (19%)
Query: 400 IGRGSFGSVF--------KARLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRN 449
           +G G+FG V         K +     +VA+K+       +       E EMMK I +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNI 494
           II ++ +C+ +    +++EY   G+L +YL               H+    L     ++ 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  +EYL    S + IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNGEMTLKHWV 608
              + +MAPE   +   +   DV+SFG++L E FT         P +E+F          
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK--------- 263
Query: 609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                           L +E         C + ++ +  +C    P QR   K++V  L 
Sbjct: 264 ----------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 669 KI 670
           +I
Sbjct: 308 RI 309

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 130/310 (41%), Gaps = 59/310 (19%)
Query: 392 DGFSENNLIGRGSFGSVF--------KARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMM 442
           D  +    +G G+FG V         K +  + + VA+K+  +    +       E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 443 KSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YILDIYQR----- 491
           K I +H+NII ++ +C+ +    +++ Y   G+L +YL +       Y  DI +      
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 492 -----LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
                ++    +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNG 600
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +E+F  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 661 KEIVTKLLKI 670
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/272 (25%), Positives = 116/272 (42%), Gaps = 34/272 (12%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           ++G+G FG   K    +  EV  MK          ++F  E ++M+ + H N++K I   
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
             ++    + EY+  G+L   + S +      QR++   D+AS + YLH   S  +IH D
Sbjct: 77  YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTRED---------QSTIQTQTLATIG---YMAPEY 565
           L   N L+ +N    ++DFG+A+L+  E          +   + +    +G   +MAPE 
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 625
                     DV+SFGI+L E   R        N +        D+LP      +D  L 
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGR-------VNAD-------PDYLP----RTMDFGLN 235
Query: 626 SREDINFVAKEQCVSFVFNVAMECTVESPEQR 657
            R  ++      C    F + + C    PE+R
Sbjct: 236 VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 107/219 (48%), Gaps = 8/219 (3%)
Query: 376 EAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKS 434
           E ++++ S + +      ++    IG+G+ G+V+ A  +  G EVA++  NLQ     + 
Sbjct: 4   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 63
Query: 435 FDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI 494
              E  +M+  ++ NI+  + S    +   +V+EY+  GSL   +  +   +D  Q   +
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAV 121
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
             +   ALE+LH   S QVIH D+K  N+LL  +    L+DFG    +T E     +++ 
Sbjct: 122 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEM 176
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           + T  +MAPE           D++S GIM +E    + P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 129/294 (43%), Gaps = 44/294 (14%)
Query: 397 NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRV-----FKSFDVECEMMKSIRHRNII 451
           + +IG+G FG V+     D  +  ++       R+      ++F  E  +M+ + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 452 KVIS-SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
            +I      E    ++L YM HG L +++ S      +   ++  + VA  +EYL     
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AE 142
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGKE 568
            + +H DL   N +LD++    ++DFG+A+ +   +  ++Q    A   + + A E  + 
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 569 GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 628
            R +   DV+SFG++L E  TR  P           +H             +DP  L+  
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAP---------PYRH-------------IDPFDLT-- 238
Query: 629 DINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
             +F+A+       E C   ++ V  +C    P  R   + +V ++ +I  +LL
Sbjct: 239 --HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 398 NLIGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIK 452
            +IG G FG V     +L    E+ + +  L+ G   +  + F  E  +M    H N+I 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +    +      ++ E+M +GSL+ +L  ++    + Q + ++  +A+ ++YL       
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMN 155
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-----TIGYMAPEYGK 567
            +H DL   N+L++ N+V  +SDFG+++ L  ED ++  T T A      I + APE  +
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 568 EGRVSANGDVYSFGIMLMETFT 589
             + ++  DV+S+GI++ E  +
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMS 235

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/310 (24%), Positives = 130/310 (41%), Gaps = 59/310 (19%)
Query: 392 DGFSENNLIGRGSFGSVF--------KARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMM 442
           D  +    +G G+FG V         K +  + + VA+K+  +    +       E EMM
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 443 KSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-----YILDIYQR----- 491
           K I +H+NII ++ +C+ +    +++ Y   G+L +YL +       Y  DI +      
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 492 -----LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
                ++    +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK------PTDEIFNG 600
                T     + +MAPE   +   +   DV+SFG+++ E FT         P +E+F  
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 270
Query: 601 EMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA 660
                                   L +E         C + ++ +  +C    P QR   
Sbjct: 271 ------------------------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 306
Query: 661 KEIVTKLLKI 670
           K++V  L +I
Sbjct: 307 KQLVEDLDRI 316

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 115/266 (43%), Gaps = 26/266 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G GS+GSV+KA     G  VA+K   ++     +    E  +M+     +++K   S  
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
                 +V+EY   GS+   +   N  L   +   I+      LEYLHF    + IH D+
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDI 151
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  N+LL+    A L+DFG+A  LT  D    +   + T  +MAPE  +E   +   D++
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIW 209
Query: 579 SFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQC 638
           S GI  +E    K P  +I           N   P  T     P L S    +FV     
Sbjct: 210 SLGITAIEMAEGKPPYADIHPMRAIFMIPTN---PPPT--FRKPELWSDNFTDFVK---- 260
Query: 639 VSFVFNVAMECTVESPEQRINAKEIV 664
                    +C V+SPEQR  A +++
Sbjct: 261 ---------QCLVKSPEQRATATQLL 277

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 110/220 (50%), Gaps = 13/220 (5%)
Query: 385 LELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMK 443
           LE     D   +  ++G+G++G V+  R L + + +A+K    +  R  +    E  + K
Sbjct: 1   LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 60
Query: 444 SIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMI-DVASA 501
            ++H+NI++ + S S   F  + +E +P GSL   L S    + D  Q +      +   
Sbjct: 61  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 120
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           L+YLH     Q++H D+K  NVL++  + V  +SDFG +K L   +  T +T T  T+ Y
Sbjct: 121 LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT-ETFT-GTLQY 175
Query: 561 MAPEY---GKEGRVSANGDVYSFGIMLMETFTRKKPTDEI 597
           MAPE    G  G   A  D++S G  ++E  T K P  E+
Sbjct: 176 MAPEIIDKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYEL 214

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 104/195 (53%), Gaps = 8/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G FG V+     +  +VA+K   L+ G +  ++F  E  +MK+++H  ++++ +  +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-NIMIDVASALEYLHFGYSAQVIHCD 517
            EE   ++ E+M  GSL  +L S      +  +L +    +A  + Y+        IH D
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 134
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L+ +NVL+ ++++  ++DFG+A+++  +++ T +      I + APE    G  +   +V
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 578 YSFGIMLMETFTRKK 592
           +SFGI+L E  T  K
Sbjct: 194 WSFGILLYEIVTYGK 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 116/260 (44%), Gaps = 38/260 (14%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           +G G FG V+ A      +VA+K        V ++F  E  +MK+++H  ++K+ +  + 
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL-EYLHFGYSAQVIHCDL 518
           E    ++ E+M  GSL  +L S        Q L  +ID ++ + E + F      IH DL
Sbjct: 249 EPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           + +N+L+  ++V  ++DFG+A++  +             I + APE    G  +   DV+
Sbjct: 305 RAANILVSASLVCKIADFGLARVGAK-----------FPIKWTAPEAINFGSFTIKSDVW 353
Query: 579 SFGIMLMETFTRKK-PTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQ 637
           SFGI+LME  T  + P   + N E+                      L R        E 
Sbjct: 354 SFGILLMEIVTYGRIPYPGMSNPEVI-------------------RALER-GYRMPRPEN 393
Query: 638 CVSFVFNVAMECTVESPEQR 657
           C   ++N+ M C    PE+R
Sbjct: 394 CPEELYNIMMRCWKNRPEER 413

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 8/219 (3%)
Query: 376 EAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKS 434
           E ++++ S + +      ++    IG+G+ G+V+ A  +  G EVA++  NLQ     + 
Sbjct: 4   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 63
Query: 435 FDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI 494
              E  +M+  ++ NI+  + S    +   +V+EY+  GSL   +  +   +D  Q   +
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAV 121
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
             +   ALE+LH   S QVIH D+K  N+LL  +    L+DFG    +T E     ++  
Sbjct: 122 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXM 176
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           + T  +MAPE           D++S GIM +E    + P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 8/219 (3%)
Query: 376 EAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKS 434
           E ++++ S + +      ++    IG+G+ G+V+ A  +  G EVA++  NLQ     + 
Sbjct: 4   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 63
Query: 435 FDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI 494
              E  +M+  ++ NI+  + S    +   +V+EY+  GSL   +  +   +D  Q   +
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAV 121
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
             +   ALE+LH   S QVIH D+K  N+LL  +    L+DFG    +T E     ++  
Sbjct: 122 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTM 176
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           + T  +MAPE           D++S GIM +E    + P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 106/219 (48%), Gaps = 8/219 (3%)
Query: 376 EAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKS 434
           E ++++ S + +      ++    IG+G+ G+V+ A  +  G EVA++  NLQ     + 
Sbjct: 5   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 64
Query: 435 FDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI 494
              E  +M+  ++ NI+  + S    +   +V+EY+  GSL   +  +   +D  Q   +
Sbjct: 65  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAV 122
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
             +   ALE+LH   S QVIH D+K  N+LL  +    L+DFG    +T E     ++  
Sbjct: 123 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXM 177
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           + T  +MAPE           D++S GIM +E    + P
Sbjct: 178 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 24/231 (10%)
Query: 367 PPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGME--VAM 421
           P   AN   + + R+F   EL +         ++G G FG+V K      G+ ++  V +
Sbjct: 16  PSEKAN---KVLARIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCI 65
Query: 422 KVFNLQYGRVFKSFDVECEMM---KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKY 478
           KV   + GR  +SF    + M    S+ H +I++++  C     + LV +Y+P GSL  +
Sbjct: 66  KVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDH 122
Query: 479 LHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI 538
           +      L     LN  + +A  + YL       ++H +L   NVLL       ++DFG+
Sbjct: 123 VRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGV 179
Query: 539 AKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           A LL  +D+  + ++    I +MA E    G+ +   DV+S+G+ + E  T
Sbjct: 180 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/234 (32%), Positives = 110/234 (47%), Gaps = 45/234 (19%)
Query: 399 LIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           LIGRG +G+V+K  L D   VA+KVF+    + F + +     +  + H NI + I    
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN-EKNIYRVPLMEHDNIARFI--VG 75
Query: 459 NEEFKA-------LVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEYLHF-- 507
           +E   A       LV+EY P+GSL KYL  H+S+++        +   V   L YLH   
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWV----SSCRLAHSVTRGLAYLHTEL 131
Query: 508 ----GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT--------REDQSTIQTQTL 555
                Y   + H DL   NVL+ ++    +SDFG++  LT         ED + I    +
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI--SEV 189
Query: 556 ATIGYMAPEYGKEGRVSANG--------DVYSFGIMLMETFTRKKPTDEIFNGE 601
            TI YMAPE   EG V+           D+Y+ G++  E F R     ++F GE
Sbjct: 190 GTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMR---CTDLFPGE 239

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 110/220 (50%), Gaps = 13/220 (5%)
Query: 385 LELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMK 443
           LE     D   +  ++G+G++G V+  R L + + +A+K    +  R  +    E  + K
Sbjct: 15  LEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHK 74
Query: 444 SIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMI-DVASA 501
            ++H+NI++ + S S   F  + +E +P GSL   L S    + D  Q +      +   
Sbjct: 75  HLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG 134
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           L+YLH     Q++H D+K  NVL++  + V  +SDFG +K L   +  T +T T  T+ Y
Sbjct: 135 LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT-ETFT-GTLQY 189
Query: 561 MAPEY---GKEGRVSANGDVYSFGIMLMETFTRKKPTDEI 597
           MAPE    G  G   A  D++S G  ++E  T K P  E+
Sbjct: 190 MAPEIIDKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYEL 228

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 27/207 (13%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGME-VAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +++  +IG GSFG V++A+L D  E VA+K   +  G+ FK  + E ++M+ + H NI++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 453 V------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALE 503
           +           +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 504 YLH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYR 189
Query: 562 APE--YGKEGRVSANGDVYSFGIMLME 586
           APE  +G     S+  DV+S G +L E
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 106/222 (47%), Gaps = 21/222 (9%)
Query: 376 EAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGME--VAMKVFNLQYGR 430
           + + R+F   EL +         ++G G FG+V K      G+ ++  V +KV   + GR
Sbjct: 4   KVLARIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR 56
Query: 431 VFKSFDVECEMM---KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +SF    + M    S+ H +I++++  C     + LV +Y+P GSL  ++      L 
Sbjct: 57  --QSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALG 113
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL       ++H +L   NVLL       ++DFG+A LL  +D+
Sbjct: 114 PQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
             + ++    I +MA E    G+ +   DV+S+G+ + E  T
Sbjct: 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 20/209 (9%)
Query: 397 NNLIGRGSFGSVFKARLGD----GMEVAMKVFNLQYGR---VFKSFDVECEMMKSIRHRN 449
            + +G G+FG   K ++G+    G +VA+K+ N Q  R   V      E + +K  RH +
Sbjct: 16  GDTLGVGTFG---KVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           IIK+    S      +V+EY+  G L  Y+     + ++  R  +   + SA++Y H   
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH--- 128
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
              V+H DLKP NVLLD +M A ++DFG++ +++  D   ++T +  +  Y APE    G
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRT-SCGSPNYAAPEV-ISG 184
Query: 570 RVSANG--DVYSFGIMLMETFTRKKPTDE 596
           R+ A    D++S G++L        P D+
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 394 FSENNL-----IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR- 446
           F  NNL     +G G+FG V +A   G G E A+    ++  +     D +  +M  ++ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 447 ------HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
                 H NI+ ++ +C++     ++ EY  +G L  +L   + +L+      I    AS
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 501 ALEYLHFGYSAQV------------IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS 548
             + LHF  S+QV            IH D+   NVLL +  VA + DFG+A+ +  +   
Sbjct: 163 TRDLLHF--SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
            ++      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 108/246 (43%), Gaps = 38/246 (15%)
Query: 379 QRMFSYLELCRATDGFSENNL-----IGRGSFGSVFKARLGDGME------VAMKVFNLQ 427
           QRM   L     +  +  NN+     IG G+FG VF+AR    +       VA+K+   +
Sbjct: 29  QRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE 88
Query: 428 YGRVFKS-FDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN--- 483
                ++ F  E  +M    + NI+K++  C+  +   L+ EYM +G L ++L S +   
Sbjct: 89  ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHT 148
Query: 484 --------------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNV 523
                                 L   ++L I   VA+ + YL      + +H DL   N 
Sbjct: 149 VCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNC 205
Query: 524 LLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIM 583
           L+ +NMV  ++DFG+++ +   D           I +M PE     R +   DV+++G++
Sbjct: 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 265
Query: 584 LMETFT 589
           L E F+
Sbjct: 266 LWEIFS 271

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 27/207 (13%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGME-VAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +++  +IG GSFG V++A+L D  E VA+K   +  G+ FK  + E ++M+ + H NI++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 453 V------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALE 503
           +           +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 504 YLH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYR 189
Query: 562 APE--YGKEGRVSANGDVYSFGIMLME 586
           APE  +G     S+  DV+S G +L E
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/207 (32%), Positives = 108/207 (52%), Gaps = 27/207 (13%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGME-VAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +++  +IG GSFG V++A+L D  E VA+K   +  G+ FK  + E ++M+ + H NI++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 453 V------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALE 503
           +           +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 504 YLH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYR 189
Query: 562 APE--YGKEGRVSANGDVYSFGIMLME 586
           APE  +G     S+  DV+S G +L E
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 20/222 (9%)
Query: 398 NLIGRGSFGSVFKARL----GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNII 451
            ++G G FGSV +  L    G  ++VA+K   L     R  + F  E   MK   H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 452 KVISSCSNEEFKAL-----VLEYMPHGSLEKYLHSSNY-----ILDIYQRLNIMIDVASA 501
           +++  C     + +     +L +M +G L  YL  S        + +   L  M+D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           +EYL    +   +H DL   N +L D+M   ++DFG++K +   D           + ++
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 562 APEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEM 602
           A E   +   ++  DV++FG+ + E  TR   P   + N EM
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G + K L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYC 129
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 182
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T+   T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTELCGTLDYLPPEM 177
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 177
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 20/209 (9%)
Query: 397 NNLIGRGSFGSVFKARLGD----GMEVAMKVFNLQYGR---VFKSFDVECEMMKSIRHRN 449
            + +G G+FG   K ++G+    G +VA+K+ N Q  R   V      E + +K  RH +
Sbjct: 16  GDTLGVGTFG---KVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           IIK+    S      +V+EY+  G L  Y+     + ++  R  +   + SA++Y H   
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH--- 128
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
              V+H DLKP NVLLD +M A ++DFG++ +++          +  +  Y APE    G
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRDSCGSPNYAAPEV-ISG 184
Query: 570 RVSANG--DVYSFGIMLMETFTRKKPTDE 596
           R+ A    D++S G++L        P D+
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 177
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 177
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 150
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 203
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 204 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQ-------YGRVFKSFDVECEMMK 443
           + F   NL+G+GSF  V++A  +  G+EVA+K+ + +         RV     + C++  
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-- 68
Query: 444 SIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALE 503
             +H +I+++ +   +  +  LVLE   +G + +YL +        +  + M  + + + 
Sbjct: 69  --KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT--REDQSTIQTQTLATIGYM 561
           YLH   S  ++H DL  SN+LL  NM   ++DFG+A  L    E   T+      T  Y+
Sbjct: 127 YLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL----CGTPNYI 179
Query: 562 APEYGKEGRVSANGDVYSFGIMLMETFTRKKPTD 595
           +PE           DV+S G M       + P D
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTXLCGTLDYLPPEM 177
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 123
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 124 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 176
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 177 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 398 NLIGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIK 452
            +IG G FG V     +L    E+ + +  L+ G   +  + F  E  +M    H N+I 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +    +      ++ E+M +GSL+ +L  ++    + Q + ++  +A+ ++YL       
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMN 129
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-----TIGYMAPEYGK 567
            +H  L   N+L++ N+V  +SDFG+++ L  ED ++  T T A      I + APE  +
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSRFL--EDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 568 EGRVSANGDVYSFGIMLMETFT 589
             + ++  DV+S+GI++ E  +
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMS 209

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 178
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 179 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 128
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 129 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 181
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 182 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 129
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTDLCGTLDYLPPEM 182
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 129
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 182
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 406 GSVFKARLGDGMEVAMKVFNLQYGRVFKS--FDVECEMMKSIRHRNIIKVISSCSNEE-- 461
           G ++K R   G ++ +KV  ++     KS  F+ EC  ++   H N++ V+ +C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 462 FKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKP 520
              L+  +MP+GSL   LH  +N+++D  Q +   +D+A  + +LH        H  L  
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA-LNS 141
Query: 521 SNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSF 580
            +V++D++M A +S   +        QS  +    A +   A +   E     + D++SF
Sbjct: 142 RSVMIDEDMTARISMADVKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSF 197
Query: 581 GIMLMETFTRKKPTDEIFNGEMTLK 605
            ++L E  TR+ P  ++ N E+ +K
Sbjct: 198 AVLLWELVTREVPFADLSNMEIGMK 222

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 32/224 (14%)
Query: 387 LCRATDGFSENNLIGRGSFGSVFKAR--LGDGMEVAMKVFNLQYGRVFKSFDVECEM--- 441
           LCRA   +     IG G++G VFKAR     G  VA+K   +Q G          E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 442 --MKSIRHRNIIKVISSCS----NEEFK-ALVLEYMPHGSLEKYLHS-------SNYILD 487
             +++  H N++++   C+    + E K  LV E++    L  YL         +  I D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
           +      M  +   L++LH   S +V+H DLKP N+L+  +    L+DFG+A++ + +  
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK 591
               T  + T+ Y APE   +   +   D++S G +  E F RK
Sbjct: 174 -MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 141
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 142 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 194
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 195 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGME-VAMKVFNLQYGR-----VFKSFDVECEMMKSIRH 447
           + + + +G G F +V+KAR  +  + VA+K   L +       + ++   E ++++ + H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            NII ++ +  ++   +LV ++M    LE  +  ++ +L        M+     LEYLH 
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
            +   ++H DLKP+N+LLD+N V  L+DFG+AK     +++      + T  Y APE   
Sbjct: 131 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVTRWYRAPELLF 185
Query: 568 EGRVSANG-DVYSFGIMLMETFTR 590
             R+   G D+++ G +L E   R
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLR 209

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G + K L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYC 129
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +     T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLPPEM 182
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 183 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 394 FSENNL-----IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR- 446
           F  NNL     +G G+FG V +A   G G E A+    ++  +     D +  +M  ++ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 447 ------HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
                 H NI+ ++ +C++     ++ EY  +G L  +L   + +L+      I     S
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 501 ALEYLHFGYSAQV------------IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS 548
             + LHF  S+QV            IH D+   NVLL +  VA + DFG+A+ +  +   
Sbjct: 163 TRDLLHF--SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
            ++      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 121
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 122 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM 174
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 175 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 32/224 (14%)
Query: 387 LCRATDGFSENNLIGRGSFGSVFKAR--LGDGMEVAMKVFNLQYGRVFKSFDVECEM--- 441
           LCRA   +     IG G++G VFKAR     G  VA+K   +Q G          E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 442 --MKSIRHRNIIKVISSCS----NEEFK-ALVLEYMPHGSLEKYLHS-------SNYILD 487
             +++  H N++++   C+    + E K  LV E++    L  YL         +  I D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
           +      M  +   L++LH   S +V+H DLKP N+L+  +    L+DFG+A++ + +  
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK 591
               T  + T+ Y APE   +   +   D++S G +  E F RK
Sbjct: 174 -MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI+++
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVRL 86
Query: 454 ------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                      +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 145
Query: 505 LH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           +H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y A
Sbjct: 146 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRA 198
Query: 563 PE--YGKEGRVSANGDVYSFGIMLME 586
           PE  +G     S+  DV+S G +L E
Sbjct: 199 PELIFGATDYTSSI-DVWSAGCVLAE 223

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 129
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 130 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPE- 181
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR      D++S G++  E    K P
Sbjct: 182 XIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 32/224 (14%)
Query: 387 LCRATDGFSENNLIGRGSFGSVFKAR--LGDGMEVAMKVFNLQYGRVFKSFDVECEM--- 441
           LCRA   +     IG G++G VFKAR     G  VA+K   +Q G          E+   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 442 --MKSIRHRNIIKVISSCS----NEEFK-ALVLEYMPHGSLEKYLHS-------SNYILD 487
             +++  H N++++   C+    + E K  LV E++    L  YL         +  I D
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD 124
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
           +      M  +   L++LH   S +V+H DLKP N+L+  +    L+DFG+A++ + +  
Sbjct: 125 M------MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-- 173
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK 591
               T  + T+ Y APE   +   +   D++S G +  E F RK
Sbjct: 174 -MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 393 GFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
            +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVR 77
Query: 453 V------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALE 503
           +           +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 504 YLH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYR 189
Query: 562 APE--YGKEGRVSANGDVYSFGIMLME 586
           APE  +G     S+  DV+S G +L E
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI+++
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVRL 97
Query: 454 ------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                      +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 156
Query: 505 LH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           +H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y A
Sbjct: 157 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRA 209
Query: 563 PE--YGKEGRVSANGDVYSFGIMLME 586
           PE  +G     S+  DV+S G +L E
Sbjct: 210 PELIFGATDYTSSI-DVWSAGCVLAE 234

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVRL 112
Query: 454 ------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                      +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 171
Query: 505 LH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           +H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y A
Sbjct: 172 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRA 224
Query: 563 PE--YGKEGRVSANGDVYSFGIMLME 586
           PE  +G     S+  DV+S G +L E
Sbjct: 225 PELIFGATDYTSSI-DVWSAGCVLAE 249

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 400 IGRGSFGSVFKARLGDGME------VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           +G+GSFG V++    D ++      VA+K  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD---------IYQRLNIMIDVASALE 503
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL+   + + +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
           E  K+G  + + D++SFG++L E  +  +   +  + E  LK
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 393 GFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
            +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVR 77
Query: 453 V------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALE 503
           +           +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 504 YLH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYR 189
Query: 562 APE--YGKEGRVSANGDVYSFGIMLME 586
           APE  +G     S+  DV+S G +L E
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVRL 90
Query: 454 ------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                      +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 149
Query: 505 LH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           +H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y A
Sbjct: 150 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRA 202
Query: 563 PE--YGKEGRVSANGDVYSFGIMLME 586
           PE  +G     S+  DV+S G +L E
Sbjct: 203 PELIFGATDYTSSI-DVWSAGCVLAE 227

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 393 GFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
            +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI++
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVR 78
Query: 453 V------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALE 503
           +           +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L 
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 137
Query: 504 YLH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y 
Sbjct: 138 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYR 190
Query: 562 APE--YGKEGRVSANGDVYSFGIMLME 586
           APE  +G     S+  DV+S G +L E
Sbjct: 191 APELIFGATDYTSSI-DVWSAGCVLAE 216

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI+++
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVRL 82
Query: 454 ------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                      +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 141
Query: 505 LH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           +H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y A
Sbjct: 142 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRA 194
Query: 563 PE--YGKEGRVSANGDVYSFGIMLME 586
           PE  +G     S+  DV+S G +L E
Sbjct: 195 PELIFGATDYTSSI-DVWSAGCVLAE 219

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 88/311 (28%), Positives = 134/311 (43%), Gaps = 66/311 (21%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI--RHRNIIKVISSC 457
           +G+G +G V++     G  VA+K+F+    R  KS+  E E+  ++  RH NI+  I+S 
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 100
Query: 458 SNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH---FGYS 510
                 +    L+  Y   GSL  YL  +   LD    L I++ +AS L +LH   FG  
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 511 AQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT-----LATIGYMAP 563
            +  + H DLK  N+L+  N    ++D G+A +     QST Q        + T  YMAP
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNPRVGTKRYMAP 215
Query: 564 EYGKE----------GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
           E   E           RV    D+++FG++L E   R      + NG       V D+ P
Sbjct: 216 EVLDETIQVDCFDSYKRV----DIWAFGLVLWEVARRM-----VSNGI------VEDYKP 260
Query: 614 ISTKEIVDPNLLSREDINFVA--------------KEQCVSFVFNVAMECTVESPEQRIN 659
                 V PN  S ED+  V                +  ++ +  +  EC  ++P  R+ 
Sbjct: 261 PFYD--VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 318
Query: 660 AKEIVTKLLKI 670
           A  I   L KI
Sbjct: 319 ALRIKKTLTKI 329

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVRL 90
Query: 454 ------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                      +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 149
Query: 505 LH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           +H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y A
Sbjct: 150 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRA 202
Query: 563 PE--YGKEGRVSANGDVYSFGIMLME 586
           PE  +G     S+  DV+S G +L E
Sbjct: 203 PELIFGATDYTSSI-DVWSAGCVLAE 227

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 400 IGRGSFGSVFKARLGDGME------VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           +G+GSFG V++    D ++      VA+K  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD---------IYQRLNIMIDVASALE 503
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL+   + + +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
           E  K+G  + + D++SFG++L E  +  +   +  + E  LK
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI+++
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVRL 106
Query: 454 ------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                      +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 165
Query: 505 LH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           +H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y A
Sbjct: 166 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRA 218
Query: 563 PE--YGKEGRVSANGDVYSFGIMLME 586
           PE  +G     S+  DV+S G +L E
Sbjct: 219 PELIFGATDYTSSI-DVWSAGCVLAE 243

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 96/195 (49%), Gaps = 8/195 (4%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG+G+ G+V+ A  +  G EVA++  NLQ     +    E  +M+  ++ NI+  + S  
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S QVIH ++
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRNI 143
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  N+LL  +    L+DFG    +T E     ++  + T  +MAPE           D++
Sbjct: 144 KSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 579 SFGIMLMETFTRKKP 593
           S GIM +E    + P
Sbjct: 202 SLGIMAIEMIEGEPP 216

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSIRH 447
           + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH- 129
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
             S +VIH D+KP N+LL  N    ++DFG     +    S+ +T    T+ Y+ PE   
Sbjct: 130 --SKRVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRTTLCGTLDYLPPEM-I 182
Query: 568 EGRVSANG-DVYSFGIMLME 586
           EGR+     D++S G++  E
Sbjct: 183 EGRMHDEKVDLWSLGVLCYE 202

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI+++
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVRL 83
Query: 454 ------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                      +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y
Sbjct: 84  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 142
Query: 505 LH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           +H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y A
Sbjct: 143 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRA 195
Query: 563 PE--YGKEGRVSANGDVYSFGIMLME 586
           PE  +G     S+  DV+S G +L E
Sbjct: 196 PELIFGATDYTSSI-DVWSAGCVLAE 220

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVRL 112
Query: 454 ------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                      +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 171
Query: 505 LH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           +H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y A
Sbjct: 172 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRA 224
Query: 563 PE--YGKEGRVSANGDVYSFGIMLME 586
           PE  +G     S+  DV+S G +L E
Sbjct: 225 PELIFGATDYTSSI-DVWSAGCVLAE 249

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI+++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVRL 116
Query: 454 ------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                      +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 175
Query: 505 LH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           +H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y A
Sbjct: 176 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRA 228
Query: 563 PE--YGKEGRVSANGDVYSFGIMLME 586
           PE  +G     S+  DV+S G +L E
Sbjct: 229 PELIFGATDYTSSI-DVWSAGCVLAE 253

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI+++
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVRL 114
Query: 454 ------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                      +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 173
Query: 505 LH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           +H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y A
Sbjct: 174 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRA 226
Query: 563 PE--YGKEGRVSANGDVYSFGIMLME 586
           PE  +G     S+  DV+S G +L E
Sbjct: 227 PELIFGATDYTSSI-DVWSAGCVLAE 251

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +T    T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSCHAPSSRRTTLSGTLDYLPPEM 178
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 179 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 400 IGRGSFGSVFKARLGDGME------VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           +G+GSFG V++    D ++      VA+K  N     R    F  E  +MK     ++++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD---------IYQRLNIMIDVASALE 503
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL+   + + +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
           E  K+G  + + D++SFG++L E  +  +   +  + E  LK
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 240

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 393 GFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
            +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVR 77
Query: 453 V------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALE 503
           +           +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLA 136
Query: 504 YLH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           Y+H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y 
Sbjct: 137 YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYR 189
Query: 562 APE--YGKEGRVSANGDVYSFGIMLME 586
           APE  +G     S+  DV+S G +L E
Sbjct: 190 APELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI+++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVRL 157
Query: 454 ------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                      +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 216
Query: 505 LH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           +H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y A
Sbjct: 217 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRA 269
Query: 563 PE--YGKEGRVSANGDVYSFGIMLME 586
           PE  +G     S+  DV+S G +L E
Sbjct: 270 PELIFGATDYTSSI-DVWSAGCVLAE 294

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 25/206 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI+++
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVRL 91
Query: 454 ------ISSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                      +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 150
Query: 505 LH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           +H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y A
Sbjct: 151 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRA 203
Query: 563 PE--YGKEGRVSANGDVYSFGIMLME 586
           PE  +G     S+  DV+S G +L E
Sbjct: 204 PELIFGATDYTSSI-DVWSAGCVLAE 228

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR  +   + A+KV     L+   V      E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +     T+ Y+ PE 
Sbjct: 125 H---SKKVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEM 177
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 88/311 (28%), Positives = 134/311 (43%), Gaps = 66/311 (21%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI--RHRNIIKVISSC 457
           +G+G +G V++     G  VA+K+F+    R  KS+  E E+  ++  RH NI+  I+S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 458 SNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH---FGYS 510
                 +    L+  Y   GSL  YL  +   LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 511 AQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT-----LATIGYMAP 563
            +  + H DLK  N+L+  N    ++D G+A +     QST Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 564 EYGKE----------GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
           E   E           RV    D+++FG++L E   R      + NG       V D+ P
Sbjct: 187 EVLDETIQVDCFDSYKRV----DIWAFGLVLWEVARRM-----VSNGI------VEDYKP 231
Query: 614 ISTKEIVDPNLLSREDINFVA--------------KEQCVSFVFNVAMECTVESPEQRIN 659
                 V PN  S ED+  V                +  ++ +  +  EC  ++P  R+ 
Sbjct: 232 PFYD--VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 660 AKEIVTKLLKI 670
           A  I   L KI
Sbjct: 290 ALRIKKTLTKI 300

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 398 NLIGRGSFGSVFKARLGD----GMEVAMKVFNLQYGR---VFKSFDVECEMMKSIRHRNI 450
           + +G G+FG   K ++G     G +VA+K+ N Q  R   V      E + +K  RH +I
Sbjct: 22  DTLGVGTFG---KVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
           IK+    S      +V+EY+  G L  Y+   N  LD  +   +   + S ++Y H    
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH---R 134
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
             V+H DLKP NVLLD +M A ++DFG++ +++          +  +  Y APE    GR
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGEFLRXSCGSPNYAAPEV-ISGR 190
Query: 571 VSANG--DVYSFGIMLMETFTRKKPTDE 596
           + A    D++S G++L        P D+
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 9/216 (4%)
Query: 384 YLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSF-DVECEM 441
           Y +     + F++   IG+GSFG VFK       +V A+K+ +L+           E  +
Sbjct: 19  YFQSMDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 78
Query: 442 MKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
           +       + K   S   +    +++EY+  GS    L      LD  Q   I+ ++   
Sbjct: 79  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKG 136
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           L+YLH   S + IH D+K +NVLL ++    L+DFG+A  LT  D    +   + T  +M
Sbjct: 137 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWM 191
Query: 562 APEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEI 597
           APE  K+    +  D++S GI  +E    + P  E+
Sbjct: 192 APEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 25/206 (12%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +++  +IG GSFG V++A+L D  E+      LQ  R FK  + E ++M+ + H NI+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-FK--NRELQIMRKLDHCNIVRL 78
Query: 454 ----ISSCSNEE--FKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                SS   ++  +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 505 LH-FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           +H FG    + H D+KP N+LLD D  V  L DFG AK L R + +      + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSXICSRYYRA 190
Query: 563 PE--YGKEGRVSANGDVYSFGIMLME 586
           PE  +G     S+  DV+S G +L E
Sbjct: 191 PELIFGATDYTSSI-DVWSAGCVLAE 215

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPPEM 180
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEM 180
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRAALCGTLDYLPPEM 177
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 88/311 (28%), Positives = 134/311 (43%), Gaps = 66/311 (21%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI--RHRNIIKVISSC 457
           +G+G +G V++     G  VA+K+F+    R  KS+  E E+  ++  RH NI+  I+S 
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 458 SNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH---FGYS 510
                 +    L+  Y   GSL  YL  +   LD    L I++ +AS L +LH   FG  
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 511 AQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT-----LATIGYMAP 563
            +  + H DLK  N+L+  N    ++D G+A +     QST Q        + T  YMAP
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM---HSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 564 EYGKE----------GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
           E   E           RV    D+++FG++L E   R      + NG       V D+ P
Sbjct: 187 EVLDETIQVDCFDSYKRV----DIWAFGLVLWEVARRM-----VSNGI------VEDYKP 231
Query: 614 ISTKEIVDPNLLSREDINFVA--------------KEQCVSFVFNVAMECTVESPEQRIN 659
                 V PN  S ED+  V                +  ++ +  +  EC  ++P  R+ 
Sbjct: 232 PFYD--VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
Query: 660 AKEIVTKLLKI 670
           A  I   L KI
Sbjct: 290 ALRIKKTLTKI 300

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 9/206 (4%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSF-DVECEMMKSIRHRNII 451
           F++   IG+GSFG VFK       +V A+K+ +L+           E  ++       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 123
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
           + IH D+K +NVLL ++    L+DFG+A  LT  D    +   + T  +MAPE  K+   
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAY 181
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEI 597
            +  D++S GI  +E    + P  E+
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 125
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG +       + T+      T+ Y+ PE 
Sbjct: 126 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTL----CGTLDYLPPEM 178
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 179 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 150
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +     T+ Y+ PE 
Sbjct: 151 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPPEM 203
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 204 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 9/206 (4%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSF-DVECEMMKSIRHRNII 451
           F++   IG+GSFG VFK       +V A+K+ +L+           E  ++       + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 123
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
           + IH D+K +NVLL ++    L+DFG+A  LT  D    +   + T  +MAPE  K+   
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIKQSAY 181
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEI 597
            +  D++S GI  +E    + P  E+
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSEL 207

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L F 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLAFC 126
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y APE    
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLG 184
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 240
Query: 627 RED 629
             D
Sbjct: 241 MPD 243

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 9/206 (4%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSF-DVECEMMKSIRHRNII 451
           F++   IG+GSFG VFK       +V A+K+ +L+           E  ++       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---SE 138
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
           + IH D+K +NVLL ++    L+DFG+A  LT  D    +   + T  +MAPE  K+   
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIKQSAY 196
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEI 597
            +  D++S GI  +E    + P  E+
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSEL 222

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 390 ATDGFSENNLIGRGSFGSVF----KARLGDGME--VAMKVFNLQYG-RVFKSFDVECEMM 442
           A +  + +  +G+GSFG V+    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS------SNYIL---DIYQRLN 493
           K     ++++++   S  +   +++E M  G L+ YL S      +N +L    + + + 
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           +  ++A  + YL+   + + +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 193
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
            L  + +M+PE  K+G  +   DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 246
Query: 614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                +++  LL + D        C   +F +   C   +P+ R +  EI++ + +  + 
Sbjct: 247 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294
Query: 674 LLRNV 678
             R V
Sbjct: 295 GFREV 299

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       +++FG     +    S+ +T    T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPPEM 180
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +     T+ Y+ PE 
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEM 177
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 178 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L F 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLAFC 126
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y APE    
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLG 184
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 240
Query: 627 RED 629
             D
Sbjct: 241 MPD 243

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 126
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +     T+ Y+ PE 
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEM 179
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 180 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y APE    
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLG 177
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 627 RED 629
             D
Sbjct: 234 MPD 236

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 126
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       +++FG     +    S+ +T    T+ Y+ PE 
Sbjct: 127 H---SKRVIHRDIKPENLLLGSAGELKIANFG----WSVHAPSSRRTTLCGTLDYLPPEM 179
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 180 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLSFC 119
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y APE    
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLG 177
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 627 RED 629
             D
Sbjct: 234 MPD 236

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 400 IGRGSFGSVFKARLGDGME------VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           +G+GSFG V++    D ++      VA+K  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD---------IYQRLNIMIDVASALE 503
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL+   + + +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
           E  K+G  + + D++SFG++L E  +  +   +  + E  LK
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y APE    
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLG 177
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 627 RED 629
             D
Sbjct: 234 MPD 236

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y APE    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLG 176
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 627 RED 629
             D
Sbjct: 233 MPD 235

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSI 445
           A + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           RH NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S +VIH D+KP N+LL       ++DFG     +    S+ +     T+ Y+ PE 
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPPEM 180
Query: 566 GKEGRVSANG-DVYSFGIMLMETFTRKKP 593
             EGR+     D++S G++  E    K P
Sbjct: 181 -IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 80/349 (22%), Positives = 153/349 (43%), Gaps = 44/349 (12%)
Query: 352 VVIFLIVKCRKRERGPPND----ANMPPEAMQRMFSYL--ELCRATDGFSENNLIGRGSF 405
           +VI L V  RKR      +    A++ PE       Y+  E   A +  + +  +G+GSF
Sbjct: 1   LVIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSF 60
Query: 406 GSVF----KARLGDGME--VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           G V+    K  + D  E  VA+K  N     R    F  E  +MK     ++++++   S
Sbjct: 61  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 120
Query: 459 NEEFKALVLEYMPHGSLEKYLHS------SNYIL---DIYQRLNIMIDVASALEYLHFGY 509
             +   +++E M  G L+ YL S      +N +L    + + + +  ++A  + YL+   
Sbjct: 121 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN--- 177
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
           + + +H DL   N ++ ++    + DFG+ + +   D      + L  + +M+PE  K+G
Sbjct: 178 ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 237
Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
             +   DV+SFG++L E  T  +   +  + E  L+             +++  LL + D
Sbjct: 238 VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------------VMEGGLLDKPD 285
Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRNV 678
                   C   +F +   C   +P+ R +  EI++ + +  +   R V
Sbjct: 286 -------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 327

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y APE    
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLG 177
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 627 RED 629
             D
Sbjct: 234 MPD 236

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 119/245 (48%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 118
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y APE  
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEIL 176
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 232
Query: 625 LSRED 629
            S  D
Sbjct: 233 TSMPD 237

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVA----MKVFNLQYGRVFKSFDVECEMMKSIRHRN 449
           FS+   IG GSFG+V+ AR     EV     M     Q    ++    E   ++ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS----ALEYL 505
            I+       E    LV+EY         L S++ +L+++++    +++A+    AL+ L
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 167
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
            + +S  +IH D+K  N+LL +  +  L DFG A ++   +        + T  +MAPE 
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEV 221
Query: 566 ---GKEGRVSANGDVYSFGIMLMETFTRKKP 593
                EG+     DV+S GI  +E   RK P
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y APE    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLG 176
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 627 RED 629
             D
Sbjct: 233 MPD 235

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI--RHRNIIKVISSC 457
           IG+G FG V++ +   G EVA+K+F+    R  +S+  E E+ +++  RH NI+  I++ 
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 458 SNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF---GYS 510
           + +        LV +Y  HGSL  YL  + Y + +   + + +  AS L +LH    G  
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 511 AQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST-----IQTQTLATIGYMAP 563
            +  + H DLK  N+L+  N    ++D G+A    R D +T          + T  YMAP
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 207
Query: 564 EY------GKEGRVSANGDVYSFGIMLMETFTR 590
           E        K        D+Y+ G++  E   R
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 85/308 (27%), Positives = 137/308 (44%), Gaps = 54/308 (17%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI--RHRNIIKVISSC 457
           +G+G +G V++  L  G  VA+K+F+    R  +S+  E E+  ++  RH NI+  I+S 
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFS---SRDEQSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 458 SNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH---FGYS 510
                 +    L+  Y  HGSL  +L      L+ +  L + +  A  L +LH   FG  
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFLQRQT--LEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 511 AQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTI-QTQTLATIGYMAPEYG 566
            +  + H D K  NVL+  N+   ++D G+A + ++  D   I     + T  YMAPE  
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVL 189
Query: 567 KEGRVSAN-------GDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI 619
            E ++  +        D+++FG++L E   R      I NG       V D+ P      
Sbjct: 190 DE-QIRTDCFESYKWTDIWAFGLVLWEIARRT-----IVNGI------VEDYRPPFYD-- 235
Query: 620 VDPNLLSREDI--------------NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 665
           V PN  S ED+              N +A +  +S +  +  EC   +P  R+ A  I  
Sbjct: 236 VVPNDPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKK 295
Query: 666 KLLKIRDS 673
            L KI +S
Sbjct: 296 TLQKISNS 303

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 118/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L F 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLAFC 123
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y APE    
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLG 181
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 237
Query: 627 RED 629
             D
Sbjct: 238 MPD 240

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI--RHRNIIKVISSC 457
           IG+G FG V++ +   G EVA+K+F+    R  +S+  E E+ +++  RH NI+  I++ 
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 458 SNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF---GYS 510
           + +        LV +Y  HGSL  YL  + Y + +   + + +  AS L +LH    G  
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 511 AQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST-----IQTQTLATIGYMAP 563
            +  + H DLK  N+L+  N    ++D G+A    R D +T          + T  YMAP
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 564 EY------GKEGRVSANGDVYSFGIMLMETFTR 590
           E        K        D+Y+ G++  E   R
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 9/170 (5%)
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M+ + +  I+++I  C  E +  LV+E    G L KYL  + ++ D    + ++ 
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 118
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L R D++  + QT  
Sbjct: 119 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENXYKAQTHG 174
Query: 557 T--IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMT 603
              + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSIRH 447
           + F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +RH
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH- 129
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
             S +VIH D+KP N+LL  N    ++DFG +       + T+      T+ Y+ PE   
Sbjct: 130 --SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTL----CGTLDYLPPEM-I 182
Query: 568 EGRVSANG-DVYSFGIMLME 586
           EGR+     D++S G++  E
Sbjct: 183 EGRMHDEKVDLWSLGVLCYE 202

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI--RHRNIIKVISSC 457
           IG+G FG V++ +   G EVA+K+F+    R  +S+  E E+ +++  RH NI+  I++ 
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 458 SNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF---GYS 510
           + +        LV +Y  HGSL  YL  + Y + +   + + +  AS L +LH    G  
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 511 AQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST-----IQTQTLATIGYMAP 563
            +  + H DLK  N+L+  N    ++D G+A    R D +T          + T  YMAP
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 182
Query: 564 EY------GKEGRVSANGDVYSFGIMLMETFTR 590
           E        K        D+Y+ G++  E   R
Sbjct: 183 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI--RHRNIIKVISSC 457
           IG+G FG V++ +   G EVA+K+F+    R  +S+  E E+ +++  RH NI+  I++ 
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 458 SNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF---GYS 510
           + +        LV +Y  HGSL  YL  + Y + +   + + +  AS L +LH    G  
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 511 AQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST-----IQTQTLATIGYMAP 563
            +  + H DLK  N+L+  N    ++D G+A    R D +T          + T  YMAP
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 184
Query: 564 EY------GKEGRVSANGDVYSFGIMLMETFTR 590
           E        K        D+Y+ G++  E   R
Sbjct: 185 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 9/170 (5%)
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M+ + +  I+++I  C  E +  LV+E    G L KYL  + ++ D    + ++ 
Sbjct: 61  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 118
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L R D++  + QT  
Sbjct: 119 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHG 174
Query: 557 T--IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMT 603
              + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 175 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 400 IGRGSFGSVFKARLGDGME------VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           +G+GSFG V++    D ++      VA+K  N     R    F  E  +MK     ++++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD---------IYQRLNIMIDVASALE 503
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL+   + + +H DL   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
           E  K+G  + + D++SFG++L E  +  +   +  + E  LK
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 242

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 25/211 (11%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVA----MKVFNLQYGRVFKSFDVECEMMKSIRHRN 449
           FS+   IG GSFG+V+ AR     EV     M     Q    ++    E   ++ +RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS----ALEYL 505
            I+       E    LV+EY         L S++ +L+++++    +++A+    AL+ L
Sbjct: 77  TIQYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
            + +S  +IH D+K  N+LL +  +  L DFG A ++   +        + T  +MAPE 
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEV 182
Query: 566 ---GKEGRVSANGDVYSFGIMLMETFTRKKP 593
                EG+     DV+S GI  +E   RK P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 9/170 (5%)
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M+ + +  I+++I  C  E +  LV+E    G L KYL  + ++ D    + ++ 
Sbjct: 419 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 476
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L R D++  + QT  
Sbjct: 477 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHG 532
Query: 557 T--IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMT 603
              + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 533 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 582

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI--RHRNIIKVISSC 457
           IG+G FG V++ +   G EVA+K+F+    R  +S+  E E+ +++  RH NI+  I++ 
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 458 SNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF---GYS 510
           + +        LV +Y  HGSL  YL  + Y + +   + + +  AS L +LH    G  
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 511 AQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST-----IQTQTLATIGYMAP 563
            +  + H DLK  N+L+  N    ++D G+A    R D +T          + T  YMAP
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 187
Query: 564 EY------GKEGRVSANGDVYSFGIMLMETFTR 590
           E        K        D+Y+ G++  E   R
Sbjct: 188 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 31/213 (14%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI--RHRNIIKVISSC 457
           IG+G FG V++ +   G EVA+K+F+    R  +S+  E E+ +++  RH NI+  I++ 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 458 SNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF---GYS 510
           + +        LV +Y  HGSL  YL  + Y + +   + + +  AS L +LH    G  
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 511 AQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST-----IQTQTLATIGYMAP 563
            +  + H DLK  N+L+  N    ++D G+A    R D +T          + T  YMAP
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 564 EY------GKEGRVSANGDVYSFGIMLMETFTR 590
           E        K        D+Y+ G++  E   R
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 24/219 (10%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVF-NLQYGRVFKSFDV-ECEMMKSIRHRNIIKVISS 456
           IG GS+G VFK R  D G  VA+K F   +   V K   + E  M+K ++H N++ ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQR---LNIMIDVA-SALEYLHFGYSAQ 512
              +    LV EY  H  L +        LD YQR    +++  +    L+ ++F +   
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-------Y 565
            IH D+KP N+L+  + V  L DFG A+LLT    S      +AT  Y +PE       Y
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLT--GPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTL 604
           G    V A G V++  +  +  +  K   D+++    TL
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 9/170 (5%)
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M+ + +  I+++I  C  E +  LV+E    G L KYL  + ++ D    + ++ 
Sbjct: 55  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 112
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L R D++  + QT  
Sbjct: 113 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHG 168
Query: 557 T--IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMT 603
              + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 169 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 218

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 9/170 (5%)
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M+ + +  I+++I  C  E +  LV+E    G L KYL  + ++ D    + ++ 
Sbjct: 420 AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 477
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L R D++  + QT  
Sbjct: 478 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHG 533
Query: 557 T--IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMT 603
              + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 534 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 583

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 9/170 (5%)
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M+ + +  I+++I  C  E +  LV+E    G L KYL  + ++ D    + ++ 
Sbjct: 57  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 114
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L R D++  + QT  
Sbjct: 115 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHG 170
Query: 557 T--IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMT 603
              + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 390 ATDGFSENNLIGRGSFGSVF----KARLGDGME--VAMKVFNLQYG-RVFKSFDVECEMM 442
           A +  + +  +G+GSFG V+    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS------SNYIL---DIYQRLN 493
           K     ++++++   S  +   +++E M  G L+ YL S      +N +L    + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           +  ++A  + YL+   + + +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
            L  + +M+PE  K+G  +   DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 239
Query: 614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                +++  LL + D        C   +F +   C   +P+ R +  EI++ + +  + 
Sbjct: 240 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287
Query: 674 LLRNV 678
             R V
Sbjct: 288 GFREV 292

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 9/170 (5%)
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M+ + +  I+++I  C  E +  LV+E    G L KYL  + ++ D    + ++ 
Sbjct: 67  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 124
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L R D++  + QT  
Sbjct: 125 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHG 180
Query: 557 T--IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMT 603
              + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 230

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 390 ATDGFSENNLIGRGSFGSVF----KARLGDGME--VAMKVFNLQYG-RVFKSFDVECEMM 442
           A +  + +  +G+GSFG V+    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS------SNYIL---DIYQRLN 493
           K     ++++++   S  +   +++E M  G L+ YL S      +N +L    + + + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           +  ++A  + YL+   + + +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
            L  + +M+PE  K+G  +   DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 252
Query: 614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                +++  LL + D        C   +F +   C   +P+ R +  EI++ + +  + 
Sbjct: 253 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
Query: 674 LLRNV 678
             R V
Sbjct: 301 GFREV 305

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 9/170 (5%)
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M+ + +  I+++I  C  E +  LV+E    G L KYL  + ++ D    + ++ 
Sbjct: 75  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 132
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L R D++  + QT  
Sbjct: 133 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHG 188
Query: 557 T--IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMT 603
              + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 189 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 238

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 390 ATDGFSENNLIGRGSFGSVF----KARLGDGME--VAMKVFNLQYG-RVFKSFDVECEMM 442
           A +  + +  +G+GSFG V+    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS------SNYIL---DIYQRLN 493
           K     ++++++   S  +   +++E M  G L+ YL S      +N +L    + + + 
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           +  ++A  + YL+   + + +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 193
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
            L  + +M+PE  K+G  +   DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 246
Query: 614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                +++  LL + D        C   +F +   C   +P+ R +  EI++ + +  + 
Sbjct: 247 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294
Query: 674 LLRNV 678
             R V
Sbjct: 295 GFREV 299

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 390 ATDGFSENNLIGRGSFGSVF----KARLGDGME--VAMKVFNLQYG-RVFKSFDVECEMM 442
           A +  + +  +G+GSFG V+    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS------SNYIL---DIYQRLN 493
           K     ++++++   S  +   +++E M  G L+ YL S      +N +L    + + + 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           +  ++A  + YL+   + + +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
            L  + +M+PE  K+G  +   DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 245
Query: 614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                +++  LL + D        C   +F +   C   +P+ R +  EI++ + +  + 
Sbjct: 246 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293
Query: 674 LLRNV 678
             R V
Sbjct: 294 GFREV 298

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 390 ATDGFSENNLIGRGSFGSVF----KARLGDGME--VAMKVFNLQYG-RVFKSFDVECEMM 442
           A +  + +  +G+GSFG V+    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS------SNYIL---DIYQRLN 493
           K     ++++++   S  +   +++E M  G L+ YL S      +N +L    + + + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           +  ++A  + YL+   + + +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
            L  + +M+PE  K+G  +   DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 252
Query: 614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                +++  LL + D        C   +F +   C   +P+ R +  EI++ + +  + 
Sbjct: 253 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300
Query: 674 LLRNV 678
             R V
Sbjct: 301 GFREV 305

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 390 ATDGFSENNLIGRGSFGSVF----KARLGDGME--VAMKVFNLQYG-RVFKSFDVECEMM 442
           A +  + +  +G+GSFG V+    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS------SNYIL---DIYQRLN 493
           K     ++++++   S  +   +++E M  G L+ YL S      +N +L    + + + 
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           +  ++A  + YL+   + + +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 134 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
            L  + +M+PE  K+G  +   DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 191 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 243
Query: 614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                +++  LL + D        C   +F +   C   +P+ R +  EI++ + +  + 
Sbjct: 244 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 291
Query: 674 LLRNV 678
             R V
Sbjct: 292 GFREV 296

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR---LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G+ + +     + +   V  +   E  ++K + H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L F 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLAFC 119
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y APE    
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLG 177
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 233
Query: 627 RED 629
             D
Sbjct: 234 MPD 236

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 117/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR---LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G+ + +     + +   V  +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y APE    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLG 176
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 627 RED 629
             D
Sbjct: 233 MPD 235

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 390 ATDGFSENNLIGRGSFGSVF----KARLGDGME--VAMKVFNLQYG-RVFKSFDVECEMM 442
           A +  + +  +G+GSFG V+    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS------SNYIL---DIYQRLN 493
           K     ++++++   S  +   +++E M  G L+ YL S      +N +L    + + + 
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           +  ++A  + YL+   + + +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 133 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 189
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
            L  + +M+PE  K+G  +   DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 190 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 242
Query: 614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                +++  LL + D        C   +F +   C   +P+ R +  EI++ + +  + 
Sbjct: 243 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 290
Query: 674 LLRNV 678
             R V
Sbjct: 291 GFREV 295

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 9/170 (5%)
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M+ + +  I+++I  C  E +  LV+E    G L KYL  + ++ D    + ++ 
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 134
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L R D++  + QT  
Sbjct: 135 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHG 190
Query: 557 T--IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMT 603
              + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 191 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 240

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 89/170 (52%), Gaps = 9/170 (5%)
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M+ + +  I+++I  C  E +  LV+E    G L KYL  + ++ D    + ++ 
Sbjct: 77  AEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVH 134
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            V+  ++YL     +  +H DL   NVLL     A +SDFG++K L R D++  + QT  
Sbjct: 135 QVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHG 190
Query: 557 T--IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMT 603
              + + APE     + S+  DV+SFG+++ E F+  +KP   +   E+T
Sbjct: 191 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 240

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 389 RATDGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVF-NLQYGRVFKSFDV-ECEMMKSI 445
           ++ + +    L+G GS+G V K R  D G  VA+K F      ++ K   + E +++K +
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPH---GSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
           RH N++ ++  C  ++   LV E++ H     LE + +  +Y   + Q+    I     +
Sbjct: 82  RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDY--QVVQKYLFQI-----I 134
Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
             + F +S  +IH D+KP N+L+  + V  L DFG A+ L    +  +    +AT  Y A
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRA 192
Query: 563 PE-------YGKEGRVSANGDVYSFGIMLMETF 588
           PE       YGK        DV++ G ++ E F
Sbjct: 193 PELLVGDVKYGKA------VDVWAIGCLVTEMF 219

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/297 (23%), Positives = 124/297 (41%), Gaps = 64/297 (21%)
Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K     Y    +  F +E  ++    H+NI++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALE 503
            I        + ++LE M  G L+ +L          SS  +LD+   L++  D+A   +
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 504 YL---HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           YL   HF      IH D+   N LL       VA + DFG+A+ + R          +  
Sbjct: 170 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 223
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE   EG  ++  D +SFG++L E F+                     ++P  +K
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYMPYPSK 264
Query: 618 EIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   ++E + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 265 S-------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 101/222 (45%), Gaps = 33/222 (14%)
Query: 398 NLIGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSI-RHRN 449
            ++G G+FG V  A      + G  ++VA+K+   +     + +   E +MM  +  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHS-------------SNYILDIYQRLNIMI 496
           I+ ++ +C+      L+ EY  +G L  YL S             +   L+  + LN++ 
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 497 ---------DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
                     VA  +E+L F      +H DL   NVL+    V  + DFG+A+ +  +  
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
             ++      + +MAPE   EG  +   DV+S+GI+L E F+
Sbjct: 228 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/305 (22%), Positives = 136/305 (44%), Gaps = 38/305 (12%)
Query: 390 ATDGFSENNLIGRGSFGSVF----KARLGDGME--VAMKVFNLQYG-RVFKSFDVECEMM 442
           A +  + +  +G+GSFG V+    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS------SNYIL---DIYQRLN 493
           K     ++++++   S  +   +++E M  G L+ YL S      +N +L    + + + 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           +  ++A  + YL+   + + +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
            L  + +M+PE  K+G  +   DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 245
Query: 614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                +++  LL + D        C   +F +   C   +P+ R +  EI++ + +  + 
Sbjct: 246 -----VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293
Query: 674 LLRNV 678
             R V
Sbjct: 294 GFREV 298

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 116/231 (50%), Gaps = 34/231 (14%)
Query: 393 GFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
            ++   +IG GSFG VF+A+L +  EVA+K   LQ  R FK  + E ++M+ ++H N++ 
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-LQDKR-FK--NRELQIMRIVKHPNVVD 96
Query: 453 VIS------SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI------MIDVAS 500
           + +         +E F  LVLEY+P    E    +S +   + Q + +      M  +  
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG 559
           +L Y+H   S  + H D+KP N+LLD  + V  L DFG AK+L   + +      + +  
Sbjct: 153 SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSXICSRY 206
Query: 560 YMAPE--YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWV 608
           Y APE  +G     + N D++S G ++ E   + +P   +F GE  +   V
Sbjct: 207 YRAPELIFGATN-YTTNIDIWSTGCVMAE-LMQGQP---LFPGESGIDQLV 252

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G+FG V+KA+  + G   A KV   +     + + VE E++ +  H  I+K++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
           ++    +++E+ P G+++  +   +  L   Q   I +     LE L+F +S ++IH DL
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 135
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT--LATIGYMAPEY-----GKEGRV 571
           K  NVL+       L+DFG+    + ++  T+Q +   + T  +MAPE       K+   
Sbjct: 136 KAGNVLMTLEGDIRLADFGV----SAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 191
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEI 597
               D++S GI L+E    + P  E+
Sbjct: 192 DYKADIWSLGITLIEMAQIEPPHHEL 217

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 9/206 (4%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSF-DVECEMMKSIRHRNII 451
           F++   IG+GSFG VFK       +V A+K+ +L+           E  ++       + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K   S        +++EY+  GS    L +  +  D +Q   ++ ++   L+YLH   S 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---SE 139
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
           + IH D+K +NVLL +     L+DFG+A  LT  D    +   + T  +MAPE  ++   
Sbjct: 140 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVIQQSAY 197
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEI 597
            +  D++S GI  +E    + P  ++
Sbjct: 198 DSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 397 NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVI 454
             LIG+G FG V+  R     EVA+++ +++       K+F  E    +  RH N++  +
Sbjct: 38  GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
            +C +    A++       +L   +  +  +LD+ +   I  ++   + YLH   +  ++
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGIL 152
Query: 515 HCDLKPSNVLLDDNMVAHLSDFG---IAKLLT---REDQSTIQTQTLATIGYMAPEY--- 565
           H DLK  NV  D+  V  ++DFG   I+ +L    RED+  IQ   L    ++APE    
Sbjct: 153 HKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLC---HLAPEIIRQ 208
Query: 566 ----GKEGRV--SANGDVYSFGIMLMETFTRKKP 593
                +E ++  S + DV++ G +  E   R+ P
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 127/252 (50%), Gaps = 24/252 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           +G GSFG V  A     G +VA+K+ N   L    +    + E   ++ +RH +IIK+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
              +++   +V+EY  +  L  Y+   + + +   R      + SA+EY H     +++H
Sbjct: 81  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 135
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DLKP N+LLD+++   ++DFG++ ++T  D + ++T +  +  Y APE    G++ A  
Sbjct: 136 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 191
Query: 576 --DVYSFGIMLMETFTRKKPTDE---------IFNGEMTLKHWVNDWLPISTKEIVDPNL 624
             DV+S G++L     R+ P D+         I NG  TL  +++       K ++  N 
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 251
Query: 625 LSREDINFVAKE 636
           L+R  I+ + ++
Sbjct: 252 LNRISIHEIMQD 263

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 127/252 (50%), Gaps = 24/252 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           +G GSFG V  A     G +VA+K+ N   L    +    + E   ++ +RH +IIK+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
              +++   +V+EY  +  L  Y+   + + +   R      + SA+EY H     +++H
Sbjct: 76  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 130
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DLKP N+LLD+++   ++DFG++ ++T  D + ++T +  +  Y APE    G++ A  
Sbjct: 131 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 186
Query: 576 --DVYSFGIMLMETFTRKKPTDE---------IFNGEMTLKHWVNDWLPISTKEIVDPNL 624
             DV+S G++L     R+ P D+         I NG  TL  +++       K ++  N 
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 246
Query: 625 LSREDINFVAKE 636
           L+R  I+ + ++
Sbjct: 247 LNRISIHEIMQD 258

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 118/245 (48%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 121
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 122 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 179
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 235
Query: 625 LSRED 629
            S  D
Sbjct: 236 TSMPD 240

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G+FG V+KA+  + G   A KV   +     + + VE E++ +  H  I+K++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
           ++    +++E+ P G+++  +   +  L   Q   I +     LE L+F +S ++IH DL
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHSKRIIHRDL 143
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT--LATIGYMAPEY-----GKEGRV 571
           K  NVL+       L+DFG++     ++  T+Q +   + T  +MAPE       K+   
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSA----KNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY 199
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEI 597
               D++S GI L+E    + P  E+
Sbjct: 200 DYKADIWSLGITLIEMAQIEPPHHEL 225

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G+FG V+KA+  +  +  A KV + +     + + VE +++ S  H NI+K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            E    +++E+   G+++  +      L   Q   +      AL YLH     ++IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT--LATIGYMAPEY-----GKEGRV 571
           K  N+L   +    L+DFG++   TR    TIQ +   + T  +MAPE       K+   
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTR----TIQRRDSFIGTPYWMAPEVVMCETSKDRPY 217
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEI 597
               DV+S GI L+E    + P  E+
Sbjct: 218 DYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 118/245 (48%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 120
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 178
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 625 LSRED 629
            S  D
Sbjct: 235 TSMPD 239

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 31/212 (14%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDV---------ECEMMKSIRHRN 449
           IG G++G V  AR    G +VA+K       ++  +FDV         E +++K  +H N
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLRELKILKHFKHDN 115
Query: 450 IIKVIS----SCSNEEFKAL--VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALE 503
           II +      +    EFK++  VL+ M    L + +HSS  +   + R   +  +   L+
Sbjct: 116 IIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRY-FLYQLLRGLK 173
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--TREDQSTIQTQTLATIGYM 561
           Y+H   SAQVIH DLKPSN+L+++N    + DFG+A+ L  +  +     T+ +AT  Y 
Sbjct: 174 YMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 230
Query: 562 APEYGKE-GRVSANGDVYSFGIMLMETFTRKK 592
           APE        +   D++S G +  E   R++
Sbjct: 231 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 400 IGRGSFGSVFKARLGDGME------VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           +G+GSFG V++    D ++      VA+K  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD---------IYQRLNIMIDVASALE 503
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL+   + + +H +L   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
           E  K+G  + + D++SFG++L E  +  +   +  + E  LK
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 104/222 (46%), Gaps = 19/222 (8%)
Query: 400 IGRGSFGSVFKARLGDGME------VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           +G+GSFG V++    D ++      VA+K  N     R    F  E  +MK     ++++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD---------IYQRLNIMIDVASALE 503
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL+   + + +H +L   N ++  +    + DFG+ + +   D      + L  + +MAP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
           E  K+G  + + D++SFG++L E  +  +   +  + E  LK
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 244

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 118/245 (48%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 120
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 178
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 625 LSRED 629
            S  D
Sbjct: 235 TSMPD 239

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 118/245 (48%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 119
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 177
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 233
Query: 625 LSRED 629
            S  D
Sbjct: 234 TSMPD 238

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 127/252 (50%), Gaps = 24/252 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           +G GSFG V  A     G +VA+K+ N   L    +    + E   ++ +RH +IIK+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
              +++   +V+EY  +  L  Y+   + + +   R      + SA+EY H     +++H
Sbjct: 82  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 136
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DLKP N+LLD+++   ++DFG++ ++T  D + ++T +  +  Y APE    G++ A  
Sbjct: 137 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 192
Query: 576 --DVYSFGIMLMETFTRKKPTDE---------IFNGEMTLKHWVNDWLPISTKEIVDPNL 624
             DV+S G++L     R+ P D+         I NG  TL  +++       K ++  N 
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 252
Query: 625 LSREDINFVAKE 636
           L+R  I+ + ++
Sbjct: 253 LNRISIHEIMQD 264

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/252 (27%), Positives = 127/252 (50%), Gaps = 24/252 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           +G GSFG V  A     G +VA+K+ N   L    +    + E   ++ +RH +IIK+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
              +++   +V+EY  +  L  Y+   + + +   R      + SA+EY H     +++H
Sbjct: 72  VIKSKDEIIMVIEYAGN-ELFDYIVQRDKMSEQEAR-RFFQQIISAVEYCH---RHKIVH 126
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DLKP N+LLD+++   ++DFG++ ++T  D + ++T +  +  Y APE    G++ A  
Sbjct: 127 RDLKPENLLLDEHLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-ISGKLYAGP 182
Query: 576 --DVYSFGIMLMETFTRKKPTDE---------IFNGEMTLKHWVNDWLPISTKEIVDPNL 624
             DV+S G++L     R+ P D+         I NG  TL  +++       K ++  N 
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNP 242
Query: 625 LSREDINFVAKE 636
           L+R  I+ + ++
Sbjct: 243 LNRISIHEIMQD 254

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 118/245 (48%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 119
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 177
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 233
Query: 625 LSRED 629
            S  D
Sbjct: 234 TSMPD 238

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 118/245 (48%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 117
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 175
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 625 LSRED 629
            S  D
Sbjct: 232 TSMPD 236

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/305 (21%), Positives = 135/305 (44%), Gaps = 38/305 (12%)
Query: 390 ATDGFSENNLIGRGSFGSVF----KARLGDGME--VAMKVFNLQYG-RVFKSFDVECEMM 442
           A +  + +  +G+GSFG V+    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS------SNYIL---DIYQRLN 493
           K     ++++++   S  +   +++E M  G L+ YL S      +N +L    + + + 
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           +  ++A  + YL+   + + +H DL   N ++ ++    + DFG+ + +   D      +
Sbjct: 128 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 184
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
            L  + +M+PE  K+G  +   DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 185 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 237
Query: 614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                +++  LL + D        C   +  +   C   +P+ R +  EI++ + +  + 
Sbjct: 238 -----VMEGGLLDKPD-------NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 285
Query: 674 LLRNV 678
             R V
Sbjct: 286 GFREV 290

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 117/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLG 176
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 627 RED 629
             D
Sbjct: 233 MPD 235

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 118/245 (48%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 118
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 119 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 176
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 232
Query: 625 LSRED 629
            S  D
Sbjct: 233 TSMPD 237

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 118/245 (48%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 119
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 120 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 177
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEVVWPGV 233
Query: 625 LSRED 629
            S  D
Sbjct: 234 TSMPD 238

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 118/245 (48%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 117
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 175
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 625 LSRED 629
            S  D
Sbjct: 232 TSMPD 236

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 118/245 (48%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 117
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 175
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 625 LSRED 629
            S  D
Sbjct: 232 TSMPD 236

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 117/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L F 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLAFC 120
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE    
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLG 178
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 234
Query: 627 RED 629
             D
Sbjct: 235 MPD 237

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 31/212 (14%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDV---------ECEMMKSIRHRN 449
           IG G++G V  AR    G +VA+K       ++  +FDV         E +++K  +H N
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIK-------KIPNAFDVVTNAKRTLRELKILKHFKHDN 114
Query: 450 IIKVIS----SCSNEEFKAL--VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALE 503
           II +      +    EFK++  VL+ M    L + +HSS  +   + R   +  +   L+
Sbjct: 115 IIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRY-FLYQLLRGLK 172
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL--TREDQSTIQTQTLATIGYM 561
           Y+H   SAQVIH DLKPSN+L+++N    + DFG+A+ L  +  +     T+ +AT  Y 
Sbjct: 173 YMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 229
Query: 562 APEYGKE-GRVSANGDVYSFGIMLMETFTRKK 592
           APE        +   D++S G +  E   R++
Sbjct: 230 APELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 108/228 (47%), Gaps = 12/228 (5%)
Query: 383 SYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG---RVFKSFD 436
           + L + + T+ F +  ++G G+FG+V+K      G+ +++ + +  L+     +  K   
Sbjct: 11  ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 69
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      +     LN  +
Sbjct: 70  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 128
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 129 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 185
Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
            I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 186 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 23/213 (10%)
Query: 401 GRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS---C 457
            RG FG V+KA+L +   VA+K+F LQ  + ++S + E      ++H N+++ I++    
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 458 SNEEFK-ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF--------G 508
           SN E +  L+  +   GSL  YL  +  I+   +  ++   ++  L YLH         G
Sbjct: 82  SNLEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +   + H D K  NVLL  ++ A L+DFG+A               + T  YMAPE   E
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV-LE 198
Query: 569 GRVSANG------DVYSFGIMLMETFTRKKPTD 595
           G ++         D+Y+ G++L E  +R K  D
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 117/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEILLG 176
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 627 RED 629
             D
Sbjct: 233 MPD 235

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVISSC 457
           +G G++G V+KA+   G  VA+K   L      +  +   E  ++K + H NI+ +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            +E    LV E+M    L+K L  +   L   Q   I I +   L  +   +  +++H D
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY-GKEGRVSANGD 576
           LKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP+      + S + D
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 577 VYSFGIMLMETFTRK 591
           ++S G +  E  T K
Sbjct: 203 IWSIGCIFAEMITGK 217

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 118/245 (48%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 118
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 176
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEVVWPGV 232
Query: 625 LSRED 629
            S  D
Sbjct: 233 TSMPD 237

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 118/245 (48%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 117
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 118 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 175
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 625 LSRED 629
            S  D
Sbjct: 232 TSMPD 236

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVISSC 457
           +G G++G V+KA+   G  VA+K   L      +  +   E  ++K + H NI+ +I   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            +E    LV E+M    L+K L  +   L   Q   I I +   L  +   +  +++H D
Sbjct: 89  HSERCLTLVFEFM-EKDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCHQHRILHRD 144
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY-GKEGRVSANGD 576
           LKP N+L++ +    L+DFG+A+      +S   T  + T+ Y AP+      + S + D
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPDVLMGSKKYSTSVD 202
Query: 577 VYSFGIMLMETFTRK 591
           ++S G +  E  T K
Sbjct: 203 IWSIGCIFAEMITGK 217

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 394 FSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNL--------QYGRVFKSFDVECEMMKS 444
           +   ++IGRG    V +      G E A+K+  +        Q   V ++   E  +++ 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 445 IR-HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALE 503
           +  H +II +I S  +  F  LV + M  G L  YL +    L   +  +IM  +  A+ 
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVS 214
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           +LH   +  ++H DLKP N+LLDDNM   LSDFG +  L   +      +   T GY+AP
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL---EPGEKLRELCGTPGYLAP 268
Query: 564 E------------YGKEGRVSANGDVYSFGIML 584
           E            YGKE       D+++ G++L
Sbjct: 269 EILKCSMDETHPGYGKE------VDLWACGVIL 295

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 109/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 6   PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      + 
Sbjct: 59  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIG 117
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 118 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 108/228 (47%), Gaps = 12/228 (5%)
Query: 383 SYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG---RVFKSFD 436
           + L + + T+ F +  ++G G+FG+V+K      G+ +++ + +  L+     +  K   
Sbjct: 10  ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 68
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      +     LN  +
Sbjct: 69  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 128 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 184
Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
            I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 185 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 108/228 (47%), Gaps = 12/228 (5%)
Query: 383 SYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG---RVFKSFD 436
           + L + + T+ F +  ++G G+FG+V+K      G+ +++ + +  L+     +  K   
Sbjct: 8   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 66
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      +     LN  +
Sbjct: 67  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCV 125
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 126 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 182
Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
            I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 183 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 109/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 5   PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 57
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      + 
Sbjct: 58  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIG 116
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 117 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 173
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 174 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 108/228 (47%), Gaps = 12/228 (5%)
Query: 383 SYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG---RVFKSFD 436
           + L + + T+ F +  ++G G+FG+V+K      G+ +++ + +  L+     +  K   
Sbjct: 7   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      +     LN  +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
            I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 107/228 (46%), Gaps = 12/228 (5%)
Query: 383 SYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG---RVFKSFD 436
           + L + + T+ F +  ++G G+FG+V+K      G+ +++ + +  L+     +  K   
Sbjct: 41  ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEIL 99
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  +
Sbjct: 100 DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 158
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 159 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 215
Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
            I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 216 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 103/222 (46%), Gaps = 19/222 (8%)
Query: 400 IGRGSFGSVFKARLGDGME------VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           +G+GSFG V++    D ++      VA+K  N     R    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD---------IYQRLNIMIDVASALE 503
           ++   S  +   +V+E M HG L+ YL S     +         + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL+   + + +H DL   N ++  +    + DFG+ + +          + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
           E  K+G  + + D++SFG++L E  +  +   +  + E  LK
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G+FG V+KA+  +  +  A KV + +     + + VE +++ S  H NI+K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            E    +++E+   G+++  +      L   Q   +      AL YLH     ++IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY-----GKEGRVSA 573
           K  N+L   +    L+DFG++   TR  Q   +   + T  +MAPE       K+     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 574 NGDVYSFGIMLMETFTRKKPTDEI 597
             DV+S GI L+E    + P  E+
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHEL 243

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 137/298 (45%), Gaps = 34/298 (11%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI--RHRNIIKVISS- 456
           IG+G +G V+  +   G +VA+KVF   +     S+  E E+ +++  RH NI+  I++ 
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 457 ---CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG-YSAQ 512
                +     L+ +Y  +GSL  YL S+   LD    L +     S L +LH   +S Q
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 513 ----VIHCDLKPSNVLLDDNMVAHLSDFGIA-KLLTREDQSTIQTQT-LATIGYMAPEYG 566
               + H DLK  N+L+  N    ++D G+A K ++  ++  I   T + T  YM PE  
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 567 KEG------RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI-----S 615
            E       +     D+YSFG++L E   R+  +  I   E  L +  +D +P       
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEV-ARRCVSGGIVE-EYQLPY--HDLVPSDPSYED 274
Query: 616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
            +EIV    L     N  + ++C+  +  +  EC   +P  R+ A  +   L K+ +S
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G+FG V+KA+  +  +  A KV + +     + + VE +++ S  H NI+K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            E    +++E+   G+++  +      L   Q   +      AL YLH     ++IH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY-----GKEGRVSA 573
           K  N+L   +    L+DFG++   TR  Q   +   + T  +MAPE       K+     
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQR--RDXFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 574 NGDVYSFGIMLMETFTRKKPTDEI 597
             DV+S GI L+E    + P  E+
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHEL 243

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 117/243 (48%), Gaps = 14/243 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++ H  L+ ++ +S  +  I   L I   +   L+ L F 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASA-LTGIPLPL-IKSYLFQLLQGLAFC 118
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +S +V+H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y APE    
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLG 176
Query: 569 GRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNLLS 626
            +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P + S
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 627 RED 629
             D
Sbjct: 233 MPD 235

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 4   PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 57  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 115
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 116 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 394 FSENNL-----IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR- 446
           F  NNL     +G G+FG V +A   G G E A+    ++  +     D +  +M  ++ 
Sbjct: 35  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 447 ------HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQR 491
                 H NI+ ++ +C++     ++ EY  +G L  +L               L++   
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
           L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ +  +    ++
Sbjct: 155 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 211
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
                 + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 212 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 398 NLIGRGSFGSVFKARLGDGMEV----AMKVFNLQYGRVFKSF--DVECEMMKSIRHRNII 451
            ++G+GSFG VF  +   G +     AMKV      +V       +E +++  + H  I+
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI-MIDVASALEYLHFGYS 510
           K+  +   E    L+L+++  G L  +   S  ++   + +   + ++A AL++LH   S
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLH---S 144
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
             +I+ DLKP N+LLD+     L+DFG++K     D          T+ YMAPE      
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 571 VSANGDVYSFGIMLMETFT 589
            + + D +SFG+++ E  T
Sbjct: 203 HTQSADWWSFGVLMFEMLT 221

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 392 DGFSENNLIGRGSFGSV-FKARLGDGMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRN 449
           D F     +G G+FG V        G+E  +K  N    +V  +  + E E++KS+ H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY---ILDIYQRLNIMIDVASALEYLH 506
           IIK+     +     +V+E    G L + + S+      L       +M  + +AL Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 507 FGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
              S  V+H DLKP N+L  D   +    + DFG+A+L   ++ S   T    T  YMAP
Sbjct: 142 ---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGTALYMAP 195
Query: 564 EYGKEGRVSANGDVYSFGIML 584
           E  K   V+   D++S G+++
Sbjct: 196 EVFKRD-VTFKCDIWSAGVVM 215

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 11  PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 63
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 64  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 122
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 123 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 398 NLIGRGSFGSVFKARLGDGMEV----AMKVFNLQYGRVFKSF--DVECEMMKSIRHRNII 451
            ++G+GSFG VF  +   G +     AMKV      +V       +E +++  + H  I+
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI-MIDVASALEYLHFGYS 510
           K+  +   E    L+L+++  G L  +   S  ++   + +   + ++A AL++LH   S
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLH---S 144
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
             +I+ DLKP N+LLD+     L+DFG++K     D          T+ YMAPE      
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 571 VSANGDVYSFGIMLMETFTRKKP 593
            + + D +SFG+++ E  T   P
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLP 225

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 99/224 (44%), Gaps = 22/224 (9%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRHRNIIKVIS 455
           +G GSFG V   R   +G   AMKV   +     K  +    E  M+  + H  II++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
           +  + +   ++++Y+  G L   L  S    +   +     +V  ALEYLH   S  +I+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIY 129
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DLKP N+LLD N    ++DFG AK +       +      T  Y+APE       + + 
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYXLCGTPDYIAPEVVSTKPYNKSI 184
Query: 576 DVYSFGIMLMETFTRKKP---------TDEIFNGEMTLKHWVND 610
           D +SFGI++ E      P          ++I N E+    + N+
Sbjct: 185 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNE 228

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 7   PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 59
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 60  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 118
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 119 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 176 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 23/233 (9%)
Query: 375 PEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDG-MEVAMKVF---NLQYGR 430
           P+ + R F+        D F     +G+G FG+V+ AR       VA+KV     ++   
Sbjct: 13  PDILTRHFT-------IDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEG 65
Query: 431 VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQ 490
           V      E E+   + H NI+++ +   +     L+LEY P G L K L  S    D  +
Sbjct: 66  VEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC-TFDEQR 124
Query: 491 RLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI 550
              IM ++A AL Y H     +VIH D+KP N+LL       ++DFG +         ++
Sbjct: 125 TATIMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSV-----HAPSL 176
Query: 551 QTQTL-ATIGYMAPEYGKEGRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
           + +T+  T+ Y+ PE   EGR+ +   D++  G++  E      P +   + E
Sbjct: 177 RRKTMCGTLDYLPPEM-IEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNE 228

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 4   PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 57  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 115
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 116 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 398 NLIGRGSFGSVFKARLGDGMEV----AMKVFNLQYGRVFKSF--DVECEMMKSIRHRNII 451
            ++G+GSFG VF  +   G +     AMKV      +V       +E +++  + H  I+
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI-MIDVASALEYLHFGYS 510
           K+  +   E    L+L+++  G L  +   S  ++   + +   + ++A AL++LH   S
Sbjct: 91  KLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHLH---S 145
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
             +I+ DLKP N+LLD+     L+DFG++K     D          T+ YMAPE      
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 203
Query: 571 VSANGDVYSFGIMLMETFTRKKP 593
            + + D +SFG+++ E  T   P
Sbjct: 204 HTQSADWWSFGVLMFEMLTGTLP 226

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 6   PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 59  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 117
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 118 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 174
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 10  PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 62
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 63  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 121
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 122 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 178
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 179 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 235

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 7   PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 59
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 60  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 118
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 119 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 176 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 107/228 (46%), Gaps = 12/228 (5%)
Query: 383 SYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG---RVFKSFD 436
           + L + + T+ F +  ++G G+FG+V+K      G+ +++ + +  L+     +  K   
Sbjct: 7   ALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL 65
Query: 437 VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
            E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  +
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCV 124
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++         
Sbjct: 125 QIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
            I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 182 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 7   PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 59
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 60  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 118
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 119 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 175
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 176 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 107/229 (46%), Gaps = 12/229 (5%)
Query: 382 FSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG---RVFKSF 435
            + L + + T+ F +  ++G G+FG+V+K      G+ +++ + +  L+     +  K  
Sbjct: 3   MALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 61
Query: 436 DVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM 495
             E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  
Sbjct: 62  LDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC 120
Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
           + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++        
Sbjct: 121 VQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 177
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
             I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 178 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 226

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 29  PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 81
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 82  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 140
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 141 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 197
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 198 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 254

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 106/226 (46%), Gaps = 12/226 (5%)
Query: 385 LELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG---RVFKSFDVE 438
           L + + T+ F +  ++G G+FG+V+K      G+ +++ + +  L+     +  K    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61
Query: 439 CEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDV 498
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI 558
           A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 121 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 559 GYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
            +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 117/245 (47%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+ ++ +S  +  I   L I   +   L+ L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASA-LTGIPLPL-IKSYLFQLLQGLA 120
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 178
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 625 LSRED 629
            S  D
Sbjct: 235 TSMPD 239

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 64/297 (21%)
Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K          +  F +E  ++  + H+NI++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALE 503
            I        + ++LE M  G L+ +L          SS  +LD+   L++  D+A   +
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 504 YL---HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           YL   HF      IH D+   N LL       VA + DFG+A+ + R          +  
Sbjct: 170 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 223
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE   EG  ++  D +SFG++L E F+                     ++P  +K
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYMPYPSK 264
Query: 618 EIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   ++E + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 265 S-------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 394 FSENNL-----IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR- 446
           F  NNL     +G G+FG V +A   G G E A+    ++  +     D +  +M  ++ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 447 ------HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQR 491
                 H NI+ ++ +C++     ++ EY  +G L  +L               L++   
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
           L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ +  +    ++
Sbjct: 163 LHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 219
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
                 + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 220 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 14  PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 66
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 67  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 125
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 126 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 182
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 183 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 239

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 6   PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      + 
Sbjct: 59  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIG 117
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG AKLL  E++
Sbjct: 118 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 406 GSVFKARLGDGMEVAMKVFNLQYGRVFKS--FDVECEMMKSIRHRNIIKVISSCSNEE-- 461
           G ++K R   G ++ +KV  ++     KS  F+ EC  ++   H N++ V+ +C +    
Sbjct: 24  GELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 462 FKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKP 520
              L+  + P+GSL   LH  +N+++D  Q +   +D A    +LH        H  L  
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHA-LNS 141
Query: 521 SNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSF 580
            +V +D++  A +S   +        QS  +    A +   A +   E     + D +SF
Sbjct: 142 RSVXIDEDXTARISXADVKFSF----QSPGRXYAPAWVAPEALQKKPEDTNRRSADXWSF 197
Query: 581 GIMLMETFTRKKPTDEIFNGEMTLK 605
            ++L E  TR+ P  ++ N E+  K
Sbjct: 198 AVLLWELVTREVPFADLSNXEIGXK 222

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 114/248 (45%), Gaps = 20/248 (8%)
Query: 385 LELCRATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMMK 443
           L++    + F  + ++G+GSFG VF A      +  A+K   L+   V    DVEC M++
Sbjct: 11  LQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVE 68
Query: 444 ------SIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMID 497
                 +  H  +  +  +   +E    V+EY+  G L  ++ S  +  D+ +      +
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAE 127
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           +   L++LH   S  +++ DLK  N+LLD +    ++DFG+ K     D  T   +   T
Sbjct: 128 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NEFCGT 182
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWVNDWL 612
             Y+APE     + + + D +SFG++L E    + P      +E+F+       +   WL
Sbjct: 183 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL 242
Query: 613 PISTKEIV 620
               K+++
Sbjct: 243 EKEAKDLL 250

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 8   PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 60
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      + 
Sbjct: 61  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIG 119
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG AKLL  E++
Sbjct: 120 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 176
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 177 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 64/297 (21%)
Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K          +  F +E  ++  + H+NI++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALE 503
            I        + ++LE M  G L+ +L          SS  +LD+   L++  D+A   +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 504 YL---HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           YL   HF      IH D+   N LL       VA + DFG+A+ + R          +  
Sbjct: 156 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 209
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE   EG  ++  D +SFG++L E F+                     ++P  +K
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYMPYPSK 250
Query: 618 EIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   ++E + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 251 S-------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 6   PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      + 
Sbjct: 59  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIG 117
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG AKLL  E++
Sbjct: 118 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/305 (21%), Positives = 134/305 (43%), Gaps = 38/305 (12%)
Query: 390 ATDGFSENNLIGRGSFGSVF----KARLGDGME--VAMKVFNLQYG-RVFKSFDVECEMM 442
           A +  + +  +G+GSFG V+    K  + D  E  VA+K  N     R    F  E  +M
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS------SNYIL---DIYQRLN 493
           K     ++++++   S  +   +++E M  G L+ YL S      +N +L    + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
           +  ++A  + YL+   + + +H DL   N  + ++    + DFG+ + +   D      +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
            L  + +M+PE  K+G  +   DV+SFG++L E  T  +   +  + E  L+        
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF------- 239
Query: 614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                +++  LL + D        C   +  +   C   +P+ R +  EI++ + +  + 
Sbjct: 240 -----VMEGGLLDKPD-------NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287
Query: 674 LLRNV 678
             R V
Sbjct: 288 GFREV 292

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 117/245 (47%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++ H  L+ ++ +S  +  I   L I   +   L+ L 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASA-LTGIPLPL-IKSYLFQLLQGLA 117
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 118 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 175
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEVVWPGV 231
Query: 625 LSRED 629
            S  D
Sbjct: 232 TSMPD 236

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 64/297 (21%)
Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K    +   +    F +E  ++    H+NI++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALE 503
            I        + ++LE M  G L+ +L          SS  +LD+   L++  D+A   +
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 146
Query: 504 YL---HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           YL   HF      IH D+   N LL       VA + DFG+A+ + R          +  
Sbjct: 147 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 200
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE   EG  ++  D +SFG++L E F+                     ++P  +K
Sbjct: 201 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYMPYPSK 241
Query: 618 EIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   ++E + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 242 S-------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)
Query: 400 IGRGSFGSV-FKARLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           +G GSFG V          +VA+K  +   L+   +    + E   +K +RH +IIK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             +      +V+EY   G L  Y+     + +   R      +  A+EY H     +++H
Sbjct: 77  VITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---RHKIVH 131
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DLKP N+LLDDN+   ++DFG++ ++T  D + ++T +  +  Y APE    G++ A  
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAPEV-INGKLYAGP 187
Query: 576 --DVYSFGIMLMETFTRKKPTDEIF 598
             DV+S GI+L      + P D+ F
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEF 212

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 64/297 (21%)
Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K    +   +    F +E  ++    H+NI++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALE 503
            I        + ++LE M  G L+ +L          SS  +LD+   L++  D+A   +
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 504 YL---HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           YL   HF      IH D+   N LL       VA + DFG+A+ + R          +  
Sbjct: 155 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE   EG  ++  D +SFG++L E F+                     ++P  +K
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYMPYPSK 249
Query: 618 EIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   ++E + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 250 S-------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 12/193 (6%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           IG G FG V    + +     M VA+K   N     V + F  E   M+   H +I+K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              + E    +++E    G L  +L    Y LD+   +     +++AL YL    S + +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGYMAPEYGKEGRVSA 573
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 574 NGDVYSFGIMLME 586
             DV+ FG+ + E
Sbjct: 192 ASDVWMFGVCMWE 204

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 398 NLIGRGSFGSVFKARL----GDGMEVAMKVFNLQYGRVFKSF--DVECEMMKSIRHRNII 451
            ++G+GSFG VF  R       G   AMKV      +V       +E +++  + H  ++
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI-MIDVASALEYLHFGYS 510
           K+  +   E    L+L+++  G L  +   S  ++   + +   + ++A  L++LH   S
Sbjct: 94  KLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALGLDHLH---S 148
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
             +I+ DLKP N+LLD+     L+DFG++K     D          T+ YMAPE      
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAI--DHEKKAYSFCGTVEYMAPEVVNRQG 206
Query: 571 VSANGDVYSFGIMLMETFTRKKP 593
            S + D +S+G+++ E  T   P
Sbjct: 207 HSHSADWWSYGVLMFEMLTGSLP 229

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 397 NNLIGRGSFGSVFKA----RLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNII 451
           N ++G G FG V++       G+ + VA+K          K  F  E  +MK++ H +I+
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K+I     EE   +++E  P+G L  YL  +   L +   +   + +  A+ YL    S 
Sbjct: 89  KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+PE     R 
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 203
Query: 572 SANGDVYSFGIMLMETFT 589
           +   DV+ F + + E  +
Sbjct: 204 TTASDVWMFAVCMWEILS 221

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 123/297 (41%), Gaps = 64/297 (21%)
Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K          +  F +E  ++    H+NI++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALE 503
            I        + ++LE M  G L+ +L          SS  +LD+   L++  D+A   +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 504 YL---HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           YL   HF      IH D+   N LL       VA + DFG+A+ + R          +  
Sbjct: 156 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 209
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE   EG  ++  D +SFG++L E F+                     ++P  +K
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYMPYPSK 250
Query: 618 EIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   ++E + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 251 S-------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 64/297 (21%)
Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K    +   +    F +E  ++    H+NI++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALE 503
            I        + ++LE M  G L+ +L          SS  +LD+   L++  D+A   +
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 195
Query: 504 YL---HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           YL   HF      IH D+   N LL       VA + DFG+A+ + R          +  
Sbjct: 196 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP 249
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE   EG  ++  D +SFG++L E F+                     ++P  +K
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYMPYPSK 290
Query: 618 EIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   ++E + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 291 S-------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 394 FSENNLI-----GRGSFGSVFKA-------RLGDGMEVAMKVFNLQYG-RVFKSFDVECE 440
           F   NL+     G G FG V KA       R G    VA+K+          +    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSEFN 78
Query: 441 MMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIY----------- 489
           ++K + H ++IK+  +CS +    L++EY  +GSL  +L  S  +   Y           
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 490 -----QRLNIMID-------VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG 537
                +R   M D       ++  ++YL      +++H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           +++ +  ED    ++Q    + +MA E   +   +   DV+SFG++L E  T
Sbjct: 196 LSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 64/297 (21%)
Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K    +   +    F +E  ++    H+NI++
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALE 503
            I        + ++LE M  G L+ +L          SS  +LD+   L++  D+A   +
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 161
Query: 504 YL---HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           YL   HF      IH D+   N LL       VA + DFG+A+ + R          +  
Sbjct: 162 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 215
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE   EG  ++  D +SFG++L E F+                     ++P  +K
Sbjct: 216 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYMPYPSK 256
Query: 618 EIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   ++E + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 257 S-------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 306

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 108/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++  G+FG+V+K      G+ +++ + +  L+   
Sbjct: 11  PNQALLRILKETE-------FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 63
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+++ MP G L  Y+      + 
Sbjct: 64  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIG 122
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 123 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 64/297 (21%)
Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K    +   +    F +E  ++    H+NI++
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALE 503
            I        + ++LE M  G L+ +L          SS  +LD+   L++  D+A   +
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 172
Query: 504 YL---HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           YL   HF      IH D+   N LL       VA + DFG+A+ + R          +  
Sbjct: 173 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP 226
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE   EG  ++  D +SFG++L E F+                     ++P  +K
Sbjct: 227 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYMPYPSK 267
Query: 618 EIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   ++E + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 268 S-------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 317

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IG+G+F  V  AR +  G EVA+K+ +   L    + K F  E  +MK + H NI+K+  
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 73
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               E+   LV+EY   G +  YL +  ++ +   R      + SA++Y H  +   ++H
Sbjct: 74  VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF---IVH 129
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA-N 574
            DLK  N+LLD +M   ++DFG +   T  ++         +  Y APE  +  +     
Sbjct: 130 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPE 186
Query: 575 GDVYSFGIMLMETFTRKKPTD 595
            DV+S G++L    +   P D
Sbjct: 187 VDVWSLGVILYTLVSGSLPFD 207

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 397 NNLIGRGSFGSVFKA----RLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNII 451
           N ++G G FG V++       G+ + VA+K          K  F  E  +MK++ H +I+
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K+I     EE   +++E  P+G L  YL  +   L +   +   + +  A+ YL    S 
Sbjct: 73  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 128
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+PE     R 
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 187
Query: 572 SANGDVYSFGIMLMETFT 589
           +   DV+ F + + E  +
Sbjct: 188 TTASDVWMFAVCMWEILS 205

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 64/297 (21%)
Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K    +   +    F +E  ++    H+NI++
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALE 503
            I        + ++LE M  G L+ +L          SS  +LD+   L++  D+A   +
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 171
Query: 504 YL---HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           YL   HF      IH D+   N LL       VA + DFG+A+ + R          +  
Sbjct: 172 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 225
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE   EG  ++  D +SFG++L E F+                     ++P  +K
Sbjct: 226 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYMPYPSK 266
Query: 618 EIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   ++E + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 267 S-------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 316

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 12/193 (6%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           IG G FG V    + +     M VA+K   N     V + F  E   M+   H +I+K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              + E    +++E    G L  +L    + LD+   +     +++AL YL    S + +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGYMAPEYGKEGRVSA 573
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTXXKASKGKLPIKWMAPESINFRRFTS 191
Query: 574 NGDVYSFGIMLME 586
             DV+ FG+ + E
Sbjct: 192 ASDVWMFGVCMWE 204

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 10/198 (5%)
Query: 397 NNLIGRGSFGSVFKA----RLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNII 451
           N ++G G FG V++       G+ + VA+K          K  F  E  +MK++ H +I+
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K+I     EE   +++E  P+G L  YL  +   L +   +   + +  A+ YL    S 
Sbjct: 77  KLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 132
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
             +H D+   N+L+       L DFG+++ +  ED        L  I +M+PE     R 
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESINFRRF 191
Query: 572 SANGDVYSFGIMLMETFT 589
           +   DV+ F + + E  +
Sbjct: 192 TTASDVWMFAVCMWEILS 209

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 123/297 (41%), Gaps = 64/297 (21%)
Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K          +  F +E  ++    H+NI++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALE 503
            I        + ++LE M  G L+ +L          SS  +LD+   L++  D+A   +
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 504 YL---HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           YL   HF      IH D+   N LL       VA + DFG+A+ + R          +  
Sbjct: 156 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLP 209
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE   EG  ++  D +SFG++L E F+                     ++P  +K
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYMPYPSK 250
Query: 618 EIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   ++E + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 251 S-------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/304 (23%), Positives = 131/304 (43%), Gaps = 38/304 (12%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKA-RLGDG----MEVAMKVFNLQY 428
           P +A+ R+    EL +         ++G G+FG+V+K   + DG    + VA+KV     
Sbjct: 6   PNQALLRILKETELRKV-------KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT 58
Query: 429 G-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M  +    + +++  C     + LV + MP+G L  ++  +   L 
Sbjct: 59  SPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLG 117
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+A+LL  ++ 
Sbjct: 118 SQDLLNWCMQIAKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 174
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKH 606
                     I +MA E     R +   DV+S+G+ + E  T   KP D           
Sbjct: 175 EYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDG---------- 224
Query: 607 WVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 666
                  I  +EI  P+LL + +        C   V+ + ++C +   E R   +E+V++
Sbjct: 225 -------IPAREI--PDLLEKGE-RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSE 274
Query: 667 LLKI 670
             ++
Sbjct: 275 FSRM 278

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 391 TDGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRH 447
           +D +     +G+G+F  V +      G+E A K+ N +    R F+  + E  + + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            NI+++  S   E F  LV + +  G L + + +  +    Y   +    +   LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 120
Query: 508 GYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
            +S  ++H +LKP N+LL          L+DFG+A      + S        T GY++PE
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPE 177
Query: 565 YGKEGRVSANGDVYSFGIML 584
             K+   S   D+++ G++L
Sbjct: 178 VLKKDPYSKPVDIWACGVIL 197

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 31/224 (13%)
Query: 394 FSENNL-----IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR- 446
           F  NNL     +G G+FG V +A   G G E A+    ++  +     D +  +M  ++ 
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 447 ------HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYI 485
                 H NI+ ++ +C++     ++ EY  +G L  +L               H+    
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 486 LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 545
           L     L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ +  +
Sbjct: 163 LSSRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 219
Query: 546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
               ++      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 220 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 107/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 11  PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 63
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 64  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 122
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG AKLL  E++
Sbjct: 123 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 179
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 107/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 4   PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 57  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 115
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG AKLL  E++
Sbjct: 116 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 172
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 401 GRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS---- 456
            RG FG V+KA+L +   VA+K+F +Q  + +++ + E   +  ++H NI++ I +    
Sbjct: 33  ARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRG 90
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF-------GY 509
            S +    L+  +   GSL  +L ++  ++   +  +I   +A  L YLH        G+
Sbjct: 91  TSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
              + H D+K  NVLL +N+ A ++DFG+A        +      + T  YMAPE   EG
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV-LEG 207
Query: 570 RVSANG------DVYSFGIMLMETFTRKKPTD 595
            ++         D+Y+ G++L E  +R    D
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/297 (22%), Positives = 124/297 (41%), Gaps = 64/297 (21%)
Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K    +   +    F +E  ++    H+NI++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALE 503
            I        + +++E M  G L+ +L          SS  +LD+   L++  D+A   +
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 504 YL---HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           YL   HF      IH D+   N LL       VA + DFG+A+ + R          +  
Sbjct: 155 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE   EG  ++  D +SFG++L E F+                     ++P  +K
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYMPYPSK 249
Query: 618 EIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   ++E + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 250 S-------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSIRH 447
           D F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            NI+++ +   + +   L+LE+ P G L K L       D  +    M ++A AL Y H 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH- 132
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
               +VIH D+KP N+L+       ++DFG     +    S  +     T+ Y+ PE  +
Sbjct: 133 --ERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMIE 186
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTD 595
                   D++  G++  E      P D
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/297 (22%), Positives = 123/297 (41%), Gaps = 64/297 (21%)
Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVFNLQYGRVFK-SFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K          +  F +E  ++    H+NI++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALE 503
            I        + +++E M  G L+ +L          SS  +LD+   L++  D+A   +
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 504 YL---HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           YL   HF      IH D+   N LL       VA + DFG+A+ + R          +  
Sbjct: 170 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 223
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE   EG  ++  D +SFG++L E F+                     ++P  +K
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYMPYPSK 264
Query: 618 EIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   ++E + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 265 S-------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 394 FSENNLI-----GRGSFGSVFKA-------RLGDGMEVAMKVFNLQYG-RVFKSFDVECE 440
           F   NL+     G G FG V KA       R G    VA+K+          +    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSEFN 78
Query: 441 MMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIY----------- 489
           ++K + H ++IK+  +CS +    L++EY  +GSL  +L  S  +   Y           
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 490 -----QRLNIMID-------VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG 537
                +R   M D       ++  ++YL      +++H DL   N+L+ +     +SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFG 195
Query: 538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           +++ +  ED    ++Q    + +MA E   +   +   DV+SFG++L E  T
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           IG G FG V    + +     + VA+K   N     V + F  E   M+   H +I+K+I
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              + E    +++E    G L  +L    Y LD+   +     +++AL YL    S + +
Sbjct: 106 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 161
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGYMAPEYGKEGRVSA 573
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 162 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 219
Query: 574 NGDVYSFGIMLMETFTRK-KPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF 632
             DV+ FG+ + E      KP   + N ++  +    + LP+       PN         
Sbjct: 220 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP------PN--------- 264
Query: 633 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
                C   ++++  +C    P +R    E+  +L  I
Sbjct: 265 -----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 297

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/237 (24%), Positives = 107/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++G G+FG+V+K      G+ +++ + +  L+   
Sbjct: 6   PNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 58
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 59  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 117
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG AKLL  E++
Sbjct: 118 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEK 174
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 175 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 64/297 (21%)
Query: 400 IGRGSFGSVFKARLG------DGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K    +   +    F +E  ++    H+NI++
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLH---------SSNYILDIYQRLNIMIDVASALE 503
            I        + ++LE M  G L+ +L          SS  +LD+   L++  D+A   +
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 181
Query: 504 YL---HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           YL   HF      IH D+   N LL       VA + DFG+A+ + R          +  
Sbjct: 182 YLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 235
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M PE   EG  ++  D +SFG++L E F+                     ++P  +K
Sbjct: 236 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL-------------------GYMPYPSK 276
Query: 618 EIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                   ++E + FV         + C   V+ +  +C    PE R N   I+ ++
Sbjct: 277 S-------NQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 326

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 34/229 (14%)
Query: 394 FSENNLI-----GRGSFGSVFKA-------RLGDGMEVAMKVFNLQYG-RVFKSFDVECE 440
           F   NL+     G G FG V KA       R G    VA+K+          +    E  
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAG-YTTVAVKMLKENASPSELRDLLSEFN 78
Query: 441 MMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIY----------- 489
           ++K + H ++IK+  +CS +    L++EY  +GSL  +L  S  +   Y           
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 490 -----QRLNIMIDVASALEYLHFG--YSAQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAK 540
                +R   M D+ S    +  G  Y A+  ++H DL   N+L+ +     +SDFG+++
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 541 LLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
            +  ED    ++Q    + +MA E   +   +   DV+SFG++L E  T
Sbjct: 199 DVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 391 TDGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRH 447
           +D +     +G+G+F  V +      G+E A K+ N +    R F+  + E  + + ++H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            NI+++  S   E F  LV + +  G L + + +  +    Y   +    +   LE + +
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 119
Query: 508 GYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
            +S  ++H +LKP N+LL          L+DFG+A      + S        T GY++PE
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPE 176
Query: 565 YGKEGRVSANGDVYSFGIML 584
             K+   S   D+++ G++L
Sbjct: 177 VLKKDPYSKPVDIWACGVIL 196

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 391 TDGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRH 447
           +D +     +G+G+F  V +      G+E A K+ N +    R F+  + E  + + ++H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            NI+++  S   E F  LV + +  G L + + +  +    Y   +    +   LE + +
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 143
Query: 508 GYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
            +S  ++H +LKP N+LL          L+DFG+A      + S        T GY++PE
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPE 200
Query: 565 YGKEGRVSANGDVYSFGIML 584
             K+   S   D+++ G++L
Sbjct: 201 VLKKDPYSKPVDIWACGVIL 220

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 13/200 (6%)
Query: 391 TDGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRH 447
           +D +     +G+G+F  V +      G+E A K+ N +    R F+  + E  + + ++H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            NI+++  S   E F  LV + +  G L + + +  +    Y   +    +   LE + +
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAY 120
Query: 508 GYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
            +S  ++H +LKP N+LL          L+DFG+A      + S        T GY++PE
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPE 177
Query: 565 YGKEGRVSANGDVYSFGIML 584
             K+   S   D+++ G++L
Sbjct: 178 VLKKDPYSKPVDIWACGVIL 197

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IG+G+F  V  AR +  G EVA+K+ +   L    + K F  E  +MK + H NI+K+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               E+   LV+EY   G +  YL +   + +   R      + SA++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPEYGKEGRVS 572
            DLK  N+LLD +M   ++DFG +      ++ T   +  A  G   Y APE  +  +  
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 573 A-NGDVYSFGIMLMETFTRKKPTD 595
               DV+S G++L    +   P D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           IG G FG V    + +     + VA+K   N     V + F  E   M+   H +I+K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              + E    +++E    G L  +L    Y LD+   +     +++AL YL    S + +
Sbjct: 83  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGYMAPEYGKEGRVSA 573
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 196
Query: 574 NGDVYSFGIMLMETFTRK-KPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF 632
             DV+ FG+ + E      KP   + N ++  +    + LP+       PN         
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP------PN--------- 241
Query: 633 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
                C   ++++  +C    P +R    E+  +L  I
Sbjct: 242 -----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IG+G+F  V  AR +  G EVA+K+ +   L    + K F  E  +MK + H NI+K+  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               E+   L++EY   G +  YL +   + +   R      + SA++Y H     +++H
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVH 137
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPEYGKEGRVS 572
            DLK  N+LLD +M   ++DFG +      ++ T+  +  A  G   Y APE  +  +  
Sbjct: 138 RDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 573 A-NGDVYSFGIMLMETFTRKKPTD 595
               DV+S G++L    +   P D
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 12/193 (6%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           IG G FG V    + +     + VA+K   N     V + F  E   M+   H +I+K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              + E    +++E    G L  +L    Y LD+   +     +++AL YL    S + +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGYMAPEYGKEGRVSA 573
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 134 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 574 NGDVYSFGIMLME 586
             DV+ FG+ + E
Sbjct: 192 ASDVWMFGVCMWE 204

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 22/222 (9%)
Query: 399 LIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEM------MKSIRHRNIIK 452
           +IG+GSFG V  AR     EV   V  LQ   + K  + +  M      +K+++H  ++ 
Sbjct: 45  VIGKGSFGKVLLAR-HKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +  S    +    VL+Y+  G L  +L      L+   R     ++ASAL YLH   S  
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH---SLN 159
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
           +++ DLKP N+LLD      L+DFG+ K     + +T  +    T  Y+APE   +    
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--STFCGTPEYLAPEVLHKQPYD 217
Query: 573 ANGDVYSFGIMLMETFTRKKP---------TDEIFNGEMTLK 605
              D +  G +L E      P          D I N  + LK
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 259

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 117/245 (47%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++    L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 120
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 121 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 178
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 625 LSRED 629
            S  D
Sbjct: 235 TSMPD 239

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IG+G+F  V  AR +  G EVA+K+ +   L    + K F  E  +MK + H NI+K+  
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               E+   LV+EY   G +  YL +   + +   R      + SA++Y H  Y   ++H
Sbjct: 82  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY---IVH 137
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPEYGKEGRVS 572
            DLK  N+LLD +M   ++DFG +      ++ T+  +     G   Y APE  +  +  
Sbjct: 138 RDLKAENLLLDGDMNIKIADFGFS------NEFTVGNKLDTFCGSPPYAAPELFQGKKYD 191
Query: 573 A-NGDVYSFGIMLMETFTRKKPTD 595
               DV+S G++L    +   P D
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/248 (25%), Positives = 113/248 (45%), Gaps = 20/248 (8%)
Query: 385 LELCRATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMMK 443
           L++    + F  + ++G+GSFG VF A      +  A+K   L+   V    DVEC M++
Sbjct: 10  LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVE 67
Query: 444 ------SIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMID 497
                 +  H  +  +  +   +E    V+EY+  G L  ++ S  +  D+ +      +
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAE 126
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           +   L++LH   S  +++ DLK  N+LLD +    ++DFG+ K     D  T       T
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NXFCGT 181
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWVNDWL 612
             Y+APE     + + + D +SFG++L E    + P      +E+F+       +   WL
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWL 241
Query: 613 PISTKEIV 620
               K+++
Sbjct: 242 EKEAKDLL 249

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 117/245 (47%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++    L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 118
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 119 FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 176
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 232
Query: 625 LSRED 629
            S  D
Sbjct: 233 TSMPD 237

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 107/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++  G+FG+V+K      G+ +++ + +  L+   
Sbjct: 11  PNQALLRILKETE-------FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 63
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 64  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 122
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 123 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 179
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 180 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 117/245 (47%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++    L+K++ +S  +  I   L I   +   L+ L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASA-LTGIPLPL-IKSYLFQLLQGLA 120
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 178
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 625 LSRED 629
            S  D
Sbjct: 235 TSMPD 239

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 12/193 (6%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           IG G FG V    + +     + VA+K   N     V + F  E   M+   H +I+K+I
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              + E    +++E    G L  +L    Y LD+   +     +++AL YL    S + +
Sbjct: 81  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 136
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGYMAPEYGKEGRVSA 573
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 137 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 194
Query: 574 NGDVYSFGIMLME 586
             DV+ FG+ + E
Sbjct: 195 ASDVWMFGVCMWE 207

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 12/193 (6%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           IG G FG V    + +     + VA+K   N     V + F  E   M+   H +I+K+I
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              + E    +++E    G L  +L    Y LD+   +     +++AL YL    S + +
Sbjct: 75  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGYMAPEYGKEGRVSA 573
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 574 NGDVYSFGIMLME 586
             DV+ FG+ + E
Sbjct: 189 ASDVWMFGVCMWE 201

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 107/237 (45%), Gaps = 18/237 (7%)
Query: 374 PPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG- 429
           P +A+ R+    E       F +  ++  G+FG+V+K      G+ +++ + +  L+   
Sbjct: 4   PNQALLRILKETE-------FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56
Query: 430 --RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  K    E  +M S+ + ++ +++  C     + L+ + MP G L  Y+      + 
Sbjct: 57  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG 115
Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
               LN  + +A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++
Sbjct: 116 SQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT 603
                     I +MA E       +   DV+S+G+ + E  T   KP D I   E++
Sbjct: 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 12/193 (6%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           IG G FG V    + +     + VA+K   N     V + F  E   M+   H +I+K+I
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              + E    +++E    G L  +L    Y LD+   +     +++AL YL    S + +
Sbjct: 80  GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 135
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGYMAPEYGKEGRVSA 573
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 136 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 193
Query: 574 NGDVYSFGIMLME 586
             DV+ FG+ + E
Sbjct: 194 ASDVWMFGVCMWE 206

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 391 TDGFSENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRH 447
           TD +     IG+G+F  V +  +L  G E A K+ N +    R  +  + E  + + ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            NI+++  S S E F  LV + +  G L + + +  Y    Y   +    +   LE +  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLH 118
Query: 508 GYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
            +   V+H DLKP N+LL          L+DFG+A  +  + Q+        T GY++PE
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPE 176
Query: 565 YGKEGRVSANGDVYSFGIML 584
             ++       D+++ G++L
Sbjct: 177 VLRKEAYGKPVDIWACGVIL 196

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 101/228 (44%), Gaps = 35/228 (15%)
Query: 388 CRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR 446
            R    F E  ++G+G+FG V KAR   D    A+K       ++  +   E  ++ S+ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLN 60
Query: 447 H-------------RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN--YILDIYQR 491
           H             RN +K +++   +    + +EY  +G+L   +HS N     D Y R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTI 550
           L     +  AL Y+H   S  +IH DLKP N+ +D++    + DFG+AK + R  D   +
Sbjct: 121 L--FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 551 QTQTL-----------ATIGYMAPEY-GKEGRVSANGDVYSFGIMLME 586
            +Q L            T  Y+A E     G  +   D+YS GI+  E
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 12/208 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVF---NLQYGRVFKSFDVECEMMKSIRH 447
           D F     +G+G FG+V+ AR      + A+KV     L+   V      E E+   +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            NI+++ +   + +   L+LE+ P G L K L       D  +    M ++A AL Y H 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH- 131
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
               +VIH D+KP N+L+       ++DFG     +    S  +     T+ Y+ PE  +
Sbjct: 132 --ERKVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYLPPEMIE 185
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTD 595
                   D++  G++  E      P D
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IG+G+F  V  AR +  G EVA+K+ +   L    + K F  E  +MK + H NI+K+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               E+   LV+EY   G +  YL +   + +   R      + SA++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA-N 574
            DLK  N+LLD +M   ++DFG +   T  ++         +  Y APE  +  +     
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPE 193
Query: 575 GDVYSFGIMLMETFTRKKPTD 595
            DV+S G++L    +   P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IG+G+F  V  AR +  G EVA+K+ +   L    + K F  E  +MK + H NI+K+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               E+   LV+EY   G +  YL +   + +   R      + SA++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA-N 574
            DLK  N+LLD +M   ++DFG +   T  ++         +  Y APE  +  +     
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPE 193
Query: 575 GDVYSFGIMLMETFTRKKPTD 595
            DV+S G++L    +   P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IG+G+F  V  AR +  G EVA+++ +   L    + K F  E  +MK + H NI+K+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               E+   LV+EY   G +  YL +   + +   R      + SA++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA-N 574
            DLK  N+LLD +M   ++DFG +   T  ++     +   +  Y APE  +  +     
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELFQGKKYDGPE 193
Query: 575 GDVYSFGIMLMETFTRKKPTD 595
            DV+S G++L    +   P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 40/217 (18%)
Query: 394 FSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           F E  LIG G FG VFKA+   DG    +K   ++Y    +  + E + +  + H NI+ 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIK--RVKYNN--EKAEREVKALAKLDHVNIVH 68
Query: 453 VI----------------SSCSNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIM 495
                             SS S  +   + +E+   G+LE+++       LD    L + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
             +   ++Y+H   S ++I+ DLKPSN+ L D     + DFG+   L  + +   + ++ 
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RXRSK 182
Query: 556 ATIGYMAPE------YGKEGRVSANGDVYSFGIMLME 586
            T+ YM+PE      YGKE       D+Y+ G++L E
Sbjct: 183 GTLRYMSPEQISSQDYGKE------VDLYALGLILAE 213

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKS----FDVECEMMKSIRHRNIIKV 453
           +IGRG+FG V   R     +V AMK+ + ++  + +S    F  E ++M       ++++
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQ 512
             +  ++ +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H   S  
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMG 193
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE----YGKE 568
            IH D+KP N+LLD +    L+DFG    + +E      T  + T  Y++PE     G +
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGD 252
Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
           G      D +S G+ L E      P
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKS----FDVECEMMKSIRHRNIIKV 453
           +IGRG+FG V   R     +V AMK+ + ++  + +S    F  E ++M       ++++
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQ 512
             +  ++ +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H   S  
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMG 188
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE----YGKE 568
            IH D+KP N+LLD +    L+DFG    + +E      T  + T  Y++PE     G +
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGD 247
Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
           G      D +S G+ L E      P
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 12/193 (6%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           IG G FG V    + +     M VA+K   N     V + F  E   M+   H +I+K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              + E    +++E    G L  +L    + LD+   +     +++AL YL    S + +
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGYMAPEYGKEGRVSA 573
           H D+   NVL+  N    L DFG+++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 574 NGDVYSFGIMLME 586
             DV+ FG+ + E
Sbjct: 572 ASDVWMFGVCMWE 584

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSF-DVECEMMKSIRHRNII 451
           F++ + IG+GSFG V+K       EV A+K+ +L+           E  ++       I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLH----SSNYILDIYQRLNIMIDVASALEYLHF 507
           +   S        +++EY+  GS    L        YI        I+ ++   L+YLH 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIA------TILREILKGLDYLH- 133
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
             S + IH D+K +NVLL +     L+DFG+A  LT  D    +   + T  +MAPE  K
Sbjct: 134 --SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVIK 189
Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEI 597
           +       D++S GI  +E    + P  ++
Sbjct: 190 QSAYDFKADIWSLGITAIELAKGEPPNSDL 219

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVF---KSFDVECEMMKSIRHR-N 449
           +GRG+FG V +A      +      VA+K+  L+ G      ++   E +++  I H  N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 450 IIKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMID----------- 497
           ++ ++ +C+      +V+ E+   G+L  YL S       Y+  ++  D           
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 498 --VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
             VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +    
Sbjct: 155 FQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
             + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKS----FDVECEMMKSIRHRNIIKV 453
           +IGRG+FG V   R     +V AMK+ + ++  + +S    F  E ++M       ++++
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQ 512
             +  ++ +  +V+EYMP G L   +  SNY + + + R     +V  AL+ +H   S  
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARF-YTAEVVLALDAIH---SMG 193
Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE----YGKE 568
            IH D+KP N+LLD +    L+DFG    + +E      T  + T  Y++PE     G +
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGD 252
Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
           G      D +S G+ L E      P
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 400 IGRGSFGSVFKARLGDGME-VAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVISS 456
           IG G++G+VFKA+  +  E VA+K   L      V  S   E  ++K ++H+NI+++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
             +++   LV E+     L+KY  S N  LD     + +  +   L + H   S  V+H 
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV-SANG 575
           DLKP N+L++ N    L+DFG+A+      +    +  + T+ Y  P+     ++ S + 
Sbjct: 126 DLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 576 DVYSFGIMLMETFTRKKP 593
           D++S G +  E     +P
Sbjct: 184 DMWSAGCIFAELANAARP 201

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 38/231 (16%)
Query: 394 FSENNL-----IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR- 446
           F  NNL     +G G+FG V +A   G G E A+    ++  +     D +  +M  ++ 
Sbjct: 28  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 87
Query: 447 ------HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH-------------------- 480
                 H NI+ ++ +C++     ++ EY  +G L  +L                     
Sbjct: 88  MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGL 147
Query: 481 --SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI 538
                  L++   L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+
Sbjct: 148 DKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 539 AKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           A+ +  +    ++      + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 205 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 72/238 (30%), Positives = 103/238 (43%), Gaps = 25/238 (10%)
Query: 394 FSENNLIGRGSFGSV-FKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           ++  N IGRGS+G V    + G  +  A K     +      F  E E+MKS+ H NII+
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 453 VISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           +  +  +     LV+E    G L E+ +H   +      R  IM DV SA+ Y H     
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH---KL 125
Query: 512 QVIHCDLKPSNVL-LDDNMVAHLS--DFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
            V H DLKP N L L D+  + L   DFG+A    R     +    + T  Y++P+   E
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA---ARFKPGKMMRTKVGTPYYVSPQV-LE 181
Query: 569 GRVSANGDVYSFGIMLMETFTR----KKPTD-----EIFNGEMTLKHWVNDWLPISTK 617
           G      D +S G+M+            PTD     +I  G  T      DWL +S +
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE--KDWLNVSPQ 237

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IG+G+F  V  AR +  G EVA+K+ +   L    + K F  E  +MK + H NI+K+  
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 78
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               E+   L++EY   G +  YL +   + +   R      + SA++Y H     +++H
Sbjct: 79  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH---QKRIVH 134
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPEYGKEGRVS 572
            DLK  N+LLD +M   ++DFG +      ++ T+  +     G   Y APE  +  +  
Sbjct: 135 RDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 573 A-NGDVYSFGIMLMETFTRKKPTD 595
               DV+S G++L    +   P D
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 107/247 (43%), Gaps = 23/247 (9%)
Query: 398 NLIGRGSFGSVFKARLGDG--------MEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRN 449
            ++G+G +G VF+ R   G        M+V  K   ++  +       E  +++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           I+ +I +        L+LEY+  G L   L      ++       + +++ AL +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
              +I+ DLKP N++L+      L+DFG+ K    +   T+      TI YMAPE     
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD--GTVTHTFCGTIEYMAPEILMRS 196
Query: 570 RVSANGDVYSFGIMLMETFT---------RKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 620
             +   D +S G ++ +  T         RKK  D+I   ++ L  ++        K+++
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 256
Query: 621 DPNLLSR 627
             N  SR
Sbjct: 257 KRNAASR 263

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 107/247 (43%), Gaps = 23/247 (9%)
Query: 398 NLIGRGSFGSVFKARLGDG--------MEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRN 449
            ++G+G +G VF+ R   G        M+V  K   ++  +       E  +++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           I+ +I +        L+LEY+  G L   L      ++       + +++ AL +LH   
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
              +I+ DLKP N++L+      L+DFG+ K    +   T+      TI YMAPE     
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD--GTVTHXFCGTIEYMAPEILMRS 196
Query: 570 RVSANGDVYSFGIMLMETFT---------RKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 620
             +   D +S G ++ +  T         RKK  D+I   ++ L  ++        K+++
Sbjct: 197 GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLL 256
Query: 621 DPNLLSR 627
             N  SR
Sbjct: 257 KRNAASR 263

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IG+G+F  V  AR +  G EVA+++ +   L    + K F  E  +MK + H NI+K+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFE 80
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               E+   LV+EY   G +  YL +   + +   R      + SA++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA-N 574
            DLK  N+LLD +M   ++DFG +   T  ++         +  Y APE  +  +     
Sbjct: 137 RDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKKYDGPE 193
Query: 575 GDVYSFGIMLMETFTRKKPTD 595
            DV+S G++L    +   P D
Sbjct: 194 VDVWSLGVILYTLVSGSLPFD 214

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 53/230 (23%)
Query: 394 FSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           F E  LIG G FG VFKA+   DG    ++   ++Y    +  + E + +  + H NI+ 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIR--RVKYNN--EKAEREVKALAKLDHVNIVH 69
Query: 453 VI-----------------------------SSCSNEEFKALVLEYMPHGSLEKYLHSSN 483
                                          SS S  +   + +E+   G+LE+++    
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 484 -YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 542
              LD    L +   +   ++Y+H   S ++IH DLKPSN+ L D     + DFG+   L
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 543 TREDQSTIQTQTLATIGYMAPE------YGKEGRVSANGDVYSFGIMLME 586
             + +   +T++  T+ YM+PE      YGKE       D+Y+ G++L E
Sbjct: 187 KNDGK---RTRSKGTLRYMSPEQISSQDYGKE------VDLYALGLILAE 227

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 390 ATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEM-----MK 443
           AT  +     IG G++G+V+KAR    G  VA+K   +  G          E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 444 SIRHRNIIKVISSCS----NEEFK-ALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMID 497
           +  H N+++++  C+    + E K  LV E++    L  YL  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
               L++LH   +  ++H DLKP N+L+       L+DFG+A++ + +         + T
Sbjct: 121 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALAPVVVT 174
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK 591
           + Y APE   +   +   D++S G +  E F RK
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/238 (30%), Positives = 103/238 (43%), Gaps = 25/238 (10%)
Query: 394 FSENNLIGRGSFGSV-FKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           ++  N IGRGS+G V    + G  +  A K     +      F  E E+MKS+ H NII+
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 453 VISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           +  +  +     LV+E    G L E+ +H   +      R  IM DV SA+ Y H     
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH---KL 142
Query: 512 QVIHCDLKPSNVL-LDDNMVAHLS--DFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
            V H DLKP N L L D+  + L   DFG+A    R     +    + T  Y++P+   E
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA---ARFKPGKMMRTKVGTPYYVSPQV-LE 198
Query: 569 GRVSANGDVYSFGIMLMETFTR----KKPTD-----EIFNGEMTLKHWVNDWLPISTK 617
           G      D +S G+M+            PTD     +I  G  T      DWL +S +
Sbjct: 199 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPE--KDWLNVSPQ 254

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++    L+ ++ +S  +  I   L I   +   L+ L 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASA-LTGIPLPL-IKSYLFQLLQGLA 120
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 121 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 178
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEVVWPGV 234
Query: 625 LSRED 629
            S  D
Sbjct: 235 TSMPD 239

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVF---KSFDVECEMMKSIRHR-N 449
           +GRG+FG V +A      +      VA+K+  L+ G      ++   E +++  I H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 450 IIKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYIL----DIYQRLNIM-------ID 497
           ++ ++ +C+      +V+ E+   G+L  YL S         D+Y+    +         
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +      
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVF---KSFDVECEMMKSIRHR-N 449
           +GRG+FG V +A      +      VA+K+  L+ G      ++   E +++  I H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 450 IIKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYIL----DIYQRLNIM-------ID 497
           ++ ++ +C+      +V+ E+   G+L  YL S         D+Y+    +         
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +      
Sbjct: 153 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 116/245 (47%), Gaps = 14/245 (5%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIR 446
           + + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K++     E    LV E++    L+ ++ +S  +  I   L I   +   L+ L 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASA-LTGIPLPL-IKSYLFQLLQGLA 119
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
           F +S +V+H DLKP N+L++      L+DFG+A+      ++      + T+ Y APE  
Sbjct: 120 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YXHEVVTLWYRAPEIL 177
Query: 567 KEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST-KEIVDPNL 624
              +  +   D++S G +  E  TR+     +F G+  +      +  + T  E+V P +
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQLFRIFRTLGTPDEVVWPGV 233
Query: 625 LSRED 629
            S  D
Sbjct: 234 TSMPD 238

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 97/210 (46%), Gaps = 13/210 (6%)
Query: 382 FSYLELC-RATDGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQY--GRVFKSFDV 437
           F  +  C R TD +     +G+G+F  V +  +     E A K+ N +    R  +  + 
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER 79
Query: 438 ECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMID 497
           E  + + ++H NI+++  S S E F  LV + +  G L + + +  Y    Y   +    
Sbjct: 80  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHC 135
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTREDQSTIQTQT 554
           +   LE ++  +   ++H DLKP N+LL          L+DFG+A  +  E Q+      
Sbjct: 136 IHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA- 194
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIML 584
             T GY++PE  ++       D+++ G++L
Sbjct: 195 -GTPGYLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 390 ATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEM-----MK 443
           AT  +     IG G++G+V+KAR    G  VA+K   +  G          E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 444 SIRHRNIIKVISSCS----NEEFK-ALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMID 497
           +  H N+++++  C+    + E K  LV E++    L  YL  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
               L++LH   +  ++H DLKP N+L+       L+DFG+A++ + +         + T
Sbjct: 121 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALDPVVVT 174
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK 591
           + Y APE   +   +   D++S G +  E F RK
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKS----FDVECEMMKSIRHRNIIKV 453
           +IGRG+FG V   R     +V AMK+ + ++  + +S    F  E ++M       ++++
Sbjct: 82  VIGRGAFGEVQLVRHKASQKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQL 140
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
             +  ++++  +V+EYMP G L   +  SNY +          +V  AL+ +H   S  +
Sbjct: 141 FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMGL 195
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT-LATIGYMAPE----YGKE 568
           IH D+KP N+LLD +    L+DFG    +  ++   +   T + T  Y++PE     G +
Sbjct: 196 IHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVHCDTAVGTPDYISPEVLKSQGGD 253
Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
           G      D +S G+ L E      P
Sbjct: 254 GYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVF---KSFDVECEMMKSIRHR-N 449
           +GRG+FG V +A      +      VA+K+  L+ G      ++   E +++  I H  N
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 93
Query: 450 IIKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYIL-------DIYQRLNIM------ 495
           ++ ++ +C+      +V+ E+   G+L  YL S            D+Y+    +      
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 496 -IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +   
Sbjct: 154 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
              + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           IG G FG V    + +     M VA+K   N     V + F  E   M+   H +I+K+I
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              + E    +++E    G L  +L    + LD+   +     +++AL YL    S + +
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 133
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGYMAPEYGKEGRVSA 573
           H D+   NVL+       L DFG+++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 134 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 191
Query: 574 NGDVYSFGIMLME 586
             DV+ FG+ + E
Sbjct: 192 ASDVWMFGVCMWE 204

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVF---KSFDVECEMMKSIRHR-N 449
           +GRG+FG V +A      +      VA+K+  L+ G      ++   E +++  I H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 450 IIKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSN-----YIL---DIYQRLNIM----- 495
           ++ ++ +C+      +V+ E+   G+L  YL S       Y +   D+Y+    +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 496 --IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
               VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +  
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
               + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/285 (22%), Positives = 131/285 (45%), Gaps = 36/285 (12%)
Query: 392 DGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRN 449
           D F + + +G G+ G VFK +    G+ +A K+ +L+     ++  + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-NIMIDVASALEYLHFG 508
           I+    +  ++   ++ +E+M  GSL++ L  +  I +  Q L  + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 123
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  +++H D+KPSN+L++      L DFG++  L      ++    + T  YM+PE  + 
Sbjct: 124 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG 177
Query: 569 GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 628
              S   D++S G+ L+E    + P                   P   KE   P +   E
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIP-----------------PPDAKEDSRPPMAIFE 220
Query: 629 DINFVAKE---QCVSFVFNVAME-----CTVESPEQRINAKEIVT 665
            ++++  E   +  S VF++  +     C +++P +R + K+++ 
Sbjct: 221 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 265

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVF---KSFDVECEMMKSIRHR-N 449
           +GRG+FG V +A      +      VA+K+  L+ G      ++   E +++  I H  N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 450 IIKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSN-----YIL---DIYQRLNIM----- 495
           ++ ++ +C+      +V+ E+   G+L  YL S       Y +   D+Y+    +     
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 496 --IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
               VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +  
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
               + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVF---KSFDVECEMMKSIRHR-N 449
           +GRG+FG V +A      +      VA+K+  L+ G      ++   E +++  I H  N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 450 IIKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSN-----YIL---DIYQRLNIM----- 495
           ++ ++ +C+      +V+ E+   G+L  YL S       Y +   D+Y+    +     
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 496 --IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
               VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +  
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
               + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 19/214 (8%)
Query: 390 ATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEM-----MK 443
           AT  +     IG G++G+V+KAR    G  VA+K   +  G          E+     ++
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 444 SIRHRNIIKVISSCS----NEEFK-ALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMID 497
           +  H N+++++  C+    + E K  LV E++    L  YL  +    L      ++M  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
               L++LH   +  ++H DLKP N+L+       L+DFG+A++ + +         + T
Sbjct: 121 FLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALFPVVVT 174
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK 591
           + Y APE   +   +   D++S G +  E F RK
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 391 TDGFSENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRH 447
           TD +     +G+G+F  V +  ++  G E A K+ N +    R  +  + E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            NI+++  S S E F  LV + +  G L + + +  Y    Y   +    +   LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNH 118
Query: 508 GYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
            +   ++H DLKP N+LL          L+DFG+A  +  + Q+        T GY++PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPE 176
Query: 565 YGKEGRVSANGDVYSFGIML 584
             ++       D+++ G++L
Sbjct: 177 VLRKDPYGKPVDMWACGVIL 196

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 44/228 (19%)
Query: 391 TDGFSENNLIGRGSFGSVFKA-RLGDGMEVAMK--------VFNLQYGRVFKSFDVECEM 441
           +  F   +L+G G++G V  A     G  VA+K        +F L+  R       E ++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-------EIKI 62
Query: 442 MKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH---SSNYILD------IYQRL 492
           +K  +H NII + +    + F+     Y+    ++  LH   S+  + D      IYQ L
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE------- 545
                   A++ LH    + VIH DLKPSN+L++ N    + DFG+A+++          
Sbjct: 123 R-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 546 -DQSTIQTQTLATIGYMAPEYG-KEGRVSANGDVYSFGIMLMETFTRK 591
             Q +  T+ +AT  Y APE      + S   DV+S G +L E F R+
Sbjct: 173 TGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 108/231 (46%), Gaps = 34/231 (14%)
Query: 394 FSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           FS + +IGRG FG V+  R  D G   AMK  + +  ++ +   +      ++  R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL------ALNERIMLS 244
Query: 453 VISS-------CSNEEFK-----ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
           ++S+       C +  F      + +L+ M  G L  +L       +   R     ++  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIIL 303
Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
            LE++H  +   V++ DLKP+N+LLD++    +SD G+A   +++        ++ T GY
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 356
Query: 561 MAPEYGKEG-RVSANGDVYSFGIMLME------TFTRKKPTDEIFNGEMTL 604
           MAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 108/231 (46%), Gaps = 34/231 (14%)
Query: 394 FSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           FS + +IGRG FG V+  R  D G   AMK  + +  ++ +   +      ++  R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL------ALNERIMLS 244
Query: 453 VISS-------CSNEEFK-----ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
           ++S+       C +  F      + +L+ M  G L  +L       +   R     ++  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIIL 303
Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
            LE++H  +   V++ DLKP+N+LLD++    +SD G+A   +++        ++ T GY
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 356
Query: 561 MAPEYGKEG-RVSANGDVYSFGIMLME------TFTRKKPTDEIFNGEMTL 604
           MAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 34/231 (14%)
Query: 394 FSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           FS + +IGRG FG V+  R  D G   AMK  +       K   ++     ++  R ++ 
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLS 244
Query: 453 VISS-------CSNEEFK-----ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
           ++S+       C +  F      + +L+ M  G L  +L       +   R     ++  
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIIL 303
Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
            LE++H  +   V++ DLKP+N+LLD++    +SD G+A   +++        ++ T GY
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 356
Query: 561 MAPEYGKEG-RVSANGDVYSFGIMLME------TFTRKKPTDEIFNGEMTL 604
           MAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 407

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVF---KSFDVECEMMKSIRHR-N 449
           +GRG+FG V +A      +      VA+K+  L+ G      ++   E +++  I H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 450 IIKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSN-----YIL---DIYQRLNIM----- 495
           ++ ++ +C+      +V+ E+   G+L  YL S       Y +   D+Y+    +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 496 --IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
               VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +  
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
               + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 391 TDGFSENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRH 447
           TD +     +G+G+F  V +  ++  G E A K+ N +    R  +  + E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            NI+++  S S E F  LV + +  G L + + +  Y    Y   +    +   LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNH 118
Query: 508 GYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
            +   ++H DLKP N+LL          L+DFG+A  +  + Q+        T GY++PE
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA--GTPGYLSPE 176
Query: 565 YGKEGRVSANGDVYSFGIML 584
             ++       D+++ G++L
Sbjct: 177 VLRKDPYGKPVDMWACGVIL 196

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/231 (26%), Positives = 106/231 (45%), Gaps = 34/231 (14%)
Query: 394 FSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           FS + +IGRG FG V+  R  D G   AMK  +       K   ++     ++  R ++ 
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDK------KRIKMKQGETLALNERIMLS 243
Query: 453 VISS-------CSNEEFK-----ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
           ++S+       C +  F      + +L+ M  G L  +L       +   R     ++  
Sbjct: 244 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIIL 302
Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
            LE++H  +   V++ DLKP+N+LLD++    +SD G+A   +++        ++ T GY
Sbjct: 303 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 355
Query: 561 MAPEYGKEG-RVSANGDVYSFGIMLME------TFTRKKPTDEIFNGEMTL 604
           MAPE  ++G    ++ D +S G ML +       F + K  D+     MTL
Sbjct: 356 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 406

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 96/195 (49%), Gaps = 8/195 (4%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG GS G V  AR    G +VA+K+ +L+  +  +    E  +M+  +H N++++  S  
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             E   +++E++  G+L   +  S   L+  Q   +   V  AL YLH   +  VIH D+
Sbjct: 113 VGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDI 167
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  ++LL  +    LSDFG    ++++     +   + T  +MAPE       +   D++
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 579 SFGIMLMETFTRKKP 593
           S GIM++E    + P
Sbjct: 226 SLGIMVIEMVDGEPP 240

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 35/228 (15%)
Query: 388 CRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR 446
            R    F E  ++G+G+FG V KAR   D    A+K       ++  +   E  ++ S+ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLN 60
Query: 447 H-------------RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN--YILDIYQR 491
           H             RN +K +++   +    + +EY  + +L   +HS N     D Y R
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR 120
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTI 550
           L     +  AL Y+H   S  +IH DLKP N+ +D++    + DFG+AK + R  D   +
Sbjct: 121 L--FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 551 QTQTL-----------ATIGYMAPEY-GKEGRVSANGDVYSFGIMLME 586
            +Q L            T  Y+A E     G  +   D+YS GI+  E
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 106/236 (44%), Gaps = 26/236 (11%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMK------S 444
           D F    ++G+GSFG V  AR+ + G   A+KV  L+   + +  DVEC M +      +
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLA 80
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
             H  + ++       +    V+E++  G L  ++  S    +   R     ++ SAL +
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMF 139
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAP 563
           LH      +I+ DLK  NVLLD      L+DFG+ K       + + T T   T  Y+AP
Sbjct: 140 LH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPDYIAP 193
Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIF----NGEMTLKHWVND 610
           E  +E       D ++ G++L E      P      D++F    N E+    W+++
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHE 249

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 90/193 (46%), Gaps = 12/193 (6%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           IG G FG V    + +     M VA+K   N     V + F  E   M+   H +I+K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              + E    +++E    G L  +L    + LD+   +     +++AL YL    S + +
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGYMAPEYGKEGRVSA 573
           H D+   NVL+       L DFG+++ +  ED +  + ++    I +MAPE     R ++
Sbjct: 514 HRDIAARNVLVSATDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 574 NGDVYSFGIMLME 586
             DV+ FG+ + E
Sbjct: 572 ASDVWMFGVCMWE 584

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/222 (24%), Positives = 104/222 (46%), Gaps = 13/222 (5%)
Query: 400 IGRGSFG-SVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISS 456
           IG GSFG ++      DG +  +K  N+     +  +    E  ++ +++H NI++   S
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYIL-DIYQRLNIMIDVASALEYLHFGYSAQVIH 515
                   +V++Y   G L K +++   +L    Q L+  + +  AL+++H     +++H
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILH 148
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ--TQTLATIGYMAPEYGKEGRVSA 573
            D+K  N+ L  +    L DFGIA++L     ST++     + T  Y++PE  +    + 
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLN----STVELARACIGTPYYLSPEICENKPYNN 204
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 615
             D+++ G +L E  T K   +      + LK     + P+S
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVS 246

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 44/228 (19%)
Query: 391 TDGFSENNLIGRGSFGSVFKA-RLGDGMEVAMK--------VFNLQYGRVFKSFDVECEM 441
           +  F   +L+G G++G V  A     G  VA+K        +F L+  R       E ++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-------EIKI 62
Query: 442 MKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH---SSNYILD------IYQRL 492
           +K  +H NII + +    + F+     Y+    ++  LH   S+  + D      IYQ L
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE------- 545
                   A++ LH    + VIH DLKPSN+L++ N    + DFG+A+++          
Sbjct: 123 R-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 546 -DQSTIQTQTLATIGYMAPEYG-KEGRVSANGDVYSFGIMLMETFTRK 591
             Q +  T+ +AT  Y APE      + S   DV+S G +L E F R+
Sbjct: 173 TGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 397 NNLIGRGSFGSVFKARLGD-GMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNIIKV- 453
           ++++G+G+  +VF+ R    G   A+KVFN + + R       E E++K + H+NI+K+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 454 -ISSCSNEEFKALVLEYMPHGSLEKYLH--SSNYILDIYQRLNIMIDVASALEYLHFGYS 510
            I   +    K L++E+ P GSL   L   S+ Y L   + L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 511 AQVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY- 565
             ++H ++KP N++     D   V  L+DFG A+ L  ++Q         T  Y+ P+  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VXLYGTEEYLHPDMY 187
Query: 566 -------GKEGRVSANGDVYSFGIMLMETFTRKKP 593
                    + +  A  D++S G+      T   P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 130/277 (46%), Gaps = 30/277 (10%)
Query: 392 DGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRN 449
           D F + + +G G+ G VFK +    G+ +A K+ +L+     ++  + E +++       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-NIMIDVASALEYLHFG 508
           I+    +  ++   ++ +E+M  GSL++ L  +  I +  Q L  + I V   L YL   
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 126
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  +++H D+KPSN+L++      L DFG++  L  E    +  + + T  YM+PE  + 
Sbjct: 127 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSPERLQG 180
Query: 569 GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 628
              S   D++S G+ L+E    + P   +   E+ L + VN+  P     +      S E
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFEL-LDYIVNEPPPKLPSAV-----FSLE 234
Query: 629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 665
             +FV K             C +++P +R + K+++ 
Sbjct: 235 FQDFVNK-------------CLIKNPAERADLKQLMV 258

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVF---KSFDVECEMMKSIRHR-N 449
           +GRG+FG V +A      +      VA+K+  L+ G      ++   E +++  I H  N
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 129
Query: 450 IIKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSN-----YIL---DIYQRLNIM----- 495
           ++ ++ +C+      +V+ E+   G+L  YL S       Y +   D+Y+    +     
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 496 --IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
               VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +  
Sbjct: 190 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
               + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 247 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVF---KSFDVECEMMKSIRHR-N 449
           +GRG+FG V +A      +      VA+K+  L+ G      ++   E +++  I H  N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 450 IIKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSN-----YIL---DIYQRLNIM----- 495
           ++ ++ +C+      +V+ E+   G+L  YL S       Y +   D+Y+    +     
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 496 --IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
               VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +  
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
               + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVF---KSFDVECEMMKSIRHR-N 449
           +GRG+FG V +A      +      VA+K+  L+ G      ++   E +++  I H  N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 450 IIKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSN-----YIL---DIYQRLNIM----- 495
           ++ ++ +C+      +V+ E+   G+L  YL S       Y +   D+Y+    +     
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 496 --IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
               VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +  
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
               + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 22/217 (10%)
Query: 390 ATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMK---VFNLQYGRVFKSFDVECEM---- 441
           AT  +     IG G++G+V+KAR    G  VA+K   V N   G          E+    
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 442 -MKSIRHRNIIKVISSC----SNEEFK-ALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNI 494
            +++  H N+++++  C    ++ E K  LV E++    L  YL  +    L      ++
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
           M      L++LH   +  ++H DLKP N+L+       L+DFG+A++ + +      T  
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPV 179
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK 591
           + T+ Y APE   +   +   D++S G +  E F RK
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 400 IGRGSFGSVFKARLGDGME-VAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVISS 456
           IG G++G+VFKA+  +  E VA+K   L      V  S   E  ++K ++H+NI+++   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
             +++   LV E+     L+KY  S N  LD     + +  +   L + H   S  V+H 
Sbjct: 70  LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV-SANG 575
           DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P+     ++ S + 
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 576 DVYSFGIMLMETFTRKKP 593
           D++S G +  E     +P
Sbjct: 184 DMWSAGCIFAELANAGRP 201

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 16/199 (8%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKS----FDVECEMMKSIRHRNIIKVI 454
           IG GS+G   K R   DG  +  K   L YG + ++       E  +++ ++H NI++  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 455 SSCSNEEFKAL--VLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGY 509
               +     L  V+EY   G L   +         LD    L +M  +  AL+  H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 510 SA--QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
                V+H DLKP+NV LD      L DFG+A++L  ++      + + T  YM+PE   
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED--FAKEFVGTPYYMSPEQMN 189
Query: 568 EGRVSANGDVYSFGIMLME 586
               +   D++S G +L E
Sbjct: 190 RMSYNEKSDIWSLGCLLYE 208

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRNIIKVI 454
           +G G+FGSV    ++ R    ++VA+KV      +   +    E ++M  + +  I+++I
Sbjct: 18  LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
             C  E    LV+E    G L K+L      + +     ++  V+  ++YL        +
Sbjct: 77  GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 132
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTLATIGYMAPEYGKEGRVSA 573
           H DL   NVLL +   A +SDFG++K L  +D   T ++     + + APE     + S+
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 574 NGDVYSFGIMLMETFTR-KKPTDEIFNGEM 602
             DV+S+G+ + E  +  +KP  ++   E+
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKMKGPEV 222

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVF---KSFDVECEMMKSIRHR-N 449
           +GRG+FG V +A      +      VA+K+  L+ G      ++   E +++  I H  N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 450 IIKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSN-----YIL---DIYQRLNIM----- 495
           ++ ++ +C+      +V+ E+   G+L  YL S       Y +   D+Y+    +     
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 496 --IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
               VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +  
Sbjct: 144 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
               + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 201 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 17/234 (7%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKS----FDVECEMMKSIRHRNIIKVI- 454
           IGRGSF +V+K  L     V +    LQ  ++ KS    F  E E +K ++H NI++   
Sbjct: 34  IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 455 ---SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              S+   ++   LV E    G+L+ YL     +  I    +    +   L++LH   + 
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFK-VXKIKVLRSWCRQILKGLQFLH-TRTP 150
Query: 512 QVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
            +IH DLK  N+ +        + D G+A L     +++     + T  + APE  +E +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXAPEXYEE-K 205
Query: 571 VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
              + DVY+FG   +E  T + P  E  N     +   +   P S  ++  P +
Sbjct: 206 YDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV 259

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 100/216 (46%), Gaps = 31/216 (14%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVF---KSFDVECEMMKSIRHR-N 449
           +GRG+FG V +A      +      VA+K+  L+ G      ++   E +++  I H  N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKM--LKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 450 IIKVISSCSNEEFKALVL-EYMPHGSLEKYLHSSNYIL--------DIYQRLNIM----- 495
           ++ ++ +C+      +V+ E+   G+L  YL S             D+Y+    +     
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 496 --IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
               VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +  
Sbjct: 155 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
               + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 212 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 398 NLIGRGSFGSVFKARLGDGMEV----AMKVFN----LQYGRVFKSFDVECEMMKSIRHRN 449
            ++G G++G VF  R   G +     AMKV      +Q  +  +    E ++++ IR   
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 450 IIKVISSCSNEEFK-ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI-DVASALEYLHF 507
            +  +      E K  L+L+Y+  G L  + H S         + I + ++  ALE+LH 
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHEVQIYVGEIVLALEHLH- 176
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
                +I+ D+K  N+LLD N    L+DFG++K     D++        TI YMAP+  +
Sbjct: 177 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMAPDIVR 233
Query: 568 EGRVSANG--DVYSFGIMLMETFTRKKP 593
            G    +   D +S G+++ E  T   P
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 16/199 (8%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKS----FDVECEMMKSIRHRNIIKVI 454
           IG GS+G   K R   DG  +  K   L YG + ++       E  +++ ++H NI++  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 455 SSCSNEEFKAL--VLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGY 509
               +     L  V+EY   G L   +         LD    L +M  +  AL+  H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 510 SA--QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
                V+H DLKP+NV LD      L DFG+A++L  +  ++     + T  YM+PE   
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFVGTPYYMSPEQMN 189
Query: 568 EGRVSANGDVYSFGIMLME 586
               +   D++S G +L E
Sbjct: 190 RMSYNEKSDIWSLGCLLYE 208

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 88/199 (44%), Gaps = 16/199 (8%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKS----FDVECEMMKSIRHRNIIKVI 454
           IG GS+G   K R   DG  +  K   L YG + ++       E  +++ ++H NI++  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 455 SSCSNEEFKAL--VLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGY 509
               +     L  V+EY   G L   +         LD    L +M  +  AL+  H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 510 SA--QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
                V+H DLKP+NV LD      L DFG+A++L  +  ++     + T  YM+PE   
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMSPEQMN 189
Query: 568 EGRVSANGDVYSFGIMLME 586
               +   D++S G +L E
Sbjct: 190 RMSYNEKSDIWSLGCLLYE 208

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 397 NNLIGRGSFGSVFKARLGD-GMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNIIKV- 453
           ++++G+G+  +VF+ R    G   A+KVFN + + R       E E++K + H+NI+K+ 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 454 -ISSCSNEEFKALVLEYMPHGSLEKYLH--SSNYILDIYQRLNIMIDVASALEYLHFGYS 510
            I   +    K L++E+ P GSL   L   S+ Y L   + L ++ DV   + +L     
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 511 AQVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY- 565
             ++H ++KP N++     D   V  L+DFG A+ L  ++Q         T  Y+ P+  
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMY 187
Query: 566 -------GKEGRVSANGDVYSFGIMLMETFTRKKP 593
                    + +  A  D++S G+      T   P
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 125/289 (43%), Gaps = 33/289 (11%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGDGME-VAMKVFNLQYGRVFKSFD---VECEMMKSIRH 447
           D +    +IG G+   V  A      E VA+K  NL+  +   S D    E + M    H
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE--KCQTSMDELLKEIQAMSQCHH 67
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSL--------EKYLHSSNYILDIYQRLNIMIDVA 499
            NI+   +S   ++   LV++ +  GS+         K  H S  +LD      I+ +V 
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG-VLDESTIATILREVL 126
Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST---IQTQTLA 556
             LEYLH       IH D+K  N+LL ++    ++DFG++  L      T   ++   + 
Sbjct: 127 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 183
Query: 557 TIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 615
           T  +MAPE  ++ R      D++SFGI  +E  T   P  +    ++ +    ND   + 
Sbjct: 184 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 243
Query: 616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
           T  + D  +L +   +F    + +S        C  + PE+R  A E++
Sbjct: 244 TG-VQDKEMLKKYGKSF---RKMISL-------CLQKDPEKRPTAAELL 281

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRV--------FKSFDVECEMMK 443
           D F +  ++GRG FG VF  +    M+   K++  +            ++   VE +++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 444 SIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI---DVAS 500
            +  R I+ +  +   +    LV+  M  G +  ++++ +     +Q    +     + S
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT---LAT 557
            LE+LH      +I+ DLKP NVLLDD+    +SD G+A  L        QT+T     T
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-----KAGQTKTKGYAGT 352
Query: 558 IGYMAPE--YGKEGRVSANGDVYSFGIMLMETFTRKKP 593
            G+MAPE   G+E   S   D ++ G+ L E    + P
Sbjct: 353 PGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRV--------FKSFDVECEMMK 443
           D F +  ++GRG FG VF  +    M+   K++  +            ++   VE +++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 444 SIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI---DVAS 500
            +  R I+ +  +   +    LV+  M  G +  ++++ +     +Q    +     + S
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT---LAT 557
            LE+LH      +I+ DLKP NVLLDD+    +SD G+A  L        QT+T     T
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-----KAGQTKTKGYAGT 352
Query: 558 IGYMAPE--YGKEGRVSANGDVYSFGIMLMETFTRKKP 593
            G+MAPE   G+E   S   D ++ G+ L E    + P
Sbjct: 353 PGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRV--------FKSFDVECEMMK 443
           D F +  ++GRG FG VF  +    M+   K++  +            ++   VE +++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 444 SIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI---DVAS 500
            +  R I+ +  +   +    LV+  M  G +  ++++ +     +Q    +     + S
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT---LAT 557
            LE+LH      +I+ DLKP NVLLDD+    +SD G+A  L        QT+T     T
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-----KAGQTKTKGYAGT 352
Query: 558 IGYMAPE--YGKEGRVSANGDVYSFGIMLMETFTRKKP 593
            G+MAPE   G+E   S   D ++ G+ L E    + P
Sbjct: 353 PGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 125/289 (43%), Gaps = 33/289 (11%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGDGME-VAMKVFNLQYGRVFKSFD---VECEMMKSIRH 447
           D +    +IG G+   V  A      E VA+K  NL+  +   S D    E + M    H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE--KCQTSMDELLKEIQAMSQCHH 72
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSL--------EKYLHSSNYILDIYQRLNIMIDVA 499
            NI+   +S   ++   LV++ +  GS+         K  H S  +LD      I+ +V 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG-VLDESTIATILREVL 131
Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST---IQTQTLA 556
             LEYLH       IH D+K  N+LL ++    ++DFG++  L      T   ++   + 
Sbjct: 132 EGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 557 TIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS 615
           T  +MAPE  ++ R      D++SFGI  +E  T   P  +    ++ +    ND   + 
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE 248
Query: 616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
           T  + D  +L +   +F    + +S        C  + PE+R  A E++
Sbjct: 249 TG-VQDKEMLKKYGKSF---RKMISL-------CLQKDPEKRPTAAELL 286

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 30/218 (13%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRV--------FKSFDVECEMMK 443
           D F +  ++GRG FG VF  +    M+   K++  +            ++   VE +++ 
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240
Query: 444 SIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI---DVAS 500
            +  R I+ +  +   +    LV+  M  G +  ++++ +     +Q    +     + S
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT---LAT 557
            LE+LH      +I+ DLKP NVLLDD+    +SD G+A  L        QT+T     T
Sbjct: 301 GLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-----KAGQTKTKGYAGT 352
Query: 558 IGYMAPE--YGKEGRVSANGDVYSFGIMLMETFTRKKP 593
            G+MAPE   G+E   S   D ++ G+ L E    + P
Sbjct: 353 PGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     IG GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EYMP G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     IG GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EYMP G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 390 ATDGFSENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRH 447
           ++  F +   +G G++ +V+K      G+ VA+K   L       S  + E  +MK ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-------ILDIYQRLNIMIDVAS 500
            NI+++      E    LV E+M +  L+KY+ S           L++ +     +    
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL---- 117
Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
            L+ L F +  +++H DLKP N+L++      L DFG+A+       +   +  + T+ Y
Sbjct: 118 -LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWY 174
Query: 561 MAPEYGKEGRV-SANGDVYSFGIMLMETFTRK 591
            AP+     R  S + D++S G +L E  T K
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 8/195 (4%)
Query: 400 IGRGSFGSV-FKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG GS G V        G +VA+K  +L+  +  +    E  +M+   H N++ + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL YLH   +  VIH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  ++LL  +    LSDFG    +++E     +   + T  +MAPE           D++
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 579 SFGIMLMETFTRKKP 593
           S GIM++E    + P
Sbjct: 226 SLGIMVIEMIDGEPP 240

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 89/192 (46%), Gaps = 9/192 (4%)
Query: 395 SENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           S+  ++G G FG V K      G+++A K+   +  +  +    E  +M  + H N+I++
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
             +  ++    LV+EY+  G L   +   +Y L     +  M  +   + ++H  Y   +
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---I 208
Query: 514 IHCDLKPSNVLL--DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
           +H DLKP N+L    D     + DFG+A+     ++  +      T  ++APE      V
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFV 265
Query: 572 SANGDVYSFGIM 583
           S   D++S G++
Sbjct: 266 SFPTDMWSVGVI 277

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 144
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPEYG 566
             S  +I+ DLKP N+L+D      ++DFG AK +        +T TL  T  Y+APE  
Sbjct: 145 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAPEII 196
Query: 567 KEGRVSANGDVYSFGIMLME 586
                +   D ++ G+++ E
Sbjct: 197 LSKGYNKAVDWWALGVLIYE 216

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 12/210 (5%)
Query: 400 IGRGSFGSV----FKARLGDGMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRNIIKVI 454
           +G G+FGSV    ++ R    ++VA+KV      +   +    E ++M  + +  I+++I
Sbjct: 344 LGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
             C  E    LV+E    G L K+L      + +     ++  V+  ++YL        +
Sbjct: 403 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFV 458
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQTLATIGYMAPEYGKEGRVSA 573
           H +L   NVLL +   A +SDFG++K L  +D   T ++     + + APE     + S+
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 574 NGDVYSFGIMLMETFTR-KKPTDEIFNGEM 602
             DV+S+G+ + E  +  +KP  ++   E+
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKMKGPEV 548

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 91/172 (52%), Gaps = 18/172 (10%)
Query: 400 IGRGSFGSVFK--ARLGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRNIIKVISS 456
           +G G++ +V+K  ++L D + VA+K   L++        + E  ++K ++H NI+ +   
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
              E+   LV EY+    L++YL     I++++   N+ + +   L  L + +  +V+H 
Sbjct: 69  IHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMH---NVKLFLFQLLRGLAYCHRQKVLHR 124
Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT----LATIGYMAPE 564
           DLKP N+L+++     L+DFG+A+        +I T+T    + T+ Y  P+
Sbjct: 125 DLKPQNLLINERGELKLADFGLAR------AKSIPTKTYDNEVVTLWYRPPD 170

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPEYG 566
             S  +I+ DLKP N+L+D      ++DFG AK +        +T TL  T  Y+APE  
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCGTPEYLAPEII 211
Query: 567 KEGRVSANGDVYSFGIMLME 586
                +   D ++ G+++ E
Sbjct: 212 LSKGYNKAVDWWALGVLIYE 231

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRHRN 449
           F +  ++G+G FG V   ++   G   A K    +  +  K   +   E ++++ +  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASALEYLHFG 508
           ++ +  +   ++   LVL  M  G L+ ++ H         + +    ++   LE LH  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH-- 303
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
              ++++ DLKP N+LLDD+    +SD G+A  +   +  TI+ + + T+GYMAPE  K 
Sbjct: 304 -RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGR-VGTVGYMAPEVVKN 359
Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
            R + + D ++ G +L E    + P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 44/228 (19%)
Query: 391 TDGFSENNLIGRGSFGSVFKA-RLGDGMEVAMK--------VFNLQYGRVFKSFDVECEM 441
           +  F   +L+G G++G V  A     G  VA+K        +F L+  R       E ++
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-------EIKI 62
Query: 442 MKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH---SSNYILD------IYQRL 492
           +K  +H NII + +    + F+     Y+    ++  LH   S+  + D      IYQ L
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE------- 545
                   A++ LH    + VIH DLKPSN+L++ N    + DFG+A+++          
Sbjct: 123 R-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 546 -DQSTIQTQTLATIGYMAPEYG-KEGRVSANGDVYSFGIMLMETFTRK 591
             Q +   + +AT  Y APE      + S   DV+S G +L E F R+
Sbjct: 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 22/220 (10%)
Query: 387 LCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV----ECEM 441
            C     + +   IG+G+FG VFKAR    G +VA+K   ++  +  + F +    E ++
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKI 70
Query: 442 MKSIRHRNIIKVISSCSNE-----EFKA---LVLEYMPHGSLEKYLHSSNYILDIYQRLN 493
           ++ ++H N++ +I  C  +       KA   LV ++  H  L   L +      + +   
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 129
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL--LTREDQSTIQ 551
           +M  + + L Y+H     +++H D+K +NVL+  + V  L+DFG+A+   L +  Q    
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 552 TQTLATIGYMAPE-YGKEGRVSANGDVYSFGIMLMETFTR 590
              + T+ Y  PE    E       D++  G ++ E +TR
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRHRN 449
           F +  ++G+G FG V   ++   G   A K    +  +  K   +   E ++++ +  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASALEYLHFG 508
           ++ +  +   ++   LVL  M  G L+ ++ H         + +    ++   LE LH  
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH-- 303
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
              ++++ DLKP N+LLDD+    +SD G+A  +   +  TI+ + + T+GYMAPE  K 
Sbjct: 304 -RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQTIKGR-VGTVGYMAPEVVKN 359
Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
            R + + D ++ G +L E    + P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 91/190 (47%), Gaps = 9/190 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V+KA+   G   A+K   L+     +  +   E  ++K ++H NI+K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
             ++   LV E++    L+K L      L+     + ++ + + + Y H     +V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY-GKEGRVSANGD 576
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP+      + S   D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 577 VYSFGIMLME 586
           ++S G +  E
Sbjct: 184 IWSVGCIFAE 193

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 90/191 (47%), Gaps = 14/191 (7%)
Query: 398 NLIGRGSFGSVF--KARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
            ++G G+F  VF  K RL  G   A+K           S + E  ++K I+H NI+ +  
Sbjct: 15  EVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
              +     LV++ +  G L   +       +    L I   V SA++YLH      ++H
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-QVLSAVKYLH---ENGIVH 129
Query: 516 CDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            DLKP N+L    ++N    ++DFG++K+    +Q+ I +    T GY+APE   +   S
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKPYS 185
Query: 573 ANGDVYSFGIM 583
              D +S G++
Sbjct: 186 KAVDCWSIGVI 196

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 101/225 (44%), Gaps = 44/225 (19%)
Query: 389 RATDGFSEN----NLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDV------ 437
            +T GF EN     ++GRG    V +        E A+K+ ++  G  F + +V      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 438 ---ECEMMKSIR-HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQR-- 491
              E ++++ +  H NII++  +     F  LV + M  G L  YL     + +   R  
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
           +  +++V  AL  L+      ++H DLKP N+LLDD+M   L+DFG +  L   D     
Sbjct: 130 MRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKL 180
Query: 552 TQTLATIGYMAPE------------YGKEGRVSANGDVYSFGIML 584
            +   T  Y+APE            YGKE       D++S G+++
Sbjct: 181 REVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 390 ATDGFS---------ENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDVEC 439
           +TD FS         + +++G G+   V     L    E A+K+   Q G +      E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 440 EMMKSIR-HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDV 498
           EM+   + HRN++++I     E+   LV E M  GS+  ++H   +  ++   + ++ DV
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDV 120
Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLLDD-NMVA--HLSDFGIAK-LLTREDQSTIQTQT 554
           ASAL++LH   +  + H DLKP N+L +  N V+   + DFG+   +    D S I T  
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPE 177
Query: 555 LAT----IGYMAPE----YGKEGRV-SANGDVYSFGIML 584
           L T      YMAPE    + +E  +     D++S G++L
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 35/227 (15%)
Query: 389 RATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRH 447
           R    F E  ++G+G+FG V KAR   D    A+K       ++  +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVXLLASLNH 61
Query: 448 -------------RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN--YILDIYQRL 492
                        RN +K  ++   +    +  EY  + +L   +HS N     D Y RL
Sbjct: 62  QYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRL 121
Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQ 551
                +  AL Y+H   S  +IH +LKP N+ +D++    + DFG+AK + R  D   + 
Sbjct: 122 --FRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 552 TQTL-----------ATIGYMAPEY-GKEGRVSANGDVYSFGIMLME 586
           +Q L            T  Y+A E     G  +   D YS GI+  E
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 91/190 (47%), Gaps = 9/190 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V+KA+   G   A+K   L+     +  +   E  ++K ++H NI+K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
             ++   LV E++    L+K L      L+     + ++ + + + Y H     +V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY-GKEGRVSANGD 576
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP+      + S   D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 577 VYSFGIMLME 586
           ++S G +  E
Sbjct: 184 IWSVGCIFAE 193

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 27/221 (12%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMK-VFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V  A    + + VA+K +   ++    +    E +++   RH NII +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLN------IMIDVASALEYLHFGYS 510
            N+  +A  +E M    L  +L  ++ Y L   Q L+       +  +   L+Y+H   S
Sbjct: 107 -NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 162
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEG 569
           A V+H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     
Sbjct: 163 ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 570 R-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           +  + + D++S G +L E  + +     IF G    KH+++
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 255

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 91/190 (47%), Gaps = 9/190 (4%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V+KA+   G   A+K   L+     +  +   E  ++K ++H NI+K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
             ++   LV E++    L+K L      L+     + ++ + + + Y H     +V+H D
Sbjct: 70  HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY-GKEGRVSANGD 576
           LKP N+L++      ++DFG+A+      +    T  + T+ Y AP+      + S   D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEVVTLWYRAPDVLMGSKKYSTTID 183
Query: 577 VYSFGIMLME 586
           ++S G +  E
Sbjct: 184 IWSVGCIFAE 193

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IG+G+F  V  AR +  G EVA+K+ +   L    + K F  E  + K + H NI+K+  
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKLFE 80
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               E+   LV EY   G +  YL +     +   R      + SA++Y H  +   ++H
Sbjct: 81  VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF---IVH 136
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPEYGKEGRVS 572
            DLK  N+LLD +    ++DFG +      ++ T   +  A  G   Y APE  +  +  
Sbjct: 137 RDLKAENLLLDADXNIKIADFGFS------NEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 573 A-NGDVYSFGIMLMETFTRKKPTD 595
               DV+S G++L    +   P D
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 209
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 392 DGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRN 449
           D F + + +G G+ G VFK +    G+ +A K+ +L+     ++  + E +++       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-NIMIDVASALEYLHFG 508
           I+    +  ++   ++ +E+M  GSL++ L  +  I +  Q L  + I V   L YL   
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 185
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  +++H D+KPSN+L++      L DFG++  L      ++    + T  YM+PE  + 
Sbjct: 186 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG 239
Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
              S   D++S G+ L+E    + P
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 392 DGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRN 449
           D F + + +G G+ G VFK +    G+ +A K+ +L+     ++  + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-NIMIDVASALEYLHFG 508
           I+    +  ++   ++ +E+M  GSL++ L  +  I +  Q L  + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 123
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  +++H D+KPSN+L++      L DFG++  L      ++    + T  YM+PE  + 
Sbjct: 124 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG 177
Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
              S   D++S G+ L+E    + P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 151
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 201
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 202 IILSKGYNKAVDWWALGVLIYE 223

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 392 DGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRN 449
           D F + + +G G+ G VFK +    G+ +A K+ +L+     ++  + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-NIMIDVASALEYLHFG 508
           I+    +  ++   ++ +E+M  GSL++ L  +  I +  Q L  + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 123
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  +++H D+KPSN+L++      L DFG++  L      ++    + T  YM+PE  + 
Sbjct: 124 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG 177
Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
              S   D++S G+ L+E    + P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 392 DGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRN 449
           D F + + +G G+ G VFK +    G+ +A K+ +L+     ++  + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-NIMIDVASALEYLHFG 508
           I+    +  ++   ++ +E+M  GSL++ L  +  I +  Q L  + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 123
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  +++H D+KPSN+L++      L DFG++  L      ++    + T  YM+PE  + 
Sbjct: 124 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG 177
Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
              S   D++S G+ L+E    + P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 392 DGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRN 449
           D F + + +G G+ G VFK +    G+ +A K+ +L+     ++  + E +++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-NIMIDVASALEYLHFG 508
           I+    +  ++   ++ +E+M  GSL++ L  +  I +  Q L  + I V   L YL   
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 123
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  +++H D+KPSN+L++      L DFG++  L      ++    + T  YM+PE  + 
Sbjct: 124 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG 177
Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
              S   D++S G+ L+E    + P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 25/172 (14%)
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           VA  +E+L    S + IH DL   N+LL +N V  + DFG+A+ + +      +  T   
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +MAPE   +   S   DV+S+G++L E F+          G            P    
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS--------LGGS-----------PYPGV 305
Query: 618 EIVDPNLLS--REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
           ++ D +  S  RE +   A E     ++ + ++C    P++R    E+V KL
Sbjct: 306 QM-DEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 107/231 (46%), Gaps = 24/231 (10%)
Query: 378 MQRMFSYLE--LCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKS 434
           M + +  +E   C     + +   IG+G+FG VFKAR    G +VA+K   ++  +  + 
Sbjct: 1   MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EG 58
Query: 435 FDV----ECEMMKSIRHRNIIKVISSCSNEEFKA--------LVLEYMPHGSLEKYLHSS 482
           F +    E ++++ ++H N++ +I  C  +            LV ++  H  L   L + 
Sbjct: 59  FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNV 117
Query: 483 NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL- 541
                + +   +M  + + L Y+H     +++H D+K +NVL+  + V  L+DFG+A+  
Sbjct: 118 LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 542 -LTREDQSTIQTQTLATIGYMAPE-YGKEGRVSANGDVYSFGIMLMETFTR 590
            L +  Q       + T+ Y  PE    E       D++  G ++ E +TR
Sbjct: 175 SLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 91/191 (47%), Gaps = 12/191 (6%)
Query: 400 IGRGSFGSVFK-ARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G+G+F  V +  ++  G E A K+ N +    R  +  + E  + + ++H NI+++  S
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
            S E    L+ + +  G L + + +  Y    Y   +    +   LE +   +   V+H 
Sbjct: 90  ISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 145
Query: 517 DLKPSNVLLDDNM---VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           DLKP N+LL   +      L+DFG+A  +  E Q+        T GY++PE  ++     
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPYGK 203
Query: 574 NGDVYSFGIML 584
             D+++ G++L
Sbjct: 204 PVDLWACGVIL 214

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 387 LCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV----ECEM 441
            C     + +   IG+G+FG VFKAR    G +VA+K   ++  +  + F +    E ++
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKI 70
Query: 442 MKSIRHRNIIKVISSCSNEEFKA--------LVLEYMPHGSLEKYLHSSNYILDIYQRLN 493
           ++ ++H N++ +I  C  +            LV ++  H  L   L +      + +   
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR 129
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL--LTREDQSTIQ 551
           +M  + + L Y+H     +++H D+K +NVL+  + V  L+DFG+A+   L +  Q    
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 552 TQTLATIGYMAPE-YGKEGRVSANGDVYSFGIMLMETFTR 590
              + T+ Y  PE    E       D++  G ++ E +TR
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     IG GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 387 LCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV----ECEM 441
            C     + +   IG+G+FG VFKAR    G +VA+K   ++  +  + F +    E ++
Sbjct: 13  FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKI 70
Query: 442 MKSIRHRNIIKVISSCSNEEFKA--------LVLEYMPH---GSLEKYLHSSNYILDIYQ 490
           ++ ++H N++ +I  C  +            LV ++  H   G L   L    + L   +
Sbjct: 71  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIK 128
Query: 491 RLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL--LTREDQS 548
           R+  M+     L  L++ +  +++H D+K +NVL+  + V  L+DFG+A+   L +  Q 
Sbjct: 129 RVMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 183
Query: 549 TIQTQTLATIGYMAPE-YGKEGRVSANGDVYSFGIMLMETFTR 590
                 + T+ Y  PE    E       D++  G ++ E +TR
Sbjct: 184 NRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 226

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 26/204 (12%)
Query: 387 LCRATDGFSEN--NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKS 444
           LC+  +G SE    +I +  F    K R  D  +   K     Y         E  ++KS
Sbjct: 54  LCKEKNGHSEKAIKVIKKSQFD---KGRYSDDNKNIEKFHEEIYN--------EISLLKS 102
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASALE 503
           + H NIIK+     ++++  LV E+   G L E+ ++   +  D     NIM  + S + 
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF--DECDAANIMKQILSGIC 160
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           YLH      ++H D+KP N+LL++    +   + DFG++   +++ +       L T  Y
Sbjct: 161 YLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYY 214
Query: 561 MAPEYGKEGRVSANGDVYSFGIML 584
           +APE  K+ + +   DV+S G+++
Sbjct: 215 IAPEVLKK-KYNEKCDVWSCGVIM 237

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 101/205 (49%), Gaps = 11/205 (5%)
Query: 392 DGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRN 449
           D F + + +G G+ G VFK +    G+ +A K+ +L+     ++  + E +++       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-NIMIDVASALEYLHFG 508
           I+    +  ++   ++ +E+M  GSL++ L  +  I +  Q L  + I V   L YL   
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 150
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  +++H D+KPSN+L++      L DFG++  L      ++    + T  YM+PE  + 
Sbjct: 151 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG 204
Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
              S   D++S G+ L+E    + P
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 44/225 (19%)
Query: 389 RATDGFSEN----NLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDV------ 437
            +T GF EN     ++GRG    V +        E A+K+ ++  G  F + +V      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 438 ---ECEMMKSIR-HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQR-- 491
              E ++++ +  H NII++  +     F  LV + M  G L  YL     + +   R  
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
           +  +++V  AL  L+      ++H DLKP N+LLDD+M   L+DFG +  L   D     
Sbjct: 130 MRALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKL 180
Query: 552 TQTLATIGYMAPE------------YGKEGRVSANGDVYSFGIML 584
                T  Y+APE            YGKE       D++S G+++
Sbjct: 181 RSVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/277 (23%), Positives = 129/277 (46%), Gaps = 26/277 (9%)
Query: 392 DGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRN 449
           D F + + +G G+ G VFK +    G+ +A K+ +L+     ++  + E +++       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-NIMIDVASALEYLHFG 508
           I+    +  ++   ++ +E+M  GSL++ L  +  I +  Q L  + I V   L YL   
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE--QILGKVSIAVIKGLTYLREK 142
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  +++H D+KPSN+L++      L DFG++  L      ++    + T  YM+PE  + 
Sbjct: 143 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQG 196
Query: 569 GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 628
              S   D++S G+ L+E    + P     +G M +   + D++       +   + S E
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYPIGS-GSGSMAIFELL-DYIVNEPPPKLPSGVFSLE 254
Query: 629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 665
             +FV K             C +++P +R + K+++ 
Sbjct: 255 FQDFVNK-------------CLIKNPAERADLKQLMV 278

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 109/221 (49%), Gaps = 27/221 (12%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V  A    + + VA+K  +  ++    +    E +++ + RH NII +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLN------IMIDVASALEYLHFGYS 510
            N+  +A  +E M    + + L  ++ Y L   Q L+       +  +   L+Y+H   S
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 144
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEG 569
           A V+H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 570 R-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           +  + + D++S G +L E  + +     IF G    KH+++
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 209
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 151
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 152 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 201
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 202 IILSKGYNKAVDWWALGVLIYE 223

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 25/226 (11%)
Query: 394 FSENNLIGRGSFGSVFKA--RLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNII 451
           +++   IG G++G V  A   +        K+   ++    +    E +++   RH N+I
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN------IMIDVASALEYL 505
            +         +A+   Y+    +E  L    Y L   Q+L+       +  +   L+Y+
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDL----YKLLKSQQLSNDHICYFLYQILRGLKYI 160
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPE 564
           H   SA V+H DLKPSN+L++      + DFG+A++   E D +   T+ +AT  Y APE
Sbjct: 161 H---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 565 YGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
                +  + + D++S G +L E  + +     IF G    KH+++
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 255

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 109/221 (49%), Gaps = 27/221 (12%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V  A    + + VA+K  +  ++    +    E +++ + RH NII +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI---- 88
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLN------IMIDVASALEYLHFGYS 510
            N+  +A  +E M    + + L  ++ Y L   Q L+       +  +   L+Y+H   S
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 144
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEG 569
           A V+H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     
Sbjct: 145 ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 570 R-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           +  + + D++S G +L E  + +     IF G    KH+++
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 237

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 209
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNII---KVI 454
           IG G++G V  A    + + VA+K  +  ++    +    E +++   RH NII    +I
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            + + E+ K + +++ +    L K L + +   D       +  +   L+Y+H   SA V
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH---SANV 149
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEGR-V 571
           +H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     +  
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           + + D++S G +L E  + +     IF G    KH+++
Sbjct: 210 TKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 209
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 44/221 (19%)
Query: 393 GFSEN----NLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDV---------E 438
           GF EN     ++GRG    V +        E A+K+ ++  G  F + +V         E
Sbjct: 1   GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 60
Query: 439 CEMMKSIR-HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQR--LNIM 495
            ++++ +  H NII++  +     F  LV + M  G L  YL     + +   R  +  +
Sbjct: 61  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 120
Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
           ++V  AL  L+      ++H DLKP N+LLDD+M   L+DFG +  L   D      +  
Sbjct: 121 LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVC 171
Query: 556 ATIGYMAPE------------YGKEGRVSANGDVYSFGIML 584
            T  Y+APE            YGKE       D++S G+++
Sbjct: 172 GTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 206

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNII---KVI 454
           IG G++G V  A    + + VA+K  +  ++    +    E +++   RH NII    +I
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            + + E+ K + +++ +    L K L + +   D       +  +   L+Y+H   SA V
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH---SANV 145
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEGR-V 571
           +H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     +  
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           + + D++S G +L E  + +     IF G    KH+++
Sbjct: 206 TKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 209
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+P G +  +L       + + R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 229
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 230 IILSKGYNKAVDWWALGVLIYE 251

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNII---KVI 454
           IG G++G V  A    + + VA+K  +  ++    +    E +++   RH NII    +I
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            + + E+ K + +++ +    L K L + +   D       +  +   L+Y+H   SA V
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH---SANV 149
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEGR-V 571
           +H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     +  
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           + + D++S G +L E  + +     IF G    KH+++
Sbjct: 210 TKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 239

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIRHRN 449
           D F   + +G G+ G V K +    G+ +A K+ +L+     ++  + E +++       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRLNIMIDVASALEYLHFG 508
           I+    +  ++   ++ +E+M  GSL++ L  +  I + I  +++I   V   L YL   
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREK 133
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  Q++H D+KPSN+L++      L DFG++  L      ++    + T  YMAPE  + 
Sbjct: 134 H--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMAPERLQG 187
Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
              S   D++S G+ L+E    + P
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAM-KVFNLQYGRVFKSFDVECEMMKSIRHRNII---KVI 454
           IG G++G V  A    + + VA+ K+   ++    +    E +++   RH NII    +I
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            + + E+ K + +++ +    L K L + +   D       +  +   L+Y+H   SA V
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH---SANV 149
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEGR-V 571
           +H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     +  
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           + + D++S G +L E  + +     IF G    KH+++
Sbjct: 210 TKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 239

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 27/221 (12%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMK-VFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V  A    + + VA+K +   ++    +    E +++   RH NII +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 88
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLN------IMIDVASALEYLHFGYS 510
            N+  +A  +E M    + + L  ++ Y L   Q L+       +  +   L+Y+H   S
Sbjct: 89  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 144
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEG 569
           A V+H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     
Sbjct: 145 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 570 R-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           +  + + D++S G +L E  + +     IF G    KH+++
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 237

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMK-VFNLQYGRVFKSFDVECEMMKSIRHRNII---KVI 454
           IG G++G V  A    + + VA+K +   ++    +    E +++   RH NII    +I
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            + + E+ K + +++ +    L K L + +   D       +  +   L+Y+H   SA V
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH---SANV 145
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEGR-V 571
           +H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     +  
Sbjct: 146 LHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           + + D++S G +L E  + +     IF G    KH+++
Sbjct: 206 TKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 235

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 27/221 (12%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMK-VFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V  A    + + VA+K +   ++    +    E +++   RH NII +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 84
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLN------IMIDVASALEYLHFGYS 510
            N+  +A  +E M    + + L  ++ Y L   Q L+       +  +   L+Y+H   S
Sbjct: 85  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 140
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEG 569
           A V+H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     
Sbjct: 141 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 570 R-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           +  + + D++S G +L E  + +     IF G    KH+++
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 233

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMK-VFNLQYGRVFKSFDVECEMMKSIRHRNII---KVI 454
           IG G++G V  A    + + VA+K +   ++    +    E +++   RH NII    +I
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            + + E+ K + +++ +    L K L + +   D       +  +   L+Y+H   SA V
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH---SANV 145
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEGR-V 571
           +H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     +  
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           + + D++S G +L E  + +     IF G    KH+++
Sbjct: 206 TKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 235

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 27/221 (12%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V  A    + + VA+K  +  ++    +    E +++   RH NII +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLN------IMIDVASALEYLHFGYS 510
            N+  +A  +E M    + + L  ++ Y L   Q L+       +  +   L+Y+H   S
Sbjct: 92  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 147
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEG 569
           A V+H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     
Sbjct: 148 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 207
Query: 570 R-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           +  + + D++S G +L E  + +     IF G    KH+++
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 240

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 27/221 (12%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V  A    + + VA+K  +  ++    +    E +++   RH NII +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 92
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLN------IMIDVASALEYLHFGYS 510
            N+  +A  +E M    + + L  ++ Y L   Q L+       +  +   L+Y+H   S
Sbjct: 93  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 148
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEG 569
           A V+H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     
Sbjct: 149 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 208
Query: 570 R-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           +  + + D++S G +L E  + +     IF G    KH+++
Sbjct: 209 KGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 241

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 27/221 (12%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V  A    + + VA+K  +  ++    +    E +++   RH NII +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 83
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLN------IMIDVASALEYLHFGYS 510
            N+  +A  +E M    + + L  ++ Y L   Q L+       +  +   L+Y+H   S
Sbjct: 84  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 139
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEG 569
           A V+H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     
Sbjct: 140 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 199
Query: 570 R-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           +  + + D++S G +L E  + +     IF G    KH+++
Sbjct: 200 KGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 232

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 27/221 (12%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V  A    + + VA+K  +  ++    +    E +++   RH NII +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLN------IMIDVASALEYLHFGYS 510
            N+  +A  +E M    + + L  ++ Y L   Q L+       +  +   L+Y+H   S
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEG 569
           A V+H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 570 R-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           +  + + D++S G +L E  + +     IF G    KH+++
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 239

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 27/221 (12%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V  A    + + VA+K  +  ++    +    E +++   RH NII +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLN------IMIDVASALEYLHFGYS 510
            N+  +A  +E M    + + L  ++ Y L   Q L+       +  +   L+Y+H   S
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEG 569
           A V+H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 570 R-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           +  + + D++S G +L E  + +     IF G    KH+++
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 239

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMK-VFNLQYGRVFKSFDVECEMMKSIRHRNII---KVI 454
           IG G++G V  A    + + VA+K +   ++    +    E +++   RH NII    +I
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            + + E+ K + +++ +    L K L + +   D       +  +   L+Y+H   SA V
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH---SANV 145
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEGR-V 571
           +H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     +  
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           + + D++S G +L E  + +     IF G    KH+++
Sbjct: 206 TKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 235

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNII---KVI 454
           IG G++G V  A    + + VA+K  +  ++    +    E +++   RH NII    +I
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            + + E+ K + +++ +    L K L + +   D       +  +   L+Y+H   SA V
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH---SANV 153
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEGR-V 571
           +H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     +  
Sbjct: 154 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 213
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           + + D++S G +L E  + +     IF G    KH+++
Sbjct: 214 TKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 243

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNII---KVI 454
           IG G++G V  A    + + VA+K  +  ++    +    E +++   RH NII    +I
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            + + E+ K + +++ +    L K L + +   D       +  +   L+Y+H   SA V
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH---SANV 145
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEGR-V 571
           +H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     +  
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 205
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           + + D++S G +L E  + +     IF G    KH+++
Sbjct: 206 TKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVEC-----EMMKSI 445
           D F     +G GSFG V   + +  G   AMK+ + Q  +V K  ++E       +++++
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKEIEHTLNEKRILQAV 98
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
               ++K+  S  +     +V+EY P G +  +L       + + R      +    EYL
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYL 157
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMA 562
           H   S  +I+ DLKP N+++D      ++DFG+AK         ++ +T    G   Y+A
Sbjct: 158 H---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAK--------RVKGRTWXLCGTPEYLA 206
Query: 563 PEYGKEGRVSANGDVYSFGIMLME 586
           PE       +   D ++ G+++ E
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYE 230

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNII---KVI 454
           IG G++G V  A    + + VA+K  +  ++    +    E +++   RH NII    +I
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            + + E+ K + +++ +    L K L + +   D       +  +   L+Y+H   SA V
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH---SANV 165
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEGR-V 571
           +H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     +  
Sbjct: 166 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 225
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           + + D++S G +L E  + +     IF G    KH+++
Sbjct: 226 TKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 255

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 108/218 (49%), Gaps = 21/218 (9%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNII---KVI 454
           IG G++G V  A    + + VA+K  +  ++    +    E +++   RH NII    +I
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            + + E+ K + +++ +    L K L + +   D       +  +   L+Y+H   SA V
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--HICYFLYQILRGLKYIH---SANV 143
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEGR-V 571
           +H DLKPSN+LL+      + DFG+A++   + D +   T+ +AT  Y APE     +  
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 203
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           + + D++S G +L E  + +     IF G    KH+++
Sbjct: 204 TKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 233

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 41/282 (14%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRN--IIKVIS 455
           IG G    VF+         A+K  NL+    +   S+  E   +  ++  +  II++  
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               +++  +V+E   +  L  +L     I D ++R +      + LE +H  +   ++H
Sbjct: 80  YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 134
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS-AN 574
            DLKP+N L+ D M+  L DFGIA  +  +  S ++   + T+ YM PE  K+   S  N
Sbjct: 135 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 193
Query: 575 G----------DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
           G          DV+S G +L      K P  +I N    L              I+DPN 
Sbjct: 194 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL------------HAIIDPN- 240
Query: 625 LSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT 665
               +I F    E+ +  V      C    P+QRI+  E++ 
Sbjct: 241 ---HEIEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELLA 276

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 116
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKI 233
Query: 615 ST 616
            +
Sbjct: 234 DS 235

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 116
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 615 ST 616
            +
Sbjct: 234 DS 235

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 72
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 116
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 615 ST 616
            +
Sbjct: 234 DS 235

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGH 73
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 117
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 174
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 615 ST 616
            +
Sbjct: 235 DS 236

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVEC-----EMMKSI 445
           D F     +G GSFG V   + +  G   AMK+ + Q  +V K  ++E       +++++
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ--KVVKLKEIEHTLNEKRILQAV 98
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
               ++K+  S  +     +V+EY P G +  +L       + + R      +    EYL
Sbjct: 99  NFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYL 157
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMA 562
           H   S  +I+ DLKP N+++D      ++DFG+AK         ++ +T    G   Y+A
Sbjct: 158 H---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAK--------RVKGRTWXLCGTPEYLA 206
Query: 563 PEYGKEGRVSANGDVYSFGIMLME 586
           PE       +   D ++ G+++ E
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYE 230

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 123/281 (43%), Gaps = 39/281 (13%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRN--IIKVIS 455
           IG G    VF+         A+K  NL+    +   S+  E   +  ++  +  II++  
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               +++  +V+E   +  L  +L     I D ++R +      + LE +H  +   ++H
Sbjct: 76  YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 130
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS-AN 574
            DLKP+N L+ D M+  L DFGIA  +  +  S ++   + T+ YM PE  K+   S  N
Sbjct: 131 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 189
Query: 575 G----------DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
           G          DV+S G +L      K P  +I N +++  H + D       EI  P+ 
Sbjct: 190 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLHAIID----PNHEIEFPD- 243
Query: 625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT 665
           +  +D+  V K  C          C    P+QRI+  E++ 
Sbjct: 244 IPEKDLQDVLK--C----------CLKRDPKQRISIPELLA 272

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY P G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+++D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY P G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+++D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG GS G V  A +   G  VA+K  +L+  +  +    E  +M+  +H N++++ +S  
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  ++LL  +    LSDFG    +++E     +   + T  +MAPE           D++
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVDIW 204
Query: 579 SFGIMLMETFTRKKP 593
           S GIM++E    + P
Sbjct: 205 SLGIMVIEMVDGEPP 219

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG GS G V  A +   G  VA+K  +L+  +  +    E  +M+  +H N++++ +S  
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  ++LL  +    LSDFG    +++E     +   + T  +MAPE           D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKXLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 579 SFGIMLMETFTRKKP 593
           S GIM++E    + P
Sbjct: 201 SLGIMVIEMVDGEPP 215

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG GS G V  A +   G  VA+K  +L+  +  +    E  +M+  +H N++++ +S  
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  ++LL  +    LSDFG    +++E     +   + T  +MAPE           D++
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 211
Query: 579 SFGIMLMETFTRKKP 593
           S GIM++E    + P
Sbjct: 212 SLGIMVIEMVDGEPP 226

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 41/282 (14%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRN--IIKVIS 455
           IG G    VF+         A+K  NL+    +   S+  E   +  ++  +  II++  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               +++  +V+E   +  L  +L     I D ++R +      + LE +H  +   ++H
Sbjct: 96  YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 150
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS-AN 574
            DLKP+N L+ D M+  L DFGIA  +  +  S ++   + T+ YM PE  K+   S  N
Sbjct: 151 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 575 G----------DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
           G          DV+S G +L      K P  +I N    L              I+DPN 
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL------------HAIIDPN- 256
Query: 625 LSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT 665
               +I F    E+ +  V      C    P+QRI+  E++ 
Sbjct: 257 ---HEIEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELLA 292

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 8/195 (4%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG GS G V  A +   G  VA+K  +L+  +  +    E  +M+  +H N++++ +S  
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 151
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  ++LL  +    LSDFG    +++E     +   + T  +MAPE           D++
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 209
Query: 579 SFGIMLMETFTRKKP 593
           S GIM++E    + P
Sbjct: 210 SLGIMVIEMVDGEPP 224

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 28/219 (12%)
Query: 390 ATDGFS---------ENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDVEC 439
           +TD FS         + +++G G+   V     L    E A+K+   Q G +      E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61
Query: 440 EMMKSIR-HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDV 498
           EM+   + HRN++++I     E+   LV E M  GS+  ++H   +  ++   + ++ DV
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDV 120
Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLLDD-NMVA--HLSDFGIAK-LLTREDQSTIQTQT 554
           ASAL++LH   +  + H DLKP N+L +  N V+   + DF +   +    D S I T  
Sbjct: 121 ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177
Query: 555 LAT----IGYMAPE----YGKEGRV-SANGDVYSFGIML 584
           L T      YMAPE    + +E  +     D++S G++L
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 109/230 (47%), Gaps = 16/230 (6%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG GS G V  A +   G  VA+K  +L+  +  +    E  +M+  +H N++++ +S  
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             +   +V+E++  G+L   +  +   ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 196
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  ++LL  +    LSDFG    +++E     +   + T  +MAPE           D++
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 254
Query: 579 SFGIMLMETFTRKKPTDEIFNGEMTLK--HWVNDWLPISTKEI--VDPNL 624
           S GIM++E    + P    FN E  LK    + D LP   K +  V P+L
Sbjct: 255 SLGIMVIEMVDGEPP---YFN-EPPLKAMKMIRDNLPPRLKNLHKVSPSL 300

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  + +++  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +VLEY P G +  +L       + + R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYLAPE 209
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 41/282 (14%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRN--IIKVIS 455
           IG G    VF+         A+K  NL+    +   S+  E   +  ++  +  II++  
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               +++  +V+E   +  L  +L     I D ++R +      + LE +H  +   ++H
Sbjct: 77  YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 131
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS-AN 574
            DLKP+N L+ D M+  L DFGIA  +  +  S ++   + T+ YM PE  K+   S  N
Sbjct: 132 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190
Query: 575 G----------DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
           G          DV+S G +L      K P  +I N    L              I+DPN 
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL------------HAIIDPN- 237
Query: 625 LSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT 665
               +I F    E+ +  V      C    P+QRI+  E++ 
Sbjct: 238 ---HEIEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELLA 273

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 116
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 615 ST 616
            +
Sbjct: 234 DS 235

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDI-YQRLNIMIDVASALEYLHFGYSAQVIH 515
                 + L LEY   G L   +     + +   QR      + + + YLH      + H
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITH 127
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+APE  K     A  
Sbjct: 128 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 187
Query: 576 -DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPIST 616
            DV+S GI+L      + P D+  +       W      +N W  I +
Sbjct: 188 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 235

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 116
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 615 ST 616
            +
Sbjct: 234 DS 235

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 117
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 615 ST 616
            +
Sbjct: 235 DS 236

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 116
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 615 ST 616
            +
Sbjct: 234 DS 235

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 116
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 615 ST 616
            +
Sbjct: 234 DS 235

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 116
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 615 ST 616
            +
Sbjct: 234 DS 235

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 123/282 (43%), Gaps = 41/282 (14%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRN--IIKVIS 455
           IG G    VF+         A+K  NL+    +   S+  E   +  ++  +  II++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               +++  +V+E   +  L  +L     I D ++R +   ++   LE +H  +   ++H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYWKNM---LEAVHTIHQHGIVH 178
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS-AN 574
            DLKP+N L+ D M+  L DFGIA  +  +  S ++   + T+ YM PE  K+   S  N
Sbjct: 179 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 237
Query: 575 G----------DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
           G          DV+S G +L      K P  +I N +++  H            I+DPN 
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLH-----------AIIDPN- 284
Query: 625 LSREDINFVA-KEQCVSFVFNVAMECTVESPEQRINAKEIVT 665
               +I F    E+ +  V      C    P+QRI+  E++ 
Sbjct: 285 ---HEIEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELLA 320

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY P G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+++D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 13  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 115
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 116 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 615 ST 616
            +
Sbjct: 233 DS 234

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 117
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 615 ST 616
            +
Sbjct: 235 DS 236

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 41/282 (14%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRN--IIKVIS 455
           IG G    VF+         A+K  NL+    +   S+  E   +  ++  +  II++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               +++  +V+E   +  L  +L     I D ++R +      + LE +H  +   ++H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 178
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS-AN 574
            DLKP+N L+ D M+  L DFGIA  +  +  S ++   + T+ YM PE  K+   S  N
Sbjct: 179 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 237
Query: 575 G----------DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
           G          DV+S G +L      K P  +I N    L              I+DPN 
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL------------HAIIDPN- 284
Query: 625 LSREDINFVA-KEQCVSFVFNVAMECTVESPEQRINAKEIVT 665
               +I F    E+ +  V      C    P+QRI+  E++ 
Sbjct: 285 ---HEIEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELLA 320

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 17/228 (7%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDI-YQRLNIMIDVASALEYLHFGYSAQVIH 515
                 + L LEY   G L   +     + +   QR      + + + YLH      + H
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGVVYLH---GIGITH 128
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+APE  K     A  
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEP 188
Query: 576 -DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPIST 616
            DV+S GI+L      + P D+  +       W      +N W  I +
Sbjct: 189 VDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IG GS G V  A +   G  VA+K  +L+  +  +    E  +M+  +H N++++ +S  
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
             +   +V+E++  G+L   +  ++  ++  Q   + + V  AL  LH   +  VIH D+
Sbjct: 219 VGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           K  ++LL  +    LSDFG    +++E     +   + T  +MAPE           D++
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYGPEVDIW 331
Query: 579 SFGIMLMETFTRKKP 593
           S GIM++E    + P
Sbjct: 332 SLGIMVIEMVDGEPP 346

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 116
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 615 ST 616
            +
Sbjct: 234 DS 235

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           IG G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 204
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 205 YNQTVDIWSVGCIMAELLT 223

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 116
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 615 ST 616
            +
Sbjct: 234 DS 235

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 16/209 (7%)
Query: 391 TDGFSENNLIGRGSFGSVFKARL--GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHR 448
           TDG+     IG GS+ SV K  +     ME A+K+ +       +  ++   +++  +H 
Sbjct: 21  TDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQHP 76
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NII +     + ++  +V E M  G L   +    +  +  +   ++  +   +EYLH  
Sbjct: 77  NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-REASAVLFTITKTVEYLH-- 133
Query: 509 YSAQVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
            +  V+H DLKPSN+L  D         + DFG AK L R +   + T    T  ++APE
Sbjct: 134 -AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMTPCY-TANFVAPE 190
Query: 565 YGKEGRVSANGDVYSFGIMLMETFTRKKP 593
             +     A  D++S G++L    T   P
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V  A    + + VA+K  +  ++    +    E +++   RH NII +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 90
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLN------IMIDVASALEYLHFGYS 510
            N+  +A  +E M    + + L  ++ Y L   Q L+       +  +   L+Y+H   S
Sbjct: 91  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 146
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEG 569
           A V+H DLKPSN+LL+      + DFG+A++   + D +    + +AT  Y APE     
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 206
Query: 570 R-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           +  + + D++S G +L E  + +     IF G    KH+++
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 239

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 27/221 (12%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG G++G V  A    + + VA+K  +  ++    +    E +++   RH NII +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 91
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLN------IMIDVASALEYLHFGYS 510
            N+  +A  +E M    + + L  ++ Y L   Q L+       +  +   L+Y+H   S
Sbjct: 92  -NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---S 147
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEG 569
           A V+H DLKPSN+LL+      + DFG+A++   + D +    + +AT  Y APE     
Sbjct: 148 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 207
Query: 570 R-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           +  + + D++S G +L E  + +     IF G    KH+++
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNRP----IFPG----KHYLD 240

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 117
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 615 ST 616
            +
Sbjct: 235 DS 236

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 117
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 615 ST 616
            +
Sbjct: 235 DS 236

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 99/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 117
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 615 ST 616
            +
Sbjct: 235 DS 236

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY P G +  +L       + + R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+++D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 209
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGXVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 88/178 (49%), Gaps = 14/178 (7%)
Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMK-SIRHRNIIK 452
           F   +++G G+ G++    + D  +VA+K         F   D E ++++ S  H N+I+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIR 82
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
              +  + +F+ + +E     +L++Y+   ++     + + ++    S L +LH   S  
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 513 VIHCDLKPSNVLLD-----DNMVAHLSDFGIAKLLTREDQS-TIQTQTLATIGYMAPE 564
           ++H DLKP N+L+        + A +SDFG+ K L     S + ++    T G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNAMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFD------VECEMMKSIR 446
           F    L+G+G+FG V   R    G   AMK+   +   V  + D       E  ++++ R
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE---VIIAKDEVAHTVTESRVLQNTR 63
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM-IDVASALEYL 505
           H  +  +  +    +    V+EY   G L  + H S   +   +R      ++ SALEYL
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S  V++ D+K  N++LD +    ++DFG+ K     D +T++T    T  Y+APE 
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKT-FCGTPEYLAPEV 176
Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP 593
            ++       D +  G+++ E    + P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 391 TDGFSENNLIGRGSFGSVF--KARLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSI 445
           +D +    ++G+GSFG V   K ++  G E A+KV +   ++     +S   E +++K +
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 89
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H NI+K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 148
Query: 506 HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           H     +++H DLKP N+LL+    +    + DFG++   T  + S      + T  Y+A
Sbjct: 149 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIA 202
Query: 563 PEYGKEGRVSANGDVYSFGIML 584
           PE    G      DV+S G++L
Sbjct: 203 PEV-LHGTYDEKCDVWSTGVIL 223

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMH 206
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 207 YNQTVDIWSVGCIMAELLT 225

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 83/187 (44%), Gaps = 9/187 (4%)
Query: 400 IGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G+FG V +      G     K  N  Y     +   E  +M  + H  +I +  +  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
           ++    L+LE++  G L   + + +Y +   + +N M      L+++H      ++H D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 175
Query: 519 KPSNVLLDDNMVAHLS--DFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGD 576
           KP N++ +    + +   DFG+A   T+ +   I   T AT  + APE      V    D
Sbjct: 176 KPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTD 232
Query: 577 VYSFGIM 583
           +++ G++
Sbjct: 233 MWAIGVL 239

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFD------VECEMMKSIR 446
           F    L+G+G+FG V   R    G   AMK+   +   V  + D       E  ++++ R
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE---VIIAKDEVAHTVTESRVLQNTR 63
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM-IDVASALEYL 505
           H  +  +  +    +    V+EY   G L  + H S   +   +R      ++ SALEYL
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S  V++ D+K  N++LD +    ++DFG+ K     D +T++T    T  Y+APE 
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKT-FCGTPEYLAPEV 176
Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP 593
            ++       D +  G+++ E    + P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMH 206
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 207 YNQTVDIWSVGCIMAELLT 225

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMH 206
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 207 YNQTVDIWSVGCIMAELLT 225

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 142
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 143 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 197
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 198 YNQTVDIWSVGCIMAELLT 216

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 400 IGRGSFGSVFKARLGD---GMEVAMKVFNLQYGRVFKSFD-VECEMMKSIRHRNIIKVIS 455
           +GRGSFG V   R+ D   G + A+K   L+   VF++ + + C  + S R   I+ +  
Sbjct: 101 LGRGSFGEVH--RMEDKQTGFQCAVKKVRLE---VFRAEELMACAGLTSPR---IVPLYG 152
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
           +     +  + +E +  GSL + +      L   + L  +      LEYLH   S +++H
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLVKEQG-CLPEDRALYYLGQALEGLEYLH---SRRILH 208
Query: 516 CDLKPSNVLL-DDNMVAHLSDFGIAKLLTRE--DQSTIQTQTL-ATIGYMAPEYGKEGRV 571
            D+K  NVLL  D   A L DFG A  L  +   +S +    +  T  +MAPE       
Sbjct: 209 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSC 268
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
            A  DV+S   M++       P  + F G + LK
Sbjct: 269 DAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 302

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFD------VECEMMKSIR 446
           F    L+G+G+FG V   R    G   AMK+   +   V  + D       E  ++++ R
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE---VIIAKDEVAHTVTESRVLQNTR 66
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM-IDVASALEYL 505
           H  +  +  +    +    V+EY   G L  + H S   +   +R      ++ SALEYL
Sbjct: 67  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYL 124
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S  V++ D+K  N++LD +    ++DFG+ K     D +T++T    T  Y+APE 
Sbjct: 125 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKT-FCGTPEYLAPEV 179
Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP 593
            ++       D +  G+++ E    + P
Sbjct: 180 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFD---VECEMMKSIRHRNIIKVI 454
           +IGRGS+  V   RL     + AMKV   +     +  D    E  + +   +   +  +
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            SC   E +   V+EY+  G L  ++     + + + R     +++ AL YLH      +
Sbjct: 76  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 131
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           I+ DLK  NVLLD      L+D+G+ K   R   +T  +    T  Y+APE  +      
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--SXFCGTPNYIAPEILRGEDYGF 189
Query: 574 NGDVYSFGIMLMETFTRKKPTD 595
           + D ++ G+++ E    + P D
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFD 211

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 103/231 (44%), Gaps = 30/231 (12%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMK-----VFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +GRG++G V K R +  G  +A+K     V + +  R+    D+    M+++     +  
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 115
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL------NIMIDVASALEYLHF 507
             +   E    + +E M   SL+K+      ++D  Q +       I + +  ALE+LH 
Sbjct: 116 YGALFREGDVWICMELM-DTSLDKFYKQ---VIDKGQTIPEDILGKIAVSIVKALEHLHS 171
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA----- 562
             S  VIH D+KPSNVL++      + DFGI+  L     S  +T       YMA     
Sbjct: 172 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLV---DSVAKTIDAGCKPYMAPERIN 226
Query: 563 PEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
           PE  ++G  S   D++S GI ++E    + P D        LK  V +  P
Sbjct: 227 PELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 276

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 141
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 196
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 197 YNQTVDIWSVGCIMAELLT 215

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 195
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 196 YNQTVDIWSVGCIMAELLT 214

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             + K+  S  +     +V+EY P G +  +L       + + R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+++D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 209
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFD---VECEMMKSIRHRNIIKVI 454
           +IGRGS+  V   RL     + AMKV   +     +  D    E  + +   +   +  +
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            SC   E +   V+EY+  G L  ++     + + + R     +++ AL YLH      +
Sbjct: 72  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 127
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           I+ DLK  NVLLD      L+D+G+ K   R   +T  +    T  Y+APE  +      
Sbjct: 128 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--SXFCGTPNYIAPEILRGEDYGF 185
Query: 574 NGDVYSFGIMLMETFTRKKPTD 595
           + D ++ G+++ E    + P D
Sbjct: 186 SVDWWALGVLMFEMMAGRSPFD 207

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 150 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 204
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 205 YNQTVDIWSVGCIMAELLT 223

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 141
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 142 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 196
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 197 YNQTVDIWSVGCIMAELLT 215

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPEYG 566
             S  +I+ DLKP N+L+D      ++DFG AK +        +T  LA T  Y+APE  
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWXLAGTPEYLAPEII 210
Query: 567 KEGRVSANGDVYSFGIMLME 586
                +   D ++ G+++ E
Sbjct: 211 LSKGYNKAVDWWALGVLIYE 230

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 155
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 156 DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 210
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 211 YNQTVDIWSVGCIMAELLT 229

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFD---VECEMMKSIRHRNIIKVI 454
           +IGRGS+  V   RL     + AMKV   +     +  D    E  + +   +   +  +
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            SC   E +   V+EY+  G L  ++     + + + R     +++ AL YLH      +
Sbjct: 87  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 142
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           I+ DLK  NVLLD      L+D+G+ K   R   +T  +    T  Y+APE  +      
Sbjct: 143 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--SXFCGTPNYIAPEILRGEDYGF 200
Query: 574 NGDVYSFGIMLMETFTRKKPTD 595
           + D ++ G+++ E    + P D
Sbjct: 201 SVDWWALGVLMFEMMAGRSPFD 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 201
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 202 YNQTVDIWSVGCIMAELLT 220

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 12/152 (7%)
Query: 438 ECEMMKSIRHRNIIKVISSCS--NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM 495
           E  ++K + H N++K++      NE+   +V E +  G + +         D  Q     
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED--QARFYF 143
Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
            D+   +EYLH+    ++IH D+KPSN+L+ ++    ++DFG++      D   + + T+
Sbjct: 144 QDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTV 198
Query: 556 ATIGYMAPEYGKEGRVSANG---DVYSFGIML 584
            T  +MAPE   E R   +G   DV++ G+ L
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 90/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 145
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D+     ++DFG AK         ++ +T    G   Y+APE
Sbjct: 146 --SLDLIYRDLKPENLLIDEQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 195
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 196 IILSKGYNKAVDWWALGVLIYE 217

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 204
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 205 YNQTVDIWSVGCIMAELLT 223

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 400 IGRGSFGSVFK-ARLGDGMEVAMK-----VFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           IGRG++GSV K      G  +A+K     V   +  ++    DV   +M+S     I++ 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV---VMRSSDCPYIVQF 86
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD--IYQRLNIMIDVASALEYLHFGYSA 511
             +   E    + +E M   S +K+      +LD  I + +   I +A+     H   + 
Sbjct: 87  YGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY-----G 566
           ++IH D+KPSN+LLD +    L DFGI+  L     S  +T+      YMAPE       
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKP 593
           ++G      DV+S GI L E  T + P
Sbjct: 203 RQG-YDVRSDVWSLGITLYELATGRFP 228

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 163
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 218
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 219 YNQTVDIWSVGCIMAELLT 237

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 149
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 150 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 204
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 205 YNQTVDIWSVGCIMAELLT 223

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 201
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 202 YNQTVDIWSVGCIMAELLT 220

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 143
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 144 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 198
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 199 YNQTVDIWSVGCIMAELLT 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 156
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 211
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 212 YNQTVDIWSVGCIMAELLT 230

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 147 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 201
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 202 YNQTVDIWSVGCIMAELLT 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 156
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 211
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 212 YNQTVDIWSVGCIMAELLT 230

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 89/200 (44%), Gaps = 15/200 (7%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 179
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPEYG 566
             S  +I+ DLKP N+L+D      ++DFG AK +         T TL  T  Y+APE  
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------ATWTLCGTPEYLAPEII 231
Query: 567 KEGRVSANGDVYSFGIMLME 586
                +   D ++ G+++ E
Sbjct: 232 LSKGYNKAVDWWALGVLIYE 251

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 153
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 154 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 203
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 204 IILSKGYNKAVDWWALGVLIYE 225

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   + S     D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+ +    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 14/192 (7%)
Query: 399 LIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDV--ECEMMKSIRHRNIIKVIS 455
           ++G+GSFG V K +      E A+KV N    +   +  +  E E++K + H NI+K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
              +     +V E    G L   +       + +    I+  V S + Y+H      ++H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 516 CDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            DLKP N+LL   + +    + DFG++       Q+T     + T  Y+APE  + G   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLR-GTYD 200
Query: 573 ANGDVYSFGIML 584
              DV+S G++L
Sbjct: 201 EKCDVWSAGVIL 212

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 146
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 147 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 201
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 202 YNQTVDIWSVGCIMAELLT 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 164
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 219
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 220 YNQTVDIWSVGCIMAELLT 238

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 167
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 222
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 223 YNQTVDIWSVGCIMAELLT 241

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 389 RATDGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSI 445
           R T+ +     +G+G+F  V +  ++  G E A  + N +    R  +  + E  + + +
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           +H NI+++  S S E    L+ + +  G L + + +  Y    Y   +    +   LE +
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAV 123
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNM---VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
              +   V+H +LKP N+LL   +      L+DFG+A  +  E Q+        T GY++
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYLS 181
Query: 563 PEYGKEGRVSANGDVYSFGIML 584
           PE  ++       D+++ G++L
Sbjct: 182 PEVLRKDPYGKPVDLWACGVIL 203

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 155
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 156 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 210
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 211 YNQTVDIWSVGCIMAELLT 229

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 14/192 (7%)
Query: 399 LIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDV--ECEMMKSIRHRNIIKVIS 455
           ++G+GSFG V K +      E A+KV N    +   +  +  E E++K + H NI+K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
              +     +V E    G L   +       + +    I+  V S + Y+H      ++H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 516 CDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            DLKP N+LL   + +    + DFG++       Q+T     + T  Y+APE  + G   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLR-GTYD 200
Query: 573 ANGDVYSFGIML 584
              DV+S G++L
Sbjct: 201 EKCDVWSAGVIL 212

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 151
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 206
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 207 YNQTVDIWSVGCIMAELLT 225

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 156
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 157 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 211
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 212 YNQTVDIWSVGCIMAELLT 230

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 205
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 206 YNQTVDIWSVGCIMAELLT 224

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  +  +  G+++A+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 173
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 174 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 228
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 229 YNMTVDIWSVGCIMAELLT 247

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 25/221 (11%)
Query: 399 LIGRGSFGSVFKA-RLGDGMEVAMKVF--NLQYGRVFKSFDVECEMMKSI--------RH 447
           L+G+G FG+VF   RL D ++VA+KV   N   G    S  V C +  ++         H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 448 RNIIKVISSCSNEEFKALVLEY-MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
             +I+++     +E   LVLE  +P   L  Y+     + +   R      V +A+++ H
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC-FFGQVVAAIQHCH 156
Query: 507 FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
              S  V+H D+K  N+L+D     A L DFG   LL  E  +        T  Y  PE+
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----GTRVYSPPEW 209
Query: 566 GKEGRVSA-NGDVYSFGIMLMETFTRKKPTD---EIFNGEM 602
               +  A    V+S GI+L +      P +   EI   E+
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL 250

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 41/282 (14%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRN--IIKVIS 455
           IG G    VF+         A+K  NL+    +   S+  E   +  ++  +  II++  
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               +++  +V+E   +  L  +L     I D ++R +      + LE +H  +   ++H
Sbjct: 96  YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYW---KNMLEAVHTIHQHGIVH 150
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS-AN 574
            DLKP+N L+ D M+  L DFGIA  +  +    ++   + T+ YM PE  K+   S  N
Sbjct: 151 SDLKPANFLIVDGMLK-LIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSREN 209
Query: 575 G----------DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
           G          DV+S G +L      K P  +I N    L              I+DPN 
Sbjct: 210 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL------------HAIIDPN- 256
Query: 625 LSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT 665
               +I F    E+ +  V      C    P+QRI+  E++ 
Sbjct: 257 ---HEIEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELLA 292

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 88/192 (45%), Gaps = 14/192 (7%)
Query: 399 LIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDV--ECEMMKSIRHRNIIKVIS 455
           ++G+GSFG V K +      E A+KV N    +   +  +  E E++K + H NI+K+  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
              +     +V E    G L   +       + +    I+  V S + Y+H      ++H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE-HDAARIIKQVFSGITYMH---KHNIVH 144
Query: 516 CDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
            DLKP N+LL   + +    + DFG++       Q+T     + T  Y+APE  + G   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQ---QNTKMKDRIGTAYYIAPEVLR-GTYD 200
Query: 573 ANGDVYSFGIML 584
              DV+S G++L
Sbjct: 201 EKCDVWSAGVIL 212

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 151 DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 205
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 206 YNQTVDIWSVGCIMAELLT 224

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 99/247 (40%), Gaps = 55/247 (22%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI------RHRNII 451
           +G G++G V  A  R+ +   VA+K+ +++     ++ D    + K I       H N++
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-VAVKIVDMK-----RAVDCPENIKKEICINAMLNHENVV 68
Query: 452 KVISSCSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMI 496
           K          + L LEY               MP    +++ H                
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ--------------- 113
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            + + + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   
Sbjct: 114 -LMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 169
Query: 557 TIGYMAPEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VN 609
           T+ Y+APE  K     A   DV+S GI+L      + P D+  +       W      +N
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 610 DWLPIST 616
            W  I +
Sbjct: 230 PWKKIDS 236

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 21/227 (9%)
Query: 366 GPPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVF--KARLGDGMEVAMKV 423
           GP +  +  P     MF        +D +    ++G+GSFG V   K ++  G E A+KV
Sbjct: 27  GPGDHLHATP----GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKV 81
Query: 424 FN---LQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH 480
            +   ++     +S   E +++K + H NI+K+     ++ +  LV E    G L   + 
Sbjct: 82  ISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 141
Query: 481 SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFG 537
           S     ++     I+  V S + Y+H     +++H DLKP N+LL+    +    + DFG
Sbjct: 142 SRKRFSEV-DAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFG 197
Query: 538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
           ++   T  + S      + T  Y+APE    G      DV+S G++L
Sbjct: 198 LS---THFEASKKMKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVIL 240

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 179
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 229
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 230 IILSKGYNKAVDWWALGVLIYE 251

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 21/227 (9%)
Query: 366 GPPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVF--KARLGDGMEVAMKV 423
           GP +  +  P     MF        +D +    ++G+GSFG V   K ++  G E A+KV
Sbjct: 28  GPGDHLHATP----GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKV 82
Query: 424 FN---LQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH 480
            +   ++     +S   E +++K + H NI+K+     ++ +  LV E    G L   + 
Sbjct: 83  ISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 142
Query: 481 SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFG 537
           S     ++     I+  V S + Y+H     +++H DLKP N+LL+    +    + DFG
Sbjct: 143 SRKRFSEV-DAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFG 198
Query: 538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
           ++   T  + S      + T  Y+APE    G      DV+S G++L
Sbjct: 199 LS---THFEASKKMKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVIL 241

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             + K+  S  +     +V+EY P G +  +L       + + R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+++D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 209
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 88/202 (43%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             + K+  S  +     +V+EY P G +  +L       + + R      +    EYLH 
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+++D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 209
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R  G G E A K    +       G   +  + E  +++ 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           IRH NII +     N+    L+LE +  G L  +L     + +  +    +  +   + Y
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEATQFLKQILDGVHY 123
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S ++ H DLKP N++L D  V +    L DFGIA  +   ++         T  +
Sbjct: 124 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEF 177
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVI 200

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 391 TDGFSENNLIGRGSFGSVF--KARLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSI 445
           +D +    ++G+GSFG V   K ++  G E A+KV +   ++     +S   E +++K +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H NI+K+     ++ +  LV E    G L   + S     ++     I+  V S + Y+
Sbjct: 84  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYM 142
Query: 506 HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           H     +++H DLKP N+LL+    +    + DFG++   T  + S      + T  Y+A
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIA 196
Query: 563 PEYGKEGRVSANGDVYSFGIML 584
           PE    G      DV+S G++L
Sbjct: 197 PEV-LHGTYDEKCDVWSTGVIL 217

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 205
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 206 YNQTVDIWSVGCIMAELLT 224

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +GRGSFG V + +    G + A+K   L+  RV +   V C  + S R   I+ +  +  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 120
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
              +  + +E +  GSL + +      L   + L  +      LEYLH   + +++H D+
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDV 176
Query: 519 KPSNVLL-DDNMVAHLSDFGIAKLLTRE--DQSTIQTQTL-ATIGYMAPEYGKEGRVSAN 574
           K  NVLL  D   A L DFG A  L  +   +S +    +  T  +MAPE        A 
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236
Query: 575 GDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
            D++S   M++       P  + F G + LK
Sbjct: 237 VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 90/202 (44%), Gaps = 11/202 (5%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFD---VECEMMKSIRHRNIIKVI 454
           +IGRGS+  V   RL     + AM+V   +     +  D    E  + +   +   +  +
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 455 SSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
            SC   E +   V+EY+  G L  ++     + + + R     +++ AL YLH      +
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 174
Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           I+ DLK  NVLLD      L+D+G+ K   R   +T  +    T  Y+APE  +      
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STFCGTPNYIAPEILRGEDYGF 232
Query: 574 NGDVYSFGIMLMETFTRKKPTD 595
           + D ++ G+++ E    + P D
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFD 254

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   + +  G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R  G G E A K    +       G   +  + E  +++ 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           IRH NII +     N+    L+LE +  G L  +L     + +  +    +  +   + Y
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEATQFLKQILDGVHY 130
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S ++ H DLKP N++L D  V +    L DFGIA  +   ++         T  +
Sbjct: 131 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEF 184
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLXGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMK------VFNLQYGRVFKSFDVECEMMKS 444
           D +     +G G F  V K R  G G E A K      + + + G   +  + E  +++ 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           IRH NII +     N+    L+LE +  G L  +L     + +  +    +  +   + Y
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEATQFLKQILDGVHY 144
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S ++ H DLKP N++L D  V +    L DFGIA  +   ++         T  +
Sbjct: 145 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEF 198
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 199 VAPEIVNYEPLGLEADMWSIGVI 221

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 391 TDGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRN 449
           +DG+     IG GS+    +       ME A+KV +    +   S ++E  +++  +H N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVID--KSKRDPSEEIEI-LLRYGQHPN 82
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           II +     + +   LV E M  G L   +    +  +      ++  +   +EYLH   
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTVEYLH--- 138
Query: 510 SAQVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           S  V+H DLKPSN+L  D         + DFG AK L R +   + T    T  ++APE 
Sbjct: 139 SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQL-RAENGLLMTPCY-TANFVAPEV 196
Query: 566 GKEGRVSANGDVYSFGIML 584
            K        D++S GI+L
Sbjct: 197 LKRQGYDEGCDIWSLGILL 215

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 159
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 209
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G  VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +  +    D  Q L  +  +   L+Y+H   SA
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 195
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 196 YNQTVDIWSVGCIMAELLT 214

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 384 YLELCRATDGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDVECEMM 442
           Y +    +DG+     IG GS+    +       ME A+KV +    +   S ++E  ++
Sbjct: 19  YFQSMVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVID--KSKRDPSEEIEI-LL 75
Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
           +  +H NII +     + +   LV E M  G L   +    +  +      ++  +   +
Sbjct: 76  RYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-VLHTIGKTV 134
Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLLTREDQSTIQTQTLATI 558
           EYLH   S  V+H DLKPSN+L  D         + DFG AK L R +   + T    T 
Sbjct: 135 EYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQL-RAENGLLMTPCY-TA 189
Query: 559 GYMAPEYGKEGRVSANGDVYSFGIML 584
            ++APE  K        D++S GI+L
Sbjct: 190 NFVAPEVLKRQGYDEGCDIWSLGILL 215

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 397 NNLIGRGSFGSVFKA---RLGD-----GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHR 448
           N  +G+G+F  +FK     +GD       EV +KV +  +    +SF     MM  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           +++     C   +   LV E++  GSL+ YL  +   ++I  +L +   +A+A   +HF 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFL 129
Query: 509 YSAQVIHCDLKPSNVLL---DDNMVAH-----LSDFGIAKLLTREDQSTIQTQTLATIGY 560
               +IH ++   N+LL   +D    +     LSD GI+  +T   +  +Q +    I +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS--ITVLPKDILQER----IPW 183
Query: 561 MAPEYGKEGR-VSANGDVYSFGIMLME 586
           + PE  +  + ++   D +SFG  L E
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWE 210

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 122/282 (43%), Gaps = 41/282 (14%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRN--IIKVIS 455
           IG G    VF+         A+K  NL+    +   S+  E   +  ++  +  II++  
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               +++  +V+E   +  L  +L     I D ++R +   ++   LE +H  +   ++H
Sbjct: 124 YEITDQYIYMVME-CGNIDLNSWLKKKKSI-DPWERKSYWKNM---LEAVHTIHQHGIVH 178
Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS-AN 574
            DLKP+N L+ D M+  L DFGIA  +  +  S ++   +  + YM PE  K+   S  N
Sbjct: 179 SDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSREN 237
Query: 575 G----------DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
           G          DV+S G +L      K P  +I N +++  H            I+DPN 
Sbjct: 238 GKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QISKLH-----------AIIDPN- 284
Query: 625 LSREDINFVA-KEQCVSFVFNVAMECTVESPEQRINAKEIVT 665
               +I F    E+ +  V      C    P+QRI+  E++ 
Sbjct: 285 ---HEIEFPDIPEKDLQDVLKC---CLKRDPKQRISIPELLA 320

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +GRGSFG V + +    G + A+K   L+  RV +   V C  + S R   I+ +  +  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 136
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
              +  + +E +  GSL + +      L   + L  +      LEYLH   + +++H D+
Sbjct: 137 EGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDV 192
Query: 519 KPSNVLL-DDNMVAHLSDFGIAKLLTRE--DQSTIQTQTL-ATIGYMAPEYGKEGRVSAN 574
           K  NVLL  D   A L DFG A  L  +   +S +    +  T  +MAPE        A 
Sbjct: 193 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 252
Query: 575 GDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
            D++S   M++       P  + F G + LK
Sbjct: 253 VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 283

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 98/242 (40%), Gaps = 45/242 (18%)
Query: 400 IGRGSFGSVFKA--RLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G+ G V  A  R+ +   VA+K+ +++      ++   E  + K + H N++K    
Sbjct: 14  LGEGAAGEVQLAVNRVTEEA-VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 72
Query: 457 CSNEEFKALVLEY---------------MPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
                 + L LEY               MP    +++ H                 + + 
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQ----------------LMAG 116
Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 562 APEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW------VNDWLPI 614
           APE  K     A   DV+S GI+L      + P D+  +       W      +N W  I
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 233
Query: 615 ST 616
            +
Sbjct: 234 DS 235

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 20/236 (8%)
Query: 373 MPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRV 431
           MP E  ++  + L+  + TD F+   ++G+GSFG V  A R G     A+K+  L+   V
Sbjct: 1   MPSEDRKQPSNNLDRVKLTD-FNFLMVLGKGSFGKVMLADRKGTEELYAIKI--LKKDVV 57
Query: 432 FKSFDVECEMMKS-----IRHRNIIKVISSC-SNEEFKALVLEYMPHGSLEKYLHSSNYI 485
            +  DVEC M++      +     +  + SC    +    V+EY+  G L  ++      
Sbjct: 58  IQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKF 117
Query: 486 LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 545
            +  Q +    +++  L +LH      +I+ DLK  NV+LD      ++DFG+ K    +
Sbjct: 118 KEP-QAVFYAAEISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMD 173
Query: 546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
             +T   +   T  Y+APE         + D +++G++L E    + P    F+GE
Sbjct: 174 GVTT--REFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP----FDGE 223

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 22/202 (10%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGDGME------VAMKVFNLQYGRVFKSFDVECEMMKSI 445
           D +   +++G G+F  V  A      +      +A K    + G    S + E  ++  I
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG----SMENEIAVLHKI 73
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASALEY 504
           +H NI+ +     +     L+++ +  G L ++ +    Y      RL  +  V  A++Y
Sbjct: 74  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLDAVKY 131
Query: 505 LHFGYSAQVIHCDLKPSNVL---LDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           LH      ++H DLKP N+L   LD++    +SDFG++K+   ED  ++ +    T GY+
Sbjct: 132 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYV 185
Query: 562 APEYGKEGRVSANGDVYSFGIM 583
           APE   +   S   D +S G++
Sbjct: 186 APEVLAQKPYSKAVDCWSIGVI 207

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 14/211 (6%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +GRGSFG V + +    G + A+K   L+  RV +   V C  + S R   I+ +  +  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEEL--VACAGLSSPR---IVPLYGAVR 134
Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
              +  + +E +  GSL + +      L   + L  +      LEYLH   + +++H D+
Sbjct: 135 EGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDV 190
Query: 519 KPSNVLL-DDNMVAHLSDFGIAKLLTRE--DQSTIQTQTL-ATIGYMAPEYGKEGRVSAN 574
           K  NVLL  D   A L DFG A  L  +   +S +    +  T  +MAPE        A 
Sbjct: 191 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 250
Query: 575 GDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
            D++S   M++       P  + F G + LK
Sbjct: 251 VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 281

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G  VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 195
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 196 YNQTVDIWSVGCIMAELLT 214

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 101/224 (45%), Gaps = 29/224 (12%)
Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-ECEMMKSIR 446
           R    F     +GRG FG VF+A+   D    A+K   L    + +   + E + +  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 447 HRNIIKVISS------------CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQR--L 492
           H  I++  ++             S + +  + ++     +L+ +++    I +  +   L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTI- 550
           +I + +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+   + + E++ T+ 
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 551 --------QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
                    T  + T  YM+PE       S   D++S G++L E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + D+G+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G  VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 163
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 164 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 218
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 219 YNQTVDIWSVGCIMAELLT 237

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 20/214 (9%)
Query: 400 IGRGSFGSVFKARLGD---GMEVAMKVFNLQYGRVFKSFD-VECEMMKSIRHRNIIKVIS 455
           +GRGSFG V   R+ D   G + A+K   L+   VF++ + + C  + S R   I+ +  
Sbjct: 82  LGRGSFGEVH--RMEDKQTGFQCAVKKVRLE---VFRAEELMACAGLTSPR---IVPLYG 133
Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
           +     +  + +E +  GSL + +      L   + L  +      LEYLH   S +++H
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLVKEQG-CLPEDRALYYLGQALEGLEYLH---SRRILH 189
Query: 516 CDLKPSNVLL-DDNMVAHLSDFGIAKLLTREDQST---IQTQTLATIGYMAPEYGKEGRV 571
            D+K  NVLL  D   A L DFG A  L  +              T  +MAPE       
Sbjct: 190 GDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSC 249
Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
            A  DV+S   M++       P  + F G + LK
Sbjct: 250 DAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLK 283

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G  VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 164
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 219
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 220 YNQTVDIWSVGCIMAELLT 238

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G  VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 154
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 155 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 209
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 210 YNQTVDIWSVGCIMAELLT 228

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G  VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFD------VECEMMKSIR 446
           F    L+G+G+FG V   R    G   AMK+   +   V  + D       E  ++++ R
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE---VIIAKDEVAHTVTESRVLQNTR 63
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM-IDVASALEYL 505
           H  +  +  +    +    V+EY   G L  + H S   +   +R      ++ SALEYL
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S  V++ D+K  N++LD +    ++DFG+ K     D +T++     T  Y+APE 
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKX-FCGTPEYLAPEV 176
Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP 593
            ++       D +  G+++ E    + P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFD------VECEMMKSIR 446
           F    L+G+G+FG V   R    G   AMK+   +   V  + D       E  ++++ R
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE---VIIAKDEVAHTVTESRVLQNTR 63
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM-IDVASALEYL 505
           H  +  +  +    +    V+EY   G L  + H S   +   +R      ++ SALEYL
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S  V++ D+K  N++LD +    ++DFG+ K     D +T++     T  Y+APE 
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKX-FCGTPEYLAPEV 176
Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP 593
            ++       D +  G+++ E    + P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFD------VECEMMKSIR 446
           F    L+G+G+FG V   R    G   AMK+   +   V  + D       E  ++++ R
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE---VIIAKDEVAHTVTESRVLQNTR 68
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM-IDVASALEYL 505
           H  +  +  +    +    V+EY   G L  + H S   +   +R      ++ SALEYL
Sbjct: 69  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYL 126
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S  V++ D+K  N++LD +    ++DFG+ K     D +T++     T  Y+APE 
Sbjct: 127 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKX-FCGTPEYLAPEV 181
Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP 593
            ++       D +  G+++ E    + P
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFD------VECEMMKSIR 446
           F    L+G+G+FG V   R    G   AMK+   +   V  + D       E  ++++ R
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE---VIIAKDEVAHTVTESRVLQNTR 63
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM-IDVASALEYL 505
           H  +  +  +    +    V+EY   G L  + H S   +   +R      ++ SALEYL
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H   S  V++ D+K  N++LD +    ++DFG+ K     D +T++     T  Y+APE 
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKX-FCGTPEYLAPEV 176
Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP 593
            ++       D +  G+++ E    + P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 12/218 (5%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
            +G+G F   F+    D  EV A K+     L      +   +E  + +S+ H++++   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
               + +F  +VLE     SL + LH     L   +    +  +    +YLH     +VI
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 139
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPEYGKEGRVSA 573
           H DLK  N+ L++++   + DFG+A   T+ +    + +TL  T  Y+APE   +   S 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW 611
             DV+S G ++      K P +     E  L+   N++
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 234

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 98/202 (48%), Gaps = 21/202 (10%)
Query: 400 IGRGSFGSV---FKARLGDGMEVAMKVFNLQYGRVFKSFDV--ECEMMKSIRHRNIIKVI 454
           +G G++GSV   + ARL    +VA+K  +  +  +  +     E  ++K ++H N+I ++
Sbjct: 36  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 455 S----SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
                + S E+F  + L     G+    +  S  + D + +  ++  +   L+Y+H   S
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIH---S 149
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG- 569
           A +IH DLKPSNV ++++    + DFG+A+    E      T  +AT  Y APE      
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRAPEIMLNWM 204
Query: 570 RVSANGDVYSFGIMLMETFTRK 591
             +   D++S G ++ E    K
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGK 226

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+++D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLIIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IIISKGYNKAVDWWALGVLIYE 230

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 12/218 (5%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
            +G+G F   F+    D  EV A K+     L      +   +E  + +S+ H++++   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
               + +F  +VLE     SL + LH     L   +    +  +    +YLH     +VI
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 139
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPEYGKEGRVSA 573
           H DLK  N+ L++++   + DFG+A   T+ +    + +TL  T  Y+APE   +   S 
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW 611
             DV+S G ++      K P +     E  L+   N++
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 234

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 12/218 (5%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
            +G+G F   F+    D  EV A K+     L      +   +E  + +S+ H++++   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
               + +F  +VLE     SL + LH     L   +    +  +    +YLH     +VI
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 143
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPEYGKEGRVSA 573
           H DLK  N+ L++++   + DFG+A   T+ +    + +TL  T  Y+APE   +   S 
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF 200
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW 611
             DV+S G ++      K P +     E  L+   N++
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 238

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 167
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E    +     AT  Y APE       
Sbjct: 168 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYV-----ATRWYRAPEIMLNWMH 222
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 223 YNQTVDIWSVGCIMAELLT 241

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 398 NLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVEC-----EMMKSIRHRNII 451
            +IGRG+FG V   +L +  +V AMK+ N     + K  +  C     +++ +   + I 
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
            +  +  ++    LV++Y   G L   L      L        + ++  A++ +H     
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QL 194
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY-----G 566
             +H D+KP N+L+D N    L+DFG + L   ED +   +  + T  Y++PE      G
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKP 593
            +GR     D +S G+ + E    + P
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ +
Sbjct: 209 IILSKGYNKAVDWWALGVLIYQ 230

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 22/225 (9%)
Query: 390 ATDGFSENNLIGRGSFGSVFKARLGDGME-VAMKVFNLQYGR--VFKSFDVECEMMKSIR 446
           + D +     +G G++G V+KA      E VA+K   L++    V  +   E  ++K ++
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           HRNII++ S   +     L+ EY     L+KY+  +    D+  R+ I   +   +  ++
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNP---DVSMRV-IKSFLYQLINGVN 146
Query: 507 FGYSAQVIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           F +S + +H DLKP N+LL      +  V  + DFG+A+      +    T  + T+ Y 
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIITLWYR 204
Query: 562 APEYGKEGR-VSANGDVYS----FGIMLMET--FTRKKPTDEIFN 599
            PE     R  S + D++S    +  MLM+T  F      D++F 
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFK 249

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 391 TDGFSENNLIGRGSFGSVF--KARLGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSI 445
           +D +    ++G+GSFG V   K ++  G E A+KV +   ++     +S   E +++K +
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
            H NI K+     ++ +  LV E    G L   + S     ++     I+  V S + Y 
Sbjct: 84  DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYX 142
Query: 506 HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           H     +++H DLKP N+LL+    +    + DFG++   T  + S      + T  Y+A
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKXKDKIGTAYYIA 196
Query: 563 PEYGKEGRVSANGDVYSFGIML 584
           PE    G      DV+S G++L
Sbjct: 197 PEV-LHGTYDEKCDVWSTGVIL 217

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 54/240 (22%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR----------HR 448
           +G+G++G V+K+     G  VA+K       ++F +F    +  ++ R          H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVK-------KIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 449 NIIKVIS--SCSNEEFKALVLEYMPHGSLEKYLHS--SNYILDIYQRLNIMIDVASALEY 504
           NI+ +++     N+    LV +YM     E  LH+     IL+   +  ++  +   ++Y
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-------------------E 545
           LH   S  ++H D+KPSN+LL+      ++DFG+++                       +
Sbjct: 125 LH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 546 DQSTIQTQTLATIGYMAPEYGKEGRVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTL 604
           D   I T  +AT  Y APE          G D++S G +L E    K     IF G  T+
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK----PIFPGSSTM 237

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G  VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 150
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E      T  +AT  Y APE       
Sbjct: 151 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 205
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 206 YNQTVDIWSVGCIMAELLT 224

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 397 NNLIGRGSFGSVFKA---RLGD-----GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHR 448
           N  +G+G+F  +FK     +GD       EV +KV +  +    +SF     MM  + H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           +++     C   +   LV E++  GSL+ YL  +   ++I  +L +   +A A   +HF 
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFL 129
Query: 509 YSAQVIHCDLKPSNVLL---DDNMVAH-----LSDFGIAKLLTREDQSTIQTQTLATIGY 560
               +IH ++   N+LL   +D    +     LSD GI+  +T   +  +Q +    I +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS--ITVLPKDILQER----IPW 183
Query: 561 MAPEYGKEGR-VSANGDVYSFGIMLME 586
           + PE  +  + ++   D +SFG  L E
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWE 210

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 434 SFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRL 492
           S + E  ++  I+H NI+ +     +     L+++ +  G L ++ +    Y      RL
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL 121
Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVL---LDDNMVAHLSDFGIAKLLTREDQST 549
             +  V  A++YLH      ++H DLKP N+L   LD++    +SDFG++K+   ED  +
Sbjct: 122 --IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGS 173
Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIM 583
           + +    T GY+APE   +   S   D +S G++
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G   PEY  
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCG--TPEYLA 206
Query: 568 EGRVSANG-----DVYSFGIMLME 586
              + + G     D ++ G+++ E
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYE 230

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFN----LQYGRVFKSFDVECEMMKSIR 446
           D F    +IGRG+F  V   ++   G   AMK+ N    L+ G V   F  E +++ +  
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEV-SCFREERDVLVNGD 119
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
            R I ++  +  +E +  LV+EY   G L   L      +        + ++  A++ +H
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 507 -FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE- 564
             GY    +H D+KP N+LLD      L+DFG + L  R D +      + T  Y++PE 
Sbjct: 180 RLGY----VHRDIKPDNILLDRCGHIRLADFG-SCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 565 ------YGKEGRVSANGDVYSFGIMLMETFTRKKP 593
                     G      D ++ G+   E F  + P
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 434 SFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRL 492
           S + E  ++  I+H NI+ +     +     L+++ +  G L ++ +    Y      RL
Sbjct: 62  SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL 121
Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVL---LDDNMVAHLSDFGIAKLLTREDQST 549
             +  V  A++YLH      ++H DLKP N+L   LD++    +SDFG++K+   ED  +
Sbjct: 122 --IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGS 173
Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIM 583
           + +    T GY+APE   +   S   D +S G++
Sbjct: 174 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGDGME-VAMKVFNLQY--GRVFKSFDVECEMMKSIRHR 448
           D +   +++G G+F  V  A      + VA+K    +   G+   S + E  ++  I+H 
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE-GSMENEIAVLHKIKHP 76
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
           NI+ +     +     L+++ +  G L ++ +    Y      RL  +  V  A++YLH 
Sbjct: 77  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLDAVKYLH- 133
Query: 508 GYSAQVIHCDLKPSNVL---LDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
                ++H DLKP N+L   LD++    +SDFG++K+   ED  ++ +    T GY+APE
Sbjct: 134 --DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPE 188
Query: 565 YGKEGRVSANGDVYSFGIM 583
              +   S   D +S G++
Sbjct: 189 VLAQKPYSKAVDCWSIGVI 207

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 25/220 (11%)
Query: 400 IGRGSFGSV-FKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G F  V     L DG   A+K       +  +    E +M +   H NI+++++ C 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 459 NEEFKA----LVLEYMPHGSL----EKYLHSSNYILDIYQRLNIMIDVASALEYLHF-GY 509
            E        L+L +   G+L    E+     N++ +  Q L +++ +   LE +H  GY
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED-QILWLLLGICRGLEAIHAKGY 155
Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-------ATIGYMA 562
           +    H DLKP+N+LL D     L D G         + + Q  TL        TI Y A
Sbjct: 156 A----HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 563 PE---YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFN 599
           PE         +    DV+S G +L      + P D +F 
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 30/231 (12%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMK-----VFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +GRG++G V K R +  G  +A+K     V + +  R+    D+    M+++     +  
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS---MRTVDCPFTVTF 71
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL------NIMIDVASALEYLHF 507
             +   E    + +E M   SL+K+      ++D  Q +       I + +  ALE+LH 
Sbjct: 72  YGALFREGDVWICMELM-DTSLDKFYKQ---VIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA----- 562
             S  VIH D+KPSNVL++      + DFGI+  L  +    I         YMA     
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---GCKPYMAPERIN 182
Query: 563 PEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
           PE  ++G  S   D++S GI ++E    + P D        LK  V +  P
Sbjct: 183 PELNQKG-YSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 232

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNI------ 450
           L+G G++G V+K R +  G   A+KV ++  G   +    E  M+K    HRNI      
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 451 -IKVISSCSNEEFKALVLEYMPHGSLEKYL-HSSNYILDIYQRLNIMIDVASALEYLHFG 508
            IK      +++   LV+E+   GS+   + ++    L       I  ++   L +LH  
Sbjct: 90  FIKKNPPGMDDQL-WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH-- 146
Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT-LATIGYMAPEY-- 565
              +VIH D+K  NVLL +N    L DFG++  L   D++  +  T + T  +MAPE   
Sbjct: 147 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIA 202
Query: 566 ---GKEGRVSANGDVYSFGIMLME 586
                +       D++S GI  +E
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIE 226

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 13/105 (12%)
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTI 550
           L+I I +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+   + + E++ T+
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 551 QTQTLA---------TIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
            T   A         T  YM+PE       S   D++S G++L E
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G  VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 164
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E    +     AT  Y APE       
Sbjct: 165 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXV-----ATRWYRAPEIMLNWMH 219
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 220 YNQTVDIWSVGCIMAELLT 238

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 28/163 (17%)
Query: 436 DVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL------EKYLHSSNYILDIY 489
           + E E++K + H  IIK+ +    E++  +VLE M  G L       K L  +   L  Y
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTRED 546
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L    
Sbjct: 261 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---G 307
Query: 547 QSTIQTQTLATIGYMAPE----YGKEGRVSANGDVYSFGIMLM 585
           ++++      T  Y+APE     G  G   A  D +S G++L 
Sbjct: 308 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILF 349

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    +  FG+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 28/163 (17%)
Query: 436 DVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL------EKYLHSSNYILDIY 489
           + E E++K + H  IIK+ +    E++  +VLE M  G L       K L  +   L  Y
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTRED 546
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L    
Sbjct: 247 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---G 293
Query: 547 QSTIQTQTLATIGYMAPE----YGKEGRVSANGDVYSFGIMLM 585
           ++++      T  Y+APE     G  G   A  D +S G++L 
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILF 335

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G  VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 140
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E         +AT  Y APE       
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNWMH 195
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 196 YNQTVDIWSVGCIMAELLT 214

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + D G+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 46/218 (21%)
Query: 436 DVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL------EKYLHSSNYILDIY 489
           + E E++K + H  IIK+ +    E++  +VLE M  G L       K L  +   L  Y
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTRED 546
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L    
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---G 168
Query: 547 QSTIQTQTLATIGYMAPE----YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM 602
           ++++      T  Y+APE     G  G   A  D +S G++L    +   P  E    ++
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVILFICLSGYPPFSE-HRTQV 226
Query: 603 TLKHWVND---------WLPISTKE--------IVDPN 623
           +LK  +           W  +S K         +VDP 
Sbjct: 227 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 18/236 (7%)
Query: 366 GPPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVF 424
           G P+D N   E M+   +  +     + F    L+G+G+FG V   +    G   AMK+ 
Sbjct: 126 GSPSD-NSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL 184
Query: 425 NLQYGRVFKSFD------VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKY 478
             +   V  + D       E  ++++ RH  +  +  S    +    V+EY   G L  +
Sbjct: 185 KKE---VIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--F 239
Query: 479 LHSSNYILDIYQRLNIM-IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG 537
            H S   +    R      ++ SAL+YLH      V++ DLK  N++LD +    ++DFG
Sbjct: 240 FHLSRERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFG 297
Query: 538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           + K   + D +T++T    T  Y+APE  ++       D +  G+++ E    + P
Sbjct: 298 LCKEGIK-DGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 391 TDGFSENNLIGRGSFGSVFKARLGDGM--EVAMKVFNLQYGRVFKSFDVECEMMKSIRHR 448
           TDG+     IG GS+ SV K  +      E A+K+ +       +  ++   +++  +H 
Sbjct: 21  TDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEI---LLRYGQHP 76
Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NII +     + ++  +V E    G L   +    +  +  +   ++  +   +EYLH  
Sbjct: 77  NIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSE-REASAVLFTITKTVEYLH-- 133
Query: 509 YSAQVIHCDLKPSNVLLDDNM----VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
            +  V+H DLKPSN+L  D         + DFG AK L R +   + T    T  ++APE
Sbjct: 134 -AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLXTPCY-TANFVAPE 190
Query: 565 YGKEGRVSANGDVYSFGIMLMETFTRKKP 593
             +     A  D++S G++L    T   P
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 18/236 (7%)
Query: 366 GPPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVF 424
           G P+D N   E M+   +  +     + F    L+G+G+FG V   +    G   AMK+ 
Sbjct: 123 GSPSD-NSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL 181
Query: 425 NLQYGRVFKSFD------VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKY 478
             +   V  + D       E  ++++ RH  +  +  S    +    V+EY   G L  +
Sbjct: 182 KKE---VIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--F 236
Query: 479 LHSSNYILDIYQRLNIM-IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG 537
            H S   +    R      ++ SAL+YLH      V++ DLK  N++LD +    ++DFG
Sbjct: 237 FHLSRERVFSEDRARFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFG 294
Query: 538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           + K   + D +T++T    T  Y+APE  ++       D +  G+++ E    + P
Sbjct: 295 LCKEGIK-DGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +      
Sbjct: 200 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + D G+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 46/218 (21%)
Query: 436 DVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL------EKYLHSSNYILDIY 489
           + E E++K + H  IIK+ +    E++  +VLE M  G L       K L  +   L  Y
Sbjct: 69  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTRED 546
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L    
Sbjct: 128 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---G 174
Query: 547 QSTIQTQTLATIGYMAPE----YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM 602
           ++++      T  Y+APE     G  G   A  D +S G++L    +   P  E    ++
Sbjct: 175 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVILFICLSGYPPFSE-HRTQV 232
Query: 603 TLKHWVND---------WLPISTKE--------IVDPN 623
           +LK  +           W  +S K         +VDP 
Sbjct: 233 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 270

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +      
Sbjct: 202 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 12/218 (5%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
            +G+G F   F+    D  EV A K+     L      +   +E  + +S+ H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
               + +F  +VLE     SL + LH     L   +    +  +    +YLH     +VI
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 163
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPEYGKEGRVSA 573
           H DLK  N+ L++++   + DFG+A   T+ +    + + L  T  Y+APE   +   S 
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW 611
             DV+S G ++      K P +     E  L+   N++
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 258

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 28/162 (17%)
Query: 436 DVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL------EKYLHSSNYILDIY 489
           + E E++K + H  IIK+ +    E++  +VLE M  G L       K L  +   L  Y
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTRED 546
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L    
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---G 168
Query: 547 QSTIQTQTLATIGYMAPE----YGKEGRVSANGDVYSFGIML 584
           ++++      T  Y+APE     G  G   A  D +S G++L
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVIL 209

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G  VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E         +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +      
Sbjct: 207 VAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G  VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DFG+A+    E         +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MAGFVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 28/162 (17%)
Query: 436 DVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL------EKYLHSSNYILDIY 489
           + E E++K + H  IIK+ +    E++  +VLE M  G L       K L  +   L  Y
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTRED 546
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L    
Sbjct: 121 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---G 167
Query: 547 QSTIQTQTLATIGYMAPE----YGKEGRVSANGDVYSFGIML 584
           ++++      T  Y+APE     G  G   A  D +S G++L
Sbjct: 168 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVIL 208

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 13/197 (6%)
Query: 391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRN 449
           +D F   + +GRG+   V++ +  G     A+KV      +  K    E  ++  + H N
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           IIK+          +LVLE +  G L   +    Y    Y   +    V   LE + + +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY----YSERDAADAVKQILEAVAYLH 165
Query: 510 SAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
              ++H DLKP N+L      +    ++DFG++K++  E Q  ++T    T GY APE  
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKT-VCGTPGYCAPEIL 222
Query: 567 KEGRVSANGDVYSFGIM 583
           +        D++S GI+
Sbjct: 223 RGCAYGPEVDMWSVGII 239

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 28/162 (17%)
Query: 436 DVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL------EKYLHSSNYILDIY 489
           + E E++K + H  IIK+ +    E++  +VLE M  G L       K L  +   L  Y
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTRED 546
           Q L        A++YLH      +IH DLKP NVLL   +++ +  ++DFG +K+L    
Sbjct: 122 QML-------LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL---G 168
Query: 547 QSTIQTQTLATIGYMAPE----YGKEGRVSANGDVYSFGIML 584
           ++++      T  Y+APE     G  G   A  D +S G++L
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV-DCWSLGVIL 209

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G+ VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + D G+A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +      
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
           + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 86/200 (43%), Gaps = 16/200 (8%)
Query: 394 FSENNLIGRGSFGSVFKARLGD-----GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHR 448
           F   + +G GS+G VFK R  +      ++ +M  F     R  K  +V     K  +H 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHE-KVGQHP 117
Query: 449 NIIKVISSCSNEEFKALVLEYMPHG-SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             +++  +   EE   L L+    G SL+++  +    L   Q    + D   AL +LH 
Sbjct: 118 CCVRLEQAW--EEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH- 174
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
             S  ++H D+KP+N+ L       L DFG+   L       +Q        YMAPE   
Sbjct: 175 --SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPEL-L 228
Query: 568 EGRVSANGDVYSFGIMLMET 587
           +G      DV+S G+ ++E 
Sbjct: 229 QGSYGTAADVFSLGLTILEV 248

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 12/218 (5%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
            +G+G F   F+    D  EV A K+     L      +   +E  + +S+ H++++   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
               + +F  +VLE     SL + LH     L   +    +  +    +YLH     +VI
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 161
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPEYGKEGRVSA 573
           H DLK  N+ L++++   + DFG+A   T+ +    + + L  T  Y+APE   +   S 
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 218
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW 611
             DV+S G ++      K P +     E  L+   N++
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 256

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 400 IGRGSFGSV---FKARLGDGMEVAMKVFNLQYGRVFKSFDV--ECEMMKSIRHRNIIKVI 454
           +G G++GSV   + ARL    +VA+K  +  +  +  +     E  ++K ++H N+I ++
Sbjct: 28  VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 455 S----SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
                + S E+F  + L     G+    +     + D + +  ++  +   L+Y+H   S
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH---S 141
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG- 569
           A +IH DLKPSNV ++++    + DFG+A+    E      T  +AT  Y APE      
Sbjct: 142 AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE-----MTGYVATRWYRAPEIMLNWM 196
Query: 570 RVSANGDVYSFGIMLMETFTRK 591
             +   D++S G ++ E    K
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGK 218

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 400 IGRGSFGSV---FKARLGDGMEVAMKVFNLQYGRVFKSFDV--ECEMMKSIRHRNIIKVI 454
           +G G++GSV   + ARL    +VA+K  +  +  +  +     E  ++K ++H N+I ++
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 455 S----SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
                + S E+F  + L     G+    +     + D + +  ++  +   L+Y+H   S
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH---S 149
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG- 569
           A +IH DLKPSNV ++++    + DFG+A+    E      T  +AT  Y APE      
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATRWYRAPEIMLNWM 204
Query: 570 RVSANGDVYSFGIMLMETFTRK 591
             +   D++S G ++ E    K
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGK 226

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 12/218 (5%)
Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
            +G+G F   F+    D  EV A K+     L      +   +E  + +S+ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
               + +F  +VLE     SL + LH     L   +    +  +    +YLH     +VI
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLH---RNRVI 137
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPEYGKEGRVSA 573
           H DLK  N+ L++++   + DFG+A   T+ +    + + L  T  Y+APE   +   S 
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW 611
             DV+S G ++      K P +     E  L+   N++
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 232

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 19/202 (9%)
Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDV---ECEMMKSIRH 447
           D F     +G GSFG V   +  + G   AMK+ + Q     K  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L       + + R      +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF-YAAQIVLTFEYLH- 158
Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE 564
             S  +I+ DLKP N+L+D      ++DFG AK         ++ +T    G    +APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEALAPE 208
Query: 565 YGKEGRVSANGDVYSFGIMLME 586
                  +   D ++ G+++ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 94/224 (41%), Gaps = 26/224 (11%)
Query: 386 ELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMK-VFN-LQYGRVF---------KS 434
           EL      ++    I  GS+G+V      +G+ VA+K VFN +  GR           K 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 435 FDVECEMMKSIRHRNIIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLHSSNYILDIY 489
              E  ++    H NI+ +     + E  A     LV E M    L + +H    ++   
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ 134
Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST 549
                M  +   L  LH    A V+H DL P N+LL DN    + DF +A    RED + 
Sbjct: 135 HIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLA----REDTAD 187
Query: 550 I-QTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRK 591
             +T  +    Y APE   + +  +   D++S G ++ E F RK
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 94/224 (41%), Gaps = 26/224 (11%)
Query: 386 ELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMK-VFN-LQYGRVF---------KS 434
           EL      ++    I  GS+G+V      +G+ VA+K VFN +  GR           K 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 435 FDVECEMMKSIRHRNIIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLHSSNYILDIY 489
              E  ++    H NI+ +     + E  A     LV E M    L + +H    ++   
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ 134
Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST 549
                M  +   L  LH    A V+H DL P N+LL DN    + DF +A    RED + 
Sbjct: 135 HIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLA----REDTAD 187
Query: 550 I-QTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRK 591
             +T  +    Y APE   + +  +   D++S G ++ E F RK
Sbjct: 188 ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 397 NNLIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYG----RVFKSFDVECEMMKSIRHRNII 451
           + L+G G++  V  A  L +G E A+K+   Q G    RVF+  +    + +   ++NI+
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVET---LYQCQGNKNIL 74
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           ++I    ++    LV E +  GS+  ++    +  +  +   ++ DVA+AL++LH   + 
Sbjct: 75  ELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFLH---TK 130
Query: 512 QVIHCDLKPSNVLLDDNMV---AHLSDFGIAKLLTREDQST-IQTQTLAT----IGYMAP 563
            + H DLKP N+L +         + DF +   +   +  T I T  L T      YMAP
Sbjct: 131 GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAP 190
Query: 564 EY-----GKEGRVSANGDVYSFGIML 584
           E       +        D++S G++L
Sbjct: 191 EVVEVFTDQATFYDKRCDLWSLGVVL 216

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 70/157 (44%), Gaps = 9/157 (5%)
Query: 438 ECEMMKSIRHRNIIKVISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNYILDIYQRLNIM 495
           E ++++ +RH+N+I+++    NEE + +  V+EY   G  E           + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
             +   LEYLH   S  ++H D+KP N+LL       +S  G+A+ L           + 
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 556 ATIGYMAPEYGKEGRVSANG---DVYSFGIMLMETFT 589
            +  +  PE    G  + +G   D++S G+ L    T
Sbjct: 173 GSPAFQPPEIAN-GLDTFSGFKVDIWSAGVTLYNITT 208

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 19/196 (9%)
Query: 400 IGRGSFGSV---FKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
           IG G+ G V   F   LG  + V       Q     K    E  ++K + H+NII +++ 
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 91
Query: 457 CSN----EEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
            +     EEF+   LV+E M   +L + +H     LD  +   ++  +   +++LH   S
Sbjct: 92  FTPQKTLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH---S 144
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
           A +IH DLKPSN+++  +    + DFG+A+       + + T  + T  Y APE      
Sbjct: 145 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRAPEVILGMG 201
Query: 571 VSANGDVYSFGIMLME 586
            +AN D++S G ++ E
Sbjct: 202 YAANVDIWSVGCIMGE 217

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERM 121
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 122 SYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLART---AGTSFMM 175
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 10/209 (4%)
Query: 389 RATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVFN---LQYGRVFKSFDVECEMMKS 444
           R    +     +G+G F   ++    D  EV A KV     L      +    E  + KS
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           + + +++       +++F  +VLE     SL + LH     +   +    M      ++Y
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 141
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           LH   + +VIH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+APE
Sbjct: 142 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPE 196
Query: 565 YGKEGRVSANGDVYSFGIMLMETFTRKKP 593
              +   S   D++S G +L      K P
Sbjct: 197 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 35/216 (16%)
Query: 398 NLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
            +IGRG+FG V   ++ +   + AMK+ N     + K  +  C      R    + V   
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILN--KWEMLKRAETAC-----FREERDVLVNGD 132
Query: 457 CS----------NEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNI--MIDVASALE 503
           C           +E    LV++Y   G L   L    + + +   R  I  M+    ++ 
Sbjct: 133 CQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 192
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMA 562
            LH+      +H D+KP NVLLD N    L+DFG    L   D  T+Q+   + T  Y++
Sbjct: 193 QLHY------VHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYIS 244
Query: 563 PEYGKE-----GRVSANGDVYSFGIMLMETFTRKKP 593
           PE  +      G+     D +S G+ + E    + P
Sbjct: 245 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 35/216 (16%)
Query: 398 NLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
            +IGRG+FG V   ++ +   + AMK+ N     + K  +  C      R    + V   
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKW--EMLKRAETAC-----FREERDVLVNGD 148
Query: 457 CS----------NEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNI--MIDVASALE 503
           C           +E    LV++Y   G L   L    + + +   R  I  M+    ++ 
Sbjct: 149 CQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIH 208
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMA 562
            LH+      +H D+KP NVLLD N    L+DFG    L   D  T+Q+   + T  Y++
Sbjct: 209 QLHY------VHRDIKPDNVLLDVNGHIRLADFG--SCLKMNDDGTVQSSVAVGTPDYIS 260
Query: 563 PEYGKE-----GRVSANGDVYSFGIMLMETFTRKKP 593
           PE  +      G+     D +S G+ + E    + P
Sbjct: 261 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 9/150 (6%)
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H NI+K+     ++    LV+E +  G L + +    +  +  +   IM  + SA+ ++H
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET-EASYIMRKLVSAVSHMH 123
Query: 507 FGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
                 V+H DLKP N+L    +DN+   + DFG A+L   ++Q  ++T    T+ Y AP
Sbjct: 124 ---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPCF-TLHYAAP 178
Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           E   +     + D++S G++L    + + P
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 12/210 (5%)
Query: 389 RATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVFN---LQYGRVFKSFDVECEMMKS 444
           R    +     +G+G F   ++    D  EV A KV     L      +    E  + KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           + + +++       +++F  +VLE     SL + LH     +   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAP 563
           LH   + +VIH DLK  N+ L+D+M   + DFG+A   T+ +    + +TL  T  Y+AP
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA---TKIEFDGERKKTLCGTPNYIAP 211
Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           E   +   S   D++S G +L      K P
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFK------SFDVECEM 441
           +  D +     +G G F  V K R    G+E A K    +  R  +        + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 442 MKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
           ++ + H N+I +     N     L+LE +  G L  +L +    L   +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 502 LEYLHFGYSAQVIHCDLKPSNV-LLDDNM-VAHLS--DFGIAKLLTREDQSTIQTQTLAT 557
           + YLH   + ++ H DLKP N+ LLD N+ + H+   DFG+A  +  ED    +     T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN-IFGT 181
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIM 583
             ++APE      +    D++S G++
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 19/199 (9%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVF--KSFDVECEMMKSIRHRNIIKVIS- 455
           +G G++GSV  A     G  VA+K  +  +  +   K    E  ++K ++H N+I ++  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 456 ---SCSNEEFKALVL-EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              + S EEF  + L  ++    L   +       D  Q L  +  +   L+Y+H   SA
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQILRGLKYIH---SA 144
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-R 570
            +IH DLKPSN+ ++++    + DF +A+    E      T  +AT  Y APE       
Sbjct: 145 DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 199
Query: 571 VSANGDVYSFGIMLMETFT 589
            +   D++S G ++ E  T
Sbjct: 200 YNQTVDIWSVGCIMAELLT 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFK------SFDVECEM 441
           +  D +     +G G F  V K R    G+E A K    +  R  +        + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 442 MKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
           ++ + H N+I +     N     L+LE +  G L  +L +    L   +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 502 LEYLHFGYSAQVIHCDLKPSNV-LLDDNM-VAHLS--DFGIAKLLTREDQSTIQTQTLAT 557
           + YLH   + ++ H DLKP N+ LLD N+ + H+   DFG+A  +  ED    +     T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN-IFGT 181
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIM 583
             ++APE      +    D++S G++
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+LE +  G L  +L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYY 129
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPAF 183
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFK------SFDVECEM 441
           +  D +     +G G F  V K R    G+E A K    +  R  +        + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 442 MKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
           ++ + H N+I +     N     L+LE +  G L  +L +    L   +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 502 LEYLHFGYSAQVIHCDLKPSNV-LLDDNM-VAHLS--DFGIAKLLTREDQSTIQTQTLAT 557
           + YLH   + ++ H DLKP N+ LLD N+ + H+   DFG+A  +  ED    +     T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN-IFGT 181
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIM 583
             ++APE      +    D++S G++
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFK------SFDVECEM 441
           +  D +     +G G F  V K R    G+E A K    +  R  +        + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 442 MKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
           ++ + H N+I +     N     L+LE +  G L  +L +    L   +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 502 LEYLHFGYSAQVIHCDLKPSNV-LLDDNM-VAHLS--DFGIAKLLTREDQSTIQTQTLAT 557
           + YLH   + ++ H DLKP N+ LLD N+ + H+   DFG+A  +  ED    +     T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN-IFGT 181
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIM 583
             ++APE      +    D++S G++
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 10/209 (4%)
Query: 389 RATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVFN---LQYGRVFKSFDVECEMMKS 444
           R    +     +G+G F   ++    D  EV A KV     L      +    E  + KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           + + +++       +++F  +VLE     SL + LH     +   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           LH   + +VIH DLK  N+ L+D+M   + DFG+A  +  + +   +     T  Y+APE
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPE 212
Query: 565 YGKEGRVSANGDVYSFGIMLMETFTRKKP 593
              +   S   D++S G +L      K P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+LE +  G L  +L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYY 129
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFK------SFDVECEM 441
           +  D +     +G G F  V K R    G+E A K    +  R  +        + E  +
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 442 MKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASA 501
           ++ + H N+I +     N     L+LE +  G L  +L +    L   +  + +  +   
Sbjct: 69  LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDG 127
Query: 502 LEYLHFGYSAQVIHCDLKPSNV-LLDDNM-VAHLS--DFGIAKLLTREDQSTIQTQTLAT 557
           + YLH   + ++ H DLKP N+ LLD N+ + H+   DFG+A  +  ED    +     T
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN-IFGT 181
Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIM 583
             ++APE      +    D++S G++
Sbjct: 182 PEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 10/209 (4%)
Query: 389 RATDGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVFN---LQYGRVFKSFDVECEMMKS 444
           R    +     +G+G F   ++    D  EV A KV     L      +    E  + KS
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           + + +++       +++F  +VLE     SL + LH     +   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           LH   + +VIH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+APE
Sbjct: 158 LH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKXLCGTPNYIAPE 212
Query: 565 YGKEGRVSANGDVYSFGIMLMETFTRKKP 593
              +   S   D++S G +L      K P
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+LE +  G L  +L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYY 129
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+LE +  G L  +L     + +  +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYY 128
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVI 205

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 400 IGRGSFGSVFKARLG-DGMEVAMKVF--NLQYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G G++G+V  A  G  G +VA+K      Q     K    E  ++K +RH N+I ++  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 457 CSNEEFKA------LVLEYMPH--GSLEKY--LHSSNYILDIYQRLNIMIDVASALEYLH 506
            + +E         LV+ +M    G L K+  L        +YQ L         L Y+H
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLK-------GLRYIH 145
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
              +A +IH DLKP N+ ++++    + DFG+A+    E    + T+      Y APE  
Sbjct: 146 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTR-----WYRAPEVI 197
Query: 567 KEG-RVSANGDVYSFGIMLMETFTRK 591
               R +   D++S G ++ E  T K
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+LE +  G L  +L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYY 129
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+LE +  G L  +L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYY 129
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+LE +  G L  +L     + +  +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYY 128
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVI 205

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+LE +  G L  +L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYY 129
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+LE +  G L  +L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYY 129
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 87/195 (44%), Gaps = 18/195 (9%)
Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFK------SFDVECEMMKSIRHRNIIK 452
           +G G F  V K R    G+E A K    +  R  +        + E  +++ + H NII 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +     N     L+LE +  G L  +L +    L   +  + +  +   + YLH   + +
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 513 VIHCDLKPSNV-LLDDNM-VAHLS--DFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           + H DLKP N+ LLD N+ + H+   DFG+A  +  ED    +     T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKN-IFGTPEFVAPEIVNY 192
Query: 569 GRVSANGDVYSFGIM 583
             +    D++S G++
Sbjct: 193 EPLGLEADMWSIGVI 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/225 (22%), Positives = 98/225 (43%), Gaps = 21/225 (9%)
Query: 363 RERGPPNDA-NMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAM 421
           RE G  + +     E ++++F + E    T  FSE  L    + G +F  +      +  
Sbjct: 4   RENGESSSSWKKQAEDIKKIFEFKETL-GTGAFSEVVLAEEKATGKLFAVKC-----IPK 57
Query: 422 KVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHS 481
           K    +      S + E  +++ I+H NI+ +     +     LV++ +  G L   +  
Sbjct: 58  KALKGKES----SIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVE 113
Query: 482 SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGI 538
             +    Y   +    +   L+ +++ +   ++H DLKP N+L    D+     +SDFG+
Sbjct: 114 KGF----YTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGL 169
Query: 539 AKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIM 583
           +K+   E +  + +    T GY+APE   +   S   D +S G++
Sbjct: 170 SKM---EGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 211

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/290 (20%), Positives = 118/290 (40%), Gaps = 46/290 (15%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSI-RHRNII 451
           +G G+FG V +A      +    M VA+K+         + +   E +++  +  H NI+
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLH----------SSNYILDIYQRL-------NI 494
            ++ +C+      ++ EY  +G L  +L           +S  I++  +         + 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +    ++   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI 614
              + +MAPE       +   DV+S+GI L E F+        + G           +P+
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---YPG-----------MPV 253
Query: 615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
            +K       + +E    ++ E   + ++++   C    P +R   K+IV
Sbjct: 254 DSKFYK----MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 79/155 (50%), Gaps = 16/155 (10%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
           T  + T  Y APE         N D++S G+++ E
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGE 217

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 66  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 121
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 122 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 175
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+LE +  G L  +L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYY 129
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 102/239 (42%), Gaps = 17/239 (7%)
Query: 392 DGFSENNLIGRGSFGSVFKA-RLGDGMEVAMKV-----FNLQYGRVFKSFDVECEMMKSI 445
           D +    +IG+G+F  V +      G + A+K+     F    G   +    E  +   +
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL 505
           +H +I++++ + S++    +V E+M    L   +        +Y        +   LE L
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 506 HFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
            + +   +IH D+KP NVLL   +++    L DFG+A  L   +   +    + T  +MA
Sbjct: 144 RYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG--ESGLVAGGRVGTPHFMA 201
Query: 563 PEYGKEGRVSANGDVYSFGIMLMETFTRKKP----TDEIFNGEMTLKHWVN--DWLPIS 615
           PE  K        DV+  G++L    +   P     + +F G +  K+ +N   W  IS
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWSHIS 260

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 79/155 (50%), Gaps = 16/155 (10%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
           T  + T  Y APE         N D++S G+++ E
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGE 217

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/248 (22%), Positives = 101/248 (40%), Gaps = 17/248 (6%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           +GRG FG V +       +  M  F    G        E  ++   RHRNI+ +  S  +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
            E   ++ E++    + + +++S + L+  + ++ +  V  AL++LH   S  + H D++
Sbjct: 73  MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIR 129
Query: 520 PSNVLLDDNMVAHLS--DFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           P N++      + +   +FG A+ L   D   +         Y APE  +   VS   D+
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVSTATDM 186
Query: 578 YSFGIMLMETF---------TRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 628
           +S G ++             T ++  + I N E T        + I   + VD  L+   
Sbjct: 187 WSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKER 246
Query: 629 DINFVAKE 636
                A E
Sbjct: 247 KSRMTASE 254

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/290 (20%), Positives = 118/290 (40%), Gaps = 46/290 (15%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSI-RHRNII 451
           +G G+FG V +A      +    M VA+K+         + +   E +++  +  H NI+
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLH----------SSNYILDIYQRL-------NI 494
            ++ +C+      ++ EY  +G L  +L           +S  I++  +         + 
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +    ++   
Sbjct: 174 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI 614
              + +MAPE       +   DV+S+GI L E F+        + G           +P+
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL---GSSPYPG-----------MPV 276
Query: 615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
            +K       + +E    ++ E   + ++++   C    P +R   K+IV
Sbjct: 277 DSKFYK----MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 122
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 123 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 176
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+LE +  G L  +L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYY 129
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 72  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 127
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 128 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 181
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 182 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 233

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 41/213 (19%)
Query: 374 PPEAMQRMFSYLELCRA--TDGFSENNLIGRGSFGSVFKARLGD-GMEVAMK-------- 422
           PP+A++     L  C    +  +S  + +G G+FG V+ A   +   EV +K        
Sbjct: 6   PPKAVE--LEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVL 63
Query: 423 ----VFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGS-LEK 477
               + + + G+V     +E  ++  + H NIIKV+    N+ F  LV+E   HGS L+ 
Sbjct: 64  EDCWIEDPKLGKV----TLEIAILSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLDL 117
Query: 478 YLHSSNYILDIYQRLN------IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVA 531
           +       +D + RL+      I   + SA+ YL       +IH D+K  N+++ ++   
Sbjct: 118 FA-----FIDRHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTI 169
Query: 532 HLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
            L DFG A  L R     +      TI Y APE
Sbjct: 170 KLIDFGSAAYLER---GKLFYTFCGTIEYCAPE 199

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+LE +  G L  +L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYY 129
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 385 LELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKS 444
           L +   +D +     IG G+FG     R     E+    +  +  ++  +   E    +S
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRS 71
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILD----IYQRLNIMIDVA 499
           +RH NI++           A+V+EY   G L E+  ++  +  D     +Q+L       
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------I 125
Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLTREDQSTIQTQTLAT 557
           S + Y H   + QV H DLK  N LLD +    L   DFG +K       S + +Q  +T
Sbjct: 126 SGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKST 176
Query: 558 IG---YMAPEY----GKEGRVSANGDVYSFGIML 584
           +G   Y+APE       +G+V+   DV+S G+ L
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTL 207

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 400 IGRGSFGSV---FKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
           IG G+ G V   F   LG  + V       Q     K    E  ++K + H+NII +++ 
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 89
Query: 457 CSN----EEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
            +     EEF+   LV+E M   +L + +H     LD  +   ++  +   +++LH   S
Sbjct: 90  FTPQKTLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQMLCGIKHLH---S 142
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
           A +IH DLKPSN+++  +    + DFG+A+  +    + + T  + T  Y APE      
Sbjct: 143 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAS---TNFMMTPYVVTRYYRAPEVILGMG 199
Query: 571 VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
              N D++S G ++ E          IF G   +  W
Sbjct: 200 YKENVDIWSVGCIMGELVK----GSVIFQGTDHIDQW 232

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 166
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 167 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 220
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 272

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 129
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 130 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 183
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 235

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 67  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 122
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 123 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 176
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSI-RHRNII 451
           +G G+FG V +A      +    M VA+K+         + +   E +++  +  H NI+
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLH----------SSNYILDIYQRL-------NI 494
            ++ +C+      ++ EY  +G L  +L           +S  I++  +         + 
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +    ++   
Sbjct: 167 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
              + +MAPE       +   DV+S+GI L E F+
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 74  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 129
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 130 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 183
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 235

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVISSCSN----EEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++  +     EEF+   LV+E M   +L + +      LD  + 
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME---LDHERM 166
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 167 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 220
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 272

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+LE +  G L  +L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYY 129
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/290 (20%), Positives = 118/290 (40%), Gaps = 46/290 (15%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSI-RHRNII 451
           +G G+FG V +A      +    M VA+K+         + +   E +++  +  H NI+
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLH----------SSNYILDIYQRL-------NI 494
            ++ +C+      ++ EY  +G L  +L           +S  I++  +         + 
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +    ++   
Sbjct: 174 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI 614
              + +MAPE       +   DV+S+GI L E F+        + G           +P+
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL---GSSPYPG-----------MPV 276
Query: 615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
            +K       + +E    ++ E   + ++++   C    P +R   K+IV
Sbjct: 277 DSKFYK----MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 32/214 (14%)
Query: 385 LELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKS 444
           L +   +D +     IG G+FG     R     E+    +  +  ++ ++   E    +S
Sbjct: 11  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRS 70
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILD----IYQRLNIMIDVA 499
           +RH NI++           A+V+EY   G L E+  ++  +  D     +Q+L       
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------I 124
Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLTREDQSTIQTQTLAT 557
           S + Y H   + QV H DLK  N LLD +    L   DFG +K       S + +Q  +T
Sbjct: 125 SGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKST 175
Query: 558 IG---YMAPEY----GKEGRVSANGDVYSFGIML 584
           +G   Y+APE       +G+V+   DV+S G+ L
Sbjct: 176 VGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTL 206

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/290 (20%), Positives = 118/290 (40%), Gaps = 46/290 (15%)
Query: 400 IGRGSFGSVFKA------RLGDGMEVAMKVFNLQYGRVFK-SFDVECEMMKSI-RHRNII 451
           +G G+FG V +A      +    M VA+K+         + +   E +++  +  H NI+
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLH----------SSNYILDIYQRL-------NI 494
            ++ +C+      ++ EY  +G L  +L           +S  I++  +         + 
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +    ++   
Sbjct: 169 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI 614
              + +MAPE       +   DV+S+GI L E F+        + G           +P+
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---YPG-----------MPV 271
Query: 615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
            +K       + +E    ++ E   + ++++   C    P +R   K+IV
Sbjct: 272 DSKFYK----MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 317

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 54/106 (50%), Gaps = 10/106 (9%)
Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT 552
            + + +  AL YL   +   VIH D+KPSN+LLD+     L DFGI+  L  +D++  + 
Sbjct: 128 KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKA--KD 182
Query: 553 QTLATIGYMAPEY-----GKEGRVSANGDVYSFGIMLMETFTRKKP 593
           ++     YMAPE        +       DV+S GI L+E  T + P
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 41/79 (51%), Gaps = 1/79 (1%)
Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSAN 574
           H D+KP N+L+  +  A+L DFGIA   T E  + +   T+ T+ Y APE   E   +  
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL-GNTVGTLYYXAPERFSESHATYR 215
Query: 575 GDVYSFGIMLMETFTRKKP 593
            D+Y+   +L E  T   P
Sbjct: 216 ADIYALTCVLYECLTGSPP 234

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFD------VECEMMKSIR 446
           F    L+G+G+FG V   +    G   AMK+   +   V  + D       E  ++++ R
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKE---VIVAKDEVAHTLTENRVLQNSR 66
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H  +  +  S    +    V+EY   G L  +L       +   R     ++ SAL+YLH
Sbjct: 67  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH 125
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
                 V++ DLK  N++LD +    ++DFG+ K   + D +T++     T  Y+APE  
Sbjct: 126 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKX-FCGTPEYLAPEVL 181
Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKP 593
           ++       D +  G+++ E    + P
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 97/228 (42%), Gaps = 27/228 (11%)
Query: 373 MPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRV 431
           M P      F YL+L            +G+G+FG V   +    G   AMK+   +   V
Sbjct: 3   MDPRVTMNEFEYLKL------------LGKGTFGKVILVKEKATGRYYAMKILKKE---V 47
Query: 432 FKSFD------VECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI 485
             + D       E  ++++ RH  +  +  S    +    V+EY   G L  +L      
Sbjct: 48  IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVF 107
Query: 486 LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 545
            +   R     ++ SAL+YLH      V++ DLK  N++LD +    ++DFG+ K   + 
Sbjct: 108 SEDRARF-YGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK- 163
Query: 546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
           D +T++     T  Y+APE  ++       D +  G+++ E    + P
Sbjct: 164 DGATMKX-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 399 LIGRGSFGSV-FKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI------RHRNII 451
           ++G+GSFG V    R G     A+K+  L+   V +  DVEC M++        +   + 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           ++ S     +    V+EY+  G L  ++      +  ++  + +   A     L F  S 
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
            +I+ DLK  NV+LD      ++DFG+ K    +  +T       T  Y+APE       
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KXFCGTPDYIAPEIIAYQPY 519
Query: 572 SANGDVYSFGIMLMETFTRKKP-----TDEIFNGEM 602
             + D ++FG++L E    + P      DE+F   M
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFD------VECEMMKSIR 446
           F    L+G+G+FG V   +    G   AMK+   +   V  + D       E  ++++ R
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKE---VIVAKDEVAHTLTENRVLQNSR 67
Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIM-IDVASALEYL 505
           H  +  +  S    +    V+EY   G L  + H S   +    R      ++ SAL+YL
Sbjct: 68  HPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYL 125
Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
           H      V++ DLK  N++LD +    ++DFG+ K   + D +T++     T  Y+APE 
Sbjct: 126 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKX-FCGTPEYLAPEV 181
Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP 593
            ++       D +  G+++ E    + P
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 399 LIGRGSFGSV-FKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI------RHRNII 451
           ++G+GSFG V    R G     A+K+  L+   V +  DVEC M++        +   + 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           ++ S     +    V+EY+  G L  ++      +  ++  + +   A     L F  S 
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
            +I+ DLK  NV+LD      ++DFG+ K    +  +T       T  Y+APE       
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT--KXFCGTPDYIAPEIIAYQPY 198
Query: 572 SANGDVYSFGIMLMETFTRKKP-----TDEIFNGEM 602
             + D ++FG++L E    + P      DE+F   M
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 78  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERM 133
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 134 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 187
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 188 TPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQW 239

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 385 LELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKS 444
           L +   +D +     IG G+FG     R     E+    +  +  ++ ++   E    +S
Sbjct: 12  LPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRS 71
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILD----IYQRLNIMIDVA 499
           +RH NI++           A+V+EY   G L E+  ++  +  D     +Q+L       
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------I 125
Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL--SDFGIAKLLTREDQSTIQTQTLAT 557
           S + Y H   + QV H DLK  N LLD +    L  +DFG +K       S + +Q  + 
Sbjct: 126 SGVSYAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK------ASVLHSQPKSA 176
Query: 558 IG---YMAPEY--GKE--GRVSANGDVYSFGIML 584
           +G   Y+APE    KE  G+V+   DV+S G+ L
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTL 207

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 16/155 (10%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
           T  + T  Y APE         N D++S G ++ E
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 106/224 (47%), Gaps = 38/224 (16%)
Query: 399 LIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMM-KSIRHRNIIKVISSC 457
           ++G GS G+V       G  VA+K   + +  +     +E +++ +S  H N+I+   S 
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRYYCSE 78
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNY------ILDIYQRLNIMIDVASALEYLHFGYSA 511
           + + F  + LE + + +L+  + S N       +   Y  ++++  +AS + +LH   S 
Sbjct: 79  TTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 134
Query: 512 QVIHCDLKPSNVLLD-------------DNMVAHLSDFGIAKLLTREDQSTIQT---QTL 555
           ++IH DLKP N+L+              +N+   +SDFG+ K L    QS+ +T      
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD-SGQSSFRTNLNNPS 193
Query: 556 ATIGYMAPEYGKEG-------RVSANGDVYSFGIMLMETFTRKK 592
            T G+ APE  +E        R++ + D++S G +     ++ K
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 67  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERM 122
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 123 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 176
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
           T  + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 177 TPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQW 228

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 16/155 (10%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
           T  + T  Y APE         N D++S G ++ E
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 10/95 (10%)
Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQST 549
            IM D+ +A+++LH   S  + H D+KP N+L    + + V  L+DFG AK  T   Q+ 
Sbjct: 113 EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT---QNA 166
Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
           +QT    T  Y+APE     +   + D++S G+++
Sbjct: 167 LQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 200

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 10/95 (10%)
Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQST 549
            IM D+ +A+++LH   S  + H D+KP N+L    + + V  L+DFG AK  T   Q+ 
Sbjct: 132 EIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT---QNA 185
Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
           +QT    T  Y+APE     +   + D++S G+++
Sbjct: 186 LQTPCY-TPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 16/155 (10%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
           T  + T  Y APE         N D++S G ++ E
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 16/155 (10%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
           T  + T  Y APE         N D++S G ++ E
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 35/228 (15%)
Query: 432 FKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKY-----LHSSNYIL 486
           +  F  E +++  I++   +      +N +   ++ EYM + S+ K+     +   NY  
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 487 DI-YQRLNIMID-VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 544
            I  Q +  +I  V ++  Y+H      + H D+KPSN+L+D N    LSDFG ++ +  
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV- 203
Query: 545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANG---DVYSFGIMLMETFTRKKPTD------ 595
            D+    ++   T  +M PE+      S NG   D++S GI L   F    P        
Sbjct: 204 -DKKIKGSR--GTYEFMPPEFF-SNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259
Query: 596 EIFNGEMT--------LKHWVNDWLPISTKE-IVDPNLLSREDINFVA 634
           E+FN   T          H++    P++ K+     N LS EDI+F+ 
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFL---YPLTNKKSTCSNNFLSNEDIDFLK 304

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 16/155 (10%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
           T  + T  Y APE         N D++S G ++ E
Sbjct: 183 TPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/195 (21%), Positives = 80/195 (41%), Gaps = 9/195 (4%)
Query: 392 DGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNI 450
           D +  +  +G G+FG V +      G   A K     +    ++   E + M  +RH  +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
           + +  +  ++    ++ E+M  G L + +   +  +   + +  M  V   L ++H    
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 273
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
              +H DLKP N++        L   DFG+   L  +    +   T  T  + APE  + 
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEG 330
Query: 569 GRVSANGDVYSFGIM 583
             V    D++S G++
Sbjct: 331 KPVGYYTDMWSVGVL 345

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/189 (25%), Positives = 98/189 (51%), Gaps = 30/189 (15%)
Query: 369 NDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGME---VAMKVFN 425
           + ++ P  +M R  S  ++    D +   +LIG GS+G V +A   D +E   VA+K   
Sbjct: 33  HHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAY--DKLEKRVVAIK--- 84
Query: 426 LQYGRVFKSFDVECE-------MMKSIRHRNIIKVISSC---SNEEFKAL--VLEYMPHG 473
            +  RVF+   ++C+       ++  + H +++KV+        E+F  L  VLE +   
Sbjct: 85  -KILRVFEDL-IDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE-IADS 141
Query: 474 SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL 533
             +K   +  Y+ +++ +  ++ ++   ++Y+H   SA ++H DLKP+N L++ +    +
Sbjct: 142 DFKKLFRTPVYLTELHIK-TLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKV 197
Query: 534 SDFGIAKLL 542
            DFG+A+ +
Sbjct: 198 CDFGLARTV 206

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 18/203 (8%)
Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+ E +  G L  +L     + +  +    +  + + + Y
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTE-EEATEFLKQILNGVYY 129
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 183
Query: 561 MAPEYGKEGRVSANGDVYSFGIM 583
           +APE      +    D++S G++
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/195 (21%), Positives = 80/195 (41%), Gaps = 9/195 (4%)
Query: 392 DGFSENNLIGRGSFGSVFK-ARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNI 450
           D +  +  +G G+FG V +      G   A K     +    ++   E + M  +RH  +
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
           + +  +  ++    ++ E+M  G L + +   +  +   + +  M  V   L ++H    
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 167
Query: 511 AQVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
              +H DLKP N++        L   DFG+   L  +    +   T  T  + APE  + 
Sbjct: 168 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEG 224
Query: 569 GRVSANGDVYSFGIM 583
             V    D++S G++
Sbjct: 225 KPVGYYTDMWSVGVL 239

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 78/151 (51%), Gaps = 13/151 (8%)
Query: 438 ECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMI 496
           E  ++K + H NI+K+     ++    LV+E    G L ++ +H   +  +      I+ 
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKF--NEVDAAVIIK 143
Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQ 553
            V S + YLH      ++H DLKP N+LL   + + +  + DFG++ +   E+Q  ++ +
Sbjct: 144 QVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMK-E 197
Query: 554 TLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
            L T  Y+APE  ++ +     DV+S G++L
Sbjct: 198 RLGTAYYIAPEVLRK-KYDEKCDVWSIGVIL 227

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
              + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 183 EPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKI----LFPGRDYIDQW 234

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 16/155 (10%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERM 129
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 130 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 183
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
           T  + T  Y APE         N D++S G ++ E
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 16/155 (10%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
           T  + T  Y APE         N D++S G ++ E
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 32/199 (16%)
Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG G+FG     R     E+    +  +   + ++   E    +S+RH NI++       
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 460 EEFKALVLEYMPHGSL-EKYLHSSNYILD----IYQRLNIMIDVASALEYLHFGYSAQVI 514
               A+++EY   G L E+  ++  +  D     +Q+L       S + Y H   S Q+ 
Sbjct: 88  PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------LSGVSYCH---SMQIC 138
Query: 515 HCDLKPSNVLLDDNMVAHLS--DFGIAKLLTREDQSTIQTQTLATIG---YMAPEY---- 565
           H DLK  N LLD +    L   DFG +K       S + +Q  +T+G   Y+APE     
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLRQ 192
Query: 566 GKEGRVSANGDVYSFGIML 584
             +G+++   DV+S G+ L
Sbjct: 193 EYDGKIA---DVWSCGVTL 208

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 16/155 (10%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
           T  + T  Y APE         N D++S G ++ E
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 385 LELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKS 444
           L +   +D +     IG G+FG     R     E+    +  +  ++ ++   E    +S
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRS 71
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILD----IYQRLNIMIDVA 499
           +RH NI++           A+V+EY   G L E+  ++  +  D     +Q+L       
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------I 125
Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLTREDQSTIQTQTLAT 557
           S + Y H   + QV H DLK  N LLD +    L    FG +K       S + +Q  +T
Sbjct: 126 SGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK------SSVLHSQPKST 176
Query: 558 IG---YMAPEY----GKEGRVSANGDVYSFGIML 584
           +G   Y+APE       +G+V+   DV+S G+ L
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTL 207

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 55/123 (44%), Gaps = 5/123 (4%)
Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT 552
            I + +  ALE+LH   S  VIH D+KPSNVL++        DFGI+  L  +    I  
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA 197
Query: 553 --QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND 610
             +       + PE  ++G  S   D++S GI  +E    + P D        LK  V +
Sbjct: 198 GCKPYXAPERINPELNQKG-YSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEE 256
Query: 611 WLP 613
             P
Sbjct: 257 PSP 259

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 20/176 (11%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 73  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERM 128
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 129 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 182
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
              + T  Y APE         N D++S G ++ E    K     +F G   +  W
Sbjct: 183 EPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQW 234

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 88/236 (37%), Gaps = 54/236 (22%)
Query: 400 IGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVE-----CEMMKSIRHRNIIKV 453
           IG+GS+G V  A       + A+K+ N    R     DVE       +MK + H NI ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYL---------------------------------- 479
                +E++  LV+E    G L   L                                  
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 480 -HSSNYILDIYQR----LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN--MVAH 532
            H     LD  QR     NIM  + SAL YLH   +  + H D+KP N L   N      
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 533 LSDFGIAKLLTREDQSTI--QTQTLATIGYMAPEYGKEGRVS--ANGDVYSFGIML 584
           L DFG++K   + +       T    T  ++APE       S     D +S G++L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 34/208 (16%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQY-GRVF-KSFDVECEMMKSIRHRNIIKVI-- 454
           +G G++GSV  A     G +VA+K  +  +   +F K    E  ++K ++H N+I ++  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 455 ----SSCSNEEFKALVLEYMPHGSLEKYL------HSSNYILDIYQRLNIMIDVASALEY 504
               SS  N     LV+ +M    L+K +          Y+  +YQ L         L+Y
Sbjct: 92  FTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQYL--VYQMLK-------GLKY 141
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           +H   SA V+H DLKP N+ ++++    + DFG+A+    E      T  + T  Y APE
Sbjct: 142 IH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPE 193
Query: 565 YGKEG-RVSANGDVYSFGIMLMETFTRK 591
                   +   D++S G ++ E  T K
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 34/208 (16%)
Query: 400 IGRGSFGSVFKA-RLGDGMEVAMKVFNLQY-GRVF-KSFDVECEMMKSIRHRNIIKVI-- 454
           +G G++GSV  A     G +VA+K  +  +   +F K    E  ++K ++H N+I ++  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 455 ----SSCSNEEFKALVLEYMPHGSLEKYL------HSSNYILDIYQRLNIMIDVASALEY 504
               SS  N     LV+ +M    L+K +          Y+  +YQ L         L+Y
Sbjct: 110 FTPASSLRNFYDFYLVMPFM-QTDLQKIMGMEFSEEKIQYL--VYQMLK-------GLKY 159
Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           +H   SA V+H DLKP N+ ++++    + DFG+A+    E      T  + T  Y APE
Sbjct: 160 IH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPE 211
Query: 565 YGKEG-RVSANGDVYSFGIMLMETFTRK 591
                   +   D++S G ++ E  T K
Sbjct: 212 VILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 32/214 (14%)
Query: 385 LELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKS 444
           L +   +D +     IG G+FG     R     E+    +  +  ++ ++   E    +S
Sbjct: 12  LPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRS 71
Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILD----IYQRLNIMIDVA 499
           +RH NI++           A+V+EY   G L E+  ++  +  D     +Q+L       
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------I 125
Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLS--DFGIAKLLTREDQSTIQTQTLAT 557
           S + Y H   + QV H DLK  N LLD +    L    FG +K       S + +Q   T
Sbjct: 126 SGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSK------SSVLHSQPKDT 176
Query: 558 IG---YMAPEY----GKEGRVSANGDVYSFGIML 584
           +G   Y+APE       +G+V+   DV+S G+ L
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVA---DVWSCGVTL 207

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQSTI 550
           IM  +  A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T  +    
Sbjct: 120 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 174
Query: 551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
            T+   T  Y+APE     +   + D++S G+++
Sbjct: 175 -TEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 101/228 (44%), Gaps = 27/228 (11%)
Query: 399 LIGRGSFGSVFKA-RLGDGMEVAMKVFNLQYGRVFK--------SFDVECEMMKSIRH-- 447
           L+G G FGSV+   R+ D + VA+K  +++  R+             +E  ++K +    
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIK--HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 72
Query: 448 RNIIKVISSCSNEEFKALVLEYM-PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
             +I+++      +   L+LE M P   L  ++     + +   R +    V  A+ + H
Sbjct: 73  SGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH 131
Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVA-HLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
              +  V+H D+K  N+L+D N     L DFG   LL    + T+ T    T  Y  PE+
Sbjct: 132 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEW 184
Query: 566 GKEGRVSA-NGDVYSFGIMLMETFTRKKP---TDEIFNGEMTLKHWVN 609
            +  R    +  V+S GI+L +      P    +EI  G++  +  V+
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVS 232

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 389 RATDGFSENNLIGRGSFGSVFK--ARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR 446
           R T  F E   IG G FGSVFK   RL DG   A+K       R  K      +   ++R
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK-------RSKKPLAGSVDEQNALR 55
Query: 447 ----------HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL---N 493
                     H ++++  S+ + ++   +  EY   GSL   +  +  I+  ++     +
Sbjct: 56  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 115
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLL 525
           +++ V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 116 LLLQVGRGLRYIH---SMSLVHMDIKPSNIFI 144

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 389 RATDGFSENNLIGRGSFGSVFK--ARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR 446
           R T  F E   IG G FGSVFK   RL DG   A+K       R  K      +   ++R
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK-------RSKKPLAGSVDEQNALR 57
Query: 447 ----------HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL---N 493
                     H ++++  S+ + ++   +  EY   GSL   +  +  I+  ++     +
Sbjct: 58  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 117
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLL 525
           +++ V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 118 LLLQVGRGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 389 RATDGFSENNLIGRGSFGSVFK--ARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR 446
           R T  F E   IG G FGSVFK   RL DG   A+K       R  K      +   ++R
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK-------RSKKPLAGSVDEQNALR 59
Query: 447 ----------HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL---N 493
                     H ++++  S+ + ++   +  EY   GSL   +  +  I+  ++     +
Sbjct: 60  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLL 525
           +++ V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 120 LLLQVGRGLRYIH---SMSLVHMDIKPSNIFI 148

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 103/221 (46%), Gaps = 34/221 (15%)
Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMM-KSIRHRNIIKVISS 456
            ++G GS G+V       G  VA+K   + +  +     +E +++ +S  H N+I+   S
Sbjct: 39  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRYYCS 95
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNY------ILDIYQRLNIMIDVASALEYLHFGYS 510
            + + F  + LE + + +L+  + S N       +   Y  ++++  +AS + +LH   S
Sbjct: 96  ETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---S 151
Query: 511 AQVIHCDLKPSNVLLD-------------DNMVAHLSDFGIAKLLTREDQSTIQ---TQT 554
            ++IH DLKP N+L+              +N+   +SDFG+ K L    Q   +      
Sbjct: 152 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD-SGQXXFRXNLNNP 210
Query: 555 LATIGYMAPEYGKEG---RVSANGDVYSFGIMLMETFTRKK 592
             T G+ APE  +E    R++ + D++S G +     ++ K
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 26/152 (17%)
Query: 389 RATDGFSENNLIGRGSFGSVFK--ARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR 446
           R T  F E   IG G FGSVFK   RL DG   A+K       R  K      +   ++R
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRL-DGCIYAIK-------RSKKPLAGSVDEQNALR 57
Query: 447 ----------HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL---N 493
                     H ++++  S+ + ++   +  EY   GSL   +  +  I+  ++     +
Sbjct: 58  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 117
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLL 525
           +++ V   L Y+H   S  ++H D+KPSN+ +
Sbjct: 118 LLLQVGRGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQSTI 550
           IM  +  A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T  +  T 
Sbjct: 128 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 184
Query: 551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
              T     Y+APE     +   + D++S G+++
Sbjct: 185 PCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIM 215

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQSTI 550
           IM  +  A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T  +  T 
Sbjct: 126 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 182
Query: 551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
              T     Y+APE     +   + D++S G+++
Sbjct: 183 PCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIM 213

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQSTI 550
           IM  +  A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T  +  T 
Sbjct: 121 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 177
Query: 551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
              T     Y+APE     +   + D++S G+++
Sbjct: 178 PCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIM 208

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 9/95 (9%)
Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQST 549
            IM  +  A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T  +  T
Sbjct: 126 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 182
Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
               T     Y+APE     +   + D++S G+++
Sbjct: 183 TPCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIM 214

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 21/204 (10%)
Query: 391 TDGFSENNLIGRGSFGSVF--KARLGDGMEVAMKVFNLQYGRVFKSFDV---ECEMMKSI 445
           +D +     +G G++G V   K +L  G E A+K+          +      E  ++K +
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSL--EKYLHSSNYILDIYQRLNIMIDVASALE 503
            H NI+K+     ++    LV+E    G L  E  L      +D      IM  V S   
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDA---AVIMKQVLSGTT 135
Query: 504 YLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           YLH      ++H DLKP N+LL+    + +  + DFG++      +      + L T  Y
Sbjct: 136 YLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYY 189
Query: 561 MAPEYGKEGRVSANGDVYSFGIML 584
           +APE  ++ +     DV+S G++L
Sbjct: 190 IAPEVLRK-KYDEKCDVWSCGVIL 212

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQSTI 550
           IM  +  A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T  +  T 
Sbjct: 120 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 176
Query: 551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
              T     Y+APE     +   + D++S G+++
Sbjct: 177 PCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIM 207

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQSTI 550
           IM  +  A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T  +  T 
Sbjct: 136 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 192
Query: 551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
              T     Y+APE     +   + D++S G+++
Sbjct: 193 PCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIM 223

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 103/221 (46%), Gaps = 34/221 (15%)
Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMM-KSIRHRNIIKVISS 456
            ++G GS G+V       G  VA+K   + +  +     +E +++ +S  H N+I+   S
Sbjct: 39  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRYYCS 95
Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNY------ILDIYQRLNIMIDVASALEYLHFGYS 510
            + + F  + LE + + +L+  + S N       +   Y  ++++  +AS + +LH   S
Sbjct: 96  ETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---S 151
Query: 511 AQVIHCDLKPSNVLLD-------------DNMVAHLSDFGIAKLLTREDQSTIQT---QT 554
            ++IH DLKP N+L+              +N+   +SDFG+ K L    Q   +      
Sbjct: 152 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD-SGQXXFRXNLNNP 210
Query: 555 LATIGYMAPEYGKEG---RVSANGDVYSFGIMLMETFTRKK 592
             T G+ APE  +E    R++ + D++S G +     ++ K
Sbjct: 211 SGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK 251

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 77/155 (49%), Gaps = 16/155 (10%)
Query: 438 ECEMMKSIRHRNIIKVIS----SCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQR 491
           E  +MK + H+NII +++      S EEF+   +V+E M   +L + +      LD  + 
Sbjct: 75  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME---LDHERM 130
Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
             ++  +   +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + 
Sbjct: 131 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMM 184
Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLME 586
              + T  Y APE         N D++S G ++ E
Sbjct: 185 VPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 219

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 9/95 (9%)
Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQST 549
            IM  +  A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T  +  T
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 177
Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
               T     Y+APE     +   + D++S G+++
Sbjct: 178 TPCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQSTI 550
           IM  +  A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T  +  T 
Sbjct: 122 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 178
Query: 551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
              T     Y+APE     +   + D++S G+++
Sbjct: 179 PCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIM 209

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQSTI 550
           IM  +  A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T  +  T 
Sbjct: 166 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 222
Query: 551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
                 T  Y+APE     +   + D++S G+++
Sbjct: 223 ---PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTREDQSTI 550
           IM  +  A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T  +  T 
Sbjct: 172 IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 228
Query: 551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
              T     Y+APE     +   + D++S G+++
Sbjct: 229 PCYTPY---YVAPEVLGPEKYDKSCDMWSLGVIM 259

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 22/159 (13%)
Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV----- 453
           +G G  G VF A   D    VA+K   L   +  K    E ++++ + H NI+KV     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 454 ---------ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                    + S +      +V EYM    L   L     +L+ + RL  M  +   L+Y
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGP-LLEEHARL-FMYQLLRGLKY 135
Query: 505 LHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLL 542
           +H   SA V+H DLKP+N+ ++ +++V  + DFG+A+++
Sbjct: 136 IH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 399 LIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMM-KSIRHRNIIKVISSC 457
           ++G GS G+V       G  VA+K   + +  +     +E +++ +S  H N+I+   S 
Sbjct: 22  ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRYYCSE 78
Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNY------ILDIYQRLNIMIDVASALEYLHFGYSA 511
           + + F  + LE + + +L+  + S N       +   Y  ++++  +AS + +LH   S 
Sbjct: 79  TTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 134
Query: 512 QVIHCDLKPSNVLLD-------------DNMVAHLSDFGIAKLLTREDQSTIQ---TQTL 555
           ++IH DLKP N+L+              +N+   +SDFG+ K L    Q   +       
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD-SGQXXFRXNLNNPS 193
Query: 556 ATIGYMAPEYGKEG-------RVSANGDVYSFGIMLMETFTRKK 592
            T G+ APE  +E        R++ + D++S G +     ++ K
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	678
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-85
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-84
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-75
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-69
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-68
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-68
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-56
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-19
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-07
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-81
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-78
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-70
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-64
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-56
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-56
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-55
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-55
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-48
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-47
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-47
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-36
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-35
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-26
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-55
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-54
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-54
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-54
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-53
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-52
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-51
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-50
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-47
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-47
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-44
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-38
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-52
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-48
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-45
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-44
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-42
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-40
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-43
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-43
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-41
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-40
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-40
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-37
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-34
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-29
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-42
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-42
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-39
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-39
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-38
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-35
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-41
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-40
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-39
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-39
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-37
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-35
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-29
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-39
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-39
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-38
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-38
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-38
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-38
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-37
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-29
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	5e-04
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-38
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-38
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-38
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-38
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-38
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-37
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-37
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-37
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-33
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-33
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-29
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-25
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-17
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-06
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-36
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-36
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-26
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-36
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-36
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-34
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-34
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-33
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-32
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-30
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-28
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-05
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-36
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-35
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-33
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-27
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-35
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-35
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-35
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-34
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-34
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-34
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-33
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-33
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-29
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-24
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-15
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-33
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-23
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-14
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-12
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-33
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-32
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-32
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-30
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-11
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-32
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-31
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-31
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-31
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-29
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-26
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-31
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-30
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-30
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-30
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-28
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-26
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-23
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-30
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-29
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-29
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-29
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-29
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-29
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-29
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-28
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-26
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-24
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-29
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-13
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-29
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-28
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-27
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-27
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-23
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-19
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-08
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-29
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-29
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-28
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-27
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-24
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-11
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-07
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-27
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-27
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-26
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-09
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-16
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-18
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-16
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-08
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-25
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-25
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-24
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-20
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-18
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	9e-07
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-24
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-23
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-23
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-23
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-19
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-04
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-22
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-19
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-17
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-08
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-23
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-23
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	6e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-23
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-23
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-23
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-20
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-16
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	8e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-07
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-06
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-22
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-22
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-05
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-20
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-19
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-17
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-14
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-04
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-08
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-04
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-11
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-21
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-21
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-21
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-21
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	6e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-20
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-07
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-05
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-20
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-20
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-04
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-20
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-20
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-19
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-19
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	7e-19
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-19
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	9e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-18
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-18
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-18
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-17
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-17
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-07
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-07
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-04
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-14
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	6e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-09
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-13
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-13
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-13
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	4e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-13
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-11
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-11
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	8e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	9e-11
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	4e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	4e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	6e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	9e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	8e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	6e-04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	4e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-04

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  269 bits (690), Expect = 4e-85
 Identities = 87/322 (27%), Positives = 146/322 (45%), Gaps = 49/322 (15%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSG--FIPNTFGNLRNLQALRLSNNYLTSSTLEL 64
             + G +        +++ L+LS  +      IP++  NL  L  L +            
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGG---------- 85

Query: 65  SFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT 124
                              N L G +P  ++  L+  L Y  + + NVSG IP+ +  + 
Sbjct: 86  ------------------INNLVGPIP-PAIAKLTQ-LHYLYITHTNVSGAIPDFLSQIK 125

Query: 125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYK-LELGGNK 183
            L  +    N L+G++P ++  L  L G+  + N++ G+IPDS     +L+  + +  N+
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185

Query: 184 LSGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNL 242
           L+G IP  F NL +L  + L  N L     + F + K+   ++ + N     L  ++G  
Sbjct: 186 LTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLS 243

Query: 243 KIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNF 302
           K          +L  L+L NN + G +P  L +L +L  LN+SFN L GEIP+GG+   F
Sbjct: 244 K----------NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRF 293

Query: 303 SAESFEGNELLCGSPNLRVPPC 324
              ++  N+ LCGSP   +P C
Sbjct: 294 DVSAYANNKCLCGSP---LPAC 312

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  280 bits (719), Expect = 2e-84
 Identities = 85/330 (25%), Positives = 136/330 (41%), Gaps = 27/330 (8%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
            L++W N   G IP+ +     L  L L  N  +G IP+   N  NL  + LSNN LT  
Sbjct: 446 DLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGE 505

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
                    +   ++L ++  SNN   G +P   +G+   SL + ++     +G IP  +
Sbjct: 506 -----IPKWIGRLENLAILKLSNNSFSGNIPA-ELGDCR-SLIWLDLNTNLFNGTIPAAM 558

Query: 121 GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENN--KLEGSIPDSICHSDELYKLE 178
              +      +  N + G     +      +      N  + +G   + +          
Sbjct: 559 FKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCN 614

Query: 179 LGGNKLSGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPL 237
           +      G     F+N  S+  L +  N L+  IP    ++  +  LN   N  +G +P 
Sbjct: 615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674

Query: 238 EIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGG 297
           E+G+L+           L  L+LS+N L G IP ++  L+ L +++LS N L G IP  G
Sbjct: 675 EVGDLR----------GLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMG 724

Query: 298 SFGNFSAESFEGNELLCGSPNLRVPPCKTS 327
            F  F    F  N  LCG P   +P C  S
Sbjct: 725 QFETFPPAKFLNNPGLCGYP---LPRCDPS 751

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  255 bits (654), Expect = 5e-75
 Identities = 97/296 (32%), Positives = 149/296 (50%), Gaps = 22/296 (7%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIP-NTFGNLRNLQALRLSNNYLTSS 60
           L +  N+F G +P F  + S L  L LS N+FSG +P +T   +R L+ L LS N  +  
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358

Query: 61  TLELSFLSSLSNCK-SLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEE 119
                   SL+N   SL  +  S+N   G +      N  ++L+   +     +G IP  
Sbjct: 359 -----LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPT 413

Query: 120 IGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL 179
           + N + L  ++L  N L+G+IPS+LG L KL+ L L  N LEG IP  + +   L  L L
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473

Query: 180 GGNKLSGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLE 238
             N L+G IP   +N  +L  + L +N LT  IP     L+++  L  S+N F+G +P E
Sbjct: 474 DFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAE 533

Query: 239 IGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
           +G+ +          SLI L+L+ N  +G IPA++ K S      ++ N + G+  
Sbjct: 534 LGDCR----------SLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRY 575

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  240 bits (615), Expect = 1e-69
 Identities = 83/312 (26%), Positives = 136/312 (43%), Gaps = 28/312 (8%)

Query: 2   LQMWENNFSGTIP--RFIFNASKLSILELSDNSFSGFIP-NTFGNLRNLQALRLSNNYLT 58
           L +  N+ SG +     + + S L  L +S N+       +    L +L+ L LS N ++
Sbjct: 105 LDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164

Query: 59  SSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPE 118
            + +          C  L  ++ S N + G +    V     +LE+ +++  N S GIP 
Sbjct: 165 GANV--VGWVLSDGCGELKHLAISGNKISGDVD---VSRCV-NLEFLDVSSNNFSTGIPF 218

Query: 119 EIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLE 178
            +G+ + L  + + GNKL+G     +    +L+ L + +N+  G IP     S  L  L 
Sbjct: 219 -LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKS--LQYLS 275

Query: 179 LGGNKLSGSIPEC-FNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLP 236
           L  NK +G IP+       +L  L L  N    ++P  F +   +  L  SSN F+G LP
Sbjct: 276 LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335

Query: 237 LE-IGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSY-LKDLNLSFNKLEGEIP 294
           ++ +  ++           L  L+LS N  SG +P SL  LS  L  L+LS N   G I 
Sbjct: 336 MDTLLKMR----------GLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL 385

Query: 295 RGGSFGNFSAES 306
              +       +
Sbjct: 386 P--NLCQNPKNT 395

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  237 bits (606), Expect = 3e-68
 Identities = 90/311 (28%), Positives = 137/311 (44%), Gaps = 30/311 (9%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIP--NTFGNLRNLQALRLSNNYLTS 59
           L +  ++ +G++  F   ++ L+ L+LS NS SG +    + G+   L+ L +S+N L  
Sbjct: 82  LFLSNSHINGSVSGF-KCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDF 140

Query: 60  STLELSFLSSLSNCKSLTLISFSNNPLDGILPK--TSVGNLSHSLEYFEMAYCNVSGGIP 117
                  +S      SL ++  S N + G               L++  ++   +SG + 
Sbjct: 141 P----GKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG-ELKHLAISGNKISGDVD 195

Query: 118 EEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKL 177
             +    NL  + +  N  +  IP  LG    LQ L +  NKL G    +I    EL  L
Sbjct: 196 --VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLL 252

Query: 178 ELGGNKLSGSIPECFNNLASLRILLLGSNELT-SIPLTFW-NLKDILYLNFSSNFFTGPL 235
            +  N+  G IP     L SL+ L L  N+ T  IP         +  L+ S N F G +
Sbjct: 253 NISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAV 310

Query: 236 PLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPA-SLEKLSYLKDLNLSFNKLEGEIP 294
           P   G+             L SL LS+NN SG +P  +L K+  LK L+LSFN+  GE+P
Sbjct: 311 PPFFGSCS----------LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360

Query: 295 RGGSFGNFSAE 305
              S  N SA 
Sbjct: 361 E--SLTNLSAS 369

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  236 bits (605), Expect = 5e-68
 Identities = 78/301 (25%), Positives = 133/301 (44%), Gaps = 24/301 (7%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
           N     +   + + + L  L LS++  +G +   F    +L +L LS N L+     ++ 
Sbjct: 63  NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGP---VTT 118

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI---GNL 123
           L+SL +C  L  ++ S+N LD     +    L+ SLE  +++  ++SG            
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLN-SLEVLDLSANSISGANVVGWVLSDGC 177

Query: 124 TNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNK 183
             L  + + GNK++G +   + +   L+ L + +N     IP  +     L  L++ GNK
Sbjct: 178 GELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNK 234

Query: 184 LSGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNL 242
           LSG      +    L++L + SN+    IP     LK + YL+ + N FTG +P  +   
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGA 292

Query: 243 KIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNF 302
                      +L  L+LS N+  GA+P      S L+ L LS N   GE+P   +    
Sbjct: 293 ---------CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM-DTLLKM 342

Query: 303 S 303
            
Sbjct: 343 R 343

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  203 bits (518), Expect = 4e-56
 Identities = 73/295 (24%), Positives = 127/295 (43%), Gaps = 34/295 (11%)

Query: 19  NASKLSILELSDNSFSGF---IPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKS 75
              K++ ++LS    +     + ++  +L  L++L LSN+++  S      +S      S
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGS------VSGFKCSAS 101

Query: 76  LTLISFSNNPLDGILP-KTSVGNLSHSLEYFEMAYCNVSGGIPEEIG-NLTNLTIIYLGG 133
           LT +  S N L G +   TS+G+ S  L++  ++   +        G  L +L ++ L  
Sbjct: 102 LTSLDLSRNSLSGPVTTLTSLGSCS-GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160

Query: 134 NKLNGSIPSTL---GKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPE 190
           N ++G+            +L+ L +  NK+ G +   +     L  L++  N  S  IP 
Sbjct: 161 NSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF 218

Query: 191 CFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDS 249
              + ++L+ L +  N+L+           ++  LN SSN F GP+P             
Sbjct: 219 -LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP---------- 267

Query: 250 CDLISLISLNLSNNNLSGAIPASLE-KLSYLKDLNLSFNKLEGEIPRGGSFGNFS 303
             L SL  L+L+ N  +G IP  L      L  L+LS N   G +P    FG+ S
Sbjct: 268 --LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPP--FFGSCS 318

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 90.7 bits (226), Expect = 5e-19
 Identities = 30/132 (22%), Positives = 53/132 (40%), Gaps = 16/132 (12%)

Query: 169 CHSDELYKLELGGNKLS---GSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLN 225
           C  D++  ++L    L+    ++     +L  L  L L ++ +      F     +  L+
Sbjct: 47  CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLD 106

Query: 226 FSSNFFTGPLP--LEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLE-KLSYLKDL 282
            S N  +GP+     +G+             L  LN+S+N L      S   KL+ L+ L
Sbjct: 107 LSRNSLSGPVTTLTSLGSCS----------GLKFLNVSSNTLDFPGKVSGGLKLNSLEVL 156

Query: 283 NLSFNKLEGEIP 294
           +LS N + G   
Sbjct: 157 DLSANSISGANV 168

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 51.8 bits (125), Expect = 6e-07
 Identities = 14/56 (25%), Positives = 28/56 (50%), Gaps = 3/56 (5%)

Query: 249 SCDLISLISLNLSNNNLS---GAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGN 301
           +C    + S++LS+  L+    A+ +SL  L+ L+ L LS + + G +       +
Sbjct: 46  TCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSAS 101

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  259 bits (664), Expect = 3e-81
 Identities = 95/317 (29%), Positives = 159/317 (50%), Gaps = 17/317 (5%)

Query: 367 PPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNL 426
               ++            ++L  AT+ F    LIG G FG V+K  L DG +VA+K    
Sbjct: 14  DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTP 73

Query: 427 QYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN--- 483
           +  +  + F+ E E +   RH +++ +I  C       L+ +YM +G+L+++L+ S+   
Sbjct: 74  ESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPT 133

Query: 484 YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 543
             +   QRL I I  A  L YLH      +IH D+K  N+LLD+N V  ++DFGI+K  T
Sbjct: 134 MSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGT 190

Query: 544 REDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIF-NGEM 602
             DQ+ + T    T+GY+ PEY  +GR++   DVYSFG++L E    +    +      +
Sbjct: 191 ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250

Query: 603 TLKHWVNDWLPIST-KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAK 661
            L  W  +       ++IVDPNL  +     + K        + A++C   S E R +  
Sbjct: 251 NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK------FGDTAVKCLALSSEDRPSMG 304

Query: 662 EIVTKL---LKIRDSLL 675
           +++ KL   L++++S++
Sbjct: 305 DVLWKLEYALRLQESVI 321

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  252 bits (646), Expect = 2e-78
 Identities = 101/298 (33%), Positives = 152/298 (51%), Gaps = 19/298 (6%)

Query: 380 RMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKS-FDVE 438
           + FS  EL  A+D FS  N++GRG FG V+K RL DG  VA+K    +  +  +  F  E
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77

Query: 439 CEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH---SSNYILDIYQRLNIM 495
            EM+    HRN++++   C     + LV  YM +GS+   L     S   LD  +R  I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137

Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
           +  A  L YLH     ++IH D+K +N+LLD+   A + DFG+AKL+     + + T   
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVTTAVR 196

Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIF---NGEMTLKHWVNDWL 612
            TIG++APEY   G+ S   DV+ +G+ML+E  T ++  D      + ++ L  WV    
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV--KG 254

Query: 613 PISTK---EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
            +  K    +VD +L      N+  +E  V  +  VA+ CT  SP +R    E+V  L
Sbjct: 255 LLKEKKLEALVDVDLQG----NYKDEE--VEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  231 bits (591), Expect = 1e-70
 Identities = 84/310 (27%), Positives = 141/310 (45%), Gaps = 31/310 (10%)

Query: 380 RMFSYLELCRATDGFSE------NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFK 433
             FS+ EL   T+ F E       N +G G FG V+K  + +   VA+K   L       
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKK--LAAMVDIT 69

Query: 434 S------FDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY--I 485
           +      FD E ++M   +H N+++++   S+ +   LV  YMP+GSL   L   +    
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 486 LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 545
           L  + R  I    A+ + +LH       IH D+K +N+LLD+   A +SDFG+A+   + 
Sbjct: 130 LSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK 605
            Q+ + ++ + T  YMAPE    G ++   D+YSFG++L+E  T     DE       L 
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLL 244

Query: 606 HWVNDWLPISTK--EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
               +         + +D  +    D +  + E       +VA +C  E   +R + K++
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKM---NDADSTSVEAMY----SVASQCLHEKKNKRPDIKKV 297

Query: 664 VTKLLKIRDS 673
              L ++  S
Sbjct: 298 QQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  214 bits (547), Expect = 3e-64
 Identities = 69/309 (22%), Positives = 127/309 (41%), Gaps = 26/309 (8%)

Query: 382 FSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEM 441
                L   +       +  RG FG V+KA+L     VA+K+F +Q  + ++  + E   
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQ-NEYEVYS 71

Query: 442 MKSIRHRNIIKVISSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMID 497
           +  ++H NI++ I +            L+  +   GSL  +L     ++   +  +I   
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAET 129

Query: 498 VASALEYLH-------FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI 550
           +A  L YLH        G+   + H D+K  NVLL +N+ A ++DFG+A        +  
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 551 QTQTLATIGYMAPEYGKEGRVSANG------DVYSFGIMLMETFTRKKPTDEIFNGEMTL 604
               + T  YMAPE   EG ++         D+Y+ G++L E  +R    D   +  M  
Sbjct: 190 THGQVGTRRYMAPEVL-EGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 605 KHWV--NDWLPISTKEIVDPNLLSREDI-NFVAKEQCVSFVFNVAMECTVESPEQRINAK 661
                         +E+V      R  + ++  K   ++ +     EC     E R++A 
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKK-RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 662 EIVTKLLKI 670
            +  ++ ++
Sbjct: 308 CVGERITQM 316

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  193 bits (492), Expect = 1e-56
 Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 40/286 (13%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQ-------YGRVFKSFDVECEMMKSIRHRNII 451
           IG+G FG V K R + D   VA+K   L            F+ F  E  +M ++ H NI+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K+     N     +V+E++P G L   L    + +    +L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143

Query: 512 QVIHCDLKPSNVLLD-----DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-- 564
            ++H DL+  N+ L        + A ++DFG+++           +  L    +MAPE  
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAPETI 198

Query: 565 YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
             +E   +   D YSF ++L    T + P DE   G++   + +            +  L
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-----------REEGL 247

Query: 625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
             R  I     E C   + NV   C    P++R +   IV +L ++
Sbjct: 248 --RPTIP----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  191 bits (488), Expect = 4e-56
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 11/199 (5%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG GSFG+V+K +     +VA+K+ N+     +  ++F  E  +++  RH NI+  +   
Sbjct: 32  IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
           +  +  A+V ++    SL  +LH+S    ++ + ++I    A  ++YLH   +  +IH D
Sbjct: 90  TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE---YGKEGRVSAN 574
           LK +N+ L ++    + DFG+A   +R   S    Q   +I +MAPE          S  
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 575 GDVYSFGIMLMETFTRKKP 593
            DVY+FGI+L E  T + P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  192 bits (489), Expect = 6e-56
 Identities = 66/202 (32%), Positives = 105/202 (51%), Gaps = 8/202 (3%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IG GSFG+V +A    G +VA+K+   Q         F  E  +MK +RH NI+  + + 
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN--YILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
           +     ++V EY+  GSL + LH S     LD  +RL++  DVA  + YLH   +  ++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            +LK  N+L+D      + DFG+++L      S+       T  +MAPE  ++   +   
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEVLRDEPSNEKS 220

Query: 576 DVYSFGIMLMETFTRKKPTDEI 597
           DVYSFG++L E  T ++P   +
Sbjct: 221 DVYSFGVILWELATLQQPWGNL 242

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  199 bits (509), Expect = 1e-55
 Identities = 59/315 (18%), Positives = 105/315 (33%), Gaps = 32/315 (10%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS- 60
             +  +    +I +      K + +    N+ +  +      L  L+   + N+   +  
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAEN 222

Query: 61  ------TLELSFLS-------SLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEM 107
                      +            N K LT +   N P    LP   +  L   ++   +
Sbjct: 223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT-FLKALP-EMQLINV 280

Query: 108 AYCN--------VSGGIPEEIGNLTNLTIIYLGGNKL-NGSIPSTLGKLQKLQGLGLENN 158
           A                  +      + IIY+G N L    + ++L K++KL  L    N
Sbjct: 281 ACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYN 340

Query: 159 KLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIP--LTFW 216
           +LEG +P +     +L  L L  N+++            +  L    N+L  IP      
Sbjct: 341 QLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAK 399

Query: 217 NLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKL 276
           ++  +  ++FS N            L          I++ S+NLSNN +S          
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDP---TPFKGINVSSINLSNNQISKFPKELFSTG 456

Query: 277 SYLKDLNLSFNKLEG 291
           S L  +NL  N L  
Sbjct: 457 SPLSSINLMGNMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  198 bits (505), Expect = 4e-55
 Identities = 51/315 (16%), Positives = 101/315 (32%), Gaps = 42/315 (13%)

Query: 2   LQMWENNF-SGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           + +  NN  +  +   +    KL +LE   N   G +P  FG+   L +L L+ N +T  
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEI 368

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSG------ 114
                        + +  +SF++N L  I       ++S  +   + +Y  +        
Sbjct: 369 PANF-----CGFTEQVENLSFAHNKLKYIPNIFDAKSVS-VMSAIDFSYNEIGSVDGKNF 422

Query: 115 -GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEG-------SIPD 166
             +        N++ I L  N+++            L  + L  N L            +
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482

Query: 167 SICHSDELYKLELGGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPLTFWNLKDILYL- 224
           +  ++  L  ++L  NKL+    +     L  L  + L  N  +  P    N   +    
Sbjct: 483 NFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFG 542

Query: 225 -----NFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYL 279
                +   N      P  I              SL  L + +N++   +   +     +
Sbjct: 543 IRNQRDAQGNRTLREWPEGITLCP----------SLTQLQIGSNDIRK-VNEKI--TPNI 589

Query: 280 KDLNLSFNKLEGEIP 294
             L++  N       
Sbjct: 590 SVLDIKDNPNISIDL 604

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  179 bits (455), Expect = 3e-48
 Identities = 48/287 (16%), Positives = 97/287 (33%), Gaps = 14/287 (4%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
           +  +++ L L     SG +P+  G L  L+ L L ++    +   L     +S   S   
Sbjct: 79  SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER-LFGPKGISANMSDEQ 137

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG 138
                                  L    +        I +        T I    N +  
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-T 196

Query: 139 SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASL 198
            +   + +L KL+   + N+            +           +   +    ++NL  L
Sbjct: 197 FVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTEDLKWDNLKDL 251

Query: 199 RILLLGS-NELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLIS 257
             + + +   LT +P     L ++  +N + N       L+     +A     +   +  
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE--KIQI 309

Query: 258 LNLSNNNL-SGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFS 303
           + +  NNL +  +  SL+K+  L  L   +N+LEG++P   +FG+  
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP---AFGSEI 353

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  174 bits (444), Expect = 7e-47
 Identities = 43/299 (14%), Positives = 95/299 (31%), Gaps = 36/299 (12%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSG----FIPNTFGNLRNLQALRLSNNYLTSSTL 62
              SG +P  I   ++L +L L  +        F P       + +  +    +   + +
Sbjct: 91  FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150

Query: 63  ELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGN 122
           +       S+   L     +++P    + K+S   ++           N++  + + +  
Sbjct: 151 DYDPREDFSD---LIKDCINSDPQQKSIKKSS--RITLKDTQIGQLSNNIT-FVSKAVMR 204

Query: 123 LTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGN 182
           LT L   Y+G +           + +       E  +   +      +  +L  +E+   
Sbjct: 205 LTKLRQFYMGNSPFVAENICEAWENEN-----SEYAQQYKTEDLKWDNLKDLTDVEVYNC 259

Query: 183 KLSGSIPECFNNLASLRILLLGSNELTSIP---------LTFWNLKDILYLNFSSN-FFT 232
                +P     L  ++++ +  N   S                 + I  +    N   T
Sbjct: 260 PNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT 319

Query: 233 GPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEG 291
            P+   +  +K           L  L    N L G +P +      L  LNL++N++  
Sbjct: 320 FPVETSLQKMK----------KLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE 367

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  174 bits (443), Expect = 9e-47
 Identities = 45/324 (13%), Positives = 102/324 (31%), Gaps = 39/324 (12%)

Query: 2   LQMWENNFSGTIPRFIFNA--SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS 59
            Q    ++  T   +      S L    ++ +     I  +         +   +N +T 
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197

Query: 60  STLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEE 119
                    ++     L      N+P        +  N +         Y         +
Sbjct: 198 ------VSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN-------SEYAQQYKTEDLK 244

Query: 120 IGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKL--------EGSIPDSICHS 171
             NL +LT + +        +P+ L  L ++Q + +  N+         +          
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVG 304

Query: 172 DELYKLELGGNKL-SGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNF 230
           +++  + +G N L +  +      +  L +L    N+L      F +   +  LN + N 
Sbjct: 305 EKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQ 364

Query: 231 FTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLE--KLSYLKDLNLSFNK 288
            T  +P                  + +L+ ++N L   IP   +   +S +  ++ S+N+
Sbjct: 365 ITE-IPANFCGF---------TEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNE 413

Query: 289 LEGEIPRGGSFGNFSAESFEGNEL 312
           +        +F       F+G  +
Sbjct: 414 IGSVDG--KNFDPLDPTPFKGINV 435

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  144 bits (366), Expect = 2e-36
 Identities = 37/215 (17%), Positives = 68/215 (31%), Gaps = 13/215 (6%)

Query: 6   ENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS--STLE 63
           +      +    F    +S + LS+N  S F    F     L ++ L  N LT       
Sbjct: 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSL 477

Query: 64  LSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNL 123
                +  N   LT I    N L  +        L   L   +++Y + S   P +  N 
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLP-YLVGIDLSYNSFS-KFPTQPLNS 535

Query: 124 TNLTIIYLG------GNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKL 177
           + L    +       GN+     P  +     L  L + +N +   + + I  +  +  L
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPN--ISVL 592

Query: 178 ELGGNKLSGSIPECFNNLASLRILLLGSNELTSIP 212
           ++  N                 + +L  ++   I 
Sbjct: 593 DIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIR 627

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  140 bits (355), Expect = 4e-35
 Identities = 28/288 (9%), Positives = 78/288 (27%), Gaps = 35/288 (12%)

Query: 29  SDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDG 88
             + +      +  +   +  L L     +          ++     L +++  ++    
Sbjct: 65  ELDMWGAQPGVSLNSNGRVTGLSLEGFGASG-----RVPDAIGQLTELEVLALGSHGEKV 119

Query: 89  ILPKTSVGNLSH--SLEYFEMAYCNVSGGIPEEIG--NLTNLTIIYLGGNKLNGSIPSTL 144
                    +S   S E  +    +      +     + ++L    +  +    SI  + 
Sbjct: 120 NERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179

Query: 145 GKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLG 204
               K   +G  +N +   +  ++    +L +  +G +              +       
Sbjct: 180 RITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ- 237

Query: 205 SNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNN 264
                +  L + NLKD+  +   +      LP  +  L            +  +N++ N 
Sbjct: 238 ---YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALP----------EMQLINVACNR 284

Query: 265 L--------SGAIPASLEKLSYLKDLNLSFNKL-EGEIPRGGSFGNFS 303
                         A       ++ + + +N L    +    S     
Sbjct: 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE--TSLQKMK 330

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  113 bits (284), Expect = 3e-26
 Identities = 28/240 (11%), Positives = 63/240 (26%), Gaps = 43/240 (17%)

Query: 105 FEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEG-- 162
           F              + +   +T + L G   +G +P  +G+L +L+ L L ++  +   
Sbjct: 62  FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNE 121

Query: 163 --SIPDSICHSDELYKLELGGNKLSG--------------------------SIPECFNN 194
               P  I  +    + +                                  SI +    
Sbjct: 122 RLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181

Query: 195 LASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLIS 254
                 +   SN +T +      L  +      ++ F      E    +    +      
Sbjct: 182 TLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENE--NSEYAQQYK 239

Query: 255 LISLNLSN-----------NNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFS 303
              L   N                 +P  L+ L  ++ +N++ N+          +   +
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  190 bits (485), Expect = 2e-55
 Identities = 78/280 (27%), Positives = 120/280 (42%), Gaps = 35/280 (12%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           +GRG+FG V KA+     +VA+K    +     K+F VE   +  + H NI+K+  +C N
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN 72

Query: 460 EEFKALVLEYMPHGSLEKYLHSSN--YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
                LV+EY   GSL   LH +           ++  +  +  + YLH      +IH D
Sbjct: 73  P--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130

Query: 518 LKPSNVLLDDNM-VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGD 576
           LKP N+LL     V  + DFG A      D  T  T    +  +MAPE  +    S   D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185

Query: 577 VYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL--PISTKEIVDPNLLSREDINFVA 634
           V+S+GI+L E  TR+KP DEI      +   V++    P+                    
Sbjct: 186 VFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI------------------- 226

Query: 635 KEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL 674
            +     + ++   C  + P QR + +EIV  +  +    
Sbjct: 227 -KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  187 bits (476), Expect = 1e-54
 Identities = 63/281 (22%), Positives = 118/281 (41%), Gaps = 36/281 (12%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           +     G ++K R   G ++ +KV  ++    R  + F+ EC  ++   H N++ V+ +C
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76

Query: 458 SNEEFK--ALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
            +       L+  +MP+GSL   LH  +N+++D  Q +   +D+A  + +LH      + 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE---YGKEGRV 571
              L   +V++D++M A +S   +                +    ++APE      E   
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTN 188

Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN 631
             + D++SF ++L E  TR+ P  ++ N E+ +K             +    L  R  I 
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADLSNMEIGMK-------------VALEGL--RPTI- 232

Query: 632 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD 672
                     V  +   C  E P +R     IV  L K++D
Sbjct: 233 ---PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  188 bits (479), Expect = 1e-54
 Identities = 68/288 (23%), Positives = 115/288 (39%), Gaps = 34/288 (11%)

Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G+G FG   K      G  + MK          ++F  E ++M+ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
            ++    + EY+  G+L   + S +      QR++   D+AS + YLH   S  +IH DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQST---------IQTQTLATIG---YMAPEYG 566
              N L+ +N    ++DFG+A+L+  E              + +    +G   +MAPE  
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 626
                    DV+SFGI+L E   R                   D+LP +    ++     
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRVNADP--------------DYLPRTMDFGLNVRGFL 240

Query: 627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL 674
                      C    F + + C    PE+R +  ++   L  +R  L
Sbjct: 241 DRYCP----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  188 bits (478), Expect = 4e-54
 Identities = 80/330 (24%), Positives = 122/330 (36%), Gaps = 43/330 (13%)

Query: 382 FSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEM 441
            +  E     D      LIGRG +G+V+K  L D   VA+KVF+       ++F  E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNI 58

Query: 442 MK--SIRHRNIIKVISSC-----SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI 494
            +   + H NI + I               LV+EY P+GSL KYL    +  D      +
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRL 116

Query: 495 MIDVASALEYLH------FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS 548
              V   L YLH        Y   + H DL   NVL+ ++    +SDFG++  LT     
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 549 TIQTQTLA------TIGYMAPEY-------GKEGRVSANGDVYSFGIMLMETFTRKKPTD 595
               +  A      TI YMAPE                  D+Y+ G++  E F R   TD
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC--TD 234

Query: 596 EIFNGEMT-----LKHWV-NDWLPISTKEIVDPNLLSREDI--NFVAKEQCVSFVFNVAM 647
                 +       +  V N       + +V      R      +      V  +     
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQ-RPKFPEAWKENSLAVRSLKETIE 293

Query: 648 ECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
           +C  +  E R+ A+    ++ ++     RN
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERN 323

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  183 bits (467), Expect = 3e-53
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 19/210 (9%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQ----YGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           IG G FG V++A    G EVA+K           +  ++   E ++   ++H NII +  
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
            C  E    LV+E+   G L + L      +     +N  + +A  + YLH      +IH
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIH 131

Query: 516 CDLKPSNVLLD--------DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
            DLK SN+L+          N +  ++DFG+A    RE   T +        +MAPE  +
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVIR 187

Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEI 597
               S   DV+S+G++L E  T + P   I
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  191 bits (488), Expect = 1e-52
 Identities = 73/328 (22%), Positives = 114/328 (34%), Gaps = 27/328 (8%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
            +              L  L + DN   G   N F  L NL+ L LSN++ +  TL    
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIP-EEIGNLTN 125
             SL++   L +++ + N +  I    +   L   LE  ++    +   +  +E   L N
Sbjct: 375 FVSLAH-SPLHILNLTKNKISKIES-DAFSWLG-HLEVLDLGLNEIGQELTGQEWRGLEN 431

Query: 126 LTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEG--SIPDSICHSDELYKLELGGNK 183
           +  IYL  NK      ++   +  LQ L L    L+   S P        L  L+L  N 
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491

Query: 184 LSGSIPECFNNLASLRILLLGSNELTSI---------PLTFWNLKDILYLNFSSNFFTGP 234
           ++    +    L  L IL L  N L  +               L  +  LN  SN F   
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551

Query: 235 LPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
                 +L            L  ++L  NNL+    +       LK LNL  N +     
Sbjct: 552 PVEVFKDLF----------ELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK 601

Query: 295 R--GGSFGNFSAESFEGNELLCGSPNLR 320
           +  G +F N +      N   C   ++ 
Sbjct: 602 KVFGPAFRNLTELDMRFNPFDCTCESIA 629

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  186 bits (475), Expect = 9e-51
 Identities = 59/302 (19%), Positives = 108/302 (35%), Gaps = 26/302 (8%)

Query: 6   ENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELS 65
               +  +P  +   + +++L L+ N         F     L +L +  N ++    E  
Sbjct: 13  HLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPE-- 67

Query: 66  FLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTN 125
                     L +++  +N L  +    +    + +L    +   ++            N
Sbjct: 68  ---LCQKLPMLKVLNLQHNELSQL-SDKTFAFCT-NLTELHLMSNSIQKIKNNPFVKQKN 122

Query: 126 LTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPD--SICHSDELYKLELGGNK 183
           L  + L  N L+ +   T  +L+ LQ L L NNK++    +   I  +  L KLEL  N+
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQ 182

Query: 184 LSGSIPECFNNLASLRILLLGSNELTSIP----LTFWNLKDILYLNFSSNFFTGPLPLEI 239
           +    P CF+ +  L  L L + +L                I  L+ S++  +       
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242

Query: 240 GNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSF 299
             LK          +L  L+LS NNL+     S   L  L+   L +N ++       S 
Sbjct: 243 LGLK--------WTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFS--HSL 292

Query: 300 GN 301
             
Sbjct: 293 HG 294

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  184 bits (470), Expect = 4e-50
 Identities = 67/314 (21%), Positives = 118/314 (37%), Gaps = 18/314 (5%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L +  N  S    +     + L+ L L  NS      N F   +NL  L LS+N L+S+ 
Sbjct: 78  LNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTK 137

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG 121
                L +    ++L  +  SNN +  +  +      + SL+  E++   +    P    
Sbjct: 138 -----LGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFH 192

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLG---KLQKLQGLGLENNKLEGSIPDSI--CHSDELYK 176
            +  L  ++L   +L  S+   L        ++ L L N++L  +   +        L  
Sbjct: 193 AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTM 252

Query: 177 LELGGNKLSGSIPECFNNLASLRILLLGSNELTSI-PLTFWNLKDILYLNFSSNFFTGPL 235
           L+L  N L+    + F  L  L    L  N +  +   +   L ++ YLN   +F     
Sbjct: 253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK--- 309

Query: 236 PLEIGNLKIARIDS---CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGE 292
              I    + +ID      L  L  LN+ +N++ G        L  LK L+LS +     
Sbjct: 310 -QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368

Query: 293 IPRGGSFGNFSAES 306
                +F + +   
Sbjct: 369 TLTNETFVSLAHSP 382

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  176 bits (449), Expect = 2e-47
 Identities = 66/337 (19%), Positives = 108/337 (32%), Gaps = 38/337 (11%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           ML +  NN +           +L    L  N+      ++   L N++ L L  ++   S
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311

Query: 61  TLELSF----LSSLSNCKSLTLISFSNNPLDGILPKTSVG-------NLSH--------- 100
               S       S    K L  ++  +N + GI      G       +LS+         
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371

Query: 101 ----------SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIP-STLGKLQK 149
                      L    +    +S    +    L +L ++ LG N++   +       L+ 
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431

Query: 150 LQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSG--SIPECFNNLASLRILLLGSNE 207
           +  + L  NK      +S      L +L L    L    S P  F  L +L IL L +N 
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491

Query: 208 LTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLS 266
           + +I       L+ +  L+   N              I  +    L  L  LNL +N   
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLK--GLSHLHILNLESNGFD 549

Query: 267 GAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFS 303
                  + L  LK ++L  N L         F N  
Sbjct: 550 EIPVEVFKDLFELKIIDLGLNNLNTLPA--SVFNNQV 584

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  175 bits (447), Expect = 5e-47
 Identities = 69/319 (21%), Positives = 109/319 (34%), Gaps = 31/319 (9%)

Query: 2   LQMWENNFSGTIPRFI--FNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS 59
           L +  N         +  F  S L  LELS N    F P  F  +  L  L L+N  L  
Sbjct: 150 LLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP 209

Query: 60  STLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEE 119
           S  E   L       S+  +S SN+ L      T +G    +L   +++Y N++    + 
Sbjct: 210 SLTEKLCLEL--ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267

Query: 120 IGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENN---------KLEGSIPDSICH 170
              L  L   +L  N +      +L  L  ++ L L+ +          L      S   
Sbjct: 268 FAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQW 327

Query: 171 SDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL---TFWNL--KDILYLN 225
              L  L +  N + G     F  L +L+ L L ++  +   L   TF +L    +  LN
Sbjct: 328 LKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILN 387

Query: 226 FSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPAS-LEKLSYLKDLNL 284
            + N  +         L            L  L+L  N +   +       L  + ++ L
Sbjct: 388 LTKNKISKIESDAFSWLG----------HLEVLDLGLNEIGQELTGQEWRGLENIFEIYL 437

Query: 285 SFNKLEGEIPRGGSFGNFS 303
           S+NK         SF    
Sbjct: 438 SYNKYLQLTR--NSFALVP 454

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  168 bits (428), Expect = 2e-44
 Identities = 70/337 (20%), Positives = 114/337 (33%), Gaps = 37/337 (10%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDN--SFSGFIPNTFGNLRN--LQALRLSNNYL 57
           L M +N+  G           L  L LS++  S       TF +L +  L  L L+ N +
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393

Query: 58  TSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIP 117
           +    +     + S    L ++    N +   L       L  ++    ++Y        
Sbjct: 394 SKIESD-----AFSWLGHLEVLDLGLNEIGQELTGQEWRGLE-NIFEIYLSYNKYLQLTR 447

Query: 118 EEIGNLTNLTIIYLGGNKLNG--SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELY 175
                + +L  + L    L    S PS    L+ L  L L NN +     D +   ++L 
Sbjct: 448 NSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLE 507

Query: 176 KLELGGNKLS--------GSIPECFNNLASLRILLLGSNELTSI-PLTFWNLKDILYLNF 226
            L+L  N L+        G        L+ L IL L SN    I    F +L ++  ++ 
Sbjct: 508 ILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDL 567

Query: 227 SSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEK-LSYLKDLNLS 285
             N           N            SL SLNL  N ++             L +L++ 
Sbjct: 568 GLNNLNTLPASVFNNQV----------SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMR 617

Query: 286 FNKLEGEIPRGGSFGNFSAES-----FEGNELLCGSP 317
           FN  +        F N+  E+        +  LC +P
Sbjct: 618 FNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  149 bits (378), Expect = 5e-38
 Identities = 45/227 (19%), Positives = 79/227 (34%), Gaps = 14/227 (6%)

Query: 75  SLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGN 134
           S  +   S+  L  +       +L  ++    + +  +           + LT + +G N
Sbjct: 5   SHEVADCSHLKLTQVPD-----DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59

Query: 135 KLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNN 194
            ++   P    KL  L+ L L++N+L      +      L +L L  N +       F  
Sbjct: 60  TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119

Query: 195 LASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLI 253
             +L  L L  N L+S  L T   L+++  L  S+N        E+              
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA--------NS 171

Query: 254 SLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFG 300
           SL  L LS+N +    P     +  L  L L+  +L   +       
Sbjct: 172 SLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLE 218

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  181 bits (462), Expect = 3e-52
 Identities = 71/295 (24%), Positives = 119/295 (40%), Gaps = 30/295 (10%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEM--MKSIRHRNIIKVIS 455
             +G+G +G V++     G  VA+K+F+ +     KS+  E E+     +RH NI+  I+
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIA 69

Query: 456 SCSNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH----- 506
           S       +    L+  Y   GSL  YL      LD    L I++ +AS L +LH     
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFG 127

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA--TIGYMAPE 564
                 + H DLK  N+L+  N    ++D G+A + ++              T  YMAPE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187

Query: 565 ------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS--T 616
                            D+++FG++L E   R      + + +      V +        
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247

Query: 617 KEIVDPNLLSREDI-NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           K +       R +I N    +  ++ +  +  EC  ++P  R+ A  I   L KI
Sbjct: 248 KVVCVDQQ--RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  183 bits (465), Expect = 3e-52
 Identities = 69/299 (23%), Positives = 114/299 (38%), Gaps = 30/299 (10%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEM--MKSIRHRNIIKVIS 455
             IG+G +G V+  +   G +VA+KVF         S+  E E+     +RH NI+  I+
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98

Query: 456 SCSNEEFK----ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH----- 506
           +            L+ +Y  +GSL  YL   +  LD    L +     S L +LH     
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA--TIGYMAPE 564
                 + H DLK  N+L+  N    ++D G+A     +             T  YM PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 565 ------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS--T 616
                      +     D+YSFG++L E   R      +   ++     V          
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276

Query: 617 KEIVDPNLLSREDI-NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL 674
           + +    L  R    N  + ++C+  +  +  EC   +P  R+ A  +   L K+ +S 
Sbjct: 277 EIVCIKKL--RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  181 bits (460), Expect = 9e-52
 Identities = 46/210 (21%), Positives = 91/210 (43%), Gaps = 20/210 (9%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVIS 455
            LIG+G FG V+  R     EVA+++ +++       K+F  E    +  RH N++  + 
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
           +C +    A++       +L   +  +  +LD+ +   I  ++   + YLH   +  ++H
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILH 153

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA---TIGYMAPEYGKEGRVS 572
            DLK  NV  D+  V  ++DFG+  +         + +       + ++APE  ++    
Sbjct: 154 KDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212

Query: 573 ANG---------DVYSFGIMLMETFTRKKP 593
                       DV++ G +  E   R+ P
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  173 bits (439), Expect = 1e-48
 Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 30/298 (10%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEM--MKSIRHRNIIKVIS 455
             IG+G FG V++ +   G EVA+K+F+ +     +S+  E E+     +RH NI+  I+
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA 103

Query: 456 SCSNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH----- 506
           + + +        LV +Y  HGSL  YL+   Y + +   + + +  AS L +LH     
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA--TIGYMAPE 564
                 + H DLK  N+L+  N    ++D G+A        +          T  YMAPE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221

Query: 565 ------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS--T 616
                   K        D+Y+ G++  E   R        + ++     V     +    
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281

Query: 617 KEIVDPNLLSREDI-NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
           K + +  L  R +I N     + +  +  +  EC   +   R+ A  I   L ++   
Sbjct: 282 KVVCEQKL--RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  172 bits (438), Expect = 3e-45
 Identities = 60/319 (18%), Positives = 109/319 (34%), Gaps = 37/319 (11%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
             +  N     I +    + K + +    N  +  I      L  LQ +  +N+  T   
Sbjct: 406 DAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDN 464

Query: 62  LELSFL--------------SSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEM 107
           + + +                S SN K LT +   N P    LP   + +L   L+   +
Sbjct: 465 IAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPD-FLYDLP-ELQSLNI 522

Query: 108 AYCNVSG---------GIPEEIGNLTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLEN 157
           A                + ++      + I Y+G N L     S +L K+ KL  L   +
Sbjct: 523 ACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVH 582

Query: 158 NKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIP--LTF 215
           NK+     ++   + +L  L+L  N++     +       +  L    N+L  IP     
Sbjct: 583 NKV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNA 640

Query: 216 WNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEK 275
            ++  +  ++FS N         I       +D    I+  ++ LS N +          
Sbjct: 641 KSVYVMGSVDFSYNKIGS-EGRNISCS----MDDYKGINASTVTLSYNEIQKFPTELFAT 695

Query: 276 LSYLKDLNLSFNKLEGEIP 294
            S +  + LS N +   IP
Sbjct: 696 GSPISTIILSNNLMT-SIP 713

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  170 bits (432), Expect = 1e-44
 Identities = 53/343 (15%), Positives = 102/343 (29%), Gaps = 50/343 (14%)

Query: 1   MLQMWENNFSG-TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS 59
           +  M  NN         +    KL +L+   N         FG    L  L+L  N +  
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIEE 609

Query: 60  STLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEE 119
              +       +    +  + FS+N L  I    +  ++   +   + +Y  +       
Sbjct: 610 IPEDF-----CAFTDQVEGLGFSHNKLKYIPNIFNAKSVYV-MGSVDFSYNKIGS-EGRN 662

Query: 120 IG------NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLE-------GSIPD 166
           I          N + + L  N++             +  + L NN +             
Sbjct: 663 ISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDG 722

Query: 167 SICHSDELYKLELGGNKLSGSIPE--CFNNLASLRILLLGSNELTSIPLTFWNLKDILYL 224
           +  ++  L  ++L  NKL+ S+ +      L  L  + +  N  +S P    N   +   
Sbjct: 723 NYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAF 781

Query: 225 N------FSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSY 278
                     N      P  I              SLI L + +N++   +   L     
Sbjct: 782 GIRHQRDAEGNRILRQWPTGITTCP----------SLIQLQIGSNDIRK-VDEKL--TPQ 828

Query: 279 LKDLNLSFNKLEGEIPRGGSFGNFSAE----SFEGNELLCGSP 317
           L  L+++ N     I          A      ++  + + G  
Sbjct: 829 LYILDIADNPNI-SIDVTSVCPYIEAGMYVLLYDKTQDIRGCD 870

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  163 bits (413), Expect = 4e-42
 Identities = 45/306 (14%), Positives = 97/306 (31%), Gaps = 34/306 (11%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
                    F+    +L++ +L  ++ +         ++    + L +  + + T  ++F
Sbjct: 382 RIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITF 439

Query: 67  L-SSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTN 125
           +  ++     L +I F+N+P           + +         Y            NL +
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD-------YAKQYENEELSWSNLKD 492

Query: 126 LTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEG---------SIPDSICHSDELYK 176
           LT + L        +P  L  L +LQ L +  N+             + D      ++  
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQI 552

Query: 177 LELGGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPL 235
             +G N L           +  L +L    N++  +   F     +  L    N     +
Sbjct: 553 FYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLE-AFGTNVKLTDLKLDYNQIEE-I 610

Query: 236 PLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP--ASLEKLSYLKDLNLSFNKLEGEI 293
           P +                +  L  S+N L   IP   + + +  +  ++ S+NK+  E 
Sbjct: 611 PEDFCAF---------TDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEG 660

Query: 294 PRGGSF 299
                 
Sbjct: 661 RNISCS 666

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  158 bits (400), Expect = 2e-40
 Identities = 52/323 (16%), Positives = 96/323 (29%), Gaps = 51/323 (15%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
           + +       + N  +++ L L+     G +P+  G L  L+ L    +  T S      
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 67  LS--------------------SLSNCKSLTLISFSNNPLDGILPKTSVGNLSH-SLEYF 105
                                  L   + L L     + ++       +   S  SL+  
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428

Query: 106 EMAYC-NVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSI 164
           ++    N    I + I  LT L IIY   +       +        +    +  K   + 
Sbjct: 429 QIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENE 483

Query: 165 PDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTS----------IPLT 214
             S  +  +L  +EL        +P+   +L  L+ L +  N   S          +   
Sbjct: 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543

Query: 215 FWNLKDILYLNFSSNFFTG-PLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASL 273
                 I       N     P    +  +            L  L+  +N +   +  + 
Sbjct: 544 EDTGPKIQIFYMGYNNLEEFPASASLQKMV----------KLGLLDCVHNKVR-HLE-AF 591

Query: 274 EKLSYLKDLNLSFNKLEGEIPRG 296
                L DL L +N++E EIP  
Sbjct: 592 GTNVKLTDLKLDYNQIE-EIPED 613

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 98.0 bits (244), Expect = 2e-21
 Identities = 32/214 (14%), Positives = 62/214 (28%), Gaps = 21/214 (9%)

Query: 105 FEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSI 164
           F             ++ N   +T + L G    G +P  +G+L +L+ L    +    S 
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 165 PDSICHSDELYKLELGGNKLSGSIPECF-NNLASLRILLLGSNELTSIP-------LTFW 216
                        E   +++     + F +    L +  L  + +   P        +  
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI 423

Query: 217 NLKDILYLNFSSNFFTGPLPLEIG---NLKIARIDSCDL------ISLISLNLSNNNLSG 267
           +LKD   +   +N  T  +   I     L+I    +         +     N        
Sbjct: 424 SLKD-TQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481

Query: 268 AIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGN 301
               S   L  L D+ L       ++P      +
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLP--DFLYD 513

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 48.3 bits (115), Expect = 8e-06
 Identities = 11/60 (18%), Positives = 22/60 (36%)

Query: 254 SLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL 313
            +  L+L+     G +P ++ +L+ LK L+   +         G        S E    +
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  164 bits (418), Expect = 2e-43
 Identities = 64/308 (20%), Positives = 110/308 (35%), Gaps = 24/308 (7%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSI--LELSDNSFSGFIPNTFGNLRNLQALRLSNNYLT 58
           +    + +     P       ++S+  + L  + F     NTF     LQ L L+  +L+
Sbjct: 232 LGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS 291

Query: 59  SSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPE 118
                    S L    +L  +  S N  + +  + S  N   SL +  +        +  
Sbjct: 292 E------LPSGLVGLSTLKKLVLSANKFENL-CQISASNFP-SLTHLSIKGNTKRLELGT 343

Query: 119 E-IGNLTNLTIIYLGGNKLNGS--IPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELY 175
             + NL NL  + L  + +  S      L  L  LQ L L  N+      ++     +L 
Sbjct: 344 GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403

Query: 176 KLELGGNKLSGSIPE-CFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTG 233
            L+L   +L     +  F NL  L++L L  + L       F  L  + +LN   N F  
Sbjct: 404 LLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPK 463

Query: 234 PLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEI 293
               +  +L+        L  L  L LS  +LS     +   L  +  ++LS N+L    
Sbjct: 464 GNIQKTNSLQ-------TLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516

Query: 294 PRGGSFGN 301
               +  +
Sbjct: 517 I--EALSH 522

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  162 bits (413), Expect = 8e-43
 Identities = 56/301 (18%), Positives = 98/301 (32%), Gaps = 23/301 (7%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
           N         +     L  L       S        N + L++L L +N+++S  L    
Sbjct: 91  NPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKL---- 146

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSH-SLEYFEMAYCNVSGGIPEEIGNLTN 125
                  + L ++ F NN +  +  K  + +L   +     +   N   GI     +   
Sbjct: 147 -PKGFPTEKLKVLDFQNNAIHYL-SKEDMSSLQQATNLSLNLNG-NDIAGIEPGAFDSAV 203

Query: 126 LTIIYLGGNKLNGSIPSTLG--KLQKLQGLGLENNKLEGSIPDSICHSDELY--KLELGG 181
              +  GG +    I   L    +Q L     E+   E   P       E+    + L  
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263

Query: 182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGN 241
           +         F+  + L+ L L +  L+ +P     L  +  L  S+N F     +   N
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASN 323

Query: 242 LKIARIDSCDLISLISLNLSNNNLSGAI-PASLEKLSYLKDLNLSFNKLEGEIPRGGSFG 300
                       SL  L++  N     +    LE L  L++L+LS + +E          
Sbjct: 324 FP----------SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373

Query: 301 N 301
           N
Sbjct: 374 N 374

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  159 bits (404), Expect = 1e-41
 Identities = 64/290 (22%), Positives = 107/290 (36%), Gaps = 21/290 (7%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
            + S  +P  +   S L  L LS N F      +  N  +L  L +  N           
Sbjct: 288 THLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL 346

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNL 126
                N ++L  +  S++ ++              L+   ++Y        E       L
Sbjct: 347 ----ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQL 402

Query: 127 TIIYLGGNKLNGSIP-STLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLS 185
            ++ L   +L      S    L  L+ L L ++ L+ S          L  L L GN   
Sbjct: 403 ELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462

Query: 186 GSIPEC---FNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGN 241
               +       L  L IL+L   +L+SI    F +LK + +++ S N  T      + +
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522

Query: 242 LKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEG 291
           LK            I LNL++N++S  +P+ L  LS  + +NL  N L+ 
Sbjct: 523 LK-----------GIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  155 bits (393), Expect = 3e-40
 Identities = 57/320 (17%), Positives = 99/320 (30%), Gaps = 29/320 (9%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L+   N               L+ L+L+         +TF +   L  L L+ N L    
Sbjct: 38  LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMA 97

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG 121
                  +LS  K+L  + F    +  I     + N   +LE   +   ++S     +  
Sbjct: 98  ET-----ALSGPKALKHLFFIQTGISSI-DFIPLHNQK-TLESLYLGSNHISSIKLPKGF 150

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQG--LGLENNKLEGSIPDSICHSDELYKLEL 179
               L ++    N ++      +  LQ+     L L  N +   I      S     L  
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNF 209

Query: 180 GGNKLSGSIPE--CFNNLASLRILLLGSNELTSI-PLTFWNLKD--ILYLNFSSNFFTGP 234
           GG +    I +    + + SL +      +   I P  F  L +  +  +N   ++F   
Sbjct: 210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNI 269

Query: 235 LPLEIGNL-----------KIARIDS--CDLISLISLNLSNNNLSGAIPASLEKLSYLKD 281
                               ++ + S    L +L  L LS N        S      L  
Sbjct: 270 SSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329

Query: 282 LNLSFNKLEGEIPRGGSFGN 301
           L++  N    E+   G   N
Sbjct: 330 LSIKGNTKRLELGT-GCLEN 348

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  154 bits (391), Expect = 6e-40
 Identities = 67/318 (21%), Positives = 116/318 (36%), Gaps = 30/318 (9%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
           + F           S L  L+L+    S  +P+    L  L+ L LS N   +       
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQ---- 318

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCN--VSGGIPEEIGNLT 124
             S SN  SLT +S   N     L    + NL  +L   ++++ +   S     ++ NL+
Sbjct: 319 -ISASNFPSLTHLSIKGNTKRLELGTGCLENLE-NLRELDLSHDDIETSDCCNLQLRNLS 376

Query: 125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLELGGNK 183
           +L  + L  N+          +  +L+ L L   +L+     S   +   L  L L  + 
Sbjct: 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSL 436

Query: 184 LSGSIPECFNNLASLRILLLGSNELTSIPL----TFWNLKDILYLNFSSNFFTGPLPLEI 239
           L  S  + F+ L +L+ L L  N      +    +   L  +  L  S    +       
Sbjct: 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAF 496

Query: 240 GNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSF 299
            +LK           +  ++LS+N L+ +   +L  L  +  LNL+ N +   +P     
Sbjct: 497 TSLK----------MMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILP--SLL 543

Query: 300 GNFSAES---FEGNELLC 314
              S +       N L C
Sbjct: 544 PILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  145 bits (367), Expect = 9e-37
 Identities = 55/290 (18%), Positives = 102/290 (35%), Gaps = 24/290 (8%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
            IP  +   +    LE S N        TF  L NL  L L+   +     +     +  
Sbjct: 26  EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED-----TFQ 78

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL 131
           +   L  +  + NPL  +  +T++     +L++       +S      + N   L  +YL
Sbjct: 79  SQHRLDTLVLTANPLIFM-AETALSGPK-ALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136

Query: 132 GGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDEL--YKLELGGNKLSGSIP 189
           G N ++          +KL+ L  +NN +     + +    +     L L GN ++  I 
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIE 195

Query: 190 ECFNNLASLRILLLGSNELTSIP---LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIAR 246
               + A  + L  G  +   +    L    ++ +    F         P     L    
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC--- 252

Query: 247 IDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG 296
                 +S+ S+NL  +        +    S L++L+L+   L  E+P G
Sbjct: 253 -----EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG 296

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  137 bits (346), Expect = 5e-34
 Identities = 59/296 (19%), Positives = 98/296 (33%), Gaps = 30/296 (10%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDN--SFSGFIPNTFGNLRNLQALRLSNNYLT 58
           L +  N     +      N   L  L+LS +    S        NL +LQ+L LS N   
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPL 389

Query: 59  SSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPE 118
           S   E     +   C  L L+  +   L     ++   NL H L+   +++  +     +
Sbjct: 390 SLKTE-----AFKECPQLELLDLAFTRLKVKDAQSPFQNL-HLLKVLNLSHSLLDISSEQ 443

Query: 119 EIGNLTNLTIIYLGGNKLNGSI---PSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELY 175
               L  L  + L GN          ++L  L +L+ L L    L      +      + 
Sbjct: 444 LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMN 503

Query: 176 KLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGP 234
            ++L  N+L+ S  E  ++L  +  L L SN ++ I       L     +N   N     
Sbjct: 504 HVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC- 561

Query: 235 LPLEIGNLKIARIDSCDLISLIS-LNLSNNNLSGAIPASLEKLSYLKDLNLSFNKL 289
                         +C  I  +     +   L        E    L+ + LS   L
Sbjct: 562 --------------TCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  123 bits (310), Expect = 2e-29
 Identities = 51/241 (21%), Positives = 92/241 (38%), Gaps = 13/241 (5%)

Query: 96  GNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGL 155
           G L +S E  E ++  +          L NLT + L   ++      T     +L  L L
Sbjct: 29  GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVL 88

Query: 156 ENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-T 214
             N L      ++     L  L      +S       +N  +L  L LGSN ++SI L  
Sbjct: 89  TANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148

Query: 215 FWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLE 274
            +  + +  L+F +N        ++ +L+          + +SLNL+ N+++G I     
Sbjct: 149 GFPTEKLKVLDFQNNAIHYLSKEDMSSLQ--------QATNLSLNLNGNDIAG-IEPGAF 199

Query: 275 KLSYLKDLNLSFNKLEGEIPRGGSFGNFSA---ESFEGNELLCGSPNLRVPPCKTSIHHI 331
             +  + LN    +    I +G       +    +FE  +    SP +    C+ S+  I
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI 259

Query: 332 S 332
           +
Sbjct: 260 N 260

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 57.3 bits (139), Expect = 1e-08
 Identities = 21/117 (17%), Positives = 28/117 (23%), Gaps = 18/117 (15%)

Query: 199 RILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNL-----------KIARI 247
           +     +  L  IP T         L FS N            L           +I  I
Sbjct: 15  KTYNCENLGLNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 248 DS---CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGN 301
                     L +L L+ N L      +L     LK L      +           N
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF--IPLHN 127

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  162 bits (412), Expect = 1e-42
 Identities = 54/314 (17%), Positives = 102/314 (32%), Gaps = 43/314 (13%)

Query: 6   ENNFSGTIPRFIFNASKLSILELSDNSFSGF---IPNTFGNLRNLQALRLSNNYLTSSTL 62
           E N        +     L+I E        +   I + F  L N+ +  L +        
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT------ 293

Query: 63  ELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLS-----------------HSLEYF 105
            +  +   S       +   N                                  SLE+ 
Sbjct: 294 -IERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFL 352

Query: 106 EMAY--CNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGS 163
           +++    +  G   +     T+L  + L  N +   + S    L++L+ L  +++ L+  
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQM 411

Query: 164 IPDSI-CHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTS--IPLTFWNLKD 220
              S+      L  L++       +    FN L+SL +L +  N      +P  F  L++
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471

Query: 221 ILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLK 280
           + +L+ S        P    +L           SL  LN+S+NN         + L+ L+
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLS----------SLQVLNMSHNNFFSLDTFPYKCLNSLQ 521

Query: 281 DLNLSFNKLEGEIP 294
            L+ S N +     
Sbjct: 522 VLDYSLNHIMTSKK 535

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  159 bits (405), Expect = 7e-42
 Identities = 73/349 (20%), Positives = 117/349 (33%), Gaps = 59/349 (16%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L +  N          F+  +L +L+LS           + +L +L  L L+ N + S  
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGG-IPEEI 120
           L      + S   SL  +      L  +     +G+L  +L+   +A+  +    +PE  
Sbjct: 93  LG-----AFSGLSSLQKLVAVETNLASLEN-FPIGHLK-TLKELNVAHNLIQSFKLPEYF 145

Query: 121 GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQ----GLGLENNKLEGSIPDSICHSDELYK 176
            NLTNL  + L  NK+     + L  L ++      L L  N +   I         L+K
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHK 204

Query: 177 LELGGNKLSGSIPE-CFNNLASLRILLLGSNELTS------------------------- 210
           L L  N  S ++ + C   LA L +  L   E  +                         
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264

Query: 211 ---------IPLTFWNLKDILYLNFSSNFFTGPLP---------LEIGNLKIARIDSCDL 252
                    I   F  L ++   +  S                 LE+ N K  +  +  L
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKL 324

Query: 253 ISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGN 301
            SL  L  ++N    A   S   L  L+ L+LS N L  +     S   
Sbjct: 325 KSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  153 bits (389), Expect = 1e-39
 Identities = 53/295 (17%), Positives = 98/295 (33%), Gaps = 30/295 (10%)

Query: 13  IPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSN 72
           IP  +        L+LS N        +F +   LQ L LS   + +         +  +
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-----IEDGAYQS 74

Query: 73  CKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLG 132
              L+ +  + NP+   L   +   LS SL+       N++      IG+L  L  + + 
Sbjct: 75  LSHLSTLILTGNPIQS-LALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELNVA 132

Query: 133 GNKLNG-SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDEL----YKLELGGNKLSGS 187
            N +    +P     L  L+ L L +NK++      +    ++      L+L  N ++  
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192

Query: 188 IPECFNNLASLRILLLGSNELT--SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIA 245
            P  F  +  L  L L +N  +   +      L  +         F            + 
Sbjct: 193 QPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR-------NEGNLE 244

Query: 246 RIDSCDLISLISLNLSNNNLS------GAIPASLEKLSYLKDLNLSFNKLEGEIP 294
           + D   L  L +L +    L+        I      L+ +   +L    +E    
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  152 bits (387), Expect = 2e-39
 Identities = 59/317 (18%), Positives = 106/317 (33%), Gaps = 41/317 (12%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGF-------------------IPNTFG 42
             +        +  F +N      LEL +  F  F                      +  
Sbjct: 287 FSLVSVTIER-VKDFSYN-FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV 344

Query: 43  NLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSL 102
           +L +L+ L LS N L+          S     SL  +  S N +  +            L
Sbjct: 345 DLPSLEFLDLSRNGLSFKGC---CSQSDFGTTSLKYLDLSFNGVITMSSNFLG---LEQL 398

Query: 103 EYFEMAYCNVSGGIPEEI-GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLE 161
           E+ +  + N+       +  +L NL  + +       +       L  L+ L +  N  +
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458

Query: 162 GSI-PDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTS-IPLTFWNLK 219
            +  PD       L  L+L   +L    P  FN+L+SL++L +  N   S     +  L 
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518

Query: 220 DILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPAS--LEKLS 277
            +  L++S N        E+ +            SL  LNL+ N+ +        L+ + 
Sbjct: 519 SLQVLDYSLNHIMTSKKQELQHF---------PSSLAFLNLTQNDFACTCEHQSFLQWIK 569

Query: 278 YLKDLNLSFNKLEGEIP 294
             + L +   ++E   P
Sbjct: 570 DQRQLLVEVERMECATP 586

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  149 bits (377), Expect = 4e-38
 Identities = 58/308 (18%), Positives = 104/308 (33%), Gaps = 29/308 (9%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
           N             S L  L   + + +       G+L+ L+ L +++N + S       
Sbjct: 86  NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS----FKL 141

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKT--SVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT 124
               SN  +L  +  S+N +  I       +  +       +++   ++  I        
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI 200

Query: 125 NLTIIYLGGNKLNGSIPST-LGKLQKLQGLGLENNKLEGSI---PDSICHSDELYKLELG 180
            L  + L  N  + ++  T +  L  L+   L   +               + L  L + 
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 181 GNKLS------GSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGP 234
             +L+        I + FN L ++    L S  +  +   F       +L   +  F   
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK-DFSYNFGWQHLELVNCKFGQF 319

Query: 235 LPLEIGNLK---------IARIDSCDLISLISLNLSNNNLS--GAIPASLEKLSYLKDLN 283
             L++ +LK                DL SL  L+LS N LS  G    S    + LK L+
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 284 LSFNKLEG 291
           LSFN +  
Sbjct: 380 LSFNGVIT 387

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  141 bits (357), Expect = 1e-35
 Identities = 38/209 (18%), Positives = 76/209 (36%), Gaps = 10/209 (4%)

Query: 97  NLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLE 156
           NL  S +  ++++  +         +   L ++ L   ++          L  L  L L 
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 157 NNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL--T 214
            N ++     +      L KL      L+        +L +L+ L +  N + S  L   
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 215 FWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLE 274
           F NL ++ +L+ SSN        ++  L          +  +SL+LS N ++   P + +
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP------LLNLSLDLSLNPMNFIQPGAFK 198

Query: 275 KLSYLKDLNLSFNKLEGEIPRGGSFGNFS 303
           ++  L  L L  N     + +       +
Sbjct: 199 EIR-LHKLTLRNNFDSLNVMK-TCIQGLA 225

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  137 bits (348), Expect = 2e-34
 Identities = 51/252 (20%), Positives = 89/252 (35%), Gaps = 13/252 (5%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
            +F G   +  F  + L  L+LS N     + + F  L  L+ L   ++ L      +S 
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQ----MSE 413

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGI-PEEIGNLTN 125
            S   + ++L  +  S+              LS SLE  +MA  +      P+    L N
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGI-FNGLS-SLEVLKMAGNSFQENFLPDIFTELRN 471

Query: 126 LTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLS 185
           LT + L   +L    P+    L  LQ L + +N             + L  L+   N + 
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 531

Query: 186 GSIPECFNNLA-SLRILLLGSNELT-SIPLT--FWNLKDILYLNFSSNFFTGPLPLEIGN 241
            S  +   +   SL  L L  N+   +         +KD   L           P +   
Sbjct: 532 TSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG 591

Query: 242 LKIARID-SCDL 252
           + +  ++ +C +
Sbjct: 592 MPVLSLNITCQM 603

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  152 bits (387), Expect = 6e-41
 Identities = 81/281 (28%), Positives = 122/281 (43%), Gaps = 38/281 (13%)

Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSC 457
           IGRG+FG VF  RL  D   VA+K         +   F  E  ++K   H NI+++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
           + ++   +V+E +  G    +L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   N L+ +  V  +SDFG+++       +         + + APE    GR S+  DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298

Query: 578 YSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK-- 635
           +SFGI+L ETF+          G            P        PNL +++   FV K  
Sbjct: 299 WSFGILLWETFS---------LGAS----------PY-------PNLSNQQTREFVEKGG 332

Query: 636 -----EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
                E C   VF +  +C    P QR +   I  +L  IR
Sbjct: 333 RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  148 bits (376), Expect = 5e-40
 Identities = 71/290 (24%), Positives = 131/290 (45%), Gaps = 29/290 (10%)

Query: 400 IGRGSFGSVFKARL-----GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           +G+G+FGSV   R        G  VA+K          + F+ E E++KS++H NI+K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 455 SSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
             C +   +   L++EY+P+GSL  YL      +D  + L     +   +EYL    + +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEGRV 571
            IH DL   N+L+++     + DFG+ K+L + ++   ++    + I + APE   E + 
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225

Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN 631
           S   DV+SFG++L E FT  + +       M +                   ++    I 
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI-----------GNDKQGQMIVFHLIE 274

Query: 632 FVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL 674
            +         + C   ++ +  EC   +  QR + +++  ++ +IRD +
Sbjct: 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  147 bits (372), Expect = 1e-39
 Identities = 71/290 (24%), Positives = 132/290 (45%), Gaps = 29/290 (10%)

Query: 400 IGRGSFGSVFKARL-----GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           +G+G+FGSV   R        G  VA+K          + F+ E E++KS++H NI+K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 455 SSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
             C +   +   L++EY+P+GSL  YL      +D  + L     +   +EYL    + +
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEGRV 571
            IH DL   N+L+++     + DFG+ K+L + ++   ++    + I + APE   E + 
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194

Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN 631
           S   DV+SFG++L E FT  + +       M +                   ++    I 
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI-----------GNDKQGQMIVFHLIE 243

Query: 632 FVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL 674
            +         + C   ++ +  EC   +  QR + +++  ++ +IRD++
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  147 bits (373), Expect = 2e-39
 Identities = 63/288 (21%), Positives = 115/288 (39%), Gaps = 31/288 (10%)

Query: 17  IFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSL 76
           I   + L  L L+ N  +   P    NL  L  L +  N +T        +S+L N  +L
Sbjct: 62  IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-------ISALQNLTNL 112

Query: 77  TLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKL 136
             +  + + +  I P   + NL+  +    +   +        + N+T L  + +  +K+
Sbjct: 113 RELYLNEDNISDISP---LANLT-KMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKV 167

Query: 137 NGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLA 196
               P  +  L  L  L L  N++E   P  +     L+      N+++   P    N+ 
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMT 221

Query: 197 SLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLE---------IGNLKIARI 247
            L  L +G+N++T +     NL  + +L   +N  +    ++         +G+ +I+ I
Sbjct: 222 RLNSLKIGNNKITDLS-PLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDI 280

Query: 248 DS-CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
               +L  L SL L+NN L       +  L+ L  L LS N +    P
Sbjct: 281 SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  142 bits (361), Expect = 1e-37
 Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 35/289 (12%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L +  N    T    + N + L  L L++++ S   P    NL  + +L L  N+  S  
Sbjct: 93  LYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD- 147

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG 121
                LS LSN   L  ++ + + +  + P   + NL+  L    + Y  +       + 
Sbjct: 148 -----LSPLSNMTGLNYLTVTESKVKDVTP---IANLT-DLYSLSLNYNQIED--ISPLA 196

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG 181
           +LT+L       N++    P  +  + +L  L + NNK+    P +      L  LE+G 
Sbjct: 197 SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQ--LTWLEIGT 252

Query: 182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGN 241
           N++S        +L  L++L +GSN+++ I     NL  +  L  ++N         IG 
Sbjct: 253 NQISD--INAVKDLTKLKMLNVGSNQISDIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGG 309

Query: 242 LKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
           L           +L +L LS N+++   P  L  LS +   + +   ++
Sbjct: 310 LT----------NLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  134 bits (341), Expect = 6e-35
 Identities = 55/273 (20%), Positives = 100/273 (36%), Gaps = 35/273 (12%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
           + ++     L   S +  +      L ++  L ++   + S       +  +    +L  
Sbjct: 20  DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS-------IQGIEYLTNLEY 70

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG 138
           ++ + N +  I P   + NL   L    +    ++      + NLTNL  +YL  + ++ 
Sbjct: 71  LNLNGNQITDISP---LSNLV-KLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD 124

Query: 139 SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASL 198
             P  L  L K+  L L  N    S    + +   L  L +  +K+    P    NL  L
Sbjct: 125 ISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDL 179

Query: 199 RILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISL 258
             L L  N++  I     +L  + Y     N  T   P+             ++  L SL
Sbjct: 180 YSLSLNYNQIEDIS-PLASLTSLHYFTAYVNQITDITPV------------ANMTRLNSL 226

Query: 259 NLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEG 291
            + NN ++   P  L  LS L  L +  N++  
Sbjct: 227 KIGNNKITDLSP--LANLSQLTWLEIGTNQISD 257

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  119 bits (301), Expect = 1e-29
 Identities = 53/282 (18%), Positives = 92/282 (32%), Gaps = 55/282 (19%)

Query: 23  LSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFS 82
            + L       +   P    +L       L    +T        + +    +S+T +  +
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD-------VVTQEELESITKLVVA 52

Query: 83  NNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPS 142
              +  I                            + I  LTNL  + L GN++    P 
Sbjct: 53  GEKVASI----------------------------QGIEYLTNLEYLNLNGNQITDISP- 83

Query: 143 TLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILL 202
            L  L KL  L +  NK+  +   ++ +   L +L L  + +S   P    NL  +  L 
Sbjct: 84  -LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLN 138

Query: 203 LGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLP---------LEIGNLKIARIDS-CDL 252
           LG+N   S      N+  + YL  + +      P         L +   +I  I     L
Sbjct: 139 LGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYNQIEDISPLASL 198

Query: 253 ISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
            SL       N ++   P  +  ++ L  L +  NK+    P
Sbjct: 199 TSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP 238

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 98.4 bits (246), Expect = 2e-22
 Identities = 37/185 (20%), Positives = 68/185 (36%), Gaps = 19/185 (10%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
            L +  N      P  + + + L       N  +   P    N+  L +L++ NN +T  
Sbjct: 181 SLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD- 235

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
                 LS L+N   LT +    N +  I    +V +L+  L+   +    +S      +
Sbjct: 236 ------LSPLANLSQLTWLEIGTNQISDI---NAVKDLT-KLKMLNVGSNQISD--ISVL 283

Query: 121 GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG 180
            NL+ L  ++L  N+L       +G L  L  L L  N +    P  +    ++   +  
Sbjct: 284 NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFA 341

Query: 181 GNKLS 185
              + 
Sbjct: 342 NQVIK 346

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  150 bits (380), Expect = 4e-39
 Identities = 66/276 (23%), Positives = 117/276 (42%), Gaps = 28/276 (10%)

Query: 398 NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
           + +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
           C+ E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            +L   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S   
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400

Query: 576 DVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVA 634
           DV++FG++L E  T    P   I   ++      +  +         P            
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------P------------ 441

Query: 635 KEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
            E C   V+ +   C   +P  R +  EI      +
Sbjct: 442 -EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  145 bits (367), Expect = 5e-39
 Identities = 69/286 (24%), Positives = 126/286 (44%), Gaps = 32/286 (11%)

Query: 398 NLIGRGSFGSVFKARL----GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
            +IGRG FG V+   L    G  +  A+K  N          F  E  +MK   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 453 VISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           ++  C   E   L VL YM HG L  ++ +  +   +   +   + VA  ++YL    S 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SK 147

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGKEG 569
           + +H DL   N +LD+     ++DFG+A+ +  ++  ++  +T A   + +MA E  +  
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207

Query: 570 RVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 628
           + +   DV+SFG++L E  TR   P  ++   ++             T  ++    L + 
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------------TVYLLQGRRLLQ- 253

Query: 629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL 674
                  E C   ++ V ++C     E R +  E+V+++  I  + 
Sbjct: 254 ------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  145 bits (367), Expect = 6e-39
 Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 40/292 (13%)

Query: 400 IGRGSFGSVFKARL----GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKV 453
           +G G FGSV +  L    G  ++VA+K   L     R  + F  E   MK   H N+I++
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101

Query: 454 ISSCSNEEFKA-----LVLEYMPHGSLEKYL-----HSSNYILDIYQRLNIMIDVASALE 503
           +  C     +      ++L +M +G L  YL      +    + +   L  M+D+A  +E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL    +   +H DL   N +L D+M   ++DFG++K +   D           + ++A 
Sbjct: 162 YLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218

Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 622
           E   +   ++  DV++FG+ + E  TR   P   + N EM                ++  
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-------------YDYLLHG 265

Query: 623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL 674
           + L +        E C+  ++ +   C    P  R     +  +L K+ +SL
Sbjct: 266 HRLKQ-------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  144 bits (365), Expect = 6e-39
 Identities = 66/281 (23%), Positives = 110/281 (39%), Gaps = 37/281 (13%)

Query: 397 NNLIGRGSFGSVFKAR-LGDGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +  IGRGSF +V+K       +EVA              + F  E EM+K ++H NI++ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 454 ISSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
             S  +         LV E M  G+L+ YL     ++ I    +    +   L++LH   
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 510 SAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  +IH DLK  N+ +        + D G+A L        +      T  +MAPE  +E
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----GTPEFMAPEMYEE 204

Query: 569 GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 628
                + DVY+FG+ ++E  T + P  E  N     +   +   P S        +   E
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS-----FDKVAIPE 258

Query: 629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK 669
               +               C  ++ ++R + K+    LL 
Sbjct: 259 VKEIIEG-------------CIRQNKDERYSIKD----LLN 282

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  144 bits (365), Expect = 1e-38
 Identities = 63/293 (21%), Positives = 122/293 (41%), Gaps = 35/293 (11%)

Query: 400 IGRGSFGSVFKARL-----GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV 453
           +G G FG V   R        G +VA+K    + G         E E+++++ H NI+K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 454 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              C+ +      L++E++P GSL++YL  +   +++ Q+L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEGR 570
           Q +H DL   NVL++      + DFG+ K +   ++  T++    + + + APE   + +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205

Query: 571 VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 630
                DV+SFG+ L E  T           +            I         +     +
Sbjct: 206 FYIASDVWSFGVTLHELLTY---------CDSDSSPMALFLKMIGPTH---GQMTVTRLV 253

Query: 631 NFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLR 676
           N + +         C   V+ +  +C    P  R + + ++       ++LL+
Sbjct: 254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF----EALLK 302

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  143 bits (364), Expect = 1e-38
 Identities = 70/286 (24%), Positives = 112/286 (39%), Gaps = 32/286 (11%)

Query: 400 IGRGSFGSVFKARL----GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIK 452
           +G GSFG V +       G  + VA+K               F  E   M S+ HRN+I+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +         K +V E  P GSL   L        +       + VA  + YL    S +
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 141

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYGKEGRV 571
            IH DL   N+LL    +  + DFG+ + L + D   +  +       + APE  K    
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201

Query: 572 SANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 630
           S   D + FG+ L E FT  ++P                 W+ ++  +I+    + +E  
Sbjct: 202 SHASDTWMFGVTLWEMFTYGQEP-----------------WIGLNGSQILH--KIDKEGE 242

Query: 631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLR 676
                E C   ++NV ++C    PE R     +   LL+ + + +R
Sbjct: 243 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  143 bits (362), Expect = 1e-38
 Identities = 73/283 (25%), Positives = 120/283 (42%), Gaps = 38/283 (13%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG G FG V      +  +VA+K          + F  E E+M  + H  ++++   C  
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVCLE 74

Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
           +    LV E+M HG L  YL +   +      L + +DV   + YL     A VIH DL 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLA 131

Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYS 579
             N L+ +N V  +SDFG+ + +  +DQ T  T T   + + +PE     R S+  DV+S
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWS 190

Query: 580 FGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK---- 635
           FG+++ E F+          G++          P         N  + E +  ++     
Sbjct: 191 FGVLMWEVFSE---------GKI----------PY-------ENRSNSEVVEDISTGFRL 224

Query: 636 ---EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
                  + V+ +   C  E PE R     ++ +L +I +S L
Sbjct: 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESGL 267

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  144 bits (365), Expect = 1e-38
 Identities = 62/281 (22%), Positives = 115/281 (40%), Gaps = 39/281 (13%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRH--RNIIKV 453
             IG G    VF+         A+K  NL+    +   S+  E   +  ++     II++
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
                 +++  +V+E   +  L  +L      +D ++R +   ++  A+  +H      +
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH---QHGI 148

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE--------- 564
           +H DLKP+N L+ D M+  L DFGIA  +  +  S ++   + T+ YM PE         
Sbjct: 149 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

Query: 565 --YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 622
                + ++S   DV+S G +L      K P  +I N    L   ++        EI  P
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-----PNHEIEFP 262

Query: 623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
           ++  ++  + +               C    P+QRI+  E+
Sbjct: 263 DIPEKDLQDVLKC-------------CLKRDPKQRISIPEL 290

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  145 bits (368), Expect = 1e-38
 Identities = 84/373 (22%), Positives = 152/373 (40%), Gaps = 51/373 (13%)

Query: 329 HHISRKNAFLLGIVLPLSTVF--MIVVIFLIVKCRKRERGPPNDANMPPEAMQRMFSYL- 385
           HH  R+ +   GI++P  +     I  I  +     ++ G  N        +    S L 
Sbjct: 13  HHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN 72

Query: 386 -ELCRATDGFSE---------NNLIGRGSFGSVFKARL----GDGMEVAMKVFNLQYG-R 430
            EL +A               N +IGRG FG V+   L    G  +  A+K  N      
Sbjct: 73  PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG 132

Query: 431 VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL-VLEYMPHGSLEKYLHSSNYILDIY 489
               F  E  +MK   H N++ ++  C   E   L VL YM HG L  ++ +  +   + 
Sbjct: 133 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 192

Query: 490 QRLNIMIDVASALEYL---HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
             +   + VA  +++L    F      +H DL   N +LD+     ++DFG+A+ +  ++
Sbjct: 193 DLIGFGLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246

Query: 547 QSTIQTQTLAT--IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMT 603
             ++  +T A   + +MA E  +  + +   DV+SFG++L E  TR   P  ++   ++ 
Sbjct: 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI- 305

Query: 604 LKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
                       T  ++    L +        E C   ++ V ++C     E R +  E+
Sbjct: 306 ------------TVYLLQGRRLLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSEL 346

Query: 664 VTKLLKIRDSLLR 676
           V+++  I  + + 
Sbjct: 347 VSRISAIFSTFIG 359

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  144 bits (365), Expect = 2e-38
 Identities = 46/317 (14%), Positives = 103/317 (32%), Gaps = 45/317 (14%)

Query: 11  GTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFL--- 67
           G+      ++S    L    ++      +     +       +  +        +     
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 68  -----------SSLSNCKSLTLIS--FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSG 114
                        L +      ++    + PL    P      LSH L++  +    +  
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD-QAFRLSH-LQHMTIDAAGLME 118

Query: 115 GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGL-ENNKLEGSIPDSICHSDE 173
            +P+ +     L  + L  N L  ++P+++  L +L+ L +    +L   +P+ +  +D 
Sbjct: 119 -LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT-ELPEPLASTDA 175

Query: 174 ---------LYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYL 224
                    L  L L    +  S+P    NL +L+ L + ++ L+++     +L  +  L
Sbjct: 176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEEL 234

Query: 225 NFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNL 284
           +          P   G              L  L L + +    +P  + +L+ L+ L+L
Sbjct: 235 DLRGCTALRNYPPIFGGRA----------PLKRLILKDCSNLLTLPLDIHRLTQLEKLDL 284

Query: 285 SFNKLEGEIPRGGSFGN 301
                   +P       
Sbjct: 285 RGCVNLSRLPS--LIAQ 299

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  142 bits (359), Expect = 1e-37
 Identities = 56/291 (19%), Positives = 103/291 (35%), Gaps = 58/291 (19%)

Query: 12  TIPRFIFNAS--KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSS 69
                + +A+      LEL         P+    L +LQ + +    L           +
Sbjct: 70  ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME------LPDT 122

Query: 70  LSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGN------- 122
           +     L  ++ + NPL   LP  S+ +L+  L    +  C     +PE + +       
Sbjct: 123 MQQFAGLETLTLARNPLR-ALPA-SIASLN-RLRELSIRACPELTELPEPLASTDASGEH 179

Query: 123 --LTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG 180
             L NL  + L    +  S+P+++  LQ L+ L + N+ L  ++  +I H  +L +L+L 
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLR 237

Query: 181 GNKLSGSIPECFNNLASLRIL-LLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEI 239
           G     + P  F   A L+ L L   + L +                        LPL+I
Sbjct: 238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLT------------------------LPLDI 273

Query: 240 GNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
             L            L  L+L        +P+ + +L     + +  +   
Sbjct: 274 HRLT----------QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  118 bits (299), Expect = 1e-29
 Identities = 41/206 (19%), Positives = 77/206 (37%), Gaps = 11/206 (5%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLS-NNYLTS---STLELSFL 67
            +P  +   + L  L L+ N     +P +  +L  L+ L +     LT            
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDAS 176

Query: 68  SSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLT 127
                  +L  +      +   LP  S+ NL  +L+  ++    +S  +   I +L  L 
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRS-LPA-SIANLQ-NLKSLKIRNSPLSA-LGPAIHHLPKLE 232

Query: 128 IIYLGGNKLNGSIPSTLGKLQKLQGLGLEN-NKLEGSIPDSICHSDELYKLELGGNKLSG 186
            + L G     + P   G    L+ L L++ + L  ++P  I    +L KL+L G     
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLS 291

Query: 187 SIPECFNNLASLRILLLGSNELTSIP 212
            +P     L +  I+L+  +    + 
Sbjct: 292 RLPSLIAQLPANCIILVPPHLQAQLD 317

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 50.7 bits (122), Expect = 7e-07
 Identities = 17/91 (18%), Positives = 28/91 (30%), Gaps = 7/91 (7%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L +         P      + L  L L D S    +P     L  L+ L L         
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC------ 287

Query: 62  LELSFL-SSLSNCKSLTLISFSNNPLDGILP 91
           + LS L S ++   +  +I    +    +  
Sbjct: 288 VNLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 41.9 bits (99), Expect = 5e-04
 Identities = 9/63 (14%), Positives = 21/63 (33%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L + + +   T+P  I   ++L  L+L        +P+    L     + +  +      
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317

Query: 62  LEL 64
              
Sbjct: 318 QHR 320

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  144 bits (364), Expect = 2e-38
 Identities = 54/210 (25%), Positives = 98/210 (46%), Gaps = 11/210 (5%)

Query: 400 IGRGSFGSVFKARL-----GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV 453
           +G G FG+V K           + V +KV   + G + F++       + S+ H +I+++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
           +  C     + LV +Y+P GSL  ++      L     LN  + +A  + YL       +
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           +H +L   NVLL       ++DFG+A LL  +D+  + ++    I +MA E    G+ + 
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTH 196

Query: 574 NGDVYSFGIMLMETFTR-KKPTDEIFNGEM 602
             DV+S+G+ + E  T   +P   +   E+
Sbjct: 197 QSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  143 bits (362), Expect = 2e-38
 Identities = 70/293 (23%), Positives = 127/293 (43%), Gaps = 44/293 (15%)

Query: 399 LIGRGSFGSVFKA---RLGDGMEVAMKVFNLQYGR--VFKS-FDVECEMMKSIRHRNIIK 452
            +G G   +V+ A    L   ++VA+K   +           F+ E      + H+NI+ 
Sbjct: 18  KLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +I     ++   LV+EY+   +L +Y+ S +  L +   +N    +   +++ H     +
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAH---DMR 131

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPEYGKEG 569
           ++H D+KP N+L+D N    + DFGIAK L    ++++ TQT   +G   Y +PE  K  
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKAL---SETSL-TQTNHVLGTVQYFSPEQAKGE 187

Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGE----MTLKHWVNDWLPISTKEIVDPNLL 625
                 D+YS GI+L E    + P    FNGE    + +KH + D +P  T ++   + +
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP----FNGETAVSIAIKH-IQDSVPNVTTDV-RKD-I 240

Query: 626 SREDINFVAKEQCVSFVFNVAMECTVESPEQR-INAKEIVTKLLKIRDSLLRN 677
            +   N + +              T +    R    +E+   L  +      N
Sbjct: 241 PQSLSNVILR-------------ATEKDKANRYKTIQEMKDDLSSVLHENRAN 280

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  144 bits (365), Expect = 2e-38
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 11/209 (5%)

Query: 400 IGRGSFGSVFKARLGDGME-----VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV 453
           +G G+FG+V+K       E     VA+K        +  K    E  +M S+ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
           +  C     + L+ + MP G L  Y+      +     LN  + +A  + YL      ++
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRL 138

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           +H DL   NVL+       ++DFG+AKLL  E++          I +MA E       + 
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198

Query: 574 NGDVYSFGIMLMETFTR-KKPTDEIFNGE 601
             DV+S+G+ + E  T   KP D I   E
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  144 bits (365), Expect = 2e-38
 Identities = 62/281 (22%), Positives = 115/281 (40%), Gaps = 39/281 (13%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRH--RNIIKV 453
             IG G    VF+         A+K  NL+    +   S+  E   +  ++     II++
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
                 +++  +V+E   +  L  +L      +D ++R +   ++  A+  +H      +
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH---QHGI 129

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE--------- 564
           +H DLKP+N L+ D M+  L DFGIA  +  +  S ++   + T+ YM PE         
Sbjct: 130 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 565 --YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 622
                + ++S   DV+S G +L      K P  +I N    L   ++        EI  P
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-----PNHEIEFP 243

Query: 623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
           ++  ++  + +               C    P+QRI+  E+
Sbjct: 244 DIPEKDLQDVLKC-------------CLKRDPKQRISIPEL 271

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  143 bits (363), Expect = 3e-38
 Identities = 65/290 (22%), Positives = 117/290 (40%), Gaps = 33/290 (11%)

Query: 400 IGRGSFGSVFKARL-----GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV 453
           +G G FG V          G G  VA+K      G +    +  E ++++++ H +IIK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 454 ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
              C +    +  LV+EY+P GSL  YL   +  + + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEGR 570
             IH DL   NVLLD++ +  + DFG+AK +    +   ++    + + + APE  KE +
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213

Query: 571 VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 630
                DV+SFG+ L E  T           +            +    I    +      
Sbjct: 214 FYYASDVWSFGVTLYELLTH---------CD---SSQSPPTKFLELIGIAQGQMTVLRLT 261

Query: 631 NFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
             + +       ++C + V+++   C       R   + ++  L  + + 
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  142 bits (361), Expect = 3e-38
 Identities = 67/299 (22%), Positives = 128/299 (42%), Gaps = 50/299 (16%)

Query: 396 ENNLIGRGSFGSVFKARLGDG----MEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNI 450
            + +IG+G FG V+     D     ++ A+K  +     +  ++F  E  +M+ + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 451 IKVISSCSNEE-FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL---H 506
           + +I      E    ++L YM HG L +++ S      +   ++  + VA  +EYL    
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPE 564
           F      +H DL   N +LD++    ++DFG+A+ +   +  ++Q    A   + + A E
Sbjct: 145 F------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 565 YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
             +  R +   DV+SFG++L E  TR         G            P         ++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTR---------GAP----------PY-------RHI 232

Query: 625 LSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLR 676
              +  +F+A+       E C   ++ V  +C    P  R   + +V ++ +I  +LL 
Sbjct: 233 DPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  142 bits (361), Expect = 6e-38
 Identities = 66/290 (22%), Positives = 113/290 (38%), Gaps = 32/290 (11%)

Query: 400 IGRGSFGSVFKARL-----GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           +G+G+FGSV   R        G  VA+K          + F  E +++K++    I+K  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 455 SSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
                   ++  LV+EY+P G L  +L      LD  + L     +   +EYL    S +
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLL-TREDQSTIQTQTLATIGYMAPEYGKEGRV 571
            +H DL   N+L++      ++DFG+AKLL   +D   ++    + I + APE   +   
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207

Query: 572 SANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 630
           S   DV+SFG++L E FT   K                     +               +
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKS-------------CSPSAEFLRMMGCERDVPALSRLL 254

Query: 631 NFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
             + +         C + V  +   C   SP+ R +   +  +L  +   
Sbjct: 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  142 bits (361), Expect = 6e-38
 Identities = 69/293 (23%), Positives = 130/293 (44%), Gaps = 41/293 (13%)

Query: 400 IGRGSFGSVFKARL----GDGMEVAMKVF--NLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +G+G FGSV +A+L    G  ++VA+K+   ++      + F  E   MK   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 454 ISSCSNEEFKA------LVLEYMPHGSLEKYLHSS-----NYILDIYQRLNIMIDVASAL 502
           +        K       ++L +M HG L  +L +S      + L +   +  M+D+A  +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           EYL    S   IH DL   N +L ++M   ++DFG+++ +   D       +   + ++A
Sbjct: 151 EYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207

Query: 563 PEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 621
            E   +   + + DV++FG+ + E  TR + P   I N E+                ++ 
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-------------YNYLIG 254

Query: 622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL 674
            N L +         +C+  V+++  +C    P+QR +   +  +L  I   L
Sbjct: 255 GNRLKQ-------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  140 bits (356), Expect = 8e-38
 Identities = 68/280 (24%), Positives = 118/280 (42%), Gaps = 38/280 (13%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           +G G FG V   +     +VA+K+           F  E + M  + H  ++K    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
           E    +V EY+ +G L  YL S    L+  Q L +  DV   + +L    S Q IH DL 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131

Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYS 579
             N L+D ++   +SDFG+ + +  +DQ      T   + + APE     + S+  DV++
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWA 190

Query: 580 FGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK---- 635
           FGI++ E F+          G+M          P            + E +  V++    
Sbjct: 191 FGILMWEVFSL---------GKM----------PY-------DLYTNSEVVLKVSQGHRL 224

Query: 636 ---EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD 672
                    ++ +   C  E PE+R   +++++ +  +R+
Sbjct: 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  143 bits (363), Expect = 1e-37
 Identities = 61/281 (21%), Positives = 114/281 (40%), Gaps = 39/281 (13%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRH--RNIIKV 453
             IG G    VF+         A+K  NL+    +   S+  E   +  ++     II++
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
                 +++  +V+E   +  L  +L      +D ++R +   ++  A+  +H      +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH---QHGI 176

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE--------- 564
           +H DLKP+N L+ D M+  L DFGIA  +  +  S ++   +  + YM PE         
Sbjct: 177 VHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235

Query: 565 --YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP 622
                + ++S   DV+S G +L      K P  +I N    L   ++        EI  P
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-----PNHEIEFP 290

Query: 623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
           ++  ++  + +               C    P+QRI+  E+
Sbjct: 291 DIPEKDLQDVLKC-------------CLKRDPKQRISIPEL 318

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  140 bits (356), Expect = 1e-37
 Identities = 62/281 (22%), Positives = 119/281 (42%), Gaps = 38/281 (13%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           +G G FG V   +     +VA+K+           F  E ++M ++ H  ++++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVCTK 90

Query: 460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK 519
           +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL    S Q +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147

Query: 520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYS 579
             N L++D  V  +SDFG+++ +  +D+ T    +   + +  PE     + S+  D+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWA 206

Query: 580 FGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK---- 635
           FG+++ E ++          G+M          P            + E    +A+    
Sbjct: 207 FGVLMWEIYSL---------GKM----------PY-------ERFTNSETAEHIAQGLRL 240

Query: 636 ---EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                    V+ +   C  E  ++R   K +++ +L + D 
Sbjct: 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  144 bits (366), Expect = 2e-37
 Identities = 68/275 (24%), Positives = 126/275 (45%), Gaps = 28/275 (10%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
             +G+G FG V+         VA+K          ++F  E ++MK +RH  ++++ +  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
           S E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGD 576
           DL+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   D
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 577 VYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK 635
           V+SFGI+L E  T+ + P   + N E+  +      +P        P             
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-------P------------- 403

Query: 636 EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
            +C   + ++  +C  + PE+R   + +   L   
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  145 bits (367), Expect = 3e-37
 Identities = 68/275 (24%), Positives = 126/275 (45%), Gaps = 28/275 (10%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
             +G+G FG V+         VA+K          ++F  E ++MK +RH  ++++ +  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
           S E    +V EYM  GSL  +L       L + Q +++   +AS + Y+        +H 
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGD 576
           DL+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR +   D
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 577 VYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK 635
           V+SFGI+L E  T+ + P   + N E+  +      +P        P             
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-------P------------- 486

Query: 636 EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
            +C   + ++  +C  + PE+R   + +   L   
Sbjct: 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  139 bits (352), Expect = 4e-37
 Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 7/193 (3%)

Query: 400 IGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +G G +G V++       + VA+K        V + F  E  +MK I+H N+++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   N L+ +N +  ++DFG+++L+T  D  T        I + APE     + S   DV
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195

Query: 578 YSFGIMLMETFTR 590
           ++FG++L E  T 
Sbjct: 196 WAFGVLLWEIATY 208

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  143 bits (363), Expect = 4e-37
 Identities = 52/193 (26%), Positives = 99/193 (51%), Gaps = 7/193 (3%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
             +G G FG V+ A      +VA+K        V ++F  E  +MK+++H  ++K+ +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
           + E    ++ E+M  GSL  +L S       + + ++    +A  + ++        IH 
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGD 576
           DL+ +N+L+  ++V  ++DFG+A+++  +++ T +      I + APE    G  +   D
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367

Query: 577 VYSFGIMLMETFT 589
           V+SFGI+LME  T
Sbjct: 368 VWSFGILLMEIVT 380

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  143 bits (362), Expect = 7e-37
 Identities = 79/305 (25%), Positives = 127/305 (41%), Gaps = 47/305 (15%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS-- 59
           +    N  +   P  + N +KL  + +++N  +   P    NL NL  L L NN +T   
Sbjct: 73  INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDID 128

Query: 60  --------STLELSF-----LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFE 106
                   + LELS      +S+LS   SL  +SF N   D       + NL+ +LE  +
Sbjct: 129 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK----PLANLT-TLERLD 183

Query: 107 MAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPD 166
           ++   VS      +  LTNL  +    N+++   P  LG L  L  L L  N+L+     
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IG 237

Query: 167 SICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNF 226
           ++     L  L+L  N++S   P   + L  L  L LG+N++++I      L  +  L  
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS-PLAGLTALTNLEL 294

Query: 227 SSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSF 286
           + N      P+             +L +L  L L  NN+S   P  +  L+ L+ L    
Sbjct: 295 NENQLEDISPIS------------NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340

Query: 287 NKLEG 291
           NK+  
Sbjct: 341 NKVSD 345

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  132 bits (335), Expect = 2e-33
 Identities = 65/283 (22%), Positives = 117/283 (41%), Gaps = 36/283 (12%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
           N  +   P  + N + L  L++S N  S    +    L NL++L  +NN ++        
Sbjct: 165 NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD------- 213

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNL 126
           ++ L    +L  +S + N L  I    ++ +L+ +L   ++A   +S      +  LT L
Sbjct: 214 ITPLGILTNLDELSLNGNQLKDI---GTLASLT-NLTDLDLANNQISN--LAPLSGLTKL 267

Query: 127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSG 186
           T + LG N+++   P  L  L  L  L L  N+LE   P  I +   L  L L  N +S 
Sbjct: 268 TELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323

Query: 187 SIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIAR 246
             P   ++L  L+ L   +N+++ +  +  NL +I +L+   N  +   PL         
Sbjct: 324 ISP--VSSLTKLQRLFFYNNKVSDVS-SLANLTNINWLSAGHNQISDLTPLA-------- 372

Query: 247 IDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKL 289
               +L  +  L L++   + A       +S    +      L
Sbjct: 373 ----NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  131 bits (332), Expect = 6e-33
 Identities = 65/288 (22%), Positives = 113/288 (39%), Gaps = 39/288 (13%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
            N + T+     +  +++ L+                L NL  +  SNN LT        
Sbjct: 34  TNVTDTVS--QTDLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSNNQLTD------- 82

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNL 126
           ++ L N   L  I  +NN +  I P   + NL+ +L    +    ++    + + NLTNL
Sbjct: 83  ITPLKNLTKLVDILMNNNQIADITP---LANLT-NLTGLTLFNNQITD--IDPLKNLTNL 136

Query: 127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSG 186
             + L  N ++    S L  L  LQ L   N   +      + +   L +L++  NK+S 
Sbjct: 137 NRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSD 191

Query: 187 SIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIAR 246
                   L +L  L+  +N+++ I      L ++  L+ + N       L         
Sbjct: 192 --ISVLAKLTNLESLIATNNQISDIT-PLGILTNLDELSLNGNQLKDIGTLA-------- 240

Query: 247 IDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
                L +L  L+L+NN +S   P  L  L+ L +L L  N++    P
Sbjct: 241 ----SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 282

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  119 bits (300), Expect = 8e-29
 Identities = 63/277 (22%), Positives = 101/277 (36%), Gaps = 35/277 (12%)

Query: 28  LSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLD 87
             D   +         L       L    +T          S ++   +T +      + 
Sbjct: 9   TQDTPINQIFT--DTALAEKMKTVLGKTNVTD-------TVSQTDLDQVTTLQADRLGIK 59

Query: 88  GILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKL 147
            I     V  L++ L     +   ++      + NLT L  I +  N++    P  L  L
Sbjct: 60  SI---DGVEYLNN-LTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANL 111

Query: 148 QKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNE 207
             L GL L NN++    P     +  L +LEL  N +S       + L SL+ L  G+  
Sbjct: 112 TNLTGLTLFNNQITDIDPLKNLTN--LNRLELSSNTISD--ISALSGLTSLQQLSFGNQV 167

Query: 208 LTSIPLTFWNLKDILYLNFSSNFFTGPLPLE---------IGNLKIARIDS-CDLISLIS 257
               PL   NL  +  L+ SSN  +    L            N +I+ I     L +L  
Sbjct: 168 TDLKPLA--NLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDE 225

Query: 258 LNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
           L+L+ N L      +L  L+ L DL+L+ N++    P
Sbjct: 226 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 260

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  109 bits (275), Expect = 1e-25
 Identities = 56/251 (22%), Positives = 101/251 (40%), Gaps = 27/251 (10%)

Query: 51  RLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYC 110
            L +  +T  T  ++ + + +              +   + +T +  +       +    
Sbjct: 2   PLGSATITQDT-PINQIFTDTALAEKMKTVLGKTNVTDTVSQTDLDQV----TTLQADRL 56

Query: 111 NVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICH 170
            +     + +  L NLT I    N+L    P  L  L KL  + + NN++    P  + +
Sbjct: 57  GIK--SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LAN 110

Query: 171 SDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNF 230
              L  L L  N+++   P    NL +L  L L SN ++ I      L  +  L+F +  
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLSFGNQ- 166

Query: 231 FTGPLP---------LEIGNLKIARIDS-CDLISLISLNLSNNNLSGAIPASLEKLSYLK 280
            T   P         L+I + K++ I     L +L SL  +NN +S   P  L  L+ L 
Sbjct: 167 VTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLD 224

Query: 281 DLNLSFNKLEG 291
           +L+L+ N+L+ 
Sbjct: 225 ELSLNGNQLKD 235

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 85.0 bits (211), Expect = 2e-17
 Identities = 37/184 (20%), Positives = 72/184 (39%), Gaps = 19/184 (10%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L++  N  S   P  +   + L+ LEL++N      P    NL+NL  L L  N ++   
Sbjct: 270 LKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD-- 323

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG 121
                +S +S+   L  + F NN +  +   +S+ NL+ ++ +    +  +S      + 
Sbjct: 324 -----ISPVSSLTKLQRLFFYNNKVSDV---SSLANLT-NINWLSAGHNQISD--LTPLA 372

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG 181
           NLT +T + L       +  +    +     +      L    P +I       + ++  
Sbjct: 373 NLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPATISDGGSYTEPDITW 430

Query: 182 NKLS 185
           N  S
Sbjct: 431 NLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 30/165 (18%), Positives = 55/165 (33%), Gaps = 42/165 (25%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L ++ NN S   P  + + +KL  L   +N  S        NL N+  L   +N ++   
Sbjct: 314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISD-- 367

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGI--PEE 119
                L+ L+N   +T +  ++       P     N+S           NV+G +  P  
Sbjct: 368 -----LTPLANLTRITQLGLNDQAWTNA-PVNYKANVSI-----PNTVKNVTGALIAPAT 416

Query: 120 IGNLTNLTIIYLGGNKL-----------------------NGSIP 141
           I +  + T   +  N                         +G++ 
Sbjct: 417 ISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVT 461

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  141 bits (358), Expect = 1e-36
 Identities = 76/281 (27%), Positives = 121/281 (43%), Gaps = 38/281 (13%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG+G FG V       G +VA+K   ++     ++F  E  +M  +RH N+++++     
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 460 EEFKA-LVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
           E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL        +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDV 577
           L   NVL+ ++ VA +SDFG+ K     + S+ Q      + + APE  +E + S   DV
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369

Query: 578 YSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVND--WLPISTKEIVDPNLLSREDINFVA 634
           +SFGI+L E ++  + P   I   +  +   V     +         P            
Sbjct: 370 WSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGYKMDA-------P------------ 408

Query: 635 KEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL 675
            + C   V++V   C       R    ++  +L  IR   L
Sbjct: 409 -DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  138 bits (350), Expect = 2e-36
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 11/209 (5%)

Query: 400 IGRGSFGSVFKARLGDGME-----VAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV 453
           +G G+FG+V+K       E     VA+K        +  K    E  +M S+ + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
           +  C     + L+ + MP G L  Y+      +     LN  + +A  + YL      ++
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRL 138

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           +H DL   NVL+       ++DFG+AKLL  E++          I +MA E       + 
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198

Query: 574 NGDVYSFGIMLMETFTR-KKPTDEIFNGE 601
             DV+S+G+ + E  T   KP D I   E
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  138 bits (350), Expect = 2e-36
 Identities = 67/300 (22%), Positives = 120/300 (40%), Gaps = 58/300 (19%)

Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K        +    F +E  ++    H+NI++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSS------NYILDIYQRLNIMIDVASALEYL- 505
            I        + +++E M  G L+ +L  +         L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 506 --HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
             HF      IH D+   N LL       VA + DFG+A+ + R          +  + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 561 MAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 620
           M PE   EG  ++  D +SFG++L E F+          G M          P       
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYM----------PY------ 246

Query: 621 DPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
            P+  ++E + FV         + C   V+ +  +C    PE R N   I+ ++      
Sbjct: 247 -PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  137 bits (347), Expect = 3e-36
 Identities = 53/220 (24%), Positives = 91/220 (41%), Gaps = 26/220 (11%)

Query: 399 LIGRGSFGSVFKA---RLGDGMEVAMKVFNLQYGR--VFKS-FDVECEMMKSIRHRNIIK 452
           L+GRG  G V++A          VA+K+ +       VF++    E      ++  +++ 
Sbjct: 41  LVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +      +    + +  +    L   L      L   + + I+  + SAL+  H   +A 
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAH---AAG 154

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPEYGKEG 569
             H D+KP N+L+  +  A+L DFGIA          + TQ   T+G   YMAPE   E 
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT---TDEKL-TQLGNTVGTLYYMAPERFSES 210

Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGE---MTLKH 606
             +   D+Y+   +L E  T   P    + G+   +   H
Sbjct: 211 HATYRADIYALTCVLYECLTGSPP----YQGDQLSVMGAH 246

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  136 bits (345), Expect = 3e-36
 Identities = 52/191 (27%), Positives = 98/191 (51%), Gaps = 7/191 (3%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           +G G FG V+        +VA+K           +F  E  +MK ++H+ ++++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 79

Query: 460 EEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
           E    ++ EYM +GSL  +L + +   L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135

Query: 519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVY 578
           + +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G  +   DV+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194

Query: 579 SFGIMLMETFT 589
           SFGI+L E  T
Sbjct: 195 SFGILLTEIVT 205

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  137 bits (347), Expect = 4e-36
 Identities = 53/301 (17%), Positives = 110/301 (36%), Gaps = 31/301 (10%)

Query: 13  IPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSN 72
           I     N ++  I +++D+S    + +   +  N++ L LS N L+   +  + L+  + 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ--ISAADLAPFTK 59

Query: 73  CKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLG 132
            + L L   S+N L   L    + +LS +L   ++    V      E+    ++  ++  
Sbjct: 60  LELLNL---SSNVLYETLD---LESLS-TLRTLDLNNNYVQ-----ELLVGPSIETLHAA 107

Query: 133 GNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSG-SIPEC 191
            N ++  +     + Q  + + L NNK+             +  L+L  N++   +  E 
Sbjct: 108 NNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 192 FNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCD 251
             +  +L  L L  N +  +         +  L+ SSN     +  E  +          
Sbjct: 165 AASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAA-------- 214

Query: 252 LISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNE 311
              +  ++L NN L   I  +L     L+  +L  N       R     N   ++     
Sbjct: 215 --GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271

Query: 312 L 312
           +
Sbjct: 272 V 272

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  108 bits (273), Expect = 3e-26
 Identities = 33/187 (17%), Positives = 66/187 (35%), Gaps = 20/187 (10%)

Query: 115 GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDEL 174
            I E   N     I  +  + L  ++ S       ++ L L  N L       +    +L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 175 YKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGP 234
             L L  N L     +   +L++LR L L +N +  +         I  L+ ++N     
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQELL----VGPSIETLHAANN----- 109

Query: 235 LPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
                    I+R+         ++ L+NN ++          S ++ L+L  N+++  + 
Sbjct: 110 --------NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVN 160

Query: 295 RGGSFGN 301
                 +
Sbjct: 161 FAELAAS 167

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  137 bits (347), Expect = 5e-36
 Identities = 62/302 (20%), Positives = 122/302 (40%), Gaps = 52/302 (17%)

Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIK 452
           +G+GSFG V++              VA+K  N     R    F  E  +MK     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSS---------NYILDIYQRLNIMIDVASALE 503
           ++   S  +   +++E M  G L+ YL S               + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           YL+   + + +H DL   N ++ ++    + DFG+ + +   D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 623
           E  K+G  +   DV+SFG++L E  T           E           P          
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIATL---------AEQ----------PY-------QG 243

Query: 624 LLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLR 676
           L + + + FV +       + C   +F +   C   +P+ R +  EI++ + +  +   R
Sbjct: 244 LSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303

Query: 677 NV 678
            V
Sbjct: 304 EV 305

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  142 bits (360), Expect = 6e-36
 Identities = 53/314 (16%), Positives = 105/314 (33%), Gaps = 21/314 (6%)

Query: 6   ENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELS 65
           +   S  +P  I   S    ++LS N        +F N   LQ L LS   + +   +  
Sbjct: 20  DQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK-- 74

Query: 66  FLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTN 125
              +      L+ +  + NP+       S   L+ SLE        ++      IG L  
Sbjct: 75  ---AWHGLHHLSNLILTGNPIQSF-SPGSFSGLT-SLENLVAVETKLASLESFPIGQLIT 129

Query: 126 LTIIYLGGNKLNG-SIPSTLGKLQKLQGLGLENNKLEGSIPDSICH----SDELYKLELG 180
           L  + +  N ++   +P+    L  L  + L  N ++    + +            L++ 
Sbjct: 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189

Query: 181 GNKLSGSIPECFNNLASLRILLLGSNELTS--IPLTFWNLKDILYLNFSSNFFTGPLPLE 238
            N +     + F  +  L  L L  N  +S  +     NL  +         F     LE
Sbjct: 190 LNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248

Query: 239 IGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGS 298
           I    I  ++    +++    L+  N           L+ +  ++L+   ++  +     
Sbjct: 249 IFEPSI--MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPK 305

Query: 299 FGNFSAESFEGNEL 312
              + + S    +L
Sbjct: 306 HFKWQSLSIIRCQL 319

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  138 bits (350), Expect = 1e-34
 Identities = 57/306 (18%), Positives = 95/306 (31%), Gaps = 28/306 (9%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
           N      P      + L  L   +   +       G L  L+ L +++N++ S  L   F
Sbjct: 90  NPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYF 149

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKT--SVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT 124
               SN  +L  +  S N +  I       +          +M+   +   I ++     
Sbjct: 150 ----SNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGI 204

Query: 125 NLTIIYLGGNKLNGSIPSTLGK-LQKLQGLGLENNKLEGSIPDSICHSDELYKLE----- 178
            L  + L GN  + +I  T  + L  L    L   + +      I     +  L      
Sbjct: 205 KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID 264

Query: 179 ---LGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPL 235
              L            F+ LA++  + L    +  +            L+          
Sbjct: 265 EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLE-DVPKHFKWQSLSIIRCQLKQFP 323

Query: 236 PLEIGNLKI---------ARIDSCDLISLISLNLSNNNLSGAIPASLEKLSY--LKDLNL 284
            L++  LK                 L SL  L+LS N LS +   S   L    L+ L+L
Sbjct: 324 TLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383

Query: 285 SFNKLE 290
           SFN   
Sbjct: 384 SFNGAI 389

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  137 bits (346), Expect = 4e-34
 Identities = 51/290 (17%), Positives = 87/290 (30%), Gaps = 47/290 (16%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
                 +     +  K   L +       F      +L  L++L L+ N       + S 
Sbjct: 294 GVSIKYLEDVPKH-FKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMN-------KGSI 342

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNL 126
                   SL+ +  S N L      +     ++SL + ++++      +      L  L
Sbjct: 343 SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEEL 401

Query: 127 TIIYLGGNKLNGSIP-STLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLS 185
             +    + L      S    L+KL  L +     +            L  L++ GN   
Sbjct: 402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFK 461

Query: 186 GSIPEC-FNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKI 244
            +     F N  +L  L L   +L  I                   F             
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQIS---------------WGVFDT----------- 495

Query: 245 ARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
                  L  L  LN+S+NNL     +   +L  L  L+ SFN++E    
Sbjct: 496 -------LHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKG 538

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  134 bits (339), Expect = 3e-33
 Identities = 57/297 (19%), Positives = 90/297 (30%), Gaps = 26/297 (8%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIP-NTFGNLRNLQALRLSNNYLTS----ST 61
            N    I    F   KL  L L  N  S  I      NL  L   RL             
Sbjct: 190 LNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG 121
            E S +  L +         +               L++ +    +A  ++     E++ 
Sbjct: 250 FEPSIMEGLCDVTIDEF-RLTYTNDFSDDI-VKFHCLAN-VSAMSLAGVSIKY--LEDVP 304

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG 181
                  + +   +L       L  L+ L    L  NK   SI         L  L+L  
Sbjct: 305 KHFKWQSLSIIRCQLKQFPTLDLPFLKSLT---LTMNKG--SISFKKVALPSLSYLDLSR 359

Query: 182 NKLSGSIPECFNNLA--SLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEI 239
           N LS S    +++L   SLR L L  N    +   F  L+++ +L+F  +          
Sbjct: 360 NALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSA 419

Query: 240 GNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG 296
                       L  L+ L++S  N           L+ L  L ++ N  +      
Sbjct: 420 ---------FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSN 467

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  131 bits (332), Expect = 2e-32
 Identities = 58/328 (17%), Positives = 105/328 (32%), Gaps = 34/328 (10%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L +          +       LS L L+ N    F P +F  L +L+ L      L S  
Sbjct: 61  LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS-- 118

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG 121
                   +    +L  ++ ++N +          NL+ +L + +++Y  +      ++ 
Sbjct: 119 ---LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLT-NLVHVDLSYNYIQTITVNDLQ 174

Query: 122 NLTNLTI----IYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS-DELYK 176
            L         + +  N ++  I     +  KL  L L  N    +I  +   +   L+ 
Sbjct: 175 FLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHV 233

Query: 177 LELGGNKLSGSI------PECFNNLASLRI--LLLGSNELTSI-PLTFWNLKDILYLNFS 227
             L   +           P     L  + I    L      S   + F  L ++  ++ +
Sbjct: 234 HRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLA 293

Query: 228 SNFFTGPLP---------LEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSY 278
                             L I   ++ +  + DL  L SL L+ N  S  I      L  
Sbjct: 294 GVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGS--ISFKKVALPS 351

Query: 279 LKDLNLSFNKLEGEIPRGGSFGNFSAES 306
           L  L+LS N L        S+ +    S
Sbjct: 352 LSYLDLSRNALSFSGC--CSYSDLGTNS 377

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  124 bits (313), Expect = 5e-30
 Identities = 41/241 (17%), Positives = 83/241 (34%), Gaps = 16/241 (6%)

Query: 65  SFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT 124
           S    +    ++T     +  L  +       ++  S +  ++++  +         N +
Sbjct: 3   SLNPCIEVVPNITY-QCMDQKLSKVPD-----DIPSSTKNIDLSFNPLKILKSYSFSNFS 56

Query: 125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
            L  + L   ++          L  L  L L  N ++   P S      L  L     KL
Sbjct: 57  ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116

Query: 185 SGSIPECFNNLASLRILLLGSNELTSIPL--TFWNLKDILYLNFSSNFFTGPLPLEIGNL 242
           +         L +L+ L +  N + S  L   F NL ++++++ S N+       ++  L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176

Query: 243 KIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNF 302
           +            +SL++S N +   I     +   L +L L  N     I +     N 
Sbjct: 177 RENP------QVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMK-TCLQNL 228

Query: 303 S 303
           +
Sbjct: 229 A 229

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  120 bits (302), Expect = 2e-28
 Identities = 45/213 (21%), Positives = 73/213 (34%), Gaps = 8/213 (3%)

Query: 8   NFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFL 67
           +FSG         + L  L+LS N     +   F  L  LQ L   ++ L      ++  
Sbjct: 363 SFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR----VTEF 417

Query: 68  SSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI-GNLTNL 126
           S+  + + L  +  S               L+ SL   +MA  +        +  N TNL
Sbjct: 418 SAFLSLEKLLYLDISYTNTKID-FDGIFLGLT-SLNTLKMAGNSFKDNTLSNVFANTTNL 475

Query: 127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSG 186
           T + L   +L          L +LQ L + +N L             L  L+   N++  
Sbjct: 476 TFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET 535

Query: 187 SIPECFNNLASLRILLLGSNELTSIPLTFWNLK 219
           S     +   SL    L +N +  I      L+
Sbjct: 536 SKGILQHFPKSLAFFNLTNNSVACICEHQKFLQ 568

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 13/59 (22%), Positives = 18/59 (30%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L M  NN              LS L+ S N             ++L    L+NN +   
Sbjct: 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI 560

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  136 bits (344), Expect = 9e-36
 Identities = 70/294 (23%), Positives = 124/294 (42%), Gaps = 47/294 (15%)

Query: 399 LIGRGSFGSVFKA---RLGDGMEVAMKVFNLQYGR--VFKS-FDVECEMMKSIRHRNIIK 452
           ++G G    V  A   R     +VA+KV      R   F   F  E +   ++ H  I+ 
Sbjct: 19  ILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 453 VISSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           V  +   E        +V+EY+   +L   +H+    +   + + ++ D   AL + H  
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSH-- 133

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPEY 565
               +IH D+KP+N+++       + DFGIA+ +   D     TQT A IG   Y++PE 
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIA--DSGNSVTQTAAVIGTAQYLSPEQ 190

Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE----MTLKHWVNDWLPISTKEIVD 621
            +   V A  DVYS G +L E  T + P    F G+    +  +H V +       + + 
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQH-VRE-------DPIP 238

Query: 622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQR-INAKEIVTKLLKIRDSL 674
           P          ++ +     +  V ++   ++PE R   A E+   L+++ +  
Sbjct: 239 P----SARHEGLSAD-----LDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  137 bits (347), Expect = 9e-36
 Identities = 68/300 (22%), Positives = 120/300 (40%), Gaps = 58/300 (19%)

Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           +G G+FG V++ ++         ++VA+K        +    F +E  ++    H+NI++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSS------NYILDIYQRLNIMIDVASALEYL- 505
            I        + ++LE M  G L+ +L  +         L +   L++  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 506 --HFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
             HF      IH D+   N LL       VA + DFG+A+ + R          +  + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 561 MAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 620
           M PE   EG  ++  D +SFG++L E F+          G M          P       
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSL---------GYM----------PY------ 287

Query: 621 DPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
            P+  ++E + FV         + C   V+ +  +C    PE R N   I+ ++      
Sbjct: 288 -PSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  136 bits (344), Expect = 1e-35
 Identities = 59/278 (21%), Positives = 99/278 (35%), Gaps = 38/278 (13%)

Query: 398 NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
             +GRGSFG V + +    G + A+K   L+          E      +    I+ +  +
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGA 118

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
                +  + +E +  GSL + +      L   + L  +      LEYLH   + +++H 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHG 174

Query: 517 DLKPSNVLLDDN-MVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPEYGKEGRVS 572
           D+K  NVLL  +   A L DFG A  L  +             G   +MAPE        
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234

Query: 573 ANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD-PNLLSREDIN 631
           A  D++S   M++       P  + F G + LK      +      I + P   +     
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK------IASEPPPIREIPPSCAPLTAQ 288

Query: 632 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK 669
            + +                + P  R +A E    L +
Sbjct: 289 AIQE-------------GLRKEPVHRASAME----LRR 309

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (343), Expect = 1e-35
 Identities = 74/291 (25%), Positives = 122/291 (41%), Gaps = 46/291 (15%)

Query: 400 IGRGSFGSVFKARL----GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVI 454
           IG G  G V   RL       + VA+K     Y  R  + F  E  +M    H NII++ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              +      +V EYM +GSL+ +L + +    I Q + ++  V + + YL        +
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYV 173

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYGKEGRVSA 573
           H DL   NVL+D N+V  +SDFG++++L  +  +   T      I + APE       S+
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233

Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV 633
             DV+SFG+++ E             GE    +  N                 R+ I+ V
Sbjct: 234 ASDVWSFGVVMWEVLAY---------GERPYWNMTN-----------------RDVISSV 267

Query: 634 AK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
            +         C   +  + ++C  +   QR    +IV+ L    D+L+R+
Sbjct: 268 EEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL----DALIRS 314

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  134 bits (340), Expect = 2e-35
 Identities = 76/285 (26%), Positives = 123/285 (43%), Gaps = 46/285 (16%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
             IG+G FG V       G +VA+K   ++     ++F  E  +M  +RH N+++++   
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 458 SNEEFKA-LVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL        +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 140

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DL   NVL+ ++ VA +SDFG    LT+ + S+ Q      + + APE  +E + S   
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFG----LTK-EASSTQDTGKLPVKWTAPEALREKKFSTKS 195

Query: 576 DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK 635
           DV+SFGI+L E ++          G +          P        P +  ++ +  V K
Sbjct: 196 DVWSFGILLWEIYSF---------GRV----------PY-------PRIPLKDVVPRVEK 229

Query: 636 -------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                  + C   V+ V   C       R +  ++  +L  I+  
Sbjct: 230 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  137 bits (346), Expect = 2e-35
 Identities = 69/291 (23%), Positives = 128/291 (43%), Gaps = 46/291 (15%)

Query: 400 IGRGSFGSVFKARL----GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVI 454
           +G G FG V   RL       + VA+K   + Y  +  + F  E  +M    H NII++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              +  +   +V EYM +GSL+ +L   +    + Q + ++  +AS ++YL        +
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYV 169

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYGKEGRVSA 573
           H DL   N+L++ N+V  +SDFG+ ++L  + ++   T+     I + +PE     + ++
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229

Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV 633
             DV+S+GI+L E  +          GE       N                 ++ I  V
Sbjct: 230 ASDVWSYGIVLWEVMSY---------GERPYWEMSN-----------------QDVIKAV 263

Query: 634 AK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
            +         C + ++ + ++C  +    R   ++IV+ L    D L+RN
Sbjct: 264 DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL----DKLIRN 310

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  134 bits (339), Expect = 2e-35
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 20/213 (9%)

Query: 400 IGRGSFGSVFKARL---GDGMEVAMKVFNLQYGRVFKS---FDVECEMMKSIRHRNIIKV 453
           +G G+FGSV +         ++VA+KV  L+ G           E ++M  + +  I+++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL---HFGYS 510
           I  C  E    LV+E    G L K+L      + +     ++  V+  ++YL   +F   
Sbjct: 76  IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 131

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS-TIQTQTLATIGYMAPEYGKEG 569
              +H DL   NVLL +   A +SDFG++K L  +D   T ++     + + APE     
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188

Query: 570 RVSANGDVYSFGIMLMETFTR-KKPTDEIFNGE 601
           + S+  DV+S+G+ + E  +  +KP  ++   E
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  134 bits (339), Expect = 2e-35
 Identities = 62/293 (21%), Positives = 111/293 (37%), Gaps = 53/293 (18%)

Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRH 447
           R    F E  LIG G FG VFKA+   DG    +K       +  +    E + +  + H
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDH 63

Query: 448 RNIIKVISSCSNEEFKA----------------LVLEYMPHGSLEKYLHSSN-YILDIYQ 490
            NI+         ++                  + +E+   G+LE+++       LD   
Sbjct: 64  VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123

Query: 491 RLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI 550
            L +   +   ++Y+H   S ++I+ DLKPSN+ L D     + DFG+   L  + +   
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--- 177

Query: 551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND 610
           +T++  T+ YM+PE           D+Y+ G++L E         E              
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----------- 226

Query: 611 WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
                 ++ +  ++  +++   + K                + PE R N  EI
Sbjct: 227 -FFTDLRDGIISDIFDKKEKTLLQK-------------LLSKKPEDRPNTSEI 265

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  134 bits (339), Expect = 4e-35
 Identities = 79/302 (26%), Positives = 126/302 (41%), Gaps = 57/302 (18%)

Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +G G+FG VF A         D M VA+K          K F  E E++ +++H +I+K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNIMIDV 498
              C + +   +V EYM HG L K+L                 +   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI 558
           AS + YL    S   +H DL   N L+  N++  + DFG+++ +   D   +   T+  I
Sbjct: 143 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

Query: 559 GYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 618
            +M PE     + +   DV+SFG++L E FT          G+           P     
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTY---------GKQ----------PW---- 236

Query: 619 IVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
                L + E I  + +         C   V++V + C    P+QR+N KEI   L  + 
Sbjct: 237 ---FQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALG 293

Query: 672 DS 673
            +
Sbjct: 294 KA 295

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  133 bits (337), Expect = 5e-35
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 37/279 (13%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           ++G+G++G V+  R L + + +A+K    +  R  +    E  + K ++H+NI++ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL--NIMIDVASALEYLHFGYSAQVIH 515
           S   F  + +E +P GSL   L S    L   ++        +   L+YLH     Q++H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145

Query: 516 CDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPEYGKEGRVSA 573
            D+K  NVL++  + V  +SDFG +K L   +     T+T   T+ YMAPE   +G    
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINP---CTETFTGTLQYMAPEIIDKGPRGY 202

Query: 574 NG--DVYSFGIMLMETFTRKKPTDEIFNGEMTL-KHWVNDWLPISTKEIVDPNLLSREDI 630
               D++S G  ++E  T K P  E+   +  + K  +    P    EI  P  +S E  
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP----EI--PESMSAEAK 256

Query: 631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK 669
            F+ K             C    P++R  A +    LL 
Sbjct: 257 AFILK-------------CFEPDPDKRACAND----LLV 278

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  134 bits (339), Expect = 6e-35
 Identities = 70/285 (24%), Positives = 125/285 (43%), Gaps = 43/285 (15%)

Query: 400 IGRGSFGSVFKARL-----GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKV 453
           IG G FG V+K  L        + VA+K     Y  +    F  E  +M    H NII++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
               S  +   ++ EYM +G+L+K+L   +    + Q + ++  +A+ ++YL    +   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNY 168

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ-TLATIGYMAPEYGKEGRVS 572
           +H DL   N+L++ N+V  +SDFG++++L  + ++T  T      I + APE     + +
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228

Query: 573 ANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF 632
           +  DV+SFGI++ E  T          GE       N                  E +  
Sbjct: 229 SASDVWSFGIVMWEVMTY---------GERPYWELSN-----------------HEVMKA 262

Query: 633 VAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +           C S ++ + M+C  +   +R    +IV+ L K+
Sbjct: 263 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  132 bits (335), Expect = 7e-35
 Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 11/208 (5%)

Query: 400 IGRGSFGSVFKARL----GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVI 454
           +G G FG V++       G+ + VA+K           + F  E  +MK++ H +I+K+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
                E    +++E  P+G L  YL  +   L +   +   + +  A+ YL    S   +
Sbjct: 80  GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCV 135

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSAN 574
           H D+   N+L+       L DFG+++ +  ++     + T   I +M+PE     R +  
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKASVTRLPIKWMSPESINFRRFTTA 194

Query: 575 GDVYSFGIMLMETFTR-KKPTDEIFNGE 601
            DV+ F + + E  +  K+P   + N +
Sbjct: 195 SDVWMFAVCMWEILSFGKQPFFWLENKD 222

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  139 bits (353), Expect = 7e-35
 Identities = 42/213 (19%), Positives = 83/213 (38%), Gaps = 30/213 (14%)

Query: 399 LIGRGSFGSVFKA---RLGDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKVI 454
            I  G  G ++ A    + +G  V +K          ++    E + +  + H +I+++ 
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 455 -----SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
                +    +    +V+EY+   SL++        L + + +  ++++  AL YLH   
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH--- 199

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT-LATIGYMAPEYGKE 568
           S  +++ DLKP N++L +  +  L D G    +               T G+ APE  + 
Sbjct: 200 SIGLVYNDLKPENIMLTEEQLK-LIDLGAVSRIN-------SFGYLYGTPGFQAPEIVR- 250

Query: 569 GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
              +   D+Y+ G  L              NG 
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPT----RNGR 279

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  133 bits (337), Expect = 8e-35
 Identities = 60/287 (20%), Positives = 96/287 (33%), Gaps = 50/287 (17%)

Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECE---MMKS 444
                F   + +G GS+G VFK R   DG   A+K     +           E     K 
Sbjct: 54  FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113

Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
            +H   +++  +        L  E     SL+++  +    L   Q    + D   AL +
Sbjct: 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAP 563
           LH   S  ++H D+KP+N+ L       L DFG+   L     +    +       YMAP
Sbjct: 173 LH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG----TAGAGEVQEGDPRYMAP 225

Query: 564 E-----YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 618
           E     YG         DV+S G+ ++E     +       GE         W  +    
Sbjct: 226 ELLQGSYGTA------ADVFSLGLTILEVACNMELP---HGGE--------GWQQLRQGY 268

Query: 619 IVD--PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
           +       LS E  + +                    P+ R  A+ +
Sbjct: 269 LPPEFTAGLSSELRSVLVM-------------MLEPDPKLRATAEAL 302

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  132 bits (335), Expect = 8e-35
 Identities = 61/287 (21%), Positives = 109/287 (37%), Gaps = 45/287 (15%)

Query: 400 IGRGSFGSVFKARL----GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVI 454
           IG G FG V +          + VA+K         V + F  E   M+   H +I+K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              +      +++E    G L  +L    Y LD+   +     +++AL YL    S + +
Sbjct: 83  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 138

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSAN 574
           H D+   NVL+  N    L DFG+++ +  +      ++    I +MAPE     R ++ 
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSA 197

Query: 575 GDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV 633
            DV+ FG+ + E      KP   + N ++                           I  +
Sbjct: 198 SDVWMFGVCMWEILMHGVKPFQGVKNNDV---------------------------IGRI 230

Query: 634 AK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                      C   ++++  +C    P +R    E+  +L  I + 
Sbjct: 231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  136 bits (343), Expect = 1e-34
 Identities = 47/210 (22%), Positives = 97/210 (46%), Gaps = 17/210 (8%)

Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMK-SIRHRNIIK 452
           F   +++G G+ G++    + D  +VA+K    +    F   D E ++++ S  H N+I+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
              +  + +F+ + +E     +L++Y+   ++     + + ++    S L +LH   S  
Sbjct: 83  YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138

Query: 513 VIHCDLKPSNVLL-----DDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPEY- 565
           ++H DLKP N+L+        + A +SDFG+ K L     S  +   +  T G++APE  
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 566 --GKEGRVSANGDVYSFGIMLMETFTRKKP 593
               +   +   D++S G +     +    
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  132 bits (334), Expect = 1e-34
 Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 24/215 (11%)

Query: 400 IGRGSFGSVFKARL---GDGMEVAMKVFNLQYG----RVFKSFDVECEMMKSIRHRNIIK 452
           +G G+FG+V K           VA+K+  L+       +      E  +M+ + +  I++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYL---HFGY 509
           +I  C  E +  LV+E    G L KYL  + + +     + ++  V+  ++YL   +F  
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNF-- 138

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT--IGYMAPEYGK 567
               +H DL   NVLL     A +SDFG++K L R D++  + QT     + + APE   
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSKAL-RADENYYKAQTHGKWPVKWYAPECIN 193

Query: 568 EGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGE 601
             + S+  DV+SFG+++ E F+  +KP   +   E
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  138 bits (349), Expect = 2e-34
 Identities = 60/252 (23%), Positives = 109/252 (43%), Gaps = 17/252 (6%)

Query: 359 KCRKRERGPPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARL---GD 415
           K R          +   +  +     L L R     ++  L G G+FGSV +        
Sbjct: 304 KPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIEL-GCGNFGSVRQGVYRMRKK 362

Query: 416 GMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGS 474
            ++VA+KV          +    E ++M  + +  I+++I  C  E    LV+E    G 
Sbjct: 363 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGP 421

Query: 475 LEKYLHSSNYILDIYQRLNIMIDVASALEYL---HFGYSAQVIHCDLKPSNVLLDDNMVA 531
           L K+L      + +     ++  V+  ++YL   +F      +H +L   NVLL +   A
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF------VHRNLAARNVLLVNRHYA 475

Query: 532 HLSDFGIAKLLTREDQS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR 590
            +SDFG++K L  +D   T ++     + + APE     + S+  DV+S+G+ + E  + 
Sbjct: 476 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 535

Query: 591 -KKPTDEIFNGE 601
            +KP  ++   E
Sbjct: 536 GQKPYKKMKGPE 547

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  132 bits (334), Expect = 2e-34
 Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 18/236 (7%)

Query: 366 GPPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMK-- 422
           GPP     P +A++    Y  L      F     IGRG F  V++A  L DG+ VA+K  
Sbjct: 10  GPPVPQFQPQKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV 65

Query: 423 -VFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYL-- 479
            +F+L   +       E +++K + H N+IK  +S   +    +VLE    G L + +  
Sbjct: 66  QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125

Query: 480 -HSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI 538
                 ++         + + SALE++H   S +V+H D+KP+NV +    V  L D G+
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGL 182

Query: 539 AKLLTREDQSTIQTQTLA-TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP 593
            +  +     T    +L  T  YM+PE   E   +   D++S G +L E    + P
Sbjct: 183 GRFFS---SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  130 bits (330), Expect = 4e-34
 Identities = 50/212 (23%), Positives = 91/212 (42%), Gaps = 27/212 (12%)

Query: 400 IGRGSFGSVFKARL--------GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNII 451
           +G+G+F  +FK               EV +KV +  +    +SF     MM  + H++++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
                C   +   LV E++  GSL+ YL  +   ++I  +L +   +A+A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---EN 132

Query: 512 QVIHCDLKPSNVLLD--------DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
            +IH ++   N+LL         +     LSD GI+  +  +D           I ++ P
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPP 186

Query: 564 EYGKEGRV-SANGDVYSFGIMLMETFTR-KKP 593
           E  +  +  +   D +SFG  L E  +   KP
Sbjct: 187 ECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  131 bits (332), Expect = 6e-34
 Identities = 74/298 (24%), Positives = 125/298 (41%), Gaps = 50/298 (16%)

Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           +G G+FG VF A         D M VA+K          + F  E E++  ++H++I++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYL--------------HSSNYILDIYQRLNIMIDVA 499
              C+      +V EYM HG L ++L                +   L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 500 SALEYL---HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
           + + YL   HF      +H DL   N L+   +V  + DFG+++ +   D   +  +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPIS 615
            I +M PE     + +   DV+SFG++L E FT  K+P  ++ N E  +           
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA-IDC--------- 272

Query: 616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
              I     L R          C   V+ +   C    P+QR + K++  +L  +  +
Sbjct: 273 ---ITQGRELER-------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  130 bits (329), Expect = 8e-34
 Identities = 62/315 (19%), Positives = 112/315 (35%), Gaps = 76/315 (24%)

Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRH 447
           R    F E  ++G+G+FG V KAR   D    A+K       ++  +   E  ++ S+ H
Sbjct: 3   RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNH 61

Query: 448 RNIIKVISSCSNEEFKA-------------LVLEYMPHGSLEKYLHSSNYILDIYQRLNI 494
           + +++  ++                     + +EY  +G+L   +HS N      +   +
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121

Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              +  AL Y+H   S  +IH DLKP N+ +D++    + DFG+AK + R          
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 555 LA------------TIGYMAPE-------YGKEGRVSANGDVYSFGIMLME-------TF 588
                         T  Y+A E       Y ++       D+YS GI+  E         
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFEMIYPFSTGM 232

Query: 589 TRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAME 648
            R     ++ +  +      +D      K+I+   L+                       
Sbjct: 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIR-LLIDH--------------------- 270

Query: 649 CTVESPEQRINAKEI 663
                P +R  A+ +
Sbjct: 271 ----DPNKRPGARTL 281

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  134 bits (338), Expect = 1e-33
 Identities = 50/284 (17%), Positives = 104/284 (36%), Gaps = 31/284 (10%)

Query: 13  IPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSN 72
           I     N ++  I +++D+S    + +   +  N++ L LS N L+   +  + L+  + 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQ--ISAADLAPFTK 59

Query: 73  CKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLG 132
            + L L   S+N L   L   S+  L            +++    +E+    ++  ++  
Sbjct: 60  LELLNL---SSNVLYETLDLESLSTLRT---------LDLNNNYVQELLVGPSIETLHAA 107

Query: 133 GNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSG-SIPEC 191
            N ++  +     + Q  + + L NNK+             +  L+L  N++   +  E 
Sbjct: 108 NNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164

Query: 192 FNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCD 251
             +  +L  L L  N +  +         +  L+ SSN     +  E  +          
Sbjct: 165 AASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAA-------- 214

Query: 252 LISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR 295
              +  ++L NN L   I  +L     L+  +L  N       R
Sbjct: 215 --GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLR 255

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  131 bits (332), Expect = 6e-33
 Identities = 49/331 (14%), Positives = 109/331 (32%), Gaps = 34/331 (10%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS-- 59
            ++ +++    +     +A  +  L+LS N  S            L+ L LS+N L    
Sbjct: 15  EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL 74

Query: 60  --------STLELSF--LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAY 109
                    TL+L+   +  L    S+  +  +NN +  +    S        +   +A 
Sbjct: 75  DLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRV----SCSRGQ-GKKNIYLAN 129

Query: 110 CNVSGGIPEEIGNLTNLTIIYLGGNKLNG-SIPSTLGKLQKLQGLGLENNKLEGSIPDSI 168
             ++     + G  + +  + L  N+++  +          L+ L L+ N +   +   +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188

Query: 169 CHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSS 228
             + +L  L+L  NKL+  +   F + A +  + L +N+L  I       +++ + +   
Sbjct: 189 VFA-KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRG 246

Query: 229 N-FFTGPLPLEIGNL------------KIARIDSCDLISLISLNLSNNNLSGAIPASLEK 275
           N F  G L                   K+   +  +       +              ++
Sbjct: 247 NGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306

Query: 276 LSYLKDLNLSFNKLEGEIPRGGSFGNFSAES 306
           L  LK    +    +G           +   
Sbjct: 307 LIALKRKEHALLSGQGSETERLECERENQAR 337

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  119 bits (301), Expect = 6e-29
 Identities = 38/294 (12%), Positives = 89/294 (30%), Gaps = 21/294 (7%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L    NN S  +            + L++N  +       G    +Q L L  N + +  
Sbjct: 104 LHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-- 158

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG 121
             ++F    ++  +L  ++   N +  +  +         L+  +++   ++  +  E  
Sbjct: 159 --VNFAELAASSDTLEHLNLQYNFIYDVKGQVVF----AKLKTLDLSSNKLAF-MGPEFQ 211

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLE-GSIPDSICHSDELYKLELG 180
           +   +T I L  NKL   I   L   Q L+   L  N    G++ D    +  +  +   
Sbjct: 212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK- 269

Query: 181 GNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIG 240
              +     +         +   G+     +P  F     ++ L    +     L  +  
Sbjct: 270 -QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPF--ADRLIALKRKEHAL---LSGQGS 323

Query: 241 NLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
             +    +  +      ++         I     +      L      L+ ++ 
Sbjct: 324 ETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  106 bits (266), Expect = 2e-24
 Identities = 33/187 (17%), Positives = 66/187 (35%), Gaps = 20/187 (10%)

Query: 115 GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDEL 174
            I E   N     I  +  + L  ++ S       ++ L L  N L       +    +L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 175 YKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGP 234
             L L  N L     +   +L++LR L L +N +  +         I  L+ ++N     
Sbjct: 61  ELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQELL----VGPSIETLHAANN----- 109

Query: 235 LPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
                    I+R+         ++ L+NN ++          S ++ L+L  N+++  + 
Sbjct: 110 --------NISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVN 160

Query: 295 RGGSFGN 301
                 +
Sbjct: 161 FAELAAS 167

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 78.7 bits (194), Expect = 1e-15
 Identities = 35/281 (12%), Positives = 77/281 (27%), Gaps = 16/281 (5%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
            +     +A+ ++ + L +N     I       +NL+   L  N     TL   F S   
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLR-DFFSKNQ 262

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT--NLTII 129
             +++   +            T      +     E    ++     + +  L      ++
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE----DLPAPFADRLIALKRKEHALL 318

Query: 130 YLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIP 189
              G++    +        + + +     +    I            LE     L   + 
Sbjct: 319 SGQGSETE-RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377

Query: 190 ECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDS 249
                 A L   L  +     +         +  L      +   + +E  +++   I  
Sbjct: 378 NGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE-EMYVEQQSVQNNAIRD 436

Query: 250 CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
            D+       L+  N        L+KL+   DL L+     
Sbjct: 437 WDMYQHKETQLAEENA------RLKKLNGEADLALASANAT 471

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  136 bits (343), Expect = 1e-33
 Identities = 61/287 (21%), Positives = 109/287 (37%), Gaps = 45/287 (15%)

Query: 400 IGRGSFGSVFKARL----GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVI 454
           IG G FG V +          M VA+K         V + F  E   M+   H +I+K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              +      +++E    G L  +L    + LD+   +     +++AL YL    S + +
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFV 513

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSAN 574
           H D+   NVL+  N    L DFG+++ +  +      ++    I +MAPE     R ++ 
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIKWMAPESINFRRFTSA 572

Query: 575 GDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV 633
            DV+ FG+ + E      KP   + N ++                           I  +
Sbjct: 573 SDVWMFGVCMWEILMHGVKPFQGVKNNDV---------------------------IGRI 605

Query: 634 AK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                      C   ++++  +C    P +R    E+  +L  I + 
Sbjct: 606 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  131 bits (331), Expect = 1e-33
 Identities = 47/200 (23%), Positives = 92/200 (46%), Gaps = 11/200 (5%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVIS 455
            IG GSFG     +   DG +  +K  N+     +  +    E  ++ +++H NI++   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYSAQVI 514
           S        +V++Y   G L K +++   +     Q L+  + +  AL+++H     +++
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKIL 147

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPEYGKEGRVSA 573
           H D+K  N+ L  +    L DFGIA++L   + +    +    T  Y++PE  +    + 
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTPYYLSPEICENKPYNN 204

Query: 574 NGDVYSFGIMLMETFTRKKP 593
             D+++ G +L E  T K  
Sbjct: 205 KSDIWALGCVLYELCTLKHA 224

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  135 bits (342), Expect = 1e-33
 Identities = 72/289 (24%), Positives = 114/289 (39%), Gaps = 57/289 (19%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L + +NN + ++P       +L  LE+S N  +  +P     L  L        +L    
Sbjct: 66  LVIPDNNLT-SLPALP---PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP--- 117

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG 121
                 +  S    L +     N L      TS+  L   L+   ++   ++  +P    
Sbjct: 118 ------ALPSGLCKLWI---FGNQL------TSLPVLPPGLQELSVSDNQLA-SLPALPS 161

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG 181
            L  L   +   N+L  S+P     LQ+L    + +N+L  S+P        LYKL    
Sbjct: 162 ELCKL---WAYNNQLT-SLPMLPSGLQELS---VSDNQLA-SLPTLPSE---LYKLWAYN 210

Query: 182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGN 241
           N+L+ S+P      + L+ L++  N LTS+P+    LK    L  S N  T  LP+    
Sbjct: 211 NRLT-SLPA---LPSGLKELIVSGNRLTSLPVLPSELK---ELMVSGNRLTS-LPMLPSG 262

Query: 242 LKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
           L              SL++  N L+  +P SL  LS    +NL  N L 
Sbjct: 263 LL-------------SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  103 bits (259), Expect = 3e-23
 Identities = 65/352 (18%), Positives = 112/352 (31%), Gaps = 65/352 (18%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPN-----TFGN--------LRNLQ 48
           L++  N  + ++P       +LSI                    FGN           LQ
Sbjct: 86  LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQ 144

Query: 49  ALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMA 108
            L +S+N L S        +  S    L      NN L      TS+  L   L+   ++
Sbjct: 145 ELSVSDNQLAS------LPALPSELCKLWA---YNNQL------TSLPMLPSGLQELSVS 189

Query: 109 YCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSI 168
              ++  +P     L  L   +   N+L  S+P+    L++L    +  N+L  S+P   
Sbjct: 190 DNQLAS-LPTLPSELYKL---WAYNNRLT-SLPALPSGLKELI---VSGNRLT-SLPVLP 240

Query: 169 CHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSS 228
                L +L + GN+L+ S+P      + L  L +  N+LT +P +  +L     +N   
Sbjct: 241 SE---LKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEG 293

Query: 229 NFFTGP----------LPLEIGNLKIARIDSCDLISLISL--NLSNNNLSGAIPASLEKL 276
           N  +             P   G +    +               + + L  A        
Sbjct: 294 NPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353

Query: 277 SYLKDL-----NLSFNKLEGEIPRGGSFGN---FSAESFEGNELLCGSPNLR 320
                        +F+     +    +F     F A+       L     LR
Sbjct: 354 DRWHMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQLAEDEALR 405

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 75.7 bits (186), Expect = 2e-14
 Identities = 31/152 (20%), Positives = 57/152 (37%), Gaps = 13/152 (8%)

Query: 147 LQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSN 206
                 L +  + L  ++PD +     +  L +  N L+ S+P        LR L +  N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPAH--ITTLVIPDNNLT-SLPA---LPPELRTLEVSGN 91

Query: 207 ELTSIPLTFWNLKDILYLNFSSNFFTGPLP----LEIGNLKIARIDSCDLISLISLNLSN 262
           +LTS+P+    L ++   +               L I   ++  +       L  L++S+
Sbjct: 92  QLTSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPV-LPPGLQELSVSD 150

Query: 263 NNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
           N L+ ++PA   +L  L   N     L     
Sbjct: 151 NQLA-SLPALPSELCKLWAYNNQLTSLPMLPS 181

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 67.6 bits (165), Expect = 6e-12
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 19/134 (14%)

Query: 168 ICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFS 227
            C ++    L +G + L+ ++P+C    A +  L++  N LTS+P     L+    L  S
Sbjct: 36  ACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTSLPALPPELR---TLEVS 89

Query: 228 SNFFTGPLPLEIGNLKIARIDSCDLI-------SLISLNLSNNNLSGAIPASLEKLSYLK 280
            N  T  LP+    L    I S  L         L  L +  N L+ ++P        L+
Sbjct: 90  GNQLTS-LPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT-SLPVLPPG---LQ 144

Query: 281 DLNLSFNKLEGEIP 294
           +L++S N+L   +P
Sbjct: 145 ELSVSDNQLA-SLP 157

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  130 bits (328), Expect = 1e-33
 Identities = 62/294 (21%), Positives = 104/294 (35%), Gaps = 45/294 (15%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
            +G G F  V     L DG   A+K       +  +    E +M +   H NI+++++ C
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 458 SNEEFKA----LVLEYMPHGSLEKYL---HSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
             E        L+L +   G+L   +         L   Q L +++ +   LE +H   +
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-------TIGYMAP 563
               H DLKP+N+LL D     L D G         + + Q  TL        TI Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 564 E------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           E      +      +   DV+S G +L      + P D +F    ++   V      +  
Sbjct: 213 ELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ-----NQL 264

Query: 618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
            I      S      +                    P QR +   ++++L  ++
Sbjct: 265 SIPQSPRHSSALWQLLNS-------------MMTVDPHQRPHIPLLLSQLEALQ 305

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  128 bits (324), Expect = 2e-33
 Identities = 57/214 (26%), Positives = 86/214 (40%), Gaps = 18/214 (8%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVIS 455
            IG GS+G   K R   DG  +  K  +         +    E  +++ ++H NI++   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 456 SCSNEEFKAL--VLEYMPHGSLEKYL---HSSNYILDIYQRLNIMIDVASALEYLH--FG 508
              +     L  V+EY   G L   +         LD    L +M  +  AL+  H    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPEYGK 567
               V+H DLKP+NV LD      L DFG+A++L   +  T   +T   T  YM+PE   
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL---NHDTSFAKTFVGTPYYMSPEQMN 189

Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
               +   D++S G +L E      P    F   
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMPP----FTAF 219

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  128 bits (324), Expect = 2e-33
 Identities = 62/305 (20%), Positives = 125/305 (40%), Gaps = 64/305 (20%)

Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIK 452
           +G   FG V+K  L           VA+K    +  G + + F  E  +   ++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSS---------------NYILDIYQRLNIMID 497
           ++   + ++  +++  Y  HG L ++L                     L+    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 498 VASALEYL---HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
           +A+ +EYL   H       +H DL   NVL+ D +   +SD G+ + +   D   +   +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI 614
           L  I +MAPE    G+ S + D++S+G++L E F+          G            P 
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY---------GLQ----------PY 231

Query: 615 STKEIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                      +++ +  +         + C ++V+ + +EC  E P +R   K+I ++L
Sbjct: 232 -------CGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

Query: 668 LKIRD 672
               +
Sbjct: 285 RAWGN 289

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  132 bits (334), Expect = 3e-33
 Identities = 79/322 (24%), Positives = 127/322 (39%), Gaps = 33/322 (10%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L + +N    T+ +  F +   L  LEL++N  S   P  F NL NL+ L L +N L   
Sbjct: 37  LDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL- 94

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
            + L   + LSN   L +   S N +  +L         ++L+  E+   ++   I    
Sbjct: 95  -IPLGVFTGLSNLTKLDI---SENKIVILLDYMFQDL--YNLKSLEVGDNDLV-YISHRA 147

Query: 121 -GNLTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLE 178
              L +L  + L    L  SIP+  L  L  L  L L +  +      S      L  LE
Sbjct: 148 FSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206

Query: 179 LGGNKLSGSIPECFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPL 237
           +       ++        +L  L +    LT++P L   +L  + +LN S N        
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYN-------- 258

Query: 238 EIGNLKIARIDSC---DLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
                 I+ I+     +L+ L  + L    L+   P +   L+YL+ LN+S N+L   + 
Sbjct: 259 -----PISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLE 312

Query: 295 RG--GSFGNFSAESFEGNELLC 314
                S GN      + N L C
Sbjct: 313 ESVFHSVGNLETLILDSNPLAC 334

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  129 bits (325), Expect = 1e-32
 Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 53/299 (17%)

Query: 400 IGRGSFGSVFKARL--------GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSI-RH 447
           +G G FG V  A           + + VA+K+  L+     +       E EMMK I +H
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRL 492
           +NII ++ +C+ +    +++EY   G+L +YL                     +     +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT 552
           +    +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D     T
Sbjct: 207 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263

Query: 553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDW 611
                + +MAPE   +   +   DV+SFG+++ E FT    P   I   E+         
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--------- 314

Query: 612 LPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
                K + + + + +          C + ++ +  +C    P QR   K++V  L +I
Sbjct: 315 ----FKLLKEGHRMDK-------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  127 bits (322), Expect = 1e-32
 Identities = 70/305 (22%), Positives = 126/305 (41%), Gaps = 54/305 (17%)

Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIK 452
           IG G+FG VF+AR            VA+K+   +    +   F  E  +M    + NI+K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSS-----------------------NYILDIY 489
           ++  C+  +   L+ EYM +G L ++L S                           L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST 549
           ++L I   VA+ + YL      + +H DL   N L+ +NMV  ++DFG+++ +   D   
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231

Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWV 608
                   I +M PE     R +   DV+++G++L E F+   +P   + + E+ + +  
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV-IYY-- 288

Query: 609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                     + D N+L+         E C   ++N+   C  + P  R +   I   L 
Sbjct: 289 ----------VRDGNILAC-------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331

Query: 669 KIRDS 673
           ++ + 
Sbjct: 332 RMCER 336

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  126 bits (319), Expect = 2e-32
 Identities = 61/309 (19%), Positives = 117/309 (37%), Gaps = 68/309 (22%)

Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIK 452
           +G G FG V KA             VA+K+          +    E  ++K + H ++IK
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL-----------------------HSSNYILDIY 489
           +  +CS +    L++EY  +GSL  +L                       H     L + 
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150

Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST 549
             ++    ++  ++YL      +++H DL   N+L+ +     +SDFG+++ +  ED   
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207

Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWV 608
            ++Q    + +MA E   +   +   DV+SFG++L E  T    P               
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-------------- 253

Query: 609 NDWLPISTKEIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAK 661
                        P +      N +         + C   ++ + ++C  + P++R    
Sbjct: 254 -------------PGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300

Query: 662 EIVTKLLKI 670
           +I   L K+
Sbjct: 301 DISKDLEKM 309

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  126 bits (319), Expect = 3e-32
 Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 53/299 (17%)

Query: 400 IGRGSFGSVFKARL--------GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSI-RH 447
           +G G+FG V  A           + + VA+K+  L+     +       E EMMK I +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRL 492
           +NII ++ +C+ +    +++EY   G+L +YL                     +     +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT 552
           +    +A  +EYL    S + IH DL   NVL+ +N V  ++DFG+A+ +   D     T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217

Query: 553 QTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDW 611
                + +MAPE   +   +   DV+SFG+++ E FT    P   I   E+         
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL--------- 268

Query: 612 LPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
                K + + + + +          C + ++ +  +C    P QR   K++V  L +I
Sbjct: 269 ----FKLLKEGHRMDK-------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  125 bits (317), Expect = 5e-32
 Identities = 61/297 (20%), Positives = 111/297 (37%), Gaps = 48/297 (16%)

Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNII 451
           +G G+FG V +A           M VA+K+          ++   E +++  +  H NI+
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYL-----------------HSSNYILDIYQRLNI 494
            ++ +C+      ++ EY  +G L  +L                       LD+   L+ 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +    ++   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLP 613
              + +MAPE       +   DV+S+GI L E F+    P   +       K        
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM------- 260

Query: 614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
                I +   +          E   + ++++   C    P +R   K+IV  + K 
Sbjct: 261 -----IKEGFRMLS-------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  125 bits (317), Expect = 6e-32
 Identities = 58/299 (19%), Positives = 118/299 (39%), Gaps = 44/299 (14%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
            +P+ +      ++L+L +N  +      F NL+NL  L L NN ++   +     + L 
Sbjct: 45  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK--ISPGAFAPLV 100

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI-GNLTNLTIIY 130
             + L L   S N L  +        +  +L+   +    ++  + + +   L  + ++ 
Sbjct: 101 KLERLYL---SKNQLKELPE-----KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVE 151

Query: 131 LGGNKLNGSI--PSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSI 188
           LG N L  S         ++KL  + + +  +  +IP  +  S  L +L L GNK++  +
Sbjct: 152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS--LTELHLDGNKIT-KV 207

Query: 189 PE-CFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIAR 246
                  L +L  L L  N ++++   +  N   +  L+ ++N             K+ +
Sbjct: 208 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN-------------KLVK 254

Query: 247 IDSC--DLISLISLNLSNNNLSG------AIPASLEKLSYLKDLNLSFNKLE-GEIPRG 296
           +     D   +  + L NNN+S         P    K +    ++L  N ++  EI   
Sbjct: 255 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 313

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  120 bits (302), Expect = 5e-30
 Identities = 63/294 (21%), Positives = 104/294 (35%), Gaps = 27/294 (9%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L +  N  +  I    F N   L  L L +N  S   P  F  L  L+ L LS N L   
Sbjct: 57  LDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL 115

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAY-CNVSGGIPEE 119
             ++         K+L  +    N +  +  K+    L+  +   E+      S GI   
Sbjct: 116 PEKM-P-------KTLQELRVHENEITKV-RKSVFNGLN-QMIVVELGTNPLKSSGIENG 165

Query: 120 I-GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS-DELYKL 177
               +  L+ I +    +  +IP  L     L  L L+ NK+   +  +     + L KL
Sbjct: 166 AFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKL 221

Query: 178 ELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPL 237
            L  N +S        N   LR L L +N+L  +P    + K I  +   +N  +     
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS----- 276

Query: 238 EIGNLKIARIDSCD-LISLISLNLSNNNLSGAI--PASLEKLSYLKDLNLSFNK 288
            IG+             S   ++L +N +      P++   +     + L   K
Sbjct: 277 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 44/188 (23%), Positives = 77/188 (40%), Gaps = 25/188 (13%)

Query: 125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
           +L ++      L   +P  L        L L+NNK+         +   L+ L L  NK+
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 185 SGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLN------FSSNFFTGPLP- 236
           S   P  F  L  L  L L  N+L  +P      L++ L ++         + F G L  
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQE-LRVHENEITKVRKSVFNG-LNQ 146

Query: 237 ---LEIGN--LKIARIDS---CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNK 288
              +E+G   LK + I++     +  L  + +++ N++  IP  L     L +L+L  NK
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 203

Query: 289 LEGEIPRG 296
           +  ++   
Sbjct: 204 IT-KVDAA 210

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 31/153 (20%), Positives = 60/153 (39%), Gaps = 17/153 (11%)

Query: 150 LQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELT 209
           L+ +   +  LE  +P  +    +   L+L  NK++      F NL +L  L+L +N+++
Sbjct: 33  LRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 210 SI-PLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGA 268
            I P  F  L  +  L  S N             ++  +      +L  L +  N ++  
Sbjct: 90  KISPGAFAPLVKLERLYLSKN-------------QLKELPEKMPKTLQELRVHENEITKV 136

Query: 269 IPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGN 301
             +    L+ +  + L  N L+      G+F  
Sbjct: 137 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  124 bits (314), Expect = 7e-32
 Identities = 49/224 (21%), Positives = 94/224 (41%), Gaps = 29/224 (12%)

Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIR 446
           R    F     +GRG FG VF+A+   D    A+K   L       +    E + +  + 
Sbjct: 2   RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61

Query: 447 HRNIIKVISSCSNEEFKA------------LVLEYMPHGSLEKYLHSSNYI--LDIYQRL 492
           H  I++  ++   +                + ++     +L+ +++    I   +    L
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ----- 547
           +I + +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+   + ++++     
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 548 --STIQTQTLATIG---YMAPEYGKEGRVSANGDVYSFGIMLME 586
                  +    +G   YM+PE       S   D++S G++L E
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  126 bits (318), Expect = 1e-31
 Identities = 63/317 (19%), Positives = 119/317 (37%), Gaps = 37/317 (11%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L M  N     +P  +F N   L++L L  N  S      F N   L  L +SNN L   
Sbjct: 98  LYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER- 155

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
            +E     + ++ ++L L   S+N L  +     +  +  SL +  ++Y  +S      +
Sbjct: 156 -IEDDTFQATTSLQNLQL---SSNRLTHV----DLSLIP-SLFHANVSYNLLS-----TL 201

Query: 121 GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG 180
                +  +    N +N  +   +    +L  L L++N L  +    + +   L +++L 
Sbjct: 202 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLS 256

Query: 181 GNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIG 240
            N+L   +   F  +  L  L + +N L ++ L    +  +  L+ S N     +     
Sbjct: 257 YNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQP 315

Query: 241 NLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFG 300
                         L +L L +N++   +  S      LK+L LS N  +        F 
Sbjct: 316 QFD----------RLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD-CNSLRALFR 361

Query: 301 NFSAESFEGNELLCGSP 317
           N +  + +  +  C   
Sbjct: 362 NVARPAVDDADQHCKID 378

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  113 bits (286), Expect = 2e-27
 Identities = 60/298 (20%), Positives = 102/298 (34%), Gaps = 47/298 (15%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
            I   +        + +   +   +       L N + +   N+ +    L  + L S  
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK--LPAALLDSFR 69

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL 131
             + L L   ++  ++ I                                    +  +Y+
Sbjct: 70  QVELLNL---NDLQIEEIDTYA--------------------------FAYAHTIQKLYM 100

Query: 132 GGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLELGGNKLSGSIPE 190
           G N +    P     +  L  L LE N L  S+P  I H+  +L  L +  N L     +
Sbjct: 101 GFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDD 159

Query: 191 CFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFT--GPLP----LEIGNLK 243
            F    SL+ L L SN LT + L    +L    + N S N  +          L+  +  
Sbjct: 160 TFQATTSLQNLQLSSNRLTHVDLSLIPSLF---HANVSYNLLSTLAIPIAVEELDASHNS 216

Query: 244 IARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGN 301
           I  +     + L  L L +NNL+    A L     L +++LS+N+LE +I     F  
Sbjct: 217 INVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMY-HPFVK 270

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  124 bits (314), Expect = 1e-31
 Identities = 60/296 (20%), Positives = 114/296 (38%), Gaps = 47/296 (15%)

Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSI-RHRNII 451
           +GRG+FG V +A             VA+K+          ++   E +++  I  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94

Query: 452 KVISSCSNEEFKALV-LEYMPHGSLEKYL---------------HSSNYILDIYQRLNIM 495
            ++ +C+      +V +E+   G+L  YL                     L +   +   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154

Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
             VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++     +    
Sbjct: 155 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211

Query: 556 ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPI 614
             + +MAPE   +   +   DV+SFG++L E F+    P   +   E   +         
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR-------- 263

Query: 615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
               + +   +          +     ++   ++C    P QR    E+V  L  +
Sbjct: 264 ----LKEGTRMRA-------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  125 bits (317), Expect = 1e-31
 Identities = 74/303 (24%), Positives = 123/303 (40%), Gaps = 61/303 (20%)

Query: 400 IGRGSFGSVFKARL--------GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSI-RHRN 449
           +G G+FG V  A              +VA+K+       +       E EMMK I +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNI 494
           II ++ +C+ +    +++EY   G+L +YL               H+    L     ++ 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  +EYL    S + IH DL   NVL+ ++ V  ++DFG+A+ +   D     T  
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253

Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI 614
              + +MAPE   +   +   DV+SFG++L E FT          G            P 
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL---------GGS----------PY 294

Query: 615 STKEIVDPNLLSREDINFVAK-------EQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                  P +   E    + +         C + ++ +  +C    P QR   K++V  L
Sbjct: 295 -------PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347

Query: 668 LKI 670
            +I
Sbjct: 348 DRI 350

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  124 bits (314), Expect = 1e-31
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 28/213 (13%)

Query: 398 NLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYGRV-FKSFDVECEMMKSI-RHRNIIK 452
           ++IG G+FG V KAR+   G  M+ A+K       +   + F  E E++  +  H NII 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYL---------------HSSNYILDIYQRLNIMID 497
           ++ +C +  +  L +EY PHG+L  +L               +S+   L   Q L+   D
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLA 556
           VA  ++YL      Q IH DL   N+L+ +N VA ++DFG    L+R ++    +T    
Sbjct: 151 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG----LSRGQEVYVKKTMGRL 203

Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
            + +MA E       + N DV+S+G++L E  +
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  128 bits (324), Expect = 2e-31
 Identities = 62/315 (19%), Positives = 117/315 (37%), Gaps = 37/315 (11%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L + +      I  + F  A  +  L +  N+     P+ F N+  L  L L  N L+S 
Sbjct: 80  LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS- 137

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
            L      +     +L++   SNN L+ I    +    + SL+  +++   ++  +   +
Sbjct: 138 -LPRGIFHNTPKLTTLSM---SNNNLERI-EDDTFQATT-SLQNLQLSSNRLT-HVD--L 188

Query: 121 GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG 180
             + +L    +  N L     STL     ++ L   +N +   +   +     L  L+L 
Sbjct: 189 SLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVNVE--LTILKLQ 240

Query: 181 GNKLSGSIPECFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEI 239
            N L+        N   L  + L  NEL  I    F  ++ +  L  S+N     L L  
Sbjct: 241 HNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYG 297

Query: 240 GNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSF 299
             +           +L  L+LS+N+L   +  +  +   L++L L  N +   +    + 
Sbjct: 298 QPIP----------TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTH 344

Query: 300 GNFSAESFEGNELLC 314
                 +   N+  C
Sbjct: 345 HTLKNLTLSHNDWDC 359

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  122 bits (308), Expect = 2e-29
 Identities = 63/317 (19%), Positives = 118/317 (37%), Gaps = 37/317 (11%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L M  N     +P  +F N   L++L L  N  S      F N   L  L +SNN L   
Sbjct: 104 LYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLER- 161

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
            +E     + ++ ++L L   S+N L  +     +  +  SL +  ++Y  +S      +
Sbjct: 162 -IEDDTFQATTSLQNLQL---SSNRLTHV----DLSLIP-SLFHANVSYNLLS-----TL 207

Query: 121 GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG 180
                +  +    N +N  +        +L  L L++N L  +    + +   L +++L 
Sbjct: 208 AIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLS 262

Query: 181 GNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIG 240
            N+L   +   F  +  L  L + +N L ++ L    +  +  L+ S N     +     
Sbjct: 263 YNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH-VERNQP 321

Query: 241 NLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFG 300
                         L +L L +N++   +  S      LK+L LS N  +        F 
Sbjct: 322 QFD----------RLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD-CNSLRALFR 367

Query: 301 NFSAESFEGNELLCGSP 317
           N +  + +  +  C   
Sbjct: 368 NVARPAVDDADQHCKID 384

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  114 bits (286), Expect = 1e-26
 Identities = 56/298 (18%), Positives = 103/298 (34%), Gaps = 47/298 (15%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS------------STLELSF 66
             +   I+   +++          + R ++ L L++  +                L + F
Sbjct: 49  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108

Query: 67  --LSSL-----SNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEE 119
             +  L      N   LT++    N L   LP+    N    L    M+  N+   I ++
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPK-LTTLSMSNNNLE-RIEDD 165

Query: 120 I-GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLE 178
                T+L  + L  N+L   +   L  +  L    +  N L  ++   I     + +L+
Sbjct: 166 TFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-TLAIPI----AVEELD 217

Query: 179 LGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLE 238
              N ++  +         L IL L  N LT       N   ++ ++ S N     +   
Sbjct: 218 ASHNSIN-VVRG--PVNVELTILKLQHNNLTDTA-WLLNYPGLVEVDLSYNELEKIMYHP 273

Query: 239 IGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG 296
              ++           L  L +SNN L  A+    + +  LK L+LS N L   + R 
Sbjct: 274 FVKMQ----------RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERN 319

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  112 bits (282), Expect = 3e-26
 Identities = 62/309 (20%), Positives = 106/309 (34%), Gaps = 53/309 (17%)

Query: 7   NNFSGTIPRFIFNASKLSI------LELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
            N     P +    S L        + +   +   +       L N + +   N+ +   
Sbjct: 7   YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK- 65

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
            L  + L S      + L++ ++  ++ I                               
Sbjct: 66  -LPAALLDSFRQ---VELLNLNDLQIEEIDTYA--------------------------F 95

Query: 121 GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLEL 179
                +  +Y+G N +    P     +  L  L LE N L  S+P  I H+  +L  L +
Sbjct: 96  AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSM 154

Query: 180 GGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFT--GPLP 236
             N L     + F    SL+ L L SN LT + L    +L    + N S N  +      
Sbjct: 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF---HANVSYNLLSTLAIPI 211

Query: 237 ----LEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGE 292
               L+  +  I  +     + L  L L +NNL+    A L     L +++LS+N+LE +
Sbjct: 212 AVEELDASHNSINVVRGPVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-K 268

Query: 293 IPRGGSFGN 301
           I     F  
Sbjct: 269 IMY-HPFVK 276

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  124 bits (314), Expect = 6e-31
 Identities = 60/307 (19%), Positives = 109/307 (35%), Gaps = 67/307 (21%)

Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECE-MMKSIRHRNIIK 452
                ++G GS G+V       G  VA+K   + +        +E + + +S  H N+I+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIR 73

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL------NIMIDVASALEYLH 506
              S + + F  + LE     +L+  + S N   +  +        +++  +AS + +LH
Sbjct: 74  YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 507 FGYSAQVIHCDLKPSNVLLD-------------DNMVAHLSDFGIAKLLTREDQSTIQTQ 553
              S ++IH DLKP N+L+              +N+   +SDFG+ K L     S     
Sbjct: 133 ---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 554 TLA--TIGYMAPEYGKEGRVSANG-------DVYSFGIMLMETFTRKKP--------TDE 596
                T G+ APE  +E              D++S G +     ++ K            
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 249

Query: 597 IFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQ 656
           I  G  +L                    L  E  + +++                  P +
Sbjct: 250 IIRGIFSLDEMKCLH----------DRSLIAEATDLISQ-------------MIDHDPLK 286

Query: 657 RINAKEI 663
           R  A ++
Sbjct: 287 RPTAMKV 293

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  121 bits (306), Expect = 1e-30
 Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 26/212 (12%)

Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRN 449
             +  ++++G+G+  +VF+ R    G   A+KVFN + + R       E E++K + H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 450 IIK---VISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEY 504
           I+K   +    +      L++E+ P GSL   L   S+ Y L   + L ++ DV   + +
Sbjct: 69  IVKLFAIEEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 505 LHFGYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           L       ++H ++KP N++     D   V  L+DFG A+ L   +          T  Y
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEY 181

Query: 561 MAPEYGKEGRVSANG--------DVYSFGIML 584
           + P+  +   +  +         D++S G+  
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  121 bits (307), Expect = 1e-30
 Identities = 52/215 (24%), Positives = 97/215 (45%), Gaps = 28/215 (13%)

Query: 398 NLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSI-RH 447
             +G G+FG V +A           ++VA+K+  L+        ++   E ++M  + +H
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKM--LKSTAHADEKEALMSELKIMSHLGQH 109

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYL-------------HSSNYILDIYQRLNI 494
            NI+ ++ +C++     ++ EY  +G L  +L               +N        L+ 
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
              VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ +  +    ++   
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226

Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
              + +MAPE   +   +   DV+S+GI+L E F+
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  120 bits (304), Expect = 2e-30
 Identities = 71/308 (23%), Positives = 134/308 (43%), Gaps = 48/308 (15%)

Query: 377 AMQRMFSYLELCRATD---GFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVF 432
           +M++   Y  + R  D    +     +G G+FG V+KA+    G   A KV   +     
Sbjct: 1   SMRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL 60

Query: 433 KSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL 492
           + + VE E++ +  H  I+K++ +  ++    +++E+ P G+++  +   +  L   Q  
Sbjct: 61  EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120

Query: 493 NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQT 552
            +   +  AL +LH   S ++IH DLK  NVL+       L+DFG++    +  Q   + 
Sbjct: 121 VVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ---KR 174

Query: 553 QTLATIG---YMAPE-----YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTL 604
            +   IG   +MAPE       K+       D++S GI L+E    + P  E+       
Sbjct: 175 DSF--IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL------- 225

Query: 605 KHWVNDWLPISTKE---IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAK 661
            + +   L I+  +   ++ P+  S E  +F+                  ++PE R +A 
Sbjct: 226 -NPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKI-------------ALDKNPETRPSAA 271

Query: 662 EIVTKLLK 669
           +    LL+
Sbjct: 272 Q----LLE 275

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  125 bits (315), Expect = 6e-30
 Identities = 68/327 (20%), Positives = 117/327 (35%), Gaps = 42/327 (12%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L++       TI +  F N   L IL+L  +      P+ F  L +L  LRL    L+ +
Sbjct: 53  LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
            L+  +  +L     LT +  S N +  +    S G L+ SL+  + +   +      E+
Sbjct: 113 VLKDGYFRNLKA---LTRLDLSKNQIRSLYLHPSFGKLN-SLKSIDFSSNQIFLVCEHEL 168

Query: 121 GNLT--NLTIIYLGGNKLNGSIPSTLGKLQK------LQGLGLENNKLEGSIPDSICH-- 170
             L    L+   L  N L   +    GK         L+ L +  N     I  +  +  
Sbjct: 169 EPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAI 228

Query: 171 ----------SDELYKLELGGNKLSGSIPECFNNLA--SLRILLLGSNELTSI-PLTFWN 217
                     +  +     G + +       F  LA  S+R L L    + S+    F  
Sbjct: 229 SKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFET 288

Query: 218 LKDILYLNFSSNFFTG-------PLP----LEIGNLKIARIDSCDLISLISL---NLSNN 263
           LKD+  LN + N            L     L +    +  + S +   L  +   +L  N
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348

Query: 264 NLSGAIPASLEKLSYLKDLNLSFNKLE 290
           +++     + + L  L+ L+L  N L 
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  119 bits (299), Expect = 6e-28
 Identities = 63/321 (19%), Positives = 107/321 (33%), Gaps = 25/321 (7%)

Query: 7   NNFSGTIPRFIFN---ASKLSILELSDNSFSGFIPNTFGNLRN------LQALRLSNNYL 57
           N     +            LS   L+ NS    +   +G   N      L+ L +S N  
Sbjct: 158 NQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGW 216

Query: 58  T-------SSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYC 110
           T       S+ +  S   SL     +    F  + +      T  G    S+ + ++++ 
Sbjct: 217 TVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHG 276

Query: 111 NVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICH 170
            V          L +L ++ L  NK+N         L  LQ L L  N L      +   
Sbjct: 277 FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG 336

Query: 171 SDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNF 230
             ++  ++L  N ++    + F  L  L+ L L  N LT+I          L  N     
Sbjct: 337 LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTL 396

Query: 231 FTGPLPLEIGNLKIARIDSCD-------LISLISLNLSNNNLSG-AIPASLEKLSYLKDL 282
               L   + +L   R+++ D       +  L  L L+ N  S  +   +  +   L+ L
Sbjct: 397 PKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL 456

Query: 283 NLSFNKLEGEIPRGGSFGNFS 303
            L  N L+        +  F 
Sbjct: 457 FLGENMLQLAWETELCWDVFE 477

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  114 bits (287), Expect = 2e-26
 Identities = 58/308 (18%), Positives = 103/308 (33%), Gaps = 42/308 (13%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
            N +  +P+     +    L LS N       ++F  L  LQ L L + Y   +  + +F
Sbjct: 14  CNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAF 69

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGI--PEEIGNLT 124
                N  +L ++   ++ +  + P    G     L    + +C +S  +       NL 
Sbjct: 70  ----RNLPNLRILDLGSSKIYFLHPDAFQGL--FHLFELRLYFCGLSDAVLKDGYFRNLK 123

Query: 125 NLTIIYLGGNKLNG-SIPSTLGKLQKLQGLGLENNKLEGSIPDSI--CHSDELYKLELGG 181
            LT + L  N++    +  + GKL  L+ +   +N++       +       L    L  
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183

Query: 182 NKLSGSIPECFNNLA------SLRILLLGSNELTSIP-------------LTFWNLKDIL 222
           N L   +   +           L IL +  N  T                 +      I+
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243

Query: 223 YLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDL 282
              F  +    P       L           S+  L+LS+  +        E L  LK L
Sbjct: 244 GAGFGFHNIKDPDQNTFAGLA--------RSSVRHLDLSHGFVFSLNSRVFETLKDLKVL 295

Query: 283 NLSFNKLE 290
           NL++NK+ 
Sbjct: 296 NLAYNKIN 303

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  103 bits (258), Expect = 5e-23
 Identities = 73/373 (19%), Positives = 135/373 (36%), Gaps = 67/373 (17%)

Query: 7   NNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELS 65
            N  G +    F    K++ ++L  N  +     TF  L  LQ L L +N LT       
Sbjct: 323 YNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT------- 375

Query: 66  FLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSG-GIPEEIGNLT 124
              ++    S+  I  S N L       ++  ++ +     ++   +    I   +  + 
Sbjct: 376 ---TIHFIPSIPDIFLSGNKL------VTLPKINLTANLIHLSENRLENLDILYFLLRVP 426

Query: 125 NLTIIYLGGNKLNG-SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNK 183
           +L I+ L  N+ +  S   T  +   L+ L L  N L+ +    +C              
Sbjct: 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELC-------------- 472

Query: 184 LSGSIPECFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGNL 242
                 + F  L+ L++L L  N L S+P   F +L  +  L+ +SN             
Sbjct: 473 -----WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN------------- 514

Query: 243 KIARIDSCDLI-SLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGG--SF 299
           ++  +   DL  +L  L++S N L    P     LS    L+++ NK   E       ++
Sbjct: 515 RLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSV---LDITHNKFICECELSTFINW 571

Query: 300 GNFSAESFEGN--ELLCGSPN-------LRVPPCKTSIHHISRKNAFLLGIVLPLSTVFM 350
            N +  +  G   ++ C  P+         +         + +   F L IV  ++    
Sbjct: 572 LNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLF 631

Query: 351 IVVIFLIVKCRKR 363
           ++ I  + K R  
Sbjct: 632 LMTILTVTKFRGF 644

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  118 bits (298), Expect = 7e-30
 Identities = 55/238 (23%), Positives = 106/238 (44%), Gaps = 44/238 (18%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
           L+G+GSF  V++A  +  G+EVA+K+ +   +    + +    E ++   ++H +I+++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
           +   +  +  LVLE   +G + +YL +        +  + M  + + + YLH   S  ++
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPE------YGK 567
           H DL  SN+LL  NM   ++DFG+A  L    +   +  TL  T  Y++PE      +G 
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE---KHYTLCGTPNYISPEIATRSAHGL 191

Query: 568 EGRVSANGDVYSFGIML---------------METFTRKKPTDEIFNGEMTLKHWVND 610
           E       DV+S G M                  T  +      +   +  +  +++ 
Sbjct: 192 E------SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK------VVLADYEMPSFLSI 237

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  119 bits (301), Expect = 1e-29
 Identities = 62/302 (20%), Positives = 109/302 (36%), Gaps = 53/302 (17%)

Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNII 451
           +G G+FG V  A        G  ++VA+K+   +      ++   E +MM  +  H NI+
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYL----------------------HSSNYILDIY 489
            ++ +C+      L+ EY  +G L  YL                           +L   
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172

Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST 549
             L     VA  +E+L        +H DL   NVL+    V  + DFG+A+ +  +    
Sbjct: 173 DLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229

Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWV 608
           ++      + +MAPE   EG  +   DV+S+GI+L E F+    P   I       K   
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKL-- 287

Query: 609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLL 668
                     I +   + +              ++ +   C      +R +   + + L 
Sbjct: 288 ----------IQNGFKMDQ-------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330

Query: 669 KI 670
             
Sbjct: 331 CQ 332

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  120 bits (302), Expect = 1e-29
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 26/205 (12%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFN-LQYGRVFKSFDVECEMMKSIRHRNIIK---V 453
           ++G+G+  +VF+ R    G   A+KVFN + + R       E E++K + H+NI+K   +
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
               +      L++E+ P GSL   L   S+ Y L   + L ++ DV   + +L      
Sbjct: 76  EEETTTRHK-VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131

Query: 512 QVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
            ++H ++KP N++     D   V  L+DFG A+ L   +          T  Y+ P+  +
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDEQFVSLYGTEEYLHPDMYE 188

Query: 568 EGRVSANG--------DVYSFGIML 584
              +  +         D++S G+  
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTF 213

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  118 bits (297), Expect = 2e-29
 Identities = 80/311 (25%), Positives = 124/311 (39%), Gaps = 45/311 (14%)

Query: 369 NDANMPPEAMQRMFSYLELCRATDG---FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVF 424
               +     +++    E          F     +G GS+GSV+KA     G  VA+K  
Sbjct: 3   ETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV 62

Query: 425 NLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY 484
            ++     +    E  +M+     +++K   S        +V+EY   GS+   +   N 
Sbjct: 63  PVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK 120

Query: 485 ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 544
            L   +   I+      LEYLH     + IH D+K  N+LL+    A L+DFG+A  LT 
Sbjct: 121 TLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT- 176

Query: 545 EDQSTIQTQTLATIG---YMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
              +  +  T+  IG   +MAPE  +E   +   D++S GI  +E    K P  +I    
Sbjct: 177 --DTMAKRNTV--IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI---- 228

Query: 602 MTLKHWVNDWLPISTK---EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI 658
               H +     I T        P L S    +FV +             C V+SPEQR 
Sbjct: 229 ----HPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQ-------------CLVKSPEQRA 271

Query: 659 NAKEIVTKLLK 669
            A +    LL+
Sbjct: 272 TATQ----LLQ 278

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  123 bits (309), Expect = 2e-29
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 19/220 (8%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQ-YGRVFKSFDVECEMMKSIRHRNIIKVI--- 454
           +G G FG V +      G +VA+K    +   +  + + +E ++MK + H N++      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 455 ---SSCSNEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEYLHFGY 509
                 +  +   L +EY   G L KYL    +   L       ++ D++SAL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138

Query: 510 SAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
             ++IH DLKP N++L      ++  + D G AK L   DQ  + T+ + T+ Y+APE  
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPELL 195

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKH 606
           ++ + +   D +SFG +  E  T  +P    +        
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  117 bits (296), Expect = 2e-29
 Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 52/288 (18%)

Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           ++    IG+G+ G+V+ A  +  G EVA++  NLQ     +    E  +M+  ++ NI+ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
            + S    +   +V+EY+  GSL   +  +   +D  Q   +  +   ALE+LH   S Q
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQ 136

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPEYGKEGRV 571
           VIH D+K  N+LL  +    L+DFG    +T E     +  T+  T  +MAPE       
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAY 193

Query: 572 SANGDVYSFGIMLMETFTRKKP-TDE-----IF----NGEMTLKHWVNDWLPISTKEIVD 621
               D++S GIM +E    + P  +E     ++    NG   L+               +
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ---------------N 238

Query: 622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK 669
           P  LS    +F+ +             C     E+R +AKE    LL+
Sbjct: 239 PEKLSAIFRDFLNR-------------CLEMDVEKRGSAKE----LLQ 269

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  118 bits (297), Expect = 2e-29
 Identities = 68/324 (20%), Positives = 126/324 (38%), Gaps = 62/324 (19%)

Query: 366 GPPNDANMPPEAM---QRMFSYLELCRATD---GFSENNLIGRGSFGSVFKAR-LGDGME 418
               +       +   Q   +   +    D          IG GS G V  AR    G +
Sbjct: 13  LGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQ 72

Query: 419 VAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKY 478
           VA+K+ +L+  +  +    E  +M+  +H N++++  S    E   +++E++  G+L   
Sbjct: 73  VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDI 132

Query: 479 LHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI 538
           +      L+  Q   +   V  AL YLH   +  VIH D+K  ++LL  +    LSDFG 
Sbjct: 133 VSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGF 187

Query: 539 AKLLTREDQSTIQTQTLATIG---YMAPEYGKEGRVSANGDVYSFGIMLMET------FT 589
              ++++     + ++L  +G   +MAPE       +   D++S GIM++E       + 
Sbjct: 188 CAQISKDVP---KRKSL--VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF 242

Query: 590 RKKPTDEIF----NGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNV 645
              P   +     +    LK               + + +S    +F+ +          
Sbjct: 243 SDSPVQAMKRLRDSPPPKLK---------------NSHKVSPVLRDFLER---------- 277

Query: 646 AMECTVESPEQRINAKEIVTKLLK 669
                V  P++R  A+E    LL 
Sbjct: 278 ---MLVRDPQERATAQE----LLD 294

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  122 bits (307), Expect = 3e-29
 Identities = 63/302 (20%), Positives = 106/302 (35%), Gaps = 22/302 (7%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIP-NTFGNLRNLQALRLSNNYLTSS-TLEL 64
            N    I    F   +L  L L +N  S  +       L  L+  RL      +   LE 
Sbjct: 186 LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245

Query: 65  SFLSSLSNCKSLTLISFSNNPLDGILPK-TSVGNLSHSLEYFEMAYCNVSGGIPEEIGNL 123
              S+L    +LT+  F    LD  L     + N   ++  F +    +   + +   N 
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYN- 303

Query: 124 TNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNK 183
                + L   K     P+   KL+ L+ L   +NK   +  +    S  L  L+L  N 
Sbjct: 304 FGWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSEVDLPS--LEFLDLSRNG 358

Query: 184 LS--GSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGN 241
           LS  G   +      SL+ L L  N + ++   F  L+ + +L+F  +         +  
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV-- 416

Query: 242 LKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGN 301
                     L +LI L++S+ +   A       LS L+ L ++ N  +        F  
Sbjct: 417 -------FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP-DIFTE 468

Query: 302 FS 303
             
Sbjct: 469 LR 470

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  122 bits (307), Expect = 3e-29
 Identities = 55/329 (16%), Positives = 106/329 (32%), Gaps = 42/329 (12%)

Query: 2   LQMWENNFSGTIPRFIFNA-SKLSILELSDNSFSG------FIPNTFGNLRNLQALRLSN 54
           L +  N  S  + +      + L +  L    F        F  +    L NL       
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264

Query: 55  NYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSG 114
            YL     ++      +   +++  S  +  ++ +   +        LE     +     
Sbjct: 265 AYLDYYLDDII--DLFNCLTNVSSFSLVSVTIERVKDFSYNFGW-QHLELVNCKFGQFPT 321

Query: 115 GIPEEI----------------GNLTNLTIIYLGGNKLN--GSIPSTLGKLQKLQGLGLE 156
              + +                 +L +L  + L  N L+  G    +      L+ L L 
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381

Query: 157 NNKLEGSIPDSICHSDELYKLELGGNKLSGSIPEC-FNNLASLRILLLGSNELTSIP-LT 214
            N +  ++  +    ++L  L+   + L        F +L +L  L +            
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440

Query: 215 FWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLE 274
           F  L  +  L  + N F      +I           +L +L  L+LS   L    P +  
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDI---------FTELRNLTFLDLSQCQLEQLSPTAFN 491

Query: 275 KLSYLKDLNLSFNKLEGEIPRGGSFGNFS 303
            LS L+ LN++ N+L+  +P  G F   +
Sbjct: 492 SLSSLQVLNMASNQLK-SVPD-GIFDRLT 518

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  118 bits (297), Expect = 4e-28
 Identities = 57/303 (18%), Positives = 103/303 (33%), Gaps = 34/303 (11%)

Query: 12  TIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSL 70
           ++    F   S L  L   + + +       G+L+ L+ L +++N + S  L   F    
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYF---- 145

Query: 71  SNCKSLTLISFSNNPLDGILPKT--SVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTI 128
           SN  +L  +  S+N +  I       +  +       +++   ++  I         L  
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHK 204

Query: 129 IYLGGNKLNGSIPST-LGKLQKLQGLGLE------NNKLEGSIPDSICHSDELYKLELGG 181
           + L  N  + ++  T +  L  L+   L          LE     ++     L   E   
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264

Query: 182 NKLSGS---IPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLE 238
             L      I + FN L ++    L S  +  +                 ++  G   LE
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVK--------------DFSYNFGWQHLE 310

Query: 239 IGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGS 298
           + N K  +  +  L SL  L  ++N    A   S   L  L+ L+LS N L  +     S
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQS 368

Query: 299 FGN 301
              
Sbjct: 369 DFG 371

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  113 bits (284), Expect = 2e-26
 Identities = 57/290 (19%), Positives = 99/290 (34%), Gaps = 30/290 (10%)

Query: 13  IPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSN 72
           IP  +        L+LS N        +F +   LQ L LS   + +  +E     SLS+
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT--IEDGAYQSLSH 77

Query: 73  CKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLG 132
             +L L   + NP+   L   +   LS SL+       N++      IG+L  L  + + 
Sbjct: 78  LSTLIL---TGNPIQS-LALGAFSGLS-SLQKLVAVETNLASLENFPIGHLKTLKELNVA 132

Query: 133 GNKLN-GSIPSTLGKLQKLQGLGLENNKLEGSIPDSICH----SDELYKLELGGNKLSGS 187
            N +    +P     L  L+ L L +NK++      +            L+L  N ++  
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192

Query: 188 IPECFNNLASLRILLLGSNELTS--IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIA 245
            P  F  +  L  L L +N  +   +      L  +         F            + 
Sbjct: 193 QPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR-------NEGNLE 244

Query: 246 RIDSCDLISLISLNLSNNNLSG------AIPASLEKLSYLKDLNLSFNKL 289
           + D   L  L +L +    L+        I      L+ +   +L    +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  107 bits (268), Expect = 2e-24
 Identities = 39/202 (19%), Positives = 72/202 (35%), Gaps = 9/202 (4%)

Query: 97  NLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLE 156
           NL  S +  ++++  +         +   L ++ L   ++          L  L  L L 
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84

Query: 157 NNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL--T 214
            N ++     +      L KL      L+        +L +L+ L +  N + S  L   
Sbjct: 85  GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 215 FWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLE 274
           F NL ++ +L+ SSN        ++  L          +  +SL+LS N ++  I     
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP------LLNLSLDLSLNPMNF-IQPGAF 197

Query: 275 KLSYLKDLNLSFNKLEGEIPRG 296
           K   L  L L  N     + + 
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKT 219

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  104 bits (262), Expect = 9e-24
 Identities = 47/227 (20%), Positives = 84/227 (37%), Gaps = 36/227 (15%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDN--SFSGFIPNTFGNLRNLQALRLSNNYLTSSTLEL 64
           +N  G     + +   L  L+LS N  SF G    +     +L+ L LS N + + +   
Sbjct: 334 SNKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMS--- 389

Query: 65  SFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT 124
              S+    + L  + F ++ L  +   +                            +L 
Sbjct: 390 ---SNFLGLEQLEHLDFQHSNLKQMSEFSV-------------------------FLSLR 421

Query: 125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSI-PDSICHSDELYKLELGGNK 183
           NL  + +       +       L  L+ L +  N  + +  PD       L  L+L   +
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481

Query: 184 LSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN 229
           L    P  FN+L+SL++L + SN+L S+P   F  L  +  +   +N
Sbjct: 482 LEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  118 bits (297), Expect = 3e-29
 Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 26/293 (8%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L +  N+ S  + +  F     L  L L +N  S      F  LR LQ L +S N+L   
Sbjct: 59  LDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEI 117

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAY-CNVSGGIPEE 119
              L          SL  +   +N +  + PK     L  ++   EM      + G    
Sbjct: 118 PPNLP--------SSLVELRIHDNRIRKV-PKGVFSGLR-NMNCIEMGGNPLENSGFEPG 167

Query: 120 IGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPD-SICHSDELYKLE 178
             +   L  + +   KL   IP  L   + L  L L++NK++ +I    +    +LY+L 
Sbjct: 168 AFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLG 223

Query: 179 LGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLE 238
           LG N++        + L +LR L L +N+L+ +P    +LK +  +   +N  T     +
Sbjct: 224 LGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT-----K 278

Query: 239 IGNLKIARIDSCD-LISLISLNLSNNNLSGAI--PASLEKLSYLKDLNLSFNK 288
           +G      +           ++L NN +      PA+   ++    +     K
Sbjct: 279 VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  117 bits (296), Expect = 4e-29
 Identities = 69/297 (23%), Positives = 117/297 (39%), Gaps = 41/297 (13%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
            +P+ I      ++L+L +N  S    + F  L++L AL L NN ++   +     S L 
Sbjct: 47  AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK--IHEKAFSPLR 102

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI-GNLTNLTIIY 130
             + L +   S N L  I P     NL  SL    +    +   +P+ +   L N+  I 
Sbjct: 103 KLQKLYI---SKNHLVEIPP-----NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIE 153

Query: 131 LGGNKL-NGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIP 189
           +GGN L N           KL  L +   KL   IP  +  +  L +L L  NK+  +I 
Sbjct: 154 MGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPET--LNELHLDHNKIQ-AIE 209

Query: 190 E-CFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARI 247
                  + L  L LG N++  I   +   L  +  L+  +N  +  +P  + +LK    
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLK---- 264

Query: 248 DSCDLISLISLNLSNNNLSGAIPAS-------LEKLSYLKDLNLSFNKLE-GEIPRG 296
                  L  + L  NN++  +  +         K +Y   ++L  N +   E+   
Sbjct: 265 ------LLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPA 314

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 37/177 (20%), Positives = 61/177 (34%), Gaps = 25/177 (14%)

Query: 125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
           +L ++      L  ++P  +        L L+NN +     D       LY L L  NK+
Sbjct: 34  HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 185 SGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLK 243
           S    + F+ L  L+ L +  N L  IP     +L     L    N             +
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSSLV---ELRIHDN-------------R 134

Query: 244 IARIDS---CDLISLISLNLSNNNL-SGAIPASLEKLSYLKDLNLSFNKLEGEIPRG 296
           I ++       L ++  + +  N L +            L  L +S  KL   IP+ 
Sbjct: 135 IRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKD 190

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 32/153 (20%), Positives = 58/153 (37%), Gaps = 17/153 (11%)

Query: 150 LQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELT 209
           L+ +   +  L+ ++P  I  S +   L+L  N +S    + F  L  L  L+L +N+++
Sbjct: 35  LRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91

Query: 210 SI-PLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGA 268
            I    F  L+ +  L  S N              +  I      SL+ L + +N +   
Sbjct: 92  KIHEKAFSPLRKLQKLYISKN-------------HLVEIPPNLPSSLVELRIHDNRIRKV 138

Query: 269 IPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGN 301
                  L  +  + +  N LE      G+F  
Sbjct: 139 PKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  121 bits (305), Expect = 4e-29
 Identities = 43/305 (14%), Positives = 102/305 (33%), Gaps = 17/305 (5%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L +  N  +      +   + L +L L  +  +    + F +L +L+ L LS+N+L+S +
Sbjct: 31  LDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLS 90

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEE-I 120
                        SL  ++   NP   +   +   NL+ +L+   +        I     
Sbjct: 91  SSW-----FGPLSSLKYLNLMGNPYQTLGVTSLFPNLT-NLQTLRIGNVETFSEIRRIDF 144

Query: 121 GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG 180
             LT+L  + +    L      +L  ++ +  L L  ++    +         +  LEL 
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELR 204

Query: 181 GNKLSGSIPECFN--------NLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFT 232
              L+                   + R  +L       +      + ++  + F      
Sbjct: 205 DTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN 264

Query: 233 GPLPL-EIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEG 291
           G        +  ++ +   + +++  L++    L   +      L  +K + +  +K+  
Sbjct: 265 GLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF- 323

Query: 292 EIPRG 296
            +P  
Sbjct: 324 LVPCS 328

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  119 bits (301), Expect = 1e-28
 Identities = 62/325 (19%), Positives = 120/325 (36%), Gaps = 38/325 (11%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
            +      + + +   +  L L  +  +  +      L +++ L L +  L     + S 
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR--FQFSP 215

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPK--TSVGNLSHSLEYFEMAYCNVSG---------G 115
           L        +  ++F  + L          +      L   E   C ++G          
Sbjct: 216 LPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275

Query: 116 IPEEIGNL--TNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS-D 172
           +  E+G +    +  +++    L   + +    L+K++ + +EN+K+   +P S      
Sbjct: 276 VVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLK 334

Query: 173 ELYKLELGGNKLSGSI---PECFNNLASLRILLLGSNELTSIPL---TFWNLKDILYLNF 226
            L  L+L  N +         C     SL+ L+L  N L S+         LK++  L+ 
Sbjct: 335 SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDI 394

Query: 227 SSNF-------FTGPLPLEIGNL---KIARIDSCDLISLISLNLSNNNLSGAIPASLEKL 276
           S N           P  +   NL    I  + +C   +L  L++SNNNL  +    L +L
Sbjct: 395 SRNTFHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLD-SFSLFLPRL 453

Query: 277 SYLKDLNLSFNKLEGEIPRGGSFGN 301
              ++L +S NKL+  +P    F  
Sbjct: 454 ---QELYISRNKLK-TLPDASLFPV 474

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  115 bits (291), Expect = 2e-27
 Identities = 53/310 (17%), Positives = 108/310 (34%), Gaps = 20/310 (6%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L +  +  + TI    F +   L  L+LSDN  S    + FG L +L+ L L  N   + 
Sbjct: 55  LILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT- 112

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
              L   S   N  +L  +   N      + +     L+  L   E+   ++     + +
Sbjct: 113 ---LGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS-LNELEIKALSLRNYQSQSL 168

Query: 121 GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG 180
            ++ ++  + L  ++    +      L  ++ L L +  L       +   +    ++  
Sbjct: 169 KSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228

Query: 181 GNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIG 240
             + S    E FN L  L   +L  +E+     T   L D        +  +    +E  
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSES--DVVSELGKVETV 286

Query: 241 NLKIARIDS-----------CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKL 289
            ++   I               L  +  + + N+ +     +  + L  L+ L+LS N +
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346

Query: 290 EGEIPRGGSF 299
             E  +  + 
Sbjct: 347 VEEYLKNSAC 356

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  114 bits (286), Expect = 9e-27
 Identities = 56/323 (17%), Positives = 107/323 (33%), Gaps = 32/323 (9%)

Query: 7   NNFSGTIPRFIFNA-SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELS 65
            + S  +     +  S +  LEL D + + F  +          ++      +    + S
Sbjct: 181 LSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV-LTDES 239

Query: 66  F---LSSLSNCKSLTLISFSNNPLDGI--LPKTSVGNLSH-------SLEYFEMAYCNVS 113
           F   L  L     L+ + F +  L+G+     +    +S        ++    +    + 
Sbjct: 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299

Query: 114 GGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDE 173
             +      L  +  I +  +K+     S    L+ L+ L L  N +      +      
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359

Query: 174 LYKLE---LGGNKLS--GSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSS 228
              L+   L  N L       E    L +L  L +  N    +P +    + + +LN SS
Sbjct: 360 WPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSS 419

Query: 229 N----FFTGPLP----LEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLK 280
                  T        L++ N  +       L  L  L +S N L   +P +      L 
Sbjct: 420 TGIRVVKTCIPQTLEVLDVSNNNLDSFSL-FLPRLQELYISRNKLK-TLPDAS-LFPVLL 476

Query: 281 DLNLSFNKLEGEIPRGGSFGNFS 303
            + +S N+L+  +P  G F   +
Sbjct: 477 VMKISRNQLK-SVPD-GIFDRLT 497

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  101 bits (254), Expect = 8e-23
 Identities = 38/225 (16%), Positives = 85/225 (37%), Gaps = 13/225 (5%)

Query: 6   ENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELS 65
           +      +        K+  + + ++       +   +L++L+ L LS N +    L+ S
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354

Query: 66  FLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTN 125
             +      SL  +  S N L  +     +     +L   +++       +P+       
Sbjct: 355 --ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEK 411

Query: 126 LTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLS 185
           +  + L    +   + + +   Q L+ L + NN L+ S    +     L +L +  NKL 
Sbjct: 412 MRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLK 464

Query: 186 GSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN 229
            ++P+       L ++ +  N+L S+P   F  L  +  +   +N
Sbjct: 465 -TLPDAS-LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 91.7 bits (228), Expect = 1e-19
 Identities = 36/223 (16%), Positives = 79/223 (35%), Gaps = 18/223 (8%)

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL 131
           +C +  +    +     I P      L+ +++  ++++  ++     ++    NL ++ L
Sbjct: 3   SCDASGVCDGRSRSFTSI-PS----GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLIL 57

Query: 132 GGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSG-SIPE 190
             +++N         L  L+ L L +N L             L  L L GN      +  
Sbjct: 58  KSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117

Query: 191 CFNNLASLRILLLGS-NELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARID 248
            F NL +L+ L +G+    + I  + F  L  +  L   +          + +++     
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIR----- 172

Query: 249 SCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEG 291
                 +  L L  +  +  +    + LS ++ L L    L  
Sbjct: 173 -----DIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 26/129 (20%), Positives = 49/129 (37%), Gaps = 17/129 (13%)

Query: 21  SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS---------STLELSF--LSS 69
             L+ L++S N+F   +P++      ++ L LS+  +             L++S   L S
Sbjct: 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDS 445

Query: 70  LS-NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTI 128
            S     L  +  S N L  +       +L   L   +++   +          LT+L  
Sbjct: 446 FSLFLPRLQELYISRNKLKTL----PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQK 501

Query: 129 IYLGGNKLN 137
           I+L  N  +
Sbjct: 502 IWLHTNPWD 510

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (292), Expect = 4e-29
 Identities = 57/230 (24%), Positives = 99/230 (43%), Gaps = 33/230 (14%)

Query: 398 NLIGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKV 453
             +G+G FG+V+ AR       +A+KV     L+   V      E E+   +RH NI+++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
                +     L+LEY P G++ + L   +   +       + ++A+AL Y H   S +V
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---SKRV 130

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE------YGK 567
           IH D+KP N+LL       ++DFG +       ++        T+ Y+ PE      + +
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPPEMIEGRMHDE 186

Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDE---------IFNGEMTLKHWV 608
           +       D++S G++  E    K P +          I   E T   +V
Sbjct: 187 K------VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 230

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  119 bits (299), Expect = 4e-29
 Identities = 31/244 (12%), Positives = 72/244 (29%), Gaps = 49/244 (20%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYG---------------------------- 429
           ++G+    +  +A     G    + V                                  
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 430 RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM-PHGSLEKYLH------SS 482
           +V   F    +++K  + + +I+V     +    +    Y     +L+ +        S+
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 483 NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL 542
           +  L  + RL + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 543 TREDQSTIQTQTLATIGYMAPE-----YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEI 597
                 +   +  A     A             ++   D ++ G+ +   +    P    
Sbjct: 262 G-ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316

Query: 598 FNGE 601
              +
Sbjct: 317 NTDD 320

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  119 bits (301), Expect = 5e-29
 Identities = 72/340 (21%), Positives = 108/340 (31%), Gaps = 77/340 (22%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPN---------------TFGNLRN 46
           L    N+ +  +P    +   L +   +  + S   P                   N   
Sbjct: 96  LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSF 154

Query: 47  LQALRLSNNYLTS-------------STLELSFLSSLSNCKSLTLISFSNNPLDGILPKT 93
           L+ + + NN L                  +L  L  L N   LT I   NN L       
Sbjct: 155 LKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSL------K 208

Query: 94  SVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGL 153
            + +L  SLE        +      E+ NL  LT IY   N L  ++P     L+ L   
Sbjct: 209 KLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN-- 263

Query: 154 GLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL 213
            + +N L   +P+       L  L++  N  S  + E   NL  L      SNE+ S+  
Sbjct: 264 -VRDNYLT-DLPELPQS---LTFLDVSENIFS-GLSELPPNLYYLN---ASSNEIRSLCD 314

Query: 214 TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLIS-------LISLNLSNNNLS 266
              +L+    LN S+N     LP     L+        L         L  L++  N L 
Sbjct: 315 LPPSLE---ELNVSNNKLIE-LPALPPRLERLIASFNHLAEVPELPQNLKQLHVEYNPLR 370

Query: 267 GAIPASLEKLSY----------------LKDLNLSFNKLE 290
              P   E +                  LK L++  N L 
Sbjct: 371 -EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR 409

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  118 bits (298), Expect = 1e-28
 Identities = 61/310 (19%), Positives = 108/310 (34%), Gaps = 64/310 (20%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLR-------------NLQALRLSNNYLT 58
            +P    N    +    + + +    P   G  R                 L L+N  L+
Sbjct: 25  EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84

Query: 59  SSTLELSFLSSL--------------SNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEY 104
           S       L SL               + KSL + + +   L  + P      +S+    
Sbjct: 85  SLPELPPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN---- 140

Query: 105 FEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSI 164
                 N    +PE + N + L II +  N L   +P     L+ +      NN+LE  +
Sbjct: 141 ------NQLEKLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLE-EL 188

Query: 165 PDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYL 224
           P+ + +   L  +    N L   +P+      SL  ++ G+N L  +P    NL  +  +
Sbjct: 189 PE-LQNLPFLTAIYADNNSLK-KLPD---LPLSLESIVAGNNILEELP-ELQNLPFLTTI 242

Query: 225 NFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNL 284
              +N     LP    +L+             +LN+ +N L+  +P   + L++L     
Sbjct: 243 YADNNLLKT-LPDLPPSLE-------------ALNVRDNYLT-DLPELPQSLTFLDVSEN 287

Query: 285 SFNKLEGEIP 294
            F+ L    P
Sbjct: 288 IFSGLSELPP 297

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  113 bits (286), Expect = 5e-27
 Identities = 63/322 (19%), Positives = 112/322 (34%), Gaps = 59/322 (18%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS- 59
           ++ +  N+    +P    +   L  +   +N     +P    NL  L A+   NN L   
Sbjct: 157 IIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE-ELPE-LQNLPFLTAIYADNNSLKKL 210

Query: 60  ------------STLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEM 107
                           L  L  L N   LT I   NN L       ++ +L  SLE   +
Sbjct: 211 PDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLL------KTLPDLPPSLEALNV 264

Query: 108 AYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPS--TL-----------GKLQKLQGLG 154
               ++  +PE   +LT L +     + L+   P+   L                L+ L 
Sbjct: 265 RDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELN 323

Query: 155 LENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLT 214
           + NNKL   +P        L +L    N L+  +PE      +L+ L +  N L   P  
Sbjct: 324 VSNNKLI-ELPALPP---RLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLREFPDI 375

Query: 215 FWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLI-------SLISLNLSNNNLSG 267
             +++D+   +  +      +P    NLK   +++  L        S+  L +++  +  
Sbjct: 376 PESVEDLRMNSHLAE-----VPELPQNLKQLHVETNPLREFPDIPESVEDLRMNSERVVD 430

Query: 268 AIPASLEKLSYLKDLNLSFNKL 289
               + E    L+D     +  
Sbjct: 431 PYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  104 bits (261), Expect = 8e-24
 Identities = 51/269 (18%), Positives = 90/269 (33%), Gaps = 34/269 (12%)

Query: 36  FIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSL-----SNCKSLTLISFSNNPLDGIL 90
           FI     +   LQ     ++ LT   +E   + S      +  +        N     + 
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 91  PKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKL 150
                  L       E+    +S  +PE   +L +L       N L   +P     L+ L
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSL 116

Query: 151 QGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTS 210
                    L    P        L  L +  N+L   +PE   N + L+I+ + +N L  
Sbjct: 117 LVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK 167

Query: 211 IPLTFWNLKDILYLNFSSNFFT-----GPLP----LEIGNLKIARIDSCDLISLISLNLS 261
           +P    +L+   ++   +N          LP    +   N  + ++     +SL S+   
Sbjct: 168 LPDLPPSLE---FIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDL-PLSLESIVAG 223

Query: 262 NNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
           NN L       L+ L +L  +    N L+
Sbjct: 224 NNILE--ELPELQNLPFLTTIYADNNLLK 250

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 76.6 bits (189), Expect = 6e-15
 Identities = 42/228 (18%), Positives = 75/228 (32%), Gaps = 43/228 (18%)

Query: 6   ENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELS 65
           +NN   T+P        L  L + DN  +  +P    +L  L       + L+     L 
Sbjct: 245 DNNLLKTLPDLP---PSLEALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLY 300

Query: 66  FLSSLSN--------CKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIP 117
           +L++ SN          SL  ++ SNN L        +  L   LE    ++ +++  +P
Sbjct: 301 YLNASSNEIRSLCDLPPSLEELNVSNNKL------IELPALPPRLERLIASFNHLAE-VP 353

Query: 118 EEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQ----------------KLQGLGLENNKLE 161
           E   NL  L   ++  N L    P     ++                 L+ L +E N L 
Sbjct: 354 ELPQNLKQL---HVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR 409

Query: 162 GSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELT 209
              PD     + +  L +   ++             L   +   +   
Sbjct: 410 -EFPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 65.4 bits (160), Expect = 3e-11
 Identities = 25/105 (23%), Positives = 44/105 (41%), Gaps = 8/105 (7%)

Query: 193 NNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK---IARIDS 249
            +   L+  L  S+ LT +P+   N+K       + + +    P   G  +   ++R+  
Sbjct: 8   VSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67

Query: 250 CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
           C       L L+N  LS ++P       +L+ L  S N L  E+P
Sbjct: 68  CLDRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELP 107

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  117 bits (295), Expect = 7e-29
 Identities = 42/242 (17%), Positives = 83/242 (34%), Gaps = 36/242 (14%)

Query: 391 TDGFSENNLIGRGSFGSVFKARLGD------GMEVAMKVFNLQYGRVFKSFDVECEMMKS 444
           +     ++L+G G+F  V++A  GD        +  +KV        F       E +K 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSL----EKYLHSSNYILDIYQRLNIMIDVAS 500
                 +K  S+   +    LV E   +G+L      Y ++   ++     ++  + +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH-----------LSDFGIAKLLTREDQST 549
            +E +H     ++IH D+KP N +L +  +             L D G +  +    + T
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 550 IQTQTLATIGYMAPE------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT 603
           I T    T G+   E      +  +       D +     +           +   GE  
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQ------IDYFGVAATVYCMLFGTYMKVKNEGGECK 294

Query: 604 LK 605
            +
Sbjct: 295 PE 296

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (294), Expect = 9e-29
 Identities = 32/331 (9%), Positives = 73/331 (22%), Gaps = 63/331 (19%)

Query: 373 MPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFN---LQY 428
            P  A   + S   L +          +  G    VF  R +    + A+KVF       
Sbjct: 45  WPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS 102

Query: 429 GRVFKSFDVECEMMKSIRHRNII---------------------KVISSCSNEEFKA--- 464
               +           +   +                               ++  A   
Sbjct: 103 RSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVAN 162

Query: 465 --LVLEYMPHGSLEKYLHSSNYI------LDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
             L++       LE    + +++        I     +   +      L    S  ++H 
Sbjct: 163 YLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHG 218

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY--GKEGRVSAN 574
              P N+ +  +    L D      +               + Y   E+        +  
Sbjct: 219 HFTPDNLFIMPDGRLMLGDVSALWKVG-TRGPASSV----PVTYAPREFLNASTATFTHA 273

Query: 575 GDVYSFGIMLMETFTRKKP-TDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV 633
            + +  G+ +   +    P        + + K          +        L       +
Sbjct: 274 LNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLI 333

Query: 634 AKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
            +                    +R+   E +
Sbjct: 334 GR-------------FLNFDRRRRLLPLEAM 351

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  115 bits (291), Expect = 2e-28
 Identities = 57/302 (18%), Positives = 106/302 (35%), Gaps = 58/302 (19%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFN-----------------LQYGRVFKSFDVECEMM 442
           + +G F  +      D    A+K +                  +     +  F  E +++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL-------NIM 495
             I++   +      +N +   ++ EYM + S+ K+      +   Y           I+
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL 555
             V ++  Y+H      + H D+KPSN+L+D N    LSDFG ++ +  +        + 
Sbjct: 158 KSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG----SR 211

Query: 556 ATIGYMAPE--YGKEGRVSANGDVYSFGIMLMETFTRKKPTDE----------IFNGEMT 603
            T  +M PE    +     A  D++S GI L   F    P             I    + 
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271

Query: 604 L--KHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAK 661
                    +   + K     N LS EDI+F+                  ++P +RI ++
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL-------------FLRKNPAERITSE 318

Query: 662 EI 663
           + 
Sbjct: 319 DA 320

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  113 bits (286), Expect = 3e-28
 Identities = 56/305 (18%), Positives = 106/305 (34%), Gaps = 65/305 (21%)

Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY-GRVFKSFDV-ECEMMKSI 445
           R T  F E   IG G FGSVFK     DG   A+K       G V +   + E      +
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67

Query: 446 -RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYL---HSSNYILDIYQRLNIMIDVASA 501
            +H ++++  S+ + ++   +  EY   GSL   +   +         +  ++++ V   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDN-------------------MVAHLSDFGIAKLL 542
           L Y+H   S  ++H D+KPSN+ +                      ++  + D G    +
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 543 TREDQSTIQTQTLA-TIGYMAPE--YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFN 599
           +         Q       ++A E        +    D+++  + ++     +       N
Sbjct: 185 SS-------PQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLP---RN 233

Query: 600 GEMTLKHWVNDWLPISTKEIVD-PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI 658
           G+         W  I    +   P +LS+E    +                    PE+R 
Sbjct: 234 GDQ--------WHEIRQGRLPRIPQVLSQEFTELLKV-------------MIHPDPERRP 272

Query: 659 NAKEI 663
           +A  +
Sbjct: 273 SAMAL 277

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  114 bits (287), Expect = 3e-28
 Identities = 58/287 (20%), Positives = 91/287 (31%), Gaps = 56/287 (19%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
           ++P  I   S  + LEL  N         F  L  L  L LS+N L+            +
Sbjct: 21  SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL 131
           + K L L   S N +                             +      L  L  +  
Sbjct: 79  SLKYLDL---SFNGV---------------------------ITMSSNFLGLEQLEHLDF 108

Query: 132 GGNKLNGSIP--STLGKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLELGGNKLSGSI 188
             + L   +   S    L+ L  L + +        + I +    L  L++ GN    + 
Sbjct: 109 QHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENF 166

Query: 189 PE-CFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIAR 246
               F  L +L  L L   +L  +    F +L  +  LN S N                 
Sbjct: 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN-------------NFFS 213

Query: 247 IDSC---DLISLISLNLSNNNLSGAIPASLEKL-SYLKDLNLSFNKL 289
           +D+     L SL  L+ S N++  +    L+   S L  LNL+ N  
Sbjct: 214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 39/232 (16%), Positives = 70/232 (30%), Gaps = 60/232 (25%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIP-NTFGNLRNLQALRLSNNYLTSS 60
           L +  N    T+        +L  L+   ++       + F +LRNL  L +S+ +    
Sbjct: 83  LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV- 140

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
                  + LS+ + L +    N+  +  LP                             
Sbjct: 141 -AFNGIFNGLSSLEVLKM--AGNSFQENFLPDI--------------------------F 171

Query: 121 GNLTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL 179
             L NLT + L   +L   +       L  LQ L + +N    S+               
Sbjct: 172 TELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFP----------- 218

Query: 180 GGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDIL-YLNFSSN 229
                       +  L SL++L    N + +       +    L +LN + N
Sbjct: 219 ------------YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 19/77 (24%), Positives = 32/77 (41%), Gaps = 5/77 (6%)

Query: 12  TIPRFIFNA-SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSL 70
            +    FN+ S L +L +S N+F       +  L +LQ L  S N++   T +   L   
Sbjct: 189 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM--TSKKQELQHF 246

Query: 71  SNCKSLTLISFSNNPLD 87
               SL  ++ + N   
Sbjct: 247 P--SSLAFLNLTQNDFA 261

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  114 bits (288), Expect = 4e-28
 Identities = 65/300 (21%), Positives = 113/300 (37%), Gaps = 50/300 (16%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISS 456
           ++  G F  V++A+ +G G E A+K          ++   E   MK +  H NI++  S+
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 457 CS-------NEEFKALVLEYMPHGSLEKYL--HSSNYILDIYQRLNIMIDVASALEYLHF 507
            S         + + L+L  +  G L ++L    S   L     L I      A++++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA----------T 557
                +IH DLK  N+LL +     L DFG A  ++     +   Q  A          T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 558 IGYMAPE----YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
             Y  PE    Y     +    D+++ G +L     R+ P    F     L+        
Sbjct: 214 PMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHP----FEDGAKLR-------- 260

Query: 614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
           I   +   P   ++            S +          +PE+R++  E+V +L +I  +
Sbjct: 261 IVNGKYSIPPHDTQYT-------VFHSLI----RAMLQVNPEERLSIAEVVHQLQEIAAA 309

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  112 bits (283), Expect = 7e-28
 Identities = 55/239 (23%), Positives = 103/239 (43%), Gaps = 53/239 (22%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
            +G+G FG+V+ AR   +   +A+KV     L+   V      E E+   +RH NI+++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYL---------HSSNYILDIYQRLNIMIDVASALEYL 505
           +   + +   L+LE+ P G L K L          S+ ++    +       +A AL Y 
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM---EE-------LADALHYC 130

Query: 506 HFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPE 564
           H     +VIH D+KP N+L+       ++DFG +         +++ +T+  T+ Y+ PE
Sbjct: 131 H---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH-----APSLRRRTMCGTLDYLPPE 182

Query: 565 ------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDE---------IFNGEMTLKHWV 608
                 + ++       D++  G++  E      P D          I N ++    ++
Sbjct: 183 MIEGKTHDEK------VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFL 235

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  114 bits (287), Expect = 1e-27
 Identities = 45/227 (19%), Positives = 87/227 (38%), Gaps = 19/227 (8%)

Query: 373 MPPEAMQRMFSYLELCRATDGFSENNLIGRG--SFGSVFKAR-LGDGMEVAMKVFNL--Q 427
           M     Q M S+L        +    +IG+G     +V  AR    G  V ++  NL   
Sbjct: 9   MENLYFQGMSSFLP---EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC 65

Query: 428 YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-NYIL 486
              +      E  + K   H NI+   ++   +    +V  +M +GS +  + +     +
Sbjct: 66  SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM 125

Query: 487 DIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
           +      I+  V  AL+Y+H       +H  +K S++L+  +   +LS       +    
Sbjct: 126 NELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182

Query: 547 --QSTIQTQTLATIG---YMAPEYGKEGRVSANG--DVYSFGIMLME 586
             Q  +      ++    +++PE  ++     +   D+YS GI   E
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  112 bits (282), Expect = 1e-27
 Identities = 48/241 (19%), Positives = 91/241 (37%), Gaps = 51/241 (21%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
            +G+G F   F+          A K+     L      +   +E  + +S+ H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
               + +F  +VLE     SL +       + +   R   +  +    +YLH     +VI
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 137

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI-G---YMAPE------ 564
           H DLK  N+ L++++   + DFG+A  +  + +          + G   Y+APE      
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER------KKVLCGTPNYIAPEVLSKKG 191

Query: 565 YGKEGRVSANGDVYSFGIML---------------METFTRKKPTDEIFNGEMTLKHWVN 609
           +  E       DV+S G ++                ET+ R      I   E ++   +N
Sbjct: 192 HSFE------VDVWSIGCIMYTLLVGKPPFETSCLKETYLR------IKKNEYSIPKHIN 239

Query: 610 D 610
            
Sbjct: 240 P 240

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  113 bits (284), Expect = 2e-27
 Identities = 48/241 (19%), Positives = 91/241 (37%), Gaps = 51/241 (21%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVI 454
            +G+G F   F+          A K+     L      +   +E  + +S+ H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
               + +F  +VLE     SL +       + +   R   +  +    +YLH     +VI
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RNRVI 163

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI-G---YMAPE------ 564
           H DLK  N+ L++++   + DFG+A  +  +       +    + G   Y+APE      
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG------ERKKVLCGTPNYIAPEVLSKKG 217

Query: 565 YGKEGRVSANGDVYSFGIML---------------METFTRKKPTDEIFNGEMTLKHWVN 609
           +  E       DV+S G ++                ET+ R      I   E ++   +N
Sbjct: 218 HSFE------VDVWSIGCIMYTLLVGKPPFETSCLKETYLR------IKKNEYSIPKHIN 265

Query: 610 D 610
            
Sbjct: 266 P 266

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  112 bits (282), Expect = 3e-27
 Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 9/204 (4%)

Query: 392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRN 449
           D F + + +G G+ G VFK      G+ +A K+ +L+    +      E +++       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           I+    +  ++   ++ +E+M  GSL++ L  +  I +      + I V   L YL    
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSIAVIKGLTYLR--E 149

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
             +++H D+KPSN+L++      L DFG++  L     ++     + T  YM+PE  +  
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF----VGTRSYMSPERLQGT 205

Query: 570 RVSANGDVYSFGIMLMETFTRKKP 593
             S   D++S G+ L+E    + P
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYP 229

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  110 bits (276), Expect = 7e-27
 Identities = 66/284 (23%), Positives = 115/284 (40%), Gaps = 46/284 (16%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR-VFKSFDVECEM-MKSIRHRNIIKVISS 456
           +GRG++G V K R +  G  +A+K           K   ++ ++ M+++     +    +
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN------IMIDVASALEYLHFGYS 510
              E    + +E M   SL+K+      ++D  Q +       I + +  ALE+LH    
Sbjct: 75  LFREGDVWICMELMD-TSLDKFYK---QVIDKGQTIPEDILGKIAVSIVKALEHLHSKL- 129

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPE----Y 565
             VIH D+KPSNVL++      + DFGI+  L       +     A    YMAPE     
Sbjct: 130 -SVIHRDVKPSNVLINALGQVKMCDFGISGYLV----DDVAKDIDAGCKPYMAPERINPE 184

Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL 625
             +   S   D++S GI ++E    + P D        LK  V +  P         +  
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL-----PADKF 239

Query: 626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK 669
           S E ++F ++             C  ++ ++R    E    L++
Sbjct: 240 SAEFVDFTSQ-------------CLKKNSKERPTYPE----LMQ 266

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  110 bits (276), Expect = 8e-27
 Identities = 68/299 (22%), Positives = 116/299 (38%), Gaps = 47/299 (15%)

Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRN 449
           D +    +IG G+   V  A       +VA+K  NL+  +        E + M    H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSL-------EKYLHSSNYILDIYQRLNIMIDVASAL 502
           I+   +S   ++   LV++ +  GS+              + +LD      I+ +V   L
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG--- 559
           EYLH       IH D+K  N+LL ++    ++DFG++  L      T        +G   
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 560 YMAPEYGKEGRV-SANGDVYSFGIMLMET------FTRKKPTDEIFNGEMTLKHWVND-- 610
           +MAPE  ++ R      D++SFGI  +E       + +  P   +    +TL+   ND  
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---LTLQ---NDPP 245

Query: 611 WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK 669
            L    ++        +     ++              C  + PE+R  A E    LL+
Sbjct: 246 SLETGVQDKEMLKKYGKSFRKMISL-------------CLQKDPEKRPTAAE----LLR 287

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  110 bits (276), Expect = 8e-27
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 15/205 (7%)

Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRNII 451
           F++   IG+GSFG VFK         VA+K+ +L+      +    E  ++       + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
           K   S   +    +++EY+  GS    L      LD  Q   I+ ++   L+YLH   S 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SE 138

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPEYGKE 568
           + IH D+K +NVLL ++    L+DFG+A  LT    + I+  T   +G   +MAPE  K+
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLT---DTQIKRNTF--VGTPFWMAPEVIKQ 193

Query: 569 GRVSANGDVYSFGIMLMETFTRKKP 593
               +  D++S GI  +E    + P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  110 bits (277), Expect = 1e-26
 Identities = 73/330 (22%), Positives = 122/330 (36%), Gaps = 76/330 (23%)

Query: 372 NMPPEAMQRMFSYLELCRATD---GFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQ 427
           +M  ++  R    ++L    D    F    L+G G++G V+K R +  G   A+KV ++ 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 428 YGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKA------LVLEYMPHGSLEKYLH 480
            G   +    E  M+K    HRNI     +   +          LV+E+   GS+     
Sbjct: 61  -GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----- 114

Query: 481 SSNYILDIYQRLN-----------IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM 529
                 D+ +              I  ++   L +LH     +VIH D+K  NVLL +N 
Sbjct: 115 -----TDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENA 166

Query: 530 VAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPEYGKEGRVSANG-----DVYSFG 581
              L DFG++  L R      +  T   IG   +MAPE                D++S G
Sbjct: 167 EVKLVDFGVSAQLDRTVG---RRNTF--IGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221

Query: 582 IMLMETFTRKKPTDEIFNGEMTLKH--WVNDWLPISTKEIVDPNLLSREDINFVAKEQCV 639
           I  +E      P  ++        H       +P +    +     S++  +F+      
Sbjct: 222 ITAIEMAEGAPPLCDM--------HPMRALFLIPRNPAPRLKSKKWSKKFQSFIES---- 269

Query: 640 SFVFNVAMECTVESPEQRINAKEIVTKLLK 669
                    C V++  QR   ++    L+K
Sbjct: 270 ---------CLVKNHSQRPATEQ----LMK 286

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  110 bits (278), Expect = 1e-26
 Identities = 56/289 (19%), Positives = 108/289 (37%), Gaps = 42/289 (14%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
           +IP  +     +  L+LS+N  +    +      NLQAL L++N + +  +E    SSL 
Sbjct: 45  SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT--IEEDSFSSLG 100

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL 131
           + + L L   S N L  +               F+                L++LT + L
Sbjct: 101 SLEHLDL---SYNYLSNLSSSW-----------FK---------------PLSSLTFLNL 131

Query: 132 GGNKLNGSIP--STLGKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLELGGNKLSGSI 188
            GN    ++   S    L KLQ L + N      I          L +LE+  + L    
Sbjct: 132 LGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE 190

Query: 189 PECFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARI 247
           P+   ++ ++  L+L   +   +  +       +  L             E+   +   +
Sbjct: 191 PKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSL 250

Query: 248 DSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG 296
                 +  ++ +++ +L   +   L ++S L +L  S N+L+  +P G
Sbjct: 251 I--KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDG 295

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 24/141 (17%), Positives = 52/141 (36%), Gaps = 10/141 (7%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L++  ++   +       +   +S L L        +        +++ L L +  L + 
Sbjct: 179 LEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF 237

Query: 61  TL-ELSFLS--SLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIP 117
              ELS     SL    +   +  ++  L  ++   +   +S  L   E +   +   +P
Sbjct: 238 HFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLN--QIS-GLLELEFSRNQLKS-VP 293

Query: 118 EEI-GNLTNLTIIYLGGNKLN 137
           + I   LT+L  I+L  N  +
Sbjct: 294 DGIFDRLTSLQKIWLHTNPWD 314

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  111 bits (278), Expect = 1e-26
 Identities = 42/342 (12%), Positives = 97/342 (28%), Gaps = 89/342 (26%)

Query: 373 MPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYG-- 429
                  R+ S  EL           ++G+    +  +A     G    + V        
Sbjct: 56  WNTGQPFRVES--ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP 113

Query: 430 --------------------------RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK 463
                                     +V   F    +++K  + + +I+V     +    
Sbjct: 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVL 173

Query: 464 ALVLEYM-PHGSLEKYLH------SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
           +    Y     +L+ +        S++  L  + RL + + V   L  LH      ++H 
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHT 230

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY----------- 565
            L+P +++LD      L+ F                 +  + G+  PE            
Sbjct: 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGAR------VVSSVSRGFEPPELEARRATISYHR 284

Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKP---TDEIFNGEMTLKHWVNDWLPISTKEIVDP 622
            +   ++ + D ++ G+++   +    P      +   E   +   N  +P   + +++ 
Sbjct: 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKN--IPQPVRALLE- 341

Query: 623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
             L                             E R+   + +
Sbjct: 342 GFLRYP-------------------------KEDRLLPLQAM 358

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  109 bits (275), Expect = 2e-26
 Identities = 73/283 (25%), Positives = 109/283 (38%), Gaps = 40/283 (14%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR-VFKSFDVECE-MMKSIRHRNIIKVISS 456
           IGRG++GSV K      G  +A+K           K   ++ + +M+S     I++   +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN------IMIDVASALEYLHFGYS 510
              E    + +E M   S +K+      +LD    +       I +    AL +L     
Sbjct: 90  LFREGDCWICMELMS-TSFDKFYKYVYSVLD--DVIPEEILGKITLATVKALNHLKENL- 145

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE----YG 566
            ++IH D+KPSN+LLD +    L DFGI+  L     S  +T+      YMAPE      
Sbjct: 146 -KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSA 201

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 626
                    DV+S GI L E  T + P  +  +    L   V    P  +    +    S
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS--EEREFS 259

Query: 627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK 669
              INFV               C  +   +R   KE    LLK
Sbjct: 260 PSFINFVNL-------------CLTKDESKRPKYKE----LLK 285

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  111 bits (279), Expect = 3e-26
 Identities = 68/283 (24%), Positives = 108/283 (38%), Gaps = 57/283 (20%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
            +P+ I   S    L L +N+      +TF +L +L+ L+L  N +    +E+   + L+
Sbjct: 68  EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI--RQIEVGAFNGLA 123

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL 131
           +  +L L    +N L  I               FE                L+ L  ++L
Sbjct: 124 SLNTLEL---FDNWLTVIPSGA-----------FE---------------YLSKLRELWL 154

Query: 132 GGNKLNGSIPS-TLGKLQKLQGLGL-ENNKLEGSIPDSI-CHSDELYKLELGGNKLSGSI 188
             N +  SIPS    ++  L  L L E  KLE  I +        L  L LG   +   +
Sbjct: 155 RNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DM 211

Query: 189 PECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARI 247
           P     L  L  L +  N    I   +F  L  +  L   ++             +++ I
Sbjct: 212 PN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS-------------QVSLI 257

Query: 248 DSC---DLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFN 287
           +      L SL+ LNL++NNLS         L YL +L+L  N
Sbjct: 258 ERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  108 bits (272), Expect = 3e-25
 Identities = 60/226 (26%), Positives = 90/226 (39%), Gaps = 12/226 (5%)

Query: 7   NNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELS 65
            N    I    F +   L +L+L  NS        F  L +L  L L +N+LT   +   
Sbjct: 84  ENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTV--IPSG 141

Query: 66  FLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI-GNLT 124
               LS  + L L    NNP+   +P  +   +  SL   ++        I E     L 
Sbjct: 142 AFEYLSKLRELWL---RNNPI-ESIPSYAFNRVP-SLMRLDLGELKKLEYISEGAFEGLF 196

Query: 125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
           NL  + LG   +   +P  L  L  L+ L +  N      P S      L KL +  +++
Sbjct: 197 NLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV 254

Query: 185 SGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN 229
           S      F+ LASL  L L  N L+S+P   F  L+ ++ L+   N
Sbjct: 255 SLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 80.9 bits (200), Expect = 3e-16
 Identities = 53/193 (27%), Positives = 76/193 (39%), Gaps = 23/193 (11%)

Query: 125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
             + +      L+  +P  +      + L L  N ++    D+  H   L  L+LG N +
Sbjct: 55  QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 185 SGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFT-------GPLP 236
                  FN LASL  L L  N LT IP   F  L  +  L   +N            +P
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVP 171

Query: 237 ----LEIGNL-KIARIDS---CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNK 288
               L++G L K+  I       L +L  LNL   N+   +P  L  L  L++L +S N 
Sbjct: 172 SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNH 229

Query: 289 LEGEIPRGGSFGN 301
              EI   GSF  
Sbjct: 230 FP-EIRP-GSFHG 240

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  110 bits (276), Expect = 6e-26
 Identities = 68/283 (24%), Positives = 111/283 (39%), Gaps = 57/283 (20%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
            +P  I   +   +L L +N       N+F +LR+L+ L+LS N++   T+E+   + L+
Sbjct: 57  EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI--RTIEIGAFNGLA 112

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL 131
           N  +L L    +N L  I               F                 L+ L  ++L
Sbjct: 113 NLNTLEL---FDNRLTTIPNGA-----------FV---------------YLSKLKELWL 143

Query: 132 GGNKLNGSIPS-TLGKLQKLQGLGL-ENNKLEGSIPDSICHS-DELYKLELGGNKLSGSI 188
             N +  SIPS    ++  L+ L L E  +L   I +        L  L L    L   I
Sbjct: 144 RNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EI 200

Query: 189 PECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARI 247
           P     L  L  L L  N L++I   +F  L  +  L    +             +I  I
Sbjct: 201 PN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS-------------QIQVI 246

Query: 248 DSC---DLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFN 287
           +     +L SL+ +NL++NNL+         L +L+ ++L  N
Sbjct: 247 ERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  109 bits (273), Expect = 2e-25
 Identities = 65/226 (28%), Positives = 88/226 (38%), Gaps = 12/226 (5%)

Query: 7   NNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELS 65
            N    I    F +   L IL+LS N         F  L NL  L L +N LT+  +   
Sbjct: 73  ENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTT--IPNG 130

Query: 66  FLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI-GNLT 124
               LS  K L L    NNP++ I P  +   +  SL   ++        I E     L+
Sbjct: 131 AFVYLSKLKELWL---RNNPIESI-PSYAFNRIP-SLRRLDLGELKRLSYISEGAFEGLS 185

Query: 125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
           NL  + L    L   IP  L  L KL  L L  N L    P S      L KL +  +++
Sbjct: 186 NLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI 243

Query: 185 SGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN 229
                  F+NL SL  + L  N LT +P   F  L  +  ++   N
Sbjct: 244 QVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 87.9 bits (218), Expect = 1e-18
 Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 21/197 (10%)

Query: 116 IPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELY 175
           +P+ I   TN  ++ L  N++     ++   L+ L+ L L  N +      +      L 
Sbjct: 58  VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLN 115

Query: 176 KLELGGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLN-------- 225
            LEL  N+L+ +IP   F  L+ L+ L L +N + SIP   F  +  +  L+        
Sbjct: 116 TLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS 174

Query: 226 -FSSNFFTGPLP----LEIGNLKIARIDS-CDLISLISLNLSNNNLSGAIPASLEKLSYL 279
             S   F G L     L +    +  I +   LI L  L+LS N+LS   P S + L +L
Sbjct: 175 YISEGAFEG-LSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHL 233

Query: 280 KDLNLSFNKLEGEIPRG 296
           + L +  ++++  I R 
Sbjct: 234 QKLWMIQSQIQ-VIERN 249

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 80.9 bits (200), Expect = 3e-16
 Identities = 51/188 (27%), Positives = 76/188 (40%), Gaps = 22/188 (11%)

Query: 125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL 184
             + +      L   +P  +      + L L  N+++    +S  H   L  L+L  N +
Sbjct: 44  QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 185 SGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFT-------GPLP 236
                  FN LA+L  L L  N LT+IP   F  L  +  L   +N            +P
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIP 160

Query: 237 ----LEIGNL-KIARIDS---CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNK 288
               L++G L +++ I       L +L  LNL+  NL   IP  L  L  L +L+LS N 
Sbjct: 161 SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNH 218

Query: 289 LEGEIPRG 296
           L   I  G
Sbjct: 219 LS-AIRPG 225

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 22/87 (25%), Positives = 34/87 (39%), Gaps = 7/87 (8%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L +  N+ S  I    F     L  L +  +       N F NL++L  + L++N LT  
Sbjct: 212 LDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-- 268

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLD 87
            L     + L     L  I   +NP +
Sbjct: 269 LLPHDLFTPLH---HLERIHLHHNPWN 292

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  108 bits (272), Expect = 6e-26
 Identities = 59/203 (29%), Positives = 88/203 (43%), Gaps = 23/203 (11%)

Query: 394 FSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNL---QYGRVFKSFDVECEMMKSIRHRN 449
           FS+   IG GSFG+V+ AR + +   VA+K  +    Q    ++    E   ++ +RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
            I+       E    LV+EY   GS    L      L   +   +       L YLH   
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 171

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG---YMAPE-- 564
           S  +IH D+K  N+LL +  +  L DFG A ++           +   +G   +MAPE  
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANSF--VGTPYWMAPEVI 222

Query: 565 -YGKEGRVSANGDVYSFGIMLME 586
               EG+     DV+S GI  +E
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIE 245

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  106 bits (266), Expect = 2e-25
 Identities = 60/278 (21%), Positives = 103/278 (37%), Gaps = 35/278 (12%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR-VFKSFDVECE-MMKSIRHRNIIKVISS 456
           +G G+ G V+K R    G  +A+K       +   K   ++ + ++KS     I++   +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
                   + +E M   + +        I +      + + +  AL YL   +   VIH 
Sbjct: 93  FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-KMTVAIVKALYYLKEKH--GVIHR 149

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG- 575
           D+KPSN+LLD+     L DFGI+  L        + ++     YMAPE       +    
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLVD---DKAKDRSAGCAAYMAPERIDPPDPTKPDY 206

Query: 576 ----DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN 631
               DV+S GI L+E  T + P          L   + +  P+           S +  +
Sbjct: 207 DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP----GHMGFSGDFQS 262

Query: 632 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK 669
           FV               C  +   +R    +    LL+
Sbjct: 263 FVKD-------------CLTKDHRKRPKYNK----LLE 283

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  108 bits (272), Expect = 2e-25
 Identities = 71/327 (21%), Positives = 120/327 (36%), Gaps = 53/327 (16%)

Query: 2   LQMWENNFSGTIPRFIFNA-SKLSILELSDNSF-SGFIP-NTFGNLRNLQALRLSNNYLT 58
           L++  N F   +    FN  + L +L L+  +     +  N F  L +L+ L L +N + 
Sbjct: 84  LKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142

Query: 59  SSTLELSFLSSLSNCKSLTLISFSNNPLDGI-------LPKTSVGNLS-HSLEYFEMAYC 110
                  F     N +   ++  + N +  I               L   S+   +M   
Sbjct: 143 KIQPASFF----LNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEY 198

Query: 111 NVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPS---TLGKLQKLQGLGLENNKLEG----- 162
            +           T++T + L GN    S+           K+Q L L N+   G     
Sbjct: 199 WLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGH 258

Query: 163 ----SIPDSICH---SDELYKLELGGNKLSGSIPEC-FNNLASLRILLLGSNELTSIPL- 213
                  +       +  +   +L  +K+  ++ +  F++   L  L L  NE+  I   
Sbjct: 259 TNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDN 317

Query: 214 TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSC---DLISLISLNLSNNNLSGAIP 270
            FW L  +L LN S N              +  IDS    +L  L  L+LS N++  A+ 
Sbjct: 318 AFWGLTHLLKLNLSQN-------------FLGSIDSRMFENLDKLEVLDLSYNHIR-ALG 363

Query: 271 A-SLEKLSYLKDLNLSFNKLEGEIPRG 296
             S   L  LK+L L  N+L+  +P G
Sbjct: 364 DQSFLGLPNLKELALDTNQLK-SVPDG 389

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  105 bits (265), Expect = 2e-24
 Identities = 52/294 (17%), Positives = 102/294 (34%), Gaps = 28/294 (9%)

Query: 23  LSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFS 82
           ++ ++LS NS +     +F  L++LQ L++            +F   LS+   L L    
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTF-RGLSSLIILKL---D 87

Query: 83  NNPLDGILPKTSVGNLSHSLEYFEMAYCNV-SGGIPEEI-GNLTNLTIIYLGGNKLNGSI 140
            N     L   +   L+ +LE   +  CN+    +       LT+L ++ L  N +    
Sbjct: 88  YNQFL-QLETGAFNGLA-NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ 145

Query: 141 PSTL-GKLQKLQGLGLENNKLEGSIPDSI---CHSDELYKLELGGNKL--------SGSI 188
           P++    +++   L L  NK++ SI +             L L    L            
Sbjct: 146 PASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEK 204

Query: 189 PECFNNLASLRILLLGSNELTSIPL-TFWNLKDI-----LYLNFSSNFFTGPLPLEIGNL 242
                   S+  L L  N         F++         L L+ S N  +        + 
Sbjct: 205 CGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDP 264

Query: 243 KIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG 296
                   +   + + +LS + +   + +     + L+ L L+ N++  +I   
Sbjct: 265 DNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDN 317

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 94.4 bits (235), Expect = 1e-20
 Identities = 59/309 (19%), Positives = 100/309 (32%), Gaps = 58/309 (18%)

Query: 1   MLQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNL--RNLQALRLSNNYL 57
           ML + +NN     P   F N  +  +L+L+ N           N   ++   LRLS+  L
Sbjct: 133 MLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL 192

Query: 58  TS---STLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSG 114
                  L      +     S+T +  S N     + K     ++ +     +   + + 
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252

Query: 115 GIPEEIGNL-------------TNLTIIYLGGNKLNGSIPSTL-GKLQKLQGLGLENNKL 160
           G      N              + +    L  +K+  ++  ++      L+ L L  N++
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI 311

Query: 161 EGSIPDSICHS-DELYKLELGGNKLSGSIPEC-FNNLASLRILLLGSNELTSIPLTFWNL 218
              I D+       L KL L  N L  SI    F NL  L +L L  N + ++       
Sbjct: 312 N-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALG------ 363

Query: 219 KDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSY 278
                       F G                  L +L  L L  N L        ++L+ 
Sbjct: 364 ---------DQSFLG------------------LPNLKELALDTNQLKSVPDGIFDRLTS 396

Query: 279 LKDLNLSFN 287
           L+ + L  N
Sbjct: 397 LQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 88.3 bits (219), Expect = 1e-18
 Identities = 49/274 (17%), Positives = 88/274 (32%), Gaps = 43/274 (15%)

Query: 46  NLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYF 105
           ++  + LS N +    L  +  S L +   L  +         ++               
Sbjct: 31  HVNYVDLSLNSIAE--LNETSFSRLQD---LQFLKVEQQTPGLVIR-------------- 71

Query: 106 EMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLENNKLEGSI 164
                            L++L I+ L  N+    + +     L  L+ L L    L+G++
Sbjct: 72  -----------NNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAV 119

Query: 165 --PDSICHSDELYKLELGGNKLSGSIPEC-FNNLASLRILLLGSNELTSIP-LTFWNL-- 218
              +       L  L L  N +    P   F N+    +L L  N++ SI      N   
Sbjct: 120 LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQG 179

Query: 219 KDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPA---SLEK 275
           K    L  SS          +G  K          S+ +L+LS N    ++         
Sbjct: 180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPF--KNTSITTLDLSGNGFKESMAKRFFDAIA 237

Query: 276 LSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEG 309
            + ++ L LS +   G      +F +    +F+G
Sbjct: 238 GTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKG 271

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 44/240 (18%), Positives = 79/240 (32%), Gaps = 33/240 (13%)

Query: 124 TNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLELGGN 182
            ++  + L  N +     ++  +LQ LQ L +E       I ++       L  L+L  N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 183 KLSGSIPE-CFNNLASLRILLLGSNELTSIPL---TFWNLKDILYLNFSSN--------- 229
           +    +    FN LA+L +L L    L    L    F  L  +  L    N         
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 230 FFTGPLPLEIGNLKIARIDS----------------CDLISLISLNLSNNNLSGAIPASL 273
           FF       + +L   ++ S                  L S+   +++   L      + 
Sbjct: 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208

Query: 274 EKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPCKTSIHHISR 333
            K + +  L+LS N  + E      F   +    + + +L  S N+      T+      
Sbjct: 209 FKNTSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQ-SLILSNSYNMGSSFGHTNFKDPDN 266

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 50.9 bits (122), Expect = 9e-07
 Identities = 27/82 (32%), Positives = 34/82 (41%), Gaps = 6/82 (7%)

Query: 7   NNFSGTIPRFIFNA-SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELS 65
            NF G+I   +F    KL +L+LS N        +F  L NL+ L L  N L S  +   
Sbjct: 332 QNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS--VPDG 389

Query: 66  FLSSLSNCKSLTLISFSNNPLD 87
               L    SL  I    NP D
Sbjct: 390 IFDRL---TSLQKIWLHTNPWD 408

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  104 bits (261), Expect = 6e-25
 Identities = 53/222 (23%), Positives = 90/222 (40%), Gaps = 15/222 (6%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
            +P  I   +    + L  N  S     +F   RNL  L L +N L    ++ +  + L+
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR--IDAAAFTGLA 80

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI-GNLTNLTIIY 130
             + L L   S+N     +   +   L   L    +  C +   +   +   L  L  +Y
Sbjct: 81  LLEQLDL---SDNAQLRSVDPATFHGLG-RLHTLHLDRCGLQE-LGPGLFRGLAALQYLY 135

Query: 131 LGGNKLNGSIPS-TLGKLQKLQGLGLENNKLEGSIPDSI-CHSDELYKLELGGNKLSGSI 188
           L  N L  ++P  T   L  L  L L  N++  S+P+        L +L L  N+++   
Sbjct: 136 LQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVH 193

Query: 189 PECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN 229
           P  F +L  L  L L +N L+++P      L+ + YL  + N
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 47/206 (22%), Positives = 76/206 (36%), Gaps = 21/206 (10%)

Query: 97  NLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLE 156
            +  + +   +    +S           NLTI++L  N L     +    L  L+ L L 
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 157 NNKLEGSIPDSI-CHSDELYKLELGGNKLSGSIPE-CFNNLASLRILLLGSNELTSIP-L 213
           +N    S+  +       L+ L L    L   +    F  LA+L+ L L  N L ++P  
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 214 TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDS---CDLISLISLNLSNNNLSGAIP 270
           TF +L ++ +L    N             +I+ +       L SL  L L  N ++   P
Sbjct: 148 TFRDLGNLTHLFLHGN-------------RISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194

Query: 271 ASLEKLSYLKDLNLSFNKLEGEIPRG 296
            +   L  L  L L  N L   +P  
Sbjct: 195 HAFRDLGRLMTLYLFANNLS-ALPTE 219

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 38/183 (20%), Positives = 60/183 (32%), Gaps = 39/183 (21%)

Query: 116 IPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELY 175
           +P  I        I+L GN+++    ++    + L  L L +N L      +      L 
Sbjct: 26  VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 176 KLELGGNKLSGSIP-ECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGP 234
           +L+L  N    S+    F+ L  L  L L    L  +                   F G 
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG---------------PGLFRG- 127

Query: 235 LPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPA-SLEKLSYLKDLNLSFNKLEGEI 293
                            L +L  L L +N L  A+P  +   L  L  L L  N++   +
Sbjct: 128 -----------------LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SV 168

Query: 294 PRG 296
           P  
Sbjct: 169 PER 171

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 53.5 bits (129), Expect = 8e-08
 Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 7/87 (8%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L +  N  S ++P   F     L  L L  N  +   P+ F +L  L  L L  N L++ 
Sbjct: 158 LFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA- 215

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLD 87
            L    L+ L   ++L  +  ++NP  
Sbjct: 216 -LPTEALAPL---RALQYLRLNDNPWV 238

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  105 bits (265), Expect = 8e-25
 Identities = 60/278 (21%), Positives = 99/278 (35%), Gaps = 68/278 (24%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMK-----VFNLQYGRVFKSFDV------ECEMMKSIRHR 448
           I  GS+G+V      +G+ VA+K     V + +   +     +      E  ++    H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89

Query: 449 NIIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILD-------IYQRLNIMI 496
           NI+    +             LV E M    L + +H    ++        +Y  L    
Sbjct: 90  NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILL--- 145

Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
                L  LH    A V+H DL P N+LL DN    + DF +A+  T +      T  + 
Sbjct: 146 ----GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK---THYVT 195

Query: 557 TIGYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
              Y APE       + K        D++S G ++ E F RK     +F G         
Sbjct: 196 HRWYRAPELVMQFKGFTK------LVDMWSAGCVMAEMFNRK----ALFRGSTFYNQL-- 243

Query: 610 DWLPISTKEIVDPNLL---SREDINFVAKEQCVSFVFN 644
                   +IV+  ++     ED+   +      ++ N
Sbjct: 244 -------NKIVE--VVGTPKIEDVVMFSSPSARDYLRN 272

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  104 bits (262), Expect = 1e-24
 Identities = 49/203 (24%), Positives = 84/203 (41%), Gaps = 29/203 (14%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKV-----FNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
           IG+G F  V +      G + A+K+     F    G   +    E  +   ++H +I+++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIY---QRLNIMIDVASALEYLHFGYS 510
           + + S++    +V E+M    L   +        +Y      + M  +  AL Y H    
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148

Query: 511 AQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE--- 564
             +IH D+KP  VLL   +++    L  FG+A  L       +    + T  +MAPE   
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVK 206

Query: 565 ---YGKEGRVSANGDVYSFGIML 584
              YGK        DV+  G++L
Sbjct: 207 REPYGKP------VDVWGCGVIL 223

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  103 bits (259), Expect = 2e-24
 Identities = 59/232 (25%), Positives = 97/232 (41%), Gaps = 58/232 (25%)

Query: 389 RATDGFSEN----NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV------ 437
            +T GF EN     ++GRG    V +        E A+K+ ++  G  F + +V      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 438 ---ECEMMKSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQR- 491
              E ++++ +  H NII++  +     F  LV + M  G L           D + ++ 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----------FDYLTEKV 119

Query: 492 -------LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR 544
                    IM  +   +  LH      ++H DLKP N+LLDD+M   L+DFG +  L  
Sbjct: 120 TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-D 175

Query: 545 EDQSTIQTQTLATIGYMAPE------------YGKEGRVSANGDVYSFGIML 584
             +     +   T  Y+APE            YGKE       D++S G+++
Sbjct: 176 PGEKL--REVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIM 219

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  103 bits (258), Expect = 3e-24
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 42/205 (20%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
           ++G G+F  VF  +    G   A+K           S + E  ++K I+H NI+ +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQR--------LNIMIDVASALEYLHFG 508
            +     LV++ +  G L           D I +R          ++  V SA++YLH  
Sbjct: 76  ESTTHYYLVMQLVSGGEL----------FDRILERGVYTEKDASLVIQQVLSAVKYLH-- 123

Query: 509 YSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE- 564
               ++H DLKP N+L    ++N    ++DFG++K+   E    + T    T GY+APE 
Sbjct: 124 -ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMST-ACGTPGYVAPEV 178

Query: 565 -----YGKEGRVSANGDVYSFGIML 584
                Y K        D +S G++ 
Sbjct: 179 LAQKPYSKA------VDCWSIGVIT 197

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  102 bits (257), Expect = 4e-24
 Identities = 57/235 (24%), Positives = 104/235 (44%), Gaps = 27/235 (11%)

Query: 366 GPPNDANMPPEAMQRMFSYLELCRAT-DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKV 423
           G   +      ++Q      +  +   + F    ++G GSF +V  AR      E A+K+
Sbjct: 3   GTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKI 62

Query: 424 FNLQYGRVFKSFDVEC-----EMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKY 478
              ++  + K   V       ++M  + H   +K+  +  ++E     L Y  +G L KY
Sbjct: 63  LEKRH--IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120

Query: 479 LHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI 538
           +       +   R     ++ SALEYLH      +IH DLKP N+LL+++M   ++DFG 
Sbjct: 121 IRKIGSFDETCTRFYTA-EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGT 176

Query: 539 AKLLTREDQSTIQTQTL-ATIGYMAPE------YGKEGRVSANGDVYSFGIMLME 586
           AK+L+ E +   +  +   T  Y++PE        K        D+++ G ++ +
Sbjct: 177 AKVLSPESKQA-RANSFVGTAQYVSPELLTEKSACKS------SDLWALGCIIYQ 224

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  102 bits (256), Expect = 5e-24
 Identities = 64/234 (27%), Positives = 98/234 (41%), Gaps = 58/234 (24%)

Query: 390 ATDGFSEN---------NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVEC 439
           +TD FS           +++G G+   V     L    E A+K+   Q G +      E 
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV 61

Query: 440 EMMKSIR-HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRLN---- 493
           EM+   + HRN++++I     E+   LV E M  GS+          L  I++R +    
Sbjct: 62  EMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI----------LSHIHKRRHFNEL 111

Query: 494 ----IMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTR-E 545
               ++ DVASAL++LH   +  + H DLKP N+L    +      + DF +   +    
Sbjct: 112 EASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168

Query: 546 DQSTIQTQTLATI----GYMAPE-----------YGKEGRVSANGDVYSFGIML 584
           D S I T  L T      YMAPE           Y K        D++S G++L
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR------CDLWSLGVIL 216

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (259), Expect = 1e-23
 Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 42/206 (20%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV--ECEMMKSIRHRNIIKVISS 456
           +G+G+F  V +   +  G E A  + N +         +  E  + + ++H NI+++  S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQR--------LNIMIDVASALEYLHF 507
            S E    L+ + +  G L           + I  R         + +  +  A+ + H 
Sbjct: 79  ISEEGHHYLIFDLVTGGEL----------FEDIVAREYYSEADASHCIQQILEAVLHCH- 127

Query: 508 GYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
                V+H +LKP N+LL          L+DFG+A  +  E Q+        T GY++PE
Sbjct: 128 --QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYLSPE 183

Query: 565 ------YGKEGRVSANGDVYSFGIML 584
                 YGK        D+++ G++L
Sbjct: 184 VLRKDPYGKP------VDLWACGVIL 203

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  100 bits (252), Expect = 2e-23
 Identities = 68/312 (21%), Positives = 122/312 (39%), Gaps = 68/312 (21%)

Query: 388 CRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECE------- 440
               + + +   +G G++G V+KA+   G  VA+K   L         D E E       
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL---------DAEDEGIPSTAI 67

Query: 441 ----MMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMI 496
               ++K + H NI+ +I    +E    LV E+M    L+K L  +   L   Q    + 
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLY 126

Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
            +   + + H     +++H DLKP N+L++ +    L+DFG+A+      +S   T  + 
Sbjct: 127 QLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVV 181

Query: 557 TIGYMAPE--YGKEGRVSANGDVYSFGIMLMETFTRK--------------------KPT 594
           T+ Y AP+   G + + S + D++S G +  E  T K                     P 
Sbjct: 182 TLWYRAPDVLMGSK-KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240

Query: 595 DEIFNGEMTLKHWVND----WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECT 650
              +     L  W       +       I+ P    +E I+ ++        F+      
Sbjct: 241 PREWPQVQELPLWKQRTFQVFEKKPWSSII-PGF-CQEGIDLLSN----MLCFD------ 288

Query: 651 VESPEQRINAKE 662
              P +RI+A++
Sbjct: 289 ---PNKRISARD 297

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  101 bits (253), Expect = 2e-23
 Identities = 68/309 (22%), Positives = 115/309 (37%), Gaps = 60/309 (19%)

Query: 388 CRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNL-QYGRVFKSFDV-ECEMMKS 444
            ++ + +    L+G GS+G V K R    G  VA+K F      ++ K   + E +++K 
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80

Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           +RH N++ ++  C  ++   LV E++ H ++   L      LD       +  + + + +
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
            H   S  +IH D+KP N+L+  + V  L DFG A+ L    +       +AT  Y APE
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRAPE 194

Query: 565 -------YGKEGRVSANGDVYSFGIMLMETFTRK--------------------KPTDEI 597
                  YGK   V    DV++ G ++ E F  +                          
Sbjct: 195 LLVGDVKYGKA--V----DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRH 248

Query: 598 FNGEMTLKHWVN----DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVES 653
                    +      +       E   P  LS   I+   K             C    
Sbjct: 249 QELFNKNPVFAGVRLPEIKEREPLERRYPK-LSEVVIDLAKK-------------CLHID 294

Query: 654 PEQRINAKE 662
           P++R    E
Sbjct: 295 PDKRPFCAE 303

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  103 bits (258), Expect = 2e-23
 Identities = 56/237 (23%), Positives = 100/237 (42%), Gaps = 37/237 (15%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV--ECEMMKSIRHRNIIKVISS 456
           +G G++G V   R     +E A+K+          +  +  E  ++K + H NI+K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 457 CSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             ++    LV+E    G L ++ +H   +  +      I+  V S + YLH      ++H
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKF--NEVDAAVIIKQVLSGVTYLH---KHNIVH 159

Query: 516 CDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-----YGK 567
            DLKP N+LL   + + +  + DFG++ +    +      + L T  Y+APE     Y +
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGTAYYIAPEVLRKKYDE 216

Query: 568 EGRVSANGDVYSFGIMLMETFTRKKP-----TDEIF----NGEMTLKHWVNDWLPIS 615
           +       DV+S G++L        P       EI      G+ T      +W  +S
Sbjct: 217 K------CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP--EWKNVS 265

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  101 bits (253), Expect = 2e-23
 Identities = 54/226 (23%), Positives = 90/226 (39%), Gaps = 54/226 (23%)

Query: 386 ELCRATDGFSEN----NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECE 440
           +L R +  F++       IG GS+    +       ME A+K+ +          D   E
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEE 65

Query: 441 ---MMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRLN--- 493
              +++  +H NII +     + ++  +V E M  G L          LD I ++     
Sbjct: 66  IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----------LDKILRQKFFSE 115

Query: 494 -----IMIDVASALEYLHFGYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTR 544
                ++  +   +EYLH   +  V+H DLKPSN+L      +     + DFG AK L  
Sbjct: 116 REASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172

Query: 545 EDQSTIQTQTLATIGYMAPE------YGKEGRVSANGDVYSFGIML 584
           E+          T  ++APE      Y          D++S G++L
Sbjct: 173 ENGLL--MTPCYTANFVAPEVLERQGYDAA--C----DIWSLGVLL 210

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  103 bits (258), Expect = 2e-23
 Identities = 53/310 (17%), Positives = 108/310 (34%), Gaps = 26/310 (8%)

Query: 17  IFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNN-YLTSSTLELSFLSSLSNCKS 75
            FN   L I+  ++  F   +  +   + NL+   +         +  LS L+ L     
Sbjct: 162 DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPK 221

Query: 76  LTLISFSNNPLDGILPKTSVGNLSHS-LEYFEMAYCNVSGGIPEEIG-----NLTNLTII 129
           L+ ++ +N           +  + H+ + YF ++   + G +          +L  L+I 
Sbjct: 222 LSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH 281

Query: 130 YLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIP 189
            +  +               +       +                  L+   N L+ ++ 
Sbjct: 282 QVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVF 341

Query: 190 ECFNNLASLRILLLGSNELTSIPLT---FWNLKDILYLNFSSNFFTGPLPLEI----GNL 242
           E   +L  L  L+L  N+L  +         +K +  L+ S N  +            +L
Sbjct: 342 ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401

Query: 243 KIARIDSCDLISLIS---------LNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEI 293
               + S  L   I          L+L +N +  +IP  + KL  L++LN++ N+L+  +
Sbjct: 402 LSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SV 459

Query: 294 PRGGSFGNFS 303
           P  G F   +
Sbjct: 460 PD-GIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 91.8 bits (228), Expect = 1e-19
 Identities = 58/310 (18%), Positives = 105/310 (33%), Gaps = 24/310 (7%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNL----RNLQALRLSNNY 56
           ++      F   +   +   + L +  +               L     N +   L+ N 
Sbjct: 170 IVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNN 229

Query: 57  LTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLE--YFEMAYCNVSG 114
           + ++      +  L    ++   S SN  L G L          SL+         +V G
Sbjct: 230 IETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG 289

Query: 115 GIPEEI-GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDE 173
                I    +N+ I     +           K+     L   NN L  ++ ++  H  E
Sbjct: 290 FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTE 349

Query: 174 LYKLELGGNKLSGSIPEC---FNNLASLRILLLGSNELTSI--PLTFWNLKDILYLNFSS 228
           L  L L  N+L   + +       + SL+ L +  N ++           K +L LN SS
Sbjct: 350 LETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS 408

Query: 229 NFFTGPLP---------LEIGNLKIARIDSC--DLISLISLNLSNNNLSGAIPASLEKLS 277
           N  T  +          L++ + KI  I      L +L  LN+++N L        ++L+
Sbjct: 409 NILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLT 468

Query: 278 YLKDLNLSFN 287
            L+ + L  N
Sbjct: 469 SLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 89.5 bits (222), Expect = 6e-19
 Identities = 43/255 (16%), Positives = 90/255 (35%), Gaps = 25/255 (9%)

Query: 18  FNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLT 77
              + +    +S+    G +     +        LS + + S               ++ 
Sbjct: 244 VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMN 303

Query: 78  LISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLN 137
           + +F+ +    ++       +S    + + +   ++  + E  G+LT L  + L  N+L 
Sbjct: 304 IKNFTVSGT-RMVHMLCPSKIS-PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361

Query: 138 GSIPSTLG---KLQKLQGLGLENNKLEGSIPDSICHS-DELYKLELGGNKLSGSIPECFN 193
             +        +++ LQ L +  N +        C     L  L +  N L+ +I  C  
Sbjct: 362 -ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL- 419

Query: 194 NLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSC--- 250
               +++L L SN++ SIP     L+ +  LN +SN             ++  +      
Sbjct: 420 -PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASN-------------QLKSVPDGIFD 465

Query: 251 DLISLISLNLSNNNL 265
            L SL  + L  N  
Sbjct: 466 RLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 79.5 bits (196), Expect = 1e-15
 Identities = 55/317 (17%), Positives = 97/317 (30%), Gaps = 57/317 (17%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L + +N  S      I + SKL IL +S N       + F   + L+ L LS+N L    
Sbjct: 26  LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-- 83

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG 121
             +S         +L  +  S N  D +                          I +E G
Sbjct: 84  --ISC----HPTVNLKHLDLSFNAFDAL-------------------------PICKEFG 112

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQ-GLGLENNKLEGSIPDSICHSD--ELYKLE 178
           N++ L  + L    L  S    +  L   +  L L     E   P+ +   +   L+ + 
Sbjct: 113 NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF 172

Query: 179 LGGNKLSGSIPECFNNLASLRILLL-------GSNELTSIPLTFWNLKDILYLNFSSNFF 231
               +    +      +A+L +  +         +   SI         +  L  ++   
Sbjct: 173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIET 232

Query: 232 TGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSG-----AIPASLEKLSYLKDLNLSF 286
           T    + I  L           ++   ++SN  L G         S   L  L    +  
Sbjct: 233 TWNSFIRILQLV-------WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285

Query: 287 NKLEGEIPRGGSFGNFS 303
           +      P+   +  FS
Sbjct: 286 DVF--GFPQSYIYEIFS 300

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.5 bits (170), Expect = 1e-12
 Identities = 39/199 (19%), Positives = 76/199 (38%), Gaps = 15/199 (7%)

Query: 93  TSV-GNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQ 151
             V  +LS       ++   +S     +I +L+ L I+ +  N++     S     Q+L+
Sbjct: 13  IHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72

Query: 152 GLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPEC--FNNLASLRILLLGSNELT 209
            L L +NKL   I      +  L  L+L  N    ++P C  F N++ L+ L L +  L 
Sbjct: 73  YLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLE 128

Query: 210 SIPLT-FWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGA 268
              +    +L     L      +      +   L+       +  SL  +  +N      
Sbjct: 129 KSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQD-----FNTESLHIVFPTNKEFHFI 181

Query: 269 IPASLEKLSYLKDLNLSFN 287
           +  S++ ++ L+  N+   
Sbjct: 182 LDVSVKTVANLELSNIKCV 200

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 21/105 (20%), Positives = 34/105 (32%), Gaps = 21/105 (20%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS- 59
           L + +N+ S    +        L  L +S N  +  I         ++ L L +N + S 
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSI 436

Query: 60  ----------STLELSF--LSSL-----SNCKSLTLISFSNNPLD 87
                       L ++   L S+         SL  I    NP D
Sbjct: 437 PKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  100 bits (251), Expect = 2e-23
 Identities = 66/297 (22%), Positives = 109/297 (36%), Gaps = 60/297 (20%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNL-QYGRVFKSFDV-ECEMMKSIRHRNIIKVISS 456
           IG GS+G VFK R    G  VA+K F   +   V K   + E  M+K ++H N++ ++  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
              +    LV EY  H ++   L      +  +   +I      A+ + H       IH 
Sbjct: 71  FRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCIHR 126

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-------YGKEG 569
           D+KP N+L+  + V  L DFG A+LLT           +AT  Y +PE       YG   
Sbjct: 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPELLVGDTQYGPP- 183

Query: 570 RVSANGDVYSFGIMLMETFTRK--------------------KPTDEIFNGEMTLKHWVN 609
            V    DV++ G +  E  +                                 T +++  
Sbjct: 184 -V----DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238

Query: 610 ----DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKE 662
               D   +   E+  PN +S   +  +          +         P +R+  ++
Sbjct: 239 VKIPDPEDMEPLELKFPN-ISYPALGLLKG----CLHMD---------PTERLTCEQ 281

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  102 bits (256), Expect = 3e-23
 Identities = 50/296 (16%), Positives = 97/296 (32%), Gaps = 46/296 (15%)

Query: 17  IFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTL----ELSFLS---- 68
           +   + L+ L    N  +         L  L  L    N LT   +     L++L+    
Sbjct: 81  LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCARN 137

Query: 69  -----SLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNL 123
                 +S+   LT +    N     L    V   +  L   + ++  ++     ++   
Sbjct: 138 TLTEIDVSHNTQLTELDCHLNKKITKLD---VTPQT-QLTTLDCSFNKITE---LDVSQN 190

Query: 124 TNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNK 183
             L  +    N +   +   L +  +L  L   +NKL   I  +     +L   +   N 
Sbjct: 191 KLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EIDVTPL--TQLTYFDCSVNP 244

Query: 184 LSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLP------- 236
           L+  +    + L+ L  L     +L  I LT  +   ++Y           L        
Sbjct: 245 LT-ELD--VSTLSKLTTLHCIQTDLLEIDLT--HNTQLIYFQAEGCRKIKELDVTHNTQL 299

Query: 237 --LEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
             L+     I  +D      L+ L L+N  L+  +   +   + LK L+     ++
Sbjct: 300 YLLDCQAAGITELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  101 bits (254), Expect = 5e-23
 Identities = 50/274 (18%), Positives = 93/274 (33%), Gaps = 41/274 (14%)

Query: 17  IFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSL 76
            F     +    +          +   L  L +L   N+ +T        ++ +     L
Sbjct: 14  WFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-------MTGIEKLTGL 66

Query: 77  TLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKL 136
           T +  ++N +  +     +   + +L Y       ++  +   +  LT LT +    NKL
Sbjct: 67  TKLICTSNNITTL----DLSQNT-NLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKL 118

Query: 137 NGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLA 196
              +   + +   L  L    N L   I  S      L +L+   NK    +        
Sbjct: 119 T-KLD--VSQNPLLTYLNCARNTLT-EIDVSHNTQ--LTELDCHLNKKITKLD--VTPQT 170

Query: 197 SLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLI 256
            L  L    N++T + ++    K +  LN  +N              I ++D    I L 
Sbjct: 171 QLTTLDCSFNKITELDVS--QNKLLNRLNCDTN-------------NITKLDLNQNIQLT 215

Query: 257 SLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
            L+ S+N L+  I   +  L+ L   + S N L 
Sbjct: 216 FLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT 246

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  100 bits (250), Expect = 2e-22
 Identities = 55/284 (19%), Positives = 97/284 (34%), Gaps = 44/284 (15%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSF 66
                T        + L+ L+  ++S +         L  L  L  ++N +T+       
Sbjct: 28  FEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNITTL------ 79

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNL 126
              LS   +LT ++  +N L  +     V  L+  L Y       ++     ++     L
Sbjct: 80  --DLSQNTNLTYLACDSNKLTNL----DVTPLT-KLTYLNCDTNKLT---KLDVSQNPLL 129

Query: 127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSG 186
           T +    N L   I   +    +L  L    NK    +   +    +L  L+   NK++ 
Sbjct: 130 TYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT- 183

Query: 187 SIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIAR 246
            +    +    L  L   +N +T + L       + +L+ SSN             K+  
Sbjct: 184 ELD--VSQNKLLNRLNCDTNNITKLDLN--QNIQLTFLDCSSN-------------KLTE 226

Query: 247 IDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
           ID   L  L   + S N L+  +  S   LS L  L+     L 
Sbjct: 227 IDVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 88.6 bits (220), Expect = 8e-19
 Identities = 44/282 (15%), Positives = 88/282 (31%), Gaps = 37/282 (13%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
           + ++L+ L+   N     +         L  L  S N +T           +S  K L  
Sbjct: 146 HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL--------DVSQNKLLNR 195

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG 138
           ++   N +  +     +      L + + +   ++  I   +  LT LT      N L  
Sbjct: 196 LNCDTNNITKL----DLNQNI-QLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLT- 246

Query: 139 SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASL 198
            +   +  L KL  L      L   I  +  H+ +L   +  G +    +     +   L
Sbjct: 247 ELD--VSTLSKLTTLHCIQTDLL-EIDLT--HNTQLIYFQAEGCRKIKELD--VTHNTQL 299

Query: 199 RILLLGSNELTSIPLTFWNLKDILYLNFSSNFFT----GPLP----LEIGNLKIARIDS- 249
            +L   +  +T + L+      ++YL  ++   T            L   N  I    S 
Sbjct: 300 YLLDCQAAGITELDLS--QNPKLVYLYLNNTELTELDVSHNTKLKSLSCVNAHIQDFSSV 357

Query: 250 CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEG 291
             + +L +   +          +L   S    ++       G
Sbjct: 358 GKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 82.8 bits (205), Expect = 7e-17
 Identities = 41/270 (15%), Positives = 79/270 (29%), Gaps = 41/270 (15%)

Query: 17  IFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSL------ 70
           +     L+ L    N+ +            L  L  S+N LT   ++++ L+ L      
Sbjct: 187 VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE--IDVTPLTQLTYFDCS 241

Query: 71  ---------SNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG 121
                    S    LT +      L  I       +L+H+ +               ++ 
Sbjct: 242 VNPLTELDVSTLSKLTTLHCIQTDLLEI-------DLTHNTQLIYFQAEGCRKIKELDVT 294

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG 181
           + T L ++      +   +   L +  KL  L L N +L   +  S      L  L    
Sbjct: 295 HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVSHNTK--LKSLSCVN 348

Query: 182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGN 241
             +          + +L        +  ++P         L +  S +        + GN
Sbjct: 349 AHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNS-LTIAVSPDLLD-----QFGN 400

Query: 242 LKIARIDSCDLISLISLNLSNNNLSGAIPA 271
                     +    +  ++  NLS   PA
Sbjct: 401 PMNIEPGDGGVYDQATNTITWENLSTDNPA 430

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 25/229 (10%), Positives = 61/229 (26%), Gaps = 53/229 (23%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
           + ++L   +         +     +   L  L      +T           LS    L  
Sbjct: 273 HNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGITE--------LDLSQNPKLVY 322

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG 138
           +  +N  L  +                             ++ + T L  +      +  
Sbjct: 323 LYLNNTELTEL-----------------------------DVSHNTKLKSLSCVNAHIQ- 352

Query: 139 SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELY------KLELGGNKLSGSIPECF 192
              S +GK+  L        +   ++P     ++ L        L+  GN +  +I    
Sbjct: 353 DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPM--NIEPGD 408

Query: 193 NNLASLRILLLGSNELTSIPLT---FWNLKDILYLNFSSNFFTGPLPLE 238
             +       +    L++        +  ++   +   +  F  P P++
Sbjct: 409 GGVYDQATNTITWENLSTDNPAVTYTFTSENGAIVGTVTTPFEAPQPIK 457

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  100 bits (251), Expect = 4e-23
 Identities = 61/252 (24%), Positives = 100/252 (39%), Gaps = 57/252 (22%)

Query: 361 RKRERGPPNDANMPPEAMQRMFSYLELCRATDGFSEN----NLIGRGSFGSVFKAR-LGD 415
              +      A+  P     +  Y       D  S+     + +GRG+   V++ +  G 
Sbjct: 18  LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77

Query: 416 GMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM 470
               A+KV         K+ D      E  ++  + H NIIK+          +LVLE +
Sbjct: 78  QKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130

Query: 471 PHGSLEKYLHSSNYILD-IYQR--------LNIMIDVASALEYLHFGYSAQVIHCDLKPS 521
             G L           D I ++         + +  +  A+ YLH      ++H DLKP 
Sbjct: 131 TGGEL----------FDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPE 177

Query: 522 NVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE------YGKEGRVS 572
           N+L      +    ++DFG++K++  E Q  ++T    T GY APE      YG E  V 
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIV--EHQVLMKT-VCGTPGYCAPEILRGCAYGPE--V- 231

Query: 573 ANGDVYSFGIML 584
              D++S GI+ 
Sbjct: 232 ---DMWSVGIIT 240

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score =  100 bits (250), Expect = 4e-23
 Identities = 52/282 (18%), Positives = 89/282 (31%), Gaps = 54/282 (19%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
            IP  +        L              F    +L+ + +S N +    +E    S+L 
Sbjct: 23  EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL-EVIEADVFSNLP 79

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL 131
               + +     N L  I P+            F+               NL NL  + +
Sbjct: 80  KLHEIRI--EKANNLLYINPEA-----------FQ---------------NLPNLQYLLI 111

Query: 132 GGNKLNGSIPS-TLGKLQKLQGLGL-ENNKLEGSIPDSI--CHSDELYKLELGGNKLSGS 187
               +   +P        +   L + +N  +  +I  +     S E   L L  N +   
Sbjct: 112 SNTGIK-HLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQEI 169

Query: 188 IPECFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIAR 246
               FN      + L  +N L  +P   F      + L+ S               +I  
Sbjct: 170 HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRT-------------RIHS 216

Query: 247 IDSCDLISLISLN-LSNNNLSGAIPASLEKLSYLKDLNLSFN 287
           + S  L +L  L   S  NL   +P +LEKL  L + +L++ 
Sbjct: 217 LPSYGLENLKKLRARSTYNLK-KLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 44/235 (18%), Positives = 78/235 (33%), Gaps = 18/235 (7%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIP-NTFGNLRNLQALRLSN-NYLT 58
           L+         I +  F     L  +E+S N     I  + F NL  L  +R+   N L 
Sbjct: 35  LRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL 93

Query: 59  SSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPE 118
              +      +L N + L +   SN  +  +     + +L       ++        I  
Sbjct: 94  Y--INPEAFQNLPNLQYLLI---SNTGIKHLPDVHKIHSLQ--KVLLDIQDNINIHTIER 146

Query: 119 EI--GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYK 176
               G      I++L  N +     S     Q  +    +NN LE    D    +     
Sbjct: 147 NSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 206

Query: 177 LELGGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNF 230
           L++   ++  S+P     NL  LR     +  L  +P T   L  ++  + +   
Sbjct: 207 LDISRTRIH-SLPSYGLENLKKLRA--RSTYNLKKLP-TLEKLVALMEASLTYPS 257

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  100 bits (252), Expect = 4e-23
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 61/265 (23%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVEC-----EMMKSIRHRNIIK 452
            IG+GSFG V   +  D  ++ AMK  N Q  +  +  +V       ++M+ + H  ++ 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQ--KCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 453 VISSCSNEEFKALVLEYMPHGSL----EKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           +  S  +EE   +V++ +  G L    ++ +H     + ++     + ++  AL+YL   
Sbjct: 80  LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF-----ICELVMALDYLQ-- 132

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPE--- 564
            + ++IH D+KP N+LLD++   H++DF IA +L RE     Q  T+A T  YMAPE   
Sbjct: 133 -NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET----QITTMAGTKPYMAPEMFS 187

Query: 565 ------YGKEGRVSANGDVYSFGIMLMETFTRKKP--------TDEIFNGEMTLKHWVND 610
                 Y     V    D +S G+   E    ++P        + EI +           
Sbjct: 188 SRKGAGYSFA--V----DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT---------- 231

Query: 611 WLPISTKEIVDPNLLSREDINFVAK 635
                T  +  P+  S+E ++ + K
Sbjct: 232 ---FETTVVTYPSAWSQEMVSLLKK 253

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 98.8 bits (247), Expect = 4e-23
 Identities = 59/197 (29%), Positives = 84/197 (42%), Gaps = 28/197 (14%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           IGRGS+G V  A   G  +  A K     +      F  E E+MKS+ H NII++  +  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 459 NEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQR--LNIMIDVASALEYLHFGYSAQVIH 515
           +     LV+E    G L E+ +H   +     +     IM DV SA+ Y H      V H
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVF----RESDAARIMKDVLSAVAYCH---KLNVAH 129

Query: 516 CDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-----YGK 567
            DLKP N L      +    L DFG+A          +    + T  Y++P+     YG 
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKVGTPYYVSPQVLEGLYGP 186

Query: 568 EGRVSANGDVYSFGIML 584
           E       D +S G+M+
Sbjct: 187 E------CDEWSAGVMM 197

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 99.7 bits (249), Expect = 5e-23
 Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 44/205 (21%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSC 457
           +G GSF    K          A+K+ +    R+  +   E   +K    H NI+K+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRLN--------IMIDVASALEYLHFG 508
            ++    LV+E +  G L           + I ++ +        IM  + SA+ ++H  
Sbjct: 76  HDQLHTFLVMELLNGGEL----------FERIKKKKHFSETEASYIMRKLVSAVSHMH-- 123

Query: 509 YSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE- 564
               V+H DLKP N+L    +DN+   + DFG A+L    D   ++T    T+ Y APE 
Sbjct: 124 -DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKT-PCFTLHYAAPEL 180

Query: 565 -----YGKEGRVSANGDVYSFGIML 584
                Y +        D++S G++L
Sbjct: 181 LNQNGYDES------CDLWSLGVIL 199

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 52/199 (26%), Positives = 89/199 (44%), Gaps = 30/199 (15%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G+GSFG V K +      E A+KV N      +   +   E E++K + H NI+K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 457 CSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQR--LNIMIDVASALEYLHFGYSAQV 513
             +     +V E    G L ++ +    +     +     I+  V S + Y+H      +
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRF----SEHDAARIIKQVFSGITYMH---KHNI 142

Query: 514 IHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-----Y 565
           +H DLKP N+LL   + +    + DFG++       Q+T     + T  Y+APE     Y
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLRGTY 199

Query: 566 GKEGRVSANGDVYSFGIML 584
            ++       DV+S G++L
Sbjct: 200 DEK------CDVWSAGVIL 212

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 98.9 bits (247), Expect = 6e-23
 Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 43/220 (19%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFN--------------------LQYGRVFKSFDV 437
            IG+GS+G V  A    D    AMKV +                       G   +    
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 438 ------ECEMMKSIRHRNIIK---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDI 488
                 E  ++K + H N++K   V+   + +    +V E +  G + +        L  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKP--LSE 136

Query: 489 YQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS 548
            Q      D+   +EYLH     ++IH D+KPSN+L+ ++    ++DFG++      D  
Sbjct: 137 DQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA- 192

Query: 549 TIQTQTLA-TIGYMAPEYGKEGRVSANG---DVYSFGIML 584
                    T  +MAPE   E R   +G   DV++ G+ L
Sbjct: 193 --LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 98.4 bits (246), Expect = 7e-23
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 43/206 (20%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G+G+F  V +      G+E A K+ N +    R F+  + E  + + ++H NI+++  S
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQR--------LNIMIDVASALEYLHF 507
              E F  LV + +  G L           + I  R         + +  +  ++ Y H 
Sbjct: 74  IQEESFHYLVFDLVTGGEL----------FEDIVAREFYSEADASHCIQQILESIAYCH- 122

Query: 508 GYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
             S  ++H +LKP N+LL          L+DFG+A  +   D          T GY++PE
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHG-FAGTPGYLSPE 177

Query: 565 ------YGKEGRVSANGDVYSFGIML 584
                 Y K        D+++ G++L
Sbjct: 178 VLKKDPYSKP------VDIWACGVIL 197

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 99.6 bits (249), Expect = 7e-23
 Identities = 65/340 (19%), Positives = 130/340 (38%), Gaps = 87/340 (25%)

Query: 378 MQRMFSYLEL--CRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKS 434
           M + +  +E   C     + +   IG+G+FG VFKAR    G +VA+K       +V   
Sbjct: 1   MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK-------KVL-- 51

Query: 435 FDVECE-----------MMKSIRHRNIIK---VISSCSNEEFKA-----LVLEYMPHGSL 475
            + E E           +++ ++H N++    +  + ++   +      LV ++  H  L
Sbjct: 52  MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DL 110

Query: 476 EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD 535
              L +      + +   +M  + + L Y+H     +++H D+K +NVL+  + V  L+D
Sbjct: 111 AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD 167

Query: 536 FGIAKLLTREDQSTIQ--TQTLATIGYMAPE-------YGKEGRVSANGDVYSFGIMLME 586
           FG+A+  +    S     T  + T+ Y  PE       YG    +    D++  G ++ E
Sbjct: 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP--I----DLWGAGCIMAE 221

Query: 587 TFTRK--------------------KPTDEIFNGEMTLKHWVN----DWLPISTKEIVDP 622
            +TR                       T E++      + +             K+ +  
Sbjct: 222 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA 281

Query: 623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKE 662
            +     ++ + K      V +         P QRI++ +
Sbjct: 282 YVRDPYALDLIDK----LLVLD---------PAQRIDSDD 308

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 98.4 bits (246), Expect = 7e-23
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 33/216 (15%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECE-----------MMKSIRH 447
           IG G++G+VFKA+       VA+K   L         D + E           ++K ++H
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRL---------DDDDEGVPSSALREICLLKELKH 60

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
           +NI+++     +++   LV E+     L+KY  S N  LD     + +  +   L + H 
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH- 118

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE--Y 565
             S  V+H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P+  +
Sbjct: 119 --SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLF 174

Query: 566 GKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
           G +   S + D++S G +  E     +P   +F G 
Sbjct: 175 GAK-LYSTSIDMWSAGCIFAELANAGRP---LFPGN 206

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 98.6 bits (246), Expect = 7e-23
 Identities = 40/271 (14%), Positives = 95/271 (35%), Gaps = 34/271 (12%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
             +    +    ++ +  +     +L  +  L      +T+       +  +    +L  
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG 138
           +   +N +  + P   + NL+  +   E++   +       I  L ++  + L   ++  
Sbjct: 68  LELKDNQITDLAP---LKNLTK-ITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITD 121

Query: 139 SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASL 198
             P  L  L  LQ L L+ N++  +I   +     L  L +G  ++S   P    NL+ L
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKL 175

Query: 199 RILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISL 258
             L    N+++ I     +L +++ ++  +N  +   PL             +  +L  +
Sbjct: 176 TTLKADDNKISDIS-PLASLPNLIEVHLKNNQISDVSPLA------------NTSNLFIV 222

Query: 259 NLSNNNLSGAIPASLEKLSYLKDLNLSFNKL 289
            L+N  ++         L     +       
Sbjct: 223 TLTNQTITNQPVFYNNNLVVPNVVKGPSGAP 253

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 54/292 (18%), Positives = 117/292 (40%), Gaps = 38/292 (13%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
           +   ++ L       +         L NL  L L +N +T        L+ L N   +T 
Sbjct: 39  DLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQITD-------LAPLKNLTKITE 89

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG 138
           +  S NPL  +   +++  L  S++  ++    ++      +  L+NL ++YL  N++  
Sbjct: 90  LELSGNPLKNV---SAIAGLQ-SIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQIT- 142

Query: 139 SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASL 198
           +I   L  L  LQ L + N ++   +   + +  +L  L+   NK+S  I     +L +L
Sbjct: 143 NISP-LAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKIS-DISP-LASLPNL 197

Query: 199 RILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLIS- 257
             + L +N+++ +     N  ++  +  ++   T        NL +  +      + I+ 
Sbjct: 198 IEVHLKNNQISDVS-PLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAP 256

Query: 258 ------LNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFS 303
                    ++ NL+  + + +  +SY      +FN+    +    +   FS
Sbjct: 257 ATISDNGTYASPNLTWNLTSFINNVSY------TFNQS---VTFKNTTVPFS 299

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 77.8 bits (192), Expect = 7e-16
 Identities = 41/179 (22%), Positives = 66/179 (36%), Gaps = 19/179 (10%)

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG 181
            L N   I  G + +      T   L  +  L      +  +I   + + + L  LEL  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72

Query: 182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLE--- 238
           N+++  +     NL  +  L L  N L ++      L+ I  L+ +S   T   PL    
Sbjct: 73  NQIT-DL-APLKNLTKITELELSGNPLKNVS-AIAGLQSIKTLDLTSTQITDVTPLAGLS 129

Query: 239 ------IGNLKIARIDS-CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
                 +   +I  I     L +L  L++ N  +S   P  L  LS L  L    NK+ 
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  101 bits (253), Expect = 8e-23
 Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 27/198 (13%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
           +G+GSFG V   +    G E A+KV +   ++     +S   E +++K + H NI+K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 456 SCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
              ++ +  LV E    G L ++ +    +         I+  V S + Y+H     +++
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGITYMH---KNKIV 148

Query: 515 HCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-----YG 566
           H DLKP N+LL     +    + DFG++      + S      + T  Y+APE     Y 
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAPEVLHGTYD 205

Query: 567 KEGRVSANGDVYSFGIML 584
           ++       DV+S G++L
Sbjct: 206 EK------CDVWSTGVIL 217

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 98.8 bits (246), Expect = 8e-23
 Identities = 49/310 (15%), Positives = 87/310 (28%), Gaps = 41/310 (13%)

Query: 8   NFSGTIPRF--IFNASKLSILELSDNSFSGF--------IPNTFGNLRNLQALRLSNNYL 57
           NFS   P +   FN    + +EL     S            +       +++L L    +
Sbjct: 16  NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75

Query: 58  TS---STLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSG 114
            +    +  L     +     L  ++  N  + G  P   +      L    +   + + 
Sbjct: 76  RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135

Query: 115 GIPE--EIGNL--TNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEG--SIPDSI 168
                 E+       L ++ +            +     L  L L +N   G   +  ++
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195

Query: 169 CHSD-----ELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIP--LTFWNLKDI 221
           C         L     G    SG           L+ L L  N L       +      +
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255

Query: 222 LYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKD 281
             LN S                + ++       L  L+LS N L    P+  E L  + +
Sbjct: 256 NSLNLSFT-------------GLKQVPKGLPAKLSVLDLSYNRLDR-NPSPDE-LPQVGN 300

Query: 282 LNLSFNKLEG 291
           L+L  N    
Sbjct: 301 LSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 88.0 bits (218), Expect = 3e-19
 Identities = 51/265 (19%), Positives = 81/265 (30%), Gaps = 30/265 (11%)

Query: 17  IFNASKLSILELSDNSFSGFIPNT---FGNLRNLQALRLSNNYLTSSTLELSFLSSLSNC 73
           I  +  L  L +        I         +  LQ L L N  +T +       ++  + 
Sbjct: 64  IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL 123

Query: 74  KSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGG 133
             L L + S    D  L +     L   L+   +A  +      E++     L+ + L  
Sbjct: 124 NILNLRNVSWATRDAWLAELQ-QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182

Query: 134 NKLNGSIPST----LGKLQKLQGLGLENNKLE---GSIPDSICHSDELYKLELGGNKLSG 186
           N   G           K   LQ L L N  +E   G          +L  L+L  N L  
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242

Query: 187 SIPE-CFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTG-PLPLEIGNLK 243
           +      +  + L  L L    L  +P      L     L+ S N     P P E+  + 
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS---VLDLSYNRLDRNPSPDELPQVG 299

Query: 244 IARIDSCDLISLISLNLSNNNLSGA 268
                        +L+L  N    +
Sbjct: 300 -------------NLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 39/220 (17%), Positives = 58/220 (26%), Gaps = 53/220 (24%)

Query: 16  FIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKS 75
             +    L +L ++      F          L  L LS+N                    
Sbjct: 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER-------------- 189

Query: 76  LTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNK 135
                                 L  +L              P +   L  L +   G   
Sbjct: 190 ---------------------GLISAL-------------CPLKFPTLQVLALRNAGMET 215

Query: 136 LNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSIC-HSDELYKLELGGNKLSGSIPECFNN 194
            +G   +      +LQGL L +N L  +     C    +L  L L    L   +P+    
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL-- 272

Query: 195 LASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGP 234
            A L +L L  N L   P     L  +  L+   N F   
Sbjct: 273 PAKLSVLDLSYNRLDRNPS-PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 33/163 (20%), Positives = 56/163 (34%), Gaps = 13/163 (7%)

Query: 6   ENNFSGTIP-RFIFNASKLSILELSDNSFSGFIPNT----FGNLRNLQALRLSNNYLTSS 60
               S       +     LS L+LSDN   G               LQ L L N  + + 
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET- 215

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
                  +  +    L  +  S+N L       S    S  L    +++  +   +P+ +
Sbjct: 216 -PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS-QLNSLNLSFTGLK-QVPKGL 272

Query: 121 GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGS 163
                L+++ L  N+L+   PS    L ++  L L+ N    S
Sbjct: 273 --PAKLSVLDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 50.3 bits (120), Expect = 9e-07
 Identities = 27/158 (17%), Positives = 50/158 (31%), Gaps = 12/158 (7%)

Query: 143 TLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPEC---FNNLASLR 199
             G       L   + + +      I  S  L +L +   ++   I         ++ L+
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98

Query: 200 ILLLGSNELT---SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLI 256
            L L + E+T     PL      D+  LN  +  +            +A +       L 
Sbjct: 99  ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAW------LAELQQWLKPGLK 152

Query: 257 SLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
            L+++  +        +     L  L+LS N   GE  
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 99.8 bits (249), Expect = 9e-23
 Identities = 65/259 (25%), Positives = 104/259 (40%), Gaps = 57/259 (22%)

Query: 361 RKRERGPPNDANMPPEAMQRMFSYLELCRATDGFSEN----NLIGRGSFGSVFKAR-LGD 415
           +K     P                L    A   F +     ++IGRG    V +      
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118

Query: 416 GMEVAMKVFNL--------QYGRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALV 466
           G E A+K+  +        Q   V ++   E  +++ +  H +II +I S  +  F  LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178

Query: 467 LEYMPHGSLEKYLHSSNYILD-IYQRL--------NIMIDVASALEYLHFGYSAQVIHCD 517
            + M  G L           D + +++        +IM  +  A+ +LH   +  ++H D
Sbjct: 179 FDLMRKGEL----------FDYLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRD 225

Query: 518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE------------Y 565
           LKP N+LLDDNM   LSDFG +  L    +     +   T GY+APE            Y
Sbjct: 226 LKPENILLDDNMQIRLSDFGFSCHL-EPGEKL--RELCGTPGYLAPEILKCSMDETHPGY 282

Query: 566 GKEGRVSANGDVYSFGIML 584
           GKE       D+++ G++L
Sbjct: 283 GKE------VDLWACGVIL 295

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  101 bits (253), Expect = 1e-22
 Identities = 52/197 (26%), Positives = 89/197 (45%), Gaps = 26/197 (13%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G+GSFG V K +      E A+KV N      +   +   E E++K + H NI+K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 457 CSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             +     +V E    G L ++ +    +    +    I+  V S + Y+H      ++H
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRF--SEHDAARIIKQVFSGITYMH---KHNIVH 144

Query: 516 CDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-----YGK 567
            DLKP N+LL   + +    + DFG++       Q+T     + T  Y+APE     Y +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIGTAYYIAPEVLRGTYDE 201

Query: 568 EGRVSANGDVYSFGIML 584
           +       DV+S G++L
Sbjct: 202 K------CDVWSAGVIL 212

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 99.2 bits (248), Expect = 1e-22
 Identities = 73/308 (23%), Positives = 129/308 (41%), Gaps = 52/308 (16%)

Query: 385 LELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFK-SFDV----E 438
           L++      + + + +G G F +V+KAR       VA+K   L +    K   +     E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62

Query: 439 CEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDV 498
            ++++ + H NII ++ +  ++   +LV ++M    LE  +  ++ +L        M+  
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121

Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI 558
              LEYLH      ++H DLKP+N+LLD+N V  L+DFG+AK     +++   T  + T 
Sbjct: 122 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTR 176

Query: 559 GYMAPE--YGKEGRVSANGDVYSFGIMLMETFTRK--------------------KPTDE 596
            Y APE  +G         D+++ G +L E   R                      PT+E
Sbjct: 177 WYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 235

Query: 597 IFNGEMTLKHWVN--DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESP 654
            +    +L  +V    +  I    I        + ++ +       F+FN         P
Sbjct: 236 QWPDMCSLPDYVTFKSFPGIPLHHIF-SA-AGDDLLDLIQG----LFLFN---------P 280

Query: 655 EQRINAKE 662
             RI A +
Sbjct: 281 CARITATQ 288

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 98.8 bits (246), Expect = 1e-22
 Identities = 48/257 (18%), Positives = 96/257 (37%), Gaps = 43/257 (16%)

Query: 434 SFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI--LDIYQR 491
           +  V+   M     +N +  +   S + +  + ++     +L+ +++    +   +    
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166

Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ---- 547
           L+I I +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+   + ++++    
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223

Query: 548 ------STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
                     T  + T  YM+PE       S   D++S G++L E         E     
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-- 281

Query: 602 MTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAK 661
             +    N   P+             ++   V                   SP +R  A 
Sbjct: 282 -IITDVRNLKFPL------LFTQKYPQEHMMVQD-------------MLSPSPTERPEAT 321

Query: 662 EIVTKLLKIRDSLLRNV 678
           +I      I +++  N+
Sbjct: 322 DI------IENAIFENL 332

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 18/96 (18%), Positives = 33/96 (34%), Gaps = 2/96 (2%)

Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIR 446
           R    F     +GRG FG VF+A+   D    A+K   L       +    E + +  + 
Sbjct: 3   RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 62

Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS 482
           H  I++  ++      +    E       ++     
Sbjct: 63  HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 43/206 (20%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN--LQYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
           +G+G+F  V +      G+E A K+ N      R F+  + E  + + ++H NI+++  S
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQR--------LNIMIDVASALEYLHF 507
              E F  LV + +  G L           + I  R         + +  +  ++ Y H 
Sbjct: 97  IQEESFHYLVFDLVTGGEL----------FEDIVAREFYSEADASHCIQQILESIAYCH- 145

Query: 508 GYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
             S  ++H +LKP N+LL          L+DFG+A  +   D          T GY++PE
Sbjct: 146 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHG-FAGTPGYLSPE 200

Query: 565 ------YGKEGRVSANGDVYSFGIML 584
                 Y K        D+++ G++L
Sbjct: 201 VLKKDPYSKP------VDIWACGVIL 220

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 65/338 (19%), Positives = 120/338 (35%), Gaps = 73/338 (21%)

Query: 367 PPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFN 425
                           S      + D +     +G G++G V+KA        VA+K   
Sbjct: 9   MGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR 68

Query: 426 LQYGRVFKSFDVECE-----------MMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGS 474
           L         + E E           ++K ++HRNII++ S   +     L+ EY  +  
Sbjct: 69  L---------EHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-D 118

Query: 475 LEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH-- 532
           L+KY+  +   + +    + +  + + + + H   S + +H DLKP N+LL  +  +   
Sbjct: 119 LKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETP 174

Query: 533 ---LSDFGIAKLLTREDQSTIQTQTLATIGYMAPE--YGKEGRVSANGDVYSFGIMLMET 587
              + DFG+A+      +    T  + T+ Y  PE   G     S + D++S   +  E 
Sbjct: 175 VLKIGDFGLARAFGIPIRQF--THEIITLWYRPPEILLGSR-HYSTSVDIWSIACIWAEM 231

Query: 588 FTRK--------------------KPTDEIFNGEMTLKHWVND---WLPISTKEIVDPNL 624
             +                      P D  + G   L  W      +   + K ++   L
Sbjct: 232 LMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVL-GAL 290

Query: 625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKE 662
           L  E ++ +          +         P +RI+AK 
Sbjct: 291 LDDEGLDLLTA----MLEMD---------PVKRISAKN 315

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.0 bits (247), Expect = 2e-22
 Identities = 47/230 (20%), Positives = 93/230 (40%), Gaps = 13/230 (5%)

Query: 362 KRERGPPNDANMPPEAMQRMFSYLELCRATDGFSEN----NLIGRGSFGSVFKAR-LGDG 416
           K +    ND +   E + + +    +        +       +G G+FG V +      G
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76

Query: 417 MEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLE 476
                K  N  Y     +   E  +M  + H  +I +  +  ++    L+LE++  G L 
Sbjct: 77  RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136

Query: 477 KYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL--S 534
             + + +Y +   + +N M      L+++H      ++H D+KP N++ +    + +   
Sbjct: 137 DRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 193

Query: 535 DFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
           DFG+A  L   +   I   T AT  + APE      V    D+++ G++ 
Sbjct: 194 DFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 98.0 bits (244), Expect = 2e-22
 Identities = 57/242 (23%), Positives = 86/242 (35%), Gaps = 66/242 (27%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSIRHRNIIKV 453
           IG+GS+G V  A         A+K+ N    R     DV     E  +MK + H NI ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL--------------------- 492
                +E++  LV+E    G L   L+           +                     
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 493 ------------------NIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL- 533
                             NIM  + SAL YLH   +  + H D+KP N L   N    + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 534 -SDFGIAKLLTREDQSTIQ--TQTLATIGYMAPE--------YGKEGRVSANGDVYSFGI 582
             DFG++K   + +       T    T  ++APE        YG +       D +S G+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK------CDAWSAGV 264

Query: 583 ML 584
           +L
Sbjct: 265 LL 266

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 96.8 bits (242), Expect = 2e-22
 Identities = 62/307 (20%), Positives = 119/307 (38%), Gaps = 67/307 (21%)

Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECE----------- 440
           + +     IG G++G V+KA+   G   A+K   L         + E E           
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL---------EKEDEGIPSTTIREIS 52

Query: 441 MMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
           ++K ++H NI+K+      ++   LV E++    L+K L      L+     + ++ + +
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
            + Y H     +V+H DLKP N+L++      ++DFG+A+      +    T  + T+ Y
Sbjct: 112 GIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWY 166

Query: 561 MAPE--YGKEGRVSANGDVYSFGIMLMETFTRK--------------------KPTDEIF 598
            AP+   G + + S   D++S G +  E                          P  + +
Sbjct: 167 RAPDVLMGSK-KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNW 225

Query: 599 NGEMTLKHWVND---WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPE 655
                L  +  +   + P+  +  +    L    I+ ++K        +         P 
Sbjct: 226 PNVTELPKYDPNFTVYEPLPWESFL-KG-LDESGIDLLSK----MLKLD---------PN 270

Query: 656 QRINAKE 662
           QRI AK+
Sbjct: 271 QRITAKQ 277

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 98.6 bits (246), Expect = 3e-22
 Identities = 71/307 (23%), Positives = 119/307 (38%), Gaps = 80/307 (26%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVF--KSFDV-ECEMMKSIRHRNIIK---- 452
           IG GSFG VF+A+L +  EVA+K       +V   K F   E ++M+ ++H N++     
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIK-------KVLQDKRFKNRELQIMRIVKHPNVVDLKAF 100

Query: 453 VISSCSNEEFKA--LVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             S+   ++     LVLEY+P   + +   Y      +  +  +L  M  +  +L Y+H 
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL-YMYQLLRSLAYIH- 158

Query: 508 GYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQST--IQTQTLATIGYMAPE 564
             S  + H D+KP N+LLD  + V  L DFG AK+L   + +   I      +  Y APE
Sbjct: 159 --SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI-----CSRYYRAPE 211

Query: 565 -------YGKEGRVSANGDVYSFGIMLMETFTRK--------------------KPTDEI 597
                  Y      + N D++S G ++ E    +                     P+ E 
Sbjct: 212 LIFGATNY------TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265

Query: 598 FNGEMTLKHWVN--DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPE 655
                            P    ++  P     + I+ +++       +          P 
Sbjct: 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPR-TPPDAIDLISR----LLEYT---------PS 311

Query: 656 QRINAKE 662
            R+ A E
Sbjct: 312 ARLTAIE 318

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 48/214 (22%), Positives = 85/214 (39%), Gaps = 58/214 (27%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECE---MMKSIRHRNIIKVI 454
           ++G G  G V +      G + A+K+          S     E     ++    +I+ ++
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88

Query: 455 ----SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRLN----------IMIDVA 499
               +    +    +++E M  G L             I +R +          IM D+ 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGEL----------FSRIQERGDQAFTEREAAEIMRDIG 138

Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
           +A+++LH   S  + H D+KP N+L    + + V  L+DFG AK  T+    T       
Sbjct: 139 TAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP----CY 191

Query: 557 TIGYMAPE------YGKEGRVSANGDVYSFGIML 584
           T  Y+APE      Y K        D++S G+++
Sbjct: 192 TPYYVAPEVLGPEKYDKS------CDMWSLGVIM 219

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  100 bits (249), Expect = 3e-22
 Identities = 57/323 (17%), Positives = 110/323 (34%), Gaps = 41/323 (12%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           LQ+   N S ++P  +    ++++LE++ N+    +P    +L  L      +N L++  
Sbjct: 64  LQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYLD---ACDNRLST-- 114

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG 121
                    ++ K L +    NN L      T +  L   LEY       ++  +PE   
Sbjct: 115 ----LPELPASLKHLDV---DNNQL------TMLPELPALLEYINADNNQLTM-LPELPT 160

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICH----SDELYKL 177
           +L  L    +  N+L   +P     L+ L    +  N LE S+P          +     
Sbjct: 161 SLEVL---SVRNNQLT-FLPELPESLEALD---VSTNLLE-SLPAVPVRNHHSEETEIFF 212

Query: 178 ELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPL 237
               N+++  IPE   +L     ++L  N L+S      + +           +      
Sbjct: 213 RCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271

Query: 238 EIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGG 297
           +   L     D+           +  +    I  + E   +    +   ++L  +     
Sbjct: 272 QQNTLHRPLADAV----TAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRL-SDTVSAR 326

Query: 298 SFGNFSAESFEGNELLCGSPNLR 320
           +   F  +     E L  S  LR
Sbjct: 327 NTSGFREQVAAWLEKLSASAELR 349

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 20/102 (19%), Positives = 37/102 (36%), Gaps = 13/102 (12%)

Query: 193 NNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDL 252
           NN  SL       N ++     +++  D                 E  N  ++ +  C +
Sbjct: 8   NNNFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPG--------ENRNEAVSLLKECLI 58

Query: 253 ISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
                L L+  NLS ++P +L     +  L ++ N L   +P
Sbjct: 59  NQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLP 96

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 45/204 (22%), Positives = 85/204 (41%), Gaps = 30/204 (14%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFN----LQYGRVFKSFDVECEMMKSIRHRNIIK- 452
           L+G GS+G V +          A+K+       +      +   E ++++ +RH+N+I+ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 453 --VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------SAL 502
             V+ +   ++   +V+EY   G  E      + + +  +R  +    A          L
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQEML----DSVPE--KRFPV--CQAHGYFCQLIDGL 122

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           EYLH   S  ++H D+KP N+LL       +S  G+A+ L           +  +  +  
Sbjct: 123 EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 563 PE--YGKEGRVSANGDVYSFGIML 584
           PE   G +       D++S G+ L
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTL 203

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 99.4 bits (248), Expect = 5e-22
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 37/210 (17%)

Query: 398 NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-------------ECEMMK 443
             +G G++G V   +      E A+KV         +  D              E  ++K
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 444 SIRHRNIIKVISSCSNEEFKALVLEYMPHGSL-EKYLHSSNYILDIYQRLNIMIDVASAL 502
           S+ H NIIK+     ++++  LV E+   G L E+ ++   +  D     NIM  + S +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF--DECDAANIMKQILSGI 159

Query: 503 EYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG 559
            YLH      ++H D+KP N+LL   +  +   + DFG++       +       L T  
Sbjct: 160 CYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF---SKDYKLRDRLGTAY 213

Query: 560 YMAPE-----YGKEGRVSANGDVYSFGIML 584
           Y+APE     Y ++       DV+S G+++
Sbjct: 214 YIAPEVLKKKYNEK------CDVWSCGVIM 237

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 96.0 bits (239), Expect = 5e-22
 Identities = 32/204 (15%), Positives = 56/204 (27%), Gaps = 43/204 (21%)

Query: 399 LIGRGSFGSVFKA---RLGDGMEVAMKVFNLQYGR--VFKS-FDVECEMMKSIRHRNIIK 452
             G       ++A    L    +VA+   + Q                 +  I    + +
Sbjct: 38  FHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           V+          +V E++  GSL++   +S         +  M  +A+A +  H    A 
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAG 149

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS 572
           V      PS V +  +        G                 LA    M          +
Sbjct: 150 VALSIDHPSRVRVSID--------GDVV--------------LAYPATMPD-------AN 180

Query: 573 ANGDVYSFGIMLMETFTRKKPTDE 596
              D+   G  L      + P  E
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPE 204

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 98.2 bits (245), Expect = 6e-22
 Identities = 71/225 (31%), Positives = 107/225 (47%), Gaps = 49/225 (21%)

Query: 400 IGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVF--KSFDV-ECEMMKSIRHRNIIKVI- 454
           IG GSFG V++A+L D G  VA+K       +V   K F   E ++M+ + H NI+++  
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIK-------KVLQDKRFKNRELQIMRKLDHCNIVRLRY 114

Query: 455 -----SSCSNEEFKALVLEYMP---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
                    +E +  LVL+Y+P   +     Y  +   +  IY +L  M  +  +L Y+H
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIH 173

Query: 507 FGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQST--IQTQTLATIGYMAP 563
              S  + H D+KP N+LLD D  V  L DFG AK L R + +   I      +  Y AP
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI-----CSRYYRAP 225

Query: 564 E-------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
           E       Y      +++ DV+S G +L E     +P   IF G+
Sbjct: 226 ELIFGATDY------TSSIDVWSAGCVLAELLLG-QP---IFPGD 260

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 97.8 bits (244), Expect = 6e-22
 Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 47/212 (22%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDV-----ECEMMKSIRHRNI 450
           +G G+ G V  A       +VA+++ +      G   ++        E E++K + H  I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN------IMIDVASALEY 504
           IK+ +    E++  +VLE M  G L       + ++   +RL           +  A++Y
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGEL------FDKVVG-NKRLKEATCKLYFYQMLLAVQY 254

Query: 505 LHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           LH      +IH DLKP NVLL   +++ +  ++DFG +K+L   + S ++T    T  Y+
Sbjct: 255 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT-LCGTPTYL 308

Query: 562 APE---------YGKEGRVSANGDVYSFGIML 584
           APE         Y +   V    D +S G++L
Sbjct: 309 APEVLVSVGTAGYNRA--V----DCWSLGVIL 334

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 47/212 (22%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDV-----ECEMMKSIRHRNI 450
           +G G+ G V  A       +VA+K+ +      G   ++        E E++K + H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL------NIMIDVASALEY 504
           IK+ +    E++  +VLE M  G L       + ++   +RL           +  A++Y
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGEL------FDKVVG-NKRLKEATCKLYFYQMLLAVQY 129

Query: 505 LHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           LH      +IH DLKP NVLL   +++ +  ++DFG +K+L   + S ++T    T  Y+
Sbjct: 130 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRT-LCGTPTYL 183

Query: 562 APE---------YGKEGRVSANGDVYSFGIML 584
           APE         Y +   V    D +S G++L
Sbjct: 184 APEVLVSVGTAGYNRA--V----DCWSLGVIL 209

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 97.0 bits (242), Expect = 7e-22
 Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 47/236 (19%)

Query: 391 TDGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVF--KSFDV----ECEMMK 443
            D F    + G+G+FG+V   +    GM VA+K       +V     F        + + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-------KVIQDPRFRNRELQIMQDLA 74

Query: 444 SIRHRNIIK---VISSCSNEEFK----ALVLEYMP---HGSLEKYLHSSNYILDIYQRLN 493
            + H NI++      +    + +     +V+EY+P   H     Y         I  ++ 
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV- 133

Query: 494 IMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQT 552
            +  +  ++  LH   S  V H D+KP NVL++  +    L DFG AK L+  + +    
Sbjct: 134 FLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---V 189

Query: 553 QTLATIGYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
             + +  Y APE       Y      +   D++S G +  E     +P   IF G+
Sbjct: 190 AYICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLG-EP---IFRGD 235

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 95.0 bits (237), Expect = 9e-22
 Identities = 52/198 (26%), Positives = 84/198 (42%), Gaps = 25/198 (12%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRV-FKSFDVECEMMKSIRHRNIIKVISSC 457
           +G G+FG V        G+E  +K  N    +V  +  + E E++KS+ H NIIK+    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIY---QRLNIMIDVASALEYLHFGYSAQVI 514
            +     +V+E    G L + + S+              +M  + +AL Y H   S  V+
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVV 146

Query: 515 HCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-----YG 566
           H DLKP N+L      +    + DFG+A+           T    T  YMAPE       
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAAGTALYMAPEVFKRDVT 203

Query: 567 KEGRVSANGDVYSFGIML 584
            +       D++S G+++
Sbjct: 204 FK------CDIWSAGVVM 215

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 57/253 (22%), Positives = 99/253 (39%), Gaps = 46/253 (18%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQ-----YGRVFKSFDVECEMMKSIRHRNIIK 452
            +G G++G V  A        VA+K+ +++        + K    E  + K + H N++K
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69

Query: 453 ---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------SA 501
                    N ++  L LEY   G L       + I      +      A        + 
Sbjct: 70  FYGHRRE-GNIQY--LFLEYCSGGEL------FDRIEP-DIGMPE--PDAQRFFHQLMAG 117

Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174

Query: 562 APE-YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN------DWLPI 614
           APE   +    +   DV+S GI+L      + P D+  +       W         W  I
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234

Query: 615 STKEIVDPNLLSR 627
            +  +    LL +
Sbjct: 235 DSAPL---ALLHK 244

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 95.9 bits (239), Expect = 2e-21
 Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 49/230 (21%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---------ECEMMKSIRHRN 449
           IG G+ G V  A        VA+K       ++ + F           E  +MK + H+N
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIK-------KLSRPFQNQTHAKRAYRELVLMKCVNHKN 85

Query: 450 IIKV----ISSCSNEEFKA--LVLEYMPHGSLEKYLHSS------NYILDIYQRLNIMID 497
           II +        S EEF+   +V+E M   +L + +         +Y+L  YQ L     
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLL--YQMLC---- 138

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
               +++LH   SA +IH DLKPSN+++  +    + DFG+A+       S + T  + T
Sbjct: 139 ---GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVT 189

Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
             Y APE         N D++S G ++ E          +F G   +  W
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV----LFPGTDHIDQW 235

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 97.9 bits (243), Expect = 2e-21
 Identities = 50/269 (18%), Positives = 94/269 (34%), Gaps = 56/269 (20%)

Query: 21  SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS 80
           ++     L   S +  +      L ++  +  +N+ + S       +  +    ++T + 
Sbjct: 21  AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-------VQGIQYLPNVTKLF 71

Query: 81  FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSI 140
            + N L  I                            + + NL NL  ++L  NK+   +
Sbjct: 72  LNGNKLTDI----------------------------KPLTNLKNLGWLFLDENKIK-DL 102

Query: 141 PSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRI 200
            S+L  L+KL+ L LE+N +   I + + H  +L  L LG NK++       + L  L  
Sbjct: 103 -SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDT 157

Query: 201 LLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNL 260
           L L  N+++ I      L  +  L  S N  +     ++  L         L +L  L L
Sbjct: 158 LSLEDNQISDIV-PLAGLTKLQNLYLSKNHIS-----DLRALA-------GLKNLDVLEL 204

Query: 261 SNNNLSGAIPASLEKLSYLKDLNLSFNKL 289
            +             L     +  +   L
Sbjct: 205 FSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 95.2 bits (236), Expect = 2e-20
 Identities = 54/248 (21%), Positives = 87/248 (35%), Gaps = 58/248 (23%)

Query: 43  NLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSL 102
                    L    +T          + +   S+  I  +N+ +  +             
Sbjct: 19  AFAETIKDNLKKKSVTD-------AVTQNELNSIDQIIANNSDIKSV------------- 58

Query: 103 EYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEG 162
                          + I  L N+T ++L GNKL   I   L  L+ L  L L+ NK++ 
Sbjct: 59  ---------------QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK- 100

Query: 163 SIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDIL 222
            +  S+    +L  L L  N +S  I     +L  L  L LG+N++T I      L  + 
Sbjct: 101 DL-SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDIT-VLSRLTKLD 156

Query: 223 YLNFSSNFFTGPLPLEIGNLKIARIDSCD-LISLISLNLSNNNLSGAIPASLEKLSYLKD 281
            L+   N             +I+ I     L  L +L LS N++S     +L  L  L  
Sbjct: 157 TLSLEDN-------------QISDIVPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDV 201

Query: 282 LNLSFNKL 289
           L L   + 
Sbjct: 202 LELFSQEC 209

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 90.9 bits (225), Expect = 3e-19
 Identities = 51/275 (18%), Positives = 106/275 (38%), Gaps = 41/275 (14%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
             + +  +  +++            L N+  L L+ N LT        +  L+N K+L  
Sbjct: 41  ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD-------IKPLTNLKNLGW 91

Query: 79  ISFSNNPLDGILPKTSVGNLSH--SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKL 136
           +    N +        + +L     L+   + +  +S      + +L  L  +YLG NK+
Sbjct: 92  LFLDENKI------KDLSSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKI 143

Query: 137 NGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLA 196
             +  + L +L KL  L LE+N++   I   +    +L  L L  N +S  +      L 
Sbjct: 144 --TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLK 197

Query: 197 SLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLI 256
           +L +L L S E  + P+   +  +++  N   N                 + + ++IS  
Sbjct: 198 NLDVLELFSQECLNKPI--NHQSNLVVPNTVKNT-------------DGSLVTPEIIS-D 241

Query: 257 SLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEG 291
             +    N+   +P    ++S++    ++  K + 
Sbjct: 242 DGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 276

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 77.1 bits (189), Expect = 8e-15
 Identities = 39/169 (23%), Positives = 67/169 (39%), Gaps = 21/169 (12%)

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG 181
                    L    +      T  +L  +  +   N+ ++ S+   I +   + KL L G
Sbjct: 19  AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74

Query: 182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGN 241
           NKL+  I     NL +L  L L  N++  +  +  +LK +  L+   N  +     +I  
Sbjct: 75  NKLT-DIKP-LTNLKNLGWLFLDENKIKDLS-SLKDLKKLKSLSLEHNGIS-----DING 126

Query: 242 LKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
           L         L  L SL L NN ++      L +L+ L  L+L  N++ 
Sbjct: 127 LV-------HLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS 166

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 67.4 bits (164), Expect = 7e-12
 Identities = 37/196 (18%), Positives = 63/196 (32%), Gaps = 41/196 (20%)

Query: 17  IFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSL 76
           + N   L  L L +N           +L+ L++L L +N ++        ++ L +   L
Sbjct: 83  LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGISD-------INGLVHLPQL 133

Query: 77  TLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKL 136
             +   NN +  I                              +  LT L  + L  N++
Sbjct: 134 ESLYLGNNKITDI----------------------------TVLSRLTKLDTLSLEDNQI 165

Query: 137 NGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLA 196
           +  I   L  L KLQ L L  N +  S   ++     L  LEL   +         +NL 
Sbjct: 166 S-DIVP-LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLV 221

Query: 197 SLRILLLGSNELTSIP 212
               +      L +  
Sbjct: 222 VPNTVKNTDGSLVTPE 237

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 43.2 bits (101), Expect = 3e-04
 Identities = 14/94 (14%), Positives = 33/94 (35%), Gaps = 17/94 (18%)

Query: 198 LRILLLGSNELTSI-PLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLI 256
           +   +  S  +  I P       + +  N      T  +               +L S+ 
Sbjct: 1   MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVTQN------------ELNSID 46

Query: 257 SLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
            +  +N+++  ++   ++ L  +  L L+ NKL 
Sbjct: 47  QIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT 78

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 97.6 bits (243), Expect = 2e-21
 Identities = 49/291 (16%), Positives = 96/291 (32%), Gaps = 26/291 (8%)

Query: 22  KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF 81
           +LS ++L+D +    +       R    L ++  ++ ++      L      + +  ++ 
Sbjct: 224 QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNI 283

Query: 82  SNNPLDGILPKTSVGNLSHSLEYFEM--AYCNVSGGIPEEIGN-LTNLTIIYLGGNKLNG 138
            N  +   + +        +L+   +      V     E + +    + I  L  +    
Sbjct: 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343

Query: 139 SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASL 198
                         L    N    S+         L  L L  N L  +  +      ++
Sbjct: 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNM 402

Query: 199 RILLLGSNELTSIP------LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDL 252
             L      L S+          W  + IL LN SSN  T              +  C  
Sbjct: 403 SSLETLDVSLNSLNSHAYDRTCAW-AESILVLNLSSNMLT------------GSVFRCLP 449

Query: 253 ISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFS 303
             +  L+L NN +  +IP  +  L  L++LN++ N+L+  +P  G F   +
Sbjct: 450 PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPD-GVFDRLT 497

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 83.4 bits (206), Expect = 6e-17
 Identities = 44/240 (18%), Positives = 90/240 (37%), Gaps = 21/240 (8%)

Query: 2   LQMWENNFSGTIPRFIFNASKLS-----ILELSDNSFSGFIPNTFGNLRNLQALRLSNNY 56
           L ++    +  I R  F  S+ +     I  + +  F       +     +    LS + 
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340

Query: 57  LTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGI 116
                + +    S S+    T ++F+ N     + +     L   L+   +    +    
Sbjct: 341 TPF--IHMVCPPSPSS---FTFLNFTQNVFTDSVFQGC-STLK-RLQTLILQRNGLKN-F 392

Query: 117 PEEIGNLTNLTIIYLGGNKLN----GSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSD 172
            +      N++ +      LN     +   T    + +  L L +N L GS+   +    
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PP 450

Query: 173 ELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFF 231
           ++  L+L  N++  SIP+   +L +L+ L + SN+L S+P   F  L  + Y+    N +
Sbjct: 451 KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 74.5 bits (183), Expect = 4e-14
 Identities = 51/305 (16%), Positives = 92/305 (30%), Gaps = 75/305 (24%)

Query: 21  SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS 80
           S+L +L LS N       + F   ++L+ L +S+N L +    +S         SL  + 
Sbjct: 76  SELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN----ISC----CPMASLRHLD 127

Query: 81  FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSI 140
            S N  D +                          + +E GNLT LT + L   K     
Sbjct: 128 LSFNDFDVL-------------------------PVCKEFGNLTKLTFLGLSAAKFRQLD 162

Query: 141 PSTLGKLQ-KLQGLGLENNKLEGSIPDSICHS-----------------------DELYK 176
              +  L      L L +  ++G   +S+                          + L  
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGH 222

Query: 177 LELGGNKLSGSIPECFNNLA------------SLRILLLGSNELTSIPLTFWNLKDILYL 224
           L+L   KL+    +                  +L+ +         +   FW  + + YL
Sbjct: 223 LQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP-RPVEYL 281

Query: 225 NFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNL 284
           N  +   T        + +        L SL+  ++ N     +  A     + +    L
Sbjct: 282 NIYNLTITE-----RIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336

Query: 285 SFNKL 289
           S +  
Sbjct: 337 SISDT 341

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 25/119 (21%), Positives = 45/119 (37%), Gaps = 19/119 (15%)

Query: 187 SIPECFNNLASLRILLLGSNELTSIPLT-FWNLKDILYLNFSSNFFTGPLPLEIGNLKIA 245
            +P+  +     + L L  N ++ + +     L ++  L  S N     L          
Sbjct: 45  HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-LD--------- 92

Query: 246 RIDSCD-LISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFS 303
                     L  L++S+N L   I      ++ L+ L+LSFN  +  +P    FGN +
Sbjct: 93  -FHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLT 146

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 19/67 (28%), Positives = 29/67 (43%), Gaps = 6/67 (8%)

Query: 21  SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS 80
            K+ +L+L +N     IP    +L+ LQ L +++N L S               SL  I 
Sbjct: 450 PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPD-----GVFDRLTSLQYIW 503

Query: 81  FSNNPLD 87
             +NP D
Sbjct: 504 LHDNPWD 510

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 57/221 (25%), Positives = 85/221 (38%), Gaps = 42/221 (19%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
            +P  +      +IL LS+N    F   T      L  L L    LT     L    +L 
Sbjct: 24  ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK----LQVDGTLP 77

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL 131
              +L L   S+N L       S                     +P     L  LT++ +
Sbjct: 78  VLGTLDL---SHNQL------QS---------------------LPLLGQTLPALTVLDV 107

Query: 132 GGNKLNGSIPS-TLGKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLELGGNKLSGSIP 189
             N+L  S+P   L  L +LQ L L+ N+L+ ++P  +     +L KL L  N L+  +P
Sbjct: 108 SFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELP 164

Query: 190 E-CFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSN 229
               N L +L  LLL  N L +IP  F+    + +     N
Sbjct: 165 AGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 52/197 (26%), Positives = 80/197 (40%), Gaps = 30/197 (15%)

Query: 112 VSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS 171
           +   +P       + TI++L  N L     +TL    +L  L L+  +L   +       
Sbjct: 25  LPPDLP------KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTL 76

Query: 172 DELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNF 230
             L  L+L  N+L  S+P     L +L +L +  N LTS+PL     L ++  L    N 
Sbjct: 77  PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN- 134

Query: 231 FTGPLPLEIGNLKIARIDS---CDLISLISLNLSNNNLSGAIPASL-EKLSYLKDLNLSF 286
                       ++  +          L  L+L+NNNL+  +PA L   L  L  L L  
Sbjct: 135 ------------ELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQE 181

Query: 287 NKLEGEIPRGGSFGNFS 303
           N L   IP+ G FG+  
Sbjct: 182 NSLYT-IPK-GFFGSHL 196

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 43/176 (24%), Positives = 64/176 (36%), Gaps = 18/176 (10%)

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG 181
            + +   +      L  ++P      +    L L  N L      ++     L +L L  
Sbjct: 8   KVASHLEVNCDKRNL-TALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGN 241
            +L+  +      L  L  L L  N+L S+PL    L  +  L+ S N  T  LPL    
Sbjct: 65  AELT-KLQV-DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-LPLGALR 121

Query: 242 LKIARIDSCDLISLISLNLSNNNLSGAIPASL-EKLSYLKDLNLSFNKLEGEIPRG 296
                     L  L  L L  N L   +P  L      L+ L+L+ N L  E+P G
Sbjct: 122 ---------GLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAG 166

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 34/158 (21%), Positives = 51/158 (32%), Gaps = 35/158 (22%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L +  N    ++P        L++L++S N  +         L  LQ L L  N L +  
Sbjct: 82  LDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT-- 138

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI- 120
           L    L+     + L+L   +NN L      T                      +P  + 
Sbjct: 139 LPPGLLTPTPKLEKLSL---ANNNL------TE---------------------LPAGLL 168

Query: 121 GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENN 158
             L NL  + L  N L  +IP        L    L  N
Sbjct: 169 NGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 21/87 (24%), Positives = 30/87 (34%), Gaps = 8/87 (9%)

Query: 2   LQMWENNFSGTIPRFIFNA-SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L +  N    T+P  +     KL  L L++N+ +         L NL  L L  N L + 
Sbjct: 129 LYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT- 186

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLD 87
            +   F  S      L       NP  
Sbjct: 187 -IPKGFFGSHL----LPFAFLHGNPWL 208

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 22/215 (10%)

Query: 25  ILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNN 84
            L+LS N        +F +   LQ L LS   + +  +E     SLS+  +L L   + N
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT--IEDGAYQSLSHLSTLIL---TGN 86

Query: 85  PLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI-GNLTNLTIIYLGGNKLNGSIPS- 142
           P+   L   +   LS SL+       N++  +     G+L  L  + +  N +  S    
Sbjct: 87  PIQS-LALGAFSGLS-SLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLP 142

Query: 143 -TLGKLQKLQGLGLENNKLEGSIPDSICHS-----DELYKLELGGNKLSGSIPE-CFNNL 195
                L  L+ L L +NK++ SI  +              L+L  N ++  I    F  +
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI 200

Query: 196 ASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN 229
             L+ L L +N+L S+P   F  L  +  +   +N
Sbjct: 201 -RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 86.2 bits (214), Expect = 8e-19
 Identities = 44/191 (23%), Positives = 73/191 (38%), Gaps = 29/191 (15%)

Query: 115 GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS-DE 173
            +P       +   + L  N L      +     +LQ L L   +++ +I D    S   
Sbjct: 25  NLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 174 LYKLELGGNKLSGSIP-ECFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFF 231
           L  L L GN +  S+    F+ L+SL+ L+     L S+      +LK +  LN + N  
Sbjct: 78  LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136

Query: 232 TGPLPLEIGNLKIARIDSCD-LISLISLNLSNNNLSGAIPA----SLEKLSYLK-DLNLS 285
                           +    L +L  L+LS+N +  +I       L ++  L   L+LS
Sbjct: 137 Q----------SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLS 185

Query: 286 FNKLEGEIPRG 296
            N +   I  G
Sbjct: 186 LNPMN-FIQPG 195

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 48/187 (25%), Positives = 76/187 (40%), Gaps = 30/187 (16%)

Query: 122 NLTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLEL 179
           +   L ++ L   ++  +I       L  L  L L  N ++ S+          L KL  
Sbjct: 50  SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVA 107

Query: 180 GGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPL--TFWNLKDILYLNFSSNFFTGPLP 236
               L+ S+      +L +L+ L +  N + S  L   F NL ++ +L+ SSN       
Sbjct: 108 VETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN------- 159

Query: 237 LEIGNLKIARIDSCDLISL-------ISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKL 289
                 KI  I   DL  L       +SL+LS N ++  I     K   LK+L L  N+L
Sbjct: 160 ------KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQL 212

Query: 290 EGEIPRG 296
           +  +P G
Sbjct: 213 K-SVPDG 218

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 62.3 bits (152), Expect = 8e-11
 Identities = 42/208 (20%), Positives = 73/208 (35%), Gaps = 57/208 (27%)

Query: 2   LQMWENNFSGTIPRFIFNA-SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L +  N    ++    F+  S L  L   + + +       G+L+ L+ L +++N + S 
Sbjct: 81  LILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
            L   F S+L+N + L L   S+N +       S                     I    
Sbjct: 140 KLPEYF-SNLTNLEHLDL---SSNKI------QS---------------------IYCTD 168

Query: 121 -GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL 179
              L  + ++ L                     L L  N +   I         L +L L
Sbjct: 169 LRVLHQMPLLNL--------------------SLDLSLNPMN-FIQPGAFKEIRLKELAL 207

Query: 180 GGNKLSGSIPE-CFNNLASLRILLLGSN 206
             N+L  S+P+  F+ L SL+ + L +N
Sbjct: 208 DTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 97.2 bits (242), Expect = 3e-21
 Identities = 43/233 (18%), Positives = 89/233 (38%), Gaps = 13/233 (5%)

Query: 359 KCRKRERGPPNDANMPPEAMQRMFSYLELCRATDGFSE----NNLIGRGSFGSVFKAR-L 413
           K  + +    ++ +     + + +    +    D   +    +  +G G+FG V +    
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179

Query: 414 GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG 473
             G   A K     +    ++   E + M  +RH  ++ +  +  ++    ++ E+M  G
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239

Query: 474 SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL 533
            L + +   +  +   + +  M  V   L ++H       +H DLKP N++        L
Sbjct: 240 ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNEL 296

Query: 534 --SDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
              DFG+   L   D       T  T  + APE  +   V    D++S G++ 
Sbjct: 297 KLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 97.2 bits (242), Expect = 3e-21
 Identities = 55/261 (21%), Positives = 102/261 (39%), Gaps = 45/261 (17%)

Query: 394 FSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEM-----MKSIRH 447
           F +  ++G+G FG V   ++    ++ A K   L+  R+ K       +     ++ +  
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMID---------- 497
           R ++ +  +   ++   LVL  M  G L    H       IY                  
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDL--KFH-------IYHMGQAGFPEARAVFYAAE 294

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA- 556
           +   LE LH     ++++ DLKP N+LLDD+    +SD G+A  +          +    
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ----TIKGRVG 347

Query: 557 TIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT---------RKKPTDEIFNGEMTLKHW 607
           T+GYMAPE  K  R + + D ++ G +L E            +K   +E+      +   
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407

Query: 608 VNDWLPISTKEIVDPNLLSRE 628
            ++      + +    LL ++
Sbjct: 408 YSERFSPQARSLCS-QLLCKD 427

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 94.6 bits (236), Expect = 3e-21
 Identities = 63/227 (27%), Positives = 97/227 (42%), Gaps = 60/227 (26%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMK---VF-NLQYG-RVFKSFDVECEMMKSIRHRNIIK- 452
           +G G++G V  A     G  VA+K    F    +  R  +    E +++K  +H NII  
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR----EIKILKHFKHENIITI 74

Query: 453 --VISSCSNEEFKA--LVLEYMPHGSLEKYLH---SSNYILD------IYQRLNIMIDVA 499
             +    S E F    ++ E M     +  LH   S+  + D      IYQ L       
Sbjct: 75  FNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTLR------ 123

Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-------- 551
            A++ LH    + VIH DLKPSN+L++ N    + DFG+A+++        +        
Sbjct: 124 -AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 552 TQTLATIGYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRK 591
            + +AT  Y APE       Y +        DV+S G +L E F R+
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSR------AMDVWSCGCILAELFLRR 220

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 94.7 bits (236), Expect = 4e-21
 Identities = 75/274 (27%), Positives = 122/274 (44%), Gaps = 67/274 (24%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMK---VF-NLQYG-RVFKSFDVECEMMKSIRHRNIIK- 452
           IG G++G V  A    + + VA+K    F +  Y  R  +    E +++   RH NII  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR----EIKILLRFRHENIIGI 90

Query: 453 --VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSN-------YILDIYQRLNIMIDVASA 501
             +I + + E+ K   +V + M    L K L + +       Y L  YQ L         
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFL--YQILR-------G 140

Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ-TQTLATIGY 560
           L+Y+H   SA V+H DLKPSN+LL+      + DFG+A++   +   T   T+ +AT  Y
Sbjct: 141 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 561 MAPE-------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP 613
            APE       Y K      + D++S G +L E  + +     IF G+  L         
Sbjct: 198 RAPEIMLNSKGYTK------SIDIWSVGCILAEMLSNR----PIFPGKHYLDQL------ 241

Query: 614 ISTKEIVDPNLL---SREDINFVAKEQCVSFVFN 644
                I+   +L   S+ED+N +   +  +++ +
Sbjct: 242 ---NHILG--ILGSPSQEDLNCIINLKARNYLLS 270

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 94.4 bits (235), Expect = 4e-21
 Identities = 60/239 (25%), Positives = 92/239 (38%), Gaps = 50/239 (20%)

Query: 364 ERGPPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMK 422
           +R P     +    M     Y +  +          IG G+FG     R       VA+K
Sbjct: 2   DRAPVTTGPLDMPIMHDSDRY-DFVK---------DIGSGNFGVARLMRDKLTKELVAVK 51

Query: 423 VFN---LQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYL 479
                      V +    E    +S+RH NI++           A+++EY   G L + +
Sbjct: 52  YIERGAAIDENVQR----EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI 107

Query: 480 HSSNYILDIYQRLNIMIDVA--------SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVA 531
            +         R +   D A        S + Y H   S Q+ H DLK  N LLD +   
Sbjct: 108 CN-------AGRFSE--DEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAP 155

Query: 532 HL--SDFGIAKLLTREDQSTIQTQTLATIGYMAPE--YGKE--GRVSANGDVYSFGIML 584
            L   DFG +K       S  ++ T+ T  Y+APE    +E  G+++   DV+S G+ L
Sbjct: 156 RLKICDFGYSKSSV--LHSQPKS-TVGTPAYIAPEVLLRQEYDGKIA---DVWSCGVTL 208

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 93.5 bits (233), Expect = 5e-21
 Identities = 58/256 (22%), Positives = 99/256 (38%), Gaps = 52/256 (20%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQ-----YGRVFKSFDVECEMMKSIRHRNIIK 452
            +G G++G V  A        VA+K+ +++        + K    E  + K + H N++K
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVK 69

Query: 453 ---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------SA 501
                    N ++  L LEY   G L       + I      +      A        + 
Sbjct: 70  FYGHRRE-GNIQY--LFLEYCSGGEL------FDRIEP-DIGMPE--PDAQRFFHQLMAG 117

Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           + YLH      + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174

Query: 562 APE--YGKE--GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN------DW 611
           APE    +E         DV+S GI+L      + P D+  +       W         W
Sbjct: 175 APELLKRREFHAEPV---DVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231

Query: 612 LPISTKEIVDPNLLSR 627
             I +  +    LL +
Sbjct: 232 KKIDSAPL---ALLHK 244

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 96.0 bits (239), Expect = 6e-21
 Identities = 65/264 (24%), Positives = 109/264 (41%), Gaps = 44/264 (16%)

Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEM-----MKSI 445
           D F +  ++GRG FG VF  ++    ++ A K   L   R+ K    +  M     +  +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKV 242

Query: 446 RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIY--QRLNIMI-DVASAL 502
             R I+ +  +   +    LV+  M  G +  ++++ +     +   R       + S L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYM 561
           E+LH      +I+ DLKP NVLLDD+    +SD G+A  L         T+  A T G+M
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK---TKGYAGTPGFM 356

Query: 562 APE------YGKEGRVSANGDVYSFGIMLMETFT---------RKKPTDEIFNGEMTLKH 606
           APE      Y      S   D ++ G+ L E             K    E+   +  L+ 
Sbjct: 357 APELLLGEEYDF----SV--DYFALGVTLYEMIAARGPFRARGEKVENKELK--QRVLEQ 408

Query: 607 WVN--DWLPISTKEIVDPNLLSRE 628
            V   D    ++K+  +  LL ++
Sbjct: 409 AVTYPDKFSPASKDFCE-ALLQKD 431

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 94.4 bits (235), Expect = 6e-21
 Identities = 51/232 (21%), Positives = 93/232 (40%), Gaps = 19/232 (8%)

Query: 362 KRERGPPNDANMPPEAMQRMFSYLELCRATDGFSEN------NLIGRGSFGSVFKAR-LG 414
           KR      D   PP      F +  +       +         ++G G FG V K     
Sbjct: 57  KRTSALAVDIPAPPA----PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETA 112

Query: 415 DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGS 474
            G+++A K+   +  +  +    E  +M  + H N+I++  +  ++    LV+EY+  G 
Sbjct: 113 TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172

Query: 475 LEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL- 533
           L   +   +Y L     +  M  +   + ++H      ++H DLKP N+L  +     + 
Sbjct: 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIK 229

Query: 534 -SDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIML 584
             DFG+A+   R            T  ++APE      VS   D++S G++ 
Sbjct: 230 IIDFGLAR---RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 94.9 bits (236), Expect = 6e-21
 Identities = 55/247 (22%), Positives = 97/247 (39%), Gaps = 52/247 (21%)

Query: 386 ELCRATDGFS-ENNLIGRGSFGSVFKAR---LGDGMEVAMKVFNLQYGRVFKSFDVE--C 439
           E  R  D F  E   +GRG++G V+KA+     D  + A+K              +    
Sbjct: 14  ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE------GTGISMSACR 67

Query: 440 EM--MKSIRHRNIIK---VISSCSNEEFKALVLEYMPHGSLEKYLHS--------SNYIL 486
           E+  ++ ++H N+I    V  S ++ +   L+ +Y  H  L   +              L
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125

Query: 487 DIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLL 542
                 +++  +   + YLH   +  V+H DLKP+N+L+           ++D G A+L 
Sbjct: 126 PRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182

Query: 543 TREDQS-TIQTQTLATIGYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRKKPT 594
               +        + T  Y APE       Y K   +    D+++ G +  E  T  +P 
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKA--I----DIWAIGCIFAELLTS-EP- 234

Query: 595 DEIFNGE 601
             IF+  
Sbjct: 235 --IFHCR 239

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 93.1 bits (232), Expect = 8e-21
 Identities = 59/304 (19%), Positives = 121/304 (39%), Gaps = 60/304 (19%)

Query: 392 DGFSENNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQY--GRVFKSFDV----ECEMMKS 444
           + + + + +G G++ +V+K +       VA+K   L++  G            E  ++K 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-----APCTAIREVSLLKD 56

Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           ++H NI+ +      E+   LV EY+    L++YL     I++++     +  +   L Y
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
            H     +V+H DLKP N+L+++     L+DFG+A+  +   ++      + T+ Y  P+
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPD 170

Query: 565 --YGKEGRVSANGDVYSFGIMLMETFTRK--------------------KPTDEIFNGEM 602
              G     S   D++  G +  E  T +                     PT+E + G +
Sbjct: 171 ILLGST-DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229

Query: 603 TLKHWVN----DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI 658
           + + +       +   +      P  L  +  + + K       F             RI
Sbjct: 230 SNEEFKTYNYPKYRAEALLSHA-PR-LDSDGADLLTK----LLQFE---------GRNRI 274

Query: 659 NAKE 662
           +A++
Sbjct: 275 SAED 278

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 94.0 bits (234), Expect = 9e-21
 Identities = 50/261 (19%), Positives = 91/261 (34%), Gaps = 70/261 (26%)

Query: 361 RKRERGPPNDANMPPEAMQRMFSYLELCRATDGFSEN-----NLIGRGSFGSVFKAR-LG 414
                 P      PP+   +      L    +   ++      ++G G  G V +     
Sbjct: 26  PALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKR 85

Query: 415 DGMEVAMKVFNLQYGRVFKSFDVECE---MMKSIRHRNIIKVI----SSCSNEEFKALVL 467
              + A+K+                E     ++ +  +I++++    +  +  +   +V+
Sbjct: 86  TQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138

Query: 468 EYMPHGSLEKYLHSSNYILD-IYQRLN----------IMIDVASALEYLHFGYSAQVIHC 516
           E +  G L             I  R +          IM  +  A++YLH   S  + H 
Sbjct: 139 ECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHR 185

Query: 517 DLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI----GYMAPE----- 564
           D+KP N+L      N +  L+DFG AK  T          +L T      Y+APE     
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSH-------NSLTTPCYTPYYVAPEVLGPE 238

Query: 565 -YGKEGRVSANGDVYSFGIML 584
            Y K        D++S G+++
Sbjct: 239 KYDKS------CDMWSLGVIM 253

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 93.2 bits (232), Expect = 9e-21
 Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 35/232 (15%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEM----------MKSIRHR 448
           +G G+FG V+ A       EV +K    +  +V +   +E             +  + H 
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKE--KVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLN------IMIDVASAL 502
           NIIKV+    N+ F  LV+E    G L+ +     +I D + RL+      I   + SA+
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSG-LDLF----AFI-DRHPRLDEPLASYIFRQLVSAV 143

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
            YL       +IH D+K  N+++ ++    L DFG A  L  E      T    TI Y A
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIEYCA 197

Query: 563 PE-YGKEGRVSANGDVYSFGIMLMETFTRKKP---TDEIFNGEMTLKHWVND 610
           PE            +++S G+ L      + P    +E     +   + V+ 
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSK 249

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 96.1 bits (239), Expect = 9e-21
 Identities = 63/256 (24%), Positives = 108/256 (42%), Gaps = 35/256 (13%)

Query: 394 FSENNLIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVEC--------EMMKS 444
           FS + +IGRG FG V+  R  D  ++ AMK   L   R+                 ++ +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVST 248

Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                I+ +  +    +  + +L+ M  G L  +L       +   R     ++   LE+
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA-EIILGLEH 307

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAP 563
           +H   +  V++ DLKP+N+LLD++    +SD G+A   +++     +      T GYMAP
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGYMAP 359

Query: 564 E-YGKEGRVSANGDVYSFGIMLMETFT--------RKKPTDEIFNGEMTLKHWVN--DWL 612
           E   K     ++ D +S G ML +           + K   EI    MTL   V   D  
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--RMTLTMAVELPDSF 417

Query: 613 PISTKEIVDPNLLSRE 628
               + +++  LL R+
Sbjct: 418 SPELRSLLE-GLLQRD 432

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 55/234 (23%), Positives = 90/234 (38%), Gaps = 41/234 (17%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFN----LQYGRVFKSFDV--ECEMMKSIRHR--N 449
           L+G G FGSV+    + D + VA+K         +G +     V  E  ++K +      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 450 IIKVISSCSNEEFKALVLEY-MPHGSLEKYLHSSNYILDIYQRLN------IMIDVASAL 502
           +I+++      +   L+LE   P   L  ++            L           V  A+
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAV 162

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
            + H   +  V+H D+K  N+L+D N     L DFG   LL     +        T  Y 
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTRVYS 215

Query: 562 APEY--GK--EGRVSANGDVYSFGIMLMETFTRKKP---TDEIFNGEMTLKHWV 608
            PE+       GR +    V+S GI+L +      P    +EI  G++  +  V
Sbjct: 216 PPEWIRYHRYHGRSA---AVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 266

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 94.1 bits (234), Expect = 2e-20
 Identities = 65/259 (25%), Positives = 105/259 (40%), Gaps = 47/259 (18%)

Query: 372 NMPPEAMQRMFSYLELCRAT----DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNL 426
           NM    +   F  +E+  +T      +     IG G+ G V  A        VA+K    
Sbjct: 38  NMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---- 93

Query: 427 QYGRVFKSFDV---------ECEMMKSIRHRNIIKVI----SSCSNEEFKA--LVLEYMP 471
              ++ + F           E  +MK + H+NII ++       + EEF+   LV+E M 
Sbjct: 94  ---KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD 150

Query: 472 ---HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN 528
                 ++  L        +YQ L         +++LH   SA +IH DLKPSN+++  +
Sbjct: 151 ANLCQVIQMELDHERMSYLLYQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSD 200

Query: 529 MVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETF 588
               + DFG+A+       S + T  + T  Y APE         N D++S G ++ E  
Sbjct: 201 CTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

Query: 589 TRKKPTDEIFNGEMTLKHW 607
             K     +F G   +  W
Sbjct: 258 RHK----ILFPGRDYIDQW 272

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 93.3 bits (232), Expect = 3e-20
 Identities = 44/233 (18%), Positives = 89/233 (38%), Gaps = 39/233 (16%)

Query: 363 RERGPPNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAM 421
           ++ G     +   +    M       +  D +   +LIG GS+G V +A    +   VA+
Sbjct: 24  QQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAI 83

Query: 422 KVFNLQYGRVFKSFDV---------ECEMMKSIRHRNIIK---VISSCSNEEFKA--LVL 467
           K       ++ + F+          E  ++  + H +++K   ++     E+F    +VL
Sbjct: 84  K-------KILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136

Query: 468 EYMPHGSLEKYLHSSNYILD------IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPS 521
           E       +K   +  Y+ +      +Y  L         ++Y+H   SA ++H DLKP+
Sbjct: 137 EIADS-DFKKLFRTPVYLTELHIKTLLYNLLV-------GVKYVH---SAGILHRDLKPA 185

Query: 522 NVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSAN 574
           N L++ +    + DFG+A+ +   +    Q         M        +    
Sbjct: 186 NCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 92.9 bits (231), Expect = 3e-20
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 45/213 (21%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVEC-----EMMKSIRHRNIIK 452
           +IGRG+FG V   +L +  +V AMK+  L    + K  +  C     +++ +   + I  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-----IYQRLNIMIDVASALEYLHF 507
           +  +  ++    LV++Y   G L   L      L       Y     + ++  A++ +H 
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-----LAEMVIAIDSVH- 192

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPE 564
                 +H D+KP N+L+D N   H  L+DFG    L  +   T+Q+     T  Y++PE
Sbjct: 193 --QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPE 246

Query: 565 -----------YGKEGRVSANGDVYSFGIMLME 586
                      YG E       D +S G+ + E
Sbjct: 247 ILQAMEGGKGRYGPE------CDWWSLGVCMYE 273

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 60/236 (25%), Positives = 93/236 (39%), Gaps = 43/236 (18%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFN----LQYGRVFKSFDV--ECEMMKSIR----H 447
           L+G+G FG+VF    L D ++VA+KV      L +  +  S     E  ++  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 448 RNIIKVISSCSNEEFKALVLEY-MPHGSLEKYLHSSNYILDIYQRL------NIMIDVAS 500
             +I+++     +E   LVLE  +P   L  Y+            L           V +
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-------GPLGEGPSRCFFGQVVA 150

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIG 559
           A+++ H   S  V+H D+K  N+L+D     A L DFG   LL  E  +        T  
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----FDGTRV 203

Query: 560 YMAPEY--GK--EGRVSANGDVYSFGIMLMETFTRKKP---TDEIFNGEMTLKHWV 608
           Y  PE+          +    V+S GI+L +      P     EI   E+     V
Sbjct: 204 YSPPEWISRHQYHALPA---TVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 87.7 bits (218), Expect = 5e-20
 Identities = 31/190 (16%), Positives = 67/190 (35%), Gaps = 17/190 (8%)

Query: 22  KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF 81
                 L  +S +     T   + +L  + L+N  +T        L+ +    ++  ++ 
Sbjct: 24  AYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD-------LTGIEYAHNIKDLTI 73

Query: 82  SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIP 141
           +N           +  LS +LE   +   +V+      +  LT+LT++ +  +  + SI 
Sbjct: 74  NNIHATNY---NPISGLS-NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129

Query: 142 STLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRIL 201
           + +  L K+  + L  N     I   +    EL  L +  + +         +   L  L
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQL 186

Query: 202 LLGSNELTSI 211
              S  +   
Sbjct: 187 YAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 79.2 bits (196), Expect = 4e-17
 Identities = 28/225 (12%), Positives = 59/225 (26%), Gaps = 50/225 (22%)

Query: 43  NLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSL 102
             +      L  +   + T         +   SLT I+ +N  +  +             
Sbjct: 21  TFKAYLNGLLGQSSTANITE--------AQMNSLTYITLANINVTDL------------- 59

Query: 103 EYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEG 162
                            I    N+  + +          + +  L  L+ L +    +  
Sbjct: 60  ---------------TGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTS 102

Query: 163 SIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDIL 222
               ++     L  L++  +    SI    N L  +  + L  N   +  +    L ++ 
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELK 162

Query: 223 YLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSG 267
            LN   +       +E            D   L  L   +  + G
Sbjct: 163 SLNIQFDGVHDYRGIE------------DFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.1 bits (162), Expect = 1e-12
 Identities = 27/142 (19%), Positives = 56/142 (39%), Gaps = 12/142 (8%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
            A  +  L +++   + + P     L NL+ LR+    +TS       + +LS   SLTL
Sbjct: 64  YAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDK-----IPNLSGLTSLTL 116

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG 138
           +  S++  D  +  T +  L   +   +++Y      I   +  L  L  + +  + ++ 
Sbjct: 117 LDISHSAHDDSIL-TKINTLP-KVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD 173

Query: 139 SIPSTLGKLQKLQGLGLENNKL 160
                +    KL  L   +  +
Sbjct: 174 YRG--IEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.4 bits (160), Expect = 2e-12
 Identities = 31/169 (18%), Positives = 61/169 (36%), Gaps = 19/169 (11%)

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG 181
                    LG +        T  ++  L  + L N  +   +   I ++  +  L +  
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75

Query: 182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLT-FWNLKDILYLNFSSNFFTGPLPLEIG 240
              +   P   + L++L  L +   ++TS  +     L  +  L+ S +     +  +I 
Sbjct: 76  IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 241 NLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKL 289
            L            + S++LS N     I   L+ L  LK LN+ F+ +
Sbjct: 134 TLP----------KVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 22/137 (16%), Positives = 43/137 (31%), Gaps = 12/137 (8%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST 61
           L +   + +   P  I   S L  L +     +         L +L  L +S++    S 
Sbjct: 71  LTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128

Query: 62  LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG 121
                L+ ++    +  I  S N     +    +  L   L+   + +  V       I 
Sbjct: 129 -----LTKINTLPKVNSIDLSYNGAITDI--MPLKTLP-ELKSLNIQFDGVHDYRG--IE 178

Query: 122 NLTNLTIIYLGGNKLNG 138
           +   L  +Y     + G
Sbjct: 179 DFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 50.3 bits (121), Expect = 3e-07
 Identities = 19/122 (15%), Positives = 41/122 (33%), Gaps = 16/122 (13%)

Query: 173 ELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFT 232
                 LG +  +         + SL  + L +  +T +        +I  L  ++   T
Sbjct: 24  AYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHAT 79

Query: 233 GPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGE 292
              P+              L +L  L +   +++     +L  L+ L  L++S +  +  
Sbjct: 80  NYNPIS------------GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127

Query: 293 IP 294
           I 
Sbjct: 128 IL 129

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 43.4 bits (103), Expect = 7e-05
 Identities = 13/89 (14%), Positives = 31/89 (34%), Gaps = 8/89 (8%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           +L +  +    +I   I    K++ ++LS N     I      L  L++L +  + +   
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHD- 173

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGI 89
                    + +   L  +   +  + G 
Sbjct: 174 ------YRGIEDFPKLNQLYAFSQTIGGK 196

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 91.6 bits (228), Expect = 5e-20
 Identities = 66/274 (24%), Positives = 111/274 (40%), Gaps = 75/274 (27%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---------ECEMMKSIRHRN 449
           +G G++GSV  A     G+ VA+K       ++ + F           E  ++K ++H N
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK-------KLSRPFQSIIHAKRTYRELRLLKHMKHEN 89

Query: 450 IIKV----ISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILD-----IYQRLNIMIDV 498
           +I +      + S EEF    LV   M    L   +       D     IYQ L      
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILR----- 143

Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI 558
              L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+       +   T  +AT 
Sbjct: 144 --GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADEMTGYVATR 193

Query: 559 GYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW 611
            Y APE       Y +        D++S G ++ E  T +     +F G   +       
Sbjct: 194 WYRAPEIMLNWMHYNQ------TVDIWSVGCIMAELLTGR----TLFPGTDHIDQL---- 239

Query: 612 LPISTKEIVDPNLL---SREDINFVAKEQCVSFV 642
                K I+   L+     E +  ++ E   +++
Sbjct: 240 -----KLILR--LVGTPGAELLKKISSESARNYI 266

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 89.3 bits (222), Expect = 5e-20
 Identities = 57/223 (25%), Positives = 88/223 (39%), Gaps = 42/223 (18%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
            IP  I   +    L+L  N  S      F  L  L+ L L++N L +  L       L 
Sbjct: 30  AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT--LPAGIFKELK 85

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI-GNLTNLTIIY 130
           N   L  +  ++N L       +                     +P  +   L NL  + 
Sbjct: 86  N---LETLWVTDNKL------QA---------------------LPIGVFDQLVNLAELR 115

Query: 131 LGGNKLNGSIPSTL-GKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLELGGNKLSGSI 188
           L  N+L  S+P  +   L KL  L L  N+L+ S+P  +      L +L L  N+L   +
Sbjct: 116 LDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RV 172

Query: 189 PE-CFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN 229
           PE  F+ L  L+ L L +N+L  +P   F +L+ +  L    N
Sbjct: 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 80.8 bits (200), Expect = 5e-17
 Identities = 58/186 (31%), Positives = 85/186 (45%), Gaps = 24/186 (12%)

Query: 115 GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS-DE 173
            IP       +   + L  NKL+        +L KL+ L L +NKL+ ++P  I      
Sbjct: 34  NIP------ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 174 LYKLELGGNKLSGSIPEC-FNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFF 231
           L  L +  NKL  ++P   F+ L +L  L L  N+L S+P   F +L  + YL+   N  
Sbjct: 87  LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYN-- 143

Query: 232 TGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASL-EKLSYLKDLNLSFNKLE 290
                 E+ +L     D   L SL  L L NN L   +P    +KL+ LK L L  N+L+
Sbjct: 144 ------ELQSLPKGVFDK--LTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK 194

Query: 291 GEIPRG 296
             +P G
Sbjct: 195 -RVPEG 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 17/170 (10%)

Query: 122 NLTNLTIIYLGGNKLNGSIPSTL-GKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLEL 179
            LT L ++YL  NKL  ++P+ +  +L+ L+ L + +NKL+ ++P  +      L +L L
Sbjct: 59  RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116

Query: 180 GGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPL 237
             N+L  S+P   F++L  L  L LG NEL S+P   F  L  +  L   +N     +P 
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR-VPE 174

Query: 238 EIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFN 287
              +          L  L +L L NN L      + + L  LK L L  N
Sbjct: 175 GAFD---------KLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 41/136 (30%), Positives = 70/136 (51%), Gaps = 16/136 (11%)

Query: 163 SIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDI 221
           +IP +I    +  KL+L  NKLS    + F+ L  LR+L L  N+L ++P   F  LK++
Sbjct: 30  AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87

Query: 222 LYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASL-EKLSYLK 280
             L  + N     LP+ + +          L++L  L L  N L  ++P  + + L+ L 
Sbjct: 88  ETLWVTDNKLQA-LPIGVFD---------QLVNLAELRLDRNQLK-SLPPRVFDSLTKLT 136

Query: 281 DLNLSFNKLEGEIPRG 296
            L+L +N+L+  +P+G
Sbjct: 137 YLSLGYNELQ-SLPKG 151

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 20/87 (22%), Positives = 34/87 (39%), Gaps = 7/87 (8%)

Query: 2   LQMWENNFSGTIPRFIFNA-SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L +  N    ++P+ +F+  + L  L L +N         F  L  L+ L+L NN L   
Sbjct: 138 LSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRV 196

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLD 87
                      + + L ++    NP D
Sbjct: 197 PEGA-----FDSLEKLKMLQLQENPWD 218

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 90.8 bits (226), Expect = 7e-20
 Identities = 58/275 (21%), Positives = 104/275 (37%), Gaps = 60/275 (21%)

Query: 391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---------ECE 440
              +     +G G++GSV  A     G +VA+K       ++ + F           E  
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK-------KLSRPFQSEIFAKRAYRELL 75

Query: 441 MMKSIRHRNIIK----VISSCSNEEFKA--LVLEYMP---HGSLEKYLHSSNYILDIYQR 491
           ++K ++H N+I        + S   F    LV+ +M       +            +YQ 
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM 135

Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
           L         L+Y+H   SA V+H DLKP N+ ++++    + DFG+A+           
Sbjct: 136 LK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEM 180

Query: 552 TQTLATIGYMAPE-YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND 610
           T  + T  Y APE        +   D++S G ++ E  T K     +F G+  L      
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKDYLDQL--- 233

Query: 611 WLPISTKEIVDPNLL---SREDINFVAKEQCVSFV 642
                  +I+   +      E +  +  +   S++
Sbjct: 234 ------TQILK--VTGVPGTEFVQKLNDKAAKSYI 260

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 91.3 bits (227), Expect = 8e-20
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 48/213 (22%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVEC-----EMMKSIRHRNIIK 452
           +IGRG+FG V   R     +V AMK+ +     + K  D        ++M       +++
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE--MIKRSDSAFFWEERDIMAFANSPWVVQ 133

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------SALEY 504
           +  +  ++ +  +V+EYMP G L   +             ++    A         AL+ 
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM----------SNYDVPEKWARFYTAEVVLALDA 183

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAP 563
           +H   S   IH D+KP N+LLD +    L+DFG    + +E    ++  T   T  Y++P
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAVGTPDYISP 238

Query: 564 E----------YGKEGRVSANGDVYSFGIMLME 586
           E          YG+E       D +S G+ L E
Sbjct: 239 EVLKSQGGDGYYGRE--C----DWWSVGVFLYE 265

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 90.0 bits (224), Expect = 8e-20
 Identities = 60/245 (24%), Positives = 99/245 (40%), Gaps = 66/245 (26%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMK--VF-NLQYG-RVFKSFDVECEMMKSIRHRNIIKVI 454
           +G G  G VF A        VA+K  V  + Q      +    E ++++ + H NI+KV 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR----EIKIIRRLDHDNIVKVF 74

Query: 455 ------------SSCSNEEFKA--LVLEYMPHGSLEKYLH---SSNYILD------IYQR 491
                          S  E  +  +V EYM     E  L        +L+      +YQ 
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMYQL 129

Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTI 550
           L         L+Y+H   SA V+H DLKP+N+ ++ +++V  + DFG+A+++        
Sbjct: 130 LR-------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 551 Q-TQTLATIGYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM 602
             ++ L T  Y +P        Y K        D+++ G +  E  T K     +F G  
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTK------AIDMWAAGCIFAEMLTGK----TLFAGAH 229

Query: 603 TLKHW 607
            L+  
Sbjct: 230 ELEQM 234

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 89.9 bits (224), Expect = 8e-20
 Identities = 65/212 (30%), Positives = 91/212 (42%), Gaps = 53/212 (25%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVEC-----EMMKSIRHRNIIK 452
            +G GSFG V   R        AMKV  L+   V +   VE       M+  + H  II+
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKV--LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASALE 503
           +  +  + +   ++++Y+  G L   L  S          Y  ++            ALE
Sbjct: 71  MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV----------CLALE 120

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDQSTIQTQTL-ATIGY 560
           YLH   S  +I+ DLKP N+LLD N   H  ++DFG AK           T TL  T  Y
Sbjct: 121 YLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAK----YVPDV--TYTLCGTPDY 169

Query: 561 MAPE------YGKEGRVSANGDVYSFGIMLME 586
           +APE      Y K    S   D +SFGI++ E
Sbjct: 170 IAPEVVSTKPYNK----SI--DWWSFGILIYE 195

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 30/200 (15%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSIRHRNIIK 452
            +G G+FG V        G +VA+K+ N Q  ++     V     E + +K  RH +IIK
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQ--KIRSLDVVGKIKREIQNLKLFRHPHIIK 75

Query: 453 ---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
              VIS+   + F  +V+EY+  G L  Y+   +  ++  +   +   + SA++Y H   
Sbjct: 76  LYQVIST-PTDFF--MVMEYVSGGELFDYI-CKHGRVEEMEARRLFQQILSAVDYCH--- 128

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI----GYMAPE- 564
              V+H DLKP NVLLD +M A ++DFG++ +++         + L T      Y APE 
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-------DGEFLRTSCGSPNYAAPEV 181

Query: 565 YGKEGRVSANGDVYSFGIML 584
                      D++S G++L
Sbjct: 182 ISGRLYAGPEVDIWSCGVIL 201

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 29/198 (14%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN------LQYGRVFKSFDVECEMMKSIRHRNIIK 452
           IG+G+F  V  AR +  G EVA+K+ +          ++F+    E  +MK + H NI+K
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNHPNIVK 78

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +      E+   L++EY   G +  YL +    +   +  +    + SA++Y H     +
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGR-MKEKEARSKFRQIVSAVQYCH---QKR 134

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ--TLATIGYMAPE--YGK- 567
           ++H DLK  N+LLD +M   ++DFG +   T      +           Y APE   GK 
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDAFCGAPP---YAAPELFQGKK 189

Query: 568 -EGRVSANGDVYSFGIML 584
            +G      DV+S G++L
Sbjct: 190 YDGPEV---DVWSLGVIL 204

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 90.1 bits (224), Expect = 1e-19
 Identities = 60/276 (21%), Positives = 113/276 (40%), Gaps = 79/276 (28%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---------ECEMMKSIRHRN 449
           +G G++G+V  A     G +VA+K       ++++ F           E  ++K +RH N
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIK-------KLYRPFQSELFAKRAYRELRLLKHMRHEN 85

Query: 450 IIKVI----SSCSNEEFKA--LVLEYMPHGSLEKYLHSSN-------YILDIYQRLNIMI 496
           +I ++       + ++F    LV+ +M    L K +           ++  +YQ L    
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFL--VYQMLK--- 139

Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA 556
                L Y+H   +A +IH DLKP N+ ++++    + DFG+A+        +  T  + 
Sbjct: 140 ----GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ-----ADSEMTGYVV 187

Query: 557 TIGYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN 609
           T  Y APE       Y +        D++S G ++ E  T K     +F G   L     
Sbjct: 188 TRWYRAPEVILNWMRYTQ------TVDIWSVGCIMAEMITGK----TLFKGSDHLDQL-- 235

Query: 610 DWLPISTKEIVDPNLL---SREDINFVAKEQCVSFV 642
                  KEI+   +      E +  +  ++  +++
Sbjct: 236 -------KEIMK--VTGTPPAEFVQRLQSDEAKNYM 262

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 64/303 (21%), Positives = 119/303 (39%), Gaps = 65/303 (21%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQY--GRVFKSFDV----ECEMMKSIRHRNIIK 452
           +G G++ +V+K      G+ VA+K   L    G            E  +MK ++H NI++
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG-----TPSTAIREISLMKELKHENIVR 67

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-----LDIYQRLNIMIDVASALEYLHF 507
           +      E    LV E+M +  L+KY+ S         L++         +   L + H 
Sbjct: 68  LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH- 125

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE--Y 565
               +++H DLKP N+L++      L DFG+A+       +   +  + T+ Y AP+   
Sbjct: 126 --ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYRAPDVLM 181

Query: 566 GKEGRVSANGDVYSFGIMLMETFTRK--------------------KPTDEIFNGEMTLK 605
           G     S + D++S G +L E  T K                     P + ++     L 
Sbjct: 182 GSR-TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240

Query: 606 HWVND---WLPISTKEIVDPNL---LSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN 659
            +  +     P   ++++ P+    L    ++F+          N         P+ R++
Sbjct: 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHG----LLQLN---------PDMRLS 287

Query: 660 AKE 662
           AK+
Sbjct: 288 AKQ 290

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 89.2 bits (222), Expect = 2e-19
 Identities = 60/228 (26%), Positives = 96/228 (42%), Gaps = 42/228 (18%)

Query: 388 CRATDGFSENNLIGRGSFGSVFKAR--LGDGMEVAMKVFNLQYGRVFKSFDVECE----- 440
           CRA   +     IG G++G VFKAR     G  VA+K   +             E     
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV---------QTGEEGMPLS 57

Query: 441 ---------MMKSIRHRNIIK----VISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYI- 485
                     +++  H N+++       S ++ E K  LV E++    L  YL       
Sbjct: 58  TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG 116

Query: 486 LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE 545
           +      ++M  +   L++LH   S +V+H DLKP N+L+  +    L+DFG+A++ + +
Sbjct: 117 VPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 173

Query: 546 DQSTIQTQTLATIGYMAPE--YGKEGRVSANGDVYSFGIMLMETFTRK 591
              T    TL    Y APE         +   D++S G +  E F RK
Sbjct: 174 MALTSVVVTL---WYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRK 216

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 38/194 (19%), Positives = 78/194 (40%), Gaps = 22/194 (11%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS 458
           +GRG FG V +            K   ++          E  ++   RHRNI+ +  S  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFE 71

Query: 459 NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL 518
           + E   ++ E++    + + +++S + L+  + ++ +  V  AL++LH   S  + H D+
Sbjct: 72  SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDI 128

Query: 519 KPSNVLLDDNMVAHL--SDFGIAKLLTREDQSTIQTQTLATIGYMAPE------YGKEGR 570
           +P N++      + +   +FG A+   +               Y APE            
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA-- 183

Query: 571 VSANGDVYSFGIML 584
                D++S G ++
Sbjct: 184 ----TDMWSLGTLV 193

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 67/322 (20%), Positives = 118/322 (36%), Gaps = 80/322 (24%)

Query: 388 CRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECE------ 440
             AT  +     IG G++G+V+KAR    G  VA+K   +                    
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV---------PNGGGGGGGLP 55

Query: 441 -----------MMKSIRHRNIIK----VISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNY 484
                       +++  H N+++      +S ++ E K  LV E++    L  YL  +  
Sbjct: 56  ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP 114

Query: 485 I-LDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT 543
             L      ++M      L++LH   +  ++H DLKP N+L+       L+DFG+A++ +
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYS 171

Query: 544 REDQSTIQTQTLATIGYMAPE--YGKEGRVSANGDVYSFGIMLMETFTRK---------- 591
            +   T    TL    Y APE         +   D++S G +  E F RK          
Sbjct: 172 YQMALTPVVVTL---WYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226

Query: 592 ----------KPTDEIFNGEMTLKHWVN-DWLPISTKEIVDPNLLSREDINFVAKEQCVS 640
                      P ++ +  +++L         P   + +V P  +       + +     
Sbjct: 227 QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVV-PE-MEESGAQLLLE----M 280

Query: 641 FVFNVAMECTVESPEQRINAKE 662
             FN         P +RI+A  
Sbjct: 281 LTFN---------PHKRISAFR 293

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 90.2 bits (224), Expect = 2e-19
 Identities = 41/191 (21%), Positives = 74/191 (38%), Gaps = 39/191 (20%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---------ECEMMKSIRHRN 449
           IGRGS+G V+ A        VA+K       +V + F+          E  ++  ++   
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIK-------KVNRMFEDLIDCKRILREITILNRLKSDY 86

Query: 450 IIK---VISSCSNEEFKA--LVLEYMPHGSLEKYLHSSNYILD------IYQRLNIMIDV 498
           II+   +I      +F    +VLE      L+K   +  ++ +      +Y  L      
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLL----- 140

Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI 558
                ++H    + +IH DLKP+N LL+ +    + DFG+A+ +  E  + I        
Sbjct: 141 --GENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

Query: 559 GYMAPEYGKEG 569
                    + 
Sbjct: 196 EPGPHNKNLKK 206

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 31/201 (15%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVEC-----EMMKSIRHRNIIK 452
            +G GSFG V   +  +     AMK+  L   +V K   +E       +++++    ++K
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKI--LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +  S  +     +V+EY+  G +  +L       + + R      +    EYLH   S  
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA-QIVLTFEYLH---SLD 161

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPE------Y 565
           +I+ DLKP N+L+D      ++DFG AK      +    T TL  T   +APE      Y
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGR--TWTLCGTPEALAPEIILSKGY 215

Query: 566 GKEGRVSANGDVYSFGIMLME 586
            K   V    D ++ G+++ E
Sbjct: 216 NKA--V----DWWALGVLIYE 230

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 87.2 bits (217), Expect = 4e-19
 Identities = 55/207 (26%), Positives = 84/207 (40%), Gaps = 40/207 (19%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN------LQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G G F  V K R  G G E A K          + G   +  + E  +++ IRH NII 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 453 VISSCSNEEFKALVLEYMPHGSL-----EKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
           +     N+    L+LE +  G L     EK   + +           +  +   + YLH 
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ------FLKQILDGVHYLH- 125

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAH----LSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
             S ++ H DLKP N++L D  V +    L DFGIA  +   +          T  ++AP
Sbjct: 126 --SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI---EAGNEFKNIFGTPEFVAP 180

Query: 564 E------YGKEGRVSANGDVYSFGIML 584
           E       G E       D++S G++ 
Sbjct: 181 EIVNYEPLGLE------ADMWSIGVIT 201

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 88.2 bits (219), Expect = 6e-19
 Identities = 45/198 (22%), Positives = 78/198 (39%), Gaps = 22/198 (11%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN------LQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G G F  V K R    G+E A K          + G   +  + E  +++ + H NII 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI--LDIYQRLNIMIDVASALEYLHFGYS 510
           +     N     L+LE +  G L  +L     +   +     + +  +   + YLH   +
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQILDGVNYLH---T 133

Query: 511 AQVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
            ++ H DLKP N++L           L DFG+A      +          T  ++APE  
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTPEFVAPEIV 190

Query: 567 KEGRVSANGDVYSFGIML 584
               +    D++S G++ 
Sbjct: 191 NYEPLGLEADMWSIGVIT 208

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 86.9 bits (216), Expect = 7e-19
 Identities = 44/196 (22%), Positives = 79/196 (40%), Gaps = 18/196 (9%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN------LQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G G F  V K R    G+E A K          + G   +  + E  +++ + H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +     N     L+LE +  G L  +L     + +     + +  +   + YLH   + +
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-SFIKQILDGVNYLH---TKK 135

Query: 513 VIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           + H DLKP N++L           L DFG+A  +   +          T  ++APE    
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNIFGTPEFVAPEIVNY 192

Query: 569 GRVSANGDVYSFGIML 584
             +    D++S G++ 
Sbjct: 193 EPLGLEADMWSIGVIT 208

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 87.3 bits (217), Expect = 7e-19
 Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 40/207 (19%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFN------LQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +G G F  V K R    G++ A K          + G   +  + E  ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 453 VISSCSNEEFKALVLEYMPHGSL-----EKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
           +     N+    L+LE +  G L     EK   +     +       +  + + + YLH 
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE------FLKQILNGVYYLH- 131

Query: 508 GYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
             S Q+ H DLKP N++L           + DFG+A  +   D          T  ++AP
Sbjct: 132 --SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEFVAP 186

Query: 564 E------YGKEGRVSANGDVYSFGIML 584
           E       G E       D++S G++ 
Sbjct: 187 EIVNYEPLGLE------ADMWSIGVIT 207

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 87.9 bits (218), Expect = 9e-19
 Identities = 57/254 (22%), Positives = 99/254 (38%), Gaps = 75/254 (29%)

Query: 400 IGRGSFGSVFKARLGD-GMEVAMK-VFNLQYGRVFKSFDV-ECEMMKSIRHRNIIKVI-- 454
           +G GSFG V +    + G   A+K V           +   E ++MK + H NIIK++  
Sbjct: 15  LGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNIIKLVDY 68

Query: 455 ------------------------------------SSCSNEEFKALVLEYMP---HGSL 475
                                                + S  ++  +++EY+P   H  L
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 476 EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLS 534
           + ++ S   I      +  +  +  A+ ++H   S  + H D+KP N+L++  +    L 
Sbjct: 129 KSFIRSGRSIPMNLISI-YIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLC 184

Query: 535 DFGIAKLLTREDQSTIQTQTLATIGYMAPE-------YGKEGRVSANGDVYSFGIMLMET 587
           DFG AK L   + S      + +  Y APE       Y      + + D++S G +  E 
Sbjct: 185 DFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEY------TPSIDLWSIGCVFGEL 235

Query: 588 FTRKKPTDEIFNGE 601
               KP   +F+GE
Sbjct: 236 ILG-KP---LFSGE 245

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 40/207 (19%), Positives = 75/207 (36%), Gaps = 42/207 (20%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSIRHR-NIIK 452
           +GRG F  V +      G E A K       R            E  +++  +    +I 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKK---RRRGQDCRAEILHEIAVLELAKSCPRVIN 93

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRL------NIMIDVASALEYLH 506
           +     N     L+LEY   G +         + ++ + +       ++  +   + YLH
Sbjct: 94  LHEVYENTSEIILILEYAAGGEIFSLC-----LPELAEMVSENDVIRLIKQILEGVYYLH 148

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAH---LSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
                 ++H DLKP N+LL          + DFG+++ +     +    + + T  Y+AP
Sbjct: 149 ---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI---GHACELREIMGTPEYLAP 202

Query: 564 E------YGKEGRVSANGDVYSFGIML 584
           E                 D+++ GI+ 
Sbjct: 203 EILNYDPITTA------TDMWNIGIIA 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 51/215 (23%), Positives = 88/215 (40%), Gaps = 47/215 (21%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEM-----MKSIRHRNIIK 452
           +IGRG+F  V   ++    +V AMK+  +    + K  +V C       + +   R I +
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-----IYQRLNIMIDVASALEYLHF 507
           +  +  +E +  LV+EY   G L   L      +       Y     + ++  A++ +H 
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY-----LAEIVMAIDSVH- 179

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDQSTIQTQTL-ATIGYMAPE 564
                 +H D+KP N+LLD     H  L+DFG    L  +   T+++     T  Y++PE
Sbjct: 180 --RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADG--TVRSLVAVGTPDYLSPE 233

Query: 565 -------------YGKEGRVSANGDVYSFGIMLME 586
                        YG E       D ++ G+   E
Sbjct: 234 ILQAVGGGPGTGSYGPE--C----DWWALGVFAYE 262

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 30/200 (15%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV-----ECEMMKSIRHRNIIK 452
            +G G+FG V   +    G +VA+K+ N Q  ++     V     E + +K  RH +IIK
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQ--KIRSLDVVGKIRREIQNLKLFRHPHIIK 80

Query: 453 ---VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
              VIS+  ++ F  +V+EY+  G L  Y+   N  LD  +   +   + S ++Y H   
Sbjct: 81  LYQVIST-PSDIF--MVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH--- 133

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI----GYMAPE- 564
              V+H DLKP NVLLD +M A ++DFG++ +++         + L T      Y APE 
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-------DGEFLRTSCGSPNYAAPEV 186

Query: 565 YGKEGRVSANGDVYSFGIML 584
                      D++S G++L
Sbjct: 187 ISGRLYAGPEVDIWSSGVIL 206

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 50/275 (18%), Positives = 101/275 (36%), Gaps = 41/275 (14%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
             + +  +  +++            L N+  L L+ N LT        +  L+N K+L  
Sbjct: 44  ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD-------IKPLANLKNLGW 94

Query: 79  ISFSNNPLDGILPKTSVGNLSH--SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKL 136
           +    N +        + +L     L+   + +  +S      + +L  L  +YLG NK+
Sbjct: 95  LFLDENKV------KDLSSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKI 146

Query: 137 NGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLA 196
             +  + L +L KL  L LE+N++   I   +    +L  L L  N +S  +      L 
Sbjct: 147 --TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLK 200

Query: 197 SLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLI 256
           +L +L L S E  + P+   +  +++  N   N              +      D     
Sbjct: 201 NLDVLELFSQECLNKPI--NHQSNLVVPNTVKN---------TDGSLVTPEIISDDGDYE 249

Query: 257 SLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEG 291
             N+  +      P    ++S++    ++  K + 
Sbjct: 250 KPNVKWHL-----PEFTNEVSFIFYQPVTIGKAKA 279

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 50/269 (18%), Positives = 94/269 (34%), Gaps = 56/269 (20%)

Query: 21  SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS 80
           ++     L   S +  +      L ++  +  +N+ + S       +  +    ++T + 
Sbjct: 24  AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-------VQGIQYLPNVTKLF 74

Query: 81  FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSI 140
            + N L  I                            + + NL NL  ++L  NK+   +
Sbjct: 75  LNGNKLTDI----------------------------KPLANLKNLGWLFLDENKVK-DL 105

Query: 141 PSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRI 200
            S+L  L+KL+ L LE+N +   I + + H  +L  L LG NK++       + L  L  
Sbjct: 106 -SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDT 160

Query: 201 LLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNL 260
           L L  N+++ I      L  +  L  S N  +     ++  L         L +L  L L
Sbjct: 161 LSLEDNQISDIV-PLAGLTKLQNLYLSKNHIS-----DLRALA-------GLKNLDVLEL 207

Query: 261 SNNNLSGAIPASLEKLSYLKDLNLSFNKL 289
            +             L     +  +   L
Sbjct: 208 FSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 51/223 (22%), Positives = 86/223 (38%), Gaps = 27/223 (12%)

Query: 67  LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNL 126
           + S          +     +   + +  +    +S++       ++     + I  L N+
Sbjct: 17  IFSDDAFAETIKDNLKKKSVTDAVTQNEL----NSIDQIIANNSDIK--SVQGIQYLPNV 70

Query: 127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSG 186
           T ++L GNKL   I   L  L+ L  L L+ NK++  +  S+    +L  L L  N +S 
Sbjct: 71  TKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS- 125

Query: 187 SIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIAR 246
            I     +L  L  L LG+N++T I      L  +  L+   N  +     +I  L    
Sbjct: 126 DI-NGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQIS-----DIVPLA--- 175

Query: 247 IDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKL 289
                L  L +L LS N++S      L  L  L  L L   + 
Sbjct: 176 ----GLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQEC 212

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 36/195 (18%), Positives = 63/195 (32%), Gaps = 41/195 (21%)

Query: 17  IFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSL 76
           + N   L  L L +N           +L+ L++L L +N ++        ++ L +   L
Sbjct: 86  LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISD-------INGLVHLPQL 136

Query: 77  TLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKL 136
             +   NN +  I                              +  LT L  + L  N++
Sbjct: 137 ESLYLGNNKITDI----------------------------TVLSRLTKLDTLSLEDNQI 168

Query: 137 NGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLA 196
           +  I   L  L KLQ L L  N +   +  ++     L  LEL   +         +NL 
Sbjct: 169 S-DIVP-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLV 224

Query: 197 SLRILLLGSNELTSI 211
               +      L + 
Sbjct: 225 VPNTVKNTDGSLVTP 239

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 85.7 bits (213), Expect = 3e-18
 Identities = 62/264 (23%), Positives = 103/264 (39%), Gaps = 64/264 (24%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMM-----KSIRHRNIIK 452
           L+G+G+FG V   R        AMK+  L+   +    +V   +      ++ RH  +  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASALE 503
           +  +    +    V+EY   G L  +L             Y  +I           SALE
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI----------VSALE 119

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMA 562
           YLH   S  V++ D+K  N++LD +    ++DFG+ K    +  +    +T   T  Y+A
Sbjct: 120 YLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLA 173

Query: 563 PE------YGKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWVNDW 611
           PE      YG+   V    D +  G+++ E    + P      + +F             
Sbjct: 174 PEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHERLFEL----------- 216

Query: 612 LPISTKEIVDPNLLSREDINFVAK 635
             I  +EI  P  LS E  + +A 
Sbjct: 217 --ILMEEIRFPRTLSPEAKSLLAG 238

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 86.7 bits (215), Expect = 3e-18
 Identities = 59/264 (22%), Positives = 105/264 (39%), Gaps = 63/264 (23%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEM-----MKSIRHRNIIK 452
           L+G+G+FG V   +        AMK+  L+   +    +V   +     +++ RH  +  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASALE 503
           +  S    +    V+EY   G L  +L             Y  +I           SAL+
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI----------VSALD 262

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYMA 562
           YLH   +  V++ DLK  N++LD +    ++DFG+ K   ++  +    +T   T  Y+A
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLA 317

Query: 563 PE------YGKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWVNDW 611
           PE      YG+   V    D +  G+++ E    + P      +++F             
Sbjct: 318 PEVLEDNDYGRA--V----DWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----------- 360

Query: 612 LPISTKEIVDPNLLSREDINFVAK 635
             I  +EI  P  L  E  + ++ 
Sbjct: 361 --ILMEEIRFPRTLGPEAKSLLSG 382

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 85.5 bits (212), Expect = 5e-18
 Identities = 64/292 (21%), Positives = 116/292 (39%), Gaps = 90/292 (30%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---------ECEMMKSIR-HR 448
           +G+G++G V+K+     G  VA+K       ++F +F           E  ++  +  H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVK-------KIFDAFQNSTDAQRTFREIMILTELSGHE 69

Query: 449 NIIKVISSCSNEEFKA--LVLEYMPHGSLEKYLHSSN-------YILDIYQRLNIMIDVA 499
           NI+ +++    +  +   LV +YM    L   + ++        Y+  +YQ +       
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYV--VYQLIK------ 120

Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA-------------------K 540
             ++YLH   S  ++H D+KPSN+LL+      ++DFG++                    
Sbjct: 121 -VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 541 LLTREDQSTIQTQTLATIGYMAPE-------YGKEGRVSANGDVYSFGIMLMETFTRKKP 593
               +D   I T  +AT  Y APE       Y K   +    D++S G +L E     KP
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG--I----DMWSLGCILGEILCG-KP 229

Query: 594 TDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL---SREDINFVAKEQCVSFV 642
              IF G  T+            + I+   ++   S ED+  +      + +
Sbjct: 230 ---IFPGSSTMNQL---------ERIIG--VIDFPSNEDVESIQSPFAKTMI 267

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 87.0 bits (215), Expect = 7e-18
 Identities = 64/265 (24%), Positives = 104/265 (39%), Gaps = 65/265 (24%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMM------KSIRHRNII 451
           ++G+GSFG V  +      E+ A+K+  L+   V +  DVEC M+         +   + 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASAL 502
           ++ S     +    V+EY+  G L  ++             Y  +I          A  L
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI----------AIGL 455

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYM 561
            +L    S  +I+ DLK  NV+LD      ++DFG+ K    +      T+T   T  Y+
Sbjct: 456 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYI 509

Query: 562 APE------YGKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWVND 610
           APE      YGK   V    D ++FG++L E    + P      DE+F            
Sbjct: 510 APEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELFQS---------- 553

Query: 611 WLPISTKEIVDPNLLSREDINFVAK 635
              I    +  P  +S+E +     
Sbjct: 554 ---IMEHNVAYPKSMSKEAVAICKG 575

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 66/267 (24%), Positives = 105/267 (39%), Gaps = 69/267 (25%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMM------KSIRHRNII 451
           ++G+GSFG VF A      +  A+K   L+   V    DVEC M+       +  H  + 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASAL 502
            +  +   +E    V+EY+  G L  ++ S +         Y  +I             L
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI----------ILGL 131

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDQSTIQTQTL-ATIG 559
           ++LH   S  +++ DLK  N+LLD +   H  ++DFG+ K     D     T T   T  
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTFCGTPD 183

Query: 560 YMAPE------YGKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWV 608
           Y+APE      Y          D +SFG++L E    + P      +E+F+         
Sbjct: 184 YIAPEILLGQKYNHS------VDWWSFGVLLYEMLIGQSPFHGQDEEELFHS-------- 229

Query: 609 NDWLPISTKEIVDPNLLSREDINFVAK 635
                I       P  L +E  + + K
Sbjct: 230 -----IRMDNPFYPRWLEKEAKDLLVK 251

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 67/267 (25%), Positives = 104/267 (38%), Gaps = 69/267 (25%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMM------KSIRHRNII 451
           +IG+GSFG V  AR        A+KV  LQ   + K  + +  M       K+++H  ++
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASAL 502
            +  S    +    VL+Y+  G L  +L             Y  +I          ASAL
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----------ASAL 152

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDQSTIQTQTL-ATIG 559
            YLH   S  +++ DLKP N+LLD     H  L+DFG+ K     + +   T T   T  
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTFCGTPE 204

Query: 560 YMAPE------YGKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWV 608
           Y+APE      Y +   V    D +  G +L E      P     T E+++         
Sbjct: 205 YLAPEVLHKQPYDRT--V----DWWCLGAVLYEMLYGLPPFYSRNTAEMYDN-------- 250

Query: 609 NDWLPISTKEIVDPNLLSREDINFVAK 635
                I  K +     ++    + +  
Sbjct: 251 -----ILNKPLQLKPNITNSARHLLEG 272

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 27/198 (13%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRHRNIIK-- 452
            +G GSFG V  A       +VA+K  +   L+   +    + E   +K +RH +IIK  
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 453 -VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
            VI++   +    +V+EY   G L  Y+      +   +       +  A+EY H     
Sbjct: 76  DVITT-PTDIV--MVIEYA-GGELFDYI-VEKKRMTEDEGRRFFQQIICAIEYCH---RH 127

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI----GYMAPE-YG 566
           +++H DLKP N+LLDDN+   ++DFG++ ++T           L T      Y APE   
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-------DGNFLKTSCGSPNYAAPEVIN 180

Query: 567 KEGRVSANGDVYSFGIML 584
            +       DV+S GI+L
Sbjct: 181 GKLYAGPEVDVWSCGIVL 198

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 41/207 (19%), Positives = 74/207 (35%), Gaps = 66/207 (31%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECE---MMKSIRHRNIIKVI- 454
           +G G  G V +        + A+K+                E     ++ +  +I++++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 455 ---SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD-IYQRLN----------IMIDVAS 500
              +  +  +   +V+E +  G L             I  R +          IM  +  
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGEL----------FSRIQDRGDQAFTEREASEIMKSIGE 128

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           A++YLH   S  + H D+KP N+L      N +  L+DFG AK  T E            
Sbjct: 129 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK----------- 174

Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIML 584
                  Y K        D++S G+++
Sbjct: 175 -------YDKS------CDMWSLGVIM 188

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 66/265 (24%), Positives = 104/265 (39%), Gaps = 65/265 (24%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMM------KSIRHRNII 451
           ++G+GSFG V  AR+ +  ++ A+KV  L+   + +  DVEC M        +  H  + 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASAL 502
           ++       +    V+E++  G L  ++  S          Y  +I           SAL
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEI----------ISAL 137

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYM 561
            +LH      +I+ DLK  NVLLD      L+DFG+ K       +   T T   T  Y+
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYI 191

Query: 562 APE------YGKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWVND 610
           APE      YG    V    D ++ G++L E      P      D++F            
Sbjct: 192 APEILQEMLYGPA--V----DWWAMGVLLYEMLCGHAPFEAENEDDLFE----------- 234

Query: 611 WLPISTKEIVDPNLLSREDINFVAK 635
              I   E+V P  L  +    +  
Sbjct: 235 --AILNDEVVYPTWLHEDATGILKS 257

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 82.3 bits (204), Expect = 5e-17
 Identities = 64/265 (24%), Positives = 104/265 (39%), Gaps = 65/265 (24%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMM------KSIRHRNII 451
           ++G+GSFG V  +      E+ A+K+  L+   V +  DVEC M+         +   + 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASAL 502
           ++ S     +    V+EY+  G L  ++             Y  +I          A  L
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI----------AIGL 134

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYM 561
            +L    S  +I+ DLK  NV+LD      ++DFG+ K    +      T+T   T  Y+
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPDYI 188

Query: 562 APE------YGKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWVND 610
           APE      YGK   V    D ++FG++L E    + P      DE+F            
Sbjct: 189 APEIIAYQPYGKS--V----DWWAFGVLLYEMLAGQAPFEGEDEDELFQ----------- 231

Query: 611 WLPISTKEIVDPNLLSREDINFVAK 635
              I    +  P  +S+E +     
Sbjct: 232 --SIMEHNVAYPKSMSKEAVAICKG 254

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 81.4 bits (202), Expect = 6e-17
 Identities = 64/267 (23%), Positives = 109/267 (40%), Gaps = 68/267 (25%)

Query: 399 LIGRGSFGSVFKARLGDGMEV----AMKVFNLQYGRVFKSFDVECEM----MKSIRHRNI 450
           ++G+GSFG VF  +   G +     AMKV  L+   +     V  +M    +  + H  I
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKV--LKKATLKVRDRVRTKMERDILVEVNHPFI 88

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------SAL 502
           +K+  +   E    L+L+++  G L  +         + + +    +           AL
Sbjct: 89  VKLHYAFQTEGKLYLILDFLRGGDL--FTR-------LSKEVMFTEEDVKFYLAELALAL 139

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDQSTIQTQTL-ATIG 559
           ++LH   S  +I+ DLKP N+LLD+    H  L+DFG++K     ++      +   T+ 
Sbjct: 140 DHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK---AYSFCGTVE 191

Query: 560 YMAPE------YGKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHWV 608
           YMAPE      + +    SA  D +SFG+++ E  T   P       E            
Sbjct: 192 YMAPEVVNRRGHTQ----SA--DWWSFGVLMFEMLTGTLPFQGKDRKETMTM-------- 237

Query: 609 NDWLPISTKEIVDPNLLSREDINFVAK 635
                I   ++  P  LS E  + +  
Sbjct: 238 -----ILKAKLGMPQFLSPEAQSLLRM 259

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 62/268 (23%), Positives = 103/268 (38%), Gaps = 68/268 (25%)

Query: 399 LIGRGSFGSVFKARL----GDGMEVAMKVFNLQYGRVFKSFDVECEMM-----KSIRHRN 449
           ++G+G +G VF+ R       G   AMKV       V  + D           + ++H  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM-IVRNAKDTAHTKAERNILEEVKHPF 82

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------SA 501
           I+ +I +        L+LEY+  G L  ++        + +    M D A         A
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGEL--FMQ-------LEREGIFMEDTACFYLAEISMA 133

Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDQSTIQTQTLA-TI 558
           L +LH      +I+ DLKP N++L+     H  L+DFG+ K    +      T T   TI
Sbjct: 134 LGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV---THTFCGTI 185

Query: 559 GYMAPE------YGKEGRVSANGDVYSFGIMLMETFTRKKP-----TDEIFNGEMTLKHW 607
            YMAPE      + +   V    D +S G ++ +  T   P       +  +        
Sbjct: 186 EYMAPEILMRSGHNRA--V----DWWSLGALMYDMLTGAPPFTGENRKKTIDK------- 232

Query: 608 VNDWLPISTKEIVDPNLLSREDINFVAK 635
                 I   ++  P  L++E  + + K
Sbjct: 233 ------ILKCKLNLPPYLTQEARDLLKK 254

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 42/275 (15%), Positives = 97/275 (35%), Gaps = 42/275 (15%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
             +      L   S +  +      L  +Q     N+ + S       L+ +    +L  
Sbjct: 17  GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS-------LAGMQFFTNLKE 67

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNL--TNLTIIYLGGNKL 136
           +  S+N +  +   + + +L+  LE   +    +       +  +    L+ ++L  N+L
Sbjct: 68  LHLSHNQISDL---SPLKDLTK-LEELSVNRNRLK-----NLNGIPSACLSRLFLDNNEL 118

Query: 137 NGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLA 196
                 +L  L+ L+ L + NNKL+ SI   +    +L  L+L GN+++ +       L 
Sbjct: 119 --RDTDSLIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT-NTGG-LTRLK 172

Query: 197 SLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLI 256
            +  + L   +  + P+      ++   N   +              I+     +  S +
Sbjct: 173 KVNWIDLTGQKCVNEPVK--YQPELYITNTVKD---------PDGRWISPYYISNGGSYV 221

Query: 257 SLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEG 291
              +         P   +++SY     ++  + E 
Sbjct: 222 DGCVLWEL-----PVYTDEVSYKFSEYINVGETEA 251

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 40/227 (17%), Positives = 76/227 (33%), Gaps = 26/227 (11%)

Query: 63  ELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGN 122
            ++ +       +    +     +  +    S   LS  ++ F     N+       +  
Sbjct: 8   PINQVFPDPGLANAVKQNLGKQSVTDL---VSQKELSG-VQNFNGDNSNIQ--SLAGMQF 61

Query: 123 LTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGN 182
            TNL  ++L  N++  S  S L  L KL+ L +  N+L+            L +L L  N
Sbjct: 62  FTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLKNLNGIPSAC---LSRLFLDNN 116

Query: 183 KLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNL 242
           +L     +   +L +L IL + +N+L SI      L  +  L+   N  T    L     
Sbjct: 117 ELRD--TDSLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGNEITNTGGLT---- 169

Query: 243 KIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKL 289
                    L  +  ++L+             +L     +     + 
Sbjct: 170 --------RLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW 208

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 30/173 (17%), Positives = 58/173 (33%), Gaps = 44/173 (25%)

Query: 118 EEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKL 177
                L N     LG   +  +   +  +L  +Q    +N+ ++                
Sbjct: 13  FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ---------------- 54

Query: 178 ELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPL 237
                 L+G          +L+ L L  N+++ +     +L  +  L+ + N        
Sbjct: 55  -----SLAG-----MQFFTNLKELHLSHNQISDLS-PLKDLTKLEELSVNRN-------- 95

Query: 238 EIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
                ++  ++      L  L L NN L      SL  L  L+ L++  NKL+
Sbjct: 96  -----RLKNLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK 141

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 37/177 (20%), Positives = 61/177 (34%), Gaps = 24/177 (13%)

Query: 17  IFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS---------STLELSF- 66
           +   + L  L LS N  S   P    +L  L+ L ++ N L +         S L L   
Sbjct: 59  MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNN 116

Query: 67  ----LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGN 122
                 SL + K+L ++S  NN L  I     +G LS  LE  ++    ++      +  
Sbjct: 117 ELRDTDSLIHLKNLEILSIRNNKLKSI---VMLGFLS-KLEVLDLHGNEITN--TGGLTR 170

Query: 123 LTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL 179
           L  +  I L G K          +L     +   + +     P  I +        +
Sbjct: 171 LKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW--ISPYYISNGGSYVDGCV 225

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 56/211 (26%), Positives = 85/211 (40%), Gaps = 47/211 (22%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMM------KSIRHRNII 451
           +IGRGS+  V   RL     + AMKV  ++   V    D++          ++  H  ++
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASAL 502
            + S    E     V+EY+  G L  ++             Y  +I          + AL
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI----------SLAL 123

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYM 561
            YLH      +I+ DLK  NVLLD      L+D+G+ K   R       T T   T  Y+
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYI 177

Query: 562 APE------YGKEGRVSANGDVYSFGIMLME 586
           APE      YG    V    D ++ G+++ E
Sbjct: 178 APEILRGEDYGFS--V----DWWALGVLMFE 202

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 48/221 (21%), Positives = 84/221 (38%), Gaps = 27/221 (12%)

Query: 75  SLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI-GNLTNLTIIYLGG 133
           S   +      L   +P  +  NL + +    ++       +      NL+ +T I +  
Sbjct: 32  STQTLKLIETHLR-TIPSHAFSNLPN-ISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 134 NKLNGSIPS-TLGKLQKLQGLGLENNKLEGSIPD--SICHSDELYKLELGGNKLSGSIPE 190
            +    I    L +L  L+ LG+ N  L+   PD   +  +D  + LE+  N    SIP 
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148

Query: 191 -CFNNLAS-LRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARID 248
             F  L +    L L +N  TS+    +N   +  +  +             N  +  ID
Sbjct: 149 NAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLN------------KNKYLTVID 196

Query: 249 S---CDLISLIS-LNLSNNNLSGAIPA-SLEKLSYLKDLNL 284
                 + S  S L++S  +++ A+P+  LE L  L   N 
Sbjct: 197 KDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 76.6 bits (189), Expect = 8e-16
 Identities = 41/212 (19%), Positives = 77/212 (36%), Gaps = 18/212 (8%)

Query: 23  LSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSS--LSNCKSLTLIS 80
              L+L +        + F NL N+  + +S +      + L  L S    N   +T I 
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSID------VTLQQLESHSFYNLSKVTHIE 86

Query: 81  FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEE--IGNLTNLTIIYLGGNKLNG 138
             N      +   ++  L   L++  +    +    P+   + +     I+ +  N    
Sbjct: 87  IRNTRNLTYIDPDALKELP-LLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMT 144

Query: 139 SIPS-TLGKLQK-LQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPE-CFNNL 195
           SIP      L      L L NN    S+     +  +L  + L  NK    I +  F  +
Sbjct: 145 SIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGV 203

Query: 196 AS-LRILLLGSNELTSIP-LTFWNLKDILYLN 225
            S   +L +    +T++P     +LK+++  N
Sbjct: 204 YSGPSLLDVSQTSVTALPSKGLEHLKELIARN 235

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 64.6 bits (158), Expect = 8e-12
 Identities = 34/183 (18%), Positives = 64/183 (34%), Gaps = 23/183 (12%)

Query: 123 LTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGL-ENNKLEGSIPDSICHSDELYKLELG 180
             +   + L    L  +IPS     L  +  + +  +  L+     S  +  ++  +E+ 
Sbjct: 30  PPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIR 88

Query: 181 GNKLSGSIP-ECFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLE 238
             +    I  +    L  L+ L + +  L   P LT     DI ++            LE
Sbjct: 89  NTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFI------------LE 136

Query: 239 I-GNLKIARIDSCDLISL----ISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEI 293
           I  N  +  I       L    ++L L NN  + ++       + L  + L+ NK    I
Sbjct: 137 ITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVI 195

Query: 294 PRG 296
            + 
Sbjct: 196 DKD 198

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 25/140 (17%), Positives = 48/140 (34%), Gaps = 22/140 (15%)

Query: 167 SICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLN 225
             C   +     +    +   IP   +   S + L L    L +IP   F NL +I  + 
Sbjct: 6   PPCECHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIY 61

Query: 226 FSSNFFTGPLPLEIGNLKIARIDS---CDLISLISLNLSNNNLSGAIPAS-LEKLSYLKD 281
            S +            + + +++S    +L  +  + + N      I    L++L  LK 
Sbjct: 62  VSID------------VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109

Query: 282 LNLSFNKLEGEIPRGGSFGN 301
           L +    L+   P      +
Sbjct: 110 LGIFNTGLK-MFPDLTKVYS 128

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 29/147 (19%), Positives = 49/147 (33%), Gaps = 39/147 (26%)

Query: 16  FIFNASKLSILELSDNSFSGFIP-NTFGNLRN-LQALRLSNNYLTSSTLELSFLSS--LS 71
            +++     ILE++DN +   IP N F  L N    L+L NN  TS       +     +
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-------VQGYAFN 177

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL 131
             K   +    N  L  I               F               G  +  +++ +
Sbjct: 178 GTKLDAVYLNKNKYLTVIDKDA-----------FG--------------GVYSGPSLLDV 212

Query: 132 GGNKLNGSIPSTLGKLQKLQGLGLENN 158
               +  ++PS    L+ L+ L   N 
Sbjct: 213 SQTSVT-ALPSKG--LEHLKELIARNT 236

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 52/220 (23%), Positives = 102/220 (46%), Gaps = 46/220 (20%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNL-QYGRVFKSFDVECEMMKSIR-HRNIIK---- 452
           +GRG +  VF+A  + +  +V +K+    +  ++ +    E ++++++R   NII     
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHS-SNYILD--IYQRLNIMIDVASALEYLHFGY 509
           V    S     ALV E++ +   ++   + ++Y +   +Y+ L        AL+Y H   
Sbjct: 100 VKDPVSRTP--ALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------ALDYCH--- 147

Query: 510 SAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE---- 564
           S  ++H D+KP NV++D ++    L D+G+A+      +  ++   +A+  +  PE    
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR---VASRYFKGPELLVD 204

Query: 565 ---YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE 601
              Y          D++S G ML     RK+P    F+G 
Sbjct: 205 YQMYDYS------LDMWSLGCMLASMIFRKEP---FFHGH 235

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 79.3 bits (196), Expect = 7e-16
 Identities = 63/265 (23%), Positives = 103/265 (38%), Gaps = 56/265 (21%)

Query: 399 LIGRGSFGSVFKARLGDGMEV-AMKVFNLQYGRVFKSFDVECEMM------KSIRHRNII 451
           +IGRGS+  V   RL     + AM+V  ++   V    D++          ++  H  ++
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASAL 502
            + S    E     V+EY+  G L  ++             Y  +I          + AL
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI----------SLAL 166

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTL-ATIGYM 561
            YLH      +I+ DLK  NVLLD      L+D+G+ K   R       T T   T  Y+
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYI 220

Query: 562 APE------YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND----- 610
           APE      YG    V    D ++ G+++ E    + P    F+   +  +   +     
Sbjct: 221 APEILRGEDYGFS--V----DWWALGVLMFEMMAGRSP----FDIVGSSDNPDQNTEDYL 270

Query: 611 WLPISTKEIVDPNLLSREDINFVAK 635
           +  I  K+I  P  LS +  + +  
Sbjct: 271 FQVILEKQIRIPRSLSVKAASVLKS 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.0 bits (192), Expect = 1e-15
 Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 5/160 (3%)

Query: 430 RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIY 489
           R  K +     +    R  +I    SS S+   +   L  +      + L+     L + 
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD--FLTLE 193

Query: 490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST 549
             +     VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++    
Sbjct: 194 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250

Query: 550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT 589
            +      + +MAPE   +   +   DV+SFG++L E F+
Sbjct: 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 22/93 (23%), Positives = 42/93 (45%), Gaps = 9/93 (9%)

Query: 400 IGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNII 451
           +GRG+FG V +A             VA+K+          ++   E +++  I  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 452 KVISSCSNEEFKALV-LEYMPHGSLEKYLHSSN 483
            ++ +C+      +V +E+   G+L  YL S  
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 63/273 (23%), Positives = 99/273 (36%), Gaps = 70/273 (25%)

Query: 399 LIGRGSFGSVFKARLGDGMEV----AMKVFNLQYGRVFKSFDVECEMM-----KSIRHRN 449
           ++G G++G VF  R   G +     AMKV       V K+   E         + IR   
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT-IVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 450 -IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVA--------S 500
            ++ +  +   E    L+L+Y+  G L  + H       + QR                 
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGEL--FTH-------LSQRERFTEHEVQIYVGEIVL 170

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDQSTIQTQTLA-T 557
           ALE+LH      +I+ D+K  N+LLD N   H  L+DFG++K    ++           T
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETER--AYDFCGT 223

Query: 558 IGYMAPE------YGKEGRVSANGDVYSFGIMLME---------TFTRKKPTDEIFNGEM 602
           I YMAP+       G +  V    D +S G+++ E             K    EI     
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-- 277

Query: 603 TLKHWVNDWLPISTKEIVDPNLLSREDINFVAK 635
                      I   E   P  +S    + + +
Sbjct: 278 -----------ILKSEPPYPQEMSALAKDLIQR 299

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 43/236 (18%), Positives = 91/236 (38%), Gaps = 38/236 (16%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIR---------- 446
            +G G F +V+ A+ + +   VAMK+    +     ++ + E ++++ +           
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 447 -HRNIIKVISS----CSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVAS 500
              +I+K++        N     +V E +   +L   +    +  + +     I   +  
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH------LSDFGIAKLLTREDQSTIQTQT 554
            L+Y+H      +IH D+KP NVL++            ++D G A        ++IQT+ 
Sbjct: 143 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 200

Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND 610
                Y +PE           D++S   ++ E  T       +F  +    +  +D
Sbjct: 201 -----YRSPEVLLGAPWGCGADIWSTACLIFELITGDF----LFEPDEGHSYTKDD 247

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 37/170 (21%), Positives = 60/170 (35%), Gaps = 38/170 (22%)

Query: 122 NLTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLEL 179
            LTNL  + L  N LN  I S     +  L+ L L +N L  ++ + +      L  L L
Sbjct: 62  RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119

Query: 180 GGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPL 237
             N +   +    F ++A L+ L L  N+++  P+    +                    
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNK----------------- 161

Query: 238 EIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFN 287
                         L  L+ L+LS+N L       L+KL       L  +
Sbjct: 162 --------------LPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 46/194 (23%), Positives = 71/194 (36%), Gaps = 42/194 (21%)

Query: 45  RNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEY 104
                L LS+N L+    E +  + L+N   L  +  S+N L+ I  +            
Sbjct: 39  SYTALLDLSHNNLSRLRAEWTP-TRLTN---LHSLLLSHNHLNFISSEA----------- 83

Query: 105 FEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLENNKLEGS 163
           F                 + NL  + L  N L+ ++       LQ L+ L L NN +   
Sbjct: 84  FV---------------PVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-V 126

Query: 164 IPDSI-CHSDELYKLELGGNKLSGSIPE----CFNNLASLRILLLGSNELTSIPL-TFWN 217
           +  +      +L KL L  N++S   P       N L  L +L L SN+L  +PL     
Sbjct: 127 VDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQK 185

Query: 218 LKDI--LYLNFSSN 229
           L       L   +N
Sbjct: 186 LPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 70.3 bits (172), Expect = 4e-13
 Identities = 37/148 (25%), Positives = 60/148 (40%), Gaps = 24/148 (16%)

Query: 163 SIPDSICHSDELYKLELGGNKLSGSIPEC-FNNLASLRILLLGSNELTSIP-LTFWNLKD 220
           ++P S+        L+L  N LS    E     L +L  LLL  N L  I    F  + +
Sbjct: 32  NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPN 89

Query: 221 ILYLNFSSNFFTGPLPLEIGNLKIARIDSC---DLISLISLNLSNNNLSGAIPA-SLEKL 276
           + YL+ SSN              +  +D     DL +L  L L NN++   +   + E +
Sbjct: 90  LRYLDLSSN-------------HLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDM 135

Query: 277 SYLKDLNLSFNKLEGEIPRGGSFGNFSA 304
           + L+ L LS N++    P      + + 
Sbjct: 136 AQLQKLYLSQNQIS-RFPV-ELIKDGNK 161

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.8 bits (163), Expect = 6e-12
 Identities = 43/188 (22%), Positives = 66/188 (35%), Gaps = 39/188 (20%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L +  NN S     +     + L  L LS N  +      F  + NL+ L LS+N+L + 
Sbjct: 44  LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT- 102

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
            L+    S L     L ++   NN +  +               FE              
Sbjct: 103 -LDEFLFSDLQA---LEVLLLYNNHIVVVDRNA-----------FE-------------- 133

Query: 121 GNLTNLTIIYLGGNKLNGSIP----STLGKLQKLQGLGLENNKLEGSIPDSICHSDELYK 176
            ++  L  +YL  N+++   P        KL KL  L L +NKL+      +       K
Sbjct: 134 -DMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVK 191

Query: 177 --LELGGN 182
             L L  N
Sbjct: 192 NGLYLHNN 199

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 57/204 (27%), Positives = 82/204 (40%), Gaps = 47/204 (23%)

Query: 26  LELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNP 85
           L+L     +     TF  L  L  L L  N L +  L       L+    L  +  +NN 
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT--LSAGVFDDLTE---LGTLGLANNQ 94

Query: 86  LDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTL- 144
           L              SL            G+ +   +LT L  +YLGGN+L  S+PS + 
Sbjct: 95  L-------------ASLP----------LGVFD---HLTQLDKLYLGGNQLK-SLPSGVF 127

Query: 145 GKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLELGGNKLSGSIPE-CFNNLASLRILL 202
            +L KL+ L L  N+L+ SIP         L  L L  N+L  S+P   F+ L  L+ + 
Sbjct: 128 DRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTIT 185

Query: 203 LGSNELTSIPLTFWN--LKDILYL 224
           L  N         ++    +ILYL
Sbjct: 186 LFGN-----Q---FDCSRCEILYL 201

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 49/179 (27%), Positives = 77/179 (43%), Gaps = 21/179 (11%)

Query: 112 VSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS 171
           V  GIP       +   + L    L     +T   L KL  L L+ N+L+ ++   +   
Sbjct: 29  VPSGIP------ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDD 81

Query: 172 -DELYKLELGGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSS 228
             EL  L L  N+L+ S+P   F++L  L  L LG N+L S+P   F  L  +  L  ++
Sbjct: 82  LTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNT 140

Query: 229 NFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFN 287
           N     +P           D   L +L +L+LS N L      + ++L  L+ + L  N
Sbjct: 141 NQLQS-IPAGA-------FDK--LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 16/149 (10%)

Query: 151 QGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPE-CFNNLASLRILLLGSNELT 209
           + L L++  L      +     +L  L L  N+L  ++    F++L  L  L L +N+L 
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96

Query: 210 SIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGA 268
           S+P   F +L  +  L    N     LP  +        D   L  L  L L+ N L  +
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGV-------FDR--LTKLKELRLNTNQLQ-S 145

Query: 269 IPASL-EKLSYLKDLNLSFNKLEGEIPRG 296
           IPA   +KL+ L+ L+LS N+L+  +P G
Sbjct: 146 IPAGAFDKLTNLQTLSLSTNQLQS-VPHG 173

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 49/303 (16%), Positives = 106/303 (34%), Gaps = 37/303 (12%)

Query: 21  SKLSILELSDNSFS-GFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLI 79
             +  L++     S          L+  Q +RL +  LT +  +    S+L    +L  +
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK-DISSALRVNPALAEL 61

Query: 80  SFSNNPLDGILPKTSVGNLSH---SLEYFEMAYCNVS----GGIPEEIGNLTNLTIIYLG 132
           +  +N L  +     +  L      ++   +  C ++    G +   +  L  L  ++L 
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 133 GNKLNGSIPSTLGKLQ-----KLQGLGLENNKL--EG--SIPDSICHSDELYKLELGGNK 183
            N L  +    L +       +L+ L LE   L       +   +    +  +L +  N 
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181

Query: 184 LSGS----IPECF-NNLASLRILLLGSNELT-----SIPLTFWNLKDILYLNFSSNFFTG 233
           ++ +    + +   ++   L  L L S  +T      +     +   +  L   SN    
Sbjct: 182 INEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG- 240

Query: 234 PLPLEIGNLKIARIDSCDLISLISLNLSNNNLS----GAIPASLEKLSYLKDLNLSFNKL 289
               ++G  ++          L +L +    ++    G +   L     LK+L+L+ N+L
Sbjct: 241 ----DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296

Query: 290 EGE 292
             E
Sbjct: 297 GDE 299

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 62.3 bits (152), Expect = 3e-10
 Identities = 54/298 (18%), Positives = 99/298 (33%), Gaps = 54/298 (18%)

Query: 22  KLSILELSDNSFS----GFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLT 77
           K+  L L +   +    G + +T   L  LQ L LS+N L  + L+L     L     L 
Sbjct: 86  KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145

Query: 78  LISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLN 137
            +      L       S   L+  L                      +   + +  N +N
Sbjct: 146 KLQLEYCSLSA----ASCEPLASVLR------------------AKPDFKELTVSNNDIN 183

Query: 138 GSIPSTLGKLQK-----LQGLGLENNKL--EG--SIPDSICHSDELYKLELGGNKLSGS- 187
            +    L +  K     L+ L LE+  +  +    +   +     L +L LG NKL    
Sbjct: 184 EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243

Query: 188 ----IPECFNNLASLRILLLGSNELTS-----IPLTFWNLKDILYLNFSSNFFTGPLPLE 238
                P   +  + LR L +    +T+     +       + +  L+ + N        +
Sbjct: 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG-----D 298

Query: 239 IGNLKIARIDSCDLISLISLNLSNNNLSG----AIPASLEKLSYLKDLNLSFNKLEGE 292
            G   +          L SL + + + +        + L +  +L +L +S N+LE  
Sbjct: 299 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 54.2 bits (131), Expect = 8e-08
 Identities = 67/336 (19%), Positives = 111/336 (33%), Gaps = 70/336 (20%)

Query: 21  SKLSILELSDNSF--SGFI--------PNTFGNLRNLQALRLSNNYLTSSTLELSFLSSL 70
             L  L LSDN    +G          P        L+ L+L    L++++ E    S L
Sbjct: 113 PTLQELHLSDNLLGDAGLQLLCEGLLDPQC-----RLEKLQLEYCSLSAASCE-PLASVL 166

Query: 71  SNCKSLTLISFSNNPLDGILPKTSVGNLSHS---LEYFEMAYCNVS----GGIPEEIGNL 123
                   ++ SNN ++    +     L  S   LE  ++  C V+      +   + + 
Sbjct: 167 RAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASK 226

Query: 124 TNLTIIYLGGNKLNGS-----IPSTLGKLQKLQGLGLENNKLE----GSIPDSICHSDEL 174
            +L  + LG NKL         P  L    +L+ L +    +     G +   +   + L
Sbjct: 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL 286

Query: 175 YKLELGGNKLSGS-----IPECFNNLASLRILLLGSNELTS-----IPLTFWNLKDILYL 224
            +L L GN+L                  L  L + S   T+             + +L L
Sbjct: 287 KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 346

Query: 225 NFSSNFFTGP--------LPLEIGNLKIARIDSCDL---------------ISLISLNLS 261
             S+N             L      L++  +  CD+                SL  L+LS
Sbjct: 347 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLS 406

Query: 262 NNNL--SGA--IPASLEKLSY-LKDLNLSFNKLEGE 292
           NN L  +G   +  S+ +    L+ L L       E
Sbjct: 407 NNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE 442

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 51.1 bits (123), Expect = 8e-07
 Identities = 50/321 (15%), Positives = 111/321 (34%), Gaps = 45/321 (14%)

Query: 2   LQMWENNFSGTIPRFIFNA----SKLSILELSDNSFSG----FIPNTFG-NLRNLQALRL 52
           LQ+   + S      + +          L +S+N  +      +      +   L+AL+L
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKL 206

Query: 53  SNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPL--DGI-LPKTSVGNLSHSLEYFEMAY 109
            +  +TS          +++  SL  ++  +N L   G+      + + S  L    +  
Sbjct: 207 ESCGVTSDNCR-DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265

Query: 110 CNVS----GGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKL-----QKLQGLGLENNKL 160
           C ++    G +   +    +L  + L GN+L       L +       +L+ L +++   
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325

Query: 161 --EG--SIPDSICHSDELYKLELGGNKLSGSIPECF-----NNLASLRILLLGSNELT-- 209
                      +  +  L +L++  N+L  +             + LR+L L   +++  
Sbjct: 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385

Query: 210 ---SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLS 266
              S+  T      +  L+ S+N        + G L++          L  L L +   S
Sbjct: 386 SCSSLAATLLANHSLRELDLSNNCLG-----DAGILQLVESVRQPGCLLEQLVLYDIYWS 440

Query: 267 ----GAIPASLEKLSYLKDLN 283
                 + A  +    L+ ++
Sbjct: 441 EEMEDRLQALEKDKPSLRVIS 461

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 22/202 (10%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHR------NI 450
           +IG+GSFG V KA        VA+K+  N +  R  +    E  +++ +R +      N+
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGY 509
           I ++ + +      +  E +   +L + +  + +    +         +   L+ LH   
Sbjct: 162 IHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH--- 217

Query: 510 SAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
             ++IHCDLKP N+LL     +   + DFG +    +   + IQ++      Y APE   
Sbjct: 218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAPEVIL 272

Query: 568 EGRVSANGDVYSFGIMLMETFT 589
             R     D++S G +L E  T
Sbjct: 273 GARYGMPIDMWSLGCILAELLT 294

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 40/150 (26%), Positives = 67/150 (44%), Gaps = 17/150 (11%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRH-RNIIKVISSC 457
           IG G+FG +   + L     VA+K+  ++         +E    K +     I +V    
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 458 SNEEFKALVLEYMPHG-SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
              ++ A+VLE +  G SLE      +    +   L I I + S +EY+H   S  +I+ 
Sbjct: 75  PCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYR 129

Query: 517 DLKPSNVLL------DDNMVAHLSDFGIAK 540
           D+KP N L+         ++ H+ DF +AK
Sbjct: 130 DVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 33/149 (22%), Positives = 59/149 (39%), Gaps = 15/149 (10%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRH-RNIIKVISSC 457
           IG GSFG +F+   L +  +VA+K    +          E    K +     I  V    
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
                  LV++ +   SLE  L        +         + + ++ +H      +++ D
Sbjct: 76  QEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 131

Query: 518 LKPSNVLL------DDNMVAHLSDFGIAK 540
           +KP N L+      + NM+ ++ DFG+ K
Sbjct: 132 IKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 56/234 (23%), Positives = 88/234 (37%), Gaps = 60/234 (25%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
                    + +  +  +++            L N++ L L  N L      +S L  L+
Sbjct: 33  DAVTQN-ELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLHD----ISALKELT 85

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL 131
           N   LT +  + N L       S                 +  G+ +    LTNL  + L
Sbjct: 86  N---LTYLILTGNQL------QS-----------------LPNGVFD---KLTNLKELVL 116

Query: 132 GGNKLNGSIPSTL-GKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLELGGNKLSGSIP 189
             N+L  S+P  +  KL  L  L L +N+L+ S+P  +      L +L+L  N+L  S+P
Sbjct: 117 VENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLP 173

Query: 190 E-CFNNLASLRILLLGSNELTSIPL-TFWNLK-----------------DILYL 224
           E  F+ L  L+ L L  N+L S+P   F  L                   I YL
Sbjct: 174 EGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYL 227

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 55/180 (30%), Positives = 86/180 (47%), Gaps = 24/180 (13%)

Query: 122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIP--DSICHSDELYKLEL 179
            L ++  I    + +  S+   +  L  ++ L L  NKL   I     +     L  L L
Sbjct: 39  ELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLH-DISALKELT---NLTYLIL 92

Query: 180 GGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPL 237
            GN+L  S+P   F+ L +L+ L+L  N+L S+P   F  L ++ YLN + N     LP 
Sbjct: 93  TGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPK 150

Query: 238 EIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASL-EKLSYLKDLNLSFNKLEGEIPRG 296
            +        D   L +L  L+LS N L  ++P  + +KL+ LKDL L  N+L+  +P G
Sbjct: 151 GV-------FDK--LTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 41/160 (25%), Positives = 60/160 (37%), Gaps = 37/160 (23%)

Query: 2   LQMWENNFSGTIPRFIFNA-SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L +  N    ++P  +F+  + L  L L +N         F  L NL  L L++N L S 
Sbjct: 90  LILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS- 147

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
            L       L+N   LT +  S N L       S                     +PE +
Sbjct: 148 -LPKGVFDKLTN---LTELDLSYNQL------QS---------------------LPEGV 176

Query: 121 -GNLTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLENN 158
              LT L  + L  N+L  S+P     +L  LQ + L +N
Sbjct: 177 FDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 67.4 bits (165), Expect = 6e-13
 Identities = 33/152 (21%), Positives = 64/152 (42%), Gaps = 21/152 (13%)

Query: 115 GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS-DE 173
            +P        +T I L  N +    P      +KL+ + L NN++   +          
Sbjct: 29  NLP------ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81

Query: 174 LYKLELGGNKLSGSIP-ECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFF 231
           L  L L GNK++  +P   F  L SL++LLL +N++  + +  F +L ++  L+   N  
Sbjct: 82  LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKL 140

Query: 232 TGPLPLEIGNLKIARIDSCDLISLISLNLSNN 263
              +     +          L ++ +++L+ N
Sbjct: 141 QT-IAKGTFS---------PLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 32/136 (23%), Positives = 59/136 (43%), Gaps = 16/136 (11%)

Query: 163 SIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDI 221
            IP ++   + + ++ L  N +    P  F+    LR + L +N+++ +    F  L+ +
Sbjct: 25  EIPTNL--PETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82

Query: 222 LYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPA-SLEKLSYLK 280
             L    N  T  LP  +        +   L SL  L L+ N ++  +   + + L  L 
Sbjct: 83  NSLVLYGNKITE-LPKSL-------FEG--LFSLQLLLLNANKIN-CLRVDAFQDLHNLN 131

Query: 281 DLNLSFNKLEGEIPRG 296
            L+L  NKL+  I +G
Sbjct: 132 LLSLYDNKLQ-TIAKG 146

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 38/158 (24%), Positives = 62/158 (39%), Gaps = 33/158 (20%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           +++ +N     IP   F    KL  ++LS+N  S   P+ F  LR+L +L L  N +T  
Sbjct: 37  IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITE- 94

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
            L  S    L +   L L+  + N ++ +               F+              
Sbjct: 95  -LPKSLFEGLFS---LQLLLLNANKINCLRVDA-----------FQ-------------- 125

Query: 121 GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENN 158
            +L NL ++ L  NKL      T   L+ +Q + L  N
Sbjct: 126 -DLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 20/87 (22%), Positives = 38/87 (43%), Gaps = 7/87 (8%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L ++ N  +  +P+ +F     L +L L+ N  +    + F +L NL  L L +N L + 
Sbjct: 85  LVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT- 142

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLD 87
            +     S L    ++  +  + NP  
Sbjct: 143 -IAKGTFSPLR---AIQTMHLAQNPFI 165

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 66.9 bits (164), Expect = 7e-13
 Identities = 34/118 (28%), Positives = 59/118 (50%), Gaps = 12/118 (10%)

Query: 115 GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS-DE 173
           GIP       ++T +YL GN+    +P  L   + L  + L NN++  ++ +    +  +
Sbjct: 28  GIP------RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79

Query: 174 LYKLELGGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN 229
           L  L L  N+L   IP   F+ L SLR+L L  N+++ +P   F +L  + +L   +N
Sbjct: 80  LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 40/179 (22%), Positives = 60/179 (33%), Gaps = 67/179 (37%)

Query: 48  QALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEM 107
             L L  N  T    ELS        K LTLI  SNN +  +  ++           F  
Sbjct: 34  TELYLDGNQFTLVPKELSNY------KHLTLIDLSNNRISTLSNQS-----------FS- 75

Query: 108 AYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLENNKLEGSIPD 166
                         N+T L  + L  N+L   IP  T   L+ L+ L L  N +   +P+
Sbjct: 76  --------------NMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPE 119

Query: 167 SICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLK-DILYL 224
                                    FN+L++L  L +G+N     P        ++ +L
Sbjct: 120 GA-----------------------FNDLSALSHLAIGAN-----P---LYCDCNMQWL 147

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 49.2 bits (118), Expect = 8e-07
 Identities = 25/105 (23%), Positives = 45/105 (42%), Gaps = 20/105 (19%)

Query: 2   LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS-- 59
           L +  N F+  +P+ + N   L++++LS+N  S     +F N+  L  L LS N L    
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIP 94

Query: 60  ----------STLELSF--LSSL-----SNCKSLTLISFSNNPLD 87
                       L L    +S +     ++  +L+ ++   NPL 
Sbjct: 95  PRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 26/102 (25%), Positives = 42/102 (41%), Gaps = 13/102 (12%)

Query: 196 ASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISL 255
             +  L L  N+ T +P    N K +  ++ S+N         I  L      +  +  L
Sbjct: 31  RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNN--------RISTLSNQSFSN--MTQL 80

Query: 256 ISLNLSNNNLSGAIPASL-EKLSYLKDLNLSFNKLEGEIPRG 296
           ++L LS N L   IP    + L  L+ L+L  N +   +P G
Sbjct: 81  LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEG 120

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 68.6 bits (168), Expect = 9e-13
 Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 25/153 (16%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKV-------FNLQYGRVFKSFDVECEMMKSIRH-RNI 450
           IG GSFG ++    +  G EVA+K+         L           E ++ K ++    I
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI---------ESKIYKMMQGGVGI 67

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
             +    +  ++  +V+E +   SLE   +  +    +   L +   + S +EY+H   S
Sbjct: 68  PTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---S 123

Query: 511 AQVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 540
              IH D+KP N L+       + ++ DFG+AK
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 34/166 (20%), Positives = 65/166 (39%), Gaps = 31/166 (18%)

Query: 400 IGRGSFGSVFKAR---------LGDGMEVAMKV-------FNLQ--YGRVFKSFDVECEM 441
             R + G +++A               + ++K+       FN Q  + R  K   V    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 442 -MKSIRHRNIIKVISSCSNE-EFKALVLEYMPHG-SLEKYLHSSNY-ILDIYQRLNIMID 497
            + S     I   +    ++ +++ LVL  +  G SL+  L  S   +L     L +   
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVACR 167

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 540
           +  ALE+LH     + +H ++   N+ +   D + V  L+ +G A 
Sbjct: 168 LLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 65.9 bits (161), Expect = 3e-12
 Identities = 37/123 (30%), Positives = 54/123 (43%), Gaps = 23/123 (18%)

Query: 122 NLTNLTIIYLGGNKLNGSIPSTL-GKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLEL 179
           +L NL  +YLG N+L  ++P  +   L +L  L L  N+L   +P ++      L +L +
Sbjct: 62  SLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFM 119

Query: 180 GGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLK-----------------DI 221
             NKL+  +P     L  L  L L  N+L SIP   F  L                  DI
Sbjct: 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECRDI 178

Query: 222 LYL 224
           +YL
Sbjct: 179 MYL 181

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 37/120 (30%), Positives = 58/120 (48%), Gaps = 10/120 (8%)

Query: 112 VSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS 171
           V  GIP      TN  I+YL  N++    P     L  L+ L L +N+L  ++P  +  S
Sbjct: 34  VPAGIP------TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDS 86

Query: 172 -DELYKLELGGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSN 229
             +L  L+LG N+L+  +P   F+ L  L+ L +  N+LT +P     L  + +L    N
Sbjct: 87  LTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQN 145

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 41/135 (30%), Positives = 70/135 (51%), Gaps = 15/135 (11%)

Query: 163 SIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDI 221
           S+P  I  + +   L L  N+++   P  F++L +L+ L LGSN+L ++P+  F +L  +
Sbjct: 33  SVPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90

Query: 222 LYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKD 281
             L+  +N  T  LP  +        D   L+ L  L +  N L+  +P  +E+L++L  
Sbjct: 91  TVLDLGTNQLTV-LPSAV-------FDR--LVHLKELFMCCNKLT-ELPRGIERLTHLTH 139

Query: 282 LNLSFNKLEGEIPRG 296
           L L  N+L+  IP G
Sbjct: 140 LALDQNQLKS-IPHG 153

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 34/120 (28%), Positives = 54/120 (45%), Gaps = 14/120 (11%)

Query: 115 GIPEEIGNLTNLTIIYLGGNKLNGSIPST--LGKLQKLQGLGLENNKLEGSIPDSICHS- 171
            IP       + T + L  N+L   I S    G+L  L  L L+ N+L   I  +     
Sbjct: 26  DIP------LHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGA 77

Query: 172 DELYKLELGGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN 229
             + +L+LG NK+   I    F  L  L+ L L  N+++ +   +F +L  +  LN +SN
Sbjct: 78  SHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 44.6 bits (106), Expect = 3e-05
 Identities = 25/104 (24%), Positives = 35/104 (33%), Gaps = 15/104 (14%)

Query: 196 ASLRILLLGSNELTSIPLT--FWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLI 253
                LLL  NEL  I     F  L  ++ L    N  TG +            +     
Sbjct: 29  LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNA-------FEG--AS 78

Query: 254 SLISLNLSNNNLSGAIPASL-EKLSYLKDLNLSFNKLEGEIPRG 296
            +  L L  N +   I   +   L  LK LNL  N++   +  G
Sbjct: 79  HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPG 120

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 25/106 (23%), Positives = 41/106 (38%), Gaps = 20/106 (18%)

Query: 2   LQMWENNFSGTIPRFIFNA-SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS- 59
           L + +N         +F     L  LEL  N  +G  PN F    ++Q L+L  N +   
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEI 93

Query: 60  -----------STLELSF--LSSLS-----NCKSLTLISFSNNPLD 87
                       TL L    +S +      +  SLT ++ ++NP +
Sbjct: 94  SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 34/167 (20%), Positives = 71/167 (42%), Gaps = 31/167 (18%)

Query: 399 LIGRGSFGSVFKAR------LGDGMEVAMKVFNLQYG------RVFKSFDVECEMMKSIR 446
            IG+G FG ++ A       +G      +KV     G      + ++      ++ K IR
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 447 HRNIIKV---------ISSCSNEEFKALVLEYMPHG-SLEKYLHSSNYILDIYQRLNIMI 496
            R +  +         +   + + ++ ++++    G  L+K   ++         L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSL 159

Query: 497 DVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 540
            +   LEY+H     + +H D+K SN+LL   + + V +L D+G+A 
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 36/146 (24%), Positives = 68/146 (46%), Gaps = 11/146 (7%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSC 457
           IG GSFG ++    +    EVA+K+ N++          E ++ + ++    I  V    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
              ++  LV++ +   SLE   +  +  L +   L +   + + +E++H   S   +H D
Sbjct: 73  VEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRD 128

Query: 518 LKPSNVLLDDNMVAH---LSDFGIAK 540
           +KP N L+     A+   + DFG+AK
Sbjct: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 62.0 bits (151), Expect = 5e-11
 Identities = 37/154 (24%), Positives = 62/154 (40%), Gaps = 24/154 (15%)

Query: 115 GIPEEIGNLTNLTIIYLGGNKLNGSIPST--LGKLQKLQGLGLENNKLEGSIPDSICHS- 171
            IP           + L  N+    + +T    KL +L+ +   NNK+   I +      
Sbjct: 29  HIP------QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGA 80

Query: 172 DELYKLELGGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN 229
             + ++ L  N+L  ++    F  L SL+ L+L SN +T +   +F  L  +  L+   N
Sbjct: 81  SGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN 139

Query: 230 FFTGPLPLEIGNLKIARIDSCDLISLISLNLSNN 263
             T  +            D+  L SL +LNL  N
Sbjct: 140 QIT-TVAPGA-------FDT--LHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 32/149 (21%), Positives = 53/149 (35%), Gaps = 39/149 (26%)

Query: 151 QGLGLENNKLEGSIPDSICHS-DELYKLELGGNKLSGSIPE-CFNNLASLRILLLGSNEL 208
             L L NN+        I     +L K+    NK++  I E  F   + +  +LL SN L
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL 93

Query: 209 TSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGA 268
            ++                   F G                  L SL +L L +N ++  
Sbjct: 94  ENVQ---------------HKMFKG------------------LESLKTLMLRSNRIT-C 119

Query: 269 IPA-SLEKLSYLKDLNLSFNKLEGEIPRG 296
           +   S   LS ++ L+L  N++   +  G
Sbjct: 120 VGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 24/159 (15%), Positives = 53/159 (33%), Gaps = 34/159 (21%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L++  N F+      IF    +L  +  S+N  +      F     +  + L++N L + 
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN- 95

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
            ++      L +   L  +   +N +  +   +           F               
Sbjct: 96  -VQHKMFKGLES---LKTLMLRSNRITCVGNDS-----------FI-------------- 126

Query: 121 GNLTNLTIIYLGGNKLNGSIP-STLGKLQKLQGLGLENN 158
             L+++ ++ L  N++  ++       L  L  L L  N
Sbjct: 127 -GLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 24/104 (23%), Positives = 41/104 (39%), Gaps = 15/104 (14%)

Query: 196 ASLRILLLGSNELTSIPLT--FWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLI 253
                L L +NE T +  T  F  L  +  +NFS+N  T    +E G  +          
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD---IEEGAFE-------GAS 81

Query: 254 SLISLNLSNNNLSGAIPASL-EKLSYLKDLNLSFNKLEGEIPRG 296
            +  + L++N L   +   + + L  LK L L  N++   +   
Sbjct: 82  GVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGND 123

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 21/102 (20%), Positives = 37/102 (36%), Gaps = 20/102 (19%)

Query: 6   ENNFSGTIPRFIFN-ASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS----- 59
            NN    I    F  AS ++ + L+ N         F  L +L+ L L +N +T      
Sbjct: 65  SNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDS 124

Query: 60  -------STLELS--FLSSL-----SNCKSLTLISFSNNPLD 87
                    L L    ++++         SL+ ++   NP +
Sbjct: 125 FIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 60.7 bits (148), Expect = 6e-11
 Identities = 40/133 (30%), Positives = 56/133 (42%), Gaps = 28/133 (21%)

Query: 112 VSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS 171
           V  GIP      ++ T + L  NKL         KL +L  L L  N+++ S+PD +   
Sbjct: 22  VPTGIP------SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDK 74

Query: 172 -DELYKLELGGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPL-TFWNLK--------- 219
             +L  L L  NKL  S+P   F+ L  L+ L L +N+L S+P   F  L          
Sbjct: 75  LTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 133

Query: 220 --------DILYL 224
                    I YL
Sbjct: 134 NPWDCSCPRIDYL 146

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.2 bits (105), Expect = 3e-05
 Identities = 32/93 (34%), Positives = 47/93 (50%), Gaps = 11/93 (11%)

Query: 140 IPSTLGKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLELGGNKLSGSIPE-CFNNLAS 197
           IPS+         L LE+NKL+ S+P  +     +L KL L  N++  S+P+  F+ L  
Sbjct: 26  IPSSA------TRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTK 77

Query: 198 LRILLLGSNELTSIPL-TFWNLKDILYLNFSSN 229
           L IL L  N+L S+P   F  L  +  L   +N
Sbjct: 78  LTILYLHENKLQSLPNGVFDKLTQLKELALDTN 110

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 42.6 bits (101), Expect = 8e-05
 Identities = 33/122 (27%), Positives = 47/122 (38%), Gaps = 36/122 (29%)

Query: 176 KLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPL 235
           +LEL  NKL       F+ L  L  L L  N++ S+P                  F    
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLP---------------DGVF---- 72

Query: 236 PLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASL-EKLSYLKDLNLSFNKLEGEIP 294
                       D   L  L  L L  N L  ++P  + +KL+ LK+L L  N+L+  +P
Sbjct: 73  ------------DK--LTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKS-VP 116

Query: 295 RG 296
            G
Sbjct: 117 DG 118

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 60.8 bits (148), Expect = 9e-11
 Identities = 43/124 (34%), Positives = 62/124 (50%), Gaps = 24/124 (19%)

Query: 122 NLTNLTIIYLGGNKLNGSIPSTL-GKLQKLQGLGLENNKLEGSIPDSICHS-DELYKLEL 179
            LT+LT +YLGGNKL  S+P+ +  KL  L  L L  N+L+ S+P+ +     +L +L L
Sbjct: 50  ELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELAL 107

Query: 180 GGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPL-TFWNLK-----------------D 220
             N+L  S+P+  F+ L  L+ L L  N+L S+P   F  L                   
Sbjct: 108 NTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 166

Query: 221 ILYL 224
           I YL
Sbjct: 167 IRYL 170

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 55.5 bits (134), Expect = 6e-09
 Identities = 46/142 (32%), Positives = 65/142 (45%), Gaps = 16/142 (11%)

Query: 157 NNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TF 215
            ++   S+P  I        L+L  N L       F+ L SL  L LG N+L S+P   F
Sbjct: 15  YSQGRTSVPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72

Query: 216 WNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASL-E 274
             L  + YLN S+N     LP  +        D   L  L  L L+ N L  ++P  + +
Sbjct: 73  NKLTSLTYLNLSTNQLQS-LPNGV-------FDK--LTQLKELALNTNQLQ-SLPDGVFD 121

Query: 275 KLSYLKDLNLSFNKLEGEIPRG 296
           KL+ LKDL L  N+L+  +P G
Sbjct: 122 KLTQLKDLRLYQNQLKS-VPDG 142

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 33/103 (32%), Positives = 47/103 (45%), Gaps = 10/103 (9%)

Query: 112 VSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS 171
           V  GIP         T + L  N L         +L  L  L L  NKL+ S+P+ + + 
Sbjct: 22  VPTGIP------AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNK 74

Query: 172 -DELYKLELGGNKLSGSIPE-CFNNLASLRILLLGSNELTSIP 212
              L  L L  N+L  S+P   F+ L  L+ L L +N+L S+P
Sbjct: 75  LTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLP 116

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.0 bits (152), Expect = 9e-11
 Identities = 35/200 (17%), Positives = 61/200 (30%), Gaps = 52/200 (26%)

Query: 388 CRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKV--------FNLQYGRVFKSFDVEC 439
           C  T+       IG G FG VF+    D   VA+K+         N  + + F+    E 
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74

Query: 440 EMMKSI---------RHRNIIKVISSC------------------------------SNE 460
            + K +         R    I + S                                  +
Sbjct: 75  IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134

Query: 461 EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKP 520
           +   +VLE+   G   + + +   +  +    +I+  + ++L         +  H DL  
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASL--RFEHRDLHW 190

Query: 521 SNVLLDDNMVAHLSDFGIAK 540
            NVLL    +  L      K
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK 210

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 37/165 (22%), Positives = 68/165 (41%), Gaps = 30/165 (18%)

Query: 399 LIGRGSFGSVFKA-RLGDGMEVAMKVFNLQ-------------YGRVFKSFDVECEM-MK 443
            IG G FG ++ A       + A  V  ++             Y RV K   ++  +  K
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 444 SIRHRNIIKVISS----CSNEEFKALVLEYMPHG-SLEKYLHSSNYILDIYQRLNIMIDV 498
            + +  I     S         ++ +V+E +  G  L+K     N        L + I +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKIS-GQNGTFKKSTVLQLGIRM 160

Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAK 540
              LEY+H     + +H D+K +N+LL   + + V +L+D+G++ 
Sbjct: 161 LDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 63.2 bits (153), Expect = 1e-10
 Identities = 46/288 (15%), Positives = 73/288 (25%), Gaps = 30/288 (10%)

Query: 4   MWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLE 63
            W        P  ++    L    L+D          +    + +   L  +        
Sbjct: 286 EWRTPDGRNRPSHVWLC-DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC---- 340

Query: 64  LSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNL 123
             +    +  + L     S      +  +         LE            +   +  L
Sbjct: 341 --WCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPL 398

Query: 124 TNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNK 183
                     + L    P     L  L+   L  N              ++  L L    
Sbjct: 399 LYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLEN------SVLKMEYADVRVLHLAHKD 452

Query: 184 LSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK 243
           L+  +      L  +  L L  N L ++P     L+ +  L  S N              
Sbjct: 453 LT-VLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDN-------------A 497

Query: 244 IARIDSCD-LISLISLNLSNNNLSG-AIPASLEKLSYLKDLNLSFNKL 289
           +  +D    L  L  L L NN L   A    L     L  LNL  N L
Sbjct: 498 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 63.2 bits (153), Expect = 1e-10
 Identities = 44/279 (15%), Positives = 86/279 (30%), Gaps = 48/279 (17%)

Query: 4   MWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLE 63
           +   +      R      +L   ELS    S  + +   + + LQ L   N +       
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEK-STVLQSELESCKELQELEPENKWCL----- 385

Query: 64  LSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNL 123
              L+ +   ++L  + +    L       +V  +  +      +   +           
Sbjct: 386 ---LTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL--ENSVLKMEY 440

Query: 124 TNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNK 183
            ++ +++L    L  ++   L +L  +  L L +N+L  ++P ++     L  L+   N 
Sbjct: 441 ADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA 497

Query: 184 LSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK 243
           L  ++     NL  L+ LLL +N L                              I  L 
Sbjct: 498 LE-NVDG-VANLPRLQELLLCNNRLQQSA-------------------------AIQPLV 530

Query: 244 IARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDL 282
                      L+ LNL  N+L             L  +
Sbjct: 531 -------SCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 59.8 bits (144), Expect = 2e-09
 Identities = 37/180 (20%), Positives = 59/180 (32%), Gaps = 28/180 (15%)

Query: 117 PEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYK 176
             +      L    L   K    + S L   ++LQ L  EN     +I   +   D L  
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400

Query: 177 LELGGNKLSGSIPECFNNLASLRILLLG------SNELTSIPLTFWNLKDILYLNFSSNF 230
            +              + L ++  +         S  L    +      D+  L+ +   
Sbjct: 401 EKETLQYF--------STLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452

Query: 231 FTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
            T    LE             L+ +  L+LS+N L  A+P +L  L  L+ L  S N LE
Sbjct: 453 LTVLCHLE------------QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 58.2 bits (140), Expect = 5e-09
 Identities = 39/213 (18%), Positives = 67/213 (31%), Gaps = 20/213 (9%)

Query: 110 CNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSIC 169
              S  +  E+ +   L  +         +I   +  L  L                   
Sbjct: 358 VEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPM 417

Query: 170 HSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSN 229
            +  L  L    +K            A +R+L L   +LT +      L  + +L+ S N
Sbjct: 418 RAAYLDDLR---SKFLLENSVLKMEYADVRVLHLAHKDLTVLC-HLEQLLLVTHLDLSHN 473

Query: 230 FFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKL 289
                LP  +  L+           L  L  S+N L   +   +  L  L++L L  N+L
Sbjct: 474 RLRA-LPPALAALR----------CLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL 520

Query: 290 EG--EIPRGGSFGNFSAESFEGNELLCGSPNLR 320
           +    I    S       + +GN  LC    ++
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNS-LCQEEGIQ 552

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 50/204 (24%), Positives = 88/204 (43%), Gaps = 20/204 (9%)

Query: 397 NNLIGRGSFGSVFKAR-LGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHR------ 448
           ++LIG+GSFG V KA    +   VA+K+  N +         +E  +++ +         
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHF 507
            I+ +           LV E +   +L   L ++N+  + +         + +AL +L  
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA- 174

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAH--LSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY 565
                +IHCDLKP N+LL +   +   + DFG +  L +     IQ++      Y +PE 
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEV 229

Query: 566 GKEGRVSANGDVYSFGIMLMETFT 589
                     D++S G +L+E  T
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHT 253

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 60.9 bits (148), Expect = 6e-10
 Identities = 53/298 (17%), Positives = 94/298 (31%), Gaps = 71/298 (23%)

Query: 21  SKLSILELSDNSFSGFIPNTFGNLR----------NLQALRLSNNYLTSSTLELSFLSSL 70
             L I E SD             LR           L  +RLS+N    +  E   +  L
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE-PLIDFL 118

Query: 71  SNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIY 130
           S    L  +   NN   G+ P+ +   ++ +L+   +          ++  N   L  I 
Sbjct: 119 SKHTPLEHLYLHNN---GLGPQ-AGAKIARALQELAVN---------KKAKNAPPLRSII 165

Query: 131 LGGNKLNG----SIPSTLGKLQKLQGLGLENNKL-----EGSIPDSICHSDELYKLELGG 181
            G N+L          T    + L  + +  N +     E  + + + +  EL  L+L  
Sbjct: 166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD 225

Query: 182 NKLSG----SIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPL 237
           N  +     ++     +  +LR L L    L++                           
Sbjct: 226 NTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR-------------------------- 259

Query: 238 EIGNLKIAR-IDSCDLISLISLNLSNNNLSG----AIPASL-EKLSYLKDLNLSFNKL 289
             G   +       + I L +L L  N +       +   + EK+  L  L L+ N+ 
Sbjct: 260 --GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 43/295 (14%), Positives = 90/295 (30%), Gaps = 66/295 (22%)

Query: 23  LSILELSDNSFSG----FIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
           +    L  ++ +      +        +++ + LS N + +         ++++ K L +
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAAR-WLSENIASKKDLEI 64

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG 138
             FS+     +  +                       + + +     L  + L  N    
Sbjct: 65  AEFSDIFTGRVKDEIPEALRL----------------LLQALLKCPKLHTVRLSDNAFGP 108

Query: 139 ----SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNN 194
                +   L K   L+ L L NN L            +       G K++ ++ E   N
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGL----------GPQ------AGAKIARALQELAVN 152

Query: 195 LA-----SLRILLLGSNELTS-----IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKI 244
                   LR ++ G N L +        TF + + +  +    N         I    I
Sbjct: 153 KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQN--------GIRPEGI 204

Query: 245 ARIDS---CDLISLISLNLSNNNLSG----AIPASLEKLSYLKDLNLSFNKLEGE 292
             +          L  L+L +N  +     A+  +L+    L++L L+   L   
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 41/225 (18%), Positives = 70/225 (31%), Gaps = 34/225 (15%)

Query: 19  NASKLSILELSDNSFSG----FIPNTFGNLRNLQALRLSNN--------YLTSSTLELSF 66
              KL  + LSDN+F       + +       L+ L L NN         +  +  EL+ 
Sbjct: 92  KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAV 151

Query: 67  LSSLSNCKSLTLISFSNNPL--DGILPKTSVGNLSHSLEYFEMAYCN-----VSGGIPEE 119
                N   L  I    N L    +            L   +M         +   + E 
Sbjct: 152 NKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 211

Query: 120 IGNLTNLTIIYLGGNKLNG----SIPSTLGKLQKLQGLGLENNKL--EG--SIPDSI--C 169
           +     L ++ L  N        ++   L     L+ LGL +  L   G  ++ D+    
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271

Query: 170 HSDELYKLELGGNKLSG----SIPECF-NNLASLRILLLGSNELT 209
            +  L  L L  N++      ++       +  L  L L  N  +
Sbjct: 272 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 42/211 (19%), Positives = 71/211 (33%), Gaps = 43/211 (20%)

Query: 19  NASKLSILELSDNSFSG----FIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCK 74
           NA  L  +    N            TF + R L  +++  N +    +E   L  L+ C+
Sbjct: 157 NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ 216

Query: 75  SLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGN 134
            L ++   +N        T +G                S  +   + +  NL  + L   
Sbjct: 217 ELKVLDLQDNTF------THLG----------------SSALAIALKSWPNLRELGLNDC 254

Query: 135 KLNG----SIPSTLGKL--QKLQGLGLENNKL--EG--SIPDSICHSDE-LYKLELGGNK 183
            L+     ++     KL    LQ L L+ N++  +   ++   I      L  LEL GN+
Sbjct: 255 LLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR 314

Query: 184 LS------GSIPECFNNLASLRILLLGSNEL 208
            S        I E F+      +  L   E 
Sbjct: 315 FSEEDDVVDEIREVFSTRGRGELDELDDMEE 345

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 66/370 (17%), Positives = 119/370 (32%), Gaps = 129/370 (34%)

Query: 400 IGRGSFGSVFKAR-LGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIR--------HRN 449
           +G G F +V+ +  +     VAMKV  + ++    ++   E  ++KS+R           
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT--ETALDEIRLLKSVRNSDPNDPNREM 102

Query: 450 IIKVISSCSNEEFK---------ALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVA 499
           +++++     ++FK          +V E + H  L K++  SNY  L +     I+  V 
Sbjct: 103 VVQLL-----DDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVL 156

Query: 500 SALEYLHFGYSAQVIHCDLKPSNVLL---------------------------------- 525
             L+YLH     ++IH D+KP N+LL                                  
Sbjct: 157 QGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214

Query: 526 ---------------DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
                           + +   ++D G A  + +     IQT+      Y + E      
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSG 269

Query: 571 VSANGDVYSFGIMLMETFT------------------------------------RKKPT 594
            +   D++S   M  E  T                                      K +
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329

Query: 595 DEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESP 654
            E F  +  LKH          + +V+    S+E+           F+    +      P
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEE-----AAGFTDFL----LPMLELIP 380

Query: 655 EQRINAKEIV 664
           E+R  A E +
Sbjct: 381 EKRATAAECL 390

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 41/228 (17%), Positives = 84/228 (36%), Gaps = 56/228 (24%)

Query: 399 LIGRGSFGSVFKA--RLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHR------N 449
            +G G+FG V +         +VA+K+  N+   +  ++  +E  ++K I+ +       
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVG--KYREAARLEINVLKKIKEKDKENKFL 83

Query: 450 IIKVISS-------CSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASA 501
            + +          C       +  E +   +  ++L  +N+    +    ++   +  A
Sbjct: 84  CVLMSDWFNFHGHMC-------IAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135

Query: 502 LEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI----------Q 551
           L +LH     Q+ H DLKP N+L  ++    L +   +        ++I           
Sbjct: 136 LRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192

Query: 552 TQTLATI----GYMAPE------YGKEGRVSANGDVYSFGIMLMETFT 589
            +   TI     Y  PE      +      +   DV+S G +L E + 
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGW------AQPCDVWSIGCILFEYYR 234

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 53/232 (22%), Positives = 91/232 (39%), Gaps = 60/232 (25%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHR-----NII 451
            +G G+FG V   + + +    A+KV  N++  +  +S  +E +++K I++      NI+
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK--KYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 452 KVISS-------CSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALE 503
           K           C       L+ E +   SL + +  +NY    I       I++  AL 
Sbjct: 100 KYHGKFMYYDHMC-------LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ---------------- 547
           YL       + H DLKP N+LLDD                ++ Q                
Sbjct: 152 YLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208

Query: 548 STIQTQTLATI----GYMAPE------YGKEGRVSANGDVYSFGIMLMETFT 589
           +T ++    +I     Y APE      +        + D++SFG +L E +T
Sbjct: 209 ATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYT 254

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 39/221 (17%), Positives = 84/221 (38%), Gaps = 42/221 (19%)

Query: 399 LIGRGSFGSVFKA--RLGDGMEVAMKVF-NLQYGRVFKSFDVECEMMKSIRHR------N 449
            +G G+FG V +       G  VA+K+  N+   R  ++   E ++++ +          
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNSTFR 78

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFG 508
            ++++    +     +V E +   S   ++  + ++   +     +   +  ++ +LH  
Sbjct: 79  CVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH-- 135

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI----------QTQTLATI 558
            S ++ H DLKP N+L   +      +  I +         I            +  +T+
Sbjct: 136 -SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTL 194

Query: 559 ----GYMAPE------YGKEGRVSANGDVYSFGIMLMETFT 589
                Y APE      +      S   DV+S G +L+E + 
Sbjct: 195 VSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYYL 229

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 34/169 (20%), Positives = 61/169 (36%), Gaps = 22/169 (13%)

Query: 135 KLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNN 194
           +    + +   K++    L      +E  +  ++        L L  N +   I    + 
Sbjct: 16  ERKSVVATEAEKVE----LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSG 68

Query: 195 LASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCD-LI 253
           + +LRIL LG N +  I         +  L  S N             +IA +   + L+
Sbjct: 69  MENLRILSLGRNLIKKIENLDAVADTLEELWISYN-------------QIASLSGIEKLV 115

Query: 254 SLISLNLSNNNLSGAIP-ASLEKLSYLKDLNLSFNKLEGEIPRGGSFGN 301
           +L  L +SNN ++       L  L  L+DL L+ N L  +     +   
Sbjct: 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 35/138 (25%), Positives = 62/138 (44%), Gaps = 15/138 (10%)

Query: 37  IPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVG 96
           +  T   L+  + L LS N +         +SSLS  ++L ++S   N +  I    ++ 
Sbjct: 40  MDATLSTLKACKHLALSTNNIEK-------ISSLSGMENLRILSLGRNLIKKI---ENLD 89

Query: 97  NLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLN--GSIPSTLGKLQKLQGLG 154
            ++ +LE   ++Y  ++      I  L NL ++Y+  NK+   G I   L  L KL+ L 
Sbjct: 90  AVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLL 146

Query: 155 LENNKLEGSIPDSICHSD 172
           L  N L     ++   S+
Sbjct: 147 LAGNPLYNDYKENNATSE 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 25/116 (21%), Positives = 52/116 (44%), Gaps = 7/116 (6%)

Query: 116 IPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELY 175
           +   +  L     + L  N +   I S+L  ++ L+ L L  N ++  I +    +D L 
Sbjct: 40  MDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 176 KLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIP--LTFWNLKDILYLNFSSN 229
           +L +  N+++ S+      L +LR+L + +N++T+         L  +  L  + N
Sbjct: 97  ELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.4 bits (130), Expect = 6e-08
 Identities = 20/100 (20%), Positives = 31/100 (31%), Gaps = 1/100 (1%)

Query: 134 NKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPD-SICHSDELYKLELGGNKLSGSIPECF 192
                     L   + L  L +EN +    +    +    EL  L +  + L    P+ F
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 193 NNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFT 232
           +    L  L L  N L S+         +  L  S N   
Sbjct: 77  HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 19/87 (21%), Positives = 28/87 (32%), Gaps = 7/87 (8%)

Query: 2   LQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           L +        +         +L  L +  +      P+ F     L  L LS N L   
Sbjct: 36  LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-- 93

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLD 87
           +L    +  L    SL  +  S NPL 
Sbjct: 94  SLSWKTVQGL----SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 51.7 bits (123), Expect = 4e-07
 Identities = 21/105 (20%), Positives = 33/105 (31%), Gaps = 13/105 (12%)

Query: 163 SIPDSICHSDELYKLELGGNKLSGSIP-ECFNNLASLRILLLGSNELTSI-PLTFWNLKD 220
                +  ++ L +L +   +    +       L  LR L +  + L  + P  F     
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 221 ILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNL 265
           +  LN S N         +  L           SL  L LS N L
Sbjct: 82  LSRLNLSFNALESLSWKTVQGL-----------SLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 45.1 bits (106), Expect = 5e-05
 Identities = 14/85 (16%), Positives = 30/85 (35%), Gaps = 10/85 (11%)

Query: 12 TIPRFIFNASKLSILELSDNSFSGFIPN-TFGNLRNLQALRLSNNYLTSSTLELSFLS-- 68
               +  A  L+ L + +      +       L  L+ L +  +        L F++  
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS-------GLRFVAPD 74

Query: 69 SLSNCKSLTLISFSNNPLDGILPKT 93
          +      L+ ++ S N L+ +  KT
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKT 99

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.7 bits (105), Expect = 6e-05
 Identities = 20/112 (17%), Positives = 33/112 (29%), Gaps = 19/112 (16%)

Query: 208 LTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDS---CDLISLISLNLSNNN 264
                      +++  L                   +  ++      L  L +L +  + 
Sbjct: 20  ALDSLHHLPGAENLTELYIE------------NQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 265 LSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAES--FEGNELLC 314
           L    P +      L  LNLSFN LE  +    +    S +     GN L C
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALE-SLSW-KTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 43.2 bits (101), Expect = 2e-04
 Identities = 21/113 (18%), Positives = 36/113 (31%), Gaps = 19/113 (16%)

Query: 182 NKLSGSIPECFNNLASLRILLLGSN-ELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEI 239
              +           +L  L + +   L  + L     L ++  L    +          
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS---------- 66

Query: 240 GNLKIARIDS---CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKL 289
               +  +          L  LNLS N L      +++ LS L++L LS N L
Sbjct: 67  ---GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.4 bits (99), Expect = 3e-04
 Identities = 19/101 (18%), Positives = 35/101 (34%), Gaps = 7/101 (6%)

Query: 37  IPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVG 96
             +      NL  L + N       LEL  L  L   ++LT+     + L  + P     
Sbjct: 23  SLHHLPGAENLTELYIENQQH-LQHLELRDLRGLGELRNLTI---VKSGLRFVAPDAFHF 78

Query: 97  NLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLN 137
                L    +++  +   +  +     +L  + L GN L+
Sbjct: 79  T--PRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 51.1 bits (123), Expect = 1e-07
 Identities = 38/117 (32%), Positives = 55/117 (47%), Gaps = 20/117 (17%)

Query: 112 VSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS 171
           V  GIP      T+   ++L  N++    P     L  LQ L   +NKL  +IP  +   
Sbjct: 27  VPAGIP------TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDK 79

Query: 172 -DELYKLELGGNKLSGSIPE-CFNNLASLRILLLGSNELTSIPLTFWN--LKDILYL 224
             +L +L+L  N L  SIP   F+NL SL  + L +N     P   W+   +DI+YL
Sbjct: 80  LTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN-----P---WDCECRDIMYL 127

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.5 bits (116), Expect = 5e-07
 Identities = 33/142 (23%), Positives = 49/142 (34%), Gaps = 35/142 (24%)

Query: 19  NASKLSILELSDNSFS-GFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLT 77
             S +  L L ++  + G +         L+ L   N  LTS       +++L     L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-------IANLPKLNKLK 67

Query: 78  LISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLN 137
            +  S+N                           VSGG+        NLT + L GNK+ 
Sbjct: 68  KLELSDN--------------------------RVSGGLEVLAEKCPNLTHLNLSGNKIK 101

Query: 138 G-SIPSTLGKLQKLQGLGLENN 158
             S    L KL+ L+ L L N 
Sbjct: 102 DLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 21/65 (32%), Positives = 29/65 (44%), Gaps = 4/65 (6%)

Query: 22  KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF 81
           KL  LELSDN  SG +        NL  L LS N +     +LS +  L   ++L  +  
Sbjct: 65  KLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK----DLSTIEPLKKLENLKSLDL 120

Query: 82  SNNPL 86
            N  +
Sbjct: 121 FNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 39.7 bits (93), Expect = 6e-04
 Identities = 28/99 (28%), Positives = 43/99 (43%), Gaps = 13/99 (13%)

Query: 192 FNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCD 251
            +++  L +    SNE     LT    +++ +L+  +   T      I NL         
Sbjct: 16  PSDVKELVLDNSRSNEGKLEGLTDE-FEELEFLSTINVGLT-----SIANLP-------K 62

Query: 252 LISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
           L  L  L LS+N +SG +    EK   L  LNLS NK++
Sbjct: 63  LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 36/131 (27%), Positives = 48/131 (36%), Gaps = 48/131 (36%)

Query: 112 VSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS 171
           V  GIP      T   ++YL  N++    P    +L +L  L L+NN+L   +P  +   
Sbjct: 24  VPTGIP------TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGV--- 73

Query: 172 DELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLK----------- 219
                               F+ L  L  L L  N+L SIP   F NLK           
Sbjct: 74  --------------------FDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNP 113

Query: 220 ------DILYL 224
                 DILYL
Sbjct: 114 WDCACSDILYL 124

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 46.3 bits (110), Expect = 5e-06
 Identities = 35/142 (24%), Positives = 48/142 (33%), Gaps = 35/142 (24%)

Query: 19  NASKLSILELSDNSFS-GFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLT 77
             + +  L L +   + G I        NL+ L L N  L S       +S+L     L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-------VSNLPKLPKLK 74

Query: 78  LISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLN 137
            +  S N                           + GG+      L NLT + L GNKL 
Sbjct: 75  KLELSEN--------------------------RIFGGLDMLAEKLPNLTHLNLSGNKLK 108

Query: 138 G-SIPSTLGKLQKLQGLGLENN 158
             S    L KL+ L+ L L N 
Sbjct: 109 DISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.5 bits (108), Expect = 9e-06
 Identities = 21/65 (32%), Positives = 28/65 (43%), Gaps = 4/65 (6%)

Query: 22  KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF 81
           KL  LELS+N   G +      L NL  L LS N L     ++S L  L   + L  +  
Sbjct: 72  KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK----DISTLEPLKKLECLKSLDL 127

Query: 82  SNNPL 86
            N  +
Sbjct: 128 FNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 43.6 bits (103), Expect = 4e-05
 Identities = 29/113 (25%), Positives = 46/113 (40%), Gaps = 9/113 (7%)

Query: 122 NLTNLTIIYLGGNKLN-GSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG 180
               +  + L   K N G I     +   L+ L L N  L  S+  ++    +L KLEL 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79

Query: 181 GNKLSGSIPECFNNLASLRILLLGSNELTSI----PLTFWNLKDILYLNFSSN 229
            N++ G +      L +L  L L  N+L  I    PL    L+ +  L+  + 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLK--KLECLKSLDLFNC 130

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.8 bits (109), Expect = 7e-06
 Identities = 20/101 (19%), Positives = 34/101 (33%), Gaps = 12/101 (11%)

Query: 190 ECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDS 249
             + N    R L L   ++  I      L     ++FS N        ++          
Sbjct: 13  AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-----KLDGFP------ 61

Query: 250 CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE 290
             L  L +L ++NN +        + L  L +L L+ N L 
Sbjct: 62  -LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.8 bits (109), Expect = 9e-06
 Identities = 21/117 (17%), Positives = 40/117 (34%), Gaps = 11/117 (9%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
           NA +   L+L        I N    L    A+  S+N +         L      + L  
Sbjct: 17  NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-------LDGFPLLRRLKT 68

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSG-GIPEEIGNLTNLTIIYLGGN 134
           +  +NN +  I     +      L    +   ++   G  + + +L +LT + +  N
Sbjct: 69  LLVNNNRICRIGE--GLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.4 bits (108), Expect = 1e-05
 Identities = 20/65 (30%), Positives = 30/65 (46%), Gaps = 4/65 (6%)

Query: 22  KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF 81
           +L  L +++N            L +L  L L+NN L     EL  L  L++ KSLT +  
Sbjct: 65  RLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV----ELGDLDPLASLKSLTYLCI 120

Query: 82  SNNPL 86
             NP+
Sbjct: 121 LRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 27/188 (14%), Positives = 56/188 (29%), Gaps = 45/188 (23%)

Query: 50  LRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAY 109
           ++L+   +  +       +  +N      +      +        + NL  +L+ F+   
Sbjct: 2   VKLTAELIEQA-------AQYTNAVRDRELDLRGYKI------PVIENLGATLDQFD--A 46

Query: 110 CNVSG-GIP--EEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPD 166
            + S   I   +    L  L  + +  N++          L  L  L L NN        
Sbjct: 47  IDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS------- 99

Query: 167 SICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIP----LTFWNLKDIL 222
            +    +L  L                +L SL  L +  N +T+         + +  + 
Sbjct: 100 -LVELGDLDPLA---------------SLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVR 143

Query: 223 YLNFSSNF 230
            L+F    
Sbjct: 144 VLDFQKVK 151

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 1e-05
 Identities = 71/413 (17%), Positives = 123/413 (29%), Gaps = 108/413 (26%)

Query: 258 LNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEG--NELLCG 315
           LNL N N    +   L+KL Y  D N +         +          S +     LL  
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIK------LRIHSIQAELRRLLKS 240

Query: 316 SPNLRVPPCKTSIHHISRK---NAFLLGI-VLPLSTVFMIVVIFLIVKCRKRERGPPNDA 371
            P      C   + ++      NAF L   +L L+T F  V  FL            +  
Sbjct: 241 KPY---ENCLLVLLNVQNAKAWNAFNLSCKIL-LTTRFKQVTDFLSAATTTHISLDHHSM 296

Query: 372 NMPPEAMQRMFS-YLELCRATDGFSEN--------NLIGRGSFGSVFKARL-------GD 415
            + P+ ++ +   YL+ CR  D   E         ++I          A          D
Sbjct: 297 TLTPDEVKSLLLKYLD-CRPQDLPREVLTTNPRRLSIIAE--SIRDGLATWDNWKHVNCD 353

Query: 416 GMEVAMKVF--NLQ---YGRVFKSF-----DV-----------------ECE-MMKSIRH 447
            +   ++     L+   Y ++F                           +   ++  +  
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413

Query: 448 RNIIKVISSCSNEEFK----ALVLEYMPHGSLEKYLHSSNYILDIYQRL------NIMID 497
            ++++       +E      ++ LE       E  LH S  I+D Y         +++  
Sbjct: 414 YSLVE----KQPKESTISIPSIYLELKVKLENEYALHRS--IVDHYNIPKTFDSDDLIPP 467

Query: 498 VASALEYLHFGY---SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ- 553
                 Y H G+   + +          V LD   +         K+  R D +      
Sbjct: 468 YLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLE-------QKI--RHDSTAWNASG 518

Query: 554 ----TLATI----GYMA---PEYGKEGRVSANGDVYSFGIMLMETFTRKKPTD 595
               TL  +     Y+    P+Y  E  V+    +  F   + E     K TD
Sbjct: 519 SILNTLQQLKFYKPYICDNDPKY--ERLVN---AILDFLPKIEENLICSKYTD 566

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 1e-05
 Identities = 66/476 (13%), Positives = 144/476 (30%), Gaps = 158/476 (33%)

Query: 258 LNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP 317
                 ++   +    +   ++ + +     ++ ++P+       S E  +   ++  S 
Sbjct: 14  HQYQYKDI---LSVFEDA--FVDNFD--CKDVQ-DMPKSI----LSKEEID--HII-MSK 58

Query: 318 NLRVPPCKTSIHHISRKNAFLLGIVL--PLSTV--FMIVVI-----FLIVKCRKRERGPP 368
           +            +S     L   +L      V  F+  V+     FL+   +  +R P 
Sbjct: 59  D-----------AVSGTL-RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPS 106

Query: 369 NDANMPPEAMQRMFS---------------YLELCRATDGFSENNLI---GRGSFGSVFK 410
               M  E   R+++               YL+L +A         +   G    G   K
Sbjct: 107 MMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---K 163

Query: 411 ARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNI--IKVISSCSNEEFKALVLE 468
             +                 V  S+ V+C+M        I  + +  +C++ E    +L+
Sbjct: 164 TWV-----ALD---------VCLSYKVQCKM-----DFKIFWLNL-KNCNSPETVLEMLQ 203

Query: 469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN 528
            + +     +   S++  +I  R++    + + L  L       +     +   ++L + 
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIH---SIQAELRRL-------LKSKPYENCLLVLLN- 252

Query: 529 MV---AHLSDFGI-AKLL--TREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGI 582
            V      + F +  K+L  TR  +                       +SA    +    
Sbjct: 253 -VQNAKAWNAFNLSCKILLTTR-FKQVTD------------------FLSAATTTHISLD 292

Query: 583 MLMETFTRKKPTDEIFNGEMTLKHWVN---DWLPISTKEIVDPNLLS------REDIN-- 631
               T T  +    +      LK +++     LP       +P  LS      R+ +   
Sbjct: 293 HHSMTLTPDE-VKSLL-----LK-YLDCRPQDLPREVLTT-NPRRLSIIAESIRDGLATW 344

Query: 632 ----FVAKEQCVSFVFNVAMECTVE---SPEQR-------I---NAKEIVTKLLKI 670
                V  ++         +E ++      E R       +   +A  I T LL +
Sbjct: 345 DNWKHVNCDK-----LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH-IPTILLSL 394

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.0 bits (108), Expect = 4e-05
 Identities = 58/452 (12%), Positives = 125/452 (27%), Gaps = 109/452 (24%)

Query: 153 LGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIP 212
           +  E  + +    D +   ++ +        +        +    +  +++  + ++   
Sbjct: 7   MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSK-EEIDHIIMSKDAVSGTL 65

Query: 213 LTFWNL------------KDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISL-- 258
             FW L            +++L +N+   F   P+  E       R  S      I    
Sbjct: 66  RLFWTLLSKQEEMVQKFVEEVLRINY--KFLMSPIKTE------QRQPSMMTRMYIEQRD 117

Query: 259 NLSNNNLS---GAIPASLEKLSYLKD--LNLSFNK---LEGEIPRGGSFGN--FSAESFE 308
            L N+N       +   L+    L+   L L   K   ++G     G  G    + +   
Sbjct: 118 RLYNDNQVFAKYNVS-RLQPYLKLRQALLELRPAKNVLIDG---VLG-SGKTWVALDVCL 172

Query: 309 GNELLCGSPNLRVPPCKTSIHHISRKNAFLLGIVL-PLSTVFMIVVIFLIVKCRKRERGP 367
             ++ C             I  ++ KN      VL  L  +   +      +        
Sbjct: 173 SYKVQCKMDF--------KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN-I 223

Query: 368 PNDANMPPEAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQ 427
               +     ++R+                 L+            L           N+Q
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCL-------LV------------L-L---------NVQ 254

Query: 428 YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHG-----SLE---KYL 479
             + + +F++ C+++ + R + +   +   S      + L++               KYL
Sbjct: 255 NAKAWNAFNLSCKILLTTRFKQVTDFL---SAATTTHISLDHHSMTLTPDEVKSLLLKYL 311

Query: 480 HSSNY-----ILDIYQRLNIMI-----DVASALE-YLHFGYSA--QVIHCDLKPSNVLLD 526
                     +L    R   +I     D  +  + + H        +I   L   NVL  
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL---NVLEP 368

Query: 527 DNMVAHLSDFGIAKLLTREDQSTIQTQTLATI 558
                      +         + I T  L+ I
Sbjct: 369 AEYRKMFDRLSV----FPPS-AHIPTILLSLI 395

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 47.3 bits (111), Expect = 1e-05
 Identities = 23/161 (14%), Positives = 51/161 (31%), Gaps = 14/161 (8%)

Query: 11  GTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSL 70
             +   +     L+ L++   +          NL++L    + +  L  S +E    S L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL---EIISGGLPDSVVEDILGSDL 218

Query: 71  SNCKSLTLISFSNNPLDGILPKTSVGNLSH----SLEYFEMAYCNVSGGIPEEIGN---L 123
            N + L L     +              S     +L++  +        + E       L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 124 TNLTIIYLGGNKLNGS----IPSTLGKLQKLQGLGLENNKL 160
             L  + +    L       +   + K++ L+ + ++ N L
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.6 bits (104), Expect = 8e-05
 Identities = 32/209 (15%), Positives = 63/209 (30%), Gaps = 30/209 (14%)

Query: 90  LPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQK 149
                           +         +   +  +  L  + +   K   ++         
Sbjct: 138 FAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPN 194

Query: 150 LQGLGLENNKLEGSIPDSICHSD--ELYKLELGGNKLSGSIPECFNNLASLRILLLGSNE 207
           L+ L + +  L  S+ + I  SD   L KL L    +         ++   R L      
Sbjct: 195 LKSLEIISGGLPDSVVEDILGSDLPNLEKLVL---YVGVEDYGFDGDMNVFRPLFSKD-- 249

Query: 208 LTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSG 267
                  F NLK   +L          +        I       L  L ++++S   L+ 
Sbjct: 250 ------RFPNLK---WLGIVDAEEQNVVVEMFLESDI-------LPQLETMDISAGVLTD 293

Query: 268 ----AIPASLEKLSYLKDLNLSFNKLEGE 292
                +   ++K+ +LK +N+ +N L  E
Sbjct: 294 EGARLLLDHVDKIKHLKFINMKYNYLSDE 322

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 52/276 (18%), Positives = 85/276 (30%), Gaps = 59/276 (21%)

Query: 43  NLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSL 102
               + +L LS N L S +      +  +   S+T ++ S N L       +   L   L
Sbjct: 20  IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG----FKNSDELVQIL 75

Query: 103 EYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKL-----QKLQGLGLEN 157
                                 N+T + L GN L+      L K        +  L L  
Sbjct: 76  A-----------------AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW 118

Query: 158 NKLEGSIPDSICH-----SDELYKLELGGNKLSGSIPECFNNLA--------SLRILLLG 204
           N                    +  L L GN L     +  + L         ++  L L 
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG---IKSSDELIQILAAIPANVNSLNLR 175

Query: 205 SNELTSI-------PLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLIS 257
            N L S         L       +  L+ S+N             ++A I S     ++S
Sbjct: 176 GNNLASKNCAELAKFLASIPAS-VTSLDLSANLLG-----LKSYAELAYIFSSIPNHVVS 229

Query: 258 LNLSNNNLSG----AIPASLEKLSYLKDLNLSFNKL 289
           LNL  N L G     +    + L +L+ + L ++ +
Sbjct: 230 LNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIV 265

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 44.7 bits (106), Expect = 6e-05
 Identities = 46/279 (16%), Positives = 88/279 (31%), Gaps = 57/279 (20%)

Query: 43  NLRNLQALRLSNNYLTSSTLELSFLSSL-SNCKSLTLISFSNNPLDGILPKTSVGNLSHS 101
              ++ +L LS N L     +   +  L +   ++T ++ S N L       S   L  +
Sbjct: 49  TPASVTSLNLSGNSLGFKNSD-ELVQILAAIPANVTSLNLSGNFLS----YKSSDELVKT 103

Query: 102 LEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKL-----QKLQGLGLE 156
           L                       +T++ LG N  +    S   +        +  L L 
Sbjct: 104 LAA-----------------IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLR 146

Query: 157 NNKLEGSIPDSIC-----HSDELYKLELGGNKLS----GSIPECFNNL-ASLRILLLGSN 206
            N L     D +          +  L L GN L+      + +   ++ AS+  L L +N
Sbjct: 147 GNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSAN 206

Query: 207 ELTSIPLTFW------NLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNL 260
            L                  ++ LN   N   GP    +  LK        L  L ++ L
Sbjct: 207 LLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLK------DSLKHLQTVYL 260

Query: 261 SNNNLSG-------AIPASLEKLSYLKDLNLSFNKLEGE 292
             + +         A+ A+   +  +  ++ +  ++   
Sbjct: 261 DYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 41.6 bits (98), Expect = 6e-04
 Identities = 49/305 (16%), Positives = 90/305 (29%), Gaps = 60/305 (19%)

Query: 19  NASKLSILELSDNSFS-----GFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNC 73
             + ++ L LS N  S       +         +  L L  N  +S +    F  + SN 
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSS-EFKQAFSNL 136

Query: 74  -KSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLG 132
             S+T ++   N L       S   L   L                      N+  + L 
Sbjct: 137 PASITSLNLRGNDLGI----KSSDELIQILA-----------------AIPANVNSLNLR 175

Query: 133 GNKLNGSIPSTLGKL-----QKLQGLGLENNKLEGSIPDSIC-----HSDELYKLELGGN 182
           GN L     + L K        +  L L  N L       +        + +  L L  N
Sbjct: 176 GNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLN 235

Query: 183 KLSGS----IPECFNNLASLRILLLGSNELTSIP--------LTFWNLKDILYLNFSSNF 230
            L G     +    ++L  L+ + L  + + ++           F N++ I+ ++ +   
Sbjct: 236 CLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKE 295

Query: 231 FTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGA-----IPASLEKLSYLKDLNLS 285
                     ++ I+ +           +L N  L  A         L     L++   +
Sbjct: 296 IH-----PSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQT 350

Query: 286 FNKLE 290
              L 
Sbjct: 351 CKPLL 355

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 45/272 (16%), Positives = 87/272 (31%), Gaps = 19/272 (6%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSN-NYLTSSTLELSFLSSLSNCKSLT 77
               L  L+L+       +         L+ L            +      +LS CK L 
Sbjct: 209 RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELR 268

Query: 78  LISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSG-GIPEEIGNLTNLTIIYLGGNKL 136
            +S   + +   LP  +V ++   L    ++Y  V    + + +     L  +++     
Sbjct: 269 CLSGFWDAVPAYLP--AVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIE 326

Query: 137 NGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNL- 195
           +  +       + L+ L +  ++     P+       L  + +G  KL  S+      + 
Sbjct: 327 DAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLE-SVLYFCRQMT 385

Query: 196 -ASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLIS 254
            A+L  +      +T   L     K   YL           PL+IG   I     C    
Sbjct: 386 NAALITIARNRPNMTRFRLCIIEPKAPDYLT--------LEPLDIGFGAIVE--HCK--D 433

Query: 255 LISLNLSNNNLSGAIPASLEKLSYLKDLNLSF 286
           L  L+LS                 ++ L+++F
Sbjct: 434 LRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAF 465

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 39/281 (13%), Positives = 90/281 (32%), Gaps = 28/281 (9%)

Query: 21  SKLSILELSDNSFSGFIPNTF----GNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSL 76
            + ++  L   ++ G++         NLR L+++      ++   L+    +   + ++L
Sbjct: 84  PRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL 143

Query: 77  TLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVS-------GGIPEEIGNLTNLTII 129
            L   S    DG+L   S+      ++   M   + S         + +   +L  L   
Sbjct: 144 KLDKCSGFTTDGLL---SIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFY 200

Query: 130 YLGGNKLN-GSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSI 188
                K++   + +     + L  + + + ++   +      +  L +   G       +
Sbjct: 201 MTEFAKISPKDLETIARNCRSLVSVKVGDFEI-LELVGFFKAAANLEEFCGGSLNEDIGM 259

Query: 189 PECFNNLASLR-ILLLGSNELT--SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIA 245
           PE + NL   R +  LG + +    +P+ F     I  L+             +      
Sbjct: 260 PEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTL------ 313

Query: 246 RIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSF 286
                   +L  L   N      +    +    LK L +  
Sbjct: 314 ---IQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIER 351

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	678
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.98
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.98
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.97
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.97
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.97
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.97
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.97
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.97
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.97
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.97
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.97
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.97
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.97
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.97
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.97
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.94
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.94
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.94
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.94
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.93
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.93
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.92
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.91
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.9
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.89
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.88
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.84
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.84
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.83
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.83
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.83
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.82
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.81
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.81
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.81
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.81
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.79
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.79
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.78
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.78
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.78
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.78
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.77
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.77
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.76
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.76
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.75
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.74
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.73
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.73
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.73
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.72
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.71
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.7
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.69
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.69
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.67
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.66
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.66
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.64
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.63
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.62
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.61
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.6
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.59
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.5
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.46
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.45
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.45
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.4
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.39
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.38
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.34
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.33
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.32
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.31
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.21
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.1
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	99.04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	99.03
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.92
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	98.92
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.75
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.7
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.67
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.46
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.46
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.44
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.3
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.3
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.27
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.12
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.05
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	98.03
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	98.01
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	98.0
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.94
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.87
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.82
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.73
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.56
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.54
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.29
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.04
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.01
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.92
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.92
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.79
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.74
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.74
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.73
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.57
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.41
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.07
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.62
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.78
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.9
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.96

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.2e-55  Score=441.26  Aligned_cols=260  Identities=28%  Similarity=0.474  Sum_probs=216.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      .++|.+.+.||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            356888899999999999999753      47889999997665566788999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEE
Q 005760          465 LVLEYMPHGSLEKYLHSSN------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH  532 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~k  532 (678)
                      +||||+++|+|.++++..+            ..+++.++..++.|||.||+|||   +++|+||||||+|||++.++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence            9999999999999997642            36899999999999999999999   89999999999999999999999


Q ss_pred             EEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcc
Q 005760          533 LSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDW  611 (678)
Q Consensus       533 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~  611 (678)
                      |+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.+....+  +...+...
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~~~  246 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECITQG  246 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHHHHHT
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcC
Confidence            999999987654444434445579999999999999999999999999999999999 899997643221  11111110


Q ss_pred             cCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          612 LPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      .           ...       .+..+++++.+|+.+||+.||++||||+|+++.|+++.+.
T Consensus       247 ~-----------~~~-------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          247 R-----------VLQ-------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             C-----------CCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C-----------CCC-------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            0           000       0123566799999999999999999999999999998754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1e-53  Score=432.67  Aligned_cols=264  Identities=27%  Similarity=0.449  Sum_probs=208.4

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ..+++.+.+.||+|+||+||+|++++  .||||+++...  .+..+.|.+|++++++++|||||+++|++.+ +..++||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            34678889999999999999998753  59999986432  2345789999999999999999999998865 5689999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.++++.....+++..+..|+.|||.||+|||   +++||||||||+|||+++++.+||+|||+|+.......
T Consensus       111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999999999877777999999999999999999999   89999999999999999999999999999987654333


Q ss_pred             cceeecccCCccccCccccCC---CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          548 STIQTQTLATIGYMAPEYGKE---GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ........||+.|||||++.+   +.|+.++|||||||++|||+||+.||.+....... ...+...       ...|..
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~-~~~~~~~-------~~~p~~  259 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI-IFMVGRG-------YASPDL  259 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-HHHHHTT-------CCCCCS
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH-HHHHhcC-------CCCCCc
Confidence            334456689999999998853   45899999999999999999999999764332211 1111110       011111


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      ..       .+..+++++.+++.+||+.||++||||.|+++.|+.++.++
T Consensus       260 ~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          260 SK-------LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             TT-------SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             cc-------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            00       01235677999999999999999999999999999887553

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5e-54  Score=441.24  Aligned_cols=258  Identities=28%  Similarity=0.466  Sum_probs=207.3

Q ss_pred             cCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45677789999999999999853      578899999976655567889999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcE
Q 005760          466 VLEYMPHGSLEKYLHSSN--------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVA  531 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~  531 (678)
                      ||||+++|+|.++++...              ..+++.++..|+.|||.||+|||   +++|+||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999997642              25899999999999999999999   8999999999999999999999


Q ss_pred             EEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhc
Q 005760          532 HLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVND  610 (678)
Q Consensus       532 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~  610 (678)
                      ||+|||+++...............||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+  ....+..
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~i~~  275 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AIDCITQ  275 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HHHHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HHHHHHc
Confidence            9999999987655444444556789999999999999999999999999999999999 899997643221  1111111


Q ss_pred             ccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          611 WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                      -.     ...             .+..+++++.+|+.+||+.||++||||+||++.|+++.+
T Consensus       276 g~-----~~~-------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          276 GR-----ELE-------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             TC-----CCC-------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CC-----CCC-------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            00     000             112356779999999999999999999999999999865

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.3e-54  Score=435.80  Aligned_cols=256  Identities=25%  Similarity=0.452  Sum_probs=211.6

Q ss_pred             cCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      +++++.+.||+|+||+||+|.+      .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            3456678999999999999985      256889999996543 234578999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC
Q 005760          465 LVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM  529 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~  529 (678)
                      +||||+++|+|.++++...               ..+++..+..|+.|||.||+|||   +++||||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            9999999999999996532               25889999999999999999999   89999999999999999999


Q ss_pred             cEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhh
Q 005760          530 VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWV  608 (678)
Q Consensus       530 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~  608 (678)
                      .+||+|||+++.....+.....+...||+.|||||++.++.|+.++|||||||++|||+| |..||.+....  .+...+
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~~i  260 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVEMI  260 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHHHH
Confidence            999999999987654444444556789999999999999999999999999999999999 89999764322  222222


Q ss_pred             hcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                      ....           ..       ..+..|++++.++|.+||+.||++||||+||++.|+++
T Consensus       261 ~~~~-----------~~-------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          261 RNRQ-----------VL-------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HTTC-----------CC-------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HcCC-----------CC-------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1100           00       01124667799999999999999999999999999875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.8e-52  Score=423.47  Aligned_cols=250  Identities=25%  Similarity=0.321  Sum_probs=210.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .+.|+..+.||+|+||.||+|..+ +|+.||||++........+.+.+|+++++.++|||||++++++.+++.+|+||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            356899999999999999999864 7999999999876666677889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++|+|.+++...+  +++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+....  .
T Consensus       153 ~~gg~L~~~l~~~~--l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~  225 (346)
T 4fih_A          153 LEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P  225 (346)
T ss_dssp             CTTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred             CCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC--C
Confidence            99999999998653  899999999999999999999   9999999999999999999999999999998765332  2


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....  .....+....+        +...    
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~--------~~~~----  291 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLP--------PRLK----  291 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSSC--------CCCS----
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCC--------CCCC----
Confidence            234578999999999999999999999999999999999999999753221  11111111110        0000    


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                          ....+++++.+|+.+||++||++|||++|+++
T Consensus       292 ----~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 ----NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ----CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                01124566889999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.1e-51  Score=418.29  Aligned_cols=256  Identities=23%  Similarity=0.307  Sum_probs=208.9

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      +.|++.++||+|+||.||+|+. .+|+.||||+++...     ...+|+.+++.++|||||++++++.+++.+|+||||+
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            4577788999999999999985 479999999997532     2246999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC-cEEEEeeccccccCCCCCc-
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTREDQS-  548 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~-~~kl~Dfg~~~~~~~~~~~-  548 (678)
                      +||+|.+++++.+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.+| ++||+|||+|+.+...... 
T Consensus       133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999999998765 4899999999999999999999   99999999999999999987 6999999999876543221 


Q ss_pred             --ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          549 --TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       549 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                        ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....... ........  ...+        
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~i~~~~~--~~~~--------  277 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-LKIASEPP--PIRE--------  277 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-HHHHHSCC--GGGG--------
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-HHHHcCCC--Cchh--------
Confidence              1223457999999999999999999999999999999999999999765443322 11111100  0000        


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                             .+..+++++.+++.+||++||++|||+.|+++.|.......
T Consensus       278 -------~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          278 -------IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             -------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             -------cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence                   01235567889999999999999999999999998887654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.1e-52  Score=424.45  Aligned_cols=250  Identities=21%  Similarity=0.364  Sum_probs=201.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++....  ....+.+.+|+++++.++|||||++++++.+++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            36899999999999999999985 479999999997543  234567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          468 EYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      ||++||+|.+++...+ ..+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+..... 
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-  178 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-  178 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC-
Confidence            9999999999997554 35788999999999999999999   999999999999999999999999999999876421 


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                       .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+. .........+        + .  
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-~~~i~~~~~~--------~-~--  245 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL-VLKIISGSFP--------P-V--  245 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTCCC--------C-C--
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHcCCCC--------C-C--
Confidence             1223346799999999999999999999999999999999999999976322211 1111111110        0 0  


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              +..+++++.+|+.+||++||++|||++|+++
T Consensus       246 --------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 --------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             --------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0123556889999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5e-52  Score=418.90  Aligned_cols=248  Identities=25%  Similarity=0.376  Sum_probs=209.2

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++...   .....+.+.+|+++++.++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5699999999999999999985 57999999999753   2344577899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||++||+|.+++.+.+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999998765 4899999999999999999999   99999999999999999999999999999998765444


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+ ..........       .-|     
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~-------~~p-----  254 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKLEY-------DFP-----  254 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC-------CCC-----
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC-------CCC-----
Confidence            444556789999999999999999999999999999999999999997532211 1111111100       001     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV  664 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell  664 (678)
                              ...++++.+|+.+||++||++|||++|+.
T Consensus       255 --------~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          255 --------EKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             --------TTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             --------cccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence                    12345688999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.3e-50  Score=425.15  Aligned_cols=250  Identities=25%  Similarity=0.324  Sum_probs=210.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .+.|+..+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+.+.+|+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            45799999999999999999985 47999999999876666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      |+||+|.++++..+  +++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+....  .
T Consensus       230 ~~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~  302 (423)
T 4fie_A          230 LEGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P  302 (423)
T ss_dssp             CTTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--C
T ss_pred             CCCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--c
Confidence            99999999997654  899999999999999999999   9999999999999999999999999999998765332  2


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....  .....+....+        +....   
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~i~~~~~--------~~~~~---  369 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNLP--------PRLKN---  369 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHSCC--------CCCSC---
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHHHHcCCC--------CCCcc---
Confidence            234568999999999999999999999999999999999999999753221  11111111110        00000   


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           ...+++++.+|+.+||+.||++|||+.|+++
T Consensus       370 -----~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 -----LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             -----TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 0123456889999999999999999999976

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-51  Score=427.24  Aligned_cols=271  Identities=23%  Similarity=0.367  Sum_probs=220.2

Q ss_pred             CHHHHHHhhcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCC-ccceeee
Q 005760          383 SYLELCRATDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRH-RNIIKVI  454 (678)
Q Consensus       383 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~~~  454 (678)
                      ...+.+...++|++.+.||+|+||+||+|.+.      .++.||||++..... ...+.+.+|++++++++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            33445566789999999999999999999743      246799999975433 345678999999999965 8999999


Q ss_pred             eeeecC-CeEEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCC
Q 005760          455 SSCSNE-EFKALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDL  518 (678)
Q Consensus       455 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl  518 (678)
                      |+|.+. +.+++|||||++|+|.++++..+               ..+++..+..++.|||+||+|||   +++||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCcc
Confidence            998664 56899999999999999997532               34789999999999999999999   999999999


Q ss_pred             CCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcc
Q 005760          519 KPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEI  597 (678)
Q Consensus       519 ~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~  597 (678)
                      ||+|||+++++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.+.
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987765544445556779999999999999999999999999999999998 89999764


Q ss_pred             cCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          598 FNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                      ..... +...+..-..     ..             .+..+++++.++|.+||+.||++||||+|+++.|+++.++..
T Consensus       292 ~~~~~-~~~~i~~g~~-----~~-------------~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          292 KIDEE-FCRRLKEGTR-----MR-------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             CCSHH-HHHHHHHTCC-----CC-------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             CHHHH-HHHHHHcCCC-----CC-------------CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence            33221 1111111000     00             012345678999999999999999999999999999977644

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.8e-51  Score=417.05  Aligned_cols=273  Identities=23%  Similarity=0.329  Sum_probs=200.9

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCC----eEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE----FKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  467 (678)
                      ++|.+.+.||+|+||+||+|++ +|+.||||+++.... ....+..|+..+..++|||||++++++.+++    .+++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4577889999999999999998 689999999965422 1122234555667889999999999997653    579999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG-----YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      ||+++|+|.++++...  +++..+.+++.|++.||+|||+.     ...+|+||||||+|||++.++++||+|||+|+..
T Consensus        81 Ey~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            9999999999998764  89999999999999999999932     1239999999999999999999999999999876


Q ss_pred             CCCCCc--ceeecccCCccccCccccCCC------CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc--
Q 005760          543 TREDQS--TIQTQTLATIGYMAPEYGKEG------RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL--  612 (678)
Q Consensus       543 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--  612 (678)
                      ......  .......||+.|||||++.+.      .++.++|||||||++|||+||..||..................  
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            433221  123346799999999998654      4678999999999999999998877543322211111100000  


Q ss_pred             ----CCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          613 ----PISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       613 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                          ......-.+|...     ......+++..+.+++.+||+.||++||||.|+++.|+++.++
T Consensus       239 ~~~~~~~~~~~~rp~~p-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIP-----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTTSCCCCCCC-----GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhcccCCCCCC-----ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                0000011111111     1111234667799999999999999999999999999998753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2e-50  Score=405.59  Aligned_cols=244  Identities=26%  Similarity=0.407  Sum_probs=196.4

Q ss_pred             CCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeec----CCeEEEEE
Q 005760          395 SENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSN----EEFKALVL  467 (678)
Q Consensus       395 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  467 (678)
                      ++.+.||+|+||+||+|.. .++..||+|++....  ....+.|.+|+++++.++|||||++++++.+    ++.+|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            5667899999999999985 478999999996543  2345678999999999999999999999864    45689999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEcCCCCCCeeec-CCCcEEEEeeccccccCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dl~~~Nill~-~~~~~kl~Dfg~~~~~~~  544 (678)
                      ||+++|+|.+++.+.. .+++..+..++.||+.||+|||   +++  |+||||||+|||++ .+|.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999998765 4899999999999999999999   887  99999999999998 589999999999976432


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      .    ......||+.|||||++.+ .|+.++|||||||++|||+||+.||.+................+..         
T Consensus       185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~---------  250 (290)
T 3fpq_A          185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS---------  250 (290)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG---------
T ss_pred             C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCC---------
Confidence            1    2335689999999998865 6999999999999999999999999653322111111111100000         


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               .+..+++++.+|+.+||++||++|||++|+++
T Consensus       251 ---------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          251 ---------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ---------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     01123456889999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2e-50  Score=401.88  Aligned_cols=245  Identities=25%  Similarity=0.389  Sum_probs=191.0

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||+||+|.. .+|+.||+|++....   ....+.+.+|+++++.++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999985 479999999996532   234567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+ +|+|.+++.+.+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.++++||+|||+|+.....  
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC--
Confidence            999 679999998765 4999999999999999999999   999999999999999999999999999999865432  


Q ss_pred             cceeecccCCccccCccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                       .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+..... ..........       .-|    
T Consensus       166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~-~~~~i~~~~~-------~~p----  232 (275)
T 3hyh_A          166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV-LFKNISNGVY-------TLP----  232 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC-------CCC----
T ss_pred             -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCC-------CCC----
Confidence             22345679999999999988876 589999999999999999999997532211 1111111100       001    


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               ...++++.+++.+||++||++|||++|+++
T Consensus       233 ---------~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          233 ---------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             ---------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---------CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                     123456889999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.9e-50  Score=407.62  Aligned_cols=247  Identities=26%  Similarity=0.334  Sum_probs=196.8

Q ss_pred             cCCCCCccccCCCceeEEEEEe----CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL----GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ++|++.+.||+|+||+||+|+.    .+++.||+|+++...  ......+.+|+++++.++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5699999999999999999974    257899999996542  2234567889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||++||+|.+++.+.+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999998765 4899999999999999999999   999999999999999999999999999999865332


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                      .  .......||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+ ..........       ..|   
T Consensus       180 ~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~-------~~p---  246 (304)
T 3ubd_A          180 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TMTMILKAKL-------GMP---  246 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC-------CCC---
T ss_pred             C--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-HHHHHHcCCC-------CCC---
Confidence            2  22345679999999999999999999999999999999999999997633221 1111111100       001   


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCH-----HHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINA-----KEIVT  665 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~ell~  665 (678)
                                ..+++++.+|+.+||++||++|||+     +|+++
T Consensus       247 ----------~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          247 ----------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ----------TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ----------CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                      1235568899999999999999984     56654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2e-48  Score=394.81  Aligned_cols=249  Identities=23%  Similarity=0.371  Sum_probs=188.8

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCC--------
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEE--------  461 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  461 (678)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++++.++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4588999999999999999985 4799999999975543 34467889999999999999999999986543        


Q ss_pred             ----eEEEEEEecCCCCHHHHhhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEe
Q 005760          462 ----FKALVLEYMPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD  535 (678)
Q Consensus       462 ----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~D  535 (678)
                          ..|+||||+++|+|.+++.....  ..++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999986543  3456778899999999999999   99999999999999999999999999


Q ss_pred             eccccccCCCCCc----------ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchh
Q 005760          536 FGIAKLLTREDQS----------TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK  605 (678)
Q Consensus       536 fg~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~  605 (678)
                      ||+|+........          ......+||+.|||||++.+..|+.++||||+||++|||++   ||....+.    .
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~----~  234 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER----V  234 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH----H
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH----H
Confidence            9999876533211          12234579999999999999999999999999999999996   77542211    1


Q ss_pred             hhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          606 HWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..........     .|          ......++.+.+++.+||++||++|||+.|+++
T Consensus       235 ~~~~~~~~~~-----~p----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 RTLTDVRNLK-----FP----------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHHHHHTTC-----CC----------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhcCC-----CC----------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111000000     00          111234456778999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.8e-46  Score=387.77  Aligned_cols=199  Identities=22%  Similarity=0.337  Sum_probs=170.2

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEe----CCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARL----GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  463 (678)
                      ...++|++.+.||+|+||+||+|+.    .+++.||+|++....  ....+.+|+++++.+ +||||+++++++.+.+..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            4568899999999999999999974    257889999986442  335678899999988 699999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC-CcEEEEeecccccc
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAKLL  542 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~-~~~kl~Dfg~~~~~  542 (678)
                      |+||||+++|+|.+++.    .+++..+..++.|++.||+|||   ++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus        96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~  168 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT  168 (361)
T ss_dssp             EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence            99999999999999994    3889999999999999999999   9999999999999999876 89999999999765


Q ss_pred             CCCCC--------------------------cceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCC
Q 005760          543 TREDQ--------------------------STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTD  595 (678)
Q Consensus       543 ~~~~~--------------------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~  595 (678)
                      .....                          .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~  248 (361)
T 4f9c_A          169 HDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFY  248 (361)
T ss_dssp             TTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred             CCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCC
Confidence            43211                          0112345799999999988775 48999999999999999999999995


Q ss_pred             c
Q 005760          596 E  596 (678)
Q Consensus       596 ~  596 (678)
                      .
T Consensus       249 ~  249 (361)
T 4f9c_A          249 K  249 (361)
T ss_dssp             C
T ss_pred             C
Confidence            4

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=389.31  Aligned_cols=269  Identities=26%  Similarity=0.301  Sum_probs=201.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeec------CC
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSN------EE  461 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~  461 (678)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++....  ...+.+.+|+++|+.++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            35799999999999999999985 4799999999965422  234667899999999999999999998753      46


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..|+||||++ |+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            7899999996 68999998665 5999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCC--CcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc--CCcc
Q 005760          542 LTRED--QSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL--PIST  616 (678)
Q Consensus       542 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~~~  616 (678)
                      +....  ........+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+. +........  +...
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~-l~~I~~~~g~p~~~~  286 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ-LQLIMMVLGTPSPAV  286 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCGGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH-HHHHHHhcCCCChHH
Confidence            64322  12234567899999999988775 469999999999999999999999976332111 111111000  0000


Q ss_pred             ccccc--------CccCCccchhhH-HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          617 KEIVD--------PNLLSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       617 ~~~~~--------~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .....        ..........+. .....++++.+|+.+||++||++|||+.|+++
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00000        000000000000 00124567889999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.2e-45  Score=403.74  Aligned_cols=252  Identities=19%  Similarity=0.270  Sum_probs=209.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+++|+.++|||||++++++.+.+.+|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            36899999999999999999985 47999999999765555567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC--CCcEEEEeeccccccCCCCC
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~--~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ++||+|.+++......+++..+..++.||+.||+|||   +++|+||||||+|||++.  .+.+||+|||+|+.+...  
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--  310 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--  310 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence            9999999999766667999999999999999999999   999999999999999985  489999999999877532  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                       .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+. +.........      ..+     
T Consensus       311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~i~~~~~~------~~~-----  377 (573)
T 3uto_A          311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDWN------MDD-----  377 (573)
T ss_dssp             -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCCC------CCS-----
T ss_pred             -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHhCCCC------CCc-----
Confidence             223456799999999999999999999999999999999999999976332211 1111110000      000     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           .....+++++.+|+.+||+.||++|||+.|+++
T Consensus       378 -----~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          378 -----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             -----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 001124556889999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-44  Score=395.87  Aligned_cols=248  Identities=21%  Similarity=0.298  Sum_probs=199.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHH---HHHHHHhCCCccceeeeeeeecCCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDV---ECEMMKSIRHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~  463 (678)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++....   ......+.+   ++.+++.++|||||+++++|.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            36799999999999999999985 479999999996432   222233333   45666778999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      |+||||++||+|.+++.+.+ .+++..+..++.||+.||+|||   +++||||||||+|||++.+|++||+|||+|+...
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999998765 4899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccc-hhhhhhcccCCccccccc
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT-LKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  621 (678)
                      ...    ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||.+....+.. +...+....      ..-
T Consensus       344 ~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~------~~~  413 (689)
T 3v5w_A          344 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA------VEL  413 (689)
T ss_dssp             SCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC------CCC
T ss_pred             CCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC------CCC
Confidence            332    234689999999999865 57999999999999999999999999764332211 111110000      000


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVT  665 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ell~  665 (678)
                      |             ...++++.+|+.+||+.||++|++     ++|+++
T Consensus       414 p-------------~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          414 P-------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             C-------------TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             C-------------ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            1             123456889999999999999998     677754

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.6e-44  Score=368.84  Aligned_cols=279  Identities=34%  Similarity=0.554  Sum_probs=229.9

Q ss_pred             HHHHHhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          385 LELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       385 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      .++...+++|+..+.||+|+||.||+|..++++.||+|++........+.+.+|+++++.++||||+++++++.+.+..+
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            34455778999999999999999999998889999999987766666788999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          465 LVLEYMPHGSLEKYLHSSN---YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      +||||+++|+|.+++....   ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  188 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK  188 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence            9999999999999997553   25889999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCcc-chhhhhhc-ccCCccccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM-TLKHWVND-WLPISTKEI  619 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~-~~~~~~~~-~~~~~~~~~  619 (678)
                      ..............||+.|+|||.+.++.++.++|||||||++|||++|+.||......+. ....|... .........
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (321)
T 2qkw_B          189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI  268 (321)
T ss_dssp             CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence            5433333334455689999999999888999999999999999999999999976444322 22223221 112223334


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                      .++......      ...++.++.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus       269 ~~~~~~~~~------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          269 VDPNLADKI------RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             SSSSCTTCS------CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cChhhcccc------CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            444332211      23567789999999999999999999999999998864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=362.41  Aligned_cols=265  Identities=26%  Similarity=0.410  Sum_probs=217.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            46788899999999999999986 47899999998665556678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999986667999999999999999999999   9999999999999999999999999999998764332211


Q ss_pred             ------------eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccc
Q 005760          550 ------------IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK  617 (678)
Q Consensus       550 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  617 (678)
                                  ......||+.|+|||.+.+..++.++||||||+++|||++|..|+..................     
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-----  240 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-----  240 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-----
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-----
Confidence                        111457999999999999999999999999999999999999998654332221111100000     


Q ss_pred             ccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHhh
Q 005760          618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLR  676 (678)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~~  676 (678)
                         +.          ..+..+++++.+++.+||+.||++|||+.|+++.|++++..+..
T Consensus       241 ---~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          241 ---DR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             ---HH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             ---cc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence               00          00123445688999999999999999999999999999887643

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-43  Score=365.88  Aligned_cols=276  Identities=23%  Similarity=0.319  Sum_probs=211.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCC----eEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE----FKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|+.. ++.||||++.... ........|+.+++.++||||+++++++.+..    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467999999999999999999875 7999999996543 23344566888899999999999999987643    46999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC----------CeEEcCCCCCCeeecCCCcEEEEee
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA----------QVIHCDLKPSNVLLDDNMVAHLSDF  536 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivH~dl~~~Nill~~~~~~kl~Df  536 (678)
                      |||+++|+|.++++...  +++..+..++.|++.||+|||   +.          +|+||||||+||+++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            99999999999998754  899999999999999999999   88          9999999999999999999999999


Q ss_pred             ccccccCCCCCcceeecccCCccccCccccCCC-----CCCccchHHHHHHHHHHHHcCCCCCCcccCCccc-hhhhhhc
Q 005760          537 GIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-----RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT-LKHWVND  610 (678)
Q Consensus       537 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~-~~~~~~~  610 (678)
                      |+++...............||+.|+|||++.+.     .++.++|||||||++|||++|+.||.+....... .......
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            999876544433334456799999999998763     4667899999999999999999999764332111 1000000


Q ss_pred             ccC-CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          611 WLP-ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       611 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      ... ........................++.++.+++.+||+.||++|||+.|+++.|+++++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            000 000000000001111111112234667799999999999999999999999999999865

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=6.6e-43  Score=362.68  Aligned_cols=280  Identities=36%  Similarity=0.566  Sum_probs=229.6

Q ss_pred             ccCCHHHHHHhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeee
Q 005760          380 RMFSYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCS  458 (678)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~  458 (678)
                      ..++..++....++|++.+.||+|+||.||+|..++++.||+|++..... .....+.+|+++++.++||||+++++++.
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            45788999999999999999999999999999988899999999865432 23346889999999999999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHHhhhCCC---CCCHHHHHHHHHHHHHHHHHHhcCCCC---CeEEcCCCCCCeeecCCCcEE
Q 005760          459 NEEFKALVLEYMPHGSLEKYLHSSNY---ILDIYQRLNIMIDVASALEYLHFGYSA---QVIHCDLKPSNVLLDDNMVAH  532 (678)
Q Consensus       459 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~LH~~~~~---~ivH~dl~~~Nill~~~~~~k  532 (678)
                      +.+..++||||+++|+|.+++.....   .+++..+..++.|++.||+|||   +.   +|+||||||+||+++.++.+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999986432   4899999999999999999999   66   999999999999999999999


Q ss_pred             EEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcc---cCCccchhhhhh
Q 005760          533 LSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEI---FNGEMTLKHWVN  609 (678)
Q Consensus       533 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~---~~~~~~~~~~~~  609 (678)
                      |+|||++....... ........||+.|+|||.+.+..++.++||||+||++|||++|+.||+..   .........|+.
T Consensus       175 l~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            99999998764332 23344566999999999998888999999999999999999999999642   222333444544


Q ss_pred             cccCC-cccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          610 DWLPI-STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       610 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                      ..... ......+.......      ...++.++.+++.+||+.||++|||++|+++.|+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNY------KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSC------CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHhhchhhhhhcChhhcccc------CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            33322 23333333332221      23567789999999999999999999999999974

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.7e-42  Score=354.23  Aligned_cols=251  Identities=27%  Similarity=0.341  Sum_probs=209.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            457899999999999999999985 5799999999987666666788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+++++|.+++....  +++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++.......  
T Consensus        98 ~~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  170 (297)
T 3fxz_A           98 YLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--  170 (297)
T ss_dssp             CCTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred             CCCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc--
Confidence            999999999998763  899999999999999999999   8999999999999999999999999999998765332  


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                      .......||+.|+|||.+.+..++.++||||+||++|||++|+.||......... ........    .....       
T Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~----~~~~~-------  238 (297)
T 3fxz_A          171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGT----PELQN-------  238 (297)
T ss_dssp             CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHHCS----CCCSC-------
T ss_pred             cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhCCC----CCCCC-------
Confidence            2234567999999999999999999999999999999999999999653221111 11100000    00000       


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                            +..++..+.+++.+||+.||++|||+.|+++
T Consensus       239 ------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          239 ------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                  1124556889999999999999999999976

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.9e-43  Score=369.30  Aligned_cols=261  Identities=28%  Similarity=0.442  Sum_probs=213.8

Q ss_pred             hcCCCCCccccCCCceeEEEEEe--------CCCcEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceeeeeeeecC
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL--------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKVISSCSNE  460 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~--------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  460 (678)
                      .++|++.+.||+|+||.||+|..        .++..||+|+++.... ...+.+.+|+++++.+ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            46788999999999999999974        2456799999975432 3456788999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL  525 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill  525 (678)
                      +..++||||+++|+|.+++....               ..+++..+..++.||+.||+|||   +++|+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999998653               24788999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccch
Q 005760          526 DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTL  604 (678)
Q Consensus       526 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~  604 (678)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+  .
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~  314 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L  314 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence            9999999999999987654433333344567889999999999999999999999999999999 999987633221  1


Q ss_pred             hhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          605 KHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      ...+.....        +.          .+..++.++.+++.+||+.||++||++.|+++.|+++.+..
T Consensus       315 ~~~~~~~~~--------~~----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          315 FKLLKEGHR--------MD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             HHHHHTTCC--------CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHhcCCC--------CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            111110000        00          01134566899999999999999999999999999998654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=9e-44  Score=376.28  Aligned_cols=260  Identities=29%  Similarity=0.453  Sum_probs=213.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467888999999999999999875 789999999875432 344678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+++|+|.++++.....+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++........
T Consensus       193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            99999999999876666899999999999999999999   999999999999999999999999999999765332211


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      .......+++.|+|||.+.++.++.++|||||||++|||++ |..||.......  ....+....     ...       
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~~~~~~~-----~~~-------  335 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TREFVEKGG-----RLP-------  335 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHHHHHTTC-----CCC-------
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC-----CCC-------
Confidence            11222345778999999998899999999999999999998 999987633221  111111100     000       


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                            .+..++.++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       336 ------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          336 ------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                  0112456688999999999999999999999999999865

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=362.61  Aligned_cols=260  Identities=27%  Similarity=0.434  Sum_probs=210.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC----CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      .++|++.+.||+|+||.||+|...    .+..||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            356888899999999999999863    45569999997543 2345678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++++|.++++.....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence            99999999999999877667999999999999999999999   999999999999999999999999999999876543


Q ss_pred             CC-cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          546 DQ-STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       546 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      .. ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||......+  ....+.....     ..   
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~-----~~---  274 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VISSVEEGYR-----LP---  274 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTCC-----CC---
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcCCC-----CC---
Confidence            22 222334456788999999998899999999999999999999 999986533221  1111110000     00   


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                                .+..++.++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       275 ----------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          275 ----------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ----------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence                      0012456688999999999999999999999999998754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.2e-41  Score=346.91  Aligned_cols=281  Identities=29%  Similarity=0.484  Sum_probs=225.7

Q ss_pred             ccCCHHHHHHhhcCCCCC------ccccCCCceeEEEEEeCCCcEEEEEEeeccc----CchhhhHHHHHHHHHhCCCcc
Q 005760          380 RMFSYLELCRATDGFSEN------NLIGRGSFGSVFKARLGDGMEVAMKVFNLQY----GRVFKSFDVECEMMKSIRHRN  449 (678)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~------~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~n  449 (678)
                      ..+++.++..++++|...      +.||+|+||.||+|.. +++.||+|++....    ....+.+.+|+.+++.++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            457889999999998877      8999999999999987 68899999986432    234577889999999999999


Q ss_pred             ceeeeeeeecCCeEEEEEEecCCCCHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC
Q 005760          450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS--NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD  527 (678)
Q Consensus       450 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~  527 (678)
                      |+++++++.+.+..++||||+++++|.+++...  ...+++..+..++.|++.||+|||   +++|+||||||+||+++.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcC
Confidence            999999999999999999999999999998743  335899999999999999999999   899999999999999999


Q ss_pred             CCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhh
Q 005760          528 NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW  607 (678)
Q Consensus       528 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~  607 (678)
                      ++.+||+|||++................|++.|+|||.+.+ .++.++||||||+++|+|++|..||........ ...+
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~  246 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLDI  246 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTHH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHHH
Confidence            99999999999987654433334445679999999998765 588999999999999999999999976443321 1122


Q ss_pred             hhccc--CCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          608 VNDWL--PISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       608 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      .....  ........++....       .+..++..+.+++.+||+.||++|||+.|+++.|+++.++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s  307 (307)
T 2nru_A          247 KEEIEDEEKTIEDYIDKKMND-------ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS  307 (307)
T ss_dssp             HHHHHTTSCCHHHHSCSSCSC-------CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred             HHHhhhhhhhhhhhccccccc-------cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence            11111  11122222222211       1134667799999999999999999999999999998653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-42  Score=357.46  Aligned_cols=261  Identities=29%  Similarity=0.408  Sum_probs=204.6

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ....++|++.+.||+|+||.||+|+. +|+.||+|++.....  ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            34467899999999999999999987 688999999865432  334678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          466 VLEYMPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ||||+++++|.+++.....  .+++..+..++.|++.||+|||   +++  |+||||||+||+++.++.+||+|||+++.
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            9999999999999986542  3889999999999999999999   889  99999999999999999999999999975


Q ss_pred             cCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      ....  ........||+.|+|||.+.+..++.++||||+||++|||++|+.||........  ...+....    .....
T Consensus       189 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~~~~~----~~~~~  260 (309)
T 3p86_A          189 KAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAVGFKC----KRLEI  260 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHHHSC----CCCCC
T ss_pred             cccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcC----CCCCC
Confidence            4322  2223456789999999999999999999999999999999999999975332211  11110000    00000


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      +             ..+++++.+++.+||+.||++|||+.|+++.|+.+.++
T Consensus       261 ~-------------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          261 P-------------RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             C-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             C-------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            0             12345688999999999999999999999999998765

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8e-43  Score=351.61  Aligned_cols=258  Identities=28%  Similarity=0.440  Sum_probs=214.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      .++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            357888999999999999999988899999999975432 3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI  550 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  550 (678)
                      ++++|.+++......+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||++....... ...
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  163 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccc
Confidence            999999999877777999999999999999999999   9999999999999999999999999999998654321 222


Q ss_pred             eecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......+  ....+....     ....+.      
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~~~~~~~-----~~~~~~------  230 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGF-----RLYKPR------  230 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTC-----CCCCCT------
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhcCc-----cCCCCC------
Confidence            334556788999999998899999999999999999999 899987532211  111111000     001111      


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                             .++.++.+++.+||+.||++||++.|+++.|+++.++
T Consensus       231 -------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          231 -------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -------cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                   1245588999999999999999999999999999764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=9.7e-43  Score=350.81  Aligned_cols=258  Identities=26%  Similarity=0.413  Sum_probs=213.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      .++|++.+.||+|+||.||+|..+++..||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            467889999999999999999988888999999975432 3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI  550 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  550 (678)
                      ++++|.+++......+++..++.++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++....... ...
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhc
Confidence            999999999877666999999999999999999999   8999999999999999999999999999998764332 223


Q ss_pred             eecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......+.. .......      ....+.      
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-~~~~~~~------~~~~~~------  228 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-LKVSQGH------RLYRPH------  228 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTTC------CCCCCT------
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH-HHHHcCC------CCCCCC------
Confidence            344556788999999988889999999999999999999 99998653322111 1110000      001111      


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                             .+++++.+++.+||+.||++|||+.|+++.|+++++.
T Consensus       229 -------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          229 -------LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             -------TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             -------cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                   1234588999999999999999999999999988654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.3e-42  Score=363.74  Aligned_cols=271  Identities=23%  Similarity=0.380  Sum_probs=218.6

Q ss_pred             CCHHHHHHhhcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceee
Q 005760          382 FSYLELCRATDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKV  453 (678)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~  453 (678)
                      +...+.....++|++.+.||+|+||.||+|++      .+++.||||++..... ...+.+.+|+++++.+ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34455566788999999999999999999973      3568899999975433 3346789999999999 79999999


Q ss_pred             eeeeecCC-eEEEEEEecCCCCHHHHhhhCCC------------------------------------------------
Q 005760          454 ISSCSNEE-FKALVLEYMPHGSLEKYLHSSNY------------------------------------------------  484 (678)
Q Consensus       454 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------  484 (678)
                      ++++.+.+ ..++||||+++|+|.++++....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99987754 48999999999999999976532                                                


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          485 -----------------ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       485 -----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                                       .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                             2788999999999999999999   89999999999999999999999999999987654444


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                      ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+............      ..+    
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------~~~----  318 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------RAP----  318 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC------CCC----
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC------CCC----
Confidence            444556678999999999999999999999999999999998 999997644332211111111000      000    


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                               ..+++++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       319 ---------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          319 ---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             ---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence                     123456889999999999999999999999999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-42  Score=355.35  Aligned_cols=272  Identities=26%  Similarity=0.429  Sum_probs=210.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-----CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeec--CCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-----GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN--EEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  463 (678)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|+++++.++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46789999999999999999973     3689999999976655566788999999999999999999999854  3568


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999999887767999999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCC-cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC-----ccc
Q 005760          544 REDQ-STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI-----STK  617 (678)
Q Consensus       544 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~  617 (678)
                      .... ........++..|+|||.+.+..++.++||||+|+++|||++|..|+.......   ..........     ...
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF---MRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH---HHHHCTTCCTHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH---HhhhcCccccchhHHHHH
Confidence            3322 122334557788999999999999999999999999999999999986432110   0000000000     000


Q ss_pred             ccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      ........      ...+..+++++.+++.+||+.||++|||+.|+++.|+++++++
T Consensus       243 ~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          243 ELLKNNGR------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHTTCC------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHhccCc------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            00000000      0011235667999999999999999999999999999998765

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.3e-42  Score=357.57  Aligned_cols=248  Identities=25%  Similarity=0.327  Sum_probs=205.4

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++....  ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            356899999999999999999986 589999999997543  23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++.......
T Consensus        93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            99999999999997665 4899999999999999999999   9999999999999999999999999999997664322


Q ss_pred             CcceeecccCCccccCccccCCCCCC-ccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVS-ANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                         ......||+.|+|||++.+..+. .++||||+||++|||++|+.||.+...... .........       ..|   
T Consensus       169 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~~-------~~p---  234 (328)
T 3fe3_A          169 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL-RERVLRGKY-------RIP---  234 (328)
T ss_dssp             ---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCC-------CCC---
T ss_pred             ---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCC-------CCC---
Confidence               23456799999999999888765 789999999999999999999976322111 011111000       000   


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                ..+++++.+++.+||+.||.+|||++|+++
T Consensus       235 ----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          235 ----------FYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ----------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ----------CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                      113455889999999999999999999975

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.8e-41  Score=349.07  Aligned_cols=260  Identities=24%  Similarity=0.310  Sum_probs=213.1

Q ss_pred             cCCHHHHHHhhcC----------CCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCcc
Q 005760          381 MFSYLELCRATDG----------FSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRN  449 (678)
Q Consensus       381 ~~~~~~~~~~~~~----------~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n  449 (678)
                      .++++++..+++.          |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            3567777666653          666789999999999999865 79999999998766666678899999999999999


Q ss_pred             ceeeeeeeecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC
Q 005760          450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM  529 (678)
Q Consensus       450 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~  529 (678)
                      |+++++++...+..++||||+++++|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~  178 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDG  178 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCC
Confidence            999999999999999999999999999998754  4899999999999999999999   89999999999999999999


Q ss_pred             cEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhh
Q 005760          530 VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN  609 (678)
Q Consensus       530 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~  609 (678)
                      .+||+|||++.......  .......||+.|+|||++.+..++.++||||||+++|||++|+.||......  .....+.
T Consensus       179 ~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~~~~  254 (321)
T 2c30_A          179 RVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLR  254 (321)
T ss_dssp             CEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHH
T ss_pred             cEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh
Confidence            99999999998764322  1234567999999999999999999999999999999999999999653221  1111111


Q ss_pred             cccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          610 DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ...        .+....        ...+++++.+++.+||+.||++|||+.|+++
T Consensus       255 ~~~--------~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          255 DSP--------PPKLKN--------SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HSS--------CCCCTT--------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCC--------CCCcCc--------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            110        011000        1123456889999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.9e-41  Score=347.53  Aligned_cols=265  Identities=27%  Similarity=0.406  Sum_probs=205.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHh--CCCccceeeeeeeec----CCeEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKS--IRHRNIIKVISSCSN----EEFKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~~~~  464 (678)
                      .++|++.+.||+|+||.||+|.. +++.||||++...   ....+..|.+++..  ++||||+++++++.+    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            56899999999999999999988 6899999998643   33556667777776  789999999998643    45688


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEEcCCCCCCeeecCCCcEEEEeeccc
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY-----SAQVIHCDLKPSNVLLDDNMVAHLSDFGIA  539 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~  539 (678)
                      +||||+++|+|.++++..  .+++..+..++.|++.||+|||+..     +++|+||||||+||+++.++.+||+|||++
T Consensus        83 lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            999999999999999654  4899999999999999999999322     578999999999999999999999999999


Q ss_pred             cccCCCCCcc--eeecccCCccccCccccCCC------CCCccchHHHHHHHHHHHHcC----------CCCCCcccCCc
Q 005760          540 KLLTREDQST--IQTQTLATIGYMAPEYGKEG------RVSANGDVYSFGIMLMETFTR----------KKPTDEIFNGE  601 (678)
Q Consensus       540 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslGv~l~ell~g----------~~p~~~~~~~~  601 (678)
                      +.........  ......||+.|+|||.+.+.      .++.++|||||||++|||++|          +.||.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            7654332211  12344799999999998876      455789999999999999999          77876644443


Q ss_pred             cchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          602 MTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                      ..............    ..+...     .......++.++.+++.+||+.||++|||+.|+++.|+++
T Consensus       241 ~~~~~~~~~~~~~~----~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQ----QRPNIP-----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCHHHHHHHHTTSC----CCCCCC-----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhhhhHHHhccC----CCCCCC-----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            33322222111100    001000     0111234677899999999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2e-42  Score=364.94  Aligned_cols=260  Identities=25%  Similarity=0.469  Sum_probs=201.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC----CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      .++|++.+.||+|+||.||+|+..    ++..||||+++.... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            457999999999999999999854    577899999975432 345678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++++|.++++.....+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999887767999999999999999999999   899999999999999999999999999999876433


Q ss_pred             CCc-ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          546 DQS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       546 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+  ....+....     .  .+ 
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~~~i~~~~-----~--~~-  270 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VIKAVDEGY-----R--LP-  270 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HHHHHHTTE-----E--CC-
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC-----C--CC-
Confidence            211 11223345778999999999999999999999999999998 999986533211  111111000     0  00 


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                                .+..++.++.+++.+||+.||++||++.|+++.|+++..+
T Consensus       271 ----------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          271 ----------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             ----------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ----------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                      0012456688999999999999999999999999998754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.8e-42  Score=353.48  Aligned_cols=253  Identities=23%  Similarity=0.349  Sum_probs=206.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            368999999999999999999865 899999999865432 334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++..+......
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999997654 4899999999999999999999   999999999999999999999999999999866433333


Q ss_pred             ceeecccCCccccCccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+.......      .      
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------~------  229 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL------N------  229 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS------T------
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC------C------
Confidence            33445679999999999887775 7789999999999999999999976444333332222111000      0      


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                            ....++.++.+++.+||+.||++|||+.|+++
T Consensus       230 ------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                  00123456789999999999999999999975

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-41  Score=348.13  Aligned_cols=268  Identities=22%  Similarity=0.322  Sum_probs=206.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ..++|++.+.||+|+||+||+|+..+|+.||+|++....  ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            357899999999999999999998889999999986542  233467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++ +|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....  
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP--  172 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC--
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC--
Confidence            99975 899988877777999999999999999999999   999999999999999999999999999999876432  


Q ss_pred             cceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcc---cCCccccccc--
Q 005760          548 STIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW---LPISTKEIVD--  621 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~--  621 (678)
                      ........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+. ........   .+.......+  
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHHCCCChHHhhhhhccc
Confidence            222344578999999998876 5689999999999999999999999976444322 11111100   0000000000  


Q ss_pred             ----Ccc--CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 ----PNL--LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 ----~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                          ...  ...... ......+++++.+++.+||++||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          252 LWKQRTFQVFEKKPW-SSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHSCCCCCCCCCCH-HHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhhcccccccCCcH-HHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                000  000000 0011234567899999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.9e-42  Score=349.32  Aligned_cols=259  Identities=24%  Similarity=0.436  Sum_probs=211.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..++|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            3567888999999999999999998889999999975432 346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++....... ..
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~  176 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT  176 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HH
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-cc
Confidence            9999999999875566999999999999999999999   9999999999999999999999999999998654321 12


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                      ......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||........ ....... .     ....+      
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~-~~~~~~~-~-----~~~~~------  243 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-AEHIAQG-L-----RLYRP------  243 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTT-C-----CCCCC------
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH-HHHHhcc-c-----CCCCC------
Confidence            2234456788999999998899999999999999999998 9999875332211 1111110 0     00001      


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                             ..+++++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       244 -------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          244 -------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             -------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                   11234588999999999999999999999999998754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.7e-42  Score=354.08  Aligned_cols=266  Identities=23%  Similarity=0.383  Sum_probs=218.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceeeeeeeecCC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKVISSCSNEE  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  461 (678)
                      ..++|++.+.||+|+||.||+|..      .+++.||+|++..... ...+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            456889999999999999999974      3578899999975433 3457788999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCee
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNY-----------------ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVL  524 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nil  524 (678)
                      ..++||||+++|+|.+++.....                 .+++..++.++.|++.||+|||   +++|+||||||+||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEE
Confidence            99999999999999999986543                 3889999999999999999999   899999999999999


Q ss_pred             ecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccc
Q 005760          525 LDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT  603 (678)
Q Consensus       525 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~  603 (678)
                      ++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||........ 
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-  256 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-  256 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence            99999999999999987765444334445567889999999988899999999999999999999 9999876433221 


Q ss_pred             hhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHhhc
Q 005760          604 LKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN  677 (678)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~  677 (678)
                      ....+.....     ...+             ..++.++.+++.+||+.||++|||+.|+++.|+++.++...+
T Consensus       257 ~~~~~~~~~~-----~~~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  312 (313)
T 1t46_A          257 FYKMIKEGFR-----MLSP-------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNH  312 (313)
T ss_dssp             HHHHHHHTCC-----CCCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC-
T ss_pred             HHHHhccCCC-----CCCc-------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhcC
Confidence            1111111000     0000             123456889999999999999999999999999998876554

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=351.57  Aligned_cols=251  Identities=20%  Similarity=0.302  Sum_probs=207.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .++|++.+.||+|+||.||+|... +++.||+|++... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999854 7899999998644 33456688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC--CCcEEEEeeccccccCCCCC
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~--~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      +++++|.+++......+++..+..++.|++.||.|||   +++|+||||||+||+++.  ++.+||+|||++....... 
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            9999999999877667999999999999999999999   999999999999999987  8899999999998764322 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        ......+|+.|+|||++.+..++.++||||+||++|+|++|..||....... ...........              
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~--------------  221 (321)
T 1tki_A          159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYT--------------  221 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC--------------
T ss_pred             --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCCCC--------------
Confidence              2344568999999999998889999999999999999999999997532211 11111111000              


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                        ........++.++.+++.+||+.||++|||+.|+++
T Consensus       222 --~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          222 --FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              000111235667899999999999999999999987

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.3e-41  Score=354.21  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=206.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCc------hhhhHHHHHHHHHhCCCccceeeeeeeecCCe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGR------VFKSFDVECEMMKSIRHRNIIKVISSCSNEEF  462 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  462 (678)
                      ..+.|++.+.||+|+||.||+|..+ +|+.||+|++......      ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3567999999999999999999864 7999999999754321      34678899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC----cEEEEeecc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM----VAHLSDFGI  538 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~----~~kl~Dfg~  538 (678)
                      .++||||+++|+|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++    .+||+|||+
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            999999999999999997654 5899999999999999999999   89999999999999998776    799999999


Q ss_pred             ccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc
Q 005760          539 AKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE  618 (678)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  618 (678)
                      +.......   ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+....+ ..........      
T Consensus       166 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~~~~i~~~~~------  235 (361)
T 2yab_A          166 AHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITAVSY------  235 (361)
T ss_dssp             CEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCC------
T ss_pred             ceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhcCC------
Confidence            98764322   2234579999999999999899999999999999999999999997632211 1111111000      


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                .........+++++.+++.+||++||++|||+.|+++
T Consensus       236 ----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 ----------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             ----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                      0000111234567889999999999999999999984

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=364.07  Aligned_cols=260  Identities=24%  Similarity=0.386  Sum_probs=210.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  463 (678)
                      .++|++.+.||+|+||.||+|.+.      +++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467889999999999999999842      56789999986432 23445688999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC---cEEEE
Q 005760          464 ALVLEYMPHGSLEKYLHSSN------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM---VAHLS  534 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~---~~kl~  534 (678)
                      ++||||+++|+|.+++...+      ..+++..++.++.||+.||+|||   +++|+||||||+||+++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997643      35889999999999999999999   99999999999999999555   59999


Q ss_pred             eeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccC
Q 005760          535 DFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLP  613 (678)
Q Consensus       535 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  613 (678)
                      |||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |..||......  .....+.....
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~~~~i~~~~~  304 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSGGR  304 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTTCC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC
Confidence            9999976543333333445668899999999999999999999999999999998 99998753221  11111111000


Q ss_pred             CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                           ...             +..++.++.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus       305 -----~~~-------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          305 -----MDP-------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             -----CCC-------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----CCC-------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence                 000             012445688999999999999999999999999998753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-42  Score=360.64  Aligned_cols=265  Identities=26%  Similarity=0.416  Sum_probs=213.7

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecC
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNE  460 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  460 (678)
                      ....++|++.+.||+|+||.||+|...      +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            345678999999999999999999863      458899999975432 3456788999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcC
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSN-----------------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD  517 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d  517 (678)
                      +..++||||+++++|.+++....                       ..+++..++.++.||+.||.|||   +++|+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence            99999999999999999997642                       45889999999999999999999   99999999


Q ss_pred             CCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCc
Q 005760          518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDE  596 (678)
Q Consensus       518 l~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~  596 (678)
                      |||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||.+
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999987654433333445678899999999988899999999999999999999 9999875


Q ss_pred             ccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          597 IFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                      ....+  ....+...   ..        ..       .+..++.++.+++.+||+.||++||++.|+++.|+++.+.+.
T Consensus       280 ~~~~~--~~~~~~~~---~~--------~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          280 MAHEE--VIYYVRDG---NI--------LA-------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             SCHHH--HHHHHHTT---CC--------CC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             CChHH--HHHHHhCC---Cc--------CC-------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            32211  11111100   00        00       001245568899999999999999999999999999876553

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-42  Score=361.54  Aligned_cols=262  Identities=28%  Similarity=0.436  Sum_probs=214.5

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe--------CCCcEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceeeeeeeec
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL--------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKVISSCSN  459 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~--------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  459 (678)
                      ..++|.+.+.||+|+||.||+|..        ..+..||+|++..... ...+.+.+|+++++.+ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            346888999999999999999974        2346799999975533 3446788999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCee
Q 005760          460 EEFKALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVL  524 (678)
Q Consensus       460 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nil  524 (678)
                      .+..++||||+++|+|.+++....               ..+++..+..++.|++.||+|||   +.+|+||||||+||+
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEE
Confidence            999999999999999999998654               34899999999999999999999   899999999999999


Q ss_pred             ecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccc
Q 005760          525 LDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT  603 (678)
Q Consensus       525 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~  603 (678)
                      ++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||......  .
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--~  301 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--E  301 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--H
Confidence            99999999999999987654443344445567889999999999999999999999999999999 99998653221  1


Q ss_pred             hhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          604 LKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      ....+.....     ...+             ..++.++.+++.+||+.||++|||+.|+++.|+++....
T Consensus       302 ~~~~~~~~~~-----~~~~-------------~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          302 LFKLLKEGHR-----MDKP-------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             HHHHHHTTCC-----CCCC-------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHHHHHcCCC-----CCCC-------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            1111111000     0000             123456889999999999999999999999999997653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-41  Score=347.65  Aligned_cols=260  Identities=25%  Similarity=0.411  Sum_probs=206.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            46799999999999999999985 4789999999865432   3346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999998765 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                       ........||+.|+|||.+.+..++.++||||+|+++|||++|+.||.+........... ....+.            
T Consensus       166 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~-~~~~~~------------  231 (294)
T 4eqm_A          166 -LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI-QDSVPN------------  231 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHH-SSCCCC------------
T ss_pred             -ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh-hccCCC------------
Confidence             222334568999999999999999999999999999999999999997633221111111 000000            


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRI-NAKEIVTKLLKIR  671 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~ell~~L~~~~  671 (678)
                         ........+++.+.+++.+||+.||++|| +++++.+.|+++.
T Consensus       232 ---~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          232 ---VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             ---HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             ---cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence               00000123456688999999999999999 9999999998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.5e-41  Score=350.79  Aligned_cols=248  Identities=23%  Similarity=0.323  Sum_probs=204.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            367889999999999999999864 7999999999754   233456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++|+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+++......
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            99999999999998654 4899999999999999999999   9999999999999999999999999999997543221


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                        .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .......       ...-|    
T Consensus       160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~i~~~-------~~~~p----  225 (337)
T 1o6l_A          160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILME-------EIRFP----  225 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHC-------CCCCC----
T ss_pred             --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH-HHHHHcC-------CCCCC----
Confidence              223456799999999999999999999999999999999999999975322111 1111110       00001    


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                               ..+++++.+++.+||+.||++||     +++|+++
T Consensus       226 ---------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          226 ---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                     12345688999999999999999     8999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-42  Score=356.91  Aligned_cols=263  Identities=24%  Similarity=0.382  Sum_probs=212.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhC-CCccceeeeeeeecCC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEE  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  461 (678)
                      ..++|++.+.||+|+||.||+|..      .++..||+|++.... ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457899999999999999999985      246789999996542 33457789999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCC
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNY----------------------ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK  519 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~  519 (678)
                      ..++||||+++|+|.+++.....                      .+++..+..++.|++.||+|||   +++|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999986543                      2788999999999999999999   8999999999


Q ss_pred             CCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCccc
Q 005760          520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIF  598 (678)
Q Consensus       520 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~  598 (678)
                      |+||+++.++.+||+|||++................+|+.|+|||.+.++.++.++|||||||++|||++ |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654443344455667889999999988899999999999999999998 999997643


Q ss_pred             CCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          599 NGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      .... ....+.....     ...+             ..+++++.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus       280 ~~~~-~~~~~~~~~~-----~~~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          280 VDAN-FYKLIQNGFK-----MDQP-------------FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CSHH-HHHHHHTTCC-----CCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             cHHH-HHHHHhcCCC-----CCCC-------------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            3221 1111111000     0000             123456889999999999999999999999999987654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=4.6e-42  Score=356.22  Aligned_cols=259  Identities=24%  Similarity=0.396  Sum_probs=204.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcE----EEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGME----VAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      .++|++.+.||+|+||.||+|.+. +++.    ||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            457889999999999999999853 4444    5788775432 244577899999999999999999999998765 77


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +|+||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999999999999887777999999999999999999999   89999999999999999999999999999987765


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ...........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......  ....+.....     ...  
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~-----~~~--  240 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGER-----LPQ--  240 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCC-----CCC--
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHHHcCCC-----CCC--
Confidence            444444445567889999999999999999999999999999999 999997643322  1111111000     000  


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                                 +..++.++.+++.+||+.||++||++.|+++.|+.+...
T Consensus       241 -----------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          241 -----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -----------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             -----------CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence                       012345688999999999999999999999999988643

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.2e-41  Score=366.19  Aligned_cols=253  Identities=29%  Similarity=0.446  Sum_probs=208.4

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCC-eEEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE-FKALVLE  468 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e  468 (678)
                      ..++|++.+.||+|+||.||+|... ++.||||+++...  ..+.+.+|+++++.++||||+++++++.+.+ ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467888999999999999999984 7899999997543  4578999999999999999999999986654 7899999


Q ss_pred             ecCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+++|+|.++++..+. .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....  
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            9999999999987644 3689999999999999999999   999999999999999999999999999999754321  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                         .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+.  ...+....     ...      
T Consensus       343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~i~~~~-----~~~------  406 (450)
T 1k9a_A          343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEKGY-----KMD------  406 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HHHHHTTC-----CCC------
T ss_pred             ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCC-----CCC------
Confidence               122357889999999999999999999999999999998 9999976433221  11111000     000      


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                             .+..+++++.++|.+||+.||++|||+.|+++.|+++...
T Consensus       407 -------~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          407 -------APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                   0123566799999999999999999999999999998764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.4e-41  Score=341.82  Aligned_cols=264  Identities=15%  Similarity=0.128  Sum_probs=215.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...  ...+.+.+|+.+++.+ +|+|++++++++.+....++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999985 58999999998643  2346788999999999 79999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc-----EEEEeeccccccC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV-----AHLSDFGIAKLLT  543 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~-----~kl~Dfg~~~~~~  543 (678)
                      |+ +++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.     +||+|||++....
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 99999999877667999999999999999999999   999999999999999987776     9999999998765


Q ss_pred             CCCCc-----ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccc--hhhhhhcccCCcc
Q 005760          544 REDQS-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT--LKHWVNDWLPIST  616 (678)
Q Consensus       544 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~  616 (678)
                      .....     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  .............
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  242 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence            43221     1234567999999999999999999999999999999999999999764332111  0100000000000


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                                     ......+++++.+++.+||+.||++||+++++++.|+++.+++.
T Consensus       243 ---------------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          243 ---------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             ---------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ---------------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence                           00001356779999999999999999999999999999987654

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-41  Score=351.52  Aligned_cols=261  Identities=23%  Similarity=0.389  Sum_probs=213.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF  462 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  462 (678)
                      ..++|.+.+.||+|+||.||+|..      .+++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            356788999999999999999974      3458899999975432 345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCCC-----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCC
Q 005760          463 KALVLEYMPHGSLEKYLHSSNY-----------------------ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK  519 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~-----------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~  519 (678)
                      .++||||+++++|.+++.....                       .+++..++.++.|++.||+|||   +++|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence            9999999999999999986432                       3788999999999999999999   8999999999


Q ss_pred             CCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCccc
Q 005760          520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIF  598 (678)
Q Consensus       520 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~  598 (678)
                      |+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||+|+++|||++ |..||....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987654443333445567889999999988889999999999999999999 999987643


Q ss_pred             CCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          599 NGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      ...  ....+.....        +..          +..+++++.+++.+||+.||++||++.|+++.|+++.+.
T Consensus       258 ~~~--~~~~~~~~~~--------~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          258 PER--LFNLLKTGHR--------MER----------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GGG--HHHHHHTTCC--------CCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHH--HHHHhhcCCc--------CCC----------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            321  1111111000        000          012456688999999999999999999999999998653

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.5e-41  Score=344.40  Aligned_cols=261  Identities=26%  Similarity=0.428  Sum_probs=197.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ..++|++.+.||+|+||.||+|....  .||+|++.....  ...+.+.+|+++++.++||||+++++++. .+..++||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~   98 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT   98 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEE
Confidence            45789999999999999999998643  599999865432  34567889999999999999999999654 45678999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            999999999999877777999999999999999999999   89999999999999999999999999999976543333


Q ss_pred             cceeecccCCccccCccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          548 STIQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ........||+.|+|||.+.   +..++.++||||+|+++|||++|+.||......+..................     
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  250 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV-----  250 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS-----
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc-----
Confidence            33344567899999999886   5668889999999999999999999997643322111111111111000000     


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                                ...+++++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       251 ----------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          251 ----------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             ----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ----------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                      0134566899999999999999999999999999874

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.8e-41  Score=342.74  Aligned_cols=253  Identities=28%  Similarity=0.461  Sum_probs=205.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCc-------hhhhHHHHHHHHHhCCCccceeeeeeeecCCe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGR-------VFKSFDVECEMMKSIRHRNIIKVISSCSNEEF  462 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  462 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++......       ..+.+.+|+++++.++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46899999999999999999985 58999999998654321       1267889999999999999999999997765 


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEcCCCCCCeeecCCCc-----EEEEe
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPSNVLLDDNMV-----AHLSD  535 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dl~~~Nill~~~~~-----~kl~D  535 (678)
                       ++||||+++++|.+++......+++..+..++.|++.|++|||   +++  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             6999999999999999877777999999999999999999999   888  999999999999988776     99999


Q ss_pred             eccccccCCCCCcceeecccCCccccCccccC--CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC
Q 005760          536 FGIAKLLTREDQSTIQTQTLATIGYMAPEYGK--EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP  613 (678)
Q Consensus       536 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  613 (678)
                      ||+++....     ......+|+.|+|||.+.  ...++.++||||+||++|||++|+.||...................
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            999975422     234567999999999984  4557899999999999999999999997644433322222111000


Q ss_pred             CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                             .+..          +..+++++.+++.+||+.||++|||+.|+++.|+++
T Consensus       248 -------~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          248 -------RPTI----------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -------CCCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -------CCCC----------CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                   0000          012456688999999999999999999999999863

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-41  Score=345.43  Aligned_cols=262  Identities=23%  Similarity=0.365  Sum_probs=201.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC----CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      ..++|++.+.||+|+||.||+|...    .+..||+|++.... ....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-CccE
Confidence            3568889999999999999999753    35679999986532 2345678899999999999999999999854 5678


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++.....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            999999999999999877667999999999999999999999   89999999999999999999999999999987643


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      .. ........+++.|+|||.+.+..++.++||||+|+++|||++ |..||......+  ....+.....        +.
T Consensus       169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~~~~~--------~~  237 (281)
T 1mp8_A          169 ST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGER--------LP  237 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCC--------CC
T ss_pred             cc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHHcCCC--------CC
Confidence            22 222334456789999999988899999999999999999997 899987643221  1111110000        00


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHhh
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLR  676 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~~  676 (678)
                                .+..+++++.+++.+||+.||++|||+.|+++.|+++.++-.+
T Consensus       238 ----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  280 (281)
T 1mp8_A          238 ----------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKA  280 (281)
T ss_dssp             ----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             ----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhcc
Confidence                      0012456688999999999999999999999999999877554

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.1e-41  Score=352.97  Aligned_cols=261  Identities=25%  Similarity=0.440  Sum_probs=195.6

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCC-C---cEEEEEEeecc--cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGD-G---MEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  463 (678)
                      ..++|++.+.||+|+||.||+|.... +   ..||+|++...  .....+.+.+|+++++.++||||+++++++...+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45689999999999999999998643 3   27999998654  334567889999999999999999999999776654


Q ss_pred             ------EEEEEecCCCCHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEE
Q 005760          464 ------ALVLEYMPHGSLEKYLHSSN-----YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH  532 (678)
Q Consensus       464 ------~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~k  532 (678)
                            ++||||+++++|.+++....     ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  89999999999999986432     25889999999999999999999   89999999999999999999999


Q ss_pred             EEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcc
Q 005760          533 LSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDW  611 (678)
Q Consensus       533 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~  611 (678)
                      |+|||+++...............+++.|+|||.+.+..++.++||||+||++|||++ |..||.+....+. ........
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~-~~~~~~~~  256 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI-YNYLIGGN  256 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHHTTC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-HHHHhcCC
Confidence            999999987654443334445567889999999999999999999999999999999 8999876433221 11111100


Q ss_pred             cCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          612 LPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      ..      ..             +..++.++.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus       257 ~~------~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          257 RL------KQ-------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             CC------CC-------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CC------CC-------------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            00      00             012345688999999999999999999999999998753

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-41  Score=357.76  Aligned_cols=271  Identities=15%  Similarity=0.196  Sum_probs=208.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCC------CcEEEEEEeecccCc-----------hhhhHHHHHHHHHhCCCcccee
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGD------GMEVAMKVFNLQYGR-----------VFKSFDVECEMMKSIRHRNIIK  452 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~  452 (678)
                      ..++|++.+.||+|+||.||+|.+..      ++.||||++......           ....+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35689999999999999999998654      478999998654321           1122344566677788999999


Q ss_pred             eeeeeecC----CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec--
Q 005760          453 VISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD--  526 (678)
Q Consensus       453 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~--  526 (678)
                      +++++...    ...++||||+ +++|.+++......+++..+..++.||+.||+|||   +++|+||||||+||+++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecC
Confidence            99998664    4589999999 99999999887667999999999999999999999   89999999999999999  


Q ss_pred             CCCcEEEEeeccccccCCCCCcc-----eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCc
Q 005760          527 DNMVAHLSDFGIAKLLTREDQST-----IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE  601 (678)
Q Consensus       527 ~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~  601 (678)
                      .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            89999999999998765332111     1234459999999999999999999999999999999999999998643332


Q ss_pred             cchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          602 MTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      ... .............+.++.+.         ...++.++.+++..||+.||++||++.++++.|+++.+..
T Consensus       269 ~~~-~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          269 KYV-RDSKIRYRENIASLMDKCFP---------AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             HHH-HHHHHHHHHCHHHHHHHHSC---------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHH-HHHHHHhhhhHHHHHHHhcc---------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence            111 11111111111111111110         0134677999999999999999999999999999998764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.5e-40  Score=345.51  Aligned_cols=262  Identities=20%  Similarity=0.206  Sum_probs=213.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....  ..+.+..|+++++.+ +||||+++++++.+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46799999999999999999985 589999999987543  346788999999999 89999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc-----EEEEeeccccccC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV-----AHLSDFGIAKLLT  543 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~-----~kl~Dfg~~~~~~  543 (678)
                      |+ +++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.     +||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 89999999876667999999999999999999999   899999999999999998887     9999999998764


Q ss_pred             CCCCcc-----eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccc--hhhhhhcccCCcc
Q 005760          544 REDQST-----IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT--LKHWVNDWLPIST  616 (678)
Q Consensus       544 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~  616 (678)
                      ......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......  .........+.. 
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-  240 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-  240 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-
Confidence            332211     124567999999999999999999999999999999999999999764322111  011000000000 


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                                   .. .....++ ++.+++.+||+.||.+||++.++++.|+++.+..
T Consensus       241 -------------~~-~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          241 -------------IE-VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             -------------HH-HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -------------HH-HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence                         00 0001134 7999999999999999999999999999887764

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-40  Score=345.27  Aligned_cols=272  Identities=26%  Similarity=0.379  Sum_probs=207.7

Q ss_pred             HHHHHhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhC--CCccceeeeeeeecC--
Q 005760          385 LELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI--RHRNIIKVISSCSNE--  460 (678)
Q Consensus       385 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~--  460 (678)
                      .......++|++.+.||+|+||.||+|+.. ++.||||++...   ....+..|.+++...  +||||+++++++...  
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            333445678999999999999999999885 899999998643   224455566666654  899999999998776  


Q ss_pred             --CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--------CeEEcCCCCCCeeecCCCc
Q 005760          461 --EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA--------QVIHCDLKPSNVLLDDNMV  530 (678)
Q Consensus       461 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~--------~ivH~dl~~~Nill~~~~~  530 (678)
                        ...++||||+++|+|.++++...  +++..++.++.|++.||+|||   ++        +|+||||||+||+++.++.
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CCCceEEEEeccCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCC
Confidence              68899999999999999997653  899999999999999999999   77        9999999999999999999


Q ss_pred             EEEEeeccccccCCCCCc--ceeecccCCccccCccccCCCCCCcc------chHHHHHHHHHHHHcC----------CC
Q 005760          531 AHLSDFGIAKLLTREDQS--TIQTQTLATIGYMAPEYGKEGRVSAN------GDVYSFGIMLMETFTR----------KK  592 (678)
Q Consensus       531 ~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~------~DvwslGv~l~ell~g----------~~  592 (678)
                      +||+|||++.........  .......||+.|+|||.+.+...+.+      +|||||||++|||++|          +.
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            999999999766433221  11234579999999999887766655      9999999999999999          55


Q ss_pred             CCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          593 PTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       593 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                      ||....................         ..............+++++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          261 PYHDLVPSDPSYEDMREIVCIK---------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTS---------CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cHhhhcCCCCchhhhHHHHhhh---------ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence            5544333322222211111000         0001111111223678889999999999999999999999999999987


Q ss_pred             HH
Q 005760          673 SL  674 (678)
Q Consensus       673 ~~  674 (678)
                      +.
T Consensus       332 ~~  333 (337)
T 3mdy_A          332 SQ  333 (337)
T ss_dssp             TT
T ss_pred             hc
Confidence            53

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.9e-41  Score=346.15  Aligned_cols=251  Identities=22%  Similarity=0.318  Sum_probs=205.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCc------hhhhHHHHHHHHHhCCCccceeeeeeeecCCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGR------VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  463 (678)
                      .+.|++.+.||+|+||.||+|... +|+.||+|++......      ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            456889999999999999999864 7899999999754321      356788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC----cEEEEeeccc
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM----VAHLSDFGIA  539 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~----~~kl~Dfg~~  539 (678)
                      ++||||+++++|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            99999999999999997654 5899999999999999999999   99999999999999999877    8999999999


Q ss_pred             cccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccc
Q 005760          540 KLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI  619 (678)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (678)
                      .......   ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+....+ ..........       
T Consensus       166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~-------  234 (326)
T 2y0a_A          166 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAVNY-------  234 (326)
T ss_dssp             EECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHTCC-------
T ss_pred             eECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHhcCC-------
Confidence            8764322   2234579999999999998899999999999999999999999996532211 1111100000       


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                         .      ........++.++.+++.+||+.||++|||+.|+++
T Consensus       235 ---~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          235 ---E------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             ---C------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---C------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               0      000111234567889999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.3e-41  Score=364.12  Aligned_cols=261  Identities=20%  Similarity=0.255  Sum_probs=209.4

Q ss_pred             HHHHHhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecC
Q 005760          385 LELCRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNE  460 (678)
Q Consensus       385 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  460 (678)
                      .++....++|++.+.||+|+||.||+|+.+ +++.||+|++...   .......+.+|..+++.++||||+++++++.+.
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            344455789999999999999999999865 6889999999753   223345688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      +..|+||||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~  223 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCL  223 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhh
Confidence            9999999999999999999876567999999999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCCcceeecccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCc
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS  615 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  615 (678)
                      ...... ........||+.|+|||++.     .+.++.++||||+||++|||++|+.||.+....+. .........   
T Consensus       224 ~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~-~~~i~~~~~---  298 (437)
T 4aw2_A          224 KLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-YGKIMNHKE---  298 (437)
T ss_dssp             ECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHH---
T ss_pred             hcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH-HHhhhhccc---
Confidence            664332 22334467999999999986     56789999999999999999999999976332211 111111000   


Q ss_pred             ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCC--CCCHHHHHH
Q 005760          616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVT  665 (678)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~ell~  665 (678)
                        ....|...          ...++++.+++.+||..+|++  ||+++|+++
T Consensus       299 --~~~~p~~~----------~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          299 --RFQFPTQV----------TDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             --HCCCCSSC----------CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             --cccCCccc----------ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence              00001100          013456889999999998888  999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.9e-41  Score=349.91  Aligned_cols=246  Identities=26%  Similarity=0.381  Sum_probs=202.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999985 589999999996532   23346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+ +|+|.+++.... .+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 779999887655 4899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             CcceeecccCCccccCccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                         ......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.......  .           .+.... .
T Consensus       163 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--~-----------~i~~~~-~  225 (336)
T 3h4j_B          163 ---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF--K-----------KVNSCV-Y  225 (336)
T ss_dssp             ---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB--C-----------CCCSSC-C
T ss_pred             ---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH--H-----------HHHcCC-C
Confidence               2234579999999999988776 78999999999999999999999763322110  0           000000 0


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .       .+...++++.+++.+||+.||.+|||++|+++
T Consensus       226 ~-------~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          226 V-------MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             C-------CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             C-------CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            0       00123456889999999999999999999975

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=344.95  Aligned_cols=274  Identities=20%  Similarity=0.279  Sum_probs=210.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCC--eEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE--FKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            457899999999999999999865 68999999997543 234567789999999999999999999987655  78999


Q ss_pred             EEecCCCCHHHHhhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee----cCCCcEEEEeecccc
Q 005760          467 LEYMPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIAK  540 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill----~~~~~~kl~Dfg~~~  540 (678)
                      |||+++++|.+++.....  .+++..++.++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976443  3899999999999999999999   9999999999999999    788889999999998


Q ss_pred             ccCCCCCcceeecccCCccccCccccC--------CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccch---hhhhh
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGK--------EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTL---KHWVN  609 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~---~~~~~  609 (678)
                      ......   ......+|+.|+|||++.        +..++.++|||||||++|||++|+.||..........   .....
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            764332   223456999999999875        5678999999999999999999999997533322211   11111


Q ss_pred             cccCCcccccccCcc-----CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          610 DWLPISTKEIVDPNL-----LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       610 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                      ..++.....+.....     ..............+..+.+++.+||+.||++|||++|+++..++.
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            111111111100000     0000000011245677799999999999999999999999987753

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-41  Score=342.87  Aligned_cols=258  Identities=28%  Similarity=0.438  Sum_probs=213.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      .++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            357888999999999999999988889999999975433 3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI  550 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  550 (678)
                      ++++|.+++......+++..+..++.|++.|++|||   +++++||||||+||+++.++.+||+|||++...... ....
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-QYTS  161 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH-HHHS
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc-cccc
Confidence            999999999887667899999999999999999999   999999999999999999999999999999765422 1122


Q ss_pred             eecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      .....++..|+|||.+.+..++.++||||+|+++|||++ |+.||......+  ....+....     ....+       
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~i~~~~-----~~~~~-------  227 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGF-----RLYKP-------  227 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTC-----CCCCC-------
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HHHHHhcCC-----cCCCC-------
Confidence            234457788999999988889999999999999999999 899986532211  111111000     00001       


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                            ..++.++.+++.+||+.||++||++.|+++.|+++.++
T Consensus       228 ------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          228 ------RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             ------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ------ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                  11345588999999999999999999999999999763

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7e-41  Score=347.06  Aligned_cols=258  Identities=24%  Similarity=0.403  Sum_probs=206.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcE----EEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGME----VAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      .++|++.+.||+|+||.||+|... +++.    ||+|.+.... ......+.+|+.+++.++||||+++++++.+ +..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence            357889999999999999999853 4554    7777775432 3344677889999999999999999999864 5688


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+++|+|.+++...+..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            999999999999999876666889999999999999999999   89999999999999999999999999999988765


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ...........++..|+|||.+.++.++.++||||+||++|||++ |..||......+.  ...+....     ....+.
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~~-----~~~~~~  240 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--PDLLEKGE-----RLAQPQ  240 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--HHHHHTTC-----BCCCCT
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--HHHHHcCC-----CCCCCC
Confidence            544444556678889999999998999999999999999999999 9999976433221  11111100     000111


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                                   .++.++.+++.+||+.||++||++.|+++.|+.+..
T Consensus       241 -------------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          241 -------------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -------------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -------------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                         123347789999999999999999999999998854

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.7e-41  Score=340.65  Aligned_cols=268  Identities=24%  Similarity=0.285  Sum_probs=203.3

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ++|++.+.||+|+||+||+|... +++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999864 789999999975432  334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+++ ++.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....  .
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--V  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC--C
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc--c
Confidence            9975 777777665567999999999999999999999   899999999999999999999999999999876432  2


Q ss_pred             ceeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC---Cccc---cccc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP---ISTK---EIVD  621 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~---~~~~  621 (678)
                      .......+|+.|+|||++.+.. ++.++||||+||++|||++|+.||...................   ....   ...+
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            2234567899999999987766 7999999999999999999988864322222122221111000   0000   0000


Q ss_pred             Cc---cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 PN---LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 ~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..   ...............+.++.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00   000000000001134566889999999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3e-41  Score=343.63  Aligned_cols=267  Identities=22%  Similarity=0.314  Sum_probs=201.9

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|++.+.||+|+||.||+|...+|+.||+|++.....  ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57889999999999999999988899999999865432  2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++ +|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++......  ..
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cc
Confidence            976 999999876667899999999999999999999   899999999999999999999999999999765422  12


Q ss_pred             eeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc---CCccc-----ccc
Q 005760          550 IQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL---PISTK-----EIV  620 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~-----~~~  620 (678)
                      ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+. .........   .....     ...
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHHCCCChhhchhhhccccc
Confidence            22345689999999988764 589999999999999999999999976332211 111111000   00000     000


Q ss_pred             cCccCCccchhh-HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          621 DPNLLSREDINF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       621 ~~~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ++.......... ......++++.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111000000000 000124566889999999999999999999975

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.2e-41  Score=353.09  Aligned_cols=252  Identities=21%  Similarity=0.307  Sum_probs=204.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-----CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-----GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....     ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45799999999999999999985 479999999986432     123567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc---EEEEeecc
Q 005760          465 LVLEYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV---AHLSDFGI  538 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~---~kl~Dfg~  538 (678)
                      +||||+++++|.+++...   ...+++..+..++.||+.||+|||   +++|+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999887543   235889999999999999999999   999999999999999986554   99999999


Q ss_pred             ccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc
Q 005760          539 AKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE  618 (678)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  618 (678)
                      +.......  .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+...  ............     
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~~~~-----  250 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYK-----  250 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHTCCC-----
T ss_pred             eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcCCCC-----
Confidence            98765322  223456799999999999998999999999999999999999999976321  111111111000     


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                 ........++.++.+++.+||+.||++|||+.|+++
T Consensus       251 -----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 -----------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             -----------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                       000111234567899999999999999999999985

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.9e-42  Score=370.30  Aligned_cols=257  Identities=25%  Similarity=0.437  Sum_probs=210.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..++|++.+.||+|+||.||+|..+++..||||+++... ...+.+.+|+++++.++||||+++++++. .+..++||||
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            456788899999999999999999888999999997543 34678999999999999999999999987 5678999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++|+|.++++... ..+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++...... .
T Consensus       264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~  339 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-Y  339 (454)
T ss_dssp             CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-H
T ss_pred             cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-e
Confidence            99999999997542 25788999999999999999999   8999999999999999999999999999998764321 1


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      .......++..|+|||++..+.++.++|||||||++|||++ |+.||.+....+  ....+....     ...       
T Consensus       340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~-----~~~-------  405 (454)
T 1qcf_A          340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERGY-----RMP-------  405 (454)
T ss_dssp             HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHHTC-----CCC-------
T ss_pred             eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC-----CCC-------
Confidence            12234456788999999998899999999999999999999 999997633221  111111100     000       


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                            .+..+++++.+++.+||+.||++|||+.++++.|+++..
T Consensus       406 ------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          406 ------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                  012356678999999999999999999999999998743

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=351.57  Aligned_cols=252  Identities=20%  Similarity=0.309  Sum_probs=207.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999854 7899999999765544556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec--CCCcEEEEeeccccccCCCCC
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~--~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      +++|+|.+++......+++..+..++.||+.||+|||   +++|+||||||+||+++  .++.+||+|||+++...... 
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            9999999999876667899999999999999999999   99999999999999997  45789999999998764332 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        ......+|+.|+|||++.+..++.++||||+||++|||++|..||.+....+ ...........      .++...  
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~------~~~~~~--  274 (387)
T 1kob_A          206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWE------FDEDAF--  274 (387)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCC------CCSSTT--
T ss_pred             --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC------CCcccc--
Confidence              2234569999999999999999999999999999999999999997532211 11111110000      000000  


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              ..+++++.+++.+||+.||++|||+.|+++
T Consensus       275 --------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          275 --------SSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             --------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --------ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                    123456889999999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.2e-41  Score=354.60  Aligned_cols=249  Identities=23%  Similarity=0.300  Sum_probs=199.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  464 (678)
                      ..++|++.+.||+|+||.||+|+.+ +++.||+|+++...   ....+.+..|..+++.+ +||||+++++++.+.+..+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3468999999999999999999854 68899999997542   23445678899999876 8999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+++|+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+++....
T Consensus       130 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            9999999999999998765 4899999999999999999999   99999999999999999999999999999975322


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccc---hhh-hhhcccCCcccccc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT---LKH-WVNDWLPISTKEIV  620 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~---~~~-~~~~~~~~~~~~~~  620 (678)
                      .  ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+..   ... ........   ...
T Consensus       206 ~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---~~~  280 (396)
T 4dc2_A          206 P--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---QIR  280 (396)
T ss_dssp             T--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC---CCC
T ss_pred             C--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc---ccC
Confidence            2  22334567999999999999999999999999999999999999999643221110   000 00000000   000


Q ss_pred             cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCH
Q 005760          621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA  660 (678)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  660 (678)
                      -|             ..++.++.+++.+||+.||++||++
T Consensus       281 ~p-------------~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          281 IP-------------RSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CC-------------TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CC-------------CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            01             1234568899999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.7e-41  Score=349.85  Aligned_cols=262  Identities=27%  Similarity=0.439  Sum_probs=212.5

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe--------CCCcEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceeeeeeeec
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL--------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKVISSCSN  459 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~--------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  459 (678)
                      ..++|++.+.||+|+||.||+|..        .++..||+|++..... ...+.+.+|+++++.+ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            457899999999999999999975        3567899999975432 3456788999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhhCCC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCee
Q 005760          460 EEFKALVLEYMPHGSLEKYLHSSNY---------------ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVL  524 (678)
Q Consensus       460 ~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nil  524 (678)
                      .+..++||||+++++|.+++.....               .+++..++.++.|++.||+|||   +++|+||||||+||+
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL  189 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEE
Confidence            9999999999999999999986532               3789999999999999999999   899999999999999


Q ss_pred             ecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccc
Q 005760          525 LDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMT  603 (678)
Q Consensus       525 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~  603 (678)
                      ++.++.+||+|||++................+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.+....+  
T Consensus       190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--  267 (334)
T 2pvf_A          190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  267 (334)
T ss_dssp             ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred             EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--
Confidence            99999999999999987654433333444567889999999988889999999999999999999 999986532211  


Q ss_pred             hhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          604 LKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      ....+.....        +..          +..++.++.+++.+||+.||++||++.|+++.|+++....
T Consensus       268 ~~~~~~~~~~--------~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          268 LFKLLKEGHR--------MDK----------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             HHHHHHHTCC--------CCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCC--------CCC----------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            1111111000        000          0124456889999999999999999999999999997653

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.1e-41  Score=348.95  Aligned_cols=279  Identities=26%  Similarity=0.348  Sum_probs=201.5

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHH--HhCCCccceeeeeee-----ecCCe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMM--KSIRHRNIIKVISSC-----SNEEF  462 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l--~~l~h~niv~~~~~~-----~~~~~  462 (678)
                      ..++|++.+.||+|+||.||+|+. +++.||||++....   ...+..|.++.  ..++||||+++++.+     .....
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            357899999999999999999987 68999999997432   23444455554  458999999999754     23346


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC---------CeEEcCCCCCCeeecCCCcEEE
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA---------QVIHCDLKPSNVLLDDNMVAHL  533 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivH~dl~~~Nill~~~~~~kl  533 (678)
                      .++||||+++|+|.+++....  .++..+..++.|++.||+|||   +.         +|+||||||+||+++.++.+||
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEE
Confidence            789999999999999997765  588899999999999999999   77         9999999999999999999999


Q ss_pred             EeeccccccCCCCC------cceeecccCCccccCccccCC-------CCCCccchHHHHHHHHHHHHcCCCCCCcccCC
Q 005760          534 SDFGIAKLLTREDQ------STIQTQTLATIGYMAPEYGKE-------GRVSANGDVYSFGIMLMETFTRKKPTDEIFNG  600 (678)
Q Consensus       534 ~Dfg~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~  600 (678)
                      +|||+++.......      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||......
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            99999987643221      122334579999999999876       45677899999999999999998776432221


Q ss_pred             ccchhhhhhcccCCcc----cccc-cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          601 EMTLKHWVNDWLPIST----KEIV-DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       601 ~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                      ......+.........    .... .................+++++.+++.+||+.||++|||++|+++.|+++...+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            1111100000000000    0000 0000000000001112356779999999999999999999999999999987765


Q ss_pred             hc
Q 005760          676 RN  677 (678)
Q Consensus       676 ~~  677 (678)
                      |+
T Consensus       322 ~~  323 (336)
T 3g2f_A          322 RN  323 (336)
T ss_dssp             C-
T ss_pred             hc
Confidence            53

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=355.80  Aligned_cols=254  Identities=20%  Similarity=0.287  Sum_probs=205.2

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ...++|++.+.||+|+||.||+|.. .+|+.+|+|++.....  ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            3467899999999999999999975 5899999999975432  344678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec---CCCcEEEEeecccccc
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLL  542 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~---~~~~~kl~Dfg~~~~~  542 (678)
                      ||||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++   .++.+||+|||++...
T Consensus        88 v~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            999999999999998765 4899999999999999999999   99999999999999998   5688999999999766


Q ss_pred             CCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ....  .......||+.|+|||++.+..++.++||||+||++|+|++|..||.+....+. ..........     ...+
T Consensus       164 ~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-~~~i~~~~~~-----~~~~  235 (444)
T 3soa_A          164 EGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-YQQIKAGAYD-----FPSP  235 (444)
T ss_dssp             CTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHTCCC-----CCTT
T ss_pred             cCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhCCCC-----CCcc
Confidence            4322  223456799999999999998999999999999999999999999965322111 1111111100     0000


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .           ...+++++.+++.+||+.||++|||+.|+++
T Consensus       236 ~-----------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          236 E-----------WDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             T-----------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             c-----------cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            0           0123556889999999999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.8e-41  Score=350.93  Aligned_cols=249  Identities=24%  Similarity=0.314  Sum_probs=199.4

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  464 (678)
                      ..++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ....+.+..|..+++.+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3578999999999999999999854 78999999997542   23446678899999988 6999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+++|+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus       101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            9999999999999998765 4899999999999999999999   99999999999999999999999999999975432


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      .  ........||+.|+|||++.+..++.++||||+||++|||++|+.||......+ .........       ...|. 
T Consensus       177 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~-------~~~p~-  245 (353)
T 3txo_A          177 N--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILNDE-------VVYPT-  245 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC-------CCCCT-
T ss_pred             C--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHHcCC-------CCCCC-
Confidence            2  223345679999999999998889999999999999999999999997633221 111111110       00011 


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCH------HHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA------KEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~------~ell~  665 (678)
                                  ..+.++.+++.+||++||++||++      .|+++
T Consensus       246 ------------~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          246 ------------WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             ------------TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             ------------CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                        134558899999999999999998      66654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.6e-40  Score=347.00  Aligned_cols=250  Identities=26%  Similarity=0.351  Sum_probs=202.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367899999999999999999854 68999999996542   33456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+.+|+|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+||+++.+|.+||+|||+++..... 
T Consensus        94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            99999999999998754 4899999999999999999999   999999999999999999999999999999876432 


Q ss_pred             CcceeecccCCccccCccccCC---CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          547 QSTIQTQTLATIGYMAPEYGKE---GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                        .......||+.|+|||++.+   ..++.++||||+||++|||++|+.||.......  ............   ...| 
T Consensus       169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~~~~~~---~~~p-  240 (384)
T 4fr4_A          169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHTFETTV---VTYP-  240 (384)
T ss_dssp             --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHHHHHCC---CCCC-
T ss_pred             --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHhhcc---cCCC-
Confidence              22345679999999999864   458999999999999999999999997532221  111111100000   0000 


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCC-HHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN-AKEIVT  665 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-~~ell~  665 (678)
                                  ..++.++.+++.+||+.||++||+ ++++.+
T Consensus       241 ------------~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          241 ------------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ------------TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ------------CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                        123456889999999999999998 666653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.9e-41  Score=340.62  Aligned_cols=251  Identities=27%  Similarity=0.424  Sum_probs=194.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccC----chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG----RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|... ++.||+|++.....    ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            467889999999999999999974 89999999865422    2346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---eEEcCCCCCCeeecC--------CCcEEEEe
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ---VIHCDLKPSNVLLDD--------NMVAHLSD  535 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~---ivH~dl~~~Nill~~--------~~~~kl~D  535 (678)
                      |||+++++|.+++...  .+++..++.++.|++.|++|||   +++   |+||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            9999999999999654  4899999999999999999999   777   999999999999985        78899999


Q ss_pred             eccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCc
Q 005760          536 FGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS  615 (678)
Q Consensus       536 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  615 (678)
                      ||++.......    .....+++.|+|||.+.+..++.++||||+|+++|+|++|+.||................ ..  
T Consensus       160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~--  232 (271)
T 3dtc_A          160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK-LA--  232 (271)
T ss_dssp             CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC-CC--
T ss_pred             CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC-CC--
Confidence            99997654322    224568999999999998889999999999999999999999997533221111100000 00  


Q ss_pred             ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                            ..          .+..+++++.+++.+||+.||++|||+.|+++.|+++
T Consensus       233 ------~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          233 ------LP----------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ------CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ------CC----------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                  00          0012345688999999999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-41  Score=349.68  Aligned_cols=259  Identities=24%  Similarity=0.396  Sum_probs=202.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcE----EEEEEeecc-cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGME----VAMKVFNLQ-YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      .++|++.+.||+|+||.||+|.. .+++.    ||+|.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            46799999999999999999985 35554    466666433 2345677899999999999999999999998765 78


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +|+||+.+|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999887777999999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ...........+|+.|+|||.+.+..++.++||||+||++|||++ |..||.......  ....+.....     ...  
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~-----~~~--  240 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGER-----LPQ--  240 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCC-----CCC--
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCC-----CCC--
Confidence            444444445567889999999999999999999999999999999 999997643322  1111111000     000  


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                                 +..++.++.+++.+||+.||++||++.|+++.|+++...
T Consensus       241 -----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          241 -----------PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             -----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             -----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                       012345688999999999999999999999999998744

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.3e-40  Score=341.43  Aligned_cols=263  Identities=24%  Similarity=0.419  Sum_probs=208.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-----CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecC--Ce
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-----GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE--EF  462 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~  462 (678)
                      .+.|++.+.||+|+||.||+|.+     .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            34588899999999999999983     478999999997543 23457788999999999999999999999776  67


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .++||||+++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++...
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence            89999999999999999776667999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCCc-ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCC----------ccchhhhhhcc
Q 005760          543 TREDQS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNG----------EMTLKHWVNDW  611 (678)
Q Consensus       543 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~----------~~~~~~~~~~~  611 (678)
                      ...... .......+|..|+|||.+.+..++.++||||+|+++|||++|..|+......          ...........
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL  256 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence            543322 2334556888899999999888999999999999999999999986432110          00000100000


Q ss_pred             cCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          612 LPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                      ...         ...      ..+..+++++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       257 ~~~---------~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          257 KEG---------KRL------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HTT---------CCC------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcc---------CCC------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            000         000      001134567899999999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.2e-41  Score=369.01  Aligned_cols=255  Identities=25%  Similarity=0.409  Sum_probs=211.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .++|++.+.||+|+||.||+|.++ ++..||||++.... ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            456888899999999999999865 58899999997543 3457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++|+|.++++... ..+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++..... ..
T Consensus       298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~  373 (495)
T 1opk_A          298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD-TY  373 (495)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC-CE
T ss_pred             cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCC-ce
Confidence            99999999998643 45889999999999999999999   999999999999999999999999999999876432 22


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||.......  ....+.....     ..       
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~-----~~-------  439 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYR-----ME-------  439 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTCC-----CC-------
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-----CC-------
Confidence            22334456789999999998899999999999999999999 899987643221  1111111000     00       


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                            .+..++.++.+++.+||+.||++|||+.|+++.|+.+
T Consensus       440 ------~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          440 ------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ------CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence                  0123556789999999999999999999999999876

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.3e-40  Score=340.69  Aligned_cols=268  Identities=24%  Similarity=0.337  Sum_probs=190.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999854 789999999975432 334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          469 YMPHGSLEKYLHSSN-----YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      |++ ++|.+++....     ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 59999886532     35889999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcc--cCCc-ccc-
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW--LPIS-TKE-  618 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~--~~~~-~~~-  618 (678)
                      ...  .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+ .........  .+.. ... 
T Consensus       160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCTTTCGGG
T ss_pred             CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCChhHhhhh
Confidence            321  223345789999999998764 58999999999999999999999997633211 111111100  0000 000 


Q ss_pred             ----cccCccCCccchhh------HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 ----IVDPNLLSREDINF------VAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 ----~~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                          ...+..........      ......+.++.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                00000000000000      001124567899999999999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.5e-41  Score=351.35  Aligned_cols=253  Identities=21%  Similarity=0.340  Sum_probs=205.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ..++|++.+.||+|+||.||+|..+ +|+.||+|++.....  ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3567999999999999999999854 789999999975432  3446788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC---CcEEEEeeccccccC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGIAKLLT  543 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~---~~~kl~Dfg~~~~~~  543 (678)
                      |||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.+   +.+||+|||++....
T Consensus       107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            99999999999997654 4899999999999999999999   8999999999999999864   459999999998764


Q ss_pred             CCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ...   ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+....+ ...........     ...+ 
T Consensus       183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-~~~~i~~~~~~-----~~~~-  252 (362)
T 2bdw_A          183 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYAQIKAGAYD-----YPSP-  252 (362)
T ss_dssp             TCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC-----CCTT-
T ss_pred             CCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCC-----CCcc-
Confidence            322   2234679999999999999899999999999999999999999997532211 11111111000     0000 


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                                ....+++++.+++.+||+.||++||++.|+++.
T Consensus       253 ----------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          253 ----------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ----------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                      011245668899999999999999999998753

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=346.94  Aligned_cols=253  Identities=17%  Similarity=0.162  Sum_probs=208.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEE------eCCCcEEEEEEeecccCchhhhHHHHHHHHHhCC---CccceeeeeeeecC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKAR------LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR---HRNIIKVISSCSNE  460 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~  460 (678)
                      ..++|.+.+.||+|+||.||+|.      ..+++.||+|++...   ....+..|+++++.++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            35678999999999999999993      457899999998643   3456788888888887   99999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhh----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC---------
Q 005760          461 EFKALVLEYMPHGSLEKYLHS----SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---------  527 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~---------  527 (678)
                      +..++||||+++|+|.+++..    ....+++..+..++.||+.||+|||   +++|+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999975    3346999999999999999999999   999999999999999998         


Q ss_pred             --CCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchh
Q 005760          528 --NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK  605 (678)
Q Consensus       528 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~  605 (678)
                        ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.....+.....
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  296 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE  296 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEEC
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeec
Confidence              899999999999765433444455667899999999999999999999999999999999999999865433321111


Q ss_pred             hhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCC-CCHHHHHHHHHHHHHH
Q 005760          606 HWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQR-INAKEIVTKLLKIRDS  673 (678)
Q Consensus       606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-ps~~ell~~L~~~~~~  673 (678)
                      ..            ..     ..        ...+.+.+++..|++.+|.+| |+++++.+.|+++.++
T Consensus       297 ~~------------~~-----~~--------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          297 GL------------FR-----RL--------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             SC------------CT-----TC--------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hh------------cc-----cc--------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            00            00     00        013346789999999999998 5889999999988665

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8e-41  Score=342.32  Aligned_cols=249  Identities=25%  Similarity=0.346  Sum_probs=196.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--------------------------chhhhHHHHHHHHH
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--------------------------RVFKSFDVECEMMK  443 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  443 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            47899999999999999999985 4789999999864321                          12356889999999


Q ss_pred             hCCCccceeeeeeeec--CCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCC
Q 005760          444 SIRHRNIIKVISSCSN--EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPS  521 (678)
Q Consensus       444 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~  521 (678)
                      .++||||+++++++.+  .+..++||||+++++|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            9999999999999976  56889999999999998876543  5899999999999999999999   899999999999


Q ss_pred             CeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCC---CCccchHHHHHHHHHHHHcCCCCCCccc
Q 005760          522 NVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR---VSANGDVYSFGIMLMETFTRKKPTDEIF  598 (678)
Q Consensus       522 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslGv~l~ell~g~~p~~~~~  598 (678)
                      ||+++.++.+||+|||++.......  .......||+.|+|||.+.+..   ++.++||||+||++|||++|+.||....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            9999999999999999998764322  2234567999999999987765   4778999999999999999999996532


Q ss_pred             CCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          599 NGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..  .....+....   . ..  +.           ...+++++.+++.+||+.||++|||+.|+++
T Consensus       245 ~~--~~~~~~~~~~---~-~~--~~-----------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 IM--CLHSKIKSQA---L-EF--PD-----------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HH--HHHHHHHHCC---C-CC--CS-----------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HH--HHHHHHhccc---C-CC--CC-----------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            11  1111111000   0 00  00           0123456889999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-40  Score=341.98  Aligned_cols=245  Identities=26%  Similarity=0.330  Sum_probs=203.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|+.+ +|+.||+|++....   ....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367889999999999999999864 79999999997542   23456678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+++..... 
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            99999999999998765 4899999999999999999999   999999999999999999999999999999865322 


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                          .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .........       ..-|    
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~-------~~~p----  223 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAE-------LRFP----  223 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCC-------CCCC----
T ss_pred             ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC-------CCCC----
Confidence                234579999999999999999999999999999999999999997532211 111111110       0001    


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                               ...++++.+++.+||+.||++||     +++|+++
T Consensus       224 ---------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          224 ---------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ---------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                     12345688999999999999999     8888874

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=347.55  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=196.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCC--ccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRH--RNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|...+++.||+|++.....  ...+.+.+|+.+++.++|  |||+++++++.+.+..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            457899999999999999999988899999999975432  334678899999999986  9999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      ||+ .+++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++ ++.+||+|||+++......
T Consensus        88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            995 5789999998765 4889999999999999999999   89999999999999997 5789999999998765443


Q ss_pred             CcceeecccCCccccCccccCC-----------CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCc
Q 005760          547 QSTIQTQTLATIGYMAPEYGKE-----------GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS  615 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  615 (678)
                      .........||+.|+|||++.+           ..++.++|||||||++|||++|+.||...................  
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--  239 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE--  239 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC--
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcc--
Confidence            3334456679999999998754           678999999999999999999999997533321111111111000  


Q ss_pred             ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          616 TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                         ...+.             .++.++.+++.+||+.||++|||+.|+++.
T Consensus       240 ---~~~~~-------------~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          240 ---IEFPD-------------IPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             ---CCCCC-------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---cCCcc-------------cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence               00000             112457899999999999999999999863

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.1e-40  Score=352.42  Aligned_cols=272  Identities=19%  Similarity=0.268  Sum_probs=205.6

Q ss_pred             hhcCCCCCccccCC--CceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          390 ATDGFSENNLIGRG--SFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       390 ~~~~~~~~~~ig~G--~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      ..++|++.+.||+|  +||.||+|+.. +|+.||||++.....  ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            35679999999999  99999999865 799999999976532  34567788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          465 LVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      +||||+++++|.+++... ...+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||.+....
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            999999999999999765 245899999999999999999999   9999999999999999999999999999986543


Q ss_pred             CCCC-----cceeecccCCccccCccccCC--CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcc
Q 005760          544 REDQ-----STIQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST  616 (678)
Q Consensus       544 ~~~~-----~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  616 (678)
                      ....     ........||+.|+|||++.+  ..++.++||||+||++|||++|+.||.+........... ....+...
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~~~  258 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-NGTVPCLL  258 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh-cCCCCccc
Confidence            2211     111223468899999999887  578999999999999999999999997643332221111 10000000


Q ss_pred             c-------cc-------------------ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          617 K-------EI-------------------VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       617 ~-------~~-------------------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .       ..                   ..+...............+++++.+|+.+||++||++|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0       00                   0000000000011122345677999999999999999999999985

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.4e-41  Score=358.00  Aligned_cols=257  Identities=23%  Similarity=0.288  Sum_probs=206.8

Q ss_pred             HHHHhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCC
Q 005760          386 ELCRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE  461 (678)
Q Consensus       386 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  461 (678)
                      ++....++|++.+.||+|+||.||+|+.+ +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            34445678999999999999999999865 6899999999653   2234466889999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..|+||||+++|+|.++++...  +++..+..++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+++.
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~~--~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            9999999999999999997653  889999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCcceeecccCCccccCccccCCCC----CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEGR----VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK  617 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  617 (678)
                      ..... ........||+.|+|||++.+..    ++.++||||+||++|||++|+.||.+....+ ...........    
T Consensus       218 ~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~----  291 (410)
T 3v8s_A          218 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKIMNHKNS----  291 (410)
T ss_dssp             CCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTHHHH----
T ss_pred             eccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-HHHHHHhcccc----
Confidence            64332 22234567999999999987655    7889999999999999999999997532211 11111110000    


Q ss_pred             ccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCC--CCCHHHHHH
Q 005760          618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQ--RINAKEIVT  665 (678)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--Rps~~ell~  665 (678)
                       ...|.           ...++.++.+++.+||+.+|.+  ||+++|+++
T Consensus       292 -~~~p~-----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          292 -LTFPD-----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             -CCCCT-----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             -ccCCC-----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence             00000           0123456889999999999998  999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-41  Score=339.70  Aligned_cols=261  Identities=23%  Similarity=0.375  Sum_probs=211.5

Q ss_pred             cCCCCCc-cccCCCceeEEEEEeC---CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          392 DGFSENN-LIGRGSFGSVFKARLG---DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       392 ~~~~~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ++|.+.+ .||+|+||.||+|...   ++..||+|++..... ...+.+.+|+++++.++||||+++++++. .+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence            4555665 8999999999999753   678899999975432 34577889999999999999999999994 4568999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  164 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  164 (287)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence            9999999999999877667999999999999999999999   9999999999999999999999999999998765332


Q ss_pred             Cc-ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          547 QS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       547 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      .. .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......+  ....+....        .+..
T Consensus       165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i~~~~--------~~~~  234 (287)
T 1u59_A          165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGK--------RMEC  234 (287)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHHTTC--------CCCC
T ss_pred             ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHhcCC--------cCCC
Confidence            21 12233456889999999988889999999999999999998 999997633221  111111100        0000


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHhh
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLR  676 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~~  676 (678)
                                +..+++++.+++.+||+.||++||++.|+++.|+++..+...
T Consensus       235 ----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          235 ----------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             ----------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             ----------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence                      012456688999999999999999999999999999887653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=346.32  Aligned_cols=251  Identities=21%  Similarity=0.312  Sum_probs=190.4

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....  ..+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3567999999999999999999865 68899999997543  34667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC---CCcEEEEeeccccccCCC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~---~~~~kl~Dfg~~~~~~~~  545 (678)
                      |+++++|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+|||+++.....
T Consensus       129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999999997654 4899999999999999999999   899999999999999975   899999999999765422


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                         .......||+.|+|||++.+..++.++|||||||++|||++|+.||...................     ...+ . 
T Consensus       205 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~-----~~~~-~-  274 (349)
T 2w4o_A          205 ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY-----FISP-W-  274 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC-----CCTT-T-
T ss_pred             ---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc-----cCCc-h-
Confidence               12234568999999999999899999999999999999999999996533322122221111000     0000 0 


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               ...++.++.+++.+||+.||++|||+.|+++
T Consensus       275 ---------~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          275 ---------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ---------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---------hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     0123456889999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.5e-41  Score=337.45  Aligned_cols=252  Identities=23%  Similarity=0.417  Sum_probs=205.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecC--CeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE--EFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|..+ ++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            467889999999999999999984 8999999997543  23446788999999999999999999999876  788999


Q ss_pred             EEecCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          467 LEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      |||+++|+|.+++..... .+++..+..++.|++.||+|||   +++  ++||||||+||+++.++.++++|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            999999999999987654 5899999999999999999999   888  9999999999999999999999999875432


Q ss_pred             CCCCcceeecccCCccccCccccCCCCCCc---cchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccc
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKEGRVSA---NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV  620 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (678)
                             .....+|+.|+|||.+.+..++.   ++||||+|+++|||++|+.||..................        
T Consensus       165 -------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--------  229 (271)
T 3kmu_A          165 -------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR--------  229 (271)
T ss_dssp             -------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC--------
T ss_pred             -------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC--------
Confidence                   12346889999999988765544   799999999999999999999753322211111100000        


Q ss_pred             cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                       +..          +..+++++.+++.+||+.||++|||+.|+++.|+++++
T Consensus       230 -~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          230 -PTI----------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -CCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -CCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence             000          01234568899999999999999999999999998864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.7e-40  Score=348.42  Aligned_cols=246  Identities=22%  Similarity=0.329  Sum_probs=198.2

Q ss_pred             CccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCCH
Q 005760          397 NNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSL  475 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L  475 (678)
                      .+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56899999999999985 57999999999865545567889999999999999999999999999999999999999999


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee--cCCCcEEEEeeccccccCCCCCcceeec
Q 005760          476 EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL--DDNMVAHLSDFGIAKLLTREDQSTIQTQ  553 (678)
Q Consensus       476 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  553 (678)
                      .+++......+++..+..++.||+.||+|||   +.+|+||||||+||++  +.++.+||+|||+++......   ....
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~  247 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKV  247 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cccc
Confidence            9999876667899999999999999999999   9999999999999999  677899999999998764332   2234


Q ss_pred             ccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhH
Q 005760          554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV  633 (678)
Q Consensus       554 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  633 (678)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+.........     ...     .      
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~-----~~~-----~------  310 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILACRWD-----LED-----E------  310 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC-----SCS-----G------
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCC-----CCh-----h------
Confidence            569999999999998899999999999999999999999997532211 11111111000     000     0      


Q ss_pred             HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          634 AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       634 ~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ....+++++.+++.+||++||++|||+.|+++
T Consensus       311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          311 EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00124566889999999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-40  Score=343.70  Aligned_cols=272  Identities=23%  Similarity=0.377  Sum_probs=218.7

Q ss_pred             CCHHHHHHhhcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceee
Q 005760          382 FSYLELCRATDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKV  453 (678)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~  453 (678)
                      +.........++|++.+.||+|+||.||+|..      .+++.||+|++..... ...+.+.+|+.+++.+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34445555678999999999999999999973      3578899999975433 2346788999999999 79999999


Q ss_pred             eeeeecCC-eEEEEEEecCCCCHHHHhhhCCC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcC
Q 005760          454 ISSCSNEE-FKALVLEYMPHGSLEKYLHSSNY---------------ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD  517 (678)
Q Consensus       454 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d  517 (678)
                      ++++...+ ..++||||+++++|.+++.....               .+++..+..++.|++.||.|||   +++|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCccccc
Confidence            99987654 58999999999999999986543               2788999999999999999999   89999999


Q ss_pred             CCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCc
Q 005760          518 LKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDE  596 (678)
Q Consensus       518 l~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~  596 (678)
                      |||+||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||+|+++|||++ |..||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987654444444455668899999999998899999999999999999998 9999876


Q ss_pred             ccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          597 IFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                      .................      ..+             ..+++++.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus       254 ~~~~~~~~~~~~~~~~~------~~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          254 VKIDEEFCRRLKEGTRM------RAP-------------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             CCCSHHHHHHHHHTCCC------CCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             cchhHHHHHHhccCccC------CCC-------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            43322211111111000      000             1134558899999999999999999999999999987643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.7e-41  Score=348.19  Aligned_cols=266  Identities=23%  Similarity=0.375  Sum_probs=214.6

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEeC-CC-----cEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceeeeeeeec
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARLG-DG-----MEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKVISSCSN  459 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  459 (678)
                      ....++|++.+.||+|+||.||+|... ++     ..||+|++..... ...+.+.+|+.+++.+ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            344678999999999999999999853 22     4799999975432 3456788999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhhC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec
Q 005760          460 EEFKALVLEYMPHGSLEKYLHSS-------------NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD  526 (678)
Q Consensus       460 ~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~  526 (678)
                      .+..++||||+++|+|.+++...             ...+++..+..++.|++.||+|||   +++|+||||||+||+++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEEC
Confidence            99999999999999999999753             234789999999999999999999   89999999999999999


Q ss_pred             CCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchh
Q 005760          527 DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLK  605 (678)
Q Consensus       527 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~  605 (678)
                      .++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...... ..
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~~  277 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-FY  277 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-HH
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-HH
Confidence            999999999999986654433334445567889999999988899999999999999999999 8899876433221 11


Q ss_pred             hhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          606 HWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                      ..+.....     ...+             ..++.++.+++.+||+.||++|||+.|+++.|+++.....
T Consensus       278 ~~~~~~~~-----~~~~-------------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  329 (333)
T 2i1m_A          278 KLVKDGYQ-----MAQP-------------AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR  329 (333)
T ss_dssp             HHHHHTCC-----CCCC-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHhcCCC-----CCCC-------------CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence            11111100     0000             1124568899999999999999999999999999876643

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.1e-40  Score=343.84  Aligned_cols=263  Identities=25%  Similarity=0.422  Sum_probs=199.7

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeC----CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCC-
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEE-  461 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-  461 (678)
                      ...++|.+.+.||+|+||.||+|...    ++..||+|++.....  ...+.+.+|+.+++.++||||+++++++.+.+ 
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  110 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS  110 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence            34578899999999999999999743    355899999865432  34467889999999999999999999987654 


Q ss_pred             ----eEEEEEEecCCCCHHHHhhh-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEE
Q 005760          462 ----FKALVLEYMPHGSLEKYLHS-----SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH  532 (678)
Q Consensus       462 ----~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~k  532 (678)
                          ..++||||+++++|.+++..     ....+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+|
T Consensus       111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEE
T ss_pred             cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEE
Confidence                35899999999999999853     2346899999999999999999999   99999999999999999999999


Q ss_pred             EEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcc
Q 005760          533 LSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDW  611 (678)
Q Consensus       533 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~  611 (678)
                      |+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||........ ........
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~~~~~~~  266 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM-YDYLLHGH  266 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-HHHHHTTC
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHHcCC
Confidence            999999987654333333344567889999999999899999999999999999999 8888865332211 11111110


Q ss_pred             cCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          612 LPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      .+         ..          +..+++++.+++.+||+.||++||++.|+++.|+++.+++
T Consensus       267 ~~---------~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          267 RL---------KQ----------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             CC---------CC----------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CC---------CC----------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            00         00          0124456889999999999999999999999999998764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-41  Score=354.15  Aligned_cols=259  Identities=25%  Similarity=0.439  Sum_probs=198.0

Q ss_pred             CCCCCccccCCCceeEEEEEeC--C--CcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeee-cCCeEEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLG--D--GMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCS-NEEFKALV  466 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~--~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv  466 (678)
                      .|.+.+.||+|+||.||+|...  +  +..||+|.+.... ....+.+.+|+.+++.++||||+++++++. ..+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4667789999999999999753  3  2468999986432 345577899999999999999999999864 45678999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++|+|.++++.....+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999877767899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             Cc--ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          547 QS--TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       547 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ..  .......+++.|+|||.+.+..++.++|||||||++|||++ |.+||......+.  ...+....     ....+ 
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~~~~~~-----~~~~p-  318 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLLQGR-----RLLQP-  318 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHHHHTTC-----CCCCC-
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHHHHcCC-----CCCCC-
Confidence            11  12334567889999999999999999999999999999999 6677765333221  11111000     00011 


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                                  ..++.++.+++.+||+.||++||++.|+++.|+++..++
T Consensus       319 ------------~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          319 ------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             ------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             ------------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                        124556889999999999999999999999999998764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=337.75  Aligned_cols=255  Identities=30%  Similarity=0.435  Sum_probs=199.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      .++|++.+.||+|+||.||+|... ++.||+|++..  ....+.+.+|+++++.++||||+++++++.+  ..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            357888999999999999999874 78899999863  3345778999999999999999999999874  378999999


Q ss_pred             CCCCHHHHhhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc-EEEEeeccccccCCCCC
Q 005760          471 PHGSLEKYLHSSNY--ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV-AHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       471 ~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~-~kl~Dfg~~~~~~~~~~  547 (678)
                      ++++|.+++.....  .++...+..++.|+++||+|||+...++|+||||||+||+++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            99999999986543  4788899999999999999999222289999999999999998886 799999999755321  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                         .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..................        .+...  
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~--  226 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT--------RPPLI--  226 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC--------CCCCB--
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC--------CCCcc--
Confidence               22346899999999999989999999999999999999999999754332211111111000        00000  


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                              ..++..+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       227 --------~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          227 --------KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             --------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             --------cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence                    12345688999999999999999999999999988654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.4e-40  Score=343.59  Aligned_cols=274  Identities=24%  Similarity=0.405  Sum_probs=211.4

Q ss_pred             cCC-CCCccccCCCceeEEEEEe-----CCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeec--CCe
Q 005760          392 DGF-SENNLIGRGSFGSVFKARL-----GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSN--EEF  462 (678)
Q Consensus       392 ~~~-~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~  462 (678)
                      ++| ++.+.||+|+||.||++.+     .+++.||||++..... ...+.+.+|+++++.++||||+++++++.+  ...
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            344 8899999999999998864     2688999999975532 345678899999999999999999999976  467


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .++||||+++++|.+++....  +++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            899999999999999998764  899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCc-ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc-CCcccccc
Q 005760          543 TREDQS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL-PISTKEIV  620 (678)
Q Consensus       543 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~  620 (678)
                      ...... .......++..|+|||.+.+..++.++||||+|+++|||++|..||............+..... ........
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            543221 2234456888899999999888999999999999999999999998653221100000000000 00000000


Q ss_pred             cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHhh
Q 005760          621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLR  676 (678)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~~  676 (678)
                      .......      .+..++.++.+++.+||+.||++|||+.|+++.|+++.+++..
T Consensus       265 ~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  314 (318)
T 3lxp_A          265 ERGERLP------RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG  314 (318)
T ss_dssp             HTTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             hcccCCC------CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence            0000000      0123456799999999999999999999999999999988754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.7e-41  Score=349.63  Aligned_cols=250  Identities=23%  Similarity=0.309  Sum_probs=202.9

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCe
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEF  462 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  462 (678)
                      ....++|.+.+.||+|+||.||+|+.+ +|+.||+|+++...   ....+.+..|..+++.+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            445688999999999999999999864 78999999997542   23446677899999876 89999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .|+||||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+++..
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            999999999999999998754 4899999999999999999999   899999999999999999999999999999754


Q ss_pred             CCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ...  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....  .....+....      ..-|
T Consensus       169 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~~------~~~p  238 (345)
T 1xjd_A          169 MLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMDN------PFYP  238 (345)
T ss_dssp             CCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC------CCCC
T ss_pred             ccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHhCC------CCCC
Confidence            322  12234567999999999999999999999999999999999999999753221  1111111000      0001


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHH-HHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAK-EIV  664 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-ell  664 (678)
                                   ..++.++.+++.+||+.||++||++. |++
T Consensus       239 -------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          239 -------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -------------cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                         11345688999999999999999997 554

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3e-40  Score=338.03  Aligned_cols=261  Identities=26%  Similarity=0.447  Sum_probs=206.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCC----CcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeee-ecCCeEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGD----GMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSC-SNEEFKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~  464 (678)
                      ..+|++.+.||+|+||.||+|...+    +..||+|.+..... ...+.+.+|+.+++.++||||+++++++ ...+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            4568888999999999999998532    33689999865332 3456788999999999999999999985 5566889


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            999999999999999877667899999999999999999999   99999999999999999999999999999986643


Q ss_pred             CCC--cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcC-CCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          545 EDQ--STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTR-KKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       545 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      ...  ........+|+.|+|||.+.+..++.++||||+|+++|||++| .+||......+. .........      ...
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-~~~~~~~~~------~~~  253 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-TVYLLQGRR------LLQ  253 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH-HHHHHTTCC------CCC
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH-HHHHhcCCC------CCC
Confidence            321  1223445678899999999988999999999999999999995 455544222211 111111100      000


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      +             ..++.++.+++.+||+.||++|||+.|+++.|+++.+++
T Consensus       254 ~-------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          254 P-------------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             C-------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             C-------------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            1             113456889999999999999999999999999998764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.5e-40  Score=344.13  Aligned_cols=250  Identities=23%  Similarity=0.336  Sum_probs=198.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCC-------
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEE-------  461 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  461 (678)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+++++.++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457889999999999999999865 899999999975433 35577899999999999999999999875433       


Q ss_pred             --------------------------------------------------eEEEEEEecCCCCHHHHhhhCCC--CCCHH
Q 005760          462 --------------------------------------------------FKALVLEYMPHGSLEKYLHSSNY--ILDIY  489 (678)
Q Consensus       462 --------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~--~~~~~  489 (678)
                                                                        ..++||||+++++|.+++.....  ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              37899999999999999986543  35666


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC----------cceeecccCCcc
Q 005760          490 QRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ----------STIQTQTLATIG  559 (678)
Q Consensus       490 ~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~~~~~  559 (678)
                      .++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.......          ........||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78999999999999999   99999999999999999999999999999987654321          122344579999


Q ss_pred             ccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHH
Q 005760          560 YMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCV  639 (678)
Q Consensus       560 y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  639 (678)
                      |+|||.+.+..++.++||||+||++|||++|..|+.....    ......           .. .      ........+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~----~~~~~~-----------~~-~------~~~~~~~~~  299 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR----IITDVR-----------NL-K------FPLLFTQKY  299 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH----HHHHHH-----------TT-C------CCHHHHHHC
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH----HHHHhh-----------cc-C------CCcccccCC
Confidence            9999999999999999999999999999998877532110    000000           00 0      001123455


Q ss_pred             HHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          640 SFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       640 ~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      +++.+++.+||+.||++|||+.|+++
T Consensus       300 ~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          300 PQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            67889999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.8e-40  Score=341.19  Aligned_cols=276  Identities=24%  Similarity=0.376  Sum_probs=215.0

Q ss_pred             HHHHHHhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHh--CCCccceeeeeeeecCC
Q 005760          384 YLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKS--IRHRNIIKVISSCSNEE  461 (678)
Q Consensus       384 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~  461 (678)
                      ........++|++.+.||+|+||.||+|.. +++.||+|++...   ....+..|.++++.  ++||||+++++++...+
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            344455677899999999999999999988 5899999998643   34567788898887  78999999999998765


Q ss_pred             ----eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----CCCeEEcCCCCCCeeecCCCcEE
Q 005760          462 ----FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY-----SAQVIHCDLKPSNVLLDDNMVAH  532 (678)
Q Consensus       462 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dl~~~Nill~~~~~~k  532 (678)
                          ..++||||+++|+|.+++...  .+++..++.++.|++.||+|||...     +.+|+||||||+||+++.++.+|
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred             CccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence                789999999999999999865  3899999999999999999999321     47899999999999999999999


Q ss_pred             EEeeccccccCCCCCcc--eeecccCCccccCccccCCCC------CCccchHHHHHHHHHHHHcC----------CCCC
Q 005760          533 LSDFGIAKLLTREDQST--IQTQTLATIGYMAPEYGKEGR------VSANGDVYSFGIMLMETFTR----------KKPT  594 (678)
Q Consensus       533 l~Dfg~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslGv~l~ell~g----------~~p~  594 (678)
                      |+|||++..........  ......+|+.|+|||.+.+..      ++.++|||||||++|||++|          ..||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            99999997664332211  234557999999999987652      34689999999999999999          6777


Q ss_pred             CcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          595 DEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      ............+........    ..+...     .......++..+.+++.+||+.||++|||+.|+++.|+++.++.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          268 YDLVPSDPSVEEMRKVVCEQK----LRPNIP-----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSC----CCCCCC-----GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cccCcCcccHHHHHHHHHHHH----hCCCCc-----ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            654443333333222111110    111110     01112356677999999999999999999999999999998753

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.2e-40  Score=334.45  Aligned_cols=265  Identities=19%  Similarity=0.228  Sum_probs=209.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeee-ecCCeEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC-SNEEFKALVL  467 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  467 (678)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++....  ..+.+.+|+.+++.++|++++..++.+ .+.+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999985 588999999876433  335788999999999988877776655 6677889999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee---cCCCcEEEEeeccccccCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill---~~~~~~kl~Dfg~~~~~~~  544 (678)
                      ||+ +++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||++   +.++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 89999999876667999999999999999999999   9999999999999999   7899999999999987654


Q ss_pred             CCCc-----ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccc--hhhhhhcccCCccc
Q 005760          545 EDQS-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT--LKHWVNDWLPISTK  617 (678)
Q Consensus       545 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~  617 (678)
                      ....     .......+|+.|+|||.+.+..++.++||||+||++|||++|+.||.........  ............  
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--  238 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP--  238 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch--
Confidence            3221     1234567999999999999999999999999999999999999999764332211  111100000000  


Q ss_pred             ccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                                   .......+++++.+++.+||+.||++|||++|+++.|+++.++..
T Consensus       239 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          239 -------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             -------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             -------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence                         000001245679999999999999999999999999999987754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1e-40  Score=339.77  Aligned_cols=259  Identities=25%  Similarity=0.415  Sum_probs=214.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ..++|++.+.||+|+||.||+|... ++..||+|++... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4567889999999999999999865 5889999999754 3345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+++++|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence            999999999998643 45899999999999999999999   8999999999999999999999999999998765332 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                      ........+++.|+|||.+.+..++.++||||+|+++|+|++ |..||.......  ....+.....     ...+    
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~~~~~~~~-----~~~~----  234 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEKDYR-----MERP----  234 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHHHTTCC-----CCCC----
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhccCC-----CCCC----
Confidence            233444567889999999998899999999999999999999 899987533221  1111111000     0000    


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                               ..+++++.+++.+||+.||++|||+.|+++.|+++...
T Consensus       235 ---------~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          235 ---------EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             ---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence                     12345688999999999999999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.4e-41  Score=364.86  Aligned_cols=256  Identities=26%  Similarity=0.440  Sum_probs=204.4

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..++|++.+.||+|+||.||+|.++++..||||++.... ...+.+.+|+++++.++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            346788899999999999999998888889999997543 234678999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++|+|.++++.. ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...... .
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-e
Confidence            9999999999753 235899999999999999999999   9999999999999999999999999999998664322 2


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      .......++..|+|||.+.++.++.++|||||||++|||++ |+.||.+....+  ....+.....     ..       
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~-----~~-------  401 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYR-----MP-------  401 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCC-----CC-------
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-----CC-------
Confidence            22334557889999999998899999999999999999999 899987533221  1111110000     00       


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                            .+..+++++.+++.+||+.||++|||+.++++.|+++.
T Consensus       402 ------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          402 ------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             ------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                  01135567899999999999999999999999998764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-40  Score=342.07  Aligned_cols=273  Identities=26%  Similarity=0.434  Sum_probs=214.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-----CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCC--eE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-----GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE--FK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~  463 (678)
                      .++|++.+.||+|+||.||+|..     .+++.||+|++........+.+.+|+++++.++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45688999999999999999983     468999999997765666678999999999999999999999886644  78


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999999887767999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCc-ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC-----Cccc
Q 005760          544 REDQS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP-----ISTK  617 (678)
Q Consensus       544 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~  617 (678)
                      ..... .......++..|+|||.+.+..++.++||||||+++|||++|..|+......   ..........     ....
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCCTHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccchhhhHHHHH
Confidence            43222 1123345777899999998888999999999999999999999987542110   0000000000     0000


Q ss_pred             ccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                      ..+......      ..+..++.++.+++.+||+.||++|||+.|+++.|+++++++.
T Consensus       274 ~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          274 ELLKNNGRL------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             HHHHTTCCC------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHhhcCCCC------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            000000000      0012345678999999999999999999999999999998864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.9e-40  Score=345.15  Aligned_cols=254  Identities=24%  Similarity=0.294  Sum_probs=195.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            3568999999999999999999865 89999999997543 234678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc--EEEEeeccccccCCCC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV--AHLSDFGIAKLLTRED  546 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~--~kl~Dfg~~~~~~~~~  546 (678)
                      |+++|+|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.  +||+|||+++....  
T Consensus        97 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~--  170 (361)
T 3uc3_A           97 YASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--  170 (361)
T ss_dssp             CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence            999999999997655 4899999999999999999999   999999999999999987765  99999999874322  


Q ss_pred             CcceeecccCCccccCccccCCCCCCcc-chHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSAN-GDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                       ........||+.|+|||++.+..++.+ +||||+||++|+|++|+.||......... ............. .  +.  
T Consensus       171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-~~~~~~~~~~~~~-~--~~--  243 (361)
T 3uc3_A          171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY-RKTIQRILSVKYS-I--PD--  243 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH-HHHHHHHHTTCCC-C--CT--
T ss_pred             -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH-HHHHHHHhcCCCC-C--CC--
Confidence             222334579999999999988887655 89999999999999999999764332221 1111111110000 0  00  


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                               ...+++++.+++.+||+.||++|||+.|+++.
T Consensus       244 ---------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          244 ---------DIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ---------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ---------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                     00134568899999999999999999999863

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.3e-40  Score=334.04  Aligned_cols=251  Identities=24%  Similarity=0.297  Sum_probs=206.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ..++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            4567999999999999999999854 678999999987666667889999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee---cCCCcEEEEeeccccccCCC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill---~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      |+++++|.+++.... .+++..+..++.|++.|++|||   +++|+||||||+||++   +.++.+||+|||++......
T Consensus        87 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           87 LCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             ccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            999999999987665 4899999999999999999999   9999999999999999   78899999999999876432


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                      .   ......+|+.|+|||.+.+ .++.++||||+|+++|||++|+.||......+. ..........            
T Consensus       163 ~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~------------  225 (277)
T 3f3z_A          163 K---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-MLKIREGTFT------------  225 (277)
T ss_dssp             S---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCC------------
T ss_pred             c---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCC------------
Confidence            2   2344569999999998865 489999999999999999999999975332211 1111110000            


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                          ........+++++.+++.+||+.||++|||+.|+++
T Consensus       226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          226 ----FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ----CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                000011134567899999999999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=352.73  Aligned_cols=259  Identities=23%  Similarity=0.289  Sum_probs=207.2

Q ss_pred             HHHHhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCC
Q 005760          386 ELCRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE  461 (678)
Q Consensus       386 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  461 (678)
                      +.....++|++.+.||+|+||.||+|+.+ +|+.||+|++...   .....+.+.+|..++..++||||+++++++.+.+
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  134 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN  134 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            34445688999999999999999999864 7999999999653   2234567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..|+||||+++|+|.+++.+.+..+++..+..++.||+.||+|||   +++|+||||||+||+++.++++||+|||+++.
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGla~~  211 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLK  211 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence            999999999999999999876556999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCcceeecccCCccccCccccC-------CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGK-------EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI  614 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  614 (678)
                      ..... ........||+.|+|||++.       ...++.++||||+||++|||++|+.||......+. .........  
T Consensus       212 ~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~~--  287 (412)
T 2vd5_A          212 LRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET-YGKIVHYKE--  287 (412)
T ss_dssp             CCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTHHH--
T ss_pred             ccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH-HHHHHhccc--
Confidence            64332 22233467999999999887       35689999999999999999999999976332211 111111000  


Q ss_pred             cccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCC---CCHHHHHH
Q 005760          615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQR---INAKEIVT  665 (678)
Q Consensus       615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---ps~~ell~  665 (678)
                         ....|.          ....+++++.+++.+||+ +|++|   |+++|+++
T Consensus       288 ---~~~~p~----------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          288 ---HLSLPL----------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             ---HCCCC--------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             ---CcCCCc----------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence               000000          011345668899999999 99998   58988864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-40  Score=338.63  Aligned_cols=261  Identities=24%  Similarity=0.417  Sum_probs=207.5

Q ss_pred             CCCCCccccCCCceeEEEEEeC-C---CcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeE-EEE
Q 005760          393 GFSENNLIGRGSFGSVFKARLG-D---GMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK-ALV  466 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv  466 (678)
                      .|...+.||+|+||.||+|... +   +..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4556789999999999999742 2   33799999865333 3457788999999999999999999999776655 899


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+.+++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999886667899999999999999999999   8999999999999999999999999999997654322


Q ss_pred             --CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          547 --QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       547 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                        .........+++.|+|||.+.+..++.++||||+|+++|+|++|+.|+....... .....+.....     ...+  
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~~-----~~~~--  250 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLTHFLAQGRR-----LPQP--  250 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHHHHHHTTCC-----CCCC--
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHHHHhhcCCC-----CCCC--
Confidence              1222344567889999999999999999999999999999999666654322211 11111111100     0000  


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                                 ..++.++.+++.+||+.||++|||+.|+++.|+++.+++.
T Consensus       251 -----------~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          251 -----------EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             -----------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             -----------ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence                       1234568899999999999999999999999999987753

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=5.6e-40  Score=332.08  Aligned_cols=253  Identities=23%  Similarity=0.349  Sum_probs=207.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467889999999999999999864 789999999975432 345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+++++|.+++.... .+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||.+.........
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            999999999997654 4899999999999999999999   899999999999999999999999999999765433222


Q ss_pred             ceeecccCCccccCccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      .......+++.|+|||.+.+..+ +.++||||+|+++|||++|+.||............+......           .. 
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~-  229 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-----------LN-  229 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-----------ST-
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-----------cC-
Confidence            33345678999999999987765 778999999999999999999997644433333322221000           00 


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                            ....++.++.+++.+||+.||++|||+.|+++
T Consensus       230 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          230 ------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                  00123456889999999999999999999975

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.3e-40  Score=337.82  Aligned_cols=259  Identities=24%  Similarity=0.392  Sum_probs=206.8

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC----CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      ..++|.+.+.||+|+||.||+|...    ++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            3567899999999999999999743    23469999987542 23457788999999999999999999998764 468


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++.....
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            999999999999999877667899999999999999999999   99999999999999999999999999999986643


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      .. ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+  ....+.....     ...+ 
T Consensus       166 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~~~~-----~~~~-  236 (281)
T 3cc6_A          166 ED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEKGDR-----LPKP-  236 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHHTCC-----CCCC-
T ss_pred             cc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhcCCC-----CCCC-
Confidence            22 222334557889999999988899999999999999999998 999986533221  1111110000     0000 


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                                  ..+++.+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus       237 ------------~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          237 ------------DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             ------------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                        12345688999999999999999999999999998764

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.5e-40  Score=349.89  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=196.7

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCC--CccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIR--HRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ..|++.+.||+|+||.||+|...+++.||||++....  ....+.+.+|+++++.++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4599999999999999999998889999999997543  234577889999999996  599999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      | +.+++|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+||+++ ++.+||+|||+++.......
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 56789999998765 5888899999999999999999   99999999999999996 58999999999987654333


Q ss_pred             cceeecccCCccccCccccCC-----------CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcc
Q 005760          548 STIQTQTLATIGYMAPEYGKE-----------GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIST  616 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  616 (678)
                      ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........+.........   
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~---  286 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE---  286 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC---
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc---
Confidence            333455679999999998764           468899999999999999999999997533221111111111000   


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                        ...+.             ..+.++.+++.+||+.||++|||+.|+++
T Consensus       287 --~~~~~-------------~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          287 --IEFPD-------------IPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             --CCCCC-------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --CCCCc-------------cchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence              00000             11345889999999999999999999985

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.6e-41  Score=348.25  Aligned_cols=274  Identities=24%  Similarity=0.346  Sum_probs=212.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-----CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeee--cCCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-----GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS--NEEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~  463 (678)
                      .++|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|+++++.++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            46789999999999999999983     468899999997665556677899999999999999999999876  45678


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++||||+++++|.+++......+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++....
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            9999999999999999876556999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCc-ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC-Cccccccc
Q 005760          544 REDQS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP-ISTKEIVD  621 (678)
Q Consensus       544 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  621 (678)
                      ..... .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||................... ........
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            33222 22344568888999999988889999999999999999999999986532210000000000000 00000000


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      ......      .+..+++++.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       259 ~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          259 EGQRLP------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             TTCCCC------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             cccCCC------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            000000      0123456789999999999999999999999999988654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.7e-40  Score=339.43  Aligned_cols=263  Identities=24%  Similarity=0.359  Sum_probs=201.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            45799999999999999999985 579999999997532   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          467 LEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      |||+++++|.+++..   ....+++..++.++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999864   3445899999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ...  .......+++.|+|||.+.+..++.++||||||+++|||++|+.||.+...........+...   ..     +.
T Consensus       188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~-----~~  257 (310)
T 2wqm_A          188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---DY-----PP  257 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT---CS-----CC
T ss_pred             CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc---cC-----CC
Confidence            321  222345689999999999998999999999999999999999999875332221111111110   00     00


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                      ..         ...++.++.+++.+||+.||++|||+.|+++.|+++++..+
T Consensus       258 ~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          258 LP---------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             CC---------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             Cc---------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence            00         01234568899999999999999999999999999987643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-40  Score=345.16  Aligned_cols=259  Identities=27%  Similarity=0.473  Sum_probs=203.1

Q ss_pred             cCCCCCccccCCCceeEEEEEeCC-----CcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGD-----GMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ++|+..+.||+|+||.||+|....     +..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467778999999999999997532     34699999975432 344578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++......
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999999999877667999999999999999999999   899999999999999999999999999999876433


Q ss_pred             CC-cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          546 DQ-STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       546 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      .. ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+  ....+....     ....  
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~~~~-----~~~~--  271 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAINDGF-----RLPT--  271 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTTC-----CCCC--
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHCCC-----cCCC--
Confidence            21 112233456788999999998899999999999999999999 999986532211  111111000     0000  


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                                 +..++.++.+++.+||+.||++||++.|+++.|+++...
T Consensus       272 -----------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          272 -----------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             -----------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                       012455688999999999999999999999999998754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.1e-40  Score=345.40  Aligned_cols=248  Identities=24%  Similarity=0.293  Sum_probs=199.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC---chhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG---RVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  465 (678)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++.....   ...+.+.+|..+++.+ +||||+++++++.+.+..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            357889999999999999999864 689999999975432   2345678899999987 89999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++|+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+||+++.++++||+|||+++.....
T Consensus        88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999999999998654 4899999999999999999999   999999999999999999999999999999754322


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCcc----chhhhhhcccCCccccccc
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM----TLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  621 (678)
                        ........||+.|+|||++.+..++.++||||+||++|||++|+.||........    ............   ...-
T Consensus       164 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~---~~~~  238 (345)
T 3a8x_A          164 --GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---QIRI  238 (345)
T ss_dssp             --TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC---CCCC
T ss_pred             --CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC---CCCC
Confidence              1223456799999999999999999999999999999999999999965322110    000000000000   0000


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA  660 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~  660 (678)
                      |             ...+.++.+++.+||+.||++||++
T Consensus       239 p-------------~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          239 P-------------RSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             C-------------TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             C-------------CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            0             1234568899999999999999996

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.5e-40  Score=336.85  Aligned_cols=259  Identities=25%  Similarity=0.438  Sum_probs=210.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..++|++.+.||+|+||.||+|...++..||+|++.... ...+.+.+|+++++.++||||+++++++.+ +..++||||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~   88 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence            456788999999999999999998888899999986543 345778999999999999999999999875 457899999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++++|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++....... .
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  164 (279)
T 1qpc_A           89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y  164 (279)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred             CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-c
Confidence            99999999997543 25899999999999999999999   9999999999999999999999999999998764322 2


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      .......++..|+|||.+.++.++.++||||+|+++|||++ |+.||......+  ....+....     ....+     
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~~-----~~~~~-----  232 (279)
T 1qpc_A          165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLERGY-----RMVRP-----  232 (279)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTC-----CCCCC-----
T ss_pred             ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHHHHhccc-----CCCCc-----
Confidence            22334457788999999988889999999999999999999 899986532211  111111000     00000     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                              ..++.++.+++.+||+.||++|||+.++++.|+++....
T Consensus       233 --------~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          233 --------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             --------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --------ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence                    123456889999999999999999999999999987653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.1e-39  Score=333.44  Aligned_cols=264  Identities=19%  Similarity=0.232  Sum_probs=211.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeee-ecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC-SNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....  ..+.+.+|+.+++.++|++++..+..+ .+.+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            57899999999999999999985 689999999986543  335688999999999998877666655 66778899999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee---cCCCcEEEEeeccccccCCC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill---~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      |+ +++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||++   +.++.+||+|||++......
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 89999999866667999999999999999999999   9999999999999999   48899999999999876543


Q ss_pred             CCc-----ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCcc--chhhhhhcccCCcccc
Q 005760          546 DQS-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM--TLKHWVNDWLPISTKE  618 (678)
Q Consensus       546 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~  618 (678)
                      ...     .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||........  ..............  
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  239 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--  239 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH--
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch--
Confidence            221     123456799999999999999999999999999999999999999976432211  11111110000000  


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                                   ......+++++.+++.+||+.||++||++.|+++.|+++.....
T Consensus       240 -------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          240 -------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             -------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             -------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence                         00012345679999999999999999999999999999987643

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.8e-40  Score=339.72  Aligned_cols=260  Identities=22%  Similarity=0.290  Sum_probs=206.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeee----cCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS----NEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~l  465 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+++++.++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46799999999999999999985 589999999987655556678899999999999999999999986    3457889


Q ss_pred             EEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          466 VLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      ||||+++++|.+++..   ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999999876   3456899999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCc-------ceeecccCCccccCccccCCCC---CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc
Q 005760          543 TREDQS-------TIQTQTLATIGYMAPEYGKEGR---VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL  612 (678)
Q Consensus       543 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  612 (678)
                      ......       .......+++.|+|||.+.+..   ++.++||||||+++|||++|+.||..................
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  264 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL  264 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence            321110       0112345799999999987554   688999999999999999999999753332222222111100


Q ss_pred             CCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          613 PISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                      .       .+.           ...++.++.+++.+||+.||.+||++.|+++.|+++.
T Consensus       265 ~-------~~~-----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          265 S-------IPQ-----------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             --------CCC-----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             C-------CCc-----------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            0       000           0123456889999999999999999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2e-40  Score=346.01  Aligned_cols=244  Identities=21%  Similarity=0.252  Sum_probs=203.3

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999864 79999999996542   234567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+++.....  
T Consensus       121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence            9999999999998765 4899999999999999999999   999999999999999999999999999999866432  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+ ..........       .-|     
T Consensus       195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~~~~-------~~p-----  258 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGKV-------RFP-----  258 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC-------CCC-----
T ss_pred             ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-HHHHHHcCCC-------CCC-----
Confidence               234568999999999999999999999999999999999999997532211 1111111100       001     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ell~  665 (678)
                              ..++.++.+++.+||+.||++||+     ++|+++
T Consensus       259 --------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          259 --------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                    123456889999999999999998     788764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=347.62  Aligned_cols=266  Identities=14%  Similarity=0.159  Sum_probs=209.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC---------CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCcccee---------
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG---------DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK---------  452 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  452 (678)
                      .++|++.+.||+|+||.||+|...         +++.||+|++...     +.+.+|+++++.++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            368999999999999999999865         3789999998643     56889999999999999998         


Q ss_pred             ------eeeeeec-CCeEEEEEEecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCee
Q 005760          453 ------VISSCSN-EEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVL  524 (678)
Q Consensus       453 ------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nil  524 (678)
                            +++++.. .+..++||||+ +++|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence                  5566654 67889999999 99999999875 346899999999999999999999   899999999999999


Q ss_pred             ecCCC--cEEEEeeccccccCCCCCc-----ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcc
Q 005760          525 LDDNM--VAHLSDFGIAKLLTREDQS-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEI  597 (678)
Q Consensus       525 l~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~  597 (678)
                      ++.++  .+||+|||+++........     .......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999876533211     1223457999999999999989999999999999999999999999875


Q ss_pred             cCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          598 FNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                      .............+.. ....+.+....         ...+++++.+++.+||+.||++||+++|+++.|+++.++..
T Consensus       272 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVD-KPGPFVGPCGH---------WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             TTCHHHHHHHHHHHHH-SCCCEECTTSC---------EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CcCHHHHHHHHHhccC-Chhhhhhhccc---------cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            4333222222221111 01111111000         00134568899999999999999999999999999987653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.2e-40  Score=337.56  Aligned_cols=253  Identities=23%  Similarity=0.354  Sum_probs=204.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CC-------cEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DG-------MEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF  462 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  462 (678)
                      .++|.+.+.||+|+||.||+|... ++       ..||+|++........+.+.+|+++++.++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            467889999999999999999753 33       5799999976666667889999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc--------EEEE
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV--------AHLS  534 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~--------~kl~  534 (678)
                      .++||||+++++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999887666999999999999999999999   999999999999999998887        9999


Q ss_pred             eeccccccCCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC
Q 005760          535 DFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP  613 (678)
Q Consensus       535 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  613 (678)
                      |||++......      ....+++.|+|||.+.+ ..++.++||||+|+++|||++|..|+......... .........
T Consensus       164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~~~~  236 (289)
T 4fvq_A          164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYEDRHQ  236 (289)
T ss_dssp             CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTTCC
T ss_pred             cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhccCC
Confidence            99998654321      23457889999999887 67899999999999999999966554332221111 111110000


Q ss_pred             CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                        .     +.             ..+.++.+++.+||+.||++|||+.|+++.|+++...
T Consensus       237 --~-----~~-------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          237 --L-----PA-------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             --C-----CC-------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             --C-----CC-------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence              0     00             0123377899999999999999999999999987654

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=351.92  Aligned_cols=277  Identities=20%  Similarity=0.273  Sum_probs=211.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCC--eEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE--FKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv  466 (678)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            457899999999999999999865 69999999997543 234567789999999999999999999987654  78999


Q ss_pred             EEecCCCCHHHHhhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee----cCCCcEEEEeecccc
Q 005760          467 LEYMPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL----DDNMVAHLSDFGIAK  540 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill----~~~~~~kl~Dfg~~~  540 (678)
                      |||+++|+|.+++.....  .+++..++.++.|++.||+|||   +++|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976432  3899999999999999999999   9999999999999999    788889999999998


Q ss_pred             ccCCCCCcceeecccCCccccCccccCC--------CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhh---hhh
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKE--------GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKH---WVN  609 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~---~~~  609 (678)
                      ......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||............   ...
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            764322   2234579999999998764        56788999999999999999999999754332222111   111


Q ss_pred             cccCCcccccccCcc-----CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          610 DWLPISTKEIVDPNL-----LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       610 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      ..++.....+.....     ..............+..+.+++.+||+.||++||++.|+++.++++.+.
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            111111110000000     0000000111245677799999999999999999999999999887653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=333.58  Aligned_cols=250  Identities=23%  Similarity=0.396  Sum_probs=185.8

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            346799999999999999999985 579999999996542   2234678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++++|.+++......+++..+..++.|++.|++|||   +++++||||||+||+++.++.+||+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999999877667899999999999999999999   899999999999999999999999999999866432


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                      ..  ......+++.|+|||.+.+..++.++||||+|+++|||++|+.||........ ....    .   ......+   
T Consensus       166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~----~---~~~~~~~---  232 (278)
T 3cok_A          166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKV----V---LADYEMP---  232 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------C----C---SSCCCCC---
T ss_pred             CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHH----h---hcccCCc---
Confidence            21  22345689999999999988899999999999999999999999875322211 0000    0   0000001   


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                ..++.++.+++.+||+.||++|||+.|+++
T Consensus       233 ----------~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          233 ----------SFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ----------TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ----------cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                      123456889999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.3e-40  Score=340.35  Aligned_cols=244  Identities=25%  Similarity=0.359  Sum_probs=203.2

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--------chhhhHHHHHHHHHhCCCccceeeeeeeec
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--------RVFKSFDVECEMMKSIRHRNIIKVISSCSN  459 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  459 (678)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++.....        ...+.+.+|+.+++.++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            3457899999999999999999984 5789999999975431        134567789999999999999999999999


Q ss_pred             CCeEEEEEEecCCC-CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecc
Q 005760          460 EEFKALVLEYMPHG-SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI  538 (678)
Q Consensus       460 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~  538 (678)
                      .+..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            99999999998776 9999998765 4899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCcceeecccCCccccCccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccc
Q 005760          539 AKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK  617 (678)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  617 (678)
                      +.......   ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||......       ...       
T Consensus       177 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~-------  239 (335)
T 3dls_A          177 AAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------VEA-------  239 (335)
T ss_dssp             CEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------TTT-------
T ss_pred             ceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------Hhh-------
Confidence            98764332   2234568999999999888776 78999999999999999999999652211       000       


Q ss_pred             ccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      ....+.             .+++++.+++.+||++||++|||+.|+++.
T Consensus       240 ~~~~~~-------------~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          240 AIHPPY-------------LVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CCCCSS-------------CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ccCCCc-------------ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000011             134558899999999999999999999873

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=348.07  Aligned_cols=265  Identities=17%  Similarity=0.195  Sum_probs=201.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC----CCcEEEEEEeecccCc-----------hhhhHHHHHHHHHhCCCccceeeee
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYGR-----------VFKSFDVECEMMKSIRHRNIIKVIS  455 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~  455 (678)
                      .++|.+.+.||+|+||.||+|...    ++..||+|++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467999999999999999999864    5788999998754321           1234667888999999999999999


Q ss_pred             eeec----CCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC--
Q 005760          456 SCSN----EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM--  529 (678)
Q Consensus       456 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~--  529 (678)
                      ++.+    ....++||||+ +++|.+++...+ .+++..++.++.|++.||+|||   +++|+||||||+||+++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCC
Confidence            9877    77899999999 999999998765 5899999999999999999999   89999999999999998877  


Q ss_pred             cEEEEeeccccccCCCCCc-----ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccch
Q 005760          530 VAHLSDFGIAKLLTREDQS-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTL  604 (678)
Q Consensus       530 ~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~  604 (678)
                      .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            9999999999876432211     11244579999999999999899999999999999999999999996533332222


Q ss_pred             hhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          605 KHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                      ........... ....         ........++.++.+++.+||+.||++||++.|+++.|+.+
T Consensus       271 ~~~~~~~~~~~-~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          271 QTAKTNLLDEL-PQSV---------LKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHTT-THHH---------HHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHhhcccc-cHHH---------HhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            21111111000 0000         00000013556799999999999999999999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.1e-40  Score=338.13  Aligned_cols=251  Identities=22%  Similarity=0.314  Sum_probs=205.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCc------hhhhHHHHHHHHHhCCCccceeeeeeeecCCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGR------VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  463 (678)
                      .++|++.+.||+|+||.||+|... +|+.||+|++......      ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            457889999999999999999864 7899999999754321      346788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC----cEEEEeeccc
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM----VAHLSDFGIA  539 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~----~~kl~Dfg~~  539 (678)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            99999999999999997654 4889999999999999999999   89999999999999999888    8999999999


Q ss_pred             cccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccc
Q 005760          540 KLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI  619 (678)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (678)
                      .......   ......+|+.|+|||.+.+..++.++||||+|+++|+|++|+.||......+ ..........       
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~-------  235 (321)
T 2a2a_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANITSVSY-------  235 (321)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHTTCC-------
T ss_pred             eecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhccc-------
Confidence            8764322   2234568999999999998899999999999999999999999996532211 1111100000       


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                            .   ........++..+.+++.+||+.||++|||+.|+++
T Consensus       236 ------~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          236 ------D---FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             ------C---CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             ------c---cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  0   000111234566889999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=5.8e-40  Score=339.71  Aligned_cols=247  Identities=20%  Similarity=0.276  Sum_probs=180.2

Q ss_pred             CccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEEEEecCCCC
Q 005760          397 NNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALVLEYMPHGS  474 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~  474 (678)
                      .+.||+|+||.||+|... +++.||||++...   ....+.+|+.+++.+. ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999864 7899999999643   3466788999999997 9999999999999999999999999999


Q ss_pred             HHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC---cEEEEeeccccccCCCCCccee
Q 005760          475 LEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM---VAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       475 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      |.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++   .+||+|||+++.....  ....
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~  166 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPL  166 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC--CCcc
Confidence            999998764 5899999999999999999999   99999999999999997665   8999999999865432  2223


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCc--cchhhhhhcccCCcccccccCccCCccc
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGE--MTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      ....+|+.|+|||++.+..++.++||||+||++|||++|+.||.......  ............        ...    .
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~--------~~~----~  234 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK--------GDF----S  234 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT--------TCC----C
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc--------CCC----C
Confidence            44568999999999999999999999999999999999999997643221  011111111000        000    0


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV  664 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell  664 (678)
                      ........+++++.+++.+||+.||++|||++|++
T Consensus       235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            01111234567799999999999999999999886

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-40  Score=370.46  Aligned_cols=252  Identities=23%  Similarity=0.385  Sum_probs=202.8

Q ss_pred             cccCCCceeEEEEEeC---CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCCCC
Q 005760          399 LIGRGSFGSVFKARLG---DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGS  474 (678)
Q Consensus       399 ~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  474 (678)
                      .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|+++++.++||||+++++++.+ +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999753   56789999997543 2356789999999999999999999999976 56899999999999


Q ss_pred             HHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC-cceeec
Q 005760          475 LEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQTQ  553 (678)
Q Consensus       475 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~  553 (678)
                      |.+++......+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++....... ......
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~  498 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA  498 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence            99999877667999999999999999999999   89999999999999999999999999999987643321 112233


Q ss_pred             ccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhh
Q 005760          554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF  632 (678)
Q Consensus       554 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  632 (678)
                      ..+++.|+|||++.++.++.++|||||||++|||++ |+.||......+  ....+.....     ..            
T Consensus       499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~-----~~------------  559 (613)
T 2ozo_A          499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQGKR-----ME------------  559 (613)
T ss_dssp             ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHHTTCC-----CC------------
T ss_pred             CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCC-----CC------------
Confidence            446689999999998999999999999999999998 999997643322  1111111000     00            


Q ss_pred             HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          633 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       633 ~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                       .+..+++++.++|.+||+.||++||++.++++.|+.+..+.
T Consensus       560 -~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          560 -CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             -CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             -CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence             01135667999999999999999999999999999987664

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.1e-40  Score=345.86  Aligned_cols=249  Identities=20%  Similarity=0.261  Sum_probs=202.8

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  464 (678)
                      ..++|++.+.||+|+||.||+|+.+ +++.||+|++....   ....+.+..|..+++.+ +||+|+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4578999999999999999999865 58899999997542   23456678899999987 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+++|+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+++....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999998754 4899999999999999999999   89999999999999999999999999999975432


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      .  ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ..........       .-|  
T Consensus       174 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~~-------~~p--  241 (353)
T 2i0e_A          174 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEHNV-------AYP--  241 (353)
T ss_dssp             T--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC-------CCC--
T ss_pred             C--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-HHHHHHhCCC-------CCC--
Confidence            2  122345679999999999999999999999999999999999999997532211 1111111000       001  


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ell~  665 (678)
                                 ...+.++.+++.+||+.||++||+     +.|+++
T Consensus       242 -----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          242 -----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -----------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -----------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                       123456889999999999999995     566654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.8e-40  Score=342.49  Aligned_cols=248  Identities=24%  Similarity=0.336  Sum_probs=194.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEe----CCCcEEEEEEeeccc----CchhhhHHHHHHHHHhCCCccceeeeeeeecCCe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL----GDGMEVAMKVFNLQY----GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF  462 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  462 (678)
                      .++|++.+.||+|+||.||+|+.    .+++.||+|++....    ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999985    478999999986532    2334567889999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .++||||+++++|.+++.... .+++..+..++.||+.||.|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999998654 4888999999999999999999   899999999999999999999999999998754


Q ss_pred             CCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ...  ........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..........       ..+
T Consensus       172 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~-------~~p  241 (327)
T 3a62_A          172 IHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDKILKCKL-------NLP  241 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCC-------CCC
T ss_pred             ccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCC-------CCC
Confidence            322  122344579999999999999899999999999999999999999997532211 1111111000       000


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                                   ...+.++.+++.+||+.||++||     ++.|+++
T Consensus       242 -------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          242 -------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                         12345688999999999999999     7778765

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=338.77  Aligned_cols=244  Identities=22%  Similarity=0.243  Sum_probs=194.1

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||+||+|... +|+.||||++.....  ........|+..+..+ +||||+++++++.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999865 799999999865332  2233444555555544 8999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+ +++|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 66999999877777999999999999999999999   8999999999999999999999999999997764322 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        ......||+.|+|||++.+ .++.++|||||||++|||++|..|+....    ..........               
T Consensus       212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~~~~~~~---------------  269 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQQLRQGYL---------------  269 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHHHHTTTCC---------------
T ss_pred             --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHhccCC---------------
Confidence              2334568999999998875 78999999999999999999977654311    1111111000               


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                         ....+..+++++.+++.+||+.||++|||+.|+++
T Consensus       270 ---~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 ---PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence               00111235667999999999999999999999985

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=6.9e-41  Score=344.94  Aligned_cols=259  Identities=24%  Similarity=0.408  Sum_probs=196.8

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCC----e
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEE----F  462 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  462 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....   .....+.+|+++++.++||||+++++++...+    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999985 5889999999975432   23456889999999999999999999986654    3


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .++||||+++++|.++++... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++...
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            489999999999999998665 4899999999999999999999   899999999999999999999999999999866


Q ss_pred             CCCCCc-ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          543 TREDQS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       543 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      ...... .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.......... .......         
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~~---------  236 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-QHVREDP---------  236 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHCCC---------
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhcCCC---------
Confidence            433222 22334568999999999999999999999999999999999999997533221111 1111000         


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHH-HHHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKE-IVTKLLKI  670 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e-ll~~L~~~  670 (678)
                         ..    .......++.++.+++.+||+.||++||++.+ +...+.+.
T Consensus       237 ---~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          237 ---IP----PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             ---CC----HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ---CC----cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence               00    00111235667899999999999999996555 44555444

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=342.65  Aligned_cols=265  Identities=20%  Similarity=0.287  Sum_probs=197.6

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCc-hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGR-VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999864 7899999998654322 223455799999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      ++ ++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......  ..
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence            97 5999999887777999999999999999999999   999999999999999999999999999999765322  22


Q ss_pred             eeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc---CCccccccc----
Q 005760          550 IQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL---PISTKEIVD----  621 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~----  621 (678)
                      ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ ..........   +........    
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHhchhhhcchhh
Confidence            2344568999999998876 568999999999999999999999997633221 1111111000   000000000    


Q ss_pred             -----CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 -----PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 -----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           +.....  ........+++++.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          235 KTYNYPKYRAE--ALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHTCCCCCCCC--CHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccch--hhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                 000000  001111235667899999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.4e-40  Score=355.01  Aligned_cols=247  Identities=26%  Similarity=0.387  Sum_probs=204.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467899999999999999999864 89999999997542   23346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++|+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++.......
T Consensus        95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999997654 4899999999999999999999   9999999999999999999999999999998764322


Q ss_pred             CcceeecccCCccccCccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                         ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+..... ..........       ..|   
T Consensus       171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~~i~~~~~-------~~p---  236 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT-LFKKICDGIF-------YTP---  236 (476)
T ss_dssp             ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH-HHHHHHTTCC-------CCC---
T ss_pred             ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH-HHHHHhcCCc-------CCC---
Confidence               2234579999999999988765 689999999999999999999997532211 1111111100       001   


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                ..+++++.+++.+||+.||++|||+.|+++
T Consensus       237 ----------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          237 ----------QYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             ----------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----------ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                      113455889999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=335.02  Aligned_cols=268  Identities=24%  Similarity=0.327  Sum_probs=200.3

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC-----chhhhHHHHHHHHHhCC---CccceeeeeeeecC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-----RVFKSFDVECEMMKSIR---HRNIIKVISSCSNE  460 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~  460 (678)
                      ..++|++.+.||+|+||+||+|.. .+++.||+|++.....     .....+.+|+.+++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999985 5789999999865421     12346677888877764   99999999998765


Q ss_pred             C-----eEEEEEEecCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEE
Q 005760          461 E-----FKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLS  534 (678)
Q Consensus       461 ~-----~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~  534 (678)
                      .     ..++||||++ ++|.+++..... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5789999996 599999986643 4899999999999999999999   8999999999999999999999999


Q ss_pred             eeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc--
Q 005760          535 DFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL--  612 (678)
Q Consensus       535 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--  612 (678)
                      |||+++.....   .......+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+. .........  
T Consensus       163 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~  238 (308)
T 3g33_A          163 DFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-LGKIFDLIGLP  238 (308)
T ss_dssp             SCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH-HHHHHHHHCCC
T ss_pred             eCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCC
Confidence            99999765422   223456789999999999999999999999999999999999999976332211 111111100  


Q ss_pred             C-Ccccccc---cCccCCccchh-hHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          613 P-ISTKEIV---DPNLLSREDIN-FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       613 ~-~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      + .......   ........... ......+++++.+++.+||++||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0 0000000   00000000000 0011235567899999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.8e-40  Score=348.85  Aligned_cols=269  Identities=22%  Similarity=0.320  Sum_probs=193.1

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc--cCchhhhHHHHHHHHHhCC-CccceeeeeeeecC--Ce
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIR-HRNIIKVISSCSNE--EF  462 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~  462 (678)
                      ...++|++.+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.+++.+. ||||+++++++...  ..
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3467899999999999999999985 57999999998543  2234566788999999997 99999999998654  37


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .|+||||++ ++|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            899999997 5999999875  4899999999999999999999   999999999999999999999999999999865


Q ss_pred             CCCC-------------------CcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCcc
Q 005760          543 TRED-------------------QSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM  602 (678)
Q Consensus       543 ~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~  602 (678)
                      ....                   .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-  238 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN-  238 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence            3211                   1122344679999999998876 578999999999999999999999997633211 


Q ss_pred             chhhhhhcccCCcccccc----cC-----------------ccCCccchhhH--------HHHHHHHHHHHHHhhccccC
Q 005760          603 TLKHWVNDWLPISTKEIV----DP-----------------NLLSREDINFV--------AKEQCVSFVFNVAMECTVES  653 (678)
Q Consensus       603 ~~~~~~~~~~~~~~~~~~----~~-----------------~~~~~~~~~~~--------~~~~~~~~l~~l~~~cl~~d  653 (678)
                      .+..... ....+..+..    .+                 ..... .....        ....+++++.+|+.+||+.|
T Consensus       239 ~~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          239 QLERIIG-VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRD-IFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             HHHHHHH-HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCC-CHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHH-hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHH-hCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence            1111111 0000000000    00                 00000 00000        00134667999999999999


Q ss_pred             cCCCCCHHHHHHH
Q 005760          654 PEQRINAKEIVTK  666 (678)
Q Consensus       654 P~~Rps~~ell~~  666 (678)
                      |++|||+.|+++.
T Consensus       317 P~~R~t~~e~l~H  329 (388)
T 3oz6_A          317 PNKRISANDALKH  329 (388)
T ss_dssp             GGGSCCHHHHTTS
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999763

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.4e-40  Score=343.60  Aligned_cols=259  Identities=23%  Similarity=0.319  Sum_probs=201.2

Q ss_pred             HHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc-----cCchhhhHHHHHHHHHhCCCccceeeeeeeecC
Q 005760          387 LCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ-----YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNE  460 (678)
Q Consensus       387 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  460 (678)
                      +....++|++.+.||+|+||.||+|.. .+++.||+|++...     .....+.+.+|+++++.++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            455677899999999999999999985 57889999998654     234557889999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhhC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 005760          461 EFKALVLEYMPHGSLEKYLHSS---------------------------------------NYILDIYQRLNIMIDVASA  501 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~  501 (678)
                      +..++||||+++|+|.+++...                                       ...+++..++.++.|++.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999998521                                       1123567788899999999


Q ss_pred             HHHHhcCCCCCeEEcCCCCCCeeecCCC--cEEEEeeccccccCCCC--CcceeecccCCccccCccccCC--CCCCccc
Q 005760          502 LEYLHFGYSAQVIHCDLKPSNVLLDDNM--VAHLSDFGIAKLLTRED--QSTIQTQTLATIGYMAPEYGKE--GRVSANG  575 (678)
Q Consensus       502 l~~LH~~~~~~ivH~dl~~~Nill~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~  575 (678)
                      |+|||   +++|+||||||+||+++.++  .+||+|||++.......  .........+|+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999   89999999999999998776  89999999998654322  1222345679999999998865  6789999


Q ss_pred             hHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcC
Q 005760          576 DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPE  655 (678)
Q Consensus       576 DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  655 (678)
                      |||||||++|||++|+.||......+. ..........     ...+           ....+++++.+++.+||+.||+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~-----~~~~-----------~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADT-ISQVLNKKLC-----FENP-----------NYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCC-----TTSG-----------GGGGSCHHHHHHHHHHSCSCTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHhcccc-----cCCc-----------ccccCCHHHHHHHHHHcCCChh
Confidence            999999999999999999975332211 1111111000     0000           0112356688999999999999


Q ss_pred             CCCCHHHHHH
Q 005760          656 QRINAKEIVT  665 (678)
Q Consensus       656 ~Rps~~ell~  665 (678)
                      +||++.|+++
T Consensus       321 ~Rps~~~~l~  330 (345)
T 3hko_A          321 ERFDAMRALQ  330 (345)
T ss_dssp             TSCCHHHHHH
T ss_pred             HCCCHHHHhc
Confidence            9999999987

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.9e-40  Score=343.46  Aligned_cols=261  Identities=23%  Similarity=0.411  Sum_probs=210.7

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecC
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNE  460 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  460 (678)
                      ....++|++.+.||+|+||.||+|...      +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG  100 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence            445678999999999999999999753      468899999865432 3345688999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcE
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVA  531 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~  531 (678)
                      +..++||||+++++|.+++...+         ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCE
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeE
Confidence            99999999999999999997532         34688999999999999999999   8999999999999999999999


Q ss_pred             EEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhc
Q 005760          532 HLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVND  610 (678)
Q Consensus       532 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~  610 (678)
                      ||+|||++................+++.|+|||.+.+..++.++||||+|+++|||++ |..||.......  ....+..
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~  255 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFVME  255 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HHHHHHT
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--HHHHHHc
Confidence            9999999976643333333344557889999999998899999999999999999999 888886532211  1111110


Q ss_pred             ccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          611 WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                         ...        ...       +..++.++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       256 ---~~~--------~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          256 ---GGL--------LDK-------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             ---TCC--------CCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             ---CCc--------CCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence               000        000       0124556889999999999999999999999998764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=335.65  Aligned_cols=265  Identities=24%  Similarity=0.334  Sum_probs=199.6

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.....  ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57899999999999999999864 699999999855432  234667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+++++|.+++.... .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||++.......  
T Consensus        83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  156 (311)
T 4agu_A           83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--  156 (311)
T ss_dssp             CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--
Confidence            999999998887554 4899999999999999999999   9999999999999999999999999999998764322  


Q ss_pred             ceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccch--hhhhhcccC--------C---
Q 005760          549 TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTL--KHWVNDWLP--------I---  614 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~--~~~~~~~~~--------~---  614 (678)
                      .......+|+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+....+...  ........+        .   
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence            22334578999999998876 568999999999999999999999997643221110  000000000        0   


Q ss_pred             cccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ......++....  ... .....++.++.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~--~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          237 SGVKIPDPEDME--PLE-LKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TTCCCCCCSSCC--CHH-HHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccCcCCCccccc--hhh-hhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000111111110  000 011235667899999999999999999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.2e-39  Score=329.21  Aligned_cols=251  Identities=22%  Similarity=0.352  Sum_probs=204.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999985 4789999999975432  34467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc---EEEEeeccccccCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV---AHLSDFGIAKLLTR  544 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~---~kl~Dfg~~~~~~~  544 (678)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999999887664 4899999999999999999999   899999999999999986655   99999999976643


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ..   ......+++.|+|||.+.+..++.++||||+|+++|+|++|+.||........ ..........     ...+. 
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-----~~~~~-  230 (284)
T 3kk8_A          161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-YAQIKAGAYD-----YPSPE-  230 (284)
T ss_dssp             SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCC-----CCTTT-
T ss_pred             Cc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-HHHHHhcccc-----CCchh-
Confidence            22   22346789999999999999999999999999999999999999965322111 1111111000     00000 


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                ...+++++.+++.+||+.||++|||+.|+++
T Consensus       231 ----------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          231 ----------WDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             ----------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----------hcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                      0123456889999999999999999999987

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.2e-40  Score=338.75  Aligned_cols=267  Identities=21%  Similarity=0.279  Sum_probs=199.4

Q ss_pred             hcCCCCC-ccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEE
Q 005760          391 TDGFSEN-NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       391 ~~~~~~~-~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      .+.|++. +.||+|+||.||+|.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3567774 7899999999999985 47999999999766555667889999999885 7999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc---EEEEeeccccccCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV---AHLSDFGIAKLLTR  544 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~---~kl~Dfg~~~~~~~  544 (678)
                      ||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.   +||+|||++.....
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            9999999999998764 4899999999999999999999   899999999999999988776   99999999876532


Q ss_pred             CCC-----cceeecccCCccccCccccCC-----CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhh--hhccc
Q 005760          545 EDQ-----STIQTQTLATIGYMAPEYGKE-----GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW--VNDWL  612 (678)
Q Consensus       545 ~~~-----~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~--~~~~~  612 (678)
                      ...     ........||+.|+|||++.+     ..++.++||||+||++|||++|+.||......+......  .....
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            211     111223469999999998865     458899999999999999999999997643322110000  00000


Q ss_pred             CCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          613 PISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ......+..... .   ........++.++.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~i~~~~~-~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          247 NMLFESIQEGKY-E---FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHCCC-C---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCc-c---cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            000000000000 0   000011234667899999999999999999999987

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.4e-40  Score=332.77  Aligned_cols=247  Identities=25%  Similarity=0.364  Sum_probs=200.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            46789999999999999999975 467899999986532   22346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.+++.... .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++...... 
T Consensus        88 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence            99999999999998664 4899999999999999999999   999999999999999999999999999998654322 


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                         ......+++.|+|||.+.+..++.++||||+|+++|+|++|..||......+  ....+....      ...+    
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~------~~~~----  227 (279)
T 3fdn_A          163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TYKRISRVE------FTFP----  227 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHHTC------CCCC----
T ss_pred             ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--HHHHHHhCC------CCCC----
Confidence               2234578999999999999899999999999999999999999997532211  111110000      0000    


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                               ..++.++.+++.+||+.||++|||+.|+++.
T Consensus       228 ---------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          228 ---------DFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ---------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ---------CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                     1134558899999999999999999999873

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2.6e-40  Score=343.19  Aligned_cols=261  Identities=23%  Similarity=0.384  Sum_probs=205.8

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF  462 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  462 (678)
                      ..++|++.+.||+|+||.||+|..      .+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            357899999999999999999973      357789999986432 2345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC---CCcEEE
Q 005760          463 KALVLEYMPHGSLEKYLHSSN------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHL  533 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~---~~~~kl  533 (678)
                      .++||||+++++|.+++....      ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEE
Confidence            999999999999999998654      34889999999999999999999   899999999999999984   456999


Q ss_pred             EeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhccc
Q 005760          534 SDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWL  612 (678)
Q Consensus       534 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~  612 (678)
                      +|||++................+++.|+|||.+.+..++.++||||||+++|||++ |..||......  .....+....
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~~  262 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EVLEFVTSGG  262 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHTTC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--HHHHHHhcCC
Confidence            99999976543333333345568899999999988899999999999999999998 88998653221  1111111100


Q ss_pred             CCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          613 PISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      .        +..          +..++..+.+++.+||+.||++||++.|+++.|+.+...
T Consensus       263 ~--------~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          263 R--------MDP----------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             C--------CCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C--------CCC----------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            0        000          012345688999999999999999999999999988653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.2e-40  Score=335.78  Aligned_cols=261  Identities=23%  Similarity=0.356  Sum_probs=207.4

Q ss_pred             hhcCCCCCc-cccCCCceeEEEEEe---CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeE
Q 005760          390 ATDGFSENN-LIGRGSFGSVFKARL---GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       390 ~~~~~~~~~-~ig~G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  463 (678)
                      ..++|.+.+ .||+|+||.||+|.+   .+++.||+|++....  ....+.+.+|+++++.++||||+++++++ +.+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            345777777 999999999999953   357889999996543  23357789999999999999999999999 55678


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            89999999999999998764 4899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCc-ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          544 REDQS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       544 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+.....        
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~--------  238 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER--------  238 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC--------
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCC--------
Confidence            43222 12233456788999999988889999999999999999999 99998753321  11111111000        


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                      +..          +..+++++.+++.+||+.||++||++.|+++.|+++..+..
T Consensus       239 ~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          239 MGC----------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             CCC----------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             CCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            000          01245668899999999999999999999999999987643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.7e-39  Score=351.80  Aligned_cols=261  Identities=23%  Similarity=0.261  Sum_probs=195.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc--cCchhhhHHHHHHHHHhCCCccceeeeeeeecC------C
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNE------E  461 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  461 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            57899999999999999999975 47899999999754  223456788999999999999999999998654      4


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            67999999976 57776653   3889999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhc-----------
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND-----------  610 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-----------  610 (678)
                      ...   ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. +...+..           
T Consensus       214 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          214 AGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             ------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHTT
T ss_pred             cCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHH
Confidence            543   2223456799999999999999999999999999999999999999976322110 0000000           


Q ss_pred             -------ccC-------CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          611 -------WLP-------ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       611 -------~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                             +..       .............   .........++++.+|+.+||++||++|||++|+++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFP---ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSC---CSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccc---cccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   000       0000000000000   001112234677999999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.4e-40  Score=335.15  Aligned_cols=252  Identities=28%  Similarity=0.435  Sum_probs=199.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeec-CCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN-EEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  469 (678)
                      .++|++.+.||+|+||.||+|.. +|+.||+|++...  ...+.+.+|+++++.++||||+++++++.+ .+..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46789999999999999999987 4889999998643  245778999999999999999999998754 4578999999


Q ss_pred             cCCCCHHHHhhhCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++++|.+++..... .+++..+..++.|++.|++|||   +++++||||||+||+++.++.+||+|||++......   
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            999999999976532 3788899999999999999999   899999999999999999999999999998754322   


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        .....+++.|+|||.+.+..++.++||||+|+++|||++ |..||......+  ....+....        .+..   
T Consensus       171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~~~~--------~~~~---  235 (278)
T 1byg_A          171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGY--------KMDA---  235 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTTTC--------CCCC---
T ss_pred             --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHhcCC--------CCCC---
Confidence              123357889999999988899999999999999999998 999987532211  111111000        0000   


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                             +..+++++.+++.+||+.||++||++.|+++.|++++..
T Consensus       236 -------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          236 -------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                   012456688999999999999999999999999999865

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.1e-39  Score=327.94  Aligned_cols=256  Identities=24%  Similarity=0.327  Sum_probs=205.2

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC------chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG------RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      ++|++.+.||+|+||.||+|... +++.||+|++.....      ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56889999999999999999865 799999999865422      13567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC----cEEEEeecccc
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM----VAHLSDFGIAK  540 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~----~~kl~Dfg~~~  540 (678)
                      +||||+++++|.+++.... .+++..+..++.|++.||.|||   +++++||||||+||+++.++    .+||+|||++.
T Consensus        85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            9999999999999997654 4899999999999999999999   89999999999999998877    89999999998


Q ss_pred             ccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccc
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV  620 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (678)
                      ......   ......+++.|+|||.+.+..++.++||||+|+++|+|++|+.||......+ ..........        
T Consensus       161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--------  228 (283)
T 3bhy_A          161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTNISAVNY--------  228 (283)
T ss_dssp             ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTCC--------
T ss_pred             eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHHhHhccc--------
Confidence            664322   2234568999999999998899999999999999999999999997532211 1111100000        


Q ss_pred             cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH--HHHHHH
Q 005760          621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT--KLLKIR  671 (678)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~--~L~~~~  671 (678)
                              .........++..+.+++.+||+.||++||++.|+++  .++.++
T Consensus       229 --------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          229 --------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             --------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             --------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence                    0001111234566889999999999999999999997  455554

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-39  Score=340.78  Aligned_cols=246  Identities=28%  Similarity=0.390  Sum_probs=200.5

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      +.|+..+.||+|+||.||+|.. .+++.||||++.....   ...+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999985 5899999999975432   23467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+. |++.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++......  
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence            9997 5898888766667999999999999999999999   899999999999999999999999999999765322  


Q ss_pred             cceeecccCCccccCccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          548 STIQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                          ....||+.|+|||++.   .+.++.++|||||||++|||++|+.||....... .........         .+..
T Consensus       208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~---------~~~~  273 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNE---------SPAL  273 (348)
T ss_dssp             ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSC---------CCCC
T ss_pred             ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcC---------CCCC
Confidence                2456899999999874   5678999999999999999999999986532211 111111110         0100


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      ..         ..++..+.+++.+||+.||++|||+.|+++.
T Consensus       274 ~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          274 QS---------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CC---------CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00         1234558899999999999999999999853

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.6e-39  Score=336.63  Aligned_cols=271  Identities=21%  Similarity=0.326  Sum_probs=204.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeec--------
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSN--------  459 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  459 (678)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++.....  .....+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46899999999999999999986 5899999999855432  234567899999999999999999999876        


Q ss_pred             CCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccc
Q 005760          460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA  539 (678)
Q Consensus       460 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~  539 (678)
                      .+..++||||+++ +|.+.+......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            3468999999975 888888776667999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCC--CcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccc--hhhhhhcccCC
Q 005760          540 KLLTRED--QSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT--LKHWVNDWLPI  614 (678)
Q Consensus       540 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~  614 (678)
                      +......  .........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.......  .........+.
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            8764322  2223345678999999998876 45799999999999999999999999763322110  00000111111


Q ss_pred             cccccccC---------ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          615 STKEIVDP---------NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       615 ~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ........         ................++++.+++.+||+.||++|||++|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            11100000         0000011111111223567899999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-39  Score=330.15  Aligned_cols=250  Identities=27%  Similarity=0.365  Sum_probs=197.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|.+.+.||+|+||.||+|.. .++..||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            46789999999999999999985 4789999999976543 345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee---cCCCcEEEEeecccccc
Q 005760          469 YMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       469 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill---~~~~~~kl~Dfg~~~~~  542 (678)
                      |+++++|.+++...   ...+++..+..++.|++.||+|||   +++|+||||||+||++   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988543   346899999999999999999999   9999999999999999   55688999999999765


Q ss_pred             CCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ...   .......+++.|+|||.+. +.++.++||||+|+++|||++|+.||......+.  ........+         
T Consensus       178 ~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~---------  242 (285)
T 3is5_A          178 KSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKATYKEP---------  242 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCC---------
T ss_pred             CCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--HhhhccCCc---------
Confidence            432   2234556899999999875 5688999999999999999999999975332211  111110000         


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .... .      ....++++.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~-~------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 NYAV-E------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CCCC---------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cccc-c------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0000 0      0012455889999999999999999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.9e-39  Score=346.22  Aligned_cols=253  Identities=23%  Similarity=0.284  Sum_probs=194.1

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--------CchhhhHHHHHHHHHhCCCccceeeeeeeec
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--------GRVFKSFDVECEMMKSIRHRNIIKVISSCSN  459 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  459 (678)
                      ...++|.+.+.||+|+||.||+|.. .+++.||+|++....        ......+.+|+++++.++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3567899999999999999999975 478999999997532        1223468899999999999999999999865


Q ss_pred             CCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC---CcEEEEee
Q 005760          460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN---MVAHLSDF  536 (678)
Q Consensus       460 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~---~~~kl~Df  536 (678)
                      . ..++||||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.+   +.+||+||
T Consensus       212 ~-~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 E-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             S-EEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             C-ceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeec
Confidence            4 5789999999999999987654 4899999999999999999999   8999999999999999754   45999999


Q ss_pred             ccccccCCCCCcceeecccCCccccCccccCC---CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC
Q 005760          537 GIAKLLTREDQSTIQTQTLATIGYMAPEYGKE---GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP  613 (678)
Q Consensus       537 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  613 (678)
                      |+++.....   .......||+.|+|||++.+   ..++.++||||+||++|||++|+.||...................
T Consensus       287 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~  363 (419)
T 3i6u_A          287 GHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN  363 (419)
T ss_dssp             STTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCC
T ss_pred             ccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCC
Confidence            999876432   22334679999999998853   567889999999999999999999997633322211111110000


Q ss_pred             CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                      ........+++++.+++.+||+.||++|||+.|+++
T Consensus       364 ----------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          364 ----------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             ----------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                            000011234667899999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.3e-40  Score=341.60  Aligned_cols=258  Identities=28%  Similarity=0.451  Sum_probs=205.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcE--EEEEEeecc-cCchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGME--VAMKVFNLQ-YGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  465 (678)
                      .++|++.+.||+|+||.||+|... ++..  ||+|.+... .....+.+.+|+++++.+ +||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            367899999999999999999853 5664  499988643 233456788999999999 89999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc
Q 005760          466 VLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV  530 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~  530 (678)
                      ||||+++++|.+++....               ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence            999999999999997654               35899999999999999999999   999999999999999999999


Q ss_pred             EEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhh
Q 005760          531 AHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVN  609 (678)
Q Consensus       531 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~  609 (678)
                      +||+|||+++....   ........+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......+  ....+.
T Consensus       181 ~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~~~~~  255 (327)
T 1fvr_A          181 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYEKLP  255 (327)
T ss_dssp             EEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHGG
T ss_pred             EEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HHHHhh
Confidence            99999999874321   112233457889999999988889999999999999999998 999986532211  111111


Q ss_pred             cccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          610 DWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      ...        ....          +..+++++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       256 ~~~--------~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          256 QGY--------RLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             GTC--------CCCC----------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             cCC--------CCCC----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            000        0000          0123456889999999999999999999999999987653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.8e-40  Score=346.33  Aligned_cols=248  Identities=24%  Similarity=0.279  Sum_probs=193.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC---chhhhHHHHHHH-HHhCCCccceeeeeeeecCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG---RVFKSFDVECEM-MKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++.....   .....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467899999999999999999864 688999999975432   233455666665 567899999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++|+|.+++.+.+ .+++..+..++.||+.||+|||   +++|+||||||+||+++.+|++||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999998755 4888999999999999999999   999999999999999999999999999999754222


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                        ........||+.|+|||++.+..++.++||||+||++|||++|..||......+ .........       ..-+   
T Consensus       193 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~-------~~~~---  259 (373)
T 2r5t_A          193 --NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILNKP-------LQLK---  259 (373)
T ss_dssp             --CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHHHSC-------CCCC---
T ss_pred             --CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcc-------cCCC---
Confidence              222345679999999999999999999999999999999999999997532211 111111100       0000   


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                ..++.++.+++.+||+.||++||++.+.++
T Consensus       260 ----------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~  289 (373)
T 2r5t_A          260 ----------PNITNSARHLLEGLLQKDRTKRLGAKDDFM  289 (373)
T ss_dssp             ----------SSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred             ----------CCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence                      113455889999999999999999864333

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=8.2e-40  Score=339.57  Aligned_cols=272  Identities=21%  Similarity=0.276  Sum_probs=196.8

Q ss_pred             HHHHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCC
Q 005760          385 LELCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEE  461 (678)
Q Consensus       385 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  461 (678)
                      .......++|++.+.||+|+||.||+|.. .+++.||+|++.....  ...+.+.+|+++++.++||||+++++++.+.+
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           27 APSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH  106 (329)
T ss_dssp             -----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred             CCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            34455678899999999999999999974 4789999999865432  23456778999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec-----CCCcEEEEee
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD-----DNMVAHLSDF  536 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~-----~~~~~kl~Df  536 (678)
                      ..++||||+++ +|.+++..... +++..+..++.||+.||+|||   +++|+||||||+||+++     .++.+||+||
T Consensus       107 ~~~lv~e~~~~-~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          107 RLHLIFEYAEN-DLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EEEEEEECCSE-EHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EEEEEEecCCC-CHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            99999999975 99999987654 899999999999999999999   89999999999999994     5556999999


Q ss_pred             ccccccCCCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcc--cC
Q 005760          537 GIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW--LP  613 (678)
Q Consensus       537 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~--~~  613 (678)
                      |+++.....  ........+|+.|+|||++.+. .++.++||||+||++|||++|+.||......+. ........  ..
T Consensus       182 g~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~  258 (329)
T 3gbz_A          182 GLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LFKIFEVLGLPD  258 (329)
T ss_dssp             THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCC
T ss_pred             CCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HHHHHHHhCCCc
Confidence            999876432  1223445689999999998775 489999999999999999999999976332211 11111100  00


Q ss_pred             C-ccc------cc--ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          614 I-STK------EI--VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       614 ~-~~~------~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      . ...      .+  ..+... ...........++.++.+++.+||+.||++|||+.|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFR-GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCC-CCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhc-cccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            0 000      00  000000 011111112235677899999999999999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.8e-39  Score=332.46  Aligned_cols=263  Identities=22%  Similarity=0.278  Sum_probs=200.7

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCCeE
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  463 (678)
                      ....++|++.+.||+|+||.||+|... +++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL  109 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence            344578999999999999999999864 789999999865422   2346788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          110 YVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            99999999999999998754 4899999999999999999999   8999999999999999999999999999997654


Q ss_pred             CCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ... ........+++.|+|||.+.+..++.++||||||+++|||++|+.||......  .....+....+       .+.
T Consensus       186 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~-------~~~  255 (309)
T 2h34_A          186 DEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIP-------RPS  255 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCC-------CGG
T ss_pred             ccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCC-------Ccc
Confidence            322 12233456899999999999989999999999999999999999999753221  11111111000       000


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI-NAKEIVTKLLKIRDS  673 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~ell~~L~~~~~~  673 (678)
                      .         .+..++.++.+++.+||+.||++|| +++++++.|+++.+.
T Consensus       256 ~---------~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          256 T---------VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             G---------TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             c---------cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            0         0112445688999999999999999 999999999987543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.2e-39  Score=356.70  Aligned_cols=250  Identities=22%  Similarity=0.330  Sum_probs=205.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|++....   ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467899999999999999999864 79999999996532   23446678999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          467 LEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      |||+++|+|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+++.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999997654 34899999999999999999999   899999999999999999999999999999876432


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCcc--chhhhhhcccCCcccccccCc
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM--TLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      .   ......||+.|+|||++.+..++.++||||+||++|||++|+.||........  .....+.... ..        
T Consensus       340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~-~~--------  407 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP-EE--------  407 (576)
T ss_dssp             C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC-CC--------
T ss_pred             c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc-cc--------
Confidence            2   23345799999999999998999999999999999999999999976433211  1111111100 00        


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                       ..         ..+++++.+++.+||+.||++||     ++.|+++
T Consensus       408 -~p---------~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          408 -YS---------ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -CC---------TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -CC---------ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence             00         12345688999999999999999     7888875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.5e-40  Score=366.85  Aligned_cols=256  Identities=26%  Similarity=0.440  Sum_probs=209.3

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..++|++.+.||+|+||.||+|.+.++..||||++.... ...+.+.+|+++++.++||||+++++++.+ +..++||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            456788899999999999999998888889999997543 234678999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++|+|.++++.. ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  418 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-H
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-e
Confidence            9999999999753 235889999999999999999999   9999999999999999999999999999997654221 1


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      .......++..|+|||.+.++.++.++|||||||++|||++ |+.||.+....+  ....+.....     ..       
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~~~i~~~~~-----~~-------  484 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVERGYR-----MP-------  484 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HHHHHHTTCC-----CC-------
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC-----CC-------
Confidence            12234457789999999998899999999999999999999 899987533221  1111110000     00       


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                            .+..++.++.++|.+||+.||++|||+.++++.|+.+.
T Consensus       485 ------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          485 ------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                  01134566899999999999999999999999998764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.7e-40  Score=349.90  Aligned_cols=249  Identities=15%  Similarity=0.179  Sum_probs=193.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc---cCchhhhHHHHHH---HHHhCCCccceeee-------ee
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ---YGRVFKSFDVECE---MMKSIRHRNIIKVI-------SS  456 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~---~l~~l~h~niv~~~-------~~  456 (678)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+.   .++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999985 57999999999743   3345577889994   55556899999998       55


Q ss_pred             eecCC-----------------eEEEEEEecCCCCHHHHhhhCCCC------CCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 005760          457 CSNEE-----------------FKALVLEYMPHGSLEKYLHSSNYI------LDIYQRLNIMIDVASALEYLHFGYSAQV  513 (678)
Q Consensus       457 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~LH~~~~~~i  513 (678)
                      +.+++                 ..++||||+ +|+|.+++......      +++..+..++.||+.||+|||   +++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            55443                 378999999 67999999864322      225788889999999999999   8999


Q ss_pred             EEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCC-----------CCCccchHHHHHH
Q 005760          514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-----------RVSANGDVYSFGI  582 (678)
Q Consensus       514 vH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwslGv  582 (678)
                      +||||||+||+++.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985321     2344567 999999999887           8999999999999


Q ss_pred             HHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHH
Q 005760          583 MLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKE  662 (678)
Q Consensus       583 ~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  662 (678)
                      ++|||++|+.||......... ..            +.. ..           ..+++++.+++.+||+.||++|||+.|
T Consensus       302 il~elltg~~Pf~~~~~~~~~-~~------------~~~-~~-----------~~~~~~~~~li~~~L~~dp~~Rpt~~e  356 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGS-EW------------IFR-SC-----------KNIPQPVRALLEGFLRYPKEDRLLPLQ  356 (377)
T ss_dssp             HHHHHHHSSCCC------CCS-GG------------GGS-SC-----------CCCCHHHHHHHHHHTCSSGGGCCCHHH
T ss_pred             HHHHHHHCCCCCcccccccch-hh------------hhh-hc-----------cCCCHHHHHHHHHHcCCCchhCCCHHH
Confidence            999999999999653322111 00            000 00           123456889999999999999999999


Q ss_pred             HHH--HHHHHHHHH
Q 005760          663 IVT--KLLKIRDSL  674 (678)
Q Consensus       663 ll~--~L~~~~~~~  674 (678)
                      +++  .++.+.+..
T Consensus       357 ~l~hp~f~~~~~~~  370 (377)
T 3byv_A          357 AMETPEYEQLRTEL  370 (377)
T ss_dssp             HHTSHHHHHHHHHH
T ss_pred             HhhChHHHHHHHHH
Confidence            996  666665543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-39  Score=352.79  Aligned_cols=195  Identities=25%  Similarity=0.372  Sum_probs=154.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeec-----CCe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSN-----EEF  462 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~  462 (678)
                      .++|++.+.||+|+||.||+|... +++.||||++.....  ...+.+.+|+++++.++||||+++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999754 789999999864322  345678899999999999999999999843     357


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .|+||||+ +++|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 569999997654 5899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCc-------------------------ceeecccCCccccCcccc-CCCCCCccchHHHHHHHHHHHHcC
Q 005760          543 TREDQS-------------------------TIQTQTLATIGYMAPEYG-KEGRVSANGDVYSFGIMLMETFTR  590 (678)
Q Consensus       543 ~~~~~~-------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslGv~l~ell~g  590 (678)
                      ......                         .......||+.|+|||++ .+..++.++||||+||++|||++|
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            432111                         123456789999999975 566799999999999999999994

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.3e-39  Score=348.67  Aligned_cols=201  Identities=25%  Similarity=0.367  Sum_probs=168.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecC-----C
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNE-----E  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  461 (678)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++.....  ...+.+.+|+++++.++||||+++++++...     +
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            357899999999999999999985 4789999999965322  3446788999999999999999999998765     5


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..|+||||++ ++|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            7899999996 59999997654 4899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCc--------------------ceeecccCCccccCcccc-CCCCCCccchHHHHHHHHHHHHcCCCCCC
Q 005760          542 LTREDQS--------------------TIQTQTLATIGYMAPEYG-KEGRVSANGDVYSFGIMLMETFTRKKPTD  595 (678)
Q Consensus       542 ~~~~~~~--------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslGv~l~ell~g~~p~~  595 (678)
                      .......                    .......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            6433211                    123567899999999975 56679999999999999999998766654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6.5e-39  Score=341.14  Aligned_cols=249  Identities=22%  Similarity=0.300  Sum_probs=191.0

Q ss_pred             cCCCCC-ccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHH-hCCCccceeeeeeeec----CCeEE
Q 005760          392 DGFSEN-NLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMK-SIRHRNIIKVISSCSN----EEFKA  464 (678)
Q Consensus       392 ~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~----~~~~~  464 (678)
                      ++|.+. +.||+|+||.||+|... +++.||||++..     ...+.+|++++. ..+||||+++++++..    .+..+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 68999999999999854 789999999863     245677888874 5589999999998865    56789


Q ss_pred             EEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC---CCcEEEEeecccc
Q 005760          465 LVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAK  540 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~---~~~~kl~Dfg~~~  540 (678)
                      +||||+++|+|.+++.... ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999998653 35899999999999999999999   899999999999999987   7899999999998


Q ss_pred             ccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccc--hhhhhhcccCCcccc
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT--LKHWVNDWLPISTKE  618 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~  618 (678)
                      .....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ....+....    ..
T Consensus       213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~----~~  285 (400)
T 1nxk_A          213 ETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ----YE  285 (400)
T ss_dssp             ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC----CC
T ss_pred             ccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc----cc
Confidence            65422   2234567899999999999999999999999999999999999999764332211  111111000    00


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      ...+           ....++.++.+++.+||+.||++|||+.|+++.
T Consensus       286 ~~~~-----------~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          286 FPNP-----------EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CCTT-----------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCc-----------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0000           001245668899999999999999999999873

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-39  Score=340.42  Aligned_cols=270  Identities=23%  Similarity=0.307  Sum_probs=200.0

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-----chhhhHHHHHHHHHhCCCccceeeeeeeecCC
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-----RVFKSFDVECEMMKSIRHRNIIKVISSCSNEE  461 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  461 (678)
                      ....++|++.+.||+|+||.||+|... +|+.||+|++.....     ...+.+.+|+++++.++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            445678999999999999999999864 689999999864322     12356789999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..++||||+++ +|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            99999999976 899999877667888999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc---CCccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL---PISTK  617 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~  617 (678)
                      .....  .......+|+.|+|||.+.+. .++.++||||+||++|||++|.+||.+....+ .+........   .....
T Consensus       162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSS
T ss_pred             ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHcCCCChhhhh
Confidence            64322  223456789999999988664 48899999999999999999999986533211 1111111100   00000


Q ss_pred             c---cccC---ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          618 E---IVDP---NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       618 ~---~~~~---~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .   ..+.   ......... .....++.++.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLH-HIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHH-HHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccCcccccccccCCCChH-HhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0   0000   000000000 001234567999999999999999999999986

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.9e-39  Score=340.05  Aligned_cols=206  Identities=27%  Similarity=0.356  Sum_probs=179.3

Q ss_pred             cCCHHHHHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-----Cccceeee
Q 005760          381 MFSYLELCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-----HRNIIKVI  454 (678)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~  454 (678)
                      .+++.+.....++|++.+.||+|+||.||+|.. .+++.||||++... ......+..|+.+++.++     ||||++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            345555555678999999999999999999986 57899999998642 233456778999999986     99999999


Q ss_pred             eeeecCCeEEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC------
Q 005760          455 SSCSNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD------  527 (678)
Q Consensus       455 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~------  527 (678)
                      +++...+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+||+++.      
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~  178 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKS  178 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccccc
Confidence            9999999999999999 889999998654 35889999999999999999999   999999999999999975      


Q ss_pred             -------------------CCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHH
Q 005760          528 -------------------NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETF  588 (678)
Q Consensus       528 -------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell  588 (678)
                                         ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||+||++|||+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             ccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                               889999999999764322     23457899999999999999999999999999999999


Q ss_pred             cCCCCCCc
Q 005760          589 TRKKPTDE  596 (678)
Q Consensus       589 ~g~~p~~~  596 (678)
                      +|+.||..
T Consensus       254 ~g~~pf~~  261 (360)
T 3llt_A          254 TGSLLFRT  261 (360)
T ss_dssp             HSSCSCCC
T ss_pred             HCCCCCCC
Confidence            99999975

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.6e-39  Score=328.60  Aligned_cols=250  Identities=25%  Similarity=0.393  Sum_probs=204.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeec----------
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN----------  459 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----------  459 (678)
                      .++|++.+.||+|+||.||+|... +++.||+|++....    +.+.+|+++++.++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            457889999999999999999865 79999999997542    456789999999999999999998754          


Q ss_pred             ------CCeEEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEE
Q 005760          460 ------EEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAH  532 (678)
Q Consensus       460 ------~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~k  532 (678)
                            ....++||||+++++|.+++.... ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEE
Confidence                  445789999999999999997542 45899999999999999999999   89999999999999999999999


Q ss_pred             EEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc
Q 005760          533 LSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL  612 (678)
Q Consensus       533 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  612 (678)
                      |+|||++.......   ......+++.|+|||.+.+..++.++||||||+++|||++|..|+.....       ......
T Consensus       163 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-------~~~~~~  232 (284)
T 2a19_B          163 IGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-------FFTDLR  232 (284)
T ss_dssp             ECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-------HHHHHH
T ss_pred             ECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-------HHHHhh
Confidence            99999998764332   22345689999999999988999999999999999999999988753211       111000


Q ss_pred             CCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          613 PISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                      ...    . +             ..++.++.+++.+||+.||++|||+.|+++.|+.++++..
T Consensus       233 ~~~----~-~-------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          233 DGI----I-S-------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             TTC----C-C-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             ccc----c-c-------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            000    0 0             0133457899999999999999999999999999876543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.2e-40  Score=356.26  Aligned_cols=248  Identities=24%  Similarity=0.304  Sum_probs=195.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999985 47999999999754   233446677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      |||+++|+|.+++...+ .+++..+..++.|++.||+|||   + ++|+||||||+||+++.++.+||+|||+++.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999997665 4899999999999999999999   7 89999999999999999999999999999754322


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                        ........||+.|+|||++.+..++.++||||+||++|||++|+.||......  .....+...      ....|   
T Consensus       303 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~i~~~------~~~~p---  369 (446)
T 4ejn_A          303 --GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELILME------EIRFP---  369 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHC------CCCCC---
T ss_pred             --CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHHhC------CCCCC---
Confidence              22234567999999999999999999999999999999999999999653221  111111000      00001   


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                                ..+++++.+++.+||+.||++||     +++|+++
T Consensus       370 ----------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          370 ----------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ----------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ----------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                      11345688999999999999999     9999985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=338.60  Aligned_cols=256  Identities=23%  Similarity=0.310  Sum_probs=189.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-Cccceeeeeee--------ecC
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSC--------SNE  460 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~--------~~~  460 (678)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.+. ||||+++++++        ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            45789999999999999999985 478999999987665556677889999999996 99999999988        344


Q ss_pred             CeEEEEEEecCCCCHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEcCCCCCCeeecCCCcEEEEee
Q 005760          461 EFKALVLEYMPHGSLEKYLHS--SNYILDIYQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPSNVLLDDNMVAHLSDF  536 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dl~~~Nill~~~~~~kl~Df  536 (678)
                      ...++||||++ |+|.+++..  ....+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            56889999996 699998865  3345899999999999999999999   888  999999999999999999999999


Q ss_pred             ccccccCCCCCcc----------eeecccCCccccCcccc---CCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccc
Q 005760          537 GIAKLLTREDQST----------IQTQTLATIGYMAPEYG---KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT  603 (678)
Q Consensus       537 g~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~  603 (678)
                      |+++.........          ......+|+.|+|||++   .+..++.++|||||||++|||++|+.||........ 
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-  261 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-  261 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence            9998765332111          11244589999999988   566789999999999999999999999965322111 


Q ss_pred             hhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          604 LKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                          ......     ...+             ..++..+.+++.+||+.||++||++.|+++.|+.+...
T Consensus       262 ----~~~~~~-----~~~~-------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          262 ----VNGKYS-----IPPH-------------DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             --------CC-----CCTT-------------CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----hcCccc-----CCcc-------------cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                000000     0000             01122367899999999999999999999999999765

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.9e-39  Score=326.15  Aligned_cols=246  Identities=26%  Similarity=0.394  Sum_probs=197.3

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeec----CCeEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSN----EEFKAL  465 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l  465 (678)
                      .|.+.+.||+|+||.||+|.. .++..||+|++....  ....+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            477788999999999999975 478899999987543  2345678899999999999999999998754    456899


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEcCCCCCCeeec-CCCcEEEEeecccccc
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLL  542 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dl~~~Nill~-~~~~~kl~Dfg~~~~~  542 (678)
                      ||||+++++|.+++.... .+++..+..++.|++.||.|||   +.+  |+||||||+||+++ .++.+||+|||++...
T Consensus       107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            999999999999998754 4889999999999999999999   888  99999999999997 8899999999999754


Q ss_pred             CCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ...    ......+++.|+|||.+. +.++.++||||+|+++|+|++|+.||..................+..       
T Consensus       183 ~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  250 (290)
T 1t4h_A          183 RAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS-------  250 (290)
T ss_dssp             CTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG-------
T ss_pred             ccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccc-------
Confidence            322    223456899999999876 45899999999999999999999999753332221111111100000       


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                 .+...++++.+++.+||+.||++|||+.|+++
T Consensus       251 -----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          251 -----------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -----------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -----------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                       00112345889999999999999999999986

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.9e-38  Score=366.35  Aligned_cols=301  Identities=36%  Similarity=0.565  Sum_probs=263.2

Q ss_pred             ccccCCcCcccCCccccC--CCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEE
Q 005760            2 LQMWENNFSGTIPRFIFN--ASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLI   79 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~--l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L   79 (678)
                      |+|++|++++.+|..+..  +++|++|+|++|++++..|..|.++++|+.|+|++|.+....+     ..|.++++|+.|
T Consensus       373 L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-----~~l~~l~~L~~L  447 (768)
T 3rgz_A          373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP-----SSLGSLSKLRDL  447 (768)
T ss_dssp             EECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCC-----GGGGGCTTCCEE
T ss_pred             EEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCccc-----HHHhcCCCCCEE
Confidence            567777777777766666  7788888888888888888888888999999999988875443     357888899999


Q ss_pred             ECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCc
Q 005760           80 SFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNK  159 (678)
Q Consensus        80 ~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~  159 (678)
                      +|++|.+.+..|.. +..++ +|++|++++|++++..|..+.++++|++|+|++|++++..|..|+.+++|++|+|++|+
T Consensus       448 ~L~~n~l~~~~p~~-~~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  525 (768)
T 3rgz_A          448 KLWLNMLEGEIPQE-LMYVK-TLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS  525 (768)
T ss_dssp             ECCSSCCCSCCCGG-GGGCT-TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred             ECCCCcccCcCCHH-HcCCC-CceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCc
Confidence            99999998887766 66666 89999999999998899999999999999999999988889999999999999999999


Q ss_pred             CCCCCCCcccCCCCccEEecCCCcCCCCChhhh-----------------------------------------------
Q 005760          160 LEGSIPDSICHSDELYKLELGGNKLSGSIPECF-----------------------------------------------  192 (678)
Q Consensus       160 i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~-----------------------------------------------  192 (678)
                      +++.+|..+..+++|+.|++++|.+.+.+|..+                                               
T Consensus       526 l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  605 (768)
T 3rgz_A          526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN  605 (768)
T ss_dssp             CEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGG
T ss_pred             ccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhh
Confidence            988889999999999999999998887666543                                               


Q ss_pred             -----------------------hccccccceeccccccc-cccccccccccccEEEecCCcccCCCCcccccccccccc
Q 005760          193 -----------------------NNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARID  248 (678)
Q Consensus       193 -----------------------~~l~~L~~L~l~~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~  248 (678)
                                             ..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++|.+|..+++++     
T Consensus       606 ~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~-----  680 (768)
T 3rgz_A          606 RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLR-----  680 (768)
T ss_dssp             GGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT-----
T ss_pred             ccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCC-----
Confidence                                   23567889999999998 6788999999999999999999999999999888     


Q ss_pred             ccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccCccccCCCCC
Q 005760          249 SCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNL  319 (678)
Q Consensus       249 ~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~c~~~~~  319 (678)
                           +|+.|||++|++++.+|..+..++.|++|++++|++++.+|....+..+...++.|||..|+.|..
T Consensus       681 -----~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~  746 (768)
T 3rgz_A          681 -----GLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP  746 (768)
T ss_dssp             -----TCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC
T ss_pred             -----CCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc
Confidence                 999999999999999999999999999999999999999999999999999999999999998843

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1e-39  Score=366.21  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=201.5

Q ss_pred             ccccCCCceeEEEEEe---CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||.||+|.+   +.++.||||+++....  ...+.+.+|+++++.++||||+++++++.+ +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999954   3568899999975432  345788999999999999999999999975 457899999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC-ccee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ-STIQ  551 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~  551 (678)
                      |+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++....... ....
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999997654 4899999999999999999999   89999999999999999999999999999987653322 2223


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccch
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI  630 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  630 (678)
                      ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+  ....+.....        ..       
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~--------~~-------  592 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGER--------MG-------  592 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCC--------CC-------
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC--------CC-------
Confidence            34457789999999999999999999999999999998 999997643321  1111111000        00       


Q ss_pred             hhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       631 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                         .+..++.++.+++.+||+.||++||++.+++++|+++..++.
T Consensus       593 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~  634 (635)
T 4fl3_A          593 ---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  634 (635)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred             ---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence               011355678999999999999999999999999999987653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.9e-39  Score=340.33  Aligned_cols=275  Identities=21%  Similarity=0.253  Sum_probs=202.0

Q ss_pred             CHHHHHHhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCc-----------hhhhHHHHHHHHHhCCCccce
Q 005760          383 SYLELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGR-----------VFKSFDVECEMMKSIRHRNII  451 (678)
Q Consensus       383 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv  451 (678)
                      ...++....++|++.+.||+|+||.||+|...+|+.||||++......           ..+.+.+|+++++.++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            346778889999999999999999999999888999999998543221           126788999999999999999


Q ss_pred             eeeeeee-----cCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec
Q 005760          452 KVISSCS-----NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD  526 (678)
Q Consensus       452 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~  526 (678)
                      ++++++.     .....++||||++ |+|.+++......+++..+..++.|++.||.|||   +++|+||||||+||+++
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~  168 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLA  168 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEC
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEEc
Confidence            9999983     3447899999997 5999998877667999999999999999999999   89999999999999999


Q ss_pred             CCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchh
Q 005760          527 DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK  605 (678)
Q Consensus       527 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~  605 (678)
                      .++.+||+|||++......   .......+|+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+....+ ...
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~  244 (362)
T 3pg1_A          169 DNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-QLN  244 (362)
T ss_dssp             TTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHH
T ss_pred             CCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-HHH
Confidence            9999999999999754322   22345578999999998876 678999999999999999999999997632211 111


Q ss_pred             hhhhcccCCc-----------ccccccCccCCccc-hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          606 HWVNDWLPIS-----------TKEIVDPNLLSRED-INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       606 ~~~~~~~~~~-----------~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..........           .............. ........+++.+.+++.+||+.||++|||+.|+++
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            1110000000           00000000000000 000111234567899999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.6e-39  Score=337.73  Aligned_cols=264  Identities=19%  Similarity=0.298  Sum_probs=206.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCch-----------------hhhHHHHHHHHHhCCCccceee
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRV-----------------FKSFDVECEMMKSIRHRNIIKV  453 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~  453 (678)
                      .++|++.+.||+|+||.||+|.. +++.||+|++.......                 .+.+.+|+++++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999998 89999999996542211                 1778999999999999999999


Q ss_pred             eeeeecCCeEEEEEEecCCCCHHHH------hhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEcCCCCCCeee
Q 005760          454 ISSCSNEEFKALVLEYMPHGSLEKY------LHSS-NYILDIYQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPSNVLL  525 (678)
Q Consensus       454 ~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dl~~~Nill  525 (678)
                      ++++.+.+..++||||+++++|.++      +... ...+++..+..++.|++.||+|||   + ++|+||||+|+||++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEE
Confidence            9999999999999999999999998      6542 346899999999999999999999   7 999999999999999


Q ss_pred             cCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCC-CCCc-cchHHHHHHHHHHHHcCCCCCCcccCCccc
Q 005760          526 DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-RVSA-NGDVYSFGIMLMETFTRKKPTDEIFNGEMT  603 (678)
Q Consensus       526 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwslGv~l~ell~g~~p~~~~~~~~~~  603 (678)
                      +.++.+||+|||.+......    ......+++.|+|||.+.+. .++. ++||||+|+++|||++|+.||.........
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99999999999999765322    34456799999999999877 5665 999999999999999999999764432222


Q ss_pred             hhhhhhcccCCc--ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          604 LKHWVNDWLPIS--TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       604 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ............  ......+. ...  ........++.++.+++.+||+.||++|||+.|+++
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPL-TNK--KSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTT-CC----------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHhccCcCCccchhhhhccc-ccc--ccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            221111111000  00000000 000  000111345677999999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.1e-40  Score=342.75  Aligned_cols=252  Identities=23%  Similarity=0.328  Sum_probs=198.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ..++|++.+.||+|+||.||+|..+ +++.||+|++....    ....+|++++.++ +||||+++++++.+.+..|+||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3567999999999999999999864 78999999997543    2345688888887 7999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-C---CcEEEEeeccccccC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-N---MVAHLSDFGIAKLLT  543 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-~---~~~kl~Dfg~~~~~~  543 (678)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+||++.. +   +.+||+|||+++...
T Consensus        96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999997665 4899999999999999999999   999999999999999843 2   359999999998654


Q ss_pred             CCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ...  .......+|+.|+|||++.+..++.++||||+||++|||++|..||......  ............... .... 
T Consensus       172 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~~~~-~~~~-  245 (342)
T 2qr7_A          172 AEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIGSGKFS-LSGG-  245 (342)
T ss_dssp             CTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHHHCCCC-CCST-
T ss_pred             CCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHccCCcc-cCcc-
Confidence            322  2233457899999999998888999999999999999999999999753211  111111110000000 0000 


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                ....++.++.+++.+||+.||++||++.|+++
T Consensus       246 ----------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          246 ----------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ----------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                      00123556889999999999999999999876

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.7e-40  Score=335.38  Aligned_cols=260  Identities=26%  Similarity=0.402  Sum_probs=199.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC--CCc--EEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG--DGM--EVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  463 (678)
                      .++|++.+.||+|+||.||+|.+.  +++  .||+|++...   .....+.+.+|+++++.++||||+++++++.+.+ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            467899999999999999999742  333  6899998654   2345577889999999999999999999998765 7


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++|+||+++++|.+++......+++..+..++.|++.||.|||   +++++|+||||+||+++.++.+||+|||++....
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            8999999999999999876566899999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCCc-ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          544 REDQS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       544 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      ..... .......++..|+|||.+.+..++.++||||+|+++|||++ |+.||......+  ....+..   ... ....
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~---~~~-~~~~  246 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDK---EGE-RLPR  246 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHT---SCC-CCCC
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--HHHHHHc---cCC-CCCC
Confidence            43322 12334567888999999988889999999999999999999 999987532211  1111100   000 0000


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                                   +..++.++.+++.+||+.||++|||+.|+++.|++++..
T Consensus       247 -------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          247 -------------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             -------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             -------------CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence                         012456688999999999999999999999999998654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.8e-39  Score=328.98  Aligned_cols=251  Identities=22%  Similarity=0.326  Sum_probs=202.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            3567899999999999999999864 799999999976544445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee---cCCCcEEEEeeccccccCCC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill---~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      |+++++|.+++...+ .+++..+..++.|++.|+.|||   +.+|+||||||+||++   +.++.+||+|||++......
T Consensus        87 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           87 LVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             cCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            999999999987654 4889999999999999999999   8999999999999999   78899999999998754321


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                          ......+++.|+|||.+.+..++.++||||+|+++|||++|+.||....... ...........     ...+   
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~-----~~~~---  229 (304)
T 2jam_A          163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKIKEGYYE-----FESP---  229 (304)
T ss_dssp             ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHCCCC-----CCTT---
T ss_pred             ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCC-----CCcc---
Confidence                1233468999999999999999999999999999999999999997532211 11111111100     0000   


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              ....++.++.+++.+||+.||++||++.|+++
T Consensus       230 --------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          230 --------FWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             --------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             --------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                    00123456889999999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.7e-39  Score=352.79  Aligned_cols=251  Identities=23%  Similarity=0.316  Sum_probs=202.8

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ..++|++.+.||+|+||+||+|... +++.||||++....  ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4567999999999999999999864 79999999996432  33457788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec---CCCcEEEEeeccccccC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~---~~~~~kl~Dfg~~~~~~  543 (678)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||   +++|+||||||+||+++   .++.+||+|||+++...
T Consensus       100 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            99999999999987654 4899999999999999999999   99999999999999995   56689999999997654


Q ss_pred             CCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ..   .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+....+. ............        
T Consensus       176 ~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~--------  242 (486)
T 3mwu_A          176 QN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-LKRVETGKYAFD--------  242 (486)
T ss_dssp             CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCCSC--------
T ss_pred             CC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCCC--------
Confidence            32   22345679999999999875 589999999999999999999999976322111 111111100000        


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              ......+++++.+++.+||+.||++|||+.|+++
T Consensus       243 --------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          243 --------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             --------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             --------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                    0011234566889999999999999999999987

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2e-39  Score=332.68  Aligned_cols=253  Identities=24%  Similarity=0.338  Sum_probs=200.8

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            4568999999999999999999865 689999999976655667888999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+++++|.+++......+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......  .
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--L  171 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--H
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--c
Confidence            99999999999876667999999999999999999999   899999999999999999999999999987543211  1


Q ss_pred             ceeecccCCccccCcccc-----CCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          549 TIQTQTLATIGYMAPEYG-----KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      .......+++.|+|||.+     .+..++.++||||||+++|+|++|+.||........ .........         +.
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~---------~~  241 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSDP---------PT  241 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSCC---------CC
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHhccCC---------cc
Confidence            122345689999999987     466789999999999999999999999875332111 111111100         00


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..        .+..++.++.+++.+||+.||++|||+.|+++
T Consensus       242 ~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 LL--------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CS--------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cC--------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00        01123456889999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.3e-38  Score=344.82  Aligned_cols=262  Identities=18%  Similarity=0.207  Sum_probs=210.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCC-ccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRH-RNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.....  ...+..|+++++.++| +++..+..++.+.+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999985 5799999999865433  3568899999999987 455566666677888899999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee---cCCCcEEEEeeccccccCCC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill---~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      |+ +++|.+++......+++..++.++.||+.||+|||   +++|+||||||+|||+   +.++.+||+|||+++.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 89999999876667999999999999999999999   9999999999999999   68899999999999876543


Q ss_pred             CCc-----ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccc--hhhhhhcccCCcccc
Q 005760          546 DQS-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT--LKHWVNDWLPISTKE  618 (678)
Q Consensus       546 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~  618 (678)
                      ...     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  +...........   
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~---  236 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS---  236 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC---
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc---
Confidence            221     1223567999999999999999999999999999999999999999764332111  111000000000   


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                                  .......++.++.+++.+||+.||++||++.++++.|+.+...
T Consensus       237 ------------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          237 ------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             ------------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ------------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence                        0001123567799999999999999999999999999998764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.2e-39  Score=338.06  Aligned_cols=255  Identities=25%  Similarity=0.360  Sum_probs=205.2

Q ss_pred             HHHhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--------chhhhHHHHHHHHHhC-CCccceeeeee
Q 005760          387 LCRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--------RVFKSFDVECEMMKSI-RHRNIIKVISS  456 (678)
Q Consensus       387 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~~~~~  456 (678)
                      .....++|++.+.||+|+||.||+|... +|+.||||++.....        ...+.+.+|+.+++.+ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445678999999999999999999865 799999999975432        1245678899999999 79999999999


Q ss_pred             eecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEee
Q 005760          457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF  536 (678)
Q Consensus       457 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Df  536 (678)
                      +...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||   +.||+|+||||+||+++.++.+||+||
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEec
Confidence            999999999999999999999998654 4899999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceeecccCCccccCccccCC------CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhc
Q 005760          537 GIAKLLTREDQSTIQTQTLATIGYMAPEYGKE------GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND  610 (678)
Q Consensus       537 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~  610 (678)
                      |++.......   ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||......  .....+..
T Consensus       245 G~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~i~~  319 (365)
T 2y7j_A          245 GFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI--LMLRMIME  319 (365)
T ss_dssp             TTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred             CcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHh
Confidence            9998764322   2344679999999998753      35888999999999999999999999652211  11111110


Q ss_pred             ccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          611 WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..           .    .........++.++.+++.+||+.||++|||+.|+++
T Consensus       320 ~~-----------~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          320 GQ-----------Y----QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             TC-----------C----CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CC-----------C----CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00           0    0000111234566889999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3e-39  Score=328.21  Aligned_cols=246  Identities=25%  Similarity=0.352  Sum_probs=203.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            467999999999999999999864 68899999986532   23346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.+++.... .+++..+..++.|++.|+.|||   +.+|+||||+|+||+++.++.+||+|||++...... 
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            99999999999998765 4899999999999999999999   999999999999999999999999999998765322 


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                         ......+++.|+|||.+.+..++.++||||+|+++|+|++|+.||......+. .......    .   ...+    
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~----~---~~~~----  232 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-HRRIVNV----D---LKFP----  232 (284)
T ss_dssp             ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTT----C---CCCC----
T ss_pred             ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-HHHHhcc----c---cCCC----
Confidence               22345689999999999998999999999999999999999999975322111 1111000    0   0000    


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               ...+.++.+++.+||+.||++||++.|+++
T Consensus       233 ---------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          233 ---------PFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             ---------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                     123455889999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=329.19  Aligned_cols=252  Identities=27%  Similarity=0.362  Sum_probs=201.0

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ...++|++.+.||+|+||.||+|... +|+.||+|++....  ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34678999999999999999999864 69999999997543  3467889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++++|.+++......+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.+||+|||.+......  
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--  178 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence            999999999999865566999999999999999999999   999999999999999999999999999999765432  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      ........+++.|+|||.+.+..++.++||||+|+++|+|++|+.||........  ........        .+...  
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~--------~~~~~--  246 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--IFMIPTNP--------PPTFR--  246 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSC--------CCCCS--
T ss_pred             ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhcCC--------CcccC--
Confidence            2223445789999999999998999999999999999999999999975322111  00000000        00000  


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                            .+..++.++.+++.+||+.||++|||+.|+++
T Consensus       247 ------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          247 ------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                  01123456889999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=325.56  Aligned_cols=250  Identities=25%  Similarity=0.394  Sum_probs=198.2

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      +|.....||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            455556999999999999985 5789999999977655666788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-CCcEEEEeeccccccCCCCCc
Q 005760          472 HGSLEKYLHSSNY--ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       472 ~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++|.+++.....  ..++..+..++.|++.||+|||   +++|+|+||+|+||+++. ++.+||+|||.+.......  
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--  177 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--  177 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence            9999999986532  4568889999999999999999   899999999999999987 8999999999998664321  


Q ss_pred             ceeecccCCccccCccccCCCC--CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          549 TIQTQTLATIGYMAPEYGKEGR--VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                      .......+++.|+|||.+.+..  ++.++||||||+++|||++|+.||...............  ..      ..+... 
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~------~~~~~~-  248 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM--FK------VHPEIP-  248 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH--HC------CCCCCC-
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc--cc------cccccc-
Confidence            2233456899999999987653  789999999999999999999999753322111111000  00      000000 


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               ..++.++.+++.+||+.||++||++.|+++
T Consensus       249 ---------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          249 ---------ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             ---------TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ---------ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                     123456889999999999999999999975

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.5e-39  Score=333.75  Aligned_cols=264  Identities=24%  Similarity=0.337  Sum_probs=187.2

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ....++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            44568899999999999999999985 478999999986442 2345678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhh-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecc
Q 005760          466 VLEYMPHGSLEKYLHS-------SNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGI  538 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~  538 (678)
                      ||||+++++|.+++..       ....+++..+..++.|++.||+|||   +++++||||+|+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999999874       2345899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCC---cceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC
Q 005760          539 AKLLTREDQ---STIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI  614 (678)
Q Consensus       539 ~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  614 (678)
                      +........   ........+++.|+|||++.+ ..++.++||||+|+++|||++|+.||........... ......+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~  246 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-TLQNDPPS  246 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-HHTSSCCC
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-HhccCCCc
Confidence            976543211   112234568999999998876 5689999999999999999999999976433221111 11111110


Q ss_pred             cccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ......++...          ..++.++.+++.+||+.||++||++.|+++
T Consensus       247 ~~~~~~~~~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          247 LETGVQDKEML----------KKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             TTC-----CCC----------CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cccccccchhh----------hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00011111111          123456889999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.2e-39  Score=351.84  Aligned_cols=253  Identities=24%  Similarity=0.312  Sum_probs=204.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|...+.||+|+||.||+|+.+ +|+.||+|++....   ....+.+..|+++++.++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367888999999999999999864 79999999996542   23346788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          467 LEYMPHGSLEKYLHSSN---YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      |||+++|+|.+++....   ..+++..+..++.||+.||+|||   +++|+||||||+||+++.+|.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999987643   35899999999999999999999   9999999999999999999999999999998764


Q ss_pred             CCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ....  ......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ............   ..-| 
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~~~~---~~~p-  413 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVLEQA---VTYP-  413 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHHHCC---CCCC-
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHhhcc---cCCC-
Confidence            3221  22345799999999999999999999999999999999999999976432211 111111100000   0000 


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCH-----HHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA-----KEIVT  665 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~ell~  665 (678)
                                  ..+++++.+++.+||+.||++||++     .|+++
T Consensus       414 ------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          414 ------------DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ------------TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ------------cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                        1234568899999999999999965     56653

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.2e-39  Score=330.90  Aligned_cols=248  Identities=19%  Similarity=0.287  Sum_probs=204.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467899999999999999999865 68899999987542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.+++.... .+++..+..++.|++.|++|||   +++++||||||+||+++.++.+||+|||++.......
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999987654 4899999999999999999999   8999999999999999999999999999998764322


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                        .......+++.|+|||.+.+..++.++||||+|+++|+|++|+.||......+. ........       ...+    
T Consensus       170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~-------~~~~----  235 (294)
T 2rku_A          170 --ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNE-------YSIP----  235 (294)
T ss_dssp             --CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHTTC-------CCCC----
T ss_pred             --cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHhhcc-------CCCc----
Confidence              223445689999999999988899999999999999999999999975322111 11110000       0000    


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               ..++..+.+++.+||+.||++|||+.|+++
T Consensus       236 ---------~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          236 ---------KHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             ---------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---------cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                     113345889999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-38  Score=326.13  Aligned_cols=249  Identities=27%  Similarity=0.379  Sum_probs=205.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .+.|+..+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            45788999999999999999975 578999999997553 3345778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+++++|.+++...  .+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.+||+|||++.......  
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            99999999999764  4899999999999999999999   8999999999999999999999999999997654322  


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......  ....+....        .+...   
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~--------~~~~~---  240 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKNN--------PPTLE---  240 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSC--------CCCCC---
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcCC--------CCCCc---
Confidence            22345578999999999999999999999999999999999999986532211  111111000        00000   


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                             ..++.++.+++.+||+.||++|||+.|+++.
T Consensus       241 -------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          241 -------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             -------SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             -------cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                   1234558899999999999999999999874

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.4e-39  Score=351.42  Aligned_cols=251  Identities=22%  Similarity=0.339  Sum_probs=201.8

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-------------chhhhHHHHHHHHHhCCCccceeeee
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-------------RVFKSFDVECEMMKSIRHRNIIKVIS  455 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~  455 (678)
                      ..++|.+.+.||+|+||+||+|... +++.||+|++.....             ...+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999854 689999999865321             23467889999999999999999999


Q ss_pred             eeecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC---cEE
Q 005760          456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM---VAH  532 (678)
Q Consensus       456 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~---~~k  532 (678)
                      ++.+.+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++   .+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEE
Confidence            9999999999999999999999987654 4899999999999999999999   89999999999999998776   699


Q ss_pred             EEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc
Q 005760          533 LSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL  612 (678)
Q Consensus       533 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  612 (678)
                      |+|||++......   .......||+.|+|||++. +.++.++||||+||++|+|++|..||.+....+  ....+... 
T Consensus       190 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~i~~~-  262 (504)
T 3q5i_A          190 IVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--IIKKVEKG-  262 (504)
T ss_dssp             ECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHC-
T ss_pred             EEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHcC-
Confidence            9999999876432   2234457999999999886 468999999999999999999999997633211  11111100 


Q ss_pred             CCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          613 PISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                .    ..........+++++.+++.+||++||.+|||+.|+++
T Consensus       263 ----------~----~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          263 ----------K----YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             ----------C----CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ----------C----CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                      0    00011112235667899999999999999999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.7e-39  Score=336.15  Aligned_cols=267  Identities=25%  Similarity=0.360  Sum_probs=200.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            467889999999999999999864 689999999865432  23456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++++|.++..... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus       104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  178 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  178 (331)
T ss_dssp             ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence            9999988888766544 4899999999999999999999   8999999999999999999999999999997654322 


Q ss_pred             cceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc-----------C-C
Q 005760          548 STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL-----------P-I  614 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-----------~-~  614 (678)
                       .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||......+. .........           . .
T Consensus       179 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          179 -EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             -cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCChhhhhHhhhcc
Confidence             223445689999999988775 689999999999999999999999976332211 111100000           0 0


Q ss_pred             cccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .......+......... .....+++++.+++.+||+.||++|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLE-RRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGTTCCCCCCSSCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ccccccCccccccchhh-hcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00011111111111111 111245677999999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.7e-39  Score=352.53  Aligned_cols=250  Identities=22%  Similarity=0.332  Sum_probs=198.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      .++|++.+.||+|+||.||+|..+ ++..||+|++....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457899999999999999999864 78999999997542  234577889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC---CCcEEEEeeccccccCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~---~~~~kl~Dfg~~~~~~~  544 (678)
                      ||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.   ++.+||+|||++.....
T Consensus       116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999999887654 4899999999999999999999   899999999999999975   45599999999987643


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      .   .......||+.|+|||++. +.++.++||||+||++|+|++|..||.+....+. ..........     ...+  
T Consensus       192 ~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~-----~~~~--  259 (494)
T 3lij_A          192 Q---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-LRKVEKGKYT-----FDSP--  259 (494)
T ss_dssp             T---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCC-----CCSG--
T ss_pred             C---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC-----CCch--
Confidence            2   2234567999999999876 5689999999999999999999999976332211 1111111000     0000  


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               ....+++++.+++.+||++||.+|||+.|+++
T Consensus       260 ---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          260 ---------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             ---------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                     01124556889999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.3e-39  Score=333.90  Aligned_cols=262  Identities=21%  Similarity=0.285  Sum_probs=199.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-Cccceeeeeeeec--CCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSCSN--EEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++..   ...+.+.+|+++++.++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            46799999999999999999974 5789999999863   33477889999999997 9999999999987  6678999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC-cEEEEeeccccccCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTRE  545 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~-~~kl~Dfg~~~~~~~~  545 (678)
                      |||+++++|.+++..    ++...+..++.|++.||+|||   +++|+||||||+||+++.++ .+||+|||+++.....
T Consensus       112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999999853    788899999999999999999   99999999999999999776 8999999999866432


Q ss_pred             CCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCc---------
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS---------  615 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---------  615 (678)
                      .   ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.........+...........         
T Consensus       185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            2   2344578999999998877 66899999999999999999999998542221111111110000000         


Q ss_pred             ------ccccccCccCCc--cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          616 ------TKEIVDPNLLSR--EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       616 ------~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                            ............  ..........+++++.+++.+||++||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  000000000000  00000001124667899999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.3e-39  Score=342.02  Aligned_cols=262  Identities=12%  Similarity=0.126  Sum_probs=186.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC---chhhhHHHHHHHHHhC--CCccceeee-------eee
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG---RVFKSFDVECEMMKSI--RHRNIIKVI-------SSC  457 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~~~-------~~~  457 (678)
                      ..+|.+.+.||+|+||.||+|... +|+.||+|++.....   ...+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            345888999999999999999854 899999999976432   3345667785544444  699988755       333


Q ss_pred             ecC-----------------CeEEEEEEecCCCCHHHHhhhCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCeE
Q 005760          458 SNE-----------------EFKALVLEYMPHGSLEKYLHSSNYILDIYQR------LNIMIDVASALEYLHFGYSAQVI  514 (678)
Q Consensus       458 ~~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~iv  514 (678)
                      ...                 ...++||||++ ++|.+++......++...+      ..++.||+.||+|||   +++|+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence            222                 34799999998 8999999875444555556      778899999999999   99999


Q ss_pred             EcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCC--CCCCccchHHHHHHHHHHHHcCCC
Q 005760          515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLMETFTRKK  592 (678)
Q Consensus       515 H~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~ell~g~~  592 (678)
                      ||||||+||+++.++.+||+|||+++....     ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999986532     1224567799999999987  679999999999999999999999


Q ss_pred             CCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH--HHHHH
Q 005760          593 PTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT--KLLKI  670 (678)
Q Consensus       593 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~--~L~~~  670 (678)
                      ||..........  +.....    .........      ......+++++.+++.+||++||++|||+.|+++  .++++
T Consensus       292 Pf~~~~~~~~~~--~~~~~~----~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          292 PFGLVTPGIKGS--WKRPSL----RVPGTDSLA------FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             STTBCCTTCTTC--CCBCCT----TSCCCCSCC------CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CCCCcCcccccc--hhhhhh----hhccccccc------hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            998754332111  100000    000000000      0001134566889999999999999999999985  45555


Q ss_pred             HHH
Q 005760          671 RDS  673 (678)
Q Consensus       671 ~~~  673 (678)
                      ...
T Consensus       360 ~~~  362 (371)
T 3q60_A          360 QNE  362 (371)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-39  Score=339.48  Aligned_cols=260  Identities=25%  Similarity=0.339  Sum_probs=194.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCC------
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEE------  461 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  461 (678)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++.....  ...+.+.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999985 5799999999854322  23467889999999999999999999987653      


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..|+||||+ +++|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            469999999 78999999874  4899999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV  620 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (678)
                      ....     .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+..... .......+..
T Consensus       178 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~-~~g~~~~~~~  250 (367)
T 1cm8_A          178 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMK-VTGTPPAEFV  250 (367)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH-HHCCCCHHHH
T ss_pred             cccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-hcCCCCHHHH
Confidence            5422     234578999999998876 678999999999999999999999997532211 1111110 0000000000


Q ss_pred             c--------------CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          621 D--------------PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       621 ~--------------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .              +.........  ....+++++.+++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFAS--ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGG--TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHH--HCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            0              0000000000  00134567899999999999999999999987

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-38  Score=335.32  Aligned_cols=261  Identities=22%  Similarity=0.247  Sum_probs=192.8

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCC------
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE------  461 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  461 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....  ....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46899999999999999999975 478999999997532  233466789999999999999999999987654      


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..++||||+++ +|.+++..   .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            78999999975 78888863   3889999999999999999999   89999999999999999999999999999976


Q ss_pred             cCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC--------
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP--------  613 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------  613 (678)
                      ....   .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .....+.....        
T Consensus       177 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          177 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CCCCCHHHHTT
T ss_pred             cccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHHH
Confidence            5322   22344678999999999999899999999999999999999999997632211 01110000000        


Q ss_pred             -----------------CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          614 -----------------ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       614 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                       ....... +....  ..........+.++.+++.+||+.||++|||++|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLF-PDVLF--PADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHS-CGGGS--CCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhHHHHHHhhCccccccchhhhc-ccccC--cccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                             0000000 00000  0011122345678999999999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.5e-39  Score=336.85  Aligned_cols=248  Identities=19%  Similarity=0.288  Sum_probs=204.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|.+.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467899999999999999999864 68899999987542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++.......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999987654 4899999999999999999999   8999999999999999999999999999998764322


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                        .......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+. .........       ..+    
T Consensus       196 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~-------~~~----  261 (335)
T 2owb_A          196 --ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNEY-------SIP----  261 (335)
T ss_dssp             --CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCC-------CCC----
T ss_pred             --ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHhcCCC-------CCC----
Confidence              223445689999999999988899999999999999999999999965322111 111100000       000    


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               ..++.++.+++.+||+.||++||++.|+++
T Consensus       262 ---------~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          262 ---------KHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             ---------TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             ---------ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     113345889999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.2e-39  Score=327.46  Aligned_cols=251  Identities=24%  Similarity=0.297  Sum_probs=188.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++.....  ...+.+.++...++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            356889999999999999999985 5899999999965422  2223344555668888999999999999999999999


Q ss_pred             EEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          467 LEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      |||+++ +|.+++..   ....+++..+..++.|++.|++|||   ++ +|+||||||+||+++.++.+||+|||++...
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999975 88887754   3456899999999999999999999   87 9999999999999999999999999999765


Q ss_pred             CCCCCcceeecccCCccccCcccc----CCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYG----KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE  618 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  618 (678)
                      ...   .......+|+.|+|||.+    .+..++.++||||+|+++|||++|+.||..................+.    
T Consensus       161 ~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----  233 (290)
T 3fme_A          161 VDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ----  233 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC----
T ss_pred             ccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC----
Confidence            432   222334689999999985    566789999999999999999999999975333222222222111100    


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           ..         ...+++++.+++.+||+.||++|||+.|+++
T Consensus       234 -----~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          234 -----LP---------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -----CC---------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----cc---------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                 00         0123456889999999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.8e-39  Score=340.16  Aligned_cols=267  Identities=21%  Similarity=0.311  Sum_probs=202.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            457999999999999999999864 78999999997653 2345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+++++|.+++.... .+++..+..++.|++.|++|||   +. +|+||||||+||+++.++.+||+|||++......  
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999998765 4889999999999999999999   75 8999999999999999999999999998754321  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhh--c----ccC------Cc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN--D----WLP------IS  615 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~--~----~~~------~~  615 (678)
                        ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...............  .    ..+      ..
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence              223457899999999999999999999999999999999999999753221110000000  0    000      00


Q ss_pred             ccccccCccCCccchhhH-----------HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          616 TKEIVDPNLLSREDINFV-----------AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       616 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..................           ....++.++.+++.+||+.||++|||+.|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            000000000000000000           00124567899999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.9e-39  Score=325.20  Aligned_cols=247  Identities=27%  Similarity=0.380  Sum_probs=195.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            468999999999999999999865 79999999996542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   +++++|+||+|+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999997665 4889999999999999999999   8999999999999999999999999999997654322


Q ss_pred             CcceeecccCCccccCccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                         ......+++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||......  .....+....      ...+   
T Consensus       166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~------~~~~---  231 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--TLFKKIRGGV------FYIP---  231 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCC------CCCC---
T ss_pred             ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--HHHHHhhcCc------ccCc---
Confidence               2234568999999999887765 68999999999999999999998653211  1111111000      0001   


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                ..++.++.+++.+||+.||++|||+.|+++
T Consensus       232 ----------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          232 ----------EYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ----------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                      113455889999999999999999999987

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-38  Score=337.21  Aligned_cols=271  Identities=24%  Similarity=0.303  Sum_probs=199.2

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeec-------
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN-------  459 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------  459 (678)
                      ....++|++.+.||+|+||.||+|.. .+|+.||+|++....    ....+|+++++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999975 589999999986442    223479999999999999999998843       


Q ss_pred             -------------------------------CCeEEEEEEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHH
Q 005760          460 -------------------------------EEFKALVLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYL  505 (678)
Q Consensus       460 -------------------------------~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~L  505 (678)
                                                     ....++||||+++ +|.+.+..   ....+++..+..++.|++.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           3348899999984 88777653   344689999999999999999999


Q ss_pred             hcCCCCCeEEcCCCCCCeeec-CCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHH
Q 005760          506 HFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIM  583 (678)
Q Consensus       506 H~~~~~~ivH~dl~~~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~  583 (678)
                      |   +++|+||||||+||+++ .++.+||+|||+++......   ......+|+.|+|||.+.+. .++.++||||+||+
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9   99999999999999998 68999999999998764332   23345689999999988765 48999999999999


Q ss_pred             HHHHHcCCCCCCcccCCccchhhhhhcccCC----------cccccccCccCCccchhhHHHHHHHHHHHHHHhhccccC
Q 005760          584 LMETFTRKKPTDEIFNGEMTLKHWVNDWLPI----------STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVES  653 (678)
Q Consensus       584 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d  653 (678)
                      +|||++|+.||.+....+ .+...+......          ......-+... ........+..++.++.+++.+||++|
T Consensus       232 l~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          232 FGELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLK-AKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCC-CCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHhCcccccccCCccC-cccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            999999999997633221 111111100000          00000011111 111111112235677999999999999


Q ss_pred             cCCCCCHHHHHH--HHHHHH
Q 005760          654 PEQRINAKEIVT--KLLKIR  671 (678)
Q Consensus       654 P~~Rps~~ell~--~L~~~~  671 (678)
                      |++|||+.|+++  .++.++
T Consensus       310 P~~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          310 PDLRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             GGGSCCHHHHHTSGGGHHHH
T ss_pred             hhhCCCHHHHhcCHHHHHHH
Confidence            999999999984  344443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.5e-39  Score=354.21  Aligned_cols=250  Identities=23%  Similarity=0.347  Sum_probs=204.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            457899999999999999999865 89999999996542   23457788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee---cCCCcEEEEeeccccccC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL---DDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill---~~~~~~kl~Dfg~~~~~~  543 (678)
                      |||+.+++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||++   +.++.+||+|||+++...
T Consensus       105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999997655 4899999999999999999999   8999999999999999   567899999999998764


Q ss_pred             CCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          544 REDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       544 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ...   ......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+....+. ............        
T Consensus       181 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~~~--------  247 (484)
T 3nyv_A          181 ASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI-LKKVEKGKYTFE--------  247 (484)
T ss_dssp             CCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCCC--------
T ss_pred             ccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHcCCCCCC--------
Confidence            332   2234569999999998865 689999999999999999999999976322111 111111100000        


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              ......+++++.+++.+||++||++|||+.|+++
T Consensus       248 --------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          248 --------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             --------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                    0011234566889999999999999999999985

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-38  Score=324.76  Aligned_cols=244  Identities=20%  Similarity=0.282  Sum_probs=196.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  465 (678)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467899999999999999999865 79999999997542  23456778899999998 89999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC--------------
Q 005760          466 VLEYMPHGSLEKYLHSSN---YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN--------------  528 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~--------------  528 (678)
                      ||||+++++|.+++....   ..+++..+..++.|++.||+|||   +++|+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999997642   35899999999999999999999   8999999999999999844              


Q ss_pred             -----CcEEEEeeccccccCCCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCcc
Q 005760          529 -----MVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM  602 (678)
Q Consensus       529 -----~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~  602 (678)
                           ..+||+|||.+.......      ...+|+.|+|||.+.+. .++.++|||||||++|||++|.+|+....    
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence                 489999999998764322      23589999999998766 56689999999999999999988764311    


Q ss_pred             chhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          603 TLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..........+         ...          ..+++++.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~---------~~~----------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 QWHEIRQGRLP---------RIP----------QVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HHHHHHTTCCC---------CCS----------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHcCCCC---------CCC----------cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            11111111100         000          123456889999999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-39  Score=338.62  Aligned_cols=254  Identities=23%  Similarity=0.338  Sum_probs=201.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEe----CCCcEEEEEEeeccc----CchhhhHHHHHHHHHhC-CCccceeeeeeeecCC
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL----GDGMEVAMKVFNLQY----GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEE  461 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  461 (678)
                      .++|++.+.||+|+||.||+|+.    .+++.||||+++...    ....+.+.+|+++++.+ +||||+++++++.+.+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36789999999999999999986    478999999986432    23345677899999999 6999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..++||||+++++|.+++.... .+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999998654 4899999999999999999999   89999999999999999999999999999986


Q ss_pred             cCCCCCcceeecccCCccccCccccCCC--CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI  619 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (678)
                      ..... ........||+.|+|||++.++  .++.++|||||||++|||++|+.||........ ...........     
T Consensus       209 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~-----  281 (355)
T 1vzo_A          209 FVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEISRRILKS-----  281 (355)
T ss_dssp             CCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHHHHHHHHC-----
T ss_pred             cccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHHHHHHHhcc-----
Confidence            54322 2223345799999999998753  478899999999999999999999975332211 11111111000     


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVTK  666 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~~  666 (678)
                       .+..          +..++..+.+++.+||+.||++||     +++|+++.
T Consensus       282 -~~~~----------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          282 -EPPY----------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             -CCCC----------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -CCCC----------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence             0000          012345588999999999999999     99999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.9e-38  Score=328.43  Aligned_cols=252  Identities=24%  Similarity=0.299  Sum_probs=197.4

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--------CchhhhHHHHHHHHHhCCCccceeeeeeeecC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--------GRVFKSFDVECEMMKSIRHRNIIKVISSCSNE  460 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  460 (678)
                      ..++|.+.+.||+|+||.||+|.. .+++.||||++....        ......+.+|+++++.++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            346799999999999999999985 468999999986432        12335688999999999999999999998776


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc---EEEEeec
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV---AHLSDFG  537 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~---~kl~Dfg  537 (678)
                      + .++||||+++++|.+++.... .+++..+..++.|++.||.|||   +++|+||||||+||+++.++.   +||+|||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            5 799999999999999997654 5899999999999999999999   899999999999999987654   9999999


Q ss_pred             cccccCCCCCcceeecccCCccccCccccC---CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC
Q 005760          538 IAKLLTREDQSTIQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI  614 (678)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  614 (678)
                      ++......   .......+++.|+|||++.   ...++.++|||||||++|+|++|..||........ ....+..... 
T Consensus       163 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-  237 (322)
T 2ycf_A          163 HSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LKDQITSGKY-  237 (322)
T ss_dssp             TCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HHHHHHHTCC-
T ss_pred             cceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HHHHHHhCcc-
Confidence            99876422   1223456899999999863   56788999999999999999999999975433221 1111110000 


Q ss_pred             cccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                 .   ........++.++.+++.+||+.||++||++.|+++
T Consensus       238 -----------~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          238 -----------N---FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -----------C---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----------c---cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                       0   000011234567899999999999999999999984

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.8e-38  Score=334.29  Aligned_cols=267  Identities=23%  Similarity=0.297  Sum_probs=201.3

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecC-----CeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNE-----EFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  463 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+++++.++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            46899999999999999999985 4789999999964332 2346788999999999999999999998654     468


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++||||++ ++|.+++....  +++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++....
T Consensus       106 ~iv~e~~~-~~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            99999997 49999997654  899999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCCCc-ceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          544 REDQS-TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       544 ~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      ..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+. ....... ......+...
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~-~~~~~~~~~~  257 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGI-LGSPSQEDLN  257 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-HHHHHHH-HCSCCHHHHH
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHHH-hCCCCHHHHH
Confidence            33221 12244579999999997654 4589999999999999999999999976432211 1111110 0000000000


Q ss_pred             C-----------ccCCccchhh-HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 P-----------NLLSREDINF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 ~-----------~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .           .......... .....++.++.+++.+||++||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0           0000000000 000234567899999999999999999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.3e-39  Score=332.11  Aligned_cols=255  Identities=19%  Similarity=0.251  Sum_probs=200.9

Q ss_pred             HHhhcCCCCC-ccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCC-CccceeeeeeeecCCe
Q 005760          388 CRATDGFSEN-NLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEF  462 (678)
Q Consensus       388 ~~~~~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  462 (678)
                      ....+.|.+. +.||+|+||.||+|... +++.||+|++.....  .....+.+|+.+++.++ ||||+++++++.+.+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3445667776 88999999999999854 799999999975432  33567889999999985 6999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC---CCcEEEEeecc
Q 005760          463 KALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGI  538 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~---~~~~kl~Dfg~  538 (678)
                      .++||||+++|+|.+++... ...+++..+..++.|++.||+|||   +++|+||||||+||+++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            99999999999999998653 346899999999999999999999   899999999999999987   78999999999


Q ss_pred             ccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc
Q 005760          539 AKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE  618 (678)
Q Consensus       539 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  618 (678)
                      ++......   ......+|+.|+|||++.+..++.++||||+|+++|||++|+.||......+.. .........     
T Consensus       181 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~i~~~~~~-----  251 (327)
T 3lm5_A          181 SRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY-LNISQVNVD-----  251 (327)
T ss_dssp             CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHTCCC-----
T ss_pred             ccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-HHHHhcccc-----
Confidence            98764322   223457999999999999999999999999999999999999999653322111 111100000     


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      . .+.          ....+++.+.+++.+||+.||++|||++|+++
T Consensus       252 ~-~~~----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          252 Y-SEE----------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             C-CTT----------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             c-Cch----------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            0 000          00123456889999999999999999999975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.2e-39  Score=331.68  Aligned_cols=262  Identities=21%  Similarity=0.336  Sum_probs=202.2

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ....++|++.+.||+|+||.||+|..+.  .||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            3346789999999999999999998753  49999986542  2344667889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++++|.+++...+..+++..+..++.|++.||+|||   +++++||||||+||+++ ++.+||+|||++......
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            99999999999999887767899999999999999999999   89999999999999998 679999999998754321


Q ss_pred             C---CcceeecccCCccccCccccCC---------CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC
Q 005760          546 D---QSTIQTQTLATIGYMAPEYGKE---------GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP  613 (678)
Q Consensus       546 ~---~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  613 (678)
                      .   .........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||........ ........  
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~--  259 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI-IWQMGTGM--  259 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-HHHHHTTC--
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhccCC--
Confidence            1   1122334568899999998764         3578899999999999999999999975322111 11111110  


Q ss_pred             CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                             .+....         ..++.++.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus       260 -------~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          260 -------KPNLSQ---------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             -------CCCCCC---------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             -------CCCCCc---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence                   000000         012344789999999999999999999999999987654

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.9e-38  Score=327.05  Aligned_cols=254  Identities=25%  Similarity=0.379  Sum_probs=196.6

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccC--chhhhHHHHHHHHHhCC--CccceeeeeeeecCCeEE
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIR--HRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~  464 (678)
                      ...++|++.+.||+|+||.||+|...+++.||+|++.....  ...+.+.+|+++++.++  ||||+++++++.+.+..+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            34567999999999999999999988899999999965432  34577889999999997  599999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||| +.+++|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||++++ +.+||+|||++.....
T Consensus       105 lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred             EEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence            9999 55789999998765 5889999999999999999999   899999999999999965 8999999999987654


Q ss_pred             CCCcceeecccCCccccCccccCC-----------CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKE-----------GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP  613 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  613 (678)
                      ...........+++.|+|||.+.+           ..++.++||||||+++|||++|+.||...................
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  258 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  258 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence            333333345578999999998765           468889999999999999999999997533221111111110000


Q ss_pred             CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                           ...+.             .++.++.+++.+||+.||++||++.|+++.
T Consensus       259 -----~~~~~-------------~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          259 -----IEFPD-------------IPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             -----CCCCC-------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----cCCcc-------------cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence                 00000             123458899999999999999999999863

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.1e-38  Score=360.16  Aligned_cols=249  Identities=20%  Similarity=0.268  Sum_probs=203.9

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc---cCchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  464 (678)
                      ..++|++.+.||+|+||.||+|..+ +++.||||++...   .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999854 7889999999753   233456778899999987 7999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+++|+|.++++..+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.++++||+|||+++....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999998765 4899999999999999999999   99999999999999999999999999999986432


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ ........    .   ..-|  
T Consensus       495 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~----~---~~~p--  562 (674)
T 3pfq_A          495 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEH----N---VAYP--  562 (674)
T ss_dssp             TT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHSS----C---CCCC--
T ss_pred             CC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH-HHHHHHhC----C---CCCC--
Confidence            22  22345679999999999999999999999999999999999999997633211 11111110    0   0001  


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCH-----HHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINA-----KEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~-----~ell~  665 (678)
                                 ...+.++.+|+.+||++||++||++     +|+++
T Consensus       563 -----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          563 -----------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -----------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -----------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                       1234568899999999999999997     66653

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.5e-39  Score=360.53  Aligned_cols=259  Identities=23%  Similarity=0.372  Sum_probs=206.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC----CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      .++|++.+.||+|+||.||+|...    .+..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence            456788899999999999999753    356799999865332 345778899999999999999999999854 56899


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++|+|.++++.....+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            99999999999999877667899999999999999999999   899999999999999999999999999999876433


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      . ........+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+  ....+.....        +. 
T Consensus       545 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~~i~~~~~--------~~-  612 (656)
T 2j0j_A          545 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGER--------LP-  612 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHHTCC--------CC-
T ss_pred             c-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHcCCC--------CC-
Confidence            2 222334457789999999988899999999999999999997 899987533221  1111110000        00 


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                               .+..+++++.+++.+||+.||++|||+.|+++.|+++.+.-
T Consensus       613 ---------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          613 ---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                     00134566889999999999999999999999999997654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=325.64  Aligned_cols=251  Identities=21%  Similarity=0.298  Sum_probs=199.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc----CchhhhHHHHHHHHHhCCCccceeeeeee--ecCCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY----GRVFKSFDVECEMMKSIRHRNIIKVISSC--SNEEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~~  463 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....    ....+.+.+|+++++.++||||+++++++  .+.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            47899999999999999999986 478999999996542    23457789999999999999999999998  455688


Q ss_pred             EEEEEecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          464 ALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      ++||||++++ +.+++... ...+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||.+...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 77777643 346899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCCcceeecccCCccccCccccCCCC--CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccc
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEGR--VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV  620 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (678)
                      .............+++.|+|||.+.+..  ++.++||||+|+++|||++|+.||......  .....+...   ..   .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~---~~---~  231 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--KLFENIGKG---SY---A  231 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHC---CC---C
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--HHHHHHhcC---CC---C
Confidence            5433344445567999999999887644  478999999999999999999999753211  111111100   00   0


Q ss_pred             cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHH
Q 005760          621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK  666 (678)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~  666 (678)
                      .+             ..++.++.+++.+||+.||++|||+.|+++.
T Consensus       232 ~~-------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          232 IP-------------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             CC-------------SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CC-------------CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00             1234568899999999999999999999863

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.8e-38  Score=324.82  Aligned_cols=253  Identities=23%  Similarity=0.344  Sum_probs=203.3

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC---------chhhhHHHHHHHHHhCC-Cccceeeeeee
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG---------RVFKSFDVECEMMKSIR-HRNIIKVISSC  457 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~  457 (678)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|++.....         ...+.+.+|+++++.+. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999864 789999999975431         23456788999999996 99999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeec
Q 005760          458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG  537 (678)
Q Consensus       458 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg  537 (678)
                      .+.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||   +++++|+||+|+||+++.++.+||+|||
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEeccc
Confidence            99999999999999999999998654 4899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcceeecccCCccccCccccC------CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcc
Q 005760          538 IAKLLTREDQSTIQTQTLATIGYMAPEYGK------EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW  611 (678)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~  611 (678)
                      ++.......   ......+++.|+|||++.      ...++.++||||+|+++|||++|..||....... .........
T Consensus       170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~  245 (298)
T 1phk_A          170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGN  245 (298)
T ss_dssp             TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC
T ss_pred             chhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-HHHHHhcCC
Confidence            998764322   223456899999999874      4568899999999999999999999986532211 111111100


Q ss_pred             cCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          612 LPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..     ...+           ....++.++.+++.+||+.||++|||+.|+++
T Consensus       246 ~~-----~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          246 YQ-----FGSP-----------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CC-----CCTT-----------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cc-----cCcc-----------cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            00     0000           00124566889999999999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.6e-39  Score=337.01  Aligned_cols=262  Identities=23%  Similarity=0.326  Sum_probs=183.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecC------C
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNE------E  461 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~  461 (678)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++.....  ...+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            47899999999999999999974 5799999999865322  3456778999999999999999999998654      5


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..++|+||+ +++|.+++...  .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 67999988763  4899999999999999999999   99999999999999999999999999999976


Q ss_pred             cCCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV  620 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (678)
                      ....     .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+ .+..... .......+..
T Consensus       182 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~-~~g~p~~~~~  254 (367)
T 2fst_X          182 TADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILR-LVGTPGAELL  254 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH-HHCSCCHHHH
T ss_pred             cccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HhCCCCHHHH
Confidence            5321     234578999999998876 678999999999999999999999997633211 1111111 0000000000


Q ss_pred             cC-----------ccCCccchhhH-HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          621 DP-----------NLLSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       621 ~~-----------~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..           .+.......+. ....+++++.+|+.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            00           00000000000 00134567899999999999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.2e-39  Score=324.50  Aligned_cols=252  Identities=23%  Similarity=0.320  Sum_probs=200.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeee--cCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCS--NEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l  465 (678)
                      .++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+++++.++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467899999999999999999864 78999999997543  234567889999999999999999999874  4678899


Q ss_pred             EEEecCCCCHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-----eEEcCCCCCCeeecCCCcEEEEeec
Q 005760          466 VLEYMPHGSLEKYLHSS---NYILDIYQRLNIMIDVASALEYLHFGYSAQ-----VIHCDLKPSNVLLDDNMVAHLSDFG  537 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dl~~~Nill~~~~~~kl~Dfg  537 (678)
                      ||||+++++|.+++...   ...+++..++.++.|++.||+|||   +.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999753   234899999999999999999999   777     9999999999999999999999999


Q ss_pred             cccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccc
Q 005760          538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK  617 (678)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  617 (678)
                      .+.......  .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......  .....+....   . 
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~i~~~~---~-  233 (279)
T 2w5a_A          162 LARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREGK---F-  233 (279)
T ss_dssp             HHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHTC---C-
T ss_pred             hheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHHHhhcc---c-
Confidence            997654321  1123356899999999999888999999999999999999999998753221  1111111000   0 


Q ss_pred             ccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHH
Q 005760          618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL  667 (678)
Q Consensus       618 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L  667 (678)
                          +..          +..++.++.+++.+||+.||++||++.|+++.+
T Consensus       234 ----~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          234 ----RRI----------PYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             ----CCC----------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             ----ccC----------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence                000          012345688999999999999999999999754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.2e-38  Score=340.25  Aligned_cols=197  Identities=23%  Similarity=0.318  Sum_probs=171.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhC------CCccceeeeeeeecCCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI------RHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~  463 (678)
                      ..+|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+|+++++.+      .|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            45799999999999999999975 468999999996432 2345677788888877      577999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc--EEEEeecccc
Q 005760          464 ALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV--AHLSDFGIAK  540 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~--~kl~Dfg~~~  540 (678)
                      ++||||+. ++|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+||+++.++.  +||+|||++.
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 59999987654 35899999999999999999999   899999999999999999887  9999999997


Q ss_pred             ccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcc
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEI  597 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~  597 (678)
                      .....     .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            54322     23457899999999999999999999999999999999999999764

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=330.44  Aligned_cols=256  Identities=25%  Similarity=0.343  Sum_probs=198.1

Q ss_pred             HHHHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeec---
Q 005760          385 LELCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSN---  459 (678)
Q Consensus       385 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~---  459 (678)
                      .++....++|++.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|+.+++.+ +||||+++++++..   
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            34445678899999999999999999986 578999999997543 3457788999999998 79999999999866   


Q ss_pred             ---CCeEEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEe
Q 005760          460 ---EEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD  535 (678)
Q Consensus       460 ---~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~D  535 (678)
                         .+..++||||+++++|.+++.... ..++...+..++.|++.||+|||   +.+|+|+||||+||+++.++.+||+|
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEee
Confidence               468899999999999999998643 35889999999999999999999   89999999999999999999999999


Q ss_pred             eccccccCCCCCcceeecccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhc
Q 005760          536 FGIAKLLTREDQSTIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND  610 (678)
Q Consensus       536 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~  610 (678)
                      ||++......  ........+++.|+|||.+.     +..++.++|||||||++|+|++|+.||........ .......
T Consensus       173 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~  249 (326)
T 2x7f_A          173 FGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LFLIPRN  249 (326)
T ss_dssp             CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHS
T ss_pred             CcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHhhcC
Confidence            9999765422  11233456899999999886     56688999999999999999999999865322111 1110000


Q ss_pred             ccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          611 WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..         +....         ..++.++.+++.+||..||++||++.|+++
T Consensus       250 ~~---------~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          250 PA---------PRLKS---------KKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             CC---------CCCSC---------SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cc---------ccCCc---------cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            00         00000         113456889999999999999999999987

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.8e-38  Score=337.22  Aligned_cols=265  Identities=22%  Similarity=0.228  Sum_probs=199.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCC--------Cccceeeeeeee---
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR--------HRNIIKVISSCS---  458 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~---  458 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+++++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            36799999999999999999975 57899999999643 234567889999999985        788999999987   


Q ss_pred             -cCCeEEEEEEecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEcCCCCCCeeecCCC------
Q 005760          459 -NEEFKALVLEYMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPSNVLLDDNM------  529 (678)
Q Consensus       459 -~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dl~~~Nill~~~~------  529 (678)
                       +....++||||+ ++++.+++... ...+++..+..++.||+.||+|||   ++ +|+||||||+||+++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence             567889999999 55666666544 356899999999999999999999   87 999999999999999775      


Q ss_pred             -------------------------------------------cEEEEeeccccccCCCCCcceeecccCCccccCcccc
Q 005760          530 -------------------------------------------VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG  566 (678)
Q Consensus       530 -------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  566 (678)
                                                                 .+||+|||++......     .....+|+.|+|||++
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence                                                       8999999999865432     2345789999999999


Q ss_pred             CCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccch----hhhhhcccCCc--------------------ccccccC
Q 005760          567 KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTL----KHWVNDWLPIS--------------------TKEIVDP  622 (678)
Q Consensus       567 ~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~----~~~~~~~~~~~--------------------~~~~~~~  622 (678)
                      .+..++.++|||||||++|||++|+.||......+...    ...+.......                    ...+.+.
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            99999999999999999999999999997643322110    00000000000                    0000000


Q ss_pred             ccCCcc---chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          623 NLLSRE---DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       623 ~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ......   ..........+.++.+|+.+||+.||++|||+.|+++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000000   0000011356778999999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.7e-38  Score=337.84  Aligned_cols=200  Identities=23%  Similarity=0.348  Sum_probs=155.2

Q ss_pred             cCCCC-CccccCCCceeEEEEEeC---CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeee--ecCCeEEE
Q 005760          392 DGFSE-NNLIGRGSFGSVFKARLG---DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC--SNEEFKAL  465 (678)
Q Consensus       392 ~~~~~-~~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~~~l  465 (678)
                      +.|++ +++||+|+||.||+|+.+   +++.||+|++...  .....+.+|+.+++.++||||+++++++  ......++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            34655 568999999999999854   5789999998643  2335788999999999999999999998  44778999


Q ss_pred             EEEecCCCCHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee----cCCCcEEE
Q 005760          466 VLEYMPHGSLEKYLHSSN--------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL----DDNMVAHL  533 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill----~~~~~~kl  533 (678)
                      ||||+++ +|.+++....        ..+++..++.++.||+.||+|||   +++|+||||||+||++    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999965 8888775321        24889999999999999999999   9999999999999999    77899999


Q ss_pred             EeeccccccCCCCC-cceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcc
Q 005760          534 SDFGIAKLLTREDQ-STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEI  597 (678)
Q Consensus       534 ~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~  597 (678)
                      +|||+++....... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            99999987643211 1233456789999999988774 5899999999999999999999999754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.2e-38  Score=335.45  Aligned_cols=263  Identities=24%  Similarity=0.316  Sum_probs=193.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCC------eEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE------FKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~  464 (678)
                      ..+|++.+.||+|+||.||+|+...+..||+|++....    ....+|+++++.++||||+++++++...+      ..+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            35689999999999999999998777779999885432    22246999999999999999999984432      378


Q ss_pred             EEEEecCCCCHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec-CCCcEEEEeeccccc
Q 005760          465 LVLEYMPHGSLEKYLH--SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKL  541 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~-~~~~~kl~Dfg~~~~  541 (678)
                      +||||++++.+.....  .....+++..+..++.|++.||+|||   +++|+||||||+||+++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999998744333322  23446899999999999999999999   99999999999999999 799999999999987


Q ss_pred             cCCCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC------
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI------  614 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------  614 (678)
                      .....   ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+ .+...+......      
T Consensus       192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p~~~~~~  267 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVLGTPSREQIK  267 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHH
T ss_pred             ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence            64322   22346789999999988765 58999999999999999999999997633211 111111100000      


Q ss_pred             ----cccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          615 ----STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       615 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                          ......-+.. .........+..+++++.+++.+||++||++|||+.|+++
T Consensus       268 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          268 TMNPNYMEHKFPQI-RPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHCGGGSSSCCCCC-CCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hhChhhhhhccccc-cCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                0000000000 0011111111235667999999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.9e-38  Score=323.89  Aligned_cols=268  Identities=22%  Similarity=0.280  Sum_probs=194.8

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeee-----------
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCS-----------  458 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-----------  458 (678)
                      .++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999865 58999999997665556678899999999999999999998873           


Q ss_pred             ---cCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec-CCCcEEEE
Q 005760          459 ---NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLS  534 (678)
Q Consensus       459 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~-~~~~~kl~  534 (678)
                         +.+..++||||++ |+|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+||+++ .++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               4467899999997 5999999754  4889999999999999999999   89999999999999997 57799999


Q ss_pred             eeccccccCCCCC-cceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc
Q 005760          535 DFGIAKLLTREDQ-STIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL  612 (678)
Q Consensus       535 Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  612 (678)
                      |||++........ ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ..........
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~  242 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILESIP  242 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHSC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence            9999986543211 122334567899999998765 678999999999999999999999997633211 1111111000


Q ss_pred             CCc---cccc-------ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          613 PIS---TKEI-------VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       613 ~~~---~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ...   ..++       ..................++.++.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            000   0000       0000000000000011235677999999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.4e-38  Score=328.93  Aligned_cols=267  Identities=24%  Similarity=0.286  Sum_probs=199.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecC-----CeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNE-----EFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  463 (678)
                      .++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+|+++++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            568999999999999999999864 789999999964322 3346678999999999999999999987654     678


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccC
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT  543 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~  543 (678)
                      ++||||++ ++|.+++...  .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++....
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999997 5999999774  4899999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCCCcc--------eeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc-C
Q 005760          544 REDQST--------IQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL-P  613 (678)
Q Consensus       544 ~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~  613 (678)
                      ......        ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+...... ......... +
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~  242 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ-LLLIFGIIGTP  242 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCC
Confidence            322111        1223568999999997654 6789999999999999999999999976332111 000000000 0


Q ss_pred             C---ccccccc--------C-ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          614 I---STKEIVD--------P-NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       614 ~---~~~~~~~--------~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .   .......        . ......... .....+++++.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0   0000000        0 000000000 011245677899999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=9.3e-38  Score=323.91  Aligned_cols=268  Identities=26%  Similarity=0.378  Sum_probs=202.1

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEe--CCCcEEEEEEeecccC--chhhhHHHHHHHHHhC---CCccceeeeeeee---
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARL--GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSI---RHRNIIKVISSCS---  458 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~---  458 (678)
                      ...++|++.+.||+|+||.||+|..  .+|+.||+|++.....  .....+.+|+.+++.+   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3567899999999999999999986  4688999999865432  2335677888887776   8999999999986   


Q ss_pred             --cCCeEEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEe
Q 005760          459 --NEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSD  535 (678)
Q Consensus       459 --~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~D  535 (678)
                        .....++||||++ |+|.+++.... ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence              5678899999997 59999997654 34889999999999999999999   89999999999999999999999999


Q ss_pred             eccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc-C-
Q 005760          536 FGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL-P-  613 (678)
Q Consensus       536 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-~-  613 (678)
                      ||++......   .......+++.|+|||.+.+..++.++||||+||++|||++|+.||.+..... .......... + 
T Consensus       164 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~  239 (326)
T 1blx_A          164 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPG  239 (326)
T ss_dssp             CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred             CcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCC
Confidence            9999765422   22345678999999999999899999999999999999999999997533211 1111111000 0 


Q ss_pred             -Ccccccc-cC--ccC--CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          614 -ISTKEIV-DP--NLL--SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       614 -~~~~~~~-~~--~~~--~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                       ....... .+  ...  ...... .....++.++.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          240 EEDWPRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGG-GTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccCccccccchhhhcccCcchhh-hccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             0000000 00  000  000000 001134566889999999999999999999984

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.6e-38  Score=332.74  Aligned_cols=261  Identities=22%  Similarity=0.294  Sum_probs=195.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeE----
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK----  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----  463 (678)
                      .++|.+.+.||+|+||.||+|.. .+|+.||+|++.....  ...+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46899999999999999999985 4799999999965432  2356788999999999999999999999876654    


Q ss_pred             --EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          464 --ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       464 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                        ++||||+. ++|.+++..   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999997 588888743   3899999999999999999999   89999999999999999999999999999975


Q ss_pred             cCCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV  620 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (678)
                      ....     .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+ ........ ......+..
T Consensus       194 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~-~~~~~~~~~  266 (371)
T 4exu_A          194 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKV-TGVPGTEFV  266 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH-HCCCCHHHH
T ss_pred             cccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH-hCCCcHHHH
Confidence            5322     234578999999998877 678999999999999999999999997632211 11111110 000000000


Q ss_pred             cC-----------ccCCccchhhH-HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          621 DP-----------NLLSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       621 ~~-----------~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..           ........... ....+++++.+++.+||+.||++|||+.|+++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            00           00000000000 01234677999999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.7e-38  Score=321.23  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=192.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeec----------
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN----------  459 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----------  459 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            46789999999999999999985 47999999999643 2345778899999999999999999998754          


Q ss_pred             ---CCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEee
Q 005760          460 ---EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF  536 (678)
Q Consensus       460 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Df  536 (678)
                         .+..++||||+++++|.+++......+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeC
Confidence               45789999999999999999877667888999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCC------------CcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccc
Q 005760          537 GIAKLLTRED------------QSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT  603 (678)
Q Consensus       537 g~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~  603 (678)
                      |++.......            .........+++.|+|||.+.+. .++.++||||+||++|||++   ||........ 
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~-  236 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN-  236 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH-
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH-
Confidence            9997654221            01223345689999999998764 68999999999999999998   5432111111 


Q ss_pred             hhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          604 LKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ....+.....     ...+. ..         ..++..+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~-----~~~~~-~~---------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          237 ILKKLRSVSI-----EFPPD-FD---------DNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHSTTC-----CCCTT-CC---------TTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhcccccc-----ccCcc-cc---------ccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            1111110000     00000 00         123455789999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.3e-38  Score=335.43  Aligned_cols=261  Identities=25%  Similarity=0.325  Sum_probs=192.9

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeec------CCeEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN------EEFKA  464 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~~  464 (678)
                      .+|+..+.||+|+||.||+|... +|+.||||++....    ....+|+++++.++||||+++++++..      ....+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999864 69999999986432    233479999999999999999998743      22467


Q ss_pred             EEEEecCCCCHHHHhh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC-CcEEEEeecccc
Q 005760          465 LVLEYMPHGSLEKYLH---SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN-MVAHLSDFGIAK  540 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~-~~~kl~Dfg~~~  540 (678)
                      +||||+++ ++.+.+.   .....+++..+..++.||+.||+|||   +++|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999976 6666654   23456899999999999999999999   9999999999999999955 678999999998


Q ss_pred             ccCCCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC------
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP------  613 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~------  613 (678)
                      ......   ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+ .+...+.....      
T Consensus       206 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             ECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHH
T ss_pred             hcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence            764322   22345789999999988765 68999999999999999999999997633211 11111111000      


Q ss_pred             ----CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          614 ----ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       614 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                          ........+.... ...........++++.+|+.+||++||++||++.|+++
T Consensus       282 ~~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKA-HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHCSCCCCCCCCCCCC-CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhChhhhhhccCccCC-CCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                0000111111100 00000011234567999999999999999999999985

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=339.32  Aligned_cols=303  Identities=23%  Similarity=0.223  Sum_probs=273.1

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      +|+|++|++++..|..|..+++|++|+|++|.|+++.|++|.++++|++|+|++|.++.++..     .|.++++|++|+
T Consensus        36 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~  110 (477)
T 2id5_A           36 LLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLG-----VFTGLSNLTKLD  110 (477)
T ss_dssp             EEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTT-----SSTTCTTCCEEE
T ss_pred             EEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcc-----cccCCCCCCEEE
Confidence            378999999988889999999999999999999998899999999999999999999988754     488999999999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcC
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKL  160 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i  160 (678)
                      |++|.+.+..+.. +..++ +|++|+|++|.+.+..+..|.++++|++|+|++|++++..+..|.++++|+.|+|++|.+
T Consensus       111 Ls~n~i~~~~~~~-~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i  188 (477)
T 2id5_A          111 ISENKIVILLDYM-FQDLY-NLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI  188 (477)
T ss_dssp             CTTSCCCEECTTT-TTTCT-TCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCC
T ss_pred             CCCCccccCChhH-ccccc-cCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcC
Confidence            9999998887655 67777 899999999999999999999999999999999999977777899999999999999999


Q ss_pred             CCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccCCCCccc
Q 005760          161 EGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEI  239 (678)
Q Consensus       161 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~  239 (678)
                      ++..+..|..+++|+.|++++|.+.+.++..+....+|+.|+|++|.|+.+|. .+..+++|+.|+|++|.+++..+..|
T Consensus       189 ~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~  268 (477)
T 2id5_A          189 NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSML  268 (477)
T ss_dssp             CEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSC
T ss_pred             cEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhc
Confidence            97778889999999999999998887777766667799999999999999985 68899999999999999998888777


Q ss_pred             cccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC-CccccccccccccCccccCCCC
Q 005760          240 GNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSPN  318 (678)
Q Consensus       240 ~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~-~~~~~l~~~~~~~n~~~c~~~~  318 (678)
                      .+++          +|+.|+|++|++++..|..+..+++|+.|++++|.++...+.. ..+..++.+++.+||+.|+|+.
T Consensus       269 ~~l~----------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~  338 (477)
T 2id5_A          269 HELL----------RLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL  338 (477)
T ss_dssp             TTCT----------TCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred             cccc----------cCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch
Confidence            7776          9999999999999988999999999999999999999776654 6678899999999999999875


Q ss_pred             CC
Q 005760          319 LR  320 (678)
Q Consensus       319 ~~  320 (678)
                      .|
T Consensus       339 ~~  340 (477)
T 2id5_A          339 LW  340 (477)
T ss_dssp             HH
T ss_pred             Hh
Confidence            44

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.6e-38  Score=324.69  Aligned_cols=253  Identities=26%  Similarity=0.317  Sum_probs=177.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC-chhhhHHHHHH-HHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-RVFKSFDVECE-MMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            46889999999999999999986 4799999999975432 23344555555 677789999999999999999999999


Q ss_pred             EecCCCCHHHHhhh----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          468 EYMPHGSLEKYLHS----SNYILDIYQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       468 e~~~~~~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      ||+++ +|.+++..    ....+++..+..++.|++.|+.|||   +. +|+||||||+||+++.++.+||+|||++...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 88887753    2346899999999999999999999   77 9999999999999999999999999999765


Q ss_pred             CCCCCcceeecccCCccccCcccc----CCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYG----KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE  618 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  618 (678)
                      ....   ......+++.|+|||.+    .+..++.++||||||+++|||++|+.||.................    .  
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----~--  247 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD----P--  247 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC----C--
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC----C--
Confidence            4321   22334689999999998    456789999999999999999999999975332211111111100    0  


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                         +......      ...+++++.+++.+||+.||++||++.|+++
T Consensus       248 ---~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          248 ---PQLSNSE------EREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             ---CCCCCCS------SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCCCcc------cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence               0000000      0123456889999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.6e-38  Score=319.95  Aligned_cols=253  Identities=22%  Similarity=0.302  Sum_probs=203.1

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      ....++|++.+.||+|+||.||+|... +++.||+|++....  ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            445678999999999999999999865 78999999996543  234577889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC---CcEEEEeeccccc
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN---MVAHLSDFGIAKL  541 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~---~~~kl~Dfg~~~~  541 (678)
                      +|+||+++++|.+++.... .+++..+..++.|++.||.|||   +++++||||+|+||+++.+   +.+||+|||++..
T Consensus        98 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            9999999999999887654 4899999999999999999999   8999999999999999754   4799999999976


Q ss_pred             cCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      .....   ......+++.|+|||.+.+ .++.++||||+|+++|+|++|..||......+ .............      
T Consensus       174 ~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~------  242 (287)
T 2wei_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGKYAFD------  242 (287)
T ss_dssp             BCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCCCCC------
T ss_pred             ecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCCCCC------
Confidence            54322   1223458899999998865 48999999999999999999999987532211 1111111100000      


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                                ......++.++.+++.+||+.||++|||+.|+++
T Consensus       243 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          243 ----------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             ----------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                      0001123556889999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.2e-37  Score=335.14  Aligned_cols=251  Identities=23%  Similarity=0.359  Sum_probs=186.8

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEEEec
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      +.|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+++++.+ +||||+++++++.+.+..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            344556889999999998776668999999998653   235677899999876 8999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCC------CHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC-------------CcE
Q 005760          471 PHGSLEKYLHSSNYIL------DIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN-------------MVA  531 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~------~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~-------------~~~  531 (678)
                      + |+|.+++.......      ++..++.++.||+.||+|||   +++|+||||||+||+++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 59999998654311      22245679999999999999   8999999999999999754             489


Q ss_pred             EEEeeccccccCCCCCc--ceeecccCCccccCccccCC-------CCCCccchHHHHHHHHHHHHc-CCCCCCcccCCc
Q 005760          532 HLSDFGIAKLLTREDQS--TIQTQTLATIGYMAPEYGKE-------GRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGE  601 (678)
Q Consensus       532 kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~  601 (678)
                      ||+|||+++........  .......||+.|+|||++.+       ..++.++||||+||++|||++ |..||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999876543221  12234579999999998865       568999999999999999999 899986533221


Q ss_pred             cchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          602 MTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .   .........       +..      .......++.++.+++.+||+.||++|||+.|+++
T Consensus       248 ~---~i~~~~~~~-------~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 S---NIIRGIFSL-------DEM------KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H---HHHHTCCCC-------CCC------TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H---HHhcCCCCc-------ccc------cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1   111111100       000      00011245677999999999999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.2e-37  Score=324.50  Aligned_cols=274  Identities=20%  Similarity=0.254  Sum_probs=190.4

Q ss_pred             HHHHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCC--
Q 005760          385 LELCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE--  461 (678)
Q Consensus       385 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  461 (678)
                      .......++|++.+.||+|+||.||+|.. .+|+.||||++.... .......+|++.++.++||||+++++++...+  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            45567788999999999999999999986 478999999986542 33456677888889999999999999985533  


Q ss_pred             -----eEEEEEEecCCCCHHHHhh---hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-CCcEE
Q 005760          462 -----FKALVLEYMPHGSLEKYLH---SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAH  532 (678)
Q Consensus       462 -----~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-~~~~k  532 (678)
                           ..++||||+++ +|.+.+.   .....+++..+..++.|++.|+.||| .++++|+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                 27899999976 5554443   23345889999999999999999999 33688999999999999996 89999


Q ss_pred             EEeeccccccCCCCCcceeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcc
Q 005760          533 LSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW  611 (678)
Q Consensus       533 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~  611 (678)
                      |+|||++.......   ......+|+.|+|||++.+.. ++.++|||||||++|||++|+.||....... .........
T Consensus       173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~  248 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIVRVL  248 (360)
T ss_dssp             ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH
T ss_pred             EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHHHHc
Confidence            99999998764332   223456899999999886654 8999999999999999999999997632211 111111100


Q ss_pred             c--CCcccccccCccC-----CccchhhH-----HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          612 L--PISTKEIVDPNLL-----SREDINFV-----AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       612 ~--~~~~~~~~~~~~~-----~~~~~~~~-----~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .  +.......++...     ........     ....++.++.+++.+||++||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            0  0000000000000     00000000     00124677999999999999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.3e-37  Score=320.59  Aligned_cols=264  Identities=19%  Similarity=0.276  Sum_probs=201.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEe--CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCcc------ceeeeeeeecCCe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL--GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRN------IIKVISSCSNEEF  462 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~  462 (678)
                      .++|++.+.||+|+||.||+|..  .+++.||+|++... ....+.+.+|+++++.++|++      ++++++++.+.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999975  36899999998643 234567888999999887664      9999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC--------------
Q 005760          463 KALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD--------------  527 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~--------------  527 (678)
                      .++||||+ +++|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 889999997664 35889999999999999999999   899999999999999987              


Q ss_pred             -----CCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCcc
Q 005760          528 -----NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM  602 (678)
Q Consensus       528 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~  602 (678)
                           ++.+||+|||+++.....     .....+|+.|+|||++.+..++.++||||+||++|||++|..||......+.
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                 678999999999764322     2345789999999999998999999999999999999999999975332211


Q ss_pred             chhhhhhcc--cCCcc------ccccc---CccCCcc-------------chhhHHHHHHHHHHHHHHhhccccCcCCCC
Q 005760          603 TLKHWVNDW--LPIST------KEIVD---PNLLSRE-------------DINFVAKEQCVSFVFNVAMECTVESPEQRI  658 (678)
Q Consensus       603 ~~~~~~~~~--~~~~~------~~~~~---~~~~~~~-------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  658 (678)
                       ........  .+...      .....   .......             .........+++++.+++.+||+.||++||
T Consensus       243 -~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          243 -LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             -HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             -HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence             11000000  00000      00000   0000000             000001124567899999999999999999


Q ss_pred             CHHHHHH
Q 005760          659 NAKEIVT  665 (678)
Q Consensus       659 s~~ell~  665 (678)
                      |+.|+++
T Consensus       322 t~~ell~  328 (339)
T 1z57_A          322 TLREALK  328 (339)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.6e-38  Score=325.88  Aligned_cols=245  Identities=22%  Similarity=0.287  Sum_probs=200.0

Q ss_pred             HHHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCc------hhhhHHHHHHHHHhCC--Cccceeeeee
Q 005760          386 ELCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGR------VFKSFDVECEMMKSIR--HRNIIKVISS  456 (678)
Q Consensus       386 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~  456 (678)
                      +.....++|++.+.||+|+||.||+|.. .+++.||||++......      ..+.+..|+.+++.++  ||||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            3344567899999999999999999974 57899999999764321      2356778999999996  5999999999


Q ss_pred             eecCCeEEEEEEecCC-CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec-CCCcEEEE
Q 005760          457 CSNEEFKALVLEYMPH-GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLS  534 (678)
Q Consensus       457 ~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~-~~~~~kl~  534 (678)
                      +.+.+..++|+|++.+ ++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++ .++.+||+
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            9999999999999976 89999998754 4899999999999999999999   99999999999999999 78999999


Q ss_pred             eeccccccCCCCCcceeecccCCccccCccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC
Q 005760          535 DFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP  613 (678)
Q Consensus       535 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~  613 (678)
                      |||++......    ......+|+.|+|||++.+..+ +.++||||||+++|||++|+.||.....       ...... 
T Consensus       193 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~~~~~-  260 (320)
T 3a99_A          193 DFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRGQV-  260 (320)
T ss_dssp             CCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHCCC-
T ss_pred             eCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------hhcccc-
Confidence            99999876432    2234568999999998877665 6789999999999999999999865211       111000 


Q ss_pred             CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          614 ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                            ..+             ..+++++.+++.+||+.||++|||+.|+++
T Consensus       261 ------~~~-------------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          261 ------FFR-------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ------CCS-------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------ccc-------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  000             113456889999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=334.18  Aligned_cols=250  Identities=20%  Similarity=0.372  Sum_probs=188.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..+|...+.||+|+||+||.....+++.||||++...   ....+.+|+++++.+ +||||+++++++.+.+..++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            4568888999999999976555568999999998643   234567899999999 799999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-----CCcEEEEeeccccccCC
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-----~~~~kl~Dfg~~~~~~~  544 (678)
                      ++ |+|.+++...........+..++.||+.||+|||   +++|+||||||+||+++.     ...+||+|||+++....
T Consensus       100 ~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            96 5999999877655555567789999999999999   899999999999999943     33688999999987643


Q ss_pred             CCC-cceeecccCCccccCccccC---CCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCccccc
Q 005760          545 EDQ-STIQTQTLATIGYMAPEYGK---EGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEI  619 (678)
Q Consensus       545 ~~~-~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (678)
                      ... ........||+.|+|||++.   ...++.++||||+||++|||++ |..||........  ......    .....
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--~~~~~~----~~~~~  249 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--NILLGA----CSLDC  249 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--HHHTTC----CCCTT
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--HHHhcc----CCccc
Confidence            321 12334567999999999987   4567889999999999999999 8888854222111  000000    00000


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..+            ....+..+.+++.+||+.||++|||+.|+++
T Consensus       250 ~~~------------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          250 LHP------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             SCT------------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCc------------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            000            0123455789999999999999999999984

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.8e-37  Score=326.34  Aligned_cols=200  Identities=25%  Similarity=0.337  Sum_probs=170.3

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCC-Cc-----cceeeeeeeecCCe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HR-----NIIKVISSCSNEEF  462 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~  462 (678)
                      ..++|++.+.||+|+||.||+|... +++.||||++... ......+..|+.+++.++ |+     +++++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            3578999999999999999999854 7899999999643 223456777888888875 44     49999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec--CCCcEEEEeeccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD--DNMVAHLSDFGIA  539 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~--~~~~~kl~Dfg~~  539 (678)
                      .++||||++ ++|.+++.... ..+++..+..++.|++.||.|||. .+.+|+||||||+||+++  .++.+||+|||++
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999996 49999998654 458999999999999999999992 246899999999999994  5788999999999


Q ss_pred             cccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcc
Q 005760          540 KLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEI  597 (678)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~  597 (678)
                      +.....     .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus       209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            876422     23457899999999999999999999999999999999999999763

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.1e-37  Score=320.03  Aligned_cols=252  Identities=19%  Similarity=0.270  Sum_probs=173.0

Q ss_pred             hhcCCCCCc-cccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeec----CCeE
Q 005760          390 ATDGFSENN-LIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN----EEFK  463 (678)
Q Consensus       390 ~~~~~~~~~-~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  463 (678)
                      ..++|.+.+ .||+|+||.||+|... +++.||+|++....    ....+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            456788854 6999999999999865 79999999986421    222233344667799999999999865    4568


Q ss_pred             EEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC---CCcEEEEeeccc
Q 005760          464 ALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIA  539 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~---~~~~kl~Dfg~~  539 (678)
                      ++||||+++|+|.+++.... ..+++..++.++.|++.||+|||   +++|+||||||+||+++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998654 36899999999999999999999   899999999999999976   456999999999


Q ss_pred             cccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccc
Q 005760          540 KLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI  619 (678)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (678)
                      ......    ......+|+.|+|||++.+..++.++||||+||++|+|++|+.||............. .... ......
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~-~~~~~~  252 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK-RRIR-LGQYGF  252 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------CC
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH-Hhhh-cccccc
Confidence            765422    2234568999999999988889999999999999999999999997643322110000 0000 000000


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..+           ....++.++.+++.+||+.||++|||+.|+++
T Consensus       253 ~~~-----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          253 PNP-----------EWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             CTT-----------TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             Cch-----------hhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            000           00124566889999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=318.72  Aligned_cols=251  Identities=22%  Similarity=0.275  Sum_probs=181.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCc--hhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGR--VFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      .++|++.+.||+|+||.||+|... +|+.||+|++......  ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            457888999999999999999864 7999999999754322  2233445556788889999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      ||+ ++.+..+.......+++..+..++.|++.||.|||   ++ +|+||||||+||+++.++.+||+|||++.......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 55666666654556899999999999999999999   75 99999999999999999999999999997654321


Q ss_pred             CcceeecccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          547 QSTIQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                         ......+++.|+|||.+.     ...++.++||||||+++|||++|+.||..................+        
T Consensus       180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------  248 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP--------  248 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC--------
T ss_pred             ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC--------
Confidence               223456899999999984     4568899999999999999999999997532222122221111110        


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                       .....        ..++.++.+++.+||+.||.+||++.|+++
T Consensus       249 -~~~~~--------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 -LLPGH--------MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             -CCCSS--------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -CCCcc--------CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             00000        013456889999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=325.43  Aligned_cols=262  Identities=22%  Similarity=0.274  Sum_probs=194.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCe-----
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF-----  462 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  462 (678)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++.....  ...+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            46789999999999999999985 4799999999965422  234678899999999999999999999977654     


Q ss_pred             -EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          463 -KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       463 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                       .++||||++ ++|.+++..   .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++..
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 588887753   3899999999999999999999   89999999999999999999999999999976


Q ss_pred             cCCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhc--ccCCccc-
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVND--WLPISTK-  617 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~-  617 (678)
                      ....     .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+ .+......  ..+.... 
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHHCBCCHHHHT
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence            4321     234568999999998876 678999999999999999999999997533211 01111100  0000000 


Q ss_pred             ccccC-------ccCCccchhh-HHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          618 EIVDP-------NLLSREDINF-VAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       618 ~~~~~-------~~~~~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .+.+.       .........+ .....+++++.+++.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000       0000000000 000134567899999999999999999999985

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=7.6e-37  Score=332.32  Aligned_cols=302  Identities=22%  Similarity=0.284  Sum_probs=249.9

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccc-cCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSG-FIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLI   79 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L   79 (678)
                      +|+|++|++++..|..|..+++|++|+|++|.+.+ +.+.+|.++++|++|+|++|.+..+.+.     .|.++++|++|
T Consensus        34 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~-----~~~~l~~L~~L  108 (455)
T 3v47_A           34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETG-----AFNGLANLEVL  108 (455)
T ss_dssp             EEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTT-----TTTTCTTCCEE
T ss_pred             EEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChh-----hccCcccCCEE
Confidence            37899999998888889999999999999999873 4567899999999999999998876543     58889999999


Q ss_pred             ECccCCCcccCCh-hhhhcccccccEEEcccccccccCCcc-ccCCCCCcEEEccCCccCCcCChhhhcc----------
Q 005760           80 SFSNNPLDGILPK-TSVGNLSHSLEYFEMAYCNVSGGIPEE-IGNLTNLTIIYLGGNKLNGSIPSTLGKL----------  147 (678)
Q Consensus        80 ~L~~n~i~~~~~~-~~~~~l~~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l----------  147 (678)
                      +|++|++++..+. ..+..++ +|++|+|++|++++..|.. |.++++|++|++++|++++..+..+..+          
T Consensus       109 ~L~~n~l~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l  187 (455)
T 3v47_A          109 TLTQCNLDGAVLSGNFFKPLT-SLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRL  187 (455)
T ss_dssp             ECTTSCCBTHHHHSSTTTTCT-TCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEEC
T ss_pred             eCCCCCCCccccCcccccCcc-cCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccc
Confidence            9999998764332 2255565 8999999999999887776 7889999999999999987777766554          


Q ss_pred             ------------------------CCCCEEEccCCcCCCCCCCccc----------------------------------
Q 005760          148 ------------------------QKLQGLGLENNKLEGSIPDSIC----------------------------------  169 (678)
Q Consensus       148 ------------------------~~L~~L~L~~n~i~~~~~~~~~----------------------------------  169 (678)
                                              ++|++|+|++|.+++..|..+.                                  
T Consensus       188 ~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~  267 (455)
T 3v47_A          188 SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF  267 (455)
T ss_dssp             TTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTT
T ss_pred             ccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccc
Confidence                                    5677777777776543322221                                  


Q ss_pred             -----CCCCccEEecCCCcCCCCChhhhhccccccceecccccccccc-ccccccccccEEEecCCcccCCCCccccccc
Q 005760          170 -----HSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGNLK  243 (678)
Q Consensus       170 -----~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  243 (678)
                           ..++|++|++++|.+.+..|..|..+++|+.|+|++|+++.++ ..|..+++|+.|+|++|.+++..+..|.+++
T Consensus       268 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  347 (455)
T 3v47_A          268 TFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLD  347 (455)
T ss_dssp             TTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCT
T ss_pred             ccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcc
Confidence                 1257888888888888888888999999999999999999874 4788999999999999999888888887777


Q ss_pred             cccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC-CccccccccccccCccccCCCC
Q 005760          244 IARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSPN  318 (678)
Q Consensus       244 ~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~-~~~~~l~~~~~~~n~~~c~~~~  318 (678)
                                +|+.|+|++|++++..|..+..+++|++|++++|++++.++.. ..+..++.+++.+|++.|+||.
T Consensus       348 ----------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~  413 (455)
T 3v47_A          348 ----------KLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  413 (455)
T ss_dssp             ----------TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             ----------cCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCc
Confidence                      9999999999999888999999999999999999999876654 6788999999999999999984

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.3e-37  Score=327.28  Aligned_cols=265  Identities=17%  Similarity=0.244  Sum_probs=197.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-----------Cccceeeeeeee
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-----------HRNIIKVISSCS  458 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~  458 (678)
                      .++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.+++.++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            46899999999999999999985 57899999998643 223466788999998876           899999999987


Q ss_pred             cCC----eEEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCC-CeEEcCCCCCCeeec------
Q 005760          459 NEE----FKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSA-QVIHCDLKPSNVLLD------  526 (678)
Q Consensus       459 ~~~----~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dl~~~Nill~------  526 (678)
                      ..+    ..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||   ++ +|+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            544    789999999 889999997643 35899999999999999999999   87 999999999999994      


Q ss_pred             CCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCcc----
Q 005760          527 DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM----  602 (678)
Q Consensus       527 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~----  602 (678)
                      ..+.+||+|||++......     .....+|+.|+|||++.+..++.++|||||||++|||++|+.||........    
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence            4458999999999866432     2345789999999999998999999999999999999999999975432111    


Q ss_pred             -chhhhhhcccCC------------------c-ccccccCccCCcc---chhhHHHHHHHHHHHHHHhhccccCcCCCCC
Q 005760          603 -TLKHWVNDWLPI------------------S-TKEIVDPNLLSRE---DINFVAKEQCVSFVFNVAMECTVESPEQRIN  659 (678)
Q Consensus       603 -~~~~~~~~~~~~------------------~-~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps  659 (678)
                       ............                  . ...+.........   ......+..++.++.+++.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence             011111000000                  0 0000000000000   0000011456788999999999999999999


Q ss_pred             HHHHHH
Q 005760          660 AKEIVT  665 (678)
Q Consensus       660 ~~ell~  665 (678)
                      +.|+++
T Consensus       328 ~~ell~  333 (373)
T 1q8y_A          328 AGGLVN  333 (373)
T ss_dssp             HHHHHT
T ss_pred             HHHHhh
Confidence            999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=8e-38  Score=322.26  Aligned_cols=244  Identities=25%  Similarity=0.328  Sum_probs=191.2

Q ss_pred             HHHhhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC------chhhhHHHHHHHHHhC----CCccceeeee
Q 005760          387 LCRATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG------RVFKSFDVECEMMKSI----RHRNIIKVIS  455 (678)
Q Consensus       387 ~~~~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~~~~  455 (678)
                      .....++|++.+.||+|+||.||+|.. .+++.||+|++.....      .....+.+|+.+++.+    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            344567899999999999999999985 5789999999865422      1234566799999988    8999999999


Q ss_pred             eeecCCeEEEEEEe-cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec-CCCcEEE
Q 005760          456 SCSNEEFKALVLEY-MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHL  533 (678)
Q Consensus       456 ~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~-~~~~~kl  533 (678)
                      ++.+.+..++|+|| +.+++|.+++.... .+++..++.++.|++.||+|||   +.+|+||||||+||+++ .++.+||
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEE
Confidence            99999999999999 78999999998755 4899999999999999999999   89999999999999999 8999999


Q ss_pred             EeeccccccCCCCCcceeecccCCccccCccccCCCCCC-ccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc
Q 005760          534 SDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVS-ANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL  612 (678)
Q Consensus       534 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  612 (678)
                      +|||++.......    .....++..|+|||++.+..+. .++||||+|+++|||++|+.||.....       ......
T Consensus       182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~  250 (312)
T 2iwi_A          182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-------ILEAEL  250 (312)
T ss_dssp             CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHTCC
T ss_pred             EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-------Hhhhcc
Confidence            9999998764322    2345689999999988776664 589999999999999999999864211       100000


Q ss_pred             CCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          613 PISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                             ..+             ..++.++.+++.+||+.||++|||+.|+++
T Consensus       251 -------~~~-------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          251 -------HFP-------------AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -------CCC-------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------CCc-------------ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   000             123455889999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-36  Score=319.21  Aligned_cols=264  Identities=22%  Similarity=0.291  Sum_probs=198.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CC-cEEEEEEeecccCchhhhHHHHHHHHHhCCCcc------ceeeeeeeecCCe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DG-MEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRN------IIKVISSCSNEEF  462 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~  462 (678)
                      .++|++.+.||+|+||.||+|... ++ +.||+|++... ....+.+.+|+.+++.++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999853 44 78999999643 234567788999999997766      8999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee----------------
Q 005760          463 KALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL----------------  525 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill----------------  525 (678)
                      .++||||+ ++++.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 667777776543 46899999999999999999999   9999999999999999                


Q ss_pred             ---cCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCcc
Q 005760          526 ---DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM  602 (678)
Q Consensus       526 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~  602 (678)
                         +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+.
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence               56889999999999764322     2345789999999999999999999999999999999999999975332110


Q ss_pred             chhhhhhcc--cCCcc-------cccccCcc-CCcc-c-------------hhhHHHHHHHHHHHHHHhhccccCcCCCC
Q 005760          603 TLKHWVNDW--LPIST-------KEIVDPNL-LSRE-D-------------INFVAKEQCVSFVFNVAMECTVESPEQRI  658 (678)
Q Consensus       603 ~~~~~~~~~--~~~~~-------~~~~~~~~-~~~~-~-------------~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp  658 (678)
                       ........  .+...       ........ .... .             .........+.++.+++.+||+.||++||
T Consensus       248 -~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          248 -LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             -HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             -HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence             11000000  00000       00000000 0000 0             00000113356799999999999999999


Q ss_pred             CHHHHHH
Q 005760          659 NAKEIVT  665 (678)
Q Consensus       659 s~~ell~  665 (678)
                      |+.|+++
T Consensus       327 t~~e~l~  333 (355)
T 2eu9_A          327 TLAEALL  333 (355)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999984

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=330.25  Aligned_cols=302  Identities=21%  Similarity=0.218  Sum_probs=275.9

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      +|+|++|.+++..|..|.++++|++|+|++|+++.+.+..|.++++|++|+|++|.+..+...     .|.++++|+.|+
T Consensus        60 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~-----~~~~l~~L~~L~  134 (477)
T 2id5_A           60 ELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDY-----MFQDLYNLKSLE  134 (477)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTT-----TTTTCTTCCEEE
T ss_pred             EEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChh-----HccccccCCEEE
Confidence            378999999988899999999999999999999988888899999999999999999877643     589999999999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcC
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKL  160 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i  160 (678)
                      |++|.+.++.+.. +..++ +|++|+|++|++++..+..|.++++|+.|+|++|.+.+..+..|..+++|++|++++|.+
T Consensus       135 l~~n~l~~~~~~~-~~~l~-~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~  212 (477)
T 2id5_A          135 VGDNDLVYISHRA-FSGLN-SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY  212 (477)
T ss_dssp             ECCTTCCEECTTS-STTCT-TCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTT
T ss_pred             CCCCccceeChhh-ccCCC-CCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcc
Confidence            9999999887765 67776 899999999999988888899999999999999999988888999999999999999998


Q ss_pred             CCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccCCCCccc
Q 005760          161 EGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEI  239 (678)
Q Consensus       161 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~  239 (678)
                      .+.+|.......+|+.|++++|.++...+..|..+++|+.|+|++|.|+.++. .|..+++|+.|+|++|++++..|..|
T Consensus       213 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  292 (477)
T 2id5_A          213 LDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAF  292 (477)
T ss_dssp             CCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTB
T ss_pred             ccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHh
Confidence            87788777777899999999999997777889999999999999999998876 68999999999999999999889888


Q ss_pred             cccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccCccccCCCCC
Q 005760          240 GNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNL  319 (678)
Q Consensus       240 ~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~c~~~~~  319 (678)
                      .+++          +|+.|+|++|+|++..+..|..+++|+.|++++|+|.|+|+..+.+.+.....+.++.+.|.+|..
T Consensus       293 ~~l~----------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~  362 (477)
T 2id5_A          293 RGLN----------YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEF  362 (477)
T ss_dssp             TTCT----------TCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESGG
T ss_pred             cCcc----------cCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCchH
Confidence            8777          999999999999998888999999999999999999999988776666677788889999988753

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.7e-36  Score=334.86  Aligned_cols=264  Identities=23%  Similarity=0.314  Sum_probs=195.5

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeec------CC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSN------EE  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~  461 (678)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+++++.++||||+++++++..      .+
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            347899999999999999999985 478999999986542 2345678899999999999999999998755      67


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCc---EEEEee
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNY--ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMV---AHLSDF  536 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~---~kl~Df  536 (678)
                      ..++||||+++|+|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccc
Confidence            78999999999999999986542  5788899999999999999999   899999999999999997665   999999


Q ss_pred             ccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCc-
Q 005760          537 GIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS-  615 (678)
Q Consensus       537 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-  615 (678)
                      |++.......   ......+|+.|+|||.+.+..++.++||||+||++|||++|..||......    ..|........ 
T Consensus       169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i~~~~~  241 (676)
T 3qa8_A          169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKVREKSN  241 (676)
T ss_dssp             CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTCC----
T ss_pred             cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhhhcccc
Confidence            9998764322   234567999999999999999999999999999999999999998652111    11111000000 


Q ss_pred             ----ccccccCcc-C-CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHH
Q 005760          616 ----TKEIVDPNL-L-SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI  663 (678)
Q Consensus       616 ----~~~~~~~~~-~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el  663 (678)
                          ......... . .............+.++.+++.+||.+||++|||+.|+
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence                000000000 0 00000000012356779999999999999999999884

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.9e-36  Score=304.09  Aligned_cols=233  Identities=15%  Similarity=0.050  Sum_probs=185.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....   ...+.+.+|+..++.++||||+++++++.+.+..|+|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999864 689999999975432   2346788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.++++..   .....+..++.|++.||+|||   +++|+||||||+||+++.+|.+||+++|.        
T Consensus       110 ~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~--------  175 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPAT--------  175 (286)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccc--------
Confidence            9999999999999653   355678889999999999999   99999999999999999999999974432        


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                                    ++       .++.++|||||||++|||++|+.||.+........ ....         ....... 
T Consensus       176 --------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~-~~~~---------~~~~~~~-  223 (286)
T 3uqc_A          176 --------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-PAER---------DTAGQPI-  223 (286)
T ss_dssp             --------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE-ECCB---------CTTSCBC-
T ss_pred             --------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH-HHHH---------HhccCCC-
Confidence                          22       26789999999999999999999997643322100 0000         0000000 


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                         ........+++++.+++.+||+.||++| |+.|+++.|+++...
T Consensus       224 ---~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          224 ---EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             ---CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             ---ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence               0000112356678999999999999999 999999999998643

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.8e-35  Score=341.50  Aligned_cols=231  Identities=33%  Similarity=0.570  Sum_probs=140.3

Q ss_pred             ccccCCcCcccCCcc-ccCCCCCCEEecCCCcccccCCccccCCC-CCCEEEccCccCCCCccchhhcccccC--CCCCc
Q 005760            2 LQMWENNFSGTIPRF-IFNASKLSILELSDNSFSGFIPNTFGNLR-NLQALRLSNNYLTSSTLELSFLSSLSN--CKSLT   77 (678)
Q Consensus         2 L~l~~~~~~~~~p~~-~~~l~~L~~L~l~~n~i~~~~~~~~~~l~-~L~~L~l~~n~i~~~~~~~~~~~~~~~--l~~L~   77 (678)
                      |+|++|++++.+|.. +..+++|++|+|++|++++..|..+.+++ +|++|++++|.+......     .+..  +++|+
T Consensus       323 L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~-----~~~~~~~~~L~  397 (768)
T 3rgz_A          323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP-----NLCQNPKNTLQ  397 (768)
T ss_dssp             EECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCT-----TTTCSTTCCCC
T ss_pred             EECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcCh-----hhhhcccCCcc
Confidence            678888887777755 77788888888888888877777777776 777777777776532211     1222  45556


Q ss_pred             EEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccC
Q 005760           78 LISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLEN  157 (678)
Q Consensus        78 ~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  157 (678)
                      +|++++|++++..|.. +..++ +|++|+|++|++++..|..|..+++|+.|++++|++++..|..+..+++|++|+|++
T Consensus       398 ~L~L~~n~l~~~~p~~-l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~  475 (768)
T 3rgz_A          398 ELYLQNNGFTGKIPPT-LSNCS-ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF  475 (768)
T ss_dssp             EEECCSSEEEEECCGG-GGGCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCS
T ss_pred             EEECCCCccccccCHH-HhcCC-CCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecC
Confidence            6666666555555543 44444 555555555555555555555555555555555555555555555555555555555


Q ss_pred             CcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccc-cccccccccccccEEEecCCcccCCCC
Q 005760          158 NKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLP  236 (678)
Q Consensus       158 n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~~~~  236 (678)
                      |++++.+|..+..+++|++|++++|++++.+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++.+.+|
T Consensus       476 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip  555 (768)
T 3rgz_A          476 NDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP  555 (768)
T ss_dssp             SCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCC
T ss_pred             CcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCC
Confidence            5555555555555555555555555555555555555555555555555555 345555555555555555555555555


Q ss_pred             ccc
Q 005760          237 LEI  239 (678)
Q Consensus       237 ~~~  239 (678)
                      ..+
T Consensus       556 ~~~  558 (768)
T 3rgz_A          556 AAM  558 (768)
T ss_dssp             GGG
T ss_pred             hHH
Confidence            443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.8e-36  Score=340.48  Aligned_cols=242  Identities=20%  Similarity=0.294  Sum_probs=196.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC--CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCe-----
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG--DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF-----  462 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  462 (678)
                      .++|++.+.||+|+||.||+|.+.  +|+.||||++.... ......+.+|+++++.++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999864  68999999986432 2345678899999999999999999999977655     


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .|+||||+++++|.+++..   .+++..+..++.||+.||.|||   +++|+||||||+||+++.+ .+||+|||+++..
T Consensus       159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            7999999999999988765   4899999999999999999999   8999999999999999985 9999999999865


Q ss_pred             CCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ...      ....||+.|+|||++.++ ++.++|||||||++|+|++|..||........                   +
T Consensus       232 ~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-------------------~  285 (681)
T 2pzi_A          232 NSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-------------------P  285 (681)
T ss_dssp             TCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-------------------C
T ss_pred             ccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc-------------------c
Confidence            432      345699999999988765 48899999999999999999888754221100                   0


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI-NAKEIVTKLLKIRDS  673 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~ell~~L~~~~~~  673 (678)
                         .     .......++.+.+++.+||++||++|| +++++.+.|..+...
T Consensus       286 ---~-----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          286 ---E-----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             ---T-----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             ---c-----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence               0     001123456688999999999999999 577788888777543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.6e-35  Score=301.42  Aligned_cols=230  Identities=20%  Similarity=0.305  Sum_probs=179.7

Q ss_pred             hcCCCCC-ccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHH-HhCCCccceeeeeeeec----CCeE
Q 005760          391 TDGFSEN-NLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMM-KSIRHRNIIKVISSCSN----EEFK  463 (678)
Q Consensus       391 ~~~~~~~-~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~  463 (678)
                      .++|.+. +.||+|+||.||+|.. .+++.||+|++..     ...+.+|+.++ +..+||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3567776 7899999999999985 5789999999863     24567888887 56689999999999876    6788


Q ss_pred             EEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC---CCcEEEEeeccc
Q 005760          464 ALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIA  539 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~---~~~~kl~Dfg~~  539 (678)
                      ++||||+++++|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998754 35899999999999999999999   999999999999999997   889999999998


Q ss_pred             cccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccc
Q 005760          540 KLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI  619 (678)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (678)
                      ....                        +..++.++||||+||++|||++|+.||...........          ....
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~----------~~~~  213 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----------MKTR  213 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC----------SCCS
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH----------HHHH
Confidence            6432                        13467789999999999999999999965332211000          0000


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..   .............+++++.+++.+||+.||++|||+.|+++
T Consensus       214 ~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          214 IR---MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             SC---TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             Hh---hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00   00000111112345677999999999999999999999986

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=6.8e-35  Score=328.79  Aligned_cols=300  Identities=22%  Similarity=0.209  Sum_probs=273.4

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      |++++|++++..+..|..+++|++|+|++|+++ .+|..|.++++|++|++++|.+..++..     .+.++++|++|++
T Consensus       259 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l  332 (606)
T 3t6q_A          259 INLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQI-----SASNFPSLTHLSI  332 (606)
T ss_dssp             EECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGG-----CGGGCTTCSEEEC
T ss_pred             EEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchh-----hhhccCcCCEEEC
Confidence            689999999888888999999999999999999 6788999999999999999999977543     5889999999999


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccC--CccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCc
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGI--PEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNK  159 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~  159 (678)
                      ++|.+.+..+...+..++ +|++|++++|.+.+..  +..+.++++|++|++++|++.+..|..|..+++|++|++++|.
T Consensus       333 ~~n~~~~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  411 (606)
T 3t6q_A          333 KGNTKRLELGTGCLENLE-NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTR  411 (606)
T ss_dssp             CSCSSCCBCCSSTTTTCT-TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCC
T ss_pred             CCCCcccccchhhhhccC-cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCc
Confidence            999998777766677777 8999999999999876  7889999999999999999998889999999999999999999


Q ss_pred             CCCCCCC-cccCCCCccEEecCCCcCCCCChhhhhccccccceecccccccc--cc--ccccccccccEEEecCCcccCC
Q 005760          160 LEGSIPD-SICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTS--IP--LTFWNLKDILYLNFSSNFFTGP  234 (678)
Q Consensus       160 i~~~~~~-~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~--l~--~~~~~l~~L~~L~l~~N~l~~~  234 (678)
                      +++..+. .+..+++|++|++++|.+.+..|..+..+++|++|+|++|+++.  ++  ..+..+++|+.|++++|++++.
T Consensus       412 l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~  491 (606)
T 3t6q_A          412 LKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI  491 (606)
T ss_dssp             EECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEE
T ss_pred             CCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCcc
Confidence            9876554 48999999999999999999999999999999999999999986  23  4689999999999999999998


Q ss_pred             CCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC-CccccccccccccCccc
Q 005760          235 LPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELL  313 (678)
Q Consensus       235 ~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~-~~~~~l~~~~~~~n~~~  313 (678)
                      .|..|.+++          +|+.|+|++|++++..|..+..++.| .|++++|++++.+|.. ..+..++.+++.+||+.
T Consensus       492 ~~~~~~~l~----------~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  560 (606)
T 3t6q_A          492 DQHAFTSLK----------MMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD  560 (606)
T ss_dssp             CTTTTTTCT----------TCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEE
T ss_pred             Chhhhcccc----------CCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcc
Confidence            898888877          99999999999999999999999999 9999999999887764 66788999999999999


Q ss_pred             cCCCCC
Q 005760          314 CGSPNL  319 (678)
Q Consensus       314 c~~~~~  319 (678)
                      |+|+..
T Consensus       561 c~c~~~  566 (606)
T 3t6q_A          561 CTCSNI  566 (606)
T ss_dssp             CSGGGH
T ss_pred             ccCCcH
Confidence            999843

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=5.1e-35  Score=317.89  Aligned_cols=283  Identities=23%  Similarity=0.280  Sum_probs=248.8

Q ss_pred             CccccCCcCcccC-CccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEE
Q 005760            1 MLQMWENNFSGTI-PRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLI   79 (678)
Q Consensus         1 ~L~l~~~~~~~~~-p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L   79 (678)
                      +|+|++|.+.+.+ |..|..+++|++|+|++|++++..|++|.++++|++|+|++|.++.....   ...|..+++|++|
T Consensus        58 ~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~---~~~~~~l~~L~~L  134 (455)
T 3v47_A           58 FLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLS---GNFFKPLTSLEML  134 (455)
T ss_dssp             EEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHH---SSTTTTCTTCCEE
T ss_pred             EEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccC---cccccCcccCCEE
Confidence            4789999997655 57788999999999999999988899999999999999999999763221   1237889999999


Q ss_pred             ECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCC----------------------------------CC
Q 005760           80 SFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNL----------------------------------TN  125 (678)
Q Consensus        80 ~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l----------------------------------~~  125 (678)
                      +|++|++++..|...+..++ +|++|++++|++++..+..+..+                                  ++
T Consensus       135 ~L~~n~l~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~  213 (455)
T 3v47_A          135 VLRDNNIKKIQPASFFLNMR-RFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTS  213 (455)
T ss_dssp             ECCSSBCCSCCCCGGGGGCT-TCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCE
T ss_pred             ECCCCccCccCcccccCCCC-cccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccccccce
Confidence            99999999888877677777 89999999999998888766554                                  67


Q ss_pred             CcEEEccCCccCCcCChhhhcc---------------------------------------CCCCEEEccCCcCCCCCCC
Q 005760          126 LTIIYLGGNKLNGSIPSTLGKL---------------------------------------QKLQGLGLENNKLEGSIPD  166 (678)
Q Consensus       126 L~~L~l~~N~l~~~~~~~~~~l---------------------------------------~~L~~L~L~~n~i~~~~~~  166 (678)
                      |++|++++|++++..|..+..+                                       ++|++|++++|.+++.+|.
T Consensus       214 L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  293 (455)
T 3v47_A          214 ITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKS  293 (455)
T ss_dssp             EEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTT
T ss_pred             eeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchh
Confidence            9999999998876555544322                                       6899999999999988899


Q ss_pred             cccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccc-cccccccccccEEEecCCcccCCCCccccccccc
Q 005760          167 SICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSI-PLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIA  245 (678)
Q Consensus       167 ~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l-~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~  245 (678)
                      .+..+++|++|++++|.+++..|..|..+++|+.|+|++|.++.+ |..+..+++|+.|+|++|++++..|..|.+++  
T Consensus       294 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--  371 (455)
T 3v47_A          294 VFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLP--  371 (455)
T ss_dssp             TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCT--
T ss_pred             hcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccc--
Confidence            999999999999999999998899999999999999999999988 45789999999999999999988888888777  


Q ss_pred             cccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCC
Q 005760          246 RIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGG  297 (678)
Q Consensus       246 ~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~  297 (678)
                              +|++|+|++|+|++..+..+..+++|+.|++++|+|+|++|...
T Consensus       372 --------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  415 (455)
T 3v47_A          372 --------NLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  415 (455)
T ss_dssp             --------TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             --------cccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence                    99999999999998888888999999999999999999999753

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=1.7e-34  Score=325.50  Aligned_cols=190  Identities=20%  Similarity=0.205  Sum_probs=140.6

Q ss_pred             ccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCC-CcccCCCCccEEecCCCcCCCCChhhhhccccc
Q 005760          120 IGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIP-DSICHSDELYKLELGGNKLSGSIPECFNNLASL  198 (678)
Q Consensus       120 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L  198 (678)
                      +..+++|++|++++|.++ ..|..|..+++|++|++++|.+++..| ..+..+++|++|++++|.+.+..|..+..+++|
T Consensus       372 ~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  450 (606)
T 3vq2_A          372 DLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL  450 (606)
T ss_dssp             HHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTC
T ss_pred             hccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCC
Confidence            333444444444444443 233455556666666666666665544 466677777777777777776677777777777


Q ss_pred             cceecccccccc--ccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcc
Q 005760          199 RILLLGSNELTS--IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKL  276 (678)
Q Consensus       199 ~~L~l~~N~l~~--l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l  276 (678)
                      ++|+|++|.++.  +|..+..+++|+.|++++|.+++..|..|.+++          +|+.|+|++|++++..|..+..+
T Consensus       451 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~----------~L~~L~Ls~N~l~~~~~~~~~~l  520 (606)
T 3vq2_A          451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH----------RLQLLNMSHNNLLFLDSSHYNQL  520 (606)
T ss_dssp             CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT----------TCCEEECCSSCCSCEEGGGTTTC
T ss_pred             CEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccc----------cCCEEECCCCcCCCcCHHHccCC
Confidence            777777777775  466777788888888888888777777776666          99999999999999999999999


Q ss_pred             cCCCceecccccccccCCCCCccc-cccccccccCccccCCCCCC
Q 005760          277 SYLKDLNLSFNKLEGEIPRGGSFG-NFSAESFEGNELLCGSPNLR  320 (678)
Q Consensus       277 ~~L~~L~l~~N~~~~~~~~~~~~~-~l~~~~~~~n~~~c~~~~~~  320 (678)
                      ++|+.|++++|+++..++....++ +++.+++.+||+.|+|+..|
T Consensus       521 ~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~  565 (606)
T 3vq2_A          521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQK  565 (606)
T ss_dssp             TTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTHH
T ss_pred             CcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccHH
Confidence            999999999999997666655665 59999999999999998644

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.9e-36  Score=320.52  Aligned_cols=241  Identities=15%  Similarity=0.148  Sum_probs=180.2

Q ss_pred             hcCCCCCccccCCCceeEEEEE-eCCCcEEEEEEeecccC---chhhhHHHHHHHHHhCCC-ccceeee-----------
Q 005760          391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRH-RNIIKVI-----------  454 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~~~-----------  454 (678)
                      ...|...+.||+|+||.||+|. ..+|+.||||++.....   ...+.+.+|+.+++.++| +|...+.           
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3457778899999999999998 45799999999874322   235778899999999977 3221111           


Q ss_pred             ----------eeeec-----CCeEEEEEEecCCCCHHHHhh------hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 005760          455 ----------SSCSN-----EEFKALVLEYMPHGSLEKYLH------SSNYILDIYQRLNIMIDVASALEYLHFGYSAQV  513 (678)
Q Consensus       455 ----------~~~~~-----~~~~~lv~e~~~~~~L~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  513 (678)
                                .++..     ....+++|+++ +++|.+++.      .....+++..+..++.|++.||+|||   +++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence                      11111     22456777765 679999884      22335678889999999999999999   9999


Q ss_pred             EEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCcccc----------CCCCCCccchHHHHHHH
Q 005760          514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG----------KEGRVSANGDVYSFGIM  583 (678)
Q Consensus       514 vH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DvwslGv~  583 (678)
                      +||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+..++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999998765322     344567 999999998          55668899999999999


Q ss_pred             HHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHH
Q 005760          584 LMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI  663 (678)
Q Consensus       584 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~el  663 (678)
                      +|||++|+.||......+...             .+...    .        ..+++++.+++.+||+.||++||++.|+
T Consensus       307 l~elltg~~Pf~~~~~~~~~~-------------~~~~~----~--------~~~~~~~~~li~~~l~~dP~~Rpt~~~~  361 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSE-------------WIFRS----C--------KNIPQPVRALLEGFLRYPKEDRLLPLQA  361 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSG-------------GGGSS----C--------CCCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHHHHHCCCCCCCcchhhhHH-------------HHHhh----c--------ccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            999999999997533221100             00000    0        0123568899999999999999999888


Q ss_pred             HHH
Q 005760          664 VTK  666 (678)
Q Consensus       664 l~~  666 (678)
                      ++.
T Consensus       362 l~~  364 (413)
T 3dzo_A          362 MET  364 (413)
T ss_dssp             TTS
T ss_pred             HhC
Confidence            653

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=1e-34  Score=338.66  Aligned_cols=314  Identities=23%  Similarity=0.206  Sum_probs=204.2

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCcc--ccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEE
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNT--FGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLI   79 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~--~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L   79 (678)
                      |+|++|++.+..|+.|.++++|++|+|++|.+++..+..  |.++++|++|+|++|.+......    ..|.++++|++|
T Consensus        78 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~----~~~~~L~~L~~L  153 (844)
T 3j0a_A           78 LDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH----PSFGKLNSLKSI  153 (844)
T ss_dssp             EECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCC----GGGGTCSSCCEE
T ss_pred             EECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccc----hhHhhCCCCCEE
Confidence            566666666666666666666666666666666544433  66666666666666666554321    246667777777


Q ss_pred             ECccCCCcccCChhhhhcc-------------------------------------------------------------
Q 005760           80 SFSNNPLDGILPKTSVGNL-------------------------------------------------------------   98 (678)
Q Consensus        80 ~L~~n~i~~~~~~~~~~~l-------------------------------------------------------------   98 (678)
                      +|++|.+++..+.. +..+                                                             
T Consensus       154 ~Ls~N~i~~~~~~~-l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~  232 (844)
T 3j0a_A          154 DFSSNQIFLVCEHE-LEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ  232 (844)
T ss_dssp             EEESSCCCCCCSGG-GHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCC
T ss_pred             ECCCCcCCeeCHHH-cccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCccc
Confidence            77777665443322 1100                                                             


Q ss_pred             --------------------------------cccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhc
Q 005760           99 --------------------------------SHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGK  146 (678)
Q Consensus        99 --------------------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  146 (678)
                                                      ..+|++|++++|.+.+..+..|..+++|+.|+|++|++++..+..|.+
T Consensus       233 l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~  312 (844)
T 3j0a_A          233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYG  312 (844)
T ss_dssp             BSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTT
T ss_pred             ccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcC
Confidence                                            124666777777777777777888888888888888888777888888


Q ss_pred             cCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-------------
Q 005760          147 LQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-------------  213 (678)
Q Consensus       147 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-------------  213 (678)
                      +++|++|+|++|.+++..|..|..+++|+.|++++|.+....+..|..+++|+.|+|++|.++.++.             
T Consensus       313 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~  392 (844)
T 3j0a_A          313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNK  392 (844)
T ss_dssp             CSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCC
T ss_pred             CCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCC
Confidence            8888888888888887778888888888888888888887777778888888888888887765431             


Q ss_pred             ----------------------------cccccccccEEEecCCcccCCCCcc----cccccccc---------------
Q 005760          214 ----------------------------TFWNLKDILYLNFSSNFFTGPLPLE----IGNLKIAR---------------  246 (678)
Q Consensus       214 ----------------------------~~~~l~~L~~L~l~~N~l~~~~~~~----~~~l~~~~---------------  246 (678)
                                                  .+..+++|+.|+|++|++++..+..    ...++..+               
T Consensus       393 l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~  472 (844)
T 3j0a_A          393 LVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELC  472 (844)
T ss_dssp             CCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCC
T ss_pred             cccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccc
Confidence                                        1225667777777777776433221    01110000               


Q ss_pred             -ccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC--------------------Ccccccccc
Q 005760          247 -IDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG--------------------GSFGNFSAE  305 (678)
Q Consensus       247 -~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~--------------------~~~~~l~~~  305 (678)
                       ..+.++++|+.|+|++|+|++..|..+..+++|+.|+|++|.+++.++..                    ..+..+..+
T Consensus       473 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l  552 (844)
T 3j0a_A          473 WDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVL  552 (844)
T ss_dssp             SSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEE
T ss_pred             hhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEE
Confidence             01223455555555555555555555555555555555555555433321                    124578889


Q ss_pred             ccccCccccCCCCCC
Q 005760          306 SFEGNELLCGSPNLR  320 (678)
Q Consensus       306 ~~~~n~~~c~~~~~~  320 (678)
                      ++.+|||.|+|+..+
T Consensus       553 ~l~~Np~~C~c~~~~  567 (844)
T 3j0a_A          553 DITHNKFICECELST  567 (844)
T ss_dssp             EEEEECCCCSSSCCS
T ss_pred             EecCCCcccccccHH
Confidence            999999999998654

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.8e-34  Score=317.50  Aligned_cols=303  Identities=22%  Similarity=0.264  Sum_probs=190.3

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      |+|++|++++..|..|..+++|++|+|++|+|++..|++|.++++|++|+|++|+++.++.       . .+++|++|+|
T Consensus        26 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~-------~-~l~~L~~L~L   97 (520)
T 2z7x_B           26 LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISC-------H-PTVNLKHLDL   97 (520)
T ss_dssp             EECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEEC-------C-CCCCCSEEEC
T ss_pred             EECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCc-------c-ccCCccEEec
Confidence            6777777776666677777777777777777777667777777777777777777765442       1 5666666666


Q ss_pred             ccCCCccc-CChhhhhcccccccEEEcccccccccCCccccCCCCC--cEEEccCCcc--CCcCChhhhccC--------
Q 005760           82 SNNPLDGI-LPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNL--TIIYLGGNKL--NGSIPSTLGKLQ--------  148 (678)
Q Consensus        82 ~~n~i~~~-~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L--~~L~l~~N~l--~~~~~~~~~~l~--------  148 (678)
                      ++|++++. .|.. +..++ +|++|++++|++.+   ..+..+++|  +.|++++|.+  .+..|..+..+.        
T Consensus        98 ~~N~l~~~~~p~~-~~~l~-~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l  172 (520)
T 2z7x_B           98 SFNAFDALPICKE-FGNMS-QLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVF  172 (520)
T ss_dssp             CSSCCSSCCCCGG-GGGCT-TCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEEC
T ss_pred             cCCccccccchhh-hccCC-cceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEe
Confidence            66666553 2222 45554 55555555555543   123333333  4444444333  222232222211        


Q ss_pred             ---------------------------------------------------------------------------CCCEE
Q 005760          149 ---------------------------------------------------------------------------KLQGL  153 (678)
Q Consensus       149 ---------------------------------------------------------------------------~L~~L  153 (678)
                                                                                                 +|++|
T Consensus       173 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L  252 (520)
T 2z7x_B          173 PTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF  252 (520)
T ss_dssp             CSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEE
T ss_pred             ccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEE
Confidence                                                                                       34444


Q ss_pred             EccCCcCCCCCCCcc-----------------------------------------------------cCCCCccEEecC
Q 005760          154 GLENNKLEGSIPDSI-----------------------------------------------------CHSDELYKLELG  180 (678)
Q Consensus       154 ~L~~n~i~~~~~~~~-----------------------------------------------------~~l~~L~~L~l~  180 (678)
                      ++++|.+++.+|..+                                                     ..+++|++|+++
T Consensus       253 ~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls  332 (520)
T 2z7x_B          253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS  332 (520)
T ss_dssp             EEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECC
T ss_pred             EeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeE
Confidence            444444443333332                                                     455667777777


Q ss_pred             CCcCCCCChhhhhccccccceeccccccccc---cccccccccccEEEecCCcccCCCCcc-ccc---ccccccccc---
Q 005760          181 GNKLSGSIPECFNNLASLRILLLGSNELTSI---PLTFWNLKDILYLNFSSNFFTGPLPLE-IGN---LKIARIDSC---  250 (678)
Q Consensus       181 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l---~~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~---l~~~~~~~~---  250 (678)
                      +|.+++..|..+..+++|+.|+|++|+++.+   |..+..+++|+.|++++|.+++.+|.. +..   ++..++..+   
T Consensus       333 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~  412 (520)
T 2z7x_B          333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT  412 (520)
T ss_dssp             SSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCC
T ss_pred             CCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCC
Confidence            7777766666666777777777777776643   345666777777777777776534322 322   111111111   


Q ss_pred             -----Cc-ccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCC-CCccccccccccccCccccCCCC
Q 005760          251 -----DL-ISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLCGSPN  318 (678)
Q Consensus       251 -----~~-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~-~~~~~~l~~~~~~~n~~~c~~~~  318 (678)
                           .+ ++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++..++. ...+..++.+++.+|++.|+|+.
T Consensus       413 ~~~~~~l~~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          413 DTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             GGGGGSCCTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             cchhhhhcccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence                 12 58999999999999 5666667999999999999999976655 56788899999999999999874

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=6.9e-34  Score=317.19  Aligned_cols=305  Identities=21%  Similarity=0.198  Sum_probs=199.4

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      |+|++|++.+..|..|..+++|++|+|++|+|+++.|++|.++++|++|+|++|.++.++.       . .+++|++|+|
T Consensus        57 L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~-------~-~l~~L~~L~L  128 (562)
T 3a79_B           57 LSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISC-------C-PMASLRHLDL  128 (562)
T ss_dssp             EECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECS-------C-CCTTCSEEEC
T ss_pred             EECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCc-------c-ccccCCEEEC
Confidence            6777777776666777777888888888888877777777777888888888877775542       1 5677777777


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCC--cEEEccCCcc--CCcCChhhhccC---------
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNL--TIIYLGGNKL--NGSIPSTLGKLQ---------  148 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L--~~L~l~~N~l--~~~~~~~~~~l~---------  148 (678)
                      ++|+++++.....+..++ +|++|++++|++++.   .+..+++|  ++|++++|.+  ++..|..|..+.         
T Consensus       129 s~N~l~~l~~p~~~~~l~-~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~  204 (562)
T 3a79_B          129 SFNDFDVLPVCKEFGNLT-KLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH  204 (562)
T ss_dssp             CSSCCSBCCCCGGGGGCT-TCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEEC
T ss_pred             CCCCccccCchHhhcccC-cccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEec
Confidence            777776543222355565 677777776666542   23333333  5555555554  333333333221         


Q ss_pred             ------------------------------------------------------------------------CCCEEEcc
Q 005760          149 ------------------------------------------------------------------------KLQGLGLE  156 (678)
Q Consensus       149 ------------------------------------------------------------------------~L~~L~L~  156 (678)
                                                                                              +|++|+++
T Consensus       205 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~  284 (562)
T 3a79_B          205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY  284 (562)
T ss_dssp             SSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEE
T ss_pred             CccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEe
Confidence                                                                                    45555555


Q ss_pred             CCcCCCCCCCcc-----------------------------------------------------cCCCCccEEecCCCc
Q 005760          157 NNKLEGSIPDSI-----------------------------------------------------CHSDELYKLELGGNK  183 (678)
Q Consensus       157 ~n~i~~~~~~~~-----------------------------------------------------~~l~~L~~L~l~~N~  183 (678)
                      +|.+++.+|..+                                                     ..+++|++|++++|.
T Consensus       285 ~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~  364 (562)
T 3a79_B          285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNV  364 (562)
T ss_dssp             EEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSC
T ss_pred             ccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCc
Confidence            555554444433                                                     455667777777777


Q ss_pred             CCCCChhhhhccccccceecccccccccc---ccccccccccEEEecCCcccCCCCc-cccccc---ccc--------cc
Q 005760          184 LSGSIPECFNNLASLRILLLGSNELTSIP---LTFWNLKDILYLNFSSNFFTGPLPL-EIGNLK---IAR--------ID  248 (678)
Q Consensus       184 i~~~~~~~~~~l~~L~~L~l~~N~l~~l~---~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~---~~~--------~~  248 (678)
                      +++..|..+..+++|+.|+|++|+++.++   ..+..+++|+.|++++|.+++.+|. .+..++   ...        ..
T Consensus       365 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~  444 (562)
T 3a79_B          365 FTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV  444 (562)
T ss_dssp             CCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGG
T ss_pred             cccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcch
Confidence            77666666777777777777777776543   3466677777777777777653332 232221   111        11


Q ss_pred             ccCc-ccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCC-CCccccccccccccCccccCCCCC
Q 005760          249 SCDL-ISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLCGSPNL  319 (678)
Q Consensus       249 ~~~~-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~-~~~~~~l~~~~~~~n~~~c~~~~~  319 (678)
                      +..+ ++|+.|+|++|+|+. +|..+..+++|+.|++++|+++..++. ...++.++.+++.+|||.|+|+..
T Consensus       445 ~~~l~~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~  516 (562)
T 3a79_B          445 FRCLPPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGI  516 (562)
T ss_dssp             GSSCCTTCSEEECCSSCCCC-CCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHH
T ss_pred             hhhhcCcCCEEECCCCcCcc-cChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchH
Confidence            1223 589999999999994 555555999999999999999976665 577889999999999999999843

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.5e-33  Score=322.14  Aligned_cols=308  Identities=21%  Similarity=0.221  Sum_probs=194.8

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhc----ccccCCCCCc
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFL----SSLSNCKSLT   77 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~----~~~~~l~~L~   77 (678)
                      |+|++|++++..|..+..+++|++|+|++|++++..+.+|.++++|+.|++++|..........++    ..|..+++|+
T Consensus       253 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~  332 (680)
T 1ziw_A          253 LDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE  332 (680)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCC
T ss_pred             EECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCC
Confidence            456666666555556666666666666666666555555554444444444433222100000000    0344455555


Q ss_pred             EEECccCCCcccCChhhhhccc---------------------------ccccEEEcccccccccCCccccCCCCCcEEE
Q 005760           78 LISFSNNPLDGILPKTSVGNLS---------------------------HSLEYFEMAYCNVSGGIPEEIGNLTNLTIIY  130 (678)
Q Consensus        78 ~L~L~~n~i~~~~~~~~~~~l~---------------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  130 (678)
                      +|++++|.+.++.+.. +..++                           .+|+.|++++|++++..|..|.++++|+.|+
T Consensus       333 ~L~l~~n~l~~~~~~~-~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  411 (680)
T 1ziw_A          333 HLNMEDNDIPGIKSNM-FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLD  411 (680)
T ss_dssp             EEECCSCCBCCCCTTT-TTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             EEECCCCccCCCChhH-hccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEe
Confidence            5555555554443322 11111                           2455555666666666666677777777777


Q ss_pred             ccCCccCCcCC-hhhhccCCCCEEEccCCcCCC--------------------------CCCCcccCCCCccEEecCCCc
Q 005760          131 LGGNKLNGSIP-STLGKLQKLQGLGLENNKLEG--------------------------SIPDSICHSDELYKLELGGNK  183 (678)
Q Consensus       131 l~~N~l~~~~~-~~~~~l~~L~~L~L~~n~i~~--------------------------~~~~~~~~l~~L~~L~l~~N~  183 (678)
                      |++|.+.+..| ..|.++++|++|++++|++++                          ..|..|..+++|+.|++++|.
T Consensus       412 L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~  491 (680)
T 1ziw_A          412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN  491 (680)
T ss_dssp             CCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSC
T ss_pred             CCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCC
Confidence            77777654333 456666666666666666543                          345566666777777777777


Q ss_pred             CCCCChhhhhccccccceeccccccccccc---------cccccccccEEEecCCcccCCCCccccccccccccccCccc
Q 005760          184 LSGSIPECFNNLASLRILLLGSNELTSIPL---------TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLIS  254 (678)
Q Consensus       184 i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~---------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~  254 (678)
                      +++..+..|.++++|+.|+|++|+++.++.         .+.++++|+.|+|++|+++...+..|.+++          +
T Consensus       492 l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~----------~  561 (680)
T 1ziw_A          492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLF----------E  561 (680)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT----------T
T ss_pred             CCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccccc----------C
Confidence            776666667777777777777777765532         256667777777777777754445566555          9


Q ss_pred             ccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC-C-ccccccccccccCccccCCCC-CC
Q 005760          255 LISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG-G-SFGNFSAESFEGNELLCGSPN-LR  320 (678)
Q Consensus       255 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~-~-~~~~l~~~~~~~n~~~c~~~~-~~  320 (678)
                      |+.|+|++|+++++.+..|..+++|+.|++++|.+++..+.. . .+..+..+++.+|||.|+|+. .|
T Consensus       562 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~  630 (680)
T 1ziw_A          562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAW  630 (680)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSS
T ss_pred             cceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHH
Confidence            999999999999888888899999999999999999876654 2 578899999999999999985 44

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.5e-35  Score=305.79  Aligned_cols=243  Identities=17%  Similarity=0.184  Sum_probs=182.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccC--------chhhhHHHHHHHHHhCC---------Ccc----
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG--------RVFKSFDVECEMMKSIR---------HRN----  449 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~n----  449 (678)
                      .++|++.+.||+|+||.||+|+. +|+.||||++.....        ...+.+.+|+.+++.++         |||    
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46788999999999999999988 789999999976532        23367889999999886         544    


Q ss_pred             -------------ceeeeeeeec-------------CCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHH
Q 005760          450 -------------IIKVISSCSN-------------EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALE  503 (678)
Q Consensus       450 -------------iv~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~  503 (678)
                                   |+++++++.+             .+..++||||+++|++.+.+.+  ..+++..+..++.||+.||+
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence                         4555554443             6789999999999977776654  34899999999999999999


Q ss_pred             HHhcCCCCCeEEcCCCCCCeeecCCC--------------------cEEEEeeccccccCCCCCcceeecccCCccccCc
Q 005760          504 YLHFGYSAQVIHCDLKPSNVLLDDNM--------------------VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP  563 (678)
Q Consensus       504 ~LH~~~~~~ivH~dl~~~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  563 (678)
                      |||+  +++|+||||||+|||++.++                    .+||+|||+|+....       ....||+.|+||
T Consensus       176 ~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP  246 (336)
T 2vuw_A          176 VAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE  246 (336)
T ss_dssp             HHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred             HHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence            9993  47899999999999999887                    999999999986532       124689999999


Q ss_pred             cccCCCCCCccchHHHHHHH-HHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHH
Q 005760          564 EYGKEGRVSANGDVYSFGIM-LMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFV  642 (678)
Q Consensus       564 E~~~~~~~~~~~DvwslGv~-l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  642 (678)
                      |++.+.. +.++||||+|++ .+++++|..||................        ...+     ..........+++++
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~-----~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQ--------MTFK-----TKCNTPAMKQIKRKI  312 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHT--------CCCS-----SCCCSHHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhh--------hccC-----cccchhhhhhcCHHH
Confidence            9998766 889999998777 778889999985411000000000000        0000     000111234678889


Q ss_pred             HHHHhhccccCcCCCCCHHHHH
Q 005760          643 FNVAMECTVESPEQRINAKEIV  664 (678)
Q Consensus       643 ~~l~~~cl~~dP~~Rps~~ell  664 (678)
                      .+|+.+||++|     |+.|++
T Consensus       313 ~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHhccC-----CHHHHH
Confidence            99999999977     999987

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=1.4e-33  Score=314.21  Aligned_cols=309  Identities=20%  Similarity=0.206  Sum_probs=179.8

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      |+|++|++++..|..|..+++|++|+|++|+|++..|++|.++++|++|+|++|.+..++..     .|.++++|++|+|
T Consensus        31 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-----~~~~l~~L~~L~L  105 (549)
T 2z81_A           31 LDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSS-----WFGPLSSLKYLNL  105 (549)
T ss_dssp             EECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHH-----HHTTCTTCCEEEC
T ss_pred             EECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHH-----HhccCCCCcEEEC
Confidence            67788888777777777788888888888888877777788888888888888877766643     2566666666666


Q ss_pred             ccCCCcccCChhhhhccc------------------------ccccEEEcccccccccCCccccC---------------
Q 005760           82 SNNPLDGILPKTSVGNLS------------------------HSLEYFEMAYCNVSGGIPEEIGN---------------  122 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~------------------------~~L~~L~l~~n~l~~~~~~~~~~---------------  122 (678)
                      ++|++++......+..++                        .+|++|++++|.+++..|..+..               
T Consensus       106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~  185 (549)
T 2z81_A          106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA  185 (549)
T ss_dssp             TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST
T ss_pred             CCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc
Confidence            666665432111233333                        14555555555555444444332               


Q ss_pred             ---------CCCCcEEEccCCccCCc------------------------------------------------------
Q 005760          123 ---------LTNLTIIYLGGNKLNGS------------------------------------------------------  139 (678)
Q Consensus       123 ---------l~~L~~L~l~~N~l~~~------------------------------------------------------  139 (678)
                               +++|++|++++|++++.                                                      
T Consensus       186 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~  265 (549)
T 2z81_A          186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG  265 (549)
T ss_dssp             THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEEC
T ss_pred             ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccc
Confidence                     23333334444433321                                                      


Q ss_pred             -----------------------------------------------------------CChhh-hccCCCCEEEccCCc
Q 005760          140 -----------------------------------------------------------IPSTL-GKLQKLQGLGLENNK  159 (678)
Q Consensus       140 -----------------------------------------------------------~~~~~-~~l~~L~~L~L~~n~  159 (678)
                                                                                 +|..+ ..+++|++|+|++|.
T Consensus       266 ~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~  345 (549)
T 2z81_A          266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENL  345 (549)
T ss_dssp             CSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSC
T ss_pred             cccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcCccccEEEccCCc
Confidence                                                                       00001 123334444444444


Q ss_pred             CCCCCC---CcccCCCCccEEecCCCcCCCCCh--hhhhccccccceeccccccccccccccccccccEEEecCCcccCC
Q 005760          160 LEGSIP---DSICHSDELYKLELGGNKLSGSIP--ECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGP  234 (678)
Q Consensus       160 i~~~~~---~~~~~l~~L~~L~l~~N~i~~~~~--~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~  234 (678)
                      +++..|   ..+..+++|++|++++|.+++..+  ..+..+++|++|+|++|+++.+|..+..+++|+.|++++|.++..
T Consensus       346 l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~l  425 (549)
T 2z81_A          346 MVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVV  425 (549)
T ss_dssp             CCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSCC
T ss_pred             cccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCcccc
Confidence            432221   123344444444444444443221  234555555555555555555555555555566666666655432


Q ss_pred             CCcccccccccccc-------ccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCC-CCccccccccc
Q 005760          235 LPLEIGNLKIARID-------SCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR-GGSFGNFSAES  306 (678)
Q Consensus       235 ~~~~~~~l~~~~~~-------~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~-~~~~~~l~~~~  306 (678)
                      .......++..++.       ...+++|+.|+|++|+|+. +|. ...+++|+.|++++|++++.++. ...+..++.++
T Consensus       426 ~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~~-ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  503 (549)
T 2z81_A          426 KTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKT-LPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW  503 (549)
T ss_dssp             CTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCSS-CCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEE
T ss_pred             cchhcCCceEEECCCCChhhhcccCChhcEEECCCCccCc-CCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEE
Confidence            22111122211111       1367789999999999984 444 46788999999999999987776 46778899999


Q ss_pred             cccCccccCCC
Q 005760          307 FEGNELLCGSP  317 (678)
Q Consensus       307 ~~~n~~~c~~~  317 (678)
                      +.+|++.|+||
T Consensus       504 l~~N~~~~~~~  514 (549)
T 2z81_A          504 LHTNPWDCSCP  514 (549)
T ss_dssp             CCSSCBCCCHH
T ss_pred             ecCCCccCCCc
Confidence            99999999887

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.6e-33  Score=317.66  Aligned_cols=303  Identities=23%  Similarity=0.291  Sum_probs=239.7

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      +|||++|+|++..|.+|.++++|++|+|++|+|+++.+++|.++++|++|+|++|+|+.++..     .|.++++|++|+
T Consensus        56 ~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~-----~f~~L~~L~~L~  130 (635)
T 4g8a_A           56 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG-----AFSGLSSLQKLV  130 (635)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGG-----GGTTCTTCCEEE
T ss_pred             EEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHH-----HhcCCCCCCEEE
Confidence            489999999977778899999999999999999988899999999999999999999988764     589999999999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEccccccccc-CCccccCCCCCcEEEccCCccCCcCChhhhc-------------
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGG-IPEEIGNLTNLTIIYLGGNKLNGSIPSTLGK-------------  146 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~-------------  146 (678)
                      |++|+++++.+.. +.+++ +|++|+|++|.++.. .|..+..+++|++|+|++|++++..+..|..             
T Consensus       131 Ls~N~l~~l~~~~-~~~L~-~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~l  208 (635)
T 4g8a_A          131 AVETNLASLENFP-IGHLK-TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDL  208 (635)
T ss_dssp             CTTSCCCCSTTCC-CTTCT-TCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEEC
T ss_pred             CCCCcCCCCChhh-hhcCc-ccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhc
Confidence            9999998776544 77777 899999999999864 5788889999999999999876543332211             


Q ss_pred             --------------------------------------------------------------------------------
Q 005760          147 --------------------------------------------------------------------------------  146 (678)
Q Consensus       147 --------------------------------------------------------------------------------  146 (678)
                                                                                                      
T Consensus       209 s~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~  288 (635)
T 4g8a_A          209 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL  288 (635)
T ss_dssp             TTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEE
T ss_pred             ccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhh
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 005760          147 --------------------------------------------------------------------------------  146 (678)
Q Consensus       147 --------------------------------------------------------------------------------  146 (678)
                                                                                                      
T Consensus       289 ~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~  368 (635)
T 4g8a_A          289 AYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEV  368 (635)
T ss_dssp             ECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCC
T ss_pred             hhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccc
Confidence                                                                                            


Q ss_pred             -cCCCCEEEccCCcCCC--------------------------------------------------CCCCcccCCCCcc
Q 005760          147 -LQKLQGLGLENNKLEG--------------------------------------------------SIPDSICHSDELY  175 (678)
Q Consensus       147 -l~~L~~L~L~~n~i~~--------------------------------------------------~~~~~~~~l~~L~  175 (678)
                       +++|+.|++++|.+..                                                  ..+..|..+++++
T Consensus       369 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~  448 (635)
T 4g8a_A          369 DLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI  448 (635)
T ss_dssp             BCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCC
T ss_pred             cccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccc
Confidence             1222333333332210                                                  0011223334444


Q ss_pred             EEecCCCcCCCCChhhhhccccccceeccccccc-c-ccccccccccccEEEecCCcccCCCCccccccccccccccCcc
Q 005760          176 KLELGGNKLSGSIPECFNNLASLRILLLGSNELT-S-IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLI  253 (678)
Q Consensus       176 ~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~-~-l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~  253 (678)
                      .++++.|.+....+..+..+++|+.|+|++|.+. . +|..|..+++|+.|+|++|++++..|..|.+++          
T Consensus       449 ~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~----------  518 (635)
T 4g8a_A          449 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS----------  518 (635)
T ss_dssp             EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT----------
T ss_pred             cccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCC----------
Confidence            5555555555555666677788888899888744 3 466789999999999999999999999998887          


Q ss_pred             cccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC-Ccc-ccccccccccCccccCCCCCC
Q 005760          254 SLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG-GSF-GNFSAESFEGNELLCGSPNLR  320 (678)
Q Consensus       254 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~-~~~-~~l~~~~~~~n~~~c~~~~~~  320 (678)
                      +|++|+|++|+|++..+..|..+++|+.|++++|++++..|.. ..+ .+++.+++.+|||.|+|...|
T Consensus       519 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~  587 (635)
T 4g8a_A          519 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQS  587 (635)
T ss_dssp             TCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHH
T ss_pred             CCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHH
Confidence            9999999999999999999999999999999999999988765 444 579999999999999998543

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=8.3e-34  Score=320.16  Aligned_cols=303  Identities=25%  Similarity=0.286  Sum_probs=256.8

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCc-------------------------------------------------
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNS-------------------------------------------------   32 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~-------------------------------------------------   32 (678)
                      |+|++|++.+.+|.+++++++|++|+|++|.                                                 
T Consensus        86 L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l  165 (636)
T 4eco_A           86 LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDC  165 (636)
T ss_dssp             EECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHH
T ss_pred             EEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHH
Confidence            7899999999999999999999999999984                                                 


Q ss_pred             -----------------------------ccccCCccccCCCCCCEEEccCccCCCCccchh------------hccccc
Q 005760           33 -----------------------------FSGFIPNTFGNLRNLQALRLSNNYLTSSTLELS------------FLSSLS   71 (678)
Q Consensus        33 -----------------------------i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~------------~~~~~~   71 (678)
                                                   +++ +|..|+++++|++|+|++|.++.......            +++.+.
T Consensus       166 ~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~  244 (636)
T 4eco_A          166 INSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK  244 (636)
T ss_dssp             HHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCC
T ss_pred             hhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhh
Confidence                                         444 78899999999999999999987100000            234566


Q ss_pred             --CCCCCcEEECccCCCcccCChhhhhcccccccEEEccccc-ccc-cCCccccCC------CCCcEEEccCCccCCcCC
Q 005760           72 --NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCN-VSG-GIPEEIGNL------TNLTIIYLGGNKLNGSIP  141 (678)
Q Consensus        72 --~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~-l~~-~~~~~~~~l------~~L~~L~l~~N~l~~~~~  141 (678)
                        ++++|++|+|++|.+.+..|.. +..++ +|++|+|++|+ +++ .+|..++.+      ++|++|++++|+++ .+|
T Consensus       245 ~~~l~~L~~L~L~~n~l~~~~p~~-l~~l~-~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip  321 (636)
T 4eco_A          245 WDNLKDLTDVEVYNCPNLTKLPTF-LKALP-EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFP  321 (636)
T ss_dssp             GGGCTTCCEEEEECCTTCSSCCTT-TTTCS-SCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCC
T ss_pred             hcccCCCCEEEecCCcCCccChHH-HhcCC-CCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccC
Confidence              9999999999999999988865 78887 89999999998 988 889888876      99999999999999 778


Q ss_pred             h--hhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhcccc-ccceecccccccccccccccc
Q 005760          142 S--TLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLAS-LRILLLGSNELTSIPLTFWNL  218 (678)
Q Consensus       142 ~--~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~-L~~L~l~~N~l~~l~~~~~~l  218 (678)
                      .  .|+.+++|++|+|++|.+++.+| .|..+++|++|++++|.++ .+|..+..+++ |++|+|++|.++.+|..+..+
T Consensus       322 ~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~~~~~  399 (636)
T 4eco_A          322 VETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAK  399 (636)
T ss_dssp             CHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCSCCCTT
T ss_pred             chhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccchhhhhc
Confidence            7  89999999999999999998888 8999999999999999999 78888999999 999999999999999877765


Q ss_pred             c--cccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC
Q 005760          219 K--DILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG  296 (678)
Q Consensus       219 ~--~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  296 (678)
                      +  +|+.|++++|.+.+..|..+....   .....+++|+.|+|++|+++...+..+..+++|+.|++++|.++..++..
T Consensus       400 ~l~~L~~L~Ls~N~l~~~~p~~l~~~~---~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~  476 (636)
T 4eco_A          400 SVSVMSAIDFSYNEIGSVDGKNFDPLD---PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNS  476 (636)
T ss_dssp             CSSCEEEEECCSSCTTTTTTCSSCTTC---SSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSS
T ss_pred             ccCccCEEECcCCcCCCcchhhhcccc---cccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHH
Confidence            5  899999999999999998887211   11112348999999999999776677778999999999999999443333


Q ss_pred             Cccc--------cccccccccCccc
Q 005760          297 GSFG--------NFSAESFEGNELL  313 (678)
Q Consensus       297 ~~~~--------~l~~~~~~~n~~~  313 (678)
                      ....        .++.+++.+|...
T Consensus       477 ~~~~~~~~~~l~~L~~L~Ls~N~l~  501 (636)
T 4eco_A          477 LKDENENFKNTYLLTSIDLRFNKLT  501 (636)
T ss_dssp             SEETTEECTTGGGCCEEECCSSCCC
T ss_pred             hccccccccccCCccEEECcCCcCC
Confidence            2211        7888899888765

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=7.6e-34  Score=292.02  Aligned_cols=258  Identities=32%  Similarity=0.550  Sum_probs=207.5

Q ss_pred             CCCCEEEccCccCCCCccchhhcccccCCCCCcEEECcc-CCCcccCChhhhhcccccccEEEcccccccccCCccccCC
Q 005760           45 RNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSN-NPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNL  123 (678)
Q Consensus        45 ~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l  123 (678)
                      .+++.|+|++|.+....   .++..|.++++|++|+|++ |.+.+..|.. +..++ +|++|+|++|++++..|..|.++
T Consensus        50 ~~l~~L~L~~~~l~~~~---~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~-l~~l~-~L~~L~Ls~n~l~~~~p~~~~~l  124 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPY---PIPSSLANLPYLNFLYIGGINNLVGPIPPA-IAKLT-QLHYLYITHTNVSGAIPDFLSQI  124 (313)
T ss_dssp             CCEEEEEEECCCCSSCE---ECCGGGGGCTTCSEEEEEEETTEESCCCGG-GGGCT-TCSEEEEEEECCEEECCGGGGGC
T ss_pred             ceEEEEECCCCCccCCc---ccChhHhCCCCCCeeeCCCCCcccccCChh-HhcCC-CCCEEECcCCeeCCcCCHHHhCC
Confidence            46666667666665310   0112456667777777764 6666666655 55565 67777777777777778888888


Q ss_pred             CCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCC-CccEEecCCCcCCCCChhhhhcccccccee
Q 005760          124 TNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSD-ELYKLELGGNKLSGSIPECFNNLASLRILL  202 (678)
Q Consensus       124 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~  202 (678)
                      ++|++|+|++|.+++..|..|..+++|++|+|++|.+++.+|..+..++ +|+.|++++|.+++..|..+..++ |+.|+
T Consensus       125 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~  203 (313)
T 1ogq_A          125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVD  203 (313)
T ss_dssp             TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEE
T ss_pred             CCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEE
Confidence            8999999999988888888888889999999999998878888888887 889999999998888888888887 99999


Q ss_pred             cccccccc-ccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCc
Q 005760          203 LGSNELTS-IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKD  281 (678)
Q Consensus       203 l~~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  281 (678)
                      |++|.++. +|..+..+++|+.|+|++|.+++..+. +..++          +|++|+|++|++++..|..+..+++|+.
T Consensus       204 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~----------~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  272 (313)
T 1ogq_A          204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSK----------NLNGLDLRNNRIYGTLPQGLTQLKFLHS  272 (313)
T ss_dssp             CCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCT----------TCCEEECCSSCCEECCCGGGGGCTTCCE
T ss_pred             CcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccC----------CCCEEECcCCcccCcCChHHhcCcCCCE
Confidence            99998885 455788899999999999998866554 55444          9999999999999889999999999999


Q ss_pred             eecccccccccCCCCCccccccccccccCccccCCCCC
Q 005760          282 LNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNL  319 (678)
Q Consensus       282 L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~c~~~~~  319 (678)
                      |++++|++++.+|....++.+..+++.+|++.|+.|..
T Consensus       273 L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~  310 (313)
T 1ogq_A          273 LNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP  310 (313)
T ss_dssp             EECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred             EECcCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence            99999999999998888899999999999999998754

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.7e-33  Score=317.34  Aligned_cols=299  Identities=23%  Similarity=0.287  Sum_probs=262.0

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCC-CCccchhhcccccCCCCCcEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLT-SSTLELSFLSSLSNCKSLTLI   79 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~-~~~~~~~~~~~~~~l~~L~~L   79 (678)
                      .|+|++|+++ .+|..+..+++|++|++++|++++..|..|.++++|++|++++|.+. .++.     ..|..+++|++|
T Consensus       282 ~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~-----~~~~~l~~L~~L  355 (606)
T 3t6q_A          282 ELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT-----GCLENLENLREL  355 (606)
T ss_dssp             EEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCS-----STTTTCTTCCEE
T ss_pred             EEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccch-----hhhhccCcCCEE
Confidence            3789999999 89999999999999999999999888999999999999999999887 3332     248899999999


Q ss_pred             ECccCCCcccC--ChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCCh-hhhccCCCCEEEcc
Q 005760           80 SFSNNPLDGIL--PKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLE  156 (678)
Q Consensus        80 ~L~~n~i~~~~--~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~  156 (678)
                      ++++|.+.+..  +.. +..++ +|++|++++|++.+..|..|..+++|++|++++|++++..+. .|..+++|++|+++
T Consensus       356 ~l~~n~l~~~~~~~~~-~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~  433 (606)
T 3t6q_A          356 DLSHDDIETSDCCNLQ-LRNLS-HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS  433 (606)
T ss_dssp             ECCSSCCCEEEESTTT-TTTCT-TCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECT
T ss_pred             ECCCCccccccCcchh-cccCC-CCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECC
Confidence            99999998775  333 66676 899999999999999999999999999999999999876654 48999999999999


Q ss_pred             CCcCCCCCCCcccCCCCccEEecCCCcCCC---CChhhhhccccccceeccccccccc-cccccccccccEEEecCCccc
Q 005760          157 NNKLEGSIPDSICHSDELYKLELGGNKLSG---SIPECFNNLASLRILLLGSNELTSI-PLTFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       157 ~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~---~~~~~~~~l~~L~~L~l~~N~l~~l-~~~~~~l~~L~~L~l~~N~l~  232 (678)
                      +|.+++..|..+..+++|++|++++|.+.+   ..+..+..+++|+.|+|++|+++.+ |..|..+++|+.|+|++|+++
T Consensus       434 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  513 (606)
T 3t6q_A          434 HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT  513 (606)
T ss_dssp             TCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccC
Confidence            999998889999999999999999999986   2346789999999999999999988 558999999999999999999


Q ss_pred             CCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCcccccccc--cc-cc
Q 005760          233 GPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAE--SF-EG  309 (678)
Q Consensus       233 ~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~--~~-~~  309 (678)
                      +..|..+.+++          +| .|+|++|++++..|..+..+++|+.|++++|+|.|+|+..+...++..-  .+ ..
T Consensus       514 ~~~~~~l~~l~----------~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~w~~~~~~~~~~~  582 (606)
T 3t6q_A          514 SSSIEALSHLK----------GI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYKENMQKLEDT  582 (606)
T ss_dssp             GGGGGGGTTCC----------SC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHHHHHHHHHCGGGEECG
T ss_pred             cCChhHhCccc----------cc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHHHHHHHHhCcccccCC
Confidence            99999998887          99 9999999999999999999999999999999999999976555444321  11 22


Q ss_pred             CccccCCCC
Q 005760          310 NELLCGSPN  318 (678)
Q Consensus       310 n~~~c~~~~  318 (678)
                      ....|..|.
T Consensus       583 ~~~~C~~p~  591 (606)
T 3t6q_A          583 EDTLCENPP  591 (606)
T ss_dssp             GGCBEEESG
T ss_pred             CCCeeCCch
Confidence            346677664

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=2.9e-33  Score=297.53  Aligned_cols=291  Identities=19%  Similarity=0.197  Sum_probs=234.4

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      |++++|.+....+..+..+++|++|+|++|+|+.+.+.+|.++++|++|+|++|.++.++..     .|.++++|++|+|
T Consensus        50 l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L  124 (390)
T 3o6n_A           50 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH-----VFQNVPLLTVLVL  124 (390)
T ss_dssp             EEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTTCCEEEC
T ss_pred             EEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHH-----HhcCCCCCCEEEC
Confidence            67888888844445567799999999999999988888999999999999999999887754     4788999999999


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCC------------
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQK------------  149 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~------------  149 (678)
                      ++|+++.+.+ ..+..++ +|++|++++|++++..+..|..+++|++|++++|++++..   +..+++            
T Consensus       125 ~~n~l~~l~~-~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~l~~n~l~  199 (390)
T 3o6n_A          125 ERNDLSSLPR-GIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS  199 (390)
T ss_dssp             CSSCCCCCCT-TTTTTCT-TCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred             CCCccCcCCH-HHhcCCC-CCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceeeccccccc
Confidence            9999985543 3356666 8999999999999888888999999999999999998553   333444            


Q ss_pred             -------CCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccc-cccccccccc
Q 005760          150 -------LQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSI-PLTFWNLKDI  221 (678)
Q Consensus       150 -------L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l-~~~~~~l~~L  221 (678)
                             |++|++++|.++. +|..  ..++|+.|++++|.+++.  ..+..+++|++|+|++|.++.+ |..+..+++|
T Consensus       200 ~~~~~~~L~~L~l~~n~l~~-~~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L  274 (390)
T 3o6n_A          200 TLAIPIAVEELDASHNSINV-VRGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL  274 (390)
T ss_dssp             EEECCSSCSEEECCSSCCCE-EECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSC
T ss_pred             ccCCCCcceEEECCCCeeee-cccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccC
Confidence                   4555555555552 2222  246899999999999964  5789999999999999999987 5689999999


Q ss_pred             cEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCcccc
Q 005760          222 LYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGN  301 (678)
Q Consensus       222 ~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~  301 (678)
                      +.|+|++|++++. +..+..          +++|+.|+|++|+++ ..|..+..+++|+.|++++|+++...  ...++.
T Consensus       275 ~~L~L~~n~l~~~-~~~~~~----------l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~  340 (390)
T 3o6n_A          275 ERLYISNNRLVAL-NLYGQP----------IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHT  340 (390)
T ss_dssp             CEEECCSSCCCEE-ECSSSC----------CTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCC
T ss_pred             CEEECCCCcCccc-CcccCC----------CCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC--chhhcc
Confidence            9999999999853 333344          449999999999998 45666888999999999999998663  556788


Q ss_pred             ccccccccCccccCCCCCCC
Q 005760          302 FSAESFEGNELLCGSPNLRV  321 (678)
Q Consensus       302 l~~~~~~~n~~~c~~~~~~~  321 (678)
                      ++.+++.+|++.|++...++
T Consensus       341 L~~L~l~~N~~~~~~~~~~~  360 (390)
T 3o6n_A          341 LKNLTLSHNDWDCNSLRALF  360 (390)
T ss_dssp             CSEEECCSSCEEHHHHHHHT
T ss_pred             CCEEEcCCCCccchhHHHHH
Confidence            99999999999998764443

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=2.2e-33  Score=316.77  Aligned_cols=291  Identities=21%  Similarity=0.321  Sum_probs=218.7

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCc-ccc-cCCccccCC------CCCCEEEccCccCCCCccchhhcccccC
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNS-FSG-FIPNTFGNL------RNLQALRLSNNYLTSSTLELSFLSSLSN   72 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~-i~~-~~~~~~~~l------~~L~~L~l~~n~i~~~~~~~~~~~~~~~   72 (678)
                      +|+|++|++.+.+|+.+.++++|++|+|++|+ +++ .+|..++++      ++|++|+|++|.++.++..    ..|.+
T Consensus       253 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~----~~l~~  328 (636)
T 4eco_A          253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE----TSLQK  328 (636)
T ss_dssp             EEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCH----HHHTT
T ss_pred             EEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCch----hhhcc
Confidence            37889999999999999999999999999998 887 788888876      8999999999999866641    14788


Q ss_pred             CCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCC-CcEEEccCCccCCcCChhhhccC--C
Q 005760           73 CKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTN-LTIIYLGGNKLNGSIPSTLGKLQ--K  149 (678)
Q Consensus        73 l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~--~  149 (678)
                      +++|++|++++|++++..|  .+..++ +|++|+|++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++  +
T Consensus       329 l~~L~~L~L~~N~l~g~ip--~~~~l~-~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~  403 (636)
T 4eco_A          329 MKKLGMLECLYNQLEGKLP--AFGSEI-KLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSV  403 (636)
T ss_dssp             CTTCCEEECCSCCCEEECC--CCEEEE-EESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSC
T ss_pred             CCCCCEEeCcCCcCccchh--hhCCCC-CCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCc
Confidence            9999999999999987777  477776 8999999999998 77888888988 999999999998 6777776654  8


Q ss_pred             CCEEEccCCcCCCCCCCccc-------CCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccc-----
Q 005760          150 LQGLGLENNKLEGSIPDSIC-------HSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWN-----  217 (678)
Q Consensus       150 L~~L~L~~n~i~~~~~~~~~-------~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~-----  217 (678)
                      |++|+|++|.+++..|..+.       .+++|++|+|++|.++...+..+..+++|+.|+|++|+|+.+|..+..     
T Consensus       404 L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~  483 (636)
T 4eco_A          404 MSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENEN  483 (636)
T ss_dssp             EEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEE
T ss_pred             cCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhcccccc
Confidence            88999999998887887777       777888888888888865555566788888888888888877764322     


Q ss_pred             ---cccccEEEecCCcccCCCCcccc--ccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceec------cc
Q 005760          218 ---LKDILYLNFSSNFFTGPLPLEIG--NLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNL------SF  286 (678)
Q Consensus       218 ---l~~L~~L~l~~N~l~~~~~~~~~--~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l------~~  286 (678)
                         +++|+.|+|++|+++ .+|..+.  .++          +|+.|+|++|++++ +|..+..+++|+.|++      ++
T Consensus       484 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~----------~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~  551 (636)
T 4eco_A          484 FKNTYLLTSIDLRFNKLT-KLSDDFRATTLP----------YLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG  551 (636)
T ss_dssp             CTTGGGCCEEECCSSCCC-BCCGGGSTTTCT----------TCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTC
T ss_pred             ccccCCccEEECcCCcCC-ccChhhhhccCC----------CcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCccccc
Confidence               227888888888877 4555543  444          66666666666654 4555555666666666      33


Q ss_pred             ccccccCCCC-CccccccccccccCcc
Q 005760          287 NKLEGEIPRG-GSFGNFSAESFEGNEL  312 (678)
Q Consensus       287 N~~~~~~~~~-~~~~~l~~~~~~~n~~  312 (678)
                      |.+.+..|.. ..+..|+.+++++|..
T Consensus       552 N~l~~~~p~~l~~l~~L~~L~Ls~N~l  578 (636)
T 4eco_A          552 NRTLREWPEGITLCPSLTQLQIGSNDI  578 (636)
T ss_dssp             CBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred             CcccccChHHHhcCCCCCEEECCCCcC
Confidence            4444444432 4455555555655554

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=2.3e-33  Score=288.51  Aligned_cols=255  Identities=26%  Similarity=0.399  Sum_probs=235.3

Q ss_pred             CCCCEEecCCCcccc--cCCccccCCCCCCEEEccC-ccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhc
Q 005760           21 SKLSILELSDNSFSG--FIPNTFGNLRNLQALRLSN-NYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGN   97 (678)
Q Consensus        21 ~~L~~L~l~~n~i~~--~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~   97 (678)
                      .++++|+|++|.+++  .+|..|.++++|++|+|++ |.+....+     ..|.++++|++|+|++|++++..|.. +..
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p-----~~l~~l~~L~~L~Ls~n~l~~~~p~~-~~~  123 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP-----PAIAKLTQLHYLYITHTNVSGAIPDF-LSQ  123 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCC-----GGGGGCTTCSEEEEEEECCEEECCGG-GGG
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCC-----hhHhcCCCCCEEECcCCeeCCcCCHH-HhC
Confidence            689999999999998  8999999999999999995 88874332     35889999999999999999888876 777


Q ss_pred             ccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccC-CCCEEEccCCcCCCCCCCcccCCCCccE
Q 005760           98 LSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQ-KLQGLGLENNKLEGSIPDSICHSDELYK  176 (678)
Q Consensus        98 l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~  176 (678)
                      ++ +|++|+|++|.+++..|..|..+++|++|+|++|++++..|..+..++ +|++|+|++|.+++.+|..+..+. |+.
T Consensus       124 l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~  201 (313)
T 1ogq_A          124 IK-TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAF  201 (313)
T ss_dssp             CT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSE
T ss_pred             CC-CCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccE
Confidence            77 899999999999999999999999999999999999989999999998 999999999999988999999987 999


Q ss_pred             EecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCccccc
Q 005760          177 LELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLI  256 (678)
Q Consensus       177 L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~  256 (678)
                      |++++|.+++..|..|..+++|+.|+|++|.++..+..+..+++|+.|+|++|.+++..|..+..++          +|+
T Consensus       202 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~----------~L~  271 (313)
T 1ogq_A          202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK----------FLH  271 (313)
T ss_dssp             EECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCT----------TCC
T ss_pred             EECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCc----------CCC
Confidence            9999999999999999999999999999999997766788999999999999999999999998877          999


Q ss_pred             EEEccCCcCCCcchHHHhcccCCCceecccccccccCC
Q 005760          257 SLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP  294 (678)
Q Consensus       257 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  294 (678)
                      .|+|++|++++.+|.. ..+++|+.+++++|++.|..|
T Consensus       272 ~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~~lc~~p  308 (313)
T 1ogq_A          272 SLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             EEECCSSEEEEECCCS-TTGGGSCGGGTCSSSEEESTT
T ss_pred             EEECcCCcccccCCCC-ccccccChHHhcCCCCccCCC
Confidence            9999999999888876 889999999999999776544

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=8.1e-33  Score=310.28  Aligned_cols=290  Identities=19%  Similarity=0.200  Sum_probs=235.7

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      |++++|.+....+..+..+++|++|+|++|.|+++.+.+|.++++|+.|+|++|.++.++..     .|.++++|++|+|
T Consensus        56 l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L  130 (597)
T 3oja_B           56 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH-----VFQNVPLLTVLVL  130 (597)
T ss_dssp             EEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTTCCEEEC
T ss_pred             EEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHH-----HHcCCCCCCEEEe
Confidence            67888888855556677799999999999999988888999999999999999999987754     4788999999999


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCE---------
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQG---------  152 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~---------  152 (678)
                      ++|.++++.+ ..+..++ +|++|+|++|.+++..|..|.++++|+.|+|++|.+++..   +..+++|+.         
T Consensus       131 ~~n~l~~l~~-~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~  205 (597)
T 3oja_B          131 ERNDLSSLPR-GIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS  205 (597)
T ss_dssp             CSSCCCCCCT-TTTTTCT-TCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred             eCCCCCCCCH-HHhccCC-CCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccc
Confidence            9999986544 3366776 8999999999999998889999999999999999998654   333445544         


Q ss_pred             ----------EEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccc-cccccccccc
Q 005760          153 ----------LGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSI-PLTFWNLKDI  221 (678)
Q Consensus       153 ----------L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l-~~~~~~l~~L  221 (678)
                                |++++|.++. ++..+  .++|+.|+|++|.+++.  ..+..+++|+.|+|++|.++.+ |..|..+++|
T Consensus       206 ~l~~~~~L~~L~ls~n~l~~-~~~~~--~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  280 (597)
T 3oja_B          206 TLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL  280 (597)
T ss_dssp             EEECCTTCSEEECCSSCCCE-EECSC--CSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSC
T ss_pred             cccCCchhheeeccCCcccc-ccccc--CCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccCC
Confidence                      4555555442 22222  25799999999999963  6789999999999999999977 5689999999


Q ss_pred             cEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCcccc
Q 005760          222 LYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGN  301 (678)
Q Consensus       222 ~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~  301 (678)
                      +.|+|++|.+++. |..+..          +++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++...  ...++.
T Consensus       281 ~~L~Ls~N~l~~l-~~~~~~----------l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~  346 (597)
T 3oja_B          281 ERLYISNNRLVAL-NLYGQP----------IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHT  346 (597)
T ss_dssp             CEEECTTSCCCEE-ECSSSC----------CTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCC
T ss_pred             CEEECCCCCCCCC-Cccccc----------CCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--hhhcCC
Confidence            9999999999853 444444          449999999999999 56677889999999999999998764  456788


Q ss_pred             ccccccccCccccCCCCCC
Q 005760          302 FSAESFEGNELLCGSPNLR  320 (678)
Q Consensus       302 l~~~~~~~n~~~c~~~~~~  320 (678)
                      +..+++.+|+|.|+|...+
T Consensus       347 L~~L~l~~N~~~~~~~~~~  365 (597)
T 3oja_B          347 LKNLTLSHNDWDCNSLRAL  365 (597)
T ss_dssp             CSEEECCSSCEEHHHHHHH
T ss_pred             CCEEEeeCCCCCChhHHHH
Confidence            9999999999999876444

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-32  Score=307.70  Aligned_cols=143  Identities=22%  Similarity=0.247  Sum_probs=95.4

Q ss_pred             ccCCCCccEEecCCCcCCCCCh-hhhhccccccceeccccccccc-cccccccccccEEEecCCccc-CCCCcccccccc
Q 005760          168 ICHSDELYKLELGGNKLSGSIP-ECFNNLASLRILLLGSNELTSI-PLTFWNLKDILYLNFSSNFFT-GPLPLEIGNLKI  244 (678)
Q Consensus       168 ~~~l~~L~~L~l~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~l-~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~  244 (678)
                      +..+++|++|++++|.+.+..+ ..+..+++|+.|+|++|.++.. |..+..+++|+.|++++|.+. +..|..+.    
T Consensus       392 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~----  467 (570)
T 2z63_A          392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT----  467 (570)
T ss_dssp             EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCT----
T ss_pred             ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhh----
Confidence            4444444444444444443332 2344444555555555544432 234444555555555555544 23444444    


Q ss_pred             ccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC-CccccccccccccCccccCCCCCC
Q 005760          245 ARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSPNLR  320 (678)
Q Consensus       245 ~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~-~~~~~l~~~~~~~n~~~c~~~~~~  320 (678)
                            .+++|+.|+|++|++++..|..+..+++|+.|++++|++++.++.. ..+..++.+++.+|++.|+||..+
T Consensus       468 ------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~  538 (570)
T 2z63_A          468 ------ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  538 (570)
T ss_dssp             ------TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             ------cccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence                  4559999999999999888999999999999999999999887754 678899999999999999998643

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=2.3e-32  Score=313.66  Aligned_cols=301  Identities=23%  Similarity=0.235  Sum_probs=250.0

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEec-CCCccccc--------------------------------------------
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILEL-SDNSFSGF--------------------------------------------   36 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l-~~n~i~~~--------------------------------------------   36 (678)
                      |+|++|++.+.+|.+|+++++|++|+| ++|.+.+.                                            
T Consensus       328 L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~  407 (876)
T 4ecn_A          328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA  407 (876)
T ss_dssp             EECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHH
T ss_pred             EECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHH
Confidence            789999999999999999999999999 77755433                                            


Q ss_pred             --------------------------------CCccccCCCCCCEEEccCccCCCCccc---h---------hhccccc-
Q 005760           37 --------------------------------IPNTFGNLRNLQALRLSNNYLTSSTLE---L---------SFLSSLS-   71 (678)
Q Consensus        37 --------------------------------~~~~~~~l~~L~~L~l~~n~i~~~~~~---~---------~~~~~~~-   71 (678)
                                                      +|..|+++++|+.|+|++|.++.....   .         .+++.+. 
T Consensus       408 l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f  487 (876)
T 4ecn_A          408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW  487 (876)
T ss_dssp             HHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCG
T ss_pred             hhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhh
Confidence                                            788899999999999999999871000   0         0223455 


Q ss_pred             -CCCCCcEEECccCCCcccCChhhhhcccccccEEEccccc-ccc-cCCccccCCC-------CCcEEEccCCccCCcCC
Q 005760           72 -NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCN-VSG-GIPEEIGNLT-------NLTIIYLGGNKLNGSIP  141 (678)
Q Consensus        72 -~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~-l~~-~~~~~~~~l~-------~L~~L~l~~N~l~~~~~  141 (678)
                       ++++|++|+|++|++.+..|.. +..++ +|++|+|++|+ +++ .+|..++.++       +|+.|+|++|+++ .+|
T Consensus       488 ~~L~~L~~L~Ls~N~l~~~iP~~-l~~L~-~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip  564 (876)
T 4ecn_A          488 SNLKDLTDVELYNCPNMTQLPDF-LYDLP-ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFP  564 (876)
T ss_dssp             GGCTTCCEEEEESCTTCCSCCGG-GGGCS-SCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCC
T ss_pred             ccCCCCCEEECcCCCCCccChHH-HhCCC-CCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccC
Confidence             9999999999999999998865 78887 89999999998 888 7888776665       9999999999999 778


Q ss_pred             h--hhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhcccc-ccceecccccccccccccccc
Q 005760          142 S--TLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLAS-LRILLLGSNELTSIPLTFWNL  218 (678)
Q Consensus       142 ~--~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~-L~~L~l~~N~l~~l~~~~~~l  218 (678)
                      .  .|+++++|++|+|++|.++ .+| .|..+++|+.|+|++|.++ .+|..+..+++ |+.|+|++|.|+.+|..+..+
T Consensus       565 ~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~~~~~~  641 (876)
T 4ecn_A          565 ASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAK  641 (876)
T ss_dssp             CHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCSCCCTT
T ss_pred             ChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCchhhhcc
Confidence            7  9999999999999999999 788 8999999999999999999 88888999999 999999999999999877766


Q ss_pred             cc--ccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC
Q 005760          219 KD--ILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG  296 (678)
Q Consensus       219 ~~--L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  296 (678)
                      +.  |+.|+|++|++.+.+|.....+     ....+++|+.|+|++|+++...+..+..+++|+.|+|++|.++..++..
T Consensus       642 ~~~~L~~L~Ls~N~l~g~ip~l~~~l-----~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~  716 (876)
T 4ecn_A          642 SVYVMGSVDFSYNKIGSEGRNISCSM-----DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS  716 (876)
T ss_dssp             CSSCEEEEECCSSCTTTTSSSCSSCT-----TTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTS
T ss_pred             ccCCCCEEECcCCcCCCccccchhhh-----ccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHH
Confidence            54  9999999999998766432111     1123458999999999999666666678899999999999998444333


Q ss_pred             Cc--------cccccccccccCccc
Q 005760          297 GS--------FGNFSAESFEGNELL  313 (678)
Q Consensus       297 ~~--------~~~l~~~~~~~n~~~  313 (678)
                      ..        ++.|..+++++|...
T Consensus       717 ~~~~~~~l~nl~~L~~L~Ls~N~L~  741 (876)
T 4ecn_A          717 LKPKDGNYKNTYLLTTIDLRFNKLT  741 (876)
T ss_dssp             SSCTTSCCTTGGGCCEEECCSSCCC
T ss_pred             hccccccccccCCccEEECCCCCCc
Confidence            22        127888889888765

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=5.7e-32  Score=309.11  Aligned_cols=288  Identities=23%  Similarity=0.273  Sum_probs=225.6

Q ss_pred             cccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCcc----------------------------CCCCccchhhc
Q 005760           16 FIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNY----------------------------LTSSTLELSFL   67 (678)
Q Consensus        16 ~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~----------------------------i~~~~~~~~~~   67 (678)
                      .+..+++|++|++++|++++..+..|.++++|++|++++|.                            +..+.     +
T Consensus       324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~-----~  398 (680)
T 1ziw_A          324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIE-----S  398 (680)
T ss_dssp             TTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEEC-----T
T ss_pred             hcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEC-----h
Confidence            45556666666666666666666666666666666665554                            43332     2


Q ss_pred             ccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccC--CcCChhhh
Q 005760           68 SSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLN--GSIPSTLG  145 (678)
Q Consensus        68 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~~~~~~  145 (678)
                      ..|..+++|+.|+|++|.+.+..+...+..++ +|++|++++|++.+..+..|..+++|+.|++++|.++  +..|..|.
T Consensus       399 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~  477 (680)
T 1ziw_A          399 DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE-NIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ  477 (680)
T ss_dssp             TTTTTCTTCCEEECCSSCCEEECCSGGGTTCT-TCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTT
T ss_pred             hhhhCCCCCCEEeCCCCcCccccCcccccCcc-cccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccc
Confidence            35778899999999999998777766577777 8999999999999888888999999999999999886  46788999


Q ss_pred             ccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCCh--------hhhhccccccceeccccccccccc-ccc
Q 005760          146 KLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIP--------ECFNNLASLRILLLGSNELTSIPL-TFW  216 (678)
Q Consensus       146 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~--------~~~~~l~~L~~L~l~~N~l~~l~~-~~~  216 (678)
                      ++++|++|+|++|+|++..+..|..+++|++|++++|.+++..+        ..|.++++|+.|+|++|+++.+|. .|.
T Consensus       478 ~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~  557 (680)
T 1ziw_A          478 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFK  557 (680)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             cCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcc
Confidence            99999999999999998778889999999999999999985422        247889999999999999999987 589


Q ss_pred             ccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHh-cccCCCceecccccccccCCC
Q 005760          217 NLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLE-KLSYLKDLNLSFNKLEGEIPR  295 (678)
Q Consensus       217 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~l~~N~~~~~~~~  295 (678)
                      ++++|+.|+|++|++++..+..|.+++          +|+.|+|++|+|++..+..+. .+++|+.|++++|||.|+|+.
T Consensus       558 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~----------~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          558 DLFELKIIDLGLNNLNTLPASVFNNQV----------SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCT----------TCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             cccCcceeECCCCCCCcCCHhHhCCCC----------CCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            999999999999999988777787777          999999999999999998888 899999999999999999986


Q ss_pred             -CCcccccccc--ccc--cCccccCCCCC
Q 005760          296 -GGSFGNFSAE--SFE--GNELLCGSPNL  319 (678)
Q Consensus       296 -~~~~~~l~~~--~~~--~n~~~c~~~~~  319 (678)
                       .+...++...  .+.  .....|..|..
T Consensus       628 ~~~~~~~~~~~~~~~~~~~~~~~C~~p~~  656 (680)
T 1ziw_A          628 IAWFVNWINETHTNIPELSSHYLCNTPPH  656 (680)
T ss_dssp             CSSEECCSSCC------------------
T ss_pred             HHHHHHHHHhcCcccccccCCcEECCchH
Confidence             5554454432  222  23567777743

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=6.1e-32  Score=280.71  Aligned_cols=282  Identities=24%  Similarity=0.296  Sum_probs=236.9

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      +++++++++ .+|..+.  ++|++|+|++|+|++..+++|.++++|++|+|++|.++.+...     .|.++++|++|+|
T Consensus        38 l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L  109 (332)
T 2ft3_A           38 VQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEK-----AFSPLRKLQKLYI  109 (332)
T ss_dssp             EECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGG-----GSTTCTTCCEEEC
T ss_pred             EECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHh-----HhhCcCCCCEEEC
Confidence            678889988 7887664  6899999999999988889999999999999999999877543     5889999999999


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccC--CcCChhhhccCCCCEEEccCCc
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLN--GSIPSTLGKLQKLQGLGLENNK  159 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~L~L~~n~  159 (678)
                      ++|+++.+.+.. +    .+|++|++++|++.+..+..|.++++|+.|++++|.++  +..+..|..+ +|++|++++|+
T Consensus       110 ~~n~l~~l~~~~-~----~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~  183 (332)
T 2ft3_A          110 SKNHLVEIPPNL-P----SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAK  183 (332)
T ss_dssp             CSSCCCSCCSSC-C----TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSB
T ss_pred             CCCcCCccCccc-c----ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCC
Confidence            999998543322 2    48999999999999888888999999999999999996  3677888888 99999999999


Q ss_pred             CCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccCCCCcc
Q 005760          160 LEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLE  238 (678)
Q Consensus       160 i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~  238 (678)
                      ++ .+|..+.  ++|+.|++++|.+++..+..|..+++|+.|+|++|+++.++. .+..+++|+.|++++|+++ .+|..
T Consensus       184 l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~  259 (332)
T 2ft3_A          184 LT-GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG  259 (332)
T ss_dssp             CS-SCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTT
T ss_pred             CC-ccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChh
Confidence            99 4666554  789999999999998888899999999999999999998876 7899999999999999998 66666


Q ss_pred             ccccccccccccCcccccEEEccCCcCCCcchHHHhcc------cCCCceecccccccc--cCCC-CCcccccccccccc
Q 005760          239 IGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKL------SYLKDLNLSFNKLEG--EIPR-GGSFGNFSAESFEG  309 (678)
Q Consensus       239 ~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~l~~N~~~~--~~~~-~~~~~~l~~~~~~~  309 (678)
                      +..++          +|+.|+|++|+|++..+..|..+      +.|+.|++++|++..  ..+. ...+..++.+++.+
T Consensus       260 l~~l~----------~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~  329 (332)
T 2ft3_A          260 LPDLK----------LLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGN  329 (332)
T ss_dssp             GGGCT----------TCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC--
T ss_pred             hhcCc----------cCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccc
Confidence            77666          99999999999998877777653      678999999999873  3332 35567788888877


Q ss_pred             Cc
Q 005760          310 NE  311 (678)
Q Consensus       310 n~  311 (678)
                      |.
T Consensus       330 n~  331 (332)
T 2ft3_A          330 YK  331 (332)
T ss_dssp             --
T ss_pred             cc
Confidence            63

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=8.8e-32  Score=279.30  Aligned_cols=282  Identities=19%  Similarity=0.257  Sum_probs=217.2

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      +++++++++ .+|..+.  ++|++|+|++|+|++..+..|.++++|++|+|++|.++.+.+.     .|.++++|++|+|
T Consensus        36 l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L  107 (330)
T 1xku_A           36 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG-----AFAPLVKLERLYL  107 (330)
T ss_dssp             EECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTT-----TTTTCTTCCEEEC
T ss_pred             EEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHH-----HhcCCCCCCEEEC
Confidence            567777777 6776554  5888899999999877777888899999999999988876543     5788889999999


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCC--cCChhhhccCCCCEEEccCCc
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG--SIPSTLGKLQKLQGLGLENNK  159 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~L~~n~  159 (678)
                      ++|+++.+ |..    +..+|++|++++|.+++..+..|.++++|+.|++++|.++.  ..+..|.++++|++|++++|.
T Consensus       108 s~n~l~~l-~~~----~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~  182 (330)
T 1xku_A          108 SKNQLKEL-PEK----MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN  182 (330)
T ss_dssp             CSSCCSBC-CSS----CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred             CCCcCCcc-Chh----hcccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc
Confidence            99988744 322    12478899999998888888888888999999999988853  567788888899999999998


Q ss_pred             CCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccCCCCcc
Q 005760          160 LEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLE  238 (678)
Q Consensus       160 i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~  238 (678)
                      ++ .+|..+.  ++|++|++++|.+++..+..|..+++|+.|+|++|.++.++. .+..+++|+.|+|++|+++ .+|..
T Consensus       183 l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~  258 (330)
T 1xku_A          183 IT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG  258 (330)
T ss_dssp             CC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred             cc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChh
Confidence            88 4555554  788899999998888778888888889999999998888765 6888888999999999888 56666


Q ss_pred             ccccccccccccCcccccEEEccCCcCCCcchHHHhc------ccCCCceeccccccccc--C-CCCCcccccccccccc
Q 005760          239 IGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEK------LSYLKDLNLSFNKLEGE--I-PRGGSFGNFSAESFEG  309 (678)
Q Consensus       239 ~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~------l~~L~~L~l~~N~~~~~--~-~~~~~~~~l~~~~~~~  309 (678)
                      +..++          +|+.|+|++|+|++..+..|..      .+.|+.|++++|++...  . ........+..+++++
T Consensus       259 l~~l~----------~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~  328 (330)
T 1xku_A          259 LADHK----------YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN  328 (330)
T ss_dssp             TTTCS----------SCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC--
T ss_pred             hccCC----------CcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecc
Confidence            66555          8889999999888777776643      36778888888888642  1 1223445566666666


Q ss_pred             C
Q 005760          310 N  310 (678)
Q Consensus       310 n  310 (678)
                      |
T Consensus       329 N  329 (330)
T 1xku_A          329 Y  329 (330)
T ss_dssp             -
T ss_pred             c
Confidence            5

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=6.2e-32  Score=280.46  Aligned_cols=271  Identities=21%  Similarity=0.210  Sum_probs=236.3

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      +|+|++|++++..+..|..+++|++|+|++|+++++.|++|.++++|++|+|++|.++.++...        .++|++|+
T Consensus        56 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~--------~~~L~~L~  127 (330)
T 1xku_A           56 LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKM--------PKTLQELR  127 (330)
T ss_dssp             EEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSC--------CTTCCEEE
T ss_pred             EEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCCccChhh--------cccccEEE
Confidence            3799999999777778999999999999999999888999999999999999999999877542        27999999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEcccccccc--cCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCC
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSG--GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENN  158 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n  158 (678)
                      +++|.+++..+.. +..++ +|++|++++|.+..  ..+..|.++++|+.|++++|.++. +|..+.  ++|++|+|++|
T Consensus       128 l~~n~l~~~~~~~-~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n  202 (330)
T 1xku_A          128 VHENEITKVRKSV-FNGLN-QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGN  202 (330)
T ss_dssp             CCSSCCCBBCHHH-HTTCT-TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTS
T ss_pred             CCCCcccccCHhH-hcCCc-cccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCC
Confidence            9999998765543 67777 89999999999974  778889999999999999999984 555444  89999999999


Q ss_pred             cCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCcc
Q 005760          159 KLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLE  238 (678)
Q Consensus       159 ~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~  238 (678)
                      .+++..+..|..+++|++|++++|.+++..+..+..+++|+.|+|++|+++.+|..+..+++|+.|++++|+|++..+..
T Consensus       203 ~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~~~~~~  282 (330)
T 1xku_A          203 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSND  282 (330)
T ss_dssp             CCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCTTS
T ss_pred             cCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCccChhh
Confidence            99988889999999999999999999988888999999999999999999999999999999999999999999888877


Q ss_pred             ccccccccccccCcccccEEEccCCcCCC--cchHHHhcccCCCceeccccc
Q 005760          239 IGNLKIARIDSCDLISLISLNLSNNNLSG--AIPASLEKLSYLKDLNLSFNK  288 (678)
Q Consensus       239 ~~~l~~~~~~~~~~~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~l~~N~  288 (678)
                      |....    .....++|+.|++++|.+..  +.|..|..+..++.+++++|+
T Consensus       283 f~~~~----~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          283 FCPPG----YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             SSCSS----CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             cCCcc----cccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence            75432    11234589999999999874  667889999999999999985

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.98  E-value=7.3e-32  Score=280.11  Aligned_cols=266  Identities=20%  Similarity=0.260  Sum_probs=215.8

Q ss_pred             CCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccccc
Q 005760           22 KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHS  101 (678)
Q Consensus        22 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~  101 (678)
                      +++.+++++|.++ .+|..+.  ++|+.|+|++|.++.++..     .|.++++|++|+|++|+++++.+.. +..++ +
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l~-~  103 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKD-----DFKGLQHLYALVLVNNKISKIHEKA-FSPLR-K  103 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTT-----TTTTCTTCCEEECCSSCCCEECGGG-STTCT-T
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHh-----HhhCCCCCcEEECCCCccCccCHhH-hhCcC-C
Confidence            6899999999998 5566553  6899999999998877643     5888999999999999998776655 67776 8


Q ss_pred             ccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCC--CCCCcccCCCCccEEec
Q 005760          102 LEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEG--SIPDSICHSDELYKLEL  179 (678)
Q Consensus       102 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~l  179 (678)
                      |++|+|++|+++.. |..+.  ++|++|++++|++++..+..|.++++|++|++++|.++.  ..+..+..+ +|+.|++
T Consensus       104 L~~L~L~~n~l~~l-~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l  179 (332)
T 2ft3_A          104 LQKLYISKNHLVEI-PPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRI  179 (332)
T ss_dssp             CCEEECCSSCCCSC-CSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBC
T ss_pred             CCEEECCCCcCCcc-Ccccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEEC
Confidence            99999999999844 44433  889999999999987777788999999999999999863  567778777 8999999


Q ss_pred             CCCcCCCCChhhhhccccccceecccccccccc-ccccccccccEEEecCCcccCCCCccccccccccccccCcccccEE
Q 005760          180 GGNKLSGSIPECFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISL  258 (678)
Q Consensus       180 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L  258 (678)
                      ++|.+++ +|..+.  ++|++|+|++|.++.++ ..+..+++|+.|++++|.+++..+..+..++          +|+.|
T Consensus       180 ~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~----------~L~~L  246 (332)
T 2ft3_A          180 SEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLP----------TLREL  246 (332)
T ss_dssp             CSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCT----------TCCEE
T ss_pred             cCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCC----------CCCEE
Confidence            9999985 444443  78999999999999886 4788899999999999999988777777766          99999


Q ss_pred             EccCCcCCCcchHHHhcccCCCceecccccccccCCCCC-------ccccccccccccCccccC
Q 005760          259 NLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGG-------SFGNFSAESFEGNELLCG  315 (678)
Q Consensus       259 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~-------~~~~l~~~~~~~n~~~c~  315 (678)
                      +|++|+++ .+|..+..+++|+.|++++|++++..+...       ....+..+++.+||+.+.
T Consensus       247 ~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~  309 (332)
T 2ft3_A          247 HLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW  309 (332)
T ss_dssp             ECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG
T ss_pred             ECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccc
Confidence            99999998 667778889999999999999987654431       135577888999988743

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.98  E-value=9.2e-32  Score=297.36  Aligned_cols=285  Identities=20%  Similarity=0.234  Sum_probs=223.3

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      +||+++|+++ .+|..++  ++|++|+|++|+|++..|++|.++++|++|+|++|+++.+.+.     .|.++++|++|+
T Consensus         4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-----~~~~l~~L~~L~   75 (520)
T 2z7x_B            4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS-----VFKFNQELEYLD   75 (520)
T ss_dssp             EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGG-----GGTTCTTCCEEE
T ss_pred             eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChH-----HhhcccCCCEEe
Confidence            4799999999 7887776  8999999999999988889999999999999999999977543     589999999999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEcccccccc-cCCccccCCCCCcEEEccCCccCCcCChhhhccCCC--CEEEccC
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSG-GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKL--QGLGLEN  157 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L--~~L~L~~  157 (678)
                      |++|+++.+.+.    .++ +|++|+|++|.+++ ..|..|+++++|++|++++|++++   ..+..+++|  ++|+|++
T Consensus        76 Ls~N~l~~lp~~----~l~-~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~  147 (520)
T 2z7x_B           76 LSHNKLVKISCH----PTV-NLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVL  147 (520)
T ss_dssp             CCSSCCCEEECC----CCC-CCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEE
T ss_pred             cCCCceeecCcc----ccC-CccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeec
Confidence            999999865332    455 89999999999998 478999999999999999999985   567888888  9999999


Q ss_pred             CcC--CCCCCCcccCCC---------------------------------------------------------------
Q 005760          158 NKL--EGSIPDSICHSD---------------------------------------------------------------  172 (678)
Q Consensus       158 n~i--~~~~~~~~~~l~---------------------------------------------------------------  172 (678)
                      |.+  ++..|..+..+.                                                               
T Consensus       148 n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l  227 (520)
T 2z7x_B          148 GETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTL  227 (520)
T ss_dssp             CTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEE
T ss_pred             ccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccc
Confidence            999  666666665532                                                               


Q ss_pred             --------------------CccEEecCCCcCCCCChhhh----------------------------------------
Q 005760          173 --------------------ELYKLELGGNKLSGSIPECF----------------------------------------  192 (678)
Q Consensus       173 --------------------~L~~L~l~~N~i~~~~~~~~----------------------------------------  192 (678)
                                          +|++|++++|.+++.+|..+                                        
T Consensus       228 ~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L  307 (520)
T 2z7x_B          228 NNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNF  307 (520)
T ss_dssp             EEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEE
T ss_pred             cccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEE
Confidence                                67788888888876665544                                        


Q ss_pred             -------------hccccccceecccccccc-ccccccccccccEEEecCCcccC--CCCccccccccccccccCccccc
Q 005760          193 -------------NNLASLRILLLGSNELTS-IPLTFWNLKDILYLNFSSNFFTG--PLPLEIGNLKIARIDSCDLISLI  256 (678)
Q Consensus       193 -------------~~l~~L~~L~l~~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~~~~~~~~~~~L~  256 (678)
                                   ..+++|++|++++|+++. +|..+..+++|+.|++++|++++  ..|..+..++          +|+
T Consensus       308 ~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~----------~L~  377 (520)
T 2z7x_B          308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK----------SLQ  377 (520)
T ss_dssp             EEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCT----------TCC
T ss_pred             EcCCCccccccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCC----------CCC
Confidence                         567899999999999997 67789999999999999999986  3345565555          677


Q ss_pred             EEEccCCcCCCcch-HHHhcccCCCceecccccccccCCCCCccccccccccccCcc
Q 005760          257 SLNLSNNNLSGAIP-ASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL  312 (678)
Q Consensus       257 ~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~  312 (678)
                      .|+|++|++++..| ..+..+++|+.|++++|.+++..+.... ..++.+++++|..
T Consensus       378 ~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-~~L~~L~Ls~N~l  433 (520)
T 2z7x_B          378 QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-PRIKVLDLHSNKI  433 (520)
T ss_dssp             EEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC-TTCCEEECCSSCC
T ss_pred             EEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc-ccCCEEECCCCcc
Confidence            77777777765333 3355556666666666666544333211 3455555555543

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.97  E-value=7.5e-32  Score=303.91  Aligned_cols=138  Identities=22%  Similarity=0.206  Sum_probs=112.7

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      .|+|++|++++..|..|.++++|++|+|++|+|+++.|++|.++++|++|+|++|.+..+.+.     .|.++++|++|+
T Consensus        36 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~-----~~~~l~~L~~L~  110 (606)
T 3vq2_A           36 NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG-----SFSGLTSLENLV  110 (606)
T ss_dssp             EEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTT-----SSTTCTTCCEEE
T ss_pred             EEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChh-----hcCCcccCCEEE
Confidence            378889999877777888899999999999999888888899999999999999988887543     578888899999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEcccccccc-cCCccccCCCCCcEEEccCCccCCcCChhhh
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSG-GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLG  145 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  145 (678)
                      |++|.+.+..+.. +..+. +|++|++++|.+.+ .+|..|+++++|++|++++|++++..+..|.
T Consensus       111 L~~n~l~~~~~~~-~~~l~-~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~  174 (606)
T 3vq2_A          111 AVETKLASLESFP-IGQLI-TLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ  174 (606)
T ss_dssp             CTTSCCCCSSSSC-CTTCT-TCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTH
T ss_pred             ccCCccccccccc-cCCCC-CCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhh
Confidence            9999887766554 66776 78888888888886 4588888888888888888888766555443

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.97  E-value=6.8e-31  Score=274.70  Aligned_cols=277  Identities=25%  Similarity=0.378  Sum_probs=166.4

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      |++++|.+. .+|. +..+++|++|+|++|+++...+  |.++++|++|++++|.++.++       .|.++++|++|++
T Consensus        49 L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~~-------~~~~l~~L~~L~l  117 (347)
T 4fmz_A           49 LVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDIS-------ALQNLTNLRELYL  117 (347)
T ss_dssp             EECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-------GGTTCTTCSEEEC
T ss_pred             EEEeCCccc-cchh-hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCch-------HHcCCCcCCEEEC
Confidence            567777776 4453 6777778888888887775433  777777788888777777653       3667777777777


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCC
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLE  161 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~  161 (678)
                      ++|.+.+..+   +..++ +|++|++++|......+. +..+++|++|++++|.+.+..+  +..+++|++|++++|.++
T Consensus       118 ~~n~i~~~~~---~~~l~-~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~  190 (347)
T 4fmz_A          118 NEDNISDISP---LANLT-KMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIE  190 (347)
T ss_dssp             TTSCCCCCGG---GTTCT-TCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCC
T ss_pred             cCCcccCchh---hccCC-ceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccc
Confidence            7777765433   34444 566666666644433322 5555566666666655553222  555555555555555555


Q ss_pred             CCCC--------------------CcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccc
Q 005760          162 GSIP--------------------DSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDI  221 (678)
Q Consensus       162 ~~~~--------------------~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L  221 (678)
                      +..+                    ..+..+++|++|++++|.+++..+  +..+++|+.|++++|.++.++ .+..+++|
T Consensus       191 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~-~~~~l~~L  267 (347)
T 4fmz_A          191 DISPLASLTSLHYFTAYVNQITDITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDIN-AVKDLTKL  267 (347)
T ss_dssp             CCGGGGGCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-GGTTCTTC
T ss_pred             ccccccCCCccceeecccCCCCCCchhhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCCh-hHhcCCCc
Confidence            2211                    014444555555555555553322  455555555555555555542 34455555


Q ss_pred             cEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCcccc
Q 005760          222 LYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGN  301 (678)
Q Consensus       222 ~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~  301 (678)
                      +.|++++|.+++.  ..+.          .+++|+.|+|++|++++..+..+..+++|+.|++++|++++..| ...++.
T Consensus       268 ~~L~l~~n~l~~~--~~~~----------~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~  334 (347)
T 4fmz_A          268 KMLNVGSNQISDI--SVLN----------NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSK  334 (347)
T ss_dssp             CEEECCSSCCCCC--GGGG----------GCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTT
T ss_pred             CEEEccCCccCCC--hhhc----------CCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhc
Confidence            5555555555532  1222          33477778888877777777777777778888888887776655 556677


Q ss_pred             ccccccccCcc
Q 005760          302 FSAESFEGNEL  312 (678)
Q Consensus       302 l~~~~~~~n~~  312 (678)
                      ++.+++.+|+.
T Consensus       335 L~~L~l~~N~i  345 (347)
T 4fmz_A          335 MDSADFANQVI  345 (347)
T ss_dssp             CSEESSSCC--
T ss_pred             cceeehhhhcc
Confidence            77777777764

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.97  E-value=7.9e-32  Score=309.22  Aligned_cols=289  Identities=19%  Similarity=0.286  Sum_probs=201.6

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCc-ccc-cCCccccCCC-------CCCEEEccCccCCCCccchhhcccccC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNS-FSG-FIPNTFGNLR-------NLQALRLSNNYLTSSTLELSFLSSLSN   72 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~-i~~-~~~~~~~~l~-------~L~~L~l~~n~i~~~~~~~~~~~~~~~   72 (678)
                      |+|++|++.+.+|..|.++++|++|+|++|+ +++ .+|..|.+++       +|+.|+|++|.+..++..    ..|.+
T Consensus       496 L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~----~~l~~  571 (876)
T 4ecn_A          496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPAS----ASLQK  571 (876)
T ss_dssp             EEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCH----HHHTT
T ss_pred             EECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCCh----hhhhc
Confidence            6778888888888888888888888888887 776 5666555444       888888888888755530    13677


Q ss_pred             CCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCC-CcEEEccCCccCCcCChhhhccCC--
Q 005760           73 CKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTN-LTIIYLGGNKLNGSIPSTLGKLQK--  149 (678)
Q Consensus        73 l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~~~~~~~l~~--  149 (678)
                      +++|+.|+|++|+++ ..|  .+..++ +|++|+|++|++. .+|..+.++++ |+.|+|++|+++ .+|..+..++.  
T Consensus       572 L~~L~~L~Ls~N~l~-~lp--~~~~L~-~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~  645 (876)
T 4ecn_A          572 MVKLGLLDCVHNKVR-HLE--AFGTNV-KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYV  645 (876)
T ss_dssp             CTTCCEEECTTSCCC-BCC--CCCTTS-EESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSC
T ss_pred             CCCCCEEECCCCCcc-cch--hhcCCC-cceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCC
Confidence            888888888888887 444  356665 7888888888887 67777778887 888888888887 56666665543  


Q ss_pred             CCEEEccCCcCCCCCCCcc---c--CCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccc-------
Q 005760          150 LQGLGLENNKLEGSIPDSI---C--HSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWN-------  217 (678)
Q Consensus       150 L~~L~L~~n~i~~~~~~~~---~--~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~-------  217 (678)
                      |+.|+|++|.+++.+|...   .  .+++|+.|+|++|.++...+..+..+++|+.|+|++|+|+.+|..+..       
T Consensus       646 L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~  725 (876)
T 4ecn_A          646 MGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK  725 (876)
T ss_dssp             EEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCT
T ss_pred             CCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhcccccccc
Confidence            7777777777776544322   1  334778888888888854444455778888888888888877764332       


Q ss_pred             -cccccEEEecCCcccCCCCcccc--ccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceeccc------cc
Q 005760          218 -LKDILYLNFSSNFFTGPLPLEIG--NLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSF------NK  288 (678)
Q Consensus       218 -l~~L~~L~l~~N~l~~~~~~~~~--~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~------N~  288 (678)
                       +++|+.|+|++|+++ .+|..+.  .++          +|+.|+|++|+|++ +|..+..+++|+.|+|++      |.
T Consensus       726 nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~----------~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~  793 (876)
T 4ecn_A          726 NTYLLTTIDLRFNKLT-SLSDDFRATTLP----------YLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNR  793 (876)
T ss_dssp             TGGGCCEEECCSSCCC-CCCGGGSTTTCT----------TCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCB
T ss_pred             ccCCccEEECCCCCCc-cchHHhhhccCC----------CcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCccccc
Confidence             237888888888887 5555554  444          77777777777775 465666777777777755      55


Q ss_pred             ccccCCCC-CccccccccccccCcc
Q 005760          289 LEGEIPRG-GSFGNFSAESFEGNEL  312 (678)
Q Consensus       289 ~~~~~~~~-~~~~~l~~~~~~~n~~  312 (678)
                      +.+..|.. ..+..|+.+++++|..
T Consensus       794 l~~~ip~~l~~L~~L~~L~Ls~N~L  818 (876)
T 4ecn_A          794 ILRQWPTGITTCPSLIQLQIGSNDI  818 (876)
T ss_dssp             CCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred             ccccChHHHhcCCCCCEEECCCCCC
Confidence            55555533 5566677777777665

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.97  E-value=1.7e-31  Score=283.92  Aligned_cols=270  Identities=18%  Similarity=0.206  Sum_probs=228.7

Q ss_pred             CCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcc
Q 005760           19 NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNL   98 (678)
Q Consensus        19 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l   98 (678)
                      .+++++.|++++|.++.+.+..|.++++|++|+|++|.++.++..     .|..+++|++|+|++|.+++..+.. +..+
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l  116 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTY-----AFAYAHTIQKLYMGFNAIRYLPPHV-FQNV  116 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTT-----TTTTCTTCCEEECCSSCCCCCCTTT-TTTC
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChh-----hccCCCCcCEEECCCCCCCcCCHHH-hcCC
Confidence            468999999999999977777799999999999999999887653     5899999999999999998876654 6777


Q ss_pred             cccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEe
Q 005760           99 SHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLE  178 (678)
Q Consensus        99 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~  178 (678)
                      + +|++|+|++|+++...+..|.++++|++|++++|++++..+..|..+++|++|++++|.+++..   +..+++|+.|+
T Consensus       117 ~-~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~l~~L~~L~  192 (390)
T 3o6n_A          117 P-LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHAN  192 (390)
T ss_dssp             T-TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---GGGCTTCSEEE
T ss_pred             C-CCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---cccccccceee
Confidence            7 8999999999999777777899999999999999999888889999999999999999998542   34445555555


Q ss_pred             c-------------------CCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccc
Q 005760          179 L-------------------GGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEI  239 (678)
Q Consensus       179 l-------------------~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~  239 (678)
                      +                   ++|.+... |.  ...++|+.|++++|.++.++ .+..+++|+.|++++|.+++..|..|
T Consensus       193 l~~n~l~~~~~~~~L~~L~l~~n~l~~~-~~--~~~~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~Ls~n~l~~~~~~~~  268 (390)
T 3o6n_A          193 VSYNLLSTLAIPIAVEELDASHNSINVV-RG--PVNVELTILKLQHNNLTDTA-WLLNYPGLVEVDLSYNELEKIMYHPF  268 (390)
T ss_dssp             CCSSCCSEEECCSSCSEEECCSSCCCEE-EC--CCCSSCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCEEESGGG
T ss_pred             cccccccccCCCCcceEEECCCCeeeec-cc--cccccccEEECCCCCCcccH-HHcCCCCccEEECCCCcCCCcChhHc
Confidence            5                   44544422 21  12368999999999999874 68899999999999999998888888


Q ss_pred             cccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccCccc
Q 005760          240 GNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL  313 (678)
Q Consensus       240 ~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~  313 (678)
                      .+++          +|+.|+|++|++++ .+..+..+++|+.|++++|+++..++....++.++.+++.+|+..
T Consensus       269 ~~l~----------~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~N~i~  331 (390)
T 3o6n_A          269 VKMQ----------RLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV  331 (390)
T ss_dssp             TTCS----------SCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSCCC
T ss_pred             cccc----------cCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcceecCccccccCcCCEEECCCCccc
Confidence            8777          99999999999985 455567899999999999999977666677889999999999864

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.97  E-value=2.9e-31  Score=309.51  Aligned_cols=296  Identities=21%  Similarity=0.173  Sum_probs=214.9

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCccc-ccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFS-GFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLI   79 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L   79 (678)
                      .|||++|.|++..|..|.++++|++|+|++|.+. .+.|++|.++++|++|+|++|.+..+.+.     .|.++++|++|
T Consensus        28 ~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~-----~~~~l~~L~~L  102 (844)
T 3j0a_A           28 RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD-----AFQGLFHLFEL  102 (844)
T ss_dssp             EEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT-----SSCSCSSCCCE
T ss_pred             EEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh-----HccCCcccCEe
Confidence            3789999999888888999999999999999554 34488899999999999999998876543     58889999999


Q ss_pred             ECccCCCcccCCh-hhhhcccccccEEEcccccccccCC-ccccCCCCCcEEEccCCccCCcCChhhhcc--CCCCEEEc
Q 005760           80 SFSNNPLDGILPK-TSVGNLSHSLEYFEMAYCNVSGGIP-EEIGNLTNLTIIYLGGNKLNGSIPSTLGKL--QKLQGLGL  155 (678)
Q Consensus        80 ~L~~n~i~~~~~~-~~~~~l~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l--~~L~~L~L  155 (678)
                      +|++|.+++..+. ..+..++ +|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..|..+  ++|+.|+|
T Consensus       103 ~Ls~n~l~~~~~~~~~~~~L~-~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L  181 (844)
T 3j0a_A          103 RLYFCGLSDAVLKDGYFRNLK-ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL  181 (844)
T ss_dssp             ECTTCCCSSCCSTTCCCSSCS-SCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEE
T ss_pred             eCcCCCCCcccccCccccccC-CCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEEC
Confidence            9999998875443 2356666 89999999999987765 578899999999999999988888888777  78888888


Q ss_pred             cCCcCCCCCCCcccCCCC------ccEEecCCCcCCCCChhhhhc-----------------------------------
Q 005760          156 ENNKLEGSIPDSICHSDE------LYKLELGGNKLSGSIPECFNN-----------------------------------  194 (678)
Q Consensus       156 ~~n~i~~~~~~~~~~l~~------L~~L~l~~N~i~~~~~~~~~~-----------------------------------  194 (678)
                      ++|.+.+..|..+..+++      |+.|++++|.+++..+..+..                                   
T Consensus       182 ~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~  261 (844)
T 3j0a_A          182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA  261 (844)
T ss_dssp             CCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTT
T ss_pred             CCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhh
Confidence            888887666666655554      777777777666544433322                                   


Q ss_pred             ---cccccceecccccccccc-ccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcch
Q 005760          195 ---LASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP  270 (678)
Q Consensus       195 ---l~~L~~L~l~~N~l~~l~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~  270 (678)
                         .++|+.|+|++|.++.++ ..|..+++|+.|+|++|.+.+..+..|.+++          +|+.|+|++|++++..+
T Consensus       262 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~----------~L~~L~Ls~N~l~~~~~  331 (844)
T 3j0a_A          262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLD----------NLQVLNLSYNLLGELYS  331 (844)
T ss_dssp             TTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCS----------SCCEEEEESCCCSCCCS
T ss_pred             ccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCC----------CCCEEECCCCCCCccCH
Confidence               145777777777776653 3566677777777777777766666666555          66666666666666666


Q ss_pred             HHHhcccCCCceecccccccccCCC-CCccccccccccccCcc
Q 005760          271 ASLEKLSYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNEL  312 (678)
Q Consensus       271 ~~~~~l~~L~~L~l~~N~~~~~~~~-~~~~~~l~~~~~~~n~~  312 (678)
                      ..+..+++|+.|++++|.+....+. ...+..|+.+++.+|..
T Consensus       332 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l  374 (844)
T 3j0a_A          332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL  374 (844)
T ss_dssp             CSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCS
T ss_pred             HHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCC
Confidence            6666666666666666666554443 24455566666666554

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.97  E-value=1.8e-31  Score=297.70  Aligned_cols=286  Identities=21%  Similarity=0.207  Sum_probs=205.7

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      +|+|++|++++..|+.|..+++|++|+|++|+|+. +|..  .+++|++|+|++|++..++.    +..|.++++|++|+
T Consensus        80 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~Ls~N~l~~l~~----p~~~~~l~~L~~L~  152 (562)
T 3a79_B           80 VLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC--PMASLRHLDLSFNDFDVLPV----CKEFGNLTKLTFLG  152 (562)
T ss_dssp             EEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-ECSC--CCTTCSEEECCSSCCSBCCC----CGGGGGCTTCCEEE
T ss_pred             EEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-cCcc--ccccCCEEECCCCCccccCc----hHhhcccCcccEEe
Confidence            47899999998889999999999999999999994 5555  89999999999999987653    13588899999999


Q ss_pred             CccCCCcccCChhhhhcccccc--cEEEcccccc--cccCCccccCCC--------------------------------
Q 005760           81 FSNNPLDGILPKTSVGNLSHSL--EYFEMAYCNV--SGGIPEEIGNLT--------------------------------  124 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L--~~L~l~~n~l--~~~~~~~~~~l~--------------------------------  124 (678)
                      |++|++.+..    +..+. +|  ++|++++|.+  ++..|..|..+.                                
T Consensus       153 L~~n~l~~~~----~~~l~-~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~  227 (562)
T 3a79_B          153 LSAAKFRQLD----LLPVA-HLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN  227 (562)
T ss_dssp             EECSBCCTTT----TGGGT-TSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEE
T ss_pred             cCCCccccCc----hhhhh-hceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEec
Confidence            9999987532    23332 33  6677777666  544444444332                                


Q ss_pred             -------------------------------------------------CCcEEEccCCccCCcCChhh-----------
Q 005760          125 -------------------------------------------------NLTIIYLGGNKLNGSIPSTL-----------  144 (678)
Q Consensus       125 -------------------------------------------------~L~~L~l~~N~l~~~~~~~~-----------  144 (678)
                                                                       +|++|++++|.+++.+|..+           
T Consensus       228 l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L  307 (562)
T 3a79_B          228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSL  307 (562)
T ss_dssp             EECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEE
T ss_pred             ccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchhe
Confidence                                                             45555556666554444433           


Q ss_pred             ------------------------------------------hccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCC
Q 005760          145 ------------------------------------------GKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGN  182 (678)
Q Consensus       145 ------------------------------------------~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N  182 (678)
                                                                ..+++|++|+|++|.+++..|..+..+++|++|++++|
T Consensus       308 ~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  387 (562)
T 3a79_B          308 MIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN  387 (562)
T ss_dssp             EEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSS
T ss_pred             ehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCC
Confidence                                                      45677777777777777667777777777777777777


Q ss_pred             cCCCCC--hhhhhccccccceecccccccc-ccc-cccccccccEEEecCCcccCCCCcccc-ccccc--------ccc-
Q 005760          183 KLSGSI--PECFNNLASLRILLLGSNELTS-IPL-TFWNLKDILYLNFSSNFFTGPLPLEIG-NLKIA--------RID-  248 (678)
Q Consensus       183 ~i~~~~--~~~~~~l~~L~~L~l~~N~l~~-l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~~--------~~~-  248 (678)
                      .+++..  |..+..+++|+.|+|++|+++. +|. .+..+++|+.|++++|++++..|..+. .++..        .++ 
T Consensus       388 ~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~~ip~  467 (562)
T 3a79_B          388 GLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPK  467 (562)
T ss_dssp             CCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCCCCCT
T ss_pred             CcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhcCcCCEEECCCCcCcccCh
Confidence            777533  3556777777777777777776 665 366666777777777776655554442 22211        111 


Q ss_pred             -ccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCc
Q 005760          249 -SCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGS  298 (678)
Q Consensus       249 -~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~  298 (678)
                       ...+++|+.|+|++|+|+++.+..+..+++|+.|++++|+|.|+|+..+.
T Consensus       468 ~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~  518 (562)
T 3a79_B          468 DVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRY  518 (562)
T ss_dssp             TTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHHHHH
T ss_pred             hhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcchHHH
Confidence             12567999999999999966555599999999999999999999987654

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=6.8e-32  Score=277.03  Aligned_cols=274  Identities=21%  Similarity=0.253  Sum_probs=193.2

Q ss_pred             CEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccC--Chhhhhccccc
Q 005760           24 SILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGIL--PKTSVGNLSHS  101 (678)
Q Consensus        24 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~--~~~~~~~l~~~  101 (678)
                      +.++++++.++ .+|..+.  ++|++|+|++|.++.++..     .|.++++|++|+|++|.++...  +.. +..++ +
T Consensus        10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~~~-~~~~~-~   79 (306)
T 2z66_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHG-----VFDKLTQLTKLSLSSNGLSFKGCCSQS-DFGTT-S   79 (306)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTT-----TTTTCTTCSEEECCSSCCCEEEEEEHH-HHSCS-C
T ss_pred             CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHh-----HhhccccCCEEECCCCccCcccCcccc-ccccc-c
Confidence            45566666665 3343332  4566666666666655533     2556666666666666665332  222 23333 5


Q ss_pred             ccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCC-hhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          102 LEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIP-STLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       102 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      |++|+|++|.+.. +|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..+..+++|++|+++
T Consensus        80 L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  158 (306)
T 2z66_A           80 LKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA  158 (306)
T ss_dssp             CCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECT
T ss_pred             cCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECC
Confidence            6666666666663 45557778888888888888875544 577888888888888888887777778888888888888


Q ss_pred             CCcCCC-CChhhhhccccccceeccccccccc-cccccccccccEEEecCCcccCCCCccccccccccccccCcccccEE
Q 005760          181 GNKLSG-SIPECFNNLASLRILLLGSNELTSI-PLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISL  258 (678)
Q Consensus       181 ~N~i~~-~~~~~~~~l~~L~~L~l~~N~l~~l-~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L  258 (678)
                      +|.+.+ ..|..+..+++|++|+|++|+++.+ |..+..+++|+.|+|++|.+++..+..+.+++          +|+.|
T Consensus       159 ~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~----------~L~~L  228 (306)
T 2z66_A          159 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN----------SLQVL  228 (306)
T ss_dssp             TCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCT----------TCCEE
T ss_pred             CCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcc----------cCCEe
Confidence            888875 4677788888888888888888877 45788888888888888888877766666665          88899


Q ss_pred             EccCCcCCCcchHHHhccc-CCCceecccccccccCCCCCccccc---cccccccCccccCCCC
Q 005760          259 NLSNNNLSGAIPASLEKLS-YLKDLNLSFNKLEGEIPRGGSFGNF---SAESFEGNELLCGSPN  318 (678)
Q Consensus       259 ~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~~~~~~~~~~~~~~l---~~~~~~~n~~~c~~~~  318 (678)
                      +|++|++++..+..+..++ +|++|++++|+|+|+++..+...++   ..+....+...|..|.
T Consensus       229 ~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~  292 (306)
T 2z66_A          229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS  292 (306)
T ss_dssp             ECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred             ECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence            9999988888888888874 8999999999998887754333333   3445566777777764

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=1e-31  Score=281.59  Aligned_cols=272  Identities=20%  Similarity=0.207  Sum_probs=134.8

Q ss_pred             cccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECc
Q 005760            3 QMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFS   82 (678)
Q Consensus         3 ~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~   82 (678)
                      +.++++++ .+|..+.  ++|++|+|++|+|+++.++.|.++++|++|+|++|.++.++..     .|.++++|++|+|+
T Consensus        37 ~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~Ls  108 (353)
T 2z80_A           37 KGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEED-----SFSSLGSLEHLDLS  108 (353)
T ss_dssp             ECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTT-----TTTTCTTCCEEECC
T ss_pred             eCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHh-----hcCCCCCCCEEECC
Confidence            44555555 4554433  2566666666666655555566666666666666655544322     35555666666666


Q ss_pred             cCCCcccCChhhhhcccccccEEEcccccccccCC-ccccCCCCCcEEEccCC-ccCCcCChhhhccCCCCEEEccCCcC
Q 005760           83 NNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIP-EEIGNLTNLTIIYLGGN-KLNGSIPSTLGKLQKLQGLGLENNKL  160 (678)
Q Consensus        83 ~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~L~~n~i  160 (678)
                      +|+++++.+ ..+..++ +|++|++++|++++..+ ..|.++++|++|++++| .+....+..|.++++|++|++++|.+
T Consensus       109 ~n~l~~~~~-~~~~~l~-~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l  186 (353)
T 2z80_A          109 YNYLSNLSS-SWFKPLS-SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL  186 (353)
T ss_dssp             SSCCSSCCH-HHHTTCT-TCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCcCCcCCH-hHhCCCc-cCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCc
Confidence            665553322 2234443 55555555555554333 34555555555555555 34444444555555555555555555


Q ss_pred             CCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-c---ccccccccEEEecCCcccCC--
Q 005760          161 EGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-T---FWNLKDILYLNFSSNFFTGP--  234 (678)
Q Consensus       161 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~---~~~l~~L~~L~l~~N~l~~~--  234 (678)
                      ++..|..+..+++|++|++++|.++...+..+..+++|+.|++++|.++.++. .   ....+.++.++|++|.+.+.  
T Consensus       187 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l  266 (353)
T 2z80_A          187 QSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL  266 (353)
T ss_dssp             CEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHH
T ss_pred             CccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcch
Confidence            54445555555555555555555543222233345555555555555554322 1   12233444555555544321  


Q ss_pred             --CCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCC
Q 005760          235 --LPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP  294 (678)
Q Consensus       235 --~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  294 (678)
                        +|..+.+++          +|+.|+|++|+++.+.+..+..+++|++|++++|++.|+++
T Consensus       267 ~~l~~~l~~l~----------~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          267 FQVMKLLNQIS----------GLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             HHHHHHHHTCT----------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             hhhHHHHhccc----------CCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence              122222222          55555555555553333334555555555555555555554

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.97  E-value=5.6e-31  Score=298.46  Aligned_cols=304  Identities=21%  Similarity=0.241  Sum_probs=237.6

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      +|+|++|+|++..|.+|.++++|++|+|++|+|++..+++|.++++|++|+|++|+++.++..     .|.++++|++|+
T Consensus        80 ~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~-----~~~~L~~L~~L~  154 (635)
T 4g8a_A           80 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF-----PIGHLKTLKELN  154 (635)
T ss_dssp             EEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTC-----CCTTCTTCCEEE
T ss_pred             EEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChh-----hhhcCcccCeec
Confidence            478899999876677888899999999999999877778899999999999999988887754     477778888888


Q ss_pred             CccCCCcccCChhhhhcccccccEEEcccccccccCCcccc---------------------------------------
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG---------------------------------------  121 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~---------------------------------------  121 (678)
                      |++|.+++......+..++ +|++|+|++|++++..+..|.                                       
T Consensus       155 Ls~N~l~~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~  233 (635)
T 4g8a_A          155 VAHNLIQSFKLPEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRN  233 (635)
T ss_dssp             CCSSCCCCCCCCGGGGGCT-TCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEES
T ss_pred             cccCccccCCCchhhccch-hhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhc
Confidence            8888776654444455565 677777777766543222111                                       


Q ss_pred             --------------------------------------------------------------------------------
Q 005760          122 --------------------------------------------------------------------------------  121 (678)
Q Consensus       122 --------------------------------------------------------------------------------  121 (678)
                                                                                                      
T Consensus       234 n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~  313 (635)
T 4g8a_A          234 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSL  313 (635)
T ss_dssp             CCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEE
T ss_pred             ccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccc
Confidence                                                                                            


Q ss_pred             -------------------------------------------------------CCCCCcEEEccCCccCCc-------
Q 005760          122 -------------------------------------------------------NLTNLTIIYLGGNKLNGS-------  139 (678)
Q Consensus       122 -------------------------------------------------------~l~~L~~L~l~~N~l~~~-------  139 (678)
                                                                             .+++|+.|++++|.+...       
T Consensus       314 ~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~  393 (635)
T 4g8a_A          314 VSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD  393 (635)
T ss_dssp             ESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHH
T ss_pred             cccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccch
Confidence                                                                   133455555555544210       


Q ss_pred             -------------------------------------------CChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccE
Q 005760          140 -------------------------------------------IPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYK  176 (678)
Q Consensus       140 -------------------------------------------~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~  176 (678)
                                                                 .+..|.++++++.++++.|.+.+..+..+..+++|+.
T Consensus       394 ~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~  473 (635)
T 4g8a_A          394 FGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV  473 (635)
T ss_dssp             HSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred             hhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhh
Confidence                                                       1124556778888999999999888889999999999


Q ss_pred             EecCCCcCC-CCChhhhhccccccceecccccccccc-ccccccccccEEEecCCcccCCCCccccccccccccccCccc
Q 005760          177 LELGGNKLS-GSIPECFNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLIS  254 (678)
Q Consensus       177 L~l~~N~i~-~~~~~~~~~l~~L~~L~l~~N~l~~l~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~  254 (678)
                      |++++|.+. ...|+.|..+++|+.|+|++|+|+.++ ..|.++++|+.|+|++|+|++..+..|.+++          +
T Consensus       474 L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~----------~  543 (635)
T 4g8a_A          474 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN----------S  543 (635)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCT----------T
T ss_pred             hhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCC----------C
Confidence            999999854 467888999999999999999999885 5799999999999999999999998888887          9


Q ss_pred             ccEEEccCCcCCCcchHHHhcc-cCCCceecccccccccCCCCCcccccccc---ccccCccccCCCCCC
Q 005760          255 LISLNLSNNNLSGAIPASLEKL-SYLKDLNLSFNKLEGEIPRGGSFGNFSAE---SFEGNELLCGSPNLR  320 (678)
Q Consensus       255 L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~l~~N~~~~~~~~~~~~~~l~~~---~~~~n~~~c~~~~~~  320 (678)
                      |+.|+|++|+|++..|..+..+ ++|+.|+|++|||.|+|...++..+++..   ........|..|...
T Consensus       544 L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl~~~~~~~~~~~~~~C~~P~~~  613 (635)
T 4g8a_A          544 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK  613 (635)
T ss_dssp             CCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHHHHHHTTTTBSCGGGCBBCSSTTT
T ss_pred             CCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHHHHHhCCCccCCCCCceeCCchHH
Confidence            9999999999999999999988 68999999999999999876665555432   122345788888544

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.97  E-value=9.8e-31  Score=293.37  Aligned_cols=272  Identities=18%  Similarity=0.202  Sum_probs=230.5

Q ss_pred             CCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcc
Q 005760           19 NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNL   98 (678)
Q Consensus        19 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l   98 (678)
                      .+.+++.|++++|.++.+.+..|.++++|+.|+|++|.+..++..     .|..+++|++|+|++|.++++.+.. +..+
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l  122 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTY-----AFAYAHTIQKLYMGFNAIRYLPPHV-FQNV  122 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTT-----TTTTCTTCCEEECCSSCCCCCCTTT-TTTC
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChH-----HhcCCCCCCEEECCCCcCCCCCHHH-HcCC
Confidence            468899999999999988888899999999999999999987653     5899999999999999999876654 7777


Q ss_pred             cccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEe
Q 005760           99 SHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLE  178 (678)
Q Consensus        99 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~  178 (678)
                      + +|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++..   +..+++|+.|+
T Consensus       123 ~-~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~  198 (597)
T 3oja_B          123 P-LLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHAN  198 (597)
T ss_dssp             T-TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEE
T ss_pred             C-CCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhh
Confidence            7 8999999999999887888899999999999999999888889999999999999999998543   44455565555


Q ss_pred             cCCCcCCCC------------------ChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCcccc
Q 005760          179 LGGNKLSGS------------------IPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIG  240 (678)
Q Consensus       179 l~~N~i~~~------------------~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  240 (678)
                      +++|.+++.                  .+..  ..++|+.|+|++|.++.. ..+..+++|+.|+|++|.+++..|..|.
T Consensus       199 l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~--~~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~  275 (597)
T 3oja_B          199 VSYNLLSTLAIPIAVEELDASHNSINVVRGP--VNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFV  275 (597)
T ss_dssp             CCSSCCSEEECCTTCSEEECCSSCCCEEECS--CCSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred             cccCccccccCCchhheeeccCCcccccccc--cCCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhc
Confidence            555555421                  1111  125788888888888875 5688999999999999999999898888


Q ss_pred             ccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccCcccc
Q 005760          241 NLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLC  314 (678)
Q Consensus       241 ~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~c  314 (678)
                      +++          +|+.|+|++|++++ +|..+..+++|+.|+|++|+++..++....++.|..+++.+|+...
T Consensus       276 ~l~----------~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~l~~L~~L~L~~N~l~~  338 (597)
T 3oja_B          276 KMQ----------RLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIVT  338 (597)
T ss_dssp             TCS----------SCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCCCGGGHHHHTTCSEEECCSSCCCC
T ss_pred             Ccc----------CCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCccCcccccCCCCCEEECCCCCCCC
Confidence            877          99999999999996 4666678999999999999999776666778899999999998743

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.97  E-value=1.2e-30  Score=291.82  Aligned_cols=305  Identities=25%  Similarity=0.227  Sum_probs=248.6

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      |+|++|++++..+.+|..+++|++|+|++|+|+++.+++|.++++|++|+|++|.+..++..     .|.++++|++|++
T Consensus        33 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~L  107 (570)
T 2z63_A           33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALG-----AFSGLSSLQKLVA  107 (570)
T ss_dssp             EECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTT-----TTTTCTTCCEEEC
T ss_pred             EEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHh-----hhcCccccccccc
Confidence            78999999977788899999999999999999988888999999999999999998877643     5889999999999


Q ss_pred             ccCCCcccCChhhhhcccccccEEEccccccccc-CCccccCCCCCcEEEccCCccCCcCChhhhccCCC----CEEEcc
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGG-IPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKL----QGLGLE  156 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L----~~L~L~  156 (678)
                      ++|+++++.+.. +..+. +|++|++++|.+++. +|..|.++++|++|++++|++++..+..|..+++|    ++|+++
T Consensus       108 ~~n~l~~l~~~~-~~~l~-~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~  185 (570)
T 2z63_A          108 VETNLASLENFP-IGHLK-TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS  185 (570)
T ss_dssp             TTSCCCCSTTCS-CTTCT-TCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECT
T ss_pred             cccccccCCCcc-ccccc-cccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccC
Confidence            999998765544 66776 899999999999874 68889999999999999999988778888888888    889999


Q ss_pred             CCcCCCCCCCcccCCCCccEEecCCC------------------------------------------------------
Q 005760          157 NNKLEGSIPDSICHSDELYKLELGGN------------------------------------------------------  182 (678)
Q Consensus       157 ~n~i~~~~~~~~~~l~~L~~L~l~~N------------------------------------------------------  182 (678)
                      +|.+++..+..+... +|+.|++++|                                                      
T Consensus       186 ~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l  264 (570)
T 2z63_A          186 LNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL  264 (570)
T ss_dssp             TCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEE
T ss_pred             CCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhh
Confidence            999987666666554 7888887776                                                      


Q ss_pred             ----cCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCcccccccccc---------ccc
Q 005760          183 ----KLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIAR---------IDS  249 (678)
Q Consensus       183 ----~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~---------~~~  249 (678)
                          .+.+..+..+..+++|+.|++++|.++.+|..+..+ +|+.|++++|.+.......+..++...         ...
T Consensus       265 ~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~-~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~  343 (570)
T 2z63_A          265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE  343 (570)
T ss_dssp             EETTEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCC-CCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCC
T ss_pred             hcchhhhhhchhhhcCcCcccEEEecCccchhhhhhhccC-CccEEeeccCcccccCcccccccCEEeCcCCcccccccc
Confidence                333455667778889999999999999998888888 899999999988844444444333221         112


Q ss_pred             cCcccccEEEccCCcCCCcc--hHHHhcccCCCceecccccccccCCCCCccccccccccccCccccC
Q 005760          250 CDLISLISLNLSNNNLSGAI--PASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCG  315 (678)
Q Consensus       250 ~~~~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~c~  315 (678)
                      ..+++|+.|++++|++++..  +..+..+++|+.|++++|.+.+..+....+..+..+++.+|.....
T Consensus       344 ~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~  411 (570)
T 2z63_A          344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQM  411 (570)
T ss_dssp             CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESC
T ss_pred             ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccc
Confidence            46789999999999998664  7888999999999999999988777667778899999998876543

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.97  E-value=4.9e-30  Score=268.16  Aligned_cols=272  Identities=27%  Similarity=0.331  Sum_probs=196.3

Q ss_pred             ccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhh
Q 005760           17 IFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVG   96 (678)
Q Consensus        17 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~   96 (678)
                      +..+++|++|++++|.+... + .|..+++|++|++++|.++.++.       |..+++|++|++++|.++.+.   .+.
T Consensus        40 ~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~-------~~~l~~L~~L~L~~n~i~~~~---~~~  107 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP-------LSNLVKLTNLYIGTNKITDIS---ALQ  107 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-------GTTCTTCCEEECCSSCCCCCG---GGT
T ss_pred             chhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh-------hhcCCcCCEEEccCCcccCch---HHc
Confidence            56789999999999999854 3 49999999999999999988662       789999999999999998652   366


Q ss_pred             cccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccE
Q 005760           97 NLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYK  176 (678)
Q Consensus        97 ~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~  176 (678)
                      .++ +|++|++++|.+.+..+  +..+++|+.|++++|..... +..+..+++|++|++++|.+++..+  +..+++|+.
T Consensus       108 ~l~-~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~  181 (347)
T 4fmz_A          108 NLT-NLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYS  181 (347)
T ss_dssp             TCT-TCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSE
T ss_pred             CCC-cCCEEECcCCcccCchh--hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcCCchh--hccCCCCCE
Confidence            776 89999999999997644  88999999999999976533 4559999999999999999984433  889999999


Q ss_pred             EecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccc---ccc-------
Q 005760          177 LELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK---IAR-------  246 (678)
Q Consensus       177 L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~---~~~-------  246 (678)
                      |++++|.+.+..+  +..+++|+.|++++|.++.++. +..+++|+.|++++|.+++..+  +..++   ..+       
T Consensus       182 L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~  256 (347)
T 4fmz_A          182 LSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS  256 (347)
T ss_dssp             EECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             EEccCCccccccc--ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccC
Confidence            9999999996543  7777778888888877777655 6677777777777777765443  33332   000       


Q ss_pred             -c-cccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC-CccccccccccccCccc
Q 005760          247 -I-DSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELL  313 (678)
Q Consensus       247 -~-~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~-~~~~~l~~~~~~~n~~~  313 (678)
                       + .+..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..+.. ..++.++.+++.+|++.
T Consensus       257 ~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~  324 (347)
T 4fmz_A          257 DINAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT  324 (347)
T ss_dssp             CCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCC
T ss_pred             CChhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccc
Confidence             0 012333555555555555533  23445555555555555554433321 33445555555555543

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=1.5e-30  Score=264.05  Aligned_cols=209  Identities=23%  Similarity=0.232  Sum_probs=179.2

Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCc-cCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEec
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNK-LNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL  179 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l  179 (678)
                      +|++|++++|.+++..+..|.++++|++|++++|. ++...+..|..+++|++|+|++|.+++..+..|..+++|++|++
T Consensus        57 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  136 (285)
T 1ozn_A           57 NLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYL  136 (285)
T ss_dssp             TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEEC
Confidence            44444444444445556678888999999999997 87666888899999999999999998777888889999999999


Q ss_pred             CCCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccCCCCccccccccccccccCcccccEE
Q 005760          180 GGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISL  258 (678)
Q Consensus       180 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L  258 (678)
                      ++|.+++..+..|..+++|+.|+|++|+++.++. .+..+++|+.|++++|.+++..|..|.+++          +|+.|
T Consensus       137 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~----------~L~~L  206 (285)
T 1ozn_A          137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG----------RLMTL  206 (285)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT----------TCCEE
T ss_pred             CCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcc----------cccEe
Confidence            9999998777788999999999999999998877 588999999999999999988888887777          99999


Q ss_pred             EccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccCccccCCCCC
Q 005760          259 NLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNL  319 (678)
Q Consensus       259 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~c~~~~~  319 (678)
                      +|++|++++..+..+..+++|+.|++++|+|.|+++..+.+.++.......+.+.|..|..
T Consensus       207 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             ECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGG
T ss_pred             eCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCchH
Confidence            9999999998888899999999999999999999988777778888888888888887743

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=1.8e-30  Score=280.45  Aligned_cols=260  Identities=20%  Similarity=0.208  Sum_probs=217.0

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccc
Q 005760           21 SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSH  100 (678)
Q Consensus        21 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~  100 (678)
                      .+.+.++.+++.++ .+|..+.  ++++.|+|++|++..++..     .|.++++|++|+|++|.|+.+.+.. +..++ 
T Consensus        43 ~~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~-----~~~~l~~L~~L~Ls~n~i~~i~~~~-~~~l~-  112 (440)
T 3zyj_A           43 NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVN-----SFKHLRHLEILQLSRNHIRTIEIGA-FNGLA-  112 (440)
T ss_dssp             TTSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTT-----TTSSCSSCCEEECCSSCCCEECGGG-GTTCS-
T ss_pred             CCCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHH-----HhhCCCCCCEEECCCCcCCccChhh-ccCCc-
Confidence            34678888888888 4566554  6888899999988877654     5788888999999999888765544 66676 


Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccC-CcCCCCCCCcccCCCCccEEec
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLEN-NKLEGSIPDSICHSDELYKLEL  179 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~l  179 (678)
                      +|++|+|++|+++...+..|..+++|++|+|++|+++...+..|.++++|++|+|++ |.++...+..|.++++|++|+|
T Consensus       113 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L  192 (440)
T 3zyj_A          113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL  192 (440)
T ss_dssp             SCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEEC
T ss_pred             cCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecC
Confidence            789999999988887778899999999999999999877777899999999999998 4555444567889999999999


Q ss_pred             CCCcCCCCChhhhhccccccceeccccccccc-cccccccccccEEEecCCcccCCCCccccccccccccccCcccccEE
Q 005760          180 GGNKLSGSIPECFNNLASLRILLLGSNELTSI-PLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISL  258 (678)
Q Consensus       180 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l-~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L  258 (678)
                      ++|.++. +| .+..+++|+.|+|++|+|+.+ |..|.++++|+.|+|++|.+++..+..|.+++          +|+.|
T Consensus       193 ~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~----------~L~~L  260 (440)
T 3zyj_A          193 AMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQ----------SLVEI  260 (440)
T ss_dssp             TTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCT----------TCCEE
T ss_pred             CCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCC----------CCCEE
Confidence            9999994 44 488899999999999999988 45799999999999999999988888887777          99999


Q ss_pred             EccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccc
Q 005760          259 NLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNF  302 (678)
Q Consensus       259 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l  302 (678)
                      +|++|+|++..+..+..+++|+.|+|++|+|.|+|...+...++
T Consensus       261 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~~l~~~~  304 (440)
T 3zyj_A          261 NLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILWLSWWI  304 (440)
T ss_dssp             ECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTHHHHHHH
T ss_pred             ECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCchHHHHHH
Confidence            99999999888888999999999999999999999765443333

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=1e-30  Score=273.98  Aligned_cols=282  Identities=20%  Similarity=0.215  Sum_probs=240.2

Q ss_pred             CCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcc
Q 005760           19 NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNL   98 (678)
Q Consensus        19 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l   98 (678)
                      .++.....++++|.++ .+|..+.  ++|++|++++|.++.++..     .|.++++|++|+|++|+++++.+.. +..+
T Consensus        29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~~-~~~l   99 (353)
T 2z80_A           29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNS-----DLQRCVNLQALVLTSNGINTIEEDS-FSSL   99 (353)
T ss_dssp             EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTT-----TTTTCTTCCEEECTTSCCCEECTTT-TTTC
T ss_pred             CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHH-----HhccCCCCCEEECCCCccCccCHhh-cCCC
Confidence            3456677999999999 4566555  4999999999999987753     5889999999999999999877655 6777


Q ss_pred             cccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCC-hhhhccCCCCEEEccCC-cCCCCCCCcccCCCCccE
Q 005760           99 SHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIP-STLGKLQKLQGLGLENN-KLEGSIPDSICHSDELYK  176 (678)
Q Consensus        99 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~  176 (678)
                      + +|++|+|++|++++..+..|.++++|++|++++|++++..+ ..|..+++|++|++++| .++...+..|..+++|++
T Consensus       100 ~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~  178 (353)
T 2z80_A          100 G-SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE  178 (353)
T ss_dssp             T-TCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEE
T ss_pred             C-CCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCE
Confidence            6 89999999999998777779999999999999999995554 58999999999999999 577666788999999999


Q ss_pred             EecCCCcCCCCChhhhhccccccceecccccccccccc-ccccccccEEEecCCcccCCCCccccccccccccccCcccc
Q 005760          177 LELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLT-FWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISL  255 (678)
Q Consensus       177 L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L  255 (678)
                      |++++|.+++..|..+..+++|++|++++|+++.+|.. +..+++|+.|++++|.+++..+..+....       ..+.+
T Consensus       179 L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~-------~~~~l  251 (353)
T 2z80_A          179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE-------TNSLI  251 (353)
T ss_dssp             EEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-------------CCCCC
T ss_pred             EECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccccc-------ccchh
Confidence            99999999998899999999999999999999999875 55689999999999999987766554322       23478


Q ss_pred             cEEEccCCcCCC----cchHHHhcccCCCceecccccccccCCCC-CccccccccccccCccccCCC
Q 005760          256 ISLNLSNNNLSG----AIPASLEKLSYLKDLNLSFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSP  317 (678)
Q Consensus       256 ~~L~L~~N~l~~----~~~~~~~~l~~L~~L~l~~N~~~~~~~~~-~~~~~l~~~~~~~n~~~c~~~  317 (678)
                      +.++|++|.+++    .+|..+..+++|+.|++++|+++..++.. ..+.+++.+++.+|++.|+||
T Consensus       252 ~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~  318 (353)
T 2z80_A          252 KKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  318 (353)
T ss_dssp             CEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             hccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence            899999998876    46778899999999999999999665554 678899999999999999987

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.97  E-value=5.8e-30  Score=278.53  Aligned_cols=287  Identities=26%  Similarity=0.392  Sum_probs=148.9

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      |+|++|.+++..|  +..+++|++|++++|++++..+  |.++++|++|++++|.++.++.       +.++++|++|++
T Consensus        73 L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-------~~~l~~L~~L~l  141 (466)
T 1o6v_A           73 INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-------LKNLTNLNRLEL  141 (466)
T ss_dssp             EECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-------GTTCTTCSEEEE
T ss_pred             EECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH-------HcCCCCCCEEEC
Confidence            6777777774433  6677777777777777775433  6677777777777776665541       445555555555


Q ss_pred             ccCCCcccCCh------------------hhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChh
Q 005760           82 SNNPLDGILPK------------------TSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPST  143 (678)
Q Consensus        82 ~~n~i~~~~~~------------------~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~  143 (678)
                      ++|.+.+....                  ..+..++ +|++|++++|.+.+.  ..+..+++|++|++++|.+.+..+  
T Consensus       142 ~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~-~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--  216 (466)
T 1o6v_A          142 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLT-TLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--  216 (466)
T ss_dssp             EEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCT-TCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred             CCCccCCChhhccCCcccEeecCCcccCchhhccCC-CCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--
Confidence            55555432110                  0122222 455566666555543  235555555555555555553332  


Q ss_pred             hhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccE
Q 005760          144 LGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILY  223 (678)
Q Consensus       144 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~  223 (678)
                      ++.+++|++|++++|.+++ + ..+..+++|+.|++++|.+.+..+  +..+++|+.|++++|.++.++. +..+++|+.
T Consensus       217 ~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~  291 (466)
T 1o6v_A          217 LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTN  291 (466)
T ss_dssp             GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSE
T ss_pred             ccccCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCe
Confidence            4445555555555555542 2 234445555555555555543322  4444555555555555544443 444444444


Q ss_pred             EEecCCcccCCCCccccccc---ccc---------ccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccc
Q 005760          224 LNFSSNFFTGPLPLEIGNLK---IAR---------IDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEG  291 (678)
Q Consensus       224 L~l~~N~l~~~~~~~~~~l~---~~~---------~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  291 (678)
                      |++++|++.+..+  +..++   ..+         .+...+++|+.|++++|++++.  ..+..+++|+.|++++|++++
T Consensus       292 L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~  367 (466)
T 1o6v_A          292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISD  367 (466)
T ss_dssp             EECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCB
T ss_pred             EEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCc
Confidence            4444444443322  22221   000         0011233666666666666544  245566666666666666665


Q ss_pred             cCCCCCccccccccccccCcccc
Q 005760          292 EIPRGGSFGNFSAESFEGNELLC  314 (678)
Q Consensus       292 ~~~~~~~~~~l~~~~~~~n~~~c  314 (678)
                      ..| ...++.+..+++.+|++..
T Consensus       368 ~~~-~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          368 LTP-LANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             CGG-GTTCTTCCEEECCCEEEEC
T ss_pred             cch-hhcCCCCCEEeccCCcccC
Confidence            554 4555666666666666554

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=1.2e-30  Score=282.80  Aligned_cols=259  Identities=21%  Similarity=0.213  Sum_probs=215.7

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccc
Q 005760           21 SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSH  100 (678)
Q Consensus        21 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~  100 (678)
                      .+.+.++.+++.++ .+|..+.  ++|+.|+|++|.++.++..     .|.++++|++|+|++|+|+++.+.. +..++ 
T Consensus        54 ~~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~-----~~~~l~~L~~L~Ls~n~i~~~~~~~-~~~l~-  123 (452)
T 3zyi_A           54 NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQAD-----TFRHLHHLEVLQLGRNSIRQIEVGA-FNGLA-  123 (452)
T ss_dssp             SSSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTT-----TTTTCTTCCEEECCSSCCCEECTTT-TTTCT-
T ss_pred             CCCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHH-----HcCCCCCCCEEECCCCccCCcChhh-ccCcc-
Confidence            34677888888888 4565554  5888888888888876643     5788888888888888888776654 66676 


Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccC-CcCCCCCCCcccCCCCccEEec
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLEN-NKLEGSIPDSICHSDELYKLEL  179 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~l  179 (678)
                      +|++|+|++|+++...+..|.++++|++|+|++|+++.+.+..|.++++|++|+|++ |.+....+..|.++++|++|+|
T Consensus       124 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L  203 (452)
T 3zyi_A          124 SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNL  203 (452)
T ss_dssp             TCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEEC
T ss_pred             cCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEEC
Confidence            788888888888888788899999999999999999877777899999999999998 5555444567889999999999


Q ss_pred             CCCcCCCCChhhhhccccccceeccccccccc-cccccccccccEEEecCCcccCCCCccccccccccccccCcccccEE
Q 005760          180 GGNKLSGSIPECFNNLASLRILLLGSNELTSI-PLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISL  258 (678)
Q Consensus       180 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l-~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L  258 (678)
                      ++|.+++. | .+..+++|+.|+|++|+|+.+ |..|..+++|+.|+|++|.+++..+..|.+++          +|+.|
T Consensus       204 ~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~----------~L~~L  271 (452)
T 3zyi_A          204 GMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLA----------SLVEL  271 (452)
T ss_dssp             TTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCT----------TCCEE
T ss_pred             CCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCC----------CCCEE
Confidence            99999954 3 488899999999999999987 55799999999999999999988888887777          99999


Q ss_pred             EccCCcCCCcchHHHhcccCCCceecccccccccCCCCCcccc
Q 005760          259 NLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGN  301 (678)
Q Consensus       259 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~  301 (678)
                      +|++|+|++..+..+..+++|+.|+|++|+|.|+|...+...+
T Consensus       272 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~~l~~~  314 (452)
T 3zyi_A          272 NLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILWLAWW  314 (452)
T ss_dssp             ECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTHHHHHH
T ss_pred             ECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCchHHHHH
Confidence            9999999988888889999999999999999999986544333

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.97  E-value=1.2e-30  Score=290.46  Aligned_cols=198  Identities=21%  Similarity=0.227  Sum_probs=163.0

Q ss_pred             cccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECc
Q 005760            3 QMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFS   82 (678)
Q Consensus         3 ~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~   82 (678)
                      |.++++++ .+|..+.  ++|++|+|++|+|++..|.+|.++++|++|+|++|+++.++..     .|.++++|++|+|+
T Consensus        11 ~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~-----~~~~l~~L~~L~Ls   82 (549)
T 2z81_A           11 DGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD-----AFYSLGSLEHLDLS   82 (549)
T ss_dssp             ECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT-----TTTTCTTCCEEECT
T ss_pred             ECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh-----hccccccCCEEECC
Confidence            56788888 7887665  7999999999999998899999999999999999999977643     58999999999999


Q ss_pred             cCCCcccCChhhhhcccccccEEEccccccccc-CCccccCCCCCcEEEccCCc-cCCcCChhhhccCCCCEEEccCCcC
Q 005760           83 NNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGG-IPEEIGNLTNLTIIYLGGNK-LNGSIPSTLGKLQKLQGLGLENNKL  160 (678)
Q Consensus        83 ~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~L~~n~i  160 (678)
                      +|++++..+.. +..++ +|++|++++|.+++. .|..|.++++|++|++++|. +....+..|.++++|++|++++|.+
T Consensus        83 ~n~l~~~~~~~-~~~l~-~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l  160 (549)
T 2z81_A           83 DNHLSSLSSSW-FGPLS-SLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL  160 (549)
T ss_dssp             TSCCCSCCHHH-HTTCT-TCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCccCccCHHH-hccCC-CCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence            99998776554 77777 899999999999974 57789999999999999998 5544457899999999999999999


Q ss_pred             CCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceecccccccc
Q 005760          161 EGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTS  210 (678)
Q Consensus       161 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~  210 (678)
                      ++..|..+..+++|+.|++++|.+.......+..+++|+.|++++|+++.
T Consensus       161 ~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~  210 (549)
T 2z81_A          161 RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR  210 (549)
T ss_dssp             CEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTT
T ss_pred             cccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCcccc
Confidence            98888888887777777777776653322223446666666666666554

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.97  E-value=1.8e-29  Score=274.65  Aligned_cols=276  Identities=26%  Similarity=0.374  Sum_probs=226.1

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      |++++|++. .+|. +..+++|++|+|++|.+++..+  |.++++|++|++++|.+..++.       +.++++|++|++
T Consensus        51 L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-------~~~l~~L~~L~L  119 (466)
T 1o6v_A           51 LQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-------LANLTNLTGLTL  119 (466)
T ss_dssp             EECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-------GTTCTTCCEEEC
T ss_pred             EecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh-------hcCCCCCCEEEC
Confidence            678899998 5674 8889999999999999997654  9999999999999999987662       789999999999


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccCC-------------------ccccCCCCCcEEEccCCccCCcCCh
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIP-------------------EEIGNLTNLTIIYLGGNKLNGSIPS  142 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~-------------------~~~~~l~~L~~L~l~~N~l~~~~~~  142 (678)
                      ++|.+.+..+   +..++ +|++|++++|.+.+...                   ..+.++++|+.|++++|.+++.  .
T Consensus       120 ~~n~l~~~~~---~~~l~-~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~  193 (466)
T 1o6v_A          120 FNNQITDIDP---LKNLT-NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--S  193 (466)
T ss_dssp             CSSCCCCCGG---GTTCT-TCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--G
T ss_pred             CCCCCCCChH---HcCCC-CCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--h
Confidence            9999987743   66676 89999999999886421                   2366788999999999999854  4


Q ss_pred             hhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceecccccccccccccccccccc
Q 005760          143 TLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDIL  222 (678)
Q Consensus       143 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~  222 (678)
                      .+..+++|++|++++|.+++..|  +..+++|+.|++++|.+++.  ..+..+++|+.|++++|.++.++. +..+++|+
T Consensus       194 ~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~  268 (466)
T 1o6v_A          194 VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP-LSGLTKLT  268 (466)
T ss_dssp             GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCS
T ss_pred             hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh-hhcCCCCC
Confidence            58899999999999999996544  78899999999999999964  468899999999999999998876 88999999


Q ss_pred             EEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccc
Q 005760          223 YLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNF  302 (678)
Q Consensus       223 ~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l  302 (678)
                      .|++++|.+++..+  +..++          +|+.|+|++|++++..+  +..+++|+.|++++|++++..+ ...+..+
T Consensus       269 ~L~l~~n~l~~~~~--~~~l~----------~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L  333 (466)
T 1o6v_A          269 ELKLGANQISNISP--LAGLT----------ALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKL  333 (466)
T ss_dssp             EEECCSSCCCCCGG--GTTCT----------TCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTC
T ss_pred             EEECCCCccCcccc--ccCCC----------ccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccC
Confidence            99999999986654  44444          77777777777776544  6677777777777777776554 4556667


Q ss_pred             cccccccCcccc
Q 005760          303 SAESFEGNELLC  314 (678)
Q Consensus       303 ~~~~~~~n~~~c  314 (678)
                      +.+++.+|....
T Consensus       334 ~~L~l~~n~l~~  345 (466)
T 1o6v_A          334 QRLFFYNNKVSD  345 (466)
T ss_dssp             CEEECCSSCCCC
T ss_pred             CEeECCCCccCC
Confidence            777777765543

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.97  E-value=5.2e-30  Score=276.80  Aligned_cols=254  Identities=21%  Similarity=0.226  Sum_probs=229.4

Q ss_pred             CCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCC
Q 005760           46 NLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTN  125 (678)
Q Consensus        46 ~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~  125 (678)
                      ..+.++.+++.++.+|..+        .++++.|+|++|+|+.+.+.. +..++ +|++|+|++|++.+..+..|.++++
T Consensus        44 ~~~~v~c~~~~l~~iP~~~--------~~~l~~L~L~~n~i~~~~~~~-~~~l~-~L~~L~Ls~n~i~~i~~~~~~~l~~  113 (440)
T 3zyj_A           44 QFSKVICVRKNLREVPDGI--------STNTRLLNLHENQIQIIKVNS-FKHLR-HLEILQLSRNHIRTIEIGAFNGLAN  113 (440)
T ss_dssp             TSCEEECCSCCCSSCCSCC--------CTTCSEEECCSCCCCEECTTT-TSSCS-SCCEEECCSSCCCEECGGGGTTCSS
T ss_pred             CCCEEEeCCCCcCcCCCCC--------CCCCcEEEccCCcCCeeCHHH-hhCCC-CCCEEECCCCcCCccChhhccCCcc
Confidence            4678999999999988652        278999999999999887655 77787 8999999999999999999999999


Q ss_pred             CcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCC-CcCCCCChhhhhccccccceecc
Q 005760          126 LTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG-NKLSGSIPECFNNLASLRILLLG  204 (678)
Q Consensus       126 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~-N~i~~~~~~~~~~l~~L~~L~l~  204 (678)
                      |++|+|++|+++.+.+..|.++++|++|+|++|.|+...+..|..+++|++|++++ |.+....+..|.++++|+.|+|+
T Consensus       114 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~  193 (440)
T 3zyj_A          114 LNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA  193 (440)
T ss_dssp             CCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECT
T ss_pred             CCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCC
Confidence            99999999999977778899999999999999999977777899999999999999 45665566689999999999999


Q ss_pred             ccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceec
Q 005760          205 SNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNL  284 (678)
Q Consensus       205 ~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  284 (678)
                      +|.|+.+| .+..+++|+.|+|++|++++..+..|.+++          +|+.|+|++|+|++..+..|..+++|+.|+|
T Consensus       194 ~n~l~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~----------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  262 (440)
T 3zyj_A          194 MCNLREIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLM----------HLQKLWMIQSQIQVIERNAFDNLQSLVEINL  262 (440)
T ss_dssp             TSCCSSCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCT----------TCCEEECTTCCCCEECTTSSTTCTTCCEEEC
T ss_pred             CCcCcccc-ccCCCcccCEEECCCCccCccChhhhccCc----------cCCEEECCCCceeEEChhhhcCCCCCCEEEC
Confidence            99999998 588999999999999999988898888877          9999999999999999999999999999999


Q ss_pred             ccccccccCCCC-CccccccccccccCccccCCCCCC
Q 005760          285 SFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSPNLR  320 (678)
Q Consensus       285 ~~N~~~~~~~~~-~~~~~l~~~~~~~n~~~c~~~~~~  320 (678)
                      ++|+++...+.. ..+..++.+++.+|||.|+|...|
T Consensus       263 ~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l~~  299 (440)
T 3zyj_A          263 AHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILW  299 (440)
T ss_dssp             TTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTTHH
T ss_pred             CCCCCCccChhHhccccCCCEEEcCCCCccCCCCchH
Confidence            999999877664 667899999999999999998544

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.97  E-value=8.4e-30  Score=276.14  Aligned_cols=254  Identities=22%  Similarity=0.226  Sum_probs=229.2

Q ss_pred             CCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCC
Q 005760           46 NLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTN  125 (678)
Q Consensus        46 ~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~  125 (678)
                      ....++.+++.++.+|..+        .++|++|+|++|+|+++.+.. +..++ +|++|+|++|++++..+..|.++++
T Consensus        55 ~~~~v~c~~~~l~~iP~~~--------~~~l~~L~L~~n~i~~~~~~~-~~~l~-~L~~L~Ls~n~i~~~~~~~~~~l~~  124 (452)
T 3zyi_A           55 QFSKVVCTRRGLSEVPQGI--------PSNTRYLNLMENNIQMIQADT-FRHLH-HLEVLQLGRNSIRQIEVGAFNGLAS  124 (452)
T ss_dssp             SSCEEECCSSCCSSCCSCC--------CTTCSEEECCSSCCCEECTTT-TTTCT-TCCEEECCSSCCCEECTTTTTTCTT
T ss_pred             CCcEEEECCCCcCccCCCC--------CCCccEEECcCCcCceECHHH-cCCCC-CCCEEECCCCccCCcChhhccCccc
Confidence            4678999999999888542        268999999999999887765 77787 8999999999999999999999999


Q ss_pred             CcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCC-CcCCCCChhhhhccccccceecc
Q 005760          126 LTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG-NKLSGSIPECFNNLASLRILLLG  204 (678)
Q Consensus       126 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~-N~i~~~~~~~~~~l~~L~~L~l~  204 (678)
                      |++|+|++|+++...+..|.++++|++|+|++|.|+...+..|..+++|+.|++++ |.+....+..|.++++|+.|+|+
T Consensus       125 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~  204 (452)
T 3zyi_A          125 LNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG  204 (452)
T ss_dssp             CCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECT
T ss_pred             CCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECC
Confidence            99999999999988888899999999999999999977777899999999999999 55665556679999999999999


Q ss_pred             ccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceec
Q 005760          205 SNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNL  284 (678)
Q Consensus       205 ~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  284 (678)
                      +|.|+.+| .+..+++|+.|+|++|.+++..|..|.+++          +|+.|+|++|++++..+..|..+++|+.|+|
T Consensus       205 ~n~l~~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~----------~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  273 (452)
T 3zyi_A          205 MCNIKDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLS----------SLKKLWVMNSQVSLIERNAFDGLASLVELNL  273 (452)
T ss_dssp             TSCCSSCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCT----------TCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCcccccc-cccccccccEEECcCCcCcccCcccccCcc----------CCCEEEeCCCcCceECHHHhcCCCCCCEEEC
Confidence            99999997 588899999999999999998898888877          9999999999999999999999999999999


Q ss_pred             ccccccccCCCC-CccccccccccccCccccCCCCCC
Q 005760          285 SFNKLEGEIPRG-GSFGNFSAESFEGNELLCGSPNLR  320 (678)
Q Consensus       285 ~~N~~~~~~~~~-~~~~~l~~~~~~~n~~~c~~~~~~  320 (678)
                      ++|+++..++.. ..+..+..+++.+|||.|+|...|
T Consensus       274 ~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~~~  310 (452)
T 3zyi_A          274 AHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILW  310 (452)
T ss_dssp             CSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTTHH
T ss_pred             CCCcCCccChHHhccccCCCEEEccCCCcCCCCCchH
Confidence            999999777654 567889999999999999998554

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.97  E-value=3.8e-29  Score=270.16  Aligned_cols=280  Identities=19%  Similarity=0.168  Sum_probs=214.1

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      .|++++|++++ +| .+..+++|++|+|++|+|+++ +  |+.+++|++|++++|.++.++        +.++++|++|+
T Consensus        46 ~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~~--------~~~l~~L~~L~  112 (457)
T 3bz5_A           46 SLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNLD--------VTPLTKLTYLN  112 (457)
T ss_dssp             EEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCCC--------CTTCTTCCEEE
T ss_pred             EEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCceee--------cCCCCcCCEEE
Confidence            37899999995 46 689999999999999999975 3  899999999999999998763        67899999999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcC
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKL  160 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i  160 (678)
                      +++|+++++ +   +..++ +|++|++++|++++. +  ++.+++|++|++++|+..+..  .+..+++|++|++++|++
T Consensus       113 L~~N~l~~l-~---~~~l~-~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l  182 (457)
T 3bz5_A          113 CDTNKLTKL-D---VSQNP-LLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKI  182 (457)
T ss_dssp             CCSSCCSCC-C---CTTCT-TCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCC
T ss_pred             CCCCcCCee-c---CCCCC-cCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcc
Confidence            999999875 3   56666 899999999999985 3  788999999999999554444  478889999999999999


Q ss_pred             CCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCcccc
Q 005760          161 EGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIG  240 (678)
Q Consensus       161 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  240 (678)
                      ++ +|  +..+++|+.|++++|.+++.   .+..+++|+.|++++|+++.+|  +..+++|+.|++++|++++..+..+.
T Consensus       183 ~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~~~~~~l~  254 (457)
T 3bz5_A          183 TE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTELDVSTLS  254 (457)
T ss_dssp             CC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSCCCCTTCT
T ss_pred             ce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCCcCHHHCC
Confidence            95 44  78889999999999999965   3888899999999999999987  78889999999999999987766666


Q ss_pred             ccccc-------------------cccccCcccccEEEccCCcCCCcchH--------HHhcccCCCceecccccccccC
Q 005760          241 NLKIA-------------------RIDSCDLISLISLNLSNNNLSGAIPA--------SLEKLSYLKDLNLSFNKLEGEI  293 (678)
Q Consensus       241 ~l~~~-------------------~~~~~~~~~L~~L~L~~N~l~~~~~~--------~~~~l~~L~~L~l~~N~~~~~~  293 (678)
                      .++..                   .++.+.+++|+.|+|++|...+..|.        .+..+++|+.|++++|.+++. 
T Consensus       255 ~L~~L~l~~n~L~~L~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-  333 (457)
T 3bz5_A          255 KLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-  333 (457)
T ss_dssp             TCCEEECTTCCCSCCCCTTCTTCCEEECTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-
T ss_pred             CCCEEeccCCCCCEEECCCCccCCcccccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-
Confidence            55421                   12223445666666666654433332        133445666666666666653 


Q ss_pred             CCCCccccccccccccCccc
Q 005760          294 PRGGSFGNFSAESFEGNELL  313 (678)
Q Consensus       294 ~~~~~~~~l~~~~~~~n~~~  313 (678)
                       ....++.++.+++.+|...
T Consensus       334 -~l~~l~~L~~L~l~~N~l~  352 (457)
T 3bz5_A          334 -DVSHNTKLKSLSCVNAHIQ  352 (457)
T ss_dssp             -CCTTCTTCSEEECCSSCCC
T ss_pred             -ccccCCcCcEEECCCCCCC
Confidence             2445556666666666543

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=4.8e-31  Score=271.84  Aligned_cols=262  Identities=21%  Similarity=0.224  Sum_probs=216.9

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      ++++.+++....+..+..+++|++|+|++|+|++..|++|.++++|++|+|++|.+...+       .|..+++|++|+|
T Consensus        15 ~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-------~~~~l~~L~~L~L   87 (317)
T 3o53_A           15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL-------DLESLSTLRTLDL   87 (317)
T ss_dssp             ESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEE-------EETTCTTCCEEEC
T ss_pred             eeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcch-------hhhhcCCCCEEEC
Confidence            466777777555565666789999999999999888889999999999999999997544       2788999999999


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCC
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLE  161 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~  161 (678)
                      ++|+++++.+.       .+|++|++++|++++..+..   +++|++|++++|++++..+..|..+++|++|+|++|.++
T Consensus        88 s~n~l~~l~~~-------~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  157 (317)
T 3o53_A           88 NNNYVQELLVG-------PSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID  157 (317)
T ss_dssp             CSSEEEEEEEC-------TTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCC
T ss_pred             cCCccccccCC-------CCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCC
Confidence            99999865432       38999999999998776543   678999999999999877778999999999999999998


Q ss_pred             CCCCCccc-CCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCcccc
Q 005760          162 GSIPDSIC-HSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIG  240 (678)
Q Consensus       162 ~~~~~~~~-~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  240 (678)
                      +..+..+. .+++|++|+|++|.+++. + ....+++|++|+|++|+|+.+|..+..+++|+.|+|++|+++ .+|..+.
T Consensus       158 ~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~  234 (317)
T 3o53_A          158 TVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALR  234 (317)
T ss_dssp             EEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCC
T ss_pred             cccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhh
Confidence            76666664 789999999999999855 3 234588999999999999999888999999999999999998 4565666


Q ss_pred             ccccccccccCcccccEEEccCCcCC-CcchHHHhcccCCCceeccccc-ccccC
Q 005760          241 NLKIARIDSCDLISLISLNLSNNNLS-GAIPASLEKLSYLKDLNLSFNK-LEGEI  293 (678)
Q Consensus       241 ~l~~~~~~~~~~~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~-~~~~~  293 (678)
                      .++          +|+.|+|++|+++ +..+..+..+++|+.|++++|+ +++..
T Consensus       235 ~l~----------~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~  279 (317)
T 3o53_A          235 FSQ----------NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN  279 (317)
T ss_dssp             CCT----------TCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSS
T ss_pred             cCC----------CCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCc
Confidence            655          9999999999998 7788888999999999998554 45433

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=4.6e-31  Score=287.68  Aligned_cols=244  Identities=21%  Similarity=0.225  Sum_probs=177.5

Q ss_pred             cCCccccCCC----CCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCc
Q 005760           12 TIPRFIFNAS----KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLD   87 (678)
Q Consensus        12 ~~p~~~~~l~----~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~   87 (678)
                      .+|..+..+.    +|++|+|++|.|++..|++|.++++|++|+|++|.++..+       .|..+++|++|+|++|.++
T Consensus        21 ~l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-------~l~~l~~L~~L~Ls~N~l~   93 (487)
T 3oja_A           21 SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL-------DLESLSTLRTLDLNNNYVQ   93 (487)
T ss_dssp             THHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEE-------ECTTCTTCCEEECCSSEEE
T ss_pred             hhHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCc-------ccccCCCCCEEEecCCcCC
Confidence            3445555544    8999999999999888889999999999999999887544       2778889999999999887


Q ss_pred             ccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCc
Q 005760           88 GILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDS  167 (678)
Q Consensus        88 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~  167 (678)
                      ++.+.       .+|++|++++|.+++..+.   .+++|+.|+|++|.+++..|..|+.+++|++|+|++|.|++..|..
T Consensus        94 ~l~~~-------~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  163 (487)
T 3oja_A           94 ELLVG-------PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE  163 (487)
T ss_dssp             EEEEC-------TTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGG
T ss_pred             CCCCC-------CCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHH
Confidence            65432       2788888888888766543   3567778888888887776777777777888888888777666666


Q ss_pred             cc-CCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCcccccccccc
Q 005760          168 IC-HSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIAR  246 (678)
Q Consensus       168 ~~-~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~  246 (678)
                      +. .+++|++|+|++|.|++..  .+..+++|+.|+|++|.|+.+|..+..+++|+.|+|++|.+++ +|..+..++   
T Consensus       164 l~~~l~~L~~L~Ls~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~---  237 (487)
T 3oja_A          164 LAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQ---  237 (487)
T ss_dssp             GGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCT---
T ss_pred             HhhhCCcccEEecCCCcccccc--ccccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCC---
Confidence            65 6777777777777777542  2335777777777777777777777777777777777777774 444454444   


Q ss_pred             ccccCcccccEEEccCCcCC-CcchHHHhcccCCCceecc
Q 005760          247 IDSCDLISLISLNLSNNNLS-GAIPASLEKLSYLKDLNLS  285 (678)
Q Consensus       247 ~~~~~~~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~  285 (678)
                             +|+.|+|++|.++ +..|..+..++.|+.++++
T Consensus       238 -------~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          238 -------NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             -------TCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             -------CCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence                   7777777777776 5556666666666666665

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=2.1e-29  Score=255.56  Aligned_cols=252  Identities=22%  Similarity=0.279  Sum_probs=185.0

Q ss_pred             CEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccccccc
Q 005760           24 SILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLE  103 (678)
Q Consensus        24 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~  103 (678)
                      +.++++++.++. +|..+  .++|++|+|++|.++.++..     .|..+++|++|+|++|.++++.+.. +..++ +|+
T Consensus        14 ~~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~-----~~~~~~~L~~L~l~~n~l~~~~~~~-~~~l~-~L~   83 (285)
T 1ozn_A           14 VTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAA-----SFRACRNLTILWLHSNVLARIDAAA-FTGLA-LLE   83 (285)
T ss_dssp             CEEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTT-----TTTTCTTCCEEECCSSCCCEECTTT-TTTCT-TCC
T ss_pred             eEEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHH-----HcccCCCCCEEECCCCccceeCHhh-cCCcc-CCC
Confidence            566677776663 34333  35677777777777665533     3666677777777777776655543 55555 677


Q ss_pred             EEEccccc-ccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCC
Q 005760          104 YFEMAYCN-VSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGN  182 (678)
Q Consensus       104 ~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N  182 (678)
                      +|++++|. +....+..|..+++|++|++++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|++++|
T Consensus        84 ~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  163 (285)
T 1ozn_A           84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN  163 (285)
T ss_dssp             EEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCC
Confidence            77777776 66666777888888888888888888777788888888888888888888666667888888888888888


Q ss_pred             cCCCCChhhhhccccccceeccccccccc-cccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEcc
Q 005760          183 KLSGSIPECFNNLASLRILLLGSNELTSI-PLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLS  261 (678)
Q Consensus       183 ~i~~~~~~~~~~l~~L~~L~l~~N~l~~l-~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~  261 (678)
                      .+++..+..|..+++|+.|+|++|.++.+ |..+..+++|+.|++++|.+++..+..+..++          +|+.|+|+
T Consensus       164 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~----------~L~~L~l~  233 (285)
T 1ozn_A          164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR----------ALQYLRLN  233 (285)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCT----------TCCEEECC
T ss_pred             cccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCc----------ccCEEecc
Confidence            88877677788888888888888888877 55788888888888888888876666676666          88999999


Q ss_pred             CCcCCCcchHHHhcccCCCceecccccccccCCCC
Q 005760          262 NNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG  296 (678)
Q Consensus       262 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  296 (678)
                      +|+++...+. ..-+..++.+..+.|.+.|..|..
T Consensus       234 ~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~  267 (285)
T 1ozn_A          234 DNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQR  267 (285)
T ss_dssp             SSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGG
T ss_pred             CCCccCCCCc-HHHHHHHHhcccccCccccCCchH
Confidence            9988743332 112234556667888888887764

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=4.2e-29  Score=256.23  Aligned_cols=251  Identities=20%  Similarity=0.262  Sum_probs=221.5

Q ss_pred             CCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEccccccccc--CCccccCCC
Q 005760           47 LQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGG--IPEEIGNLT  124 (678)
Q Consensus        47 L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~--~~~~~~~l~  124 (678)
                      -+.++++++.++.+|...        .++|++|+|++|+++.+. ...+..++ +|++|+|++|.++..  .+..+..++
T Consensus         9 ~~~l~c~~~~l~~ip~~~--------~~~l~~L~L~~n~l~~i~-~~~~~~l~-~L~~L~L~~n~l~~~~~~~~~~~~~~   78 (306)
T 2z66_A            9 GTEIRCNSKGLTSVPTGI--------PSSATRLELESNKLQSLP-HGVFDKLT-QLTKLSLSSNGLSFKGCCSQSDFGTT   78 (306)
T ss_dssp             TTEEECCSSCCSSCCSCC--------CTTCCEEECCSSCCCCCC-TTTTTTCT-TCSEEECCSSCCCEEEEEEHHHHSCS
T ss_pred             CCEEEcCCCCcccCCCCC--------CCCCCEEECCCCccCccC-HhHhhccc-cCCEEECCCCccCcccCccccccccc
Confidence            368999999999888542        268999999999998554 44467777 899999999999844  367788899


Q ss_pred             CCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCC-CcccCCCCccEEecCCCcCCCCChhhhhccccccceec
Q 005760          125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIP-DSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLL  203 (678)
Q Consensus       125 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l  203 (678)
                      +|++|+|++|.+. .+|..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.+..+..+..+++|++|+|
T Consensus        79 ~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  157 (306)
T 2z66_A           79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM  157 (306)
T ss_dssp             CCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEEC
T ss_pred             ccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEEC
Confidence            9999999999998 567779999999999999999996554 58999999999999999999888999999999999999


Q ss_pred             ccccccc--ccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCc
Q 005760          204 GSNELTS--IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKD  281 (678)
Q Consensus       204 ~~N~l~~--l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  281 (678)
                      ++|.++.  +|..+..+++|+.|++++|.+++..|..|.+++          +|+.|+|++|++++..+..+..+++|+.
T Consensus       158 ~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~----------~L~~L~L~~N~l~~~~~~~~~~l~~L~~  227 (306)
T 2z66_A          158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS----------SLQVLNMSHNNFFSLDTFPYKCLNSLQV  227 (306)
T ss_dssp             TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT----------TCCEEECTTSCCSBCCSGGGTTCTTCCE
T ss_pred             CCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCC----------CCCEEECCCCccCccChhhccCcccCCE
Confidence            9999986  688899999999999999999988888887777          9999999999999888888999999999


Q ss_pred             eecccccccccCCCC-Ccc-ccccccccccCccccCCCC
Q 005760          282 LNLSFNKLEGEIPRG-GSF-GNFSAESFEGNELLCGSPN  318 (678)
Q Consensus       282 L~l~~N~~~~~~~~~-~~~-~~l~~~~~~~n~~~c~~~~  318 (678)
                      |++++|++++..+.. ..+ ..+..+++.+|++.|+|+.
T Consensus       228 L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~  266 (306)
T 2z66_A          228 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH  266 (306)
T ss_dssp             EECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGG
T ss_pred             eECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccCh
Confidence            999999999877654 455 4899999999999999874

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.96  E-value=6.5e-30  Score=278.64  Aligned_cols=247  Identities=20%  Similarity=0.143  Sum_probs=209.1

Q ss_pred             cCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCcccc
Q 005760           42 GNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG  121 (678)
Q Consensus        42 ~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~  121 (678)
                      ...++|+.|+|++|.++.+++.     .|..+++|++|+|++|.+++..+   +..++ +|++|+|++|.+++..     
T Consensus        31 ~~~~~L~~L~Ls~n~l~~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~~---l~~l~-~L~~L~Ls~N~l~~l~-----   96 (487)
T 3oja_A           31 QSAWNVKELDLSGNPLSQISAA-----DLAPFTKLELLNLSSNVLYETLD---LESLS-TLRTLDLNNNYVQELL-----   96 (487)
T ss_dssp             TTGGGCCEEECCSSCCCCCCGG-----GGTTCTTCCEEECTTSCCEEEEE---CTTCT-TCCEEECCSSEEEEEE-----
T ss_pred             ccCCCccEEEeeCCcCCCCCHH-----HHhCCCCCCEEEeeCCCCCCCcc---cccCC-CCCEEEecCCcCCCCC-----
Confidence            3445999999999999987754     58999999999999999987765   66666 8999999999998654     


Q ss_pred             CCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhh-ccccccc
Q 005760          122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFN-NLASLRI  200 (678)
Q Consensus       122 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~-~l~~L~~  200 (678)
                      ..++|+.|++++|.+++..+.   .+++|++|+|++|.+++..|..+..+++|++|+|++|.+++..|..+. .+++|+.
T Consensus        97 ~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~  173 (487)
T 3oja_A           97 VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH  173 (487)
T ss_dssp             ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCE
T ss_pred             CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccE
Confidence            348999999999999976554   458999999999999988888999999999999999999988888886 7999999


Q ss_pred             eeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCC
Q 005760          201 LLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLK  280 (678)
Q Consensus       201 L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~  280 (678)
                      |+|++|.|+.++.. ..+++|+.|+|++|.+++..+. +..++          +|+.|+|++|+|++ +|..+..+++|+
T Consensus       174 L~Ls~N~l~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~l~----------~L~~L~Ls~N~l~~-lp~~l~~l~~L~  240 (487)
T 3oja_A          174 LNLQYNFIYDVKGQ-VVFAKLKTLDLSSNKLAFMGPE-FQSAA----------GVTWISLRNNKLVL-IEKALRFSQNLE  240 (487)
T ss_dssp             EECTTSCCCEEECC-CCCTTCCEEECCSSCCCEECGG-GGGGT----------TCSEEECTTSCCCE-ECTTCCCCTTCC
T ss_pred             EecCCCcccccccc-ccCCCCCEEECCCCCCCCCCHh-HcCCC----------CccEEEecCCcCcc-cchhhccCCCCC
Confidence            99999999998653 4589999999999999975554 66666          99999999999995 677788999999


Q ss_pred             ceecccccccccCCC--CCccccccccccc-------cCccccCCCC
Q 005760          281 DLNLSFNKLEGEIPR--GGSFGNFSAESFE-------GNELLCGSPN  318 (678)
Q Consensus       281 ~L~l~~N~~~~~~~~--~~~~~~l~~~~~~-------~n~~~c~~~~  318 (678)
                      .|++++|++.|....  ...++.+..+++.       ++++.|.++.
T Consensus       241 ~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~~~~~~~~~~~~c~~~~  287 (487)
T 3oja_A          241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT  287 (487)
T ss_dssp             EEECTTCCBCHHHHHHHHTTCHHHHHHHHHHHHHHTSSSSCCCSSTT
T ss_pred             EEEcCCCCCcCcchHHHHHhCCCCcEEeccccccccCCCcccccCCc
Confidence            999999999965432  2455666666665       7888888764

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=4.4e-28  Score=250.54  Aligned_cols=234  Identities=21%  Similarity=0.259  Sum_probs=136.1

Q ss_pred             CCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccc
Q 005760           20 ASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLS   99 (678)
Q Consensus        20 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~   99 (678)
                      ..+++.|+|++|+++ .+|..+.++++|++|+|++|.+..++.      .|.++++|++|+|++|+++ ..|.. +..++
T Consensus        80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~~lp~------~~~~l~~L~~L~Ls~n~l~-~lp~~-l~~l~  150 (328)
T 4fcg_A           80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPD------TMQQFAGLETLTLARNPLR-ALPAS-IASLN  150 (328)
T ss_dssp             STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCCCCCS------CGGGGTTCSEEEEESCCCC-CCCGG-GGGCT
T ss_pred             ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCccchhH------HHhccCCCCEEECCCCccc-cCcHH-HhcCc
Confidence            467888888888888 567777778888888888888875553      3677788888888888776 33433 44554


Q ss_pred             ccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEec
Q 005760          100 HSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL  179 (678)
Q Consensus       100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l  179 (678)
                       +|++|+|++|++.+.+|..+...               ..++.|.++++|++|+|++|.++ .+|..+..+++|++|+|
T Consensus       151 -~L~~L~L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L  213 (328)
T 4fcg_A          151 -RLRELSIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI  213 (328)
T ss_dssp             -TCCEEEEEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEE
T ss_pred             -CCCEEECCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEc
Confidence             56666666666655555544320               00011223455555555555555 44444555555555555


Q ss_pred             CCCcCCCCChhhhhccccccceeccccccc-cccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEE
Q 005760          180 GGNKLSGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISL  258 (678)
Q Consensus       180 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L  258 (678)
                      ++|.+++ +|..+..+++|+.|+|++|.+. .+|..+..+++|+.|+|++|++.+..|..+.+++          +|+.|
T Consensus       214 ~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~----------~L~~L  282 (328)
T 4fcg_A          214 RNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT----------QLEKL  282 (328)
T ss_dssp             ESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCT----------TCCEE
T ss_pred             cCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCC----------CCCEE
Confidence            5555552 3334555555555555554433 3344555555555555555555555555555444          66666


Q ss_pred             EccCCcCCCcchHHHhcccCCCceeccccccc
Q 005760          259 NLSNNNLSGAIPASLEKLSYLKDLNLSFNKLE  290 (678)
Q Consensus       259 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  290 (678)
                      +|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus       283 ~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          283 DLRGCVNLSRLPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             ECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred             eCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence            66666655566666666666666666555443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=6.9e-28  Score=249.05  Aligned_cols=230  Identities=22%  Similarity=0.315  Sum_probs=167.9

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      .|+|++|+++ .+|..++.+++|++|+|++|.++ .+|..|+++++|++|+|++|.++.++.      .|.++++|++|+
T Consensus        85 ~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~------~l~~l~~L~~L~  156 (328)
T 4fcg_A           85 ALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPA------SIASLNRLRELS  156 (328)
T ss_dssp             EEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCG------GGGGCTTCCEEE
T ss_pred             EEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCcH------HHhcCcCCCEEE
Confidence            3789999999 88999999999999999999999 889999999999999999999997653      478999999999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcC
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKL  160 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i  160 (678)
                      |++|++.+..|.. +..       .         ..+..|.++++|++|+|++|+++ .+|..+..+++|++|+|++|.+
T Consensus       157 L~~n~~~~~~p~~-~~~-------~---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l  218 (328)
T 4fcg_A          157 IRACPELTELPEP-LAS-------T---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL  218 (328)
T ss_dssp             EEEETTCCCCCSC-SEE-------E---------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCC
T ss_pred             CCCCCCccccChh-Hhh-------c---------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCC
Confidence            9999888777754 221       1         11233556666666666666666 5566666666666666666666


Q ss_pred             CCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccc-cccccccccccccEEEecCCcccCCCCccc
Q 005760          161 EGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEI  239 (678)
Q Consensus       161 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~  239 (678)
                      + .+|..+..+++|++|++++|.+.+.+|..+..+++|+.|+|++|.+. .+|..+..+++|+.|+|++|++.+.+|..+
T Consensus       219 ~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l  297 (328)
T 4fcg_A          219 S-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI  297 (328)
T ss_dssp             C-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGG
T ss_pred             C-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHH
Confidence            6 34455666666666666666666666666666666666666665433 456666666677777777766666666666


Q ss_pred             cccccccccccCcccccEEEccCCcCCC
Q 005760          240 GNLKIARIDSCDLISLISLNLSNNNLSG  267 (678)
Q Consensus       240 ~~l~~~~~~~~~~~~L~~L~L~~N~l~~  267 (678)
                      ..++          +|+.+++..|.+..
T Consensus       298 ~~L~----------~L~~l~l~~~~~~~  315 (328)
T 4fcg_A          298 AQLP----------ANCIILVPPHLQAQ  315 (328)
T ss_dssp             GGSC----------TTCEEECCGGGSCC
T ss_pred             hhcc----------CceEEeCCHHHHHH
Confidence            6665          67777766666553

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.95  E-value=2e-27  Score=256.71  Aligned_cols=262  Identities=20%  Similarity=0.203  Sum_probs=221.4

Q ss_pred             cCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCc
Q 005760            8 NFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLD   87 (678)
Q Consensus         8 ~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~   87 (678)
                      +.....+..+..+++|++|+|++|.|++. | .|..+++|++|+|++|.++.++        +..+++|++|++++|+++
T Consensus        29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~~--------~~~l~~L~~L~Ls~N~l~   98 (457)
T 3bz5_A           29 EMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTLD--------LSQNTNLTYLACDSNKLT   98 (457)
T ss_dssp             TCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCCC--------CTTCTTCSEEECCSSCCS
T ss_pred             CcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeEc--------cccCCCCCEEECcCCCCc
Confidence            34445566788899999999999999975 5 7999999999999999999864        678999999999999998


Q ss_pred             ccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCc
Q 005760           88 GILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDS  167 (678)
Q Consensus        88 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~  167 (678)
                      ++ +   +..++ +|++|++++|++++. +  ++.+++|++|++++|++++. +  ++.+++|++|++++|...+.+  .
T Consensus        99 ~~-~---~~~l~-~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~  165 (457)
T 3bz5_A           99 NL-D---VTPLT-KLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--D  165 (457)
T ss_dssp             CC-C---CTTCT-TCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--C
T ss_pred             ee-e---cCCCC-cCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--c
Confidence            76 2   66676 899999999999985 4  89999999999999999964 3  889999999999999655455  5


Q ss_pred             ccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccc
Q 005760          168 ICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARI  247 (678)
Q Consensus       168 ~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~  247 (678)
                      +..+++|+.|++++|.+++. |  +..+++|+.|++++|+++.++  +..+++|+.|++++|++++ +|  +..++    
T Consensus       166 ~~~l~~L~~L~ls~n~l~~l-~--l~~l~~L~~L~l~~N~l~~~~--l~~l~~L~~L~Ls~N~l~~-ip--~~~l~----  233 (457)
T 3bz5_A          166 VTPQTQLTTLDCSFNKITEL-D--VSQNKLLNRLNCDTNNITKLD--LNQNIQLTFLDCSSNKLTE-ID--VTPLT----  233 (457)
T ss_dssp             CTTCTTCCEEECCSSCCCCC-C--CTTCTTCCEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSC-CC--CTTCT----
T ss_pred             cccCCcCCEEECCCCcccee-c--cccCCCCCEEECcCCcCCeec--cccCCCCCEEECcCCcccc-cC--ccccC----
Confidence            88899999999999999974 4  889999999999999999884  8889999999999999997 34  55555    


Q ss_pred             cccCcccccEEEccCCcCCCcchHHHhccc-------CCCceecccccccccCCCCCccccccccccccCc
Q 005760          248 DSCDLISLISLNLSNNNLSGAIPASLEKLS-------YLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNE  311 (678)
Q Consensus       248 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~-------~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~  311 (678)
                            +|+.|++++|++++..+..+..+.       +|+.|++++|++.+..|. ..+..++.+++.+|+
T Consensus       234 ------~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~~-~~l~~L~~L~Ls~n~  297 (457)
T 3bz5_A          234 ------QLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQA-EGCRKIKELDVTHNT  297 (457)
T ss_dssp             ------TCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEEC-TTCTTCCCCCCTTCT
T ss_pred             ------CCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCcccc-cccccCCEEECCCCc
Confidence                  999999999999987665555554       567777777777766663 456788888888876

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=2.6e-29  Score=258.87  Aligned_cols=260  Identities=19%  Similarity=0.144  Sum_probs=219.1

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccc
Q 005760           21 SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSH  100 (678)
Q Consensus        21 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~  100 (678)
                      .+++.++++.+.+.......+..+++|++|+|++|.++.++..     .|.++++|++|+|++|.+++..+   +..++ 
T Consensus        10 ~~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~Ls~n~l~~~~~---~~~l~-   80 (317)
T 3o53_A           10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA-----DLAPFTKLELLNLSSNVLYETLD---LESLS-   80 (317)
T ss_dssp             TEEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHH-----HHTTCTTCCEEECTTSCCEEEEE---ETTCT-
T ss_pred             CceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHH-----HhhCCCcCCEEECCCCcCCcchh---hhhcC-
Confidence            4577788899999877778888899999999999999987754     58899999999999999987654   56666 


Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      +|++|++++|++++..     ..++|++|++++|++++..+..   +++|++|++++|++++..+..+..+++|++|+++
T Consensus        81 ~L~~L~Ls~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls  152 (317)
T 3o53_A           81 TLRTLDLNNNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLK  152 (317)
T ss_dssp             TCCEEECCSSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECT
T ss_pred             CCCEEECcCCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECC
Confidence            8999999999998643     4599999999999998665543   6889999999999997778889999999999999


Q ss_pred             CCcCCCCChhhh-hccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEE
Q 005760          181 GNKLSGSIPECF-NNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLN  259 (678)
Q Consensus       181 ~N~i~~~~~~~~-~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~  259 (678)
                      +|.+++..+..+ ..+++|++|+|++|.|+.++.. ..+++|+.|+|++|++++..+ .+..++          +|+.|+
T Consensus       153 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~l~~L~~L~Ls~N~l~~l~~-~~~~l~----------~L~~L~  220 (317)
T 3o53_A          153 LNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ-VVFAKLKTLDLSSNKLAFMGP-EFQSAA----------GVTWIS  220 (317)
T ss_dssp             TSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECC-CCCTTCCEEECCSSCCCEECG-GGGGGT----------TCSEEE
T ss_pred             CCCCCcccHHHHhhccCcCCEEECCCCcCcccccc-cccccCCEEECCCCcCCcchh-hhcccC----------cccEEE
Confidence            999998777777 4789999999999999998653 358999999999999996544 466666          999999


Q ss_pred             ccCCcCCCcchHHHhcccCCCceecccccccccCCCC--CccccccccccccC
Q 005760          260 LSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG--GSFGNFSAESFEGN  310 (678)
Q Consensus       260 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~--~~~~~l~~~~~~~n  310 (678)
                      |++|+|+ .+|..+..+++|+.|++++|++.|.....  ..++.+..+++.++
T Consensus       221 L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~  272 (317)
T 3o53_A          221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV  272 (317)
T ss_dssp             CTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHH
T ss_pred             CcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCc
Confidence            9999999 56777899999999999999999654332  45566777776643

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=8.4e-30  Score=261.92  Aligned_cols=197  Identities=21%  Similarity=0.249  Sum_probs=85.4

Q ss_pred             cccEEEcccccccccCCccc--cCCCCCcEEEccCCccCCcCChhhhcc-----CCCCEEEccCCcCCCCCCCcccCCCC
Q 005760          101 SLEYFEMAYCNVSGGIPEEI--GNLTNLTIIYLGGNKLNGSIPSTLGKL-----QKLQGLGLENNKLEGSIPDSICHSDE  173 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~l~~N~l~~~~~~~~~~l-----~~L~~L~L~~n~i~~~~~~~~~~l~~  173 (678)
                      +|++|+|++|++++..|..+  ..+++|++|+|++|++++. |..+..+     ++|++|+|++|+|++..|..|..+++
T Consensus        96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~  174 (312)
T 1wwl_A           96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA  174 (312)
T ss_dssp             CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred             CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence            44444444444444444433  4444444444444444433 4444443     44444444444444444444444444


Q ss_pred             ccEEecCCCcCCCC--Chhhh--hccccccceecccccccccc---c-cccccccccEEEecCCcccCCCC-cccccccc
Q 005760          174 LYKLELGGNKLSGS--IPECF--NNLASLRILLLGSNELTSIP---L-TFWNLKDILYLNFSSNFFTGPLP-LEIGNLKI  244 (678)
Q Consensus       174 L~~L~l~~N~i~~~--~~~~~--~~l~~L~~L~l~~N~l~~l~---~-~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~  244 (678)
                      |++|++++|.+.+.  .+..+  ..+++|++|+|++|+|+.++   . .+..+++|+.|+|++|++++..| ..+..++ 
T Consensus       175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~-  253 (312)
T 1wwl_A          175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS-  253 (312)
T ss_dssp             CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT-
T ss_pred             CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC-
Confidence            44444444444322  11222  44444444444444444222   1 12334444444554444444332 1222222 


Q ss_pred             ccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccCcc
Q 005760          245 ARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL  312 (678)
Q Consensus       245 ~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~  312 (678)
                               +|+.|+|++|+|+ .+|..+.  ++|+.|++++|++++. |....++.++.+++.+|++
T Consensus       254 ---------~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l  308 (312)
T 1wwl_A          254 ---------QLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPF  308 (312)
T ss_dssp             ---------TCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTT
T ss_pred             ---------CCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCC
Confidence                     4444455444444 2232222  3444444444444443 2234444444444444443

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=6.6e-29  Score=255.24  Aligned_cols=255  Identities=16%  Similarity=0.152  Sum_probs=205.4

Q ss_pred             cccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhc---ccccCCCCCcEEECccCCCcccCCh
Q 005760           16 FIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFL---SSLSNCKSLTLISFSNNPLDGILPK   92 (678)
Q Consensus        16 ~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~---~~~~~l~~L~~L~L~~n~i~~~~~~   92 (678)
                      .+...++|++|++++|.+  .+|..+...  |+.|+|++|.+..........   -.+.++++|++|+|++|++++..|.
T Consensus        38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  113 (312)
T 1wwl_A           38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP  113 (312)
T ss_dssp             EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred             EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence            345577899999999999  567766654  999999999996543221000   0122689999999999999988887


Q ss_pred             hhh-hcccccccEEEcccccccccCCccccCC-----CCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCC--C
Q 005760           93 TSV-GNLSHSLEYFEMAYCNVSGGIPEEIGNL-----TNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGS--I  164 (678)
Q Consensus        93 ~~~-~~l~~~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~--~  164 (678)
                      ..+ ..++ +|++|+|++|++++. |..+..+     ++|++|+|++|++++..+..|+.+++|++|+|++|++.+.  .
T Consensus       114 ~~~~~~l~-~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  191 (312)
T 1wwl_A          114 PLLEATGP-DLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL  191 (312)
T ss_dssp             CSSSCCSC-CCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHH
T ss_pred             HHHHhcCC-CccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHH
Confidence            643 5666 899999999999988 8888877     9999999999999988889999999999999999998643  2


Q ss_pred             CCcc--cCCCCccEEecCCCcCCCC---Chhhhhccccccceecccccccccc--ccccccccccEEEecCCcccCCCCc
Q 005760          165 PDSI--CHSDELYKLELGGNKLSGS---IPECFNNLASLRILLLGSNELTSIP--LTFWNLKDILYLNFSSNFFTGPLPL  237 (678)
Q Consensus       165 ~~~~--~~l~~L~~L~l~~N~i~~~---~~~~~~~l~~L~~L~l~~N~l~~l~--~~~~~l~~L~~L~l~~N~l~~~~~~  237 (678)
                      +..+  ..+++|++|+|++|.+++.   ....+..+++|+.|+|++|+++..+  ..+..+++|+.|+|++|.++ .+|.
T Consensus       192 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~  270 (312)
T 1wwl_A          192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK  270 (312)
T ss_dssp             HHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCS
T ss_pred             HHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhh
Confidence            3333  7899999999999999832   2244567899999999999999765  35677899999999999998 5565


Q ss_pred             cccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccc
Q 005760          238 EIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEG  291 (678)
Q Consensus       238 ~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  291 (678)
                      .+.  +          +|+.|+|++|+|++. |. +..+++|+.|++++|++++
T Consensus       271 ~~~--~----------~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~  310 (312)
T 1wwl_A          271 GLP--A----------KLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD  310 (312)
T ss_dssp             SCC--S----------EEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred             hcc--C----------CceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence            554  4          899999999999976 55 8899999999999999985

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=5e-29  Score=275.30  Aligned_cols=186  Identities=20%  Similarity=0.124  Sum_probs=131.6

Q ss_pred             cccCCCceeEEEEE-eCCCcEEEEEEeeccc----------CchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEE
Q 005760          399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY----------GRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       399 ~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ..+.|+.|.+..++ .-.|+.+|+|++....          ....+++.+|+++|+++ .|+||+++++++++.+..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            34566666666553 3368899999996542          12346689999999999 699999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||++|++|.+++...+. ++..   +|+.||+.||+|+|   ++|||||||||+|||++.+|.+||+|||+|+......
T Consensus       321 MEyv~G~~L~d~i~~~~~-l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEE-IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EECCCSEEHHHHHHTTCC-CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             EecCCCCcHHHHHHhCCC-CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            999999999999987653 5554   48899999999999   9999999999999999999999999999998764322


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPT  594 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~  594 (678)
                        ......+||+.|+|||.+.+ .+..++|+||+|++++++.++..|+
T Consensus       394 --~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          394 --SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             --ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence              22345679999999999865 5677899999999998887765543

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=2.1e-26  Score=232.28  Aligned_cols=228  Identities=24%  Similarity=0.247  Sum_probs=165.7

Q ss_pred             EEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccccE
Q 005760           25 ILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEY  104 (678)
Q Consensus        25 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~  104 (678)
                      ..+..+.+++ .+|..+.  ++|++|+|++|.++.++..     .|.++++|++|++++|+++                 
T Consensus        11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~-----------------   65 (276)
T 2z62_A           11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSY-----SFFSFPELQVLDLSRCEIQ-----------------   65 (276)
T ss_dssp             EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTT-----TTTTCTTCSEEECTTCCCC-----------------
T ss_pred             eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHh-----HhccccCCcEEECCCCcCC-----------------
Confidence            3455555555 3344332  3566666666666554432     3455555555555555554                 


Q ss_pred             EEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcC
Q 005760          105 FEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKL  184 (678)
Q Consensus       105 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i  184 (678)
                               +..+..|.++++|++|+|++|++++..+..|.++++|++|++++|.+++..+..+..+++|++|++++|.+
T Consensus        66 ---------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  136 (276)
T 2z62_A           66 ---------TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI  136 (276)
T ss_dssp             ---------EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCC
T ss_pred             ---------ccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCcc
Confidence                     44455677778888888888888777777788888888888888888866666788888888888888888


Q ss_pred             CCC-Chhhhhccccccceeccccccccccc-ccccccccc----EEEecCCcccCCCCccccccccccccccCcccccEE
Q 005760          185 SGS-IPECFNNLASLRILLLGSNELTSIPL-TFWNLKDIL----YLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISL  258 (678)
Q Consensus       185 ~~~-~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~----~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L  258 (678)
                      ++. +|..|..+++|+.|+|++|+++.++. .+..+++|+    .|++++|++++..+..+.. .          +|+.|
T Consensus       137 ~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~----------~L~~L  205 (276)
T 2z62_A          137 QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-I----------RLKEL  205 (276)
T ss_dssp             CCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-C----------CEEEE
T ss_pred             ceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-C----------cccEE
Confidence            764 47788888888888888888887754 566666666    8899999998666555432 2          79999


Q ss_pred             EccCCcCCCcchHHHhcccCCCceecccccccccCCCCC
Q 005760          259 NLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGG  297 (678)
Q Consensus       259 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~  297 (678)
                      +|++|++++..+..+..+++|+.|++++|+|.|.|+...
T Consensus       206 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l~  244 (276)
T 2z62_A          206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  244 (276)
T ss_dssp             ECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTTH
T ss_pred             ECCCCceeecCHhHhcccccccEEEccCCcccccCCchH
Confidence            999999998888888999999999999999999998653

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.94  E-value=2.7e-26  Score=230.61  Aligned_cols=207  Identities=26%  Similarity=0.319  Sum_probs=173.5

Q ss_pred             CCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEE
Q 005760           75 SLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLG  154 (678)
Q Consensus        75 ~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  154 (678)
                      +.+.+++++|+++.+ |.    .++.++++|+|++|++++..+..|.++++|++|+|++|+++.+.+..|.++++|++|+
T Consensus        17 ~~~~l~~~~~~l~~i-p~----~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~   91 (270)
T 2o6q_A           17 NKNSVDCSSKKLTAI-PS----NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLW   91 (270)
T ss_dssp             TTTEEECTTSCCSSC-CS----CCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEE
T ss_pred             CCCEEEccCCCCCcc-CC----CCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEE
Confidence            455666666666532 21    1223677777777777766677788999999999999999877777788899999999


Q ss_pred             ccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccC
Q 005760          155 LENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTG  233 (678)
Q Consensus       155 L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~  233 (678)
                      |++|.+++..+..|..+++|++|++++|.+++..+..|..+++|++|+|++|.|+.+|. .|..+++|+.|+|++|.+++
T Consensus        92 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  171 (270)
T 2o6q_A           92 VTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR  171 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcE
Confidence            99999997777788899999999999999998888889999999999999999999877 48889999999999999998


Q ss_pred             CCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC
Q 005760          234 PLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG  296 (678)
Q Consensus       234 ~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  296 (678)
                      ..+..|.+++          +|+.|+|++|++++..+..+..+++|+.|++++|+|.|+++..
T Consensus       172 ~~~~~~~~l~----------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~  224 (270)
T 2o6q_A          172 VPEGAFDKLT----------ELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNGI  224 (270)
T ss_dssp             CCTTTTTTCT----------TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSSS
T ss_pred             eChhHhccCC----------CcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCccH
Confidence            7777777776          9999999999999888888999999999999999999998753

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.94  E-value=6.7e-26  Score=251.93  Aligned_cols=254  Identities=26%  Similarity=0.277  Sum_probs=183.4

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      .|++++|+++ .+|..++  ++|++|+|++|+|+. +|.   .+++|++|+|++|+++.++.         .+++|++|+
T Consensus        44 ~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~---------~l~~L~~L~  107 (622)
T 3g06_A           44 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLPV---------LPPGLLELS  107 (622)
T ss_dssp             EEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSCCCC---------CCTTCCEEE
T ss_pred             EEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCcCCC---------CCCCCCEEE
Confidence            3789999999 8887776  799999999999994 454   67899999999999987663         568999999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcC
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKL  160 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i  160 (678)
                      |++|+++++..      ...+|++|++++|+++++ |..   +++|++|+|++|++++ +|.   .+++|+.|++++|.|
T Consensus       108 Ls~N~l~~l~~------~l~~L~~L~L~~N~l~~l-p~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l  173 (622)
T 3g06_A          108 IFSNPLTHLPA------LPSGLCKLWIFGNQLTSL-PVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQL  173 (622)
T ss_dssp             ECSCCCCCCCC------CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCC
T ss_pred             CcCCcCCCCCC------CCCCcCEEECCCCCCCcC-CCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCC
Confidence            99999986533      224899999999998864 432   5889999999999984 443   346788888888888


Q ss_pred             CCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCcccc
Q 005760          161 EGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIG  240 (678)
Q Consensus       161 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  240 (678)
                      + .+|   ..+++|+.|++++|.+++ +|..   +++|+.|++++|.|+.+|..   +++|+.|+|++|.|++ +|.   
T Consensus       174 ~-~l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~-lp~---  238 (622)
T 3g06_A          174 T-SLP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LPV---  238 (622)
T ss_dssp             S-CCC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC-CCC---
T ss_pred             C-CCc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccccCCC---CCCCCEEEccCCccCc-CCC---
Confidence            8 455   345778888888888884 3332   36777777888777777643   3677777777777774 231   


Q ss_pred             ccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccCccc
Q 005760          241 NLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL  313 (678)
Q Consensus       241 ~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~  313 (678)
                      .+          ++|+.|+|++|+|+.+.+    .+++|+.|+|++|.++..++....++++..+++.+|++.
T Consensus       239 ~l----------~~L~~L~Ls~N~L~~lp~----~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l~  297 (622)
T 3g06_A          239 LP----------SELKELMVSGNRLTSLPM----LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS  297 (622)
T ss_dssp             CC----------TTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCCC
T ss_pred             CC----------CcCcEEECCCCCCCcCCc----ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCCC
Confidence            12          266777777777664332    456677777777776644444455666666666666654

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.94  E-value=3.3e-26  Score=246.94  Aligned_cols=247  Identities=28%  Similarity=0.327  Sum_probs=126.2

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccc
Q 005760           21 SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSH  100 (678)
Q Consensus        21 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~  100 (678)
                      ++|++|++++|++++ +| .|+++++|++|++++|+++.++..         ..+|++|++++|+++++ |  .+..++ 
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~---------~~~L~~L~L~~n~l~~l-~--~~~~l~-  195 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDL---------PPSLEFIAAGNNQLEEL-P--ELQNLP-  195 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCC---------CTTCCEEECCSSCCSSC-C--CCTTCT-
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCC---------cccccEEECcCCcCCcC-c--cccCCC-
Confidence            467777777777764 44 467777777777777776655421         13555555555555542 2  133443 


Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      +|++|++++|++++ +|..   .++|++|++++|+++ .+| .+..+++|++|++++|++++ +|..   +++|+.|+++
T Consensus       196 ~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~  265 (454)
T 1jl5_A          196 FLTAIYADNNSLKK-LPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVR  265 (454)
T ss_dssp             TCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECC
T ss_pred             CCCEEECCCCcCCc-CCCC---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECC
Confidence            45555555555543 2211   134555555555554 333 24455555555555555542 2321   2344444444


Q ss_pred             CCcCCCCChhhhh-----------------ccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccc
Q 005760          181 GNKLSGSIPECFN-----------------NLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK  243 (678)
Q Consensus       181 ~N~i~~~~~~~~~-----------------~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  243 (678)
                      +|.+++ +|..+.                 -.++|+.|++++|+++.++..   .++|+.|++++|++++ +|..     
T Consensus       266 ~N~l~~-l~~~~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~---~~~L~~L~Ls~N~l~~-lp~~-----  335 (454)
T 1jl5_A          266 DNYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDL---PPSLEELNVSNNKLIE-LPAL-----  335 (454)
T ss_dssp             SSCCSC-CCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCC---CTTCCEEECCSSCCSC-CCCC-----
T ss_pred             CCcccc-cCcccCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCC---cCcCCEEECCCCcccc-cccc-----
Confidence            444443 222110                 013455555555555443311   1467777777777774 3322     


Q ss_pred             cccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccc--cCCCC-Ccc-------------cccccccc
Q 005760          244 IARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEG--EIPRG-GSF-------------GNFSAESF  307 (678)
Q Consensus       244 ~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~--~~~~~-~~~-------------~~l~~~~~  307 (678)
                              +++|+.|+|++|++++ +|.   .+++|+.|++++|++++  ..|.. ..+             ..++.+++
T Consensus       336 --------~~~L~~L~L~~N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~l  403 (454)
T 1jl5_A          336 --------PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHV  403 (454)
T ss_dssp             --------CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-----------------
T ss_pred             --------CCcCCEEECCCCcccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEEC
Confidence                    2489999999999985 444   47889999999999988  44433 333             56788888


Q ss_pred             ccCcccc
Q 005760          308 EGNELLC  314 (678)
Q Consensus       308 ~~n~~~c  314 (678)
                      .+|+...
T Consensus       404 s~N~l~~  410 (454)
T 1jl5_A          404 ETNPLRE  410 (454)
T ss_dssp             -------
T ss_pred             CCCcCCc
Confidence            8888764

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.94  E-value=1.2e-26  Score=250.24  Aligned_cols=263  Identities=22%  Similarity=0.218  Sum_probs=181.4

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCC-------------CEEEccCccCCCCccchhhc
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNL-------------QALRLSNNYLTSSTLELSFL   67 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L-------------~~L~l~~n~i~~~~~~~~~~   67 (678)
                      .|++++|++ +.+|++++++++|++|++++|++.+..|..++++++|             ++|++++|.++.++..    
T Consensus        15 ~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~----   89 (454)
T 1jl5_A           15 EPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL----   89 (454)
T ss_dssp             --------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC----
T ss_pred             hhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC----
Confidence            478899999 6999999999999999999999999999999998875             9999999999887632    


Q ss_pred             ccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhcc
Q 005760           68 SSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKL  147 (678)
Q Consensus        68 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  147 (678)
                           .++|++|++++|.++++ |..     ..+|++|++++|++++... .   .++|++|++++|++++ +| .|+++
T Consensus        90 -----~~~L~~L~l~~n~l~~l-p~~-----~~~L~~L~l~~n~l~~l~~-~---~~~L~~L~L~~n~l~~-lp-~~~~l  152 (454)
T 1jl5_A           90 -----PPHLESLVASCNSLTEL-PEL-----PQSLKSLLVDNNNLKALSD-L---PPLLEYLGVSNNQLEK-LP-ELQNS  152 (454)
T ss_dssp             -----CTTCSEEECCSSCCSSC-CCC-----CTTCCEEECCSSCCSCCCS-C---CTTCCEEECCSSCCSS-CC-CCTTC
T ss_pred             -----cCCCCEEEccCCcCCcc-ccc-----cCCCcEEECCCCccCcccC-C---CCCCCEEECcCCCCCC-Cc-ccCCC
Confidence                 36888999999888863 321     1378888888888875321 1   2688888888888875 55 58888


Q ss_pred             CCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEec
Q 005760          148 QKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFS  227 (678)
Q Consensus       148 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~  227 (678)
                      ++|++|++++|++++ +|..+   ++|++|++++|.+++ +| .+..+++|+.|++++|+++.+|...   ++|+.|+++
T Consensus       153 ~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~  223 (454)
T 1jl5_A          153 SFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDLP---LSLESIVAG  223 (454)
T ss_dssp             TTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCCC---TTCCEEECC
T ss_pred             CCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCCc---CcccEEECc
Confidence            888888888888884 55443   478888888888885 44 5788888888888888888776533   478888888


Q ss_pred             CCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCcccccccccc
Q 005760          228 SNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESF  307 (678)
Q Consensus       228 ~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~  307 (678)
                      +|.+. .+| .+..++          +|+.|++++|++++. |.   .+++|+.|++++|.+++. |..  ...++.+++
T Consensus       224 ~n~l~-~lp-~~~~l~----------~L~~L~l~~N~l~~l-~~---~~~~L~~L~l~~N~l~~l-~~~--~~~L~~L~l  284 (454)
T 1jl5_A          224 NNILE-ELP-ELQNLP----------FLTTIYADNNLLKTL-PD---LPPSLEALNVRDNYLTDL-PEL--PQSLTFLDV  284 (454)
T ss_dssp             SSCCS-SCC-CCTTCT----------TCCEEECCSSCCSSC-CS---CCTTCCEEECCSSCCSCC-CCC--CTTCCEEEC
T ss_pred             CCcCC-ccc-ccCCCC----------CCCEEECCCCcCCcc-cc---cccccCEEECCCCccccc-Ccc--cCcCCEEEC
Confidence            88887 444 355555          888888888888753 32   246788888888887763 322  356777777


Q ss_pred             ccCccc
Q 005760          308 EGNELL  313 (678)
Q Consensus       308 ~~n~~~  313 (678)
                      .+|...
T Consensus       285 s~N~l~  290 (454)
T 1jl5_A          285 SENIFS  290 (454)
T ss_dssp             CSSCCS
T ss_pred             cCCccC
Confidence            776544

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=7.2e-26  Score=228.38  Aligned_cols=220  Identities=20%  Similarity=0.215  Sum_probs=180.4

Q ss_pred             cCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccC
Q 005760            5 WENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNN   84 (678)
Q Consensus         5 ~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n   84 (678)
                      .+.++. .+|..+.  ++|++|+|++|+|++..+..|.++++|++|+|++|.++.++..     .|.++++|++|+|++|
T Consensus        15 ~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~L~~n   86 (276)
T 2z62_A           15 MELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG-----AYQSLSHLSTLILTGN   86 (276)
T ss_dssp             TTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTT-----TTTTCTTCCEEECTTC
T ss_pred             cCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHH-----HccCCcCCCEEECCCC
Confidence            444555 6776554  5899999999999988888999999999999999999877643     4788888888888888


Q ss_pred             CCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCC-
Q 005760           85 PLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGS-  163 (678)
Q Consensus        85 ~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~-  163 (678)
                      ++++..                          +..|.++++|++|++++|++.+..+..+..+++|++|+|++|.+++. 
T Consensus        87 ~l~~~~--------------------------~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  140 (276)
T 2z62_A           87 PIQSLA--------------------------LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK  140 (276)
T ss_dssp             CCCEEC--------------------------TTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCC
T ss_pred             ccCccC--------------------------hhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceec
Confidence            876443                          34567788888888888888866666788888888888888888753 


Q ss_pred             CCCcccCCCCccEEecCCCcCCCCChhhhhcccccc----ceeccccccccccccccccccccEEEecCCcccCCCCccc
Q 005760          164 IPDSICHSDELYKLELGGNKLSGSIPECFNNLASLR----ILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEI  239 (678)
Q Consensus       164 ~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~----~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~  239 (678)
                      +|..+..+++|++|++++|.+++..+..+..+++|+    .|++++|.++.++.......+|+.|++++|.+++..+..|
T Consensus       141 l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~  220 (276)
T 2z62_A          141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIF  220 (276)
T ss_dssp             CCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTT
T ss_pred             CchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHh
Confidence            578888888999999999998887777888777777    8899999999988766666689999999999997777667


Q ss_pred             cccccccccccCcccccEEEccCCcCCCc
Q 005760          240 GNLKIARIDSCDLISLISLNLSNNNLSGA  268 (678)
Q Consensus       240 ~~l~~~~~~~~~~~~L~~L~L~~N~l~~~  268 (678)
                      .+++          +|+.|+|++|+++..
T Consensus       221 ~~l~----------~L~~L~l~~N~~~c~  239 (276)
T 2z62_A          221 DRLT----------SLQKIWLHTNPWDCS  239 (276)
T ss_dssp             TTCC----------SCCEEECCSSCBCCC
T ss_pred             cccc----------cccEEEccCCccccc
Confidence            7666          999999999999854

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.94  E-value=5e-26  Score=230.69  Aligned_cols=206  Identities=22%  Similarity=0.176  Sum_probs=157.0

Q ss_pred             cCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCC
Q 005760           71 SNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKL  150 (678)
Q Consensus        71 ~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  150 (678)
                      .++++++.+++++|.++.+.+     .++..++.|+|++|.+++..+..|.++++|+.|+|++|.+++..+.  ..+++|
T Consensus         7 ~~l~~l~~l~~~~~~l~~ip~-----~~~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L   79 (290)
T 1p9a_G            7 SKVASHLEVNCDKRNLTALPP-----DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL   79 (290)
T ss_dssp             ECSTTCCEEECTTSCCSSCCS-----CCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred             cccCCccEEECCCCCCCcCCC-----CCCCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence            344455555555555443211     1123566666666666666667788888888888888888754332  678889


Q ss_pred             CEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCC
Q 005760          151 QGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN  229 (678)
Q Consensus       151 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N  229 (678)
                      ++|+|++|+|+ .+|..+..+++|++|++++|+|++..+..|..+++|+.|+|++|+|+.+|. .|..+++|+.|+|++|
T Consensus        80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  158 (290)
T 1p9a_G           80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN  158 (290)
T ss_dssp             CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence            99999999888 677788888899999999999987777888888899999999999888876 4778889999999999


Q ss_pred             cccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCC
Q 005760          230 FFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR  295 (678)
Q Consensus       230 ~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  295 (678)
                      ++++..+..|.+++          +|+.|+|++|+|+ .+|..+..+++|+.|++++|+|.|.|..
T Consensus       159 ~l~~l~~~~~~~l~----------~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~~  213 (290)
T 1p9a_G          159 NLTELPAGLLNGLE----------NLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI  213 (290)
T ss_dssp             CCSCCCTTTTTTCT----------TCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred             cCCccCHHHhcCcC----------CCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCcc
Confidence            98877666677666          8999999999998 5566666778899999999999988754

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.93  E-value=1.8e-28  Score=266.68  Aligned_cols=304  Identities=18%  Similarity=0.183  Sum_probs=173.0

Q ss_pred             ccccCCcCcc----cCCccccCCCCCCEEecCCCcccccCCccc-cCCC----CCCEEEccCccCCCCccchhhcccccC
Q 005760            2 LQMWENNFSG----TIPRFIFNASKLSILELSDNSFSGFIPNTF-GNLR----NLQALRLSNNYLTSSTLELSFLSSLSN   72 (678)
Q Consensus         2 L~l~~~~~~~----~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~-~~l~----~L~~L~l~~n~i~~~~~~~~~~~~~~~   72 (678)
                      |+|++|++.+    .+|..+..+++|++|+|++|.++...+..+ ..++    +|++|+|++|.++..... .++..|..
T Consensus        33 L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~-~l~~~l~~  111 (461)
T 1z7x_W           33 VRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG-VLSSTLRT  111 (461)
T ss_dssp             EEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHH-HHHHHTTS
T ss_pred             EEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHH-HHHHHHcc
Confidence            5566666653    345555666666666666666654333222 2233    566777776666543311 12345666


Q ss_pred             CCCCcEEECccCCCcccCChhhhhccc---ccccEEEcccccccccC----CccccCCCCCcEEEccCCccCCcCChhhh
Q 005760           73 CKSLTLISFSNNPLDGILPKTSVGNLS---HSLEYFEMAYCNVSGGI----PEEIGNLTNLTIIYLGGNKLNGSIPSTLG  145 (678)
Q Consensus        73 l~~L~~L~L~~n~i~~~~~~~~~~~l~---~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  145 (678)
                      +++|++|+|++|.+++..+......+.   .+|++|++++|++++..    +..+..+++|++|++++|.+.+..+..+.
T Consensus       112 ~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~  191 (461)
T 1z7x_W          112 LPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLC  191 (461)
T ss_dssp             CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHH
T ss_pred             CCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHH
Confidence            677777777777765443333222211   14777777777766533    44555567777777777776544333333


Q ss_pred             -----ccCCCCEEEccCCcCCCC----CCCcccCCCCccEEecCCCcCCCCChh-----hhhccccccceecccccccc-
Q 005760          146 -----KLQKLQGLGLENNKLEGS----IPDSICHSDELYKLELGGNKLSGSIPE-----CFNNLASLRILLLGSNELTS-  210 (678)
Q Consensus       146 -----~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~l~~N~i~~~~~~-----~~~~l~~L~~L~l~~N~l~~-  210 (678)
                           .+++|++|+|++|.+++.    ++..+..+++|++|++++|.+++....     .+..+++|++|+|++|.++. 
T Consensus       192 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~  271 (461)
T 1z7x_W          192 QGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAK  271 (461)
T ss_dssp             HHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred             HHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHH
Confidence                 245777777777777642    345566667777777777776643221     12246677777777777775 


Q ss_pred             ----ccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCc----chHHHhcccCCCce
Q 005760          211 ----IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGA----IPASLEKLSYLKDL  282 (678)
Q Consensus       211 ----l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L  282 (678)
                          ++..+..+++|+.|++++|.+.+..+..+...     .....++|+.|+|++|.+++.    .+..+..+++|+.|
T Consensus       272 ~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~-----l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L  346 (461)
T 1z7x_W          272 GCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET-----LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL  346 (461)
T ss_dssp             HHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH-----HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEE
T ss_pred             HHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHH-----hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEE
Confidence                55566667777777777777654443333221     001123677777777777654    34455566777777


Q ss_pred             ecccccccccCCCC-C-----ccccccccccccCc
Q 005760          283 NLSFNKLEGEIPRG-G-----SFGNFSAESFEGNE  311 (678)
Q Consensus       283 ~l~~N~~~~~~~~~-~-----~~~~l~~~~~~~n~  311 (678)
                      ++++|+++...+.. .     ....++.+++.+|.
T Consensus       347 ~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~  381 (461)
T 1z7x_W          347 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD  381 (461)
T ss_dssp             ECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred             EccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence            77777765432211 0     13456666666654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.93  E-value=4.2e-28  Score=263.81  Aligned_cols=301  Identities=19%  Similarity=0.164  Sum_probs=209.5

Q ss_pred             CccccCCcCcccCCccccC-CC----CCCEEecCCCcccc----cCCccccCCCCCCEEEccCccCCCCccchhhccc-c
Q 005760            1 MLQMWENNFSGTIPRFIFN-AS----KLSILELSDNSFSG----FIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSS-L   70 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~-l~----~L~~L~l~~n~i~~----~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~-~   70 (678)
                      .|+|++|.+.+..+..+.. ++    +|++|+|++|+|+.    .++.+|.++++|++|+|++|.++..... .+... +
T Consensus        60 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~-~l~~~l~  138 (461)
T 1z7x_W           60 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQ-LLCEGLL  138 (461)
T ss_dssp             EEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHH-HHHHHHT
T ss_pred             EEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHH-HHHHHHh
Confidence            3788999988765544443 55    69999999999984    4588889999999999999988754322 11111 2


Q ss_pred             cCCCCCcEEECccCCCcccCChh---hhhcccccccEEEcccccccccCCcccc-----CCCCCcEEEccCCccCCc---
Q 005760           71 SNCKSLTLISFSNNPLDGILPKT---SVGNLSHSLEYFEMAYCNVSGGIPEEIG-----NLTNLTIIYLGGNKLNGS---  139 (678)
Q Consensus        71 ~~l~~L~~L~L~~n~i~~~~~~~---~~~~l~~~L~~L~l~~n~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~~---  139 (678)
                      ..+++|++|+|++|++++.....   .+..++ +|++|++++|.+.+..+..+.     ..++|++|++++|.+++.   
T Consensus       139 ~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~-~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~  217 (461)
T 1z7x_W          139 DPQCRLEKLQLEYCSLSAASCEPLASVLRAKP-DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR  217 (461)
T ss_dssp             STTCCCCEEECTTSCCBGGGHHHHHHHHHHCT-TCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHH
T ss_pred             cCCCcceEEECCCCCCCHHHHHHHHHHHhhCC-CCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHH
Confidence            34668999999999887644222   123334 789999999988765544443     356889999999988753   


Q ss_pred             -CChhhhccCCCCEEEccCCcCCCCC-----CCcccCCCCccEEecCCCcCCCC----Chhhhhccccccceeccccccc
Q 005760          140 -IPSTLGKLQKLQGLGLENNKLEGSI-----PDSICHSDELYKLELGGNKLSGS----IPECFNNLASLRILLLGSNELT  209 (678)
Q Consensus       140 -~~~~~~~l~~L~~L~L~~n~i~~~~-----~~~~~~l~~L~~L~l~~N~i~~~----~~~~~~~l~~L~~L~l~~N~l~  209 (678)
                       ++..+..+++|++|+|++|.+++..     +..+..+++|++|++++|.+++.    ++..+..+++|++|+|++|.++
T Consensus       218 ~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~  297 (461)
T 1z7x_W          218 DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG  297 (461)
T ss_dssp             HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH
T ss_pred             HHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc
Confidence             3666777888999999998887422     22233578888999999888853    5666777888889999888887


Q ss_pred             cccc-ccc-----ccccccEEEecCCcccCCCC----ccccccccccccccCcccccEEEccCCcCCCcchHHHhc----
Q 005760          210 SIPL-TFW-----NLKDILYLNFSSNFFTGPLP----LEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEK----  275 (678)
Q Consensus       210 ~l~~-~~~-----~l~~L~~L~l~~N~l~~~~~----~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~----  275 (678)
                      .... .+.     ..++|+.|++++|.+++...    ..+..++          +|+.|+|++|++++..+..+..    
T Consensus       298 ~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~----------~L~~L~Ls~n~i~~~~~~~l~~~l~~  367 (461)
T 1z7x_W          298 DEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR----------FLLELQISNNRLEDAGVRELCQGLGQ  367 (461)
T ss_dssp             HHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCS----------SCCEEECCSSBCHHHHHHHHHHHHTS
T ss_pred             hHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCC----------CccEEEccCCccccccHHHHHHHHcC
Confidence            4321 222     23588888888888875532    2333334          8888888888887666655543    


Q ss_pred             -ccCCCceecccccccc----cCC-CCCccccccccccccCccc
Q 005760          276 -LSYLKDLNLSFNKLEG----EIP-RGGSFGNFSAESFEGNELL  313 (678)
Q Consensus       276 -l~~L~~L~l~~N~~~~----~~~-~~~~~~~l~~~~~~~n~~~  313 (678)
                       .++|+.|++++|.++.    .++ .....+.++.+++.+|+..
T Consensus       368 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~  411 (461)
T 1z7x_W          368 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG  411 (461)
T ss_dssp             TTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred             CCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence             5688888888888774    233 2344667778888877653

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.93  E-value=4.6e-25  Score=245.21  Aligned_cols=238  Identities=27%  Similarity=0.343  Sum_probs=199.8

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      .|+|++|+++ .+|.   .+++|++|+|++|+|+. +|.   .+++|++|+|++|.++.++.         .+++|+.|+
T Consensus        65 ~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l~~---------~l~~L~~L~  127 (622)
T 3g06_A           65 TLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTHLPA---------LPSGLCKLW  127 (622)
T ss_dssp             EEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCCCCC---------CCTTCCEEE
T ss_pred             EEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCCCCC---------CCCCcCEEE
Confidence            3789999999 6776   57899999999999995 454   78999999999999998763         468999999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcC
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKL  160 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i  160 (678)
                      +++|+++.+.. .    + .+|++|+|++|++++. |.   .+++|+.|++++|.+++ +|   ..+++|+.|+|++|.|
T Consensus       128 L~~N~l~~lp~-~----l-~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l  193 (622)
T 3g06_A          128 IFGNQLTSLPV-L----P-PGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQL  193 (622)
T ss_dssp             CCSSCCSCCCC-C----C-TTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCC
T ss_pred             CCCCCCCcCCC-C----C-CCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCC
Confidence            99999986533 1    2 4899999999999864 33   35889999999999985 55   4579999999999999


Q ss_pred             CCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCcccc
Q 005760          161 EGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIG  240 (678)
Q Consensus       161 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  240 (678)
                      ++ +|..   +++|+.|++++|.++. +|.   .+++|+.|+|++|+|+.+|   ..+++|+.|+|++|.|+. +|.   
T Consensus       194 ~~-l~~~---~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~~-lp~---  258 (622)
T 3g06_A          194 AS-LPTL---PSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLTS-LPM---  258 (622)
T ss_dssp             SC-CCCC---CTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC-CCC---
T ss_pred             CC-CCCc---cchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCCc-CCc---
Confidence            94 5543   4789999999999994 443   2478999999999999998   456899999999999984 333   


Q ss_pred             ccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCC
Q 005760          241 NLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR  295 (678)
Q Consensus       241 ~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  295 (678)
                      .++          +|+.|+|++|+|+ .+|..+..+++|+.|+|++|++++..+.
T Consensus       259 ~~~----------~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~  302 (622)
T 3g06_A          259 LPS----------GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  302 (622)
T ss_dssp             CCT----------TCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred             ccc----------cCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence            233          8999999999999 5677899999999999999999987655

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=1.4e-25  Score=225.64  Aligned_cols=228  Identities=21%  Similarity=0.243  Sum_probs=175.3

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccc
Q 005760           21 SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSH  100 (678)
Q Consensus        21 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~  100 (678)
                      .++..+++..+.+...  ..+..+++|+.|++++|.+..++       .+..+++|++|++++|.+.+..   .+..++ 
T Consensus        19 ~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~~-------~l~~l~~L~~L~l~~n~l~~~~---~l~~l~-   85 (272)
T 3rfs_A           19 AETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSVQ-------GIQYLPNVRYLALGGNKLHDIS---ALKELT-   85 (272)
T ss_dssp             HHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCCT-------TGGGCTTCCEEECTTSCCCCCG---GGTTCT-
T ss_pred             HHHHHHHhcCcccccc--cccccccceeeeeeCCCCccccc-------ccccCCCCcEEECCCCCCCCch---hhcCCC-
Confidence            3455566666666544  33456677777777777766544       3566777777777777776531   245555 


Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      +|++|++++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+++
T Consensus        86 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  165 (272)
T 3rfs_A           86 NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLS  165 (272)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECC
Confidence            67777777777777777778888999999999999887777778888999999999999987767778888999999999


Q ss_pred             CCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEE
Q 005760          181 GNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLN  259 (678)
Q Consensus       181 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~  259 (678)
                      +|.+++..+..|..+++|+.|+|++|+++.++. .+..+++|+.|++++|++.+                 .+++|+.|+
T Consensus       166 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-----------------~~~~l~~l~  228 (272)
T 3rfs_A          166 YNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-----------------TCPGIRYLS  228 (272)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC-----------------CTTTTHHHH
T ss_pred             CCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc-----------------cCcHHHHHH
Confidence            999988877778888999999999999988766 47888999999999998763                 234788889


Q ss_pred             ccCCcCCCcchHHHhcccC
Q 005760          260 LSNNNLSGAIPASLEKLSY  278 (678)
Q Consensus       260 L~~N~l~~~~~~~~~~l~~  278 (678)
                      +..|++++.+|..++.++.
T Consensus       229 ~~~n~~~g~ip~~~~~~~~  247 (272)
T 3rfs_A          229 EWINKHSGVVRNSAGSVAP  247 (272)
T ss_dssp             HHHHHTGGGBBCTTSCBCG
T ss_pred             HHHHhCCCcccCcccccCC
Confidence            9999999888888877665

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=6.2e-25  Score=222.63  Aligned_cols=202  Identities=23%  Similarity=0.314  Sum_probs=115.9

Q ss_pred             ccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhh
Q 005760           17 IFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVG   96 (678)
Q Consensus        17 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~   96 (678)
                      +.++++++++++++|+++. +|..+.  ++|+.|+|++|.++.++..     .|.++++|++|+|++|.++++.+.   .
T Consensus         6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~~~---~   74 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLA-----TLMPYTRLTQLNLDRAELTKLQVD---G   74 (290)
T ss_dssp             EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGG-----GGTTCTTCCEEECTTSCCCEEECC---S
T ss_pred             ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHH-----HhhcCCCCCEEECCCCccCcccCC---C
Confidence            5677888888888888884 454443  5788888888888766543     477888888888888887755332   2


Q ss_pred             cccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccE
Q 005760           97 NLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYK  176 (678)
Q Consensus        97 ~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~  176 (678)
                      .++ +|++|+|++|+++ .+|..+..+++|++|+|++|++++..+..|.++++|++|+|++|+|++..+..|..+++|+.
T Consensus        75 ~l~-~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  152 (290)
T 1p9a_G           75 TLP-VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK  152 (290)
T ss_dssp             CCT-TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             CCC-cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence            222 4555555555554 33444455555555555555555444445555555555555555555444444445555555


Q ss_pred             EecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcc
Q 005760          177 LELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFF  231 (678)
Q Consensus       177 L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l  231 (678)
                      |+|++|+++...+..|..+++|+.|+|++|+|+.+|..+..+.+|+.|+|++|++
T Consensus       153 L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~  207 (290)
T 1p9a_G          153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPW  207 (290)
T ss_dssp             EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCB
T ss_pred             EECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCc
Confidence            5555555554444444445555555555555555544444444444444444444

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=1e-24  Score=219.08  Aligned_cols=203  Identities=23%  Similarity=0.292  Sum_probs=175.0

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccc
Q 005760           21 SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSH  100 (678)
Q Consensus        21 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~  100 (678)
                      .+++.+++++++++. +|..+.  ++|+.|+|++|.++.++..     .|.++++|++|+|++|+++.+.+. .+..++ 
T Consensus        16 ~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~i~~~-~~~~l~-   85 (270)
T 2o6q_A           16 NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSK-----AFHRLTKLRLLYLNDNKLQTLPAG-IFKELK-   85 (270)
T ss_dssp             TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTT-----SSSSCTTCCEEECCSSCCSCCCTT-TTSSCT-
T ss_pred             CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHH-----HhcCCCCCCEEECCCCccCeeChh-hhcCCC-
Confidence            457889999998884 565554  5788999999988877753     578888999999999988755443 356666 


Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      +|++|+|++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.|++..+..|..+++|+.|+++
T Consensus        86 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  165 (270)
T 2o6q_A           86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLY  165 (270)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEec
Confidence            89999999999988888889999999999999999998888889999999999999999997767778999999999999


Q ss_pred             CCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccC
Q 005760          181 GNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTG  233 (678)
Q Consensus       181 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~  233 (678)
                      +|.+++..+..|..+++|+.|+|++|+|+.+|. .|..+++|+.|+|++|++..
T Consensus       166 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  219 (270)
T 2o6q_A          166 NNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDC  219 (270)
T ss_dssp             SSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeC
Confidence            999998888889999999999999999999987 58889999999999999873

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=1e-25  Score=226.53  Aligned_cols=222  Identities=23%  Similarity=0.251  Sum_probs=192.4

Q ss_pred             CCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCC
Q 005760           45 RNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT  124 (678)
Q Consensus        45 ~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~  124 (678)
                      +++..+++..+.+....       .+..+++|+.|++++|.+.....   +..++ +|++|++++|.+++.  ..+..++
T Consensus        19 ~~l~~l~l~~~~~~~~~-------~~~~l~~L~~L~l~~~~i~~~~~---l~~l~-~L~~L~l~~n~l~~~--~~l~~l~   85 (272)
T 3rfs_A           19 AETIKANLKKKSVTDAV-------TQNELNSIDQIIANNSDIKSVQG---IQYLP-NVRYLALGGNKLHDI--SALKELT   85 (272)
T ss_dssp             HHHHHHHHTCSCTTSEE-------CHHHHTTCCEEECTTSCCCCCTT---GGGCT-TCCEEECTTSCCCCC--GGGTTCT
T ss_pred             HHHHHHHhcCccccccc-------ccccccceeeeeeCCCCcccccc---cccCC-CCcEEECCCCCCCCc--hhhcCCC
Confidence            45566777777776554       35678999999999999875532   55666 899999999999874  4788999


Q ss_pred             CCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceecc
Q 005760          125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLG  204 (678)
Q Consensus       125 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~  204 (678)
                      +|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|++++|.+++..+..|..+++|+.|+++
T Consensus        86 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  165 (272)
T 3rfs_A           86 NLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLS  165 (272)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECC
Confidence            99999999999998888889999999999999999997777788999999999999999998888888999999999999


Q ss_pred             ccccccccc-cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCcee
Q 005760          205 SNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLN  283 (678)
Q Consensus       205 ~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  283 (678)
                      +|+++.++. .+..+++|+.|++++|++++..+..+..++          +|+.|+|++|.+.+.       ++.|+.|+
T Consensus       166 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~----------~L~~L~l~~N~~~~~-------~~~l~~l~  228 (272)
T 3rfs_A          166 YNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT----------SLQYIWLHDNPWDCT-------CPGIRYLS  228 (272)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT----------TCCEEECCSSCBCCC-------TTTTHHHH
T ss_pred             CCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCc----------CCCEEEccCCCcccc-------CcHHHHHH
Confidence            999998876 478899999999999999988887777777          999999999998754       56799999


Q ss_pred             cccccccccCCCC
Q 005760          284 LSFNKLEGEIPRG  296 (678)
Q Consensus       284 l~~N~~~~~~~~~  296 (678)
                      +.+|.+++.+|..
T Consensus       229 ~~~n~~~g~ip~~  241 (272)
T 3rfs_A          229 EWINKHSGVVRNS  241 (272)
T ss_dssp             HHHHHTGGGBBCT
T ss_pred             HHHHhCCCcccCc
Confidence            9999999988875

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.92  E-value=1.5e-26  Score=242.79  Aligned_cols=265  Identities=17%  Similarity=0.182  Sum_probs=155.8

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCC----ccccCCC-CCCEEEccCccCCCCccchhhcccccCC-CC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIP----NTFGNLR-NLQALRLSNNYLTSSTLELSFLSSLSNC-KS   75 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~----~~~~~l~-~L~~L~l~~n~i~~~~~~~~~~~~~~~l-~~   75 (678)
                      ++|++|++++.+|..+...++|++|+|++|.|+...+    ++|.+++ +|++|+|++|.++..... .+...+... ++
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~-~l~~~l~~~~~~   81 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSD-ELVQILAAIPAN   81 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHH-HHHHHHHTSCTT
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHH-HHHHHHhccCCC
Confidence            5688888888888877777778999999988887666    7788888 888888888888776543 111222233 78


Q ss_pred             CcEEECccCCCcccCChhhhhc---ccccccEEEcccccccccCCccccC-----CCCCcEEEccCCccCCcCCh----h
Q 005760           76 LTLISFSNNPLDGILPKTSVGN---LSHSLEYFEMAYCNVSGGIPEEIGN-----LTNLTIIYLGGNKLNGSIPS----T  143 (678)
Q Consensus        76 L~~L~L~~n~i~~~~~~~~~~~---l~~~L~~L~l~~n~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~~~~~----~  143 (678)
                      |++|+|++|.+++..+......   .+.+|++|+|++|++++..+..+..     .++|++|+|++|++++....    .
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~  161 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI  161 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence            8888888888876655432221   2136777777777776655544332     24677777777766643332    2


Q ss_pred             hhccC-CCCEEEccCCcCCCCCCCcc----cCC-CCccEEecCCCcCCCCC----hhhhhc-cccccceecccccccccc
Q 005760          144 LGKLQ-KLQGLGLENNKLEGSIPDSI----CHS-DELYKLELGGNKLSGSI----PECFNN-LASLRILLLGSNELTSIP  212 (678)
Q Consensus       144 ~~~l~-~L~~L~L~~n~i~~~~~~~~----~~l-~~L~~L~l~~N~i~~~~----~~~~~~-l~~L~~L~l~~N~l~~l~  212 (678)
                      +..++ +|++|+|++|+|++..+..+    ..+ ++|++|+|++|.|++..    +..+.. .++|++|+|++|.|+..+
T Consensus       162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~  241 (362)
T 3goz_A          162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS  241 (362)
T ss_dssp             HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred             HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence            33444 66666666666664444322    233 36666666666666432    233333 236666666666665432


Q ss_pred             -----ccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcch
Q 005760          213 -----LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP  270 (678)
Q Consensus       213 -----~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~  270 (678)
                           ..+..+++|+.|+|++|.+.+..+..+..+.   -.+..+++|+.|+|++|++....+
T Consensus       242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~---~~~~~l~~L~~LdL~~N~l~~~~~  301 (362)
T 3goz_A          242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALG---AAFPNIQKIILVDKNGKEIHPSHS  301 (362)
T ss_dssp             HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHH---TTSTTCCEEEEECTTSCBCCGGGC
T ss_pred             HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHH---HHhccCCceEEEecCCCcCCCcch
Confidence                 2244556666666666665443333221111   011133356666666666654433

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=1.2e-25  Score=235.97  Aligned_cols=260  Identities=18%  Similarity=0.191  Sum_probs=207.4

Q ss_pred             EEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCC-CCcEEECccCCCcccCChhhhhcc----c
Q 005760           25 ILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCK-SLTLISFSNNPLDGILPKTSVGNL----S   99 (678)
Q Consensus        25 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~~l----~   99 (678)
                      .++|++|++++.+|..+...++|++|+|++|.++..+.. .+...|..++ +|++|+|++|.+++..+.. +..+    .
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~-~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~-l~~~l~~~~   79 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTV-ELIQAFANTPASVTSLNLSGNSLGFKNSDE-LVQILAAIP   79 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHH-HHHHHHHTCCTTCCEEECCSSCGGGSCHHH-HHHHHHTSC
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHH-HHHHHHHhCCCceeEEECcCCCCCHHHHHH-HHHHHhccC
Confidence            578999999998888888888899999999999987753 3345688898 9999999999998776655 4443    2


Q ss_pred             ccccEEEcccccccccCCccccC----C-CCCcEEEccCCccCCcCChhhhc-----cCCCCEEEccCCcCCCCCC----
Q 005760          100 HSLEYFEMAYCNVSGGIPEEIGN----L-TNLTIIYLGGNKLNGSIPSTLGK-----LQKLQGLGLENNKLEGSIP----  165 (678)
Q Consensus       100 ~~L~~L~l~~n~l~~~~~~~~~~----l-~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~L~~n~i~~~~~----  165 (678)
                      .+|++|+|++|.+++..+..+..    + ++|++|+|++|++++..+..+..     .++|++|+|++|.+++..+    
T Consensus        80 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~  159 (362)
T 3goz_A           80 ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI  159 (362)
T ss_dssp             TTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred             CCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH
Confidence            48999999999999887775444    4 89999999999998776665543     3699999999999985433    


Q ss_pred             CcccCCC-CccEEecCCCcCCCCChhhhhc----c-ccccceecccccccc-----cccccccc-ccccEEEecCCcccC
Q 005760          166 DSICHSD-ELYKLELGGNKLSGSIPECFNN----L-ASLRILLLGSNELTS-----IPLTFWNL-KDILYLNFSSNFFTG  233 (678)
Q Consensus       166 ~~~~~l~-~L~~L~l~~N~i~~~~~~~~~~----l-~~L~~L~l~~N~l~~-----l~~~~~~l-~~L~~L~l~~N~l~~  233 (678)
                      ..+..++ +|++|+|++|.+++..+..+..    + ++|+.|+|++|.|+.     ++..+..+ ++|+.|+|++|.+++
T Consensus       160 ~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~  239 (362)
T 3goz_A          160 QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG  239 (362)
T ss_dssp             HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCC
T ss_pred             HHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCc
Confidence            3445555 9999999999999888765554    4 699999999999997     67777764 599999999999997


Q ss_pred             CCCccccccccccccccCcccccEEEccCCcCCCcchH-------HHhcccCCCceeccccccccc
Q 005760          234 PLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPA-------SLEKLSYLKDLNLSFNKLEGE  292 (678)
Q Consensus       234 ~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~L~l~~N~~~~~  292 (678)
                      ..+..+..+      ...+++|+.|+|++|.++...+.       .+..+++|+.||+++|++...
T Consensus       240 ~~~~~l~~~------~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~  299 (362)
T 3goz_A          240 PSLENLKLL------KDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS  299 (362)
T ss_dssp             CCHHHHHHT------TTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred             HHHHHHHHH------HhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence            766444322      13445999999999996655443       445678899999999998865

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=1.4e-24  Score=213.95  Aligned_cols=195  Identities=22%  Similarity=0.207  Sum_probs=120.0

Q ss_pred             CCCEEecCCCcccccCCccccCCCCCCEEEccCcc-CCCCccchhhcccccCCCCCcEEECcc-CCCcccCChhhhhccc
Q 005760           22 KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNY-LTSSTLELSFLSSLSNCKSLTLISFSN-NPLDGILPKTSVGNLS   99 (678)
Q Consensus        22 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~~l~   99 (678)
                      +|++|+|++|+|+++.+.+|.++++|++|++++|. ++.++..     .|.++++|++|++++ |+++            
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~-----~f~~l~~L~~L~l~~~n~l~------------   94 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESH-----SFYNLSKVTHIEIRNTRNLT------------   94 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTT-----TEESCTTCCEEEEEEETTCC------------
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHh-----HcCCCcCCcEEECCCCCCee------------
Confidence            56666666666665555566666666666666664 5554432     355555555555555 5554            


Q ss_pred             ccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCC---EEEccCC-cCCCCCCCcccCCCCcc
Q 005760          100 HSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQ---GLGLENN-KLEGSIPDSICHSDELY  175 (678)
Q Consensus       100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~---~L~L~~n-~i~~~~~~~~~~l~~L~  175 (678)
                                    +..+..|.++++|++|++++|++++ +|. |..+++|+   +|++++| .+++..+..|..+++|+
T Consensus        95 --------------~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~  158 (239)
T 2xwt_C           95 --------------YIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET  158 (239)
T ss_dssp             --------------EECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSE
T ss_pred             --------------EcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcce
Confidence                          3444556666677777777777664 444 66666666   7777777 66655555566677777


Q ss_pred             -EEecCCCcCCCCChhhhhccccccceeccccc-cccccc-ccccc-ccccEEEecCCcccCCCCccccccccccccccC
Q 005760          176 -KLELGGNKLSGSIPECFNNLASLRILLLGSNE-LTSIPL-TFWNL-KDILYLNFSSNFFTGPLPLEIGNLKIARIDSCD  251 (678)
Q Consensus       176 -~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~-l~~l~~-~~~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~  251 (678)
                       .|++++|.++...+..|.. ++|+.|+|++|+ ++.++. .|..+ ++|+.|++++|++++..+..   ++        
T Consensus       159 ~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~~---~~--------  226 (239)
T 2xwt_C          159 LTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKG---LE--------  226 (239)
T ss_dssp             EEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCTT---CT--------
T ss_pred             eEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChhH---hc--------
Confidence             7777777776444444444 667777777774 776654 46666 77777777777776443332   22        


Q ss_pred             cccccEEEccCC
Q 005760          252 LISLISLNLSNN  263 (678)
Q Consensus       252 ~~~L~~L~L~~N  263 (678)
                        +|+.|+++++
T Consensus       227 --~L~~L~l~~~  236 (239)
T 2xwt_C          227 --HLKELIARNT  236 (239)
T ss_dssp             --TCSEEECTTC
T ss_pred             --cCceeeccCc
Confidence              6777777665

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.91  E-value=6.2e-26  Score=240.58  Aligned_cols=256  Identities=18%  Similarity=0.261  Sum_probs=157.1

Q ss_pred             cCCccccCCCCCCEEecCCCcccccC----CccccCCCCCCEEEccCccCCCCccch-----hhcccccCCCCCcEEECc
Q 005760           12 TIPRFIFNASKLSILELSDNSFSGFI----PNTFGNLRNLQALRLSNNYLTSSTLEL-----SFLSSLSNCKSLTLISFS   82 (678)
Q Consensus        12 ~~p~~~~~l~~L~~L~l~~n~i~~~~----~~~~~~l~~L~~L~l~~n~i~~~~~~~-----~~~~~~~~l~~L~~L~L~   82 (678)
                      .++..+..+++|++|+|++|+|+...    +..|.++++|++|+|++|.+..+...+     .+...|..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            45555666666777777777666542    233556667777777666555443211     111233556666666666


Q ss_pred             cCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhh----cc---------CC
Q 005760           83 NNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLG----KL---------QK  149 (678)
Q Consensus        83 ~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~----~l---------~~  149 (678)
                      +|.++.....                      .++..+..+++|++|+|++|.+++..+..+.    .+         ++
T Consensus       103 ~n~l~~~~~~----------------------~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~  160 (386)
T 2ca6_A          103 DNAFGPTAQE----------------------PLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPP  160 (386)
T ss_dssp             SCCCCTTTHH----------------------HHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             CCcCCHHHHH----------------------HHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCC
Confidence            6665532111                      2344566677777777777776533333333    23         77


Q ss_pred             CCEEEccCCcCC-CCCC---CcccCCCCccEEecCCCcCCC-----CChhhhhccccccceecccccc-----ccccccc
Q 005760          150 LQGLGLENNKLE-GSIP---DSICHSDELYKLELGGNKLSG-----SIPECFNNLASLRILLLGSNEL-----TSIPLTF  215 (678)
Q Consensus       150 L~~L~L~~n~i~-~~~~---~~~~~l~~L~~L~l~~N~i~~-----~~~~~~~~l~~L~~L~l~~N~l-----~~l~~~~  215 (678)
                      |++|+|++|+++ ..++   ..+..+++|++|+|++|.++.     ..+..+..+++|+.|+|++|.|     ..+|..+
T Consensus       161 L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l  240 (386)
T 2ca6_A          161 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL  240 (386)
T ss_dssp             CCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred             CcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHH
Confidence            777777777775 2233   355567777777777777762     2333667777888888888887     4566677


Q ss_pred             cccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCC----cchHHH-hcccCCCceeccccccc
Q 005760          216 WNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSG----AIPASL-EKLSYLKDLNLSFNKLE  290 (678)
Q Consensus       216 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~l~~N~~~  290 (678)
                      ..+++|+.|+|++|.+++.....+..    .+..+.+++|+.|+|++|+++.    .+|..+ ..+++|+.|++++|+++
T Consensus       241 ~~~~~L~~L~L~~n~i~~~~~~~l~~----~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~  316 (386)
T 2ca6_A          241 KSWPNLRELGLNDCLLSARGAAAVVD----AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  316 (386)
T ss_dssp             GGCTTCCEEECTTCCCCHHHHHHHHH----HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             ccCCCcCEEECCCCCCchhhHHHHHH----HHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCC
Confidence            77888888888888877542221111    0001224488888888888886    366666 55788888888888887


Q ss_pred             ccC
Q 005760          291 GEI  293 (678)
Q Consensus       291 ~~~  293 (678)
                      +..
T Consensus       317 ~~~  319 (386)
T 2ca6_A          317 EED  319 (386)
T ss_dssp             TTS
T ss_pred             cch
Confidence            554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=1.9e-25  Score=245.32  Aligned_cols=185  Identities=18%  Similarity=0.206  Sum_probs=144.3

Q ss_pred             CCCccccCCCceeEEEEEeCCCcEEEEEEeecccC--------chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          395 SENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG--------RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       395 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ...+.||+|+||.||+|.. .++.+++|+......        ...+.+.+|+++++.++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999955 578899998643211        1234578999999999999999666666566777999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++++|.+++..         +..++.|+++||+|||   +++|+||||||+||+++.  .+||+|||+++......
T Consensus       418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~  483 (540)
T 3en9_A          418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE  483 (540)
T ss_dssp             EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred             EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence            999999999999976         4579999999999999   999999999999999999  99999999998765322


Q ss_pred             Ccc-----eeecccCCccccCccccCC--CCCCccchHHHHHHHHHHHHcCCCCC
Q 005760          547 QST-----IQTQTLATIGYMAPEYGKE--GRVSANGDVYSFGIMLMETFTRKKPT  594 (678)
Q Consensus       547 ~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~ell~g~~p~  594 (678)
                      ...     ......||+.|+|||++..  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            111     1235679999999999876  56788899999999888888777665

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=3.6e-23  Score=205.32  Aligned_cols=143  Identities=29%  Similarity=0.344  Sum_probs=73.2

Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      .+++|+|++|++.+..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|+
T Consensus        36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  115 (251)
T 3m19_A           36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG  115 (251)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence            34444444444444444445555555555555555555555555555555555555555554444455555555555555


Q ss_pred             CCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccCCCCccccccc
Q 005760          181 GNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLK  243 (678)
Q Consensus       181 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  243 (678)
                      +|.|++..+..|..+++|+.|+|++|+|+.++. .|..+++|+.|+|++|++++..+..|..++
T Consensus       116 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  179 (251)
T 3m19_A          116 GNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLG  179 (251)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCT
T ss_pred             CCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCC
Confidence            555554444445555555555555555555444 344444555555555544444443443333

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=6.2e-24  Score=209.28  Aligned_cols=197  Identities=20%  Similarity=0.165  Sum_probs=134.7

Q ss_pred             CCcEEECccCCCcccCChhhhhcccccccEEEccccc-ccccCCccccCCCCCcEEEccC-CccCCcCChhhhccCCCCE
Q 005760           75 SLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCN-VSGGIPEEIGNLTNLTIIYLGG-NKLNGSIPSTLGKLQKLQG  152 (678)
Q Consensus        75 ~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~  152 (678)
                      +|++|++++|+++++.+.. +..++ +|++|++++|+ ++.+.+..|.++++|++|++++ |+++++.+..|.++++|++
T Consensus        32 ~l~~L~l~~n~l~~i~~~~-~~~l~-~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~  109 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHA-FSNLP-NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF  109 (239)
T ss_dssp             TCCEEEEESCCCSEECTTT-TTTCT-TCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCE
T ss_pred             cccEEEEeCCcceEECHHH-ccCCC-CCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCE
Confidence            3444444444444332222 33333 44444444443 4444455677888888888887 8888766778888888888


Q ss_pred             EEccCCcCCCCCCCcccCCCCcc---EEecCCC-cCCCCChhhhhcccccc-ceeccccccccccccccccccccEEEec
Q 005760          153 LGLENNKLEGSIPDSICHSDELY---KLELGGN-KLSGSIPECFNNLASLR-ILLLGSNELTSIPLTFWNLKDILYLNFS  227 (678)
Q Consensus       153 L~L~~n~i~~~~~~~~~~l~~L~---~L~l~~N-~i~~~~~~~~~~l~~L~-~L~l~~N~l~~l~~~~~~l~~L~~L~l~  227 (678)
                      |+|++|.+++ +|. |..+++|+   +|++++| .+++..+..|.++++|+ .|++++|+++.+|......++|+.|+++
T Consensus       110 L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~  187 (239)
T 2xwt_C          110 LGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLN  187 (239)
T ss_dssp             EEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECT
T ss_pred             EeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcC
Confidence            8888888884 555 77777777   8888888 88877777788888888 8888888888887743333778888888


Q ss_pred             CCc-ccCCCCcccccc-ccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceeccccc
Q 005760          228 SNF-FTGPLPLEIGNL-KIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNK  288 (678)
Q Consensus       228 ~N~-l~~~~~~~~~~l-~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  288 (678)
                      +|+ +++..+..|.++ +          +|+.|+|++|++++..+.   .+++|+.|+++++.
T Consensus       188 ~n~~l~~i~~~~~~~l~~----------~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          188 KNKYLTVIDKDAFGGVYS----------GPSLLDVSQTSVTALPSK---GLEHLKELIARNTW  237 (239)
T ss_dssp             TCTTCCEECTTTTTTCSB----------CCSEEECTTCCCCCCCCT---TCTTCSEEECTTC-
T ss_pred             CCCCcccCCHHHhhcccc----------CCcEEECCCCccccCChh---HhccCceeeccCcc
Confidence            884 776666666665 5          788888888888755443   56677777777653

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.90  E-value=1.6e-25  Score=237.49  Aligned_cols=261  Identities=22%  Similarity=0.228  Sum_probs=166.2

Q ss_pred             CccccCCcCcccCC----ccccCCCCCCEEecCCCcc---cccCCccc-------cCCCCCCEEEccCccCCCCccchhh
Q 005760            1 MLQMWENNFSGTIP----RFIFNASKLSILELSDNSF---SGFIPNTF-------GNLRNLQALRLSNNYLTSSTLELSF   66 (678)
Q Consensus         1 ~L~l~~~~~~~~~p----~~~~~l~~L~~L~l~~n~i---~~~~~~~~-------~~l~~L~~L~l~~n~i~~~~~~~~~   66 (678)
                      .|+|++|++.+..+    ..+..+++|++|+|++|.+   ++.+|..+       .++++|++|+|++|.++..... .+
T Consensus        36 ~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~-~l  114 (386)
T 2ca6_A           36 EIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE-PL  114 (386)
T ss_dssp             EEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH-HH
T ss_pred             EEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHH-HH
Confidence            37899999987644    4477899999999999754   44445444       7899999999999999874322 23


Q ss_pred             cccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccC-CcCC---h
Q 005760           67 LSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLN-GSIP---S  142 (678)
Q Consensus        67 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~---~  142 (678)
                      +..+..+++|++|+|++|.++...+......+.    .  +..|.+.       +..++|++|+|++|+++ ...+   .
T Consensus       115 ~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~----~--l~~~~~~-------~~~~~L~~L~L~~n~l~~~~~~~l~~  181 (386)
T 2ca6_A          115 IDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQ----E--LAVNKKA-------KNAPPLRSIICGRNRLENGSMKEWAK  181 (386)
T ss_dssp             HHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHH----H--HHHHHHH-------HTCCCCCEEECCSSCCTGGGHHHHHH
T ss_pred             HHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHH----H--Hhhhhhc-------ccCCCCcEEECCCCCCCcHHHHHHHH
Confidence            446788999999999999996443332111111    0  0000110       01166666666666665 2222   3


Q ss_pred             hhhccCCCCEEEccCCcCCC-----CCCCcccCCCCccEEecCCCcCC----CCChhhhhccccccceeccccccccc--
Q 005760          143 TLGKLQKLQGLGLENNKLEG-----SIPDSICHSDELYKLELGGNKLS----GSIPECFNNLASLRILLLGSNELTSI--  211 (678)
Q Consensus       143 ~~~~l~~L~~L~L~~n~i~~-----~~~~~~~~l~~L~~L~l~~N~i~----~~~~~~~~~l~~L~~L~l~~N~l~~l--  211 (678)
                      .+..+++|++|+|++|+|+.     ..+..+..+++|+.|+|++|.++    ..+|..+..+++|+.|+|++|.|+..  
T Consensus       182 ~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~  261 (386)
T 2ca6_A          182 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGA  261 (386)
T ss_dssp             HHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHH
T ss_pred             HHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhH
Confidence            45566677777777776652     22335666777777777777774    35566677777777777777777643  


Q ss_pred             ---cccc--cccccccEEEecCCcccC----CCCccc-cccccccccccCcccccEEEccCCcCCCcch--HHH-hcccC
Q 005760          212 ---PLTF--WNLKDILYLNFSSNFFTG----PLPLEI-GNLKIARIDSCDLISLISLNLSNNNLSGAIP--ASL-EKLSY  278 (678)
Q Consensus       212 ---~~~~--~~l~~L~~L~l~~N~l~~----~~~~~~-~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~--~~~-~~l~~  278 (678)
                         +..+  +.+++|+.|+|++|.+++    .+|..+ .+++          +|+.|+|++|++++..+  ..+ ..+++
T Consensus       262 ~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~----------~L~~L~l~~N~l~~~~~~~~~l~~~l~~  331 (386)
T 2ca6_A          262 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMP----------DLLFLELNGNRFSEEDDVVDEIREVFST  331 (386)
T ss_dssp             HHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCT----------TCCEEECTTSBSCTTSHHHHHHHHHHHH
T ss_pred             HHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCC----------CceEEEccCCcCCcchhHHHHHHHHhhh
Confidence               4445  337778888888887775    244433 2233          88888888888887664  322 23455


Q ss_pred             CCceecc
Q 005760          279 LKDLNLS  285 (678)
Q Consensus       279 L~~L~l~  285 (678)
                      ++.+++.
T Consensus       332 ~~~~~l~  338 (386)
T 2ca6_A          332 RGRGELD  338 (386)
T ss_dssp             HTCCEEC
T ss_pred             cCcchhh
Confidence            5545443

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.90  E-value=1.8e-23  Score=213.99  Aligned_cols=205  Identities=21%  Similarity=0.362  Sum_probs=115.6

Q ss_pred             ccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECcc
Q 005760            4 MWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSN   83 (678)
Q Consensus         4 l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~   83 (678)
                      +..+++.+.++  +..+++|++|++++|.++.. + .+..+++|+.|+|++|.+..++.       +..+++|++|+|++
T Consensus        26 l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~-------~~~l~~L~~L~L~~   94 (308)
T 1h6u_A           26 AGKSNVTDTVT--QADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP-------LKNLTKITELELSG   94 (308)
T ss_dssp             TTCSSTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-------GTTCCSCCEEECCS
T ss_pred             hCCCCcCceec--HHHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh-------HccCCCCCEEEccC
Confidence            34445544333  34566777777777777743 3 57777777777777777766542       56677777777777


Q ss_pred             CCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCC
Q 005760           84 NPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGS  163 (678)
Q Consensus        84 n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~  163 (678)
                      |++++..   .+..++ +|++|++++|++++..  .+..+++|++|++++|++++..+  +..+++|++|+|++|.+++ 
T Consensus        95 n~l~~~~---~~~~l~-~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-  165 (308)
T 1h6u_A           95 NPLKNVS---AIAGLQ-SIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-  165 (308)
T ss_dssp             CCCSCCG---GGTTCT-TCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-
T ss_pred             CcCCCch---hhcCCC-CCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-
Confidence            7776441   234443 5555555555555432  25555555555555555553322  5555555555555555553 


Q ss_pred             CCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCccc
Q 005760          164 IPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       164 ~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~  232 (678)
                      ++. +..+++|+.|++++|.+++..+  +..+++|++|+|++|+++.++. +..+++|+.|++++|+++
T Consensus       166 ~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          166 LTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEEEEEEE
T ss_pred             Chh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc-ccCCCCCCEEEccCCeee
Confidence            222 5555555555555555553322  5555555555555555555542 455555555555555554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=3e-23  Score=205.90  Aligned_cols=182  Identities=24%  Similarity=0.279  Sum_probs=163.0

Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      +.++++++++.++. +|..+.  ++|+.|+|++|.+++..+..|.++++|++|+|++|.|++..+..|..+++|++|+|+
T Consensus        15 ~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           15 GKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            45667777777764 444443  689999999999998888899999999999999999998888889999999999999


Q ss_pred             CCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEE
Q 005760          181 GNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLN  259 (678)
Q Consensus       181 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~  259 (678)
                      +|.+++..+..|..+++|++|+|++|+|+.++. .|..+++|+.|+|++|.+++..+..|.+++          +|+.|+
T Consensus        92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~----------~L~~L~  161 (251)
T 3m19_A           92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT----------NLQTLS  161 (251)
T ss_dssp             TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT----------TCCEEE
T ss_pred             CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCc----------CCCEEE
Confidence            999998888899999999999999999999987 478999999999999999988887888777          999999


Q ss_pred             ccCCcCCCcchHHHhcccCCCceecccccccccCCC
Q 005760          260 LSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR  295 (678)
Q Consensus       260 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  295 (678)
                      |++|++++..+..+..+++|+.|++++|+|.|.+..
T Consensus       162 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~  197 (251)
T 3m19_A          162 LSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCE  197 (251)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTSTT
T ss_pred             CCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCccc
Confidence            999999988888999999999999999999998433

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.90  E-value=3.2e-23  Score=212.16  Aligned_cols=214  Identities=21%  Similarity=0.341  Sum_probs=142.6

Q ss_pred             CCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccccc
Q 005760           22 KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHS  101 (678)
Q Consensus        22 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~  101 (678)
                      ++..+.+..+.++...  .+..+++|++|++++|.+..++       .+..+++|++|+|++|.+.++.           
T Consensus        20 ~~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l~-------~~~~l~~L~~L~L~~n~i~~~~-----------   79 (308)
T 1h6u_A           20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIE-------GVQYLNNLIGLELKDNQITDLA-----------   79 (308)
T ss_dssp             HHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCCT-------TGGGCTTCCEEECCSSCCCCCG-----------
T ss_pred             HHHHHHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCch-------hhhccCCCCEEEccCCcCCCCh-----------
Confidence            3444556666665432  2445677777777777776654       2556667777777777665332           


Q ss_pred             ccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCC
Q 005760          102 LEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG  181 (678)
Q Consensus       102 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~  181 (678)
                                     +  +..+++|++|+|++|++++.  ..+..+++|++|+|++|.+++ ++ .+..+++|+.|++++
T Consensus        80 ---------------~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~  138 (308)
T 1h6u_A           80 ---------------P--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDL  138 (308)
T ss_dssp             ---------------G--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECCS
T ss_pred             ---------------h--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-ch-hhcCCCCCCEEECCC
Confidence                           2  55667777777777777642  356677777777777777763 33 366777777777777


Q ss_pred             CcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEcc
Q 005760          182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLS  261 (678)
Q Consensus       182 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~  261 (678)
                      |.+++..+  +..+++|+.|+|++|+++.++. +..+++|+.|++++|.+++..+  +..++          +|+.|+|+
T Consensus       139 n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~----------~L~~L~L~  203 (308)
T 1h6u_A          139 NQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDISP--LASLP----------NLIEVHLK  203 (308)
T ss_dssp             SCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCT----------TCCEEECT
T ss_pred             CccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCcChh--hcCCC----------CCCEEEcc
Confidence            77775433  6777777777777777777665 6777777777777777775443  44444          78888888


Q ss_pred             CCcCCCcchHHHhcccCCCceecccccccccC
Q 005760          262 NNNLSGAIPASLEKLSYLKDLNLSFNKLEGEI  293 (678)
Q Consensus       262 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  293 (678)
                      +|++++..+  +..+++|+.|++++|++++.+
T Consensus       204 ~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~  233 (308)
T 1h6u_A          204 NNQISDVSP--LANTSNLFIVTLTNQTITNQP  233 (308)
T ss_dssp             TSCCCBCGG--GTTCTTCCEEEEEEEEEECCC
T ss_pred             CCccCcccc--ccCCCCCCEEEccCCeeecCC
Confidence            888876553  677888888888888887643

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.90  E-value=2.1e-23  Score=213.99  Aligned_cols=227  Identities=18%  Similarity=0.141  Sum_probs=180.6

Q ss_pred             CCCCCEEecCCCcccccCC---ccccCCCCCCEEEccCccCCCCccchhhcccc--cCCCCCcEEECccCCCcccCCh--
Q 005760           20 ASKLSILELSDNSFSGFIP---NTFGNLRNLQALRLSNNYLTSSTLELSFLSSL--SNCKSLTLISFSNNPLDGILPK--   92 (678)
Q Consensus        20 l~~L~~L~l~~n~i~~~~~---~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~--~~l~~L~~L~L~~n~i~~~~~~--   92 (678)
                      ...++.|.+.++.++....   ..+..+++|++|+|++|.+....+.     .+  ..+++|++|+|++|.+++..+.  
T Consensus        63 ~~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-----~~~~~~~~~L~~L~Ls~n~i~~~~~~~~  137 (310)
T 4glp_A           63 ALRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPP-----LPLEATGLALSSLRLRNVSWATGRSWLA  137 (310)
T ss_dssp             SCCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCC-----CSSSCCCBCCSSCEEESCCCSSTTSSHH
T ss_pred             hcceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhh-----hhhhccCCCCCEEEeecccccchhhhhH
Confidence            3457889999988864211   1122457799999999999866543     34  7899999999999999875541  


Q ss_pred             -hhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCc---C-ChhhhccCCCCEEEccCCcCCCCCCC-
Q 005760           93 -TSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGS---I-PSTLGKLQKLQGLGLENNKLEGSIPD-  166 (678)
Q Consensus        93 -~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~---~-~~~~~~l~~L~~L~L~~n~i~~~~~~-  166 (678)
                       ..+..++ +|++|+|++|++.+..+..|.++++|++|+|++|++.+.   . +..+..+++|++|+|++|+++ .++. 
T Consensus       138 ~~~~~~~~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~  215 (310)
T 4glp_A          138 ELQQWLKP-GLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGV  215 (310)
T ss_dssp             HHHTTBCS-CCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHH
T ss_pred             HHHhhhcc-CCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHH
Confidence             2233454 899999999999999889999999999999999998642   1 223468899999999999998 4443 


Q ss_pred             ---cccCCCCccEEecCCCcCCCCChhhhhcc---ccccceeccccccccccccccccccccEEEecCCcccCCCCcccc
Q 005760          167 ---SICHSDELYKLELGGNKLSGSIPECFNNL---ASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIG  240 (678)
Q Consensus       167 ---~~~~l~~L~~L~l~~N~i~~~~~~~~~~l---~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  240 (678)
                         .+..+++|++|+|++|.+++..|..+..+   ++|++|+|++|+|+.+|..+.  ++|+.|+|++|++++. |. +.
T Consensus       216 ~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~  291 (310)
T 4glp_A          216 CAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRA-PQ-PD  291 (310)
T ss_dssp             HHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSC-CC-TT
T ss_pred             HHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCC-ch-hh
Confidence               35778999999999999998878777776   699999999999999998765  7999999999999964 22 34


Q ss_pred             ccccccccccCcccccEEEccCCcCCC
Q 005760          241 NLKIARIDSCDLISLISLNLSNNNLSG  267 (678)
Q Consensus       241 ~l~~~~~~~~~~~~L~~L~L~~N~l~~  267 (678)
                      .++          +|+.|+|++|+++.
T Consensus       292 ~l~----------~L~~L~L~~N~l~~  308 (310)
T 4glp_A          292 ELP----------EVDNLTLDGNPFLV  308 (310)
T ss_dssp             SCC----------CCSCEECSSTTTSC
T ss_pred             hCC----------CccEEECcCCCCCC
Confidence            444          99999999999975

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=1.9e-23  Score=214.23  Aligned_cols=200  Identities=18%  Similarity=0.168  Sum_probs=88.4

Q ss_pred             ccEEEcccccccccCCccc--cCCCCCcEEEccCCccCCcCC----hhhhccCCCCEEEccCCcCCCCCCCcccCCCCcc
Q 005760          102 LEYFEMAYCNVSGGIPEEI--GNLTNLTIIYLGGNKLNGSIP----STLGKLQKLQGLGLENNKLEGSIPDSICHSDELY  175 (678)
Q Consensus       102 L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~l~~N~l~~~~~----~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~  175 (678)
                      |++|++++|.+.+..|..+  ..+++|++|+|++|.+++..+    ..+..+++|++|+|++|.+++..+..|..+++|+
T Consensus        93 L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~  172 (310)
T 4glp_A           93 LKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALT  172 (310)
T ss_dssp             CCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCC
T ss_pred             eeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCC
Confidence            4444444444444444444  444555555555555443222    2223344555555555555444444444555555


Q ss_pred             EEecCCCcCCCC--C--hhhhhccccccceecccccccccccc----ccccccccEEEecCCcccCCCCccccccccccc
Q 005760          176 KLELGGNKLSGS--I--PECFNNLASLRILLLGSNELTSIPLT----FWNLKDILYLNFSSNFFTGPLPLEIGNLKIARI  247 (678)
Q Consensus       176 ~L~l~~N~i~~~--~--~~~~~~l~~L~~L~l~~N~l~~l~~~----~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~  247 (678)
                      +|+|++|++.+.  .  +..+..+++|++|+|++|+|+.++..    +..+++|++|+|++|.+++..|..+..+.    
T Consensus       173 ~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~----  248 (310)
T 4glp_A          173 SLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCM----  248 (310)
T ss_dssp             EEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCC----
T ss_pred             EEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhcc----
Confidence            555555544321  1  11123444555555555555444331    23444555555555555544444333321    


Q ss_pred             cccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccCcc
Q 005760          248 DSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL  312 (678)
Q Consensus       248 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~  312 (678)
                         .+++|++|+|++|+|+ .+|..+.  ++|+.|++++|++++. |....++.++.+++.+|++
T Consensus       249 ---~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~L~~N~l  306 (310)
T 4glp_A          249 ---WSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQPDELPEVDNLTLDGNPF  306 (310)
T ss_dssp             ---CCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CCTTSCCCCSCEECSSTTT
T ss_pred             ---CcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-chhhhCCCccEEECcCCCC
Confidence               1124555555555554 2232221  4455555555555432 2223344445555555543

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.89  E-value=6.4e-23  Score=214.05  Aligned_cols=239  Identities=21%  Similarity=0.202  Sum_probs=141.1

Q ss_pred             CEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccccccc
Q 005760           24 SILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLE  103 (678)
Q Consensus        24 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~  103 (678)
                      +.++.++++++ .+|..+  .+++++|+|++|+|+.++..     +|.++++|++|+|++|++.+..+...+.+++..++
T Consensus        12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~-----~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~   83 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKG-----AFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHE   83 (350)
T ss_dssp             TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTT-----SSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCE
T ss_pred             CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHH-----HHcCCCCCCEEECcCCCCCCccChhHhhcchhhhh
Confidence            56777777777 445544  25777888888888776654     47777888888888887765555444555553334


Q ss_pred             EEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccC-CcCCCCCCCcccCCC-CccEEecCC
Q 005760          104 YFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLEN-NKLEGSIPDSICHSD-ELYKLELGG  181 (678)
Q Consensus       104 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~-~L~~L~l~~  181 (678)
                      .+.+++|+++.+.|..|.++++|++|++++|+++...+..+....++..|++.+ |.+....+..|..+. .++.|+|++
T Consensus        84 ~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~  163 (350)
T 4ay9_X           84 IRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK  163 (350)
T ss_dssp             EEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCS
T ss_pred             hhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccc
Confidence            455566666666666667777777777777777655555555556666666644 455544444555543 466666666


Q ss_pred             CcCCCCChhhhhccccccceecc-ccccccccc-cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEE
Q 005760          182 NKLSGSIPECFNNLASLRILLLG-SNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLN  259 (678)
Q Consensus       182 N~i~~~~~~~~~~l~~L~~L~l~-~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~  259 (678)
                      |+|+.+.+..| ...+|+.|+++ +|.++.+|. .|..+++|+.|+|++|+|+...+..|.             +|+.|.
T Consensus       164 N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~-------------~L~~L~  229 (350)
T 4ay9_X          164 NGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE-------------NLKKLR  229 (350)
T ss_dssp             SCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT-------------TCCEEE
T ss_pred             ccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc-------------cchHhh
Confidence            66664433333 33456666665 355666655 456666666666666666644433333             344444


Q ss_pred             ccCC-cCCCcchHHHhcccCCCceeccc
Q 005760          260 LSNN-NLSGAIPASLEKLSYLKDLNLSF  286 (678)
Q Consensus       260 L~~N-~l~~~~~~~~~~l~~L~~L~l~~  286 (678)
                      +.++ +++ ..| .+..+++|+.+++.+
T Consensus       230 ~l~~~~l~-~lP-~l~~l~~L~~l~l~~  255 (350)
T 4ay9_X          230 ARSTYNLK-KLP-TLEKLVALMEASLTY  255 (350)
T ss_dssp             CTTCTTCC-CCC-CTTTCCSCCEEECSC
T ss_pred             hccCCCcC-cCC-CchhCcChhhCcCCC
Confidence            3333 233 333 245555666665543

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.89  E-value=9.7e-24  Score=219.28  Aligned_cols=253  Identities=17%  Similarity=0.237  Sum_probs=189.7

Q ss_pred             CCCEEecCCCcccccCCccccCC--CCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccc
Q 005760           22 KLSILELSDNSFSGFIPNTFGNL--RNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLS   99 (678)
Q Consensus        22 ~L~~L~l~~n~i~~~~~~~~~~l--~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~   99 (678)
                      .++.|++++|.+.   +..+..+  ++++.|++++|.+......      +..+++|++|+|++|.+.+......+..++
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~------~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~  118 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE------HFSPFRVQHMDLSNSVIEVSTLHGILSQCS  118 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS------CCCCBCCCEEECTTCEECHHHHHHHHTTBC
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh------hccCCCCCEEEccCCCcCHHHHHHHHhhCC
Confidence            4788888888877   4666777  8888999998888776543      457888999999988876542223355565


Q ss_pred             ccccEEEcccccccccCCccccCCCCCcEEEccCC-ccCCc-CChhhhccCCCCEEEccCC-cCCCC-CCCcccCCC-Cc
Q 005760          100 HSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGN-KLNGS-IPSTLGKLQKLQGLGLENN-KLEGS-IPDSICHSD-EL  174 (678)
Q Consensus       100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~l~~L~~L~L~~n-~i~~~-~~~~~~~l~-~L  174 (678)
                       +|++|+|++|.+++..+..+..+++|++|+|++| .+++. .+..+.++++|++|+|++| .+++. ++..+..++ +|
T Consensus       119 -~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L  197 (336)
T 2ast_B          119 -KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI  197 (336)
T ss_dssp             -CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred             -CCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCC
Confidence             8899999999888888888888999999999999 67642 5666788899999999999 88743 466678888 99


Q ss_pred             cEEecCCC--cCC-CCChhhhhccccccceeccccc-cc-cccccccccccccEEEecCCcccCCCCccccccccccccc
Q 005760          175 YKLELGGN--KLS-GSIPECFNNLASLRILLLGSNE-LT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDS  249 (678)
Q Consensus       175 ~~L~l~~N--~i~-~~~~~~~~~l~~L~~L~l~~N~-l~-~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~  249 (678)
                      ++|++++|  .++ +.++..+..+++|+.|+|++|. ++ ..+..+..+++|+.|++++|.  +..+..+..+       
T Consensus       198 ~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~--~~~~~~~~~l-------  268 (336)
T 2ast_B          198 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY--DIIPETLLEL-------  268 (336)
T ss_dssp             CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT--TCCGGGGGGG-------
T ss_pred             CEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC--CCCHHHHHHH-------
Confidence            99999999  455 3556777889999999999998 65 456678888999999999996  2334322111       


Q ss_pred             cCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCC
Q 005760          250 CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRG  296 (678)
Q Consensus       250 ~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~  296 (678)
                      ..+++|+.|+|++| ++...-..+.  ..+..|++++|++++..|..
T Consensus       269 ~~~~~L~~L~l~~~-i~~~~~~~l~--~~l~~L~l~~n~l~~~~~~~  312 (336)
T 2ast_B          269 GEIPTLKTLQVFGI-VPDGTLQLLK--EALPHLQINCSHFTTIARPT  312 (336)
T ss_dssp             GGCTTCCEEECTTS-SCTTCHHHHH--HHSTTSEESCCCSCCTTCSS
T ss_pred             hcCCCCCEEeccCc-cCHHHHHHHH--hhCcceEEecccCccccCCc
Confidence            13459999999999 5543333332  24777888999998877764

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.89  E-value=1.8e-22  Score=210.61  Aligned_cols=238  Identities=18%  Similarity=0.190  Sum_probs=190.0

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCC-CccchhhcccccCCCCCcE-E
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTS-STLELSFLSSLSNCKSLTL-I   79 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~-~~~~~~~~~~~~~l~~L~~-L   79 (678)
                      ++-++++++ .+|..+.  +++++|+|++|+|+.+.+++|.++++|++|+|++|++.. ++..     .|.++++|+. +
T Consensus        14 v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~-----~f~~L~~l~~~l   85 (350)
T 4ay9_X           14 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD-----VFSNLPKLHEIR   85 (350)
T ss_dssp             EEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT-----SBCSCTTCCEEE
T ss_pred             EEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh-----Hhhcchhhhhhh
Confidence            345678888 8887664  689999999999998878899999999999999999855 4433     5889988775 6


Q ss_pred             ECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccC-CccCCcCChhhhccC-CCCEEEccC
Q 005760           80 SFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGG-NKLNGSIPSTLGKLQ-KLQGLGLEN  157 (678)
Q Consensus        80 ~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~-~L~~L~L~~  157 (678)
                      .++.|+++.+.+.. +..++ +|++|++++|++....+..+....++..|++.+ |++..+.+..|..+. .++.|+|++
T Consensus        86 ~~~~N~l~~l~~~~-f~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~  163 (350)
T 4ay9_X           86 IEKANNLLYINPEA-FQNLP-NLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK  163 (350)
T ss_dssp             EEEETTCCEECTTS-BCCCT-TCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCS
T ss_pred             cccCCcccccCchh-hhhcc-ccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccc
Confidence            67789998877665 77787 899999999999988888888888999999966 678877777888775 699999999


Q ss_pred             CcCCCCCCCcccCCCCccEEecCC-CcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccCCC
Q 005760          158 NKLEGSIPDSICHSDELYKLELGG-NKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPL  235 (678)
Q Consensus       158 n~i~~~~~~~~~~l~~L~~L~l~~-N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~  235 (678)
                      |+|+ .++......++|+.|++++ |.++.+.++.|.++++|+.|+|++|+|+.+|. .+.   +|+.|.+.++.-....
T Consensus       164 N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~---~L~~L~~l~~~~l~~l  239 (350)
T 4ay9_X          164 NGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE---NLKKLRARSTYNLKKL  239 (350)
T ss_dssp             SCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT---TCCEEECTTCTTCCCC
T ss_pred             cccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc---cchHhhhccCCCcCcC
Confidence            9999 5565666678999999975 77886666789999999999999999999987 354   5555554444333344


Q ss_pred             CccccccccccccccCcccccEEEccCCc
Q 005760          236 PLEIGNLKIARIDSCDLISLISLNLSNNN  264 (678)
Q Consensus       236 ~~~~~~l~~~~~~~~~~~~L~~L~L~~N~  264 (678)
                      | .+..++          +|+.+++.++.
T Consensus       240 P-~l~~l~----------~L~~l~l~~~~  257 (350)
T 4ay9_X          240 P-TLEKLV----------ALMEASLTYPS  257 (350)
T ss_dssp             C-CTTTCC----------SCCEEECSCHH
T ss_pred             C-CchhCc----------ChhhCcCCCCc
Confidence            4 244444          99999997653

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.88  E-value=7.3e-24  Score=220.19  Aligned_cols=251  Identities=16%  Similarity=0.188  Sum_probs=200.9

Q ss_pred             ccccCCcCcccCCccccCC--CCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEE
Q 005760            2 LQMWENNFSGTIPRFIFNA--SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLI   79 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L   79 (678)
                      |+++++++.   |..+..+  .+++.|++++|.+.+..+. +.++++|++|+|++|.+....    ++..+..+++|++|
T Consensus        52 l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~----~~~~~~~~~~L~~L  123 (336)
T 2ast_B           52 LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST----LHGILSQCSKLQNL  123 (336)
T ss_dssp             EECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHH----HHHHHTTBCCCSEE
T ss_pred             eccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHH----HHHHHhhCCCCCEE
Confidence            678888876   5667777  8999999999999977665 567999999999999976421    22357889999999


Q ss_pred             ECccCCCcccCChhhhhcccccccEEEcccc-ccccc-CCccccCCCCCcEEEccCC-ccCCc-CChhhhccC-CCCEEE
Q 005760           80 SFSNNPLDGILPKTSVGNLSHSLEYFEMAYC-NVSGG-IPEEIGNLTNLTIIYLGGN-KLNGS-IPSTLGKLQ-KLQGLG  154 (678)
Q Consensus        80 ~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n-~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~l~-~L~~L~  154 (678)
                      +|++|.+++..+.. +..++ +|++|+|++| .+++. ++..+.++++|++|++++| .+++. .+..+..++ +|++|+
T Consensus       124 ~L~~~~l~~~~~~~-l~~~~-~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~  201 (336)
T 2ast_B          124 SLEGLRLSDPIVNT-LAKNS-NLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLN  201 (336)
T ss_dssp             ECTTCBCCHHHHHH-HTTCT-TCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEE
T ss_pred             eCcCcccCHHHHHH-HhcCC-CCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEE
Confidence            99999998666554 55665 8999999999 67763 6777889999999999999 98854 567788999 999999


Q ss_pred             ccCCc--CC-CCCCCcccCCCCccEEecCCCc-CCCCChhhhhccccccceeccccc-cccc-cccccccccccEEEecC
Q 005760          155 LENNK--LE-GSIPDSICHSDELYKLELGGNK-LSGSIPECFNNLASLRILLLGSNE-LTSI-PLTFWNLKDILYLNFSS  228 (678)
Q Consensus       155 L~~n~--i~-~~~~~~~~~l~~L~~L~l~~N~-i~~~~~~~~~~l~~L~~L~l~~N~-l~~l-~~~~~~l~~L~~L~l~~  228 (678)
                      |++|.  ++ +.++..+..+++|++|++++|. +++..+..+..+++|++|+|++|. ++.- ...+..+++|+.|++++
T Consensus       202 l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~  281 (336)
T 2ast_B          202 LSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG  281 (336)
T ss_dssp             CCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred             eCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccC
Confidence            99994  54 3456677889999999999999 777778889999999999999995 3321 12578899999999999


Q ss_pred             CcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhc
Q 005760          229 NFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEK  275 (678)
Q Consensus       229 N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~  275 (678)
                      | +.   ...+..+.         .+|+.|++++|++++..|..++.
T Consensus       282 ~-i~---~~~~~~l~---------~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          282 I-VP---DGTLQLLK---------EALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             S-SC---TTCHHHHH---------HHSTTSEESCCCSCCTTCSSCSS
T ss_pred             c-cC---HHHHHHHH---------hhCcceEEecccCccccCCcccc
Confidence            9 33   23333332         14778889999999988876554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.86  E-value=2.3e-22  Score=194.96  Aligned_cols=178  Identities=23%  Similarity=0.333  Sum_probs=135.9

Q ss_pred             cEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceecccc
Q 005760          127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSN  206 (678)
Q Consensus       127 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N  206 (678)
                      +.+++++|.++ .+|..+.  ++|++|+|++|+|++..+..|..+++|+.|+|++|.|++..|..|.++++|++|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            46777777776 4455443  57788888888887666667777888888888888888777778888888888888888


Q ss_pred             cccccccc-ccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecc
Q 005760          207 ELTSIPLT-FWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLS  285 (678)
Q Consensus       207 ~l~~l~~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  285 (678)
                      +|+.+|.. |..+++|+.|+|++|+|++..+..|.+++          +|+.|+|++|+|++..+..+..+++|+.|+|+
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~----------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  160 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLH----------NLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLA  160 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT----------TCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCC----------CCCEEECCCCcCCEECHHHHhCCCCCCEEEeC
Confidence            88888764 67788888888888888888788787776          89999999999998888888899999999999


Q ss_pred             cccccccCCCCCccccccccccccCccccCCC
Q 005760          286 FNKLEGEIPRGGSFGNFSAESFEGNELLCGSP  317 (678)
Q Consensus       286 ~N~~~~~~~~~~~~~~l~~~~~~~n~~~c~~~  317 (678)
                      +|+|.|++...+...++....+......|..|
T Consensus       161 ~N~~~c~c~l~~l~~~l~~~~~~~~~~~C~~P  192 (220)
T 2v9t_B          161 QNPFICDCHLKWLADYLHTNPIETSGARCTSP  192 (220)
T ss_dssp             SSCEECSGGGHHHHHHHHHCCCBCSCCBEEES
T ss_pred             CCCcCCCCccHHHHHHHHhCCCCccCCCcCCc
Confidence            99999988765444444433334445556655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=8e-23  Score=205.74  Aligned_cols=151  Identities=17%  Similarity=0.131  Sum_probs=120.1

Q ss_pred             HHHhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccC------------------chhhhHHHHHHHHHhCCCc
Q 005760          387 LCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG------------------RVFKSFDVECEMMKSIRHR  448 (678)
Q Consensus       387 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~  448 (678)
                      .......|.+.+.||+|+||.||+|...+|+.||+|+++....                  .....+.+|+++++.++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3444556777899999999999999887899999999864321                  12456889999999998  


Q ss_pred             cceeeeeeeecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCC
Q 005760          449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDN  528 (678)
Q Consensus       449 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~  528 (678)
                      | +++.+++.. +..++||||+++++|.+ +..       .....++.|++.|+.|||   +.+|+||||||+||+++ +
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-T
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-C
Confidence            4 666665543 55689999999999988 422       123469999999999999   99999999999999999 9


Q ss_pred             CcEEEEeeccccccCCCCCcceeecccCCccccCccccCC
Q 005760          529 MVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE  568 (678)
Q Consensus       529 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  568 (678)
                      +.+||+|||+++.               +..+.|||++..
T Consensus       229 ~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          229 EGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             TEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             CcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence            9999999999863               234678887643

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.86  E-value=4.5e-22  Score=192.93  Aligned_cols=178  Identities=23%  Similarity=0.239  Sum_probs=122.0

Q ss_pred             cEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCC-CcccCCCCccEEecCCCcCCCCChhhhhccccccceeccc
Q 005760          127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIP-DSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGS  205 (678)
Q Consensus       127 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~  205 (678)
                      +.+++++|.++ .+|..+.  +.+++|+|++|.|++..+ ..|..+++|+.|+|++|.|++..+..|..+++|++|+|++
T Consensus        14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~   90 (220)
T 2v70_A           14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS   90 (220)
T ss_dssp             TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence            35666666665 3444332  345666777776664433 3466667777777777777766666677777777777777


Q ss_pred             cccccccc-cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceec
Q 005760          206 NELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNL  284 (678)
Q Consensus       206 N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  284 (678)
                      |+|+.++. .|..+++|+.|+|++|+|++..|..|.+++          +|+.|+|++|+|++..|..|..+++|+.|++
T Consensus        91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~----------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  160 (220)
T 2v70_A           91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLS----------SVRLLSLYDNQITTVAPGAFDTLHSLSTLNL  160 (220)
T ss_dssp             SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCT----------TCSEEECTTSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCc----------cCCEEECCCCcCCEECHHHhcCCCCCCEEEe
Confidence            77776655 467777777778888887777777777666          8888888888888887888888888999999


Q ss_pred             ccccccccCCCCCccccccccccccCccccCCC
Q 005760          285 SFNKLEGEIPRGGSFGNFSAESFEGNELLCGSP  317 (678)
Q Consensus       285 ~~N~~~~~~~~~~~~~~l~~~~~~~n~~~c~~~  317 (678)
                      ++|+|.|+++..+...++.......+...|..|
T Consensus       161 ~~N~l~c~c~l~~l~~~~~~~~~~~~~~~C~~P  193 (220)
T 2v70_A          161 LANPFNCNCYLAWLGEWLRKKRIVTGNPRCQKP  193 (220)
T ss_dssp             CSCCEECSGGGHHHHHHHHHSCCBCCCCEEEES
T ss_pred             cCcCCcCCCchHHHHHHHHhcCccccCCccCCC
Confidence            999998888765444444433333333456665

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=2.6e-21  Score=186.15  Aligned_cols=129  Identities=29%  Similarity=0.367  Sum_probs=56.9

Q ss_pred             ccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCC
Q 005760          102 LEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG  181 (678)
Q Consensus       102 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~  181 (678)
                      |++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|++++
T Consensus        30 l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~  109 (208)
T 2o6s_A           30 TTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNT  109 (208)
T ss_dssp             CSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCC
Confidence            33333333333333333344445555555555555443334444445555555555555433333344444444444444


Q ss_pred             CcCCCCChhhhhccccccceecccccccccccc-ccccccccEEEecCCc
Q 005760          182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLT-FWNLKDILYLNFSSNF  230 (678)
Q Consensus       182 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~-~~~l~~L~~L~l~~N~  230 (678)
                      |.+++..+..|..+++|+.|+|++|+++.++.. +..+++|+.|++++|+
T Consensus       110 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  159 (208)
T 2o6s_A          110 NQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP  159 (208)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCC
T ss_pred             CcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCC
Confidence            444444443444444444444444444444332 3334444444444443

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.85  E-value=8.4e-21  Score=192.39  Aligned_cols=189  Identities=22%  Similarity=0.286  Sum_probs=118.8

Q ss_pred             CCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccc
Q 005760           23 LSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSL  102 (678)
Q Consensus        23 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L  102 (678)
                      +..+.+..+.+++.  ..+..+++|+.|++++|.+..++       .+..+++|+.|+|++|++++..+   +..++ +|
T Consensus        26 ~~~~~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~~-------~~~~l~~L~~L~L~~n~l~~~~~---l~~l~-~L   92 (291)
T 1h6t_A           26 TIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSVQ-------GIQYLPNVTKLFLNGNKLTDIKP---LANLK-NL   92 (291)
T ss_dssp             HHHHHTTCSCTTSE--ECHHHHHTCCEEECTTSCCCCCT-------TGGGCTTCCEEECCSSCCCCCGG---GTTCT-TC
T ss_pred             HHHHHhcCCCcccc--cchhhcCcccEEEccCCCcccCh-------hHhcCCCCCEEEccCCccCCCcc---cccCC-CC
Confidence            44445555555533  22345566666666666665543       24556666666666666654432   33333 45


Q ss_pred             cEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCC
Q 005760          103 EYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGN  182 (678)
Q Consensus       103 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N  182 (678)
                      ++|++++|++++.  ..+..+++|++|++++|++++.  ..+..+++|++|+|++|++++.  ..+..+++|+.|++++|
T Consensus        93 ~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N  166 (291)
T 1h6t_A           93 GWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDN  166 (291)
T ss_dssp             CEEECCSSCCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSS
T ss_pred             CEEECCCCcCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCC
Confidence            5555555555442  2366777777777777777643  4567777777777777777743  46777777777777777


Q ss_pred             cCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccC
Q 005760          183 KLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTG  233 (678)
Q Consensus       183 ~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~  233 (678)
                      .+++..+  +..+++|+.|+|++|.|+.++. +..+++|+.|++++|++..
T Consensus       167 ~l~~~~~--l~~l~~L~~L~L~~N~i~~l~~-l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          167 QISDIVP--LAGLTKLQNLYLSKNHISDLRA-LAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCCCCGG--GTTCTTCCEEECCSSCCCBCGG-GTTCTTCSEEEEEEEEEEC
T ss_pred             ccccchh--hcCCCccCEEECCCCcCCCChh-hccCCCCCEEECcCCcccC
Confidence            7775544  7777777777777777777753 6677777777777777664

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.85  E-value=5.9e-21  Score=209.54  Aligned_cols=189  Identities=27%  Similarity=0.378  Sum_probs=130.5

Q ss_pred             CCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCC
Q 005760           46 NLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTN  125 (678)
Q Consensus        46 ~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~  125 (678)
                      +|+.|+|++|.++.++..      +  .++|++|+|++|+|+.+ | .    ...+|++|+|++|++++ +|. +.+  +
T Consensus        60 ~L~~L~Ls~n~L~~lp~~------l--~~~L~~L~Ls~N~l~~i-p-~----~l~~L~~L~Ls~N~l~~-ip~-l~~--~  121 (571)
T 3cvr_A           60 QFSELQLNRLNLSSLPDN------L--PPQITVLEITQNALISL-P-E----LPASLEYLDACDNRLST-LPE-LPA--S  121 (571)
T ss_dssp             TCSEEECCSSCCSCCCSC------C--CTTCSEEECCSSCCSCC-C-C----CCTTCCEEECCSSCCSC-CCC-CCT--T
T ss_pred             CccEEEeCCCCCCccCHh------H--cCCCCEEECcCCCCccc-c-c----ccCCCCEEEccCCCCCC-cch-hhc--C
Confidence            666666666666655432      1  25566666666666532 2 1    12366777777777666 444 444  7


Q ss_pred             CcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccc
Q 005760          126 LTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGS  205 (678)
Q Consensus       126 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~  205 (678)
                      |+.|+|++|+|++ +|.   .+++|++|+|++|.|++ +|.   .+++|+.|+|++|.|++ +|. |.  ++|+.|+|++
T Consensus       122 L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~  189 (571)
T 3cvr_A          122 LKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVST  189 (571)
T ss_dssp             CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCS
T ss_pred             CCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcC
Confidence            8888888888875 444   56788888888888874 554   46778888888888885 454 55  7888888888


Q ss_pred             cccccccccccccccc-------cEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccC
Q 005760          206 NELTSIPLTFWNLKDI-------LYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSY  278 (678)
Q Consensus       206 N~l~~l~~~~~~l~~L-------~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~  278 (678)
                      |.|+.+|. +..  +|       +.|+|++|+|+ .+|..+..++          +|+.|+|++|++++..|..+..+..
T Consensus       190 N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~----------~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          190 NLLESLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLD----------PTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             SCCSSCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSC----------TTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             CCCCchhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCC----------CCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            88888877 554  66       88999999888 4566665566          8999999999999888888877654

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=1.5e-20  Score=206.42  Aligned_cols=185  Identities=23%  Similarity=0.330  Sum_probs=79.4

Q ss_pred             CCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccccc
Q 005760           22 KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHS  101 (678)
Q Consensus        22 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~  101 (678)
                      +|+.|+|++|+|++ +|..+.  ++|+.|+|++|.|+.++ .        .+++|++|+|++|+|+++ |.  +   ..+
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~ip-~--------~l~~L~~L~Ls~N~l~~i-p~--l---~~~  121 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALISLP-E--------LPASLEYLDACDNRLSTL-PE--L---PAS  121 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSCCC-C--------CCTTCCEEECCSSCCSCC-CC--C---CTT
T ss_pred             CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcccc-c--------ccCCCCEEEccCCCCCCc-ch--h---hcC
Confidence            44445554444443 233221  34444455544444333 1        134444455554444432 21  1   114


Q ss_pred             ccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCC
Q 005760          102 LEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG  181 (678)
Q Consensus       102 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~  181 (678)
                      |++|+|++|++++ +|.   .+++|+.|+|++|+|++ +|.   .+++|++|+|++|.|++ +|. |.  ++|+.|+|++
T Consensus       122 L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~  189 (571)
T 3cvr_A          122 LKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVST  189 (571)
T ss_dssp             CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCS
T ss_pred             CCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcC
Confidence            4444555444444 222   34444444555444443 222   23444445555444442 333 32  4444455554


Q ss_pred             CcCCCCChhhhhccccc-------cceeccccccccccccccccccccEEEecCCcccCCCCcccc
Q 005760          182 NKLSGSIPECFNNLASL-------RILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIG  240 (678)
Q Consensus       182 N~i~~~~~~~~~~l~~L-------~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~  240 (678)
                      |.|+ .+|. |..  +|       +.|+|++|+|+.+|..+..+++|+.|+|++|++++..|..+.
T Consensus       190 N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~  251 (571)
T 3cvr_A          190 NLLE-SLPA-VPV--RNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIRESLS  251 (571)
T ss_dssp             SCCS-SCCC-CC----------CCEEEECCSSCCCCCCGGGGGSCTTEEEECCSSSCCHHHHHHHH
T ss_pred             CCCC-chhh-HHH--hhhcccccceEEecCCCcceecCHHHhcCCCCCEEEeeCCcCCCcCHHHHH
Confidence            4444 2222 222  33       444454444444444444444444455555544444444433

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.84  E-value=5.2e-21  Score=200.41  Aligned_cols=163  Identities=25%  Similarity=0.237  Sum_probs=88.6

Q ss_pred             CcEEEccCCccCCcCChhhh-ccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceecc
Q 005760          126 LTIIYLGGNKLNGSIPSTLG-KLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLG  204 (678)
Q Consensus       126 L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~  204 (678)
                      ++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|..+++|++|+|++|.|+...+..|..+++|+.|+|+
T Consensus        41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  120 (361)
T 2xot_A           41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY  120 (361)
T ss_dssp             CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence            44444444444433333343 44444444444444443333444444444444444444444444444445555555555


Q ss_pred             cccccccc-ccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccC--CCc
Q 005760          205 SNELTSIP-LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSY--LKD  281 (678)
Q Consensus       205 ~N~l~~l~-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~--L~~  281 (678)
                      +|+|+.++ ..|.++++|+.|+|++|.|++..+..|.++       ..+++|+.|+|++|+|+...+..+..++.  |+.
T Consensus       121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~-------~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~  193 (361)
T 2xot_A          121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDG-------NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG  193 (361)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC-----------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTT
T ss_pred             CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCc-------ccCCcCCEEECCCCCCCccCHHHhhhccHhhcce
Confidence            55555442 245555555555555555554333333211       12338888888888888777777888776  478


Q ss_pred             eecccccccccCCC
Q 005760          282 LNLSFNKLEGEIPR  295 (678)
Q Consensus       282 L~l~~N~~~~~~~~  295 (678)
                      |+|++|+|.|+|..
T Consensus       194 l~l~~N~~~C~C~l  207 (361)
T 2xot_A          194 LYLHNNPLECDCKL  207 (361)
T ss_dssp             EECCSSCEECCHHH
T ss_pred             EEecCCCccCCcCc
Confidence            99999999988764

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.84  E-value=2.7e-20  Score=188.58  Aligned_cols=170  Identities=28%  Similarity=0.372  Sum_probs=129.9

Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      +|++|++++|.+...  ..+..+++|++|+|++|++++..+  +..+++|++|+|++|.+++ ++ .+..+++|++|+++
T Consensus        47 ~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~  120 (291)
T 1h6t_A           47 SIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLE  120 (291)
T ss_dssp             TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECT
T ss_pred             cccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECC
Confidence            566666666666544  236778888888888888875443  7788888888888888873 33 47888888888888


Q ss_pred             CCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEc
Q 005760          181 GNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNL  260 (678)
Q Consensus       181 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L  260 (678)
                      +|.+++.  ..+..+++|+.|++++|+++.+ ..+..+++|+.|++++|.+++..+  +..++          +|+.|+|
T Consensus       121 ~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~----------~L~~L~L  185 (291)
T 1h6t_A          121 HNGISDI--NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLT----------KLQNLYL  185 (291)
T ss_dssp             TSCCCCC--GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCT----------TCCEEEC
T ss_pred             CCcCCCC--hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCC----------ccCEEEC
Confidence            8888854  4577888888888888888887 467888888888888888886554  55555          8999999


Q ss_pred             cCCcCCCcchHHHhcccCCCceecccccccccC
Q 005760          261 SNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEI  293 (678)
Q Consensus       261 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  293 (678)
                      ++|+|++. + .+..+++|+.|++++|+++...
T Consensus       186 ~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~~  216 (291)
T 1h6t_A          186 SKNHISDL-R-ALAGLKNLDVLELFSQECLNKP  216 (291)
T ss_dssp             CSSCCCBC-G-GGTTCTTCSEEEEEEEEEECCC
T ss_pred             CCCcCCCC-h-hhccCCCCCEEECcCCcccCCc
Confidence            99988864 3 3788889999999999887643

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.83  E-value=2.5e-20  Score=179.20  Aligned_cols=180  Identities=24%  Similarity=0.271  Sum_probs=116.9

Q ss_pred             CEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccccccc
Q 005760           24 SILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLE  103 (678)
Q Consensus        24 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~  103 (678)
                      +.++++++.++. +|..+  .++|++|++++|.++.++..     .|..+++|++|++++|+++++              
T Consensus        10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~--------------   67 (208)
T 2o6s_A           10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNG-----VFDELTSLTQLYLGGNKLQSL--------------   67 (208)
T ss_dssp             TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTT-----TTTTCTTCSEEECCSSCCCCC--------------
T ss_pred             CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChh-----hhcccccCcEEECCCCccCcc--------------
Confidence            566777777763 34333  34677777777777665543     356666666666666666533              


Q ss_pred             EEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCc
Q 005760          104 YFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNK  183 (678)
Q Consensus       104 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~  183 (678)
                                  .+..|..+++|++|+|++|++++..+..|.++++|++|+|++|.|++..+..|..+++|++|++++|.
T Consensus        68 ------------~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~  135 (208)
T 2o6s_A           68 ------------PNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQ  135 (208)
T ss_dssp             ------------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ------------ChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCc
Confidence                        33445666777777777777765555566677777777777777775555556677777777777777


Q ss_pred             CCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccc
Q 005760          184 LSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK  243 (678)
Q Consensus       184 i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  243 (678)
                      +++..+..|..+++|+.|+|++|.+.      ..+++|+.|+++.|.++|.+|..++.++
T Consensus       136 l~~~~~~~~~~l~~L~~L~l~~N~~~------~~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          136 LKSVPDGVFDRLTSLQYIWLHDNPWD------CTCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             CSCCCTTTTTTCTTCCEEECCSCCBC------CCTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             cceeCHHHhccCCCccEEEecCCCee------cCCCCHHHHHHHHHhCCceeeccCcccc
Confidence            77666666677777777777777554      2345677777777777777776665544

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.83  E-value=4.7e-21  Score=212.74  Aligned_cols=193  Identities=21%  Similarity=0.277  Sum_probs=118.8

Q ss_pred             CCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccccc
Q 005760           22 KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHS  101 (678)
Q Consensus        22 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~  101 (678)
                      ++..+++..+.+....+  +..+++|+.|++++|.+..++       .|..+++|+.|+|++|++.++.+   +..++ +
T Consensus        22 ~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l~-------~l~~l~~L~~L~Ls~N~l~~~~~---l~~l~-~   88 (605)
T 1m9s_A           22 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ-------GIQYLPNVTKLFLNGNKLTDIKP---LTNLK-N   88 (605)
T ss_dssp             HHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCCT-------TGGGCTTCCEEECTTSCCCCCGG---GGGCT-T
T ss_pred             HHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCCh-------HHccCCCCCEEEeeCCCCCCChh---hccCC-C
Confidence            34455555555554322  345566666666666665543       24556666666666666654433   33443 5


Q ss_pred             ccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCC
Q 005760          102 LEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG  181 (678)
Q Consensus       102 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~  181 (678)
                      |+.|+|++|.+.+.  ..+..+++|+.|+|++|++.+.  ..+..+++|+.|+|++|.|++.  ..+..+++|+.|+|++
T Consensus        89 L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~  162 (605)
T 1m9s_A           89 LGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLED  162 (605)
T ss_dssp             CCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCS
T ss_pred             CCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcC
Confidence            55555555555542  2466677777777777777642  3466777777777777777643  4566777777777777


Q ss_pred             CcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCC
Q 005760          182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLP  236 (678)
Q Consensus       182 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~  236 (678)
                      |.|.+..|  +..+++|+.|+|++|+|+.++ .+..+++|+.|+|++|++.+...
T Consensus       163 N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~L~~N~l~~~p~  214 (605)
T 1m9s_A          163 NQISDIVP--LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFSQECLNKPI  214 (605)
T ss_dssp             SCCCCCGG--GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEECCSEEEECCCC
T ss_pred             CcCCCchh--hccCCCCCEEECcCCCCCCCh-HHccCCCCCEEEccCCcCcCCcc
Confidence            77775544  667777777777777777664 46667777777777777664433

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.83  E-value=2.1e-20  Score=207.55  Aligned_cols=189  Identities=23%  Similarity=0.345  Sum_probs=164.3

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      ++++.+.+.+..+  +..+++|+.|+|++|.|... + .|..+++|+.|+|++|.+..++.       |..+++|+.|+|
T Consensus        26 l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~-------l~~l~~L~~L~L   94 (605)
T 1m9s_A           26 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP-------LTNLKNLGWLFL   94 (605)
T ss_dssp             HHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG-------GGGCTTCCEEEC
T ss_pred             HhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh-------hccCCCCCEEEC
Confidence            3566777775555  57789999999999999954 3 69999999999999999998763       789999999999


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCC
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLE  161 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~  161 (678)
                      ++|.+.++.   .+..++ +|++|+|++|++.+.  ..+..+++|+.|+|++|++++.  ..|..+++|+.|+|++|.|+
T Consensus        95 s~N~l~~l~---~l~~l~-~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~  166 (605)
T 1m9s_A           95 DENKIKDLS---SLKDLK-KLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS  166 (605)
T ss_dssp             CSSCCCCCT---TSTTCT-TCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCC
T ss_pred             cCCCCCCCh---hhccCC-CCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCC
Confidence            999998653   366676 899999999999974  5689999999999999999965  67999999999999999999


Q ss_pred             CCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc
Q 005760          162 GSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL  213 (678)
Q Consensus       162 ~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~  213 (678)
                      +..|  +..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|.++..|.
T Consensus       167 ~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~  214 (605)
T 1m9s_A          167 DIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPI  214 (605)
T ss_dssp             CCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCC
T ss_pred             Cchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcc
Confidence            6655  99999999999999999965  458999999999999999998765

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.82  E-value=1.8e-20  Score=196.21  Aligned_cols=156  Identities=24%  Similarity=0.240  Sum_probs=109.4

Q ss_pred             cccEEEcccccccccCCcccc-CCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEec
Q 005760          101 SLEYFEMAYCNVSGGIPEEIG-NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL  179 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l  179 (678)
                      .++.|+|++|++++..+..|. ++++|+.|+|++|+|+++.+.+|.++++|++|+|++|+|+...+..|..+++|+.|+|
T Consensus        40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  119 (361)
T 2xot_A           40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL  119 (361)
T ss_dssp             TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence            455555555555555555565 6777777777777777666667777777777777777777555666777777777777


Q ss_pred             CCCcCCCCChhhhhccccccceecccccccccccc-c---cccccccEEEecCCcccCCCCccccccccccccccCccc-
Q 005760          180 GGNKLSGSIPECFNNLASLRILLLGSNELTSIPLT-F---WNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLIS-  254 (678)
Q Consensus       180 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~-~---~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~-  254 (678)
                      ++|.|+...+..|.++++|+.|+|++|+|+.+|.. |   ..+++|+.|+|++|+|+...+..+..++          + 
T Consensus       120 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~----------~~  189 (361)
T 2xot_A          120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLP----------AW  189 (361)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSC----------HH
T ss_pred             CCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhcc----------Hh
Confidence            77777766677777777777777777777777664 3   4577788888888888766556665554          4 


Q ss_pred             -ccEEEccCCcCC
Q 005760          255 -LISLNLSNNNLS  266 (678)
Q Consensus       255 -L~~L~L~~N~l~  266 (678)
                       |+.|+|++|.+.
T Consensus       190 ~l~~l~l~~N~~~  202 (361)
T 2xot_A          190 VKNGLYLHNNPLE  202 (361)
T ss_dssp             HHTTEECCSSCEE
T ss_pred             hcceEEecCCCcc
Confidence             477888888876

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=8.5e-20  Score=178.10  Aligned_cols=136  Identities=30%  Similarity=0.335  Sum_probs=70.7

Q ss_pred             CCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEe
Q 005760          148 QKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNF  226 (678)
Q Consensus       148 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l  226 (678)
                      ++|++|+|++|.|++..|..|..+++|++|+|++|.|+...+..|..+++|+.|+|++|+|+.++. .|..+++|+.|+|
T Consensus        40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L  119 (229)
T 3e6j_A           40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM  119 (229)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence            444444444444444334444444444444444444443333444444444444444444444433 2344555555555


Q ss_pred             cCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCC
Q 005760          227 SSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP  294 (678)
Q Consensus       227 ~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  294 (678)
                      ++|+|+ .+|..+.+++          +|+.|+|++|+|++..+..+..+++|+.|++++|+|.|.++
T Consensus       120 s~N~l~-~lp~~~~~l~----------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          120 CCNKLT-ELPRGIERLT----------HLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             CSSCCC-SCCTTGGGCT----------TCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             cCCccc-ccCcccccCC----------CCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            555554 3344444333          66666666666665555556666667777777777776665

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.81  E-value=4e-22  Score=223.81  Aligned_cols=133  Identities=14%  Similarity=0.055  Sum_probs=75.3

Q ss_pred             CCCccEEecCCCcCCCCChhhhhc-cccccceecc----cccccccc------ccccccccccEEEecCCc--ccCCCCc
Q 005760          171 SDELYKLELGGNKLSGSIPECFNN-LASLRILLLG----SNELTSIP------LTFWNLKDILYLNFSSNF--FTGPLPL  237 (678)
Q Consensus       171 l~~L~~L~l~~N~i~~~~~~~~~~-l~~L~~L~l~----~N~l~~l~------~~~~~l~~L~~L~l~~N~--l~~~~~~  237 (678)
                      +++|++|+++.|.+++..+..+.. +++|+.|+++    .|.++..|      ..+.++++|+.|++++|.  +++....
T Consensus       377 ~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~  456 (592)
T 3ogk_B          377 CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLS  456 (592)
T ss_dssp             CTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHH
T ss_pred             CccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHH
Confidence            455555555555555444444433 5555555553    44454322      224445555555554322  3322222


Q ss_pred             cccccccccccccCcccccEEEccCCcCCCc-chHHHhcccCCCceeccccccccc-CCCC-CccccccccccccCcc
Q 005760          238 EIGNLKIARIDSCDLISLISLNLSNNNLSGA-IPASLEKLSYLKDLNLSFNKLEGE-IPRG-GSFGNFSAESFEGNEL  312 (678)
Q Consensus       238 ~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~l~~N~~~~~-~~~~-~~~~~l~~~~~~~n~~  312 (678)
                      .+.         ..+++|+.|+|++|++++. .+..+..+++|++|++++|+++.. ++.. ..+++++.+++++|..
T Consensus       457 ~~~---------~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~i  525 (592)
T 3ogk_B          457 YIG---------QYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA  525 (592)
T ss_dssp             HHH---------HSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBC
T ss_pred             HHH---------HhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcC
Confidence            211         1245889999998888763 345557788899999999987543 2222 3467788888888873

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.81  E-value=4.4e-19  Score=173.04  Aligned_cols=155  Identities=24%  Similarity=0.260  Sum_probs=120.6

Q ss_pred             ccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCC
Q 005760          102 LEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG  181 (678)
Q Consensus       102 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~  181 (678)
                      -+.++.++++++. +|..+  .++|++|+|++|++++..|..|.++++|++|+|++|+|+...+..|..+++|++|+|++
T Consensus        21 ~~~v~c~~~~l~~-ip~~~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHAS-VPAGI--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcCc-cCCCC--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            4556666666653 33333  27788888888888877777888888888888888888755556678888888888888


Q ss_pred             CcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEcc
Q 005760          182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLS  261 (678)
Q Consensus       182 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~  261 (678)
                      |.|++..+..|..+++|+.|+|++|+|+.+|..+..+++|+.|+|++|+|++..+..|..++          +|+.|+|+
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~----------~L~~L~l~  167 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS----------SLTHAYLF  167 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCT----------TCCEEECT
T ss_pred             CcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCC----------CCCEEEee
Confidence            88887777778888888888888888888888888888888888888888877766676666          88999999


Q ss_pred             CCcCCCcc
Q 005760          262 NNNLSGAI  269 (678)
Q Consensus       262 ~N~l~~~~  269 (678)
                      +|.++...
T Consensus       168 ~N~~~c~c  175 (229)
T 3e6j_A          168 GNPWDCEC  175 (229)
T ss_dssp             TSCBCTTB
T ss_pred             CCCccCCc
Confidence            99887543

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.81  E-value=1.6e-19  Score=174.91  Aligned_cols=114  Identities=25%  Similarity=0.309  Sum_probs=68.4

Q ss_pred             ccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhcccccc
Q 005760          120 IGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLR  199 (678)
Q Consensus       120 ~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~  199 (678)
                      |..+++|++|+|++|+|+++.+..|.++++|++|+|++|.|++..+..|..+++|++|+|++|.|++..|..|..+++|+
T Consensus        53 ~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  132 (220)
T 2v70_A           53 FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR  132 (220)
T ss_dssp             GGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCS
T ss_pred             hccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCC
Confidence            45555666666666666555555556666666666666666544445555666666666666666655555666666666


Q ss_pred             ceeccccccccc-cccccccccccEEEecCCcccC
Q 005760          200 ILLLGSNELTSI-PLTFWNLKDILYLNFSSNFFTG  233 (678)
Q Consensus       200 ~L~l~~N~l~~l-~~~~~~l~~L~~L~l~~N~l~~  233 (678)
                      .|+|++|+|+.+ |..|..+++|+.|+|++|++..
T Consensus       133 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  167 (220)
T 2v70_A          133 LLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC  167 (220)
T ss_dssp             EEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred             EEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence            666666666655 3456666666666666666653

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.81  E-value=2e-19  Score=174.28  Aligned_cols=132  Identities=23%  Similarity=0.265  Sum_probs=87.4

Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      +|++|+|++|++++..+..|.++++|++|+|++|+++++.|..|.++++|++|+|++|+|+...+..|.++++|++|+|+
T Consensus        33 ~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~  112 (220)
T 2v9t_B           33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLN  112 (220)
T ss_dssp             TCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECC
Confidence            45555555555555555566677777777777777776667777777777777777777775445556667777777777


Q ss_pred             CCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCccc
Q 005760          181 GNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       181 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~  232 (678)
                      +|.|++..+..|..+++|+.|+|++|+|+.++. .|..+++|+.|+|++|++.
T Consensus       113 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B          113 ANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            777776666667767777777777776666654 3555666666666666554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.79  E-value=5.2e-22  Score=219.12  Aligned_cols=122  Identities=20%  Similarity=0.224  Sum_probs=89.1

Q ss_pred             CCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecC
Q 005760          149 KLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSS  228 (678)
Q Consensus       149 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~  228 (678)
                      .|+.|+|++|.|++ +|. |..+++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|+|+.+| .+..+++|+.|+|++
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~  517 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCN  517 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCS
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCC
Confidence            47777777777773 554 777777777777777777 66677777777777777777777777 677777788888888


Q ss_pred             CcccCCC-CccccccccccccccCcccccEEEccCCcCCCcch---HHHhcccCCCceec
Q 005760          229 NFFTGPL-PLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP---ASLEKLSYLKDLNL  284 (678)
Q Consensus       229 N~l~~~~-~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~l  284 (678)
                      |.|++.. |..+.+++          +|+.|+|++|++++..|   ..+..+++|+.|++
T Consensus       518 N~l~~~~~p~~l~~l~----------~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          518 NRLQQSAAIQPLVSCP----------RLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             SCCCSSSTTGGGGGCT----------TCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCCCCCCCcHHHhcCC----------CCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            8777666 77776666          78888888887776544   23445777777754

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.79  E-value=2.5e-20  Score=209.07  Aligned_cols=279  Identities=12%  Similarity=0.026  Sum_probs=193.6

Q ss_pred             ccccCCcCc----ccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCc----------------
Q 005760            2 LQMWENNFS----GTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSST----------------   61 (678)
Q Consensus         2 L~l~~~~~~----~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~----------------   61 (678)
                      |++++|.++    +.++..+.++++|++|+|++|.+.+ .+..+.++++|++|+++.+......                
T Consensus       197 L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L  275 (592)
T 3ogk_B          197 LNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRL  275 (592)
T ss_dssp             EECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEE
T ss_pred             EEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhcccccccc
Confidence            678888886    4556666778999999999998875 4566777777777777642211000                


Q ss_pred             -----cchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEcc----
Q 005760           62 -----LELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLG----  132 (678)
Q Consensus        62 -----~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~----  132 (678)
                           ....++..+..+++|++|+|++|.+++......+..++ +|++|+++++-..+.++..+..+++|++|+++    
T Consensus       276 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~-~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~  354 (592)
T 3ogk_B          276 GLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCP-NLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGAD  354 (592)
T ss_dssp             EETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCT-TCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCC
T ss_pred             CccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCc-CCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCcc
Confidence                 00012233566788888888888876544333344555 78888888333333344445678899999999    


Q ss_pred             -------CCccCCcCCh-hhhccCCCCEEEccCCcCCCCCCCcccC-CCCccEEecC----CCcCCCC-----Chhhhhc
Q 005760          133 -------GNKLNGSIPS-TLGKLQKLQGLGLENNKLEGSIPDSICH-SDELYKLELG----GNKLSGS-----IPECFNN  194 (678)
Q Consensus       133 -------~N~l~~~~~~-~~~~l~~L~~L~L~~n~i~~~~~~~~~~-l~~L~~L~l~----~N~i~~~-----~~~~~~~  194 (678)
                             .|.+++.... .+..+++|++|+++.|.+++..+..+.. +++|+.|+++    .|.+++.     ++..+.+
T Consensus       355 ~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~  434 (592)
T 3ogk_B          355 EQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIG  434 (592)
T ss_dssp             SSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHH
T ss_pred             ccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHh
Confidence                   3566533222 2456899999999999998665556655 8999999996    7788864     3344778


Q ss_pred             cccccceeccccc--ccc-ccccc-cccccccEEEecCCcccCCC-CccccccccccccccCcccccEEEccCCcCCCcc
Q 005760          195 LASLRILLLGSNE--LTS-IPLTF-WNLKDILYLNFSSNFFTGPL-PLEIGNLKIARIDSCDLISLISLNLSNNNLSGAI  269 (678)
Q Consensus       195 l~~L~~L~l~~N~--l~~-l~~~~-~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~  269 (678)
                      +++|+.|++++|.  ++. ....+ ..+++|+.|++++|.+++.. +..+.+++          +|++|+|++|.+++..
T Consensus       435 ~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~----------~L~~L~l~~n~l~~~~  504 (592)
T 3ogk_B          435 CKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCP----------NLQKLEMRGCCFSERA  504 (592)
T ss_dssp             CTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCT----------TCCEEEEESCCCBHHH
T ss_pred             CCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCc----------ccCeeeccCCCCcHHH
Confidence            9999999998543  553 22233 34789999999999987533 22234444          9999999999987553


Q ss_pred             -hHHHhcccCCCceeccccccccc
Q 005760          270 -PASLEKLSYLKDLNLSFNKLEGE  292 (678)
Q Consensus       270 -~~~~~~l~~L~~L~l~~N~~~~~  292 (678)
                       +..+..+++|+.|++++|+++..
T Consensus       505 ~~~~~~~l~~L~~L~ls~n~it~~  528 (592)
T 3ogk_B          505 IAAAVTKLPSLRYLWVQGYRASMT  528 (592)
T ss_dssp             HHHHHHHCSSCCEEEEESCBCCTT
T ss_pred             HHHHHHhcCccCeeECcCCcCCHH
Confidence             34456799999999999998754

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.78  E-value=4.3e-19  Score=176.88  Aligned_cols=172  Identities=20%  Similarity=0.309  Sum_probs=108.0

Q ss_pred             CCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccc
Q 005760           20 ASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLS   99 (678)
Q Consensus        20 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~   99 (678)
                      +.+++.+++++|.++...  .+..+++|+.|++++|.+++++       .+..+++|+.|+|++|+++++.+   +..++
T Consensus        18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l~-------~l~~l~~L~~L~L~~N~i~~~~~---l~~l~   85 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSLA-------GMQFFTNLKELHLSHNQISDLSP---LKDLT   85 (263)
T ss_dssp             HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCCT-------TGGGCTTCCEEECCSSCCCCCGG---GTTCS
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccch-------HHhhCCCCCEEECCCCccCCChh---hccCC
Confidence            445556666666666432  4556666666666666665544       24556666666666666655433   44444


Q ss_pred             ccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEec
Q 005760          100 HSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL  179 (678)
Q Consensus       100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l  179 (678)
                       +|++|+|++|++++..+  +.. ++|+.|+|++|++++.  ..+..+++|++|+|++|+|++ ++ .+..+++|+.|++
T Consensus        86 -~L~~L~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L  157 (263)
T 1xeu_A           86 -KLEELSVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDL  157 (263)
T ss_dssp             -SCCEEECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEEC
T ss_pred             -CCCEEECCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEEC
Confidence             56666666666665322  222 6777777777777643  346777777777777777773 33 5677777777777


Q ss_pred             CCCcCCCCChhhhhccccccceeccccccccccc
Q 005760          180 GGNKLSGSIPECFNNLASLRILLLGSNELTSIPL  213 (678)
Q Consensus       180 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~  213 (678)
                      ++|.+++.  ..+..+++|+.|++++|.++..|.
T Consensus       158 ~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~~  189 (263)
T 1xeu_A          158 HGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPV  189 (263)
T ss_dssp             TTSCCCBC--TTSTTCCCCCEEEEEEEEEECCCE
T ss_pred             CCCcCcch--HHhccCCCCCEEeCCCCcccCCcc
Confidence            77777755  556777777777777777776554

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.78  E-value=7.4e-22  Score=217.91  Aligned_cols=206  Identities=20%  Similarity=0.191  Sum_probs=158.3

Q ss_pred             cCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCcc-------------CCCCccchhhcccccCCCCCcEEE-Ccc
Q 005760           18 FNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNY-------------LTSSTLELSFLSSLSNCKSLTLIS-FSN   83 (678)
Q Consensus        18 ~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~-------------i~~~~~~~~~~~~~~~l~~L~~L~-L~~   83 (678)
                      ...++|+.|+|++|+++ .+|..++++++|+.|++++|.             +...     .+..+..+++|+.|+ ++.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~-----~~~~l~~l~~L~~L~~l~~  419 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY-----EKETLQYFSTLKAVDPMRA  419 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGG-----HHHHHHHHHHHHHHCGGGH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccC-----CHHHHHHHHhcccCcchhh
Confidence            56889999999999998 779999999999999998875             1111     123466777788887 666


Q ss_pred             CCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCC
Q 005760           84 NPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGS  163 (678)
Q Consensus        84 n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~  163 (678)
                      |.+.             .|+.+.+++|.+....+      ..|+.|+|++|+|++ +|. |+.+++|++|+|++|.|+ .
T Consensus       420 n~~~-------------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~  477 (567)
T 1dce_A          420 AYLD-------------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-A  477 (567)
T ss_dssp             HHHH-------------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-C
T ss_pred             cccc-------------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-c
Confidence            6543             45666677777665322      248889999998885 565 888889999999999988 7


Q ss_pred             CCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccc--cccccccccccEEEecCCcccCCCCccccc
Q 005760          164 IPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSI--PLTFWNLKDILYLNFSSNFFTGPLPLEIGN  241 (678)
Q Consensus       164 ~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l--~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  241 (678)
                      +|..|..+++|+.|+|++|.|++ +| .+..+++|+.|+|++|+|+.+  |..+..+++|+.|+|++|++++..+... .
T Consensus       478 lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~-~  554 (567)
T 1dce_A          478 LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE-R  554 (567)
T ss_dssp             CCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTT-H
T ss_pred             cchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHH-H
Confidence            78888889999999999999886 56 788888999999999999887  7788889999999999998886655321 1


Q ss_pred             cccccccccCcccccEEEc
Q 005760          242 LKIARIDSCDLISLISLNL  260 (678)
Q Consensus       242 l~~~~~~~~~~~~L~~L~L  260 (678)
                      +.      ..+|+|+.|+|
T Consensus       555 l~------~~lp~L~~L~l  567 (567)
T 1dce_A          555 LA------EMLPSVSSILT  567 (567)
T ss_dssp             HH------HHCTTCSEEEC
T ss_pred             HH------HHCcccCccCC
Confidence            11      13458888875

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.78  E-value=7.8e-19  Score=167.09  Aligned_cols=127  Identities=19%  Similarity=0.214  Sum_probs=75.4

Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      +|++|++++|.+.. +| .+..+++|++|++++|.++  .+..+..+++|++|++++|.+++..+..+..+++|++|+++
T Consensus        45 ~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls  120 (197)
T 4ezg_A           45 SLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDIS  120 (197)
T ss_dssp             TCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECC
T ss_pred             CccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEec
Confidence            45555555555552 22 3556666666666666554  22356666666666666666665455566666666666666


Q ss_pred             CCcCCCCChhhhhccccccceeccccc-cccccccccccccccEEEecCCccc
Q 005760          181 GNKLSGSIPECFNNLASLRILLLGSNE-LTSIPLTFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       181 ~N~i~~~~~~~~~~l~~L~~L~l~~N~-l~~l~~~~~~l~~L~~L~l~~N~l~  232 (678)
                      +|.+++..+..+..+++|++|+|++|. ++.+| .+..+++|+.|++++|.++
T Consensus       121 ~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~  172 (197)
T 4ezg_A          121 HSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVH  172 (197)
T ss_dssp             SSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCC
T ss_pred             CCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCc
Confidence            666665555666666666666666665 55555 4555555566666555555

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.78  E-value=2.1e-19  Score=179.14  Aligned_cols=169  Identities=20%  Similarity=0.260  Sum_probs=114.8

Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      .+..+++++|.+++..  .+..+++|+.|++++|.++. ++ .+..+++|++|+|++|+|++..+  +..+++|+.|+|+
T Consensus        20 ~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~   93 (263)
T 1xeu_A           20 NAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVN   93 (263)
T ss_dssp             HHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECC
T ss_pred             HHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECC
Confidence            3455556666655443  35667777777777777763 33 56677777777777777774333  6777777777777


Q ss_pred             CCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEc
Q 005760          181 GNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNL  260 (678)
Q Consensus       181 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L  260 (678)
                      +|++++. +. +.. ++|+.|+|++|+|+.++ .+..+++|+.|++++|++++. + .+..++          +|+.|+|
T Consensus        94 ~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~----------~L~~L~L  157 (263)
T 1xeu_A           94 RNRLKNL-NG-IPS-ACLSRLFLDNNELRDTD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLS----------KLEVLDL  157 (263)
T ss_dssp             SSCCSCC-TT-CCC-SSCCEEECCSSCCSBSG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCT----------TCCEEEC
T ss_pred             CCccCCc-Cc-ccc-CcccEEEccCCccCCCh-hhcCcccccEEECCCCcCCCC-h-HHccCC----------CCCEEEC
Confidence            7777743 22 222 67777777777777765 467777778888888877754 2 344444          7888888


Q ss_pred             cCCcCCCcchHHHhcccCCCceecccccccccC
Q 005760          261 SNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEI  293 (678)
Q Consensus       261 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  293 (678)
                      ++|++++.  ..+..+++|+.|++++|++++.+
T Consensus       158 ~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~  188 (263)
T 1xeu_A          158 HGNEITNT--GGLTRLKKVNWIDLTGQKCVNEP  188 (263)
T ss_dssp             TTSCCCBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred             CCCcCcch--HHhccCCCCCEEeCCCCcccCCc
Confidence            88888765  56777888888888888887664

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.77  E-value=2.4e-19  Score=169.71  Aligned_cols=129  Identities=30%  Similarity=0.405  Sum_probs=86.2

Q ss_pred             cEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCC-cccCCCCccEEecCCCcCCCCChhhhhccccccceeccc
Q 005760          127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPD-SICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGS  205 (678)
Q Consensus       127 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~  205 (678)
                      +.+++++|+++ .+|..+.  ++|++|+|++|.|++..+. .|..+++|++|+|++|.|++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            67788888876 4555443  3777888888887755443 367777777777777777777677777777777777777


Q ss_pred             cccccccc-cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCc
Q 005760          206 NELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGA  268 (678)
Q Consensus       206 N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~  268 (678)
                      |+|+.++. .|..+++|+.|+|++|++++..|..|..++          +|+.|+|++|+++..
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~----------~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN----------SLTSLNLASNPFNCN  141 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCT----------TCCEEECTTCCBCCS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCC----------CCCEEEeCCCCccCc
Confidence            77776654 366666666666666666655555555544          666666666665543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.77  E-value=1.4e-18  Score=165.37  Aligned_cols=154  Identities=18%  Similarity=0.241  Sum_probs=103.4

Q ss_pred             cCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCcccc
Q 005760           42 GNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIG  121 (678)
Q Consensus        42 ~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~  121 (678)
                      ..+++|+.|++++|.+.+++       .+..+++|++|++++|.+....   .+..++ +|++|++++|++++..+..|.
T Consensus        41 ~~l~~L~~L~l~~n~i~~l~-------~l~~l~~L~~L~l~~n~~~~~~---~l~~l~-~L~~L~l~~n~l~~~~~~~l~  109 (197)
T 4ezg_A           41 AQMNSLTYITLANINVTDLT-------GIEYAHNIKDLTINNIHATNYN---PISGLS-NLERLRIMGKDVTSDKIPNLS  109 (197)
T ss_dssp             HHHHTCCEEEEESSCCSCCT-------TGGGCTTCSEEEEESCCCSCCG---GGTTCT-TCCEEEEECTTCBGGGSCCCT
T ss_pred             hhcCCccEEeccCCCccChH-------HHhcCCCCCEEEccCCCCCcch---hhhcCC-CCCEEEeECCccCcccChhhc
Confidence            44555666666666665444       1445556666666666544321   244444 566666666666666666777


Q ss_pred             CCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCc-CCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccc
Q 005760          122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNK-LEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRI  200 (678)
Q Consensus       122 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~  200 (678)
                      .+++|++|++++|++++..+..+..+++|++|+|++|. ++ .++ .+..+++|+.|++++|.+++. + .+..+++|+.
T Consensus       110 ~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~  185 (197)
T 4ezg_A          110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQ  185 (197)
T ss_dssp             TCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCE
T ss_pred             CCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCE
Confidence            88888888888888876677778888888888888887 66 444 678888888888888888854 3 6778888888


Q ss_pred             eecccccccc
Q 005760          201 LLLGSNELTS  210 (678)
Q Consensus       201 L~l~~N~l~~  210 (678)
                      |++++|++..
T Consensus       186 L~l~~N~i~~  195 (197)
T 4ezg_A          186 LYAFSQTIGG  195 (197)
T ss_dssp             EEECBC----
T ss_pred             EEeeCcccCC
Confidence            8888887753

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.76  E-value=8.9e-19  Score=165.80  Aligned_cols=154  Identities=25%  Similarity=0.311  Sum_probs=103.2

Q ss_pred             CEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCC
Q 005760          151 QGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN  229 (678)
Q Consensus       151 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N  229 (678)
                      +.+++++|.++ .+|..+.  ++|++|++++|.|+ .+|..|..+++|+.|+|++|+|+.++. .|.++++|+.|+|++|
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            34555555555 3443332  35566666666665 444556666666666666666666644 4666677777777777


Q ss_pred             cccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCcccccccccccc
Q 005760          230 FFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEG  309 (678)
Q Consensus       230 ~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~  309 (678)
                      +|++..+..|.+++          +|+.|+|++|+|+...+..|..+++|+.|++++|+|.|+|...+...++.......
T Consensus        89 ~l~~i~~~~f~~l~----------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~~~~~~~~~  158 (193)
T 2wfh_A           89 RLRCIPPRTFDGLK----------SLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWVKSEYKEP  158 (193)
T ss_dssp             CCCBCCTTTTTTCT----------TCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHHHHSSCCC
T ss_pred             ccCEeCHHHhCCCC----------CCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHHHHhccCCC
Confidence            77766666676666          88888888888887777788889999999999999999988665555554444444


Q ss_pred             CccccCCCC
Q 005760          310 NELLCGSPN  318 (678)
Q Consensus       310 n~~~c~~~~  318 (678)
                      +...|..|.
T Consensus       159 ~~~~C~~P~  167 (193)
T 2wfh_A          159 GIARCAGPG  167 (193)
T ss_dssp             SCCBEEESG
T ss_pred             CCcCcCCch
Confidence            556677664

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.76  E-value=4.4e-20  Score=207.22  Aligned_cols=307  Identities=13%  Similarity=0.082  Sum_probs=160.5

Q ss_pred             ccccCCcCcccCCcccc-CCCCCCEEecCCC-ccccc-CCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcE
Q 005760            2 LQMWENNFSGTIPRFIF-NASKLSILELSDN-SFSGF-IPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL   78 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~-~l~~L~~L~l~~n-~i~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~   78 (678)
                      |+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.++...... +..-...+++|+.
T Consensus       110 L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~-l~~~~~~~~~L~~  188 (594)
T 2p1m_B          110 IRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHW-LSHFPDTYTSLVS  188 (594)
T ss_dssp             EEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGG-GGGSCTTCCCCCE
T ss_pred             EEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHH-HHHHhhcCCcCcE
Confidence            67777777766666665 5778888888877 55432 3344446777888888877766544220 1111235667777


Q ss_pred             EECccCC--CcccCChhhhhcccccccEEEccccc---------------------------------------------
Q 005760           79 ISFSNNP--LDGILPKTSVGNLSHSLEYFEMAYCN---------------------------------------------  111 (678)
Q Consensus        79 L~L~~n~--i~~~~~~~~~~~l~~~L~~L~l~~n~---------------------------------------------  111 (678)
                      |++++|.  +........+..++ +|++|++++|.                                             
T Consensus       189 L~l~~~~~~~~~~~l~~l~~~~~-~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L  267 (594)
T 2p1m_B          189 LNISCLASEVSFSALERLVTRCP-NLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKEL  267 (594)
T ss_dssp             EECTTCCSCCCHHHHHHHHHHCT-TCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTC
T ss_pred             EEecccCCcCCHHHHHHHHHhCC-CCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCc
Confidence            7777765  21111111111222 56666666651                                             


Q ss_pred             -----ccc----cCCccccCCCCCcEEEccCCccCCcCCh-hhhccCCCCEEEccCCcCCCC-CCCcccCCCCccEEecC
Q 005760          112 -----VSG----GIPEEIGNLTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLENNKLEGS-IPDSICHSDELYKLELG  180 (678)
Q Consensus       112 -----l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~l~  180 (678)
                           +..    .++..+..+++|++|+|++|.+++.... .+..+++|++|++++| ++.. ++.....+++|++|+++
T Consensus       268 ~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~  346 (594)
T 2p1m_B          268 RCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVF  346 (594)
T ss_dssp             CEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEE
T ss_pred             ccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEe
Confidence                 110    1122223567888888888886533222 2456778888888777 4311 11222246667777662


Q ss_pred             ---------CCcCCCCChhhhh-ccccccceecccccccccc-ccc-cccccccEEEec--C----CcccCCCCc-c---
Q 005760          181 ---------GNKLSGSIPECFN-NLASLRILLLGSNELTSIP-LTF-WNLKDILYLNFS--S----NFFTGPLPL-E---  238 (678)
Q Consensus       181 ---------~N~i~~~~~~~~~-~l~~L~~L~l~~N~l~~l~-~~~-~~l~~L~~L~l~--~----N~l~~~~~~-~---  238 (678)
                               .|.+++.....+. .+++|+.|.++.|.++... ..+ ..+++|+.|+++  +    |.++..... .   
T Consensus       347 ~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~  426 (594)
T 2p1m_B          347 PSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGA  426 (594)
T ss_dssp             CSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHH
T ss_pred             cCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHH
Confidence                     2344432222232 3666666666666665321 122 245666666666  3    333321110 0   


Q ss_pred             -ccc---cccccccc-----------cCcccccEEEccCCcCCCcchHHH-hcccCCCceecccccccccCC--CCCccc
Q 005760          239 -IGN---LKIARIDS-----------CDLISLISLNLSNNNLSGAIPASL-EKLSYLKDLNLSFNKLEGEIP--RGGSFG  300 (678)
Q Consensus       239 -~~~---l~~~~~~~-----------~~~~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~l~~N~~~~~~~--~~~~~~  300 (678)
                       +.+   ++..++..           ..+++|+.|+|++|.+++.....+ ..+++|+.|++++|+++....  ....++
T Consensus       427 l~~~~~~L~~L~L~~~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~  506 (594)
T 2p1m_B          427 IVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLE  506 (594)
T ss_dssp             HHHHCTTCCEEECCSSCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGG
T ss_pred             HHhhCCCccEEeecCcccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCC
Confidence             111   11000000           014467777777777765555444 556777777777777643221  113356


Q ss_pred             cccccccccCc
Q 005760          301 NFSAESFEGNE  311 (678)
Q Consensus       301 ~l~~~~~~~n~  311 (678)
                      +|+.+++.+|+
T Consensus       507 ~L~~L~l~~~~  517 (594)
T 2p1m_B          507 TMRSLWMSSCS  517 (594)
T ss_dssp             GSSEEEEESSC
T ss_pred             CCCEEeeeCCC
Confidence            66666666654

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.75  E-value=1.7e-19  Score=186.42  Aligned_cols=239  Identities=13%  Similarity=0.062  Sum_probs=123.0

Q ss_pred             CCCCCEEecCCCcccccCCccccC-CCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhc-
Q 005760           20 ASKLSILELSDNSFSGFIPNTFGN-LRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGN-   97 (678)
Q Consensus        20 l~~L~~L~l~~n~i~~~~~~~~~~-l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~-   97 (678)
                      +.++++|.++++ +.......+.. +++|+.|||++|++.......      ..++.+..+.+..|.|    |...|.+ 
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~------~~~~~~~~~~~~~~~I----~~~aF~~~   92 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKA------GTYPNGKFYIYMANFV----PAYAFSNV   92 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESS------SSSGGGCCEEECTTEE----CTTTTEEE
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcc------cccccccccccccccc----CHHHhccc
Confidence            567888888865 22222223333 788888888888887221110      0111133333333322    1122333 


Q ss_pred             -------ccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcC----CCCCCC
Q 005760           98 -------LSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKL----EGSIPD  166 (678)
Q Consensus        98 -------l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i----~~~~~~  166 (678)
                             +. +|++|+|.+ +++.+.+.+|.++++|+.|++++|.+..+.+.+|.++.++..+.+..+..    ......
T Consensus        93 ~~~~~~g~~-~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~  170 (329)
T 3sb4_A           93 VNGVTKGKQ-TLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHF  170 (329)
T ss_dssp             ETTEEEECT-TCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTS
T ss_pred             ccccccccC-CCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccc
Confidence                   33 555555555 55555555555555555555555555545555555544444444433211    101111


Q ss_pred             ccc--------------------------------------------------CCCCccEEecCCCcCCCCChhhhhccc
Q 005760          167 SIC--------------------------------------------------HSDELYKLELGGNKLSGSIPECFNNLA  196 (678)
Q Consensus       167 ~~~--------------------------------------------------~l~~L~~L~l~~N~i~~~~~~~~~~l~  196 (678)
                      +|.                                                  .+++|+.|+|++|.++.+.+.+|.+++
T Consensus       171 ~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~  250 (329)
T 3sb4_A          171 AFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKK  250 (329)
T ss_dssp             CEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCT
T ss_pred             ccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCC
Confidence            121                                                  145566666666666555555566666


Q ss_pred             cccceeccccccccccc-ccccccccc-EEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHh
Q 005760          197 SLRILLLGSNELTSIPL-TFWNLKDIL-YLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLE  274 (678)
Q Consensus       197 ~L~~L~l~~N~l~~l~~-~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~  274 (678)
                      +|+.|+|++| ++.++. +|.++++|+ .+++.+ .++.+.+..|.+++          +|+.|+|++|+++.+.+.+|.
T Consensus       251 ~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~----------~L~~l~l~~n~i~~I~~~aF~  318 (329)
T 3sb4_A          251 YLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCD----------NLRYVLATGDKITTLGDELFG  318 (329)
T ss_dssp             TCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCT----------TEEEEEECSSCCCEECTTTTC
T ss_pred             CCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCc----------cCCEEEeCCCccCccchhhhc
Confidence            6666666655 555544 455666665 666655 44444455555544          666666666666555555666


Q ss_pred             cccCCCcee
Q 005760          275 KLSYLKDLN  283 (678)
Q Consensus       275 ~l~~L~~L~  283 (678)
                      ++++|+.|+
T Consensus       319 ~~~~L~~ly  327 (329)
T 3sb4_A          319 NGVPSKLIY  327 (329)
T ss_dssp             TTCCCCEEE
T ss_pred             CCcchhhhc
Confidence            666665554

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.74  E-value=2.3e-19  Score=201.31  Aligned_cols=133  Identities=15%  Similarity=0.055  Sum_probs=78.4

Q ss_pred             cCCCCEEEccCCcCCCCCCCccc-CCCCccEEecC--C----CcCCCCCh-----hhhhccccccceeccccccccc-cc
Q 005760          147 LQKLQGLGLENNKLEGSIPDSIC-HSDELYKLELG--G----NKLSGSIP-----ECFNNLASLRILLLGSNELTSI-PL  213 (678)
Q Consensus       147 l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~l~--~----N~i~~~~~-----~~~~~l~~L~~L~l~~N~l~~l-~~  213 (678)
                      +++|++|.++.|.+++.....+. .+++|+.|+++  +    |.+++...     ..+..+++|+.|+|++ .++.. ..
T Consensus       371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~  449 (594)
T 2p1m_B          371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE  449 (594)
T ss_dssp             CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred             chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence            44555555544554432222232 35666666666  3    34442211     1244556666666655 34421 22


Q ss_pred             cccc-cccccEEEecCCcccCCCCccc-cccccccccccCcccccEEEccCCcCCCcchH-HHhcccCCCceeccccccc
Q 005760          214 TFWN-LKDILYLNFSSNFFTGPLPLEI-GNLKIARIDSCDLISLISLNLSNNNLSGAIPA-SLEKLSYLKDLNLSFNKLE  290 (678)
Q Consensus       214 ~~~~-l~~L~~L~l~~N~l~~~~~~~~-~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~N~~~  290 (678)
                      .+.. +++|+.|+|++|.+++.....+ .+          +++|+.|+|++|.+++.... ....+++|+.|++++|+++
T Consensus       450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~----------~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~  519 (594)
T 2p1m_B          450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSG----------CDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS  519 (594)
T ss_dssp             HHHHHCTTCCEEEEESCCSSHHHHHHHHHH----------CTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred             HHHHhchhccEeeccCCCCcHHHHHHHHhc----------CCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence            3333 6778888888887764443333 22          45999999999999755444 3455899999999999984

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.73  E-value=2e-18  Score=196.44  Aligned_cols=133  Identities=25%  Similarity=0.326  Sum_probs=75.7

Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      .|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|+++++|++|+|++|.|+ .+|..|..+++|++|+|+
T Consensus       225 ~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~  301 (727)
T 4b8c_D          225 LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF  301 (727)
T ss_dssp             CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred             CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence            4555555555544 33444446666666666666665 55566666666666666666666 556666666666666666


Q ss_pred             CCcCCCCChhhhhccccccceeccccccccc-cccccccc-cccEEEecCCcccCCCCc
Q 005760          181 GNKLSGSIPECFNNLASLRILLLGSNELTSI-PLTFWNLK-DILYLNFSSNFFTGPLPL  237 (678)
Q Consensus       181 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l-~~~~~~l~-~L~~L~l~~N~l~~~~~~  237 (678)
                      +|.|+ .+|..|..+++|+.|+|++|.|+.. |..+..+. .+..|+|++|.+++..|.
T Consensus       302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~  359 (727)
T 4b8c_D          302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH  359 (727)
T ss_dssp             SSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred             CCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence            66665 4455566666666666666666643 33333322 122355666666655544

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.73  E-value=1.3e-17  Score=157.82  Aligned_cols=127  Identities=28%  Similarity=0.407  Sum_probs=61.9

Q ss_pred             cEEEcccccccccCCccccCCCCCcEEEccCCccCCcCCh-hhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCC
Q 005760          103 EYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG  181 (678)
Q Consensus       103 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~  181 (678)
                      +++++++|+++. +|..+.  .+|++|++++|++++..+. .|..+++|++|+|++|.|++..|..|..+++|++|+|++
T Consensus        11 ~~l~~s~~~l~~-ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcCc-CccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            345555555532 232221  2455555555555433332 244555555555555555544445555555555555555


Q ss_pred             CcCCCCChhhhhccccccceeccccccccc-cccccccccccEEEecCCccc
Q 005760          182 NKLSGSIPECFNNLASLRILLLGSNELTSI-PLTFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       182 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l-~~~~~~l~~L~~L~l~~N~l~  232 (678)
                      |+|++..+..|.++++|++|+|++|+|+.+ |..|..+++|+.|+|++|++.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  139 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence            555544444455555555555555555544 334445555555555555544

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.73  E-value=9e-19  Score=174.00  Aligned_cols=137  Identities=22%  Similarity=0.285  Sum_probs=105.7

Q ss_pred             CCCCccccCCCceeEEEEEe-CCCcE--EEEEEeecccCc------------------------hhhhHHHHHHHHHhCC
Q 005760          394 FSENNLIGRGSFGSVFKARL-GDGME--VAMKVFNLQYGR------------------------VFKSFDVECEMMKSIR  446 (678)
Q Consensus       394 ~~~~~~ig~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  446 (678)
                      |.+.+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|+.+++.++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56788999999999999987 68889  999997543111                        0125788999999998


Q ss_pred             Cccc--eeeeeeeecCCeEEEEEEecCC-C----CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCC
Q 005760          447 HRNI--IKVISSCSNEEFKALVLEYMPH-G----SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK  519 (678)
Q Consensus       447 h~ni--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~  519 (678)
                      |+++  ..++++    +..++||||+.+ |    +|.++...    .++..+..++.|++.|+.|||.  +.+|+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence            8764  333332    356899999942 3    67766543    1234567899999999999994  5789999999


Q ss_pred             CCCeeecCCCcEEEEeecccccc
Q 005760          520 PSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       520 ~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      |+|||++.  .++|+|||+|...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  9999999999754

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.72  E-value=4.9e-18  Score=193.31  Aligned_cols=192  Identities=19%  Similarity=0.224  Sum_probs=119.1

Q ss_pred             CCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccc----hhhcccccCCCCCcEEECccCCCcccCChhhh
Q 005760           20 ASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLE----LSFLSSLSNCKSLTLISFSNNPLDGILPKTSV   95 (678)
Q Consensus        20 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~----~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~   95 (678)
                      .+.++.|+|.+|.+... +..+     |+.++|+.|.|..+...    ......|..+++|+.|+|++|.+.. .+.. +
T Consensus       172 ~~~~~~l~L~~n~~~~~-~~~~-----l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~-l~~~-~  243 (727)
T 4b8c_D          172 TPLTPKIELFANGKDEA-NQAL-----LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIFN-ISAN-I  243 (727)
T ss_dssp             --------------------------------------------------------CCCCCCEEECTTSCCSC-CCGG-G
T ss_pred             CCccceEEeeCCCCCcc-hhhH-----hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCCC-CChh-h
Confidence            35688999999999853 3333     33344444444332210    0112357889999999999999984 4444 4


Q ss_pred             hcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCcc
Q 005760           96 GNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELY  175 (678)
Q Consensus        96 ~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~  175 (678)
                      ..++ +|++|+|++|.|+ .+|..|.++++|++|+|++|+|+ .+|..|+++++|++|+|++|.|+ .+|..|..+++|+
T Consensus       244 ~~l~-~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~  319 (727)
T 4b8c_D          244 FKYD-FLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQ  319 (727)
T ss_dssp             GGCC-SCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCC
T ss_pred             cCCC-CCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCcc
Confidence            4666 8999999999999 78899999999999999999999 77999999999999999999998 7788899999999


Q ss_pred             EEecCCCcCCCCChhhhhcccc-ccceecccccccc-ccccccccccccEEEecCC
Q 005760          176 KLELGGNKLSGSIPECFNNLAS-LRILLLGSNELTS-IPLTFWNLKDILYLNFSSN  229 (678)
Q Consensus       176 ~L~l~~N~i~~~~~~~~~~l~~-L~~L~l~~N~l~~-l~~~~~~l~~L~~L~l~~N  229 (678)
                      +|+|++|.|++.+|..+..+.. +..|+|++|.++. +|.      .|..|+++.|
T Consensus       320 ~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n  369 (727)
T 4b8c_D          320 FLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTD  369 (727)
T ss_dssp             CEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C---------
T ss_pred             EEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeecc
Confidence            9999999999999988876543 3458899999884 343      5677778877

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.71  E-value=1.3e-16  Score=168.47  Aligned_cols=239  Identities=10%  Similarity=0.111  Sum_probs=117.2

Q ss_pred             CCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccccc
Q 005760           22 KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHS  101 (678)
Q Consensus        22 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~  101 (678)
                      +|+.+.|..+ ++.+...+|.+ .+|+.+.|.+ .+..++..     +|.+|++|+.+++++|+++.+.... |..  .+
T Consensus       136 ~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~-----aF~~c~~L~~l~l~~n~l~~I~~~a-F~~--~~  204 (401)
T 4fdw_A          136 QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKED-----IFYYCYNLKKADLSKTKITKLPAST-FVY--AG  204 (401)
T ss_dssp             CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSS-----TTTTCTTCCEEECTTSCCSEECTTT-TTT--CC
T ss_pred             CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHH-----HhhCcccCCeeecCCCcceEechhh-Eee--cc
Confidence            4555555544 55455555555 3455555553 44444432     3555556666666555555444333 221  25


Q ss_pred             ccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCC
Q 005760          102 LEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG  181 (678)
Q Consensus       102 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~  181 (678)
                      |+++.|.. .++.+...+|.++++|+.+++.+| ++.+...+|.+ .+|+.+.|. +.++.....+|.++++|+.+.+.+
T Consensus       205 L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l~~  280 (401)
T 4fdw_A          205 IEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTTYG  280 (401)
T ss_dssp             CSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEEES
T ss_pred             cCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEeCC
Confidence            55555553 255455555555555555555543 33344455554 455555552 334323445555555555555555


Q ss_pred             CcCC-----CCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccCCCCccccccccccccccCcccc
Q 005760          182 NKLS-----GSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISL  255 (678)
Q Consensus       182 N~i~-----~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L  255 (678)
                      |.+.     .+.+.+|.+|++|+.++|. +.++.++. +|.++.+|+.+.|..| ++.+....|.+          + +|
T Consensus       281 ~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~----------~-~L  347 (401)
T 4fdw_A          281 STFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNN----------T-GI  347 (401)
T ss_dssp             SCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSS----------S-CC
T ss_pred             ccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCC----------C-CC
Confidence            5443     2334455555555555555 23555543 4555555555555333 33222333322          2 45


Q ss_pred             cEEEccCCcCCCcchHHHhccc-CCCceeccccc
Q 005760          256 ISLNLSNNNLSGAIPASLEKLS-YLKDLNLSFNK  288 (678)
Q Consensus       256 ~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~  288 (678)
                      +.|++.+|.+....+..|..++ .+..|++..+.
T Consensus       348 ~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~  381 (401)
T 4fdw_A          348 KEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES  381 (401)
T ss_dssp             CEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred             CEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence            5555555555444444444442 34444444443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.70  E-value=2e-17  Score=170.80  Aligned_cols=220  Identities=16%  Similarity=0.174  Sum_probs=155.3

Q ss_pred             CCCCCEEecCCCccc--------------------ccCCccccC--------CCCCCEEEccCccCCCCccchhhccccc
Q 005760           20 ASKLSILELSDNSFS--------------------GFIPNTFGN--------LRNLQALRLSNNYLTSSTLELSFLSSLS   71 (678)
Q Consensus        20 l~~L~~L~l~~n~i~--------------------~~~~~~~~~--------l~~L~~L~l~~n~i~~~~~~~~~~~~~~   71 (678)
                      +++|+.|||++|+|.                    .+...+|.+        +++|+.|+|.+ .++.++..     +|.
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~-----aF~  121 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDA-----AFK  121 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTT-----TTT
T ss_pred             hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHH-----Hhh
Confidence            788999999999998                    344556666        77777777777 66666644     477


Q ss_pred             CCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccc----cccCCccccCCCCCc-EEEc---------------
Q 005760           72 NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNV----SGGIPEEIGNLTNLT-IIYL---------------  131 (678)
Q Consensus        72 ~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l----~~~~~~~~~~l~~L~-~L~l---------------  131 (678)
                      +|++|+.|++++|.+..+.+.. |.+.. ++.++.+..+..    .......|.++.+|+ .+.+               
T Consensus       122 ~~~~L~~l~l~~n~i~~i~~~a-F~~~~-~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~  199 (329)
T 3sb4_A          122 GCDNLKICQIRKKTAPNLLPEA-LADSV-TAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGL  199 (329)
T ss_dssp             TCTTCCEEEBCCSSCCEECTTS-SCTTT-CEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTC
T ss_pred             cCcccceEEcCCCCccccchhh-hcCCC-ceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhccc
Confidence            7777777777777776555544 33332 455554444221    122233344444444 2222               


Q ss_pred             ----------cCCccCCcCChhh-hccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhcccccc-
Q 005760          132 ----------GGNKLNGSIPSTL-GKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLR-  199 (678)
Q Consensus       132 ----------~~N~l~~~~~~~~-~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~-  199 (678)
                                .++-.. .....+ ..+++|++|+|++|+++...+.+|.++++|+.|++++| +..+.+.+|.++++|+ 
T Consensus       200 ~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~  277 (329)
T 3sb4_A          200 QPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAG  277 (329)
T ss_dssp             CGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCE
T ss_pred             CccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccE
Confidence                      221100 001111 13789999999999999677788999999999999998 8878888999999999 


Q ss_pred             ceeccccccccccc-cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEc
Q 005760          200 ILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNL  260 (678)
Q Consensus       200 ~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L  260 (678)
                      .|++.+ .++.++. +|.++++|+.|++++|.++.+.+..|.+++          +|+.|+.
T Consensus       278 ~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~----------~L~~ly~  328 (329)
T 3sb4_A          278 TLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGV----------PSKLIYK  328 (329)
T ss_dssp             EEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTC----------CCCEEEC
T ss_pred             EEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCc----------chhhhcc
Confidence            999999 8888875 799999999999999999988888888877          9998874

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.69  E-value=7.3e-17  Score=149.15  Aligned_cols=107  Identities=25%  Similarity=0.257  Sum_probs=60.6

Q ss_pred             CCCcEEEccCCccC-CcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhcccccccee
Q 005760          124 TNLTIIYLGGNKLN-GSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILL  202 (678)
Q Consensus       124 ~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~  202 (678)
                      ++|+.|++++|+++ +.+|..+..+++|++|+|++|.+++.  ..+..+++|++|++++|.+++.+|..+..+++|+.|+
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            55666666666655 34455555666666666666666533  4555566666666666666654555555566666666


Q ss_pred             cccccccccc--ccccccccccEEEecCCccc
Q 005760          203 LGSNELTSIP--LTFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       203 l~~N~l~~l~--~~~~~l~~L~~L~l~~N~l~  232 (678)
                      |++|.|+.++  ..+..+++|+.|++++|+++
T Consensus       102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~  133 (168)
T 2ell_A          102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVT  133 (168)
T ss_dssp             CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG
T ss_pred             ccCCccCcchhHHHHhcCCCCCEEEeeCCcCc
Confidence            6666665554  34444444444444444444

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.69  E-value=4.5e-17  Score=150.57  Aligned_cols=130  Identities=27%  Similarity=0.286  Sum_probs=70.7

Q ss_pred             cccEEEccccccc-ccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEec
Q 005760          101 SLEYFEMAYCNVS-GGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL  179 (678)
Q Consensus       101 ~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l  179 (678)
                      +|++|++++|+++ +.+|..+..+++|++|++++|.+++.  ..|..+++|++|+|++|++++.+|..+..+++|++|++
T Consensus        25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  102 (168)
T 2ell_A           25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL  102 (168)
T ss_dssp             SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred             cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence            3444444444444 33444455555555555655555533  44555555666666666655444544445556666666


Q ss_pred             CCCcCCCCCh-hhhhccccccceeccccccccccc----cccccccccEEEecCCccc
Q 005760          180 GGNKLSGSIP-ECFNNLASLRILLLGSNELTSIPL----TFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       180 ~~N~i~~~~~-~~~~~l~~L~~L~l~~N~l~~l~~----~~~~l~~L~~L~l~~N~l~  232 (678)
                      ++|.+++... ..+..+++|+.|++++|.++.+|.    .+..+++|+.|++++|.+.
T Consensus       103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            6665553321 455555666666666666665554    4555555666666655554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.67  E-value=1.2e-16  Score=144.43  Aligned_cols=111  Identities=20%  Similarity=0.254  Sum_probs=71.4

Q ss_pred             CCCCcEEEccCCccC-CcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccce
Q 005760          123 LTNLTIIYLGGNKLN-GSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRIL  201 (678)
Q Consensus       123 l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L  201 (678)
                      .++|+.|++++|.++ +.+|..+..+++|++|++++|.+++.  ..+..+++|++|++++|.+++.+|..+..+++|++|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            356666777777665 45566666667777777777777633  556667777777777777776566666667777777


Q ss_pred             ecccccccccc--ccccccccccEEEecCCcccCCC
Q 005760          202 LLGSNELTSIP--LTFWNLKDILYLNFSSNFFTGPL  235 (678)
Q Consensus       202 ~l~~N~l~~l~--~~~~~l~~L~~L~l~~N~l~~~~  235 (678)
                      ++++|+++.++  ..+..+++|+.|++++|++++..
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~  129 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN  129 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGST
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchH
Confidence            77777776654  45555555555555555555433

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.67  E-value=8.8e-17  Score=152.02  Aligned_cols=133  Identities=21%  Similarity=0.261  Sum_probs=119.7

Q ss_pred             cEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCccc
Q 005760          175 YKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLIS  254 (678)
Q Consensus       175 ~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~  254 (678)
                      +++++++|.++ .+|..+.  ++|+.|+|++|.|+.+|..|..+++|+.|+|++|.|++..+..|.+++          +
T Consensus        13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~----------~   79 (193)
T 2wfh_A           13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMT----------Q   79 (193)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCT----------T
T ss_pred             CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCC----------C
Confidence            68999999999 5555443  689999999999999999999999999999999999988888888877          9


Q ss_pred             ccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCC-CCccccccccccccCccccCCCCCC
Q 005760          255 LISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR-GGSFGNFSAESFEGNELLCGSPNLR  320 (678)
Q Consensus       255 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~-~~~~~~l~~~~~~~n~~~c~~~~~~  320 (678)
                      |+.|+|++|+|++..+..|..+++|+.|+|++|.++...+. ...+..+..+++.+|||.|+|...|
T Consensus        80 L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~  146 (193)
T 2wfh_A           80 LLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQW  146 (193)
T ss_dssp             CCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHH
T ss_pred             CCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHH
Confidence            99999999999999999999999999999999999977765 4668899999999999999997543

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.66  E-value=1.2e-15  Score=160.93  Aligned_cols=242  Identities=11%  Similarity=0.091  Sum_probs=175.1

Q ss_pred             CCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccc
Q 005760           20 ASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLS   99 (678)
Q Consensus        20 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~   99 (678)
                      ...++.+.+.. .++.+...+|.+. +|+.+.|..| ++.++..     +|.++ +|+.+.+.+ .+..+.... |.++.
T Consensus       112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~-----aF~~~-~L~~i~lp~-~l~~I~~~a-F~~c~  180 (401)
T 4fdw_A          112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDM-----AFFNS-TVQEIVFPS-TLEQLKEDI-FYYCY  180 (401)
T ss_dssp             CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTT-----TTTTC-CCCEEECCT-TCCEECSST-TTTCT
T ss_pred             cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHH-----hcCCC-CceEEEeCC-CccEehHHH-hhCcc
Confidence            46777777765 4666777888874 7888888776 6666654     57774 688888875 666555544 66665


Q ss_pred             ccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEec
Q 005760          100 HSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL  179 (678)
Q Consensus       100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l  179 (678)
                       +|+++++++|+++.+....|. ..+|+.+.|..+ ++.+...+|.++++|+.+.|..| ++.....+|.+ .+|+.+.+
T Consensus       181 -~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l  255 (401)
T 4fdw_A          181 -NLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL  255 (401)
T ss_dssp             -TCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE
T ss_pred             -cCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe
Confidence             788888888888877777776 578888888744 66677778888888888888775 45355566666 77888888


Q ss_pred             CCCcCCCCChhhhhccccccceeccccccc-----cccc-cccccccccEEEecCCcccCCCCccccccccccccccCcc
Q 005760          180 GGNKLSGSIPECFNNLASLRILLLGSNELT-----SIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLI  253 (678)
Q Consensus       180 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~-----~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~  253 (678)
                       .|.++.+...+|.+|++|+.+++.+|.+.     .++. +|.++++|+.++|.+ .++.+....|.++.          
T Consensus       256 -p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~----------  323 (401)
T 4fdw_A          256 -PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNR----------  323 (401)
T ss_dssp             -ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCC----------
T ss_pred             -CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCC----------
Confidence             44566566778888888888888887765     5654 688888888888884 46656666666666          


Q ss_pred             cccEEEccCCcCCCcchHHHhcccCCCceecccccccc
Q 005760          254 SLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEG  291 (678)
Q Consensus       254 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  291 (678)
                      +|+.|+|.+| ++.+...+|..+ +|+.|++.+|....
T Consensus       324 ~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~  359 (401)
T 4fdw_A          324 KVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQ  359 (401)
T ss_dssp             SCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCB
T ss_pred             CccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcc
Confidence            8888888554 666777788888 88888888886553

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.66  E-value=2.9e-16  Score=146.44  Aligned_cols=132  Identities=24%  Similarity=0.282  Sum_probs=69.1

Q ss_pred             cEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceecccc
Q 005760          127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSN  206 (678)
Q Consensus       127 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N  206 (678)
                      +.+++++|+++ .+|..+.  ++|++|++++|++++..+..|..+++|++|++++|.+++..+..|..+++|        
T Consensus        10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L--------   78 (177)
T 2o6r_A           10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL--------   78 (177)
T ss_dssp             TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTC--------
T ss_pred             CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCcc--------
Confidence            45556666555 2332222  455555555555554444444555555555555555554444444444444        


Q ss_pred             ccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceeccc
Q 005760          207 ELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSF  286 (678)
Q Consensus       207 ~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  286 (678)
                                     +.|+|++|.+++..+..|.+++          +|+.|+|++|++++..+..+..+++|+.|++++
T Consensus        79 ---------------~~L~l~~N~l~~~~~~~~~~l~----------~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~  133 (177)
T 2o6r_A           79 ---------------TILYLHENKLQSLPNGVFDKLT----------QLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT  133 (177)
T ss_dssp             ---------------CEEECCSSCCCCCCTTTTTTCT----------TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred             ---------------CEEECCCCCccccCHHHhhCCc----------ccCEEECcCCcceEeCHHHhcCCcccCEEEecC
Confidence                           4455555544444444444443          566666666666555444555566666666666


Q ss_pred             ccccccCC
Q 005760          287 NKLEGEIP  294 (678)
Q Consensus       287 N~~~~~~~  294 (678)
                      |+|.|.++
T Consensus       134 N~~~~~~~  141 (177)
T 2o6r_A          134 NPWDCSCP  141 (177)
T ss_dssp             SCBCCCHH
T ss_pred             CCeeccCc
Confidence            66666555

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.65  E-value=1.1e-16  Score=144.72  Aligned_cols=126  Identities=23%  Similarity=0.278  Sum_probs=100.0

Q ss_pred             cccEEEccccccc-ccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEec
Q 005760          101 SLEYFEMAYCNVS-GGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL  179 (678)
Q Consensus       101 ~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l  179 (678)
                      +|++|++++|.++ +.+|..+..+++|+.|++++|.+++.  ..+..+++|++|+|++|.+++.+|..+..+++|++|++
T Consensus        18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l   95 (149)
T 2je0_A           18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL   95 (149)
T ss_dssp             GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred             cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence            6777777777776 56677778888888888888888755  67888888888888888888657777777888888888


Q ss_pred             CCCcCCCC-Chhhhhccccccceeccccccccccc----cccccccccEEEecC
Q 005760          180 GGNKLSGS-IPECFNNLASLRILLLGSNELTSIPL----TFWNLKDILYLNFSS  228 (678)
Q Consensus       180 ~~N~i~~~-~~~~~~~l~~L~~L~l~~N~l~~l~~----~~~~l~~L~~L~l~~  228 (678)
                      ++|.+++. .+..+..+++|++|++++|.++.++.    .+..+++|+.|++++
T Consensus        96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            88888853 34778888888888888888888765    577788888887763

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.64  E-value=9.8e-17  Score=165.15  Aligned_cols=138  Identities=14%  Similarity=0.161  Sum_probs=97.5

Q ss_pred             CCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCc--------------hhhhH--------HHHHHHHHhCCCccc
Q 005760          393 GFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGR--------------VFKSF--------DVECEMMKSIRHRNI  450 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------~~~~~--------~~e~~~l~~l~h~ni  450 (678)
                      =|++.+.||+|++|.||+|...+|+.||||+++.....              .....        ..|...+.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            38899999999999999999889999999998542110              00111        234445555433332


Q ss_pred             eeeeeeeecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC-
Q 005760          451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM-  529 (678)
Q Consensus       451 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~-  529 (678)
                      ....-+..  ...++||||++|++|.++...     +  ....++.|++.++.|||   +.|||||||||.|||++++| 
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~-----~--~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV-----P--DPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCCC-----S--CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEEC
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhccc-----H--HHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCC
Confidence            11111111  123699999999888655421     1  23468899999999999   89999999999999998776 


Q ss_pred             ---------cEEEEeecccccc
Q 005760          530 ---------VAHLSDFGIAKLL  542 (678)
Q Consensus       530 ---------~~kl~Dfg~~~~~  542 (678)
                               .+.|+||+-+...
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEET
T ss_pred             cccccccccceEEEEeCCcccC
Confidence                     3899999988654

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.63  E-value=9.7e-18  Score=159.61  Aligned_cols=152  Identities=25%  Similarity=0.281  Sum_probs=82.3

Q ss_pred             CCCCcEEEccCCccCCcCCh------hhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccc
Q 005760          123 LTNLTIIYLGGNKLNGSIPS------TLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLA  196 (678)
Q Consensus       123 l~~L~~L~l~~N~l~~~~~~------~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~  196 (678)
                      ...++.++++.|.+.+..|.      .|..+++|++|+|++|.+++ +| .+..+++|++|++++|.++ .+|..+..++
T Consensus        17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~   93 (198)
T 1ds9_A           17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD   93 (198)
T ss_dssp             TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred             cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence            34444444444444444443      55555555555555555553 34 5555555555555555555 3444455555


Q ss_pred             cccceeccccccccccccccccccccEEEecCCcccCCCC-ccccccccccccccCcccccEEEccCCcCCCcchH----
Q 005760          197 SLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLP-LEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPA----  271 (678)
Q Consensus       197 ~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~----  271 (678)
                      +|+.|+|++|+++.+| .+..+++|+.|++++|++++..+ ..+..++          +|+.|++++|++++..|.    
T Consensus        94 ~L~~L~L~~N~l~~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~----------~L~~L~l~~N~l~~~~~~~~~~  162 (198)
T 1ds9_A           94 TLEELWISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALD----------KLEDLLLAGNPLYNDYKENNAT  162 (198)
T ss_dssp             HCSEEEEEEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTT----------TCSEEEECSCHHHHHHHTTTTH
T ss_pred             cCCEEECcCCcCCcCC-ccccCCCCCEEECCCCcCCchhHHHHHhcCC----------CCCEEEecCCccccccccccch
Confidence            5666666666655555 45555566666666665553222 2333333          666666666666544332    


Q ss_pred             ------HHhcccCCCceeccccccc
Q 005760          272 ------SLEKLSYLKDLNLSFNKLE  290 (678)
Q Consensus       272 ------~~~~l~~L~~L~l~~N~~~  290 (678)
                            .+..+++|+.||  +|+++
T Consensus       163 ~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          163 SEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             HHHHHHHHHhCCCcEEEC--CcccC
Confidence                  366777888775  66665

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.62  E-value=3.2e-15  Score=139.34  Aligned_cols=108  Identities=27%  Similarity=0.308  Sum_probs=50.8

Q ss_pred             CCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceecc
Q 005760          125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLG  204 (678)
Q Consensus       125 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~  204 (678)
                      +|++|++++|++++..+..|..+++|++|+|++|.|++..+..|..+++|++|++++|.+++..+..|..+++|+.|+|+
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  108 (177)
T 2o6r_A           29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD  108 (177)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence            44444444444443333344444444444444444443333334444444444444444444444444444555555555


Q ss_pred             cccccccccc-ccccccccEEEecCCccc
Q 005760          205 SNELTSIPLT-FWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       205 ~N~l~~l~~~-~~~l~~L~~L~l~~N~l~  232 (678)
                      +|+|+.+|.. +..+++|+.|+|++|++.
T Consensus       109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  137 (177)
T 2o6r_A          109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWD  137 (177)
T ss_dssp             SSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CCcceEeCHHHhcCCcccCEEEecCCCee
Confidence            5555544442 344555555555555544

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.61  E-value=9.7e-16  Score=142.72  Aligned_cols=135  Identities=15%  Similarity=0.156  Sum_probs=82.1

Q ss_pred             ccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCC
Q 005760           70 LSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQK  149 (678)
Q Consensus        70 ~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  149 (678)
                      +.++.+|+.|++++|+++.+ +.  +..+.++|++|++++|.+++.  ..|..+++|++|+|++|++++..+..|..+++
T Consensus        15 ~~~~~~L~~L~l~~n~l~~i-~~--~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPVI-EN--LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CC--GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             cCCcCCceEEEeeCCCCchh-HH--hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            44455555555555555433 11  222222455555555555543  34667777777777777777555555577777


Q ss_pred             CCEEEccCCcCCCCCCC--cccCCCCccEEecCCCcCCCCChh----hhhccccccceeccccccccc
Q 005760          150 LQGLGLENNKLEGSIPD--SICHSDELYKLELGGNKLSGSIPE----CFNNLASLRILLLGSNELTSI  211 (678)
Q Consensus       150 L~~L~L~~n~i~~~~~~--~~~~l~~L~~L~l~~N~i~~~~~~----~~~~l~~L~~L~l~~N~l~~l  211 (678)
                      |++|+|++|+|+ .+|.  .+..+++|+.|++++|.++. .|.    .+..+++|+.|++++|.+.+.
T Consensus        90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~~  155 (176)
T 1a9n_A           90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKER  155 (176)
T ss_dssp             CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHHH
T ss_pred             CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHHH
Confidence            777777777776 4444  66677777777777777763 333    366677777777777766643

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.60  E-value=1.1e-15  Score=142.42  Aligned_cols=110  Identities=22%  Similarity=0.234  Sum_probs=74.3

Q ss_pred             cccCCCCCcEEEccCCccCCcCChhhhccC-CCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhcccc
Q 005760          119 EIGNLTNLTIIYLGGNKLNGSIPSTLGKLQ-KLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLAS  197 (678)
Q Consensus       119 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~  197 (678)
                      .+.++.+|++|++++|+++. ++. +..+. +|++|+|++|.|++.  ..+..+++|++|++++|.|++..+..|..+++
T Consensus        14 ~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             hcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            35567777777777777773 343 44443 777777777777743  46777777777777777777555555577777


Q ss_pred             ccceeccccccccccc--cccccccccEEEecCCccc
Q 005760          198 LRILLLGSNELTSIPL--TFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       198 L~~L~l~~N~l~~l~~--~~~~l~~L~~L~l~~N~l~  232 (678)
                      |+.|+|++|+|+.+|.  .+..+++|+.|++++|++.
T Consensus        90 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~  126 (176)
T 1a9n_A           90 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  126 (176)
T ss_dssp             CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             CCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCC
Confidence            7777777777777665  5666666666666666665

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.59  E-value=3.9e-17  Score=155.41  Aligned_cols=144  Identities=18%  Similarity=0.199  Sum_probs=111.5

Q ss_pred             CccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccc
Q 005760          117 PEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLA  196 (678)
Q Consensus       117 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~  196 (678)
                      |..|..+++|++|+|++|++++ +| .+..+++|++|+|++|.|+ .+|..+..+++|++|++++|.+++ +| .+..++
T Consensus        41 ~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~  115 (198)
T 1ds9_A           41 DATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLV  115 (198)
T ss_dssp             HHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHH
T ss_pred             hHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCC
Confidence            3478889999999999999985 56 8889999999999999998 677778888999999999999995 44 688899


Q ss_pred             cccceeccccccccccc--cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCC
Q 005760          197 SLRILLLGSNELTSIPL--TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSG  267 (678)
Q Consensus       197 ~L~~L~l~~N~l~~l~~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~  267 (678)
                      +|+.|+|++|+++.++.  .+..+++|+.|++++|++.+..|..-..-......+..+++|+.||  +|.++.
T Consensus       116 ~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGTT
T ss_pred             CCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccCH
Confidence            99999999999998865  6889999999999999987665432000000000112344899887  777764

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.50  E-value=3e-14  Score=131.57  Aligned_cols=110  Identities=24%  Similarity=0.270  Sum_probs=61.8

Q ss_pred             CCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCC
Q 005760          150 LQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSN  229 (678)
Q Consensus       150 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N  229 (678)
                      .++|++++|.++ .+|..+.  ++|++|+|++|.|++..|..|..+++|++|+|++|+|+.+                  
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l------------------   69 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVL------------------   69 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC------------------
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCcc------------------
Confidence            345666666665 3444332  4555555555555555455555555555555555544444                  


Q ss_pred             cccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCC
Q 005760          230 FFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR  295 (678)
Q Consensus       230 ~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  295 (678)
                           .+..|.+++          +|+.|+|++|+|++..+..|..+++|+.|+|++|+|.|.++.
T Consensus        70 -----~~~~f~~l~----------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~  120 (170)
T 3g39_A           70 -----PAGVFDKLT----------QLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD  120 (170)
T ss_dssp             -----CTTTTTTCT----------TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred             -----ChhhccCCC----------CCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence                 444444444          666666666666655555666666677777777777766653

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.46  E-value=2e-13  Score=126.39  Aligned_cols=84  Identities=26%  Similarity=0.337  Sum_probs=31.9

Q ss_pred             CCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceecc
Q 005760          125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLG  204 (678)
Q Consensus       125 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~  204 (678)
                      +|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus        34 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~  113 (174)
T 2r9u_A           34 DKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLY  113 (174)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECC
T ss_pred             CCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeC
Confidence            33444444444433333333334444444444444432222223333334444444443333333333333333333333


Q ss_pred             cccc
Q 005760          205 SNEL  208 (678)
Q Consensus       205 ~N~l  208 (678)
                      +|.+
T Consensus       114 ~N~~  117 (174)
T 2r9u_A          114 NNPW  117 (174)
T ss_dssp             SSCB
T ss_pred             CCCc
Confidence            3333

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.45  E-value=2.2e-13  Score=125.76  Aligned_cols=84  Identities=29%  Similarity=0.380  Sum_probs=32.7

Q ss_pred             CCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceec
Q 005760          124 TNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLL  203 (678)
Q Consensus       124 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l  203 (678)
                      ++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  109 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL  109 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence            33344444444444333333444444444444444444333333333344444444444443333333333333333333


Q ss_pred             cccc
Q 005760          204 GSNE  207 (678)
Q Consensus       204 ~~N~  207 (678)
                      ++|.
T Consensus       110 ~~N~  113 (170)
T 3g39_A          110 LNNP  113 (170)
T ss_dssp             CSSC
T ss_pred             CCCC
Confidence            3333

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.45  E-value=2.5e-13  Score=125.82  Aligned_cols=103  Identities=30%  Similarity=0.372  Sum_probs=54.1

Q ss_pred             cEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceecccc
Q 005760          127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSN  206 (678)
Q Consensus       127 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N  206 (678)
                      +.+++++|+++ .+|..+.  ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            45566666664 3444332  55566666666665544555555555555555555555444444555555555555555


Q ss_pred             cccccccc-ccccccccEEEecCCccc
Q 005760          207 ELTSIPLT-FWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       207 ~l~~l~~~-~~~l~~L~~L~l~~N~l~  232 (678)
                      +|+.+|.. |..+++|+.|+|++|++.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcc
Confidence            55555442 444444444444444443

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.40  E-value=8e-15  Score=153.14  Aligned_cols=146  Identities=21%  Similarity=0.172  Sum_probs=66.7

Q ss_pred             CCCcEEEccCCccCCcCChhh-hccCCCCEEEccCCcCCCCCCCcc-----cCCCCccEEecCCCcCCCC----Chhhhh
Q 005760          124 TNLTIIYLGGNKLNGSIPSTL-GKLQKLQGLGLENNKLEGSIPDSI-----CHSDELYKLELGGNKLSGS----IPECFN  193 (678)
Q Consensus       124 ~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~L~~n~i~~~~~~~~-----~~l~~L~~L~l~~N~i~~~----~~~~~~  193 (678)
                      ++|++|+|++|.++......+ ..+++|++|+|++|.|+......+     ...++|++|+|++|.|++.    ++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            455555555555542222222 123445555555555542221222     1234555555555555421    222334


Q ss_pred             ccccccceecccccccc-----ccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCc
Q 005760          194 NLASLRILLLGSNELTS-----IPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGA  268 (678)
Q Consensus       194 ~l~~L~~L~l~~N~l~~-----l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~  268 (678)
                      .+++|++|+|++|.|+.     ++..+...++|+.|+|++|.|+......+...      ....++|++|+|++|.|+..
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~------L~~~~~L~~L~Ls~N~i~~~  254 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA------AREHPSLELLHLYFNELSSE  254 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH------HHHCSSCCEEECTTSSCCHH
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH------HHhCCCCCEEeccCCCCCHH
Confidence            45556666666665553     23344555566666666666553322222110      00122566666666666655


Q ss_pred             chHHHhc
Q 005760          269 IPASLEK  275 (678)
Q Consensus       269 ~~~~~~~  275 (678)
                      ....+..
T Consensus       255 g~~~L~~  261 (372)
T 3un9_A          255 GRQVLRD  261 (372)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            4444443

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.39  E-value=2e-14  Score=150.10  Aligned_cols=159  Identities=18%  Similarity=0.159  Sum_probs=122.1

Q ss_pred             CCCCcEEEccCCccCCcCChhhhcc-----CCCCEEEccCCcCCCCCCCcc-cCCCCccEEecCCCcCCCCChhhhh---
Q 005760          123 LTNLTIIYLGGNKLNGSIPSTLGKL-----QKLQGLGLENNKLEGSIPDSI-CHSDELYKLELGGNKLSGSIPECFN---  193 (678)
Q Consensus       123 l~~L~~L~l~~N~l~~~~~~~~~~l-----~~L~~L~L~~n~i~~~~~~~~-~~l~~L~~L~l~~N~i~~~~~~~~~---  193 (678)
                      +++|+.|+|++|.++......+...     ++|++|+|++|.|+......+ ..+++|+.|+|++|.+++.....+.   
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            5789999999999985554555443     799999999999974333333 3467899999999999865555553   


Q ss_pred             --ccccccceecccccccc-----ccccccccccccEEEecCCcccCCCC----ccccccccccccccCcccccEEEccC
Q 005760          194 --NLASLRILLLGSNELTS-----IPLTFWNLKDILYLNFSSNFFTGPLP----LEIGNLKIARIDSCDLISLISLNLSN  262 (678)
Q Consensus       194 --~l~~L~~L~l~~N~l~~-----l~~~~~~l~~L~~L~l~~N~l~~~~~----~~~~~l~~~~~~~~~~~~L~~L~L~~  262 (678)
                        ..++|+.|+|++|.|+.     ++..+..+++|++|+|++|.|+....    ..+...          ++|+.|+|++
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~----------~~L~~L~Ls~  220 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRN----------RQLQELNVAY  220 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGC----------SCCCEEECCS
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcC----------CCcCeEECCC
Confidence              46789999999999985     45567889999999999999875442    233333          3899999999


Q ss_pred             CcCCCcch----HHHhcccCCCceecccccccc
Q 005760          263 NNLSGAIP----ASLEKLSYLKDLNLSFNKLEG  291 (678)
Q Consensus       263 N~l~~~~~----~~~~~l~~L~~L~l~~N~~~~  291 (678)
                      |.|+....    .++...+.|++|+|++|+++.
T Consensus       221 N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          221 NGAGDTAALALARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             SCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred             CCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence            99986443    444567999999999999874

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.38  E-value=3.1e-13  Score=140.50  Aligned_cols=80  Identities=20%  Similarity=0.200  Sum_probs=39.1

Q ss_pred             EEccCC-cCCCCCCCcccCCCCccEEecCC-CcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCC
Q 005760          153 LGLENN-KLEGSIPDSICHSDELYKLELGG-NKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN  229 (678)
Q Consensus       153 L~L~~n-~i~~~~~~~~~~l~~L~~L~l~~-N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N  229 (678)
                      ++++++ +|+ .+|. +..+++|+.|+|++ |.|++..+..|.++++|+.|+|++|+|+.++. .|.++++|+.|+|++|
T Consensus        13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            445554 555 3444 55555555555553 55554444445555555555555555554433 3444444444444444


Q ss_pred             cccCC
Q 005760          230 FFTGP  234 (678)
Q Consensus       230 ~l~~~  234 (678)
                      +|++.
T Consensus        91 ~l~~~   95 (347)
T 2ifg_A           91 ALESL   95 (347)
T ss_dssp             CCSCC
T ss_pred             cccee
Confidence            44433

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.34  E-value=6.3e-12  Score=132.91  Aligned_cols=155  Identities=14%  Similarity=0.090  Sum_probs=86.0

Q ss_pred             cCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCC
Q 005760           12 TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILP   91 (678)
Q Consensus        12 ~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~   91 (678)
                      .-..+|.++.+|+.+.|.. .++.+...+|.++++|+.++|.++ ++.++..     +|.++.+|+.+.+..+ +..+..
T Consensus        62 Ig~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~-----aF~~c~~L~~i~~p~~-l~~i~~  133 (394)
T 4fs7_A           62 IGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRC-----TFSGCYALKSILLPLM-LKSIGV  133 (394)
T ss_dssp             ECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTT-----TTTTCTTCCCCCCCTT-CCEECT
T ss_pred             hHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccch-----hhcccccchhhcccCc-eeeecc
Confidence            3345677789999999974 488788899999999999999765 6655543     5888888888777654 333333


Q ss_pred             hhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCC
Q 005760           92 KTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS  171 (678)
Q Consensus        92 ~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l  171 (678)
                      .. |.+..  ++.+.+. ..+......+|.++++|+.+.+.++... +...+|.++++|+.+.+..| ++.....+|.++
T Consensus       134 ~a-F~~~~--~~~~~~~-~~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~  207 (394)
T 4fs7_A          134 EA-FKGCD--FKEITIP-EGVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAEC  207 (394)
T ss_dssp             TT-TTTCC--CSEEECC-TTCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTC
T ss_pred             ee-eeccc--ccccccC-ccccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccc
Confidence            22 22221  1111111 1122223344555555555555444322 44445555555555555444 221233344444


Q ss_pred             CCccEEecC
Q 005760          172 DELYKLELG  180 (678)
Q Consensus       172 ~~L~~L~l~  180 (678)
                      ..|+.+.+.
T Consensus       208 ~~L~~i~~~  216 (394)
T 4fs7_A          208 ILLENMEFP  216 (394)
T ss_dssp             TTCCBCCCC
T ss_pred             cccceeecC
Confidence            444444443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.33  E-value=8.5e-12  Score=131.91  Aligned_cols=256  Identities=15%  Similarity=0.107  Sum_probs=136.2

Q ss_pred             cCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccch-----------------hhcccc
Q 005760            8 NFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLEL-----------------SFLSSL   70 (678)
Q Consensus         8 ~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~-----------------~~~~~~   70 (678)
                      +++..-..+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.+..+ +..++...                 --..+|
T Consensus        81 ~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~~~~~~i~~~aF  158 (394)
T 4fs7_A           81 TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIPEGVTVIGDEAF  158 (394)
T ss_dssp             TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECCTTCCEECTTTT
T ss_pred             CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccCccccccchhhh
Confidence            455344567788999999999865 77677899999999998887654 22222110                 001257


Q ss_pred             cCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCC
Q 005760           71 SNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKL  150 (678)
Q Consensus        71 ~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  150 (678)
                      .++++|+.+.+.++. ..+.. ..|.+.. +|+.+++..+ ++.+....|.++..|+.+.+..+... + ...+....+|
T Consensus       159 ~~c~~L~~i~l~~~~-~~I~~-~~F~~c~-~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~-i-~~~~~~~~~l  232 (394)
T 4fs7_A          159 ATCESLEYVSLPDSM-ETLHN-GLFSGCG-KLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY-L-GDFALSKTGV  232 (394)
T ss_dssp             TTCTTCCEEECCTTC-CEECT-TTTTTCT-TCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE-E-CTTTTTTCCC
T ss_pred             cccCCCcEEecCCcc-ceecc-ccccCCC-CceEEEcCCC-ceEeCchhhccccccceeecCCCceE-e-ehhhcccCCC
Confidence            777888888887553 22333 2355554 6777777665 55555666777777777766655432 1 1222233455


Q ss_pred             CEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCc
Q 005760          151 QGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNF  230 (678)
Q Consensus       151 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~  230 (678)
                      +.+.+..+.-. .....|..+.+|+.+.+..+... .....|..+..|+.+....+.+..  ..|....+|+.+.+..+ 
T Consensus       233 ~~i~ip~~~~~-i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~--~~F~~~~~L~~i~l~~~-  307 (394)
T 4fs7_A          233 KNIIIPDSFTE-LGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPE--KTFYGCSSLTEVKLLDS-  307 (394)
T ss_dssp             CEEEECTTCCE-ECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECT--TTTTTCTTCCEEEECTT-
T ss_pred             ceEEECCCcee-cccccccccccceeEEcCCCcce-eeccccccccccceeccCceeecc--ccccccccccccccccc-
Confidence            55555433222 33345555666666666555433 334445555555544444332111  13444444555544433 


Q ss_pred             ccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccc
Q 005760          231 FTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFN  287 (678)
Q Consensus       231 l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N  287 (678)
                      ++.+....|.++.          +|+.++|.++ ++.+...+|.++.+|+.+++..|
T Consensus       308 i~~I~~~aF~~c~----------~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~  353 (394)
T 4fs7_A          308 VKFIGEEAFESCT----------SLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS  353 (394)
T ss_dssp             CCEECTTTTTTCT----------TCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred             cceechhhhcCCC----------CCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence            3323333333333          4444444322 33344444444444554444433

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.32  E-value=2.7e-11  Score=128.09  Aligned_cols=251  Identities=13%  Similarity=0.163  Sum_probs=144.7

Q ss_pred             CccccCCC-CCCEEecCCCcccccCCccccCCCCCCEEEccCcc---CCCCccchhhcccccCCCCCcEEECccCCCccc
Q 005760           14 PRFIFNAS-KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNY---LTSSTLELSFLSSLSNCKSLTLISFSNNPLDGI   89 (678)
Q Consensus        14 p~~~~~l~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~---i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~   89 (678)
                      ..+|.+.+ .|+.+.+..+ ++.+...+|.++.+|+.+.+..|.   ++.++..     +|.++.+|+.+.+..+ ++.+
T Consensus        56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~-----aF~~c~~L~~i~~~~~-~~~I  128 (394)
T 4gt6_A           56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQ-----AFMFCSELTDIPILDS-VTEI  128 (394)
T ss_dssp             TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTT-----TTTTCTTCCBCGGGTT-CSEE
T ss_pred             HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechh-----hchhcccceeeccCCc-ccee
Confidence            35555553 5888888754 776777888888888888887764   4444433     4666666666665543 3333


Q ss_pred             CChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCc----------------------CChhhhcc
Q 005760           90 LPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGS----------------------IPSTLGKL  147 (678)
Q Consensus        90 ~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~----------------------~~~~~~~l  147 (678)
                      .... +.... +|+.+.+.. .+..+....|.++.+|+.+.+.++ ++.+                      ...+|.++
T Consensus       129 ~~~a-F~~c~-~L~~i~lp~-~~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~~~l~~i~ip~~~~~i~~~af~~c  204 (394)
T 4gt6_A          129 DSEA-FHHCE-ELDTVTIPE-GVTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTGTALTQIHIPAKVTRIGTNAFSEC  204 (394)
T ss_dssp             CTTT-TTTCT-TCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCCCSEEEECTTCCEECTTTTTTC
T ss_pred             hhhh-hhhhc-ccccccccc-eeeeecccceecccccccccccce-eeEeccccccccceeEEEECCcccccccchhhhc
Confidence            3322 33333 566666643 233344445555555555555443 2212                      33344444


Q ss_pred             CCCCEEEccCCcC------------------------------------CCCCCCcccCCCCccEEecCCCcCCCCChhh
Q 005760          148 QKLQGLGLENNKL------------------------------------EGSIPDSICHSDELYKLELGGNKLSGSIPEC  191 (678)
Q Consensus       148 ~~L~~L~L~~n~i------------------------------------~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~  191 (678)
                      .+++......+..                                    +.....+|.++.+|+.+.+..+... ....+
T Consensus       205 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~a  283 (394)
T 4gt6_A          205 FALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSVVS-IGTGA  283 (394)
T ss_dssp             TTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTT
T ss_pred             cccceecccccccccccceeecccccccccccccccccccceEEcCCcceEcccceeeecccccEEecccccce-ecCcc
Confidence            4444433322211                                    1011235556666677766655443 45566


Q ss_pred             hhccccccceeccccccccccc-cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcch
Q 005760          192 FNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP  270 (678)
Q Consensus       192 ~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~  270 (678)
                      |.++++|+.+.+. +.++.++. +|.++.+|+.+.|..+ ++.+....|.++.          +|+.+.|.++ ++.+..
T Consensus       284 F~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~----------~L~~i~ip~s-v~~I~~  350 (394)
T 4gt6_A          284 FMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCE----------QLERIAIPSS-VTKIPE  350 (394)
T ss_dssp             TTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT----------TCCEEEECTT-CCBCCG
T ss_pred             cccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCC----------CCCEEEECcc-cCEEhH
Confidence            6777777777775 45666655 5777777777777654 4444555555555          7777777544 666667


Q ss_pred             HHHhcccCCCceecccccc
Q 005760          271 ASLEKLSYLKDLNLSFNKL  289 (678)
Q Consensus       271 ~~~~~l~~L~~L~l~~N~~  289 (678)
                      .+|.++++|+.+++.+|..
T Consensus       351 ~aF~~C~~L~~i~~~~~~~  369 (394)
T 4gt6_A          351 SAFSNCTALNNIEYSGSRS  369 (394)
T ss_dssp             GGGTTCTTCCEEEESSCHH
T ss_pred             hHhhCCCCCCEEEECCcee
Confidence            7777777888877777654

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.31  E-value=6.4e-12  Score=130.51  Aligned_cols=102  Identities=24%  Similarity=0.203  Sum_probs=65.6

Q ss_pred             EEEccCC-ccCCcCChhhhccCCCCEEEccC-CcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccc
Q 005760          128 IIYLGGN-KLNGSIPSTLGKLQKLQGLGLEN-NKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGS  205 (678)
Q Consensus       128 ~L~l~~N-~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~  205 (678)
                      .++++++ +++ .+|. +..+++|++|+|++ |.|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            4566666 666 3555 66667777777764 777655556677777777777777777766666677777777777777


Q ss_pred             ccccccccc-ccccccccEEEecCCccc
Q 005760          206 NELTSIPLT-FWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       206 N~l~~l~~~-~~~l~~L~~L~l~~N~l~  232 (678)
                      |+|+.+|.. |..++ |+.|+|.+|++.
T Consensus        90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           90 NALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            777766653 33332 555665555554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.28  E-value=1.2e-11  Score=122.98  Aligned_cols=146  Identities=16%  Similarity=0.113  Sum_probs=114.8

Q ss_pred             HHhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEE
Q 005760          388 CRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       388 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv  466 (678)
                      ...-.+|+.....+.|+.+.||++... +..+++|+...........+.+|+++++.+. +..+.++++++.+.+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            334467888888999999999999864 6889999987543334467899999999885 66788899999888899999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG--------------------------------------  508 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------  508 (678)
                      |||++|.++.+.+..      ......++.+++.++..||.-                                      
T Consensus        89 ~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           89 MSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             EEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999999876421      112346788999999999951                                      


Q ss_pred             ------------------CCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          509 ------------------YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       509 ------------------~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                                        ....++|+|+++.||++++++.+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                              01458999999999999876666799998764

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.21  E-value=2.2e-10  Score=120.95  Aligned_cols=139  Identities=14%  Similarity=0.163  Sum_probs=102.0

Q ss_pred             cccccCCccccCCC-CCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCC---CcccCChhhhhcccccccEEEc
Q 005760           32 SFSGFIPNTFGNLR-NLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNP---LDGILPKTSVGNLSHSLEYFEM  107 (678)
Q Consensus        32 ~i~~~~~~~~~~l~-~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~---i~~~~~~~~~~~l~~~L~~L~l  107 (678)
                      .++.+...+|.+.+ .|+.+.+-.+ ++.++..     +|.+|.+|+.+.+..|.   ++.+...+ |.... +|+.+.+
T Consensus        50 ~Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~-----AF~~C~~L~~i~~~~n~p~~l~~Ig~~a-F~~c~-~L~~i~~  121 (394)
T 4gt6_A           50 PVSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSN-----AFYNCTSLKRVTIQDNKPSCVKKIGRQA-FMFCS-ELTDIPI  121 (394)
T ss_dssp             EEEEECTTTTTTCCSCCCEEEECTT-CCEECTT-----TTTTCTTCCEEEEGGGCCCCCCEECTTT-TTTCT-TCCBCGG
T ss_pred             eeeEcCHhhccCCCCcCEEEEECCC-eeEEhHH-----HhhCCccCceEeecCCCCCeeeEechhh-chhcc-cceeecc
Confidence            46667788999885 5999999765 7777754     69999999999998875   65555544 55554 7888777


Q ss_pred             ccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCC
Q 005760          108 AYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGN  182 (678)
Q Consensus       108 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N  182 (678)
                      ..+ ++.+....|.++.+|+.+.+..+-- .+...+|.++.+|+.+.+..+ ++.....+|. ...|+.+.+..+
T Consensus       122 ~~~-~~~I~~~aF~~c~~L~~i~lp~~~~-~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~~i~ip~~  192 (394)
T 4gt6_A          122 LDS-VTEIDSEAFHHCEELDTVTIPEGVT-SVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALTQIHIPAK  192 (394)
T ss_dssp             GTT-CSEECTTTTTTCTTCCEEECCTTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCSEEEECTT
T ss_pred             CCc-cceehhhhhhhhcccccccccceee-eecccceecccccccccccce-eeEecccccc-ccceeEEEECCc
Confidence            654 6667778899999999999986544 477789999999999999766 3323334443 355666666543

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.10  E-value=1.9e-10  Score=114.08  Aligned_cols=136  Identities=16%  Similarity=0.109  Sum_probs=101.0

Q ss_pred             CCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCcc--ceeeeeeeecCCeEEEEEEec
Q 005760          393 GFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRN--IIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~  470 (678)
                      +|.+....+.|..+.||++...+|..+++|+....   ....+..|+.+++.+.+.+  +.+++++....+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            44443333456669999998777888999997543   3366888999999886544  456888888888889999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------------------
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY-----------------------------------------  509 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------------  509 (678)
                      +|.++.  ...    .+   ...++.+++..+..||...                                         
T Consensus        98 ~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           98 PGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             SSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            998883  211    12   2357788888888888321                                         


Q ss_pred             --------------CCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          510 --------------SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       510 --------------~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                                    ...++|+|++|.||++++++.+.++|||.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                          1129999999999999887667799999874

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.07  E-value=3.8e-09  Score=110.89  Aligned_cols=57  Identities=11%  Similarity=0.158  Sum_probs=31.2

Q ss_pred             cCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECc
Q 005760           18 FNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFS   82 (678)
Q Consensus        18 ~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~   82 (678)
                      ....+|+.+.+.. .++.+...+|.++.+|+.++|..+ ++.++..     +|.++ +|+.+.+.
T Consensus        43 ~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~-----aF~~c-~l~~i~~~   99 (379)
T 4h09_A           43 KDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDG-----AFADT-KLQSYTGM   99 (379)
T ss_dssp             GGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTT-----TTTTC-CCCEEEEC
T ss_pred             ccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechh-----hhcCC-CCceEECC
Confidence            3445566666653 355555666666666666666543 4444433     35554 45555544

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=99.04  E-value=7e-11  Score=122.16  Aligned_cols=86  Identities=19%  Similarity=0.198  Sum_probs=52.4

Q ss_pred             ccccccceecccccccc-ccccc---cccccccEEEecCCcccCCCCcccc-ccccccccccCcccccEEEccCCcCCCc
Q 005760          194 NLASLRILLLGSNELTS-IPLTF---WNLKDILYLNFSSNFFTGPLPLEIG-NLKIARIDSCDLISLISLNLSNNNLSGA  268 (678)
Q Consensus       194 ~l~~L~~L~l~~N~l~~-l~~~~---~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~~~~~~~~~~~L~~L~L~~N~l~~~  268 (678)
                      .+++|+.|+|++|.++. .+..+   ..+++|+.|+|+.|.+++.....+. +++       .+++|+.|+|++|.|+..
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~-------~l~~L~~L~L~~n~i~d~  322 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVD-------KIKHLKFINMKYNYLSDE  322 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHH-------HHTTCSEEECCSBBCCHH
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcc-------cCCcceEEECCCCcCCHH
Confidence            35677777777776653 11111   2467788888888877654332221 111       234888888888888766


Q ss_pred             chHHHhc-ccCCCceeccccc
Q 005760          269 IPASLEK-LSYLKDLNLSFNK  288 (678)
Q Consensus       269 ~~~~~~~-l~~L~~L~l~~N~  288 (678)
                      .-..+.. +  ...+++++|+
T Consensus       323 ~~~~l~~al--g~~~~~~~~~  341 (362)
T 2ra8_A          323 MKKELQKSL--PMKIDVSDSQ  341 (362)
T ss_dssp             HHHHHHHHC--CSEEECCSBC
T ss_pred             HHHHHHHHc--CCEEEecCCc
Confidence            5555554 3  3557888877

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=99.03  E-value=3e-10  Score=117.46  Aligned_cols=161  Identities=17%  Similarity=0.207  Sum_probs=109.0

Q ss_pred             ccCCCCCcEEEccCCccC---------CcCChhhhccCCCCEEEccCCc-CCCCCCCcccCCCCccEEecCCCcCCCCCh
Q 005760          120 IGNLTNLTIIYLGGNKLN---------GSIPSTLGKLQKLQGLGLENNK-LEGSIPDSICHSDELYKLELGGNKLSGSIP  189 (678)
Q Consensus       120 ~~~l~~L~~L~l~~N~l~---------~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~  189 (678)
                      ...+++|+.|.+.++...         +.+...+..+|+|+.|+|++|. +.  ++. + .+++|++|+|..|.+.....
T Consensus       135 ~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~-~~~~L~~L~L~~~~l~~~~l  210 (362)
T 2ra8_A          135 KEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-K-PRPNLKSLEIISGGLPDSVV  210 (362)
T ss_dssp             HHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCS-C-BCTTCSEEEEECSBCCHHHH
T ss_pred             hhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--ecc-c-cCCCCcEEEEecCCCChHHH
Confidence            445677777777654321         1233455678899999998874 33  333 3 37899999999888874443


Q ss_pred             hhhh--ccccccceeccc--cc------cccccccc--cccccccEEEecCCcccCCCCccccccccccccccCcccccE
Q 005760          190 ECFN--NLASLRILLLGS--NE------LTSIPLTF--WNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLIS  257 (678)
Q Consensus       190 ~~~~--~l~~L~~L~l~~--N~------l~~l~~~~--~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~  257 (678)
                      ..+.  .+++|++|+|+.  |.      +..+...+  ..+++|+.|+|++|.+.+..+..+...       ..+|+|+.
T Consensus       211 ~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a-------~~~~~L~~  283 (362)
T 2ra8_A          211 EDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES-------DILPQLET  283 (362)
T ss_dssp             HHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHC-------SSGGGCSE
T ss_pred             HHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhC-------ccCCCCCE
Confidence            4444  688999998863  21      22333333  357899999999999875443333221       13569999


Q ss_pred             EEccCCcCCCcchHH----HhcccCCCceecccccccc
Q 005760          258 LNLSNNNLSGAIPAS----LEKLSYLKDLNLSFNKLEG  291 (678)
Q Consensus       258 L~L~~N~l~~~~~~~----~~~l~~L~~L~l~~N~~~~  291 (678)
                      |+|+.|.|++..+..    +..+++|+.|++++|.++.
T Consensus       284 LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d  321 (362)
T 2ra8_A          284 MDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD  321 (362)
T ss_dssp             EECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred             EECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence            999999998754433    3567999999999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.92  E-value=1.9e-09  Score=112.20  Aligned_cols=143  Identities=13%  Similarity=0.152  Sum_probs=106.3

Q ss_pred             CCCccccCCCceeEEEEEeCCCcEEEEEEee--ccc-CchhhhHHHHHHHHHhCC--CccceeeeeeeecC---CeEEEE
Q 005760          395 SENNLIGRGSFGSVFKARLGDGMEVAMKVFN--LQY-GRVFKSFDVECEMMKSIR--HRNIIKVISSCSNE---EFKALV  466 (678)
Q Consensus       395 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv  466 (678)
                      ...+.++.|.++.||+....+ ..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+.   +..++|
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             ceEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            345789999999999998754 578888875  322 123457888999999987  45578888888766   458899


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC-------------------------------------
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY-------------------------------------  509 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------  509 (678)
                      |||++|..+.+...   ..++...+..++.+++..|+.||...                                     
T Consensus       120 me~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          120 MEFVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EECCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99999987744221   23677788889999999999999520                                     


Q ss_pred             ------------------CCCeEEcCCCCCCeeecCCCc--EEEEeeccccc
Q 005760          510 ------------------SAQVIHCDLKPSNVLLDDNMV--AHLSDFGIAKL  541 (678)
Q Consensus       510 ------------------~~~ivH~dl~~~Nill~~~~~--~kl~Dfg~~~~  541 (678)
                                        ...++|+|+++.||+++.++.  +.++||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              257999999999999997753  68999998864

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=98.92  E-value=3.7e-08  Score=103.27  Aligned_cols=249  Identities=11%  Similarity=0.049  Sum_probs=145.5

Q ss_pred             CcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcc
Q 005760            9 FSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDG   88 (678)
Q Consensus         9 ~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~   88 (678)
                      ++..-..+|.++.+|+.++|..+ ++.+...+|.+. +|+.+.+..+ +..++..     +|..+ +|+.+.+.++ +..
T Consensus        57 vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~-----aF~~~-~L~~i~lp~~-~~~  126 (379)
T 4h09_A           57 ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDY-----VFQGT-DLDDFEFPGA-TTE  126 (379)
T ss_dssp             EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTT-----TTTTC-CCSEEECCTT-CCE
T ss_pred             ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccc-----eeccC-CcccccCCCc-ccc
Confidence            44334467778899999999754 777888999887 7888888654 5555543     47665 7999999876 333


Q ss_pred             cCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCC------------------------------
Q 005760           89 ILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG------------------------------  138 (678)
Q Consensus        89 ~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~------------------------------  138 (678)
                      +.... +.+.  +|+.+.+.. .++.+....|..+.+++.+.+..+....                              
T Consensus       127 i~~~~-F~~~--~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (379)
T 4h09_A          127 IGNYI-FYNS--SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIP  202 (379)
T ss_dssp             ECTTT-TTTC--CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECC
T ss_pred             ccccc-cccc--eeeeeeccc-eeeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccc
Confidence            43333 3332  566666654 3555666778888888888776543220                              


Q ss_pred             -----cCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc
Q 005760          139 -----SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL  213 (678)
Q Consensus       139 -----~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~  213 (678)
                           ....++....+|+.+.+..+--. ....+|.++..|+.+.+..+ ++.....+|.++.+|+.+.+..+ ++.++.
T Consensus       203 ~~~~~i~~~~f~~~~~l~~i~~~~~~~~-i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~  279 (379)
T 4h09_A          203 STVKTVTAYGFSYGKNLKKITITSGVTT-LGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPY  279 (379)
T ss_dssp             TTCCEECTTTTTTCSSCSEEECCTTCCE-ECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECT
T ss_pred             cceeEEeecccccccccceeeeccceeE-EccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccc
Confidence                 11123333444555554433221 33445555555666655544 33344455555566666655433 444444


Q ss_pred             -cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecc
Q 005760          214 -TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLS  285 (678)
Q Consensus       214 -~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  285 (678)
                       .|.++.+|+.+.+.++.++.+....|.++.          +|+.+.|.++ ++.+...+|.++.+|+.+.+.
T Consensus       280 ~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~----------~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip  341 (379)
T 4h09_A          280 LLCSGCSNLTKVVMDNSAIETLEPRVFMDCV----------KLSSVTLPTA-LKTIQVYAFKNCKALSTISYP  341 (379)
T ss_dssp             TTTTTCTTCCEEEECCTTCCEECTTTTTTCT----------TCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred             cccccccccccccccccccceehhhhhcCCC----------CCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence             455566666666665555544445555444          5666666443 444555556666666655554

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.75  E-value=1.9e-09  Score=109.51  Aligned_cols=187  Identities=17%  Similarity=0.156  Sum_probs=120.6

Q ss_pred             CccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-Ccc--ceeeeeeeecCC---eEEEEEEec
Q 005760          397 NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRN--IIKVISSCSNEE---FKALVLEYM  470 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~  470 (678)
                      .+.++.|....||+..    ..+++|+....  .....+.+|.++++.+. +..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4668999999999864    46889986432  33567888999998874 333  344555443333   347899999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG------------------------------------------  508 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------------------------------------------  508 (678)
                      +|.++.+....   .++..++..++.+++..++.||..                                          
T Consensus        99 ~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  175 (304)
T 3sg8_A           99 KGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD  175 (304)
T ss_dssp             CCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred             CCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence            99888654332   256677778888888888888841                                          


Q ss_pred             -------------CCCCeEEcCCCCCCeeecC--CCcEEEEeeccccccCCCCCcceeecccCCccccCccccC----C-
Q 005760          509 -------------YSAQVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK----E-  568 (678)
Q Consensus       509 -------------~~~~ivH~dl~~~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-  568 (678)
                                   ....++|+|+++.||++++  +..+.++||+.+..-.+..  ... .......-..|+...    . 
T Consensus       176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~--Dl~-~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN--DFI-SLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH--HHH-TTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH--HHH-HHHhhccccCHHHHHHHHHHc
Confidence                         0135899999999999998  5567899999986532210  000 000000001222110    0 


Q ss_pred             CC---------CCccchHHHHHHHHHHHHcCCCCCC
Q 005760          569 GR---------VSANGDVYSFGIMLMETFTRKKPTD  595 (678)
Q Consensus       569 ~~---------~~~~~DvwslGv~l~ell~g~~p~~  595 (678)
                      +.         .....+.|++|.++|++.+|..+|.
T Consensus       253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            00         1122589999999999999988763

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.70  E-value=3.2e-09  Score=98.99  Aligned_cols=122  Identities=16%  Similarity=0.190  Sum_probs=63.1

Q ss_pred             ccccCCCCCCEEEccCc-cCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccc--ccccEEEccccccccc
Q 005760           39 NTFGNLRNLQALRLSNN-YLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLS--HSLEYFEMAYCNVSGG  115 (678)
Q Consensus        39 ~~~~~l~~L~~L~l~~n-~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~--~~L~~L~l~~n~l~~~  115 (678)
                      ..+...++|++|+|++| .+...... .+...+...++|++|+|++|.|...........+.  .+|++|+|++|.|...
T Consensus        30 ~~l~~~~~L~~L~L~~n~~i~~~g~~-~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~  108 (185)
T 1io0_A           30 RIQNNDPDLEEVNLNNIMNIPVPTLK-ACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGS  108 (185)
T ss_dssp             HHHTTCTTCCEEECTTCTTCCHHHHH-HHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHH
T ss_pred             HHHhcCCCCCEEEecCCCCCCHHHHH-HHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHH
Confidence            34444455555555555 44432211 12233444455555555555554322211111111  2455555555555532


Q ss_pred             ----CCccccCCCCCcEEEc--cCCccCCcC----ChhhhccCCCCEEEccCCcCC
Q 005760          116 ----IPEEIGNLTNLTIIYL--GGNKLNGSI----PSTLGKLQKLQGLGLENNKLE  161 (678)
Q Consensus       116 ----~~~~~~~l~~L~~L~l--~~N~l~~~~----~~~~~~l~~L~~L~L~~n~i~  161 (678)
                          +...+...++|++|+|  ++|.|....    ...+...++|++|+|++|.|.
T Consensus       109 g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          109 GILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence                3445666777888888  778876432    234445578888888888875

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.67  E-value=4.2e-09  Score=98.24  Aligned_cols=117  Identities=15%  Similarity=0.156  Sum_probs=63.0

Q ss_pred             cccCCCCCcEEECccC-CCcccCChhhhhccc--ccccEEEccccccccc----CCccccCCCCCcEEEccCCccCCc--
Q 005760           69 SLSNCKSLTLISFSNN-PLDGILPKTSVGNLS--HSLEYFEMAYCNVSGG----IPEEIGNLTNLTIIYLGGNKLNGS--  139 (678)
Q Consensus        69 ~~~~l~~L~~L~L~~n-~i~~~~~~~~~~~l~--~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~--  139 (678)
                      .+...++|++|+|++| .|...........+.  .+|++|+|++|.+...    +...+...++|++|+|++|.|...  
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            4555666666666666 665332222111111  2566666666666543    233344456666666666666532  


Q ss_pred             --CChhhhccCCCCEEEc--cCCcCCCC----CCCcccCCCCccEEecCCCcCC
Q 005760          140 --IPSTLGKLQKLQGLGL--ENNKLEGS----IPDSICHSDELYKLELGGNKLS  185 (678)
Q Consensus       140 --~~~~~~~l~~L~~L~L--~~n~i~~~----~~~~~~~l~~L~~L~l~~N~i~  185 (678)
                        +..++...++|++|+|  ++|.|+..    +...+...++|++|+|++|.+.
T Consensus       111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence              1334445566666666  56666532    2234444566666666666665

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.46  E-value=3.2e-08  Score=96.86  Aligned_cols=87  Identities=23%  Similarity=0.320  Sum_probs=43.2

Q ss_pred             ccCCCCCcE--EEccCCccCCcCCh----hhhccCCCCEEEccCCcCCC--CCCCcccCCCCccEEecCCCcCCCCChhh
Q 005760          120 IGNLTNLTI--IYLGGNKLNGSIPS----TLGKLQKLQGLGLENNKLEG--SIPDSICHSDELYKLELGGNKLSGSIPEC  191 (678)
Q Consensus       120 ~~~l~~L~~--L~l~~N~l~~~~~~----~~~~l~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~l~~N~i~~~~~~~  191 (678)
                      |...+.|..  ++++.|+.. .++.    ...++++|++|+|++|+|++  .+|..+..+++|+.|+|++|.|++.  ..
T Consensus       137 l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~  213 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RE  213 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GG
T ss_pred             cCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hh
Confidence            444555555  556666433 2222    22345666666666666664  2234444556666666666665533  22


Q ss_pred             hhccc--cccceeccccccc
Q 005760          192 FNNLA--SLRILLLGSNELT  209 (678)
Q Consensus       192 ~~~l~--~L~~L~l~~N~l~  209 (678)
                      +..+.  +|++|+|++|.+.
T Consensus       214 l~~l~~l~L~~L~L~~Npl~  233 (267)
T 3rw6_A          214 LDKIKGLKLEELWLDGNSLC  233 (267)
T ss_dssp             GGGGTTSCCSEEECTTSTTG
T ss_pred             hhhcccCCcceEEccCCcCc
Confidence            22222  4444444444443

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.44  E-value=4.2e-08  Score=96.07  Aligned_cols=80  Identities=28%  Similarity=0.319  Sum_probs=38.8

Q ss_pred             ccccccceecccccccccc---ccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcch
Q 005760          194 NLASLRILLLGSNELTSIP---LTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP  270 (678)
Q Consensus       194 ~l~~L~~L~l~~N~l~~l~---~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~  270 (678)
                      ++++|+.|+|++|+|+.++   ..+..+++|+.|+|++|.|++.  ..+..++       .+ +|++|+|++|.+++..|
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~-------~l-~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIK-------GL-KLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGT-------TS-CCSEEECTTSTTGGGCS
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcc-------cC-CcceEEccCCcCccccC
Confidence            3455555555555555433   2344555555555555555533  1222221       12 45566666665553222


Q ss_pred             -------HHHhcccCCCcee
Q 005760          271 -------ASLEKLSYLKDLN  283 (678)
Q Consensus       271 -------~~~~~l~~L~~L~  283 (678)
                             ..+..+|+|+.||
T Consensus       238 ~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          238 DQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             SHHHHHHHHHHHCTTCCEES
T ss_pred             cchhHHHHHHHHCcccCeEC
Confidence                   2344556655553

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.30  E-value=2.8e-06  Score=84.23  Aligned_cols=134  Identities=16%  Similarity=0.100  Sum_probs=96.5

Q ss_pred             cccCCCce-eEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEEEEecCCCCH
Q 005760          399 LIGRGSFG-SVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALVLEYMPHGSL  475 (678)
Q Consensus       399 ~ig~G~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L  475 (678)
                      .+..|..| .||+.... ++..+++|+-...   ....+..|...++.+. +-.+.++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556665 68998754 5678999986532   3456788999998875 33366788888888899999999999888


Q ss_pred             HHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------------------
Q 005760          476 EKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY----------------------------------------------  509 (678)
Q Consensus       476 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------------  509 (678)
                      .+......     .....+..+++..+..||...                                              
T Consensus       108 ~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            77654321     122345566666666666210                                              


Q ss_pred             ---------CCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          510 ---------SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       510 ---------~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                               ...++|+|+.+.||++++++.+-|+||+.+.
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                     1137999999999999988777899998874

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.27  E-value=2.6e-06  Score=86.15  Aligned_cols=136  Identities=15%  Similarity=0.135  Sum_probs=92.5

Q ss_pred             CccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCc---cceeeeeeee-cCCeEEEEEEecCC
Q 005760          397 NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHR---NIIKVISSCS-NEEFKALVLEYMPH  472 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~  472 (678)
                      .+.++.|....||+.    +..+++|+...  ......+..|.++++.+.+.   .+.+++.++. ..+..++||||++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888888999988    56788888532  23446788999999998742   3556666663 45567899999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG--------------------------------------------  508 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------------------------------------------  508 (678)
                      .++.+....   .++......++.+++..++.||..                                            
T Consensus        98 ~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~  174 (306)
T 3tdw_A           98 QILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL  174 (306)
T ss_dssp             EECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred             eECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence            887653211   123344444455555555555421                                            


Q ss_pred             -------------CCCCeEEcCCCCCCeeecC---CCcE-EEEeeccccc
Q 005760          509 -------------YSAQVIHCDLKPSNVLLDD---NMVA-HLSDFGIAKL  541 (678)
Q Consensus       509 -------------~~~~ivH~dl~~~Nill~~---~~~~-kl~Dfg~~~~  541 (678)
                                   ....++|+|+++.||+++.   ++.+ .|+||+.+..
T Consensus       175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                         1345799999999999987   4554 8999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.12  E-value=3.9e-06  Score=86.92  Aligned_cols=80  Identities=8%  Similarity=-0.013  Sum_probs=56.4

Q ss_pred             Cccc-cCCCceeEEEEEeC-------CCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCC---ccceeeeeeeecC--
Q 005760          397 NNLI-GRGSFGSVFKARLG-------DGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRH---RNIIKVISSCSNE--  460 (678)
Q Consensus       397 ~~~i-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~--  460 (678)
                      .+.| +.|....+|+....       ++..+++|+.....   ......+..|+.+++.+..   -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88889999998753       26778999865432   1113567889999988852   2466778777655  


Q ss_pred             -CeEEEEEEecCCCCHH
Q 005760          461 -EFKALVLEYMPHGSLE  476 (678)
Q Consensus       461 -~~~~lv~e~~~~~~L~  476 (678)
                       +..++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999987654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=98.03  E-value=1.2e-06  Score=81.09  Aligned_cols=119  Identities=13%  Similarity=0.187  Sum_probs=56.4

Q ss_pred             CCCCCEEecCCC-ccccc----CCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhh
Q 005760           20 ASKLSILELSDN-SFSGF----IPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTS   94 (678)
Q Consensus        20 l~~L~~L~l~~n-~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~   94 (678)
                      -+.|++|+|++| +|...    +.+++...+.|+.|+|++|.|++.... .+.+.+...+.|+.|+|+.|.|+...... 
T Consensus        40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~-alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a-  117 (197)
T 1pgv_A           40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEAR-GLIELIETSPSLRVLNVESNFLTPELLAR-  117 (197)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHT-THHHHHHHCSSCCEEECCSSBCCHHHHHH-
T ss_pred             CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHH-HHHHHHhcCCccCeEecCCCcCCHHHHHH-
Confidence            344555555553 44321    233444445555555555555443322 23334444455555555555554332222 


Q ss_pred             hhcccccccEEEcccccccccCCccccCCCCCcEEEccCCc---cCCc----CChhhhccCCCCEEEccCCcCC
Q 005760           95 VGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNK---LNGS----IPSTLGKLQKLQGLGLENNKLE  161 (678)
Q Consensus        95 ~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~---l~~~----~~~~~~~l~~L~~L~L~~n~i~  161 (678)
                                           +.+.+..-+.|++|+|++|.   +...    +..++..-+.|+.|+++.|.+.
T Consensus       118 ---------------------la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          118 ---------------------LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             ---------------------HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             ---------------------HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence                                 22334445567777776542   2211    1234445567777777766543

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=98.01  E-value=2.6e-06  Score=77.22  Aligned_cols=85  Identities=14%  Similarity=0.229  Sum_probs=49.0

Q ss_pred             CCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCC-CcccCChhhhhcc---cccccEEEccccc-ccccCCcc
Q 005760           45 RNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNP-LDGILPKTSVGNL---SHSLEYFEMAYCN-VSGGIPEE  119 (678)
Q Consensus        45 ~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~~l---~~~L~~L~l~~n~-l~~~~~~~  119 (678)
                      .+|+.|||++|.|++...     ..+.++++|+.|+|++|. |++..-.. +..+   .++|++|+|++|. +++..-..
T Consensus        61 ~~L~~LDLs~~~Itd~GL-----~~L~~~~~L~~L~L~~C~~ItD~gL~~-L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~  134 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGF-----DHMEGLQYVEKIRLCKCHYIEDGCLER-LSQLENLQKSMLEMEIISCGNVTDKGIIA  134 (176)
T ss_dssp             CCEEEEEEESCCCCGGGG-----GGGTTCSCCCEEEEESCTTCCHHHHHH-HHTCHHHHHHCCEEEEESCTTCCHHHHHH
T ss_pred             ceEeEEeCcCCCccHHHH-----HHhcCCCCCCEEEeCCCCccCHHHHHH-HHhcccccCCCCEEEcCCCCcCCHHHHHH
Confidence            467777777777665443     246677777777777774 44322111 2221   1246666666663 55444444


Q ss_pred             ccCCCCCcEEEccCCc
Q 005760          120 IGNLTNLTIIYLGGNK  135 (678)
Q Consensus       120 ~~~l~~L~~L~l~~N~  135 (678)
                      +..+++|++|+|+++.
T Consensus       135 L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          135 LHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             GGGCTTCCEEEEESCT
T ss_pred             HhcCCCCCEEECCCCC
Confidence            5666777777777664

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=98.00  E-value=3.8e-06  Score=72.69  Aligned_cols=65  Identities=22%  Similarity=0.228  Sum_probs=48.2

Q ss_pred             cccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccc--cccCccccCCCC
Q 005760          254 SLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAES--FEGNELLCGSPN  318 (678)
Q Consensus       254 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~--~~~n~~~c~~~~  318 (678)
                      +|+.|+|++|+|+.+.+..|..+++|+.|+|++|||.|++...+...++....  .......|..|.
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l~~l~~wl~~~~~~~~~~~~~C~~P~   98 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRLVPLRAWLAGRPERAPYRDLRCVAPP   98 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGGHHHHHHHHTSSCSGGGTTCBCCBST
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCccHHHHHHHHhCcccccccCcEeCcCh
Confidence            78899999999988888888999999999999999999888655444443221  123456676664

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.94  E-value=1.5e-06  Score=78.69  Aligned_cols=13  Identities=23%  Similarity=0.493  Sum_probs=5.9

Q ss_pred             ccccccEEEecCC
Q 005760          217 NLKDILYLNFSSN  229 (678)
Q Consensus       217 ~l~~L~~L~l~~N  229 (678)
                      ++++|+.|+++++
T Consensus       137 ~~~~L~~L~L~~c  149 (176)
T 3e4g_A          137 HFRNLKYLFLSDL  149 (176)
T ss_dssp             GCTTCCEEEEESC
T ss_pred             cCCCCCEEECCCC
Confidence            3444444444444

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.87  E-value=3.9e-06  Score=77.55  Aligned_cols=125  Identities=14%  Similarity=0.217  Sum_probs=81.9

Q ss_pred             CccccCCCCCCEEEccCc-cCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccC
Q 005760           38 PNTFGNLRNLQALRLSNN-YLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGI  116 (678)
Q Consensus        38 ~~~~~~l~~L~~L~l~~n-~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~  116 (678)
                      ...+.+-+.|++|+|++| .|...... .+.+++.....|+.|+|++|+|....-.                      .+
T Consensus        34 ~~ll~~n~~L~~L~L~~nn~igd~ga~-~la~aL~~N~~L~~L~L~~n~igd~ga~----------------------al   90 (197)
T 1pgv_A           34 NRLREDDTDLKEVNINNMKRVSKERIR-SLIEAACNSKHIEKFSLANTAISDSEAR----------------------GL   90 (197)
T ss_dssp             HHHHTTCSSCCEEECTTCCSSCHHHHH-HHHHHHTTCSCCCEEECTTSCCBHHHHT----------------------TH
T ss_pred             HHHHhcCCCccEEECCCCCCCCHHHHH-HHHHHHhhCCCcCEEEccCCCCChHHHH----------------------HH
Confidence            344455677777777774 66543322 3455666677777777777777533211                      22


Q ss_pred             CccccCCCCCcEEEccCCccCCcCCh----hhhccCCCCEEEccCCcC---CC----CCCCcccCCCCccEEecCCCcCC
Q 005760          117 PEEIGNLTNLTIIYLGGNKLNGSIPS----TLGKLQKLQGLGLENNKL---EG----SIPDSICHSDELYKLELGGNKLS  185 (678)
Q Consensus       117 ~~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~L~L~~n~i---~~----~~~~~~~~l~~L~~L~l~~N~i~  185 (678)
                      .+.+..-+.|++|+|++|.|......    ++..-+.|++|+|++|..   ..    .+...+..-+.|+.|+++.|.+.
T Consensus        91 A~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A           91 IELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence            34555678899999999999744333    444557799999997643   32    13346677789999999988765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.82  E-value=7.5e-05  Score=78.43  Aligned_cols=75  Identities=17%  Similarity=0.140  Sum_probs=49.5

Q ss_pred             CccccCCCceeEEEEEeC-CCcEEEEEEeecccC-------chhhhHHHHHHHHHhCCC--cc-ceeeeeeeecCCeEEE
Q 005760          397 NNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG-------RVFKSFDVECEMMKSIRH--RN-IIKVISSCSNEEFKAL  465 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~n-iv~~~~~~~~~~~~~l  465 (678)
                      .+.+|.|..+.||++... +++.+++|.......       ...+.+..|.++++.+..  |. +.+++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            467999999999999754 568899998643211       123456789999887742  43 34555443  344579


Q ss_pred             EEEecCCC
Q 005760          466 VLEYMPHG  473 (678)
Q Consensus       466 v~e~~~~~  473 (678)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.73  E-value=6.4e-05  Score=77.13  Aligned_cols=138  Identities=17%  Similarity=0.176  Sum_probs=78.4

Q ss_pred             ccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-----Cccceeee-e--eeecCCeEEEEEEe
Q 005760          398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-----HRNIIKVI-S--SCSNEEFKALVLEY  469 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e~  469 (678)
                      +.|+.|..+.||+....+| .+++|+....    ...+..|..+++.+.     .|.++... |  +....+..++||||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999987655 4889988642    133444556555553     23333311 1  11245677899999


Q ss_pred             cCCCCHH-----------H---Hhhh--CCC-----------CCCHHHH-------------------------------
Q 005760          470 MPHGSLE-----------K---YLHS--SNY-----------ILDIYQR-------------------------------  491 (678)
Q Consensus       470 ~~~~~L~-----------~---~l~~--~~~-----------~~~~~~~-------------------------------  491 (678)
                      ++|.++.           +   .+|.  ...           ...|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986432           1   1111  000           0112110                               


Q ss_pred             HHHHHHHHHHHHHHhc----------CCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          492 LNIMIDVASALEYLHF----------GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       492 ~~i~~~i~~~l~~LH~----------~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      ..+..++..++.+|+.          .....++|+|+++.||+++.++.+.++||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            0111223345666652          025789999999999999888899999998764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.56  E-value=0.00029  Score=70.82  Aligned_cols=136  Identities=13%  Similarity=0.110  Sum_probs=90.8

Q ss_pred             CCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCC---CccceeeeeeeecCCeEEEEEEecCC
Q 005760          396 ENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR---HRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       396 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      ..+.|+.|....+|+... ++..+++|+....   ....+..|...++.+.   ...+.+++.++...+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            346789999999999986 4678889987632   3466788999988874   35678888888878889999999998


Q ss_pred             CCHH--------H---HhhhCCC---------------------CCCHHHHH---HHH----------------HHHHHH
Q 005760          473 GSLE--------K---YLHSSNY---------------------ILDIYQRL---NIM----------------IDVASA  501 (678)
Q Consensus       473 ~~L~--------~---~l~~~~~---------------------~~~~~~~~---~i~----------------~~i~~~  501 (678)
                      ..+.        +   .++....                     .-+|....   ++.                .+++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            7541        1   1222110                     01333221   011                112212


Q ss_pred             -HHHHh-cCCCCCeEEcCCCCCCeeecCCCcEEEEee
Q 005760          502 -LEYLH-FGYSAQVIHCDLKPSNVLLDDNMVAHLSDF  536 (678)
Q Consensus       502 -l~~LH-~~~~~~ivH~dl~~~Nill~~~~~~kl~Df  536 (678)
                       ...|. ......++|+|+.+.|++++.++ +.+.|+
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~  231 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNP  231 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcC
Confidence             23343 12356799999999999999887 888887

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.54  E-value=0.00026  Score=70.58  Aligned_cols=78  Identities=13%  Similarity=0.122  Sum_probs=57.4

Q ss_pred             CCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCc---cceeeeeeeecCCeEEEEEEe
Q 005760          393 GFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHR---NIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ...-.+.+|.|..+.||+.+..+|+.|++|+...........+..|+..|+.+.-.   .+.+++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            34456789999999999999999999999987654444445678899999988422   244555542    23689999


Q ss_pred             cCCCC
Q 005760          470 MPHGS  474 (678)
Q Consensus       470 ~~~~~  474 (678)
                      ++++.
T Consensus        92 l~~~~   96 (288)
T 3f7w_A           92 VDERP   96 (288)
T ss_dssp             CCCCC
T ss_pred             ecccC
Confidence            98764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.29  E-value=0.0008  Score=71.04  Aligned_cols=80  Identities=11%  Similarity=0.062  Sum_probs=47.7

Q ss_pred             CCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCC---CCCccchHHHHHHHHHH
Q 005760          510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG---RVSANGDVYSFGIMLME  586 (678)
Q Consensus       510 ~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslGv~l~e  586 (678)
                      ...++|+|+++.||+++.++ ++++||+.+..-.+. .........-...|.+|+.....   ......++.+....+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            68899999999999999876 999999988643211 00000000011345666544311   11223455677888888


Q ss_pred             HHcCC
Q 005760          587 TFTRK  591 (678)
Q Consensus       587 ll~g~  591 (678)
                      .+.+.
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.04  E-value=0.0012  Score=66.96  Aligned_cols=155  Identities=17%  Similarity=0.168  Sum_probs=84.8

Q ss_pred             CHHHHHHhhcCCCC-----CccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCcc--ceeeee
Q 005760          383 SYLELCRATDGFSE-----NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRN--IIKVIS  455 (678)
Q Consensus       383 ~~~~~~~~~~~~~~-----~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~  455 (678)
                      +.+++...-..|..     .+.|+.|....+|+....+| .+++|+....  ...+.+..|..+++.+....  +.+++.
T Consensus         8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~   84 (322)
T 2ppq_A            8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP   84 (322)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence            34444444455654     24567788899999987655 6889988642  12345667888777764212  233332


Q ss_pred             e------eecCCeEEEEEEecCCCCHHH--------------HhhhC----CCC----CC---HHHHHH-----------
Q 005760          456 S------CSNEEFKALVLEYMPHGSLEK--------------YLHSS----NYI----LD---IYQRLN-----------  493 (678)
Q Consensus       456 ~------~~~~~~~~lv~e~~~~~~L~~--------------~l~~~----~~~----~~---~~~~~~-----------  493 (678)
                      .      ....+..+++++|++|..+..              .++..    ...    ..   |.....           
T Consensus        85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~  164 (322)
T 2ppq_A           85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  164 (322)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence            1      122356789999998864311              01111    000    01   111000           


Q ss_pred             -HHHHHHHHHHHHhc----CCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          494 -IMIDVASALEYLHF----GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       494 -i~~~i~~~l~~LH~----~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                       +...+...+++++.    ....+++|+|+.+.||++++++.+.++||+.+.
T Consensus       165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             00113334444442    124579999999999999987666899998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.01  E-value=0.0021  Score=64.46  Aligned_cols=71  Identities=11%  Similarity=0.089  Sum_probs=45.6

Q ss_pred             CccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccc-eeeeeeeecCCeEEEEEEec-CCCC
Q 005760          397 NNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNI-IKVISSCSNEEFKALVLEYM-PHGS  474 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~~~  474 (678)
                      .+.|+.|....+|+.     ..+++|+...... .......|+.+++.+....+ .++++++.+  .-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCcc
Confidence            678999999999998     5688998764322 22334568888877742222 455555433  335899999 6644


Q ss_pred             H
Q 005760          475 L  475 (678)
Q Consensus       475 L  475 (678)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.92  E-value=0.007  Score=56.07  Aligned_cols=103  Identities=15%  Similarity=0.089  Sum_probs=69.5

Q ss_pred             CHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcceeec
Q 005760          474 SLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQ  553 (678)
Q Consensus       474 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  553 (678)
                      +|.+.+...+.+++++++|.++.|.+.+|.-.-.  ++.-..+=+.|..|++..+|.|...+ +.+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            8999999999999999999999999999877721  11111223456889999999998763 1110             


Q ss_pred             ccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCC
Q 005760          554 TLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPT  594 (678)
Q Consensus       554 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~  594 (678)
                       .....+.|||... ...+.+.-|||+|+++|.-+-...|-
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e  136 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE  136 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence             1123466888763 35567889999999999999766553

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.92  E-value=0.0054  Score=62.31  Aligned_cols=139  Identities=12%  Similarity=0.086  Sum_probs=74.0

Q ss_pred             ccccCCCcee-EEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCC--ccceeeeeeeecCCeEEEEEEecCCCC
Q 005760          398 NLIGRGSFGS-VFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRH--RNIIKVISSCSNEEFKALVLEYMPHGS  474 (678)
Q Consensus       398 ~~ig~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~  474 (678)
                      +.++.|+... +|+....+|..+++|......   ...+..|+.+++.+..  -.+.+++.+..+.+  +++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4566665554 677776446777777654321   1445567777777642  23455666644433  68999997766


Q ss_pred             HHHHhhhCC-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHHh---
Q 005760          475 LEKYLHSSN-------------------------YILDIYQRL-------N-I------------MIDVASALEYLH---  506 (678)
Q Consensus       475 L~~~l~~~~-------------------------~~~~~~~~~-------~-i------------~~~i~~~l~~LH---  506 (678)
                      +.+++....                         ..++.....       . +            ...+...+..+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654432110                         011111100       0 0            001111222221   


Q ss_pred             cCCCCCeEEcCCCCCCeeecCC----CcEEEEeeccccc
Q 005760          507 FGYSAQVIHCDLKPSNVLLDDN----MVAHLSDFGIAKL  541 (678)
Q Consensus       507 ~~~~~~ivH~dl~~~Nill~~~----~~~kl~Dfg~~~~  541 (678)
                      ......++|+|+.+.||+++.+    +.+.++||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1125679999999999999874    6899999998864

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.79  E-value=0.0031  Score=65.07  Aligned_cols=139  Identities=15%  Similarity=0.173  Sum_probs=81.8

Q ss_pred             CccccCCCceeEEEEEeC--------CCcEEEEEEeecccCchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEEE
Q 005760          397 NNLIGRGSFGSVFKARLG--------DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  467 (678)
                      .+.+..|....+|+....        ++..+++|+.... ......+.+|.++++.+. +.-..++++.+.+    .+|+
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            456778889999999864        3578999986432 123455678999998874 2223566666654    2899


Q ss_pred             EecCCCCHHH--------------H---hhhCC----CCCC--HHHHHHHHHHHHH-------------------HHHH-
Q 005760          468 EYMPHGSLEK--------------Y---LHSSN----YILD--IYQRLNIMIDVAS-------------------ALEY-  504 (678)
Q Consensus       468 e~~~~~~L~~--------------~---l~~~~----~~~~--~~~~~~i~~~i~~-------------------~l~~-  504 (678)
                      ||++|.++..              .   +|...    ....  +.++.++..++..                   .+.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            9998855421              0   11111    1122  2344444433321                   1222 


Q ss_pred             ---Hhc-CCCCCeEEcCCCCCCeeecCC----CcEEEEeecccc
Q 005760          505 ---LHF-GYSAQVIHCDLKPSNVLLDDN----MVAHLSDFGIAK  540 (678)
Q Consensus       505 ---LH~-~~~~~ivH~dl~~~Nill~~~----~~~kl~Dfg~~~  540 (678)
                         |.. .....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               221 123568999999999999876    789999998874

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.74  E-value=0.0013  Score=69.36  Aligned_cols=72  Identities=19%  Similarity=0.265  Sum_probs=49.5

Q ss_pred             CccccCCCceeEEEEEeCC--------CcEEEEEEeecccCchhhhHHHHHHHHHhCCCccc-eeeeeeeecCCeEEEEE
Q 005760          397 NNLIGRGSFGSVFKARLGD--------GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNI-IKVISSCSNEEFKALVL  467 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  467 (678)
                      .+.|+.|....+|+....+        +..+++|+....  ...+.+..|..+++.+...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3578888899999998653        578999998431  111455679998888753333 566766553    2899


Q ss_pred             EecCCCC
Q 005760          468 EYMPHGS  474 (678)
Q Consensus       468 e~~~~~~  474 (678)
                      ||++|.+
T Consensus       152 e~l~G~~  158 (429)
T 1nw1_A          152 EYIPSRP  158 (429)
T ss_dssp             CCCCEEE
T ss_pred             EEeCCcc
Confidence            9998643

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.74  E-value=0.0021  Score=55.20  Aligned_cols=35  Identities=34%  Similarity=0.471  Sum_probs=16.6

Q ss_pred             ccEEecCCCcCCCCChhhhhccccccceecccccc
Q 005760          174 LYKLELGGNKLSGSIPECFNNLASLRILLLGSNEL  208 (678)
Q Consensus       174 L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l  208 (678)
                      |+.|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus        33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            44444444444444444444444555555555543

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.73  E-value=0.0034  Score=66.60  Aligned_cols=74  Identities=15%  Similarity=0.171  Sum_probs=49.0

Q ss_pred             CccccCCCceeEEEEEeCC-CcEEEEEEeecccCchhhhHHHHHHHHHhCCCccc-eeeeeeeecCCeEEEEEEecCCCC
Q 005760          397 NNLIGRGSFGSVFKARLGD-GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNI-IKVISSCSNEEFKALVLEYMPHGS  474 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~~~  474 (678)
                      .+.|+.|....+|+....+ +..+++|+....... .-....|..+++.+...++ .++++.+..    .+|+||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            3578889899999998764 578899987543222 2223689999998865444 466776632    25999998744


Q ss_pred             H
Q 005760          475 L  475 (678)
Q Consensus       475 L  475 (678)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.57  E-value=0.012  Score=59.39  Aligned_cols=139  Identities=12%  Similarity=0.171  Sum_probs=80.7

Q ss_pred             ccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCcc--ceeeeee-----eecCCeEEEEEEec
Q 005760          398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRN--IIKVISS-----CSNEEFKALVLEYM  470 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~-----~~~~~~~~lv~e~~  470 (678)
                      +.++ |....||+....+|+.+++|+..... .....+..|..+++.+....  +.+++..     ....+..++|+||+
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 88899999887778889999986432 23356677888887774222  3444433     11244567899999


Q ss_pred             CCCCHH-----H------H---hhh----C----CCCCCHHHH----------------------HHHHHHHHHHHHHHh
Q 005760          471 PHGSLE-----K------Y---LHS----S----NYILDIYQR----------------------LNIMIDVASALEYLH  506 (678)
Q Consensus       471 ~~~~L~-----~------~---l~~----~----~~~~~~~~~----------------------~~i~~~i~~~l~~LH  506 (678)
                      +|..+.     .      .   ++.    .    ....++...                      ...+.+++..+...-
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            875321     1      1   111    0    001121110                      011112222222221


Q ss_pred             c-CCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          507 F-GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       507 ~-~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      . .....++|+|+++.||+++ + .+.++||+.+.
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            1 1246689999999999999 4 89999998774

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.41  E-value=0.0032  Score=65.07  Aligned_cols=73  Identities=12%  Similarity=0.191  Sum_probs=44.9

Q ss_pred             CccccCCCceeEEEEEeCC---------CcEEEEEEeecccCchhhhHHHHHHHHHhCCCcc-ceeeeeeeecCCeEEEE
Q 005760          397 NNLIGRGSFGSVFKARLGD---------GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRN-IIKVISSCSNEEFKALV  466 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv  466 (678)
                      .+.++.|....+|+....+         +..+++|+...... .......|..+++.+...+ ..++++.+.    -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence            3567888889999998654         26888998754322 2223467888888875333 345665542    2589


Q ss_pred             EEecCCCC
Q 005760          467 LEYMPHGS  474 (678)
Q Consensus       467 ~e~~~~~~  474 (678)
                      +||++|.+
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.07  E-value=0.051  Score=55.18  Aligned_cols=67  Identities=10%  Similarity=0.127  Sum_probs=42.9

Q ss_pred             CCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCC---Cccceeeeee------eecCCeEEEEEEecCC
Q 005760          402 RGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR---HRNIIKVISS------CSNEEFKALVLEYMPH  472 (678)
Q Consensus       402 ~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~------~~~~~~~~lv~e~~~~  472 (678)
                      .|....||+....+| .+++|+......      ..|...++.+.   -|.+.+++..      ....+..++||+|++|
T Consensus        33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G  105 (339)
T 3i1a_A           33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA  105 (339)
T ss_dssp             SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred             CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence            333689999987777 899998764321      34666665553   2224444432      2335678899999998


Q ss_pred             CCH
Q 005760          473 GSL  475 (678)
Q Consensus       473 ~~L  475 (678)
                      ..+
T Consensus       106 ~~~  108 (339)
T 3i1a_A          106 PNG  108 (339)
T ss_dssp             CBT
T ss_pred             CcC
Confidence            655

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.78  E-value=0.044  Score=57.29  Aligned_cols=74  Identities=14%  Similarity=0.239  Sum_probs=49.1

Q ss_pred             CccccCCCceeEEEEEeCC--------CcEEEEEEeecccCchhhhHHHHHHHHHhCCCcc-ceeeeeeeecCCeEEEEE
Q 005760          397 NNLIGRGSFGSVFKARLGD--------GMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRN-IIKVISSCSNEEFKALVL  467 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  467 (678)
                      .+.+..|-...+|+....+        +..+++|+..... ...-+..+|..+++.+...+ ..++++.+.    -+.|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3567788889999998653        5789999875432 22234567888888875222 345555443    26899


Q ss_pred             EecCCCCH
Q 005760          468 EYMPHGSL  475 (678)
Q Consensus       468 e~~~~~~L  475 (678)
                      ||++|.++
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.90  E-value=0.11  Score=54.04  Aligned_cols=29  Identities=28%  Similarity=0.387  Sum_probs=24.4

Q ss_pred             CeEEcCCCCCCeee------cCCCcEEEEeecccc
Q 005760          512 QVIHCDLKPSNVLL------DDNMVAHLSDFGIAK  540 (678)
Q Consensus       512 ~ivH~dl~~~Nill------~~~~~~kl~Dfg~~~  540 (678)
                      .++|+|+.+.||++      +++..++++||.+|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            35799999999999      456789999998874

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.96  E-value=2.2  Score=39.31  Aligned_cols=122  Identities=11%  Similarity=0.233  Sum_probs=79.6

Q ss_pred             CCccceeeeeeeecCCeEEEEEEecC-CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCee
Q 005760          446 RHRNIIKVISSCSNEEFKALVLEYMP-HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVL  524 (678)
Q Consensus       446 ~h~niv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nil  524 (678)
                      .||+.+.. ..-.+.+.+.+.++.-+ +.++.. ++    ..+...+++++.+|+....+++   .+  +|--+.|+|++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~---~r--~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNR---TR--YTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGG---SS--EECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhc---Cc--eEEEEecceEE
Confidence            58887765 45556666555555433 223322 22    3678899999999998886665   22  68899999999


Q ss_pred             ecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCcc
Q 005760          525 LDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM  602 (678)
Q Consensus       525 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~  602 (678)
                      ++.++.+++.-.|+-..+                   +|.     ..+...=.-.+=+++..+++++..|+.-..+..
T Consensus       112 f~~~~~p~i~~RGik~~l-------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l~~G~l  165 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVV-------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDALVEGNL  165 (215)
T ss_dssp             ECTTSCEEESCCEETTTB-------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHHHHSCG
T ss_pred             EcCCCCEEEEEccCccCC-------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHHHcChH
Confidence            999999999876654322                   221     111111233566788889999999876554433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	678
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-67
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-58
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-58
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-56
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	8e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-54
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-54
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-53
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-53
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-52
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-52
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-51
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-51
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	8e-51
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-49
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-48
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-47
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-45
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-38
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-38
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-38
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-37
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-35
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-35
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-32
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-32
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-27
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-23
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-10
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-16
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-20
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-09
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	5e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	5e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	8e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.004
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	8e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	1e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	7e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.001
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.002

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 5e-67
 Identities = 69/282 (24%), Positives = 127/282 (45%), Gaps = 26/282 (9%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVIS 455
             IG GSFG+V+K +     +VA+K+ N+     +  ++F  E  +++  RH NI+  + 
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             +     A+V ++    SL  +LH      ++ + ++I    A  ++YLH      +IH
Sbjct: 72  YST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIH 127

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY---GKEGRVS 572
            DLK +N+ L +++   + DFG+A + +R   S    Q   +I +MAPE      +   S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 573 ANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINF 632
              DVY+FGI+L E  T + P   I N +  +      +L     ++             
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV------------- 234

Query: 633 VAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL 674
             +  C   +  +  EC  +  ++R    +I+  +  +  SL
Sbjct: 235 --RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 1e-59
 Identities = 73/280 (26%), Positives = 119/280 (42%), Gaps = 24/280 (8%)

Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
            +    IG G FG V      +  +VA+K          + F  E E+M  + H  ++++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
              C  +    LV E+M HG L  YL +   +      L + +DV   + YL     A V
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACV 122

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           IH DL   N L+ +N V  +SDFG+ + +  +DQ T  T T   + + +PE     R S+
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV 633
             DV+SFG+++ E F+  K   E  +    ++     +       +  P L S       
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------RLYKPRLASTH----- 230

Query: 634 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                   V+ +   C  E PE R     ++ +L +I +S
Sbjct: 231 --------VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-58
 Identities = 63/277 (22%), Positives = 121/277 (43%), Gaps = 24/277 (8%)

Query: 394 FSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV 453
            +    +G G FG V   +     +VA+K+           F  E ++M ++ H  ++++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
              C+ +    ++ EYM +G L  YL    +     Q L +  DV  A+EYL      Q 
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQF 121

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           +H DL   N L++D  V  +SDFG+++ +  +D+ T    +   + +  PE     + S+
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV 633
             D+++FG+++ E ++  K   E F    T +H            +  P+L S +     
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL------RLYRPHLASEK----- 229

Query: 634 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
                   V+ +   C  E  ++R   K +++ +L +
Sbjct: 230 --------VYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 2e-58
 Identities = 62/277 (22%), Positives = 121/277 (43%), Gaps = 26/277 (9%)

Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNII 451
           +       +G G FG V+        +VA+K           +F  E  +MK ++H+ ++
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI-LDIYQRLNIMIDVASALEYLHFGYS 510
           ++ +  + E    ++ EYM +GSL  +L + + I L I + L++   +A  + ++     
Sbjct: 72  RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
              IH DL+ +N+L+ D +   ++DFG+A+L+  +++ T +      I + APE    G 
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 571 VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 630
            +   DV+SFGI+L E  T  +           +++    +       +V P+    E  
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------RMVRPDNCPEE-- 238

Query: 631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                      ++ +   C  E PE R     + + L
Sbjct: 239 -----------LYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  195 bits (497), Expect = 6e-58
 Identities = 65/313 (20%), Positives = 133/313 (42%), Gaps = 43/313 (13%)

Query: 382 FSYLELCRATDGFSEN---------NLIGRGSFGSVFKARL----GDGMEVAMKVFNLQY 428
           F++ +   A   F++           +IG G FG V    L       + VA+K     Y
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 429 G-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILD 487
             +  + F  E  +M    H N+I +    +      ++ E+M +GSL+ +L  ++    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
           + Q + ++  +A+ ++YL        +H DL   N+L++ N+V  +SDFG+++ L  +  
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 548 STIQTQTL---ATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTL 604
               T  L     I + APE  +  + ++  DV+S+GI++ E  +  +            
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP---------- 233

Query: 605 KHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
                 +  ++ +++++      +D        C S +  + ++C  +    R    +IV
Sbjct: 234 ------YWDMTNQDVIN---AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 665 TKLLKIRDSLLRN 677
             L    D ++RN
Sbjct: 285 NTL----DKMIRN 293

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 3e-56
 Identities = 66/297 (22%), Positives = 119/297 (40%), Gaps = 32/297 (10%)

Query: 400 IGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN 459
           IG+G FG V++ +   G EVA+K+F+ +  R +   + E      +RH NI+  I++ + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNK 68

Query: 460 EEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH-----FGYS 510
           +        LV +Y  HGSL  YL+   Y + +   + + +  AS L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ--STIQTQTLATIGYMAPEY--- 565
             + H DLK  N+L+  N    ++D G+A                 + T  YMAPE    
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186

Query: 566 ---GKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN------DWLPIST 616
               K        D+Y+ G++  E   R        + ++     V       +   +  
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246

Query: 617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
           ++ + PN+ +R         + +  +  +  EC   +   R+ A  I   L ++   
Sbjct: 247 EQKLRPNIPNRWQ-----SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 8e-56
 Identities = 62/299 (20%), Positives = 117/299 (39%), Gaps = 29/299 (9%)

Query: 386 ELCRATDGFS-ENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYGRVF-KSFDVECE 440
           +L    D     +  +G G+FGSV +         ++VA+KV      +   +    E +
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 441 MMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
           +M  + +  I+++I  C  E    LV+E    G L K+L      + +     ++  V+ 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED-QSTIQTQTLATIG 559
            ++YL        +H DL   NVLL +   A +SDFG++K L  +D   T ++     + 
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 560 YMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI 619
           + APE     + S+  DV+S+G+ + E  +  +   +   G   +               
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM------ 231

Query: 620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRNV 678
             P     E             ++ +  +C +   E R +   +  ++     SL   V
Sbjct: 232 ECPPECPPE-------------LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-54
 Identities = 71/276 (25%), Positives = 114/276 (41%), Gaps = 32/276 (11%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
             IG+G FG V       G +VA+K          ++F  E  +M  +RH N+++++   
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 458 SNEEFK-ALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
             E+    +V EYM  GSL  YL S    +L     L   +DV  A+EYL        +H
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
            DL   NVL+ ++ VA +SDFG+ K       S+ Q      + + APE  +E + S   
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTAPEALREKKFSTKS 181

Query: 576 DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK 635
           DV+SFGI+L E ++  +        +  +      +                      A 
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM-------------------DAP 222

Query: 636 EQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
           + C   V+ V   C       R +  ++  +L  I+
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 2e-54
 Identities = 64/272 (23%), Positives = 116/272 (42%), Gaps = 29/272 (10%)

Query: 398 NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISS 456
             +G G+FG V+KA+     +  A KV + +     + + VE +++ S  H NI+K++ +
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHC 516
              E    +++E+   G+++  +      L   Q   +      AL YLH     ++IH 
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY-----GKEGRV 571
           DLK  N+L   +    L+DFG++   TR  Q       + T  +MAPE       K+   
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPY 192

Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN 631
               DV+S GI L+E    + P  E+    + LK   ++   ++      P+  S    +
Sbjct: 193 DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-----QPSRWSSNFKD 247

Query: 632 FVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
           F+ K             C  ++ + R    ++
Sbjct: 248 FLKK-------------CLEKNVDARWTTSQL 266

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 2e-54
 Identities = 61/293 (20%), Positives = 116/293 (39%), Gaps = 16/293 (5%)

Query: 385 LELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKS-FDVECEMM 442
           +EL    D F + + +G G+ G VFK      G+ +A K+ +L+     ++    E +++
Sbjct: 1   MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 443 KSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
                  I+    +  ++   ++ +E+M  GSL++ L  +   +       + I V   L
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
            YL      +++H D+KPSN+L++      L DFG++  L      ++    + T  YM+
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMS 171

Query: 563 PEYGKEGRVSANGDVYSFGIMLMETFTRKKP---TDEIFNGEMTLKHWVNDWLPISTKEI 619
           PE  +    S   D++S G+ L+E    + P    D      M       D      +  
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI--NAKEIVTKLLKI 670
                LS   ++          +  +  E   + P        ++ V K L  
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-54
 Identities = 64/277 (23%), Positives = 120/277 (43%), Gaps = 26/277 (9%)

Query: 392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNII 451
           +       +G+G FG V+         VA+K          ++F  E ++MK +RH  ++
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY-ILDIYQRLNIMIDVASALEYLHFGYS 510
           ++ +  S E    +V EYM  GSL  +L       L + Q +++   +AS + Y+     
Sbjct: 76  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR 570
              +H DL+ +N+L+ +N+V  ++DFG+A+L+  +++ T +      I + APE    GR
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 571 VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI 630
            +   DV+SFGI+L E  T+ +           L      +      E  +         
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES-------- 242

Query: 631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                      + ++  +C  + PE+R   + +   L
Sbjct: 243 -----------LHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 3e-54
 Identities = 58/275 (21%), Positives = 106/275 (38%), Gaps = 25/275 (9%)

Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRN 449
           + +     +G G++G V  A        VA+K+ +++      ++   E  + K + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           ++K          + L LEY   G L   +   +  +           + + + YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
              + H D+KP N+LLD+     +SDFG+A +    ++  +  +   T+ Y+APE  K  
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 570 RVSANG-DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 628
              A   DV+S GI+L      + P D+  +       W      ++         +   
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-----PWKKIDSA 235

Query: 629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
            +  + K               VE+P  RI   +I
Sbjct: 236 PLALLHK-------------ILVENPSARITIPDI 257

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 2e-53
 Identities = 67/287 (23%), Positives = 130/287 (45%), Gaps = 29/287 (10%)

Query: 394 FSENNLIGRGSFGSVFKARLGDG-----MEVAMKVFNLQYG-RVFKSFDVECEMMKSIRH 447
            +   +IG G FG V+K  L        + VA+K     Y  +    F  E  +M    H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            NII++    S  +   ++ EYM +G+L+K+L   +    + Q + ++  +A+ ++YL  
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 127

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYMAPEYG 566
             +   +H DL   N+L++ N+V  +SDFG++++L  + ++T  T      I + APE  
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 626
              + ++  DV+SFGI++ E  T  +      +    +K   + +   +  +        
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD-------- 237

Query: 627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS 673
                      C S ++ + M+C  +   +R    +IV+ L K+  +
Sbjct: 238 -----------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-53
 Identities = 64/288 (22%), Positives = 120/288 (41%), Gaps = 30/288 (10%)

Query: 397 NNLIGRGSFGSVFKARL----GDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHRNII 451
           N +IGRG FG V+   L    G  +  A+K  N          F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 452 KVISSCSNEEFKA-LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
            ++  C   E    +VL YM HG L  ++ +  +   +   +   + VA  +++L     
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS--- 148

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED--QSTIQTQTLATIGYMAPEYGKE 568
            + +H DL   N +LD+     ++DFG+A+ +  ++      +T     + +MA E  + 
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208

Query: 569 GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 628
            + +   DV+SFG++L E  TR  P     N      + +        + ++ P      
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG------RRLLQPEYCPDP 262

Query: 629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLR 676
                        ++ V ++C     E R +  E+V+++  I  + + 
Sbjct: 263 -------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 3e-53
 Identities = 65/277 (23%), Positives = 118/277 (42%), Gaps = 33/277 (11%)

Query: 392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFN---LQYGRVFKSFDVECEMMKSIRH 447
           + F     +G+G FG+V+ AR       +A+KV     L+   V      E E+   +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
            NI+++     +     L+LEY P G++ + L   +   D  +    + ++A+AL Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH- 123

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
             S +VIH D+KP N+LL       ++DFG +       ++T+      T+ Y+ PE  +
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCG----TLDYLPPEMIE 177

Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
                   D++S G++  E    K P    F      + +      IS  E   P+ ++ 
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKR----ISRVEFTFPDFVTE 229

Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
              + +++                 +P QR   +E++
Sbjct: 230 GARDLISR-------------LLKHNPSQRPMLREVL 253

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 3e-53
 Identities = 66/286 (23%), Positives = 103/286 (36%), Gaps = 33/286 (11%)

Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSI 445
           RA D +     IG GS+G   K R   DG  +  K  +         +    E  +++ +
Sbjct: 2   RAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 446 RHRNIIKVISSCSNEEFKAL--VLEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVAS 500
           +H NI++      +     L  V+EY   G L   +         LD    L +M  +  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 501 ALEYLH--FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI 558
           AL+  H        V+H DLKP+NV LD      L DFG+A++L  +         + T 
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KAFVGTP 178

Query: 559 GYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 618
            YM+PE       +   D++S G +L E      P       E+  K     +  I    
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---- 234

Query: 619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
              P   S E    + +                     R + +EI+
Sbjct: 235 ---PYRYSDELNEIITR-------------MLNLKDYHRPSVEEIL 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 7e-53
 Identities = 64/276 (23%), Positives = 117/276 (42%), Gaps = 33/276 (11%)

Query: 397 NNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKV 453
           +  IGRGSF +V+K       +EVA      +       + F  E EM+K ++H NI++ 
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 454 ISSC----SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
             S       ++   LV E M  G+L+ YL     ++ I    +    +   L++LH   
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT-R 131

Query: 510 SAQVIHCDLKPSNVLLDD-NMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  +IH DLK  N+ +        + D G+A L     +++     + T  +MAPE   E
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEM-YE 186

Query: 569 GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 628
            +   + DVY+FG+ ++E  T + P  E  N     +   +   P S  ++  P +    
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK--- 243

Query: 629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
                           +   C  ++ ++R + K+++
Sbjct: 244 ---------------EIIEGCIRQNKDERYSIKDLL 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  180 bits (457), Expect = 2e-52
 Identities = 65/281 (23%), Positives = 115/281 (40%), Gaps = 26/281 (9%)

Query: 392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNI 450
              +  + +G G +G V++       + VA+K        V + F  E  +MK I+H N+
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGY 509
           ++++  C+ E    ++ E+M +G+L  YL   N   +     L +   ++SA+EYL    
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
               IH DL   N L+ +N +  ++DFG+++L+T  D  T        I + APE     
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYN 191

Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
           + S   DV++FG++L E  T         +     +                      +D
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------------------EKD 232

Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
                 E C   V+ +   C   +P  R +  EI      +
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 5e-52
 Identities = 62/278 (22%), Positives = 111/278 (39%), Gaps = 30/278 (10%)

Query: 396 ENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNI 450
           E+  +G G+FG+V K           VA+K+   +     +      E  +M+ + +  I
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS 510
           +++I  C  E +  LV+E    G L KYL  + + +     + ++  V+  ++YL     
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEE--- 125

Query: 511 AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE-DQSTIQTQTLATIGYMAPEYGKEG 569
           +  +H DL   NVLL     A +SDFG++K L  + +    QT     + + APE     
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
           + S+  DV+SFG+++ E F+  +       G                     P    RE 
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM------GCPAGCPRE- 238

Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
                       ++++   C     E R     +  +L
Sbjct: 239 ------------MYDLMNLCWTYDVENRPGFAAVELRL 264

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 6e-52
 Identities = 59/299 (19%), Positives = 108/299 (36%), Gaps = 51/299 (17%)

Query: 399 LIGRGSFGSVFKARL------GDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSI-RHRNI 450
           ++G G+FG V  A        G  ++VA+K+   +      ++   E +MM  +  H NI
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 451 IKVISSCSNEEFKALVLEYMPHGSLEKYLHSSN----------------------YILDI 488
           + ++ +C+      L+ EY  +G L  YL S                         +L  
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 489 YQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS 548
              L     VA  +E+L        +H DL   NVL+    V  + DFG+A+ +  +   
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWV 608
            ++      + +MAPE   EG  +   DV+S+GI+L E F+           +      +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280

Query: 609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
            +   +         +                  + +   C      +R +   + + L
Sbjct: 281 QNGFKMDQPFYATEEI------------------YIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (456), Expect = 7e-52
 Identities = 67/281 (23%), Positives = 107/281 (38%), Gaps = 36/281 (12%)

Query: 391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNL---QYGRVFKSFDVECEMMKSIR 446
              FS+   IG GSFG+V+ AR + +   VA+K  +    Q    ++    E   ++ +R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H N I+       E    LV+EY    + +         L   +   +       L YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEY- 565
              S  +IH D+K  N+LL +  +  L DFG A ++            + T  +MAPE  
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVI 183

Query: 566 --GKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 623
               EG+     DV+S GI  +E   RK P   +           N+   + +       
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---- 239

Query: 624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
             S    NFV               C  + P+ R  ++ ++
Sbjct: 240 --SEYFRNFVDS-------------CLQKIPQDRPTSEVLL 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-51
 Identities = 75/289 (25%), Positives = 127/289 (43%), Gaps = 26/289 (8%)

Query: 376 EAMQRMFSYLELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKS 434
           E ++++ S + +      ++    IG+G+ G+V+ A  +  G EVA++  NLQ     + 
Sbjct: 4   EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 63

Query: 435 FDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNI 494
              E  +M+  ++ NI+  + S    +   +V+EY+  GSL   +  +    D  Q   +
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAV 121

Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
             +   ALE+LH   S QVIH D+K  N+LL  +    L+DFG    +T E      +  
Sbjct: 122 CRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STM 176

Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI 614
           + T  +MAPE           D++S GIM +E    + P     N    L     +  P 
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP- 234

Query: 615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
              E+ +P  LS    +F+ +             C     E+R +AKE+
Sbjct: 235 ---ELQNPEKLSAIFRDFLNR-------------CLDMDVEKRGSAKEL 267

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (448), Expect = 6e-51
 Identities = 72/319 (22%), Positives = 125/319 (39%), Gaps = 54/319 (16%)

Query: 382 FSYLELCRATDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQY-GRVFKS 434
              LE  R  +       IG G+FG VF+AR            VA+K+   +    +   
Sbjct: 5   LLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD 62

Query: 435 FDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNY---------- 484
           F  E  +M    + NI+K++  C+  +   L+ EYM +G L ++L S +           
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 485 -------------ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVA 531
                         L   ++L I   VA+ + YL      + +H DL   N L+ +NMV 
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVV 179

Query: 532 HLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK 591
            ++DFG+++ +   D           I +M PE     R +   DV+++G++L E F+  
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 592 KPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTV 651
                    E  + +            + D N+L+         E C   ++N+   C  
Sbjct: 240 LQPYYGMAHEEVIYY------------VRDGNILACP-------ENCPLELYNLMRLCWS 280

Query: 652 ESPEQRINAKEIVTKLLKI 670
           + P  R +   I   L ++
Sbjct: 281 KLPADRPSFCSIHRILQRM 299

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 7e-51
 Identities = 68/280 (24%), Positives = 102/280 (36%), Gaps = 30/280 (10%)

Query: 400 IGRGSFGSVFKARL----GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIK 452
           +G GSFG V +       G  + VA+K               F  E   M S+ HRN+I+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 453 VISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ 512
           +         K +V E  P GSL   L        +       + VA  + YL    S +
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131

Query: 513 VIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR-EDQSTIQTQTLATIGYMAPEYGKEGRV 571
            IH DL   N+LL    +  + DFG+ + L + +D   +Q        + APE  K    
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191

Query: 572 SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN 631
           S   D + FG+ L E FT  +      NG   L     +   +   E    ++       
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY------ 245

Query: 632 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
                       NV ++C    PE R     +   LL+ +
Sbjct: 246 ------------NVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 7e-51
 Identities = 65/279 (23%), Positives = 113/279 (40%), Gaps = 29/279 (10%)

Query: 389 RATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYG---RVFKSFDVECEMMKS 444
           +  + F    ++G GSF +V  AR L    E A+K+   ++            E ++M  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           + H   +K+  +  ++E     L Y  +G L KY+       D         ++ SALEY
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEY 123

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           LH      +IH DLKP N+LL+++M   ++DFG AK+L+ E +       + T  Y++PE
Sbjct: 124 LH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180

Query: 565 YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL 624
              E     + D+++ G ++ +      P    F        +      I   E   P  
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLIFQK----IIKLEYDFPEK 232

Query: 625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
              +  + V K               V    +R+  +E+
Sbjct: 233 FFPKARDLVEK-------------LLVLDATKRLGCEEM 258

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 8e-51
 Identities = 59/304 (19%), Positives = 110/304 (36%), Gaps = 46/304 (15%)

Query: 392 DGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYGRVF-KSFDVECEMMKS 444
           +  S    +G G+FG V +A           M VA+K+          ++   E +++  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 445 I-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSS-----------------NYIL 486
           +  H NI+ ++ +C+      ++ EY  +G L  +L                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 487 DIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
           D+   L+    VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKH 606
              ++      + +MAPE       +   DV+S+GI L E F+           +     
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 607 WVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 666
            + +   + + E     +                   ++   C    P +R   K+IV  
Sbjct: 260 MIKEGFRMLSPEHAPAEMY------------------DIMKTCWDADPLKRPTFKQIVQL 301

Query: 667 LLKI 670
           + K 
Sbjct: 302 IEKQ 305

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 2e-49
 Identities = 58/292 (19%), Positives = 120/292 (41%), Gaps = 30/292 (10%)

Query: 385 LELCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKV-----FNLQYGRVFKSFDVE 438
           L + + T+ F +  ++G G+FG+V+K   + +G +V + V           +  K    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 439 CEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDV 498
             +M S+ + ++ +++  C     + L+ + MP G L  Y+      +     LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 499 ASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATI 558
           A  + YL      +++H DL   NVL+       ++DFG+AKLL  E++          I
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 559 GYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE 618
            +MA E       +   DV+S+G+ + E  T      +                    + 
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------ER 231

Query: 619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
           +  P + + +             V+ + ++C +   + R   +E++ +  K+
Sbjct: 232 LPQPPICTID-------------VYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  174 bits (441), Expect = 2e-49
 Identities = 49/268 (18%), Positives = 98/268 (36%), Gaps = 26/268 (9%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
            +G G+FG V +      G   A K     +    ++   E + M  +RH  ++ +  + 
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            ++    ++ E+M  G L + +   +  +   + +  M  V   L ++H       +H D
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 149

Query: 518 LKPSNVLL--DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
           LKP N++     +    L DFG+   L  +    + T T     + APE  +   V    
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAPEVAEGKPVGYYT 206

Query: 576 DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK 635
           D++S G++     +   P     + E        DW    +      + +S +  +F+ K
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA----FSGISEDGKDFIRK 262

Query: 636 EQCVSFVFNVAMECTVESPEQRINAKEI 663
                          +  P  R+   + 
Sbjct: 263 -------------LLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  172 bits (438), Expect = 6e-49
 Identities = 52/268 (19%), Positives = 100/268 (37%), Gaps = 26/268 (9%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
            +G G+FG V +      G     K  N  Y     +   E  +M  + H  +I +  + 
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            ++    L+LE++  G L   + + +Y +   + +N M      L+++H      ++H D
Sbjct: 96  EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLD 152

Query: 518 LKPSNVLLD--DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
           +KP N++ +        + DFG+A  L   +   I   T AT  + APE      V    
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYT 209

Query: 576 DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK 635
           D+++ G++     +   P     + E        DW           + +S E  +F+  
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA----FSSVSPEAKDFIKN 265

Query: 636 EQCVSFVFNVAMECTVESPEQRINAKEI 663
                           + P +R+   + 
Sbjct: 266 -------------LLQKEPRKRLTVHDA 280

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 3e-48
 Identities = 72/307 (23%), Positives = 128/307 (41%), Gaps = 45/307 (14%)

Query: 392 DGFSENNLIGRGSFGSVFKARL---GDGMEVAMKVFNLQYGR-VFKSFDVECEMMKSI-R 446
           +     ++IG G+FG V KAR+   G  M+ A+K       +   + F  E E++  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI---------------LDIYQR 491
           H NII ++ +C +  +  L +EY PHG+L  +L  S  +               L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 492 LNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ 551
           L+   DVA  ++YL      Q IH DL   N+L+ +N VA ++DFG+++    ++    +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKK 183

Query: 552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW 611
           T     + +MA E       + N DV+S+G++L E  +               +     +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243

Query: 612 LPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR 671
                     P     E             V+++  +C  E P +R +  +I+  L ++ 
Sbjct: 244 RL------EKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQILVSLNRML 284

Query: 672 DSLLRNV 678
           +     V
Sbjct: 285 EERKTYV 291

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 4e-48
 Identities = 58/279 (20%), Positives = 104/279 (37%), Gaps = 29/279 (10%)

Query: 399 LIGRGSFGSVFKARL----GDGMEVAMKVFNLQYGRVFKS-FDVECEMMKSIRHRNIIKV 453
            IG G FG V +          + VA+K          +  F  E   M+   H +I+K+
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
           I   + E    +++E    G L  +L    Y LD+   +     +++AL YL    S + 
Sbjct: 74  IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRF 129

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           +H D+   NVL+  N    L DFG+++ +  +      ++    I +MAPE     R ++
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRRFTS 188

Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV 633
             DV+ FG+ + E         +       +    N            P           
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP------MPPNCPPT----- 237

Query: 634 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD 672
                   ++++  +C    P +R    E+  +L  I +
Sbjct: 238 --------LYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  167 bits (423), Expect = 1e-47
 Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 31/292 (10%)

Query: 391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGR---VFKSFDVECEMMKSIR 446
           +D +    ++G G    V  AR L    +VA+KV      R    +  F  E +   ++ 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 447 HRNIIKVISSCSNEEFKA----LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
           H  I+ V  +   E        +V+EY+   +L   +H+    +   + + ++ D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLA-TIGYM 561
            + H      +IH D+KP+N+++       + DFGIA+ +     S  QT  +  T  Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 562 APEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD 621
           +PE  +   V A  DVYS G +L E  T + P        +  +H   D +P S +    
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR---- 237

Query: 622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI-NAKEIVTKLLKIRD 672
              LS +    V K                ++PE R   A E+   L+++ +
Sbjct: 238 HEGLSADLDAVVLK-------------ALAKNPENRYQTAAEMRADLVRVHN 276

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 1e-47
 Identities = 62/301 (20%), Positives = 127/301 (42%), Gaps = 38/301 (12%)

Query: 394 FSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIR 446
            + +  +G+GSFG V++              VA+K  N     R    F  E  +MK   
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYI---------LDIYQRLNIMID 497
             ++++++   S  +   +++E M  G L+ YL S               + + + +  +
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 498 VASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLAT 557
           +A  + YL+   + + +H DL   N ++ ++    + DFG+ + +   D      + L  
Sbjct: 142 IADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 558 IGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTK 617
           + +M+PE  K+G  +   DV+SFG++L E  T  +   +  + E  L+            
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----------- 247

Query: 618 EIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN 677
            +++  LL + D        C   +F +   C   +P+ R +  EI++ + +  +   R 
Sbjct: 248 -VMEGGLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

Query: 678 V 678
           V
Sbjct: 300 V 300

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 3e-45
 Identities = 73/304 (24%), Positives = 120/304 (39%), Gaps = 47/304 (15%)

Query: 392 DGFSENNLIGRGSFGSVFKARL--------GDGMEVAMKVFNLQYG-RVFKSFDVECEMM 442
           D       +G G+FG V  A              +VA+K+       +       E EMM
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 443 KSI-RHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLH---------------SSNYIL 486
           K I +H+NII ++ +C+ +    +++EY   G+L +YL                +    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 487 DIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
                ++    VA  +EYL    S + IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKH 606
                T     + +MAPE   +   +   DV+SFG++L E FT           E   K 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 607 WVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTK 666
                          P+  + E             ++ +  +C    P QR   K++V  
Sbjct: 250 LKEGHRM------DKPSNCTNE-------------LYMMMRDCWHAVPSQRPTFKQLVED 290

Query: 667 LLKI 670
           L +I
Sbjct: 291 LDRI 294

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 2e-43
 Identities = 53/268 (19%), Positives = 106/268 (39%), Gaps = 27/268 (10%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
            +GRG FG V +            K   ++ G        E  ++   RHRNI+ +  S 
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
            + E   ++ E++    + + +++S + L+  + ++ +  V  AL++LH   S  + H D
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFD 127

Query: 518 LKPSNVLLD--DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANG 575
           ++P N++     +    + +FG A+ L   D   +         Y APE  +   VS   
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYAPEVHQHDVVSTAT 184

Query: 576 DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAK 635
           D++S G ++    +   P     N ++       ++             +S E ++FV +
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA----FKEISIEAMDFVDR 240

Query: 636 EQCVSFVFNVAMECTVESPEQRINAKEI 663
                          V+  + R+ A E 
Sbjct: 241 -------------LLVKERKSRMTASEA 255

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 9e-43
 Identities = 59/306 (19%), Positives = 110/306 (35%), Gaps = 45/306 (14%)

Query: 392 DGFSENNLIGRGSFGSVFKAR------LGDGMEVAMKVFNLQYGR-VFKSFDVECEMMKS 444
           D       +GRG+FG V +A             VA+K+          ++   E +++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 445 IRHRNIIKVISSCSNEEFKAL--VLEYMPHGSLEKYLHSSNY---------------ILD 487
           I H   +  +     +    L  ++E+   G+L  YL S                   L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 488 IYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ 547
           +   +     VA  +E+L    S + IH DL   N+LL +  V  + DFG+A+ + ++  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW 607
              +      + +MAPE   +   +   DV+SFG++L E F+           +      
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249

Query: 608 VNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKL 667
           + +   +   +   P +                  +   ++C    P QR    E+V  L
Sbjct: 250 LKEGTRMRAPDYTTPEM------------------YQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 668 LKIRDS 673
             +  +
Sbjct: 292 GNLLQA 297

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (389), Expect = 1e-42
 Identities = 49/275 (17%), Positives = 102/275 (37%), Gaps = 23/275 (8%)

Query: 391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHR 448
            D +   +++G G+F  V  A        VA+K    +       S + E  ++  I+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+ +     +     L+++ +  G L   +    +         ++  V  A++YLH  
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
                           LD++    +SDFG++K+   ED  ++ +    T GY+APE   +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQ 183

Query: 569 GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 628
              S   D +S G++         P  +  + ++  +    ++   S       + +S  
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY----WDDISDS 239

Query: 629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
             +F+                  + PE+R   ++ 
Sbjct: 240 AKDFIRH-------------LMEKDPEKRFTCEQA 261

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  152 bits (386), Expect = 2e-42
 Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 41/289 (14%)

Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDV---------ECEM 441
           + +    ++GRG    V +        E A+K+ ++  G  F + +V         E ++
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 442 MKSIR-HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVAS 500
           ++ +  H NII++  +     F  LV + M  G L  YL      L   +   IM  +  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLE 121

Query: 501 ALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGY 560
            +  LH      ++H DLKP N+LLDD+M   L+DFG +  L   D      +   T  Y
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSY 175

Query: 561 MAPEYGKEGRVSANG------DVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI 614
           +APE  +      +       D++S G+++        P        + L+  ++     
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQF 234

Query: 615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
            + E  D    S    + V++               V  P++R  A+E 
Sbjct: 235 GSPEWDD---YSDTVKDLVSR-------------FLVVQPQKRYTAEEA 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 3e-41
 Identities = 60/278 (21%), Positives = 109/278 (39%), Gaps = 32/278 (11%)

Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRV---FKSFDVECE-MMKSIR 446
           + F  + ++G+GSFG VF A         A+K        +    +   VE   +  +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 447 HRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLH 506
           H  +  +  +   +E    V+EY+  G L  ++ S +   D+ +      ++   L++LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120

Query: 507 FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYG 566
              S  +++ DLK  N+LLD +    ++DFG+ K     D          T  Y+APE  
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPEIL 175

Query: 567 KEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS 626
              + + + D +SFG++L E    + P     + E        D           P  L 
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSIRMDNPFY-------PRWLE 227

Query: 627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIV 664
           +E  + + K               V  PE+R+  +  +
Sbjct: 228 KEAKDLLVK-------------LFVREPEKRLGVRGDI 252

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  149 bits (378), Expect = 6e-41
 Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 34/276 (12%)

Query: 398 NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKV 453
             +G GSFG V   R   +G   AMKV   +     +  +  + E  M+  + H  II++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 454 ISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
             +  + +   ++++Y+  G     L   +             +V  ALEYLH   S  +
Sbjct: 70  WGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125

Query: 514 IHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSA 573
           I+ DLKP N+LLD N    ++DFG AK +     +        T  Y+APE       + 
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNK 180

Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFV 633
           + D +SFGI++ E      P    F    T+K +      I   E+  P   + +  + +
Sbjct: 181 SIDWWSFGILIYEMLAGYTP----FYDSNTMKTYEK----ILNAELRFPPFFNEDVKDLL 232

Query: 634 AKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK 669
           ++                    QR+   +  T+ +K
Sbjct: 233 SR-------------LITRDLSQRLGNLQNGTEDVK 255

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  146 bits (369), Expect = 4e-40
 Identities = 58/277 (20%), Positives = 118/277 (42%), Gaps = 17/277 (6%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHRNIIKVIS 455
             IG G++G V+KA+   G   A+K   L  +   +  +   E  ++K ++H NI+K+  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 456 SCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIH 515
               ++   LV E++    L+K L      L+     + ++ + + + Y H     +V+H
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLH 123

Query: 516 CDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-YGKEGRVSAN 574
            DLKP N+L++      ++DFG+A+      +       + T+ Y AP+      + S  
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYT--HEIVTLWYRAPDVLMGSKKYSTT 181

Query: 575 GDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHW-------VNDWLPISTKEIVDPNLLSR 627
            D++S G +  E          +   +  ++ +         +W  ++     DPN    
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241

Query: 628 EDINFVAKEQCVSFVF-NVAMECTVESPEQRINAKEI 663
           E + + +  + +     ++  +     P QRI AK+ 
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 6e-40
 Identities = 68/296 (22%), Positives = 124/296 (41%), Gaps = 26/296 (8%)

Query: 387 LCRATDGFSENNLIGRGSFGSVFKAR--LGDGMEVAMKVFNLQYG--RVFKSFDVECEMM 442
           LCRA   +     IG G++G VFKAR     G  VA+K   +Q G   +  S   E  ++
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61

Query: 443 K---SIRHRNIIKVISSCSNEEFKA-----LVLEYMPHGSLEKYLHSSNYILDIYQRLNI 494
           +   +  H N++++   C+           LV E++               +      ++
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121

Query: 495 MIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQT 554
           M  +   L++LH   S +V+H DLKP N+L+  +    L+DFG+A++ + +      T  
Sbjct: 122 MFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSV 175

Query: 555 LATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI 614
           + T+ Y APE   +   +   D++S G +  E F RK       + +  L   ++     
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLP 234

Query: 615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAME-------CTVESPEQRINAKEI 663
             ++      L R+  +  + +    FV ++          C   +P +RI+A   
Sbjct: 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  146 bits (369), Expect = 6e-40
 Identities = 53/281 (18%), Positives = 94/281 (33%), Gaps = 27/281 (9%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
            IG GSFG ++    +  G EVA+K+  ++         +E ++ K ++    I  I  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
             E    +++  +   SLE   +  +    +   L +   + S +EY+H   S   IH D
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRD 128

Query: 518 LKPSNVL---LDDNMVAHLSDFGIAKLLTREDQSTIQ-----TQTLATIGYMAPEYGKEG 569
           +KP N L        + ++ DFG+AK                     T  Y +       
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188

Query: 570 RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED 629
             S   D+ S G +LM       P   +       K+       +ST   V       E 
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEF 248

Query: 630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI 670
             ++               C     + + +   +      +
Sbjct: 249 ATYLNF-------------CRSLRFDDKPDYSYLRQLFRNL 276

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-39
 Identities = 66/284 (23%), Positives = 118/284 (41%), Gaps = 28/284 (9%)

Query: 398 NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY-----GRVFKSFDVECEMMKSIRHRNII 451
           + +G G F +V+KAR       VA+K   L +       + ++   E ++++ + H NII
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 452 KVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSA 511
            ++ +  ++   +LV ++M        +  ++ +L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 512 QVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRV 571
            ++H DLKP+N+LLD+N V  L+DFG+AK     +++   T  + T  Y APE     R+
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARM 177

Query: 572 -SANGDVYSFGIMLMETFTRKKP---------TDEIFN--GEMTLKHWVNDWLPISTKEI 619
                D+++ G +L E   R               IF   G  T + W +          
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237

Query: 620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
                +    I   A +  +  +        + +P  RI A + 
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLI----QGLFLFNPCARITATQA 277

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  147 bits (371), Expect = 1e-39
 Identities = 53/241 (21%), Positives = 103/241 (42%), Gaps = 16/241 (6%)

Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNL------QYGRVFKSFDVECEMMKS 444
           + FS + +IGRG FG V+  R    G   AMK  +       Q   +  +  +   ++ +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
                I+ +  +    +  + +L+ M  G L  +L       +         ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE 564
           +H   +  V++ DLKP+N+LLD++    +SD G+A   +++        ++ T GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPE 175

Query: 565 YGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN 623
             ++G    ++ D +S G ML +      P  +    +      +   + +   +   P 
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 235

Query: 624 L 624
           L
Sbjct: 236 L 236

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-39
 Identities = 50/275 (18%), Positives = 97/275 (35%), Gaps = 34/275 (12%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECE-MMKSIRHRNIIKVISS 456
           ++G G  G V +        + A+K+              E E   ++ +  +I++++  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73

Query: 457 C----SNEEFKALVLEYMPHGSLEKYLHS-SNYILDIYQRLNIMIDVASALEYLHFGYSA 511
                +  +   +V+E +  G L   +    +      +   IM  +  A++YLH   S 
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 512 QVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
            + H D+KP N+L      N +  L+DFG AK  T  +     T    T  Y+APE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGP 187

Query: 569 GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE 628
            +   + D++S G+++        P        ++        +        + + +S E
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247

Query: 629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
               +                    P QR+   E 
Sbjct: 248 VKMLIRN-------------LLKTEPTQRMTITEF 269

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 1e-38
 Identities = 60/283 (21%), Positives = 108/283 (38%), Gaps = 35/283 (12%)

Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKS 444
           D +     +G G F  V K R    G++ A K    +       G   +  + E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 445 IRHRNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           I+H N+I +     N+    L+LE +  G L  +  +    L   +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYY 128

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVA----HLSDFGIAKLLTREDQSTIQTQTLATIGY 560
           LH   S Q+ H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182

Query: 561 MAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 620
           +APE      +    D++S G++     +   P    F G+   +   N        E  
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP----FLGDTKQETLANVSAVNYEFEDE 238

Query: 621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
             +  S    +F+ +               V+ P++R+  ++ 
Sbjct: 239 YFSNTSALAKDFIRR-------------LLVKDPKKRMTIQDS 268

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 3e-38
 Identities = 67/284 (23%), Positives = 119/284 (41%), Gaps = 17/284 (5%)

Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNL--QYGRVFKSFDVECEMMKSIRHR 448
           + F +   IG G++G V+KAR    G  VA+K   L  +   V  +   E  ++K + H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 449 NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG 508
           NI+K++     E    LV E++     +    S+   + +    + +  +   L + H  
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH-- 119

Query: 509 YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-YGK 567
            S +V+H DLKP N+L++      L+DFG+A+      +    T  + T+ Y APE    
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLG 176

Query: 568 EGRVSANGDVYSFGIMLMETFTRKKP------TDEIFNGEMTLKHWVN-DWLPISTKEIV 620
               S   D++S G +  E  TR+         D++F    TL       W  +++    
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 621 DPNLLSREDINFVAKEQCVSFVF-NVAMECTVESPEQRINAKEI 663
            P+       +F      +     ++  +     P +RI+AK  
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 3e-38
 Identities = 61/288 (21%), Positives = 110/288 (38%), Gaps = 27/288 (9%)

Query: 394 FSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIK 452
           +++  +IG GSFG V++A+L   G  VA+K          +  + E ++M+ + H NI++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77

Query: 453 VISSC------SNEEFKALVLEYMPHGSLEKYLH--SSNYILDIYQRLNIMIDVASALEY 504
           +           +E +  LVL+Y+P        H   +   L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 505 LHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAP 563
           +H   S  + H D+KP N+LLD D  V  L DFG AK L R +     +   +       
Sbjct: 138 IH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPE 192

Query: 564 EYGKEGRVSANGDVYSFGIMLMETFTRKKP------TDEIFNGEMTLKHWVNDWLPISTK 617
                   +++ DV+S G +L E    +         D++      L     + +     
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252

Query: 618 EIVDPNL--LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
              +     +       V + +       +       +P  R+   E 
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 1e-37
 Identities = 54/276 (19%), Positives = 93/276 (33%), Gaps = 45/276 (16%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY------GRVFKSFDVECEMMKSIR--HRN 449
           L+G G FGSV+    + D + VA+K                    +E  ++K +      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 450 IIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
           +I+++      +   L+LE            +    L      +    V  A+ + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH--- 127

Query: 510 SAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKE 568
           +  V+H D+K  N+L+D +     L DFG   LL     +        T  Y  PE+ + 
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIRY 183

Query: 569 GRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
            R    +  V+S GI+L +      P    F  +            I   ++     +S 
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIP----FEHDE----------EIIRGQVFFRQRVSS 229

Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
           E  + +               C    P  R   +EI
Sbjct: 230 ECQHLIRW-------------CLALRPSDRPTFEEI 252

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 2e-37
 Identities = 63/291 (21%), Positives = 119/291 (40%), Gaps = 23/291 (7%)

Query: 391 TDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVF-KSFDVECEMMKSIRHR 448
              ++  + IG G++G V  A    + + VA+K  +    + + +    E +++   RH 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 449 NIIKVISSCSNEEFKAL----VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEY 504
           NII +         + +    ++ ++    L K L + +  L        +  +   L+Y
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKY 124

Query: 505 LHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLT-REDQSTIQTQTLATIGYMAP 563
           +H   SA V+H DLKPSN+LL+      + DFG+A++     D +   T+ +AT  Y AP
Sbjct: 125 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 564 EYGKEGRVSAN-GDVYSFGIMLMETFTRKKP------TDEIFNGEMTLKHWVNDWLPIST 616
           E     +      D++S G +L E  + +         D++ +    L     + L    
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241

Query: 617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAME----CTVESPEQRINAKEI 663
                  LLS    N V   +      + A++        +P +RI  ++ 
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  135 bits (341), Expect = 4e-36
 Identities = 45/287 (15%), Positives = 90/287 (31%), Gaps = 29/287 (10%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
            IG GSFG +F+   L +  +VA+K    +          E    K +     I  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 458 SNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCD 517
             E    +++  +   SLE  L        +         + + ++ +H      +++ D
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126

Query: 518 LKPSNVLLDDNMVAH-----LSDFGIAKLL----TREDQSTIQTQTLA-TIGYMAPEYGK 567
           +KP N L+      +     + DFG+ K      T++     + + L+ T  YM+     
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
               S   D+ + G + M       P   +       K+        ST           
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPE 246

Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL 674
           E   ++                   + +   +   +     K+ + L
Sbjct: 247 EFYKYMHY-------------ARNLAFDATPDYDYLQGLFSKVLERL 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 1e-35
 Identities = 58/279 (20%), Positives = 114/279 (40%), Gaps = 19/279 (6%)

Query: 398 NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVI 454
             IG G++G+VFKA+       VA+K   L      V  S   E  ++K ++H+NI+++ 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 455 SSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVI 514
               +++   LV E+      + +   +  + D     + +  +   L + H      V+
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS---RNVL 123

Query: 515 HCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPE-YGKEGRVSA 573
           H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  P+        S 
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFGAKLYST 181

Query: 574 NGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN--------DWLPISTKEIVDPNLL 625
           + D++S G +  E     +P     + +  LK             W  ++      P  +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 626 SREDINFVAKEQCVSFVF-NVAMECTVESPEQRINAKEI 663
                + V     ++    ++       +P QRI+A+E 
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-35
 Identities = 61/302 (20%), Positives = 122/302 (40%), Gaps = 29/302 (9%)

Query: 387 LCRATDGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY--GRVFKSFDVECEMMK 443
            C     + +   IG+G+FG VFKAR    G +VA+K   ++        +   E ++++
Sbjct: 5   FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64

Query: 444 SIRHRNIIKVISSCSNEEFKA--------LVLEYMPHGSLEKYLHSSNYILDIYQRLNIM 495
            ++H N++ +I  C  +            LV ++  H       +       + +   +M
Sbjct: 65  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVM 123

Query: 496 IDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS--TIQTQ 553
             + + L Y+H     +++H D+K +NVL+  + V  L+DFG+A+  +    S     T 
Sbjct: 124 QMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 554 TLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTD-----------EIFNGE 601
            + T+ Y  PE     R      D++  G ++ E +TR                    G 
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 240

Query: 602 MTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAK 661
           +T + W N       +++       R+  + +       +  ++  +  V  P QRI++ 
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSD 300

Query: 662 EI 663
           + 
Sbjct: 301 DA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-35
 Identities = 60/275 (21%), Positives = 108/275 (39%), Gaps = 31/275 (11%)

Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRH 447
           + F    L+G+G+FG V   R    G   AMK+   +             E  ++++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             +  +  +    +    V+EY   G L  +L     +    +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH- 122

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
             S  V++ D+K  N++LD +    ++DFG+ K    +  +        T  Y+APE  +
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEVLE 178

Query: 568 EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR 627
           +       D +  G+++ E    + P    F  +   + +      I  +EI  P  LS 
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQDHERLFEL----ILMEEIRFPRTLSP 230

Query: 628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKE 662
           E  + +A                 + P+QR+    
Sbjct: 231 EAKSLLAG-------------LLKKDPKQRLGGGP 252

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 4e-33
 Identities = 65/288 (22%), Positives = 117/288 (40%), Gaps = 38/288 (13%)

Query: 392 DGFSENNLIGRGSFGSVFKARL----GDGMEVAMKVFN----LQYGRVFKSFDVECEMMK 443
           + F    ++G G++G VF  R       G   AMKV      +Q  +  +    E ++++
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 444 SIRHR-NIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
            IR    ++ +  +   E    L+L+Y+  G L  +L         ++    + ++  AL
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLAL 142

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMA 562
           E+LH      +I+ D+K  N+LLD N    L+DFG++K     D++        TI YMA
Sbjct: 143 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMA 198

Query: 563 PE--YGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV 620
           P+   G +       D +S G+++ E  T   P    F  +            I   E  
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEISRRILKSEPP 254

Query: 621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEI 663
            P  +S    + + +               ++ P++R+     +A EI
Sbjct: 255 YPQEMSALAKDLIQR-------------LLMKDPKKRLGCGPRDADEI 289

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  125 bits (315), Expect = 3e-32
 Identities = 52/249 (20%), Positives = 96/249 (38%), Gaps = 22/249 (8%)

Query: 392 DGFSENNLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRH 447
           D F     +G GSFG V   +    G   AMK+ + Q     +  +    E  +++++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 448 RNIIKVISSCSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHF 507
             ++K+  S  +     +V+EY+  G +  +L                  +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH- 158

Query: 508 GYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGK 567
             S  +I+ DLKP N+L+D      ++DFG AK                T   +APE   
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIIL 211

Query: 568 EGRVSANGDVYSFGIMLMETFTRKKP---------TDEIFNGEMTLKHWVNDWLPISTKE 618
               +   D ++ G+++ E      P          ++I +G++      +  L    + 
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271

Query: 619 IVDPNLLSR 627
           ++  +L  R
Sbjct: 272 LLQVDLTKR 280

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 5e-32
 Identities = 64/305 (20%), Positives = 113/305 (37%), Gaps = 33/305 (10%)

Query: 382 FSYLELCRATDGFSEN----NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY--GRVFKS 434
           F   E+ +              +G G++G+V  A     G +VA+K     +      K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 435 FDVECEMMKSIRHRNIIKVISSCSNEEFKA------LVLEYMPHGSLEKYLHSSNYILDI 488
              E  ++K +RH N+I ++   + +E         LV+ +M  G+    L      L  
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGE 120

Query: 489 YQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS 548
            +   ++  +   L Y+H   +A +IH DLKP N+ ++++    + DFG+A    R+  S
Sbjct: 121 DRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA----RQADS 173

Query: 549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP---------TDEIFN 599
            +    +              R +   D++S G ++ E  T K             EI  
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233

Query: 600 GEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVF-NVAMECTVESPEQRI 658
              T        L     +     L   E  +F +     S +  N+  +  V   EQR+
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293

Query: 659 NAKEI 663
            A E 
Sbjct: 294 TAGEA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  122 bits (306), Expect = 4e-31
 Identities = 56/289 (19%), Positives = 116/289 (40%), Gaps = 36/289 (12%)

Query: 398 NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVIS 455
             +GRG +  VF+A  + +  +V +K+      +  K    E ++++++R   NII +  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 97

Query: 456 SCSNEEFK--ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQV 513
              +   +  ALV E++ +   ++   +    L  Y     M ++  AL+Y H   S  +
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGI 150

Query: 514 IHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGR-V 571
           +H D+KP NV++D ++    L D+G+A+      +       +A+  +  PE   + +  
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMY 207

Query: 572 SANGDVYSFGIMLMETFTRKKPTD-------------EIFNGEMTLKHWVNDWLPISTKE 618
             + D++S G ML     RK+P               ++   E    +     + +  + 
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 267

Query: 619 IVDPNLLSREDINFVAKEQCVSFVFNVAME----CTVESPEQRINAKEI 663
                  SR+        +    V   A++          + R+ A+E 
Sbjct: 268 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 3e-30
 Identities = 58/303 (19%), Positives = 111/303 (36%), Gaps = 29/303 (9%)

Query: 382 FSYLELCRATDGFSEN----NLIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY--GRVFKS 434
           F   EL +      E     + +G G++GSV  A     G+ VA+K  +  +      K 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 435 FDVECEMMKSIRHRNIIKVISSCSNE----EFKALVLEYMPHGSLEKYLHSSNYILDIYQ 490
              E  ++K ++H N+I ++   +      EF  + L     G+    +      L    
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDH 122

Query: 491 RLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI 550
              ++  +   L+Y+H   SA +IH DLKPSN+ ++++    + DFG+A+    E    +
Sbjct: 123 VQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV 179

Query: 551 QTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKP---------TDEIFNGE 601
            T                   +   D++S G ++ E  T +              I    
Sbjct: 180 AT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 235

Query: 602 MTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVS-FVFNVAMECTVESPEQRINA 660
            T    +   +   +      +L     +NF       +    ++  +  V   ++RI A
Sbjct: 236 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 295

Query: 661 KEI 663
            + 
Sbjct: 296 AQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 9e-28
 Identities = 59/295 (20%), Positives = 112/295 (37%), Gaps = 40/295 (13%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVIS 455
            IG G+ G V  A        VA+K  +  +      K    E  +MK + H+NII +++
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 456 SCSNEEFK------ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY 509
             + ++         LV+E M     +          D  +   ++  +   +++LH   
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQMLCGIKHLH--- 136

Query: 510 SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEG 569
           SA +IH DLKPSN+++  +    + DFG+A+       S + T  + T  Y APE     
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYRAPEVILGM 193

Query: 570 RVSANGDVYSFGIMLMETFTRKKP---------------------TDEIFNGEMTLKHWV 608
               N D++S G ++ E    K                        + +   + T++++V
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253

Query: 609 NDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEI 663
            +    +          S    +    +   S   ++  +  V  P +RI+  + 
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  111 bits (278), Expect = 3e-27
 Identities = 50/309 (16%), Positives = 103/309 (33%), Gaps = 47/309 (15%)

Query: 399 LIGRGSFGSVFKAR-LGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSC 457
            +G G F +V+ A+ + +   VAMK+         ++ + E ++++ +   +  K  S  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 458 SNEEFK---------------ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASAL 502
           +N   K                +V E +    L       +  + +     I   +   L
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 503 EYLHFGYSAQVIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYM 561
           +Y+H      +IH D+KP NVL++  +   +L    IA L          T ++ T  Y 
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 562 APEYGKEGRVSANGDVYSFGIMLMETFTRKKP---------------------------T 594
           +PE           D++S   ++ E  T                               +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256

Query: 595 DEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESP 654
             + NG+ T   + +  L  +  ++    L       +   +     + +         P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316

Query: 655 EQRINAKEI 663
            +R +A  +
Sbjct: 317 RKRADAGGL 325

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 98.3 bits (243), Expect = 5e-23
 Identities = 77/295 (26%), Positives = 127/295 (43%), Gaps = 17/295 (5%)

Query: 30  DNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGI 89
           + ++ G + +T      +  L LS   L          SSL+N   L  +       + +
Sbjct: 35  NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP---YPIPSSLANLPYLNFLYIGGIN-NLV 90

Query: 90  LPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQK 149
            P          L Y  + + NVSG IP+ +  +  L  +    N L+G++P ++  L  
Sbjct: 91  GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150

Query: 150 LQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELT 209
           L G+  + N++ G+IPDS     +L+           S+    N L         +  L 
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFT----------SMTISRNRLTGKIPPTFANLNLA 200

Query: 210 SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAI 269
            + L+   L+    + F S+  T  + L   +L           +L  L+L NN + G +
Sbjct: 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTL 260

Query: 270 PASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNLRVPPC 324
           P  L +L +L  LN+SFN L GEIP+GG+   F   ++  N+ LCGSP   +P C
Sbjct: 261 PQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 59.4 bits (142), Expect = 4e-10
 Identities = 16/86 (18%), Positives = 31/86 (36%), Gaps = 6/86 (6%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
                  N        +  +  L+ L+L +N   G +P     L+ L +L +S N L   
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPL 86
                 +    N +   + +++NN  
Sbjct: 284 ------IPQGGNLQRFDVSAYANNKC 303

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 97.4 bits (241), Expect = 8e-23
 Identities = 53/286 (18%), Positives = 92/286 (32%), Gaps = 17/286 (5%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           +L +  N  +        N   L  L L +N  S   P  F  L  L+ L LS N L   
Sbjct: 35  LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKEL 94

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI 120
             ++         K+L  +    N +  +      G     +          SG      
Sbjct: 95  PEKM--------PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146

Query: 121 GNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG 180
             +  L+ I +    +          L +L    L+ NK+      S+   + L KL L 
Sbjct: 147 QGMKKLSYIRIADTNITTIPQGLPPSLTELH---LDGNKITKVDAASLKGLNNLAKLGLS 203

Query: 181 GNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIG 240
            N +S        N   LR L L +N+L  +P    + K I  +   +N  +     +  
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263

Query: 241 NLKIARIDSCDLISLISLNLSNNNLS--GAIPASLEKLSYLKDLNL 284
                   +    S   ++L +N +      P++   +     + L
Sbjct: 264 PPGY----NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 88.9 bits (219), Expect = 5e-20
 Identities = 51/285 (17%), Positives = 98/285 (34%), Gaps = 29/285 (10%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
            +P+ +      ++L+L +N  +      F NL+NL  L L NN ++          + +
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-----ISPGAFA 76

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL 131
               L  +  S N L  +     +      L   E     V   +   +  +  + +   
Sbjct: 77  PLVKLERLYLSKNQLKELPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT- 133

Query: 132 GGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPEC 191
              K +G        ++KL  + + +  +  +IP  +  S  L +L L GNK++      
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS--LTELHLDGNKITKVDAAS 190

Query: 192 FNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCD 251
              L +L  L L  N ++++          L     +N            L        D
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN----------KLVKVPGGLAD 240

Query: 252 LISLISLNLSNNNLSG------AIPASLEKLSYLKDLNLSFNKLE 290
              +  + L NNN+S         P    K +    ++L  N ++
Sbjct: 241 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.8 bits (190), Expect = 3e-16
 Identities = 46/222 (20%), Positives = 74/222 (33%), Gaps = 13/222 (5%)

Query: 97  NLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLE 156
           +L       ++    ++     +  NL NL  + L  NK++   P     L KL+ L L 
Sbjct: 28  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87

Query: 157 NNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFW 216
            N+L+           EL   E    K+  S+    N +  + +              F 
Sbjct: 88  KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147

Query: 217 NLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKL 276
            +K + Y+  +    T              I      SL  L+L  N ++    ASL+ L
Sbjct: 148 GMKKLSYIRIADTNIT-------------TIPQGLPPSLTELHLDGNKITKVDAASLKGL 194

Query: 277 SYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN 318
           + L  L LSFN +        +      E    N  L   P 
Sbjct: 195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG 236

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.9 bits (217), Expect = 1e-20
 Identities = 23/163 (14%), Positives = 51/163 (31%), Gaps = 26/163 (15%)

Query: 398 NLIGRGSFGSVFKARLGDGMEVAMKVFNL----------QYGRVFKSFDVECEMMKSIRH 447
            L+G G   +VF        E  +K   +          +       F V          
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 448 RNIIKVISSCSNEEF----KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALE 503
           R + K+      + +     A+++E +             Y + +     ++  +   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAK--------ELYRVRVENPDEVLDMILEEVA 117

Query: 504 YLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED 546
             +      ++H DL   NVL+ +  +  + DF  +  +  E 
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.3 bits (204), Expect = 4e-18
 Identities = 55/269 (20%), Positives = 93/269 (34%), Gaps = 21/269 (7%)

Query: 45  RNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEY 104
              Q + L  N ++          S   C++LT++   +N L  I      G      + 
Sbjct: 32  AASQRIFLHGNRISHVPAA-----SFRACRNLTILWLHSNVLARIDAAAFTGLALLE-QL 85

Query: 105 FEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSI 164
                  +    P     L  L  ++L    L    P     L  LQ L L++N L+   
Sbjct: 86  DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145

Query: 165 PDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSI-PLTFWNLKDILY 223
            D+      L  L L GN++S      F  L SL  LLL  N +  + P  F +L  ++ 
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205

Query: 224 LNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLN 283
           L   +N              +       L +L  L L++N        +    ++L+   
Sbjct: 206 LYLFANNL----------SALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFR 254

Query: 284 LSFNKLEGEIP---RGGSFGNFSAESFEG 309
            S +++   +P    G      +A   +G
Sbjct: 255 GSSSEVPCSLPQRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.0 bits (146), Expect = 8e-11
 Identities = 46/245 (18%), Positives = 73/245 (29%), Gaps = 12/245 (4%)

Query: 74  KSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGG 133
            +   I    N +  + P  S     +    +  +            G      +     
Sbjct: 32  AASQRIFLHGNRISHV-PAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90

Query: 134 NKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFN 193
            +L    P+T   L +L  L L+   L+   P        L  L L  N L     + F 
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150

Query: 194 NLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDL 252
           +L +L  L L  N ++S+P   F  L  +  L    N      P    +L          
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL-- 208

Query: 253 ISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNEL 312
                     NNLS     +L  L  L+ L L+ N    +      +          +E+
Sbjct: 209 --------FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEV 260

Query: 313 LCGSP 317
            C  P
Sbjct: 261 PCSLP 265

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 78.5 bits (192), Expect = 4e-16
 Identities = 44/200 (22%), Positives = 74/200 (37%), Gaps = 35/200 (17%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
            L    N  S   P  I   + L  L L+ N        T  +L NL  L L+NN +++ 
Sbjct: 201 SLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN- 255

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLS------------------HSL 102
                 L+ LS    LT +    N +  I P   +  L+                   +L
Sbjct: 256 ------LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309

Query: 103 EYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEG 162
            Y  + + N+S   P  + +LT L  ++   NK++    S+L  L  +  L   +N++  
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365

Query: 163 SIPDSICHSDELYKLELGGN 182
             P +      + +L L   
Sbjct: 366 LTPLANLTR--ITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 76.2 bits (186), Expect = 2e-15
 Identities = 53/191 (27%), Positives = 76/191 (39%), Gaps = 23/191 (12%)

Query: 104 YFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGS 163
                   +S   P  I   TNL  + L GN+L      TL  L  L  L L NN++   
Sbjct: 201 SLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256

Query: 164 IPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILY 223
            P S      L +L+LG N++S   P     L +L  L L  N+L  I     NLK++ Y
Sbjct: 257 APLSGLTK--LTELKLGANQISNISP--LAGLTALTNLELNENQLEDIS-PISNLKNLTY 311

Query: 224 LNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLN 283
           L    N  +   P+              L  L  L  +NN +S    +SL  L+ +  L+
Sbjct: 312 LTLYFNNISDISPV------------SSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357

Query: 284 LSFNKLEGEIP 294
              N++    P
Sbjct: 358 AGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 75.8 bits (185), Expect = 3e-15
 Identities = 42/213 (19%), Positives = 80/213 (37%), Gaps = 43/213 (20%)

Query: 71  SNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIY 130
           +   +L  +  +NN +  I P      +  +L+   +    +       + +LTNLT + 
Sbjct: 194 AKLTNLESLIATNNQISDITPL----GILTNLDELSLNGNQLKD--IGTLASLTNLTDLD 247

Query: 131 LGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDE----------------- 173
           L  N+++   P  L  L KL  L L  N++    P +   +                   
Sbjct: 248 LANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN 305

Query: 174 ---LYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNF 230
              L  L L  N +S   P   ++L  L+ L   +N+++ +  +  NL +I +L+   N 
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVS-SLANLTNINWLSAGHNQ 362

Query: 231 FTGPLPLEIGNLKIARIDSCDLISLISLNLSNN 263
            +   PL             +L  +  L L++ 
Sbjct: 363 ISDLTPL------------ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 56.2 bits (134), Expect = 6e-09
 Identities = 47/285 (16%), Positives = 88/285 (30%), Gaps = 33/285 (11%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
             ++     L   + +  +  +  +L  +  L+     + S       +  +    +LT 
Sbjct: 20  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-------IDGVEYLNNLTQ 70

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG 138
           I+FSNN L  I P  ++  L   L                 +  LT         + L  
Sbjct: 71  INFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130

Query: 139 SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFN----- 193
                  +L       +       S+      +       L        +    N     
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI 190

Query: 194 ----NLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDS 249
                L +L  L+  +N+++ I      L ++  L+ + N       L            
Sbjct: 191 SVLAKLTNLESLIATNNQISDIT-PLGILTNLDELSLNGNQLKDIGTL------------ 237

Query: 250 CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIP 294
             L +L  L+L+NN +S   P  L  L+ L +L L  N++    P
Sbjct: 238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP 280

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 4e-05
 Identities = 41/246 (16%), Positives = 79/246 (32%), Gaps = 15/246 (6%)

Query: 71  SNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIY 130
           +              +   + +T +  ++      +     +     + +  L NLT I 
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQTDLDQVTT----LQADRLGIKS--IDGVEYLNNLTQIN 72

Query: 131 LGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHS----DELYKLELGGNKLSG 186
              N+L    P  L  L KL  + + NN++    P +   +              + L  
Sbjct: 73  FSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130

Query: 187 SIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIAR 246
                   L+S  I  + +    +          +  L   +N  T        N     
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI 190

Query: 247 IDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAES 306
                L +L SL  +NN +S   P  +   + L +L+L+ N+L+  I    S  N +   
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD-IGTLASLTNLTDLD 247

Query: 307 FEGNEL 312
              N++
Sbjct: 248 LANNQI 253

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 4e-08
 Identities = 41/213 (19%), Positives = 75/213 (35%), Gaps = 13/213 (6%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
             +    +     + +  +P      ++   L LS N L + +L     ++L     LT 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSL-----ATLMPYTRLTQ 59

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG 138
           ++     L  +    ++  L                G       + +++   L       
Sbjct: 60  LNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRL-----TS 114

Query: 139 SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASL 198
                L  L +LQ L L+ N+L+   P  +  + +L KL L  N L+       N L +L
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENL 174

Query: 199 RILLLGSNELTSIPLTFWNLKDILYLNFSSNFF 231
             LLL  N L +IP  F+    + +     N +
Sbjct: 175 DTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.5 bits (106), Expect = 9e-06
 Identities = 41/200 (20%), Positives = 63/200 (31%), Gaps = 16/200 (8%)

Query: 116 IPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELY 175
           +P ++    + TI++L  N L     +TL    +L  L L+    E +          L 
Sbjct: 25  LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA--ELTKLQVDGTLPVLG 80

Query: 176 KLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPL 235
            L+L  N+L           A   + +  +   +        L ++  L    N      
Sbjct: 81  TLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLP 140

Query: 236 PLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR 295
           P  +         S           +NNNL+      L  L  L  L L  N L   IP+
Sbjct: 141 PGLLTPTPKLEKLSL----------ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189

Query: 296 G-GSFGNFSAESFEGNELLC 314
           G             GN  LC
Sbjct: 190 GFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (105), Expect = 1e-05
 Identities = 18/87 (20%), Positives = 25/87 (28%), Gaps = 6/87 (6%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
            L +  N      P  +    KL  L L++N+ +         L NL  L L  N L + 
Sbjct: 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYT- 186

Query: 61  TLELSFLSSLSNCKSLTLISFSNNPLD 87
                          L       NP  
Sbjct: 187 -----IPKGFFGSHLLPFAFLHGNPWL 208

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.6 bits (122), Expect = 6e-08
 Identities = 28/221 (12%), Positives = 72/221 (32%), Gaps = 24/221 (10%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
             +    +    ++ +  +  T  +L  +  L      +T+       +  +    +L  
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 79  ISFSNNPL-----DGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGG 133
           +   +N +        L K +   LS +      A   +      ++ +     +  L G
Sbjct: 68  LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127

Query: 134 NKLNGSIPSTLGKLQKLQGLGLENNKLEG-------SIPDSICHSDELYKLELGGNKLSG 186
                 +   L ++  +  L    N           S    + +  +L  L+   NK+S 
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187

Query: 187 SIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFS 227
             P    +L +L  + L +N+++ +     N  ++  +  +
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVS-PLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.2 bits (108), Expect = 4e-06
 Identities = 21/83 (25%), Positives = 38/83 (45%), Gaps = 9/83 (10%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           +  +   N   +    + N SKL+ L+  DN  S   P    +L NL  + L NN ++  
Sbjct: 153 LQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD- 209

Query: 61  TLELSFLSSLSNCKSLTLISFSN 83
                 +S L+N  +L +++ +N
Sbjct: 210 ------VSPLANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 4e-04
 Identities = 33/247 (13%), Positives = 59/247 (23%), Gaps = 42/247 (17%)

Query: 43  NLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSL 102
            L N   +    + +T          + ++   +T +S     +  I             
Sbjct: 17  ALANAIKIAAGKSNVTD-------TVTQADLDGITTLSAFGTGVTTI------------- 56

Query: 103 EYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEG 162
                          E +  L NL  + L  N++    P           L     K   
Sbjct: 57  ---------------EGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVS 101

Query: 163 SIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDIL 222
           +I                 +    +       L      +   + L  +      L    
Sbjct: 102 AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLT-NLQYLSIGN 160

Query: 223 YLNFSSNFFTGPLPLEIGNLKIARIDS----CDLISLISLNLSNNNLSGAIPASLEKLSY 278
                         L        +I        L +LI ++L NN +S   P  L   S 
Sbjct: 161 AQVSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSN 218

Query: 279 LKDLNLS 285
           L  + L+
Sbjct: 219 LFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.2 bits (90), Expect = 7e-04
 Identities = 13/58 (22%), Positives = 23/58 (39%), Gaps = 4/58 (6%)

Query: 100 HSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLEN 157
             L   +     +S   P  + +L NL  ++L  N+++   P  L     L  + L N
Sbjct: 173 SKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.5 bits (124), Expect = 8e-08
 Identities = 23/99 (23%), Positives = 34/99 (34%), Gaps = 18/99 (18%)

Query: 182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGN 241
           N  S  I    +   SL  L + +N+L  +P     L+    L  S N     +P    N
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---RLIASFNHLAE-VPELPQN 325

Query: 242 LKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLK 280
           LK              L++  N L    P   E +  L+
Sbjct: 326 LK-------------QLHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.5 bits (124), Expect = 8e-08
 Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 9/97 (9%)

Query: 104 YFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGS 163
                    S  I        +L  + +  NKL   +P+   +L++L       N L   
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-E 318

Query: 164 IPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRI 200
           +P+   +   L +L +  N L    P+   ++  LR+
Sbjct: 319 VPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.1 bits (97), Expect = 2e-04
 Identities = 20/98 (20%), Positives = 35/98 (35%), Gaps = 11/98 (11%)

Query: 54  NNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVS 113
            N    +       S      SL  ++ SNN L        +  L   LE    ++ +++
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL------IELPALPPRLERLIASFNHLA 317

Query: 114 GGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQ 151
             +PE   NL  L   ++  N L    P     ++ L+
Sbjct: 318 E-VPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.1 bits (97), Expect = 2e-04
 Identities = 19/101 (18%), Positives = 35/101 (34%), Gaps = 16/101 (15%)

Query: 28  LSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLD 87
              N+ S  I +      +L+ L +SNN L          +     + L     S N L 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI------ELPALPPRLERLIA---SFNHL- 316

Query: 88  GILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTI 128
                  V  L  +L+   + Y  +    P+   ++ +L +
Sbjct: 317 -----AEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.001
 Identities = 19/80 (23%), Positives = 29/80 (36%), Gaps = 19/80 (23%)

Query: 215 FWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLE 274
                 +  LN S+N     LP     L+              L  S N+L+  +P   +
Sbjct: 280 CDLPPSLEELNVSNNKLIE-LPALPPRLE-------------RLIASFNHLA-EVPELPQ 324

Query: 275 KLSYLKDLNLSFNKLEGEIP 294
            L   K L++ +N L  E P
Sbjct: 325 NL---KQLHVEYNPLR-EFP 340

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.2 bits (114), Expect = 2e-07
 Identities = 23/108 (21%), Positives = 43/108 (39%), Gaps = 4/108 (3%)

Query: 116 IPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELY 175
           +   +  L  +T + L  N+L    P+ L  L+ L+ L  + +       D + +   L 
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNALENVDGVANLPRLQ 68

Query: 176 KLELGGNKL-SGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDIL 222
           +L L  N+L   +  +   +   L +L L  N L         L ++L
Sbjct: 69  ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.9 bits (108), Expect = 1e-06
 Identities = 20/126 (15%), Positives = 43/126 (34%), Gaps = 12/126 (9%)

Query: 25  ILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNN 84
           +L L+    +  +      L  +  L LS+N L +    L+ L  L   ++      +  
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQA---SDNALE 56

Query: 85  PLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTL 144
            +DG+     +  L       +           + + +   L ++ L GN L        
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQ------QSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQ 109

Query: 145 GKLQKL 150
            +L ++
Sbjct: 110 ERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.1 bits (106), Expect = 2e-06
 Identities = 29/117 (24%), Positives = 37/117 (31%), Gaps = 15/117 (12%)

Query: 177 LELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLP 236
           L L    L+  +      L  +  L L  N L ++P     L+ +  L  S N       
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 237 LEIGNLKIARIDSCDLISLISLNLSNNNL-SGAIPASLEKLSYLKDLNLSFNKLEGE 292
                         +L  L  L L NN L   A    L     L  LNL  N L  E
Sbjct: 61  ------------VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.2 bits (88), Expect = 5e-04
 Identities = 24/132 (18%), Positives = 42/132 (31%), Gaps = 15/132 (11%)

Query: 153 LGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIP 212
           L L +  L  ++   +     +  L+L  N+L    P     L  L +L    N L ++ 
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59

Query: 213 LTFWNLKDILYLNFSSNFFTG-PLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPA 271
               NL  +  L   +N          + +             L+ LNL  N+L      
Sbjct: 60  -GVANLPRLQELLLCNNRLQQSAAIQPLVSCP----------RLVLLNLQGNSLCQEEGI 108

Query: 272 SLEKLSYLKDLN 283
                  L  ++
Sbjct: 109 QERLAEMLPSVS 120

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 48.7 bits (114), Expect = 1e-06
 Identities = 42/295 (14%), Positives = 90/295 (30%), Gaps = 15/295 (5%)

Query: 13  IPRFIFNASKLSILELSDNSFSG----FIPNTFGNLRNLQALRLSNNYLTSSTLELS--- 65
           +   +     +  + LS N+       ++     + ++L+    S+ +      E+    
Sbjct: 23  VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82

Query: 66  --FLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNL 123
              L +L  C  L  +  S+N       +  +  LS       +   N   G        
Sbjct: 83  RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142

Query: 124 TNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNK 183
             L  + +     N     ++   +     G      +      + H+ ++ +  +    
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202

Query: 184 LSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK 243
           +   + E       L++L L  N  T +  +   +    + N         L    G   
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262

Query: 244 IAR-IDSCDLISLISLNLSNNNLSGAIPASL-----EKLSYLKDLNLSFNKLEGE 292
           +       + I L +L L  N +      +L     EK+  L  L L+ N+   E
Sbjct: 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.6 bits (93), Expect = 5e-04
 Identities = 40/295 (13%), Positives = 83/295 (28%), Gaps = 19/295 (6%)

Query: 15  RFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCK 74
           RF      L +  ++       +        +++ + LS N + +         ++++ K
Sbjct: 2   RFSIEGKSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAAR-WLSENIASKK 59

Query: 75  SLTLISFSNNPLDGILPKT--------SVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNL 126
            L +  FS+     +  +                 L    ++         E + +  + 
Sbjct: 60  DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 119

Query: 127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSG 186
                     N  +    G         L  NK   + P          +LE G  K   
Sbjct: 120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 179

Query: 187 SIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIAR 246
              +    L +++++  G        L    L     L                      
Sbjct: 180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF---THLGSSALA 236

Query: 247 IDSCDLISLISLNLSNNNLSGAIPASL------EKLSYLKDLNLSFNKLEGEIPR 295
           I      +L  L L++  LS    A++       +   L+ L L +N++E +  R
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 291

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (108), Expect = 5e-06
 Identities = 38/268 (14%), Positives = 83/268 (30%), Gaps = 33/268 (12%)

Query: 26  LELSDNSFSGFIPNTFGNL--RNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSN 83
           L+L+  +     P+  G L  + + A R   +++         L+   +   +  +  SN
Sbjct: 5   LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQP------LAEHFSPFRVQHMDLSN 55

Query: 84  NPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTI--------IYLGGNK 135
           + ++       +   S  L+   +    +S  I   +   +NL                +
Sbjct: 56  SVIEVSTLHGILSQCSK-LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ 114

Query: 136 LNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNL 195
              S  S L +L            ++ ++        +L       N     +       
Sbjct: 115 TLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRC 174

Query: 196 ASLRILLLGSNELTS--IPLTFWNLKDILYLNFSS-NFFTGPLPLEIGNLKIARIDSCDL 252
            +L  L L  + +        F+ L  + +L+ S          LE+G +          
Sbjct: 175 PNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP--------- 225

Query: 253 ISLISLNLSNNNLSGAIPASLEKLSYLK 280
            +L +L +      G +    E L +L+
Sbjct: 226 -TLKTLQVFGIVPDGTLQLLKEALPHLQ 252

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.7 bits (104), Expect = 2e-05
 Identities = 35/251 (13%), Positives = 77/251 (30%), Gaps = 18/251 (7%)

Query: 7   NNFSGTIPRFIFNASKLSILELSDNSFSG-FIPNTFGNLRNLQALRLSNNYLTSSTLELS 65
            +F        F+  ++  ++LS++      +         LQ L L    L+   +   
Sbjct: 32  RSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVN-- 89

Query: 66  FLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEI---GN 122
              +L+   +L  ++ S           ++ +    L+   +++C        ++     
Sbjct: 90  ---TLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHV 146

Query: 123 LTNLTIIYLGGNKLN----GSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLE 178
              +T + L G + N                +     ++  L+          + L  L 
Sbjct: 147 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS 206

Query: 179 LGG-NKLSGSIPECFNNLASLRIL-LLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLP 236
           L     +          + +L+ L + G     ++ L    L     L  + + FT    
Sbjct: 207 LSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIAR 263

Query: 237 LEIGNLKIARI 247
             IGN K   I
Sbjct: 264 PTIGNKKNQEI 274

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.1 bits (102), Expect = 2e-05
 Identities = 15/56 (26%), Positives = 23/56 (41%), Gaps = 1/56 (1%)

Query: 1   MLQMWENNFSGTIPRFIF-NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNN 55
            L + +NN    +P  +F  AS   IL++S             NL+ L+A    N 
Sbjct: 180 ELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 3e-04
 Identities = 9/60 (15%), Positives = 19/60 (31%)

Query: 100 HSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNK 159
              E       N+     +     +   I+ +   +++      L  L+KL+     N K
Sbjct: 177 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 8e-04
 Identities = 26/219 (11%), Positives = 59/219 (26%), Gaps = 6/219 (2%)

Query: 12  TIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS 71
            IP  +        L              F    +L+ + +S N +        F +   
Sbjct: 22  EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL 131
             +     + +   ++    +         +    + +      I      L ++     
Sbjct: 80  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI- 138

Query: 132 GGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPEC 191
             N       S +G   +   L L  N ++     +   +          N L     + 
Sbjct: 139 --NIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDV 196

Query: 192 FNNLASLRILLLGSNELTSIP-LTFWNLKDILYLNFSSN 229
           F+  +   IL +    + S+P     NLK +   +  + 
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.001
 Identities = 11/85 (12%), Positives = 25/85 (29%), Gaps = 2/85 (2%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSS 60
           +L + +N                 +    +N+      + F        L +S   + S 
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS- 215

Query: 61  TLELSFLSSLSNCKSLTLISFSNNP 85
            L    L +L   ++ +  +    P
Sbjct: 216 -LPSYGLENLKKLRARSTYNLKKLP 239

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.003
 Identities = 7/39 (17%), Positives = 13/39 (33%)

Query: 250 CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNK 288
                 + L++S   +       LE L  L+  +    K
Sbjct: 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 3e-05
 Identities = 16/96 (16%), Positives = 29/96 (30%), Gaps = 4/96 (4%)

Query: 1   MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSG----FIPNTFGNLRNLQALRLSNNY 56
             ++ +              S L +L L+D   S      +  T     +L+ L LSNN 
Sbjct: 349 NNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC 408

Query: 57  LTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPK 92
           L  + +     S       L  +   +      +  
Sbjct: 409 LGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMED 444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 8e-05
 Identities = 15/126 (11%), Positives = 33/126 (26%), Gaps = 26/126 (20%)

Query: 46  NLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYF 105
           ++Q+L +    L+ +      L  L  C+ + L    +  L     K             
Sbjct: 3   DIQSLDIQCEELSDARWA-ELLPLLQQCQVVRL---DDCGLTEARCKD------------ 46

Query: 106 EMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIP 165
                     I   +     L  + L  N+L       + +  +     ++   L+    
Sbjct: 47  ----------ISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

Query: 166 DSICHS 171
                 
Sbjct: 97  TGAGCG 102

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 1e-04
 Identities = 17/93 (18%), Positives = 32/93 (34%), Gaps = 10/93 (10%)

Query: 189 PECFNNLASLRILLLGSNELT-----SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLK 243
                  + LR+L L   +++     S+  T      +  L+ S+N        + G L+
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG-----DAGILQ 416

Query: 244 IARIDSCDLISLISLNLSNNNLSGAIPASLEKL 276
           +          L  L L +   S  +   L+ L
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 2e-04
 Identities = 16/80 (20%), Positives = 28/80 (35%), Gaps = 13/80 (16%)

Query: 220 DILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSG----AIPASLEK 275
           DI  L+            E+ + + A +    L     + L +  L+      I ++L  
Sbjct: 3   DIQSLDIQCE--------ELSDARWAELLPL-LQQCQVVRLDDCGLTEARCKDISSALRV 53

Query: 276 LSYLKDLNLSFNKLEGEIPR 295
              L +LNL  N+L      
Sbjct: 54  NPALAELNLRSNELGDVGVH 73

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 2e-04
 Identities = 19/93 (20%), Positives = 35/93 (37%), Gaps = 13/93 (13%)

Query: 122 NLTNLTIIYLGGNKLNG----SIPSTLGKLQKLQGLGLENNKLEGSIPDSIC-----HSD 172
             + L +++L    ++     S+ +TL     L+ L L NN L  +    +         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 173 ELYKLELGGNKLSGSIPECFNNLA----SLRIL 201
            L +L L     S  + +    L     SLR++
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 3e-04
 Identities = 16/92 (17%), Positives = 35/92 (38%), Gaps = 10/92 (10%)

Query: 125 NLTIIYLGGNKLNGS-IPSTLGKLQKLQGLGLENNKLEG----SIPDSICHSDELYKLEL 179
           ++  + +   +L+ +     L  LQ+ Q + L++  L       I  ++  +  L +L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 180 GGNKLSGSIPECF-----NNLASLRILLLGSN 206
             N+L      C           ++ L L + 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 0.001
 Identities = 12/88 (13%), Positives = 24/88 (27%), Gaps = 5/88 (5%)

Query: 2  LQMWENNFSGT-IPRFIFNASKLSILELSDNSFSG----FIPNTFGNLRNLQALRLSNNY 56
          L +     S       +    +  ++ L D   +      I +       L  L L +N 
Sbjct: 7  LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 57 LTSSTLELSFLSSLSNCKSLTLISFSNN 84
          L    +        +    +  +S  N 
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.003
 Identities = 12/46 (26%), Positives = 22/46 (47%), Gaps = 4/46 (8%)

Query: 254 SLISLNLSNNNLSG----AIPASLEKLSYLKDLNLSFNKLEGEIPR 295
            L  L L++ ++S     ++ A+L     L++L+LS N L      
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 415

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.004
 Identities = 14/78 (17%), Positives = 27/78 (34%), Gaps = 9/78 (11%)

Query: 100 HSLEYFEMAYCNVSG----GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQK-----L 150
             L    +A C+VS      +   +    +L  + L  N L  +    L +  +     L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 151 QGLGLENNKLEGSIPDSI 168
           + L L +      + D +
Sbjct: 429 EQLVLYDIYWSEEMEDRL 446

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 8e-05
 Identities = 40/210 (19%), Positives = 80/210 (38%), Gaps = 22/210 (10%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
             ++     L   S +  +      L ++  +  +N+ + S       +  +    ++T 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-------VQGIQYLPNVTK 72

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG 138
           +  + N L  I     + NL +    F            +++  L +L++ + G + +NG
Sbjct: 73  LFLNGNKLTDI---KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDING 129

Query: 139 SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASL 198
                L  L +L+ L L NNK+      S     +   LE   N++S  +P     L  L
Sbjct: 130 -----LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLE--DNQISDIVP--LAGLTKL 180

Query: 199 RILLLGSNELTSIPLTFWNLKDILYLNFSS 228
           + L L  N ++ +      LK++  L   S
Sbjct: 181 QNLYLSKNHISDLR-ALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.1 bits (95), Expect = 1e-04
 Identities = 28/182 (15%), Positives = 50/182 (27%), Gaps = 15/182 (8%)

Query: 111 NVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDS--- 167
           +V+  + +    L ++  I    + +       +  L  +  L L  NKL    P +   
Sbjct: 35  SVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLK 90

Query: 168 ----ICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILY 223
               +   +   K       L         +     I  L             N    + 
Sbjct: 91  NLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDIT 150

Query: 224 LNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLN 283
           +             +     I  +    L  L +L LS N++S     +L  L  L  L 
Sbjct: 151 VLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLE 206

Query: 284 LS 285
           L 
Sbjct: 207 LF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 35/189 (18%), Positives = 61/189 (32%), Gaps = 19/189 (10%)

Query: 116 IPEEIG------NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSIC 169
           +P  I                L    +  ++  T  +L  +  +   N+ ++      I 
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQ 65

Query: 170 HSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSN 229
           +   + KL L GNKL+   P           L     +  S       LK +   +   +
Sbjct: 66  YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS 125

Query: 230 FFTG-------PLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDL 282
              G              N          L  L +L+L +N +S  +P  L  L+ L++L
Sbjct: 126 DINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL 183

Query: 283 NLSFNKLEG 291
            LS N +  
Sbjct: 184 YLSKNHISD 192

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 1e-04
 Identities = 31/194 (15%), Positives = 59/194 (30%), Gaps = 21/194 (10%)

Query: 19  NASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTL 78
             ++     L   + +  +  +  +L  +  L+     + S       +  +    +LT 
Sbjct: 16  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-------IDGVEYLNNLTQ 66

Query: 79  ISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNG 138
           I+FSNN L  I            L+        +                   G    N 
Sbjct: 67  INFSNNQLTDI----------TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNN 116

Query: 139 SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASL 198
            I              LE +    S   ++     L +L    N+++   P    NL +L
Sbjct: 117 QITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTL 174

Query: 199 RILLLGSNELTSIP 212
             L + SN+++ I 
Sbjct: 175 ERLDISSNKVSDIS 188

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (92), Expect = 2e-04
 Identities = 24/139 (17%), Positives = 44/139 (31%), Gaps = 12/139 (8%)

Query: 18  FNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLT 77
            NA +   L+L        I N    L    A+  S+N +         L      + L 
Sbjct: 15  TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-------KLDGFPLLRRLK 66

Query: 78  LISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNK-- 135
            +  +NN +  I             E        V  G  + + +L +LT + +  N   
Sbjct: 67  TLLVNNNRICRIGEGLDQAL-PDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125

Query: 136 -LNGSIPSTLGKLQKLQGL 153
                    + K+ +++ L
Sbjct: 126 NKKHYRLYVIYKVPQVRVL 144

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.0 bits (89), Expect = 7e-04
 Identities = 35/182 (19%), Positives = 63/182 (34%), Gaps = 12/182 (6%)

Query: 72  NCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL 131
           +C    L          I   T+   L+ +      +            G L +L  + L
Sbjct: 14  DCTGRGLKEIP----RDIPLHTTELLLNDNELGRISSDGL--------FGRLPHLVKLEL 61

Query: 132 GGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPEC 191
             N+L G  P+       +Q L L  NK++           +L  L L  N++S  +P  
Sbjct: 62  KRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGS 121

Query: 192 FNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCD 251
           F +L SL  L L SN         W  + +   + +        P ++ +++I  +   +
Sbjct: 122 FEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSE 181

Query: 252 LI 253
             
Sbjct: 182 FK 183

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 0.001
 Identities = 26/140 (18%), Positives = 46/140 (32%), Gaps = 11/140 (7%)

Query: 155 LENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLT 214
           L+  ++E  +   +    +  +  L    L               +L   S+   ++ + 
Sbjct: 4   LKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAATLRII 60

Query: 215 FWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLE 274
             N+ ++L LN S+N       +     K          +L  LNLS N L         
Sbjct: 61  EENIPELLSLNLSNNRLYRLDDMSSIVQK--------APNLKILNLSGNELKSERELDKI 112

Query: 275 KLSYLKDLNLSFNKLEGEIP 294
           K   L++L L  N L     
Sbjct: 113 KGLKLEELWLDGNSLSDTFR 132

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (85), Expect = 0.002
 Identities = 24/132 (18%), Positives = 38/132 (28%), Gaps = 12/132 (9%)

Query: 37  IPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVG 96
           +        +     L    L S       L + +    L   S     L  I       
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLRS----DPDLVAQNIDVVLNRRSSMAATLRIIEENIP-- 65

Query: 97  NLSHSLEYFEMAYCNVSG--GIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLG 154
                L    ++   +     +   +    NL I+ L GN+L         K  KL+ L 
Sbjct: 66  ----ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELW 121

Query: 155 LENNKLEGSIPD 166
           L+ N L  +  D
Sbjct: 122 LDGNSLSDTFRD 133

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 34/187 (18%), Positives = 59/187 (31%), Gaps = 31/187 (16%)

Query: 21  SKLSILELSDNSFSGFIP------NTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCK 74
             +   E       G IP       T   L+  + L LS N +         +SSLS  +
Sbjct: 18  KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-------ISSLSGME 70

Query: 75  SLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGN 134
           +L ++S   N +  I    +V +    L        ++SG        +  ++   +   
Sbjct: 71  NLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITNW 130

Query: 135 KLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNN 194
                + +      KL+ L L  N L     ++              N  S    E    
Sbjct: 131 GEIDKLAAL----DKLEDLLLAGNPLYNDYKEN--------------NATSEYRIEVVKR 172

Query: 195 LASLRIL 201
           L +L+ L
Sbjct: 173 LPNLKKL 179

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	678
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.94
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.92
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.92
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.83
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.82
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.81
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.8
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.8
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.79
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.78
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.77
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.77
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.77
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.77
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.75
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.67
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.62
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.6
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.6
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.58
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.58
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.57
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.56
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.54
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.51
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.47
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.45
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.43
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.39
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.62
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.55
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.45
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.09
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.08
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.91
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.75
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.58
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.38
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.69
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.16
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.13

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-52  Score=413.96  Aligned_cols=262  Identities=26%  Similarity=0.419  Sum_probs=207.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecc--cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||+||+|+.+  ..||||+++..  .....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            578999999999999999999874  35999998644  23456788999999999999999999998765 45789999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+++|+|.+++...+..+++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+........
T Consensus        84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999999877777999999999999999999999   899999999999999999999999999999876544444


Q ss_pred             ceeecccCCccccCccccCC---CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccC
Q 005760          549 TIQTQTLATIGYMAPEYGKE---GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLL  625 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  625 (678)
                      .......||+.|+|||++.+   +.++.++|||||||++|||+||+.||.+................+.....       
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~-------  233 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK-------  233 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGG-------
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchh-------
Confidence            44456789999999998864   35889999999999999999999999764332211111111111100000       


Q ss_pred             CccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          626 SREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       626 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                              .+..+++++.+++.+||+.||++||||+|+++.|+.+.++
T Consensus       234 --------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         234 --------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             --------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence                    0123566799999999999999999999999999988764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-52  Score=411.43  Aligned_cols=258  Identities=27%  Similarity=0.424  Sum_probs=204.5

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      ++|++.+.||+|+||+||+|++.+++.||||+++.. ....+++.+|++++++++||||++++|++.+++..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            578889999999999999999988899999998754 3345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      +|+|.+++......+++..+..++.|||.||+|||   +++|+||||||+||+++.++.+||+|||+++....... ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS  159 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence            99999999887777899999999999999999999   99999999999999999999999999999987643322 223


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccchh
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDIN  631 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  631 (678)
                      ....||+.|+|||++.++.++.++|||||||++|||+|++.|+...... ......+....     ....|         
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~-----~~~~p---------  224 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGF-----RLYKP---------  224 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHHHTC-----CCCCC---------
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHHHhcC-----CCCCc---------
Confidence            3467899999999999999999999999999999999965554332211 11111111110     01111         


Q ss_pred             hHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          632 FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       632 ~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                          ..+++++.+++.+||+.||++||||+|+++.|+++.++
T Consensus       225 ----~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         225 ----RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             ----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence                12445688999999999999999999999999999764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-51  Score=405.80  Aligned_cols=252  Identities=23%  Similarity=0.333  Sum_probs=206.4

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.... .+..+.+.+|+++++.++||||+++++++.+++..|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            5789999999999999999986 479999999996543 23456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++|+|.+++.... .+++..+..++.|+++||+|||   +++|+||||||+|||++.++.+||+|||+|+.........
T Consensus        85 ~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~  160 (271)
T d1nvra_          85 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  160 (271)
T ss_dssp             CTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             cCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence            99999999997654 5899999999999999999999   9999999999999999999999999999998765443334


Q ss_pred             eeecccCCccccCccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                      ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||............+......            .. 
T Consensus       161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~------------~~-  227 (271)
T d1nvra_         161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------------LN-  227 (271)
T ss_dssp             CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT------------ST-
T ss_pred             cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------CC-
Confidence            4456789999999999988776 578999999999999999999997644433222222111000            00 


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           ....+++++.+++.+||+.||++|||++|+++
T Consensus       228 -----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 -----PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                 00123456889999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-50  Score=403.63  Aligned_cols=250  Identities=28%  Similarity=0.359  Sum_probs=209.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+++++.++|||||++++++.+++..|+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            35799999999999999999985 57999999999876655667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++|+|.+++...  .+++..+..++.||+.||+|||   ++||+||||||+|||++.+|++||+|||+|+......  .
T Consensus        99 ~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~  171 (293)
T d1yhwa1          99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S  171 (293)
T ss_dssp             CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred             cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc--c
Confidence            9999999988765  3899999999999999999999   9999999999999999999999999999998764332  2


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      ......||+.|+|||++.++.++.++||||+||++|||++|+.||.+...... .........+    ....        
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~----~~~~--------  238 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTP----ELQN--------  238 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSC----CCSS--------
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHHHhCCCC----CCCC--------
Confidence            33456799999999999999999999999999999999999999965332211 1111111000    0000        


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           +..+++++.+++.+||++||++|||++|+++
T Consensus       239 -----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         239 -----PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 1124566889999999999999999999975

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=398.17  Aligned_cols=253  Identities=24%  Similarity=0.424  Sum_probs=214.3

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecC
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMP  471 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  471 (678)
                      ++|++.+.||+|+||+||+|++++++.||||+++... ...+++.+|+.++++++||||++++|++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            6899999999999999999999889999999997543 345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCccee
Q 005760          472 HGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQ  551 (678)
Q Consensus       472 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  551 (678)
                      +|+|.+++......+++..+.+++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++...... ....
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~  158 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSS  158 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-ceee
Confidence            99999998877777999999999999999999999   8999999999999999999999999999998765433 2234


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccch
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI  630 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  630 (678)
                      ....+|+.|+|||++.++.++.++|||||||++|||+| |+.||......+  ....+...     .....|        
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~-----~~~~~p--------  223 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQG-----LRLYRP--------  223 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTT-----CCCCCC--------
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhC-----CCCCCc--------
Confidence            45679999999999999999999999999999999998 788987643322  11111110     011111        


Q ss_pred             hhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       631 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                           ..+++++.+++.+||+.||++|||++|+++.|.+
T Consensus       224 -----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         224 -----HLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                 1234568899999999999999999999998864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=398.76  Aligned_cols=245  Identities=26%  Similarity=0.369  Sum_probs=205.8

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||+||+|+.+ +++.||+|++...   .....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57899999999999999999864 7899999998643   2344567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.+++.... .+++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            9999999999998765 4899999999999999999999   999999999999999999999999999999765422  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ......+..       ...|     
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~-------~~~p-----  224 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-TYKRISRVE-------FTFP-----  224 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHTTC-------CCCC-----
T ss_pred             --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-HHHHHHcCC-------CCCC-----
Confidence              2345679999999999999999999999999999999999999997532211 111111100       0001     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              ..+++++.+++.+||++||++|||++|+++
T Consensus       225 --------~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         225 --------DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                    123456889999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-50  Score=401.79  Aligned_cols=252  Identities=24%  Similarity=0.339  Sum_probs=209.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .+.|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|+++++.++|||||++++++.+++..++||||
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            35688999999999999999985 47899999999876666778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +++|+|.+++.+....+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.....  ..
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~  165 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ  165 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HH
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--cc
Confidence            9999999998776667999999999999999999999   999999999999999999999999999999754321  12


Q ss_pred             eeecccCCccccCccccC-----CCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          550 IQTQTLATIGYMAPEYGK-----EGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ......||+.|+|||++.     +..|+.++||||+||++|||++|+.||.+....+. .........+    .+.    
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~~~~~~----~~~----  236 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPP----TLA----  236 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHHSCCC----CCS----
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcCCCC----CCC----
Confidence            234567999999999873     45689999999999999999999999976433221 1111111100    000    


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               .+..+++++.+++.+||+.||++|||++|+++
T Consensus       237 ---------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         237 ---------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ---------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     01134566889999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-50  Score=402.38  Aligned_cols=262  Identities=23%  Similarity=0.371  Sum_probs=213.6

Q ss_pred             cCCCCCc-cccCCCceeEEEEEeC---CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          392 DGFSENN-LIGRGSFGSVFKARLG---DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       392 ~~~~~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ++|.+.. .||+|+||+||+|.++   ++..||||+++.... ...+.|.+|++++++++|||||+++|++.+ +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4455566 4999999999999753   456899999965433 345788999999999999999999999875 457899


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++|+|.+++...+..+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus        87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            9999999999998877667999999999999999999999   8999999999999999999999999999998775433


Q ss_pred             Cc-ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          547 QS-TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       547 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      .. .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....  .....+.....        +. 
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~~~~--------~~-  232 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGKR--------ME-  232 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTCC--------CC-
T ss_pred             cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC--------CC-
Confidence            22 22344568999999999999999999999999999999998 89999764322  12222211000        00 


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHhhc
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLLRN  677 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~  677 (678)
                               .+..+++++.+|+.+||+.||++||||.++++.|+.+..++...
T Consensus       233 ---------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~  276 (285)
T d1u59a_         233 ---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  276 (285)
T ss_dssp             ---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             ---------CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence                     01235567899999999999999999999999999988776554

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=402.19  Aligned_cols=258  Identities=24%  Similarity=0.415  Sum_probs=210.1

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ..++|++.+.||+|+||.||+|.+++++.||||+++... ...+.+.+|++++++++|||||+++|++.+ +..++||||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence            346788899999999999999999888999999997543 345779999999999999999999998865 457899999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++|+|.+++.... ..+++..+..++.||++||.|||   +++|+||||||+||+++.++.+||+|||+|+..... ..
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~  164 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EY  164 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CE
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC-cc
Confidence            99999999876443 25899999999999999999999   899999999999999999999999999999876533 23


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCcc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRE  628 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  628 (678)
                      .......+|+.|+|||++.++.++.++|||||||++|||+||+.|+........ ....+....     ....|      
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-~~~~i~~~~-----~~~~p------  232 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-VIQNLERGY-----RMVRP------  232 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTC-----CCCCC------
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhcC-----CCCCc------
Confidence            334456789999999999989999999999999999999997666543222111 111111100     00011      


Q ss_pred             chhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          629 DINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       629 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                             ..+++++.+++.+||+.||++||||+|+++.|+.+-.
T Consensus       233 -------~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         233 -------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence                   1345668899999999999999999999999998764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-50  Score=408.68  Aligned_cols=258  Identities=24%  Similarity=0.425  Sum_probs=200.7

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CC---cEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DG---MEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ++|++.+.||+|+||+||+|.++ ++   ..||||.+..... ...+.|.+|++++++++|||||+++|++.+++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            45777899999999999999864 33   3589998865433 3456799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++|+|.+++......+++.++..++.||++||+|||   +++|+||||||+|||++.++++||+|||+++......
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            9999999999999887767999999999999999999999   8999999999999999999999999999998765332


Q ss_pred             Cc---ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          547 QS---TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       547 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ..   .......+|+.|+|||.+.++.++.++|||||||++|||+| |+.||.+....  .....+.....        +
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~~~--------~  252 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDYR--------L  252 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCC--------C
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC--------C
Confidence            21   12233567899999999999999999999999999999998 89998763322  12121111000        0


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                                ..+..++.++.+++.+||+.||++||||.|+++.|+++.+
T Consensus       253 ----------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         253 ----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             ----------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                      0012355678999999999999999999999999998864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-49  Score=399.86  Aligned_cols=258  Identities=24%  Similarity=0.380  Sum_probs=212.5

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ..++|++.+.||+|+||+||+|.++ +++.||||+++... ...+++.+|++++++++|||||++++++.+++..++|||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            4567888999999999999999864 68999999987543 345779999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSS-NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+++|+|.+++... ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+..... .
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-~  169 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-T  169 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-S
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCC-C
Confidence            99999999999754 446899999999999999999999   899999999999999999999999999999876433 2


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      ........+++.|+|||++.++.++.++|||||||++|||++|+.||....... .....+....        .+.    
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~~i~~~~--------~~~----  236 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDY--------RME----  236 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHTTC--------CCC----
T ss_pred             ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-HHHHHHhcCC--------CCC----
Confidence            333445568999999999999999999999999999999999877764322211 1111111100        000    


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                            .+..+++++.+|+.+||+.||++|||++|+++.|+.+.
T Consensus       237 ------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         237 ------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                  01134566899999999999999999999999998874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=397.20  Aligned_cols=259  Identities=25%  Similarity=0.440  Sum_probs=203.1

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCC-----cEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDG-----MEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      +.|+..+.||+|+||.||+|.++..     ..||||++..... .....|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            5678889999999999999975422     4799999865433 334578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+.++++.+++......+++..+..++.||+.|++|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999999887777999999999999999999999   999999999999999999999999999999876433


Q ss_pred             CC-cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          546 DQ-STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       546 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      .. ........||+.|+|||++.++.++.++|||||||++|||++|+.|+....... .....+....        .+. 
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~~~i~~~~--------~~~-  233 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAINDGF--------RLP-  233 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHHHHHTTC--------CCC-
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHHHHHhccC--------CCC-
Confidence            22 223345568999999999999999999999999999999999776654322211 1111111100        000 


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                               .+..++.++.+++.+||+.||++||||.|+++.|+.+.+
T Consensus       234 ---------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         234 ---------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ---------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence                     011245668899999999999999999999999998864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=399.77  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=203.7

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++...   .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5699999999999999999986 57999999999653   2334567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+||++++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999988765 4899999999999999999999   99999999999999999999999999999987754444


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... ......+.    .   ..-|     
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~----~---~~~p-----  230 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-IFQKIIKL----E---YDFP-----  230 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTT----C---CCCC-----
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-HHHHHHcC----C---CCCC-----
Confidence            444455679999999999999999999999999999999999999997532211 11111110    0   0001     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                              ..+++++.+|+.+||+.||++|||++|+++
T Consensus       231 --------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         231 --------EKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             --------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             --------ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                    123456889999999999999999999754

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=405.10  Aligned_cols=258  Identities=23%  Similarity=0.377  Sum_probs=209.0

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeCC------CcEEEEEEeecc-cCchhhhHHHHHHHHHhC-CCccceeeeeeeecCC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLGD------GMEVAMKVFNLQ-YGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEE  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  461 (678)
                      ..++|++.+.||+|+||+||+|+...      ...||+|.+... .......+.+|+.+++++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            34678999999999999999997532      236999998543 234456788999999988 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCC
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNY----------------------ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLK  519 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~  519 (678)
                      ..++||||+++|+|.++++..+.                      .+++..+..++.||+.||+|||   +++|+|||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCc
Confidence            99999999999999999976532                      4788999999999999999999   8999999999


Q ss_pred             CCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCccc
Q 005760          520 PSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIF  598 (678)
Q Consensus       520 ~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~  598 (678)
                      |+||+++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |+.||.+..
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987655444444556678999999999999999999999999999999998 899987643


Q ss_pred             CCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHH
Q 005760          599 NGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLK  669 (678)
Q Consensus       599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~  669 (678)
                      ... .+...+.....        +.          .+..+++++.+|+.+||+.||++|||++||++.|..
T Consensus       272 ~~~-~~~~~~~~~~~--------~~----------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         272 VDA-NFYKLIQNGFK--------MD----------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CSH-HHHHHHHTTCC--------CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHH-HHHHHHhcCCC--------CC----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            322 22222221100        00          011345678999999999999999999999999863

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=387.17  Aligned_cols=244  Identities=26%  Similarity=0.407  Sum_probs=196.2

Q ss_pred             CCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeec----CCeEEEEE
Q 005760          395 SENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSN----EEFKALVL  467 (678)
Q Consensus       395 ~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~  467 (678)
                      ++.+.||+|+||+||+|.. .+++.||+|++....  ....+.+.+|++++++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            5667899999999999985 478999999987543  2345678899999999999999999999854    45679999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--eEEcCCCCCCeeec-CCCcEEEEeeccccccCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQ--VIHCDLKPSNVLLD-DNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dl~~~Nill~-~~~~~kl~Dfg~~~~~~~  544 (678)
                      ||+++|+|.+++.+.. .+++..+..++.||++||+|||   +++  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999998765 4899999999999999999999   777  99999999999996 589999999999976432


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      .    ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.+................+..         
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~---------  233 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS---------  233 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG---------
T ss_pred             C----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcc---------
Confidence            2    2235679999999998865 6999999999999999999999999753322211111111110000         


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               ....+++++.+++.+||++||++|||++|+++
T Consensus       234 ---------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         234 ---------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ---------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                     01123456889999999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-49  Score=404.99  Aligned_cols=270  Identities=21%  Similarity=0.299  Sum_probs=207.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+.+++.++|||||+++++|.+++..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            56899999999999999999985 579999999997543 3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYS-AQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      |+++|+|.+++.+.+ .+++..+..++.|++.||.|||   + ++|+||||||+|||++.+|.+||+|||+|+.....  
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999998765 4899999999999999999999   6 48999999999999999999999999999865322  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhh--cccCC----------c
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN--DWLPI----------S  615 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~--~~~~~----------~  615 (678)
                        ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.............  .....          .
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence              223468999999999999999999999999999999999999999763322111100000  00000          0


Q ss_pred             cc-ccccCccCCccchhhHHH-----------HHHHHHHHHHHhhccccCcCCCCCHHHHHH--HHHH
Q 005760          616 TK-EIVDPNLLSREDINFVAK-----------EQCVSFVFNVAMECTVESPEQRINAKEIVT--KLLK  669 (678)
Q Consensus       616 ~~-~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~l~~~cl~~dP~~Rps~~ell~--~L~~  669 (678)
                      .. ...+.. ......+....           ...+.++.+++.+||++||++||||+|+++  .+++
T Consensus       237 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         237 LSSYGMDSR-PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             ccccccccc-cchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence            00 000000 00000000000           013467899999999999999999999987  3544

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=392.96  Aligned_cols=252  Identities=23%  Similarity=0.338  Sum_probs=191.5

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeec--CCeEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSN--EEFKALV  466 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  466 (678)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|++....  ....+.+.+|++++++++|||||++++++.+  .+..|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5799999999999999999985 479999999986543  2345678899999999999999999998864  4568999


Q ss_pred             EEecCCCCHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          467 LEYMPHGSLEKYLHS---SNYILDIYQRLNIMIDVASALEYLHFGY--SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      |||+++|+|.+++.+   .+..+++..++.++.|++.||.|||+..  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            999999999999864   2346999999999999999999999311  13499999999999999999999999999987


Q ss_pred             cCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....  .....+...   ....+  
T Consensus       164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~~i~~~---~~~~~--  234 (269)
T d2java1         164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREG---KFRRI--  234 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHT---CCCCC--
T ss_pred             cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHHHHHcC---CCCCC--
Confidence            64322  2234567999999999999999999999999999999999999999753321  111111110   00000  


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      +             ..+++++.+++.+||+.||++|||++|+++
T Consensus       235 ~-------------~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         235 P-------------YRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             C-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-------------cccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            0             124556889999999999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-49  Score=393.22  Aligned_cols=252  Identities=24%  Similarity=0.370  Sum_probs=202.3

Q ss_pred             ccccCCCceeEEEEEeC---CCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEecCC
Q 005760          398 NLIGRGSFGSVFKARLG---DGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYMPH  472 (678)
Q Consensus       398 ~~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  472 (678)
                      +.||+|+||+||+|.++   .++.||||+++...  ....+.+.+|++++++++|||||+++++|.++ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            57999999999999753   35789999986432  33457799999999999999999999999654 57899999999


Q ss_pred             CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc-cee
Q 005760          473 GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS-TIQ  551 (678)
Q Consensus       473 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~  551 (678)
                      |+|.++++... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+|++|||+++........ ...
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999998765 4899999999999999999999   899999999999999999999999999999876543322 223


Q ss_pred             ecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCccch
Q 005760          552 TQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDI  630 (678)
Q Consensus       552 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  630 (678)
                      ....||+.|+|||.+.++.++.++|||||||++|||++ |+.||.+....  .....+.....        +.       
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~~--------~~-------  230 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGER--------MG-------  230 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTCC--------CC-------
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcCCC--------CC-------
Confidence            44578999999999999999999999999999999998 89999763322  11111111000        00       


Q ss_pred             hhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          631 NFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       631 ~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                         .+..+++++.+|+.+||+.||++|||++|++++|+.+-.+.
T Consensus       231 ---~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  271 (277)
T d1xbba_         231 ---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  271 (277)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             ---CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence               01235567899999999999999999999999999876543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.7e-49  Score=397.00  Aligned_cols=252  Identities=20%  Similarity=0.301  Sum_probs=191.3

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ..+.|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4567999999999999999999864 78999999997543 223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec---CCCcEEEEeeccccccCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~---~~~~~kl~Dfg~~~~~~~  544 (678)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+||++.   +++.+||+|||+|+....
T Consensus        87 E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          87 QLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             eccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            9999999999997654 5999999999999999999999   99999999999999994   578999999999986542


Q ss_pred             CCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      .   .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. ..........     ...+  
T Consensus       163 ~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~i~~~~~~-----~~~~--  231 (307)
T d1a06a_         163 G---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL-FEQILKAEYE-----FDSP--  231 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHTTCCC-----CCTT--
T ss_pred             C---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHhccCCC-----CCCc--
Confidence            2   223346799999999999999999999999999999999999999976332211 1111111000     0000  


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               ....+++++.+++.+||++||++|||++|+++
T Consensus       232 ---------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         232 ---------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ---------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                     01124566889999999999999999999987

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-48  Score=401.79  Aligned_cols=252  Identities=19%  Similarity=0.274  Sum_probs=209.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      -++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+++.++|||||++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            45899999999999999999985 47999999999765555567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec--CCCcEEEEeeccccccCCCCC
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~--~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      +++|+|.+++......+++..+..++.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+++.....  
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~--  179 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--  179 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT--
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccc--
Confidence            9999999999766667999999999999999999999   99999999999999995  4689999999999876432  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ...........      .++     
T Consensus       180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~------~~~-----  246 (350)
T d1koaa2         180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWN------MDD-----  246 (350)
T ss_dssp             -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC------SCC-----
T ss_pred             -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC------CCc-----
Confidence             22345679999999999999999999999999999999999999997532211 11111111000      000     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           .....+++++.+|+.+||++||++|||++|+++
T Consensus       247 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         247 -----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             -----GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 001124556889999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.9e-48  Score=396.94  Aligned_cols=252  Identities=20%  Similarity=0.300  Sum_probs=209.6

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+++++.++|||||++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            45799999999999999999985 57999999999765545566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec--CCCcEEEEeeccccccCCCCC
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD--DNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~--~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      +++|+|.+++......+++..+..++.||+.||+|||   ++||+||||||+|||++  .++.+||+|||+|+...... 
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            9999999988777667999999999999999999999   99999999999999997  67899999999998775332 


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        ......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. +.........      ..+..   
T Consensus       184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~~~------~~~~~---  251 (352)
T d1koba_         184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-LQNVKRCDWE------FDEDA---  251 (352)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHHCCCC------CCSST---
T ss_pred             --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCC------CCccc---
Confidence              23456789999999999999999999999999999999999999975332211 1111111000      00000   


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                             ...+++++.+|+.+||++||++|||++|+++
T Consensus       252 -------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         252 -------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             -------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -------ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   0123556889999999999999999999986

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=387.01  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=206.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC------chhhhHHHHHHHHHhCCCccceeeeeeeecCCeE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG------RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFK  463 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  463 (678)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.....      ...+.+.+|+++++.++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46799999999999999999986 5799999999965321      2356789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC----cEEEEeeccc
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM----VAHLSDFGIA  539 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~----~~kl~Dfg~~  539 (678)
                      |+||||+++|+|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++    .+|++|||++
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999998765 4899999999999999999999   99999999999999998776    5999999999


Q ss_pred             cccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccc
Q 005760          540 KLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI  619 (678)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (678)
                      +......   ......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ ..........       
T Consensus       165 ~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~~-------  233 (293)
T d1jksa_         165 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLANVSAVNY-------  233 (293)
T ss_dssp             EECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHTTCC-------
T ss_pred             hhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH-HHHHHHhcCC-------
Confidence            8764322   2345578999999999999999999999999999999999999997532211 1111111000       


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                               .........+++++.+++.+||+.||++|||++|+++
T Consensus       234 ---------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 ---------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ---------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                     0001112235667889999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-48  Score=393.46  Aligned_cols=245  Identities=27%  Similarity=0.361  Sum_probs=200.2

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      +.|+..+.||+|+||+||+|+. .+|+.||||++.....   ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3588899999999999999985 5789999999975432   33466889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+++|++..++.... .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+....   
T Consensus        95 E~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             ECCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            9999999877665543 5899999999999999999999   99999999999999999999999999999976532   


Q ss_pred             cceeecccCCccccCccccCC---CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          548 STIQTQTLATIGYMAPEYGKE---GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                         .....||+.|+|||++.+   +.|+.++|||||||++|||++|+.||.+..... ..........         +..
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~---------~~~  234 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNES---------PAL  234 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCC---------CCC
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCC---------CCC
Confidence               234579999999998754   458999999999999999999999997532211 1111111100         000


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..         ..+++++.+|+.+||++||++|||++|+++
T Consensus       235 ~~---------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         235 QS---------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             SC---------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC---------CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            00         123456889999999999999999999975

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-48  Score=394.59  Aligned_cols=258  Identities=24%  Similarity=0.392  Sum_probs=205.8

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCc----EEEEEEeecc-cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGM----EVAMKVFNLQ-YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      ++|++.+.||+|+||+||+|.+. +|+    +||+|.+... ..+..+.+.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46899999999999999999753 444    5888888543 334567899999999999999999999999875 4678


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ++||+.+|+|.+++......+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            89999999999999888778999999999999999999999   899999999999999999999999999999887654


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      ..........||+.|+|||++.++.++.++|||||||++|||+| |..||.+....+  +...+.....     ..    
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~~~-----~~----  233 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGER-----LP----  233 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHTCC-----CC----
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCC-----CC----
Confidence            44444455678999999999999999999999999999999999 788886543222  2222211000     00    


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                               .+..+++++.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       234 ---------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         234 ---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             ---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ---------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                     0123456688999999999999999999999999988643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-48  Score=386.75  Aligned_cols=259  Identities=23%  Similarity=0.373  Sum_probs=201.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC----CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG----DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKAL  465 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  465 (678)
                      .++|++.+.||+|+||.||+|.+.    .+..||||.++.... ...+.+.+|+++++.++||||+++++++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            467899999999999999999753    245688998854332 345678999999999999999999999964 56899


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCC
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~  545 (678)
                      ||||+++|+|.+++......+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999998877777999999999999999999999   999999999999999999999999999999865432


Q ss_pred             CCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCcc
Q 005760          546 DQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNL  624 (678)
Q Consensus       546 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  624 (678)
                      . ........+|+.|+|||++.++.++.++|||||||++|||++ |.+||.+....+  ....+.....        +. 
T Consensus       162 ~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i~~~~~--------~~-  229 (273)
T d1mp8a_         162 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIENGER--------LP-  229 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCC--------CC-
T ss_pred             c-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCC--------CC-
Confidence            2 223345568999999999999999999999999999999998 888887643322  1111111000        00 


Q ss_pred             CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          625 LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       625 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                               .+..+++++.+|+.+||+.||++|||+.|+++.|+++.++-
T Consensus       230 ---------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         230 ---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                     01134567899999999999999999999999999997653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-48  Score=389.43  Aligned_cols=256  Identities=25%  Similarity=0.418  Sum_probs=202.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      .++|++.+.||+|+||.||+|..++++.||||++... ....+.|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            4679999999999999999999888889999999654 3345789999999999999999999999865 4578999999


Q ss_pred             CCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          471 PHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       471 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      ++|+|.+++.... ..+++.++..++.||+.||+|||   +++|+||||||+|||++.++++||+|||+++...... ..
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-ce
Confidence            9999999887542 35899999999999999999999   8999999999999999999999999999998664332 23


Q ss_pred             eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCccc
Q 005760          550 IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSRED  629 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  629 (678)
                      ......+|+.|+|||++..+.++.++|||||||++|||++|+.|+..................         +.      
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~---------~~------  234 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---------MP------  234 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------CC------
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------CC------
Confidence            344567899999999999999999999999999999999977776442222211111111100         00      


Q ss_pred             hhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          630 INFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       630 ~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                          .+..+++++.+++.+||+.||++||+++||+++|+.+.
T Consensus       235 ----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         235 ----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ----CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence                01134566889999999999999999999999888653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.2e-48  Score=391.64  Aligned_cols=262  Identities=26%  Similarity=0.406  Sum_probs=213.1

Q ss_pred             HHHhhcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeec
Q 005760          387 LCRATDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSN  459 (678)
Q Consensus       387 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  459 (678)
                      ++...++|++.+.||+|+||+||+|+.+      +++.||||++..... ...+++.+|++++++++||||+++++++.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3446788999999999999999999753      467899999875433 345678999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhhCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEc
Q 005760          460 EEFKALVLEYMPHGSLEKYLHSSN-----------------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHC  516 (678)
Q Consensus       460 ~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  516 (678)
                      .+..++||||+++|+|.++++...                       ..+++..+..++.|++.||+|||   +++|+||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEee
Confidence            999999999999999999997532                       14788899999999999999999   9999999


Q ss_pred             CCCCCCeeecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCC-CCCC
Q 005760          517 DLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK-KPTD  595 (678)
Q Consensus       517 dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~-~p~~  595 (678)
                      ||||+||+++.++.+||+|||+|+...........+...+++.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999998765544444555677899999999999999999999999999999999986 5665


Q ss_pred             cccCCccchhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          596 EIFNGEMTLKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                      +....  .....+.....        +.          .+..+++++.+|+.+||+.||++||||.||+++|++|.
T Consensus       245 ~~~~~--e~~~~v~~~~~--------~~----------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHE--EVIYYVRDGNI--------LA----------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHH--HHHHHHHTTCC--------CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHH--HHHHHHHcCCC--------CC----------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            43222  12222221100        00          01134556889999999999999999999999999874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-48  Score=382.66  Aligned_cols=251  Identities=28%  Similarity=0.434  Sum_probs=198.7

Q ss_pred             hcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeec-CCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN-EEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  469 (678)
                      .++|++.+.||+|+||.||+|+. .|+.||||+++..  ...+.+.+|++++++++||||++++|++.+ .+..++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            35678889999999999999998 4789999999643  345789999999999999999999998854 5668999999


Q ss_pred             cCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          470 MPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       470 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      +++|+|.+++.... ..+++..+.+++.||+.||+|||   +.+|+||||||+||+++.++.+|++|||+++.....   
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC---
Confidence            99999999997543 35899999999999999999999   899999999999999999999999999999765322   


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                        .....+++.|+|||++.++.++.++|||||||++|||+| |+.||......  .....+....        .+..   
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~~--------~~~~---  221 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGY--------KMDA---  221 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTTC--------CCCC---
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC--------CCCC---
Confidence              233457899999999999999999999999999999998 67777653222  2222221100        0000   


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                             +..+++++.+++.+||+.||++||||.|++++|+.++.
T Consensus       222 -------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         222 -------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                   11234568899999999999999999999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-47  Score=389.00  Aligned_cols=248  Identities=23%  Similarity=0.307  Sum_probs=206.8

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      -++|++++.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            36799999999999999999985 58999999999754   233457788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++|+|.+++.+.+. +++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~~~~-~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhcccC-CcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            999999999999987664 888999999999999999999   9999999999999999999999999999998654322


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                        .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+. ........       ..-|    
T Consensus       160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~i~~~~-------~~~p----  225 (337)
T d1o6la_         160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-FELILMEE-------IRFP----  225 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCC-------CCCC----
T ss_pred             --cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-HHHHhcCC-------CCCC----
Confidence              223456799999999999999999999999999999999999999976432211 11111100       0001    


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ell~  665 (678)
                               ..+++++.+|+.+||++||++|++     ++|+++
T Consensus       226 ---------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         226 ---------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                     123456889999999999999995     888875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-48  Score=385.63  Aligned_cols=256  Identities=26%  Similarity=0.391  Sum_probs=198.5

Q ss_pred             cCCCCCccccCCCceeEEEEEeC--C--CcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG--D--GMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~--~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      ++|++.+.||+|+||.||+|+..  +  ...||||++...   ..+..+.|.+|+.+++.++||||++++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            56889999999999999999742  2  347899998653   234457889999999999999999999999764 578


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+++|++.+++......+++..+..++.||+.||.|||   +++|+||||||+||+++.++.+|++|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999998877667999999999999999999999   89999999999999999999999999999998754


Q ss_pred             CCCcc-eeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccchhhhhhcccCCcccccccC
Q 005760          545 EDQST-IQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDP  622 (678)
Q Consensus       545 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  622 (678)
                      ..... ......++..|+|||.+.+..++.++|||||||++|||+| |+.||.+....+  ....+...   .. ...  
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~~~i~~~---~~-~~~--  235 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--ILHKIDKE---GE-RLP--  235 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHHHTS---CC-CCC--
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HHHHHHhC---CC-CCC--
Confidence            43322 2334567889999999999999999999999999999998 899987532221  11111100   00 000  


Q ss_pred             ccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHH
Q 005760          623 NLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKI  670 (678)
Q Consensus       623 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~  670 (678)
                                 .+..++.++.+++.+||++||++||||+|+++.|++.
T Consensus       236 -----------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         236 -----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             -----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                       0113445688999999999999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-47  Score=383.88  Aligned_cols=271  Identities=24%  Similarity=0.342  Sum_probs=201.6

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHH--HHHHHHhCCCccceeeeeeeecCC----eEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDV--ECEMMKSIRHRNIIKVISSCSNEE----FKAL  465 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~--e~~~l~~l~h~niv~~~~~~~~~~----~~~l  465 (678)
                      .+|.+.+.||+|+||+||+|+. +|+.||||+++...   ...+..  |+..++.++||||+++++++.+.+    ..++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            4577789999999999999997 68999999986432   233444  444556789999999999986543    6789


Q ss_pred             EEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          466 VLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFG-----YSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       466 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      ||||+++|+|.+++++..  +++..+..++.|+|.|++|+|..     .+++|+||||||+|||++.++.+||+|||+++
T Consensus        79 v~Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEecccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            999999999999998764  88999999999999999999932     13699999999999999999999999999998


Q ss_pred             ccCCCCCc--ceeecccCCccccCccccCCCC------CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc
Q 005760          541 LLTREDQS--TIQTQTLATIGYMAPEYGKEGR------VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL  612 (678)
Q Consensus       541 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~  612 (678)
                      ........  .......||+.|+|||++.+..      ++.++|||||||++|||+||..||..................
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            76543222  2334567999999999877542      577899999999999999999887543222111111100000


Q ss_pred             C------CcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          613 P------ISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       613 ~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      .      .......+|..     ........+...+.+++.+||+.||++|||+.||++.|+++.++
T Consensus       237 ~~~~~~~~~~~~~~~p~~-----~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         237 SVEEMRKVVCEQKLRPNI-----PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCC-----CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhccccCCCC-----CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            0      00001111111     11222234667799999999999999999999999999999865

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-47  Score=385.23  Aligned_cols=264  Identities=23%  Similarity=0.380  Sum_probs=202.0

Q ss_pred             HhhcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceeeeeeeec-
Q 005760          389 RATDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKVISSCSN-  459 (678)
Q Consensus       389 ~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-  459 (678)
                      ...++|++.+.||+|+||.||+|.+.      +++.||||+++.... ...+.+..|..++.++ +|+||+.+++++.+ 
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            34578999999999999999999742      356899999865432 3345677777777766 68999999998765 


Q ss_pred             CCeEEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCee
Q 005760          460 EEFKALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVL  524 (678)
Q Consensus       460 ~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nil  524 (678)
                      .+..++||||+++|+|.++++..+               ..+++..+..++.||++||+|||   +++|+||||||+|||
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NIL  166 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNIL  166 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCcccee
Confidence            456899999999999999997542               24789999999999999999999   999999999999999


Q ss_pred             ecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCC-CCCCcccCCccc
Q 005760          525 LDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK-KPTDEIFNGEMT  603 (678)
Q Consensus       525 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~-~p~~~~~~~~~~  603 (678)
                      ++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||++|. .||....... .
T Consensus       167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-~  245 (299)
T d1ywna1         167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E  245 (299)
T ss_dssp             ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-H
T ss_pred             ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-H
Confidence            9999999999999998765544444455667999999999999999999999999999999999975 5665433222 2


Q ss_pred             hhhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          604 LKHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      +...+.....        +..          +..+++++.+++.+||+.||++|||++|+++.|+++.++.
T Consensus       246 ~~~~~~~~~~--------~~~----------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         246 FCRRLKEGTR--------MRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             HHHHHHHTCC--------CCC----------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHhcCCC--------CCC----------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence            2222111100        000          0124556889999999999999999999999999997654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.2e-47  Score=381.10  Aligned_cols=260  Identities=24%  Similarity=0.401  Sum_probs=203.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC---chhhhHHHHHHHHHhCCCccceeeeeeeecCC----e
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG---RVFKSFDVECEMMKSIRHRNIIKVISSCSNEE----F  462 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~  462 (678)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++....   ...+.+.+|+++++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999985 5899999999975432   33467889999999999999999999986543    4


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .|+||||+++++|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.++++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            789999999999999987765 4899999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCC-CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccccc
Q 005760          543 TRED-QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVD  621 (678)
Q Consensus       543 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  621 (678)
                      .... .........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.. ...+.....       .
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-~~~~~~~~~-------~  233 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-YQHVREDPI-------P  233 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHCCCC-------C
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH-HHHHhcCCC-------C
Confidence            4322 223345567999999999999999999999999999999999999999753322211 111111000       0


Q ss_pred             CccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCC-CHHHHHHHHHHHH
Q 005760          622 PNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI-NAKEIVTKLLKIR  671 (678)
Q Consensus       622 ~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-s~~ell~~L~~~~  671 (678)
                      +..         ....+++++.+++.+||++||++|| |++|+++.|.+++
T Consensus       234 ~~~---------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         234 PSA---------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             GGG---------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             Cch---------hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            000         0012456688999999999999999 8999999998876

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=380.05  Aligned_cols=256  Identities=26%  Similarity=0.456  Sum_probs=207.0

Q ss_pred             CccccCCCceeEEEEEeCC----CcEEEEEEeecc-cCchhhhHHHHHHHHHhCCCccceeeeeeeec-CCeEEEEEEec
Q 005760          397 NNLIGRGSFGSVFKARLGD----GMEVAMKVFNLQ-YGRVFKSFDVECEMMKSIRHRNIIKVISSCSN-EEFKALVLEYM  470 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  470 (678)
                      .++||+|+||+||+|.+.+    ...||||+++.. .....++|.+|++++++++||||++++|++.+ +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999998542    236899998643 33455789999999999999999999999765 56889999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC--c
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ--S  548 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~--~  548 (678)
                      ++|+|.++++......++..+..++.|++.||.|+|   +++|+||||||+|||+++++.+||+|||+++.......  .
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999887777889999999999999999999   99999999999999999999999999999987654322  2


Q ss_pred             ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhh-cccCCcccccccCccCCc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVN-DWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  627 (678)
                      .......||+.|+|||.+.++.++.++||||||+++|||++|+.||....... ....++. ...      ...|     
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~~------~~~p-----  256 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRR------LLQP-----  256 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTCC------CCCC-----
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCCC------CCCc-----
Confidence            22334578999999999999999999999999999999999888876533221 1112111 111      1111     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHHh
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSLL  675 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~~  675 (678)
                              ..+++++.+++.+||+.||++||++.||++.|+++.+++.
T Consensus       257 --------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~  296 (311)
T d1r0pa_         257 --------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  296 (311)
T ss_dssp             --------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             --------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence                    1245568899999999999999999999999999987643

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.7e-47  Score=383.84  Aligned_cols=244  Identities=26%  Similarity=0.329  Sum_probs=204.3

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc---cCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ---YGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++..   .....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5689999999999999999986 47999999999753   2334577889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||++||+|..++..... ++...+..++.||+.|++|||   +++|+||||||+|||++.+|.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCcccccccccccc-ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            99999999999887654 788888999999999999999   999999999999999999999999999999876432  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+. .........       .-|     
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~-------~~p-----  221 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-YEKILNAEL-------RFP-----  221 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHCCC-------CCC-----
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-HHHHHcCCC-------CCC-----
Confidence               2346799999999999999999999999999999999999999976322111 111111100       000     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                              ...++++.+++.+||++||++|+     |++|+++
T Consensus       222 --------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         222 --------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             --------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             --------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence                    12345688999999999999996     8999876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-46  Score=383.24  Aligned_cols=251  Identities=20%  Similarity=0.285  Sum_probs=206.9

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      .++|++.+.||+|+||+||+|..+ +|+.||||+++... .....+.+|+++++.++||||+++++++.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467999999999999999999864 78999999997543 2345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC--CCcEEEEeeccccccCCCCC
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD--NMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~--~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      +++|+|.+++...+..+++.++..++.||+.||+|||   +++|+||||||+||+++.  .+.+||+|||++......  
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--  157 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence            9999999999877667999999999999999999999   999999999999999984  458999999999876432  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                       .......+++.|+|||...+..++.++||||+||++|+|++|+.||......+. .........               
T Consensus       158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-~~~i~~~~~---------------  220 (321)
T d1tkia_         158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-IENIMNAEY---------------  220 (321)
T ss_dssp             -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCC---------------
T ss_pred             -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCC---------------
Confidence             223445789999999999999999999999999999999999999976332211 111111000               


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                       .........+++++.+|+.+||++||++|||++|+++
T Consensus       221 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         221 -TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0001111234567899999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-46  Score=380.95  Aligned_cols=263  Identities=23%  Similarity=0.377  Sum_probs=215.3

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe------CCCcEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceeeeeeeecCC
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL------GDGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKVISSCSNEE  461 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  461 (678)
                      ..++|++.+.||+|+||.||+|++      .+++.||||+++.... .....+.+|+.+++.+ +|||||++++++.+++
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~  100 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence            346888999999999999999974      3567899999975433 3456788999999999 6999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCee
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNY-----------------ILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVL  524 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nil  524 (678)
                      ..++||||+++|+|.++++....                 .+++..+..++.||+.|++|||   +++++||||||+||+
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl  177 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNIL  177 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccccccc
Confidence            99999999999999999976432                 5788999999999999999999   999999999999999


Q ss_pred             ecCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccch
Q 005760          525 LDDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTL  604 (678)
Q Consensus       525 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~  604 (678)
                      ++.++.+|++|||.++...............+|+.|+|||++.++.++.++|||||||++|||+|++.|+.........+
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~  257 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999988765555555667789999999999999999999999999999999999555543323332223


Q ss_pred             hhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          605 KHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      ...+......     ..+             ..++.++.+|+.+||++||++||||.|++++|+++...
T Consensus       258 ~~~i~~~~~~-----~~~-------------~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         258 YKMIKEGFRM-----LSP-------------EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHTCCC-----CCC-------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHhcCCCC-----CCc-------------ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            3332211100     000             12345688999999999999999999999999987654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-46  Score=374.69  Aligned_cols=250  Identities=24%  Similarity=0.340  Sum_probs=204.1

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC---------chhhhHHHHHHHHHhCC-CccceeeeeeeecC
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG---------RVFKSFDVECEMMKSIR-HRNIIKVISSCSNE  460 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  460 (678)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.....         ...+.+.+|+.+++.++ ||||+++++++.+.
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6789999999999999999985 5799999999975432         12346788999999997 99999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      +..|+||||+++|+|.++++... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999998665 5899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCCcceeecccCCccccCccccCC------CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC
Q 005760          541 LLTREDQSTIQTQTLATIGYMAPEYGKE------GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI  614 (678)
Q Consensus       541 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  614 (678)
                      ......   ......||+.|+|||.+.+      ..++.++||||+||++|||++|+.||.+....+ ........... 
T Consensus       159 ~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-~~~~i~~~~~~-  233 (277)
T d1phka_         159 QLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-MLRMIMSGNYQ-  233 (277)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCC-
T ss_pred             EccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-HHHHHHhCCCC-
Confidence            764322   2345679999999998753      347889999999999999999999997643221 11111111000 


Q ss_pred             cccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          615 STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                          ..     ..      ....+++++.+++.+||++||++|||+.|+++
T Consensus       234 ----~~-----~~------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         234 ----FG-----SP------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ----CC-----TT------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----CC-----Cc------ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                00     00      01134567899999999999999999999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-47  Score=383.43  Aligned_cols=259  Identities=28%  Similarity=0.439  Sum_probs=207.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEeC--------CCcEEEEEEeecccC-chhhhHHHHHHHHHhC-CCccceeeeeeeecC
Q 005760          391 TDGFSENNLIGRGSFGSVFKARLG--------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSI-RHRNIIKVISSCSNE  460 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  460 (678)
                      .++|++.+.||+|+||.||+|+..        ++..||||++..... .....+.+|...+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            468889999999999999999742        235799999976543 3456788898888888 799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhhCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeee
Q 005760          461 EFKALVLEYMPHGSLEKYLHSSN---------------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLL  525 (678)
Q Consensus       461 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill  525 (678)
                      +..++||||+++|+|.+++....               ..+++.+++.++.||+.||+|||   +++|+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            99999999999999999997553               24799999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHc-CCCCCCcccCCccch
Q 005760          526 DDNMVAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFT-RKKPTDEIFNGEMTL  604 (678)
Q Consensus       526 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~-g~~p~~~~~~~~~~~  604 (678)
                      +.++.+||+|||+++...............+++.|+|||.+.++.|+.++|||||||++|||++ |..||.+....  ..
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~  246 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL  246 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--HH
Confidence            9999999999999987765544444556678999999999999999999999999999999998 67777643221  11


Q ss_pred             hhhhhcccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHH
Q 005760          605 KHWVNDWLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRD  672 (678)
Q Consensus       605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~  672 (678)
                      ...+......     ..|             ..+++++.+++.+||++||++||||.||++.|+++.+
T Consensus       247 ~~~i~~~~~~-----~~p-------------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         247 FKLLKEGHRM-----DKP-------------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHHHHTTCCC-----CCC-------------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCC-----CCC-------------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            1222111000     000             1244568899999999999999999999999999865

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-46  Score=379.58  Aligned_cols=251  Identities=21%  Similarity=0.270  Sum_probs=199.2

Q ss_pred             hcCCCCCc-cccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHh-CCCccceeeeeeeec----CCeE
Q 005760          391 TDGFSENN-LIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKS-IRHRNIIKVISSCSN----EEFK  463 (678)
Q Consensus       391 ~~~~~~~~-~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~~~~  463 (678)
                      .++|.+.. .||+|+||+||+|+. .+++.||||+++.     ...+.+|++++.+ .+|||||++++++.+    ...+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            45788764 699999999999985 5799999999863     2557789988654 589999999999865    4678


Q ss_pred             EEEEEecCCCCHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC---CCcEEEEeeccc
Q 005760          464 ALVLEYMPHGSLEKYLHSSN-YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD---NMVAHLSDFGIA  539 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~---~~~~kl~Dfg~~  539 (678)
                      |+||||++||+|.+++...+ ..+++..+..++.||+.||+|||   +++|+||||||+||+++.   .+.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999997653 46899999999999999999999   999999999999999975   567999999999


Q ss_pred             cccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCccccc
Q 005760          540 KLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEI  619 (678)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  619 (678)
                      +......   ......||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+........ ....        .+
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-~~~~--------~i  229 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKT--------RI  229 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------CC
T ss_pred             eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-HHHH--------HH
Confidence            8764332   2345679999999999999999999999999999999999999997643221110 0000        00


Q ss_pred             ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          620 VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       620 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ...    ...........+++++.+|+.+||++||++|||+.|+++
T Consensus       230 ~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         230 RMG----QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CSC----SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcC----CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            000    000011122356778999999999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-45  Score=382.82  Aligned_cols=248  Identities=22%  Similarity=0.298  Sum_probs=198.4

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHH---HHHHHHhCCCccceeeeeeeecCCeEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDV---ECEMMKSIRHRNIIKVISSCSNEEFKA  464 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~  464 (678)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++....   ......+.+   |+++++.++|||||++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            6799999999999999999985 479999999986432   112223333   466777788999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      +||||+++|+|.+++.+.. .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+....
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            9999999999999998765 4889999999999999999999   99999999999999999999999999999987653


Q ss_pred             CCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCc
Q 005760          545 EDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPN  623 (678)
Q Consensus       545 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  623 (678)
                      ..    .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........  ..........   ...+ 
T Consensus       160 ~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~~~~---~~~~-  229 (364)
T d1omwa3         160 KK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTMA---VELP-  229 (364)
T ss_dssp             SC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH--HHHHHSSSCC---CCCC-
T ss_pred             Cc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcccCC---CCCC-
Confidence            32    234579999999999865 46899999999999999999999999764332211  1111100000   0000 


Q ss_pred             cCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCC-----HHHHHH
Q 005760          624 LLSREDINFVAKEQCVSFVFNVAMECTVESPEQRIN-----AKEIVT  665 (678)
Q Consensus       624 ~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps-----~~ell~  665 (678)
                                  ..+++++.+++.+||++||++|||     |+|+++
T Consensus       230 ------------~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         230 ------------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ------------SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ------------CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                        123456889999999999999999     688875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-46  Score=378.76  Aligned_cols=256  Identities=28%  Similarity=0.454  Sum_probs=203.8

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCc--EEEEEEeecc-cCchhhhHHHHHHHHHhC-CCccceeeeeeeecCCeEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGM--EVAMKVFNLQ-YGRVFKSFDVECEMMKSI-RHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ++|++.+.||+|+||+||+|.++ +|.  .||||.+... ..+..+.+.+|+++++++ +|||||++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            67889999999999999999864 444  5788887543 334567899999999998 799999999999999999999


Q ss_pred             EEecCCCCHHHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcE
Q 005760          467 LEYMPHGSLEKYLHSS---------------NYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVA  531 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~  531 (678)
                      |||+++|+|.++++..               ...+++..+..++.||+.|+.|+|   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999754               246899999999999999999999   9999999999999999999999


Q ss_pred             EEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCC-CCCcccCCccchhhhhhc
Q 005760          532 HLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKK-PTDEIFNGEMTLKHWVND  610 (678)
Q Consensus       532 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~-p~~~~~~~~~~~~~~~~~  610 (678)
                      ||+|||+++......   ......+|..|+|||.+.++.++.++|||||||++|||++|.. ||.+....  .+...+..
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~~i~~  241 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQ  241 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHGGG
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--HHHHHHHh
Confidence            999999997653222   2234468999999999999999999999999999999999765 56442211  11121111


Q ss_pred             ccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          611 WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                      ..        .+.          .+..+++++.+|+.+||+.||++||||+|+++.|+++.++
T Consensus       242 ~~--------~~~----------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         242 GY--------RLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             TC--------CCC----------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cC--------CCC----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            00        000          0112456689999999999999999999999999998754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-45  Score=379.43  Aligned_cols=244  Identities=21%  Similarity=0.253  Sum_probs=204.4

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++|++++.||+|+||.||+|+. .+|+.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999986 479999999996532   234567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQ  547 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~  547 (678)
                      ||+.+|+|.+++...+ .+++..+..++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||+|+.....  
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999998765 4899999999999999999999   999999999999999999999999999999876432  


Q ss_pred             cceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCCc
Q 005760          548 STIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLSR  627 (678)
Q Consensus       548 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  627 (678)
                         .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... ..........       ..+     
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~-------~~p-----  258 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGKV-------RFP-----  258 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC-------CCC-----
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-HHHHHhcCCC-------CCC-----
Confidence               234579999999999999999999999999999999999999997532211 1111111100       001     


Q ss_pred             cchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          628 EDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       628 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                              ..+++++.+++.+||++||++|+     |++|+++
T Consensus       259 --------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         259 --------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                    12345688999999999999995     8999886

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-46  Score=379.20  Aligned_cols=247  Identities=23%  Similarity=0.337  Sum_probs=201.6

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc---CchhhhHHHHHHHHH-hCCCccceeeeeeeecCCeEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY---GRVFKSFDVECEMMK-SIRHRNIIKVISSCSNEEFKALV  466 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv  466 (678)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++...   ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5789999999999999999985 479999999997532   233455666666654 68999999999999999999999


Q ss_pred             EEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCC
Q 005760          467 LEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTRED  546 (678)
Q Consensus       467 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~  546 (678)
                      |||+++|+|.++++... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++++|++|||+++..... 
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccc-
Confidence            99999999999998765 4889999999999999999999   999999999999999999999999999999865432 


Q ss_pred             CcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccccCccCC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIVDPNLLS  626 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  626 (678)
                       ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....  .....+....+      .-|    
T Consensus       157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~~~~------~~p----  223 (320)
T d1xjda_         157 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRMDNP------FYP----  223 (320)
T ss_dssp             -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC------CCC----
T ss_pred             -cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHHHcCCC------CCC----
Confidence             22334567999999999999999999999999999999999999999753321  11111111000      001    


Q ss_pred             ccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHH-HHHH
Q 005760          627 REDINFVAKEQCVSFVFNVAMECTVESPEQRINAK-EIVT  665 (678)
Q Consensus       627 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~-ell~  665 (678)
                               ..+++++.+|+.+||++||++||++. |+++
T Consensus       224 ---------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         224 ---------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                     12345688999999999999999995 6653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-46  Score=376.24  Aligned_cols=259  Identities=24%  Similarity=0.423  Sum_probs=210.5

Q ss_pred             hhcCCCCCccccCCCceeEEEEEeC------CCcEEEEEEeecccC-chhhhHHHHHHHHHhCCCccceeeeeeeecCCe
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARLG------DGMEVAMKVFNLQYG-RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEF  462 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  462 (678)
                      ..++|++.+.||+|+||+||+|.+.      +++.||||+++.... .....+.+|++++++++||||+++++++...+.
T Consensus        18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence            3578889999999999999999752      357899999965432 344568899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEE
Q 005760          463 KALVLEYMPHGSLEKYLHSSN---------YILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHL  533 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl  533 (678)
                      .++||||+++|+|.+++...+         ..+++..+..++.|+|+||.|||   +++|+||||||+|||++.++++||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEE
Confidence            999999999999999986432         24688999999999999999999   899999999999999999999999


Q ss_pred             EeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCC-CCCCcccCCccchhhhhhccc
Q 005760          534 SDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRK-KPTDEIFNGEMTLKHWVNDWL  612 (678)
Q Consensus       534 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~-~p~~~~~~~~~~~~~~~~~~~  612 (678)
                      +|||+++...............+|+.|+|||.+.++.++.++|||||||++|||+||. .||.+....+ ......+.  
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~-~~~~i~~~--  251 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-VLRFVMEG--  251 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-HHHHHHTT--
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHhC--
Confidence            9999998775554444455567899999999999999999999999999999999985 5664422111 11111110  


Q ss_pred             CCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHH
Q 005760          613 PISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIR  671 (678)
Q Consensus       613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~  671 (678)
                                ....       .+..+++.+.+++.+||+.||++|||++|+++.|++..
T Consensus       252 ----------~~~~-------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         252 ----------GLLD-------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             ----------CCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             ----------CCCC-------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                      0000       00124566999999999999999999999999998764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=371.73  Aligned_cols=268  Identities=24%  Similarity=0.295  Sum_probs=201.0

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++...  ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999985 579999999996543  2345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      |+.++.+..........+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+|++|||.|+.....  .
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~--~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--V  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC--S
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC--c
Confidence            99765444444444556999999999999999999999   999999999999999999999999999999876432  2


Q ss_pred             ceeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc--CC----ccccccc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL--PI----STKEIVD  621 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~----~~~~~~~  621 (678)
                      .......||+.|+|||.+.... ++.++||||+||++|+|++|+.||.+....+. +........  ..    ......+
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-LFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH-HHHHHHhcCCCchhhccccccccc
Confidence            2334457999999999876655 57899999999999999999999975332111 111111000  00    0000000


Q ss_pred             --CccCCccchhhH-HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 --PNLLSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 --~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                        +........... .....++++.+|+.+||++||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence              000000000000 11234567899999999999999999999986

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=372.45  Aligned_cols=262  Identities=24%  Similarity=0.284  Sum_probs=194.5

Q ss_pred             CccccCCCceeEEEEEe-CCCcEEEEEEeecccC-----chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEec
Q 005760          397 NNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG-----RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEYM  470 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  470 (678)
                      .+.||+|+||+||+|+. .+|+.||||+++....     ...+.+.+|+++++.++|||||++++++.+++..|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            57899999999999986 4799999999864322     12456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcce
Q 005760          471 PHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQSTI  550 (678)
Q Consensus       471 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  550 (678)
                      .++++..+... ...+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++......  ..
T Consensus        83 ~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~  156 (299)
T d1ua2a_          83 ETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RA  156 (299)
T ss_dssp             SEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CC
T ss_pred             cchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc--cc
Confidence            88776665543 445888899999999999999999   9999999999999999999999999999998664332  22


Q ss_pred             eecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC---Ccc---cccccCc
Q 005760          551 QTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP---IST---KEIVDPN  623 (678)
Q Consensus       551 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~~~  623 (678)
                      .....||+.|+|||++.++ .++.++||||+||++|||++|+.||.+....+. +....+....   ...   .......
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ-LTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH-HHHHHHhcCCCChhhccchhccchhh
Confidence            3346799999999987654 579999999999999999999999975332211 1111110000   000   0000000


Q ss_pred             cC-CccchhhH-HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          624 LL-SREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       624 ~~-~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .. ........ .....++++.+|+.+||++||++||||+|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00 00000000 00134567899999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=368.34  Aligned_cols=240  Identities=22%  Similarity=0.288  Sum_probs=197.1

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC------chhhhHHHHHHHHHhCC--CccceeeeeeeecCC
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG------RVFKSFDVECEMMKSIR--HRNIIKVISSCSNEE  461 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~  461 (678)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.....      .....+.+|+.+++.++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            36799999999999999999985 5799999999975421      12344678999999986  899999999999999


Q ss_pred             eEEEEEEecCC-CCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-CCcEEEEeeccc
Q 005760          462 FKALVLEYMPH-GSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-NMVAHLSDFGIA  539 (678)
Q Consensus       462 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-~~~~kl~Dfg~~  539 (678)
                      ..++||||+.+ +++.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++. ++.+||+|||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccc
Confidence            99999999976 68888887654 4899999999999999999999   999999999999999985 579999999999


Q ss_pred             cccCCCCCcceeecccCCccccCccccCCCCC-CccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccc
Q 005760          540 KLLTREDQSTIQTQTLATIGYMAPEYGKEGRV-SANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKE  618 (678)
Q Consensus       540 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  618 (678)
                      +.....    ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....       ..+...      
T Consensus       159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------i~~~~~------  221 (273)
T d1xwsa_         159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------IIRGQV------  221 (273)
T ss_dssp             EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------HHHCCC------
T ss_pred             eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------Hhhccc------
Confidence            865432    2345679999999999887765 5678999999999999999999965211       111000      


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                       ..+             ..+++++.+++.+||+.||++|||++|+++
T Consensus       222 -~~~-------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 -FFR-------------QRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -CCS-------------SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCC-------------CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence             000             013456889999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=8.3e-45  Score=366.42  Aligned_cols=267  Identities=21%  Similarity=0.283  Sum_probs=199.9

Q ss_pred             cCCCCCccccCCCceeEEEEEeCCCcEEEEEEeeccc--CchhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEEe
Q 005760          392 DGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQY--GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLEY  469 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  469 (678)
                      ++|++.+.||+|+||+||+|+.++|+.||||+++...  ....+.+.+|+.++++++||||+++++++.+.+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5789999999999999999998899999999996542  23357789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCcc
Q 005760          470 MPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQST  549 (678)
Q Consensus       470 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  549 (678)
                      +.++.+..+.... ..+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+|++|||.+.......  .
T Consensus        82 ~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (286)
T ss_dssp             CSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc--c
Confidence            9876666655544 46999999999999999999999   8999999999999999999999999999998764332  2


Q ss_pred             eeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCc---c---ccc--c
Q 005760          550 IQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS---T---KEI--V  620 (678)
Q Consensus       550 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~---~---~~~--~  620 (678)
                      ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+. +...........   .   ...  .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHHHHHhhCCCChhhccchhhhhhc
Confidence            23445689999999988654 568999999999999999999999975332111 111111000000   0   000  0


Q ss_pred             cCccCCccchh-hHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          621 DPNLLSREDIN-FVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       621 ~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      +.......... .......++++.+++.+||++||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000000000 0001124556889999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=368.36  Aligned_cols=267  Identities=24%  Similarity=0.320  Sum_probs=200.7

Q ss_pred             hhcCCCCCccccCCCceeEEEEEe-CC-CcEEEEEEeecccC--chhhhHHHHHHHHHhC---CCccceeeeeeee----
Q 005760          390 ATDGFSENNLIGRGSFGSVFKARL-GD-GMEVAMKVFNLQYG--RVFKSFDVECEMMKSI---RHRNIIKVISSCS----  458 (678)
Q Consensus       390 ~~~~~~~~~~ig~G~~g~V~~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~----  458 (678)
                      ..++|++.+.||+|+||+||+|+. ++ ++.||||+++....  .....+.+|+.+++.+   +||||++++++|.    
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            457899999999999999999985 34 67799999865432  2345667788877765   7999999999884    


Q ss_pred             -cCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeec
Q 005760          459 -NEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFG  537 (678)
Q Consensus       459 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg  537 (678)
                       .....+++|||++++++..........+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence             345788999999988776666666667899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhccc-----
Q 005760          538 IAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWL-----  612 (678)
Q Consensus       538 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~-----  612 (678)
                      +++....   ........||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+ .+........     
T Consensus       162 ~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         162 LARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGEE  237 (305)
T ss_dssp             SCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCGG
T ss_pred             hhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCchh
Confidence            9876532   233456779999999999999999999999999999999999999997643211 1111111000     


Q ss_pred             --CCc--ccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          613 --PIS--TKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       613 --~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                        +..  ................  .....++++.+|+.+||++||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEK--FVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGG--TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhhccccccchhh--ccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence              000  0000000000000000  01123456889999999999999999999975

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-42  Score=356.21  Aligned_cols=271  Identities=20%  Similarity=0.299  Sum_probs=199.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecc--cCchhhhHHHHHHHHHhCCCccceeeeeeeec--------
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQ--YGRVFKSFDVECEMMKSIRHRNIIKVISSCSN--------  459 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  459 (678)
                      .++|++.+.||+|+||+||+|+. ++|+.||||++...  ......++.+|+++++.++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999985 58999999998544  23345678899999999999999999998754        


Q ss_pred             CCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccc
Q 005760          460 EEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIA  539 (678)
Q Consensus       460 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~  539 (678)
                      .+..++||||+.++.+..+. .....++...++.++.|++.||.|||   +++|+||||||+||+++.++.+|++|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            34688999999876655444 44446889999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCC--cceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccc--hhhhhhcccCC
Q 005760          540 KLLTREDQ--STIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT--LKHWVNDWLPI  614 (678)
Q Consensus       540 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~  614 (678)
                      +.......  ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+..  .........+.
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            76653322  2223345799999999988765 6899999999999999999999999753221110  00111111111


Q ss_pred             ccccc---------ccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          615 STKEI---------VDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       615 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .....         ....................+++.+|+.+||++||++||||+|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            00000         0011111111111222344667889999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-42  Score=352.47  Aligned_cols=262  Identities=19%  Similarity=0.213  Sum_probs=204.2

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceee-eeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKV-ISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~-~~~~~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++....  ..+.+..|+++++.++|++++.. .+++.+.+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            35799999999999999999985 578999999987543  33678899999999987775555 556677888899999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeec---CCCcEEEEeeccccccCCC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLD---DNMVAHLSDFGIAKLLTRE  545 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~---~~~~~kl~Dfg~~~~~~~~  545 (678)
                      |+ ++++.+.+......+++..+..++.|++.||+|||   +++|+||||||+||+++   .+..+|++|||+|+.+...
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            99 55777777766667999999999999999999999   99999999999999875   4567999999999876543


Q ss_pred             CCc-----ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchh--hhhhcccCCcccc
Q 005760          546 DQS-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK--HWVNDWLPISTKE  618 (678)
Q Consensus       546 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~  618 (678)
                      ...     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........  ..........   
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~---  236 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---  236 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC---
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC---
Confidence            221     223456799999999999999999999999999999999999999976433221111  1100000000   


Q ss_pred             cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHH
Q 005760          619 IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDS  673 (678)
Q Consensus       619 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~  673 (678)
                                  .......+++++.+++.+||+.+|++||+++++.+.|+.+..+
T Consensus       237 ------------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         237 ------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             ------------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ------------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence                        0001124567799999999999999999999999999887543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.2e-42  Score=348.85  Aligned_cols=263  Identities=16%  Similarity=0.156  Sum_probs=212.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCC-ccceeeeeeeecCCeEEEEEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRH-RNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  468 (678)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++....  ..+.+.+|++.++.++| +|++.+++++.+....++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            46899999999999999999985 478999999986432  34667889999999975 899999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecC-----CCcEEEEeeccccccC
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDD-----NMVAHLSDFGIAKLLT  543 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~-----~~~~kl~Dfg~~~~~~  543 (678)
                      |+ +++|.+++......++...+..++.|++.||+|||   +++|+||||||+||+++.     ++.+||+|||+|+.+.
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99 68999999887777999999999999999999999   999999999999999974     6789999999998764


Q ss_pred             CCCCc-----ceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchh-hhhhc-ccCCcc
Q 005760          544 REDQS-----TIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK-HWVND-WLPIST  616 (678)
Q Consensus       544 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~-~~~~~-~~~~~~  616 (678)
                      .....     .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.+......... ..+.. ......
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  237 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence            33211     223456799999999999999999999999999999999999999976433322110 00000 000000


Q ss_pred             cccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHHHHHHHHHHH
Q 005760          617 KEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVTKLLKIRDSL  674 (678)
Q Consensus       617 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~~L~~~~~~~  674 (678)
                      .             +  ....+++++.+++..|+..+|++||+++.+.+.|+++.++.
T Consensus       238 ~-------------~--l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         238 R-------------E--LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             H-------------H--HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             H-------------H--hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            0             0  00235677999999999999999999999999999886654

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-42  Score=360.19  Aligned_cols=268  Identities=21%  Similarity=0.246  Sum_probs=196.4

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeeccc-CchhhhHHHHHHHHHhCCCccceeeeeeeecCC----eEE
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQY-GRVFKSFDVECEMMKSIRHRNIIKVISSCSNEE----FKA  464 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~  464 (678)
                      +++|++++.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++++.++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999975 589999999996543 234567889999999999999999999986543    234


Q ss_pred             EEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCC
Q 005760          465 LVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTR  544 (678)
Q Consensus       465 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~  544 (678)
                      ++++|+.+|+|.+++...+  +++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        87 ~l~~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            5556677999999997653  899999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCCc-ceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCc-------
Q 005760          545 EDQS-TIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPIS-------  615 (678)
Q Consensus       545 ~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-------  615 (678)
                      .... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+...........+..       
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            3222 22345679999999998855 45789999999999999999999999764322111100000000000       


Q ss_pred             ---ccc--cccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          616 ---TKE--IVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       616 ---~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                         ...  ...+.... ..... .....++++.+|+.+||++||++|||++|+++
T Consensus       242 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         242 NLKARNYLLSLPHKNK-VPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CHHHHHHHHTSCCCCC-CCHHH-HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccCCccCC-CCHHH-hCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               000  00000000 00000 00123456889999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-42  Score=350.58  Aligned_cols=268  Identities=22%  Similarity=0.254  Sum_probs=204.0

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCCeEEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEEFKALVLE  468 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  468 (678)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++....  .....+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999985 5889999999965432  345778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccccCCCCCc
Q 005760          469 YMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLLTREDQS  548 (678)
Q Consensus       469 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~~~~~~~  548 (678)
                      ++.++++..++...+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+|++|||.++....... 
T Consensus        82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            999988888776554 5889999999999999999999   99999999999999999999999999999987653322 


Q ss_pred             ceeecccCCccccCccccCCCC-CCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCC---c---cccccc
Q 005760          549 TIQTQTLATIGYMAPEYGKEGR-VSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPI---S---TKEIVD  621 (678)
Q Consensus       549 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~  621 (678)
                       ......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||....................   .   .....+
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence             233456788999999887665 68999999999999999999999743222111111111100000   0   000000


Q ss_pred             Ccc---CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          622 PNL---LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       622 ~~~---~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ...   ..............++++.+|+.+||++||.+||||+|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000   00000000011233556889999999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-42  Score=355.74  Aligned_cols=260  Identities=25%  Similarity=0.341  Sum_probs=191.4

Q ss_pred             CCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccceeeeeeeec------CCeEEE
Q 005760          393 GFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNIIKVISSCSN------EEFKAL  465 (678)
Q Consensus       393 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~~~l  465 (678)
                      +|+..++||+|+||+||+|+. .+|+.||||++....    ....+|+++++.++||||++++++|..      ..+.++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            578889999999999999986 479999999996543    223479999999999999999998843      335789


Q ss_pred             EEEecCCCCHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC-cEEEEeecccccc
Q 005760          466 VLEYMPHGSLEKYLH--SSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLL  542 (678)
Q Consensus       466 v~e~~~~~~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~-~~kl~Dfg~~~~~  542 (678)
                      ||||++++.+..+..  .....+++..+..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998754333332  23446899999999999999999999   99999999999999999775 8999999999876


Q ss_pred             CCCCCcceeecccCCccccCccccCC-CCCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhh-----------hc
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKE-GRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWV-----------ND  610 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~-----------~~  610 (678)
                      ....   ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +....           ..
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHH
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhhh
Confidence            4332   2334679999999997664 5689999999999999999999999975332111 11111           10


Q ss_pred             ccCCcccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          611 WLPISTKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..+.. ....-+...... .........++++.+|+.+||++||++|||++|+++
T Consensus       250 ~~~~~-~~~~~~~~~~~~-~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         250 MNPNY-TEFKFPQIKAHP-WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HCC----CCCCCCCCCCC-GGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccch-hhccccccccCc-hhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000 000000000000 000011134566889999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=359.72  Aligned_cols=261  Identities=25%  Similarity=0.322  Sum_probs=193.0

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecCC------
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNEE------  461 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  461 (678)
                      .++|++++.||+|+||+||+|.. .+|+.||||+++....  ...+.+.+|+++++.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            56899999999999999999985 5799999999964322  33567889999999999999999999987654      


Q ss_pred             eEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeeccccc
Q 005760          462 FKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKL  541 (678)
Q Consensus       462 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~  541 (678)
                      ..|+||||+ +.+|..+.+..  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            569999999 56888887655  3899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcc--cCCcccc
Q 005760          542 LTREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDW--LPISTKE  618 (678)
Q Consensus       542 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~  618 (678)
                      ....     .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.+..... .+.......  .+.....
T Consensus       171 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         171 ADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHH
T ss_pred             cCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhccCCCcHHHHh
Confidence            6432     2456799999999988764 56899999999999999999999997532211 111111000  0000000


Q ss_pred             cc-----------cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          619 IV-----------DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       619 ~~-----------~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      ..           .+.........  .....++++.+|+.+||++||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFAS--ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGG--TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhcchhhhhhhccCCcccccchHH--hccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00           00000000000  00123556889999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-41  Score=353.94  Aligned_cols=261  Identities=23%  Similarity=0.262  Sum_probs=190.5

Q ss_pred             cCCCCCccccCCCceeEEEEEeC-CCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeec------CCe
Q 005760          392 DGFSENNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSN------EEF  462 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~~  462 (678)
                      ++|++.+.||+|+||+||+|... +|+.||||++.....  .....+.+|+.+++.++||||+++++++..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999864 799999999975432  334568899999999999999999999853      468


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .|+||||+.++ +.+.+..   .+++..++.++.||+.||+|||   ++||+||||||+||+++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~-l~~~~~~---~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchH-HHHhhhc---CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            89999999764 4444432   4889999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCccc-------------------
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMT-------------------  603 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~-------------------  603 (678)
                      ..   ........+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.......                   
T Consensus       170 ~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         170 GT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             cc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            43   23345567899999999999999999999999999999999999999653211100                   


Q ss_pred             --hhhhhhcccCC---cccccccCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          604 --LKHWVNDWLPI---STKEIVDPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       604 --~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                        ...........   ...........   ..........++++.+|+.+||++||++||||+|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLF---PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGS---CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhHHHHhhcCccccccccccccccccc---cccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence              00000000000   00000100111   1111233456788999999999999999999999984

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-42  Score=352.96  Aligned_cols=252  Identities=24%  Similarity=0.345  Sum_probs=201.6

Q ss_pred             cCCCCCccccCCCceeEEEEEe----CCCcEEEEEEeecc----cCchhhhHHHHHHHHHhCCC-ccceeeeeeeecCCe
Q 005760          392 DGFSENNLIGRGSFGSVFKARL----GDGMEVAMKVFNLQ----YGRVFKSFDVECEMMKSIRH-RNIIKVISSCSNEEF  462 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  462 (678)
                      ++|++.+.||+|+||+||+|..    .+|+.||||+++..    .....+.+.+|++++++++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999974    25899999998543    22345677889999999976 899999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .++||||+.+|+|.+++...+. .+...+..++.||+.|++|+|   +++|+||||||+||+++.++.+||+|||+++.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            9999999999999999987764 678888999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCCcceeecccCCccccCccccCCC--CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccCCcccccc
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEG--RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLPISTKEIV  620 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  620 (678)
                      .... ........|++.|+|||.+.+.  .++.++||||+||++|||++|+.||.......... ..........     
T Consensus       180 ~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~-~i~~~~~~~~-----  252 (322)
T d1vzoa_         180 VADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA-EISRRILKSE-----  252 (322)
T ss_dssp             CGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH-HHHHHHHHCC-----
T ss_pred             cccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHhcccCC-----
Confidence            4332 2233456799999999988654  46889999999999999999999997654332211 1111110000     


Q ss_pred             cCccCCccchhhHHHHHHHHHHHHHHhhccccCcCCCC-----CHHHHHH
Q 005760          621 DPNLLSREDINFVAKEQCVSFVFNVAMECTVESPEQRI-----NAKEIVT  665 (678)
Q Consensus       621 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rp-----s~~ell~  665 (678)
                       +..          +..+++++.+++.+||++||++||     +++|+++
T Consensus       253 -~~~----------~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 -PPY----------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -CCC----------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -CCC----------cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence             000          012456788999999999999999     4889875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-41  Score=350.56  Aligned_cols=261  Identities=21%  Similarity=0.291  Sum_probs=196.3

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-Cccceeeeeeeec--CCeEEEEE
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSCSN--EEFKALVL  467 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~  467 (678)
                      ++|++++.||+|+||+||+|+. .+|+.||||+++..   ..+.+.+|+++++.++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999985 57999999998643   3467889999999995 9999999999864  45789999


Q ss_pred             EecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC-cEEEEeeccccccCCCC
Q 005760          468 EYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM-VAHLSDFGIAKLLTRED  546 (678)
Q Consensus       468 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~-~~kl~Dfg~~~~~~~~~  546 (678)
                      ||+++++|..+.+    .+++..+..++.||+.||+|||   +++|+||||||+|||++.++ .+|++|||+|+......
T Consensus       112 e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            9999999877643    4899999999999999999999   99999999999999998654 69999999998764332


Q ss_pred             CcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchh------------hhhhcccC
Q 005760          547 QSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLK------------HWVNDWLP  613 (678)
Q Consensus       547 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~------------~~~~~~~~  613 (678)
                         ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...........            .+......
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             ---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence               23456789999999987765 479999999999999999999999865322110000            00000000


Q ss_pred             C---cccccccCcc--CCccchhhHHHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          614 I---STKEIVDPNL--LSREDINFVAKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       614 ~---~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                      .   ..........  ..............++++.+|+.+||++||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0   0000000000  00000000111234567899999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-41  Score=350.03  Aligned_cols=263  Identities=21%  Similarity=0.291  Sum_probs=194.5

Q ss_pred             hcCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccC--chhhhHHHHHHHHHhCCCccceeeeeeeecC-----Ce
Q 005760          391 TDGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYG--RVFKSFDVECEMMKSIRHRNIIKVISSCSNE-----EF  462 (678)
Q Consensus       391 ~~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  462 (678)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++....  ...+.+.+|+++++.++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            56899999999999999999985 5899999999975432  2345678999999999999999999998532     34


Q ss_pred             EEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEeecccccc
Q 005760          463 KALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAKLL  542 (678)
Q Consensus       463 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~~~  542 (678)
                      .+++++|+.+|+|.+++...  .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+|++|||.+...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            46677888899999999765  4899999999999999999999   999999999999999999999999999999754


Q ss_pred             CCCCCcceeecccCCccccCccccCCC-CCCccchHHHHHHHHHHHHcCCCCCCcccCCccchhhhhhcccC--Cc----
Q 005760          543 TREDQSTIQTQTLATIGYMAPEYGKEG-RVSANGDVYSFGIMLMETFTRKKPTDEIFNGEMTLKHWVNDWLP--IS----  615 (678)
Q Consensus       543 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~----  615 (678)
                      ..     ......|++.|+|||...+. .++.++||||+||++|+|++|+.||.+...... ..........  ..    
T Consensus       172 ~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         172 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             TG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHTT
T ss_pred             Cc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChHHhhh
Confidence            32     23446789999999976665 468999999999999999999999975322111 0000000000  00    


Q ss_pred             -----ccccccCccCCccchhhH-HHHHHHHHHHHHHhhccccCcCCCCCHHHHHH
Q 005760          616 -----TKEIVDPNLLSREDINFV-AKEQCVSFVFNVAMECTVESPEQRINAKEIVT  665 (678)
Q Consensus       616 -----~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~Rps~~ell~  665 (678)
                           ...... .........+. .....++++.+|+.+||+.||++||||+|+++
T Consensus       246 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         246 ISSESARNYIQ-SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CCCHHHHHHHT-TSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccchhhhhhhh-hcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                 000000 00000000000 01234567889999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-36  Score=317.44  Aligned_cols=266  Identities=17%  Similarity=0.186  Sum_probs=187.3

Q ss_pred             cCCCCCccccCCCceeEEEEEe-CCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-----------Cccceeeeeeeec
Q 005760          392 DGFSENNLIGRGSFGSVFKARL-GDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-----------HRNIIKVISSCSN  459 (678)
Q Consensus       392 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~  459 (678)
                      ++|++++.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            4599999999999999999985 589999999997542 23456778998888775           5789999988754


Q ss_pred             --CCeEEEEEEecCCCCHHH--HhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCC------
Q 005760          460 --EEFKALVLEYMPHGSLEK--YLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNM------  529 (678)
Q Consensus       460 --~~~~~lv~e~~~~~~L~~--~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~------  529 (678)
                        ....+++++++..+....  ........+++..+..++.||+.|++|||+  ..+|+||||||+|||++.++      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccc
Confidence              455667777765543322  223334468889999999999999999992  38999999999999998655      


Q ss_pred             cEEEEeeccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHHHHHHHcCCCCCCcccCCcc-----ch
Q 005760          530 VAHLSDFGIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIMLMETFTRKKPTDEIFNGEM-----TL  604 (678)
Q Consensus       530 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~ell~g~~p~~~~~~~~~-----~~  604 (678)
                      .++++|||.+.....     ......||+.|+|||.+.+..++.++||||+||+++||++|+.||........     ..
T Consensus       170 ~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         170 QIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             eeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence            499999999976532     22456799999999999999999999999999999999999999865322110     00


Q ss_pred             hhhhhccc--CCc-------ccccc-------cCccCCccchhh------HHHHHHHHHHHHHHhhccccCcCCCCCHHH
Q 005760          605 KHWVNDWL--PIS-------TKEIV-------DPNLLSREDINF------VAKEQCVSFVFNVAMECTVESPEQRINAKE  662 (678)
Q Consensus       605 ~~~~~~~~--~~~-------~~~~~-------~~~~~~~~~~~~------~~~~~~~~~l~~l~~~cl~~dP~~Rps~~e  662 (678)
                      ...+....  +..       .....       ............      ......++++.+|+.+||++||++||||+|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            11000000  000       00000       000000000000      011356778999999999999999999999


Q ss_pred             HHH
Q 005760          663 IVT  665 (678)
Q Consensus       663 ll~  665 (678)
                      +++
T Consensus       325 ~L~  327 (362)
T d1q8ya_         325 LVN  327 (362)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            975

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=2.9e-29  Score=255.73  Aligned_cols=256  Identities=32%  Similarity=0.563  Sum_probs=181.6

Q ss_pred             CCCEEEccCccCCCCccchhhcccccCCCCCcEEECcc-CCCcccCChhhhhcccccccEEEcccccccccCCccccCCC
Q 005760           46 NLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSN-NPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLT  124 (678)
Q Consensus        46 ~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~  124 (678)
                      +++.|+|++|.+....   .+++.+.++++|++|+|++ |++.+..|.. +.+++ +|++|+|++|++.+..+..+..+.
T Consensus        51 ~v~~L~L~~~~l~g~~---~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~-i~~L~-~L~~L~Ls~N~l~~~~~~~~~~~~  125 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPY---PIPSSLANLPYLNFLYIGGINNLVGPIPPA-IAKLT-QLHYLYITHTNVSGAIPDFLSQIK  125 (313)
T ss_dssp             CEEEEEEECCCCSSCE---ECCGGGGGCTTCSEEEEEEETTEESCCCGG-GGGCT-TCSEEEEEEECCEEECCGGGGGCT
T ss_pred             EEEEEECCCCCCCCCC---CCChHHhcCccccccccccccccccccccc-ccccc-ccchhhhccccccccccccccchh
Confidence            4555566555554321   1223455566666666654 5555555544 55555 566666666666666666677777


Q ss_pred             CCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCc-cEEecCCCcCCCCChhhhhccccccceec
Q 005760          125 NLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDEL-YKLELGGNKLSGSIPECFNNLASLRILLL  203 (678)
Q Consensus       125 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L-~~L~l~~N~i~~~~~~~~~~l~~L~~L~l  203 (678)
                      +|+.++++.|.+.+..|..+.++++|+++++++|.+++.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++
T Consensus       126 ~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l  204 (313)
T d1ogqa_         126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDL  204 (313)
T ss_dssp             TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEEC
T ss_pred             hhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccc
Confidence            77777777777777777777777777777777777777777777776665 677777777777777777666444 5777


Q ss_pred             cccccc-cccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCce
Q 005760          204 GSNELT-SIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDL  282 (678)
Q Consensus       204 ~~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  282 (678)
                      ++|... .+|..+..+++|+.|++++|.+.+..+ .+..++          +|+.|+|++|++++.+|..+.++++|++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~----------~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L  273 (313)
T d1ogqa_         205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSK----------NLNGLDLRNNRIYGTLPQGLTQLKFLHSL  273 (313)
T ss_dssp             CSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCT----------TCCEEECCSSCCEECCCGGGGGCTTCCEE
T ss_pred             cccccccccccccccccccccccccccccccccc-cccccc----------ccccccCccCeecccCChHHhCCCCCCEE
Confidence            777665 455567777788888888888775544 454444          88888888888888888888888888888


Q ss_pred             ecccccccccCCCCCccccccccccccCccccCCCC
Q 005760          283 NLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN  318 (678)
Q Consensus       283 ~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~c~~~~  318 (678)
                      +|++|++++.+|....+..+..+++.+|+..|+.|.
T Consensus       274 ~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~pl  309 (313)
T d1ogqa_         274 NVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             ECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             ECcCCcccccCCCcccCCCCCHHHhCCCccccCCCC
Confidence            888888888888877788888888899988888773

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=1.4e-29  Score=258.12  Aligned_cols=253  Identities=26%  Similarity=0.388  Sum_probs=226.9

Q ss_pred             CCCCEEecCCCcccc--cCCccccCCCCCCEEEccC-ccCC-CCccchhhcccccCCCCCcEEECccCCCcccCChhhhh
Q 005760           21 SKLSILELSDNSFSG--FIPNTFGNLRNLQALRLSN-NYLT-SSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVG   96 (678)
Q Consensus        21 ~~L~~L~l~~n~i~~--~~~~~~~~l~~L~~L~l~~-n~i~-~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~   96 (678)
                      .++++|+|++|.+++  .+|..++++++|++|+|++ |.+. .+|      +.|.++++|++|+|++|++.+..+.. +.
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP------~~i~~L~~L~~L~Ls~N~l~~~~~~~-~~  122 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP------PAIAKLTQLHYLYITHTNVSGAIPDF-LS  122 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCC------GGGGGCTTCSEEEEEEECCEEECCGG-GG
T ss_pred             EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccc------cccccccccchhhhcccccccccccc-cc
Confidence            469999999999987  4789999999999999986 7776 444      35889999999999999999887765 56


Q ss_pred             cccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCC-CEEEccCCcCCCCCCCcccCCCCcc
Q 005760           97 NLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKL-QGLGLENNKLEGSIPDSICHSDELY  175 (678)
Q Consensus        97 ~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-~~L~L~~n~i~~~~~~~~~~l~~L~  175 (678)
                      .+. .|+.+++++|.+.+.+|..+.++++|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..|..+..+.. .
T Consensus       123 ~~~-~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~  200 (313)
T d1ogqa_         123 QIK-TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-A  200 (313)
T ss_dssp             GCT-TCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-S
T ss_pred             chh-hhcccccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccc-c
Confidence            665 89999999999999999999999999999999999999999999988886 88999999999888888877654 4


Q ss_pred             EEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccc
Q 005760          176 KLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISL  255 (678)
Q Consensus       176 ~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L  255 (678)
                      .+++++|.+.+..|..+..+++|+.|++++|.++..+..+..+++|+.|+|++|+++|.+|..|.+++          +|
T Consensus       201 ~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~----------~L  270 (313)
T d1ogqa_         201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK----------FL  270 (313)
T ss_dssp             EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCT----------TC
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCC----------CC
Confidence            79999999999999999999999999999999997777889999999999999999999999998888          99


Q ss_pred             cEEEccCCcCCCcchHHHhcccCCCceecccccccccC
Q 005760          256 ISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEI  293 (678)
Q Consensus       256 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  293 (678)
                      ++|+|++|+|++.+|. +..+++|+.+++++|++.|..
T Consensus       271 ~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~  307 (313)
T d1ogqa_         271 HSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGS  307 (313)
T ss_dssp             CEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEEST
T ss_pred             CEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCC
Confidence            9999999999988884 678999999999999966543

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=2e-26  Score=233.65  Aligned_cols=260  Identities=20%  Similarity=0.309  Sum_probs=219.5

Q ss_pred             cCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccC
Q 005760            5 WENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNN   84 (678)
Q Consensus         5 ~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n   84 (678)
                      ++++++ .+|..++  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+++.     .|.++++|++|++++|
T Consensus        18 ~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~-----~f~~l~~L~~L~l~~n   89 (305)
T d1xkua_          18 SDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG-----AFAPLVKLERLYLSKN   89 (305)
T ss_dssp             TTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTT-----TTTTCTTCCEEECCSS
T ss_pred             cCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchh-----hhhCCCccCEecccCC
Confidence            445666 7787775  5899999999999977777999999999999999999988754     5899999999999999


Q ss_pred             CCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccC--CcCChhhhccCCCCEEEccCCcCCC
Q 005760           85 PLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLN--GSIPSTLGKLQKLQGLGLENNKLEG  162 (678)
Q Consensus        85 ~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~L~L~~n~i~~  162 (678)
                      +++.+...     ....++.|.+.+|.+.+..+..+.....+..++...|...  ...+..|..+++|+.+++++|.++ 
T Consensus        90 ~l~~l~~~-----~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-  163 (305)
T d1xkua_          90 QLKELPEK-----MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-  163 (305)
T ss_dssp             CCSBCCSS-----CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred             ccCcCccc-----hhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-
Confidence            99865332     2237899999999999888888888999999999988654  344667889999999999999998 


Q ss_pred             CCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccCCCCccccc
Q 005760          163 SIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGN  241 (678)
Q Consensus       163 ~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~  241 (678)
                      .+|..+  .++|+.|++++|.+....+..|.+++.++.|++++|.++.++. .+.++++|++|+|++|+|+ .+|..|.+
T Consensus       164 ~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~  240 (305)
T d1xkua_         164 TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD  240 (305)
T ss_dssp             SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred             ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccc
Confidence            555544  5799999999999998889999999999999999999998855 7889999999999999998 45667777


Q ss_pred             cccccccccCcccccEEEccCCcCCCcchHHH------hcccCCCceecccccccc
Q 005760          242 LKIARIDSCDLISLISLNLSNNNLSGAIPASL------EKLSYLKDLNLSFNKLEG  291 (678)
Q Consensus       242 l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~------~~l~~L~~L~l~~N~~~~  291 (678)
                      ++          +|++|+|++|+|+.+....|      ..++.|+.|++++|+|..
T Consensus       241 l~----------~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~  286 (305)
T d1xkua_         241 HK----------YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY  286 (305)
T ss_dssp             CS----------SCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred             cc----------CCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCcc
Confidence            76          99999999999997655444      356788899999999863

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=4.6e-27  Score=235.66  Aligned_cols=250  Identities=23%  Similarity=0.259  Sum_probs=194.0

Q ss_pred             EEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccccE
Q 005760           25 ILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEY  104 (678)
Q Consensus        25 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~  104 (678)
                      .+++++++++ .+|..+.  +++++|+|++|+|+.++..     .|.++++|++|++++|++.                 
T Consensus        15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~-----~f~~l~~L~~L~ls~n~l~-----------------   69 (284)
T d1ozna_          15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAA-----SFRACRNLTILWLHSNVLA-----------------   69 (284)
T ss_dssp             EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTT-----TTTTCTTCCEEECCSSCCC-----------------
T ss_pred             EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHH-----Hhhcccccccccccccccc-----------------
Confidence            3455555555 3344332  3456666666666555432     3555555555555555554                 


Q ss_pred             EEcccccccccCCccccCCCCCcEEEcc-CCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCc
Q 005760          105 FEMAYCNVSGGIPEEIGNLTNLTIIYLG-GNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNK  183 (678)
Q Consensus       105 L~l~~n~l~~~~~~~~~~l~~L~~L~l~-~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~  183 (678)
                               ...+..+.+++.++.+... .|.++.+.+..|.++++|++|++++|.+....+..+...++|+.+++++|.
T Consensus        70 ---------~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~  140 (284)
T d1ozna_          70 ---------RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA  140 (284)
T ss_dssp             ---------EECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ---------ccccccccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccc
Confidence                     4445556777888887654 567776778888889999999999999886667778888899999999999


Q ss_pred             CCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccC
Q 005760          184 LSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSN  262 (678)
Q Consensus       184 i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~  262 (678)
                      ++++.+..|..+++|+.|++++|+|+.++. .|.++++|+.+++++|.+++..|..|.+++          +|+.|++++
T Consensus       141 l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~----------~L~~L~l~~  210 (284)
T d1ozna_         141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG----------RLMTLYLFA  210 (284)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT----------TCCEEECCS
T ss_pred             ccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhh----------hcccccccc
Confidence            987778888888999999999999998865 688899999999999999988888888877          999999999


Q ss_pred             CcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccCccccCCCC
Q 005760          263 NNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN  318 (678)
Q Consensus       263 N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~c~~~~  318 (678)
                      |++++..+..|..+++|++|++++|+|.|+|+..+...+++......+...|..|.
T Consensus       211 N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~  266 (284)
T d1ozna_         211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQ  266 (284)
T ss_dssp             SCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESG
T ss_pred             cccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCch
Confidence            99999999999999999999999999999998776667777777777788887653

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=2.4e-26  Score=233.01  Aligned_cols=265  Identities=21%  Similarity=0.217  Sum_probs=221.3

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEE
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLIS   80 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~   80 (678)
                      +|+|++|+|+...+.+|.++++|++|++++|.+..+.|++|.++++|++|++++|+++.++..        ....++.|.
T Consensus        35 ~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~--------~~~~l~~L~  106 (305)
T d1xkua_          35 LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK--------MPKTLQELR  106 (305)
T ss_dssp             EEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSS--------CCTTCCEEE
T ss_pred             EEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccc--------hhhhhhhhh
Confidence            489999999955556789999999999999999988899999999999999999999988743        346899999


Q ss_pred             CccCCCcccCChhhhhcccccccEEEccccccc--ccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCC
Q 005760           81 FSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVS--GGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENN  158 (678)
Q Consensus        81 L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n  158 (678)
                      +.+|.+..+.+.. +.... .+..++...|...  ...+..|.++++|+.+++++|.+. ..|..+  +++|++|++++|
T Consensus       107 ~~~n~l~~l~~~~-~~~~~-~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n  181 (305)
T d1xkua_         107 VHENEITKVRKSV-FNGLN-QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN  181 (305)
T ss_dssp             CCSSCCCBBCHHH-HTTCT-TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTS
T ss_pred             ccccchhhhhhhh-hhccc-cccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCC
Confidence            9999998765543 43333 6778888887655  445677899999999999999998 455443  589999999999


Q ss_pred             cCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCcc
Q 005760          159 KLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLE  238 (678)
Q Consensus       159 ~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~  238 (678)
                      .++...+..|..++.++.|++++|.+.+..+..+.++++|++|+|++|+|+++|.++..+++|+.|+|++|+|+......
T Consensus       182 ~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~  261 (305)
T d1xkua_         182 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSND  261 (305)
T ss_dssp             CCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCTTS
T ss_pred             cCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccCccChhh
Confidence            99988889999999999999999999998899999999999999999999999999999999999999999999776666


Q ss_pred             ccccccccccccCcccccEEEccCCcCC--CcchHHHhcccCCCce
Q 005760          239 IGNLKIARIDSCDLISLISLNLSNNNLS--GAIPASLEKLSYLKDL  282 (678)
Q Consensus       239 ~~~l~~~~~~~~~~~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L  282 (678)
                      |....    ....+++|+.|+|++|+++  .+.|.+|..+.....+
T Consensus       262 f~~~~----~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~~  303 (305)
T d1xkua_         262 FCPPG----YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV  303 (305)
T ss_dssp             SSCSS----CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGE
T ss_pred             ccCcc----hhcccCCCCEEECCCCcCccCcCCHhHhcccccCccc
Confidence            65433    1234568999999999886  4566666554444333

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.94  E-value=5.9e-26  Score=237.99  Aligned_cols=273  Identities=27%  Similarity=0.379  Sum_probs=198.1

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      |++++|+|++ + +.+..+++|++|+|++|+|+.+.  .|+++++|++|++++|.+..++       .+.++++|+.|++
T Consensus        49 L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~-------~l~~l~~L~~L~~  117 (384)
T d2omza2          49 LQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT-------PLANLTNLTGLTL  117 (384)
T ss_dssp             EECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG-------GGTTCTTCCEEEC
T ss_pred             EECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc-------ccccccccccccc
Confidence            6788888873 4 35778888999999999888653  4888888999999988887654       3678888888888


Q ss_pred             ccCCCcccCChh--------------------------------------------------------------hhhccc
Q 005760           82 SNNPLDGILPKT--------------------------------------------------------------SVGNLS   99 (678)
Q Consensus        82 ~~n~i~~~~~~~--------------------------------------------------------------~~~~l~   99 (678)
                      ++|.+++..+..                                                              ....++
T Consensus       118 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  197 (384)
T d2omza2         118 FNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLT  197 (384)
T ss_dssp             CSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccccccccccc
Confidence            888876432211                                                              111122


Q ss_pred             ccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEec
Q 005760          100 HSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL  179 (678)
Q Consensus       100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l  179 (678)
                       +++.+++++|.+++..|  +...++|++|++++|+++. + +.+..+++|+.|++++|.+++..  .+..+++|++|++
T Consensus       198 -~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l  270 (384)
T d2omza2         198 -NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKL  270 (384)
T ss_dssp             -TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEEC
T ss_pred             -ccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCEeec
Confidence             56677777777776544  4556777777777777763 2 35677777888888877777432  3667777888888


Q ss_pred             CCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEE
Q 005760          180 GGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLN  259 (678)
Q Consensus       180 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~  259 (678)
                      ++|.+++..  .+..++.++.+++++|+++.++ .+..+++++.|++++|++++..+  +..++          +|++|+
T Consensus       271 ~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~~-~~~~~~~l~~L~ls~n~l~~l~~--l~~l~----------~L~~L~  335 (384)
T d2omza2         271 GANQISNIS--PLAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDISP--VSSLT----------KLQRLF  335 (384)
T ss_dssp             CSSCCCCCG--GGTTCTTCSEEECCSSCCSCCG-GGGGCTTCSEEECCSSCCSCCGG--GGGCT----------TCCEEE
T ss_pred             cCcccCCCC--cccccccccccccccccccccc-ccchhcccCeEECCCCCCCCCcc--cccCC----------CCCEEE
Confidence            777777443  3667777777788777777654 46777888888888888876532  44444          899999


Q ss_pred             ccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccC
Q 005760          260 LSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGN  310 (678)
Q Consensus       260 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n  310 (678)
                      |++|+|++. + .+..+++|++|++++|++++..| ...+++|+.+++++|
T Consensus       336 L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N  383 (384)
T d2omza2         336 FANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred             CCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence            999999854 3 58889999999999999986654 566778888888776

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.7e-26  Score=228.99  Aligned_cols=248  Identities=24%  Similarity=0.285  Sum_probs=143.0

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      ++.++++++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..++..     .+..+..++.+..
T Consensus        16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~-----~~~~~~~~~~l~~   87 (284)
T d1ozna_          16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA-----AFTGLALLEQLDL   87 (284)
T ss_dssp             EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT-----TTTTCTTCCEEEC
T ss_pred             EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccc-----ccccccccccccc
Confidence            345677777 7887665  5799999999999988888999999999999999999987754     4677788888776


Q ss_pred             c-cCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcC
Q 005760           82 S-NNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKL  160 (678)
Q Consensus        82 ~-~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i  160 (678)
                      . .|.++.+.+                          ..|.++++|++|++++|.+....+..+...++|+.+++++|.|
T Consensus        88 ~~~~~~~~l~~--------------------------~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l  141 (284)
T d1ozna_          88 SDNAQLRSVDP--------------------------ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL  141 (284)
T ss_dssp             CSCTTCCCCCT--------------------------TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             ccccccccccc--------------------------hhhcccccCCEEecCCcccccccccccchhcccchhhhccccc
Confidence            4 444443333                          3344445555555555554434444444445555555555555


Q ss_pred             CCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccc-cccccccccccEEEecCCcccCCCCccc
Q 005760          161 EGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSI-PLTFWNLKDILYLNFSSNFFTGPLPLEI  239 (678)
Q Consensus       161 ~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l-~~~~~~l~~L~~L~l~~N~l~~~~~~~~  239 (678)
                      ++..+..|..+++|+.|++++|++....+..|.++++|+.+++++|+++.+ |..|..+++|+.|++++|++.+..+..|
T Consensus       142 ~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~  221 (284)
T d1ozna_         142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL  221 (284)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHH
T ss_pred             cccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccc
Confidence            433344444445555555555555544444455555555555555555544 2345555555555555555554444444


Q ss_pred             cccccccccccCcccccEEEccCCcCCCcch-HHHhcccCCCceecccccccccCCC
Q 005760          240 GNLKIARIDSCDLISLISLNLSNNNLSGAIP-ASLEKLSYLKDLNLSFNKLEGEIPR  295 (678)
Q Consensus       240 ~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~~~~~~~~  295 (678)
                      .+++          +|+.|+|++|++...-+ .++  ...++.+....+++.|..|.
T Consensus       222 ~~~~----------~L~~L~l~~N~l~C~C~~~~l--~~~l~~~~~~~~~~~C~~p~  266 (284)
T d1ozna_         222 APLR----------ALQYLRLNDNPWVCDCRARPL--WAWLQKFRGSSSEVPCSLPQ  266 (284)
T ss_dssp             TTCT----------TCCEEECCSSCEECSGGGHHH--HHHHHHCCSEECCCBEEESG
T ss_pred             cccc----------ccCEEEecCCCCCCCccchHH--HHHHHhCcCCCCceEeCCch
Confidence            4444          55555555555542211 111  11233444455555554443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.8e-25  Score=220.03  Aligned_cols=208  Identities=22%  Similarity=0.162  Sum_probs=168.9

Q ss_pred             cCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCC
Q 005760           71 SNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKL  150 (678)
Q Consensus        71 ~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  150 (678)
                      .+..++.+++.++++++.+ |.    +++.++++|+|++|+|++..+.+|.++++|++|+|++|+|+.+ + .++.+++|
T Consensus         7 ~~~~~~~~v~C~~~~L~~i-P~----~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L   79 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLTAL-PP----DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVL   79 (266)
T ss_dssp             ECSTTCCEEECTTSCCSSC-CS----CCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTC
T ss_pred             cccCCCeEEEccCCCCCee-Cc----CcCcCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-cccccccc
Confidence            3445556666666666543 32    2334677777777777776677888999999999999999843 3 36788999


Q ss_pred             CEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCC
Q 005760          151 QGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSN  229 (678)
Q Consensus       151 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N  229 (678)
                      ++|+|++|+++ ..+..+..+++|+.|++++|.+....+..+..+.+|+.|++++|.++.++. .+..+++|+.|++++|
T Consensus        80 ~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N  158 (266)
T d1p9ag_          80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN  158 (266)
T ss_dssp             CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred             ccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccc
Confidence            99999999998 567788899999999999999998888888889999999999999998876 5778899999999999


Q ss_pred             cccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCC
Q 005760          230 FFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGG  297 (678)
Q Consensus       230 ~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~  297 (678)
                      ++++..+..|..++          +|++|+|++|+|+ .+|..+..+++|+.|+|++|||.|+|...+
T Consensus       159 ~l~~~~~~~~~~l~----------~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~~~~  215 (266)
T d1p9ag_         159 NLTELPAGLLNGLE----------NLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEILY  215 (266)
T ss_dssp             CCSCCCTTTTTTCT----------TCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGGGHH
T ss_pred             cccccCcccccccc----------ccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcchHH
Confidence            99988888887777          9999999999999 566667788999999999999999886543

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.92  E-value=2.6e-24  Score=225.31  Aligned_cols=256  Identities=26%  Similarity=0.333  Sum_probs=214.5

Q ss_pred             CccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchh---------------
Q 005760            1 MLQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELS---------------   65 (678)
Q Consensus         1 ~L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~---------------   65 (678)
                      +|+|++|+|++ +|. +.++++|++|++++|+|.++.  .++++++|+.|++++|.+........               
T Consensus        70 ~L~Ls~N~l~~-l~~-l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  145 (384)
T d2omza2          70 QINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTIS  145 (384)
T ss_dssp             EEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEEC
T ss_pred             EEeCcCCcCCC-Ccc-ccCCccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccc
Confidence            48999999995 443 899999999999999999653  48999999999999998876543210               


Q ss_pred             -------------------------------------------hcccccCCCCCcEEECccCCCcccCChhhhhcccccc
Q 005760           66 -------------------------------------------FLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSL  102 (678)
Q Consensus        66 -------------------------------------------~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L  102 (678)
                                                                 ....+..+++++.+++++|.+++..+.   ... .+|
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~~---~~~-~~L  221 (384)
T d2omza2         146 DISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPL---GIL-TNL  221 (384)
T ss_dssp             CCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGGG---GGC-TTC
T ss_pred             ccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccCCccCCCCcc---ccc-CCC
Confidence                                                       012456789999999999999877553   233 389


Q ss_pred             cEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCC
Q 005760          103 EYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGN  182 (678)
Q Consensus       103 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N  182 (678)
                      ++|++++|.++..  ..+..+++|+.|++++|.+++..  .+..+++|++|++++|.+++. + .+..++.++.+++++|
T Consensus       222 ~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~-~-~~~~~~~l~~l~~~~n  295 (384)
T d2omza2         222 DELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNI-S-PLAGLTALTNLELNEN  295 (384)
T ss_dssp             CEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCSEEECCSS
T ss_pred             CEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCC-C-cccccccccccccccc
Confidence            9999999999864  46889999999999999998543  388899999999999999844 3 4788999999999999


Q ss_pred             cCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccC
Q 005760          183 KLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSN  262 (678)
Q Consensus       183 ~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~  262 (678)
                      .+.+.  ..+..+++++.|++++|+++.++ .+..+++|+.|++++|++++. + .+.+++          +|+.|+|++
T Consensus       296 ~l~~~--~~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~----------~L~~L~l~~  360 (384)
T d2omza2         296 QLEDI--SPISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVSDV-S-SLANLT----------NINWLSAGH  360 (384)
T ss_dssp             CCSCC--GGGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCCCC-G-GGGGCT----------TCCEEECCS
T ss_pred             ccccc--cccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCCCC-h-hHcCCC----------CCCEEECCC
Confidence            99954  45888999999999999999986 488899999999999999853 2 466655          999999999


Q ss_pred             CcCCCcchHHHhcccCCCceecccc
Q 005760          263 NNLSGAIPASLEKLSYLKDLNLSFN  287 (678)
Q Consensus       263 N~l~~~~~~~~~~l~~L~~L~l~~N  287 (678)
                      |+|++..|  +.++++|+.|+|++|
T Consensus       361 N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         361 NQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             SCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CcCCCChh--hccCCCCCEeeCCCC
Confidence            99997765  889999999999998

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=8.1e-25  Score=216.70  Aligned_cols=202  Identities=23%  Similarity=0.285  Sum_probs=132.5

Q ss_pred             cCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhc
Q 005760           18 FNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGN   97 (678)
Q Consensus        18 ~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~   97 (678)
                      ....++.+.+.++++++ .+|..+.  ++|++|+|++|+|+.++..     .|.++++|++|+|++|+|+.+.+   ++.
T Consensus         7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~-----~f~~l~~L~~L~L~~N~l~~l~~---~~~   75 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLA-----TLMPYTRLTQLNLDRAELTKLQV---DGT   75 (266)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGG-----GGTTCTTCCEEECTTSCCCEEEC---CSC
T ss_pred             cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHH-----Hhhcccccccccccccccccccc---ccc
Confidence            34556667788888887 3565553  4678888888888776643     47778888888888887764432   223


Q ss_pred             ccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEE
Q 005760           98 LSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKL  177 (678)
Q Consensus        98 l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L  177 (678)
                      ++ +|++|+|++|+++.. +..+.++++|+.|++++|.+....+..+..+.++++|++++|.++...+..+..+++|+.|
T Consensus        76 l~-~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l  153 (266)
T d1p9ag_          76 LP-VLGTLDLSHNQLQSL-PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL  153 (266)
T ss_dssp             CT-TCCEEECCSSCCSSC-CCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             cc-ccccccccccccccc-ccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhc
Confidence            33 555555555555532 4456666777777777777666666666666777777777777765555566666677777


Q ss_pred             ecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCccc
Q 005760          178 ELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       178 ~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~  232 (678)
                      ++++|++++..+..|..+++|++|+|++|+|+.+|..+..+++|+.|+|++|++.
T Consensus       154 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         154 SLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             ECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBC
T ss_pred             ccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCC
Confidence            7777777766666666667777777777777666666666666666666666554

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=5e-23  Score=192.68  Aligned_cols=168  Identities=16%  Similarity=0.163  Sum_probs=118.9

Q ss_pred             CCCccccCCCceeEEEEEeCCCcEEEEEEeecccC------------------chhhhHHHHHHHHHhCCCccceeeeee
Q 005760          395 SENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYG------------------RVFKSFDVECEMMKSIRHRNIIKVISS  456 (678)
Q Consensus       395 ~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~~~  456 (678)
                      .+.+.||+|+||+||+|...+|+.||||+++....                  ........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45789999999999999988999999998753211                  011334568888999999999988766


Q ss_pred             eecCCeEEEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEEcCCCCCCeeecCCCcEEEEee
Q 005760          457 CSNEEFKALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGYSAQVIHCDLKPSNVLLDDNMVAHLSDF  536 (678)
Q Consensus       457 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl~~~Nill~~~~~~kl~Df  536 (678)
                      ..    .+++|||+++..+.+        ++......++.|++.+++|||   +++|+||||||+|||+++++ ++++||
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EEECCC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EEEEEC
Confidence            43    369999998865432        233345678999999999999   99999999999999999764 899999


Q ss_pred             ccccccCCCCCcceeecccCCccccCccccCCCCCCccchHHHHHHH
Q 005760          537 GIAKLLTREDQSTIQTQTLATIGYMAPEYGKEGRVSANGDVYSFGIM  583 (678)
Q Consensus       537 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~  583 (678)
                      |.|+....+.........+.   . ..+. ..+.|+.++|+||..--
T Consensus       147 G~a~~~~~~~~~~~l~rd~~---~-~~~~-f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         147 PQSVEVGEEGWREILERDVR---N-IITY-FSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             TTCEETTSTTHHHHHHHHHH---H-HHHH-HHHHHCCCCCHHHHHHH
T ss_pred             CCcccCCCCCcHHHHHHHHH---H-HHHH-HcCCCCCcccHHHHHHH
Confidence            99976543221110000000   0 0011 13567888999997543

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.83  E-value=2.9e-20  Score=178.99  Aligned_cols=184  Identities=21%  Similarity=0.322  Sum_probs=95.5

Q ss_pred             ccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECcc
Q 005760            4 MWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSN   83 (678)
Q Consensus         4 l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~   83 (678)
                      ++.+++++.++  +..+++|+.|++.+|+|+..  ..+.++++|++|++++|.+..+.       .|..+++|+++++++
T Consensus        26 l~~~~~~d~~~--~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~-------~l~~l~~l~~l~~~~   94 (227)
T d1h6ua2          26 AGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA-------PLKNLTKITELELSG   94 (227)
T ss_dssp             TTCSSTTSEEC--HHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG-------GGTTCCSCCEEECCS
T ss_pred             hCCCCcCCcCC--HHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc-------ccccccccccccccc
Confidence            44444443332  34455556666666655532  23555566666666665555433       245555555555555


Q ss_pred             CCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCC
Q 005760           84 NPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGS  163 (678)
Q Consensus        84 n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~  163 (678)
                      |.++.+                            ..+..+++|+.+++++|...+.  ..+...+.++.+.++++.+...
T Consensus        95 n~~~~i----------------------------~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~  144 (227)
T d1h6ua2          95 NPLKNV----------------------------SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI  144 (227)
T ss_dssp             CCCSCC----------------------------GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC
T ss_pred             cccccc----------------------------cccccccccccccccccccccc--chhccccchhhhhchhhhhchh
Confidence            555432                            1244555555555555555422  2244455555555555555421


Q ss_pred             CCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccC
Q 005760          164 IPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTG  233 (678)
Q Consensus       164 ~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~  233 (678)
                        ..+..+++|+.|++++|.+.+..  .+.++++|+.|+|++|+++.++. +.++++|++|+|++|++++
T Consensus       145 --~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~-l~~l~~L~~L~Ls~N~lt~  209 (227)
T d1h6ua2         145 --SPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISD  209 (227)
T ss_dssp             --GGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCB
T ss_pred             --hhhccccccccccccccccccch--hhcccccceecccCCCccCCChh-hcCCCCCCEEECcCCcCCC
Confidence              23455555666666655555322  25555566666666666555542 4555566666666666553

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.82  E-value=1.6e-20  Score=180.83  Aligned_cols=209  Identities=21%  Similarity=0.306  Sum_probs=159.1

Q ss_pred             CCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccc
Q 005760           20 ASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLS   99 (678)
Q Consensus        20 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~   99 (678)
                      +.++..++++.+++++..  .+..+.+|+.|++++|.|++++       .+..+++|++|++++|.+.+           
T Consensus        18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l~-------~l~~l~~L~~L~ls~n~i~~-----------   77 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIE-------GVQYLNNLIGLELKDNQITD-----------   77 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCCT-------TGGGCTTCCEEECCSSCCCC-----------
T ss_pred             HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcch-------hHhcCCCCcEeecCCceeec-----------
Confidence            334445566666666442  3455666677777776666543       24566666666666666542           


Q ss_pred             ccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEec
Q 005760          100 HSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLEL  179 (678)
Q Consensus       100 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l  179 (678)
                                     ..  .+..+++|+.|++++|.++. + ..+.++++|+++++++|.+.+.  ..+...+.+..+.+
T Consensus        78 ---------------~~--~l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~  136 (227)
T d1h6ua2          78 ---------------LA--PLKNLTKITELELSGNPLKN-V-SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYL  136 (227)
T ss_dssp             ---------------CG--GGTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEEC
T ss_pred             ---------------cc--cccccccccccccccccccc-c-cccccccccccccccccccccc--chhccccchhhhhc
Confidence                           22  27788999999999999984 3 4588999999999999998733  35778899999999


Q ss_pred             CCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEE
Q 005760          180 GGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLN  259 (678)
Q Consensus       180 ~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~  259 (678)
                      +.+.+...  ..+..+++|+.|++++|.++..+. +.++++|+.|+|++|++++..+  +.+++          +|++|+
T Consensus       137 ~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~l~~--l~~l~----------~L~~L~  201 (227)
T d1h6ua2         137 DLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDISP--LASLP----------NLIEVH  201 (227)
T ss_dssp             CSSCCCCC--GGGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCT----------TCCEEE
T ss_pred             hhhhhchh--hhhccccccccccccccccccchh-hcccccceecccCCCccCCChh--hcCCC----------CCCEEE
Confidence            99999854  347889999999999999987654 7889999999999999985432  55555          999999


Q ss_pred             ccCCcCCCcchHHHhcccCCCceeccc
Q 005760          260 LSNNNLSGAIPASLEKLSYLKDLNLSF  286 (678)
Q Consensus       260 L~~N~l~~~~~~~~~~l~~L~~L~l~~  286 (678)
                      |++|+|+++.|  +..+++|+.|++++
T Consensus       202 Ls~N~lt~i~~--l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         202 LKNNQISDVSP--LANTSNLFIVTLTN  226 (227)
T ss_dssp             CTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred             CcCCcCCCCcc--cccCCCCCEEEeeC
Confidence            99999997654  88999999999974

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=7.1e-20  Score=178.15  Aligned_cols=207  Identities=19%  Similarity=0.159  Sum_probs=99.7

Q ss_pred             cCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccC
Q 005760            5 WENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNN   84 (678)
Q Consensus         5 ~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n   84 (678)
                      ++++++ .+|..++  .++++|+|++|+|+.+.+++|.++++|++|+|++|.+......    ..|.++++++.+.+.. 
T Consensus        16 ~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~----~~f~~l~~l~~l~~~~-   87 (242)
T d1xwdc1          16 QESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA----DVFSNLPKLHEIRIEK-   87 (242)
T ss_dssp             ESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECS----SSEESCTTCCEEEEEC-
T ss_pred             eCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeec----cccccccccccccccc-
Confidence            344444 4443332  2455555555555544444555555555555555544332111    1244444555444432 


Q ss_pred             CCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCCh-hhhccCCCCEEEccCCcCCCC
Q 005760           85 PLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPS-TLGKLQKLQGLGLENNKLEGS  163 (678)
Q Consensus        85 ~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~n~i~~~  163 (678)
                                              .|++....+..|.++++|+.|++++|++....+. .+..+..+..+...++.+...
T Consensus        88 ------------------------~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i  143 (242)
T d1xwdc1          88 ------------------------ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTI  143 (242)
T ss_dssp             ------------------------CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEE
T ss_pred             ------------------------cccccccccccccccccccccccchhhhcccccccccccccccccccccccccccc
Confidence                                    2344444455555666666666666655432221 222334444445555555533


Q ss_pred             CCCcccCCC-CccEEecCCCcCCCCChhhhhccccccceeccccccccccc-cccccccccEEEecCCcccCCCCccccc
Q 005760          164 IPDSICHSD-ELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGN  241 (678)
Q Consensus       164 ~~~~~~~l~-~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~  241 (678)
                      .+..|.+++ .++.|++++|+++...+..+....-++.+++++|+|+++|. .|.++++|+.|+|++|+|+...+..|.+
T Consensus       144 ~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~  223 (242)
T d1xwdc1         144 ERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN  223 (242)
T ss_dssp             CTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTT
T ss_pred             cccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcC
Confidence            444454443 55666666666664433333322222333455556666654 3556666666666666666444444444


Q ss_pred             cc
Q 005760          242 LK  243 (678)
Q Consensus       242 l~  243 (678)
                      ++
T Consensus       224 l~  225 (242)
T d1xwdc1         224 LK  225 (242)
T ss_dssp             CC
T ss_pred             Cc
Confidence            44

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=2.4e-19  Score=169.98  Aligned_cols=185  Identities=22%  Similarity=0.287  Sum_probs=114.3

Q ss_pred             CCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccccc
Q 005760           22 KLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHS  101 (678)
Q Consensus        22 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~  101 (678)
                      ++...+++.+.+++.++.  ..+.+|+.|++++|.++++.       .+..+++|++|+|++|+|+++.+   +..++ +
T Consensus        25 ~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~-------~l~~l~~L~~L~L~~n~i~~l~~---~~~l~-~   91 (210)
T d1h6ta2          25 ETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ-------GIQYLPNVTKLFLNGNKLTDIKP---LANLK-N   91 (210)
T ss_dssp             HHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT-------TGGGCTTCCEEECCSSCCCCCGG---GTTCT-T
T ss_pred             HHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCch-------hHhhCCCCCEEeCCCccccCccc---cccCc-c
Confidence            344456666766654432  24667778888888777654       25667778888888887765432   33343 5


Q ss_pred             ccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCC
Q 005760          102 LEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGG  181 (678)
Q Consensus       102 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~  181 (678)
                      |++|++++|++++. + .+.++++|+.|++++|.+..  ...+..++++++++++.|.+++  +..+..+++|+++++++
T Consensus        92 L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~  165 (210)
T d1h6ta2          92 LGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLED  165 (210)
T ss_dssp             CCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCS
T ss_pred             cccccccccccccc-c-cccccccccccccccccccc--cccccccccccccccccccccc--ccccccccccccccccc
Confidence            55666666655542 2 35666777777777776652  2346666677777777777662  23455666677777777


Q ss_pred             CcCCCCChhhhhccccccceeccccccccccccccccccccEEEecC
Q 005760          182 NKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSS  228 (678)
Q Consensus       182 N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~  228 (678)
                      |++++. + .+.++++|+.|+|++|+|++++ .+.++++|+.|+|++
T Consensus       166 n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         166 NQISDI-V-PLAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             SCCCCC-G-GGTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEEE
T ss_pred             cccccc-c-cccCCCCCCEEECCCCCCCCCh-hhcCCCCCCEEEccC
Confidence            766643 2 2666666777777777666665 466666666666653

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=9.2e-20  Score=177.34  Aligned_cols=220  Identities=19%  Similarity=0.127  Sum_probs=166.3

Q ss_pred             CEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhccccccc
Q 005760           24 SILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLE  103 (678)
Q Consensus        24 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~  103 (678)
                      +.++.++++++ .+|+.+.  +++++|+|++|+|+.++..     +|.++++|++|++++|.+...              
T Consensus        11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~-----~f~~l~~L~~L~ls~n~~~~~--------------   68 (242)
T d1xwdc1          11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKG-----AFSGFGDLEKIEISQNDVLEV--------------   68 (242)
T ss_dssp             SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTT-----TTTTCTTCCEEEEESCTTCCE--------------
T ss_pred             CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChh-----Hhhccchhhhhhhccccccce--------------
Confidence            56677777777 4444432  4677777777777666543     366677777777777666432              


Q ss_pred             EEEcccccccccCCccccCCCCCcEEEccC-CccCCcCChhhhccCCCCEEEccCCcCCCCCCC-cccCCCCccEEecCC
Q 005760          104 YFEMAYCNVSGGIPEEIGNLTNLTIIYLGG-NKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPD-SICHSDELYKLELGG  181 (678)
Q Consensus       104 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~l~~  181 (678)
                                 ..+..|.+++++++|.+.. |++....+..|.++++|++|++++|.+....+. .+..+..+..+..++
T Consensus        69 -----------i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n  137 (242)
T d1xwdc1          69 -----------IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN  137 (242)
T ss_dssp             -----------ECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESC
T ss_pred             -----------eeccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccc
Confidence                       2245688899999998764 788878888999999999999999999844332 344567777888888


Q ss_pred             CcCCCCChhhhhccc-cccceeccccccccccccccccccccEE-EecCCcccCCCCccccccccccccccCcccccEEE
Q 005760          182 NKLSGSIPECFNNLA-SLRILLLGSNELTSIPLTFWNLKDILYL-NFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLN  259 (678)
Q Consensus       182 N~i~~~~~~~~~~l~-~L~~L~l~~N~l~~l~~~~~~l~~L~~L-~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~  259 (678)
                      +.+....+..|.+++ .++.|++++|+++.++.......++..+ ++++|.++...+..|.+++          +|++|+
T Consensus       138 ~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~----------~L~~L~  207 (242)
T d1xwdc1         138 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGAS----------GPVILD  207 (242)
T ss_dssp             TTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSC----------CCSEEE
T ss_pred             cccccccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCC----------CCCEEE
Confidence            899877777888775 7899999999999998866666676655 5788889866666777776          999999


Q ss_pred             ccCCcCCCcchHHHhcccCCCceeccc
Q 005760          260 LSNNNLSGAIPASLEKLSYLKDLNLSF  286 (678)
Q Consensus       260 L~~N~l~~~~~~~~~~l~~L~~L~l~~  286 (678)
                      |++|+|+...+..|..+++|+.+++.+
T Consensus       208 Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         208 ISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             CTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             CCCCcCCccCHHHHcCCcccccCcCCC
Confidence            999999977777888888888887754

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=1e-18  Score=164.16  Aligned_cols=179  Identities=25%  Similarity=0.310  Sum_probs=87.9

Q ss_pred             CCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccc
Q 005760           23 LSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSL  102 (678)
Q Consensus        23 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L  102 (678)
                      +..+.++.+.+++...  ...+++|++|++++|.+.+++       .+..+++|++|++++|+++++.+   +.+++ +|
T Consensus        20 ~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l~-------~l~~l~nL~~L~Ls~N~l~~~~~---l~~l~-~L   86 (199)
T d2omxa2          20 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSID-------GVEYLNNLTQINFSNNQLTDITP---LKNLT-KL   86 (199)
T ss_dssp             HHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCCT-------TGGGCTTCCEEECCSSCCCCCGG---GTTCT-TC
T ss_pred             HHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCcc-------ccccCCCcCcCccccccccCccc---ccCCc-cc
Confidence            3444555555554322  234556666666666665543       24556666666666666654321   22222 33


Q ss_pred             cEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCC
Q 005760          103 EYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGN  182 (678)
Q Consensus       103 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N  182 (678)
                      ++|++++|.+....  .+.++++|+.|++++|.+...  ..+..+++|+.|++++|++. .++ .+..+++|+.|++++|
T Consensus        87 ~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n  160 (199)
T d2omxa2          87 VDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSN  160 (199)
T ss_dssp             CEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSS
T ss_pred             cccccccccccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccc
Confidence            33333333333221  244555555555555555422  23445555555555555554 222 3555555555555555


Q ss_pred             cCCCCChhhhhccccccceeccccccccccccccccccccE
Q 005760          183 KLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILY  223 (678)
Q Consensus       183 ~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~  223 (678)
                      .+++..  .++++++|+.|++++|+|++++ .+..+++|+.
T Consensus       161 ~l~~l~--~l~~l~~L~~L~ls~N~i~~i~-~l~~L~~L~~  198 (199)
T d2omxa2         161 QVTDLK--PLANLTTLERLDISSNKVSDIS-VLAKLTNLES  198 (199)
T ss_dssp             CCCCCG--GGTTCTTCCEEECCSSCCCCCG-GGGGCTTCSE
T ss_pred             cccCCc--cccCCCCCCEEECCCCCCCCCc-cccCCCCCCc
Confidence            555331  2555555555555555555543 2444444444

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.78  E-value=2.7e-19  Score=167.09  Aligned_cols=175  Identities=26%  Similarity=0.355  Sum_probs=100.5

Q ss_pred             cEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCC-CCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccc
Q 005760          127 TIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSI-PDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGS  205 (678)
Q Consensus       127 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~  205 (678)
                      +.++.++|+++ .+|..+.  +++++|+|++|+|++.+ +..|.++++|+.|+|++|.+....+..|..+++|++|+|++
T Consensus        11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            34555555555 3443332  45666666666665322 34455566666666666666655556666666666666666


Q ss_pred             cccccccc-cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcch-HHHhcccCCCcee
Q 005760          206 NELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIP-ASLEKLSYLKDLN  283 (678)
Q Consensus       206 N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~  283 (678)
                      |+|+.++. .|.++++|+.|+|++|+|++..+..|.+++          +|++|+|++|.+..... .++.  ..+..+.
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~----------~L~~l~L~~N~~~~~~~~~~~~--~~l~~~~  155 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN----------SLTSLNLASNPFNCNCHLAWFA--EWLRKKS  155 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCT----------TCCEEECTTCCBCCSGGGHHHH--HHHHHHC
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCc----------ccccccccccccccccchHHHh--hhhhhhc
Confidence            66666644 456666666666666666655555565555          66677777666653222 1221  2345566


Q ss_pred             cccccccccCCCCCccccccccccccCccccCCCC
Q 005760          284 LSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPN  318 (678)
Q Consensus       284 l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~c~~~~  318 (678)
                      +..|.++|..|..  +..+...++..|.+.|.++.
T Consensus       156 l~~~~~~c~~p~~--l~~~~l~~L~~n~l~C~~~~  188 (192)
T d1w8aa_         156 LNGGAARCGAPSK--VRDVQIKDLPHSEFKCSSEN  188 (192)
T ss_dssp             CSGGGCBBCSSTT--TTTSBGGGSCTTTCCCCCC-
T ss_pred             ccCCCeEeCCChh--hcCCEeeecCHhhCcCCCCC
Confidence            6677777665542  44455566777777776653

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.77  E-value=8.9e-18  Score=172.57  Aligned_cols=269  Identities=27%  Similarity=0.280  Sum_probs=148.4

Q ss_pred             ccccCCcCcccCCccccCCCCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEEC
Q 005760            2 LQMWENNFSGTIPRFIFNASKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISF   81 (678)
Q Consensus         2 L~l~~~~~~~~~p~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L   81 (678)
                      |||++++++ .+|+.   .++|++|+|++|+|+ .+|+.   +.+|+.|++++|.++.++.-         .++|++|++
T Consensus        43 LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l~~l---------p~~L~~L~L  105 (353)
T d1jl5a_          43 LELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKALSDL---------PPLLEYLGV  105 (353)
T ss_dssp             EECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCCSC---------CTTCCEEEC
T ss_pred             EEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchhhhh---------ccccccccc
Confidence            677777776 56753   456777788887777 44544   34677777777777765421         135777777


Q ss_pred             ccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCC
Q 005760           82 SNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLE  161 (678)
Q Consensus        82 ~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~  161 (678)
                      ++|.+..+..   ++.+. +|+.|++++|.+.....    ....+..+.+..+...  ....+..++.++.|.++.|.+.
T Consensus       106 ~~n~l~~lp~---~~~l~-~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~  175 (353)
T d1jl5a_         106 SNNQLEKLPE---LQNSS-FLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK  175 (353)
T ss_dssp             CSSCCSSCCC---CTTCT-TCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred             cccccccccc---hhhhc-cceeecccccccccccc----ccccccchhhcccccc--ccccccccccceeccccccccc
Confidence            7777765432   34444 67777777776653321    1233334444333332  1233444555566665555543


Q ss_pred             C-------------------CCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceecccccccccccccccccccc
Q 005760          162 G-------------------SIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDIL  222 (678)
Q Consensus       162 ~-------------------~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~  222 (678)
                      .                   .+ ..+..++.|+.+++++|.... .+.   ...++..+.+.+|.+...+...   +.+.
T Consensus       176 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l~~~~~~~~~~~~~~~~~---~~l~  247 (353)
T d1jl5a_         176 KLPDLPLSLESIVAGNNILEEL-PELQNLPFLTTIYADNNLLKT-LPD---LPPSLEALNVRDNYLTDLPELP---QSLT  247 (353)
T ss_dssp             SCCCCCTTCCEEECCSSCCSSC-CCCTTCTTCCEEECCSSCCSS-CCS---CCTTCCEEECCSSCCSCCCCCC---TTCC
T ss_pred             cccccccccccccccccccccc-ccccccccccccccccccccc-ccc---cccccccccccccccccccccc---cccc
Confidence            2                   12 235567788888888887773 332   2345666777777666544322   2334


Q ss_pred             EEEecCCcccCCCCc--cccc--c---ccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCC
Q 005760          223 YLNFSSNFFTGPLPL--EIGN--L---KIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPR  295 (678)
Q Consensus       223 ~L~l~~N~l~~~~~~--~~~~--l---~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  295 (678)
                      ..++..|.+.+....  ....  +   .+.. ....+++|++|+|++|+|+. +|.   .+++|+.|++++|.++. +|.
T Consensus       248 ~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~-~~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~~-l~~  321 (353)
T d1jl5a_         248 FLDVSENIFSGLSELPPNLYYLNASSNEIRS-LCDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLAE-VPE  321 (353)
T ss_dssp             EEECCSSCCSEESCCCTTCCEEECCSSCCSE-ECCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC
T ss_pred             ccccccccccccccccchhcccccccCcccc-ccccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCCc-ccc
Confidence            444444333211100  0000  0   0000 01224577777777777774 332   35677777777777764 333


Q ss_pred             CCccccccccccccCccc
Q 005760          296 GGSFGNFSAESFEGNELL  313 (678)
Q Consensus       296 ~~~~~~l~~~~~~~n~~~  313 (678)
                      .  ..+|+.+++++|+..
T Consensus       322 ~--~~~L~~L~L~~N~L~  337 (353)
T d1jl5a_         322 L--PQNLKQLHVEYNPLR  337 (353)
T ss_dssp             C--CTTCCEEECCSSCCS
T ss_pred             c--cCCCCEEECcCCcCC
Confidence            2  346777777777654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=4.9e-19  Score=167.81  Aligned_cols=182  Identities=26%  Similarity=0.355  Sum_probs=133.9

Q ss_pred             EEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccC
Q 005760           78 LISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLEN  157 (678)
Q Consensus        78 ~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~  157 (678)
                      ..+++.+.+++..+..   .+. +|++|++++|.++...  .+..+++|++|+|++|++++..  .++.+++|++|++++
T Consensus        28 ~~~l~~~~~~~~~~~~---~L~-~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~   99 (210)
T d1h6ta2          28 KDNLKKKSVTDAVTQN---ELN-SIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDE   99 (210)
T ss_dssp             HHHTTCSCTTSEECHH---HHH-TCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCS
T ss_pred             HHHhCcCccCCccCHH---Hhc-CccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccc
Confidence            3455566665554432   233 6777788877777543  3777888888888888887543  367788888888888


Q ss_pred             CcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCc
Q 005760          158 NKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPL  237 (678)
Q Consensus       158 n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~  237 (678)
                      |+|+ .++ .+..+++|+.|++++|.+...  ..+..+++|+.+++++|.++.++ .+..+++|+.+++++|++++..+ 
T Consensus       100 n~i~-~l~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~~~-~~~~l~~L~~l~l~~n~l~~i~~-  173 (210)
T d1h6ta2         100 NKVK-DLS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISDIVP-  173 (210)
T ss_dssp             SCCC-CGG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG-
T ss_pred             cccc-ccc-ccccccccccccccccccccc--ccccccccccccccccccccccc-ccccccccccccccccccccccc-
Confidence            8888 344 578888888888888888743  35778888888888888888755 45677888889999888875332 


Q ss_pred             cccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCceeccc
Q 005760          238 EIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSF  286 (678)
Q Consensus       238 ~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  286 (678)
                       +.+++          +|++|+|++|+|+++ + .+..+++|++|+|++
T Consensus       174 -l~~l~----------~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         174 -LAGLT----------KLQNLYLSKNHISDL-R-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             -GTTCT----------TCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEE
T ss_pred             -ccCCC----------CCCEEECCCCCCCCC-h-hhcCCCCCCEEEccC
Confidence             44444          899999999988854 3 588888899988864

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.77  E-value=2.2e-19  Score=167.70  Aligned_cols=157  Identities=24%  Similarity=0.302  Sum_probs=75.8

Q ss_pred             CCcEEEccCCccCC-cCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceec
Q 005760          125 NLTIIYLGGNKLNG-SIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLL  203 (678)
Q Consensus       125 ~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l  203 (678)
                      ++++|+|++|+|++ ..+..|.++++|++|+|++|.++...+..|..+++|++|+|++|+|+...++.|.++++|++|+|
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L  109 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence            34444444444432 22333444444444444444444444444444444444444444444444444444555555555


Q ss_pred             cccccccccc-cccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHHhcccCCCce
Q 005760          204 GSNELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASLEKLSYLKDL  282 (678)
Q Consensus       204 ~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  282 (678)
                      ++|+|+.++. .|..+++|++|+|++|++.......+. ..          .++.+.+..|.++...|..   +..++.+
T Consensus       110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~-~~----------~l~~~~l~~~~~~c~~p~~---l~~~~l~  175 (192)
T d1w8aa_         110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF-AE----------WLRKKSLNGGAARCGAPSK---VRDVQIK  175 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH-HH----------HHHHHCCSGGGCBBCSSTT---TTTSBGG
T ss_pred             CCccccccCHHHhcCCcccccccccccccccccchHHH-hh----------hhhhhcccCCCeEeCCChh---hcCCEee
Confidence            5555554433 344555555555555555432221110 11          3445555666665544433   4456677


Q ss_pred             ecccccccccCCC
Q 005760          283 NLSFNKLEGEIPR  295 (678)
Q Consensus       283 ~l~~N~~~~~~~~  295 (678)
                      +++.|.+.|..+.
T Consensus       176 ~L~~n~l~C~~~~  188 (192)
T d1w8aa_         176 DLPHSEFKCSSEN  188 (192)
T ss_dssp             GSCTTTCCCCCC-
T ss_pred             ecCHhhCcCCCCC
Confidence            8888888876654

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.77  E-value=3.5e-18  Score=160.37  Aligned_cols=159  Identities=30%  Similarity=0.407  Sum_probs=108.8

Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      ++++|++++|.++..  +.+..+++|++|++++|++++..+  ++++++|++|++++|.+. .++ .+..++.|+.|+++
T Consensus        41 ~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~  114 (199)
T d2omxa2          41 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLF  114 (199)
T ss_dssp             TCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECC
T ss_pred             CCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccc
Confidence            455555555555533  235667788888888887774432  777788888888888776 333 47777888888888


Q ss_pred             CCcCCCCChhhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCccccccccccccccCcccccEEEc
Q 005760          181 GNKLSGSIPECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNL  260 (678)
Q Consensus       181 ~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L  260 (678)
                      +|.+...  +.+..+++|+.|++++|+++.++ .+..+++|+.|++++|++++..  .+.+++          +|++|++
T Consensus       115 ~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~----------~L~~L~l  179 (199)
T d2omxa2         115 NNQITDI--DPLKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLNFSSNQVTDLK--PLANLT----------TLERLDI  179 (199)
T ss_dssp             SSCCCCC--GGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCG--GGTTCT----------TCCEEEC
T ss_pred             ccccccc--cccchhhhhHHhhhhhhhhcccc-cccccccccccccccccccCCc--cccCCC----------CCCEEEC
Confidence            7777743  34677778888888888777765 4677778888888888777432  244444          8888888


Q ss_pred             cCCcCCCcchHHHhcccCCCce
Q 005760          261 SNNNLSGAIPASLEKLSYLKDL  282 (678)
Q Consensus       261 ~~N~l~~~~~~~~~~l~~L~~L  282 (678)
                      ++|+|+++ + .++++++|+.|
T Consensus       180 s~N~i~~i-~-~l~~L~~L~~L  199 (199)
T d2omxa2         180 SSNKVSDI-S-VLAKLTNLESL  199 (199)
T ss_dssp             CSSCCCCC-G-GGGGCTTCSEE
T ss_pred             CCCCCCCC-c-cccCCCCCCcC
Confidence            88888754 2 46677777654

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.75  E-value=6.4e-17  Score=166.07  Aligned_cols=255  Identities=25%  Similarity=0.249  Sum_probs=173.7

Q ss_pred             CCCCEEecCCCcccccCCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccc
Q 005760           21 SKLSILELSDNSFSGFIPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSH  100 (678)
Q Consensus        21 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~  100 (678)
                      .++++|+|++|+++ .+|+.   .++|++|+|++|+|+++|..         ..+|+.|++++|+++.+      ..+++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~---------~~~L~~L~l~~n~l~~l------~~lp~   98 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPEL---------PQSLKSLLVDNNNLKAL------SDLPP   98 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCC---------CTTCCEEECCSSCCSCC------CSCCT
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccc---------hhhhhhhhhhhcccchh------hhhcc
Confidence            47999999999999 56754   57899999999999987732         46899999999999744      34556


Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecC
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELG  180 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~  180 (678)
                      .|++|++++|.+... |. ++.+++|+.|++++|.+.. .+.   ....+..+.+..+...  ....+..++.++.|+++
T Consensus        99 ~L~~L~L~~n~l~~l-p~-~~~l~~L~~L~l~~~~~~~-~~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~  170 (353)
T d1jl5a_          99 LLEYLGVSNNQLEKL-PE-LQNSSFLKIIDVDNNSLKK-LPD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYAD  170 (353)
T ss_dssp             TCCEEECCSSCCSSC-CC-CTTCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECC
T ss_pred             ccccccccccccccc-cc-hhhhccceeeccccccccc-ccc---ccccccchhhcccccc--ccccccccccceecccc
Confidence            899999999999854 43 6789999999999999973 333   3467888888887776  34567888999999999


Q ss_pred             CCcCCCCCh------------------hhhhccccccceeccccccccccccccccccccEEEecCCcccCCCCcccccc
Q 005760          181 GNKLSGSIP------------------ECFNNLASLRILLLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLPLEIGNL  242 (678)
Q Consensus       181 ~N~i~~~~~------------------~~~~~l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l  242 (678)
                      +|.+.....                  ..+..++.|+.+++++|....++..   ..++..+.+..|.+... +.....+
T Consensus       171 ~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~---~~~l~~~~~~~~~~~~~-~~~~~~l  246 (353)
T d1jl5a_         171 NNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTDL-PELPQSL  246 (353)
T ss_dssp             SSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSCC-CCCCTTC
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccc-ccccccc
Confidence            887763221                  1123455666666666666655432   23455666666665422 2222222


Q ss_pred             ccccccc---cCc----ccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCccccccccccccCccc
Q 005760          243 KIARIDS---CDL----ISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELL  313 (678)
Q Consensus       243 ~~~~~~~---~~~----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~  313 (678)
                      .......   .++    ......++..|.+.+.    ...+++|++|++++|+++.. |.  .+++++.+++.+|...
T Consensus       247 ~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~~l-p~--~~~~L~~L~L~~N~L~  317 (353)
T d1jl5a_         247 TFLDVSENIFSGLSELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLIEL-PA--LPPRLERLIASFNHLA  317 (353)
T ss_dssp             CEEECCSSCCSEESCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCSCC-CC--CCTTCCEEECCSSCCS
T ss_pred             cccccccccccccccccchhcccccccCccccc----cccCCCCCEEECCCCccCcc-cc--ccCCCCEEECCCCcCC
Confidence            1111111   111    1234455555555532    23367899999999999854 33  3678889999888653

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.67  E-value=5.9e-18  Score=173.59  Aligned_cols=255  Identities=16%  Similarity=0.230  Sum_probs=149.2

Q ss_pred             cCCccccCCCCCCEEecCCCccccc----CCccccCCCCCCEEEccCccCCCCccch-----hhcccccCCCCCcEEECc
Q 005760           12 TIPRFIFNASKLSILELSDNSFSGF----IPNTFGNLRNLQALRLSNNYLTSSTLEL-----SFLSSLSNCKSLTLISFS   82 (678)
Q Consensus        12 ~~p~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~~~~~-----~~~~~~~~l~~L~~L~L~   82 (678)
                      .+...+.....|++|+|++|.|...    +...+...++|+.|+++++.+.......     .++..+..+++|+.|+|+
T Consensus        22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~  101 (344)
T d2ca6a1          22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  101 (344)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence            3455667788888999998888643    3445667788888888888765543221     234456677888888888


Q ss_pred             cCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcCCh-------------hhhccCC
Q 005760           83 NNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPS-------------TLGKLQK  149 (678)
Q Consensus        83 ~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-------------~~~~l~~  149 (678)
                      +|.++.......                      ...+...++|+.|++++|.+......             .....+.
T Consensus       102 ~n~i~~~~~~~l----------------------~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~  159 (344)
T d2ca6a1         102 DNAFGPTAQEPL----------------------IDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPP  159 (344)
T ss_dssp             SCCCCTTTHHHH----------------------HHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             ccccccccccch----------------------hhhhcccccchheecccccccccccccccccccccccccccccCcc
Confidence            888764322221                      12223344455555555544311000             0123455


Q ss_pred             CCEEEccCCcCCCC----CCCcccCCCCccEEecCCCcCCCC-----Chhhhhccccccceecccccccc-----ccccc
Q 005760          150 LQGLGLENNKLEGS----IPDSICHSDELYKLELGGNKLSGS-----IPECFNNLASLRILLLGSNELTS-----IPLTF  215 (678)
Q Consensus       150 L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~l~~N~i~~~-----~~~~~~~l~~L~~L~l~~N~l~~-----l~~~~  215 (678)
                      |+.|.+++|.++..    +...+...+.|+.|+|++|.|+..     +...+..+++|+.|+|++|.++.     +...+
T Consensus       160 L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l  239 (344)
T d2ca6a1         160 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL  239 (344)
T ss_dssp             CCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred             cceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccc
Confidence            66666666665421    122334456666677766666531     22335556677777777777653     34456


Q ss_pred             cccccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCCcchH----HHh-cccCCCceeccccccc
Q 005760          216 WNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPA----SLE-KLSYLKDLNLSFNKLE  290 (678)
Q Consensus       216 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~----~~~-~l~~L~~L~l~~N~~~  290 (678)
                      ...++|++|+|++|.|++.....+..    .+.....++|++|+|++|+|+.....    .+. +++.|+.|+|++|.+.
T Consensus       240 ~~~~~L~~L~Ls~n~i~~~g~~~l~~----~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         240 KSWPNLRELGLNDCLLSARGAAAVVD----AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             GGCTTCCEEECTTCCCCHHHHHHHHH----HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             cccccchhhhhhcCccCchhhHHHHH----HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence            67777778888888776443333321    01112234788888888888753332    232 4677888888888886


Q ss_pred             cc
Q 005760          291 GE  292 (678)
Q Consensus       291 ~~  292 (678)
                      .+
T Consensus       316 ~~  317 (344)
T d2ca6a1         316 EE  317 (344)
T ss_dssp             TT
T ss_pred             Cc
Confidence            43

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.62  E-value=1.4e-17  Score=177.55  Aligned_cols=110  Identities=16%  Similarity=0.172  Sum_probs=52.3

Q ss_pred             ccccCCcCcccC-CccccCCCCCCEEecCCCccccc----CCccccCCCCCCEEEccCccCCCCccchhhccccc-CCCC
Q 005760            2 LQMWENNFSGTI-PRFIFNASKLSILELSDNSFSGF----IPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLS-NCKS   75 (678)
Q Consensus         2 L~l~~~~~~~~~-p~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~-~l~~   75 (678)
                      |||+++++++.. .+.+..+++++.|+|++|.|+..    +..++..+++|++|||++|.|++.+.. .+...+. ...+
T Consensus         7 ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~-~l~~~l~~~~~~   85 (460)
T d1z7xw1           7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVH-CVLQGLQTPSCK   85 (460)
T ss_dssp             EEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHH-HHHHTTCSTTCC
T ss_pred             EEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHH-HHHHHHhcCCCC
Confidence            566666665421 23344456666666666665522    234455566666666666655432211 1112222 1235


Q ss_pred             CcEEECccCCCcccCChhh---hhcccccccEEEccccccc
Q 005760           76 LTLISFSNNPLDGILPKTS---VGNLSHSLEYFEMAYCNVS  113 (678)
Q Consensus        76 L~~L~L~~n~i~~~~~~~~---~~~l~~~L~~L~l~~n~l~  113 (678)
                      |++|+|++|+++...-...   +... ++|++|++++|.+.
T Consensus        86 L~~L~L~~n~it~~~~~~l~~~l~~~-~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          86 IQKLSLQNCCLTGAGCGVLSSTLRTL-PTLQELHLSDNLLG  125 (460)
T ss_dssp             CCEEECTTSCCBGGGHHHHHHHTTSC-TTCCEEECCSSBCH
T ss_pred             CCEEECCCCCccccccccccchhhcc-ccccccccccccch
Confidence            6666666666543322111   1112 25666666666543

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=1.6e-17  Score=177.07  Aligned_cols=115  Identities=19%  Similarity=0.285  Sum_probs=88.3

Q ss_pred             CCCEEecCCCcccccC-CccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcc--
Q 005760           22 KLSILELSDNSFSGFI-PNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNL--   98 (678)
Q Consensus        22 ~L~~L~l~~n~i~~~~-~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l--   98 (678)
                      +|++||+++|+|+... .+.+..+++|++|+|++|.++..... .+...+..+++|+.|+|++|+|+..........+  
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~-~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCK-DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHH-HHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHH-HHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            5899999999998643 34577789999999999998754432 3445678999999999999999643222222222  


Q ss_pred             -cccccEEEccccccccc----CCccccCCCCCcEEEccCCccC
Q 005760           99 -SHSLEYFEMAYCNVSGG----IPEEIGNLTNLTIIYLGGNKLN  137 (678)
Q Consensus        99 -~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~N~l~  137 (678)
                       ..+|++|+|++|++++.    ++..+..+++|++|+|++|.+.
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence             23799999999999865    3566788999999999999864

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=4.3e-16  Score=140.05  Aligned_cols=108  Identities=20%  Similarity=0.218  Sum_probs=44.4

Q ss_pred             CCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccce
Q 005760          122 NLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRIL  201 (678)
Q Consensus       122 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L  201 (678)
                      +..+|++|+|++|+|+. +++.+..+++|+.|+|++|.|+ .++ .|..+++|++|++++|.++...+..+..+++|+.|
T Consensus        16 n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L   92 (162)
T d1a9na_          16 NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL   92 (162)
T ss_dssp             CTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred             CcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence            33344444444444432 2333333444444444444444 221 23444444444444444443333333344444444


Q ss_pred             eccccccccccc--cccccccccEEEecCCccc
Q 005760          202 LLGSNELTSIPL--TFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       202 ~l~~N~l~~l~~--~~~~l~~L~~L~l~~N~l~  232 (678)
                      +|++|+|+.++.  .+..+++|+.|++++|++.
T Consensus        93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             eeccccccccccccccccccccchhhcCCCccc
Confidence            444444444432  2344444444444444443

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=9.9e-16  Score=137.65  Aligned_cols=85  Identities=20%  Similarity=0.238  Sum_probs=41.1

Q ss_pred             hccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceecccccccccccc-ccccccccE
Q 005760          145 GKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNELTSIPLT-FWNLKDILY  223 (678)
Q Consensus       145 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~l~~~-~~~l~~L~~  223 (678)
                      .+..+|++|+|++|+|+ .++..+..+++|+.|+|++|.|+..  +.|..+++|++|++++|+|+.++.. +..+++|+.
T Consensus        15 ~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~   91 (162)
T d1a9na_          15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   91 (162)
T ss_dssp             ECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             cCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccccc
Confidence            34444555555555555 3344444455555555555555522  2244455555555555555555442 334555555


Q ss_pred             EEecCCccc
Q 005760          224 LNFSSNFFT  232 (678)
Q Consensus       224 L~l~~N~l~  232 (678)
                      |++++|+|.
T Consensus        92 L~L~~N~i~  100 (162)
T d1a9na_          92 LILTNNSLV  100 (162)
T ss_dssp             EECCSCCCC
T ss_pred             ceecccccc
Confidence            555555544

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.58  E-value=1.4e-16  Score=163.21  Aligned_cols=247  Identities=19%  Similarity=0.205  Sum_probs=155.1

Q ss_pred             ccccCCcCcc----cCCccccCCCCCCEEecCCCccccc----------CCccccCCCCCCEEEccCccCCCCccchhhc
Q 005760            2 LQMWENNFSG----TIPRFIFNASKLSILELSDNSFSGF----------IPNTFGNLRNLQALRLSNNYLTSSTLELSFL   67 (678)
Q Consensus         2 L~l~~~~~~~----~~p~~~~~l~~L~~L~l~~n~i~~~----------~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~   67 (678)
                      |+|++|.+..    .+.+.+...++|+.|+++++.+...          +..++...++|+.|+|++|.++..... .+.
T Consensus        36 L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~-~l~  114 (344)
T d2ca6a1          36 IVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQE-PLI  114 (344)
T ss_dssp             EECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHH-HHH
T ss_pred             EECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccccccc-chh
Confidence            7889998855    3445567789999999998865422          234566789999999999999875432 234


Q ss_pred             ccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCcC----Chh
Q 005760           68 SSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSI----PST  143 (678)
Q Consensus        68 ~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~----~~~  143 (678)
                      ..+..+++|+.|++++|.+...........+    ..+..         .......+.|+.|++++|+++...    ...
T Consensus       115 ~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l----~~~~~---------~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~  181 (344)
T d2ca6a1         115 DFLSKHTPLEHLYLHNNGLGPQAGAKIARAL----QELAV---------NKKAKNAPPLRSIICGRNRLENGSMKEWAKT  181 (344)
T ss_dssp             HHHHHCTTCCEEECCSSCCHHHHHHHHHHHH----HHHHH---------HHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred             hhhcccccchheecccccccccccccccccc----ccccc---------ccccccCcccceeecccccccccccccccch
Confidence            4567889999999999988533221111111    11100         011234566777777777665322    223


Q ss_pred             hhccCCCCEEEccCCcCCCC-----CCCcccCCCCccEEecCCCcCCCC----Chhhhhccccccceecccccccc----
Q 005760          144 LGKLQKLQGLGLENNKLEGS-----IPDSICHSDELYKLELGGNKLSGS----IPECFNNLASLRILLLGSNELTS----  210 (678)
Q Consensus       144 ~~~l~~L~~L~L~~n~i~~~-----~~~~~~~l~~L~~L~l~~N~i~~~----~~~~~~~l~~L~~L~l~~N~l~~----  210 (678)
                      +...+.|++|+|++|.|+..     +...+..+++|+.|+|++|.++..    +...+..+++|++|+|++|.|+.    
T Consensus       182 l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~  261 (344)
T d2ca6a1         182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA  261 (344)
T ss_dssp             HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred             hhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhH
Confidence            44566777777777777521     234466677788888888877632    23455677788888888887773    


Q ss_pred             -ccccccc--cccccEEEecCCcccCCCCccccccccccccccCcccccEEEccCCcCCC
Q 005760          211 -IPLTFWN--LKDILYLNFSSNFFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSG  267 (678)
Q Consensus       211 -l~~~~~~--l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~  267 (678)
                       +...+..  .+.|+.|++++|.|+......+..     .-..++++|+.|+|++|++..
T Consensus       262 ~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~-----~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT-----VIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHH-----HHHHHCTTCCEEECTTSBSCT
T ss_pred             HHHHHhhhccCCCCCEEECCCCcCChHHHHHHHH-----HHHccCCCCCEEECCCCcCCC
Confidence             2223332  356888888888876433222221     111134478888898888874

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.57  E-value=6.5e-15  Score=125.67  Aligned_cols=100  Identities=24%  Similarity=0.326  Sum_probs=55.9

Q ss_pred             EEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccceeccccc
Q 005760          128 IIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRILLLGSNE  207 (678)
Q Consensus       128 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N~  207 (678)
                      .|+|++|+++ .++ .+..+++|++|++++|+|+ .+|..+..+++|++|++++|.|+.. | .+..+++|+.|++++|+
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence            4566666665 233 2556666666666666665 4455556666666666666666632 2 35555666666666666


Q ss_pred             cccccc--cccccccccEEEecCCccc
Q 005760          208 LTSIPL--TFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       208 l~~l~~--~~~~l~~L~~L~l~~N~l~  232 (678)
                      |+.++.  .+..+++|+.|++++|++.
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~  103 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLC  103 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence            555542  3455555555555555544

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.56  E-value=7.5e-15  Score=125.28  Aligned_cols=117  Identities=22%  Similarity=0.221  Sum_probs=86.0

Q ss_pred             cEEEcccccccccCCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCC
Q 005760          103 EYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGN  182 (678)
Q Consensus       103 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N  182 (678)
                      +.|+|++|+++.. + .+.++++|++|++++|+|+ .+|..|+.+++|++|++++|.|+ .+| .+..+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence            3566666666643 2 3778888888888888887 56677888888888888888888 444 4888888888888888


Q ss_pred             cCCCCC-hhhhhccccccceeccccccccccc----cccccccccEE
Q 005760          183 KLSGSI-PECFNNLASLRILLLGSNELTSIPL----TFWNLKDILYL  224 (678)
Q Consensus       183 ~i~~~~-~~~~~~l~~L~~L~l~~N~l~~l~~----~~~~l~~L~~L  224 (678)
                      +|+... ...+..+++|+.|++++|+++..+.    .+..+|+|+.|
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            888543 2567888888999999988876542    23345555554

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=2.9e-15  Score=148.38  Aligned_cols=179  Identities=20%  Similarity=0.244  Sum_probs=93.9

Q ss_pred             cccEEEcccccccccCCccccCCCCCcEEEccCC-ccCCcC-ChhhhccCCCCEEEccCC-cCCCC-CCCcccC-CCCcc
Q 005760          101 SLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGN-KLNGSI-PSTLGKLQKLQGLGLENN-KLEGS-IPDSICH-SDELY  175 (678)
Q Consensus       101 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~-~~~~~~l~~L~~L~L~~n-~i~~~-~~~~~~~-l~~L~  175 (678)
                      +|++|+|++|.+.+..+..+..+++|++|+++++ .+++.. ...+.++++|++|+++++ .++.. +...+.. .++|+
T Consensus        72 ~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~  151 (284)
T d2astb2          72 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETIT  151 (284)
T ss_dssp             CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCC
T ss_pred             CcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccc
Confidence            3444444444333333444555666666666663 343211 112245666777776664 23311 1112222 35677


Q ss_pred             EEecCCC--cCCCC-Chhhhhccccccceeccccc-ccc-ccccccccccccEEEecCC-cccCCCCccccccccccccc
Q 005760          176 KLELGGN--KLSGS-IPECFNNLASLRILLLGSNE-LTS-IPLTFWNLKDILYLNFSSN-FFTGPLPLEIGNLKIARIDS  249 (678)
Q Consensus       176 ~L~l~~N--~i~~~-~~~~~~~l~~L~~L~l~~N~-l~~-l~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~~~~~~  249 (678)
                      .|+++++  .+++. +...+..+++|++|+|++|. ++. ....+.++++|++|++++| .+++.....++.+       
T Consensus       152 ~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~-------  224 (284)
T d2astb2         152 QLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI-------  224 (284)
T ss_dssp             EEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGC-------
T ss_pred             hhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcC-------
Confidence            7777654  33322 22233557778888887753 552 3445667778888888884 4554444444433       


Q ss_pred             cCcccccEEEccCCcCCCcchHHHhcccCCCceeccccccccc
Q 005760          250 CDLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGE  292 (678)
Q Consensus       250 ~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  292 (678)
                         |+|+.|+++++--.+........+|+   |.++.++++..
T Consensus       225 ---~~L~~L~l~~~~~d~~l~~l~~~lp~---L~i~~~~ls~~  261 (284)
T d2astb2         225 ---PTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTI  261 (284)
T ss_dssp             ---TTCCEEECTTSSCTTCHHHHHHHSTT---SEESCCCSCCT
T ss_pred             ---CCCCEEeeeCCCCHHHHHHHHHhCcc---ccccCccCCCC
Confidence               48888888887322233333334444   45566666644

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=3.2e-15  Score=148.07  Aligned_cols=216  Identities=17%  Similarity=0.230  Sum_probs=155.0

Q ss_pred             cccCCCCCCEEecCCCccccc-CCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccC-CCcccCChh
Q 005760           16 FIFNASKLSILELSDNSFSGF-IPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNN-PLDGILPKT   93 (678)
Q Consensus        16 ~~~~l~~L~~L~l~~n~i~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n-~i~~~~~~~   93 (678)
                      ......+|++|||++|.++.. +...+.++++|++|+|++|.+....     +..+..+++|++|++++| .++...-..
T Consensus        41 ~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~-----~~~l~~~~~L~~L~Ls~c~~itd~~l~~  115 (284)
T d2astb2          41 EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPI-----VNTLAKNSNLVRLNLSGCSGFSEFALQT  115 (284)
T ss_dssp             SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHH-----HHHHTTCTTCSEEECTTCBSCCHHHHHH
T ss_pred             hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHH-----HHHHhcCCCCcCccccccccccccccch
Confidence            345567899999999999754 3556889999999999999876433     345788999999999995 565332222


Q ss_pred             hhhcccccccEEEccccc-cccc-CCcccc-CCCCCcEEEccCCc--cCCc-CChhhhccCCCCEEEccCC-cCCCCCCC
Q 005760           94 SVGNLSHSLEYFEMAYCN-VSGG-IPEEIG-NLTNLTIIYLGGNK--LNGS-IPSTLGKLQKLQGLGLENN-KLEGSIPD  166 (678)
Q Consensus        94 ~~~~l~~~L~~L~l~~n~-l~~~-~~~~~~-~l~~L~~L~l~~N~--l~~~-~~~~~~~l~~L~~L~L~~n-~i~~~~~~  166 (678)
                      .+..++ +|++|++++|. ++.. ....+. ..++|+.|+++++.  ++.. +...+.++++|++|+|++| .+++....
T Consensus       116 l~~~~~-~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~  194 (284)
T d2astb2         116 LLSSCS-RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQ  194 (284)
T ss_dssp             HHHHCT-TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGG
T ss_pred             hhHHHH-hccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhh
Confidence            233444 89999999974 4432 222333 35799999999863  3322 2223456899999999986 47766677


Q ss_pred             cccCCCCccEEecCCC-cCCCCChhhhhccccccceecccccccc--ccccccccccccEEEecCCcccCCCCccccc
Q 005760          167 SICHSDELYKLELGGN-KLSGSIPECFNNLASLRILLLGSNELTS--IPLTFWNLKDILYLNFSSNFFTGPLPLEIGN  241 (678)
Q Consensus       167 ~~~~l~~L~~L~l~~N-~i~~~~~~~~~~l~~L~~L~l~~N~l~~--l~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  241 (678)
                      .+..+++|++|++++| .+++.....++++++|+.|+++++ ++.  +..-...   +..|.++.++++...+..++.
T Consensus       195 ~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~---lp~L~i~~~~ls~~~~~~~~~  268 (284)
T d2astb2         195 EFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEA---LPHLQINCSHFTTIARPTIGN  268 (284)
T ss_dssp             GGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHH---STTSEESCCCSCCTTCSSCSS
T ss_pred             hhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHh---CccccccCccCCCCCCCccCc
Confidence            8889999999999995 688766677889999999999988 332  2222233   444567888888777666654

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.47  E-value=1.4e-15  Score=141.75  Aligned_cols=112  Identities=21%  Similarity=0.283  Sum_probs=68.7

Q ss_pred             CCccccCCCCCcEEEccCCccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhcc
Q 005760          116 IPEEIGNLTNLTIIYLGGNKLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNL  195 (678)
Q Consensus       116 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l  195 (678)
                      ++..+..+++|++|+|++|+|+. ++ .+.++++|++|+|++|.|+ .++..+..+++|+.|++++|+++..  +.+..+
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l  114 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL  114 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred             hhhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccc
Confidence            34556666777777777777663 33 3666667777777777666 4444444455666666666666632  335666


Q ss_pred             ccccceeccccccccccc--cccccccccEEEecCCccc
Q 005760          196 ASLRILLLGSNELTSIPL--TFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       196 ~~L~~L~l~~N~l~~l~~--~~~~l~~L~~L~l~~N~l~  232 (678)
                      ++|+.|++++|+|+.++.  .+..+++|+.|+|++|++.
T Consensus       115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~  153 (198)
T d1m9la_         115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY  153 (198)
T ss_dssp             HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred             ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence            666666666666666543  4556666666666666554

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=5.1e-14  Score=125.39  Aligned_cols=134  Identities=18%  Similarity=0.084  Sum_probs=91.0

Q ss_pred             CccEEecCCCcCCCCChhhhhccccccceecccc-ccccccc-cccccccccEEEecCCcccCCCCcccccccccccccc
Q 005760          173 ELYKLELGGNKLSGSIPECFNNLASLRILLLGSN-ELTSIPL-TFWNLKDILYLNFSSNFFTGPLPLEIGNLKIARIDSC  250 (678)
Q Consensus       173 ~L~~L~l~~N~i~~~~~~~~~~l~~L~~L~l~~N-~l~~l~~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~~~~~~~  250 (678)
                      ....++++++.+. ..|..+..+++|++|+|++| .|+.++. +|.++++|+.|+|++|+|+.+.+..|.+++       
T Consensus         9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~-------   80 (156)
T d2ifga3           9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP-------   80 (156)
T ss_dssp             SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCS-------
T ss_pred             CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccc-------
Confidence            3455666666666 44555666777777777655 4777754 577777788888888887777777777766       


Q ss_pred             CcccccEEEccCCcCCCcchHHHhcccCCCceecccccccccCCCCCcccc--ccccccccCccccCCCC
Q 005760          251 DLISLISLNLSNNNLSGAIPASLEKLSYLKDLNLSFNKLEGEIPRGGSFGN--FSAESFEGNELLCGSPN  318 (678)
Q Consensus       251 ~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~--l~~~~~~~n~~~c~~~~  318 (678)
                         +|++|+|++|+|+...+..+..+ +|+.|+|++|+|.|++...+...+  .....+..+...|..|.
T Consensus        81 ---~L~~L~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~  146 (156)
T d2ifga3          81 ---RLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (156)
T ss_dssp             ---CCCEEECCSSCCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             ---cccceeccCCCCcccChhhhccc-cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcCh
Confidence               88888888888886666666544 688999999999888765433222  23334445667776663

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.43  E-value=3.8e-15  Score=138.64  Aligned_cols=150  Identities=25%  Similarity=0.275  Sum_probs=112.0

Q ss_pred             CCCcEEEccCC--ccCCcCChhhhccCCCCEEEccCCcCCCCCCCcccCCCCccEEecCCCcCCCCChhhhhccccccce
Q 005760          124 TNLTIIYLGGN--KLNGSIPSTLGKLQKLQGLGLENNKLEGSIPDSICHSDELYKLELGGNKLSGSIPECFNNLASLRIL  201 (678)
Q Consensus       124 ~~L~~L~l~~N--~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~N~i~~~~~~~~~~l~~L~~L  201 (678)
                      ..++.+++.++  .+. ..+..+..+++|++|+|++|+|+ .++ .+..+++|++|+|++|.|+ .++..+..+++|+.|
T Consensus        23 ~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L   98 (198)
T d1m9la_          23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEEL   98 (198)
T ss_dssp             TTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEE
T ss_pred             cccceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccc
Confidence            34555666554  344 45678888999999999999998 454 5888999999999999998 445556667789999


Q ss_pred             eccccccccccccccccccccEEEecCCcccCCCC-ccccccccccccccCcccccEEEccCCcCCCcchH---------
Q 005760          202 LLGSNELTSIPLTFWNLKDILYLNFSSNFFTGPLP-LEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPA---------  271 (678)
Q Consensus       202 ~l~~N~l~~l~~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~---------  271 (678)
                      ++++|+|+.++ .+..+++|+.|++++|+|+.... ..+..+          ++|+.|+|++|+++...+.         
T Consensus        99 ~l~~N~i~~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l----------~~L~~L~L~~N~l~~~~~~~~~~~~~r~  167 (198)
T d1m9la_          99 WISYNQIASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAAL----------DKLEDLLLAGNPLYNDYKENNATSEYRI  167 (198)
T ss_dssp             ECSEEECCCHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTT----------TTCSEEEECSSHHHHHHCTTTTHHHHHH
T ss_pred             ccccccccccc-cccccccccccccccchhccccccccccCC----------CccceeecCCCccccCcccccchhhHHH
Confidence            99999999885 47788899999999999874332 234444          4999999999988643332         


Q ss_pred             -HHhcccCCCceeccccccc
Q 005760          272 -SLEKLSYLKDLNLSFNKLE  290 (678)
Q Consensus       272 -~~~~l~~L~~L~l~~N~~~  290 (678)
                       .+..+|+|+.||  +.+++
T Consensus       168 ~vi~~lp~L~~LD--~~~I~  185 (198)
T d1m9la_         168 EVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             HHHHHCSSCCEES--SGGGT
T ss_pred             HHHHHCCCcCEeC--CccCC
Confidence             266788999876  55555

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.39  E-value=2.6e-13  Score=120.65  Aligned_cols=115  Identities=17%  Similarity=0.104  Sum_probs=101.5

Q ss_pred             cccccceeccccccccccccccccccccEEEecCC-cccCCCCccccccccccccccCcccccEEEccCCcCCCcchHHH
Q 005760          195 LASLRILLLGSNELTSIPLTFWNLKDILYLNFSSN-FFTGPLPLEIGNLKIARIDSCDLISLISLNLSNNNLSGAIPASL  273 (678)
Q Consensus       195 l~~L~~L~l~~N~l~~l~~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~  273 (678)
                      +...+.++.+++.++++|..+..+++|++|++++| .|+.+.+..|.+++          +|+.|+|++|+|+.+.+.+|
T Consensus         7 c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~----------~L~~L~Ls~N~l~~i~~~~f   76 (156)
T d2ifga3           7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLG----------ELRNLTIVKSGLRFVAPDAF   76 (156)
T ss_dssp             CSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCC----------CCSEEECCSSCCCEECTTGG
T ss_pred             cCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhcccc----------ccCcceeeccccCCcccccc
Confidence            44567899999999999999999999999999877 48877778888777          99999999999999989999


Q ss_pred             hcccCCCceecccccccccCCCCCccccccccccccCccccCCCCC
Q 005760          274 EKLSYLKDLNLSFNKLEGEIPRGGSFGNFSAESFEGNELLCGSPNL  319 (678)
Q Consensus       274 ~~l~~L~~L~l~~N~~~~~~~~~~~~~~l~~~~~~~n~~~c~~~~~  319 (678)
                      ..+++|++|+|++|.++...+.......+..+++.+|||.|+|...
T Consensus        77 ~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~~  122 (156)
T d2ifga3          77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALR  122 (156)
T ss_dssp             GSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGGH
T ss_pred             cccccccceeccCCCCcccChhhhccccccccccCCCcccCCchHH
Confidence            9999999999999999977776655567899999999999998643

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.62  E-value=1.4e-09  Score=96.82  Aligned_cols=65  Identities=25%  Similarity=0.165  Sum_probs=33.9

Q ss_pred             ccCCCCccEEecCCCcCCCCC--hhhhhccccccceeccccccccccc-cccccccccEEEecCCccc
Q 005760          168 ICHSDELYKLELGGNKLSGSI--PECFNNLASLRILLLGSNELTSIPL-TFWNLKDILYLNFSSNFFT  232 (678)
Q Consensus       168 ~~~l~~L~~L~l~~N~i~~~~--~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~l~~L~~L~l~~N~l~  232 (678)
                      +..+++|++|+|++|+|+...  +..+..+++|+.|+|++|.|++++. .+....+|+.|++++|++.
T Consensus        61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence            344555555555555555432  2334555666666666666665544 2223334555555555554

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.55  E-value=8.6e-09  Score=91.50  Aligned_cols=45  Identities=22%  Similarity=0.184  Sum_probs=25.1

Q ss_pred             hhhhhccccccceecccccccccc---ccccccccccEEEecCCcccC
Q 005760          189 PECFNNLASLRILLLGSNELTSIP---LTFWNLKDILYLNFSSNFFTG  233 (678)
Q Consensus       189 ~~~~~~l~~L~~L~l~~N~l~~l~---~~~~~l~~L~~L~l~~N~l~~  233 (678)
                      +..+..+++|++|+|++|+|+.++   ..+..+++|+.|+|++|.|+.
T Consensus        58 ~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~  105 (162)
T d1koha1          58 RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS  105 (162)
T ss_dssp             HHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC
T ss_pred             HHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc
Confidence            334445666666666666666543   234455566666666666553

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.45  E-value=3.9e-07  Score=87.66  Aligned_cols=149  Identities=17%  Similarity=0.142  Sum_probs=103.5

Q ss_pred             HHHHHhhcCCCCCccccCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeE
Q 005760          385 LELCRATDGFSENNLIGRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFK  463 (678)
Q Consensus       385 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  463 (678)
                      .++...-..|+..+..+.++.+.||+... ++..+++|+...........+.+|..+++.+. +=.+.+++.++.+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            34455556777766655555678999875 45667888887665555667888999988774 33356777888888889


Q ss_pred             EEEEEecCCCCHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------------------------
Q 005760          464 ALVLEYMPHGSLEKYLHSSNYILDIYQRLNIMIDVASALEYLHFGY----------------------------------  509 (678)
Q Consensus       464 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------  509 (678)
                      ++||++++|.++.+......      ....++.+++..+..||...                                  
T Consensus        86 ~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE  159 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred             EEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence            99999999988765543211      12234555555666666211                                  


Q ss_pred             ----------------------CCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          510 ----------------------SAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       510 ----------------------~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                                            ...++|+|+.|.||++++++.+-+.||+.+.
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  1237899999999999987767799998874

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.09  E-value=9.4e-07  Score=78.34  Aligned_cols=44  Identities=16%  Similarity=0.336  Sum_probs=20.5

Q ss_pred             CCCCCCEEEccCc-cCCCCccchhhcccccCCCCCcEEECccCCCc
Q 005760           43 NLRNLQALRLSNN-YLTSSTLELSFLSSLSNCKSLTLISFSNNPLD   87 (678)
Q Consensus        43 ~l~~L~~L~l~~n-~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~   87 (678)
                      +.++|++|+|+++ .++.... ..++..+...++|+.|+|++|.+.
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~-~~l~~~L~~n~~L~~L~Ls~n~l~   57 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERI-RSLIEAACNSKHIEKFSLANTAIS   57 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHH-HHHHHHHTTCSCCCEEECTTSCCB
T ss_pred             CCCCCcEEEeCCCCCCCHHHH-HHHHHHHhhCCccceeeccccccc
Confidence            3455555555542 2322111 123344555555566666555554

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.08  E-value=4.9e-07  Score=80.26  Aligned_cols=119  Identities=11%  Similarity=0.131  Sum_probs=78.9

Q ss_pred             cCCCCCCEEecCCC-ccccc----CCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCcccCCh
Q 005760           18 FNASKLSILELSDN-SFSGF----IPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPK   92 (678)
Q Consensus        18 ~~l~~L~~L~l~~n-~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~   92 (678)
                      .+.++|++|+|+++ .|+..    +..++...++|++|+|++|.++..... .+...+...++|+.|+|++|.|+.....
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~-~la~~L~~n~~L~~L~L~~n~i~~~g~~   90 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEAR-GLIELIETSPSLRVLNVESNFLTPELLA   90 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHT-THHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHH-HHhhhhhhcccccceeeehhhcchHHHH
Confidence            34688999999984 57643    445677889999999999998754432 3445667788999999999988754322


Q ss_pred             hhhhcccccccEEEcccccccccCCccccCCCCCcEEEccCCccCCc-------CChhhhccCCCCEEEccCCc
Q 005760           93 TSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYLGGNKLNGS-------IPSTLGKLQKLQGLGLENNK  159 (678)
Q Consensus        93 ~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-------~~~~~~~l~~L~~L~L~~n~  159 (678)
                      ..+                      ..+...++|++|++++|++...       +...+...++|+.|+++.+.
T Consensus        91 ~l~----------------------~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          91 RLL----------------------RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             HHH----------------------HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHH----------------------HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence            212                      2344456677777776655422       12233445677777776554

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.91  E-value=7.8e-06  Score=77.78  Aligned_cols=74  Identities=14%  Similarity=0.078  Sum_probs=54.6

Q ss_pred             cccCCCc-eeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCC--ccceeeeeeeecCCeEEEEEEecCCCCH
Q 005760          399 LIGRGSF-GSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRH--RNIIKVISSCSNEEFKALVLEYMPHGSL  475 (678)
Q Consensus       399 ~ig~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~L  475 (678)
                      .+..|.. +.||+...+++..+++|.....   ....+..|...++.+..  -.+.+++.+..+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455554 6899999888888999986533   34567788888887743  2356678888888889999999988654

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.75  E-value=1.4e-06  Score=77.14  Aligned_cols=125  Identities=14%  Similarity=0.140  Sum_probs=70.9

Q ss_pred             CCccccCCCCCCEEecCC-Cccccc----CCccccCCCCCCEEEccCccCCCCccchhhcccccCCCCCcEEECccCCCc
Q 005760           13 IPRFIFNASKLSILELSD-NSFSGF----IPNTFGNLRNLQALRLSNNYLTSSTLELSFLSSLSNCKSLTLISFSNNPLD   87 (678)
Q Consensus        13 ~p~~~~~l~~L~~L~l~~-n~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~   87 (678)
                      +.....+.++|++|+|++ +.|+..    +..++...++|++|+|++|.++..... .+...+...++++.+++++|.++
T Consensus         9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~-~L~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_           9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAF-ALAEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHH-HHHHHHHHCSSCCEEECCSSCCC
T ss_pred             HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHH-HHHHHHhhcccchhhhhcccccc
Confidence            344445567777777776 456432    334455677777777777777653322 34445566677777777777665


Q ss_pred             ccCChhhhhcccccccEEEcccccccccCCccccCCCCCcEEEc--cCCccCCc----CChhhhccCCCCEEEccCCcC
Q 005760           88 GILPKTSVGNLSHSLEYFEMAYCNVSGGIPEEIGNLTNLTIIYL--GGNKLNGS----IPSTLGKLQKLQGLGLENNKL  160 (678)
Q Consensus        88 ~~~~~~~~~~l~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l--~~N~l~~~----~~~~~~~l~~L~~L~L~~n~i  160 (678)
                      ......                      +...+...++|+.++|  ++|.+...    +...+...++|++|+++.+..
T Consensus        88 ~~g~~~----------------------l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          88 GSGILA----------------------LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHHHH----------------------HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             chhHHH----------------------HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            332111                      1234555666766444  45555421    223444567777777766543

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.58  E-value=6.1e-06  Score=72.87  Aligned_cols=125  Identities=16%  Similarity=0.150  Sum_probs=83.0

Q ss_pred             CccccCCCCCCEEEccC-ccCCCCccchhhcccccCCCCCcEEECccCCCcccCChhhhhcccccccEEEcccccccccC
Q 005760           38 PNTFGNLRNLQALRLSN-NYLTSSTLELSFLSSLSNCKSLTLISFSNNPLDGILPKTSVGNLSHSLEYFEMAYCNVSGGI  116 (678)
Q Consensus        38 ~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~~l~~~L~~L~l~~n~l~~~~  116 (678)
                      .....+.++|++|+|++ +.++.... ..++.++..+++|+.|+|++|.++....    .                  .+
T Consensus        10 ~~~~~~~~~L~~L~L~~~~~i~~~~~-~~l~~al~~n~~L~~L~Ls~n~l~~~~~----~------------------~L   66 (166)
T d1io0a_          10 KRIQNNDPDLEEVNLNNIMNIPVPTL-KACAEALKTNTYVKKFSIVGTRSNDPVA----F------------------AL   66 (166)
T ss_dssp             HHHHTTCTTCCEEECTTCTTCCHHHH-HHHHHHHTTCCSCCEEECTTSCCCHHHH----H------------------HH
T ss_pred             HHHHhcCCCCcEEEcCCCCCCCHHHH-HHHHHHHhcCCccCeeeccCCcccHHHH----H------------------HH
Confidence            34445678888888886 44543332 2355567778888888888887753321    1                  12


Q ss_pred             CccccCCCCCcEEEccCCccCCcC----ChhhhccCCCCEEEcc--CCcCCC----CCCCcccCCCCccEEecCCCcCC
Q 005760          117 PEEIGNLTNLTIIYLGGNKLNGSI----PSTLGKLQKLQGLGLE--NNKLEG----SIPDSICHSDELYKLELGGNKLS  185 (678)
Q Consensus       117 ~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~L~--~n~i~~----~~~~~~~~l~~L~~L~l~~N~i~  185 (678)
                      ...+...++|+.|++++|.+....    ...+...++|+.++|+  .|.+..    .+...+...++|+.|+++.+...
T Consensus        67 ~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~  145 (166)
T d1io0a_          67 AEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  145 (166)
T ss_dssp             HHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence            244566788999999999886332    2456677899986665  667753    23456677899999999877543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.38  E-value=0.00032  Score=70.76  Aligned_cols=76  Identities=18%  Similarity=0.150  Sum_probs=48.8

Q ss_pred             CccccCCCceeEEEEEeC-CCcEEEEEEeeccc-------CchhhhHHHHHHHHHhCC-C-c-cceeeeeeeecCCeEEE
Q 005760          397 NNLIGRGSFGSVFKARLG-DGMEVAMKVFNLQY-------GRVFKSFDVECEMMKSIR-H-R-NIIKVISSCSNEEFKAL  465 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~-h-~-niv~~~~~~~~~~~~~l  465 (678)
                      .+.||.|....||++... +++.++||......       +....+...|.+.++.+. + | .+.+++.+..  +..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT--EMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--TTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--CCCEE
Confidence            357899999999999865 46789999754311       112345567888887663 2 3 4555655543  44579


Q ss_pred             EEEecCCCC
Q 005760          466 VLEYMPHGS  474 (678)
Q Consensus       466 v~e~~~~~~  474 (678)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.69  E-value=0.0023  Score=62.48  Aligned_cols=133  Identities=13%  Similarity=0.168  Sum_probs=78.5

Q ss_pred             ceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCCccc--eeeee-----eeecCCeEEEEEEecCCCCH--
Q 005760          405 FGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRHRNI--IKVIS-----SCSNEEFKALVLEYMPHGSL--  475 (678)
Q Consensus       405 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lv~e~~~~~~L--  475 (678)
                      --.||++..++|+.+++|+.+... ...+++..|...+..|....+  +..+.     .+...+..+.++++++|..+  
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            368999999999999999987542 345678889988887742222  11111     22345667889999876422  


Q ss_pred             ---HHH------h---hh----C----CCCCCH----------------------HHHHHHHHHHHHHHHHH-hcCCCCC
Q 005760          476 ---EKY------L---HS----S----NYILDI----------------------YQRLNIMIDVASALEYL-HFGYSAQ  512 (678)
Q Consensus       476 ---~~~------l---~~----~----~~~~~~----------------------~~~~~i~~~i~~~l~~L-H~~~~~~  512 (678)
                         ..+      +   +.    .    +...+.                      ......+.++...+.-. .+....+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence               111      0   10    0    001111                      11122333333333322 2223467


Q ss_pred             eEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          513 VIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       513 ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      ++|+|+.+.||+++++  ..+.||+-+.
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~  219 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDAR  219 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred             eecCCCCcccEEEeCC--ceEEechhcc
Confidence            9999999999999753  4588998875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.16  E-value=0.009  Score=57.68  Aligned_cols=156  Identities=16%  Similarity=0.093  Sum_probs=84.3

Q ss_pred             CCHHHHHHhhcCCCCCccc-----cCCCceeEEEEEeCCCcEEEEEEeecccCchhhhHHHHHHHHHhCCC-----ccce
Q 005760          382 FSYLELCRATDGFSENNLI-----GRGSFGSVFKARLGDGMEVAMKVFNLQYGRVFKSFDVECEMMKSIRH-----RNII  451 (678)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~i-----g~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----~niv  451 (678)
                      .+..++...-.+|.+++..     ..|.--+.|+.+..+|+ +++|++....  ..+.+..|..++..+..     |..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            3556777777888876543     45666888999876654 8999985432  23455567777776642     2222


Q ss_pred             eee-e--eeecCCeEEEEEEecCCCCHHH--------------HhhhC----CC----CCC------------------H
Q 005760          452 KVI-S--SCSNEEFKALVLEYMPHGSLEK--------------YLHSS----NY----ILD------------------I  488 (678)
Q Consensus       452 ~~~-~--~~~~~~~~~lv~e~~~~~~L~~--------------~l~~~----~~----~~~------------------~  488 (678)
                      ... |  ..........++.++.+.....              .++..    ..    ...                  .
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            211 1  1122345566777766532210              00000    00    000                  0


Q ss_pred             HHHHHHHHHHHHHHHHHh-cCCCCCeEEcCCCCCCeeecCCCcEEEEeecccc
Q 005760          489 YQRLNIMIDVASALEYLH-FGYSAQVIHCDLKPSNVLLDDNMVAHLSDFGIAK  540 (678)
Q Consensus       489 ~~~~~i~~~i~~~l~~LH-~~~~~~ivH~dl~~~Nill~~~~~~kl~Dfg~~~  540 (678)
                      ......+..+...+...+ .....|++|+|+.+.||+++.+...-+.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            011122222233333332 2335789999999999999988777899999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.13  E-value=0.0045  Score=62.08  Aligned_cols=73  Identities=19%  Similarity=0.203  Sum_probs=49.9

Q ss_pred             CccccCCCceeEEEEEeCC--------CcEEEEEEeecccCchhhhHHHHHHHHHhCC-CccceeeeeeeecCCeEEEEE
Q 005760          397 NNLIGRGSFGSVFKARLGD--------GMEVAMKVFNLQYGRVFKSFDVECEMMKSIR-HRNIIKVISSCSNEEFKALVL  467 (678)
Q Consensus       397 ~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  467 (678)
                      ++.|+.|-.-.+|++..++        ...|++++...  ........+|..+++.+. +.-..++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3578889999999998643        35677777652  222345567888888875 3334577777754    4899


Q ss_pred             EecCCCCH
Q 005760          468 EYMPHGSL  475 (678)
Q Consensus       468 e~~~~~~L  475 (678)
                      ||++|.++
T Consensus       121 efi~g~~l  128 (395)
T d1nw1a_         121 EYIPSRPL  128 (395)
T ss_dssp             CCCCEEEC
T ss_pred             EEeccccC
Confidence            99987543